<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34623788</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>385</Volume><Issue>22</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults.</ArticleTitle><Pagination><StartPage>2025</StartPage><EndPage>2035</EndPage><MedlinePgn>2025-2035</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa2113514</ELocationID><Abstract><AbstractText Label="BACKGROUND">The effects of spinal anesthesia as compared with general anesthesia on the ability to walk in older adults undergoing surgery for hip fracture have not been well studied.</AbstractText><AbstractText Label="METHODS">We conducted a pragmatic, randomized superiority trial to evaluate spinal anesthesia as compared with general anesthesia in previously ambulatory patients 50 years of age or older who were undergoing surgery for hip fracture at 46 U.S. and Canadian hospitals. Patients were randomly assigned in a 1:1 ratio to receive spinal or general anesthesia. The primary outcome was a composite of death or an inability to walk approximately 10 ft (3 m) independently or with a walker or cane at 60 days after randomization. Secondary outcomes included death within 60 days, delirium, time to discharge, and ambulation at 60 days.</AbstractText><AbstractText Label="RESULTS">A total of 1600 patients were enrolled; 795 were assigned to receive spinal anesthesia and 805 to receive general anesthesia. The mean age was 78 years, and 67.0% of the patients were women. A total of 666 patients (83.8%) assigned to spinal anesthesia and 769 patients (95.5%) assigned to general anesthesia received their assigned anesthesia. Among patients in the modified intention-to-treat population for whom data were available, the composite primary outcome occurred in 132 of 712 patients (18.5%) in the spinal anesthesia group and 132 of 733 (18.0%) in the general anesthesia group (relative risk, 1.03; 95% confidence interval [CI], 0.84 to 1.27; P&#x2009;=&#x2009;0.83). An inability to walk independently at 60 days was reported in 104 of 684 patients (15.2%) and 101 of 702 patients (14.4%), respectively (relative risk, 1.06; 95% CI, 0.82 to 1.36), and death within 60 days occurred in 30 of 768 (3.9%) and 32 of 784 (4.1%), respectively (relative risk, 0.97; 95% CI, 0.59 to 1.57). Delirium occurred in 130 of 633 patients (20.5%) in the spinal anesthesia group and in 124 of 629 (19.7%) in the general anesthesia group (relative risk, 1.04; 95% CI, 0.84 to 1.30).</AbstractText><AbstractText Label="CONCLUSIONS">Spinal anesthesia for hip-fracture surgery in older adults was not superior to general anesthesia with respect to survival and recovery of ambulation at 60 days. The incidence of postoperative delirium was similar with the two types of anesthesia. (Funded by the Patient-Centered Outcomes Research Institute; REGAIN ClinicalTrials.gov number, NCT02507505.).</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Massachusetts Medical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carson</LastName><ForeName>Jeffrey L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaskins</LastName><ForeName>Lakisha J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dillane</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sieber</LastName><ForeName>Frederick</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magaziner</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcantonio</LastName><ForeName>Edward R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Samir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menio</LastName><ForeName>Diane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Trevor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papp</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwenk</LastName><ForeName>Eric S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkassabany</LastName><ForeName>Nabil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaffe</LastName><ForeName>J Douglas</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luke</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Balram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azim</LastName><ForeName>Syed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hymes</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Ki-Jinn</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheppard</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perlman</LastName><ForeName>Barry</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sappenfield</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauck</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoeft</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giska</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranganath</LastName><ForeName>Yatish</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6106-4687</Identifier><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedore</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinlei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwofie</LastName><ForeName>M Kwesi</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nader</LastName><ForeName>Antoun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Brian F S</ForeName><Initials>BFS</Initials><Identifier Source="ORCID">0000-0002-6279-9757</Identifier><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlassakov</LastName><ForeName>Kamen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kates</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dattilo</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tierney</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephens-Shields</LastName><ForeName>Alisa J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellenberg</LastName><ForeName>Susan S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology and Critical Care (M.D.N., L.J.G., N.E., L.A.F.), Biostatistics, Epidemiology, and Informatics (R.F., A.J.S.-S., S.S.E.), and Orthopedic Surgery (S.M.) and the Centers for Perioperative Outcomes Research and Transformation (M.D.N., L.J.G., N.E., L.A.F.) and Clinical Epidemiology and Biostatistics (R.F., J.D., A.T., A.J.S.-S., S.S.E.), University of Pennsylvania Perelman School of Medicine, the Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University (E.S.S.), the Center for Advocacy for the Rights and Interests of the Elderly (D.M.), and the Department of Anesthesiology, Lewis Katz School of Medicine at Temple University (E.H.), Philadelphia; the Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.); the Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton (D.D.), the Department of Orthopaedics, University of British Columbia, Vancouver (T.S.), the Division of Orthopaedics, Ottawa Hospital Civic Campus, Ottawa (S.P.), the Department of Anesthesiology and Pain Medicine, University of Toronto (K.-J.C.), and the Department of Anesthesia, Sunnybrook Health Sciences Centre (S.C.), Toronto, and the Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax NS (M.K.K.) - all in Canada; the Department of Outcomes Research, Cleveland Clinic, Cleveland (D.I.S., S. Ayad); the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions (F.S.), and the Department of Epidemiology and Public Health, University of Maryland School of Medicine (J.M.) - both in Baltimore; the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (E.R.M.), and the Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School (K.V.), Boston, and the Department of Anesthesiology, Lahey Hospital and Medical Center, Burlington (B.S.) - all in Massachusetts; the Department of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Langone Health (M.M.), and the Department of Anesthesiology, New York-Presbyterian/Weill Cornell Medical Center (T.T.), New York, and the Department of Anesthesiology, Stony Brook University, Stony Brook (S. Azim) - all in New York; the Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC (J.D.J.); the Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh (C.L.); the Department of Orthopedic Surgery, Inova Fairfax Medical Campus, Falls Church (R.A.H.), and the Department of Orthopedic Surgery, Virginia Commonwealth University, Richmond (S.K.) - both in Virginia; the Department of Anesthesiology, Hartford Hospital, Hartford (R.S.), and the Department of Anesthesiology, Yale University School of Medicine, New Haven (J.L.) - both in Connecticut; Division of Hospital Medicine, Oregon Health and Science University, Portland (B.P.); the Department of Anesthesiology, University of Florida College of Medicine, Gainesville (J.S.); the Department of Anesthesiology, University of Vermont Larner School of Medicine, Burlington, VT (M.A.H.); the Department of Anesthesiology, Pain Management, and Perioperative Medicine, Henry Ford Health System, Detroit (M.G.); the Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City (Y.R.); the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago (A.N.); Specialty of Anaesthetics, University of Sydney, Sydney (R.D.S.); and the Division of Multispecialty Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville (B.F.S.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>REGAIN Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02507505</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>1406-18876</GrantID><Acronym>PCORI</Acronym><Agency>Patient-Centered Outcomes Research Institute</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2021 Nov 25;385(22):2088-2089. doi: 10.1056/NEJMe2116017.</RefSource><PMID Version="1">34818484</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anaesth Crit Care Pain Med. 2022 Apr;41(2):101045. doi: 10.1016/j.accpm.2022.101045.</RefSource><PMID Version="1">35192948</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Feb 24;386(8):801. doi: 10.1056/NEJMc2119756.</RefSource><PMID Version="1">35196436</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Feb 24;386(8):801. doi: 10.1056/NEJMc2119756.</RefSource><PMID Version="1">35196437</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Feb 24;386(8):801-802. doi: 10.1056/NEJMc2119756.</RefSource><PMID Version="1">35196438</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Feb 24;386(8):802. doi: 10.1056/NEJMc2119756.</RefSource><PMID Version="1">35196439</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anaesthesist. 2022 May;71(5):400-402. doi: 10.1007/s00101-022-01104-z.</RefSource><PMID Version="1">35199183</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feng</LastName><ForeName>Rui</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carson</LastName><ForeName>Jeffrey L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaskins</LastName><ForeName>Lakisha J</ForeName><Initials>LJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dillane</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sieber</LastName><ForeName>Frederick</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magaziner</LastName><ForeName>Jay</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcantonio</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stone</LastName><ForeName>Trevor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papp</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwenk</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaffe</LastName><ForeName>J Douglas</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luke</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Balram</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azim</LastName><ForeName>Syed</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hymes</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chin</LastName><ForeName>Ki-Jinn</ForeName><Initials>KJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheppard</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perelman</LastName><ForeName>Barry</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sappenfield</LastName><ForeName>Joshua</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hauck</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoeft</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giska</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ranganath</LastName><ForeName>Yatish</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tedore</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choi</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Jinlei</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwofie</LastName><ForeName>M Kwesi</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nader</LastName><ForeName>Antoun</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanders</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allen</LastName><ForeName>Brian F S</ForeName><Initials>BFS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vlassakov</LastName><ForeName>Kamen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kates</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elkassabany</LastName><ForeName>Nabil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>Samir</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dattilo</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tierney</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menio</LastName><ForeName>Diane</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stephens-Shields</LastName><ForeName>Alisa J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellenberg</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Looke</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bent</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franco-Mora</LastName><ForeName>Ariana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hedrick</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newbern</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Health</LastName><ForeName>Advent</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tadros</LastName><ForeName>Rafik</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pealer</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buckley</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gavin</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorbatov</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gosnell</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steen</LastName><ForeName>Talora</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vafai</LastName><ForeName>Avery</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zeballos</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hruslinski</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cardenas</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berry</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Getchell</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quercetti</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hospital</LastName><ForeName>Christiana</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassan</LastName><ForeName>Manal</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bajracharya</LastName><ForeName>Gauasan</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Billow</LastName><ForeName>Damien</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bloomfield</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuko</LastName><ForeName>Evis</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elyaderani</LastName><ForeName>Mehrun K</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hampton</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Honar</LastName><ForeName>Hooman</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khoshknabi</LastName><ForeName>Dilara</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krahe</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lew</LastName><ForeName>Michael M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maheshwer</LastName><ForeName>Conjeevram B</ForeName><Initials>CB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niazi</LastName><ForeName>Azfar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saha</LastName><ForeName>Partha</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salih</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Swart</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volio</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bolkus</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeAngelis</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dodson</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerritsen</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McEniry</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitrev</LastName><ForeName>Ludmil</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belliveau</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonazza</LastName><ForeName>Flynn</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Vera</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panek</LastName><ForeName>Izabela</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dabiri</LastName><ForeName>Jared</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chavez</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craig</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davidson</LastName><ForeName>Todd</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dietrichs</LastName><ForeName>Chad</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleetwood</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foley</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Getto</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hailes</LastName><ForeName>Susie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hermes</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hooper</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koener</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kohls</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Law</LastName><ForeName>Leslie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lipp</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Losey</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelson</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nieto</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rogers</LastName><ForeName>Pam</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rutman</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scales</LastName><ForeName>Garrett</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sebastian</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stanciu</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lobel</LastName><ForeName>Gregg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giampiccolo</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herman</LastName><ForeName>Dara</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaufman</LastName><ForeName>Margit</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Bryan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pau</LastName><ForeName>Clara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Puzio</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veselsky</LastName><ForeName>Marlene</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Apostle</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boyer</LastName><ForeName>Dory</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fan</LastName><ForeName>Brenda Chen</ForeName><Initials>BC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lemke</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merchant</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moola</LastName><ForeName>Farhad</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Payne</LastName><ForeName>Kyrsten</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perey</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viskontas</LastName><ForeName>Darius</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poler</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Antonio</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Amer</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fish-Fuhrmann</LastName><ForeName>Jamie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hospital</LastName><ForeName>Hartford</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fidkowski</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guthrie</LastName><ForeName>Stuart Trent</ForeName><Initials>ST</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hakeos</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayes</LastName><ForeName>Lillian</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoegler</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nowak</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beck</LastName><ForeName>Jeffery</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuff</LastName><ForeName>Jaslynn</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaski</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haaser</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holzman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malekzadeh</LastName><ForeName>A Stephen</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramsey</LastName><ForeName>Lolita</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schulman</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartzbach</LastName><ForeName>Cary</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azefor</LastName><ForeName>Tangwan</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davani</LastName><ForeName>Arman</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaberi</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masear</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haider</LastName><ForeName>Syed Basit</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chungu</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ebrahimi</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fikry</LastName><ForeName>Karim</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcantonio</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shelvan</LastName><ForeName>Anitha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanders</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clarke</LastName><ForeName>Collin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawendy</LastName><ForeName>Abdel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Gary</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Mohit</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caruci</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Commeh</LastName><ForeName>Ekow</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuevas</LastName><ForeName>Randy</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuff</LastName><ForeName>Germaine</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franco</LastName><ForeName>Lola</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Furgiuele</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giuca</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barzideh</LastName><ForeName>Omid</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cossaro</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Arduini</LastName><ForeName>Armando</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farhi</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gould</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kafel</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Anuj</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peller</LastName><ForeName>Abraham</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reshef</LastName><ForeName>Hadas</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Safur</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toscano</LastName><ForeName>Fiore</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akerman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brumberger</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>Sunday</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Friedlander</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jegarl</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lane</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyden</LastName><ForeName>John P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>Nili</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murrell</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Painter</LastName><ForeName>Nathan</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ricci</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sbrollini</LastName><ForeName>Kaitlyn</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rahul</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steel</LastName><ForeName>Peter A D</ForeName><Initials>PAD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steinkamp</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Roniel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wellman</LastName><ForeName>David Stephenson</ForeName><Initials>DS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fitzgerald</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritz</LastName><ForeName>Michaela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bryson</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craig</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farhat</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gammon</LastName><ForeName>Braden</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gofton</LastName><ForeName>Wade</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lalonde</LastName><ForeName>Karl</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liew</LastName><ForeName>Allan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meulenkamp</LastName><ForeName>Bradley</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sonnenburg</LastName><ForeName>Kendra</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wai</LastName><ForeName>Eugene</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilkin</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hospital</LastName><ForeName>Ottawa</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Troxell</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alderfer</LastName><ForeName>Mary Ellen</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brannen</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cupitt</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerhart</LastName><ForeName>Stacy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McLin</LastName><ForeName>Renee</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheidy</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yurick</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hospital</LastName><ForeName>Reading</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Fei</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dragert</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiss</LastName><ForeName>Geza</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malveaux</LastName><ForeName>Halina</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCloskey</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mellender</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mungekar</LastName><ForeName>Sagar S</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noveck</LastName><ForeName>Helaine</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sagebien</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biby</LastName><ForeName>Luat</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKelvy</LastName><ForeName>Gail</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abola</LastName><ForeName>Ramon</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayala</LastName><ForeName>Brittney</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Halper</LastName><ForeName>Darcy</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mavarez</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rizwan</LastName><ForeName>Sabeen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Awad</LastName><ForeName>Imad</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flynn</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henry</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jenkinson</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaustov</LastName><ForeName>Lilia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lappin</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McHardy</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Amara</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donnelly</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Meera</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haydel</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Livelsberger</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pazionis</LastName><ForeName>Theresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slattery</LastName><ForeName>Bridget</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vazquez-Trejo</LastName><ForeName>Maritza</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baratta</LastName><ForeName>Jaime</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cirullo</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deiling</LastName><ForeName>Brittany</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deschamps</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glick</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Katz</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krieg</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lessin</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mojica</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torjman</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jin</LastName><ForeName>Rongyu</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salpeter</LastName><ForeName>Mary Jane</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Powell</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simmons</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawson</LastName><ForeName>Prentiss</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kukreja</LastName><ForeName>Promil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graves</LastName><ForeName>Shanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sturdivant</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bryant</LastName><ForeName>Ayesha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crump</LastName><ForeName>Sandra Joyce</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verrier</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menon</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Applegate</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arias</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pineiro</LastName><ForeName>Natasha</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uppington</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wolinsky</LastName><ForeName>Phillip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gunnett</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hagen</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hollen</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holloway</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horodyski</LastName><ForeName>Mary Beth</ForeName><Initials>MB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pogue</LastName><ForeName>Trevor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramani</LastName><ForeName>Ramachandran</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Cameron</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woods</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warrick</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flynn</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mongan</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernholz</LastName><ForeName>Sean</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ingersoll-Weng</LastName><ForeName>Esperanza</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marian</LastName><ForeName>Anil</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seering</LastName><ForeName>Melinda</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sibenaller</LastName><ForeName>Zita</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stout</LastName><ForeName>Lori</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wagner</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walter</LastName><ForeName>Alicia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orwig</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Trina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dinh</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donegan</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horan</LastName><ForeName>Annamarie</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goud</LastName><ForeName>Maithri</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helker</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mezenghie</LastName><ForeName>Lydia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Brittany</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Preston</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartz</LastName><ForeName>J Sanford</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weber</LastName><ForeName>Ramona</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chelly</LastName><ForeName>Jacques E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goel</LastName><ForeName>Shiv</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goncz</LastName><ForeName>Wende</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kawabe</LastName><ForeName>Touichi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khetarpal</LastName><ForeName>Sharad</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monroe</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shick</LastName><ForeName>Vladislav</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Breidenstein</LastName><ForeName>Max</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dominick</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Friend</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathews</LastName><ForeName>Donald</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lennertz</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akere</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balweg</LastName><ForeName>Tyler</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bo</LastName><ForeName>Amber</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doro</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodspeed</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lang</LastName><ForeName>Gerald</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName><ForeName>Maggie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rettammel</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roth</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Marissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whiting</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>Tracie</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craven</LastName><ForeName>Debra</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McEvoy</LastName><ForeName>Matt</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turnbo</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morgan</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Willoughby</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weigel</LastName><ForeName>Wade</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Auyong</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fox</LastName><ForeName>Ellie</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welsh</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cusson</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dobson</LastName><ForeName>Sean</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edwards</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Lynette</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henshaw</LastName><ForeName>Daryl</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKinney</LastName><ForeName>Glen</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Segal</LastName><ForeName>B Scott</ForeName><Initials>BS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>VanEenenaam</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weller</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Treggiari</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akhtar</LastName><ForeName>Shamsuddin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blessing</LastName><ForeName>Marcelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Chanel</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kampp</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kunze</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carson</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papp</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perlman</LastName><ForeName>Barry</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chin</LastName><ForeName>Ki Jinn</ForeName><Initials>KJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allen</LastName><ForeName>Brian F S</ForeName><Initials>BFS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Rene&#xe9; H</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Alexander K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tosi</LastName><ForeName>Laura L</ForeName><Initials>LL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hymes</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Langlois</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oduwole</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rose</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34623788</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2113514</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31921329</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1749-7922</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>World journal of emergency surgery : WJES</Title><ISOAbbreviation>World J Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Perforated and bleeding peptic ulcer: WSES guidelines.</ArticleTitle><Pagination><StartPage>3</StartPage><MedlinePgn>3</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13017-019-0283-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Peptic ulcer disease is common with a lifetime prevalence in the general population of 5-10% and an incidence of 0.1-0.3% per year. Despite a sharp reduction in incidence and rates of hospital admission and mortality over the past 30&#x2009;years, complications are still encountered in 10-20% of these patients. Peptic ulcer disease remains a significant healthcare problem, which can consume considerable financial resources. Management may involve various subspecialties including surgeons, gastroenterologists, and radiologists. Successful management of patients with complicated peptic ulcer (CPU) involves prompt recognition, resuscitation when required, appropriate antibiotic therapy, and timely surgical/radiological treatment.</AbstractText><AbstractText Label="METHODS">The present guidelines have been developed according to the GRADE methodology. To create these guidelines, a panel of experts was designed and charged by the board of the WSES to perform a systematic review of the available literature and to provide evidence-based statements with immediate practical application. All the statements were presented and discussed during the 5th WSES Congress, and for each statement, a consensus among the WSES panel of experts was reached.</AbstractText><AbstractText Label="CONCLUSIONS">The population considered in these guidelines is adult patients with suspected complicated peptic ulcer disease. These guidelines present evidence-based international consensus statements on the management of complicated peptic ulcer from a collaboration of a panel of experts and are intended to improve the knowledge and the awareness of physicians around the world on this specific topic. We divided our work into the two main topics, bleeding and perforated peptic ulcer, and structured it into six main topics that cover the entire management process of patients with complicated peptic ulcer, from diagnosis at ED arrival to post-discharge antimicrobial therapy, to provide an up-to-date, easy-to-use tool that can help physicians and surgeons during the decision-making process.</AbstractText><CopyrightInformation>&#xa9; The Author(s). 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tarasconi</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6588-2268</Identifier><AffiliationInfo><Affiliation>1Emergency Surgery Department, Parma University Hospital, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coccolini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>2General, Emergency and Trauma Surgery Department, Pisa University Hospital, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biffl</LastName><ForeName>Walter L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>3Scripps Memorial Hospital La Jolla, La Jolla, CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomasoni</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>4General, Emergency and Trauma Surgery Department, Bufalini hospital, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansaloni</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>4General, Emergency and Trauma Surgery Department, Bufalini hospital, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picetti</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>5Department of Anesthesia and Intensive Care, Parma University Hospital, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molfino</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>6Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shelat</LastName><ForeName>Vishal</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>7Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cimbanassi</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>8General Surgery and Trauma Team, ASST Niguarda Milano, University of Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Dieter G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>9Royal Perth Hospital, Perth, Australia &amp; The University of Western Australia, Crawley, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Zidan</LastName><ForeName>Fikri M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>10Department of Surgery, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campanile</LastName><ForeName>Fabio C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Division of Surgery, ASL VT - Ospedale "Andosilla", Civita Castellana, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Saverio</LastName><ForeName>Salomone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>12Cambridge Colorectal Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiocchi</LastName><ForeName>Gian Luca</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>6Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casella</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>13Department of Molecular and Translational Medicine, Surgical Clinic, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Albury Hospital, Albury, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>15General, Acute Care, Abdominal Wall Reconstruction, and Trauma Surgery, Foothills Medical Centre, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leppaniemi</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>16Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Ernest E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>17Ernest E Moore Shock Trauma Center at Denver Health, Denver, CO USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peitzman</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>18University of Pittsburgh, School of Medicine, UPMC - Presbyterian, Pittsburgh, PA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraga</LastName><ForeName>Gustavo Pereira</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>19Division of Trauma Surgery, School of Medical Sciences, University of Campinas, Campinas, SP Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceresoli</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>20Department of General and Emergency Surgery, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Ronald V</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>21Department of Surgery, Harborview Medical Centre, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wani</LastName><ForeName>Imtaz</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>22Department of Surgery, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattonieri</LastName><ForeName>Vittoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>1Emergency Surgery Department, Parma University Hospital, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrone</LastName><ForeName>Gennaro</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>1Emergency Surgery Department, Parma University Hospital, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velmahos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>23Trauma, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugrue</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Letterkenny University Hospital, Donegal Clinical Research Academy Centre for Personalized Medicine, Donegal, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Macerata Hospital, Macerata, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluger</LastName><ForeName>Yoram</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>26Department of General Surgery, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catena</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>1Emergency Surgery Department, Parma University Hospital, Parma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Emerg Surg</MedlineTA><NlmUniqueID>101266603</NlmUniqueID><ISSNLinking>1749-7922</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010438" MajorTopicYN="N">Peptic Ulcer Hemorrhage</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010439" MajorTopicYN="N">Peptic Ulcer Perforation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiography</Keyword><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Embolization</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">High-risk patients</Keyword><Keyword MajorTopicYN="N">Intra-abdominal infection</Keyword><Keyword MajorTopicYN="N">Non-operative management</Keyword><Keyword MajorTopicYN="N">Pancreatitis</Keyword><Keyword MajorTopicYN="N">Peptic ulcer</Keyword><Keyword MajorTopicYN="N">Peritonitis</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Technique</Keyword><Keyword MajorTopicYN="N">Timing</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31921329</ArticleId><ArticleId IdType="pmc">PMC6947898</ArticleId><ArticleId IdType="doi">10.1186/s13017-019-0283-9</ArticleId><ArticleId IdType="pii">283</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390:613&#x2013;624. doi: 10.1016/S0140-6736(16)32404-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)32404-7</ArticleId><ArticleId IdType="pubmed">28242110</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmi H, Kautiainen H, Virta LJ, Farkkila N, Koskenpato J, Farkkila MA. Incidence and complications of peptic ulcer disease requiring hospitalisation have markedly decreased in Finland. Aliment Pharmacol Ther. 2014;39:496&#x2013;506. doi: 10.1111/apt.12620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.12620</ArticleId><ArticleId IdType="pubmed">24461085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, Ponce M, Quintero E, Perez-Aisa MA, Gisbert JP, Bujanda L, Castro M, Munoz M, Del-Pino MD, Garcia S, Calvet X. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther. 2011;33:585&#x2013;591. doi: 10.1111/j.1365-2036.2010.04563.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2010.04563.x</ArticleId><ArticleId IdType="pubmed">21205256</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow AH, Lim YY, Liew WC, Goh KL. Time trends in upper gastrointestinal diseases and Helicobacter pylori infection in a multiracial Asian population--a 20-year experience over three time periods. Aliment Pharmacol Ther. 2016;43:831&#x2013;837. doi: 10.1111/apt.13550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.13550</ArticleId><ArticleId IdType="pubmed">26847417</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenberg A. Time trends of ulcer mortality in non-European countries. Am J Gastroenterol. 2007;102:1101&#x2013;1107. doi: 10.1111/j.1572-0241.2007.01157.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2007.01157.x</ArticleId><ArticleId IdType="pubmed">17355419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenberg A. Time trends of ulcer mortality in Europe. Gastroenterology. 2007;132:2320&#x2013;2327. doi: 10.1053/j.gastro.2007.03.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2007.03.108</ArticleId><ArticleId IdType="pubmed">17570207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenberg A. Review article: historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther. 2013;38:329&#x2013;342. doi: 10.1111/apt.12380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.12380</ArticleId><ArticleId IdType="pubmed">23786250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavitt RT, Lipowska AM, Anyane-Yeboa A, Gralnek IM. Diagnosis and Treatment of Peptic Ulcer Disease. Am J Med. 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30611829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertleff MJ, Lange JF. Perforated peptic ulcer disease: a review of history and treatment. Dig Surg. 2010;27:161&#x2013;169. doi: 10.1159/000264653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000264653</ArticleId><ArticleId IdType="pubmed">20571260</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion. 2011;84:102&#x2013;113. doi: 10.1159/000323958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000323958</ArticleId><ArticleId IdType="pubmed">21494041</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;reide K, Thorsen K, Harrison EM, Bingener J, M&#xf8;ller MH, Ohene-Yeboah M, S&#xf8;reide JA. Perforated peptic ulcer. Lancet. 2015;386:1288&#x2013;1298. doi: 10.1016/S0140-6736(15)00276-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00276-7</ArticleId><ArticleId IdType="pmc">PMC4618390</ArticleId><ArticleId IdType="pubmed">26460663</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schunemann HJ, Group GW Going from evidence to recommendations. BMJ. 2008;336:1049&#x2013;1051. doi: 10.1136/bmj.39493.646875.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39493.646875.AE</ArticleId><ArticleId IdType="pmc">PMC2376019</ArticleId><ArticleId IdType="pubmed">18467413</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Soreide K, Thorsen K, Soreide JA. Strategies to improve the outcome of emergency surgery for perforated peptic ulcer. Br J Surg. 2014;101:e51&#x2013;e64. doi: 10.1002/bjs.9368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9368</ArticleId><ArticleId IdType="pubmed">24338777</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorsen K, Glomsaker TB, von Meer A, Soreide K, Soreide JA. Trends in diagnosis and surgical management of patients with perforated peptic ulcer. Gastrointest Surg. 2011;15:1329&#x2013;1335. doi: 10.1007/s11605-011-1482-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-011-1482-1</ArticleId><ArticleId IdType="pmc">PMC3145078</ArticleId><ArticleId IdType="pubmed">21567292</ArticleId></ArticleIdList></Reference><Reference><Citation>Suriya C, Kasatpibal N, Kunaviktikul W, Kayee T. Diagnostic indicators for peptic ulcer perforation at a tertiary care hospital in Thailand. Clin Exp Gastroenterol. 2011;4:283&#x2013;289. doi: 10.2147/CEG.S25501.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEG.S25501</ArticleId><ArticleId IdType="pmc">PMC3254206</ArticleId><ArticleId IdType="pubmed">22235172</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra AK, Fabian TC, Katsis SB, Gavant ML, Croce MA. Blunt Bowel and Mesenteric Injuries: The Role of Screening Computed Tomography. J Trauma. 2000;48:991&#x2013;1000. doi: 10.1097/00005373-200006000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-200006000-00001</ArticleId><ArticleId IdType="pubmed">10866242</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassi R, Romano S, Pinto A, Romano L. Gastro-duodenal perforations: conventional plain film, US and CT findings in 166 consecutive patients. Eur J Radiol. 2004;50:30&#x2013;36. doi: 10.1016/j.ejrad.2003.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2003.11.012</ArticleId><ArticleId IdType="pubmed">15093233</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung K-W, Chang M-S, Hsiao C-P, Huang J-F. CT evaluation of gastrointestinal tract perforation. Clinical Imaging. 2004;28:329&#x2013;333. doi: 10.1016/S0899-7071(03)00204-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0899-7071(03)00204-3</ArticleId><ArticleId IdType="pubmed">15471663</ArticleId></ArticleIdList></Reference><Reference><Citation>Soreide K, Thorsen K, Soreide JA. Predicting outcomes in patients with perforated gastroduodenal ulcers: artificial neural network modelling indicates a highly complex disease. Eur J Trauma Emerg Surg. 2015;41:91&#x2013;98. doi: 10.1007/s00068-014-0417-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00068-014-0417-4</ArticleId><ArticleId IdType="pmc">PMC4298653</ArticleId><ArticleId IdType="pubmed">25621078</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorsen K, Soreide JA, Soreide K. What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems. J Gastrointes Surg. 2014;18:1261&#x2013;1268. doi: 10.1007/s11605-014-2485-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-014-2485-5</ArticleId><ArticleId IdType="pmc">PMC4057623</ArticleId><ArticleId IdType="pubmed">24610235</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorsen K, Soreide JA, Soreide K. Scoring systems for outcome prediction in patients with perforated peptic ulcer. Scand J Trauma Resusc Emerg Med. 2013;21:25. doi: 10.1186/1757-7241-21-25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1757-7241-21-25</ArticleId><ArticleId IdType="pmc">PMC3626602</ArticleId><ArticleId IdType="pubmed">23574922</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross JT, Matthay MA, Harris HW. Secondary peritonitis: principles of diagnosis and intervention. BMJ. 2018;361:k1407. doi: 10.1136/bmj.k1407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k1407</ArticleId><ArticleId IdType="pmc">PMC6889898</ArticleId><ArticleId IdType="pubmed">29914871</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Kluger Y, Ansaloni L, Hardcastle TC, Rello J, Watkins RR, Bassetti M, Giamarellou E, Coccolini F, Abu-Zidan FM, Adesunkanmi AK, Augustin G, Baiocchi GL, Bala M, Baraket O, Beltran MA, Jusoh AC, Demetrashvili Z, De Simone B, de Souza HP, Cui Y, Davies RJ, Dhingra S, Diaz JJ, Di Saverio S, Dogjani A, Elmangory MM, Enani MA, Ferrada P, Fraga GP, Frattima S, Ghnnam W, Gomes CA, Kanj SS, Karamarkovic A, Kenig J, Khamis F, Khokha V, Koike K, KYY K, Isik A, Labricciosa FM, Latifi R, Lee JG, Litvin A, Machain GM, Manzano-Nunez R, Major P, Marwah S, McFarlane M, Memish ZA, Mesina C, Moore EE, Moore FA, Naidoo N, Negoi I, Ofori-Asenso R, Olaoye I, Ordonez CA, Ouadii M, Paolillo C, Picetti E, Pintar T, Ponce-de-Leon A, Pupelis G, Reis T, Sakakushev B, Kafil HS, Sato N, Shah JN, Siribumrungwong B, Talving P, Trana C, Ulrych J, Yuan KC, Catena F. Raising concerns about the Sepsis-3 definitions. World J Emerg Surg. 2018;13:6. doi: 10.1186/s13017-018-0165-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-018-0165-6</ArticleId><ArticleId IdType="pmc">PMC5784683</ArticleId><ArticleId IdType="pubmed">29416555</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, Lemeshow S, Osborn T, Terry KM, Levy MM. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med. 2017;376:2235&#x2013;2244. doi: 10.1056/NEJMoa1703058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1703058</ArticleId><ArticleId IdType="pmc">PMC5538258</ArticleId><ArticleId IdType="pubmed">28528569</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75&#x2013;87. doi: 10.1016/S0140-6736(18)30696-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30696-2</ArticleId><ArticleId IdType="pubmed">29937192</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, Deutschman CS, Escobar GJ, Angus DC. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:762&#x2013;774. doi: 10.1001/jama.2016.0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0288</ArticleId><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Askim A, Moser F, Gustad LT, Stene H, Gundersen M, Asvold BO, Dale J, Bjornsen LP, Damas JK, Solligard E. Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality - a prospective study of patients admitted with infection to the emergency department. Scand J Trauma Resusc Emerg Med. 2017;25:56. doi: 10.1186/s13049-017-0399-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13049-017-0399-4</ArticleId><ArticleId IdType="pmc">PMC5466747</ArticleId><ArticleId IdType="pubmed">28599661</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis EJ, Tsaganos T, Tsangaris I, Lada M, Routsi C, Sinapidis D, Koupetori M, Bristianou M, Adamis G, Mandragos K, Dalekos GN, Kritselis I, Giannikopoulos G, Koutelidakis I, Pavlaki M, Antoniadou E, Vlachogiannis G, Koulouras V, Prekates A, Dimopoulos G, Koutsoukou A, Pnevmatikos I, Ioakeimidou A, Kotanidou A, Orfanos SE, Armaganidis A, Gogos C, Hellenic Sepsis Study G Validation of the new Sepsis-3 definitions: proposal for improvement in early risk identification. Clin Microbiol Infect. 2017;23:104&#x2013;109. doi: 10.1016/j.cmi.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2016.11.003</ArticleId><ArticleId IdType="pubmed">27856268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusgul S, Carron PN, Yersin B, Calandra T, Dami F. Low sensitivity of qSOFA, SIRS criteria and sepsis definition to identify infected patients at risk of complication in the prehospital setting and at the emergency department triage. Scand J Trauma Resusc Emerg Med. 2017;25:108. doi: 10.1186/s13049-017-0449-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13049-017-0449-y</ArticleId><ArticleId IdType="pmc">PMC5670696</ArticleId><ArticleId IdType="pubmed">29100549</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams JM, Greenslade JH, McKenzie JV, Chu K, Brown AFT, Lipman J. Systemic Inflammatory Response Syndrome, Quick Sequential Organ Function Assessment, and Organ Dysfunction: Insights From a Prospective Database of ED Patients With Infection. Chest. 2017;151:586&#x2013;596. doi: 10.1016/j.chest.2016.10.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.10.057</ArticleId><ArticleId IdType="pubmed">27876592</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Chichom-Mefire A, Labricciosa FM, Hardcastle T, Abu-Zidan FM, Adesunkanmi AK, Ansaloni L, Bala M, Balogh ZJ, Beltr&#xe1;n MA, Ben-Ishay O, Biffl WL, Birindelli A, Cainzos MA, Catalini G, Ceresoli M, Che Jusoh A, Chiara O, Coccolini F, Coimbra R, Cortese F, Demetrashvili Z, Di Saverio S, Diaz JJ, Egiev VN, Ferrada P, Fraga GP, Ghnnam WM, Lee JG, Gomes CA, Hecker A, Herzog T, Kim JI, Inaba K, Isik A, Karamarkovic A, Kashuk J, Khokha V, Kirkpatrick AW, Kluger Y, Koike K, Kong VY, Leppaniemi A, Machain GM, Maier RV, Marwah S, McFarlane ME, Montori G, Moore EE, Negoi I, Olaoye I, Omari AH, Ordonez CA, Pereira BM, Pereira J&#xfa;nior GA, Pupelis G, Reis T, Sakakushev B, Sato N, Segovia Lohse HA, Shelat VG, S&#xf8;reide K, Uhl W, Ulrych J, Van Goor H, Velmahos GC, Yuan K-C, Wani I, Weber DG, Zachariah SK, Catena F. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2017:12.</Citation></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, LA MI, AS ML, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45:486&#x2013;552. doi: 10.1097/CCM.0000000000002255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002255</ArticleId><ArticleId IdType="pubmed">28098591</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan AJ, Berne TV, Donovan JA. Perforated Duodenal Ulcer. Arch Surg. 1998;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">9820345</ArticleId></ArticleIdList></Reference><Reference><Citation>Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK. A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med. 1989;320:970&#x2013;973. doi: 10.1056/NEJM198904133201504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198904133201504</ArticleId><ArticleId IdType="pubmed">2927479</ArticleId></ArticleIdList></Reference><Reference><Citation>Songne B, Jean F, Foulatier O, Khalil H, Scotte M. Non operative treatment for perforated peptic ulcer: results of a prospective study. Ann Chir. 2004;129:578&#x2013;582. doi: 10.1016/j.anchir.2004.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anchir.2004.06.012</ArticleId><ArticleId IdType="pubmed">15581818</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung KT, Shelat VG. Perforated peptic ulcer - an update. World J Gastrointest Surg. 2017;9:1&#x2013;12. doi: 10.4240/wjgs.v9.i1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.4240/wjgs.v9.i1.1</ArticleId><ArticleId IdType="pmc">PMC5237817</ArticleId><ArticleId IdType="pubmed">28138363</ArticleId></ArticleIdList></Reference><Reference><Citation>Surapaneni S, S R, Reddy AV. The Perforation-Operation time Interval; An Important Mortality Indicator in Peptic Ulcer Perforation. J Clin Diagn Res. 2013;7:880&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3681060</ArticleId><ArticleId IdType="pubmed">23814733</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck DL, Vester-Andersen M, Moller MH. Danish Clinical Register of Emergency S. Surgical delay is a critical determinant of survival in perforated peptic ulcer. Br J Surg. 2013;100:1045&#x2013;1049. doi: 10.1002/bjs.9175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9175</ArticleId><ArticleId IdType="pubmed">23754645</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsinelos P, Beltsis A, Paroutoglou G, Galanis I, Tsolkas P, Mimidis K, Pilpilidis I, Baltagiannis S, Kamberis E, Papaziogas B. Endoclipping for Gastric Perforation After Endoscopic Polypectomy: An Alternative Treatment to Avoid Surgery. Surg Laparosc Endosc Percutan Tech. 2004:279&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">15492658</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi MA, Gadhire M, Paranjpe AA. Treatment of duodenal peptic ulcer perforation by endoscopic clips: A novel approach. J Dig Endosc. 2017;8:24. doi: 10.4103/jde.jde_69_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jde.jde_69_16</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkov IS, Zaynutdinov AM, Veliyev NA, Tagirov MR, Merrell RC. Laparoscopic and endoscopic management of perforated duodenal ulcers. J Am Coll Surg. 2004;198:352&#x2013;355. doi: 10.1016/j.jamcollsurg.2003.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2003.10.015</ArticleId><ArticleId IdType="pubmed">14992735</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado-Aparicio HA, Moreno-Portillo M. Multimedia article: management of duodenal ulcer perforation with combined laparoscopic and endoscopic methods. Surg Endosc. 2004;18:1394. doi: 10.1007/s00464-004-8142-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-004-8142-4</ArticleId><ArticleId IdType="pubmed">15803242</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergstrom M, Arroyo Vazquez JA, Park PO. Self-expandable metal stents as a new treatment option for perforated duodenal ulcer. Endoscopy. 2013;45:222&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">23208777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunevicius R, Morkevicius M. Risk factors influencing the early outcome results after laparoscopic repair of perforated duodenal ulcer and their predictive value. Langenbecks Arch Surg. 2005;390:413&#x2013;420. doi: 10.1007/s00423-005-0569-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-005-0569-0</ArticleId><ArticleId IdType="pubmed">16041553</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivaram P, Sreekumar A. Preoperative factors influencing mortality and morbidity in peptic ulcer perforation. Eur J Trauma Emerg Surg. 2018;44:251&#x2013;257. doi: 10.1007/s00068-017-0777-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00068-017-0777-7</ArticleId><ArticleId IdType="pubmed">28258286</ArticleId></ArticleIdList></Reference><Reference><Citation>Moller MH, Adamsen S, Thomsen RW, Moller AM. Preoperative prognostic factors for mortality in peptic ulcer perforation: a systematic review. Scand J Gastroenterol. 2010;45:785&#x2013;805. doi: 10.3109/00365521003783320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365521003783320</ArticleId><ArticleId IdType="pubmed">20384526</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirocchi R, Soreide K, Di Saverio S, Rossi E, Arezzo A, Zago M, Abraha I, Vettoretto N, Chiarugi M. Meta-analysis of perioperative outcomes of acute laparoscopic vs open repair of perforated gastroduodenal ulcers. J Trauma Acute Care Surg. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">29659470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma KC, Brandstetter RD, Brensilver JM, Jung LD. Cardiopulmonary Physiology and Pathophysiology as a Consequence Of Laparoscopic Surgery. Chest. 1996;110:810&#x2013;815. doi: 10.1378/chest.110.3.810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.110.3.810</ArticleId><ArticleId IdType="pubmed">8797429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee FY, Leung KL, Lai PB, Lau JW. Selection of patients for laparoscopic repair of perforated peptic ulcer. Br J Surg. 2001;88:133&#x2013;136. doi: 10.1046/j.1365-2168.2001.01642.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2168.2001.01642.x</ArticleId><ArticleId IdType="pubmed">11136326</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YC, Hsieh CH, Lo HC, Su LT. Sutureless onlay omental patch for the laparoscopic repair of perforated peptic ulcers. World J Surg. 2014;38:1917&#x2013;1921. doi: 10.1007/s00268-014-2503-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-014-2503-5</ArticleId><ArticleId IdType="pubmed">24663480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin BC, Liao CH, Wang SY, Hwang TL. Laparoscopic repair of perforated peptic ulcer: simple closure versus omentopexy. J Surg Res. 2017;220:341&#x2013;345. doi: 10.1016/j.jss.2017.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2017.07.034</ArticleId><ArticleId IdType="pubmed">29180201</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd Ellatif ME, Salama AF, Elezaby AF, El-Kaffas HF, Hassan A, Magdy A, Abdallah E, El-Morsy G. Laparoscopic repair of perforated peptic ulcer: patch versus simple closure. Int J Surg. 2013;11:948&#x2013;951. doi: 10.1016/j.ijsu.2013.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2013.06.014</ArticleId><ArticleId IdType="pubmed">23806652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo HC, Wu SC, Huang HC, Yeh CC, Huang JC, Hsieh CH. Laparoscopic simple closure alone is adequate for low risk patients with perforated peptic ulcer. World J Surg. 2011;35:1873&#x2013;1878. doi: 10.1007/s00268-011-1106-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-011-1106-7</ArticleId><ArticleId IdType="pubmed">21533964</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcus F, Beuran M, Lica I, Turculet C, Cotarlet AV, Georgescu S, Vintila D, Sabau D, Sabau A, Ciuce C, Bintintan V, Georgescu E, Popescu R, Tarta C, Surlin V. Laparoscopic Repair for Perforated Peptic Ulcer: A Retrospective Study. World J Surg. 2017;41:948&#x2013;953. doi: 10.1007/s00268-016-3821-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-016-3821-6</ArticleId><ArticleId IdType="pubmed">27882415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ates M, Sevil S, Bakircioglu E, Colak C. Laparoscopic repair of peptic ulcer perforation without omental patch versus conventional open repair. J Laparoendosc Adv Surg Tech A. 2007;17:615&#x2013;619. doi: 10.1089/lap.2006.0195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2006.0195</ArticleId><ArticleId IdType="pubmed">17907974</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Kaushik R, Sharma R, Attri A. The management of large perforations of duodenal ulcers. BMC Surg. 2005;5:15. doi: 10.1186/1471-2482-5-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2482-5-15</ArticleId><ArticleId IdType="pmc">PMC1173121</ArticleId><ArticleId IdType="pubmed">15978134</ArticleId></ArticleIdList></Reference><Reference><Citation>Siow SL, Mahendran HA. Laparoscopic repair of perforated peptic ulcers: the sutured omental patch and focused sequential lavage technique. Surg Laparosc Endosc Percutan Tech. 2014;24:134&#x2013;139. doi: 10.1097/SLE.0b013e31828fa951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLE.0b013e31828fa951</ArticleId><ArticleId IdType="pubmed">24686348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Khan HM, Hasanrabba S. Treatment of perforated giant gastric ulcer in an emergency setting. World J Gastrointest Surg. 2014;6:5&#x2013;8. doi: 10.4240/wjgs.v6.i1.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.4240/wjgs.v6.i1.5</ArticleId><ArticleId IdType="pmc">PMC3951808</ArticleId><ArticleId IdType="pubmed">24627735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ergul E, Gozetlik EO. Emergency spontaneous gastric perforations: ulcus versus cancer. Langenbecks Arch Surg. 2009;394:643&#x2013;646. doi: 10.1007/s00423-008-0331-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-008-0331-5</ArticleId><ArticleId IdType="pubmed">18418626</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Saverio S, Segalini E, Birindelli A, Todero S, Podda M, Rizzuto A, Tugnoli G, Biondi A. Pancreas-sparing, ampulla-preserving duodenectomy for major duodenal (D1-D2) perforations. Br J Surg. 2018;105:1487&#x2013;1492. doi: 10.1002/bjs.10910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10910</ArticleId><ArticleId IdType="pubmed">30024637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansaloni L, Ceresoli M, Fugazzola P, Tomasoni M, Palamara F, Sartelli M, Catena F, Montori G, Raimondo S, Coccolini F. An innovative duodenal perforation surgical repair technique: the BIOPATCH technique. Journal of Peritoneum (and other serosal surfaces) 2018.</Citation></Reference><Reference><Citation>Jani Kalpesh, Saxena A K., Vaghasia Rasik. Omental Plugging for Large-sized Duodenal Peptic Perforations: A Prospective Randomized Study of 100 Patients. Southern Medical Journal. 2006;99(5):467&#x2013;471. doi: 10.1097/01.smj.0000203814.87306.cd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.smj.0000203814.87306.cd</ArticleId><ArticleId IdType="pubmed">16711308</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Saverio S, Bassi M, Smerieri N, Masetti M, Ferrara F, Fabbri C, Ansaloni L, Ghersi S, Serenari M, Coccolini F, Naidoo N, Sartelli M, Tugnoli G, Catena F, Cennamo V, Jovine E. Diagnosis and treatment of perforated or bleeding peptic ulcers: 2013 WSES position paper. World J Emerg Surg 2014;9:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4127969</ArticleId><ArticleId IdType="pubmed">25114715</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccolini F, Montori G, Ceresoli M, Catena F, Moore EE, Ivatury R, Biffl W, Peitzman A, Coimbra R, Rizoli S, Kluger Y, Abu-Zidan FM, Sartelli M, De Moya M, Velmahos G, Fraga GP, Pereira BM, Leppaniemi A, Boermeester MA, Kirkpatrick AW, Maier R, Bala M, Sakakushev B, Khokha V, Malbrain M, Agnoletti V, Martin-Loeches I, Sugrue M, Di Saverio S, Griffiths E, Soreide K, Mazuski JE, May AK, Montravers P, Melotti RM, Pisano M, Salvetti F, Marchesi G, Valetti TM, Scalea T, Chiara O, Kashuk JL, Ansaloni L. The role of open abdomen in non-trauma patient: WSES Consensus Paper. World J Emerg Surg. 2017;12:39. doi: 10.1186/s13017-017-0146-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-017-0146-1</ArticleId><ArticleId IdType="pmc">PMC5557069</ArticleId><ArticleId IdType="pubmed">28814969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick AW, Coccolini F, Ansaloni L, Roberts DJ, Tolonen M, McKee JL, Leppaniemi A, Faris P, Doig CJ, Catena F, Fabian T, Jenne CN, Chiara O, Kubes P, Manns B, Kluger Y, Fraga GP, Pereira BM, Diaz JJ, Sugrue M, Moore EE, Ren J, Ball CG, Coimbra R, Balogh ZJ, Abu-Zidan FM, Dixon E, Biffl W, MacLean A, Ball I, Drover J, McBeth PB, Posadas-Calleja JG, Parry NG, Di Saverio S, Ordonez CA, Xiao J, Sartelli M. Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial. World J Emerg Surg 2018;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015449</ArticleId><ArticleId IdType="pubmed">29977328</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolonen M, Coccolini F, Ansaloni L, Sartelli M, Roberts DJ, JL MK, Leppaniemi A, Doig CJ, Catena F, Fabian T, Jenne CN, Chiara O, Kubes P, Kluger Y, Fraga GP, Pereira BM, Diaz JJ, Sugrue M, Moore EE, Ren J, Ball CG, Coimbra R, Dixon E, Biffl W, MacLean A, PB MB, Posadas-Calleja JG, Di Saverio S, Xiao J, Kirkpatrick AW. From the Closed Or Open after Laparotomy for Source Control in Severe Complicated Intra-Abdominal Sepsis I. Getting the invite list right: a discussion of sepsis severity scoring systems in severe complicated intra-abdominal sepsis and randomized trial inclusion criteria. World J Emerg Surg. 2018;13:17. doi: 10.1186/s13017-018-0177-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-018-0177-2</ArticleId><ArticleId IdType="pmc">PMC5889572</ArticleId><ArticleId IdType="pubmed">29636790</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig CJ, Page SA, McKee JL, Moore EE, Abu-Zidan FM, Carroll R, Marshall JC, Faris PD, Tolonen M, Catena F, Cocolini F, Sartelli M, Ansaloni L, Minor SF, Peirera BM, Diaz JJ, Kirkpatrick AW. Ethical considerations in conducting surgical research in severe complicated intra-abdominal sepsis. World J Emerg Surg. 2019;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6683332</ArticleId><ArticleId IdType="pubmed">31404221</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Catena F, Di Saverio S, Ansaloni L, Malangoni M, Moore EE, Moore FA, Ivatury R, Coimbra R, Leppaniemi A, Biffl W, Kluger Y, Fraga GP, Ordonez CA, Marwah S, Gerych I, Lee JG, Trana C, Coccolini F, Corradetti F, Kirkby-Bott J. Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg. 2014;9:22. doi: 10.1186/1749-7922-9-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-7922-9-22</ArticleId><ArticleId IdType="pmc">PMC3986828</ArticleId><ArticleId IdType="pubmed">24674057</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan YS, Hsu HP, Hsieh YH, Sy ED, Lee JC, Lin PW. Significance of intraoperative peritoneal culture of fungus in perforated peptic ulcer. Br J Surg. 2003;90:1215&#x2013;1219. doi: 10.1002/bjs.4267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.4267</ArticleId><ArticleId IdType="pubmed">14515289</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash A, Sharma D, Saxena A, Somashekar U, Khare N, Mishra A, Anvikar A. Effect of Candida infection on outcome in patients with perforation peritonitis. Indian J Gastroenterol. 2008;27:107&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">18787280</ArticleId></ArticleIdList></Reference><Reference><Citation>Li WS, Lee CH, Liu JW. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid. J Microbiol Immunol Infect. 2017;50:370&#x2013;376. doi: 10.1016/j.jmii.2015.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2015.07.004</ArticleId><ArticleId IdType="pubmed">26321461</ArticleId></ArticleIdList></Reference><Reference><Citation>Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O. AmarCand study g. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect. 2011;17:1061&#x2013;1067. doi: 10.1111/j.1469-0691.2010.03360.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2010.03360.x</ArticleId><ArticleId IdType="pubmed">20825438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133&#x2013;164. doi: 10.1086/649554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/649554</ArticleId><ArticleId IdType="pubmed">20034345</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell LL, Wilson SE. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Surg Infect (Larchmt) 2000;1:57&#x2013;63. doi: 10.1089/109629600321308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/109629600321308</ArticleId><ArticleId IdType="pubmed">12594910</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Weber DG, Rupp&#xe9; E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent J-L, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltr&#xe1;n MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzm&#xe1;n-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong S-K, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, KYY K, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre P-F, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira J&#xfa;nior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakhushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit J-F, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan K-C, Zachariah SK, Zahar J-R, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4946132</ArticleId><ArticleId IdType="pubmed">27429642</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, Cook CH, O&#x2019;Neill PJ, Mazuski JE, Askari R, Wilson MA, Napolitano LM, Namias N, Miller PR, Dellinger EP, Watson CM, Coimbra R, Dent DL, Lowry SF, Cocanour CS, West MA, Banton KL, Cheadle WG, Lipsett PA, Guidry CA, Popovsky K. Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection. New England J Med. 2015;372:1996&#x2013;2005. doi: 10.1056/NEJMoa1411162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1411162</ArticleId><ArticleId IdType="pmc">PMC4469182</ArticleId><ArticleId IdType="pubmed">25992746</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro HA, Mavrakis A, Mylonakis E. Candida peritonitis: an update on the latest research and treatments. World J Surg. 2011;35:2650&#x2013;2659. doi: 10.1007/s00268-011-1305-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-011-1305-2</ArticleId><ArticleId IdType="pubmed">21976010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourkoumpetis TK, Velmahos GC, Ziakas PD, Tampakakis E, Manolakaki D, Coleman JJ, Mylonakis E. The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients. Mycopathologia. 2011;171:85&#x2013;91. doi: 10.1007/s11046-010-9369-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11046-010-9369-3</ArticleId><ArticleId IdType="pmc">PMC4093797</ArticleId><ArticleId IdType="pubmed">20927595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasibeder W, Halabi M. Candida peritonitis. Minerva Anestesiol. 2014;80:470&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">24002461</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Dhahab H, McNabb-Baltar J, Al-Taweel T, Barkun A. State-of-the-art management of acute bleeding peptic ulcer disease. Saudi J Gastroenterol. 2013;19:195&#x2013;204. doi: 10.4103/1319-3767.118116.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-3767.118116</ArticleId><ArticleId IdType="pmc">PMC3793470</ArticleId><ArticleId IdType="pubmed">24045592</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingina A, Barkun AN, Razzaghi A, Martel M, Bardou M, Gralnek I, Investigators R. Systematic review: the presenting international normalised ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal bleeding. Aliment Pharmacol Ther. 2011;33:1010&#x2013;1018. doi: 10.1111/j.1365-2036.2011.04618.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2011.04618.x</ArticleId><ArticleId IdType="pubmed">21385193</ArticleId></ArticleIdList></Reference><Reference><Citation>Stunell H, Buckley O, Lyburn ID, McGann G, Farrell M, Torreggiani WC. The role of computerized tomography in the evaluation of gastrointestinal bleeding following negative or failed endoscopy: a review of current status. J Postgrad Med. 2008;54:126&#x2013;134. doi: 10.4103/0022-3859.40779.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0022-3859.40779</ArticleId><ArticleId IdType="pubmed">18480529</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing CJ, Tobias T, Rosenblum DI, Banker WL, Tseng L, Tamarkin SW. Acute gastrointestinal bleeding: emerging role of multidetector CT angiography and review of current imaging techniques. Radiographics. 2007;27:1055&#x2013;1070. doi: 10.1148/rg.274065095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.274065095</ArticleId><ArticleId IdType="pubmed">17620467</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. Gastroenterology. 1992;102:139&#x2013;148. doi: 10.1016/0016-5085(92)91793-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0016-5085(92)91793-4</ArticleId><ArticleId IdType="pubmed">1530782</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmo R, Rotondano G, Bianco MA, Piscopo R, Prisco A, Cipolletta L. Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest Endosc. 2003;57:62&#x2013;67. doi: 10.1067/mge.2003.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mge.2003.48</ArticleId><ArticleId IdType="pubmed">12518133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoi KK, Chiu PW, Sung JJ. Endoscopy for upper gastrointestinal bleeding: is routine second-look necessary? Nat Rev Gastroenterol Hepatol. 2009;6:717&#x2013;722. doi: 10.1038/nrgastro.2009.186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2009.186</ArticleId><ArticleId IdType="pubmed">19946305</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SH, Sung JJ. Management of GI emergencies: peptic ulcer acute bleeding. Best Pract Res Clin Gastroenterol. 2013;27:639&#x2013;647. doi: 10.1016/j.bpg.2013.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpg.2013.08.003</ArticleId><ArticleId IdType="pubmed">24160924</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley AJ, Dalton HR, Blatchford O, Ashley D, Mowat C, Cahill A, Gaya DR, Thompson E, Warshow U, Hare N, Groome M, Benson G, Murray W. Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage. Aliment Pharmacol Ther. 2011;34:470&#x2013;475. doi: 10.1111/j.1365-2036.2011.04747.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2011.04747.x</ArticleId><ArticleId IdType="pubmed">21707681</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtare M, Bozorgi V, Agah S, Nikkhah M, Faghihi A, Boghratian A, Shalbaf N, Khanlari A, Seifmanesh H. Comparison of Glasgow-Blatchford score and full Rockall score systems to predict clinical outcomes in patients with upper gastrointestinal bleeding. Clin Exp Gastroenterol. 2016;9:337&#x2013;343. doi: 10.2147/CEG.S114860.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEG.S114860</ArticleId><ArticleId IdType="pmc">PMC5096755</ArticleId><ArticleId IdType="pubmed">27826205</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelms DW, Pelaez CA. The Acute Upper Gastrointestinal Bleed. Surg Clin North Am. 2018;98:1047&#x2013;1057. doi: 10.1016/j.suc.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suc.2018.05.004</ArticleId><ArticleId IdType="pubmed">30243446</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, Komadina R, Maegele M, Nardi G, Riddez L, Samama CM, Vincent JL, Rossaint R. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23:98. doi: 10.1186/s13054-019-2347-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2347-3</ArticleId><ArticleId IdType="pmc">PMC6436241</ArticleId><ArticleId IdType="pubmed">30917843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316&#x2013;321. doi: 10.1136/gut.38.3.316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.38.3.316</ArticleId><ArticleId IdType="pmc">PMC1383057</ArticleId><ArticleId IdType="pubmed">8675081</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for uppergastrointestinal haemorrhage. Lancet. 2000;356:1318&#x2013;1321. doi: 10.1016/S0140-6736(00)02816-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02816-6</ArticleId><ArticleId IdType="pubmed">11073021</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradarian R, Ramdhaney S, Chapalamadugu R, Skoczylas L, Wang K, Rivilis S, Remus K, Mayer I, Iswara K, Tenner S. Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am J Gastroenterol. 2004;99:619&#x2013;622. doi: 10.1111/j.1572-0241.2004.04073.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2004.04073.x</ArticleId><ArticleId IdType="pubmed">15089891</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santalo M, Muniz E, Guarner C. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11&#x2013;21. doi: 10.1056/NEJMoa1211801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211801</ArticleId><ArticleId IdType="pubmed">23281973</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Alcala A, Monkemuller K. Emerging Endoscopic Treatments for Nonvariceal Upper Gastrointestinal Hemorrhage. Gastrointest Endosc Clin N Am. 2018;28:307&#x2013;320. doi: 10.1016/j.giec.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.giec.2018.02.004</ArticleId><ArticleId IdType="pubmed">29933777</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc. 2009;69:786&#x2013;799. doi: 10.1016/j.gie.2008.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2008.05.031</ArticleId><ArticleId IdType="pubmed">19152905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacks HS, Chalmers TC, Blum AL, Berrier J, Pagano D. Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers. JAMA. 1990;264:494&#x2013;499. doi: 10.1001/jama.1990.03450040090037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1990.03450040090037</ArticleId><ArticleId IdType="pubmed">2142225</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley AJ, Laine L, Dalton HR, Ngu JH, Schultz M, Abazi R, Zakko L, Thornton S, Wilkinson K, Khor CJ, Murray IA, Laursen SB. International Gastrointestinal Bleeding C. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017;356:i6432. doi: 10.1136/bmj.i6432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i6432</ArticleId><ArticleId IdType="pmc">PMC5217768</ArticleId><ArticleId IdType="pubmed">28053181</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmo R, Rotondano G, Piscopo R, Bianco MA, D'Angella R, Cipolletta L. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol. 2007;102:279&#x2013;289. doi: 10.1111/j.1572-0241.2006.01023.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2006.01023.x</ArticleId><ArticleId IdType="pubmed">17311650</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergara M, Bennett C, Calvet X, Gisbert JP. Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers. Cochrane Database Syst Rev 2014:CD005584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10714126</ArticleId><ArticleId IdType="pubmed">25308912</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi K, Shen Z, Zhu G, Meng F, Gu M, Ji F. Systematic review with network meta-analysis: dual therapy for high-risk bleeding peptic ulcers. BMC Gastroenterol. 2017;17:55. doi: 10.1186/s12876-017-0610-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-017-0610-0</ArticleId><ArticleId IdType="pmc">PMC5395769</ArticleId><ArticleId IdType="pubmed">28424073</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung JJ, Chiu PW, Chan FKL, Lau JY, Goh KL, Ho LH, Jung HY, Sollano JD, Gotoda T, Reddy N, Singh R, Sugano K, Wu KC, Wu CY, Bjorkman DJ, Jensen DM, Kuipers EJ, Lanas A. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut. 2018;67:1757&#x2013;1768. doi: 10.1136/gutjnl-2018-316276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-316276</ArticleId><ArticleId IdType="pmc">PMC6145289</ArticleId><ArticleId IdType="pubmed">29691276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleau BL, Gostout CJ, Sherman KE, Shaw MJ, Harford WV, Keate RF, Bracy WP, Fleischer DE. Recurrent bleeding from peptic ulcer associated with adherent clot: A randomized study comparing endoscopic treatment with medical therapy. Gastrointestinal Endoscopy. 2002;56:1&#x2013;6. doi: 10.1067/mge.2002.125365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mge.2002.125365</ArticleId><ArticleId IdType="pubmed">12085028</ArticleId></ArticleIdList></Reference><Reference><Citation>Manno M, Mangiafico S, Caruso A, Barbera C, Bertani H, Mirante VG, Pigo F, Amardeep K, Conigliaro R. First-line endoscopic treatment with OTSC in patients with high-risk non-variceal upper gastrointestinal bleeding: preliminary experience in 40 cases. Surg Endosc. 2016;30:2026&#x2013;2029. doi: 10.1007/s00464-015-4436-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4436-y</ArticleId><ArticleId IdType="pubmed">26201415</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter-Schrag HJ, Glatz T, Walker C, Fischer A, Thimme R. First-line endoscopic treatment with over-the-scope clips significantly improves the primary failure and rebleeding rates in high-risk gastrointestinal bleeding: A single-center experience with 100 cases. World J Gastroenterol. 2016;22:9162&#x2013;9171. doi: 10.3748/wjg.v22.i41.9162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v22.i41.9162</ArticleId><ArticleId IdType="pmc">PMC5107597</ArticleId><ArticleId IdType="pubmed">27895403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedi E, Fischer A, Hochberger J, Jung C, Orkut S, Richter-Schrag HJ. Multicenter evaluation of first-line endoscopic treatment with the OTSC in acute non-variceal upper gastrointestinal bleeding and comparison with the Rockall cohort: the FLETRock study. Surg Endosc. 2018;32:307&#x2013;314. doi: 10.1007/s00464-017-5678-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-017-5678-7</ArticleId><ArticleId IdType="pubmed">28656336</ArticleId></ArticleIdList></Reference><Reference><Citation>Manta R, Galloro G, Mangiavillano B, Conigliaro R, Pasquale L, Arezzo A, Masci E, Bassotti G, Frazzoni M. Over-the-scope clip (OTSC) represents an effective endoscopic treatment for acute GI bleeding after failure of conventional techniques. Surg Endosc. 2013;27:3162&#x2013;3164. doi: 10.1007/s00464-013-2871-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-013-2871-1</ArticleId><ArticleId IdType="pubmed">23436101</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner M, Gutierrez J, Neumann H, Wilcox C, Burski C, M&#xf6;nkem&#xfc;ller K. Over-the-scope clip placement is effective rescue therapy for severe acute upper gastrointestinal bleeding. Endoscopy International Open. 2014;2:E37&#x2013;E40. doi: 10.1055/s-0034-1365282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1365282</ArticleId><ArticleId IdType="pmc">PMC4423243</ArticleId><ArticleId IdType="pubmed">26134611</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan SM, Chiu PW, Teoh AY, Lau JY. Use of the Over-The-Scope Clip for treatment of refractory upper gastrointestinal bleeding: a case series. Endoscopy. 2014;46:428&#x2013;431. doi: 10.1055/s-0034-1364932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1364932</ArticleId><ArticleId IdType="pubmed">24505017</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen DM, Ohning GV, Kovacs TO. Ghassemi KA, Jutabha R, Dulai GS, Machicado GA. Doppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding. Gastrointest Endosc. 2016;83:129&#x2013;136. doi: 10.1016/j.gie.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4691549</ArticleId><ArticleId IdType="pubmed">26318834</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen DM, Kovacs TOG, Ohning GV, Ghassemi K, Machicado GA, Dulai GS, Sedarat A, Jutabha R, Gornbein J. Doppler Endoscopic Probe Monitoring of Blood Flow Improves Risk Stratification and Outcomes of Patients With Severe Nonvariceal Upper Gastrointestinal Hemorrhage. Gastroenterology. 2017;152:1310&#x2013;1318. doi: 10.1053/j.gastro.2017.01.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.01.042</ArticleId><ArticleId IdType="pmc">PMC5613762</ArticleId><ArticleId IdType="pubmed">28167214</ArticleId></ArticleIdList></Reference><Reference><Citation>Selby N, Kubba A, Hawkey C. Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'. Alimentary Pharmacology and Therapeutics. 2000;14:1119&#x2013;1126. doi: 10.1046/j.1365-2036.2000.00822.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.2000.00822.x</ArticleId><ArticleId IdType="pubmed">10971227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HJ, Lo WC, Cheng YC, Perng CL. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Am J Gastroenterol. 2006;101:500&#x2013;505. doi: 10.1111/j.1572-0241.2006.00399.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2006.00399.x</ArticleId><ArticleId IdType="pubmed">16542286</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung JJY. Intravenous Esomeprazole for Prevention of Recurrent Peptic Ulcer Bleeding. Ann Intern Med. 2009;150:455. doi: 10.7326/0003-4819-150-7-200904070-00105.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-7-200904070-00105</ArticleId><ArticleId IdType="pubmed">19221370</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 2009;7:33&#x2013;47. doi: 10.1016/j.cgh.2008.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2008.08.016</ArticleId><ArticleId IdType="pubmed">18986845</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann I, Letelier LM, Rada G, Claro JC, Martin J, Howden CW, Yuan Y, Leontiadis GI. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2013:CD007999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10114080</ArticleId><ArticleId IdType="pubmed">23760821</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan A, Martin J, Leontiadis GI, Dorward S, Howden CW, Forman D, Moayyedi P. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010:CD005415.</Citation><ArticleIdList><ArticleId IdType="pubmed">17054257</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JYW, Barkun A, D-m F, Kuipers EJ, Yang Y-s, Chan FKL. Challenges in the management of acute peptic ulcer bleeding. Lancet. 2013;381:2033&#x2013;2043. doi: 10.1016/S0140-6736(13)60596-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60596-6</ArticleId><ArticleId IdType="pubmed">23746903</ArticleId></ArticleIdList></Reference><Reference><Citation>Theivanayagam S, Lim RG, Cobell WJ, Gowda JT, Matteson ML, Choudhary A, Bechtold ML. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi J Gastroenterol. 2013;19:205&#x2013;210. doi: 10.4103/1319-3767.118120.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-3767.118120</ArticleId><ArticleId IdType="pmc">PMC3793471</ArticleId><ArticleId IdType="pubmed">24045593</ArticleId></ArticleIdList></Reference><Reference><Citation>Szary NM, Gupta R, Choudhary A, Matteson ML, Arif M, Hammad HT, Bechtold ML. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scand J Gastroenterol. 2011;46:920&#x2013;924. doi: 10.3109/00365521.2011.568520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365521.2011.568520</ArticleId><ArticleId IdType="pubmed">21561232</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkun AN, Bardou M, Martel M, Gralnek IM, Sung JJ. Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointest Endosc. 2010;72:1138&#x2013;1145. doi: 10.1016/j.gie.2010.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2010.08.011</ArticleId><ArticleId IdType="pubmed">20970794</ArticleId></ArticleIdList></Reference><Reference><Citation>Aljebreen AM, Fallone CA, Barkun AN, for the Ri Nasogastric aspirate predicts high-risk endoscopic lesions in patients with acute upper-GI bleeding. Gastrointestinal Endoscopy. 2004;59:172&#x2013;178. doi: 10.1016/S0016-5107(03)02543-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0016-5107(03)02543-4</ArticleId><ArticleId IdType="pubmed">14745388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122:896&#x2013;903. doi: 10.1016/j.amjmed.2009.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2009.04.014</ArticleId><ArticleId IdType="pubmed">19786155</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan FKL, Sung JJY, Sydney Chung SC, To KF, Yung MY, Leung VKS, Lee YT, Chan CSY, Li EKM, Woo J. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997;350:975&#x2013;979. doi: 10.1016/S0140-6736(97)04523-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(97)04523-6</ArticleId><ArticleId IdType="pubmed">9329511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JY, Sung JJ, Lam YH, Chan AC, Ng EK, Lee DW, Chan FK, Suen RC, Chung SC. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med. 1999;340:751&#x2013;756. doi: 10.1056/NEJM199903113401002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199903113401002</ArticleId><ArticleId IdType="pubmed">10072409</ArticleId></ArticleIdList></Reference><Reference><Citation>Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, Rotondano G, Hucl T, Dinis-Ribeiro M, Marmo R, Racz I, Arezzo A, Hoffmann RT, Lesur G, de Franchis R, Aabakken L, Veitch A, Radaelli F, Salgueiro P, Cardoso R, Maia L, Zullo A, Cipolletta L, Hassan C. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47:a1&#x2013;46. doi: 10.1055/s-0034-1393172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1393172</ArticleId><ArticleId IdType="pubmed">26417980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheynel N, Peschaud F, Hagry O, Rat P, Ognois-Ausset P, Favre JP. Ulc&#xe8;re gastroduod&#xe9;nal h&#xe9;morragique : r&#xe9;sultats du traitement chirurgical1Communication pr&#xe9;sent&#xe9;e &#xe0; l'Acad&#xe9;mie nationale de chirurgie au cours de la s&#xe9;ance du 31 janvier 2001. Annales de Chirurgie. 2001;126:232&#x2013;235. doi: 10.1016/S0003-3944(01)00505-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-3944(01)00505-3</ArticleId><ArticleId IdType="pubmed">11340708</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffroy R, Favelier S, Pottecher P, Estivalet L, Genson PY, Gehin S, Cercueil JP, Krause D. Transcatheter arterial embolization for acute nonvariceal upper gastrointestinal bleeding: Indications, techniques and outcomes. Diagn Interv Imaging. 2015;96:731&#x2013;744. doi: 10.1016/j.diii.2015.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diii.2015.05.002</ArticleId><ArticleId IdType="pubmed">26054245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejaddam AY, Cropano CM, Kalva S, Walker TG, Imam AM, Velmahos GC, de Moya MA, King DR. Outcomes following &#x201c;rescue&#x201d; superselective angioembolization for gastrointestinal hemorrhage in hemodynamically unstable patients. J Trauma Acute Care Surg. 2013;75:398&#x2013;403. doi: 10.1097/TA.0b013e31829a8b7a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31829a8b7a</ArticleId><ArticleId IdType="pubmed">23928742</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffroy R, Guiu B, D'Athis P, Mezzetta L, Gagnaire A, Jouve JL, Ortega-Deballon P, Cheynel N, Cercueil JP, Krause D. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol. 2009;7:515&#x2013;523. doi: 10.1016/j.cgh.2009.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2009.02.003</ArticleId><ArticleId IdType="pubmed">19418601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyaw M, Tse Y, Ang D, Ang TL, Lau J. Embolization versus surgery for peptic ulcer bleeding after failed endoscopic hemostasis: a meta-analysis. Endosc Int Open. 2014;2:E6&#x2013;E14. doi: 10.1055/s-0034-1365235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1365235</ArticleId><ArticleId IdType="pmc">PMC4423253</ArticleId><ArticleId IdType="pubmed">26134614</ArticleId></ArticleIdList></Reference><Reference><Citation>Beggs AD, Dilworth MP, Powell SL, Atherton H, Griffiths EA. A systematic review of transarterial embolization versus emergency surgery in treatment of major nonvariceal upper gastrointestinal bleeding. Clin Exp Gastroenterol. 2014;7:93&#x2013;104. doi: 10.2147/CEG.S56725.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEG.S56725</ArticleId><ArticleId IdType="pmc">PMC3998850</ArticleId><ArticleId IdType="pubmed">24790465</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarasconi A, Baiocchi GL, Pattonieri V, Perrone G, Abongwa HK, Molfino S, Portolani N, Sartelli M, Di Saverio S, Heyer A, Ansaloni L, Coccolini F, Catena F. Transcatheter arterial embolization versus surgery for refractory non-variceal upper gastrointestinal bleeding: a meta-analysis. World J Emerg Surg. 2019;14:3. doi: 10.1186/s13017-019-0223-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-019-0223-8</ArticleId><ArticleId IdType="pmc">PMC6359767</ArticleId><ArticleId IdType="pubmed">30733822</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyk&#xe4;nen T, Peltola E, Kyl&#xe4;np&#xe4;&#xe4; L, Udd M. Bleeding gastric and duodenal ulcers: case-control study comparing angioembolization and surgery. Scandinavian Journal of Gastroenterology. 2017;52:523&#x2013;530. doi: 10.1080/00365521.2017.1288756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365521.2017.1288756</ArticleId><ArticleId IdType="pubmed">28270041</ArticleId></ArticleIdList></Reference><Reference><Citation>Aina R, Oliva VL, Therasse &#xc9;, Perreault P, Bui BT, Dufresne M-P, Soulez G. Arterial Embolotherapy for Upper Gastrointestinal Hemorrhage: Outcome Assessment. Journal of Vascular and Interventional Radiology. 2001;12:195&#x2013;200. doi: 10.1016/S1051-0443(07)61825-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1051-0443(07)61825-9</ArticleId><ArticleId IdType="pubmed">11265883</ArticleId></ArticleIdList></Reference><Reference><Citation>Padia SA, Geisinger MA, Newman JS, Pierce G, Obuchowski NA, Sands MJ. Effectiveness of coil embolization in angiographically detectable versus non-detectable sources of upper gastrointestinal hemorrhage. J Vasc Interv Radiol. 2009;20:461&#x2013;466. doi: 10.1016/j.jvir.2009.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2009.01.006</ArticleId><ArticleId IdType="pubmed">19328425</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh R. Role of angiography and embolization for massive gastroduodenal hemorrhage. J Gastrointest Surg. 1999;3:61&#x2013;66. doi: 10.1016/S1091-255X(99)80010-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1091-255X(99)80010-9</ArticleId><ArticleId IdType="pubmed">10457326</ArticleId></ArticleIdList></Reference><Reference><Citation>Defreyne L, Vanlangenhove P, Decruyenaere J, Van Maele G, De Vos M, Troisi R, Pattyn P. Outcome of acute nonvariceal gastrointestinal haemorrhage after nontherapeutic arteriography compared with embolization. Eur Radiol. 2003;13:2604&#x2013;2614. doi: 10.1007/s00330-003-1882-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-003-1882-z</ArticleId><ArticleId IdType="pubmed">12692680</ArticleId></ArticleIdList></Reference><Reference><Citation>Laursen SB, Hansen JM, Andersen PE, Schaffalitzky de Muckadell OB. Supplementary arteriel embolization an option in high-risk ulcer bleeding--a randomized study. Scand J Gastroenterol. 2014;49:75&#x2013;83. doi: 10.3109/00365521.2013.854829.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365521.2013.854829</ArticleId><ArticleId IdType="pubmed">24256098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JYW, Pittayanon R, Wong KT, Pinjaroen N, Chiu PWY, Rerknimitr R, Holster IL, Kuipers EJ, Wu KC, Au KWL, Chan FKL, Sung JJY. Prophylactic angiographic embolisation after endoscopic control of bleeding to high-risk peptic ulcers: a randomised controlled trial. Gut. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">29802172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mille M, Huber J, Wlasak R, Engelhardt T, Hillner Y, Kriechling H, Aschenbach R, Ende K, Scharf JG, Puls R, Stier A. Prophylactic Transcatheter Arterial Embolization After Successful Endoscopic Hemostasis in the Management of Bleeding Duodenal Ulcer. J Clin Gastroenterol. 2015;49:738&#x2013;745. doi: 10.1097/MCG.0000000000000259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0000000000000259</ArticleId><ArticleId IdType="pubmed">25319738</ArticleId></ArticleIdList></Reference><Reference><Citation>Lolle I, M&#xf8;ller MH, Rosenstock SJ. Association between ulcer site and outcome in complicated peptic ulcer disease: a Danish nationwide cohort study. Scand J Gastroenterol. 2016;51:1165&#x2013;1171. doi: 10.1080/00365521.2016.1190398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365521.2016.1190398</ArticleId><ArticleId IdType="pubmed">27248208</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder VT, Pappas TN, Vaslef SN, De La Fuente SG, Scarborough JE. Vagotomy/drainage is superior to local oversew in patients who require emergency surgery for bleeding peptic ulcers. Ann Surg. 2014;259:1111&#x2013;1118. doi: 10.1097/SLA.0000000000000386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000386</ArticleId><ArticleId IdType="pubmed">24368635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon H, Lee DH, Jang ES, Kim J, Shin CM, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N. Optimal initiation of Helicobacter pylori eradication in patients with peptic ulcer bleeding. World J Gastroenterol. 2015;21:2497&#x2013;2503. doi: 10.3748/wjg.v21.i8.2497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v21.i8.2497</ArticleId><ArticleId IdType="pmc">PMC4342929</ArticleId><ArticleId IdType="pubmed">25741160</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh K, Yoshino J, Akamatsu T, Itoh T, Kato M, Kamada T, Takagi A, Chiba T, Nomura S, Mizokami Y, Murakami K, Sakamoto C, Hiraishi H, Ichinose M, Uemura N, Goto H, Joh T, Miwa H, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016;51:177&#x2013;194. doi: 10.1007/s00535-016-1166-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-016-1166-4</ArticleId><ArticleId IdType="pubmed">26879862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz E. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther. 2004;19:617&#x2013;629. doi: 10.1111/j.1365-2036.2004.01898.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2004.01898.x</ArticleId><ArticleId IdType="pubmed">15023164</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ, European Helicobacter Study G. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012;61:646&#x2013;664. doi: 10.1136/gutjnl-2012-302084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2012-302084</ArticleId><ArticleId IdType="pubmed">22491499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagari RM, Romano M, Ojetti V, Stockbrugger R, Gullini S, Annibale B, Farinati F, Ierardi E, Maconi G, Rugge M, Calabrese C, Di Mario F, Luzza F, Pretolani S, Savio A, Gasbarrini G, Caselli M. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015. Dig Liver Dis. 2015;47:903&#x2013;912. doi: 10.1016/j.dld.2015.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2015.06.010</ArticleId><ArticleId IdType="pubmed">26253555</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Caro S, Fini L, Daoud Y, Grizzi F, Gasbarrini A, De Lorenzo A, Di Renzo L, McCartney S, Bloom S. Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line. World J Gastroenterol. 2012;18:5669&#x2013;5678. doi: 10.3748/wjg.v18.i40.5669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v18.i40.5669</ArticleId><ArticleId IdType="pmc">PMC3484334</ArticleId><ArticleId IdType="pubmed">23155306</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013;347:f4587. doi: 10.1136/bmj.f4587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f4587</ArticleId><ArticleId IdType="pmc">PMC3736972</ArticleId><ArticleId IdType="pubmed">23926315</ArticleId></ArticleIdList></Reference><Reference><Citation>Das R, Sureshkumar S, Sreenath GS, Kate V. Sequential versus concomitant therapy for eradication of Helicobacter Pylori in patients with perforated duodenal ulcer: A randomized trial. Saudi J Gastroenterol. 2016;22:309&#x2013;315. doi: 10.4103/1319-3767.187605.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-3767.187605</ArticleId><ArticleId IdType="pmc">PMC4991202</ArticleId><ArticleId IdType="pubmed">27488326</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35363452</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>386</Volume><Issue>21</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Tranexamic Acid in Patients Undergoing Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>1986</StartPage><EndPage>1997</EndPage><MedlinePgn>1986-1997</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa2201171</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative bleeding is common in patients undergoing noncardiac surgery. Tranexamic acid is an antifibrinolytic drug that may safely decrease such bleeding.</AbstractText><AbstractText Label="METHODS">We conducted a trial involving patients undergoing noncardiac surgery. Patients were randomly assigned to receive tranexamic acid (1-g intravenous bolus) or placebo at the start and end of surgery (reported here) and, with the use of a partial factorial design, a hypotension-avoidance or hypertension-avoidance strategy (not reported here). The primary efficacy outcome was life-threatening bleeding, major bleeding, or bleeding into a critical organ (composite bleeding outcome) at 30 days. The primary safety outcome was myocardial injury after noncardiac surgery, nonhemorrhagic stroke, peripheral arterial thrombosis, or symptomatic proximal venous thromboembolism (composite cardiovascular outcome) at 30 days. To establish the noninferiority of tranexamic acid to placebo for the composite cardiovascular outcome, the upper boundary of the one-sided 97.5% confidence interval for the hazard ratio had to be below 1.125, and the one-sided P value had to be less than 0.025.</AbstractText><AbstractText Label="RESULTS">A total of 9535 patients underwent randomization. A composite bleeding outcome event occurred in 433 of 4757 patients (9.1%) in the tranexamic acid group and in 561 of 4778 patients (11.7%) in the placebo group (hazard ratio, 0.76; 95% confidence interval [CI], 0.67 to 0.87; absolute difference, -2.6 percentage points; 95% CI, -3.8 to -1.4; two-sided P&lt;0.001 for superiority). A composite cardiovascular outcome event occurred in 649 of 4581 patients (14.2%) in the tranexamic acid group and in 639 of 4601 patients (13.9%) in the placebo group (hazard ratio, 1.02; 95% CI, 0.92 to 1.14; upper boundary of the one-sided 97.5% CI, 1.14; absolute difference, 0.3 percentage points; 95% CI, -1.1 to 1.7; one-sided P&#x2009;=&#x2009;0.04 for noninferiority).</AbstractText><AbstractText Label="CONCLUSIONS">Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo. Although the between-group difference in the composite cardiovascular outcome was small, the noninferiority of tranexamic acid was not established. (Funded by the Canadian Institutes of Health Research and others; POISE-3 ClinicalTrials.gov number, NCT03505723.).</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Massachusetts Medical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0003-2935-637X</Identifier><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Painter</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conen</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><Identifier Source="ORCID">0000-0001-9932-3077</Identifier><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MTV</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges</LastName><ForeName>Flavia K</ForeName><Initials>FK</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Zapata</LastName><ForeName>Mar&#xed;a J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chew Yin</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xavier</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ofori</LastName><ForeName>Sandra N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Michael K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Efremov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinlugtenbelt</LastName><ForeName>Ydo V</ForeName><Initials>YV</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmartz</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Short</LastName><ForeName>Timothy G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wittmann</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amir</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Ameen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parlow</LastName><ForeName>Joel L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polanczyk</LastName><ForeName>Carisi A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astrakov</LastName><ForeName>Sergey V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Mangala</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>William K K</ForeName><Initials>WKK</Initials><Identifier Source="ORCID">0000-0002-5662-5240</Identifier><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Keyur</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Nadal</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery V</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paniagua</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguado</LastName><ForeName>Hector J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Richard P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0002-6863-5884</Identifier><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGillion</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prystajecky</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Copland</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balasubramanian</LastName><ForeName>Kumar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turan</LastName><ForeName>Alparslan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangdiwala</LastName><ForeName>Shrikant I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stillo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>Peter L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cafaro</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfonsi</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roshanov</LastName><ForeName>Pavel S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belley-C&#xf4;t&#xe9;</LastName><ForeName>Emilie P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9872-4653</Identifier><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>VanHelder</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guyatt</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yusuf</LastName><ForeName>Salim</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8512-3517</Identifier><AffiliationInfo><Affiliation>From the Population Health Research Institute (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.L., R.P.W., M.H.M., J.V., J.E., I.C., K. Balasubramanian, S.I.B., D. Stillo, T.C., P.S.R., E.P.B.-C., J.S., W.M., S.Y.), the Departments of Health Research Methods, Evidence, and Impact (P.J.D., M.M., D.C., F.K.B., S.N.O., M.K.W., A.X.G., S.I.B., J.S., G.G.), Medicine (P.J.D., M.M., D.C., F.K.B., M.K.W., A.P., V.T., J.E., P.L.G., E.P.B.-C., W.M., G.G., S.Y.), Surgery (A.L., R.P.W.), and Anesthesia (J.S., T.V.) and the School of Nursing (M.H.M.), McMaster University, Hamilton, the Departments of Medicine (A.X.G., P.S.R.) and Epidemiology and Biostatistics (A.X.G.), Western University, London, and the Department of Anesthesiology and Perioperative Medicine, Queen's University and Kingston Health Sciences Centre, Kingston (J.L.P.), ON, the Department of Medicine, Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (E.D.), and the Department of Medicine, Jewish General Hospital, McGill University (T.C.), Montreal, and the Department of Medicine, University of Saskatchewan, Saskatoon (M.P.) - all in Canada; the Discipline of Acute Care Medicine, University of Adelaide (T.W.P.), and the Department of Anaesthesia, Royal Adelaide Hospital (T.W.P.), Adelaide, SA, and the Department of Anaesthesia and Perioperative Medicine, Monash University (T.R.), and the Department of Critical Care Medicine, Melbourne Medical School, University of Melbourne (K.L.), Melbourne, VIC - all in Australia; the Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center (V.L.), and the Department of Anesthesiology and Intensive Care (V.L.) and the Department of Anesthesiology, V. Zelman Institute of Medicine and Psychology (S.V.A.), Novosibirsk State University, Novosibirsk, Saint Petersburg State University Hospital, Saint Petersburg (S.E.), and V. Negovsky Reanimatology Research Institute, Anesthesia and Intensive Care Department, First Moscow State Medical University (Sechenov University), Moscow (V.V.L.) - all in Russia; the Departments of Outcomes Research (D.I.S., K.R., A.T.) and General Anesthesia (K.R., A.T.) and the Anesthesiology Institute (D.I.S., K.R., A.T.), Cleveland Clinic, Cleveland; Chinese University of Hong Kong, Shatin, China (M.T.V.C., W.K.K.W.); Iberoamerican Cochrane Center, Public Health and Clinical Epidemiology Service, Institut d'Investigaci&#xf3; Biom&#xe8;dica Sant Pau, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Epidemiolog&#xed;a y Salud P&#xfa;blica (M.J.M.-Z.), the Department of Anesthesiology and Intensive Care, Hospital Vall d'Hebron, Universitat Aut&#xf2;noma de Barcelona (M.N.), and the Anesthesiology Department, Santa Creu i Sant Pau University Hospital (P.P.), Barcelona, and the Trauma and Orthopedic Surgery Department, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid (H.J.A.) - all in Spain; the Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.); St. John's Medical College, Bangalore (D.X., M.R.), and the Department of Gastrointestinal Surgery, Surat Institute of Digestive Sciences Hospital and Research Center, Surat (K. Bhatt) - both in India; the Department of Anesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan (G.L.); the Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, the Netherlands (Y.V.K.); Jagiellonian University Medical College, Center for Intensive Care and Perioperative Medicine, Krakow, Poland (W.S.); Centre Hospitalier Universitaire Brugmann, Universit&#xe9; Libre de Bruxelles, Brussels (D. Schmartz); the Department of Anesthesia, Auckland City Hospital, and the School of Health Sciences, University of Auckland, Auckland, New Zealand (T.G.S.); the Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany (M.W.); the Department of Anesthesia and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen (C.S.M.); Shifa International Hospital, Islamabad, Pakistan (M.A.); Departamento de Epidemiolog&#xed;a y Estudios en Salud, Universidad de Los Andes, and Servicio de Anestesiolog&#xed;a, Cl&#xed;nica Santa Mar&#xed;a, Santiago, Chile (D.T.); the Department of Anesthesia, General Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna (E.F.); Universidade Federal do Rio Grande do Sul, Hospital de Cl&#xed;nicas de Porto Alegre, National Institute for Health Technology Assessment, and Hospital Moinhos de Vento, Porto Alegre, Brazil (C.A.P.); and the Department of Anesthesia, Hospital Paris Saint Joseph, University of Paris, Paris (P.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>POISE-3 Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03505723</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>MR/M009211/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>Project Grant 1162362</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>FDN-143302</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Cardiol. 2022 Jun;19(6):352. doi: 10.1038/s41569-022-00710-z.</RefSource><PMID Version="1">35422522</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 May 26;386(21):2052-2053. doi: 10.1056/NEJMe2204599.</RefSource><PMID Version="1">35613026</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Sep 1;387(9):858. doi: 10.1056/NEJMc2208614.</RefSource><PMID Version="1">36053522</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2022 Sep 1;387(9):858. doi: 10.1056/NEJMc2208614.</RefSource><PMID Version="1">36053523</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="Y">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="Y">Tranexamic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bangdiwala</LastName><ForeName>Shrikant I</ForeName><Initials>SI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borges</LastName><ForeName>Flavia K</ForeName><Initials>FK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conen</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Copland</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guyatt</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Maura</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MTV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Painter</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parlow</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tandon</LastName><ForeName>Vikas</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xavier</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alfonsi</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amir</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bangdiwala</LastName><ForeName>Shrikant</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Edith</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gross</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayaram</LastName><ForeName>Raja</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleinlugtenbelt</LastName><ForeName>Ydo V</ForeName><Initials>YV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinez Zapata</LastName><ForeName>Maria Jos&#xe9;</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lemanach</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGillion</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polanczyk</LastName><ForeName>Carisi</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roshanov</LastName><ForeName>Pavel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmartz</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srinathan</LastName><ForeName>Sadeesh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torres</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Chew Yin</ForeName><Initials>CY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Dale</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wittmann</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yusuf</LastName><ForeName>Salim</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Michael Ke</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ofori</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cafaro</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prystajecky</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yadgarov</LastName><ForeName>Mikhail Ya</ForeName><Initials>MY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borisov</LastName><ForeName>Dmitry B</ForeName><Initials>DB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorman</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Italiano</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valenzuela Su&#xe1;rez</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blum</LastName><ForeName>Steffen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruiz-L&#xf3;pez</LastName><ForeName>Nuria</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haarmark Nielssen</LastName><ForeName>Christian E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>W&#x142;udarczyk</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Germini</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vasquez</LastName><ForeName>Javiera Paz</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bleijerveen</LastName><ForeName>L J</ForeName><Initials>LJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Font</LastName><ForeName>Adri&#xe0;</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schandelmaier</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Popov</LastName><ForeName>Jesse</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moller</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moliner Ab&#xf3;s</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Losik</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Arnav</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belley-C&#xf4;t&#xe9;</LastName><ForeName>Emilie</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulkens</LastName><ForeName>Chantal</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>Elizaveta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wrona</LastName><ForeName>Pawel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sramek</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stella</LastName><ForeName>Steffan F</ForeName><Initials>SF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nucera</LastName><ForeName>Antonia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuestermann</LastName><ForeName>Franziska</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Egom</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>Shaan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morillo</LastName><ForeName>Luis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thiel</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roberts</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fergusson</LastName><ForeName>Dean</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fo&#xeb;x</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>McAlister</LastName><ForeName>Finlay</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Diodato</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Howe</LastName><ForeName>Rosemary</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mastrangelo</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGall</LastName><ForeName>Clare</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mercuri</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molnar</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stillo</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Southall</LastName><ForeName>Trisha</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swanson</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tosh</LastName><ForeName>Makayla</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balasubramanian</LastName><ForeName>Kumar</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deng</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marsden</LastName><ForeName>Tamara</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molec</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shestakovska</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Robin</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoeft</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleinlugtenbelt</LastName><ForeName>Ydo</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Chaoran</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ormond</LastName><ForeName>Gillian</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Prinse</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lumb</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macklin</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osborn</LastName><ForeName>Christine S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Somfleth</LastName><ForeName>Johanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>Carolyn M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Highton</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sivalingam</LastName><ForeName>Palvannan</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kearney</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oishi</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forrester</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pilling</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathew-Kurian</LastName><ForeName>Sibi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cummins</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muller</LastName><ForeName>Juanita</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malhotra</LastName><ForeName>Surbhi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glazov</LastName><ForeName>Lucy</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wright</LastName><ForeName>Duncan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bennett</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marneros</LastName><ForeName>Priscilla</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cai</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pfund</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerridge</LastName><ForeName>Ross K</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Healey</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douglas</LastName><ForeName>Jeanene L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frost</LastName><ForeName>Bernard D</ForeName><Initials>BD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Challis</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alcock</LastName><ForeName>David R</ForeName><Initials>DR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seale</LastName><ForeName>Robyn A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bramley</LastName><ForeName>David Edmund Piers</ForeName><Initials>DEP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szental</LastName><ForeName>Joshua</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yeung</LastName><ForeName>Justin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Towns</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gill</LastName><ForeName>Kerry</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bates</LastName><ForeName>Samantha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowman</LastName><ForeName>Sarah R</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moody</LastName><ForeName>Amos</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slocomb</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smedley</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marckwald</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machado Mu&#xf1;oz</LastName><ForeName>Libia E</ForeName><Initials>LE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chew</LastName><ForeName>Sue</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barton</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Skiller</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boschen</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bulach</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maggio</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bulfin</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nazareth</LastName><ForeName>Justin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baulch</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Saskia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Claxton</LastName><ForeName>Gayle</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riedel</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coleman</LastName><ForeName>Kimberley</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koerber</LastName><ForeName>Jason P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Badenoch</LastName><ForeName>Adam D</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rattigan</LastName><ForeName>Susan M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scotland</LastName><ForeName>Vanessa J</ForeName><Initials>VJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vlachtsis</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tomas B</ForeName><Initials>TB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toner</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taaka Mahumani</LastName><ForeName>Alfred</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cope</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark-MacKay</LastName><ForeName>Elenore</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dunk</LastName><ForeName>Nigel J W</ForeName><Initials>NJW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douglas</LastName><ForeName>Ned W R</ForeName><Initials>NWR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Surah</LastName><ForeName>Amit</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ha</LastName><ForeName>Vi</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kabon</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reiterer</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taschner</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adamowitsch</LastName><ForeName>Nikolas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zotti</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bidgoli Seyed</LastName><ForeName>Javad</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dzechi</LastName><ForeName>Christiane</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Lerberghe</LastName><ForeName>C&#xe9;line</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Besse</LastName><ForeName>H&#xe9;l&#xe8;ne Tatiana</ForeName><Initials>HT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stany</LastName><ForeName>Ida</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Momeni</LastName><ForeName>Mona</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieu</LastName><ForeName>Audrey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Loic</LastName><ForeName>Benoit</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergo</LastName><ForeName>Ricardo R</ForeName><Initials>RR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dall'Orto</LastName><ForeName>Frederico C</ForeName><Initials>FC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Gislayne R</ForeName><Initials>GR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bitencourt</LastName><ForeName>Keyla C</ForeName><Initials>KC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stefani</LastName><ForeName>Luciana Cadore</ForeName><Initials>LC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minuzzi</LastName><ForeName>Ros&#xe2;ngela da Rosa</ForeName><Initials>RDR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prato Schmidt</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dornelles</LastName><ForeName>Debora Roberta</ForeName><Initials>DR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brand&#xe3;o</LastName><ForeName>Mariana</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Ameen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Joseph</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magloire</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Amna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cox</LastName><ForeName>Conor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gregus</LastName><ForeName>Krysten</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alazzoni</LastName><ForeName>Baha</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hare</LastName><ForeName>Jacquie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tushinski</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raza</LastName><ForeName>Samir</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haider</LastName><ForeName>Shariq</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chakroborty</LastName><ForeName>Amitabha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zandi</LastName><ForeName>Shervin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wyne</LastName><ForeName>Ahraaz</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huynh</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huynh</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>VanHelder</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Leary</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harlock</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panju</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srivaratharajan</LastName><ForeName>Kajenny</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chui</LastName><ForeName>Betty</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Proc</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trombetta</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rapanos</LastName><ForeName>Ted</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pettit</LastName><ForeName>Shirley</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shanthanna</LastName><ForeName>Harsha</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neary</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connolly</LastName><ForeName>Katie</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abdulrahman</LastName><ForeName>Muammar</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wikkerink</LastName><ForeName>Spencer</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quraishi</LastName><ForeName>Faraaz</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nenshi</LastName><ForeName>Rahima</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Joly</LastName><ForeName>Nikola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrier</LastName><ForeName>Francois-Martin</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carling</LastName><ForeName>Roberta Daila</ForeName><Initials>RD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amzallag</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lapointe</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baptiste</LastName><ForeName>Diane</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boko</LastName><ForeName>M&#xe9;lodie Fanay</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massicotte</LastName><ForeName>Luc</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thibault</LastName><ForeName>Maxime</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Migneault</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Plante</LastName><ForeName>Francois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Girard</LastName><ForeName>Francois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guzman</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parlow</LastName><ForeName>Joel L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dumerton</LastName><ForeName>Deborah A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erb</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shelley</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vowotor</LastName><ForeName>Elorm</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karizhenskaia</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peponoulas</LastName><ForeName>Emile</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacka</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graham</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greene</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dillane</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bigam</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMurtry</LastName><ForeName>Ella</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaugg</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foerster</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zarnke</LastName><ForeName>Kelly B</ForeName><Initials>KB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiplagat</LastName><ForeName>Linet</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruzycki</LastName><ForeName>Shannon M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schneider</LastName><ForeName>Prism S</ForeName><Initials>PS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mrkobrada</LastName><ForeName>Marko</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dresser</LastName><ForeName>George K</ForeName><Initials>GK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ernst</LastName><ForeName>Jaclyn A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nicolaou</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubois</LastName><ForeName>Luc</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duncan</LastName><ForeName>Audra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broadhurst</LastName><ForeName>Karen L</ForeName><Initials>KL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnston</LastName><ForeName>Brogan M</ForeName><Initials>BM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Handsor</LastName><ForeName>Stephanie N</ForeName><Initials>SN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kidane</LastName><ForeName>Biniam</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Funk</LastName><ForeName>Duane</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tan</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buduhan</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Enns</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poole</LastName><ForeName>Emma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCluskey</LastName><ForeName>Stuart A</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayach</LastName><ForeName>Nour</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carroll</LastName><ForeName>Jo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wasowicz</LastName><ForeName>Marcin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parotto</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Djaiani</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poonawala</LastName><ForeName>Humara</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hedlin</LastName><ForeName>Peter D</ForeName><Initials>PD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Amrita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhavsar</LastName><ForeName>Shrijal</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMullen</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lefebvre</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moliner</LastName><ForeName>Peter Ramon</ForeName><Initials>PR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lanthier</LastName><ForeName>Luc</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fuentes</LastName><ForeName>Maite</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vasquez</LastName><ForeName>Javiera</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paz</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cares</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>D&#xed;az</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herrera</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>de la Puente</LastName><ForeName>Tiare</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merino</LastName><ForeName>Waldo</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrasco-Moyano</LastName><ForeName>Ruben</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carcamo</LastName><ForeName>Claudio</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Joynt</LastName><ForeName>Gavin M</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gin</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choi</LastName><ForeName>Gordon Y S</ForeName><Initials>GYS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Wai Tat</ForeName><Initials>WT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>Linda M L</ForeName><Initials>LML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Chi-Fai</ForeName><Initials>CF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiu</LastName><ForeName>Philip W Y</ForeName><Initials>PWY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lau</LastName><ForeName>James Y W</ForeName><Initials>JYW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Underwood</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fung</LastName><ForeName>Beaker</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hui</LastName><ForeName>Ka Yan</ForeName><Initials>KY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Chee Sam</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Winnie Wing Sam</ForeName><Initials>WWS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Qi</LastName><ForeName>Sihua</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xie</LastName><ForeName>Yuying</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mengdi</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ye</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaofen</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Rui</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deng</LastName><ForeName>Xiaoqian</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xf8;gaard</LastName><ForeName>Marlene</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gundel</LastName><ForeName>Ossian N</ForeName><Initials>ON</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moseholm</LastName><ForeName>Viktor</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Diana B</ForeName><Initials>DB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hansen</LastName><ForeName>Mia K</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bendixen</LastName><ForeName>Grethe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Anne Sofie</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thorsager Olesen</LastName><ForeName>Sanne Dahl</ForeName><Initials>SD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadler</LastName><ForeName>Naomi</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krogh &#xd8;sterby</LastName><ForeName>Mette</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vazin Kjeldsen</LastName><ForeName>Mojgan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zahid</LastName><ForeName>Jawad Ahmad</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azawi</LastName><ForeName>Nessn</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>G&#xf6;genur</LastName><ForeName>Ismail</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aasvang</LastName><ForeName>Eske Kvanner</ForeName><Initials>EK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brandt H&#xf8;jlund-Hansen</LastName><ForeName>Niels</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bak</LastName><ForeName>Theis Simon</ForeName><Initials>TS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kistorp</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>R&#xf8;der</LastName><ForeName>Martin Andreas</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lavergne</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Makoudi</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beaussier</LastName><ForeName>Helene</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lurati Buse</LastName><ForeName>Giovanna A L</ForeName><Initials>GAL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roth</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stroda</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huhn-Wientgen</LastName><ForeName>Ragnar</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nienhaus</LastName><ForeName>Johnnes</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>M Pembele</LastName><ForeName>Rene</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adelowo</LastName><ForeName>Antony</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossaint</LastName><ForeName>Rolf</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kowark</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ziemann</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gr&#xfc;&#xdf;er</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallqvist</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kowark</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bach</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellerkmann</LastName><ForeName>Richard K</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiefer</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pohl</LastName><ForeName>Holger</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Houben</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amarasekara</LastName><ForeName>Mihiri U</ForeName><Initials>MU</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Anke</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>H&#xf6;hn</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coburn</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neumann</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Velten</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fingerhut</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massoth</LastName><ForeName>Gregor</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rao</LastName><ForeName>Mangala</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xavier</LastName><ForeName>Freeda</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Subbin</LastName><ForeName>Susan Maria</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Keyur</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mangukiya</LastName><ForeName>Dhaval</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Jignesh</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kachhadiya</LastName><ForeName>Daxa</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thumar</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parekh</LastName><ForeName>Viral</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vitthalrao Rahate</LastName><ForeName>Prashant</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh Sidhu</LastName><ForeName>Ravinder</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaur Sidhu</LastName><ForeName>Gursaran</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laiker</LastName><ForeName>Naveen</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sidhu</LastName><ForeName>Abhitej</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vishwanath</LastName><ForeName>B Sachin</ForeName><Initials>BS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gopal</LastName><ForeName>Shivaraj Veena</ForeName><Initials>SV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ajay</LastName><ForeName>Veena S</ForeName><Initials>VS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zachariah</LastName><ForeName>Varghese</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kumar</LastName><ForeName>Anil</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Narasimhan</LastName><ForeName>Venkat</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chakravarthy Joel Jacob</LastName><ForeName>Priya P</ForeName><Initials>PP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vishnuvardhan</LastName><ForeName>Nithya M</ForeName><Initials>NM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravi Patil</LastName><ForeName>Niranjan M</ForeName><Initials>NM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sengupta</LastName><ForeName>Shantanu P</ForeName><Initials>SP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sengupta</LastName><ForeName>Rajasi</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uikey</LastName><ForeName>Suchitra S</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mungulmare</LastName><ForeName>Kunda</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sahare</LastName><ForeName>Shashikant</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patankar</LastName><ForeName>Suresh B</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khaladkar</LastName><ForeName>Suparn K</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padsalgi</LastName><ForeName>Gururaj A</ForeName><Initials>GA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhiraaj</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Surendra Kumar</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goyal</LastName><ForeName>Puneet</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Rajneesh Kumar</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mayilvagnan</LastName><ForeName>Sabaretnam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Anil</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prakash</LastName><ForeName>Anand</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menon</LastName><ForeName>Prem Haridas</ForeName><Initials>PH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nair Sarojini Amma</LastName><ForeName>Rajeev Damodaran</ForeName><Initials>RD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gurjar</LastName><ForeName>Vipul</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maharau</LastName><ForeName>Honeypal</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sigamani</LastName><ForeName>Alen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stephen</LastName><ForeName>Manesh</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chaudhry</LastName><ForeName>Navneet Kumar</ForeName><Initials>NK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abraham</LastName><ForeName>Valsamma</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calton</LastName><ForeName>Rajneesh</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guhabiswas</LastName><ForeName>Rahul</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomasso</LastName><ForeName>Nora Di</ForeName><Initials>ND</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dalessandro</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galbiati</LastName><ForeName>Carola</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nisi</LastName><ForeName>Francesco G</ForeName><Initials>FG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valsecchi</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Donato</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrara</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oriani</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerrerio</LastName><ForeName>Tancredi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donarini</LastName><ForeName>Cesare</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iacurti</LastName><ForeName>Marisa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghanem</LastName><ForeName>Georges</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brusasco</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orefice</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corradi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gandini</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosa</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maio</LastName><ForeName>Silvia Di</ForeName><Initials>SD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spanio Capra</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mameli</LastName><ForeName>Leila</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bosio</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Blasio</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zagra</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perazzo</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colombo</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marra</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheong</LastName><ForeName>Chao Chia</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Tyng Yan</ForeName><Initials>TY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mansor</LastName><ForeName>Marzida</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hussain</LastName><ForeName>Nur Azreen</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yeow</LastName><ForeName>Ri Qi</ForeName><Initials>RQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Xue Lin</ForeName><Initials>XL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choy</LastName><ForeName>Yang Qun</ForeName><Initials>YQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>Yuen Sin</ForeName><Initials>YS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gan</LastName><ForeName>Choo Kian</ForeName><Initials>CK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Ka Ting</ForeName><Initials>KT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shahril</LastName><ForeName>Nor Fadhilah</ForeName><Initials>NF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Razali</LastName><ForeName>Farah Nadia</ForeName><Initials>FN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahmad Adlan</LastName><ForeName>Aizura Syafinaz</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chee</LastName><ForeName>Kok-Han</ForeName><Initials>KH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Boon Keat</ForeName><Initials>BK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teo</LastName><ForeName>Shu Ching</ForeName><Initials>SC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsan</LastName><ForeName>Samuel E H</ForeName><Initials>SEH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lim</LastName><ForeName>Yong Peng</ForeName><Initials>YP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khaw</LastName><ForeName>Soon Keong</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Tze Ling</ForeName><Initials>TL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ngen</LastName><ForeName>Camilla J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ak Dennis Gimang</LastName><ForeName>Abigail D R</ForeName><Initials>ADR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sim</LastName><ForeName>Hran Cisca Hy</ForeName><Initials>HCH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jap</LastName><ForeName>Choo Pei</ForeName><Initials>CP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sia</LastName><ForeName>Kee Chai</ForeName><Initials>KC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siow</LastName><ForeName>Sze Li</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheah</LastName><ForeName>Seleen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Loo</LastName><ForeName>Su Yin</ForeName><Initials>SY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poh</LastName><ForeName>Yeh Han</ForeName><Initials>YH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woo</LastName><ForeName>Yoke Yin</ForeName><Initials>YY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tahir</LastName><ForeName>Siti Hawa</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Meng-Li</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chin</LastName><ForeName>Im Im</ForeName><Initials>II</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mansor</LastName><ForeName>Azelia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tang</LastName><ForeName>Eric B K</ForeName><Initials>EBK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muslim</LastName><ForeName>Halimatun S</ForeName><Initials>HS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shuib</LastName><ForeName>Zettie</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yong</LastName><ForeName>Chow Yen</ForeName><Initials>CY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luah</LastName><ForeName>Lean Wah</ForeName><Initials>LW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khoo</LastName><ForeName>Teik Hooi</ForeName><Initials>TH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manogharan</LastName><ForeName>Hema Malini</ForeName><Initials>HM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohd Saleh</LastName><ForeName>Siti Sufia</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tusirin</LastName><ForeName>Teh Wahida</ForeName><Initials>TW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ismail</LastName><ForeName>Sabreena</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lau</LastName><ForeName>Boon Tiang</ForeName><Initials>BT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shio</LastName><ForeName>Soon Keat</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiang</LastName><ForeName>Chun Fai</ForeName><Initials>CF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tien</LastName><ForeName>Joyce</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landman</LastName><ForeName>Ellie B M</ForeName><Initials>EBM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gelderman</LastName><ForeName>Stefan J</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cobben</LastName><ForeName>Jan-Hein M G</ForeName><Initials>JMG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Staffhorst</LastName><ForeName>Bas</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mes</LastName><ForeName>Roel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elskamp-Meijerman</LastName><ForeName>Hannie</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voskamp-Wierik Te</LastName><ForeName>Monique</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dijkgraaf</LastName><ForeName>Rochel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welberg</LastName><ForeName>Kim M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Postmus</LastName><ForeName>Judith J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wagenvoort</LastName><ForeName>Silke J</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Lier</LastName><ForeName>Felix</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Bruchem</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gr&#xfc;ne</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maxwell</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campbell</LastName><ForeName>Douglas</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McAllister</LastName><ForeName>Davina</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Vikrant</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Leanda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dandy</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vogts</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall Wilson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dale-Gandar</LastName><ForeName>Julius</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Denman</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lightfoot</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olliff</LastName><ForeName>Sue</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Houston</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Breadnam</LastName><ForeName>Reuben</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masters</LastName><ForeName>Sioux</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Termaat</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mans</LastName><ForeName>Gay</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldstone</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mouton</LastName><ForeName>Glenda</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zahid</LastName><ForeName>Tehreem</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azam</LastName><ForeName>Sumeyya</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sohail</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aimon</LastName><ForeName>Yumna Sibgha</ForeName><Initials>YS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uneeb</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yusufi</LastName><ForeName>Maaz Ahmed</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nazir</LastName><ForeName>Zia</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Awan</LastName><ForeName>Sundus Ayub</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nazir</LastName><ForeName>Mohsin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rasheed</LastName><ForeName>Madeeha</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Haris</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rehman</LastName><ForeName>Azhar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shariff</LastName><ForeName>Amir</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rehman</LastName><ForeName>Zia Ur</ForeName><Initials>ZU</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anjum</LastName><ForeName>Anila</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chwala</LastName><ForeName>Maciej</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorka</LastName><ForeName>Jacek</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Studzi&#x144;ska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jelinek</LastName><ForeName>Marcin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Domaszewicz</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wajda</LastName><ForeName>Weronika</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kudli&#x144;ski</LastName><ForeName>Bartosz</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zawisza</LastName><ForeName>Jaros&#x142;aw</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kauf</LastName><ForeName>Ilona</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wirtek</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grochulski</LastName><ForeName>Damian</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grudzien</LastName><ForeName>Pawel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mirek</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Efremov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kulikov</LastName><ForeName>Alexey Y</ForeName><Initials>AY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alexeev</LastName><ForeName>Mikhail A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trukhin</LastName><ForeName>Konstantin S</ForeName><Initials>KS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cherednichenko</LastName><ForeName>Andrey A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andrianova</LastName><ForeName>Irina A</ForeName><Initials>IA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mikhailova</LastName><ForeName>Svetlana S</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sorokin</LastName><ForeName>Andrey A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leonova</LastName><ForeName>Elizaveta A</ForeName><Initials>EA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dzhumatov</LastName><ForeName>Timur A</ForeName><Initials>TA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuleshov</LastName><ForeName>Oleg V</ForeName><Initials>OV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Safronov</LastName><ForeName>Alexander A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nepomnyaschaya</LastName><ForeName>Svetlana L</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kotova</LastName><ForeName>Anna S</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stoliarov</LastName><ForeName>Maxim S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shmatov</LastName><ForeName>Dmitry V</ForeName><Initials>DV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kubin</LastName><ForeName>Nikita S</ForeName><Initials>NS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalieva</LastName><ForeName>Nazym A</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shkarupa</LastName><ForeName>Dmitry D</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shirshova</LastName><ForeName>Elena A</ForeName><Initials>EA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Astrakov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neporada</LastName><ForeName>Elena L</ForeName><Initials>EL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kungurtsev</LastName><ForeName>Konstantin N</ForeName><Initials>KN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhukov</LastName><ForeName>Vyacheslav V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Werner</LastName><ForeName>Ilya G</ForeName><Initials>IG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chudnovets</LastName><ForeName>Igor Yu</ForeName><Initials>IY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karpenko</LastName><ForeName>Andrey A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ismoilov</LastName><ForeName>Samandar M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abubakirova</LastName><ForeName>Olga A</ForeName><Initials>OA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zeidlits</LastName><ForeName>Galina A</ForeName><Initials>GA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deryagin</LastName><ForeName>Mikhail N</ForeName><Initials>MN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vedernikov</LastName><ForeName>Pavel E</ForeName><Initials>PE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomivorotova</LastName><ForeName>Liudmila V</ForeName><Initials>LV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cherniavskiy</LastName><ForeName>Alexander M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moroz</LastName><ForeName>Gleb B</ForeName><Initials>GB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osinsky</LastName><ForeName>Roman V</ForeName><Initials>RV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abubakirov</LastName><ForeName>Marat N</ForeName><Initials>MN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirov</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuzkov</LastName><ForeName>Vsevolod V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hussain</LastName><ForeName>Ayyaz</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smetkin</LastName><ForeName>Alexey A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carionova</LastName><ForeName>Darja V</ForeName><Initials>DV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ilyina</LastName><ForeName>Yana Y</ForeName><Initials>YY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volkov</LastName><ForeName>Dmitrii A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fot</LastName><ForeName>Evgenia V</ForeName><Initials>EV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sokolova</LastName><ForeName>Maria M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veshnyakova</LastName><ForeName>Maria V</ForeName><Initials>MV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lochekhina</LastName><ForeName>Evgenia B</ForeName><Initials>EB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ovezov</LastName><ForeName>Alexey M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berikashvili</LastName><ForeName>Levan B</ForeName><Initials>LB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerasimenko</LastName><ForeName>Oleg N</ForeName><Initials>ON</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ermokhina</LastName><ForeName>Nadezhda V</ForeName><Initials>NV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryabova</LastName><ForeName>Ekaterina V</ForeName><Initials>EV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Subbotin</LastName><ForeName>Valerii V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kusovlev</LastName><ForeName>Artem N</ForeName><Initials>AN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kadanceva</LastName><ForeName>Kristina K</ForeName><Initials>KK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klimov</LastName><ForeName>Andrei A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yadgarov</LastName><ForeName>Mikhail Y</ForeName><Initials>MY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsiryateva</LastName><ForeName>S B</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergh</LastName><ForeName>Kobus</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cloete</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coetzee</LastName><ForeName>Ettienne</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flint</LastName><ForeName>Margot</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nejthardt</LastName><ForeName>Marcin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becker</LastName><ForeName>Jan H R</ForeName><Initials>JHR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathijs</LastName><ForeName>SSophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenhard</LastName><ForeName>Bernd G</ForeName><Initials>BG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frankish</LastName><ForeName>Leanne K</ForeName><Initials>LK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paniagua</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diaz</LastName><ForeName>Ruben</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Felipe</LastName><ForeName>Mar</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guadalupe</LastName><ForeName>Nerea</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azparren</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cegarra</LastName><ForeName>Virginia</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>India</LastName><ForeName>Inma</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Aranzazu</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delgado</LastName><ForeName>Anabel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fite</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alvarez-Garcia</LastName><ForeName>Jesus</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguado</LastName><ForeName>Hector J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berrocal-Cuadrado</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mateos-&#xc1;lvarez</LastName><ForeName>Elvira</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pereda-Manso</LastName><ForeName>Adela</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cervera-D&#xed;az</LastName><ForeName>M Carmen</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mart&#xed;nez-Municio</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garc&#xed;a-Virto</LastName><ForeName>Virginia</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alvarez-Ramos</LastName><ForeName>Bego&#xf1;a A</ForeName><Initials>BA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Plata</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ganso</LastName><ForeName>Abel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vall&#xe9;s-Urriza</LastName><ForeName>Pablo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noriega</LastName><ForeName>David C</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Nadal</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cano</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasini</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galan</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madrid</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camio</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Miguel</LastName><ForeName>Marcos</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chocron</LastName><ForeName>Ivette</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Susana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butron</LastName><ForeName>Dina</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidal</LastName><ForeName>Gemma</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Maria T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bel&#xe9;n Serrano</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>G&#xf3;mez-Rojo</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Candela-Toha</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Del Rey</LastName><ForeName>Jose Manuel</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castro</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garc&#xed;a S&#xe1;nchez</LastName><ForeName>J I</ForeName><Initials>JI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Molina</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zamudio</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Var&#xf3;n</LastName><ForeName>Viviana</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tena</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Comino-Trinidad</LastName><ForeName>Oscar</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sol&#xe9;</LastName><ForeName>Carla</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vendrell</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monsalve</LastName><ForeName>Concepci&#xf3;n</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beltran</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matute</LastName><ForeName>Purificaci&#xf3;n</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez-Baamonde</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ti&#xf3;</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vives</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Regi</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torres</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rampal</LastName><ForeName>Tarannum</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Makowski</LastName><ForeName>Arystarch Miron</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Iram</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kyere-Diabour</LastName><ForeName>Thyra</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vizcaychipi</LastName><ForeName>Marcela P</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shashank</LastName><ForeName>Patil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carungcong</LastName><ForeName>Jaime</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thayaparan</LastName><ForeName>Surendini</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maheshwari</LastName><ForeName>Kamal</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kopyeva</LastName><ForeName>Tatyana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traul</LastName><ForeName>David E</ForeName><Initials>DE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avitsian</LastName><ForeName>Rafi</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cywinski</LastName><ForeName>Jacek B</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keebler</LastName><ForeName>Allen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritzman</LastName><ForeName>Stacy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machado</LastName><ForeName>Sandra B</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manlapaz</LastName><ForeName>Mariel R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turan</LastName><ForeName>Alparslan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabry</LastName><ForeName>Ayad</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chahar</LastName><ForeName>Praveen</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ekrami</LastName><ForeName>Elyad</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez-Patarroyo</LastName><ForeName>Fabio A</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bravo</LastName><ForeName>Mauro</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cohen</LastName><ForeName>Barak</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Essber</LastName><ForeName>Hani</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agudelo-Jimenez</LastName><ForeName>Ruben</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivas</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saha</LastName><ForeName>Partha</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niazi</LastName><ForeName>Azfar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volio</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Daniel D</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Araujo-Duran</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scher</LastName><ForeName>Eitan</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassan</LastName><ForeName>Manal</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Subramanium</LastName><ForeName>Gandhivarma</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pelle</LastName><ForeName>Dominic</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosen</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorgun</LastName><ForeName>Emre</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kumar</LastName><ForeName>Priya A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arora</LastName><ForeName>Harendra</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Meena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cata</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corrales</LastName><ForeName>German</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Purugganan</LastName><ForeName>Ronaldo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Norman</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Idowu</LastName><ForeName>Olakunle</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weaver</LastName><ForeName>Tristan E</ForeName><Initials>TE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergese</LastName><ForeName>Sergio D</ForeName><Initials>SD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uribe</LastName><ForeName>Alberto A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasek</LastName><ForeName>Joshua D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borell-Vega</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hatten</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dada</LastName><ForeName>Olufunke</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKeown</LastName><ForeName>Johnny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorda-Diaz</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Echeverria-Villalobos</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Essandoh</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Camila</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nasim</LastName><ForeName>Syed</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noguera</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luis</LastName><ForeName>Santiago</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pimentel</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raut</LastName><ForeName>Snehal</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baral</LastName><ForeName>Sameep</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Plata Aguilar</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arazo</LastName><ForeName>Luz Divina</ForeName><Initials>LD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giraldo</LastName><ForeName>Andres</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minear</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Scott Alan</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cusson</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Lynne</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rose</LastName><ForeName>Sydney E</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinkert</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akhtar</LastName><ForeName>Shamsuddin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Treggiari</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kampp</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Snegovskikh</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kendall</LastName><ForeName>Mark C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wagener</LastName><ForeName>Gebhard</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hittesdorf</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35363452</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2201171</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39288368</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>210</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Lung-Protective Mechanical Ventilation in Patients with Severe Acute Brain Injury: A Multicenter Randomized Clinical Trial (PROLABI).</ArticleTitle><Pagination><StartPage>1123</StartPage><EndPage>1131</EndPage><MedlinePgn>1123-1131</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.202402-0375OC</ELocationID><Abstract><AbstractText><b>Rationale:</b> Lung-protective strategies using low Vt and moderate positive end-expiratory pressure (PEEP) are considered best practice in critical care, but interventional trials have never been conducted in patients with acute brain injuries because of concerns about carbon dioxide control and the effect of PEEP on cerebral hemodynamics. <b>Objectives:</b> To test the hypothesis that ventilation with lower VT and higher PEEP compared to conventional ventilation would improve clinical outcomes in patients with acute brain injury. <b>Methods:</b> In this multicenter, open-label, controlled clinical trial, 190 adult patients with acute brain injury were assigned to receive either a lung-protective or a conventional ventilatory strategy. The primary outcome was a composite endpoint of death, ventilator dependency, and acute respiratory distress syndrome (ARDS) at Day 28. Neurological outcome was assessed at ICU discharge by the Oxford Handicap Scale and at 6 months by the Glasgow Outcome Scale. <b>Measurements and Main Results:</b> The two study arms had similar characteristics at baseline. In the lung-protective and conventional strategy groups, using an intention-to-treat approach, the composite outcome at 28 days was 61.5% and 45.3% (relative risk [RR], 1.35; 95% confidence interval [CI], 1.03-1.79; <i>P</i>&#x2009;=&#x2009;0.025). Mortality was 28.9% and 15.1% (RR, 1.91; 95% CI, 1.06-3.42; <i>P</i>&#x2009;=&#x2009;0.02), ventilator dependency was 42.3% and 27.9% (RR, 1.52; 95% CI, 1.01-2.28; <i>P</i>&#x2009;=&#x2009;0.039), and incidence of ARDS was 30.8% and 22.1% (RR, 1.39; 95% CI, 0.85-2.27; <i>P</i>&#x2009;=&#x2009;0.179), respectively. The trial was stopped after enrolling 190 subjects because of termination of funding. <b>Conclusions:</b> In patients with acute brain injury without ARDS, a lung-protective ventilatory strategy, as compared with a conventional strategy, did not reduce mortality, percentage of patients weaned from mechanical ventilation, or incidence of ARDS and was not beneficial in terms of neurological outcomes. Because of the early termination, these preliminary results require confirmation in larger trials. Clinical trial registered with www.clinicaltrials.gov (NCT01690819).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mascia</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine (DIMES), Campus Ecotekne, University of Salento, Lecce, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fanelli</LastName><ForeName>Vito</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care, and Emergency, Citt&#xe0; della Salute e della Scienza di Torino University Hospital - Molinette Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mistretta</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Unit, Citt&#xe0; della Salute e della Scienza di Torino University Hospital - Orthopedic and Trauma Center, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care, and Emergency, Spedali Civili University Hospital, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanin</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berardino</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Unit, Citt&#xe0; della Salute e della Scienza di Torino University Hospital - Orthopedic and Trauma Center, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzeo</LastName><ForeName>Anna Teresa</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Adult and Pediatric Pathology, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caricato</LastName><ForeName>Anselmo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurosurgical Intensive Care Unit and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesiology and Critical Care, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Corte</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine, Universit&#xe0; del Piemonte Orientale, Novara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care Medicine, Maggiore della Carit&#xe0; University Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grossi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care Medicine, Maggiore della Carit&#xe0; University Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munari</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, University Hospital of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caravello</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Intensive Care, University Hospital of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessandri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General Surgery and Organ Transplantation Unit, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavalli</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences (DIMEC) and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezzapesa</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Surgery and Organ Transplantation Unit, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvestri</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Surgery and Organ Transplantation Unit, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casartelli Liviero</LastName><ForeName>Marilena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Integrated University Hospital of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanatta</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Integrated University Hospital of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Citerio</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Neuroscience, Neurointensive Care, ASST-Monza, Monza, Italy; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rucci</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), Alma Mater Studiorum University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasulo</LastName><ForeName>Frank A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care, and Emergency, Spedali Civili University Hospital, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonetti</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9676-3595</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences (DIMEC) and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and General Intensive Care Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01690819</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>ex 60% 2012-2015</GrantID><Agency>Universit&#xe0; degli Studi di Torino</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2024 Nov 1;210(9):1073-1075. doi: 10.1164/rccm.202409-1766ED.</RefSource><PMID Version="1">39404599</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="N">Brain Injuries</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute brain injury</Keyword><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">lung-protective ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>17</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>17</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39288368</ArticleId><ArticleId IdType="doi">10.1164/rccm.202402-0375OC</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37280579</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Mechanical ventilation in patients with acute brain injury: a systematic review with meta-analysis.</ArticleTitle><Pagination><StartPage>221</StartPage><MedlinePgn>221</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">221</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-023-04509-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To describe the potential effects of ventilatory strategies on the outcome of acute brain-injured patients undergoing invasive mechanical ventilation.</AbstractText><AbstractText Label="DESIGN">Systematic review with an individual data meta-analysis.</AbstractText><AbstractText Label="SETTING">Observational and interventional (before/after) studies published up to August 22nd, 2022, were considered for inclusion. We investigated the effects of low tidal volume Vt&#x2009;&lt;&#x2009;8&#xa0;ml/Kg of IBW versus Vt&#x2009;&gt;&#x2009;&#x2009;=&#x2009;8&#xa0;ml/Kg of IBW, positive end-expiratory pressure (PEEP)&#x2009;&lt;&#x2009;or&#x2009;&gt;&#x2009;&#x2009;=&#x2009;5 cmH<sub>2</sub>O and protective ventilation (association of both) on relevant clinical outcomes.</AbstractText><AbstractText Label="POPULATION">Patients with acute brain injury (trauma or haemorrhagic stroke) with invasive mechanical ventilation for&#x2009;&#x2265;&#x2009;24&#xa0;h.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary outcome was mortality at 28&#xa0;days or in-hospital mortality. Secondary outcomes were the incidence of acute respiratory distress syndrome (ARDS), the duration of mechanical ventilation and the partial pressure of oxygen (PaO<sub>2</sub>)/fraction of inspired oxygen (FiO<sub>2</sub>) ratio.</AbstractText><AbstractText Label="RESULTS">The meta-analysis included eight studies with a total of 5639 patients. There was no difference in mortality between low and high tidal volume [Odds Ratio, OR 0.88 (95%Confidence Interval, CI 0.74 to 1.05), p&#x2009;=&#x2009;0.16, I<sup>2</sup>&#x2009;=&#x2009;20%], low and moderate to high PEEP [OR 0.8 (95% CI 0.59 to 1.07), p&#x2009;=&#x2009;0.13, I<sup>2</sup>&#x2009;=&#x2009;80%] or protective and non-protective ventilation [OR 1.03 (95% CI 0.93 to 1.15), p&#x2009;=&#x2009;0.6, I<sup>2</sup>&#x2009;=&#x2009;11]. Low tidal volume [OR 0.74 (95% CI 0.45 to 1.21, p&#x2009;=&#x2009;0.23, I<sup>2</sup>&#x2009;=&#x2009;88%], moderate PEEP [OR 0.98 (95% CI 0.76 to 1.26), p&#x2009;=&#x2009;0.9, I<sup>2</sup>&#x2009;=&#x2009;21%] or protective ventilation [OR 1.22 (95% CI 0.94 to 1.58), p&#x2009;=&#x2009;0.13, I<sup>2</sup>&#x2009;=&#x2009;22%] did not affect the incidence of acute respiratory distress syndrome. Protective ventilation improved the PaO<sub>2</sub>/FiO<sub>2</sub> ratio in the first five days of mechanical ventilation (p&#x2009;&lt;&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSIONS">Low tidal volume, moderate to high PEEP, or protective ventilation were not associated with mortality and lower incidence of ARDS in patients with acute brain injury undergoing invasive mechanical ventilation. However, protective ventilation improved oxygenation and could be safely considered in this setting. The exact role of ventilatory management on the outcome of patients with a severe brain injury needs to be more accurately delineated.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asehnoune</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France. karim.asehnoune@chu-nantes.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, H&#xf4;tel-Dieu, University Hospital of Nantes, 1 Place Alexis Ricordeau, 44093, Nantes, France. karim.asehnoune@chu-nantes.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rooze</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Robba</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anesthesia and Critical Care, San Martino Policlinico Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouras</LastName><ForeName>Marwan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascia</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinotti</LastName><ForeName>Rapha&#xeb;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, 44000, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Critical Care, San Martino Policlinico Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roquilly</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, CHU Nantes, P&#xf4;le Anesth&#xe9;sie R&#xe9;animations, Service d'Anesth&#xe9;sie R&#xe9;animation Chirurgicale, H&#xf4;tel Dieu, 44093, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nantes Universit&#xe9;, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, 44000, Nantes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="Y">Brain Injuries</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Dr Cinotti has received consulting fees for PAION outside the scope of the study. Dr Roquilly reported receiving grants and consulting fees from Merck and bioM&#xe9;rieux outside the scope of the study. Dr Asehnoune reported receiving lecture fees from Baxter, Fisher &amp; Paykel, and LFB and consulting fees from Edwards Lifesciences and LFB, outside the scope of this study. The other authors do not have any conflict of interest to declare. No competing interest is to be declared regarding the present work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>6</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37280579</ArticleId><ArticleId IdType="pmc">PMC10242967</ArticleId><ArticleId IdType="doi">10.1186/s13054-023-04509-3</ArticleId><ArticleId IdType="pii">10.1186/s13054-023-04509-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collaborators G. TBI and SCI (2019) Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2016;18:56&#x2013;87. doi: 10.1016/s1474-4422(18)30415-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(18)30415-0</ArticleId><ArticleId IdType="pmc">PMC6291456</ArticleId><ArticleId IdType="pubmed">30497965</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990&#x2013;2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877&#x2013;897. 10.1016/s1474-4422(17)30299-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641502</ArticleId><ArticleId IdType="pubmed">28931491</ArticleId></ArticleIdList></Reference><Reference><Citation>Roquilly A, Cinotti R, Jaber S, et al. Implementation of an evidence-based extubation readiness bundle in 499 brain-injured patients. a before-after evaluation of a quality improvement project. Am J Respir Crit Care Med. 2013;188:958&#x2013;966. doi: 10.1164/rccm.201301-0116oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201301-0116oc</ArticleId><ArticleId IdType="pubmed">23927561</ArticleId></ArticleIdList></Reference><Reference><Citation>Beduneau G, Pham T, Schortgen F, et al. Epidemiology of weaning outcome according to a new definition. The WIND Study. Am J Respir Crit Care Med. 2016 doi: 10.1164/rccm.201602-0320oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201602-0320oc</ArticleId><ArticleId IdType="pubmed">27626706</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascia L, Andrews PJ. Acute lung injury in head trauma patients. Intensive Care Med. 1998;24:1115&#x2013;1116. doi: 10.1007/s001340050727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050727</ArticleId><ArticleId IdType="pubmed">9840251</ArticleId></ArticleIdList></Reference><Reference><Citation>The ARDS Definition Task Force*. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526&#x2013;2533 10.1001/jama.2012.5669.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Cardoso SO, Manetta JA, et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA J Am Med Assoc. 2012;308:1651&#x2013;1659. doi: 10.1001/jama.2012.13730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.13730</ArticleId><ArticleId IdType="pubmed">23093163</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban A, Ferguson ND, Meade MO, et al. Evolution of mechanical ventilation in response to clinical research. Am J Respir Crit Care Med. 2008;177:170&#x2013;177. doi: 10.1164/rccm.200706-893oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200706-893oc</ArticleId><ArticleId IdType="pubmed">17962636</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Ferguson ND, Frutos-Vivar F, et al. Management and outcome of mechanically ventilated neurologic patients*. Crit Care Med. 2011;39:1482&#x2013;1492. doi: 10.1097/ccm.0b013e31821209a8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0b013e31821209a8</ArticleId><ArticleId IdType="pubmed">21378554</ArticleId></ArticleIdList></Reference><Reference><Citation>Asehnoune K, Mrozek S, Perrigault PF, et al. A multi-faceted strategy to reduce ventilation-associated mortality in brain-injured patients. The BI-VILI project: a nationwide quality improvement project. Intensive Care Med. 2017;287:345&#x2013;414. doi: 10.1007/s00134-017-4764-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4764-6</ArticleId><ArticleId IdType="pubmed">28315940</ArticleId></ArticleIdList></Reference><Reference><Citation>Picetti E, Pelosi P, Taccone FS, et al. VENTILatOry strategies in patients with severe traumatic brain injury: the VENTILO survey of the European society of intensive care medicine (ESICM) Crit Care. 2020;24:158. doi: 10.1186/s13054-020-02875-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02875-w</ArticleId><ArticleId IdType="pmc">PMC7165367</ArticleId><ArticleId IdType="pubmed">32303255</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M, Higgins JPT, Hedges LV, Rothstein HR. Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Res Synth Methods. 2017;8:5&#x2013;18. doi: 10.1002/jrsm.1230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1230</ArticleId><ArticleId IdType="pubmed">28058794</ArticleId></ArticleIdList></Reference><Reference><Citation>Asehnoune K, Lasocki S, Seguin P, et al. Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury&#x2014;a multicentre prospective cohort study and systematic review. Crit Care. 2017;21:2383&#x2013;2411. doi: 10.1186/s13054-017-1918-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1918-4</ArticleId><ArticleId IdType="pmc">PMC5745762</ArticleId><ArticleId IdType="pubmed">29282104</ArticleId></ArticleIdList></Reference><Reference><Citation>Asehnoune K, Seguin P, Lasocki S, et al. Extubation success prediction in a multicentric cohort of patients with severe brain injury. Anesthesiology. 2017;127:338&#x2013;346. doi: 10.1097/aln.0000000000001725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000001725</ArticleId><ArticleId IdType="pubmed">28640020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasocki S, Chudeau N, Papet T, et al. Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study. Crit Care. 2014;18:542. doi: 10.1186/s13054-014-0542-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0542-9</ArticleId><ArticleId IdType="pmc">PMC4219000</ArticleId><ArticleId IdType="pubmed">25529060</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Poole D, McNett M, et al. Mechanical ventilation in patients with acute brain injury: recommendations of the European society of intensive care medicine consensus. Intens Care Med. 2020;14:S261&#x2013;S314. doi: 10.1007/s00134-020-06283-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06283-0</ArticleId><ArticleId IdType="pmc">PMC7655906</ArticleId><ArticleId IdType="pubmed">33175276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesnut RM, Temkin N, Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012;367:2471&#x2013;2481. doi: 10.1056/nejmoa1207363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1207363</ArticleId><ArticleId IdType="pmc">PMC3565432</ArticleId><ArticleId IdType="pubmed">23234472</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth M, Thom&#xe9; C, Schmiedek,, et al. Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants: clinical article. J Neurosurg. 2009;110:955&#x2013;960. doi: 10.3171/2008.2.17670.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2008.2.17670</ArticleId><ArticleId IdType="pubmed">19216650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Dionne S, Simard S, et al. High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology. 2012;116:1072&#x2013;1082. doi: 10.1097/aln.0b013e3182522df5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0b013e3182522df5</ArticleId><ArticleId IdType="pubmed">22450472</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301&#x2013;8. 10.1056/nejm200005043421801</Citation><ArticleIdList><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Dianti J, Tisminetzky M, Ferreyro BL, et al. Association of positive end-expiratory pressure and lung recruitment selection strategies with mortality in acute respiratory distress syndrome: a systematic review and network meta-analysis. Am J Resp Crit Care. 2022;205:1300&#x2013;1310. doi: 10.1164/rccm.202108-1972oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1972oc</ArticleId><ArticleId IdType="pubmed">35180042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball, L., Serpa Neto, A., Trifiletti, V. et al. Effects of higher PEEP and recruitment manoeuvres on mortality in patients with ARDS: a systematic review, meta-analysis, meta-regression and trial sequential analysis of randomized controlled trials. Intens Care Med Exp 8:39 10.1186/s40635-020-00322-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746429</ArticleId><ArticleId IdType="pubmed">33336325</ArticleId></ArticleIdList></Reference><Reference><Citation>Albaiceta GM, Brochard L, Santos CCD, et al. The central nervous system during lung injury and mechanical ventilation: a narrative review. Brit J Anaesth. 2021;127:648&#x2013;659. doi: 10.1016/j.bja.2021.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.05.038</ArticleId><ArticleId IdType="pubmed">34340836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina E, Pelosi P, Muriel A, et al. Association between ventilatory settings and development of acute respiratory distress syndrome in mechanically ventilated patients due to brain injury. J Crit Care. 2017;38:341&#x2013;345. doi: 10.1016/j.jcrc.2016.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.11.010</ArticleId><ArticleId IdType="pubmed">27914908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006 doi: 10.1097/01.ccm.0000201903.46435.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000201903.46435.35</ArticleId><ArticleId IdType="pubmed">16521258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn JM, Caldwell EC, Deem S, et al. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med. 2006;34:196&#x2013;202. doi: 10.1097/01.ccm.0000194540.44020.8e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000194540.44020.8e</ArticleId><ArticleId IdType="pubmed">16374174</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators WG for the Pr, Simonis FD, Neto AS et al. Effect of a low vs. intermediate tidal volume strategy on ventilator-free days in intensive care unit patients without ARDS: a randomized clinical trial. JAMA 2018;320:1872. 10.1001/jama.2018.14280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248136</ArticleId><ArticleId IdType="pubmed">30357256</ArticleId></ArticleIdList></Reference><Reference><Citation>Group WC and SC for the RelaC. Algera AG, Pisani L, et al. Effect of a lower vs. higher positive end-expiratory pressure strategy on ventilator-free days in ICU patients without ARDS. JAMA. 2020;324:2509&#x2013;2520. doi: 10.1001/jama.2020.23517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.23517</ArticleId><ArticleId IdType="pmc">PMC7726701</ArticleId><ArticleId IdType="pubmed">33295981</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ldner A, Kiss T, Neto AS, et al. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications. Anesthesiology. 2015;123:692&#x2013;713. doi: 10.1097/aln.0000000000000754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000000754</ArticleId><ArticleId IdType="pubmed">26120769</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, et al. Effect of intraoperative low tidal volume vs. conventional tidal volume on postoperative pulmonary complications in patients undergoing major surgery. JAMA. 2020;324:848&#x2013;911. doi: 10.1001/jama.2020.12866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="pubmed">32870298</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos NS, Bluth T, Hemmes SNT, et al. Intraoperative positive end-expiratory pressure and postoperative pulmonary complications: a patient-level meta-analysis of three randomized clinical trials. Brit J Anaesth. 2022;128:1040&#x2013;1051. doi: 10.1016/j.bja.2022.02.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.02.039</ArticleId><ArticleId IdType="pubmed">35431038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascia L, Zavala E, Bosma K, et al. High tidal volume is associated with the development of acute lung injury after severe brain injury: an international observational study. Crit Care Med. 2007;35:1815&#x2013;1820. doi: 10.1097/01.ccm.0000275269.77467.df.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000275269.77467.df</ArticleId><ArticleId IdType="pubmed">17568331</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmer J, Hou P, Wilcox SR, et al. Acute respiratory distress syndrome after spontaneous intracerebral hemorrhage*. Crit Care Med. 2013;41:1992&#x2013;2001. doi: 10.1097/ccm.0b013e31828a3f4d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0b013e31828a3f4d</ArticleId><ArticleId IdType="pmc">PMC3752686</ArticleId><ArticleId IdType="pubmed">23760151</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemer SN, Caldeira JB, Santos RG, et al. Effects of positive end-expiratory pressure on brain tissue oxygen pressure of severe traumatic brain injury patients with acute respiratory distress syndrome: a pilot study. J Crit Care. 2015;30:1263&#x2013;1266. doi: 10.1016/j.jcrc.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.07.019</ArticleId><ArticleId IdType="pubmed">26307004</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin J-M, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369:428&#x2013;437. doi: 10.1056/nejmoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Asehnoune K, Seguin P, Allary J, et al. Corti-TC Study Group. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomized placebo-controlled trial. Lancet Respir Med. 2014;2(9):706&#x2013;16. 10.1016/S2213-2600(14)70144-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25066331</ArticleId></ArticleIdList></Reference><Reference><Citation>Valadka AB, Gopinath SP, Contant CF, et al. Relationship of brain tissue PO2 to outcome after severe head injury. Crit Care Med. 1998;26(9):1576&#x2013;1581. doi: 10.1097/00003246-199809000-00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199809000-00029</ArticleId><ArticleId IdType="pubmed">9751596</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Asgari S, Gupta A, et al. Lung injury is a predictor of cerebral hypoxia and mortality in traumatic brain injury. Front Neurol. 2020;11:771. doi: 10.3389/fneur.2020.00771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00771</ArticleId><ArticleId IdType="pmc">PMC7426476</ArticleId><ArticleId IdType="pubmed">32849225</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31726013</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>201</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Mechanical Ventilation for Acute Respiratory Distress Syndrome during Extracorporeal Life Support. Research and Practice.</ArticleTitle><Pagination><StartPage>514</StartPage><EndPage>525</EndPage><MedlinePgn>514-525</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201907-1283CI</ELocationID><Abstract><AbstractText>Ventilator-induced lung injury remains a key contributor to the morbidity and mortality of acute respiratory distress syndrome (ARDS). Efforts to minimize this injury are typically limited by the need to preserve adequate gas exchange. In the most severe forms of the syndrome, extracorporeal life support is increasingly being deployed for severe hypoxemia or hypercapnic acidosis refractory to conventional ventilator management strategies. Data from a recent randomized controlled trial, a <i>post hoc</i> analysis of that trial, a meta-analysis, and a large international multicenter observational study suggest that extracorporeal life support, when combined with lower Vt and airway pressures than the current standard of care, may improve outcomes compared with conventional management in patients with the most severe forms of ARDS. These findings raise important questions not only about the optimal ventilation strategies for patients receiving extracorporeal support but also regarding how various mechanisms of lung injury in ARDS may potentially be mitigated by ultra-lung-protective ventilation strategies when gas exchange is sufficiently managed with the extracorporeal circuit. Additional studies are needed to more precisely delineate the best strategies for optimizing invasive mechanical ventilation in this patient population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abrams</LastName><ForeName>Darryl</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Columbia University College of Physicians &amp; Surgeons/New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Acute Respiratory Failure, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INSERM, UMRS_1166-ICAN, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>T&#xe0;i</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, H&#xf4;pital de Bic&#xea;tre, H&#xf4;pitaux Universitaires Paris-Sud, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beitler</LastName><ForeName>Jeremy R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Columbia University College of Physicians &amp; Surgeons/New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Acute Respiratory Failure, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Eddy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respirology, Department of Medicine, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goligher</LastName><ForeName>Ewan C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respirology, Department of Medicine, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamee</LastName><ForeName>James J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Centre for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patroniti</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) for Oncology, San Martino Policlinico Hospital, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilcox</LastName><ForeName>M Elizabeth</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respirology, Department of Medicine, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Combes</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>INSERM, UMRS_1166-ICAN, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferguson</LastName><ForeName>Niall D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respirology, Department of Medicine, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAuley</LastName><ForeName>Danny F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Centre for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesenti</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Emergency Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintel</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University Medical Center, Georg August University, Goettingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, Prince Charles Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodgson</LastName><ForeName>Carol L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiotherapy Department and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hough</LastName><ForeName>Catherine L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercat</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de M&#xe9;decine Intensive-R&#xe9;animation et M&#xe9;decine Hyperbare, Centre Hospitalier Universitaire d'Angers, Universit&#xe9; d'Angers, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrino</LastName><ForeName>Vin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, The Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>V Marco</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Alma Mater Studiorum-Dipartimento di Scienze Mediche e Chirurgiche, Anesthesia and Intensive Care Medicine, Policlinico di Sant'Orsola, Universit&#xe0; di Bologna, Bologna, Italy; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowan</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinical Trials Unit, Intensive Care National Audit &amp; Research Centre, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shekar</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, Prince Charles Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brochard</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodie</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Columbia University College of Physicians &amp; Surgeons/New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Acute Respiratory Failure, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HTA/13/143/02</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>142M471B3J</RegistryNumber><NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 Oct 1;202(7):1058-1059. doi: 10.1164/rccm.202005-1923LE.</RefSource><PMID Version="1">32502355</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 Oct 1;202(7):1057-1058. doi: 10.1164/rccm.202005-1609LE.</RefSource><PMID Version="1">32502357</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005112" MajorTopicYN="N">Extracorporeal Circulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011659" MajorTopicYN="N">Pulmonary Gas Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055397" MajorTopicYN="N">Ventilator-Induced Lung Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">extracorporeal carbon dioxide removal</Keyword><Keyword MajorTopicYN="N">extracorporeal life support</Keyword><Keyword MajorTopicYN="N">extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">ventilator-induced lung injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31726013</ArticleId><ArticleId IdType="doi">10.1164/rccm.201907-1283CI</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32205299</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Cardiac radioablation-A systematic review.</ArticleTitle><Pagination><StartPage>1381</StartPage><EndPage>1392</EndPage><MedlinePgn>1381-1392</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2020.03.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(20)30253-8</ELocationID><Abstract><AbstractText>Failure of drugs and catheter ablation procedures for the treatment of ventricular arrhythmias is still extremely relevant. Recently, stereotactic body radiotherapy has been introduced to treat therapy refractory patients. In this systematic review (International Prospective Register of Systematic Reviews, CRD42019133212), we aimed to summarize electrophysiological and histopathological effects of radioablation in animals, patients, and extracted and perfused hearts. A systematic search was performed in OVID MEDLINE, OVID Embase, the Cochrane Central Register of Controlled Trials, Web of Science, Google Scholar, ClinicalTrials.gov, and World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) from inception to September 2019. Identified records were independently screened for eligibility by 2 reviewers. Risk of bias and methodological quality were assessed using the SYRCLE, ROBINS-I, or Murad tool and tailored to the different study designs. We included 13 preclinical and 10 clinical publications. Large heterogeneity in study designs prompted a narrative synthesis approach. Baseline, (pre-)procedural details, outcome, target tissue analyses, and safety data were extracted and summarized. In animal studies evaluating electrophysiological parameters, radioablation induced a reduction in voltage/potential amplitude or bidirectional block in target areas in 93.2% of animals. Atrioventricular block (first to third degree) was induced in 78.3% of animals, and in studies evaluating ventricular arrhythmia inducibility, 75% reduction was achieved. In patients, predominantly ventricular tachycardias were targeted with &gt;85% reduction in arrhythmia episodes during follow-up with an encouraging short-term safety profile. Preclinical and clinical evidence on the efficacy and safety of radioablation is limited in both quantity and quality. The results of radioablation for therapy refractory patients with ventricular tachycardia are promising, but further research is needed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Ree</LastName><ForeName>Martijn H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanck</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany; Department of Internal Medicine III, Cardiology, Section for Electrophysiology, University Medical Center Schleswig-Holstein, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limpens</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Medical Library, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Charlie H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balgobind</LastName><ForeName>Brian V</ForeName><Initials>BV</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieleman</LastName><ForeName>Edith M T</ForeName><Initials>EMT</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilde</LastName><ForeName>Arthur A M</ForeName><Initials>AAM</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zei</LastName><ForeName>Paul C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Groot</LastName><ForeName>Joris R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slotman</LastName><ForeName>Ben J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuculich</LastName><ForeName>Phillip S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cardiovascular Division, Washington University Hospital, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Clifford G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cardiovascular Division, Washington University Hospital, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Postema</LastName><ForeName>Pieter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands. Electronic address: p.g.postema@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmias</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Radioablation</Keyword><Keyword MajorTopicYN="N">Stereotactic body radiotherapy</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32205299</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2020.03.013</ArticleId><ArticleId IdType="pii">S1547-5271(20)30253-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37380314</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy.</ArticleTitle><Pagination><StartPage>808</StartPage><EndPage>821</EndPage><MedlinePgn>808-821</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2023.01.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(23)00088-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Catheter ablation improves ventricular tachycardia (VT) event-free (time to event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous myocardial infarction (MI). The effects of ablation on recurrent VT and implantable cardioverter-defibrillator (ICD) therapy (burden) have yet to be investigated.</AbstractText><AbstractText Label="OBJECTIVES">This study sought to compare the VT and ICD therapy burden following treatment with either ablation or escalated AAD therapy among patients with VT and previous MI in the VANISH (Ventricular tachycardia AblatioN versus escalated antiarrhythmic drug therapy in ISchemic Heart disease) trial.</AbstractText><AbstractText Label="METHODS">The VANISH trial randomized patients with previous MI and VT despite initial AAD therapy to either escalated AAD treatment or catheter ablation. VT burden was defined as the total number of VT events treated with&#xa0;&#x2265;1 appropriate ICD therapy. Appropriate ICD therapy burden was defined as the total number of appropriate shocks or antitachycardia pacing therapies (ATPs) delivered. The Anderson-Gill recurrent event model was used to compare burden between the treatment arms.</AbstractText><AbstractText Label="RESULTS">Of the 259 enrolled patients (median age, 69.8 years; 7.0% women), 132 patients were randomized to ablation and 129 patients were randomized to escalated AAD therapy. Over 23.4&#xa0;months of follow-up, ablation-treated patients had a 40% lower shock-treated VT event burden and a 39% lower appropriate shock burden compared with patients who received escalated AAD therapy (P&#xa0;&lt;0.05 for all). A reduction in VT burden, ATP-treated VT event burden, and appropriate ATP burden among ablation patients was only demonstrated in the stratum of patients with amiodarone-refractory VT (P&#xa0;&lt;0.05 for all).</AbstractText><AbstractText Label="CONCLUSIONS">Among patients with AAD-refractory VT and a previous MI, catheter ablation reduced shock-treated VT event burden and appropriate shock burden compared with escalated AAD therapy. There was also lower VT burden, ATP-treated VT event burden, and appropriate ATP burden among ablation-treated patients; however, the effect was limited to patients with amiodarone-refractory VT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Healey</LastName><ForeName>Jeff S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nault</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Quebec Heart and Lung Institute, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterns</LastName><ForeName>Laurence D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Royal Jubilee Hospital, Victoria, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Essebag</LastName><ForeName>Vidal</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>McGill University Health Centre, Montreal, Quebec, Canada; H&#xf4;pital Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hruczkowski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardner</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parkash</LastName><ForeName>Ratika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapp</LastName><ForeName>John L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: John.Sapp@nshealth.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber><NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2023 Jun;9(6):822-823. doi: 10.1016/j.jacep.2023.05.017.</RefSource><PMID Version="1">37380315</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000638" MajorTopicYN="Y">Amiodarone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICD shocks</Keyword><Keyword MajorTopicYN="N">antiarrhythmic drugs</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">shock burden</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia burden</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures The VANISH trial was funded by the Canadian Institutes of Health Research, with additional financial support from St. Jude Medical and Biosense Webster. Dr Healey has served as a consultant for and has received speaker fees and research grants from Medtronic, Boston Scientific, and Abbott. Dr Nault has received honoraria from Biosense Webster, Servier, BMS-Pfizer, and Bayer. Dr Essebag has received a Fonds de recherche du Qu&#xe9;bec clinical research scholar award; and has received honoraria from Medtronic, Abbott, and Biosense Webster. Dr Parkash has received research funding from Abbott, Medtronic, and Novartis. Dr Sapp has received research funding from Biosense Webster and Abbott; and has received speaker fees or consulting honoraria from Medtronic, Abbott, Varian, and Biosense Webster. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>20</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37380314</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2023.01.030</ArticleId><ArticleId IdType="pii">S2405-500X(23)00088-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40287932</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>COOPERATIVE-PFA: A Three-Arm Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>150</StartPage><EndPage>159</EndPage><MedlinePgn>150-159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.125.074427</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Deep analgosedation (DAS) or general anesthesia is mandatory for pulsed-field ablation of atrial fibrillation. In contrast to DAS, general anesthesia (conventional or total intravenous anesthesia [TIVA]) requires airway management. To find the optimal sedation regimen, this study compared ketamine-remimazolam DAS and propofol-opioid TIVA with propofol-opioid DAS, focusing on sedation-related adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients indicated for atrial fibrillation catheter ablation were randomly assigned at a 1:1:1 ratio to: (1) DAS using intermittent propofol-opioid boluses (arm P), (2) continuous remimazolam-ketamine DAS (arm R), or (3) continuous propofol-opioid TIVA with secured airway (arm TIVA). Catheter ablation was performed using the FARAPULSE system (Boston Scientific, MA). The major exclusion criterion was obstructive sleep apnea syndrome. The primary end point was defined as a composite of hypoxemia, hypotensive, or hypertensive events requiring intervention or leading to procedure discontinuation. Secondary end points included hemodynamic instability events, procedure time, serious adverse events, and patient satisfaction.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">One-hundred twenty-seven patients (mean age 62.9&#xb1;10.3 years, 35.1% women, 47.2% with paroxysmal atrial fibrillation) were enrolled and randomized to the P (n=42), R (n=43), or TIVA (n=42) arms. The primary end point occurred in 85.7% of P patients, 27.9% of R patients, and 66.7% of TIVA patients (<i>P</i>&lt;0.001), driven by hypoxemia in the P arm (100% of patients with the primary end point) and by hypotension in the TIVA arm (100%). The R arm showed a similar distribution of hypoxemia (50%) and hypotensive (66.7%) events. No differences were observed in mean procedural time, rate of serious adverse events, and assessment of patient satisfaction.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In pulsed-field ablation procedures for atrial fibrillation, remimazolam-ketamine DAS was superior to propofol-opioid regimens (either boluses or continuous) and had the lowest risk of hypoxemia and hypotensive events. More than 80% of patients undergoing conventional propofol-opioid analgosedation experienced hypoxemia.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="UNASSIGNED">URL: https://www.clinicaltrials.gov; Unique identifier: NCT06013345.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sochorov&#xe1;</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (V.S., V.K., F.D., P.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kun&#x161;t&#xe1;tov&#xe1;</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (V.S., V.K., F.D., P.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman&#x10d;&#xed;k</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0482-4448</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du&#x161;ka</LastName><ForeName>Franti&#x161;ek</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1559-4078</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (V.S., V.K., F.D., P.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He&#x159;man</LastName><ForeName>Dalibor</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7436-1154</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldauf</LastName><ForeName>Petr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4668-5837</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (V.S., V.K., F.D., P.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povi&#x161;er</LastName><ForeName>Luk&#xe1;&#x161;</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Znojilov&#xe1;</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipcov&#xe1;</LastName><ForeName>V&#x11b;ra</ForeName><Initials>V</Initials><Identifier Source="ORCID">0009-0002-9536-2911</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hozmanov&#xe1;</LastName><ForeName>Jana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vesel&#xe1;</LastName><ForeName>Jana</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1048-2598</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hozman</LastName><ForeName>Marek</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4111-4218</Identifier><AffiliationInfo><Affiliation>Cardiocenter, Third Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic (P.O., D.H., L.P., J.K., L.Z., V.F., J.H., J.V., M.H.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06013345</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Circulation. 2025 Jul 22;152(3):160-162. doi: 10.1161/CIRCULATIONAHA.125.075339.</RefSource><PMID Version="1">40690554</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="Y">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054810" MajorTopicYN="Y">Deep Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">deep sedation</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>18</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>27</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>27</Day><Hour>11</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40287932</ArticleId><ArticleId IdType="pmc">PMC12272916</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.125.074427</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, et al. ; ESC Scientific Document Group. 2024 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024;45:3314&#x2013;3414. doi: 10.1093/eurheartj/ehae176</Citation><ArticleIdList><ArticleId IdType="pubmed">39210723</ArticleId></ArticleIdList></Reference><Reference><Citation>Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, et al. ; Peer Review Committee Members. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1&#x2013;e156. doi: 10.1161/CIR.0000000000001193</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11095842</ArticleId><ArticleId IdType="pubmed">38033089</ArticleId></ArticleIdList></Reference><Reference><Citation>Dello Russo A, Compagnucci P, Anselmino M, Schillaci V, Campanelli F, Ascione MR, Volpato G, Cipolletta L, Parisi Q, Valeri Y, et al. Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation: results of a multicenter, real-world experience. Heart Rhythm. 2024;21:1526&#x2013;1536. doi: 10.1016/j.hrthm.2024.05.042</Citation><ArticleIdList><ArticleId IdType="pubmed">38810922</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, Sediva L, Chovanec M, Dukkipati SR, Jais P. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74:315&#x2013;326. doi: 10.1016/j.jacc.2019.04.021</Citation><ArticleIdList><ArticleId IdType="pubmed">31085321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekanem E, Reddy VY, Schmidt B, Reichlin T, Neven K, Metzner A, Hansen J, Blaauw Y, Maury P, Arentz T, et al. ; MANIFEST-PF Cooperative. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace. 2022;24:1256&#x2013;1266. doi: 10.1093/europace/euac050</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9435639</ArticleId><ArticleId IdType="pubmed">35647644</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, Cochet H, Minami K, Breskovic T, Sikiric I, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7:614&#x2013;627. doi: 10.1016/j.jacep.2021.02.014</Citation><ArticleIdList><ArticleId IdType="pubmed">33933412</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt B, Bordignon S, Neven K, Reichlin T, Blaauw Y, Hansen J, Adelino R, Ouss A, F&#xfc;ting A, Roten L, et al. European real-world outcomes with pulsed field ablation in patients with symptomatic atrial fibrillation: lessons from the multi-centre EU-PORIA registry. Europace. 2023;25. doi: 10.1093/europace/euad185</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10320231</ArticleId><ArticleId IdType="pubmed">37379528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JG, Yoo KS, Byun YJ. Continuous infusion versus intermittent bolus injection of propofol during endoscopic retrograde cholangiopancreatography. Korean J Intern Med. 2020;35:1338&#x2013;1345. doi: 10.3904/kjim.2018.233</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652665</ArticleId><ArticleId IdType="pubmed">32126750</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacopino S, Colella J, Dini D, Mantovani L, Sorrenti PF, Malacrida M, Filannino P. Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration. Europace. 2023;25. doi: 10.1093/europace/euad230</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10434732</ArticleId><ArticleId IdType="pubmed">37494101</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler DA, Bukoye B, Sawhney M, Berzin T, Sands K, Chowdary S, Shah A, Barnett S. Development and validation of the PROcedural Sedation Assessment Survey (PROSAS) for assessment of procedural sedation quality. Gastrointest Endosc. 2015;81:194&#x2013;203.e1. doi: 10.1016/j.gie.2014.07.062</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272880</ArticleId><ArticleId IdType="pubmed">25293829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode K, Whittaker P, Lucas J, M&#xfc;ssigbrodt A, Hindricks G, Richter S, Doering M. Deep sedation for transvenous lead extraction: a large single-centre experience. Europace. 2019;21:1246&#x2013;1253. doi: 10.1093/europace/euz131</Citation><ArticleIdList><ArticleId IdType="pubmed">31102530</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y, Gu W, Zhao M, Zhang Y, Wu J. The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: a randomized trial. Front Med (Lausanne). 2022;9. doi: 10.3389/fmed.2022.938940</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9394743</ArticleId><ArticleId IdType="pubmed">36004376</ArticleId></ArticleIdList></Reference><Reference><Citation>Dossa F, Medeiros B, Keng C, Acuna SA, Baxter NN. Propofol versus midazolam with or without short-acting opioids for sedation in colonoscopy: a systematic review and meta-analysis of safety, satisfaction, and efficiency outcomes. Gastrointest Endosc. 2020;91:1015&#x2013;1026.e7. doi: 10.1016/j.gie.2019.12.047</Citation><ArticleIdList><ArticleId IdType="pubmed">31926966</ArticleId></ArticleIdList></Reference><Reference><Citation>Karanth H, Murali S, Koteshwar R, Shetty V, Adappa K. Comparative study between propofol and dexmedetomidine for conscious sedation in patients undergoing outpatient colonoscopy. Anesth Essays Res. 2018;12:98&#x2013;102. doi: 10.4103/aer.AER_206_17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5872902</ArticleId><ArticleId IdType="pubmed">29628562</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang RB, Dong JZ, Zhao WD, Liu XP, Kang JP, Long DY, Yu RH, Hu FL, Liu XH, Ma CS. Unconscious sedation/analgesia with propofol versus conscious sedation with fentanyl/midazolam for catheter ablation of atrial fibrillation: a prospective, randomized study. Chin Med J (Engl). 2007;120:2036&#x2013;2038.</Citation><ArticleIdList><ArticleId IdType="pubmed">18067792</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens A, Kreuzmayr A, Manner H, Koop H, Lorenz A, Schaefer C, Plauth M, Jetschmann JU, von Tirpitz C, Ewald M, et al. Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications. Gut. 2019;68:445&#x2013;452. doi: 10.1136/gutjnl-2015-311037</Citation><ArticleIdList><ArticleId IdType="pubmed">29298872</ArticleId></ArticleIdList></Reference><Reference><Citation>van Loon K, van Rheineck Leyssius AT, van Zaane B, Denteneer M, Kalkman CJ. Capnography during deep sedation with propofol by nonanesthesiologists: a randomized controlled trial. Anesth Analg. 2014;119:49&#x2013;55. doi: 10.1213/ANE.0b013e3182a1f0a2</Citation><ArticleIdList><ArticleId IdType="pubmed">24836471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Zhang X, Li L, Wei M, Zhao B, Wang X, Pan Z, Tian J, Yu W, Su D. High-flow nasal cannula oxygen therapy and hypoxia during gastroscopy with propofol sedation: a randomized multicenter clinical trial. Gastrointest Endosc. 2019;90:591&#x2013;601. doi: 10.1016/j.gie.2019.06.033</Citation><ArticleIdList><ArticleId IdType="pubmed">31278907</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho PH, Otoch JP, Khan MA, Sakai P, Guedes HG, Artifon EL. Sedation in colonoscopy by using three different propofol infusion methods and analysis of plasma concentration levels: a prospective comparative study. Arq Bras Cir Dig. 2016;29:264&#x2013;268. doi: 10.1590/0102-6720201600040012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5225868</ArticleId><ArticleId IdType="pubmed">28076483</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia R, Waldmann V, Vanduynhoven P, Nesti M, Jansen de Oliveira Figueiredo M, Narayanan K, Conte G, Guerra JM, Boveda S, Duncker D. Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade. Europace. 2021;23:2039&#x2013;2045. doi: 10.1093/europace/euab154</Citation><ArticleIdList><ArticleId IdType="pubmed">34308973</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarracino F, Bertini P. Perioperative hypotension: causes and remedies. J Anesth Analg Crit Care. 2022;2:17. doi: 10.1186/s44158-022-00045-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10245539</ArticleId><ArticleId IdType="pubmed">37386537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu K, Wei S, Ling W, Wei Y, Ran X, Huang H, Wang M, Wei N, Liao Y, Qin Z, et al. Remimazolam versus propofol for deep sedation/anaesthesia in upper gastrointestinal endoscopy in elderly patients: a multicenter, randomized controlled trial. J Clin Pharm Ther. 2022;47:2230&#x2013;2236. doi: 10.1111/jcpt.13797</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10100088</ArticleId><ArticleId IdType="pubmed">36334013</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical Advisory Secretariat. Bispectral index monitor: an evidence-based analysis. Ont Health Technol Assess Ser. 2004;4:1&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387745</ArticleId><ArticleId IdType="pubmed">23074459</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, Lee G, Jung J, Lee T, Park S. Monitored anesthesia care using remimazolam and ketamine combination for brief gynecological surgeries: a report for four cases. J Clin Med. 2023;12:3558. doi: 10.3390/jcm12103558</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219363</ArticleId><ArticleId IdType="pubmed">37240664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Q, Liu X, Wen C, Li D, Lei X. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022;16:3957&#x2013;3974. doi: 10.2147/DDDT.S384155</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9675580</ArticleId><ArticleId IdType="pubmed">36411859</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115:274&#x2013;283. doi: 10.1213/ANE.0b013e31823f0c28</Citation><ArticleIdList><ArticleId IdType="pubmed">22190555</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Liu C, Zhu Y, Peng L, Zhang X, Wei W, Zhu T. Hemodynamic influences of remimazolam versus propofol during the induction period of general anesthesia: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2023;26:E761&#x2013;E773.</Citation><ArticleIdList><ArticleId IdType="pubmed">37976477</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55:1059&#x2013;1077. doi: 10.1007/s40262-016-0383-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27028535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippmann M, Appel PL, Mok MS, Shoemaker WC. Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients. Crit Care Med. 1983;11:730&#x2013;734. doi: 10.1097/00003246-198309000-00012</Citation><ArticleIdList><ArticleId IdType="pubmed">6884053</ArticleId></ArticleIdList></Reference><Reference><Citation>Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med. 2011;57:109&#x2013;114.e2. doi: 10.1016/j.annemergmed.2010.09.010</Citation><ArticleIdList><ArticleId IdType="pubmed">20970888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif S, Kang J, Sadeghirad B, Rizvi F, Forestell B, Greer A, Hewitt M, Fernando SM, Mehta S, Eltorki M, et al. Pharmacological agents for procedural sedation and analgesia in the emergency department and intensive care unit: a systematic review and network meta-analysis of randomised trials. Br J Anaesth. 2024;132:491&#x2013;506. doi: 10.1016/j.bja.2023.11.050</Citation><ArticleIdList><ArticleId IdType="pubmed">38185564</ArticleId></ArticleIdList></Reference><Reference><Citation>Belrose JC, Noppens RR. Anesthesiology and cognitive impairment: a narrative review of current clinical literature. BMC Anesthesiol. 2019;19:241. doi: 10.1186/s12871-019-0903-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933922</ArticleId><ArticleId IdType="pubmed">31881996</ArticleId></ArticleIdList></Reference><Reference><Citation>Furniss SS, Sneyd JR. Safe sedation in modern cardiological practice. Heart. 2015;101:1526&#x2013;1530. doi: 10.1136/heartjnl-2015-307656</Citation><ArticleIdList><ArticleId IdType="pubmed">26085525</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele H, Kurz T, Feistritzer H-J, Stachel G, Hartung P, Lurz P, Eitel I, Marquetand C, Nef H, Doerr O, et al. ; SOLVE-TAVI Investigators. General versus local anesthesia with conscious sedation in transcatheter aortic valve implantation. Circulation. 2020;142:1437&#x2013;1447. doi: 10.1161/CIRCULATIONAHA.120.046451</Citation><ArticleIdList><ArticleId IdType="pubmed">32819145</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28900864</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1534-3170</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Current cardiology reports</Title><ISOAbbreviation>Curr Cardiol Rep</ISOAbbreviation></Journal><ArticleTitle>Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.</ArticleTitle><Pagination><StartPage>105</StartPage><MedlinePgn>105</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11886-017-0924-0</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">Ventricular tachycardia occurrence in implantable cardioverter defibrillator (ICD) patients may result in shock delivery and is associated with increased morbidity and mortality. In addition, shocks may have deleterious mechanical and psychological effects. Prevention of ventricular tachycardia (VT) recurrence with the use of antiarrhythmic drugs or catheter ablation may be warranted. Antiarrhythmic drugs are limited by incomplete efficacy and an unfavorable adverse effect profile. Catheter ablation can be effective but acute complications and long-term VT recurrence risk necessitating repeat ablation should be recognized. A shared clinical decision process accounting for patients' cardiac status, comorbidities, and goals of care is often required.</AbstractText><AbstractText Label="RECENT FINDINGS">There are four published randomized trials of catheter ablation for sustained monomorphic VT (SMVT) in the setting of ischemic heart disease; there are no randomized studies for non-ischemic ventricular substrates. The most recent trial is the VANISH trial which randomly allocated patients with ICD, prior infarction, and SMVT despite first-line antiarrhythmic drug therapy to catheter ablation or more aggressive antiarrhythmic drug therapy. During 28&#xa0;months of follow-up, catheter ablation resulted in a 28% relative risk reduction in the composite endpoint of death, VT storm, and appropriate ICD shock (p&#xa0;=&#xa0;0.04). In a subgroup analysis, patients having VT despite amiodarone had better outcomes with ablation as compared to increasing amiodarone dose or adding mexiletine. There is evidence for the effectiveness of both catheter ablation and antiarrhythmic drug therapy for patients with myocardial infarction, an implantable defibrillator, and VT. If sotalol is ineffective in suppressing VT, either catheter ablation or initiation of amiodarone is a reasonable option. If VT occurs despite amiodarone therapy, there is evidence that catheter ablation is superior to administration of more aggressive antiarrhythmic drug therapy. Early catheter ablation may be appropriate in some clinical situations such as patients presenting with relatively slow VT below ICD detection, electrical storms, hemodynamically stable VT, or in very selected patients with left ventricular assist devices. The optimal first-line suppressive therapy for VT, after ICD implantation and appropriate programming, remains to be determined. Thus far, there has not been a randomized controlled trial to compare catheter ablation to antiarrhythmic drug therapy as a first-line treatment; the VANISH-2 study has been initiated as a pilot to examine this question.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>AbdelWahab</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>QEII Health Sciences Centre, Room 2501 B/F Halifax Infirmary 1796 Summer Street, Halifax, NS, B3H 3A7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapp</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>QEII Health Sciences Centre, Room 2501 B/F Halifax Infirmary 1796 Summer Street, Halifax, NS, B3H 3A7, Canada. John.sapp@nshealth.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Cardiol Rep</MedlineTA><NlmUniqueID>100888969</NlmUniqueID><ISSNLinking>1523-3782</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>A6D97U294I</RegistryNumber><NameOfSubstance UI="D013015">Sotalol</NameOfSubstance></Chemical><Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber><NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000638" MajorTopicYN="N">Amiodarone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004554" MajorTopicYN="N">Electric Countershock</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013015" MajorTopicYN="N">Sotalol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiarrhythmic medications</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">Sudden cardiac death</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28900864</ArticleId><ArticleId IdType="doi">10.1007/s11886-017-0924-0</ArticleId><ArticleId IdType="pii">10.1007/s11886-017-0924-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Europace. 2013 Jun;15(6):820-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23325044</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2004 Dec 21;110(25):3760-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15583079</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2017 Mar;10 (3):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28292755</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2010 Jan;21(1):47-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19656251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2008 Apr;85(4):1278-81</Citation><ArticleIdList><ArticleId IdType="pubmed">18355509</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2016 Oct;13(10):1957-63</Citation><ArticleIdList><ArticleId IdType="pubmed">27392945</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2017 May 1;38(17 ):1329-1335</Citation><ArticleIdList><ArticleId IdType="pubmed">27354046</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 2011 Dec;34(12):1600-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21895727</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2004 Jan;15(1):52-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15028072</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Mar;11(3):360-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24291775</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2003 Mar 20;91(6A):39D-44D</Citation><ArticleIdList><ArticleId IdType="pubmed">12670641</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Pharmacol. 2010 May;55(5):438-49</Citation><ArticleIdList><ArticleId IdType="pubmed">20509177</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Jul 14;375(2):111-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2002 May;143(5):821-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12040343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1997 Mar 8;349(9053):675-82</Citation><ArticleIdList><ArticleId IdType="pubmed">9078198</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2004 Dec 14;110(24):3646-54</Citation><ArticleIdList><ArticleId IdType="pubmed">15533855</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Lung. 1995 Jul-Aug;24(4):281-91</Citation><ArticleIdList><ArticleId IdType="pubmed">7591795</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2013 Jun;6(3):648-54</Citation><ArticleIdList><ArticleId IdType="pubmed">23778248</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2012 Jan 3;59(1):91-2</Citation><ArticleIdList><ArticleId IdType="pubmed">22192676</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1997 Jan;29(1):100-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8996301</ArticleId></ArticleIdList></Reference><Reference><Citation>J Card Fail. 2003 Oct;9(5):354-63</Citation><ArticleIdList><ArticleId IdType="pubmed">14583895</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2014 Feb 18;129(7):728-36</Citation><ArticleIdList><ArticleId IdType="pubmed">24211823</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2012 May;23(5):515-20</Citation><ArticleIdList><ArticleId IdType="pubmed">22081967</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2011 Jan;13(1):109-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20947570</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2004 Jul 13;110(2):112-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15238454</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2015 Sep;12(9):1997-2007</Citation><ArticleIdList><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 1982 Jan;49(1):166-85</Citation><ArticleIdList><ArticleId IdType="pubmed">6172033</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2000 Nov 21;102(21):2665-70</Citation><ArticleIdList><ArticleId IdType="pubmed">11085972</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Jun 17;340(24):1855-62</Citation><ArticleIdList><ArticleId IdType="pubmed">10369848</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1994 Aug 20;344(8921):493-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7914611</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2008 Jul 03;337:a424</Citation><ArticleIdList><ArticleId IdType="pubmed">18599467</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 May 27;117(21):e350-408</Citation><ArticleIdList><ArticleId IdType="pubmed">18483207</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2015 Apr;12(4):716-25</Citation><ArticleIdList><ArticleId IdType="pubmed">25530221</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 1996 Jun;7(6):531-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8743758</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Jan 11;295(2):165-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2013 May;145(5):1207-13</Citation><ArticleIdList><ArticleId IdType="pubmed">22520722</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 2;375(9708):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 1999 Sep;22(9):1305-13</Citation><ArticleIdList><ArticleId IdType="pubmed">10527011</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2004 Nov;15(11):1265-70</Citation><ArticleIdList><ArticleId IdType="pubmed">15574176</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Lung Transplant. 2008 Mar;27(3):353-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18342761</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2005 Jan 20;352(3):225-37</Citation><ArticleIdList><ArticleId IdType="pubmed">15659722</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2004 May 19;43(10):1834-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15145109</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1996 Feb 15;93(4):753-62</Citation><ArticleIdList><ArticleId IdType="pubmed">8641005</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2016 Jul;13(7):1489-96</Citation><ArticleIdList><ArticleId IdType="pubmed">26988379</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2007 Sep;4(9):1165-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17765615</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2013 Feb;6(1):151-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23255277</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2015 May 12;65(18):1954-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25913000</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1991 Mar 21;324(12):781-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1900101</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Sep 4;359(10):1009-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2005 May 3;45(9):1428-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15862414</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 1998 Jun;21(6):1207-15</Citation><ArticleIdList><ArticleId IdType="pubmed">9633062</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Med J. 2015 Feb;32(2):161-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24042252</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 2002 Nov;49(9):973-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12419728</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1989 May;79(5):990-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2713978</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2014 Dec 23;130(25):2278-86</Citation><ArticleIdList><ArticleId IdType="pubmed">25301831</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2016 Oct;13(10):1987-92</Citation><ArticleIdList><ArticleId IdType="pubmed">27291511</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2015 Dec 29;66(25):2872-2882</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2010 May;12(5):618-25</Citation><ArticleIdList><ArticleId IdType="pubmed">20304841</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1997 Sep;30(3):791-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9283542</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2015 Nov 1;36(41):2757-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26745817</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Heart Fail. 2016 Oct;4(10 ):772-779</Citation><ArticleIdList><ArticleId IdType="pubmed">27395347</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Oct;11(10):e166-96</Citation><ArticleIdList><ArticleId IdType="pubmed">25179489</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2012 Feb 28;125(8):1043-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22371442</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2000 Dec 16;356(9247):2052-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11145491</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Lung Transplant. 2009 Jul;28(7):733-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19560703</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2013 May 8;309(18):1903-11</Citation><ArticleIdList><ArticleId IdType="pubmed">23652522</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2007 Feb;28(4):469-77</Citation><ArticleIdList><ArticleId IdType="pubmed">17227788</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 2012 Sep;35(9):1081-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22817524</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Lung. 2005 May-Jun;34(3):169-78</Citation><ArticleIdList><ArticleId IdType="pubmed">16015221</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1998 Dec;32(7):1909-15</Citation><ArticleIdList><ArticleId IdType="pubmed">9857871</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2014 Sep 1;114(5):716-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25129065</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Sep 2;341(10):709-17</Citation><ArticleIdList><ArticleId IdType="pubmed">10471456</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2006 Jul 18;48(2):330-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16843184</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2011 Mar 15;123(10):e269-367</Citation><ArticleIdList><ArticleId IdType="pubmed">21382897</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Cardiol. 2013 Jan;28(1):72-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23160339</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2004 Oct 26;110(17):2591-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15492306</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2014 Apr;7(2):244-50</Citation><ArticleIdList><ArticleId IdType="pubmed">24532564</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 1981 Jul;49(1):255-65</Citation><ArticleIdList><ArticleId IdType="pubmed">7237696</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2005 Dec;2(12):1359-62</Citation><ArticleIdList><ArticleId IdType="pubmed">16360091</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2009 Jun;6(6):886-933</Citation><ArticleIdList><ArticleId IdType="pubmed">19467519</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2016 Mar;95(13):e3204</Citation><ArticleIdList><ArticleId IdType="pubmed">27043684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1997 Mar 8;349(9053):667-74</Citation><ArticleIdList><ArticleId IdType="pubmed">9078197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1996 Jul 6;348(9019):7-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8691967</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Lung. 1993 Nov-Dec;22(6):494-501</Citation><ArticleIdList><ArticleId IdType="pubmed">8288452</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Nov;11(11):2056-63</Citation><ArticleIdList><ArticleId IdType="pubmed">25016150</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2012 Jun;9(6):859-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22293139</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1990 Dec;16(7):1711-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2254558</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2015 Dec;12(12):2419-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26232765</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2000 Jul;2(3):263-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11227599</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2000 Dec;21(24):2071-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11102258</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Feb 5;105(5):589-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11827924</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Jan 29;117(4):462-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18172038</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2010 Mar;7(3):353-60</Citation><ArticleIdList><ArticleId IdType="pubmed">20185109</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2013 Jun 25;61(25):2542-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23643502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2011 Jul;92(1):334-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21718868</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2017 Mar;10 (3):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28292754</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1988 Jul;12(1):166-74</Citation><ArticleIdList><ArticleId IdType="pubmed">3379202</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 1993 Jun;4(3):253-62</Citation><ArticleIdList><ArticleId IdType="pubmed">8269297</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Sep 16;341(12 ):857-65</Citation><ArticleIdList><ArticleId IdType="pubmed">10486417</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2006 Sep 5;114(10):e385-484</Citation><ArticleIdList><ArticleId IdType="pubmed">16935995</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2011 Nov;8(11):1661-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21699857</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Clin North Am. 2012 Sep;96(5):915-31</Citation><ArticleIdList><ArticleId IdType="pubmed">22980055</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Dec 13;367(24):2275-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23131066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 1999 Jun;22(6 Pt 1):915-26</Citation><ArticleIdList><ArticleId IdType="pubmed">10392390</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Psychiatry Med. 1997;27(1):57-69</Citation><ArticleIdList><ArticleId IdType="pubmed">9565714</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2010 Aug 3;122(5):455-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20644019</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2002 Aug;144(2):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12177646</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2001 Apr 24;103(16):2066-71</Citation><ArticleIdList><ArticleId IdType="pubmed">11319196</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2009 Aug 4;120(5):366-75</Citation><ArticleIdList><ArticleId IdType="pubmed">19620503</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1144-51</Citation><ArticleIdList><ArticleId IdType="pubmed">25262159</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2017 Mar;10 (3):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzschrittmacherther Elektrophysiol. 2014 Jun;25(2):105-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24842775</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart. 1997 Dec;78(6):581-3</Citation><ArticleIdList><ArticleId IdType="pubmed">9470875</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34104317</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1947-6108</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Methodist DeBakey cardiovascular journal</Title><ISOAbbreviation>Methodist Debakey Cardiovasc J</ISOAbbreviation></Journal><ArticleTitle>Surgical Cardiac Sympathetic Denervation for Ventricular Arrhythmias: A Systematic Review.</ArticleTitle><Pagination><StartPage>24</StartPage><EndPage>35</EndPage><MedlinePgn>24-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14797/QIQG9041</ELocationID><Abstract><AbstractText>Ventricular arrhythmias are potentially life-threatening disorders that are commonly treated with medications, catheter ablation and implantable cardioverter defibrillator (ICD). Adult patients who continue to be symptomatic, with frequent ventricular arrhythmia cardiac events or defibrillation from ICD despite medical treatment, are a challenging subgroup to manage. Surgical cardiac sympathetic denervation has emerged as a possible treatment option for people refractory to less invasive medical options. Recent treatment guidelines have recommendedcardiac sympathectomy for ventricular tachycardia (VT) or VT/fibrillation storm refractory to antiarrhythmic medications, long QT syndrome, and catecholaminergic polymorphic VT, with much of the data pertaining to pediatric literature. However, for the adult population, the disease indications, complications, and risks of cardiac sympathectomy are less understood, as are the most effective surgical cardiac denervation techniques for this patient demographic. This systematic review navigates available literature evaluating surgical denervation disease state indications, techniques, and sympathectomy risks for medically refractory ventricular arrhythmia in the adult patient population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chihara</LastName><ForeName>Ray K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Houston Methodist Hospital, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Weill Cornell Medical College, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Edward Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Houston Methodist Hospital, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Weill Cornell Medical College, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meisenbach</LastName><ForeName>Leonora M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Houston Methodist Hospital, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Houston Methodist Hospital, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Weill Cornell Medical College, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methodist Debakey Cardiovasc J</MedlineTA><NlmUniqueID>101508600</NlmUniqueID><ISSNLinking>1947-6108</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="Y">innervation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013562" MajorTopicYN="Y">Sympathectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013564" MajorTopicYN="N">Sympathetic Nervous System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VATS</Keyword><Keyword MajorTopicYN="N">denervation</Keyword><Keyword MajorTopicYN="N">electrical storm</Keyword><Keyword MajorTopicYN="N">ganglion</Keyword><Keyword MajorTopicYN="N">ganglionectomy</Keyword><Keyword MajorTopicYN="N">stellate</Keyword><Keyword MajorTopicYN="N">stellectomy</Keyword><Keyword MajorTopicYN="N">sympathectomy</Keyword><Keyword MajorTopicYN="N">thoracoscopy</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmias</Keyword><Keyword MajorTopicYN="N">ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors have completed and submitted the Methodist DeBakey Cardiovascular Journal Conflict of Interest Statement and none were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34104317</ArticleId><ArticleId IdType="pmc">PMC8158456</ArticleId><ArticleId IdType="doi">10.14797/QIQG9041</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adabag A. Selcuk, Luepker Russell V., Roger V&#xe9;ronique L., Gersh Bernard J. Nature Reviews Cardiology. 4. Vol. 7. Springer Science and Business Media LLC; 2010. Sudden cardiac death: epidemiology and risk factors; pp. 216&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2010.3</ArticleId><ArticleId IdType="pmc">PMC5014372</ArticleId><ArticleId IdType="pubmed">20142817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella Della, Baratto P, Tsiachris F D. Management of ventricular tachy- cardia in the setting of a dedicated unit for the treatment of complex ventric- ular arrhythmias: long-term outcome after ablation. Circulation. 2013;127(13):1359&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">23439513</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson W G, Wilber D J, Natale A. Irrigated radiofrequency cath- eter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118(25):2773&#x2013;2782. doi: 10.1161/CIRCULATIONAHA.108.788604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.788604</ArticleId><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R, Vaseghi M, Frankel D S. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015;12(9):1997&#x2013;2007. doi: 10.1016/j.hrthm.2015.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.05.036</ArticleId><ArticleId IdType="pmc">PMC4549209</ArticleId><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Mark J., Zipes Douglas P. Circulation Research. 6. Vol. 114. Ovid Technologies (Wolters Kluwer Health); 2014. Role of the Autonomic Nervous System in Modulating Cardiac Arrhythmias; pp. 1004&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.113.302549</ArticleId><ArticleId IdType="pubmed">24625726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilde Arthur A.M., Bhuiyan Zahurul A., Crotti Lia, Facchini Mario, De Ferrari Gaetano M., Paul Thomas, Ferrandi Chiara, Koolbergen Dave R., Odero Attilio, Schwartz Peter J. New England Journal of Medicine. 19. Vol. 358. Massachusetts Medical Society; 2008. Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia; pp. 2024&#x2013;2029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa0708006</ArticleId><ArticleId IdType="pubmed">18463378</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib S M, Stevenson W G, Ackerman M J. AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;138(13):272&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">29084731</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi Marmar, Barwad Parag, Malavassi Corrales Federico J., Tandri Harikrishna, Mathuria Nilesh, Shah Rushil, Sorg Julie M., Gima Jean, Mandal Kaushik, S&#xe0;enz Morales Luis C., Lokhandwala Yash, Shivkumar Kalyanam. Journal of the American College of Cardiology. 25. Vol. 69. Elsevier BV; 2017. Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias; pp. 3070&#x2013;3080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.04.035</ArticleId><ArticleId IdType="pmc">PMC6330109</ArticleId><ArticleId IdType="pubmed">28641796</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtaza G, Sharma S P, Akella K. Role of cardiac sympathetic denerva- tion in ventricular tachycardia: A meta-analysis. Pacing Clin Electrophysiol. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32460366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola Olujimi A., Lellouche Nicholas, Bourke Tara, Tung Roderick, Ahn Samuel, Mahajan Aman, Shivkumar Kalyanam. Journal of the American College of Cardiology. 1. Vol. 59. Elsevier BV; 2012. Bilateral Cardiac Sympathetic Denervation for the Management of Electrical Storm; pp. 91&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.09.043</ArticleId><ArticleId IdType="pmc">PMC3470807</ArticleId><ArticleId IdType="pubmed">22192676</ArticleId></ArticleIdList></Reference><Reference><Citation>Assis F R, Krishnan A, Zhou X, et al. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2019;16(7):1003&#x2013;1010. doi: 10.1016/j.hrthm.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.01.019</ArticleId><ArticleId IdType="pubmed">30677492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke T, Vaseghi M, Michowitz Y. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation. 2010;121(21):2255&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2896716</ArticleId><ArticleId IdType="pubmed">20479150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai C, Dai M Y, Tian Y. Electrophysiologic effects and outcomes of sympatholysis in patients with recurrent ventricular arrhythmia and struc- tural heart disease. J Cardiovasc Electrophysiol. 2019;30(9):1499&#x2013;1507.</Citation><ArticleIdList><ArticleId IdType="pubmed">31199536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona-Guarache Ricardo, Padala Santosh K., Velazco-Davila Luis, Cassano Anthony, Abbate Antonio, Ellenbogen Kenneth A., Koneru Jayanthi N. Journal of Cardiovascular Electrophysiology. 8. Vol. 28. Wiley; 2017. Stellate ganglion blockade and bilateral cardiac sympathetic denervation in patients with life-threatening ventricular arrhythmias; pp. 903&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.13249</ArticleId><ArticleId IdType="pubmed">28471068</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinathannair R., Olshansky B., Iannettoni M., Mazur A. Europace. 7. Vol. 12. Oxford University Press (OUP); 2010. Delayed maximal response to left cardiac sympathectomy for catecholaminergic polymorphic ventricular tachycardia; pp. 1035&#x2013;1039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euq058</ArticleId><ArticleId IdType="pubmed">20219758</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez Oswaldo, Garita Elliot, Salazar Carlos. International Journal of Cardiology. 2. Vol. 119. Elsevier BV; 2007. Thoracoscopic sympathectomy for incessant polymorphic ventricular tachycardia in chronic chagasic myocarditis A case report; pp. 255&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2006.07.138</ArticleId><ArticleId IdType="pubmed">17079033</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S Y, Cho Y, Kim N K. Video-Assisted Thoracoscopic Left Cardiac Sympathetic Denervation in Patients with Hereditary Ventricular Arrhyth- mias. Pacing Clin Electrophysiol. 2017;40(3):232&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">28012188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopecky Kathleen, Afzal Aasim, Felius Joost, Hall Shelley A., Mendez Jose C., Assar Manish, Mason David P., Bindra Amarinder S. Pacing and Clinical Electrophysiology. Vol. 41. Wiley; 2018. Bilateral sympathectomy for treatment of refractory ventricular tachycardia; pp. 93&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.13164</ArticleId><ArticleId IdType="pubmed">28851062</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan Aravind, Suarez-Pierre Alejandro, Crawford Todd C., Zhou Xun, Russell Stuart D., Berger Ronald D., Calkins Hugh, Baumgartner William A., Tandri Harikrishna, Mandal Kaushik. The Annals of Thoracic Surgery. 2. Vol. 105. Elsevier BV; 2018. Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia; pp. e51&#x2013;e53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.09.023</ArticleId><ArticleId IdType="pubmed">29362191</ArticleId></ArticleIdList></Reference><Reference><Citation>Methangkool Emily, Chua Jason H., Gopinath Anupama, Shivkumar Kalyanam, Mahajan Aman. Journal of Cardiothoracic and Vascular Anesthesia. 1. Vol. 28. Elsevier BV; 2014. Anesthetic Considerations for Thoracoscopic Sympathetic Ganglionectomy to Treat Ventricular Tachycardia Storm: A Single-Center Experience; pp. 69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.08.019</ArticleId><ArticleId IdType="pmc">PMC4253028</ArticleId><ArticleId IdType="pubmed">24290748</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada David R., Assis Fabrizio R., Gilotra Nisha A., Ha Jinny S., Berger Ronald D., Calkins Hugh, Chrispin Jonathan, Mandal Kaushik, Tandri Harikrishna. Heart Rhythm. 9. Vol. 16. Elsevier BV; 2019. Cardiac sympathectomy for refractory ventricular arrhythmias in cardiac sarcoidosis; pp. 1408&#x2013;1413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.02.025</ArticleId><ArticleId IdType="pubmed">30818090</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu Mukund A., Prasad Srinivas B. V., Abhilash S. P., Thajudeen Anees, R. Balasubramoniam K., Namboodiri Narayanan. Journal of Interventional Cardiac Electrophysiology. 3. Vol. 47. Springer Science and Business Media LLC; 2016. Left sympathetic cardiac denervation in managing electrical storm: acute outcome and long term follow up; pp. 285&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-016-0153-2</ArticleId><ArticleId IdType="pubmed">27318998</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson T, Lugo R, Saavedra P. Cardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablation. Heart Rhythm. 2018;15(1):56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">28917558</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenz L C, Corrales F M, Bautista W. Cardiac sympathetic denervation for intractable ventricular arrhythmias in Chagas disease. Heart Rhythm. 2016;13(7):1388&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">26969783</ArticleId></ArticleIdList></Reference><Reference><Citation>Stec Sebastian, Zamorski Piotr, Wo&#x142;ek Wojciech, Suwalski Piotr, Zienciuk-Krajka Agnieszka. Kardiologia Polska. 6. Vol. 77. Polskie Towarzystwo Kardiologiczne; 2019. Bilateral cardiac sympathetic denervation in catecholaminergic polymorphic ventricular tachycardia; pp. 653&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/kp.14834</ArticleId><ArticleId IdType="pubmed">31099757</ArticleId></ArticleIdList></Reference><Reference><Citation>Tellez L J, Garzon J C, Vinck E E, Castellanos J D. Video-assisted thoracoscopic cardiac denervation of refractory ventricular arrhythmias and electrical storms: a single-center series. J Cardiothorac Surg. 2019;14(1):17&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6341718</ArticleId><ArticleId IdType="pubmed">30665431</ArticleId></ArticleIdList></Reference><Reference><Citation>Vel&#xe1;squez Mauricio, Fern&#xe1;ndez Liliana, Leib Carl S., Orozco Viviana, Pava Fernando, Perafan Pablo. Archivos de cardiolog&#xfffd;a de M&#xfffd;xico (English ed. Internet) 3. Vol. 89. Publicidad Permanyer, SLU; 2020. Cardiac sympathetic denervation for conventional treatment refractory arrhythmias; pp. 191&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/acme.m19000059</ArticleId><ArticleId IdType="pubmed">31967585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehman Brody, Mazzeffi Michael, Chow Robert, Watkins A. Claire, Aicher Brittany, Pham Si, Burrows Whitney, Taylor Bradley. The Annals of Thoracic Surgery. 3. Vol. 105. Elsevier BV; 2018. Thoracoscopic Sympathectomy for Refractory Electrical Storm After Coronary Artery Bypass Grafting; pp. e99&#x2013;e101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.10.005</ArticleId><ArticleId IdType="pubmed">29455831</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalin Kivanc, Liosis Spyridon, Palade Emanuel, Fink Thomas, Schierholz Stefanie, Sawan Noureddin, Eitel Charlotte, Heeger Christian H., Sciacca Vanessa, Sano Makoto, Vogler Julia, Tilz Roland Richard. Clinical Research in Cardiology. 1. Vol. 110. Springer Science and Business Media LLC; 2021. Cardiac sympathetic denervation in patients with nonischemic cardiomyopathy and refractory ventricular arrhythmias: a single-center experience; pp. 21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01643-8</ArticleId><ArticleId IdType="pubmed">32328735</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtaza Ghulam, Sharma Sharan P., Akella Krishna, Turagam Mohit K., Rocca Domenico G. Della, Lakkireddy Dhanunjaya, Gopinathannair Rakesh. Pacing and Clinical Electrophysiology. 8. Vol. 43. Wiley; 2020. Role of cardiac sympathetic denervation in ventricular tachycardia: A meta&#x2010;analysis; pp. 828&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.13968</ArticleId><ArticleId IdType="pubmed">32460366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer William H., Zado Erica, Gerstenfeld Edward P., Marchlinski Francis E., Callans David J. Heart Rhythm. Vol. 7. Elsevier BV; 2010. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator; pp. 9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2009.09.014</ArticleId><ArticleId IdType="pubmed">19939743</ArticleId></ArticleIdList></Reference><Reference><Citation>Marhold F, Izay B, Zacherl J, Tschabitscher M, Neumayer C. Thoraco- scopic and anatomic landmarks of Kuntz&#x2019;s nerve: implications for sympa- thetic surgery. Ann Thorac Surg. 2008;86(5):1653&#x2013;1661.</Citation><ArticleIdList><ArticleId IdType="pubmed">19049766</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Hidehiro, Okada Masayoshi. The Journal of Thoracic and Cardiovascular Surgery. 5. Vol. 158. Elsevier BV; 2019. The management of compensatory sweating after thoracic sympathectomy; pp. 1481&#x2013;1488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.05.062</ArticleId><ArticleId IdType="pubmed">31358338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34921464</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Ethanol ablation for ventricular arrhythmias: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>510</StartPage><EndPage>526</EndPage><MedlinePgn>510-526</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.15336</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Ethanol ablation (EA) is an alternative option for subjects with ventricular arrhythmias (VAs) refractory to conventional medical and ablative treatment. However, data on the efficacy and safety of EA remain sparse.</AbstractText><AbstractText Label="METHODS">A systematic literature search was conducted. The primary outcomes were 1) freedom from the targeted VA and 2) freedom from any VAs post-EA. Additional safety outcomes were also analyzed.</AbstractText><AbstractText Label="RESULTS">Ten studies were selected accounting for a population of 174 patients (62.3&#x2009;&#xb1;&#x2009;12.5 years, 94% male) undergoing 185 procedures. The overall acute success rate of EA was 72.4% (confidence interval [CI<sub>95%</sub> ]: 65.6-78.4). After a mean follow-up of 11.3&#x2009;&#xb1;&#x2009;5.5 months, the incidence of relapse of the targeted VA was 24.4% (CI<sub>95%</sub> : 17.1-32.8), while any VAs post-EA occurred in 41.3% (CI<sub>95%</sub> : 33.7-49.1). The overall incidence of procedural complications was 14.1% (CI<sub>95%</sub> : 9.8-19.8), with pericardial complications and complete atrioventricular block being the most frequent. An anterograde transarterial approach was associated with a higher rate of VA recurrences and complications compared to a retrograde transvenous route; however, differences in the baseline population characteristics and in the targeted ventricular areas should be accounted.</AbstractText><AbstractText Label="CONCLUSION">EA is a valuable therapeutic option for VAs refractory to conventional treatment and can result in 1-year freedom from VA recurrence in 60%-75% of the patients. However, anatomical or technical challenges preclude acute success in almost 30% of the candidates and the rate of complication is not insignificant, highlighting the importance of well-informed patient selection. The certainty of the evidence is low, and further research is necessary.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Creta</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7743-0143</Identifier><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Earley</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finlay</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sporton</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhinoja</LastName><ForeName>Mehul</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Ross J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papageorgiou</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ang</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Oliver R</ForeName><Initials>OR</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambiase</LastName><ForeName>Pier D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Science, University College of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provid&#xea;ncia</LastName><ForeName>Rui</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9141-9883</Identifier><AffiliationInfo><Affiliation>Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics Research, University College of London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3K9958V90M</RegistryNumber><NameOfSubstance UI="D000431">Ethanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000431" MajorTopicYN="N">Ethanol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">alcohol ablation</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">ethanol ablation</Keyword><Keyword MajorTopicYN="N">ventricular ectopy</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34921464</ArticleId><ArticleId IdType="doi">10.1111/jce.15336</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary. Heart Rhythm, 2020(17):e155-e205.</Citation></Reference><Reference><Citation>Martinez BK, Baker WL, Konopka A, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020;17:e206-e219.</Citation></Reference><Reference><Citation>Stevenson WG, Wilber DJ, Natale A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118:2773-2782.</Citation></Reference><Reference><Citation>Tokuda M, Kojodjojo P, Tung S, et al. Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. J Am Heart Assoc. 2013;2:e000072.</Citation></Reference><Reference><Citation>Brugada P, de Swart H, Smeets JL, Wellens HJ. Transcoronary chemical ablation of ventricular tachycardia. Circulation. 1989;79:475-482.</Citation></Reference><Reference><Citation>Schurmann P, Pe&#xf1;alver J, Valderr&#xe1;bano M. Ethanol for the treatment of cardiac arrhythmias. Curr Opin Cardiol. 2015;30:333-343.</Citation></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777-784.</Citation></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008-2012.</Citation></Reference><Reference><Citation>Lefebvre C, Glanville J, Briscoe S, et al. Chapter 4: searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, eds. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; 2020.</Citation></Reference><Reference><Citation>Menzies D. Systematic reviews and meta-analyses. Int J Tuberculosis Lung Dis. 2011;15:582-593.</Citation></Reference><Reference><Citation>National Heart LaBI. Quality assessment tool for case series studies. Accessed Januray 10, 2020. https://www.nhlbi.nih.gov/healthn-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/case_series</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785-1805.</Citation></Reference><Reference><Citation>Sacher F, Sobieszczyk P, Tedrow U, et al. Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm. 2008;5:62-68.</Citation></Reference><Reference><Citation>Tokuda M, Sobieszczyk P, Eisenhauer AC, et al. Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol. 2011;4:889-896.</Citation></Reference><Reference><Citation>Kumar S, Barbhaiya CR, Sobieszczyk P, et al. Role of alternative interventional procedures when endo- and epicardial catheter ablation attempts for ventricular arrhythmias fail. Circ Arrhythm Electrophysiol. 2015;8:606-615.</Citation></Reference><Reference><Citation>Tavares L, Lador A, Fuentes S, et al. Intramural venous ethanol infusion for refractory ventricular arrhythmias: outcomes of a multicenter experience. JACC Clin Electrophysiol. 2020;6:1420-1431.</Citation></Reference><Reference><Citation>Da-Wariboko A, Lador A, Tavares L, et al. Double-balloon technique for retrograde venous ethanol ablation of ventricular arrhythmias in the absence of suitable intramural veins. Heart Rhythm. 2020;17(2126):2134.</Citation></Reference><Reference><Citation>Kay GN, Epstein AE, Bubien RS, Anderson PG, Dailey SM, Plumb VJ. Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia. J Am Coll Cardiol. 1992;19:159-168.</Citation></Reference><Reference><Citation>Segal OR, Wong T, Chow AW, et al. Intra-coronary guidewire mapping-a novel technique to guide ablation of human ventricular tachycardia. J Interv Card Electrophysiol. 2007;18:143-154.</Citation></Reference><Reference><Citation>Roca-Luque I, Rivas-G&#xe1;ndara N, Francisco-Pascual J, et al. Preprocedural imaging to guide transcoronary ethanol ablation for refractory septal ventricular tachycardia. J Cardiovasc Electrophysiol. 2019;30:448-456.</Citation></Reference><Reference><Citation>Kreidieh B, Rodr&#xed;guez-Ma&#xf1;ero M, Schurmann P, Ibarra-Cortez SH, Dave AS, Valderr&#xe1;bano M. Retrograde coronary venous ethanol infusion for ablation of refractory ventricular tachycardia. Circ Arrhythm Electrophysiol. 2016;9(10):1161.</Citation></Reference><Reference><Citation>Nellens P, G&#xfc;rsoy S, Andries E, Brugada P. Transcoronary chemical ablation of arrhythmias. Pacing Clin Electrophysiol. 1992;15:1368-1373.</Citation></Reference><Reference><Citation>Gursoy S, Nellens P, Guiraudon G, Brugada J, Brugada P. Epicardial and subselective transcoronary chemical ablation of incessant ventricular tachycardia. Cathet Cardiovasc Diagn. 1993;28:323-327.</Citation></Reference><Reference><Citation>Dinov B, Fiedler L, Sch&#xf6;nbauer R, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation. 2014;129:728-736.</Citation></Reference><Reference><Citation>Dukkipati SR, Choudry S, Koruth JS, Miller MA, Whang W, Reddy VY. Catheter ablation of ventricular tachycardia in structurally normal hearts: indications, strategies, and outcomes-part I. J Am Coll Cardiol. 2017;70:2909-2923.</Citation></Reference><Reference><Citation>Creta A, Chow AW, Sporton S, et al. Catheter ablation for fascicular ventricular tachycardia: a systematic review. Int J Cardiol. 2019;276:136-148.</Citation></Reference><Reference><Citation>Pothineni NV, Deshmukh A, Padmanabhan D, et al. Complication rates of ventricular tachycardia ablation: comparison of safety outcomes derived from administrative databases and clinical trials. Int J Cardiol. 2015;201:529-531.</Citation></Reference><Reference><Citation>Tavares L, Valderr&#xe1;bano M. Retrograde venous ethanol ablation for ventricular tachycardia. Heart Rhythm. 2019;16:478-483.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37366571</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>04</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">euad181</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euad181</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS">Bayesian analyses can provide additional insights into the results of clinical trials, aiding in the decision-making process. We analysed the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia (SURVIVE-VT) trial using Bayesian survival models.</AbstractText><AbstractText Label="METHODS AND RESULTS">The SURVIVE-VT trial randomized patients with ischaemic cardiomyopathy and monomorphic ventricular tachycardia (VT) to catheter ablation or antiarrhythmic drugs (AAD) as a first-line strategy. The primary outcome was a composite of cardiovascular death, appropriate implantable cardioverter-defibrillator shocks, unplanned heart failure hospitalizations, or severe treatment-related complications. We used informative, skeptical, and non-informative priors with different probabilities of large effects to compute the posterior distributions using Markov Chain Monte Carlo methods. We calculated the probabilities of hazard ratios (HR) being &lt;1, &lt;0.9, and &lt;0.75, as well as 2-year survival estimates. Of the 144 randomized patients, 71 underwent catheter ablation and 73 received AAD. Regardless of the prior, catheter ablation had a &gt;98% probability of reducing the primary outcome (HR &lt; 1) and a &gt;96% probability of achieving a reduction of &gt;10% (HR &lt; 0.9). The probability of a &gt;25% (HR &lt; 0.75) reduction of treatment-related complications was &gt;90%. Catheter ablation had a high probability (&gt;93%) of reducing incessant/slow undetected VT/electric storm, unplanned hospitalizations for ventricular arrhythmias, and overall cardiovascular admissions &gt; 25%, with absolute differences of 15.2%, 21.2%, and 20.2%, respectively.</AbstractText><AbstractText Label="CONCLUSION">In patients with ischaemic cardiomyopathy and VT, catheter ablation as a first-line therapy resulted in a high probability of reducing several clinical outcomes compared to AAD. Our study highlights the value of Bayesian analysis in clinical trials and its potential for guiding treatment decisions.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov identifier: NCT03734562.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#xc1;vila</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9792-8769</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, IiSGM, Universidad Complutense, CIBERCV, Dr Esquerdo 46, 28007, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berruezo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5418-383X</Identifier><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, Hospital Clinic and Teknon Medical Centre, c/Villarroel 170, 08036, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Candil</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1831-8730</Identifier><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, IBSAL-Hospital Universitario, Universidad de Salamanca, CIBERCV, Paseo San Vicente 58-182, 37007, Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tercedor</LastName><ForeName>Luis</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9566-8809</Identifier><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, Hospital Universitario Virgen de las Nieves, Avd. Fuerzas Armadas 2, 18014, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8689-4011</Identifier><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, Hospital Universitario Central de Asturias, Instituto de Investigaci&#xf3;n Sanitaria del Principado de Asturias (ISPA), Avd Roma, s/n, 33011, Oviedo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, Hospital Cl&#xed;nico San Carlos, Prof Mart&#xed;n Lagos, S/N, Madrid, 28040, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arribas</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-2574-7923</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Hospital Doce de Octubre, Av. de C&#xf3;rdoba, s/n, 28041, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Portales</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3193-0035</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Complejo Hospitalario Universitario de C&#xe1;ceres, Av. de la Universidad 75, 10004, C&#xe1;ceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merino</LastName><ForeName>Jos&#xe9; Luis</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-1737-1903</Identifier><AffiliationInfo><Affiliation>Arrhythmia Unit, Cardiology Department, Hospital Universitario La Paz, IdiPAZ, Universidad Aut&#xf3;noma, P.&#xba; de la Castellana 261, 28046, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Madrid</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Unit, Hospital Ram&#xf3;n y Cajal, Universidad de Alcal&#xe1; de Henares, M-607, 9, 100, 28034, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Avil&#xe9;s</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5501-5275</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, IiSGM, Universidad Complutense, CIBERCV, Dr Esquerdo 46, 28007, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arenal</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><Identifier Source="ORCID">0000-0001-6636-5473</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, IiSGM, Universidad Complutense, CIBERCV, Dr Esquerdo 46, 28007, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03734562</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><Agency>Ministerio de Ciencia e Innovaci&#xf3;n</Agency><Country/></Grant><Grant><GrantID>EC08/0296</GrantID><Agency>European Regional Development Fund</Agency><Country/></Grant><Grant><Agency>Biosense Webster</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-arrhythmic drugs</Keyword><Keyword MajorTopicYN="N">Bayesian analysis</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>8</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37366571</ArticleId><ArticleId IdType="pmc">PMC10326301</ArticleId><ArticleId IdType="doi">10.1093/europace/euad181</ArticleId><ArticleId IdType="pii">7208270</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wasserstein RL, Lazar NA. The ASA statement on p-values: context, process, and purpose. Am Stat Tayl Fran 2016;70:129&#x2013;33.</Citation></Reference><Reference><Citation>Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SNet al. . Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol 2016;31:337&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4877414</ArticleId><ArticleId IdType="pubmed">27209009</ArticleId></ArticleIdList></Reference><Reference><Citation>McShane BB, Gal D. Statistical significance and the dichotomization of evidence. J Am Stat Assoc 2017;112:885&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5769160</ArticleId><ArticleId IdType="pubmed">29348701</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995;311:485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2550545</ArticleId><ArticleId IdType="pubmed">7647644</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark DB, Lee KL, Harrell FE Jr. Understanding the role of P values and hypothesis tests in clinical research. JAMA Cardiology 2016;1:1048&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">27732700</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegelhalter DJ, Freedman LS, Parmar MKB. Applying Bayesian ideas in drug development and clinical trials. Stat Med 1993;12:1501&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">8248659</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond GA, Kaul S. Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. J Am Coll Cardiol 2004;43:1929&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">15172393</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EMet al. . ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2013;61:213&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">23238451</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenal &#xc1;, &#xc1;vila P, Jim&#xe9;nez-Candil J, Tercedor L, Calvo D, Arribas Fet al. . Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol 2022;79:1441&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">35422240</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, Frankel DSet al. . Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm 2016;13:1552&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26961297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheiri B, Barbarawi M, Zayed Y, Hicks M, Osman M, Rashdan Let al. . Antiarrhythmic drugs or catheter ablation in the management of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol 2019;12:e007600.</Citation><ArticleIdList><ArticleId IdType="pubmed">31698933</ArticleId></ArticleIdList></Reference><Reference><Citation>El&#xe7;i EM, Brilleman S. Bayesian Analyses of time-to-event data using the rstanarm R package; Zenodo 2019. 10.5281/zenodo.3866164</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.3866164</ArticleId></ArticleIdList></Reference><Reference><Citation>
Stan Development Team . Stan modeling language users guide and reference manual, version 2.32; 2023. https://mc-stan.org</Citation></Reference><Reference><Citation>
Goodrich B, Gabry J, Ali I, Brilleman S. Rstanarm: Bayesian applied regression modeling via stan; R package version 2.21.3. https://mc-stan.org/rstanarm</Citation></Reference><Reference><Citation>Core Team R. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021.</Citation></Reference><Reference><Citation>Brilleman SL, Elci EM, Novik JB, Wolfe R. Bayesian survival analysis using the rstanarm R package. 2020:1&#x2013;50. arXiv:2002.09633v1.</Citation></Reference><Reference><Citation>
Gabry J, Mahr T. Bayesplot: plotting for Bayesian models; R package version 1.10.0; 2022. https://mc-stan.org/bayesplot</Citation></Reference><Reference><Citation>Kay M. Tidybayes: tidy data and geoms for Bayesian models; Zenodo; 2022. 10.5281/zenodo.7933163</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.7933163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2016.</Citation></Reference><Reference><Citation>Walsh M, Srinathan SK, McAuley DF, Mrkobrada M, Levine O, Ribic Cet al. . The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index. J Clin Epi Elsevier 2014;67:622&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24508144</ArticleId></ArticleIdList></Reference><Reference><Citation>
Harrell FE Jr. Introduction to Bayes for Evaluating Treatments. 2022. https://hbiostat.org/doc/bayes/course.html/(18 February 2023).</Citation></Reference><Reference><Citation>Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, S&#xf8;ndergaard L, Mumtaz Met al. . Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">28304219</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O&#x2019;Brien SM, Boden WEet al. . Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 2020;382:1395&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263833</ArticleId><ArticleId IdType="pubmed">32227755</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella PD, Baratto F, Vergara P, Bertocchi P, Santamaria M, Notarstefano Pet al. . Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation 2022;145:1829&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">35369700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rindskopf D. Reporting Bayesian results. Eval Rev 2020;44:354&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">33380224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruschke JK. Bayesian analysis reporting guidelines. Nat Hum Behav 2021;5:1282&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8526359</ArticleId><ArticleId IdType="pubmed">34400814</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28624892</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>A meta-analysis of manual versus remote magnetic navigation for ventricular tachycardia ablation.</ArticleTitle><Pagination><StartPage>227</StartPage><EndPage>235</EndPage><MedlinePgn>227-235</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-017-0257-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There are limited studies on the safety and efficacy of remote magnetic navigation (RMN) versus manual navigation (MAN) in ventricular tachycardia (VT) ablation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive literature search was performed using the keywords VT ablation, stereotaxis, RMN and MAN in Pubmed, Ebsco, Web of Science, Cochrane, and Google scholar databases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The analysis included seven studies (one randomized, three prospective observational, and three retrospective) including 779 patients [both structural heart disease (SHD) and idiopathic VT] comparing RMN (N&#xa0;=&#xa0;433) and MAN (N&#xa0;=&#xa0;339) in VT ablation. The primary end point of long-term VT recurrence was significantly lower with RMN (OR 0.61, 95% CI 0.44-0.85, p&#xa0;=&#xa0;0.003) compared with MAN. Other end points of acute procedural success (OR 2.13, 95% CI 1.40-3.23, p&#xa0;=&#xa0;0.0004) was significantly higher with RMN compared with MAN. Fluoroscopy [mean difference -10.42, 95% CI -12.7 to -8.1, p&#xa0;&lt;&#xa0;0.0001], procedural time [mean difference -9.79, 95% CI -19.27 to -0.3, p&#xa0;=&#xa0;0.04] and complications (OR 0.35, 95% CI 0.17-0.74, p&#xa0;=&#xa0;0.0006) were also significantly lower in RMN when compared with MAN. In a subgroup analysis SHD, there was no significant difference in VT recurrence or acute procedural success with RMN vs. MAN. In idiopathic VT, RMN significantly increased acute procedural success with no difference in VT recurrence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results demonstrate that RMN is safe and effective when compared with MAN in patients with both SHD and idiopathic VT undergoing catheter ablation. Further prospective studies are needed to further verify the safety and efficacy of RMN.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turagam</LastName><ForeName>Mohit K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Missouri Hospital and Clinics, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkins</LastName><ForeName>Donita</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital &amp; Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 6616, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Roderick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Chicago Medicine, Pritzker School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansour</LastName><ForeName>Moussa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruskin</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Texas Heart Institute, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Albert Einstein College of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital &amp; Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 6616, USA. dlakkireddy@kumc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008280" MajorTopicYN="N">Magnetics</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013238" MajorTopicYN="N">Stereotaxic Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025321" MajorTopicYN="N">Surgery, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Remote magnetic navigation and manual navigation system</Keyword><Keyword MajorTopicYN="N">Stereotaxis</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28624892</ArticleId><ArticleId IdType="doi">10.1007/s10840-017-0257-3</ArticleId><ArticleId IdType="pii">10.1007/s10840-017-0257-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Cardiovasc Electrophysiol. 2016 Mar;27 Suppl 1:S38-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26969222</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2007 Mar 13;115(10):1191-200</Citation><ArticleIdList><ArticleId IdType="pubmed">17296855</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interv Card Electrophysiol. 2017 Apr;48(3):237-245</Citation><ArticleIdList><ArticleId IdType="pubmed">28064433</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2013 Aug;10(8):1178-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23692891</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Jul 14;375(2):111-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2015 Jul 20;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">26200478</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 2008 Nov;31(11):1399-404</Citation><ArticleIdList><ArticleId IdType="pubmed">18950296</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2015 Sep;12(9):1997-2007</Citation><ArticleIdList><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2000 Mar 21;101(11):1288-96</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference><Reference><Citation>Neth Heart J. 2015 Sep;23(10):485-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26215291</ArticleId></ArticleIdList></Reference><Reference><Citation>Neth Heart J. 2013 Jun;21(6):296-303</Citation><ArticleIdList><ArticleId IdType="pubmed">23595705</ArticleId></ArticleIdList></Reference><Reference><Citation>Neth Heart J. 2013 Jun;21(6):294-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23653293</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2003 Jun 18;41(12):2228-36</Citation><ArticleIdList><ArticleId IdType="pubmed">12821253</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2001 Jul 7;323(7303):42-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11440947</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2007 May;18(5):520-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17388912</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2009 Jun;6(6):886-933</Citation><ArticleIdList><ArticleId IdType="pubmed">19467519</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 2008 Jul;31(7):893-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18684288</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Dec 3;106(23):2980-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12460882</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2013 Oct;15(10):1426-31</Citation><ArticleIdList><ArticleId IdType="pubmed">23493412</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2012 May;23(5):499-505</Citation><ArticleIdList><ArticleId IdType="pubmed">22313170</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacing Clin Electrophysiol. 2006 Nov;29(11):1285-97</Citation><ArticleIdList><ArticleId IdType="pubmed">17100685</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2011 Jul;13(7):1015-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21508006</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2012 Sep;23(9):948-54</Citation><ArticleIdList><ArticleId IdType="pubmed">22554147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35483328</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9751</ISSN><JournalIssue CitedMedium="Internet"><Volume>147</Volume><Issue>3</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Cardiology</Title><ISOAbbreviation>Cardiology</ISOAbbreviation></Journal><ArticleTitle>A Review of New-Onset Ventricular Arrhythmia after Left Ventricular Assist Device Implantation.</ArticleTitle><Pagination><StartPage>315</StartPage><EndPage>327</EndPage><MedlinePgn>315-327</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000524779</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Heart failure (HF) is a severe and terminal stage of various heart diseases. Left ventricular assist devices (LVADs) are relatively mature and have contributed to the treatment of end-stage HF. Ventricular arrhythmia (VA) is a common complication after LVAD implantation, including ventricular tachycardia and ventricular fibrillation, both of which may cause abnormal circulation.</AbstractText><AbstractText Label="METHODS">A literature search was conducted in the PubMed database, "Ventricular Arrhythmia" OR "VA" OR "Arrhythmia" OR "Ventricular Tachycardia," OR "Ventricular Fibrillation" AND "LVAD" OR "Left Ventricular Assist Device" OR "Heart Assist Device" as either keywords or MeSH terms, the authors screened the titles and abstracts of the articles. Eventually, 12 original research articles were retrieved.</AbstractText><AbstractText Label="RESULTS">The 0.83 [95% CI: 0.77, 0.89] of patients were male. A whole of 53% [95% CI: 0.25, 0.81] of VA patients had a history of atrial fibrillation and 61% [95% CI: 0.52, 0.69] had a history of VA. 39% [95% CI: 0.29, 0.49] of the participants had no prior history of VA and experienced new VA following CF-LVAD implantation. Following CF-LVAD implantation, 59% [95% CI: 0.51, 0.67] of patients developed early VA (VA &#x2264;30 days). The 30-day mortality rate of patients was 4% [95% CI: 0.01, 0.07]. And overall mortality was 28% [95% CI: 0.15, 0.41]. The reported incidence of VA after LVAD implantation is not identical in different medical centers and ranges from 20% to 60%. The mechanism of VA after LVAD implantation is summarized as primary cardiomyopathy-related, device mechanical stimulation, myocardial scarring, ventricular displacement, electrolyte regulation, and other processes.</AbstractText><AbstractText Label="CONCLUSIONS">A preoperative VA history is considered a predictor of VA following LVAD implantation in most studies. Multiple mechanisms and factors, such as prevention of "suction events," ablation, and implantable cardioverter defibrillator, should be considered for the prevention and treatment of postoperative VA in patients requiring long-term VAD treatment. This study provides a reference for the clinical application of LAVD and the prevention of postoperative VA after LVAD implantation. Future multicenter prospective studies with uniform patient follow-up are needed to screen for additional potential risk factors and predictors. These studies will help to define the incidence rate of VA after LAVD implantation. As a result, we provide guidance for the selection of preventive intervention.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s). Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cardiology</MedlineTA><NlmUniqueID>1266406</NlmUniqueID><ISSNLinking>0008-6312</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Left ventricular assist device</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmia</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>18</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35483328</ArticleId><ArticleId IdType="pmc">PMC9393833</ArticleId><ArticleId IdType="doi">10.1159/000524779</ArticleId><ArticleId IdType="pii">000524779</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Writing C, Maddox TM, Januzzi JL, Jr, Allen LA, Breathett K, Butler J, et al. 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction &#x2212; a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 Feb 16;77((6)):772&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">33446410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao G, Wang X, Chen Z, Zhang L, Zhang Y, Wei B, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012&#x2013;2015. Eur J Heart Fail. 2019 Nov;21((11)):1329&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">31746111</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina EJ, Shah P, Kiernan MS, Cornwell WK, 3rd, Copeland H, Takeda K, et al. The society of thoracic surgeons intermacs 2020 annual report. Ann Thorac Surg. 2021 Mar;111((3)):778&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">33465365</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahara S, Chien C, Gelow J, Dalouk K, Henrikson CA, Mudd J, et al. Ventricular arrhythmias after left ventricular assist device. Circ Arrhythm Electrophysiol. 2013 Jun;6((3)):648&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">23778248</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinathannair R, Cornwell WK, Dukes JW, Ellis CR, Hickey KT, Joglar JA, et al. Device therapy and arrhythmia management in left ventricular assist device recipients: a scientific statement from the American Heart Association. Circulation. 2019 May 14;139((20)):e967&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">30943783</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin JM, Katz JN. The burden of ventricular arrhythmias following left ventricular assist device implantation. Arrhythm Electrophysiol Rev. 2014 Nov;3((3)):145&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4711528</ArticleId><ArticleId IdType="pubmed">26835082</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap SC, Ramjankhan F, Muslem R, de Jonge N, Kirkels HJ, Akin S, et al. Ventricular arrhythmias in patients with a continuous-flow left ventricular assist device. J Am Coll Cardiol. 2016 Jul 19;68((3)):323&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">27417012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadado AJ, Akar JG, Hummel JP. Arrhythmias after left ventricular assist device implantation: incidence and management. Trends Cardiovasc Med. 2018 Jan;28((1)):41&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">28734595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005 May 3;45((9)):1428&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">15862414</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007 Aug 30;357((9)):885&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">17761592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchez S, De Somer F, Herck I, Van Belleghem Y, De Pauw M, Stroobandt R. Shock-refractory ventricular fibrillation in a patient implanted with a left ventricular assist device. Resuscitation. 2016 Oct;107:e1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">27402356</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith ME, Moak JH. Asymptomatic ventricular fibrillation in continuous flow left-ventricular assist device. Am J Emerg Med. 2021 Nov;49:130&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">34102458</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch MC, Haap M, Kristen A, Haas CS. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. Ann Emerg Med. 2011 Jan;57((1)):25&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20674087</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Williams JG, Brice JH. Sustained ventricular fibrillation in an alert patient: preserved hemodynamics with a left ventricular assist device. Prehosp Emerg Care. 2011 Oct-Dec;15((4)):533&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21806468</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyituoyo HO, Aben RN, Arinze NC, Vu DP, James EA. Ventricular fibrillation 7 years after left ventricular assist device implantation. Am J Case Rep. 2020 Jun 20;21:e923711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327732</ArticleId><ArticleId IdType="pubmed">32561703</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakstaite AM, Luedike P, Wakili R, Kochhauser S, Ruhparwar A, Rassaf T, et al. Case report: incessant ventricular fibrillation in a conscious left ventricular assist device patient. Eur Heart J Case Rep. 2021 Sep;5((9)):ytab337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8453423</ArticleId><ArticleId IdType="pubmed">34557636</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JD, Piacentino V, 3rd, Rothman S, Chambers S, Jessup M, Margulies KB. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail. 2005 Apr;11((3)):227&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15812752</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II) J Heart Lung Transplant. 2009 Jul;28((7)):733&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19560703</ArticleId></ArticleIdList></Reference><Reference><Citation>Garan AR, Levin AP, Topkara V, Thomas SS, Yuzefpolskaya M, Colombo PC, et al. Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2015 Dec;34((12)):1611&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26212658</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NG, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010 Apr;7((4)):466&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">20178869</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007 Apr 15;99((8)):1151&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">17437746</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenyo A, Rao M, Koneru S, Hallinan W, Shah S, Massey HT, et al. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol. 2012 May;23((5)):515&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">22081967</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins RP, Leclercq C, Bourenane H, Auffret V, Boule S, Loobuyck V, et al. Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: new insights from the ASSIST-ICD study. Heart Rhythm. 2019 Oct;16((10)):1506&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">31255846</ArticleId></ArticleIdList></Reference><Reference><Citation>Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009 Nov 3;54((19)):1747&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">19874988</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishi T. Heart failure as an autonomic nervous system dysfunction. J Cardiol. 2012 Mar;59((2)):117&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">22341431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Montoya A, Zbilut JP, Mawulawde K, Sullivan HJ, Lonchyna VA, et al. Effect of HeartMate left ventricular assist device on cardiac autonomic nervous activity. Ann Thorac Surg. 1996 Feb;61((2)):591&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">8572772</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuteberg JJ, Cleveland JC, Jr, Cowger J, Higgins RS, Goldstein DJ, Keebler M, et al. The society of thoracic surgeons intermacs 2019 annual report: the changing landscape of devices and indications. Ann Thorac Surg. 2020 Mar;109((3)):649&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">32115073</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollkron M, Voitl P, Ta J, Wieselthaler G, Schima H. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007 Aug;26((8)):819&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">17692786</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JD, Piacentino V, 3rd, Gaughan JP, Houser SR, Margulies KB. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation. 2001 Sep 11;104((11)):1241&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11551874</ArticleId></ArticleIdList></Reference><Reference><Citation>Maradey JA, Singleton MJ, O'Neill TJ, Bhave PD. Management of ventricular arrhythmias in patients with LVAD. Curr Opin Cardiol. 2020 May;35((3)):289&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">32205476</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson RD, Lee G, Virk S, Bennett RG, Hayward CS, Muthiah K, et al. Catheter ablation of ventricular tachycardia in patients with a ventricular assist device: a systematic review of procedural characteristics and outcomes. JACC Clin Electrophysiol. 2019 Jan;5((1)):39&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30678785</ArticleId></ArticleIdList></Reference><Reference><Citation>Arkles JS, Marchlinski F. When should the electrophysiologist be involved in managing patients with ventricular assist devices and ventricular arrhythmias? J Innov Card Rhythm Manag. 2019 Apr;10((4)):3605&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252896</ArticleId><ArticleId IdType="pubmed">32494416</ArticleId></ArticleIdList></Reference><Reference><Citation>Askar SF, Ramkisoensing AA, Schalij MJ, Bingen BO, Swildens J, van der Laarse A, et al. Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization. Cardiovasc Res. 2011 May 1;90((2)):295&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">21233254</ArticleId></ArticleIdList></Reference><Reference><Citation>Strecker T, R&#xf6;sch J, Weyand M, Agaimy A. Pathological findings in cardiac apex removed during implantation of left ventricular assist devices (LVAD) are non-specific: 13-year-experience at a German Heart Center. Int J Clin Exp Pathol. 2014;7((9)):5549&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4203167</ArticleId><ArticleId IdType="pubmed">25337196</ArticleId></ArticleIdList></Reference><Reference><Citation>Urso C, Brucculeri S, Caimi G. Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev. 2015 Jul;20((4)):493&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4464645</ArticleId><ArticleId IdType="pubmed">25820346</ArticleId></ArticleIdList></Reference><Reference><Citation>Monreal G, Gerhardt MA. Left ventricular assist device support induces acute changes in myocardial electrolytes in heart failure. ASAIO J. 2007 Mar&#x2013;Apr;53((2)):152&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17413553</ArticleId></ArticleIdList></Reference><Reference><Citation>Terracciano CM, Harding SE, Adamson D, Koban M, Tansley P, Birks EJ, et al. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur Heart J. 2003 Jul;24((14)):1329&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">12871690</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaselli GF. Calcium and arrhythmias: ignore at your peril. J Cardiovasc Electrophysiol. 2012 Dec;23((12)):1372&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">23131105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Bergin JD, Mahapatra S, et al. Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. J Thorac Cardiovasc Surg. 2013 May;145((5)):1207&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3658124</ArticleId><ArticleId IdType="pubmed">22520722</ArticleId></ArticleIdList></Reference><Reference><Citation>Oswald H, Schultz-Wildelau C, Gardiwal A, Lusebrink U, Konig T, Meyer A, et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010 Jun;12((6)):593&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20406799</ArticleId></ArticleIdList></Reference><Reference><Citation>Garan AR, Yuzefpolskaya M, Colombo PC, Morrow JP, Te-Frey R, Dano D, et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol. 2013 Jun 25;61((25)):2542&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23643502</ArticleId></ArticleIdList></Reference><Reference><Citation>Galand V, Flecher E, Auffret V, Boule S, Vincentelli A, Dambrin C, et al. Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. JACC Clin Electrophysiol. 2018 Sep;4((9)):1166&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">30236390</ArticleId></ArticleIdList></Reference><Reference><Citation>Galand V, Flecher E, Auffret V, Pichard C, Boule S, Vincentelli A, et al. Early ventricular arrhythmias after LVAD implantation is the strongest predictor of 30-day post-operative mortality. JACC Clin Electrophysiol. 2019 Aug;5((8)):944&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">31439296</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehorn MR, Black-Maier E, Loungani R, Sen S, Sun AY, Friedman DJ, et al. Electrical storm in patients with left ventricular assist devices: risk factors, incidence, and impact on survival. Heart Rhythm. 2021 Aug;18((8)):1263&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">33839327</ArticleId></ArticleIdList></Reference><Reference><Citation>Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012 Sep;164((3)):373&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22980304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellman Y, Malik AS, Lin H, Shen C, Wang IW, Wozniak TC, et al. B-type natriuretic peptide levels predict ventricular arrhythmia post left ventricular assist device implantation. Artif Organs. 2015 Dec;39((12)):1051&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25864448</ArticleId></ArticleIdList></Reference><Reference><Citation>Erqou S, Kormos RL, Wang NC, McNamara DM, Bazaz R. Electromagnetic interference from left ventricular assist device (LVAD) inhibiting the pacing function of an implantable cardioverter-defibrillator (ICD) device. Case Rep Cardiol. 2018;2018:6195045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192132</ArticleId><ArticleId IdType="pubmed">30402296</ArticleId></ArticleIdList></Reference><Reference><Citation>Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol. 2008 Oct;31((10)):1246&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752870</ArticleId><ArticleId IdType="pubmed">18811803</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi E, Ripplinger CM. Antiarrhythmic mechanisms of beta blocker therapy. Pharmacol Res. 2019 Aug;146:104274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679787</ArticleId><ArticleId IdType="pubmed">31100336</ArticleId></ArticleIdList></Reference><Reference><Citation>Stainback RF, Estep JD, Agler DA, Birks EJ, Bremer M, Hung J, et al. Echocardiography in the management of patients with left ventricular assist devices: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2015 Aug;28((8)):853&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">26239899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacher F, Reichlin T, Zado ES, Field ME, Viles-Gonzalez JF, Peichl P, et al. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2015 Jun;8((3)):592&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25870335</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrotty DM, Rame JE, Margulies KB. Management of ventricular arrhythmias in patients with ventricular assist devices. Curr Opin Cardiol. 2013 May;28((3)):360&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23549232</ArticleId></ArticleIdList></Reference><Reference><Citation>Emaminia A, Nagji AS, Ailawadi G, Bergin JD, Kern JA. Concomitant left ventricular assist device placement and cryoablation for treatment of ventricular tachyarrhythmias associated with heart failure. Ann Thorac Surg. 2011 Jul;92((1)):334&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21718868</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss JD, Flatley EE, Beaser AD, Shin JH, Nayak HM, Upadhyay GA, et al. Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience. JACC Clin Electrophysiol. 2017 Dec 11;3((12)):1412&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">29759673</ArticleId></ArticleIdList></Reference><Reference><Citation>Refaat MM, Tanaka T, Kormos RL, McNamara D, Teuteberg J, Winowich S, et al. Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. J Card Fail. 2012 Feb;18((2)):140&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3272629</ArticleId><ArticleId IdType="pubmed">22300782</ArticleId></ArticleIdList></Reference><Reference><Citation>Moini C, Lefoulon A, Rahim D, Yassine M, Poindron D, Amara W. [ICD and left ventricular assist device interference: case report] Ann Cardiol Angeiol. 2020 Nov;69((5)):332&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33067008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhne M, Sakumura M, Reich SS, Sarrazin JF, Wells D, Chalfoun N, et al. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure. Am J Cardiol. 2010 Feb 1;105((3)):378&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">20102952</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalcin YC, Kooij C, Theuns D, Constantinescu AA, Brugts JJ, Manintveld OC, et al. Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices. Europace. 2020 Apr 1;22((4)):584&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132535</ArticleId><ArticleId IdType="pubmed">32003803</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi M, Barwad P, Malavassi Corrales FJ, Tandri H, Mathuria N, Shah R, et al. Cardiac sympathetic denervation for refractory ventricular arrhythmias. J Am Coll Cardiol. 2017 Jun 27;69((25)):3070&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6330109</ArticleId><ArticleId IdType="pubmed">28641796</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlismas PP, Rochlani YM, Romero J, Scheinin S, Shin JJ, Goldstein D, et al. Cardiac sympathetic denervation for refractory ventricular arrhythmia in continuous-flow left ventricular assist device. JACC Case Rep. 2021 Mar;3((3)):443&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8311031</ArticleId><ArticleId IdType="pubmed">34317554</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudgh&#xe8;ne-Stambouli F, Boul&#xe9; S, Go&#xe9;minne C, Botcherby E, Marqui&#xe9; C, Kouakam C, et al. Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 2013;39((2)):177&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">24338204</ArticleId></ArticleIdList></Reference><Reference><Citation>Efimova E, Fischer J, Bertagnolli L, Dinov B, Kircher S, Rolf S, et al. Predictors of ventricular arrhythmia after left ventricular assist device implantation: A large single-center observational study. Heart Rhythm. 2017;14((12)):1812&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">28756099</ArticleId></ArticleIdList></Reference><Reference><Citation>Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices. Circ Arrhythm Electrophysiol. 2013;6((4)):668&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">23873139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoruk A, Sherazi S, Massey HT, Kutyifa V, McNitt S, Hallinan W, et al. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device. Heart Rhythm. 2016;13((5)):1052&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">26829113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Tandon V, O'Sullivan DM, Cronin E, Gluck J, Kluger J. ICD shocks in LVAD patients are not associated with increased subsequent mortality risk. J Interv Card Electrophysiol. 2019;56((3)):341&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">31506872</ArticleId></ArticleIdList></Reference><Reference><Citation>Corre J, Picard F, Garcia R, Zemmoura A, Derval N, Denis A, et al. Electrical storm in the early phase of HeartMate&#xae; II device implantation: Incidence, risk factors and prognosis. Arch Cardiovasc Dis. 2018;111((5)):332&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29217463</ArticleId></ArticleIdList></Reference><Reference><Citation>Greet BD, Pujara D, Burkland D, Pollet M, Sudhakar D, Rojas F, et al. Incidence, Predictors, and Significance of Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices: A 15-Year Institutional Experience. JACC Clin Electrophysiol. 2018;4((2)):257&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">29749947</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30544147</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1755-3245</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Cardiovascular research</Title><ISOAbbreviation>Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>Hypothermia and cardiac electrophysiology: a systematic review of clinical and experimental data.</ArticleTitle><Pagination><StartPage>501</StartPage><EndPage>509</EndPage><MedlinePgn>501-509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cvr/cvy305</ELocationID><Abstract><AbstractText>Moderate therapeutic hypothermia procedures are used in post-cardiac arrest care, while in surgical procedures, lower core temperatures are often utilized to provide cerebral protection. Involuntary reduction of core body temperature takes place in accidental hypothermia and ventricular arrhythmias are recognized as a principal cause for a high mortality rate in these patients. We assessed both clinical and experimental literature through a systematic literature search in the PubMed database, to review the effect of hypothermia on cardiac electrophysiology. From included studies, there is common experimental and clinical evidence that progressive cooling will induce changes in cardiac electrophysiology. The QT interval is prolonged and appears more sensitive to decreases in temperature than the QRS interval. Severe hypothermia is associated with more pronounced changes, some of which are proarrhythmic. This is supported clinically where severe accidental hypothermia is commonly associated with ventricular fibrillation or asystole. J-waves in human electrocardiogram recordings are regularly but not always observed in hypothermia. Its relation to ventricular repolarization and arrhythmias is not obvious. Little clinical data exist on efficacy of anti-arrhythmic drugs in hypothermia, while experimental data show the potential of some agents, such as the class III antiarrhythmic bretylium. It is apparent that QT-prolonging drugs should be avoided.</AbstractText><CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. &#xa9; The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dietrichs</LastName><ForeName>Erik Sveberg</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Medical Biology, Experimental and Clinical Pharmacology Research Group, UiT, The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Diagnostic Services, Department of Clinical Pharmacology, University Hospital of North Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tveita</LastName><ForeName>Torkjel</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Anesthesia and Critical Care Research Group, UiT, The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgical Medicine and Intensive Care, University Hospital of North Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Godfrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Cardiovascular &amp; Medical Sciences, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Res</MedlineTA><NlmUniqueID>0077427</NlmUniqueID><ISSNLinking>0008-6363</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="Y">Action Potentials</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001833" MajorTopicYN="Y">Body Temperature Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007035" MajorTopicYN="N">Hypothermia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Electrophysiology</Keyword><Keyword MajorTopicYN="N">Hypothermia</Keyword><Keyword MajorTopicYN="N">Therapeutic hypothermia</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmias</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30544147</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvy305</ArticleId><ArticleId IdType="pii">5244094</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34058895</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6817</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</Title><ISOAbbreviation>Otolaryngol Head Neck Surg</ISOAbbreviation></Journal><ArticleTitle>Tympanic Membrane Perforation After Intratympanic Steroid Injection: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>249</StartPage><EndPage>259</EndPage><MedlinePgn>249-259</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/01945998211012300</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We investigated the incidence of tympanic membrane (TM) perforations induced after intratympanic steroid injection (ITSI) in patients with sudden sensorineural hearing loss (SSNHL) through a systematic review and meta-analysis.</AbstractText><AbstractText Label="DATA SOURCES">PubMed, Embase, and MEDLINE.</AbstractText><AbstractText Label="REVIEW METHODS">Primary database searches were performed, and 1901 records were identified. After removal of 1802 articles through abstract screening, the remaining 99 full-text journals were assessed for eligibility to be included in the study. Fifty-eight studies that used either ventilation tubing (VT) or tympanocentesis (TC) for ITSI were selected for analysis. The subjects were divided into VT and TC groups. The rate of TM perforation after ITSI in 2 groups, sites of ITSI, needle gauge, and influence on residual hearing were investigated.</AbstractText><AbstractText Label="RESULTS">The cohorts comprised patients who underwent VT (n = 257, 9.6%) and TC (n = 2415, 90.4%). The proportion of TM perforation after ITSI in each group was 0.073 (95% CI, 0.0469-0.1113) and 0.010 (95% CI, 0.0045-0.0215), respectively, which suggested that the VT group showed a significantly higher TM perforation rate than the TC group (<i>P</i> &lt; .001). In the subgroup analyses, there was no significant difference in the odds ratio for the rate of TM perforation according to the injection site and needle gauge for TC. The proportion of surgical repair showed no significant difference between the 2 groups.</AbstractText><AbstractText Label="CONCLUSION">ITSI via VT may have a significantly higher risk of TM perforation than ITSI via TC, although those are relatively small overall. ITSI should be performed in the direction to minimize possible adverse effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Young Ho</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Doh Young</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dong-Han</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Konkuk University Medical Center, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Sohee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Research Collaborating Center, Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Otolaryngol Head Neck Surg</MedlineTA><NlmUniqueID>8508176</NlmUniqueID><ISSNLinking>0194-5998</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013256">Steroids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Otolaryngol Head Neck Surg. 2022 Aug;167(2):410. doi: 10.1177/01945998211043850.</RefSource><PMID Version="1">35913807</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006319" MajorTopicYN="N">Hearing Loss, Sensorineural</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069555" MajorTopicYN="N">Injection, Intratympanic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013256" MajorTopicYN="N">Steroids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018058" MajorTopicYN="N">Tympanic Membrane Perforation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">intratympanic steroid injection</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">sudden sensorineural hearing loss</Keyword><Keyword MajorTopicYN="N">tympanic membrane perforation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34058895</ArticleId><ArticleId IdType="doi">10.1177/01945998211012300</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39624903</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-3084</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Circulation. Arrhythmia and electrophysiology</Title><ISOAbbreviation>Circ Arrhythm Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>In Vivo Mapping of Human Ventricular Fibrillation in Brugada Syndrome: The Role of Repolarization Heterogeneity.</ArticleTitle><Pagination><StartPage>e013290</StartPage><MedlinePgn>e013290</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCEP.124.013290</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Brugada syndrome (BrS) is associated with ventricular fibrillation (VF). Different VF mechanisms have been described, and repolarization gradients were associated with VF in a BrS model. The aim of this study is to map VF in BrS with ECG imaging. Furthermore, spatial correlation between sinus rhythm maps and VF maps was evaluated.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Inclusion criteria were (1) BrS diagnosis and (2) VF mapped with ECG imaging during right ventricle outflow tract ablation. VF mechanism was classified into (1) rotational, (2) focal, and (3) irregular. For comparison, 6 controls were enrolled. The following sinus rhythm maps were performed: activation, recovery time, and activation-recovery interval time. Spatial overlap between steep repolarization gradients (cliffs) at recovery time and activation-recovery interval time maps and initiating VF rotational activity was evaluated with photogrammetry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 28 VF maps in 21 patients with BrS were analyzed. In the first &#x2248;7 seconds of VF, rotational, focal, and irregular mechanisms were found. In 19 patients with BrS (90.5%) and none of the controls, a right ventricle outflow tract repolarization cliff only was found. In all these patients, the singularity point of the first initiating rotational VF activity spatially overlapped with the right ventricle outflow tract cliff. Abolition of right ventricle outflow tract repolarization cliffs was confirmed in all but 2 patients (94.3%). In one patient with recurrence, VF was mapped on the anterior right ventricle over a cliff that was not targeted at the first ablation procedure.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In patients with BrS, repolarization heterogeneity has a critical role in VF. Repolarization cliffs might be a therapeutic target in VF ablation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pannone</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9769-1511</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Rocca</LastName><ForeName>Domenico Giovanni</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0003-3837-3462</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergara</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7751-6871</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorgente</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0078-9393</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Monte</LastName><ForeName>Alvise</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6672-4931</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vetta</LastName><ForeName>Giampaolo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1120-0492</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cespon Fernandez</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6549-4994</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talevi</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eltsov</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-2832-9556</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calburean</LastName><ForeName>Paul-Adrian</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-4948-2587</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overeinder</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bala</LastName><ForeName>Gezim</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7613-0712</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almorad</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9743-1661</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Str&#xf6;ker</LastName><ForeName>Erwin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappaert</LastName><ForeName>Gudrun</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9912-7121</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sieira</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Ravel</LastName><ForeName>Thomy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3361-3781</Identifier><AffiliationInfo><Affiliation>Centre for Medical Genetics (T.d.R., S.V.D.), Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Clinical Sciences, Research Group Reproduction and Genetics, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Dooren</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8583-1994</Identifier><AffiliationInfo><Affiliation>Centre for Medical Genetics (T.d.R., S.V.D.), Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Clinical Sciences, Research Group Reproduction and Genetics, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brussels Interuniversity Genomics High Throughput Core (S.V.D.), Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Clinical Sciences, Research Group Reproduction and Genetics, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gharaviri</LastName><ForeName>Ali</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1803-8237</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Meir</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6261-5110</Identifier><AffiliationInfo><Affiliation>Cardiac Surgery Department (M.L.M.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugada</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3172-6106</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chierchia</LastName><ForeName>Gian Battista</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarkozy</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6327-0487</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Asmundis</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9351-0760</Identifier><AffiliationInfo><Affiliation>Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Arrhythm Electrophysiol</MedlineTA><NlmUniqueID>101474365</NlmUniqueID><ISSNLinking>1941-3084</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053840" MajorTopicYN="Y">Brugada Syndrome</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="Y">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brugada syndrome</Keyword><Keyword MajorTopicYN="N">coronary angiography</Keyword><Keyword MajorTopicYN="N">death, sudden, cardiac</Keyword><Keyword MajorTopicYN="N">heart ventricles</Keyword><Keyword MajorTopicYN="N">ventricular fibrillation</Keyword></KeywordList><CoiStatement>Dr Sorgente received research grants from Daiichi Sankyo and Bayer; he received speaker fees from Menarini and Bayer. Dr La Meir is a consultant for AtriCure. Dr Chierchia received compensation for teaching purposes and proctoring from Medtronic, Abbott, Biotronik, and Boston Scientific. Dr Sarkozy is a consultant for Biosense Webster and Medtronic and received speaker fees from Biosense Webster, Biotronik, Pfizer, and Microport. Dr de Asmundis receives research grants on behalf of the center from Biotronik, Medtronic, Abbott, Microport, Boston Scientific, and AtriCure. Dr de Asmundis received compensation for teaching purposes and proctoring from Medtronic, Abbott, Biotronik, MicroPort, Boston Scientific, AtriCure, and Daiichi Sankyo. The other authors report no conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>17</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39624903</ArticleId><ArticleId IdType="doi">10.1161/CIRCEP.124.013290</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32043582</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1594</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Artificial organs</Title><ISOAbbreviation>Artif Organs</ISOAbbreviation></Journal><ArticleTitle>Ventricular arrhythmias following continuous-flow left ventricular assist device implantation: A systematic review.</ArticleTitle><Pagination><StartPage>E313</StartPage><EndPage>E325</EndPage><MedlinePgn>E313-E325</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aor.13665</ELocationID><Abstract><AbstractText>Ventricular arrhythmias (VA) are not uncommon after continuous-flow left ventricular assist device (CF-LVAD) implantation. In this systematic review, we sought to identify the patterns of VA that occurred following CF-LVAD implantation and evaluate their outcomes. An electronic search was performed to identify all articles reporting the development of VA following CF-LVAD implantation. VA was defined as any episode of ventricular fibrillation (VF) or sustained (&gt;30 seconds) ventricular tachycardia (VT). Eleven studies were pooled for the analysis that included 393 CF-LVAD patients with VA. The mean patient age was 57 years [95%CI: 54; 61] and 82% [95%CI: 73; 88] were male. Overall, 37% [95%CI: 19; 60] of patients experienced a new onset VA after CF-LVAD implantation, while 60% [95%CI: 51; 69] of patients had a prior history of VA. Overall, 88% of patients [95%CI: 78; 94] were supported on HeartMate II CF-LVAD, 6% [95%CI: 3; 14] on HeartWare HVAD, and 6% [95%CI: 2; 13] on other CF-LVADs. VA was symptomatic in 47% [95%CI: 28; 68] of patients and in 50% [95%CI: 37; 52], early VA (&lt;30 days from CF-LVAD) was observed. The 30-day mortality rate was 7% [95%CI: 5; 11]. Mean follow-up was 22.9 months [95%CI: 4.8; 40.8], during which 27% [95%CI: 17; 39] of patients underwent heart transplantation. In conclusion, approximately a third of patients had new VA following CF-LVAD placement. VA in CF-LVAD patients is often symptomatic, necessitates treatment, and carries a worse prognosis.</AbstractText><CopyrightInformation>&#xa9; 2020 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Jonathan S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0003-1610-7067</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maynes</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-6870-8211</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jae Hwan</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Chelsey T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Rohinton J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massey</LastName><ForeName>H Todd</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tchantchaleishvili</LastName><ForeName>Vakhtang</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4357-3533</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Artif Organs</MedlineTA><NlmUniqueID>7802778</NlmUniqueID><ISSNLinking>0160-564X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="N">Heart-Assist Devices</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">continuous-flow left ventricle assist device</Keyword><Keyword MajorTopicYN="N">left ventricle assist device</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia</Keyword><Keyword MajorTopicYN="N">ventricular assist device</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32043582</ArticleId><ArticleId IdType="doi">10.1111/aor.13665</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Adams EE, Wrightson ML. Quality of life with an LVAD: a misunderstood concept. Heart Lung. 2018 May;47:177-83.</Citation></Reference><Reference><Citation>Guzman-Gutierrez G, Shi Y, Rappelt M, Jahangir A, Thohan V. Advanced heart failure treatment options among the elderly. J Patient-cent Res Rev. 2016 Nov;3:199-206.</Citation></Reference><Reference><Citation>Rodrigo ME, Molina EJ, Majure DT, Sheikh FH, Hofmeyer MR, Ruiz G, et al. Preliminary single-center experience with left anterior mini-thoracotomy for continuous-flow LVAD implantation. J Heart Lung Transplant. 2014 Apr;33:S202.</Citation></Reference><Reference><Citation>Greet BD, Pujara D, Burkland D, Pollet M, Sudhakar D, Rojas F, et al. Incidence, predictors, and significance of ventricular arrhythmias in patients with continuous-flow left ventricular assist devices: a 15-year institutional experience. JACC Clin Electrophysiol. 2018 Feb;4:257-64.</Citation></Reference><Reference><Citation>Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The society of thoracic surgeons intermacs database annual report: evolving indications, outcomes, and scientific partnerships. Ann Thorac Surg. 2019 Feb;107:341-53.</Citation></Reference><Reference><Citation>Slaughter MS. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy. J Card Surg. 2010 Jul;25:490-4.</Citation></Reference><Reference><Citation>Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012 Sep;164:373-8.</Citation></Reference><Reference><Citation>Yoruk A, Sherazi S, Massey HT, Kutyifa V, McNitt S, Hallinan W, et al. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device. Heart Rhythm. 2016 Jan;13:1052-6.</Citation></Reference><Reference><Citation>Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009 Jul;28(7):733-5.</Citation></Reference><Reference><Citation>Yuan N, Arnaoutakis GJ, George TJ, Allen JG, Ju DG, Schaffer JM, et al. The spectrum of complications following left ventricular assist device placement. J Card Surg [Internet]. 2012 Sep;27:630-8. Available from: http://doi.wiley.com/10.1111/j.1540-8191.2012.01504.x</Citation></Reference><Reference><Citation>Efimova E, Fischer J, Bertagnolli L, Dinov B, Kircher S, Rolf S, et al. Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study. Heart Rhythm. 2017 Jul;14:1812-9.</Citation></Reference><Reference><Citation>Sacher F, Reichlin T, Zado ES, Field ME, Viles-Gonzalez JF, Peichl P, et al. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2015 Jun;8:592-7.</Citation></Reference><Reference><Citation>Oswald H, Schultz-Wildelau C, Gardiwal A, L&#xfc;sebrink U, K&#xf6;nig T, Meyer A, et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010 Jun;12:593-9.</Citation></Reference><Reference><Citation>Moss JD, Flatley EE, Beaser AD, Shin JH, Nayak HM, Upadhyay GA, et al. Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience. JACC Clin Electrophysiol. 2017 Dec;3:1412-24.</Citation></Reference><Reference><Citation>Chatur S, Chew D, Sharma N, Church M, Raj SR, Manns B, et al. Prophylactic implantable cardioverter defibrillators in patients with continuous flow left ventricular assist devices: are they cost-effective? J Am Coll Cardiol. 2019 Mar;73(9 Suppl 1):3076.</Citation></Reference><Reference><Citation>Vollkron M, Voitl P, Ta J, Wieselthaler G, Schima H. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007 Aug;26:819-25.</Citation></Reference><Reference><Citation>Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005 May;45:1428-34.</Citation></Reference><Reference><Citation>Griffin JM, Katz JN. The burden of ventricular arrhythmias following left ventricular assist device implantation. Arrhythmia Electrophysiol Rev. 2014 Nov;3:145-8.</Citation></Reference><Reference><Citation>Monreal G, Gerhardt MA. Left ventricular assist device support induces acute changes in myocardial electrolytes in heart failure. ASAIO J. 2007;53:152-8.</Citation></Reference><Reference><Citation>Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol. 2008 Oct;31:1246-52.</Citation></Reference><Reference><Citation>Imamura T, Jeevanandam V, Kim G, Raikhelkar J, Sarswat N, Kalantari S, et al. Optimal hemodynamics during left ventricular assist device support are associated with reduced readmission rates. Circ Heart Fail. 2019 Feb;12(2):e005094.</Citation></Reference><Reference><Citation>Gross C, Schima H, Schl&#xf6;glhofer T,Dimitrov K, Maw M, Riebandt J, et al. Continuous LVAD monitoring reveals high suction rates in clinically stable outpatients. Artif Organs. 2020 Jan;12(2):e005094.</Citation></Reference><Reference><Citation>Gold MR, Linde C, Abraham WT, Gardiwal A, Daubert J-C. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm. 2011 May;8(5):679-84.</Citation></Reference><Reference><Citation>Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2013 Aug;6:668-74.</Citation></Reference><Reference><Citation>Brisco MA, Sundareswaran KS, Milano CA, Feldman D, Testani JM, Ewald GA, et al. Incidence, risk, and consequences of atrial arrhythmias in patients with continuous-flow left ventricular assist devices. J Card Surg. 2014 Jul;29:572-580.</Citation></Reference><Reference><Citation>Busch MC, Haap M, Kristen A, Haas CS. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. Ann Emerg Med. 2011 Jan;57:25-8.</Citation></Reference><Reference><Citation>Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplantation. 2010;29:1-10.</Citation></Reference><Reference><Citation>Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007 Apr;99:1151-3.</Citation></Reference><Reference><Citation>Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JCJ, et al. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010 Jul;29:771-6.</Citation></Reference><Reference><Citation>Richardson TD, Hale L, Arteaga C, Xu M, Keebler M, Schlendorf K, et al. Prospective randomized evaluation of implantable cardioverter-defibrillator programming in patients with a left ventricular assist device. J Am Heart Assoc. 2018 Feb;7(5):e007748.</Citation></Reference><Reference><Citation>Erqou S, Kormos RL, Wang NC, McNamara DM, Bazaz R. Electromagnetic interference from left ventricular assist device (LVAD) inhibiting the pacing function of an implantable cardioverter-defibrillator (ICD) device. Case Rep Cardiol. United States. 2018; 2018:p. 6195045.</Citation></Reference><Reference><Citation>Labedi MR, Alharethi R, Kfoury AG, Budge D, Bruce R, Rasmusson B, et al. Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device. ASAIO J. 2013;59:136-9.</Citation></Reference><Reference><Citation>Duncker D, K&#xf6;nig T, M&#xfc;ller-Leisse J, Michalski R, Oswald H, Schmitto JD, et al. Electric smog: telemetry interference between ICD and LVAD. Herzschrittmacherther Elektrophysiol. 2017 Sep;28:257-9.</Citation></Reference><Reference><Citation>Pfeffer TJ, K&#xf6;nig T, Duncker D, Michalski R, Hohmann S, Oswald H, et al. Subcutaneous implantable cardioverter-defibrillator shocks after left ventricular assist device implantation. Circ Arrhythm Electrophysiol. 2016 Nov;9(11):e004633.</Citation></Reference><Reference><Citation>Lo R, Chia KKM, Hsia HH. Ventricular tachycardia in ischemic heart disease. Card Electrophysiol Clin. 2017 Mar;9:25-46.</Citation></Reference><Reference><Citation>Joseph JP, Rajappan K. Radiofrequency ablation of cardiac arrhythmias: past, present and future. QJM 2012 Apr;105:303-14.</Citation></Reference><Reference><Citation>Shivkumar K. Catheter ablation of ventricular arrhythmias. N Engl J Med. 2019 Apr;380:1555-64.</Citation></Reference><Reference><Citation>Gopinathannair R, Cornwell WK, Dukes JW, Ellis CR, Hickey KT, Joglar JA, et al. Device therapy and arrhythmia management in left ventricular assist device recipients: a scientific statement from the American Heart Association. Circulation. 2019 May;139(20):e967-89.</Citation></Reference><Reference><Citation>Makki N, Mesubi O, Steyers C, Olshansky B, Abraham WT. Meta-analysis of the relation of ventricular arrhythmias to all-cause mortality after implantation of a left ventricular assist device. Am J Cardiol. 2015 Nov;116:1385-90.</Citation></Reference><Reference><Citation>Brenyo A, Rao M, Koneru S, Hallinan W, Shah S, Massey HT, et al. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol. 2012 May;23:515-20.</Citation></Reference><Reference><Citation>Pedersen CT, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dickfeld T, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. EP Europace. 2014 Sep;16:1257-83.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34496734</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-6360</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Current rheumatology reviews</Title><ISOAbbreviation>Curr Rheumatol Rev</ISOAbbreviation></Journal><ArticleTitle>Psoriatic Arthritis and Risk of Vertebral Fracture: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>64</StartPage><EndPage>71</EndPage><MedlinePgn>64-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1573397117666210908094349</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study was conducted in order to determine the association between psoriatic arthritis and the risk of vertebral fracture by pooling the evidence from previous studies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Potentially eligible studies were identified from MEDLINE and EMBASE databases from inception to March 2020 using a search strategy that comprised of terms "Psoriatic Arthritis" and "Vertebral Fracture". Studies were eligible for the meta-analysis if they were cohort studies that included psoriatic arthritis and individuals without psoriasis and followed them for incident vertebral fracture. Studies were also required to report standardized incidence ration, hazard risk ratio or relative risk with related 95% confidence intervals (CI) comparing the incidence of vertebral fracture between the two cohorts. The retrieved point estimates with standard errors from each study were pooled into the final result by the random-effect model and generic inverse variance method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 26,090 articles were identified. After two rounds of independent review by three investigators, we included five cohort studies that met the eligibility criteria in the meta-analysis. PsA is significantly associated with VF with a pooled odds ratio of 2.09 (95% CI, 1.11 - 3.96; I2 70%). The funnel plot was fairly asymmetric, thus the publication bias in favor of studies may present.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This systematic review and meta-analysis indicates that psoriatic arthritis patients have a significantly elevated risk of developing a vertebral fracture.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Charoenngam</LastName><ForeName>Nipith</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponvilawan</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thongpiya</LastName><ForeName>Jerapas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yingchoncharoen</LastName><ForeName>Pitchaporn</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ungprasert</LastName><ForeName>Patompong</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Rheumatol Rev</MedlineTA><NlmUniqueID>101261938</NlmUniqueID><ISSNLinking>1573-3971</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015535" MajorTopicYN="Y">Arthritis, Psoriatic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Psoriatic arthritis</Keyword><Keyword MajorTopicYN="N">back pain</Keyword><Keyword MajorTopicYN="N">inflammatory disorder</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">osteoporosis</Keyword><Keyword MajorTopicYN="N">vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34496734</ArticleId><ArticleId IdType="doi">10.2174/1573397117666210908094349</ArticleId><ArticleId IdType="pii">CRR-EPUB-117746</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31082362</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease.</ArticleTitle><Pagination><StartPage>e206</StartPage><EndPage>e219</EndPage><MedlinePgn>e206-e219</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2019.04.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(19)30353-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with ischemic heart disease (IHD) are at risk for ventricular tachycardia (VT). Catheter ablation (CA) may reduce this risk.</AbstractText><AbstractText Label="OBJECTIVE">To perform a systematic review and meta-analysis of randomized controlled trials (RCTs) of CA of VT in patients with IHD.</AbstractText><AbstractText Label="METHODS">Literature searches of MEDLINE, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Cochrane Database of Systematic Reviews (CDSR) were performed from January 2000 through April 2018 to identify RCTs comparing a strategy of CA vs no ablation in patients with IHD and an implantable cardioverter defibrillator (ICD). Outcomes of interest included appropriate ICD therapies, appropriate ICD shocks, VT storm, recurrent VT/ventricular fibrillation (VF), cardiac hospitalizations, and all-cause mortality. Using an inverse variance random-effects model, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each endpoint.</AbstractText><AbstractText Label="RESULTS">A total of 5 RCTs (N = 635 patients) were included, with a duration of follow-up ranging from 6 months to 27.9 months. Patients who underwent CA experienced decreased odds of appropriate ICD therapies (OR 0.49; 95% CI 0.28-0.87), appropriate ICD shocks (OR 0.52; 95% CI 0.28-0.96), VT storm (OR 0.64; 95% CI 0.43-0.95), and cardiac hospitalization (OR 0.67; 95% CI 0.46-0.97) vs those who did not undergo ablation. There was no evidence of a benefit for recurrent VT/VF (OR 0.87; 95% CI 0.41-1.85), although this endpoint was not reported in all trials, or for all-cause mortality (OR 0.89; 95% CI 0.60-1.34).</AbstractText><AbstractText Label="CONCLUSION">In this systematic review and meta-analysis of RCTs, CA was associated with a significant reduction in the odds of appropriate ICD therapies, appropriate ICD shocks, VT storm, and cardiac hospitalizations in patients with IHD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Brandon K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut; Hartford Hospital Evidence-Based Practice Center, Hartford, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>William L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut; Hartford Hospital Evidence-Based Practice Center, Hartford, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konopka</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannelli</LastName><ForeName>Devon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Craig I</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut; Hartford Hospital Evidence-Based Practice Center, Hartford, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluger</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hartford HealthCare Heart and Vascular Institute, Hartford Hospital, Hartford, Connecticut; University of Connecticut School of Medicine, Farmington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronin</LastName><ForeName>Edmond M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Hartford HealthCare Heart and Vascular Institute, Hartford Hospital, Hartford, Connecticut; University of Connecticut School of Medicine, Farmington, Connecticut. Electronic address: edmond.cronin@hhchealth.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">Ischemic heart disease</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31082362</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2019.04.024</ArticleId><ArticleId IdType="pii">S1547-5271(19)30353-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35504741</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1913</ISSN><JournalIssue CitedMedium="Internet"><Volume>174</Volume><PubDate><Year>2022</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>The American journal of cardiology</Title><ISOAbbreviation>Am J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Meta-Analysis of Catheter Ablation Outcomes in Patients With Cardiac Sarcoidosis Refractory Ventricular Tachycardia.</ArticleTitle><Pagination><StartPage>136</StartPage><EndPage>142</EndPage><MedlinePgn>136-142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2022.03.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9149(22)00339-3</ELocationID><Abstract><AbstractText>Cardiac sarcoidosis (CS) frequently leads to ventricular tachycardia (VT), which is often refractory to antiarrhythmic and/or immunosuppressive medications and requires catheter ablation. We conducted a systematic review and meta-analysis to evaluate the role of catheter ablation in patients with refractory VT undergoing catheter ablation. We searched PubMed, Embase, and Scopus databases from their inception to December 31, 2021 with search terms "cardiac sarcoidosis" AND "electrophysiological studies OR ablation." Fifteen studies were ultimately included for evaluation. Patient demographics, VT mapping, and acute and long-term procedural outcomes were extracted. A total of 15 studies were included in our meta-analysis, with a total of 401 patients, of whom 66% were male, with ages ranging from 39 to 64&#xa0;years. A total of 95% of patients were on antiarrhythmics and 79% of patients were on immunosuppressants. Left ventricular ejection fraction ranged from 35% to 49% and procedure duration ranged from 269 to 462&#xa0;minutes. Ablation was reported using both irrigated and nonirrigated catheter tips. A total of 25% of patients (84/339) underwent repeat ablation. Acute procedural success was achieved in 57% (161/285). Procedure complications occurred in 5.7% (17/297) procedures. VT recurrence after first ablation was 55% (confidence interval 48% to 63%, 213/401); VT recurrence after multiple ablations was 37% (81/220). The composite end point of death, heart transplant, and left ventricular assist device implantation was 21% (confidence interval 14% to 30%, 55/297). In conclusion, catheter ablation is a useful modality in patients with CS with refractory VT. However, patients with CS presenting with refractory VT after undergoing VT ablation carry a poor prognosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adhaduk</LastName><ForeName>Mehul</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine. Electronic address: mehul-adhaduk@uiowa.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paudel</LastName><ForeName>Bishow</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashwath</LastName><ForeName>Mahi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giudici</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Cardiol</MedlineTA><NlmUniqueID>0207277</NlmUniqueID><ISSNLinking>0002-9149</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012507" MajorTopicYN="Y">Sarcoidosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosures The authors have NO conflict of interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>22</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35504741</ArticleId><ArticleId IdType="doi">10.1016/j.amjcard.2022.03.038</ArticleId><ArticleId IdType="pii">S0002-9149(22)00339-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31172632</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Endo-epicardial vs endocardial-only catheter ablation of ventricular tachycardia: A meta-analysis.</ArticleTitle><Pagination><StartPage>1537</StartPage><EndPage>1548</EndPage><MedlinePgn>1537-1548</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.14013</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The efficacy of&#xa0;endocardial catheter ablation for ventricular tachycardia (VT) can be limited by intramural or epicardial substrates. Adding epicardial mapping and ablation may improve arrhythmia outcomes compared with an endocardial-only approach.</AbstractText><AbstractText Label="METHODS">We performed a systematic review and meta-analysis of studies comparing a strategy of endo-epicardial catheter ablation to an endocardial-only approach for VT. Subanalyses were performed for ischemic and nonischemic cardiomyopathies.</AbstractText><AbstractText Label="RESULTS">A total of 22 studies including 1138 patients were included in the meta-analysis. Of those, 44% underwent an endo-epicardial approach. During intermediate to long-term follow-up (average 7 to 70 months), recurrent VT or appropriate implantable cardioverter defibrillator (ICD) therapies were significantly lower with the endo-epicardial strategy (OR, 0.52; P&#x2009;&lt;&#x2009;.01). All-cause mortality was also lower in this group (OR, 0.50; P&#x2009;=&#x2009;.03). No difference between endo-epicardial and endocardial-only ablation was noted in nonischemic cardiomyopathies. Among 323 patients with ischemic cardiomyopathy, recurrent VT or appropriate ICD therapies was less frequent in the endo-epicardial group (OR, 0.39; P&#x2009;=&#x2009;.01), as was all-cause mortality (OR, 0.38; P&#x2009;=&#x2009;.05). In patients with arrhythmogenic right ventricular cardiomyopathy, recurrent VT or appropriate ICD therapy was also lower in the endo-epicardial group (OR, 0.42; P&#x2009;=&#x2009;.04).</AbstractText><AbstractText Label="CONCLUSION">These results suggest that a strategy of combined endo- and epicardial access for mapping and ablation of VT may provide superior efficacy to an endocardial-only approach in selected patients. Randomized trials are warranted to further investigate this question.</AbstractText><CopyrightInformation>&#xa9; 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Rhanderson</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3622-7605</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assis</LastName><ForeName>Fabrizio R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Avila</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Arrhythmia Service, Hospital SOS Cardio, Florianopolis, SC, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004699" MajorTopicYN="N">Endocardium</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056149" MajorTopicYN="N">Epicardial Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010496" MajorTopicYN="N">Pericardium</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">endocardial</Keyword><Keyword MajorTopicYN="N">epicardial</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31172632</ArticleId><ArticleId IdType="doi">10.1111/jce.14013</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35693451</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2090-8016</ISSN><JournalIssue CitedMedium="Print"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Cardiology research and practice</Title><ISOAbbreviation>Cardiol Res Pract</ISOAbbreviation></Journal><ArticleTitle>Dexmedetomidine Reduces Incidences of Ventricular Arrhythmias in Adult Patients: A Meta-Analysis.</ArticleTitle><Pagination><StartPage>5158362</StartPage><MedlinePgn>5158362</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5158362</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/5158362</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">To assess the antiarrhythmic properties of dexmedetomidine in patients in the intensive care unit.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A literature review was conducted with Ovid MEDLINE (R), Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Embase, and Scopus. <i>Study Selection</i>. Randomized controlled trials were included, examining the incidence of ventricular arrhythmias, ventricular tachycardia, or ventricular fibrillation with dexmedetomidine compared to placebo or an alternative sedative agent. For each publication that met the selection criteria, the patient demographics, incidence of arrhythmias, mortality, and adverse events were collected. Data extraction was carried out by two authors independently.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We identified 6 out of 126 studies that met the selection criteria for our meta-analysis, all of which focused on the perioperative cardiac surgery period. Patients receiving dexmedetomidine demonstrated a significant reduction of the overall incidence of ventricular arrhythmias (RR 0.35, 95% CI 0.16, 0.76). In particular, dexmedetomidine significantly decreased the risk of ventricular tachycardia compared with control (RR 0.25, 95% CI 0.08, 0.80, I<sup>2</sup> 0%). Regarding adverse events, dexmedetomidine significantly increased the frequency of bradycardia (RR 2.78 95% CI 2.00, 3.87). However, there was no significant difference in mortality (RR 0.59 95% CI 0.12, 3.02).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">From this meta-analysis, we report a decreased incidence of ventricular tachycardia with dexmedetomidine in critically ill patients. This result favors the use of dexmedetomidine for its antiarrhythmic properties.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Qiaonan Zhong et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Qiaonan</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-9530-2188</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Mayo Clinic, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4249-0055</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Department of Internal Medicine, Cleveland Clinic Akron General Hospital, Akron, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deshmukh</LastName><ForeName>Abhishek</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9560-1102</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Courtney</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7186-1009</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiol Res Pract</MedlineTA><NlmUniqueID>101516542</NlmUniqueID><ISSNLinking>2090-0597</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>13</Day><Hour>3</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35693451</ArticleId><ArticleId IdType="pmc">PMC9177331</ArticleId><ArticleId IdType="doi">10.1155/2022/5158362</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Exner D. V., Pinski S. L., Wyse D. G., et al. Electrical storm presages nonsudden death. Circulation . 2001;103(16):2066&#x2013;2071. doi: 10.1161/01.cir.103.16.2066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.103.16.2066</ArticleId><ArticleId IdType="pubmed">11319196</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A., Kilicaslan F., Marrouche N. F., et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. Journal of Cardiovascular Electrophysiology . 2004;15(11):1265&#x2013;1270. doi: 10.1046/j.1540-8167.2004.04352.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1540-8167.2004.04352.x</ArticleId><ArticleId IdType="pubmed">15574176</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatzoulis K. A., Andrikopoulos G. K., Apostolopoulos T., et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace . 2005;7(2):184&#x2013;192. doi: 10.1016/j.eupc.2005.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eupc.2005.01.003</ArticleId><ArticleId IdType="pubmed">15763536</ArticleId></ArticleIdList></Reference><Reference><Citation>Graboys T. B., Lown B., Podrid P. J., DeSilva R. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. American Journal of Cardiology . 1982;50(3):437&#x2013;443. doi: 10.1016/0002-9149(82)90307-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(82)90307-1</ArticleId><ArticleId IdType="pubmed">6180622</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozma D., Tint D., Szegedi N., Sallo Z., Geller L. Update in electrical storm therapy. American Journal of Therapeutics . 2019;26(2):e257&#x2013;e267. doi: 10.1097/MJT.0000000000000918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000000918</ArticleId><ArticleId IdType="pubmed">30839374</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin J. W., Roberts R. J. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Critical Care Clinics . 2009;25(3):431&#x2013;449. doi: 10.1016/j.ccc.2009.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2009.03.003</ArticleId><ArticleId IdType="pubmed">19576523</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande P. P., Pun B. T., Herr D. L., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA . 2007;298(22):2644&#x2013;2653. doi: 10.1001/jama.298.22.2644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.22.2644</ArticleId><ArticleId IdType="pubmed">18073360</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson K. C., Reardon C., Theodore A. C., Farber H. W. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines. Chest . 2005;128(3):1674&#x2013;1681. doi: 10.1378/chest.128.3.1674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.3.1674</ArticleId><ArticleId IdType="pubmed">16162774</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemphill S., McMenamin L., Bellamy M. C., Hopkins P. M. Propofol infusion syndrome: a structured literature review and analysis of published case reports. British Journal of Anaesthesia . 2019;122(4):448&#x2013;459. doi: 10.1016/j.bja.2018.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.12.025</ArticleId><ArticleId IdType="pmc">PMC6435842</ArticleId><ArticleId IdType="pubmed">30857601</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang L., Wang S., Lu F., Zhen J., Chen W. Dexmedetomidine reduces atrial fibrillation after adult cardiac surgery: a meta-analysis of randomized controlled trials. American Journal of Cardiovascular Drugs . 2020;20(3):271&#x2013;281. doi: 10.1007/s40256-019-00380-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40256-019-00380-2</ArticleId><ArticleId IdType="pubmed">31724106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zhao X., Wang Y. Dexmedetomidine: a review of applications for cardiac surgery during perioperative period. Journal of Anesthesia . 2015;29(1):102&#x2013;111. doi: 10.1007/s00540-014-1857-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-014-1857-z</ArticleId><ArticleId IdType="pubmed">24913070</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobi J., Fraser G. L., Coursin D. B., et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Critical Care Medicine . 2002;30(1):119&#x2013;141. doi: 10.1097/00003246-200201000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200201000-00020</ArticleId><ArticleId IdType="pubmed">11902253</ArticleId></ArticleIdList></Reference><Reference><Citation>Parent B. A., Munoz R., Shiderly D., Chrysostomou C. Use of dexmedetomidine in sustained ventricular tachycardia. Anaesthesia &amp; Intensive Care . 2010;38(4):p. 781.</Citation><ArticleIdList><ArticleId IdType="pubmed">20715753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoy S. M., Keating G. M. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs . 2011;71(11):1481&#x2013;1501. doi: 10.2165/11207190-000000000-00000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11207190-000000000-00000</ArticleId><ArticleId IdType="pubmed">21812509</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen A. Update on dexmedetomidine for adult ICU sedation. Connecticut Medicine . 2009;73(8):469&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">19777981</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakob S. M., Ruokonen E., Grounds R. M., et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA . 2012;307(11):1151&#x2013;1160. doi: 10.1001/jama.2012.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.304</ArticleId><ArticleId IdType="pubmed">22436955</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams R., Brown G. T., Davidson M., et al. Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review. British Journal of Anaesthesia . 2013;111(5):703&#x2013;710. doi: 10.1093/bja/aet194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet194</ArticleId><ArticleId IdType="pubmed">23748199</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K., Lu Z., Xin Y. C., Cai Y., Chen Y., Pan S. M. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database of Systematic Reviews . 2015;1(1) doi: 10.1002/14651858.CD010269.pub2.CD010269</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010269.pub2</ArticleId><ArticleId IdType="pmc">PMC6353054</ArticleId><ArticleId IdType="pubmed">25879090</ArticleId></ArticleIdList></Reference><Reference><Citation>Djaiani G., Silverton N., Fedorko L., et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery. Anesthesiology . 2016;124(2):362&#x2013;368. doi: 10.1097/ALN.0000000000000951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000951</ArticleId><ArticleId IdType="pubmed">26575144</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehabi Y., Grant P., Wolfenden H., et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery. Anesthesiology . 2009;111(5):1075&#x2013;1084. doi: 10.1097/ALN.0b013e3181b6a783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181b6a783</ArticleId><ArticleId IdType="pubmed">19786862</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman R., Hussien M. Comparison of the renoprotective effect of dexmedetomidine and dopamine in high-risk renal patients undergoing cardiac surgery: a double-blind randomized study. Annals of Cardiac Anaesthesia . 2017;20(4):408&#x2013;415. doi: 10.4103/aca.ACA_57_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aca.ACA_57_17</ArticleId><ArticleId IdType="pmc">PMC5661309</ArticleId><ArticleId IdType="pubmed">28994675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Zhang H., Huang L., Liu Y., Liu F., Dong Z. Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Experimental and Therapeutic Medicine . 2013;6(2):497&#x2013;502. doi: 10.3892/etm.2013.1183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2013.1183</ArticleId><ArticleId IdType="pmc">PMC3786847</ArticleId><ArticleId IdType="pubmed">24137215</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett S. M., Rebuck J. A., Greene C. M., et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Critical Care Medicine . 2005;33(5):940&#x2013;945. doi: 10.1097/01.ccm.0000162565.18193.e5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000162565.18193.e5</ArticleId><ArticleId IdType="pubmed">15891317</ArticleId></ArticleIdList></Reference><Reference><Citation>Herr D. L., Sum-Ping S. T., England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. Journal of Cardiothoracic and Vascular Anesthesia . 2003;17(5):576&#x2013;584. doi: 10.1016/s1053-0770(03)00200-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1053-0770(03)00200-3</ArticleId><ArticleId IdType="pubmed">14579210</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaionen J., Hynynen M., Kuitunen A., et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology . 1997;86(2):331&#x2013;345. doi: 10.1097/00000542-199702000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199702000-00009</ArticleId><ArticleId IdType="pubmed">9054252</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaman Y., Abud B., Tekgul Z. T., Cakmak M., Yildiz M., Gonullu M. Effects of dexmedetomidine and propofol on sedation in patients after coronary artery bypass graft surgery in a fast-track recovery room setting. Journal of Anesthesia . 2015;29(4):522&#x2013;528. doi: 10.1007/s00540-015-1975-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-015-1975-2</ArticleId><ArticleId IdType="pubmed">25617159</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltani G., Jahanbakhsh S., Abbasi Tashnizi M., et al. Effects of dexmedetomidine on heart arrhythmia prevention in off-pump coronary artery bypass surgery: a randomized clinical trial. Electronic Physician . 2017;9(10):5578&#x2013;5587. doi: 10.19082/5578.</Citation><ArticleIdList><ArticleId IdType="doi">10.19082/5578</ArticleId><ArticleId IdType="pmc">PMC5718864</ArticleId><ArticleId IdType="pubmed">29238500</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng J., Qian J., Cheng H., Ji F., Liu H. The influence of perioperative dexmedetomidine on patients undergoing cardiac surgery: a meta-analysis. PLoS One . 2016;11(4) doi: 10.1371/journal.pone.0152829.e0152829</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152829</ArticleId><ArticleId IdType="pmc">PMC4822865</ArticleId><ArticleId IdType="pubmed">27049318</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y. Y., He B., Chen J., Wang Z. N. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis. Critical Care . 2012;16(5) doi: 10.1186/cc11646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11646</ArticleId><ArticleId IdType="pmc">PMC3682268</ArticleId><ArticleId IdType="pubmed">23016926</ArticleId></ArticleIdList></Reference><Reference><Citation>Szumita P. M., Baroletti S. A., Anger K. E., Wechsler M. E. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. American Journal of Health-System Pharmacy . 2007;64(1):37&#x2013;44. doi: 10.2146/ajhp050508.</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp050508</ArticleId><ArticleId IdType="pubmed">17189578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamibayashi T., Maze M., Weiskopf R., Weiskopf R., Todd M. Clinical uses of &#x3b1;2-adrenergic agonists. Anesthesiology . 2000;93(5):1345&#x2013;1349. doi: 10.1097/00000542-200011000-00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200011000-00030</ArticleId><ArticleId IdType="pubmed">11046225</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg H., Case R. B., Moss A. J., Brown M. W., Carroll E. R., Andrews M. L. Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II) Journal of the American College of Cardiology . 2004;43(8):1459&#x2013;1465. doi: 10.1016/j.jacc.2003.11.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2003.11.038</ArticleId><ArticleId IdType="pubmed">15093884</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly S. J., Dorian P., Roberts R. S., et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA . 2006;295(2):165&#x2013;171. doi: 10.1001/jama.295.2.165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.2.165</ArticleId><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrysostomou C., Beerman L., Shiderly D., Berry D., Morell V. O., Munoz R. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesthesia &amp; Analgesia . 2008;107(5):1514&#x2013;1522. doi: 10.1213/ane.0b013e318186499c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318186499c</ArticleId><ArticleId IdType="pubmed">18931208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y., Sumikawa K., Maze M., et al. Dexmedetomidine prevents epinephrine-induced arrhythmias through stimulation of central &#x3b1;2 adrenoceptors in halothane-anesthetized dogs. Anesthesiology . 1991;75(1):113&#x2013;117. doi: 10.1097/00000542-199107000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199107000-00018</ArticleId><ArticleId IdType="pubmed">1676567</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenach J. C. Mechanism of antiarrhythmic effect of dexmedetomidine on epinephrine-induced arrhythmias. Anesthesiology . 1991;75:1116&#x2013;1117. 6. doi: 10.1097/00000542-199112000-00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199112000-00024</ArticleId><ArticleId IdType="pubmed">1683744</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamibayashi T., Hayashi Y., Mammoto T., Yamatodani A., Sumikawa K., Yoshiya I. Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology . 1995;83(5):992&#x2013;999. doi: 10.1097/00000542-199511000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199511000-00013</ArticleId><ArticleId IdType="pubmed">7486186</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter M. J., Reiffel J. A. Importance of beta blockade in the therapy of serious ventricular arrhythmias. The American Journal of Cardiology . 1998;82(4):9I&#x2013;19I. doi: 10.1016/s0002-9149(98)00468-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9149(98)00468-8</ArticleId><ArticleId IdType="pubmed">9737650</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller G., Deal B. J., Benson D. W. Vagal maneuvers and adenosine for termination of atrioventricular reentrant tachycardia. American Journal of Cardiology . 1994;74(5):500&#x2013;503. doi: 10.1016/0002-9149(94)90914-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(94)90914-8</ArticleId><ArticleId IdType="pubmed">8059736</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilbur S. L., Marchlinski F. E. Adenosine as an antiarrhythmic agent. American Journal of Cardiology . 19979;79(12):30&#x2013;37. doi: 10.1016/s0002-9149(97)00261-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9149(97)00261-0</ArticleId><ArticleId IdType="pubmed">9223361</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman B. B., Belardinelli L., West G. A., Berne R. M., DiMarco J. P. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation . 1986;74(2):270&#x2013;280. doi: 10.1161/01.cir.74.2.270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.74.2.270</ArticleId><ArticleId IdType="pubmed">3015453</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobias J. D., Chrysostomou C. Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient. Pediatric Cardiology . 2013;34(4):779&#x2013;785. doi: 10.1007/s00246-013-0659-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-013-0659-7</ArticleId><ArticleId IdType="pubmed">23435789</ArticleId></ArticleIdList></Reference><Reference><Citation>Benovic J. L., Bouvier M., Caron M. G., Lefkowitz R. J. Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annual Review of Cell Biology . 1988;4:405&#x2013;428. doi: 10.1146/annurev.cb.04.110188.002201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cb.04.110188.002201</ArticleId><ArticleId IdType="pubmed">2848553</ArticleId></ArticleIdList></Reference><Reference><Citation>Snapir A., Posti J., Kentala E., et al. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology . 2006 Nov;105(5):902&#x2013;910. doi: 10.1097/00000542-200611000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200611000-00010</ArticleId><ArticleId IdType="pubmed">17065883</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Gong Y., Tan Y., et al. Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism. Annals of Translational Medicine . 2021;9(5):p. 399. doi: 10.21037/atm-20-5898.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-20-5898</ArticleId><ArticleId IdType="pmc">PMC8033317</ArticleId><ArticleId IdType="pubmed">33842620</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrysostomou C., Sanchez-de-Toledo J., Wearden P., et al. Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations. Annals of Thoracic Surgery . 2011;92(3):964&#x2013;972. doi: 10.1016/j.athoracsur.2011.04.099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.04.099</ArticleId><ArticleId IdType="pmc">PMC3289583</ArticleId><ArticleId IdType="pubmed">21871284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling X., Zhou H., Ni Y., Wu C., Zhang C., Zhu Z. Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? a meta-analysis of randomized controlled trials. PLoS One . 2018;13(3) doi: 10.1371/journal.pone.0193303.e0193303</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0193303</ArticleId><ArticleId IdType="pmc">PMC5832237</ArticleId><ArticleId IdType="pubmed">29494685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert T. J., Hall J. E., Barney J. A., Uhrich T. D., Colinco M. D. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology . 2000;93(2):382&#x2013;394. doi: 10.1097/00000542-200008000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200008000-00016</ArticleId><ArticleId IdType="pubmed">10910487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach A. T., Dasta J. F., Steinberg S., Martin L. C., Cook C. H. A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients. Journal of Critical Care . 2009;24(4):568&#x2013;574. doi: 10.1016/j.jcrc.2009.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2009.05.015</ArticleId><ArticleId IdType="pmc">PMC3725302</ArticleId><ArticleId IdType="pubmed">19682844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach A. T., Blais D. M., Jones G. M., et al. Predictors of dexmedetomidine-associated hypotension in critically ill patients. International Journal of Critical Illness and Injury Science . 2016;6(3):109&#x2013;114. doi: 10.4103/2229-5151.190656.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2229-5151.190656</ArticleId><ArticleId IdType="pmc">PMC5051052</ArticleId><ArticleId IdType="pubmed">27722111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang R., Lu J., et al. Effects of different doses of dexmedetomidine on heart rate and blood pressure in intensive care unit patients. Experimental and Therapeutic Medicine . 2016;11(1):360&#x2013;366. doi: 10.3892/etm.2015.2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2015.2872</ArticleId><ArticleId IdType="pmc">PMC4726941</ArticleId><ArticleId IdType="pubmed">26889269</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J. A., Ho K. M. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Medicine . 2010;36(6):926&#x2013;939. doi: 10.1007/s00134-010-1877-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-1877-6</ArticleId><ArticleId IdType="pubmed">20376429</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X., Meng Z. T., Wu X. H., et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet . 2016;388(10054):1893&#x2013;1902. doi: 10.1016/S0140-6736(16)30580-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)30580-3</ArticleId><ArticleId IdType="pubmed">27542303</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehabi Y., Howe B. D., Bellomo R., et al. Early sedation with dexmedetomidine in critically ill patients. New England Journal of Medicine . 2019;380(26):2506&#x2013;2517. doi: 10.1056/NEJMoa1904710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1904710</ArticleId><ArticleId IdType="pubmed">31112380</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes C. G., Mailloux P. T., Devlin J. W., et al. Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. New England Journal of Medicine . 2021;384(15):1424&#x2013;1436. doi: 10.1056/NEJMoa2024922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2024922</ArticleId><ArticleId IdType="pmc">PMC8162695</ArticleId><ArticleId IdType="pubmed">33528922</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji F., Li Z., Nguyen H., et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation . 2013;127(15):1576&#x2013;1584. doi: 10.1161/CIRCULATIONAHA.112.000936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.000936</ArticleId><ArticleId IdType="pmc">PMC3979354</ArticleId><ArticleId IdType="pubmed">23513068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawazoe Y., Miyamoto K., Morimoto T., et al. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis. JAMA . 2017;317(13):1321&#x2013;1328. doi: 10.1001/jama.2017.2088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.2088</ArticleId><ArticleId IdType="pmc">PMC5469298</ArticleId><ArticleId IdType="pubmed">28322414</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31977352</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-943X</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Season>Sep/Oct</Season></PubDate></JournalIssue><Title>ASAIO journal (American Society for Artificial Internal Organs : 1992)</Title><ISOAbbreviation>ASAIO J</ISOAbbreviation></Journal><ArticleTitle>Venoarterial Extracorporeal Membrane Oxygenation Support for Ventricular Tachycardia Ablation: A Systematic Review.</ArticleTitle><Pagination><StartPage>980</StartPage><EndPage>985</EndPage><MedlinePgn>980-985</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MAT.0000000000001125</ELocationID><Abstract><AbstractText>Refractory ventricular tachycardia (VT) and electrical storm are frequently associated with hemodynamic compromise requiring mechanical support. This study sought to review the current literature on the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for hemodynamic support during VT ablation. This was a systematic review of all published literature from 2000 to 2019 evaluating patients with VT undergoing ablation with VA-ECMO support. Studies that reported mortality, safety, and efficacy outcomes in adult (&gt;18 years) patients were included. The primary outcome was short-term mortality (intensive care unit stay, hospital stay, or &#x2264;30 days). The literature search identified 4,802 citations during the study period, of which seven studies comprising 867 patients met the inclusion criteria. Periprocedural VA-ECMO was used in 129 (15%) patients and all were placed peripherally. Average inducible VTs were 2-3 per procedure and ablation time varied between 34 mins and 4.7 hours. Median ages were between 61 and 68 years with 93% males. Median duration of VA-ECMO varied between 140 minutes and 6 days. Short-term mortality was 15% (19 patients), with the most frequent causes being refractory VT, cardiac arrest, and acute heart failure. All-cause mortality at the longest follow-up was 25%. Major bleeding, vascular/access complications, limb ischemia, stroke, and acute kidney injury were reported with varying frequency of 1-6%. In conclusion, VA-ECMO is used infrequently for hemodynamic support for VT ablation. Further data on patient selection, procedural optimization, and clinical outcomes are needed to evaluate the efficacy of this strategy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vallabhajosyula</LastName><ForeName>Saraschandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallabhajosyula</LastName><ForeName>Saarwaani</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Vaidya</LastName><ForeName>Vaibhav R</ForeName><Initials>VR</Initials></Author><Author ValidYN="Y"><LastName>Patlolla</LastName><ForeName>Sri Harsha</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Viral</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Mulpuru</LastName><ForeName>Siva K</ForeName><Initials>SK</Initials></Author><Author ValidYN="Y"><LastName>Noseworthy</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Kapa</LastName><ForeName>Suraj</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Egbe</LastName><ForeName>Alexander C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Gersh</LastName><ForeName>Bernard J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Deshmukh</LastName><ForeName>Abhishek J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000135</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ASAIO J</MedlineTA><NlmUniqueID>9204109</NlmUniqueID><ISSNLinking>1058-2916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31977352</ArticleId><ArticleId IdType="doi">10.1097/MAT.0000000000001125</ArticleId><ArticleId IdType="pii">00002480-202009000-00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eifling M, Razavi M, Massumi A. The evaluation and management of electrical storm. Tex Heart Inst J 2011.38: 111&#x2013;121.</Citation></Reference><Reference><Citation>Hendel RC, Berman DS, Di Carli MF, et al.; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Nuclear Cardiology; American College of Radiology; American Heart Association; American Society of Echocardiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; Society of Nuclear Medicine: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: A report of the American College of Cardiology Foundation appropriate use criteria task force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the society of cardiovascular computed tomography, the society for cardiovascular magnetic resonance, and the society of nuclear medicine. J Am Coll Cardiol 2009.53: 2201&#x2013;2229.</Citation></Reference><Reference><Citation>Haegeli LM, Della Bella P, Brunckhorst CB. Management of a patient with electrical storm: Role of epicardial catheter ablation. Circulation 2016.133: 672&#x2013;676.</Citation></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 2018.138: e272&#x2013;e391.</Citation></Reference><Reference><Citation>Virk SA, Keren A, John RM, Santageli P, Eslick A, Kumar S. Mechanical circulatory support during catheter ablation of ventricular tachycardia: Indications and options. Heart Lung Circ 2019.28: 134&#x2013;145.</Citation></Reference><Reference><Citation>Nakahara S, Tung R, Ramirez RJ, et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol 2010.55: 2355&#x2013;2365.</Citation></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, et al.; SOAP II Investigators: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010.362: 779&#x2013;789.</Citation></Reference><Reference><Citation>Santangeli P, Zado ES, Supple GE, et al. Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2015.8: 1413&#x2013;1421.</Citation></Reference><Reference><Citation>Bunch TJ, Mahapatra S, Madhu Reddy Y, Lakkireddy D. The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation. Europace 2012.14(suppl 2): ii26&#x2013;ii32.</Citation></Reference><Reference><Citation>Reddy YM, Chinitz L, Mansour M, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation: Multicenter experience. Circ Arrhythm Electrophysiol 2014.7: 244&#x2013;250.</Citation></Reference><Reference><Citation>Turagam MK, Vuddanda V, Koerber S, et al. Percutaneous ventricular assist device in ventricular tachycardia ablation: A systematic review and meta-analysis. J Interv Card Electrophysiol 2019.55: 197&#x2013;205.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Arora S, Lahewala S, et al. Temporary mechanical circulatory support for refractory cardiogenic shock before left ventricular assist device surgery. J Am Heart Assoc 2018.7: e010193.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Arora S, Sakhuja A, et al. Trends, predictors, and outcomes of temporary mechanical circulatory support for postcardiac surgery cardiogenic shock. Am J Cardiol 2019.123: 489&#x2013;497.</Citation></Reference><Reference><Citation>Vallabhajosyula S, O&#x2019;Horo JC, Antharam P, et al. Concomitant intra-aortic balloon pump use in cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation. Circ Cardiovasc Interv 2018.11: e006930.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Patlolla SH, Sandhyavenu H, et al. Periprocedural cardiopulmonary bypass or venoarterial extracorporeal membrane oxygenation during transcatheter aortic valve replacement: A systematic review. J Am Heart Assoc. 2018.7; e009608.</Citation></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, et al.; STROBE Initiative: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Med 2007.4: e297.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Kanmanthareddy A, Erwin PJ, Esterbrooks DJ, Morrow LE. Role of statins in delirium prevention in critical ill and cardiac surgery patients: A systematic review and meta-analysis. J Crit Care 2017.37: 189&#x2013;196.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Rayes HA, Sakhuja A, Murad MH, Geske JB, Jentzer JC. Global longitudinal strain using speckle-tracking echocardiography as a mortality predictor in sepsis: A systematic review. J Intensive Care Med 2019.34: 87&#x2013;93.</Citation></Reference><Reference><Citation>Vallabhajosyula S, O&#x2019;Horo JC, Antharam P, et al. Venoarterial extracorporeal membrane oxygenation with concomitant impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock. ASAIO J. 2020.66:497&#x2013;503.</Citation></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2012. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Baratto F, Pappalardo F, Oloriz T, et al. Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 2016.9: e004492.</Citation></Reference><Reference><Citation>Di Monaco A, Quadrini F, Troisi F, et al. Cardiopulmonary support in patients undergoing catheter ablation of poorly tolerated ventricular arrhythmias and electrical storm. J Cardiovasc Electrophysiol 2019.30: 1281&#x2013;1286.</Citation></Reference><Reference><Citation>Enriquez A, Liang J, Gentile J, et al. Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm. Heart Rhythm 2018.15: 75&#x2013;80.</Citation></Reference><Reference><Citation>Garc&#xed;a Carre&#xf1;o J, Sousa-Casasnovas I, Vicent Alaminos ML, Atienza Fern&#xe1;ndez F, Mart&#xed;nez Sell&#xe9;s M, Fern&#xe1;ndez Avil&#xe9;s F. Extracorporeal membrane oxygenation in patients with electrical storm: A single-center experience. Rev Esp Cardiol (Engl Ed) 2019.72: 182&#x2013;183.</Citation></Reference><Reference><Citation>L&#xfc; F, Eckman PM, Liao KK, et al. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. Int J Cardiol 2013.168: 3859&#x2013;3865.</Citation></Reference><Reference><Citation>Uribarri A, Bravo L, Jimenez-Candil J, Martin-Moreiras J, Villacorta E, Sanchez PL. Percutaneous extracorporeal membrane oxygenation in electrical storm: Five case reports addressing efficacy, transferring allowance or radiofrequency ablation support. Eur Heart J Acute Cardiovasc Care 2018.7: 484&#x2013;489.</Citation></Reference><Reference><Citation>Zanobini M, Rossi F, Bertera A, et al. Cardiopulmonary support during electrophysiological procedures for ventricular tachycardias not haemodynamically tolerated. Perfusion 2003.18: 79&#x2013;82.</Citation></Reference><Reference><Citation>Bhandary SP, Joseph N, Hofmann JP, Saranteas T, Papadimos TJ. Extracorporeal life support for refractory ventricular tachycardia. Ann Transl Med 2017.5: 73.</Citation></Reference><Reference><Citation>Mazzucotelli JP, Leprince P, Litzler PY, et al.; reflection group on mechanical circulatory support (GRAM): Results of mechanical circulatory support in France. Eur J Cardiothorac Surg 2011.40: e112&#x2013;e117.</Citation></Reference><Reference><Citation>Ostadal P, Mlcek M, Holy F, et al. Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model. Circ Arrhythm Electrophysiol 2012.5: 1202&#x2013;1206.</Citation></Reference><Reference><Citation>Della Bella P, Baratto F, Tsiachris D, et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation 2013.127: 1359&#x2013;1368.</Citation></Reference><Reference><Citation>Mathuria N, Wu G, Rojas-Delgado F, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol 2017.48: 27&#x2013;34.</Citation></Reference><Reference><Citation>Chen CY, Tsai J, Hsu TY, et al. ECMO used in a refractory ventricular tachycardia and ventricular fibrillation patient: A National Case-Control Study. Medicine (Baltimore) 2016.95: e3204.</Citation></Reference><Reference><Citation>Exner DV, Pinski SL, Wyse DG, et al.; AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators: Electrical storm presages nonsudden death: The antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001.103: 2066&#x2013;2071.</Citation></Reference><Reference><Citation>Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia: A single-center experience. Circ Arrhythm Electrophysiol 2014.7: 684&#x2013;690.</Citation></Reference><Reference><Citation>Smith A, Hardison D, Bridges B, Pietsch J. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion 2013.28: 54&#x2013;60.</Citation></Reference><Reference><Citation>Tanaka D, Hirose H, Cavarocchi N, Entwistle JW. The impact of vascular complications on survival of patients on venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg 2016.101: 1729&#x2013;1734.</Citation></Reference><Reference><Citation>Aziz F, Brehm CE, El-Banyosy A, Han DC, Atnip RG, Reed AB. Arterial complications in patients undergoing extracorporeal membrane oxygenation via femoral cannulation. Ann Vasc Surg 2014.28: 178&#x2013;183.</Citation></Reference><Reference><Citation>Foley PJ, Morris RJ, Woo EY, et al. Limb ischemia during femoral cannulation for cardiopulmonary support. J Vasc Surg 2010.52: 850&#x2013;853.</Citation></Reference><Reference><Citation>Tung R, Boyle NG, Shivkumar K. Catheter ablation of ventricular tachycardia. Circulation 2010.122: e389&#x2013;e391.</Citation></Reference><Reference><Citation>Rao G, Lopez-Jimenez F, Boyd J, et al.; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; and Stroke Council: Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: A scientific statement from the American Heart Association. Circulation 2017.136: e172&#x2013;e194.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34999218</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of prophylactic closed-incision negative pressure wound therapy for vascular surgery groin wounds.</ArticleTitle><Pagination><StartPage>2086</StartPage><EndPage>2093.e9</EndPage><MedlinePgn>2086-2093.e9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2021.12.070</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(21)02750-6</ELocationID><Abstract><AbstractText Label="OBJECTIVE">A previous meta-analysis of randomized controlled trials (RCTs) evaluating the efficacy of closed incision negative pressure wound therapy (ciNPWT) on vascular surgery groin wounds reported a reduction in surgical site infections (SSIs). Our aim was to perform a comprehensive, updated meta-analysis after the largest multicenter RCT on the subject to date reported no benefits from ciNPWT.</AbstractText><AbstractText Label="METHODS">A systematic review identified RCTs that had compared the primary outcome of the incidence of postoperative SSIs of groin incisions treated with ciNPWT or standard dressings. The secondary outcomes included wound dehiscence, a composite incidence of seroma, lymph leakage, and hematoma, the need for reoperation, in-hospital mortality, the need for readmission, and the hospital length of stay. The odds ratios (ORs) were compared across the studies using a random effects meta-analysis. The risk of bias was assessed using the Cochrane risk of bias tool, Harbord test, and trim-and-fill analysis.</AbstractText><AbstractText Label="RESULTS">Eight RCTs with 1125 incisions (ciNPWT, n&#xa0;= 555 [49.3%]; control, n&#xa0;= 570 [50.7%]) were included. The RCTs included three studies inside and five outside the United States. ciNPWT was associated with a significant reduction in the rate of SSIs (OR, 0.39; 95% confidence interval [CI], 0.24-0.63; P&#xa0;&lt; .001). No significant differences were found in the rate of wound dehiscence (OR, 1.11; 95% CI, 0.67-1.83; P&#xa0;= .68), composite incidence of seroma, lymph leak, or hematoma (OR, 0.49; 95% CI, 0.13-1.76; P&#xa0;= .27), need for reoperation (OR, 0.68; 95% CI, 0.40-1.16; P&#xa0;= .16), or need for readmission (OR, 0.60; 95% CI, 0.30-1.21; P&#xa0;= .15). It was not possible to quantitatively evaluate in-hospital mortality or the hospital length of stay. The risk of bias assessment identified a high risk of bias for participant blinding in all eight studies, a low risk for randomization and outcome reporting, and variability between studies for the other methods. We found no evidence of publication bias.</AbstractText><AbstractText Label="CONCLUSIONS">Our meta-analysis of pooled data has suggested that prophylactic use of ciNPWT for vascular groin incisions will be associated with reduced rates of SSIs. The greatest benefits were seen in the trials with higher baseline rates of SSIs in the control group.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boll</LastName><ForeName>Griffin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Vermont Medical Center, Burlington, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callas</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Biostatistics, University of Vermont, Burlington, Vt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertges</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Vermont Medical Center, Burlington, Vt. Electronic address: daniel.bertges@uvmhealth.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006119" MajorTopicYN="N">Groin</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006406" MajorTopicYN="N">Hematoma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054843" MajorTopicYN="Y">Negative-Pressure Wound Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049291" MajorTopicYN="N">Seroma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072836" MajorTopicYN="Y">Surgical Wound</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Negative pressure wound therapy</Keyword><Keyword MajorTopicYN="N">Surgical site infections</Keyword><Keyword MajorTopicYN="N">Wound complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>9</Day><Hour>20</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34999218</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2021.12.070</ArticleId><ArticleId IdType="pii">S0741-5214(21)02750-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30377926</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Percutaneous ventricular assist device in ventricular tachycardia ablation: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>197</StartPage><EndPage>205</EndPage><MedlinePgn>197-205</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-018-0477-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is a lack of compelling data regarding the benefit of percutaneous ventricular assist devices (PVAD) in patients undergoing ventricular tachycardia (VT) ablation. The study aims to conduct a meta-analysis comparing the safety and efficacy of PVAD versus no-PVAD (N-PVAD) during VT ablation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Studies meeting criteria were systematically reviewed. Baseline characteristics and clinical outcomes were extracted and analyzed. A meta-analysis was performed using random-effects model to calculate risk ratio (RR) and mean difference (MD) with 95% confidence interval (CI).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The meta-analysis included five retrospective, observational studies consisting of 2026 patients (PVAD group-284 patients versus N-PVAD group-1742 patients). The PVAD group was sicker with significantly higher VT storm, lower LVEF and greater proportion of NYHA class &#x2265; III than N-PVAD (p&#x2009;&lt;&#x2009;0.050). The acute procedural success [RR 0.95, 95% CI, (0.89-1.00), p&#x2009;=&#x2009;0.070], VT recurrence [RR 0.94, 95% CI, (0.66-1.34), p&#x2009;=&#x2009;0.740] and mortality [RR 1.28, 95% CI, (0.43-3.83), p&#x2009;=&#x2009;0.660] were similar on follow-up between PVAD versus N-PVAD. PVAD group also had significantly higher complications [RR 1.83, 95% CI (1.21-2.76), p&#x2009;=&#x2009;0.004] and longer fluoroscopy [MD +&#x2009;7.31&#xa0;min, 95% CI (0.91-13.71), p&#x2009;=&#x2009;0.030] and procedure time [MD +&#x2009;71.41&#xa0;min, 95% CI (31.67-111.14), p&#x2009;&lt;&#x2009;0.001] than N-PVAD.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Patients receiving PVAD support during VT ablation were sicker with no significant difference in acute procedural success, VT recurrence, and mortality compared with N-PVAD. PVAD support was also associated with higher complications and longer fluoroscopy and procedure time. A prospective randomized controlled trial will identify if using PVAD support in unstable patients undergoing VT ablation will impact clinical outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turagam</LastName><ForeName>Mohit K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuddanda</LastName><ForeName>Venkat</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koerber</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Jalaj</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yarlagadda</LastName><ForeName>Bharath</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, KS, 66221, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dar</LastName><ForeName>Tawseef</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, KS, 66221, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aryana</LastName><ForeName>Arash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mercy General Hospital and Dignity Health Heart and Vascular Institute, Sacramento, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Montefiore Medical Center, Bronx, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, KS, 66221, USA. dlakkireddy@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">ECMO</Keyword><Keyword MajorTopicYN="N">Hemodynamic support</Keyword><Keyword MajorTopicYN="N">Impella</Keyword><Keyword MajorTopicYN="N">Percutaneous ventricular assist device</Keyword><Keyword MajorTopicYN="N">Tandem heart</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30377926</ArticleId><ArticleId IdType="doi">10.1007/s10840-018-0477-1</ArticleId><ArticleId IdType="pii">10.1007/s10840-018-0477-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Jan 29;117(4):462-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18172038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 2;375(9708):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2010 May 25;55(21):2355-65</Citation><ArticleIdList><ArticleId IdType="pubmed">20488307</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2011 Feb 8;123(5):533-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21300961</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Fail Rev. 2011 Sep;16(5):467-76</Citation><ArticleIdList><ArticleId IdType="pubmed">21409555</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2011 Sep 20;58(13):1363-71</Citation><ArticleIdList><ArticleId IdType="pubmed">21920266</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Oct 18;343:d5928</Citation><ArticleIdList><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2012 May;14(5):709-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22080473</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2012 Jul;9(7):1168-76</Citation><ArticleIdList><ArticleId IdType="pubmed">22322326</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2013 Feb;6(1):151-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23255277</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2014 Apr;7(2):244-50</Citation><ArticleIdList><ArticleId IdType="pubmed">24532564</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Jul;11(7):1122-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24732372</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2015 Feb;8(1):68-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25491601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2015 May 19;65(19):e7-e26</Citation><ArticleIdList><ArticleId IdType="pubmed">25861963</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2015 Sep;12(9):1997-2007</Citation><ArticleIdList><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2015 Dec 29;66(25):2872-2882</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Jul 14;375(2):111-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2016 Aug;13(8):1589-95</Citation><ArticleIdList><ArticleId IdType="pubmed">27180621</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interv Card Electrophysiol. 2017 Jan;48(1):27-34</Citation><ArticleIdList><ArticleId IdType="pubmed">27497847</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2016 Dec;27(12):1437-1447</Citation><ArticleIdList><ArticleId IdType="pubmed">27574120</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2017 Jun;10(6):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28576780</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2017 Nov;28(11):1295-1302</Citation><ArticleIdList><ArticleId IdType="pubmed">28800178</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Clin Electrophysiol. 2017 Dec 26;3(13):1534-1543</Citation><ArticleIdList><ArticleId IdType="pubmed">29759835</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33512605</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>67</EndPage><MedlinePgn>59-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-021-00948-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Catheter ablation of ventricular tachycardia (VT) is associated with potential major complications, including mortality. The risk of acute complications in patients with ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy (NICM) has not been systematically evaluated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed was searched for studies of catheter ablation of VT published between September 2009 and September 2019. Pre-specified primary outcomes were (1) rate of major acute complications, including death, and (2) mortality rate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 7395 references were evaluated for relevance. From this, 50 studies with a total of 3833 patients undergoing 4319 VT ablation procedures fulfilled the inclusion criteria (mean age 59&#xa0;years; male 82%; 2363 [62%] ICM; 1470 [38%] NICM). The overall major complication rate in ICM cohorts was 9.4% (95% CI, 8.1-10.7) and NICM cohorts was 7.1% (95% CI, 6.0-8.3). Reported complication rates were highly variable between studies (ICM I<sup>2</sup>&#xa0;=&#x2009;90%; NICM I<sup>2</sup>&#xa0;=&#x2009;89%). Vascular complications (ICM 2.5% [95% CI, 1.9-3.1]; NICM 1.2% [95% CI, 0.7-1.7]) and cerebrovascular events (ICM 0.5% [95% CI, 0.2-0.7]; NICM, 0.1% [95% CI, 0-0.2]) were significantly higher in ICM cohorts. Acute mortality rates in the ICM and NICM cohorts were low (ICM 0.9% [95% CI, 0.5-1.3]; NICM 0.6% [95% CI, 0.3-1.0]) with the majority of overall deaths (ICM 75%; NICM 80%) due to either recurrent VT or cardiogenic shock.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Overall acute complication rates of VT ablation are comparable between ICM and NICM patients. However, the pattern and predictors of complications vary depending on the underlying cardiomyopathy.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Wern Yew</ForeName><Initials>WY</Initials><Identifier Source="ORCID">0000-0003-3596-6545</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK. dwyew@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science, Liverpool, UK. dwyew@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearman</LastName><ForeName>Charles M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Cardiac Physiology, Institute of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnett</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adlan</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Shui Hao</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denham</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unit of Cardiac Physiology, Institute of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modi</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Derick</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Mark C S</ForeName><Initials>MCS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahida</LastName><ForeName>Saagar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Liverpool Heart and Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science, Liverpool, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Death</Keyword><Keyword MajorTopicYN="N">Ischaemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Non-ischaemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Structural heart disease</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList><CoiStatement>The author declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33512605</ArticleId><ArticleId IdType="pmc">PMC8755671</ArticleId><ArticleId IdType="doi">10.1007/s10840-021-00948-6</ArticleId><ArticleId IdType="pii">10.1007/s10840-021-00948-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877&#x2013;883. doi: 10.1056/NEJMoa013474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa013474</ArticleId><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225&#x2013;237. doi: 10.1056/NEJMoa043399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa043399</ArticleId><ArticleId IdType="pubmed">15659722</ArticleId></ArticleIdList></Reference><Reference><Citation>Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, di Biase L, Roux JF, Verma A, Natale A, Essebag V. A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol. 2015;31(3):270&#x2013;277. doi: 10.1016/j.cjca.2014.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2014.11.023</ArticleId><ArticleId IdType="pubmed">25746019</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Armenta J, Andreu D, Penela D, Trucco E, Cipolletta L, Arbelo E, et al. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014;11(5):747&#x2013;754. doi: 10.1016/j.hrthm.2014.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2014.02.016</ArticleId><ArticleId IdType="pubmed">24561159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck K-H, Schaumann A, Eckardt L, Willems S, Ventura R, Delacretaz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375(9708):31&#x2013;40. doi: 10.1016/S0140-6736(09)61755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61755-4</ArticleId><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin J-F, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111&#x2013;121. doi: 10.1056/NEJMoa1513614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1513614</ArticleId><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Barra S, Begley D, Heck P, Turner I, Agarwal S. Ablation of ventricular tachycardia in the very elderly patient with cardiomyopathy: how old is too old? Can J Cardiol. 2015;31(6):717&#x2013;722. doi: 10.1016/j.cjca.2014.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2014.12.016</ArticleId><ArticleId IdType="pubmed">25869352</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahapatra S, Tucker-Schwartz J, Wiggins D, Gillies GT, Mason PK, McDaniel G, LaPar DJ, Stemland C, Sosa E, Ferguson JD, Bunch TJ, Ailawadi G, Scanavacca M. Pressure frequency characteristics of the pericardial space and thorax during subxiphoid access for epicardial ventricular tachycardia ablation. Heart Rhythm. 2010;7(5):604&#x2013;609. doi: 10.1016/j.hrthm.2010.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2010.01.011</ArticleId><ArticleId IdType="pmc">PMC3047445</ArticleId><ArticleId IdType="pubmed">20156612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunch TJ, Darby A, May HT, Ragosta M, Lim DS, Taylor AM, DiMarco JP, Ailawadi G, Revenaugh JR, Weiss JP, Mahapatra S. Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace. 2012;14(5):709&#x2013;714. doi: 10.1093/europace/eur347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eur347</ArticleId><ArticleId IdType="pmc">PMC3598428</ArticleId><ArticleId IdType="pubmed">22080473</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;2012. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Perera T, Ganesan A, Sullivan T, Lau DH, Roberts-Thomson KC, Brooks AG, Sanders P. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol. 2013;6(6):1082&#x2013;1088. doi: 10.1161/CIRCEP.113.000768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.113.000768</ArticleId><ArticleId IdType="pubmed">24243785</ArticleId></ArticleIdList></Reference><Reference><Citation>Core Team R. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2019.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046&#x2013;1055. doi: 10.1016/s0895-4356(01)00377-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0895-4356(01)00377-8</ArticleId><ArticleId IdType="pubmed">11576817</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Armenta J, Soto-Iglesias D, Silva E, Penela D, J&#xe1;uregui B, Linhart M, Bisbal F, Acosta J, Fernandez M, Borras R, Villuendas R, Cano L, Guasch E, Mont L, Berruezo A. Safety and outcomes of ventricular tachycardia substrate ablation during sinus rhythm: a prospective multicenter registry. JACC Clin Electrophysiol. 2020;6(11):1435&#x2013;1448. doi: 10.1016/j.jacep.2020.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2020.07.028</ArticleId><ArticleId IdType="pubmed">33121673</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein K, Dalziel K, Garside R, Castelnuovo E, Round A. Association between methodological characteristics and outcome in health technology assessments which included case series. Int J Technol Assess Health Care. 2005;21(3):277&#x2013;287. doi: 10.1017/S0266462305050373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462305050373</ArticleId><ArticleId IdType="pubmed">16110706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26121673</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Immediate versus Delayed Sequential Bilateral Cataract Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e0131857</StartPage><MedlinePgn>e0131857</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0131857</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0131857</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Immediately sequential bilateral cataract surgery (ISBCS), the cataract surgery that is performed in both eyes simultaneously, is gaining popularity worldwide compared to the traditional treatment paradigm: delayed sequential bilateral cataract surgery (DSBCS), the surgery that is performed in each eye on a different day as a completely separate operation. ISBCS provides advantages to patients and patients' families in the form of fewer hospital visits. Additionally, patients enjoy rapid rehabilitation, lack of anisometropia - potentially reducing accidents and falls, and avoid suboptimal visual function in daily life. The hospital may benefit due to lower cost.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To perform a systematic review and meta-analysis to evaluate ISBCS and DSBCS.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Databases including MEDLINE, EMBASE, BIOSIS, CINAHL, Health Economic Evaluations Database (HEED), ISI Web of Science (Thomson-Reuters) and the Cochrane Library were searched.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Not applicable.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature was systematically reviewed using EPPI-Reviewer 4 gateway. Meta-analysis was conducted using STATA v. 13.0. Standardized mean difference (SMD) and 95% confidence intervals (CI) were calculated and heterogeneity was assessed using I2 statistics. Fixed-effect and random-effect models were computed based on heterogeneity. Meta-analysis was done by instrument used to calculate utility score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 9,133 records were retrieved from multiple databases and an additional 128 records were identified through grey literature search. Eleven articles with 3,657 subjects were included for analysis. Our meta-analysis results indicated significant improvement in post-operative utility score using TTO, EQ5D, HUI3, VF-7, and VF-14 and a non-significant improvement using Catquest questionnaire for both surgeries. For ISBCS versus DSBCS, utility-specific fixed-effect model provided an overall SMD of the utility score using the TTO method as 0.12 (95% CI: -0.15, 0.40), EQ5D as 0.14 (95% CI: -0.14, 0.41), HUI3 as 0.12 (95% CI: -0.15, 0.40), VF-7 as -0.02 (95% CI: -0.15, 0.10), and Catquest Questionnaire as 1.45 (95% CI: -0.88, 2.01). The results for utility score, which were measured using various instruments, indicated non-significant improvement in the utility due to DSBCS compared to ISBCS. However, a significant improvement in post-operative utility score was seen using Catquest questionnaire for ISBCS compared to DSBCS. The included studies using VF-14 instrument were highly heterogeneous (I2 = 97.1%). Results provided SMD of -0.25 (95% CI:-1.06, 0.57) using VF-14 indicating non-significant improvement in the utility due to DSBCS compared to ISBCS surgery. Best corrected visual acuity (BCVA) significantly improved after both surgeries (overall SMD of BCVA due to ISBCS was -1.79 (95% CI: -2.45, -1.14) and due to DSBCS was -1.53 (95% CI: -2.25, -0.81)). A non-significant improvement was seen in BCVA due to ISBCS when compared to DSBCS (SMD = -0.18; 95% CI: -0.37, 0.01).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Both surgeries, ISBCS and DSBCS significantly improve patients' quality of life and visual acuity. Further, ISBCS may deliver certain additional benefits at the individual and societal levels as well.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malvankar-Mehta</LastName><ForeName>Monali S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yufeng Nancy</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Sangita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Angela Pui-Kei</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merchea</LastName><ForeName>Man Mohan</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodge</LastName><ForeName>William G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002387" MajorTopicYN="N">Cataract Extraction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019654" MajorTopicYN="N">Lens Implantation, Intraocular</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>6</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26121673</ArticleId><ArticleId IdType="pmc">PMC4485471</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0131857</ArticleId><ArticleId IdType="pii">PONE-D-14-41294</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (2011) Priority Eye Disease.</Citation></Reference><Reference><Citation>Dua HS, Said DG, Otri AM (2009) Are we doing too many cataract operations? Cataract surgery: a global perspective. British Journal of Ophthalmology 93: 1&#x2013;2. 10.1136/bjo.2008.143685</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.2008.143685</ArticleId><ArticleId IdType="pubmed">19098039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn U, Krummenauer F, Neuhann I (2012) Result-related success rates of cataract operations: Results of a systematic literature review. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 109: 575.</Citation><ArticleIdList><ArticleId IdType="pubmed">22534745</ArticleId></ArticleIdList></Reference><Reference><Citation>T Smith G, Liu CS (2001) Is it time for a new attitude to &#x201c;simultaneous&#x201d; bilateral cataract surgery? British Journal of Ophthalmology 85: 1489&#x2013;1496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1723798</ArticleId><ArticleId IdType="pubmed">11734526</ArticleId></ArticleIdList></Reference><Reference><Citation>International Society of Bilateral Cataract Surgeons (2014).</Citation></Reference><Reference><Citation>Covert DJ, Henry CR, Koenig SB Intraocular lens power selection in the second eye of patients undergoing bilateral, sequential cataract extraction. Ophthalmology 117: 49&#x2013;54. 10.1016/j.ophtha.2009.06.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2009.06.020</ArticleId><ArticleId IdType="pubmed">19815281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstrom M, Albrecht S, Nilsson M, Astrom B (2006) Benefit to patients of bilateral same-day cataract extraction: Randomized clinical study. Journal of Cataract &amp; Refractive Surgery 32: 826&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">16765801</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstr&#xf6;m M, Albrecht S, Roos P (2009) Immediate versus delayed sequential bilateral cataract surgery: an analysis of costs and patient value. Acta Ophthalmologica 87: 33&#x2013;38. 10.1111/j.1755-3768.2008.01343.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-3768.2008.01343.x</ArticleId><ArticleId IdType="pubmed">18786128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A, Claoue C (2010) Simultaneous bilateral cataract surgery: a further advantage. Eye 24: 1113&#x2013;1114.</Citation><ArticleIdList><ArticleId IdType="pubmed">19911022</ArticleId></ArticleIdList></Reference><Reference><Citation>O`Brien JJ, Gonder J, Botz C, Chow KY, Arshinoff SA (2010) Immediately sequential bilateral cataract surgery versus delayed sequential bilateral cataract surgery: potential hospital cost savings. Canadian Journal of Ophthalmology 45: 596 10.3129/i10-094</Citation><ArticleIdList><ArticleId IdType="doi">10.3129/i10-094</ArticleId><ArticleId IdType="pubmed">21135895</ArticleId></ArticleIdList></Reference><Reference><Citation>Malvankar-Mehta MS, Filek R, Iqbal M, Shakir A, Mao A, Si F, et al. (2013) Immediately sequential bilateral cataract surgery: a cost-effective procedure. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie 48: 482&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">24314408</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassiri N, Nassiri N, Yarandi SS, Rahnavardi M (2007) Immediate vs delayed sequential cataract surgery: a comparative study. Eye 23: 89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">17917685</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson BA, Lundh BL (2003) Bilateral same day phacoemulsification: 220 Cases retrospectively reviewed. British Journal of Ophthalmology 87: 285&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1771544</ArticleId><ArticleId IdType="pubmed">12598439</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshinoff SA (2012) Same-day Cataract Surgery Should Be the Standard of Care for Patients with Bilateral Visually Significant Cataract. Survey of Ophthalmology.</Citation><ArticleIdList><ArticleId IdType="pubmed">22995967</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshinoff SA, Strube YNJ, Yagev R (2003) Simultaneous bilateral cataract surgery. Journal of Cataract and Refractive Surgery 29: 1281&#x2013;1291.</Citation><ArticleIdList><ArticleId IdType="pubmed">12900233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstrom M, Wejde G, Stenevi U, Thorburn W, Montan P (2007) Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 114: 866&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">17324467</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J, Park SH, Lee WJ, Lee SJ (2009) Bilateral cataract surgery: a controlled clinical trial. Japanese journal of ophthalmology 53: 107&#x2013;113. 10.1007/s10384-008-0627-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10384-008-0627-6</ArticleId><ArticleId IdType="pubmed">19333693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gothwal VK, Wright TA, Lamoureux EL, Khadka J, McAlinden C, Pesudovs K, (2011) Improvements in visual ability with first-eye, second-eye, and bilateral cataract surgery measured with the visual symptoms and quality of life questionnaire. Journal of Cataract &amp; Refractive Surgery 37: 1208&#x2013;1216.</Citation><ArticleIdList><ArticleId IdType="pubmed">21700101</ArticleId></ArticleIdList></Reference><Reference><Citation>Busbee BG, Brown MM, Brown GC, Sharma S (2002) Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 109: 606&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">11874769</ArticleId></ArticleIdList></Reference><Reference><Citation>Busbee BG, Brown MM, Brown GC, Sharma S (2003) Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 110: 2310</Citation><ArticleIdList><ArticleId IdType="pubmed">14644712</ArticleId></ArticleIdList></Reference><Reference><Citation>Castells X, Comas M, Alonso J, Espallargues M, Mart&#xed;nez V, Garc&#xed;a-Arum&#xed; J, et al. (2006) In a randomized controlled trial, cataract surgery in both eyes increased benefits compared to surgery in one eye only. Journal of clinical epidemiology 59: 201&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">16426956</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiratsuka Y, Yamada M, Murakami A, Okada AA, Yamashita H, Ohashi Y, et al. (2011) Cost-effectiveness of cataract surgery in Japan. Japanese journal of ophthalmology 55: 333 10.1007/s10384-011-0041-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10384-011-0041-3</ArticleId><ArticleId IdType="pubmed">21695383</ArticleId></ArticleIdList></Reference><Reference><Citation>Leivo T, Sarikkola AU, Uusitalo RJ, Hellstedt T, Ess SL, Kivela T (2011) Simultaneous bilateral cataract surgery: economic analysis; Helsinki Simultaneous bilateral cataract surgery study report 2. Journal of Cataract &amp; Refractive Surgery 37: 1003&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType="pubmed">21596243</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Aguilar P, Ramallo-Fari&#xf1;a Y, Cabrera-Hern&#xe1;ndez JM, Perez-Silguero D, Perez-Silguero MA, Henr&#xed;quez-de la Fe F, et al. (2012) Immediately sequential versus delayed sequential bilateral cataract surgery: safety and effectiveness. Journal of Cataract &amp; Refractive Surgery 38: 1734&#x2013;1742.</Citation><ArticleIdList><ArticleId IdType="pubmed">22884569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarikkola A-U, Uusitalo RJ, Hellstedt T, Ess S-L, Leivo T, Kivela T (2011) Simultaneous bilateral versus sequential bilateral cataract surgery: Helsinki Simultaneous Bilateral Cataract Surgery Study report 1. Journal of Cataract &amp; Refractive Surgery 37: 992&#x2013;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">21497049</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshinoff SA, Bastianelli PA (2011) Incidence of postoperative endophthalmitis after immediate sequential bilateral cataract surgery. Journal of Cataract &amp;amp; Refractive Surgery 37: 2105&#x2013;2114.</Citation><ArticleIdList><ArticleId IdType="pubmed">22108106</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of epidemiology and community health 52: 377&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1756728</ArticleId><ArticleId IdType="pubmed">9764259</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315: 629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Friling E, Lundstr&#xf6;m M, Stenevi U, Montan P (2013) Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. Journal of Cataract &amp; Refractive Surgery 39: 15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">23245359</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran T. TW, Clark W., (2010) Endophthalmitis, Postoperative</Citation></Reference><Reference><Citation>Guber I, Bergin C, St&#xfc;rmer J (2014) More than 10 Years of Experience with Immediate Sequential Bilateral Cataract Extraction (ISBCE)&#x2014;A Retrospective Study. Open Journal of Ophthalmology 4: 139.</Citation></Reference><Reference><Citation>Schmier JK, Halpern MT, Covert DW, Matthews GP (2007) Evaluation of costs for cystoid macular edema among patients after cataract surgery. Retina 27: 621&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">17558326</ArticleId></ArticleIdList></Reference><Reference><Citation>Burling-Phillips L (2012) After Cataract Surgery: Watching for Cystoid Macular Edema EyeNet. San Francisco, CA: American Academy of Ophthalmology.</Citation></Reference><Reference><Citation>Dolan P, Gudex C, Kind P, Williams A (1996) The time trade&#x2010;off method: Results from a general population study. Health economics 5: 141&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">8733106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays R (2001) Development of the 25-list-item National Eye Institute Visual Function Questionnaire. Archives of ophthalmology 119: 1050&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pubmed">11448327</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso J, Espallargues M, Andersen TF, Cassard SD, Dunn E, Bernth-Petersen P, (1997) International applicability of the VF-14: An index of visual function in patients with cataracts. Ophthalmology 104: 799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">9160026</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw JW, Johnson JA, Coons SJ (2005) US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical care 43: 203&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">15725977</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks R (1996) EuroQol: the current state of play. Health policy 37: 53&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">10158943</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlong W, Feeny D, Torrance G, Goldsmith C, DePauw S, Zhu Z, et al. (1998) Multiplicative multi-attribute utility function for the Health Utilities Index Mark 3 (HUI3) system: a technical report Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23264584</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>8</Issue><PubDate><Year>2013</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>560</StartPage><EndPage>571</EndPage><MedlinePgn>560-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehs453</ELocationID><Abstract><AbstractText>Ablation has substantial evidence base in the management of ventricular arrhythmia (VA). It can be a 'lifesaving' procedure in the acute setting of VA storm. Current reports on ablation in VA storm are in the form of small series and have relative small representation in a large observational series. The purpose of this study was to systematically synthesize the available literature to appreciate the efficacy and safety of ablation in the setting of VA storm. The medical electronic databases through 31 January 2012 were searched. Ventricular arrhythmia storm was defined as recurrent (&#x2265; 3 episodes or defibrillator therapies in 24 h) or incessant (continuous &gt;12 h) VA. Studies reporting data on VA storm patients at the individual or study level were included. A total of 471 VA storm patients from 39 publications were collated for the analysis. All VAs were successfully ablated in 72% [95% confidence interval (CI) 71-89%] and 9% (95% CI: 3-10%) had a failed procedure. Procedure-related mortality occurred in three patients (0.6%). Only 6% patients had a recurrence of VA storm. The recurrence of VA was significantly higher after ablation for arrhythmic storm of monomorphic ventricular tachycardia (VT) relative to ventricular fibrillation or polymorphic VT with underlying cardiomyopathy (odds ratio 3.76; 95% CI: 1.65-8.57; P = 0.002). During the follow-up (61 &#xb1; 37 weeks), 17% of patients died (heart failure 62%, arrhythmias 23%, and non-cardiac 15%) with 55% deaths occurring within 12 weeks of intervention. The odds of death were four times higher after a failed procedure compared with those with a successful procedure (95% CI: 2.04-8.01, P &lt; 0.001). Ventricular arrhythmia storm ablation has high-acute success rates, with a low rate of recurrent storms. Heart failure is the dominant cause of death in the long term. Failure of the acute procedure carries a high mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nayyar</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, SA 5000, Australia. sachin.nayyar@adelaide.edu.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesan</LastName><ForeName>Anand N</ForeName><Initials>AN</Initials></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Roberts-Thomson</LastName><ForeName>Kurt C</ForeName><Initials>KC</Initials></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>Prashanthan</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23264584</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehs453</ArticleId><ArticleId IdType="pii">ehs453</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32124074</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1862-3514</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>02</Day></PubDate></JournalIssue><Title>Archives of osteoporosis</Title><ISOAbbreviation>Arch Osteoporos</ISOAbbreviation></Journal><ArticleTitle>A systematic review of the Irish osteoporotic vertebral fracture literature.</ArticleTitle><Pagination><StartPage>34</StartPage><MedlinePgn>34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11657-020-0704-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Vertebral fractures (VF) are the most common osteoporotic fracture. They are associated with significant morbidity and mortality and are an important predictor of future fractures. The epidemiology of VF in Ireland is limited and a greater understanding of their scale and impact is needed. Therefore, we conducted a systematic review of publications on osteoporotic VF in Ireland.</AbstractText><AbstractText Label="METHODS">Systematic searches were conducted using PubMed, Medline, Embase, Scopus and Cochrane electronic databases to identify eligible publications from Ireland addressing osteoporotic VF.</AbstractText><AbstractText Label="RESULTS">Twenty studies met the inclusion criteria out of 1558 citations. All studies were published since 2000. Data was obtained on 182,771 patients with fractures. Nine studies included more than 100 subjects and three included more than 1000. Females accounted for 70% with an overall mean age of 65.2&#xa0;years (30-94). There was significant heterogeneity in study design, methods and outcome measures including the following: use of administrative claims data on public hospital admissions, surgical and medical interventions, the impact of a fracture liaison service and the osteoporosis economic burden. The prevalence of VF was difficult to ascertain due to definitions used and differences in the study populations. Only two studies systematically reviewed spine imaging using blinded assessors and validated diagnostic criteria to assess the prevalence of fractures in patient cohorts.</AbstractText><AbstractText Label="CONCLUSIONS">Several studies show that VF are common when addressed systematically and the prevalence may be rising. However, there is a deficit of large studies systematically addressing the epidemiology and their importance in Ireland.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCabe</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland. eva.mccabe@nuigalway.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland. eva.mccabe@nuigalway.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Rajneet</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedic Surgery, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heaney</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergin</LastName><ForeName>Diane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCabe</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Trauma and Orthopaedic Surgery, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carey</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>School of Medicine, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Galway University Hospital, Galway, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Osteoporos</MedlineTA><NlmUniqueID>101318988</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007494" MajorTopicYN="N" Type="Geographic">Ireland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Spine</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32124074</ArticleId><ArticleId IdType="doi">10.1007/s11657-020-0704-0</ArticleId><ArticleId IdType="pii">10.1007/s11657-020-0704-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35734701</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2049-0801</ISSN><JournalIssue CitedMedium="Print"><Volume>78</Volume><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of medicine and surgery (2012)</Title><ISOAbbreviation>Ann Med Surg (Lond)</ISOAbbreviation></Journal><ArticleTitle>Volume-controlled ventilation versus pressure-controlled ventilation during spine surgery in the prone position: A meta-analysis.</ArticleTitle><Pagination><StartPage>103878</StartPage><MedlinePgn>103878</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103878</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amsu.2022.103878</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Many studies have investigated a comparison of the potency and safety of PCV versus VCV modes in spinal surgery in prone position. However, controversy about the maximal benefits of which ventilation modes remains. The main purpose of this meta-analysis was to investigate which one is the optimal ventilation for surgery patients undergoing spine surgery in prone position between the two ventilation modes as PCV and VCV.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a comprehensive search of PubMed, Embase, Web of Science, the Cochrane Library, and Google Scholar for potentially eligible articles. The continuous outcomes were analyzed using the mean difference and the associated 95% confidence interval. Meta-analysis was performed using Review Manager 5.4 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our meta-analysis included 8 RCTs involving a total of 454 patients between 2012 and 2020. The results demonstrated that IOB, Ppeak and CVP for VCV are significantly superior to PCV in spinal surgery in prone position. And PCV had higher Cdyn and PaO<sub>2</sub>/FiO<sub>2</sub> than VCV. But there was no significant difference between PCV and VCV in terms of POB, Hb, HCT, HR and MAP.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The PCV mode displayed a more satisfying effect than VCV mode. Compared to VCV mode in same preset of tidal volume, the patients with PCV mode in prone position demonstrated less IOB, lower Ppeak and CVP, and higher PaO<sub>2</sub>/FiO<sub>2</sub> in spinal surgery. However, there is no obvious difference between PCV and VCV in terms of hemodynamics variables (HR and MAP).</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Spine Surgery, Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, 116033, Liaoning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Spine Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalian Medical University, Dalian, 116044, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yunxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Spine Surgery, Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, 116033, Liaoning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalian Medical University, Dalian, 116044, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sanmao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Spine Surgery, Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, 116033, Liaoning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalian Medical University, Dalian, 116044, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zhenxin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Spine Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalian Medical University, Dalian, 116044, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wenzhong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Joint Surgery, Gaomi People's Hospital, Gaomi, 261500, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Spine Surgery, Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, 116033, Liaoning, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med Surg (Lond)</MedlineTA><NlmUniqueID>101616869</NlmUniqueID><ISSNLinking>2049-0801</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ASA, American Society of Anesthesiologists</Keyword><Keyword MajorTopicYN="N">BMI, body mass index</Keyword><Keyword MajorTopicYN="N">CVP, central venous pressure</Keyword><Keyword MajorTopicYN="N">Cdyn, dynamic compliance</Keyword><Keyword MajorTopicYN="N">HCT, hematocrit</Keyword><Keyword MajorTopicYN="N">HR, heart rates</Keyword><Keyword MajorTopicYN="N">Hb, hemoglobin</Keyword><Keyword MajorTopicYN="N">IOB, intra-operation blood loss</Keyword><Keyword MajorTopicYN="N">MAP, mean arterial pressure</Keyword><Keyword MajorTopicYN="N">MD, mean difference</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">NP, not provided</Keyword><Keyword MajorTopicYN="N">PCV, pressure controlled ventilation</Keyword><Keyword MajorTopicYN="N">PEEP, Positive End Expiratory Pressure</Keyword><Keyword MajorTopicYN="N">PILF, Posterior Lumbar Interbody Fusion</Keyword><Keyword MajorTopicYN="N">POB, post-operation blood loss</Keyword><Keyword MajorTopicYN="N">Pressure-controlled ventilation</Keyword><Keyword MajorTopicYN="N">Prone position</Keyword><Keyword MajorTopicYN="N">RCT, randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Randomized controlled trials</Keyword><Keyword MajorTopicYN="N">Spine surgery</Keyword><Keyword MajorTopicYN="N">VCV, volume controlled ventilation</Keyword><Keyword MajorTopicYN="N">VT, tidal volume</Keyword><Keyword MajorTopicYN="N">Volume-controlled ventilation</Keyword></KeywordList><CoiStatement>The authors declare no relevant conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>2</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35734701</ArticleId><ArticleId IdType="pmc">PMC9207057</ArticleId><ArticleId IdType="doi">10.1016/j.amsu.2022.103878</ArticleId><ArticleId IdType="pii">S2049-0801(22)00638-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bendixen H.H., Hedley-Whyte J., Laver M.B. Impaired oxygenation in surgical patients during general anesthesia with controlled ventilation. A concept of atelectasis. N. Engl. J. Med. 1963;269:991&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pubmed">14059732</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A., Cardoso S.O., Manetta J.A., Pereira V.G., Esposito D.C., Pasqualucci Mde O., Damasceno M.C., Schultz M.J. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012;308(16):1651&#x2013;1659.</Citation><ArticleIdList><ArticleId IdType="pubmed">23093163</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmon S.C., Kirsch J.R., Depper J.A., Toung T.J. The effect of the prone position on pulmonary mechanics is frame-dependent. Anesth. Analg. 1998;87(5):1175&#x2013;1180.</Citation><ArticleIdList><ArticleId IdType="pubmed">9806704</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerin C. Prone ventilation in acute respiratory distress syndrome. Eur. Respir. Rev. 2014;23(132):249&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9487564</ArticleId><ArticleId IdType="pubmed">24881080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolobow T., Moretti M.P., Fumagalli R., Mascheroni D., Prato P., Chen V., Joris M. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am. Rev. Respir. Dis. 1987;135(2):312&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">3544984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang W.S., Oh C.S., Kwon W.K., Rhee K.Y., Lee Y.G., Kim T.H., Lee S.H., Kim S.H. Effect of mechanical ventilation mode type on intra- and postoperative blood loss in patients undergoing posterior lumbar interbody fusion surgery: a randomized controlled trial. Anesthesiology. 2016;125(1):115&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">27096383</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn L.K., Taylor D.G., Chen C.J., Singla P., Fernandez L., Wiedle C.H., Hanak M.F., Tsang S., Smith J.S., Shaffrey C.I., Nemergut E.C., Durieux M.E., Blank R.S., Naik B.I. Ventilator mode does not influence blood loss or transfusion requirements during major spine surgery: a retrospective study. Anesth. Analg. 2020;130(1):100&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">31335398</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., Chou R., Glanville J., Grimshaw J.M., Hrobjartsson A., Lalu M.M., Li T., Loder E.W., Mayo-Wilson E., McDonald S., McGuinness L.A., Stewart L.A., Thomas J., Tricco A.C., Welch V.A., Whiting P., Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int. J. Surg. 2021;88:105906.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea B.J., Reeves B.C., Wells G., Thuku M., Hamel C., Moran J., Moher D., Tugwell P., Welch V., Kristjansson E., Henry D.A. Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833365</ArticleId><ArticleId IdType="pubmed">28935701</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Altman D.G., Gotzsche P.C., Juni P., Moher D., Oxman A.D., Savovic J., Schulz K.F., Weeks L., Sterne J.A., G. Cochrane Bias Methods, G. Cochrane Statistical Methods The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N. Comparison of effects of pressure controlled ventilation and volume controlled ventilation on perioperative blood loss of patients with posterior lumbar interbody fusion. J. Med. Res. 2017;46(6):154&#x2013;157.</Citation></Reference><Reference><Citation>Furukawa T.A., Barbui C., Cipriani A., Brambilla P., Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J. Clin. Epidemiol. 2006;59(1):7&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">16360555</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai L.Z.J.L.X. Comparison of efficacy of pressure-controlled ventilation and volume-controlled ventilation in patients undergoing lumbar surgery in prone position. Chin J. Anesthesiol. 2013;33(11):1365&#x2013;1367.</Citation></Reference><Reference><Citation>El-Sayed A.A., Arafa S.K., El-Demerdash A.M. Pressure-controlled ventilation could decrease intraoperative blood loss and improve airway pressure measures during lumbar discectomy in the prone position: a comparison with volume-controlled ventilation mode. J. Anaesthesiol. Clin. Pharmacol. 2019;35(4):468&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6939555</ArticleId><ArticleId IdType="pubmed">31920229</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo Y.Y., Kim J.Y., Kwak Y.L., Kim Y.B., Kwak H.J. The effect of pressure-controlled ventilation on pulmonary mechanics in the prone position during posterior lumbar spine surgery: a comparison with volume-controlled ventilation. J. Neurosurg. Anesthesiol. 2012;24(1):14&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">21897297</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C.B. Comparison of pressure-controlled and volume-controlled ventilation in patients undergoing spinal surgery in prone position supported by a Wilson frame. Chin J. Anesthesiol. 2014;34(11):1354&#x2013;1356.</Citation></Reference><Reference><Citation>Peng Zhendan X.J., Jing L.I., Ren Quan. Hemodynamic variables in patients undergoing lumbar spine fusion surgery in prone position: volume-controlled ventilation versus pressure-controlled ventilation. Chin J. Med. Phys. 2017;34(9):959&#x2013;962.</Citation></Reference><Reference><Citation>Senay H., Sivaci R., Kokulu S., Koca B., Baki E.D., Ela Y. The effect of pressure-controlled ventilation and volume-controlled ventilation in prone position on pulmonary mechanics and inflammatory markers. Inflammation. 2016;39(4):1469&#x2013;1474.</Citation><ArticleIdList><ArticleId IdType="pubmed">27221140</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell R.S., Davis B.R. Pressure-controlled versus volume-controlled ventilation: does it matter? Respir. Care. 2002;47(4):416&#x2013;424. discussion 424-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11929615</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh J.C., Lee J.S., Han D.W., Choi S., Chang C.H. Increase in airway pressure resulting from prone position patient placing may predict intraoperative surgical blood loss. Spine. 2013;38(11):E678&#x2013;E682.</Citation><ArticleIdList><ArticleId IdType="pubmed">23429680</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra A., Gupta V., Abraham M., Punetha P., Bundela Y. Quantifying the amount of bleeding and associated changes in intra-abdominal pressure and mean airway pressure in patients undergoing lumbar fixation surgeries: a comparison of three positioning systems. Asian Spine J. 2016;10(2):199&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843053</ArticleId><ArticleId IdType="pubmed">27114757</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyota S., Amaki Y. Hemodynamic evaluation of the prone position by transesophageal echocardiography. J. Clin. Anesth. 1998;10(1):32&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">9526935</ArticleId></ArticleIdList></Reference><Reference><Citation>Paksoy Y., Gormus N. Epidural venous plexus enlargements presenting with radiculopathy and back pain in patients with inferior vena cava obstruction or occlusion. Spine. 2004;29(21):2419&#x2013;2424.</Citation><ArticleIdList><ArticleId IdType="pubmed">15507805</ArticleId></ArticleIdList></Reference><Reference><Citation>Prella M., Feihl F., Domenighetti G. Effects of short-term pressure-controlled ventilation on gas exchange, airway pressures, and gas distribution in patients with acute lung injury/ARDS: comparison with volume-controlled ventilation. Chest. 2002;122(4):1382&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pubmed">12377869</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saady N., Bennett E.D. Decelerating inspiratory flow waveform improves lung mechanics and gas exchange in patients on intermittent positive-pressure ventilation. Intensive Care Med. 1985;11(2):68&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">3886741</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen O., Umutoglu T., Aydin N., Toptas M., Tutuncu A.C., Bakan M. Effects of pressure-controlled and volume-controlled ventilation on respiratory mechanics and systemic stress response during laparoscopic cholecystectomy. SpringerPlus. 2016;5:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783310</ArticleId><ArticleId IdType="pubmed">27064770</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S.D., Kundu S.B., Ghose T., Maji S., Mitra K., Mukherjee M., Mandal S., Sarbapalli D., Bhattacharya S., Bhattacharya S. A comparison between volume-controlled ventilation and pressure-controlled ventilation in providing better oxygenation in obese patients undergoing laparoscopic cholecystectomy. Indian J. Anaesth. 2012;56(3):276&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3425289</ArticleId><ArticleId IdType="pubmed">22923828</ArticleId></ArticleIdList></Reference><Reference><Citation>Rd M. In: Patient Blood Management: Transfusion Therapy, Miller's Anesthesia. eighth ed. Philadelphia Miller RD., editor. Elsevier Churchill Livingstone; 2014. pp. 1830&#x2013;1867.</Citation></Reference><Reference><Citation>Jiang J., Li B., Kang N., Wu A., Yue Y. Pressure-controlled versus volume-controlled ventilation for surgical patients: a systematic review and meta-analysis. J. Cardiothorac. Vasc. Anesth. 2016;30(2):501&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">26395394</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans G.A., Pregaldien A.A., Kaba A., Sottiaux T.M., DeRoover A., Lamy M.L., Joris J.L. Pressure-controlled ventilation does not improve gas exchange in morbidly obese patients undergoing abdominal surgery. Obes. Surg. 2008;18(1):71&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">18080725</ArticleId></ArticleIdList></Reference><Reference><Citation>Messeha M.M. Effect of switching between pressure-controlled and volume-controlled ventilation on respiratory mechanics and hemodynamics in obese patients during abdominoplasty. Anesth. Essays Res. 2017;11(1):88&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5341628</ArticleId><ArticleId IdType="pubmed">28298763</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaju R., Jaju P.B., Dubey M., Mohammad S., Bhargava A.K. Comparison of volume controlled ventilation and pressure controlled ventilation in patients undergoing robot-assisted pelvic surgeries: an open-label trial. Indian J. Anaesth. 2017;61(1):17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5296801</ArticleId><ArticleId IdType="pubmed">28216699</ArticleId></ArticleIdList></Reference><Reference><Citation>Channabasappa S.M., Shankarnarayana P. A comparative study of hemodynamic changes between prone and supine emergence from anesthesia in lumbar disc surgery. Anesth. Essays Res. 2013;7(2):173&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4173510</ArticleId><ArticleId IdType="pubmed">25885828</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dessoukey A.A., Moussa A.S., Abdelbary A.M., Zayed A., Abdallah R., Elderwy A.A., Massoud A.M., Aly A.H. Percutaneous nephrolithotomy in the oblique supine lithotomy position and prone position: a comparative study. J. Endourol. 2014;28(9):1058&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pubmed">24856575</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34935704</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4023</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of cardiovascular pharmacology</Title><ISOAbbreviation>J Cardiovasc Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Effect of Dexmedetomidine on Tachyarrhythmias After Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>315</StartPage><EndPage>324</EndPage><MedlinePgn>315-324</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/FJC.0000000000001196</ELocationID><Abstract><AbstractText>Tachyarrhythmias after cardiac surgery is a common occurrence in clinical practice, which can be life threatening. We searched 6 databases, including Embase, PubMed, Cochrane, CNKI, Wanfang, and Sinomed, to evaluate the effect of dexmedetomidine on tachyarrhythmias after adult cardiac surgery. The primary end point was the number of patients with atrial fibrillation (AF) after cardiac surgery. The secondary end points included the number of patients with supraventricular tachycardia or with ventricular tachycardia or with ventricular fibrillation or with myocardial infarction or deceased patients, the duration of mechanical ventilation, the intensive care unit stay, hospital stay, and the number of patients with bradycardia and those with hypotension. Among the 1388 retrieved studies, 18 studies (n = 3171 participants) met our inclusion criteria. Dexmedetomidine reduced the incidence of AF by 17% [relative risk (RR) = 0.83; 95% confidence interval (CI), 0.73-0.93; P = 0.002]. Through subgroup analysis, we found that when the maintenance dose of dexmedetomidine was &gt;0.7 &#xb5;g&#xb7;kg-1&#xb7;h-1, the effect of preventing AF was obvious (RR = 0.58; 95%CI 0.43-0.78; P = 0.0003). Dexmedetomidine also reduced the incidence of supraventricular tachycardia by approximately 70% (RR = 0.29; 95% CI, 0.11-0.77; P = 0.01) and the incidence of ventricular tachycardia by approximately 80% (RR = 0.23; 95% CI, 0.08-0.63; P = 0.004) but had no effect on ventricular fibrillation (RR = 1.02; 95% CI, 0.14-7.31; P = 0.99). The major side effect of dexmedetomidine was bradycardia. Dexmedetomidine can reduce the incidence of AF (especially high dosages), supraventricular tachycardia, and ventricular tachycardia after cardiac surgery in adults, but it does not affect the occurrence of ventricular fibrillation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenzhu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Jining No. 1 People's Hospital, Jining, Shandong, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency, Jining No. 1 People's Hospital, Jining, Shandong, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sishui County Hospital, Jining, Shandong, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mingshan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Qingdao Municipal Hospital Group, Qingdao, Shandong, P.R. China ; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Pharmacol</MedlineTA><NlmUniqueID>7902492</NlmUniqueID><ISSNLinking>0160-2446</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013617" MajorTopicYN="Y">Tachycardia, Supraventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>12</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34935704</ArticleId><ArticleId IdType="doi">10.1097/FJC.0000000000001196</ArticleId><ArticleId IdType="pii">00005344-202203000-00010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitchell LB. Incidence, timing and outcome of atrial tachyarrhythmias after cardiac surgery. In: Steinberg JS, ed. Atrial Fibrillation After Cardiac Surgery. Kluwer Academic Publishers, 2000:37&#x2013;50.</Citation></Reference><Reference><Citation>Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56:539&#x2013;549.</Citation></Reference><Reference><Citation>Yiin GS, Howard DP, Paul NL, et al. Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation 2014;130:1236&#x2013;1244.</Citation></Reference><Reference><Citation>Fax&#xe9;n J, Jernberg T, Hollenberg J, et al. Incidence and predictors of out-of-hospital cardiac arrest within 90 Days after myocardial infarction. J Am Coll Cardiol. 2020;76:2926&#x2013;2936.</Citation></Reference><Reference><Citation>Stanley TO, Mackensen GB, Grocott HP, et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002;94:290&#x2013;295.</Citation></Reference><Reference><Citation>Conen D, Alonso-Coello P, Douketis J, et al. Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. Eur Heart J. 2020;41:645&#x2013;651.</Citation></Reference><Reference><Citation>Kim D, Yang PS, Yu HT, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. Eur Heart J. 2019;40:2313&#x2013;2323.</Citation></Reference><Reference><Citation>Ueki M, Kawasaki T, Habe K, et al. The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass. Anaesthesia 2014;69:693&#x2013;700.</Citation></Reference><Reference><Citation>Narisawa A, Nakane M, Kano T, et al. Dexmedetomidine sedation during the nighttime reduced the incidence of postoperative atrial fibrillation in cardiovascular surgery patients after tracheal extubation. J Intensive Care 2015;3:26.</Citation></Reference><Reference><Citation>Turan A, Bashour CA, You J, et al. Dexmedetomidine sedation after cardiac surgery decreases atrial arrhythmias. J Clin Anesth. 2014;26:634&#x2013;642.</Citation></Reference><Reference><Citation>Liu X, Zhang K, Wang W, et al. Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Crit Care 2016;20:298.</Citation></Reference><Reference><Citation>Zhaoqing C, Guohua C, Liwei D, et al. Application of dexmedetomidine hydrochloride in the prevention and treatment of postoperative complications in patients undergoing valve replacement surgery. Lingnan J Cardiovasc Dis. 2018;3:293&#x2013;300.</Citation></Reference><Reference><Citation>Ren J, Zhang H, Huang L, et al. Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Exp Ther Med. 2013;6:497&#x2013;502.</Citation></Reference><Reference><Citation>Yu X, Zhang Y, Wan H. The preventive effect of dexmedetomidine on postoperative atrial fibrillation in patients undergoing cardiac surgery. Mod Chin Doctors 2019:25&#x2013;28.</Citation></Reference><Reference><Citation>G&#xf6;ksedef D, Balkanay OO, &#xd6;mero&#x11f;lu SN, et al. The effects of dexmedetomidine infusion on renal functions after coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled study. Turkish J Thorac Cardiovasc Surg. 2013;21:594&#x2013;602.</Citation></Reference><Reference><Citation>Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;17:576&#x2010;84.</Citation></Reference><Reference><Citation>Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 1997;86:331&#x2013;345.</Citation></Reference><Reference><Citation>Shi C, Jin J, Qiao L, et al. Effect of perioperative administration of dexmedetomidine on delirium after cardiac surgery in elderly patients: a double-blinded, multi-center, randomized study. Clin interventions Aging 2019;14:571&#x2013;575.</Citation></Reference><Reference><Citation>Zi J, Fan Y, Dong C, et al. Anxiety administrated by dexmedetomidine to prevent new-onset of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass graft. Int Heart J. 2020;61:263&#x2013;272.</Citation></Reference><Reference><Citation>Zhu Z, Zhou H, Ni Y, et al. Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis. Drug Des Development Ther. 2018;12:521&#x2013;531.</Citation></Reference><Reference><Citation>Balkanay OO, Goksedef D, Omeroglu SN, et al. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interactive Cardiovasc Thorac Surg. 2015;20:209&#x2013;214.</Citation></Reference><Reference><Citation>Corbett SM, Rebuck JA, Greene CM, et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med. 2005;33:940&#x2013;945.</Citation></Reference><Reference><Citation>Djaiani G, Silverton N, Fedorko L, et al. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology. 2016;124:362&#x2013;368.</Citation></Reference><Reference><Citation>Karaman Y, Abud B, Tekgul ZT, et al. Effects of dexmedetomidine and propofol on sedation in patients after coronary artery bypass graft surgery in a fast-track recovery room setting. J Anesth. 2015;29:522&#x2010;8.</Citation></Reference><Reference><Citation>Li X, Yang J, Nie XL, et al. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PLoS One 2017;12:e0170757.</Citation></Reference><Reference><Citation>Liu X, Zhang K, Wang W, et al. Dexmedetomidine versus propofol sedation improves sublingual microcirculation after cardiac surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2016;30:1509&#x2013;1515.</Citation></Reference><Reference><Citation>Park JB, Bang SH, Chee HK, et al. Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean J Thorac Cardiovasc Surg. 2014;47:249&#x2013;254.</Citation></Reference><Reference><Citation>Shehabi Y, Grant P, Wolfenden H, et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study). Anesthesiology. 2009;111:1075&#x2013;1084.</Citation></Reference><Reference><Citation>Turan A, Duncan A, Leung S, et al. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020;396:177&#x2013;185.</Citation></Reference><Reference><Citation>Hayashi Y, Sumikawa K, Maze M, et al. Dexmedetomidine prevents epinephrine-induced arrhythmias through stimulation of central alpha 2 adrenoceptors in halothane-anesthetized dogs. Anesthesiology. 1991;75:113&#x2013;117.</Citation></Reference><Reference><Citation>Tsutsui K, Hayami N, Kunishima T, et al. Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome. Circ J. 2012;76:2343&#x2013;2347.</Citation></Reference><Reference><Citation>Yu T, Liu D, Gao M, et al. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of &#x3b1;7nAChR and PI3K/Akt- mediated autophagy. Biomed Pharmacother. 2019;120:109231.</Citation></Reference><Reference><Citation>Liu XR, Li T, Cao L, et al. Dexmedetomidine attenuates H2O2-induced neonatal rat cardiomyocytes apoptosis through mitochondria- and ER-medicated oxidative stress pathways. Mol Med Rep. 2018;17:7258&#x2013;7264.</Citation></Reference><Reference><Citation>Liu Y, Zhang L, Wang S, et al. Dexmedetomidine reduces atrial fibrillation after adult cardiac surgery: a meta-analysis of randomized controlled trials. Am J Cardiovasc Drugs. 2020;20:271&#x2013;281.</Citation></Reference><Reference><Citation>Mir&#xf3; O, de la Red G, Fontanals J. Cessation of paroxysmal atrial fibrillation during acute intravenous propofol administration. Anesthesiology. 2000;92:910.</Citation></Reference><Reference><Citation>Lai LP, Lin JL, Wu MH, et al. Usefulness of intravenous propofol anesthesia for radiofrequency catheter ablation in patients with tachyarrhythmias: infeasibility for pediatric patients with ectopic atrial tachycardia. Pacing Clin Electrophysiol. 1999;22:1358&#x2013;1364.</Citation></Reference><Reference><Citation>Peng K, Ji FH, Liu HY, et al. Effects of perioperative dexmedetomidine on postoperative mortality and Morbidity: a systematic review and meta-analysis. Clin Ther. 2019;41:138&#x2013;154.e4.</Citation></Reference><Reference><Citation>Lin YY, He B, Chen J, et al. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis. Crit Care. 2012;16:R169.</Citation></Reference><Reference><Citation>Celis-Rodr&#xed;guez E, D&#xed;az Cort&#xe9;s JC, C&#xe1;rdenas Bol&#xed;var YR, et al. Evidence-based clinical practice guidelines for the management of sedoanalgesia and delirium in critically ill adult patients. Med Intensiva. 2020;44:171&#x2013;184.</Citation></Reference><Reference><Citation>Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012;307:1151&#x2013;1160.</Citation></Reference><Reference><Citation>Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;17:576&#x2013;584.</Citation></Reference><Reference><Citation>Martin E, Ramsay G, Mantz J, et al. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med. 2003;18:29&#x2013;41.</Citation></Reference><Reference><Citation>Kirchhof P, Benussi S, Kotecha D, et al. ESC guidelines for the management of atrial fibrillation Developed in Collaboration with EACTS. Rev Esp Cardiol. 2017;70:50.</Citation></Reference><Reference><Citation>Arsenault KA, Yusuf AM, Crystal E, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2013;2013:Cd003611.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35270411</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Efficacy of Treatments in Nonarteritic Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2718</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph19052718</ELocationID><Abstract><AbstractText Label="BACKGROUND">Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) is the second most common cause of optic nerve-related permanent visual loss in adults.</AbstractText><AbstractText Label="AIM">We aimed to analyze the efficacy of the noninvasive and minimally invasive therapeutic options of NAION.</AbstractText><AbstractText Label="METHODS">We performed a systematic literature search in MEDLINE, EMBASE, and CENTRAL from inception to 10 June 2019 to identify the studies that report on the effect of different therapies on visual acuity (VA) and visual field (VF). Weighted mean difference (WMD) with 95% confidence interval (CI) was calculated for these outcomes. The efficacy of steroids was investigated in quantitative, oxygen, steroid plus erythropoietin (EPO), levodopa/carbidopa, memantine, and heparin-induced extracorporeal LDL/fibrinogen precipitation (HELP) therapies and other therapeutic modalities in qualitative synthesis.</AbstractText><AbstractText Label="RESULTS">Thirty-two studies were found to be eligible. We found that steroid therapy compared to control did not improve VA (<i>p</i> = 0.182, WMD = 0.14, 95% CI: -0.07, 0.35) or VF (<i>p</i> = 0.853, WMD = 0.16, 95% CI: -1.54, 1.86). Qualitative analysis could be performed for oxygen, steroid plus EPO, and HELP as well, however, none of them showed VA and VF benefit. Two individual studies found memantine and levodopa beneficial regarding VA.</AbstractText><AbstractText Label="CONCLUSION">Our systematic review did not reveal any effective treatment. Further investigations are needed to find therapy for NAION.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lantos</LastName><ForeName>Krisztina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Medical School, University of P&#xe9;cs, 7632 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xf6;m&#xf6;t&#xf6;r</LastName><ForeName>Zsuzsa R&#xe9;ka</ForeName><Initials>ZR</Initials><Identifier Source="ORCID">0000-0002-3561-2539</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Medical School, University of Debrecen, 4032 Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farkas</LastName><ForeName>Nelli</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Bioanalysis, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiss</LastName><ForeName>Szabolcs</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5032-866X</Identifier><AffiliationInfo><Affiliation>Doctoral School of Clinical Medicine, University of Szeged, 6720 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szak&#xe1;cs</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7035-941X</Identifier><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garami</LastName><ForeName>Andr&#xe1;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2493-0571</Identifier><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varga</LastName><ForeName>G&#xe1;bor</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5506-8198</Identifier><AffiliationInfo><Affiliation>Department of Oral Biology, Faculty of Dentistry, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lujber</LastName><ForeName>L&#xe1;szl&#xf3;</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Medical School, University of P&#xe9;cs, 7621 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaan</LastName><ForeName>Reem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Public Health Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegyi</LastName><ForeName>P&#xe9;ter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feh&#xe9;r</LastName><ForeName>Gergely</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Primary Health Care, Medical School, University of P&#xe9;cs, 7624 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ga&#xe1;l</LastName><ForeName>Val&#xe9;ria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-3905-1414</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Medical School, University of P&#xe9;cs, 7632 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013256">Steroids</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical><Chemical><RegistryNumber>W8O17SJF3T</RegistryNumber><NameOfSubstance UI="D008559">Memantine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008559" MajorTopicYN="N">Memantine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018917" MajorTopicYN="Y">Optic Neuropathy, Ischemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013256" MajorTopicYN="N">Steroids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NAION</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">nonarteritic ischemic optic neuropathy</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>15</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35270411</ArticleId><ArticleId IdType="pmc">PMC8910678</ArticleId><ArticleId IdType="doi">10.3390/ijerph19052718</ArticleId><ArticleId IdType="pii">ijerph19052718</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pakravan M., Sanjari N., Esfandiari H., Pakravan P., Yaseri M. The effect of high-dose steroids, and normobaric oxygen therapy, on recent onset non-arteritic anterior ischemic optic neuropathy: A randomized clinical trial. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2016;254:2043&#x2013;2048. doi: 10.1007/s00417-016-3451-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-016-3451-6</ArticleId><ArticleId IdType="pubmed">27510295</ArticleId></ArticleIdList></Reference><Reference><Citation>Judit Somlai T.K.E. Neuro-Ophthalmology, Vascular Diseases of the Optic Nerve: The Neuro-Ophthalmologist&#x2019;s Approach. Springer International Publishing; Cham, Switzerland: 2016. p. 395.</Citation></Reference><Reference><Citation>Atkins E.J., Bruce B., Newman N.J., Biousse V. Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy. Surv. Ophthalmol. 2010;55:47&#x2013;63. doi: 10.1016/j.survophthal.2009.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.survophthal.2009.06.008</ArticleId><ArticleId IdType="pmc">PMC3721361</ArticleId><ArticleId IdType="pubmed">20006051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebolleda G., P&#xe9;rez-L&#xf3;pez M., Casas-Llera P., Contreras I., Mu&#xf1;oz-Negrete F.J. Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2013;251:255&#x2013;260. doi: 10.1007/s00417-012-1995-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-012-1995-7</ArticleId><ArticleId IdType="pubmed">22441810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakravan M., Esfandiari H., Hassanpour K., Razavi S., Pakravan P. The Effect of Combined Systemic Erythropoietin and Steroid on Non-arteritic Anterior Ischemic Optic Neuropathy: A Prospective Study. Curr. Eye Res. 2017;42:1079&#x2013;1084. doi: 10.1080/02713683.2016.1270328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02713683.2016.1270328</ArticleId><ArticleId IdType="pubmed">28632028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinori M., Ben-Bassat I., Wasserzug Y., Chetrit A., Huna-Baron R. Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy&#x2013;retrospective analysis. BMC Ophthalmol. 2014;14:62. doi: 10.1186/1471-2415-14-62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2415-14-62</ArticleId><ArticleId IdType="pmc">PMC4017224</ArticleId><ArticleId IdType="pubmed">24886579</ArticleId></ArticleIdList></Reference><Reference><Citation>Steigerwalt R.D., Cesarone M.R., Belcaro G., Pascarella A., De Angelis M., Bacci S. Nonarteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids. Int. J. Angiol. 2008;17:193&#x2013;196. doi: 10.1055/s-0031-1278308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1278308</ArticleId><ArticleId IdType="pmc">PMC2728919</ArticleId><ArticleId IdType="pubmed">22477448</ArticleId></ArticleIdList></Reference><Reference><Citation>Radoi C., Garcia T., Brugniart C., Ducasse A., Arndt C. Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2013;252:339&#x2013;345. doi: 10.1007/s00417-013-2499-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-013-2499-9</ArticleId><ArticleId IdType="pubmed">24178807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaderli B., Avci R., Yucel A., Guler K., Gelisken O. Intravitreal Triamcinolone Improves Recovery of Visual Acuity in Nonarteritic Anterior Ischemic Optic Neuropathy. J. Neuro-Ophthalmol. 2007;27:164&#x2013;168. doi: 10.1097/WNO.0b013e31814a5a9a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0b013e31814a5a9a</ArticleId><ArticleId IdType="pubmed">17895814</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayreh S.S., Zimmerman M.B. Non-arteritic anterior ischemic optic neuropathy: Role of systemic corticosteroid therapy. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2008;246:1029&#x2013;1046. doi: 10.1007/s00417-008-0805-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-008-0805-8</ArticleId><ArticleId IdType="pmc">PMC2712323</ArticleId><ArticleId IdType="pubmed">18404273</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena R., Singh D., Sharma M., James M., Sharma P., Menon V. Steroids versus No Steroids in Nonarteritic Anterior Ischemic Optic Neuropathy: A Randomized Controlled Trial. Ophthalmology. 2018;125:1623&#x2013;1627. doi: 10.1016/j.ophtha.2018.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2018.03.032</ArticleId><ArticleId IdType="pubmed">29705054</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidovi&#x107; T., Cerovski B., Peri&#x107; S., Kordi&#x107; R., Mrazovac D. Corticosteroid therapy in patients with non-arteritic anterior ischemic optic neuropathy. Coll. Antropol. 2015;39:63&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">26040070</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaman A., Selver O.B., Saatci A.O., Soylev M.F. Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy. Clin. Exp. Optom. 2008;91:561&#x2013;564. doi: 10.1111/j.1444-0938.2008.00287.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1444-0938.2008.00287.x</ArticleId><ArticleId IdType="pubmed">18976422</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokosch V., Thanos S. Visual outcome of patients following NAION after treatment with adjunctive fluocortolone. Restor. Neurol. Neurosci. 2014;32:381&#x2013;389. doi: 10.3233/RNN-120292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/RNN-120292</ArticleId><ArticleId IdType="pubmed">24225379</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson L.N., Gould T.J., Krohel G.B. Effect of Levodopa and Carbidopa on Recovery of Visual Function in Patients With Nonarteritic Anterior Ischemic Optic Neuropathy of Longer Than Six Months&#x2019; Duration. Am. J. Ophthalmol. 1996;121:77&#x2013;83. doi: 10.1016/S0002-9394(14)70536-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9394(14)70536-7</ArticleId><ArticleId IdType="pubmed">8554083</ArticleId></ArticleIdList></Reference><Reference><Citation>Simsek T., Eryilmaz T., Acaroglu G. Efficacy of levodopa and carbidopa on visual function in patients with non-arteritic anterior ischaemic optic neuropathy. Int. J. Clin. Pr. 2005;59:287&#x2013;290. doi: 10.1111/j.1742-1241.2005.00462.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2005.00462.x</ArticleId><ArticleId IdType="pubmed">15857324</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson L.N., E Guy M., Krohel G.B., Madsen R.W. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107:521&#x2013;526. doi: 10.1016/S0161-6420(99)00133-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-6420(99)00133-5</ArticleId><ArticleId IdType="pubmed">10711891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyttle D.P., Johnson L.N., Margolin E.A., Madsen R.W. Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2016;254:757&#x2013;764. doi: 10.1007/s00417-015-3191-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-015-3191-z</ArticleId><ArticleId IdType="pubmed">26483145</ArticleId></ArticleIdList></Reference><Reference><Citation>Modarres M., Falavarjani K.G., Nazari H., Sanjari M.S., Aghamohammadi F., Homaii M., Samiy N. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br. J. Ophthalmol. 2011;95:992&#x2013;995. doi: 10.1136/bjo.2010.191627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.2010.191627</ArticleId><ArticleId IdType="pubmed">21131378</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazzone H.E., Kupersmith M.J., Leibmann J. Does topical brimonidine tartrate help NAION? Br. J. Ophthalmol. 2003;87:1193&#x2013;1194. doi: 10.1136/bjo.87.9.1193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.87.9.1193</ArticleId><ArticleId IdType="pmc">PMC1771838</ArticleId><ArticleId IdType="pubmed">12928304</ArticleId></ArticleIdList></Reference><Reference><Citation>The BRAION study group. Wilhelm B., L&#xfc;dtke H., Wilhelm H. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): A 3-month, double-masked, randomised, placebo-controlled trial. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 2005;244:551&#x2013;558. doi: 10.1007/s00417-005-0102-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-005-0102-8</ArticleId><ArticleId IdType="pubmed">16151785</ArticleId></ArticleIdList></Reference><Reference><Citation>Riazi E.M., Aalami H.Z., Kiumehr S., Gholmi A., Tabasi A., Piri N., Mirshahi A., Nili A.M., Movassat M., Fakhraee G. Memantine treatment in acute nonarteric anterior ischemic optic neuropathy: A Randomized Clinical Trial. J. Curr. Ophthalmol. 2011;23:11&#x2013;20.</Citation></Reference><Reference><Citation>Aftab A.M., Iqbal M., Rauf A., Ali A. Non arteritic anterior ischemic optic neuropathy; does Anticoagulation help? J. Ayub Med Coll. Abbottabad. 2017;28:776&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">28586576</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas A., Walzl M., Jesenik F., Walzl B., Berghold A., Bergl&#xf6;ff J., Feigl B., Faulborn J. Application of HELP in nonarteritic anterior ischemic optic neuropathy: A prospective, randomized, controlled study. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 1997;235:14&#x2013;19. doi: 10.1007/BF01007832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01007832</ArticleId><ArticleId IdType="pubmed">9034837</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramunni A., Giancipoli G., Guerriero S., Lapenna L., Saracino A., Saliani M.T., Capurso A., Sborgia C., Coratelli P. LDL-Apheresis Accelerates the Recovery of Nonarteritic Acute Anterior Ischemic Optic Neuropathy. Ther. Apher. Dial. 2005;9:53&#x2013;58. doi: 10.1111/j.1774-9987.2005.00205.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1774-9987.2005.00205.x</ArticleId><ArticleId IdType="pubmed">15828907</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerriero S., Giancipoli G., Cantatore A., Sacco G., Brescia P., Saliani M.T., Ramunni A., Guerriero G.G.S. LDL apheresis in the treatment of non-arteritic ischaemic optic neuropathy: A 6-month follow-up study. Eye. 2008;23:1343&#x2013;1344. doi: 10.1038/eye.2008.287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/eye.2008.287</ArticleId><ArticleId IdType="pubmed">18806764</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajin M.S., Selver O.B., Taskin O., Yaman A., Saatci A.O. Single intravitreal ranibizumab injection in eyes with acute non-arteritic anterior ischaemic optic neuropathy. Clin. Exp. Optom. 2011;94:367&#x2013;370. doi: 10.1111/j.1444-0938.2010.00570.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1444-0938.2010.00570.x</ArticleId><ArticleId IdType="pubmed">21255078</ArticleId></ArticleIdList></Reference><Reference><Citation>Saatci A.O., Taskin O., Selver O.B., Yaman A., Bajin M.S. Efficacy of Intravitreal Ranibizumab Injection in Acute Nonarteritic Ischemic Optic Neuropathy: A Long-Term Follow Up&#xa7;. Open Ophthalmol. J. 2013;7:58&#x2013;62. doi: 10.2174/1874364101307010058.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874364101307010058</ArticleId><ArticleId IdType="pmc">PMC3795401</ArticleId><ArticleId IdType="pubmed">24133556</ArticleId></ArticleIdList></Reference><Reference><Citation>Rootman D.B., Gill H.S., A Margolin E. Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: A prospective trial. Eye. 2013;27:538&#x2013;544. doi: 10.1038/eye.2012.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/eye.2012.296</ArticleId><ArticleId IdType="pmc">PMC3626001</ArticleId><ArticleId IdType="pubmed">23370417</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L.A., PRISMA-P Group Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A., editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; Oxford, UK: 2020. Version 6.1. updated September 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Holladay J.T. Proper method for calculating average visual acuity. J. Refract. Surg. 1997;13:388&#x2013;391. doi: 10.3928/1081-597X-19970701-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/1081-597X-19970701-16</ArticleId><ArticleId IdType="pubmed">9268940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeting M.J., Sutton A., Lambert P.C. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat. Med. 2004;23:1351&#x2013;1375. doi: 10.1002/sim.1761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1761</ArticleId><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Altman D.G., G&#xf8;tzsche P.C., J&#xfc;ni P., Moher D., Oxman A.D., Savovi&#x107; J., Schulz K.F., Weeks L., Sterne J.A. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A., Hern&#xe1;n M.A., McAleenan A., Reeves B.C., Higgins J.P. Chapter 25: Assessing risk of bias in a non-randomized study. In: Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020) Cochrane; Oxford, UK: 2020.</Citation></Reference><Reference><Citation>Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., Sch&#xfc;nemann H.J. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayreh S.S., Zimmerman M.B. Nonarteritic Anterior Ischemic Optic Neuropathy: Natural History of Visual Outcome. Ophthalmology. 2008;115:298&#x2013;305.e2. doi: 10.1016/j.ophtha.2007.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2007.05.027</ArticleId><ArticleId IdType="pmc">PMC2782939</ArticleId><ArticleId IdType="pubmed">17698200</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott C.R., Sklar C.A., Lesser R.L., Adelman R.A. Is Intravitreal Bevacizumab an Effective Treatment Option for Nonarteritic Anterior Ischemic Optic Neuropathy? J. Neuro-Ophthalmol. 2012;32:51&#x2013;53. doi: 10.1097/WNO.0b013e318240596e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0b013e318240596e</ArticleId><ArticleId IdType="pubmed">22269947</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas A., Uyguner I., Sochor G., Schmut O., Vidic B., Faulborn J. Nichtarteriitische vordere isch&#xe4;mische Optikusneuropathie: Langzeitergebnisse nach H&#xe4;modilutionstherapie. Klin. Mon. F&#xfc;r Augenheilkd. 1994;205:143&#x2013;146. doi: 10.1055/s-2008-1045507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1045507</ArticleId><ArticleId IdType="pubmed">7527879</ArticleId></ArticleIdList></Reference><Reference><Citation>Boji&#x107; L., Kovacevi&#x107; H., Andri&#x107; D., Karaman-Kraljevi&#x107; K., Cagalj S. The effects of hyperbaric oxygen on visual functions in ischaemic optic neuropathy. Arch. Ind. Hyg. Toxicol. 1994;45:19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">8067909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjari N., Pakravan M., Nourinia R., Esfandiari H., Hafezi-Moghadam A., Zandi S., Nakao S., Shah-Heidari M.-H., Jamali A., Yaseri M., et al. Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy. J. Clin. Pharmacol. 2015;56:749&#x2013;753. doi: 10.1002/jcph.655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.655</ArticleId><ArticleId IdType="pubmed">26444290</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Zhu J., Chen L., Hu C., Du Y. Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2019;98:e17861. doi: 10.1097/MD.0000000000017861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000017861</ArticleId><ArticleId IdType="pmc">PMC6867765</ArticleId><ArticleId IdType="pubmed">31725628</ArticleId></ArticleIdList></Reference><Reference><Citation>Mac Grory B., Lavin P., Kirshner H., Schrag M. Thrombolytic Therapy for Acute Central Retinal Artery Occlusion. Stroke. 2020;51:687&#x2013;695. doi: 10.1161/STROKEAHA.119.027478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.119.027478</ArticleId><ArticleId IdType="pubmed">31865896</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33478701</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Renal Denervation for the Management of Refractory Ventricular Arrhythmias: A&#xa0;Systematic&#xa0;Review.</ArticleTitle><Pagination><StartPage>100</StartPage><EndPage>108</EndPage><MedlinePgn>100-108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2020.07.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(20)30701-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The authors performed a systematic review and meta-analysis to determine the efficacy of renal denervation (RDN) in patients with refractory ventricular arrhythmias (VA) or electrical storm (ES).</AbstractText><AbstractText Label="BACKGROUND">Although catheter ablation is efficacious for the treatment of structural heart disease ventricular tachycardia (VT), there are proportion of patients who have refractory VT despite multiple procedures. In this setting, novel adjunctive therapies such as renal denervation have been performed.</AbstractText><AbstractText Label="METHODS">A systematic review of published data was performed. Studies that evaluated patients undergoing RDN for VA or ES were included. Outcome measures of VA, sudden cardiac death, ES, or device therapy were required. Case reports, editorials, and conference presentations were excluded. Random effects meta-analysis was conducted to explore change or final mean values in the study outcomes.</AbstractText><AbstractText Label="RESULTS">A total of 328 articles were identified by the literature search. Seven studies met the eligibility criteria and were included in the systematic review, with a total of 121 pooled patients. The weighted mean age was 63.8 &#xb1; 13.1 years, ejection fraction 30.5 &#xb1; 10.3%, 76% were men, 99% were on a beta blocker, 79% were on amiodarone, 46% had previously undergone catheter ablation, and 8.3% had previously undergone cardiac sympathetic denervation. Meta-analysis demonstrated a significant effect of RDN in reducing implantable cardiac defibrillator therapies, with a standardized mean difference (SMD) of&#xa0;-3.11 (p&#xa0;&lt;&#xa0;0.001). RDN also reduced the number of VA episodes (SMD&#xa0;-2.13; p&#xa0;&lt;&#xa0;0.001), antitachycardia pacing episodes (SMD&#xa0;-2.82; p&#xa0;=&#xa0;0.002), and shocks (SMD&#xa0;-2.82; p&#xa0;=&#xa0;0.002).</AbstractText><AbstractText Label="CONCLUSIONS">RDN is an effective treatment for refractory VAs and ES, although randomized data are lacking.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hawson</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmer</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia; Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowan</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohaib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital and Westmead Applied Research Centre, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Western Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Western Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia; Western Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalman</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital and Westmead Applied Research Centre, Westmead, New South Wales, Australia. Electronic address: saurabh.kumar@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013562" MajorTopicYN="N">Sympathectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">electrical storm</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">renal denervation</Keyword><Keyword MajorTopicYN="N">sudden cardiac death</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmias</Keyword><Keyword MajorTopicYN="N">ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>22</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33478701</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2020.07.019</ArticleId><ArticleId IdType="pii">S2405-500X(20)30701-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28444174</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review.</ArticleTitle><Pagination><StartPage>682</StartPage><EndPage>691</EndPage><MedlinePgn>682-691</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/eux077</ELocationID><Abstract><AbstractText Label="AIMS">Cardiac sarcoidosis (CS) is associated with a poor prognosis. Important features of CS include heart failure, conduction abnormalities, and ventricular arrhythmias. Ventricular tachycardia (VT) is often refractory to antiarrhythmic drugs (AAD) and immunosuppression. Catheter ablation has emerged as a treatment option for recurrent VT. However, data on the efficacy and outcomes of VT ablation in this context are sparse.</AbstractText><AbstractText Label="METHODS AND RESULTS">A systematic search was performed on PubMed, EMBASE, and Cochrane database (from inception to September 2016) with included studies providing a minimum of information on CS patients undergoing VT ablation: age, gender, VT cycle length, CS diagnosis criteria, and baseline medications. Five studies reporting on 83 patients were identified. The mean age of patients was 50&#x2009;&#xb1;&#x2009;8 years, 53/30 (males/females) with a maximum of 56 patients receiving immunosuppressive therapy, mean ejection fraction was 39.1&#x2009;&#xb1;&#x2009;3.1% and 94% had an implantable cardioverter defibrillator in situ. The median number of VTs was 3 (2.6-4.9)/patient, mean cycle length of 360&#x2009;ms (326-400&#x2009;ms). Hundred percent of VTs received endocardial ablation, and 18% required epicardial ablation. The complication rates were 4.7-6.3%. Relapse occurred in 45 (54.2%) patients with an incidence of relapse 0.33 (95% confidence interval 0.108-0.551, P&#x2009;&lt;&#x2009;0.004). Employing a less stringent endpoint (i.e. freedom from arrhythmia or reduction of ventricular arrhythmia burden), 61 (88.4%) patients improved following ablation.</AbstractText><AbstractText Label="CONCLUSIONS">These data support the utilization of catheter ablation in selected CS cases resistant to medical treatment. However, data are derived from observational non-controlled case series, with low-methodological quality. Therefore, future well-designed, randomized controlled trials, or large-scale registries are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Papageorgiou</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Science, University College London, Gower St, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provid&#xea;ncia</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bronis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiology Department, Royal Brompton Hospital, Sydney St, SW3 6NP, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dechering</LastName><ForeName>Dirk G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital of M&#xfc;nster, Albert-Schweitzer-Campus 1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasan</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckardt</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital of M&#xfc;nster, Albert-Schweitzer-Campus 1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambiase</LastName><ForeName>Pier D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Science, University College London, Gower St, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012507" MajorTopicYN="N">Sarcoidosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28444174</ArticleId><ArticleId IdType="doi">10.1093/europace/eux077</ArticleId><ArticleId IdType="pii">3748228</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40401314</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>07</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Epicardial ablation in high-risk Brugada syndrome to prevent ventricular fibrillation: results from a randomized clinical trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">euaf097</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euaf097</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Epicardial ablation for Brugada syndrome (BrS) has shown promise in reducing ventricular fibrillation (VF), but its role remains controversial due to the lack of randomized trials. This study evaluates the efficacy of catheter ablation in high-risk BrS patients.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This prospective, single-centre, randomized (2:1) study enrolled BrS patients with cardiac arrest (CA) or appropriate ICD therapies. All patients had an ICD and were randomized to undergo epicardial ablation (ablation group) or no ablation (control group). Enrolment began in September 2017 and prematurely terminated in February 2024. The primary endpoint was freedom from VF recurrences. Secondary endpoints included procedure safety, ICD-related complications, and quality-of-life assessment. Forty patients (83% male, mean age 43.7 &#xb1; 12.1) were randomized: 26 in the ablation group and 14 in the control group. Thirty-six patients received appropriate ICD therapies before enrolment: 24 (92%) in the ablation group and 12 (86%) in the control group. One patient in the ablation group experienced a post-procedural pericardial effusion requiring pericardiocentesis. Thirteen patients (33%) had major ICD-related complications. After a mean follow-up of 4.0 &#xb1; 1.7 years, freedom from VF recurrence was 96% (25/26) in the ablation group and 50% (7/14) in the control group (P &lt; 0.001). No unexplained or arrhythmic deaths occurred during follow-up.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Epicardial catheter ablation was associated with a reduction in VF recurrence compared with ICD therapy alone. These findings support the use of epicardial ablation in high-risk BrS patients.</AbstractText><AbstractText Label="CLINICALTRIALS.GOV" NlmCategory="BACKGROUND">ID NCT03294278.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pappone</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0901-6135</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University Vita-Salute San Raffaele, Via Olgettina, 58, 20132 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Translational Cardiology (IMTC), Piazza Malan 2, 20097, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciconte</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7886-5467</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University Vita-Salute San Raffaele, Via Olgettina, 58, 20132 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Translational Cardiology (IMTC), Piazza Malan 2, 20097, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicedomini</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Translational Cardiology (IMTC), Piazza Malan 2, 20097, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Micaglio</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8298-7800</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Translational Cardiology (IMTC), Piazza Malan 2, 20097, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boccellino</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3406-2675</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University Vita-Salute San Raffaele, Via Olgettina, 58, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negro</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1531-3504</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannelli</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8141-9476</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rondine</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7143-8902</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Creo</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1545-3427</Identifier><AffiliationInfo><Affiliation>Institute of Molecular and Translational Cardiology (IMTC), Piazza Malan 2, 20097, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantino</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1859-130X</Identifier><AffiliationInfo><Affiliation>Institute of Molecular and Translational Cardiology (IMTC), Piazza Malan 2, 20097, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballarotto</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiolo</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0009-0004-2543-8583</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciaccio</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manuello</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0005-7028-4533</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locati</LastName><ForeName>Emanuela T</ForeName><Initials>ET</Initials><Identifier Source="ORCID">0000-0002-4488-0455</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Translational Cardiology (IMTC), Piazza Malan 2, 20097, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazza</LastName><ForeName>Beniamino C</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0002-8976-6568</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vecchi</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x106;alovi&#x107;</LastName><ForeName>&#x17d;arko</ForeName><Initials>&#x17d;</Initials><Identifier Source="ORCID">0000-0002-3267-9850</Identifier><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, 20097 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anastasia</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0712-2161</Identifier><AffiliationInfo><Affiliation>School of Medicine, University Vita-Salute San Raffaele, Via Olgettina, 58, 20132 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Translational Cardiology (IMTC), Piazza Malan 2, 20097, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03294278</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Agency>Italian Ministry of Health</Agency><Country/></Grant><Grant><Agency>IRCCS Policlinico San Donato</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Europace. 2025 Jun 3;27(6):euaf116. doi: 10.1093/europace/euaf116.</RefSource><PMID Version="1">40590688</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053840" MajorTopicYN="Y">Brugada Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010496" MajorTopicYN="Y">Pericardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="N">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmogenic substrate</Keyword><Keyword MajorTopicYN="N">Brugada syndrome</Keyword><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Epicardium</Keyword><Keyword MajorTopicYN="N">ICD</Keyword><Keyword MajorTopicYN="N">Ventricular fibrillation</Keyword></KeywordList><CoiStatement>Conflict of interest: The authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>22</Day><Hour>4</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40401314</ArticleId><ArticleId IdType="pmc">PMC12096002</ArticleId><ArticleId IdType="doi">10.1093/europace/euaf097</ArticleId><ArticleId IdType="pii">8140360</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zeppenfeld &#xa0;K, Tfelt-Hansen &#xa0;J, de Riva &#xa0;M, Winkel &#xa0;BG, Behr &#xa0;ER, Blom &#xa0;NA &#xa0;et al. &#xa0;2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J &#xa0;2022;43:3997&#x2013;4126.</Citation><ArticleIdList><ArticleId IdType="pubmed">36017572</ArticleId></ArticleIdList></Reference><Reference><Citation>Konemann &#xa0;H, Dagres &#xa0;N, Merino &#xa0;JL, Sticherling &#xa0;C, Zeppenfeld &#xa0;K, Tfelt-Hansen &#xa0;J &#xa0;et al. Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects. Europace &#xa0;2023;25:euad091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10228619</ArticleId><ArticleId IdType="pubmed">37102266</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Werf &#xa0;C, Postema &#xa0;PG. The psychological impact of receiving a Brugada syndrome diagnosis. Europace &#xa0;2023;25:euad293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10540668</ArticleId><ArticleId IdType="pubmed">37738638</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst &#xa0;V, Plassard-Kerdoncuf &#xa0;D, Mansourati &#xa0;J, Mabo &#xa0;P, Sacher &#xa0;F, Fruchet &#xa0;C &#xa0;et al. &#xa0;The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients. Europace &#xa0;2011;13:1034&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21427091</ArticleId></ArticleIdList></Reference><Reference><Citation>Andorin &#xa0;A, Gourraud &#xa0;JB, Mansourati &#xa0;J, Fouchard &#xa0;S, le Marec &#xa0;H, Maury &#xa0;P &#xa0;et al. &#xa0;The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk. Heart Rhythm &#xa0;2017;14:1147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">28411139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nademanee &#xa0;K, Veerakul &#xa0;G, Chandanamattha &#xa0;P, Chaothawee &#xa0;L, Ariyachaipanich &#xa0;A, Jirasirirojanakorn &#xa0;K &#xa0;et al. &#xa0;Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation &#xa0;2011;123:1270&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21403098</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugada &#xa0;J, Pappone &#xa0;C, Berruezo &#xa0;A, Vicedomini &#xa0;G, Manguso &#xa0;F, Ciconte &#xa0;G &#xa0;et al. &#xa0;Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ Arrhythm Electrophysiol &#xa0;2015;8:1373&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">26291334</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappone &#xa0;C, Brugada &#xa0;J, Vicedomini &#xa0;G, Ciconte &#xa0;G, Manguso &#xa0;F, Saviano &#xa0;M &#xa0;et al. &#xa0;Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ Arrhythm Electrophysiol &#xa0;2017;10:e005053.</Citation><ArticleIdList><ArticleId IdType="pubmed">28500178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nademanee &#xa0;K, Chung &#xa0;FP, Sacher &#xa0;F, Nogami &#xa0;A, Nakagawa &#xa0;H, Jiang &#xa0;C &#xa0;et al. &#xa0;Long-term outcomes of Brugada substrate ablation: a report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry). Circulation &#xa0;2023;147:1568&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">36960730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciconte &#xa0;G, Monasky &#xa0;MM, Santinelli &#xa0;V, Micaglio &#xa0;E, Vicedomini &#xa0;G, Anastasia &#xa0;L &#xa0;et al. &#xa0;Brugada syndrome genetics is associated with phenotype severity. Eur Heart J &#xa0;2021;42:1082&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955973</ArticleId><ArticleId IdType="pubmed">33221895</ArticleId></ArticleIdList></Reference><Reference><Citation>Nademanee &#xa0;K, Haissaguerre &#xa0;M, Hocini &#xa0;M, Nogami &#xa0;A, Cheniti &#xa0;G, Duchateau &#xa0;J &#xa0;et al. &#xa0;Mapping and ablation of ventricular fibrillation associated with early repolarization syndrome. Circulation &#xa0;2019;140:1477&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">31542949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappone &#xa0;C, Ciconte &#xa0;G, Manguso &#xa0;F, Vicedomini &#xa0;G, Mecarocci &#xa0;V, Conti &#xa0;M &#xa0;et al. &#xa0;Assessing the malignant ventricular arrhythmic substrate in patients with Brugada syndrome. J Am Coll Cardiol &#xa0;2018;71:1631&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">29650119</ArticleId></ArticleIdList></Reference><Reference><Citation>Santinelli &#xa0;V, Ciconte &#xa0;G, Manguso &#xa0;F, Anastasia &#xa0;L, Micaglio &#xa0;E, Calovic &#xa0;Z &#xa0;et al. &#xa0;High-risk Brugada syndrome: factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation. Europace &#xa0;2023;26:euae019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10824473</ArticleId><ArticleId IdType="pubmed">38252933</ArticleId></ArticleIdList></Reference><Reference><Citation>Behr &#xa0;ER, Winkel &#xa0;BG, Ensam &#xa0;B, Alfie &#xa0;A, Arbelo &#xa0;E, Berry &#xa0;C &#xa0;et al. &#xa0;The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric &amp; Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace &#xa0;2025;27:euaf067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12018878</ArticleId><ArticleId IdType="pubmed">40165484</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst &#xa0;V, Veltmann &#xa0;C, Eckardt &#xa0;L, Meregalli &#xa0;PG, Gaita &#xa0;F, Tan &#xa0;HL &#xa0;et al. &#xa0;Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. Circulation &#xa0;2010;121:635&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">20100972</ArticleId></ArticleIdList></Reference><Reference><Citation>Anguera &#xa0;I, Garcia-Alberola &#xa0;A, Dallaglio &#xa0;P, Toquero &#xa0;J, Perez &#xa0;L, Martinez &#xa0;JG &#xa0;et al. &#xa0;Shock reduction with long-term quinidine in patients with Brugada syndrome and malignant ventricular arrhythmia episodes. J Am Coll Cardiol &#xa0;2016;67:1653&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">27150692</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte &#xa0;G, Sieira &#xa0;J, Ciconte &#xa0;G, de Asmundis &#xa0;C, Chierchia &#xa0;GB, Baltogiannis &#xa0;G &#xa0;et al. &#xa0;Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. J Am Coll Cardiol &#xa0;2015;65:879&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">25744005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Ojeda &#xa0;J, Arbelo &#xa0;E, Borras &#xa0;R, Berne &#xa0;P, Tolosana &#xa0;JM, Gomez-Juanatey &#xa0;A &#xa0;et al. &#xa0;Patients with Brugada syndrome and implanted cardioverter-defibrillators: long-term follow-up. J Am Coll Cardiol &#xa0;2017;70:1991&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">29025556</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieira &#xa0;J, Conte &#xa0;G, Ciconte &#xa0;G, Chierchia &#xa0;GB, Casado-Arroyo &#xa0;R, Baltogiannis &#xa0;G &#xa0;et al. &#xa0;A score model to predict risk of events in patients with Brugada syndrome. Eur Heart J &#xa0;2017;38:1756&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28379344</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagata &#xa0;K, Horie &#xa0;M, Aiba &#xa0;T, Ogawa &#xa0;S, Aizawa &#xa0;Y, Ohe &#xa0;T &#xa0;et al. &#xa0;Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome: a Japanese Multicenter Registry. Circulation &#xa0;2017;135:2255&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28341781</ArticleId></ArticleIdList></Reference><Reference><Citation>Milman &#xa0;A, Hochstadt &#xa0;A, Andorin &#xa0;A, Gourraud &#xa0;JB, Sacher &#xa0;F, Mabo &#xa0;P &#xa0;et al. &#xa0;Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS). Europace &#xa0;2019;21:796&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">30590530</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotti &#xa0;L, Brugada &#xa0;P, Calkins &#xa0;H, Chevalier &#xa0;P, Conte &#xa0;G, Finocchiaro &#xa0;G &#xa0;et al. &#xa0;From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies. Europace &#xa0;2023;25:euad180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10450790</ArticleId><ArticleId IdType="pubmed">37622577</ArticleId></ArticleIdList></Reference><Reference><Citation>Jespersen &#xa0;CHB, Kroll &#xa0;J, Bhardwaj &#xa0;P, Winkel &#xa0;BG, Jacobsen &#xa0;PK, Jons &#xa0;C &#xa0;et al. &#xa0;Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study. Europace &#xa0;2023;25:euad112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10228627</ArticleId><ArticleId IdType="pubmed">37129985</ArticleId></ArticleIdList></Reference><Reference><Citation>Olde Nordkamp &#xa0;LR, Postema &#xa0;PG, Knops &#xa0;RE, van Dijk &#xa0;N, Limpens &#xa0;J, Wilde &#xa0;AA &#xa0;et al. &#xa0;Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm &#xa0;2016;13:443&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">26385533</ArticleId></ArticleIdList></Reference><Reference><Citation>Behr &#xa0;ER, Conte &#xa0;G, Wilde &#xa0;A. Is right ventricular outflow tract epicardial substrate ablation the standard of care in high-risk Brugada syndrome? &#xa0;Europace &#xa0;2023;26:euae020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10824472</ArticleId><ArticleId IdType="pubmed">38252938</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;L, Ding &#xa0;L, Zhou &#xa0;L, Wu &#xa0;L, Zheng &#xa0;L, Zhang &#xa0;Z &#xa0;et al. &#xa0;Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation. Europace &#xa0;2023;26:euae249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10754161</ArticleId><ArticleId IdType="pubmed">37889958</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte &#xa0;G, Probst &#xa0;V. Time to consider catheter ablation as an alternative to implantable cardioverter-defibrillator therapy in high-risk patients with Brugada syndrome? &#xa0;Europace &#xa0;2023;25:euad338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10751804</ArticleId><ArticleId IdType="pubmed">37949829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung &#xa0;R, Xue &#xa0;Y, Chen &#xa0;M, Jiang &#xa0;C, Shatz &#xa0;DY, Besser &#xa0;SA &#xa0;et al. &#xa0;First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial. Circulation &#xa0;2022;145:1839&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">35507499</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35451610</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1861-0692</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical research in cardiology : official journal of the German Cardiac Society</Title><ISOAbbreviation>Clin Res Cardiol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of catheter ablation for Brugada syndrome: an updated systematic review.</ArticleTitle><Pagination><StartPage>1715</StartPage><EndPage>1726</EndPage><MedlinePgn>1715-1726</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00392-022-02020-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with Brugada syndrome (BrS) may experience recurrent ventricular arrhythmias (VAs). Catheter ablation is becoming an emerging paradigm for treatment of BrS.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the efficacy and safety of catheter ablation in BrS in an updated systematic review.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We comprehensively searched the databases of Pubmed/Medline, EMBASE, and Cochrane Central Register of Controlled Trials from inception to 11th of August 2021.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-six studies involving 388 patients were included. A substrate-based strategy was used in 338 cases (87%), and a strategy of targeting premature ventricular complex (PVCs)/ventricular tachycardias (VTs) that triggered ventricular fibrillation (VF) in 47 cases (12%), with combined abnormal electrogram and PVC/VT ablation in 3 cases (1%). Sodium channel blocker was frequently used to augment the arrhythmogenic substrate in 309/388 cases (80%), which included a variety of agents, of which ajmaline was most commonly used. After ablation procedure, the pooled incidence of non-inducibility of VA was 87.1% (95% confidence interval [CI], 73.4-94.3; I<sup>2</sup>&#x2009;=&#x2009;51%), and acute resolution of type I ECG was seen in 74.5% (95% CI [52.3-88.6]; I<sup>2</sup>&#x2009;=&#x2009;75%). Over a weighted mean follow up of 28&#xa0;months, 7.6% (95% CI [2.1-24]; I<sup>2</sup>&#x2009;=&#x2009;67%) had recurrence of type I ECG either spontaneously or with drug challenge and 17.6% (95% CI [10.2-28.6]; I<sup>2</sup>&#x2009;=&#x2009;60%) had recurrence of VA.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Catheter ablation appears to be an efficacious strategy for elimination of arrhythmias or substrate associated with BrS. Further study is needed to identify which patients stand to benefit, and optimal provocation protocol for identifying ablation targets.</AbstractText><CopyrightInformation>&#xa9; 2022. Crown.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kotake</LastName><ForeName>Yasuhito</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Westmead Applied Research Centre, University of Sydney, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barua</LastName><ForeName>Sumita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazi</LastName><ForeName>Samia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohaib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhaskaran</LastName><ForeName>Ashwin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Westmead Applied Research Centre, University of Sydney, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Westmead Applied Research Centre, University of Sydney, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Westmead Applied Research Centre, University of Sydney, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5643-5076</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia. saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Westmead Applied Research Centre, University of Sydney, Westmead, NSW, Australia. saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Res Cardiol</MedlineTA><NlmUniqueID>101264123</NlmUniqueID><ISSNLinking>1861-0684</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Clin Res Cardiol. 2023 Jun;112(6):853. doi: 10.1007/s00392-022-02038-7.</RefSource><PMID Version="1">35652966</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053840" MajorTopicYN="Y">Brugada Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018879" MajorTopicYN="Y">Ventricular Premature Complexes</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abnormal substrate</Keyword><Keyword MajorTopicYN="N">Brugada syndrome</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Provocation strategy</Keyword></KeywordList><CoiStatement>Dr. Kumar has received research grants from Abbott Medical and Biotronik; he has received honoraria from Biosense Webster, Abbott Medical, Biotronik, and Sanofi Aventis. Mr Campbell has received speakers Honoria from Biosense Webster. All other authors have reported no other relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>12</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35451610</ArticleId><ArticleId IdType="pmc">PMC10698106</ArticleId><ArticleId IdType="doi">10.1007/s00392-022-02020-3</ArticleId><ArticleId IdType="pii">10.1007/s00392-022-02020-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932&#x2013;1963. doi: 10.1016/j.hrthm.2013.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2013.05.014</ArticleId><ArticleId IdType="pubmed">24011539</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julia J, Pappaert G, Brugada P. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. J Am Coll Cardiol. 2015;65(9):879&#x2013;888. doi: 10.1016/j.jacc.2014.12.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.12.031</ArticleId><ArticleId IdType="pubmed">25744005</ArticleId></ArticleIdList></Reference><Reference><Citation>Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, Likittanasombat K, Bhuripanyo K, Ngarmukos T. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123(12):1270&#x2013;1279. doi: 10.1161/CIRCULATIONAHA.110.972612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.972612</ArticleId><ArticleId IdType="pubmed">21403098</ArticleId></ArticleIdList></Reference><Reference><Citation>Nademanee K, Raju H, de Noronha SV, Papadakis M, Robinson L, Rothery S, Makita N, Kowase S, Boonmee N, Vitayakritsirikul V, Ratanarapee S, Sharma S, van der Wal AC, Christiansen M, Tan HL, Wilde AA, Nogami A, Sheppard MN, Veerakul G, Behr ER. Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome. J Am Coll Cardiol. 2015;66(18):1976&#x2013;1986. doi: 10.1016/j.jacc.2015.08.862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.08.862</ArticleId><ArticleId IdType="pmc">PMC4631798</ArticleId><ArticleId IdType="pubmed">26516000</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugada J, Pappone C, Berruezo A, Vicedomini G, Manguso F, Ciconte G, Giannelli L, Santinelli V. Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ Arrhythm Electrophysiol. 2015;8(6):1373&#x2013;1381. doi: 10.1161/CIRCEP.115.003220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.115.003220</ArticleId><ArticleId IdType="pubmed">26291334</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappone C, Brugada J, Vicedomini G, Ciconte G, Manguso F, Saviano M, Vitale R, Cuko A, Giannelli L, Calovic Z, Conti M, Pozzi P, Natalizia A, Crisa S, Borrelli V, Brugada R, Sarquella-Brugada G, Guazzi M, Frigiola A, Menicanti L, Santinelli V. Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ Arrhythm Electrophysiol. 2017;10(5):e005053. doi: 10.1161/CIRCEP.117.005053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.117.005053</ArticleId><ArticleId IdType="pubmed">28500178</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelke A, Tachil A, Saggu D, Jesuraj ML, Yalagudri S, Narasimhan C. Catheter ablation for electrical storm in Brugada syndrome: results of substrate based ablation. Indian Heart J. 2018;70(2):296&#x2013;302. doi: 10.1016/j.ihj.2017.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ihj.2017.07.019</ArticleId><ArticleId IdType="pmc">PMC5993914</ArticleId><ArticleId IdType="pubmed">29716710</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Tung R, Zhang Z, Sheng X, Liu Q, Jiang R, Sun Y, Chen S, Yu L, Ye Y, Fu G, Shivkumar K, Jiang C. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. Heart Rhythm. 2016;13(11):2151&#x2013;2158. doi: 10.1016/j.hrthm.2016.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2016.07.025</ArticleId><ArticleId IdType="pubmed">27453126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunsaneewitayakul B, Yao Y, Thamaree S, Zhang S. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome. J Cardiovasc Electrophysiol. 2012;23(Suppl 1):S10&#x2013;S16. doi: 10.1111/j.1540-8167.2012.02433.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2012.02433.x</ArticleId><ArticleId IdType="pubmed">22988965</ArticleId></ArticleIdList></Reference><Reference><Citation>Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA, Farre J, Leenhardt A, Sanders P, Scavee C, Hsu LF, Weerasooriya R, Shah DC, Frank R, Maury P, Delay M, Garrigue S, Clementy J. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation. 2003;108(8):925&#x2013;928. doi: 10.1161/01.CIR.0000088781.99943.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000088781.99943.95</ArticleId><ArticleId IdType="pubmed">12925452</ArticleId></ArticleIdList></Reference><Reference><Citation>Talib AK, Takagi M, Shimane A, Nakano M, Hayashi T, Okajima K, Kentaro M, Fukada K, Kowase S, Kurosaki K, Nitta J, Nishizaki M, Yui Y, Talib A, Sato N, Kawamura Y, Hasebe N, Aita S, Sai E, Komatsu Y, Kuroki K, Kaneshiro T, Dongzu X, Tajiri K, Igarashi M, Yamasaki H, Murakoshi N, Kumagai K, Sekiguchi Y, Nogami A, Aonuma K. Efficacy of endocardial ablation of drug-resistant ventricular fibrillation in Brugada syndrome: long-term outcome. Circ Arrhythm Electrophysiol. 2018;11(8):e005631. doi: 10.1161/CIRCEP.117.005631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.117.005631</ArticleId><ArticleId IdType="pubmed">30354308</ArticleId></ArticleIdList></Reference><Reference><Citation>Salghetti F, de Asmundis C, Sieira J, Coutino HE, Abugattas JP, Varnavas V, Maj R, Terasawa M, Guimaraes Osorio T, Stroker E, Capulzini L, Iacopino S, Paparella G, Umbrain V, Poelaert J, Van Dooren S, Brugada P, Chierchia GB, La Meir M. Hybrid thoracoscopic epicardial ablation of right ventricular outflow tract in patients with Brugada syndrome. Heart Rhythm. 2019;16(6):879&#x2013;887. doi: 10.1016/j.hrthm.2018.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2018.12.026</ArticleId><ArticleId IdType="pubmed">30594641</ArticleId></ArticleIdList></Reference><Reference><Citation>Haanschoten DM, Elvan A, Postema PG, Smit JJJ, Adiyaman A, Ter Bekke RMA, Asaad N, Aanhaanen WTJ, Misier ARR, Delnoy P, Crijns H, Wilde AAM. Catheter ablation in highly symptomatic Brugada patients: a dutch case series. Clin Res Cardiol. 2020;109(5):560&#x2013;569. doi: 10.1007/s00392-019-01540-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-019-01540-9</ArticleId><ArticleId IdType="pubmed">31478073</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung FP, Raharjo SB, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chao TF, Liao JN, Lin CY, Chang YT, Hung Y, Te A, Yamada S, Tasaka H, Wang CT, Chen SA. A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome. Heart Rhythm. 2017;14(4):508&#x2013;517. doi: 10.1016/j.hrthm.2017.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2017.01.006</ArticleId><ArticleId IdType="pubmed">28065832</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokioka S, Fukamizu S, Kitamura T, Miyazawa S, Kawamura I, Hojo R, Sakurada H, Hiraoka M. Catheter ablation for monomorphic ventricular tachycardia in Brugada syndrome patients: detailed characteristics and long-term follow-up. J Interv Card Electrophysiol. 2020;57(1):97&#x2013;103. doi: 10.1007/s10840-019-00620-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-019-00620-0</ArticleId><ArticleId IdType="pubmed">31606866</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamiya K, Inden Y, Yanagisawa S, Fujii A, Tomomatsu T, Okamoto H, Riku S, Suga K, Furui K, Nakagomi T, Shibata R, Murohara T. Dynamic changes in electrocardiogram parameters after epicardial substrate catheter ablation of Brugada syndrome. Circ J. 2021;85(8):1283&#x2013;1293. doi: 10.1253/circj.CJ-20-1060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-20-1060</ArticleId><ArticleId IdType="pubmed">33692251</ArticleId></ArticleIdList></Reference><Reference><Citation>Chokesuwattanaskul R, Nademanee K. Role of catheter ablation for ventricular arrhythmias in Brugada syndrome. Curr Cardiol Rep. 2021;23(5):54. doi: 10.1007/s11886-021-01479-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-021-01479-2</ArticleId><ArticleId IdType="pmc">PMC8068636</ArticleId><ArticleId IdType="pubmed">33893882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamakura T, Cochet H, Juhoor M, Nakatani Y, Ramirez FD, Andre C, Nakashima T, Krisai P, Takagi T, Tixier R, Chauvel R, Cheniti G, Duchateau J, Pambrun T, Derval N, Kusano K, Sacher F, Jais P, Haissaguerre M, Hocini M. Role of endocardial ablation in eliminating an epicardial arrhythmogenic substrate in patients with Brugada syndrome. Heart Rhythm. 2021 doi: 10.1016/j.hrthm.2021.06.1188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.06.1188</ArticleId><ArticleId IdType="pubmed">34182174</ArticleId></ArticleIdList></Reference><Reference><Citation>Negroni MS, Bacchioni G, Dello Russo A, Gianni C. Inducibility of ventricular arrhythmias after gastric distension: the catecholamine equivalent in Brugada syndrome ablation? Heart Rhythm. 2013;10(10):1549&#x2013;1552. doi: 10.1016/j.hrthm.2013.07.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2013.07.032</ArticleId><ArticleId IdType="pubmed">23891955</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Morita H, Kawada S, Tachibana M, Morimoto Y, Ito H. Open chest epicardial mapping in an asymptomatic patient with Brugada syndrome. Heart Rhythm Case Rep. 2019;5(10):501&#x2013;504. doi: 10.1016/j.hrcr.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2019.07.003</ArticleId><ArticleId IdType="pmc">PMC6831756</ArticleId><ArticleId IdType="pubmed">31700794</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha SA, Krishnan K, Madias C, Trohman RG. Combined right ventricular outflow tract epicardial and endocardial late potential ablation for treatment of brugada storm: a case report and review of the literature. Cardiol Ther. 2016;5(2):229&#x2013;243. doi: 10.1007/s40119-016-0072-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-016-0072-4</ArticleId><ArticleId IdType="pmc">PMC5125114</ArticleId><ArticleId IdType="pubmed">27646458</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez-Dias N, Placido R, Marta L, Bernardes A, Sobral S, Carpinteiro L, de Sousa J. Epicardial ablation for prevention of ventricular fibrillation in a patient with Brugada syndrome. Rev Port Cardiol. 2014;33(5):305 e1&#x2013;7. doi: 10.1016/j.repc.2014.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.repc.2014.01.010</ArticleId><ArticleId IdType="pubmed">24931179</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeplaki G, Ozcan EE, Osztheimer I, Tahin T, Merkely B, Geller L. Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with Brugada syndrome refusing implantable cardioverter defibrillator therapy. Can J Cardiol. 2014;30(10):1249 e9&#x2013;e11. doi: 10.1016/j.cjca.2014.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2014.05.019</ArticleId><ArticleId IdType="pubmed">25262866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacher F, Jesel L, Jais P, Haissaguerre M. Insight into the mechanism of Brugada syndrome: epicardial substrate and modification during ajmaline testing. Heart Rhythm. 2014;11(4):732&#x2013;734. doi: 10.1016/j.hrthm.2013.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2013.05.023</ArticleId><ArticleId IdType="pubmed">23732228</ArticleId></ArticleIdList></Reference><Reference><Citation>Forkmann M, Tomala J, Huo Y, Mayer J, Christoph M, Wunderlich C, Salmas J, Gaspar T, Piorkowski C. Epicardial ventricular tachycardia ablation in a patient with Brugada ECG pattern and mutation of PKP2 and DSP genes. Circ Arrhythm Electrophysiol. 2015;8(2):505&#x2013;507. doi: 10.1161/CIRCEP.114.002342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.114.002342</ArticleId><ArticleId IdType="pubmed">25900994</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda S, Yokoyama Y, Chik WW, Soejima K, Hirao K. First case of epicardial ablation to coexistent J waves in the inferior leads in a patient with clinical diagnosis of Brugada syndrome. Heart Rhythm Case Rep. 2015;1(2):82&#x2013;84. doi: 10.1016/j.hrcr.2015.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2015.01.012</ArticleId><ArticleId IdType="pmc">PMC5418547</ArticleId><ArticleId IdType="pubmed">28491517</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Melchor L, Brugada J, Martinez-Sande JL, Garcia-Seara J, Fernandez-Lopez JA, Pappone C, Gonzalez-Juanatey JR. Epicardial mapping and ablation of the right ventricle substrate during flecainide testing in Brugada syndrome. Heart Rhythm Case Rep. 2016;2(1):52&#x2013;56. doi: 10.1016/j.hrcr.2015.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2015.09.005</ArticleId><ArticleId IdType="pmc">PMC5412659</ArticleId><ArticleId IdType="pubmed">28491631</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, Yin X, Dong C, Xia Y, Liu J. Epicardial radiofrequency catheter ablation of Brugada syndrome with electrical storm during ventricular fibrillation: a case report. Medicine (Baltimore) 2017;96(46):e8688. doi: 10.1097/MD.0000000000008688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000008688</ArticleId><ArticleId IdType="pmc">PMC5704848</ArticleId><ArticleId IdType="pubmed">29145303</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger K, Steinfurt J, Lenz C, Keweloh B. Catheter ablation of Brugada syndrome: importance of repeated administration of ajmaline to unmask the entire epicardial substrate. JACC Clin Electrophysiol. 2017;3(11):1330&#x2013;1332. doi: 10.1016/j.jacep.2017.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2017.02.014</ArticleId><ArticleId IdType="pubmed">29759632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A, Kohler H, Wright D, Haqqani HM. Epicardial Brugada syndrome ablation unmasking inferior J waves. Pacing Clin Electrophysiol. 2017;40(11):1308&#x2013;1312. doi: 10.1111/pace.13095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.13095</ArticleId><ArticleId IdType="pubmed">28436550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim PCY, Nademanee K, Lee ECY, Teo WS. Epicardial ablation utilizing remote magnetic navigation in a patient with Brugada syndrome and inferior early repolarization. Pacing Clin Electrophysiol. 2018;41(2):214&#x2013;217. doi: 10.1111/pace.13175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.13175</ArticleId><ArticleId IdType="pubmed">28842979</ArticleId></ArticleIdList></Reference><Reference><Citation>Providencia R, Carmo P, Moscoso Costa F, Cavaco D, Morgado F, Scanavacca M, Adragao P. Brugada syndrome is associated with scar and endocardial involvement: Insights from high-density mapping with the Rhythmia mapping system. Rev Port Cardiol. 2017;36(10):773.e1&#x2013;e4. doi: 10.1016/j.repc.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.repc.2017.08.004</ArticleId><ArticleId IdType="pubmed">29050870</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Morita H, Tsushima S, Nakagawa K, Nishii N, Ito H. Recording of isolated very delayed potentials on the right ventricular epicardium in a patient with Brugada syndrome. HeartRhythm Case Rep. 2017;3(7):344&#x2013;347. doi: 10.1016/j.hrcr.2017.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2017.05.001</ArticleId><ArticleId IdType="pmc">PMC5511986</ArticleId><ArticleId IdType="pubmed">28748141</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkle G, Schafer H, Marschall C, Brugada P, Ehrlich JR. Pharmacological provocation of outflow-tract tachycardia in a patient with Brugada syndrome. Can J Cardiol. 2016;32(12):1577 e5&#x2013;e7. doi: 10.1016/j.cjca.2016.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2016.01.026</ArticleId><ArticleId IdType="pubmed">27032887</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauber PE, Mansilla V, Mercau G, Albano F, Corbalan RR, Sanchez SS, Honore SM. Correlation between functional and ultrastructural substrate in Brugada syndrome. HeartRhythm Case Rep. 2016;2(3):211&#x2013;216. doi: 10.1016/j.hrcr.2015.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2015.12.001</ArticleId><ArticleId IdType="pmc">PMC5419737</ArticleId><ArticleId IdType="pubmed">28491672</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki H, Tada H, Sekiguchi Y, Aonuma K. Right coronary cusp as a new window of ablation for pilsicainide-induced ventricular premature contractions in a patient with Brugada syndrome. Heart Vessels. 2016;31(8):1397&#x2013;1401. doi: 10.1007/s00380-015-0760-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-015-0760-3</ArticleId><ArticleId IdType="pubmed">26510553</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto M, Sato M, Kitazawa H, Komatsu Y, Fuse K, Takahashi M, Okabe M, Yamashina A, Aizawa Y. Brugada syndrome combined with monomorphic ventricular tachycardia and atrioventricular nodal reentrant tachycardia. Intern Med. 2015;54(10):1223&#x2013;1226. doi: 10.2169/internalmedicine.54.3250.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.54.3250</ArticleId><ArticleId IdType="pubmed">25986260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T, Nitta J, Goya M, Isobe M, Hirao K. Endocardial-only catheter ablation with substantial improvement in ventricular fibrillation recurrences in a patient with Brugada syndrome. HeartRhythm Case Rep. 2016;2(5):428&#x2013;431. doi: 10.1016/j.hrcr.2016.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2016.06.007</ArticleId><ArticleId IdType="pmc">PMC5419967</ArticleId><ArticleId IdType="pubmed">28491726</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarstefano P, Pieroni M, Guida R, Rio T, Oliva A, Grotti S, Fraticelli A, Bolognese L. Progression of electroanatomic substrate and electric storm recurrence in a patient with Brugada syndrome. Circulation. 2015;131(9):838&#x2013;841. doi: 10.1161/CIRCULATIONAHA.114.013773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.013773</ArticleId><ArticleId IdType="pubmed">25737504</ArticleId></ArticleIdList></Reference><Reference><Citation>Talib AK, Yui Y, Kaneshiro T, Sekiguchi Y, Nogami A, Aonuma K. Alternative approach for management of an electrical storm in Brugada syndrome: importance of primary ablation within a narrow time window. J Arrhythm. 2016;32(3):220&#x2013;222. doi: 10.1016/j.joa.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joa.2015.12.008</ArticleId><ArticleId IdType="pmc">PMC4913161</ArticleId><ArticleId IdType="pubmed">27354869</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarzadeh M, Haghjoo M. Monomorphic ventricular tachycardia originating from right ventricular outflow tract as a trigger for the recurrent ventricular fibrillation in a patient with Brugada syndrome. Res Cardiovasc Med. 2014;3(2):e17113. doi: 10.5812/cardiovascmed.17113.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/cardiovascmed.17113</ArticleId><ArticleId IdType="pmc">PMC4253787</ArticleId><ArticleId IdType="pubmed">25478533</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinek M, Purerfellner H. A phenotypic combination of idiopathic VF and Brugada syndrome. Pacing Clin Electrophysiol. 2010;33(9):e84&#x2013;e87. doi: 10.1111/j.1540-8159.2010.02715.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2010.02715.x</ArticleId><ArticleId IdType="pubmed">20230473</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa E, Takagi M, Tatsumi H, Yoshiyama M. Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome. Circ J. 2008;72(6):1025&#x2013;1029. doi: 10.1253/circj.72.1025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.72.1025</ArticleId><ArticleId IdType="pubmed">18503235</ArticleId></ArticleIdList></Reference><Reference><Citation>Darmon JP, Bettouche S, Deswardt P, Tiger F, Ricard P, Bernasconi F, Saoudi N. Radiofrequency ablation of ventricular fibrillation and multiple right and left atrial tachycardia in a patient with Brugada syndrome. J Interv Card Electrophysiol. 2004;11(3):205&#x2013;209. doi: 10.1023/B:JICE.0000048571.19462.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:JICE.0000048571.19462.54</ArticleId><ArticleId IdType="pubmed">15548887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazur A, Iakobishvili Z, Kusniec J, Strasberg B. Bundle branch reentrant ventricular tachycardia in a patient with the Brugada electrocardiographic pattern. Ann Noninvasive Electrocardiol. 2003;8(4):352&#x2013;355. doi: 10.1046/j.1542-474x.2003.08414.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1542-474x.2003.08414.x</ArticleId><ArticleId IdType="pmc">PMC7312935</ArticleId><ArticleId IdType="pubmed">14516293</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Q, Yang B, Chen M, Zou J, Chen C, Xu D, Cao K. Short-term normalization of ventricular repolarization by transcatheter ablation in a patient with suspected Brugada syndrome. J Interv Card Electrophysiol. 2008;21(1):53&#x2013;57. doi: 10.1007/s10840-007-9193-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-007-9193-y</ArticleId><ArticleId IdType="pubmed">18299974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueyama T, Shimizu A, Esato M, Yoshiga Y, Sawa A, Suzuki S, Sugi N, Matsuzaki M. Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia. Europace. 2008;10(1):86&#x2013;90. doi: 10.1093/europace/eum244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eum244</ArticleId><ArticleId IdType="pubmed">18037690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hluchy J, Prull MW, Berndt C, Brandts B. Catheter ablation of ventricular ectopy originating from the left fascicular conduction system triggering polymorphic ventricular tachycardia in Brugada syndrome. HeartRhythm Case Rep. 2019;5(6):294&#x2013;298. doi: 10.1016/j.hrcr.2019.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2019.02.009</ArticleId><ArticleId IdType="pmc">PMC6587029</ArticleId><ArticleId IdType="pubmed">31249782</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YM, Cha MS, Choi H, Kang WC, Han SH, Choi IS, Shin EK, Kim YH. Early response after catheter ablation of the epicardial substrate in a patient with Brugada syndrome can be predicted by high precordial leads. Case Rep Cardiol. 2018;2018:5980380. doi: 10.1155/2018/5980380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5980380</ArticleId><ArticleId IdType="pmc">PMC5949194</ArticleId><ArticleId IdType="pubmed">29854472</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AJ, Hocini M, Lamaison D, Sacher F, Derval N, Haissaguerre M. Regional substrate ablation abolishes Brugada syndrome. J Cardiovasc Electrophysiol. 2011;22(11):1290&#x2013;1291. doi: 10.1111/j.1540-8167.2011.02054.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2011.02054.x</ArticleId><ArticleId IdType="pubmed">21457386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamakura T, Duchateau J, Sacher F, Jais P, Haissaguerre M, Hocini M. Dormant conduction in the right ventricular outflow tract unmasked by adenosine in a patient with Brugada syndrome. J Cardiovasc Electrophysiol. 2021;32(4):1182&#x2013;1186. doi: 10.1111/jce.14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14974</ArticleId><ArticleId IdType="pubmed">33634535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamakura T, Cetran L, Sacher F, Hocini M, Duchateau J. A case of anomalous aortic origin of coronary artery associated with a coved-type electrocardiogram. J Cardiovasc Electrophysiol. 2021;32(2):554&#x2013;557. doi: 10.1111/jce.14872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14872</ArticleId><ArticleId IdType="pubmed">33421212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabeshima T, Sumitomo N, Muraji S, Mori H, Yokoyama S, Miura M. Successful endocardial catheter ablation of a drug-resistant monomorphic ventricular tachycardia in a child with Brugada syndrome. HeartRhythm Case Rep. 2020;6(9):641&#x2013;645. doi: 10.1016/j.hrcr.2020.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2020.06.011</ArticleId><ArticleId IdType="pmc">PMC7498634</ArticleId><ArticleId IdType="pubmed">32983884</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco C, Galli A, Chierchia GB, Cecchini F, La Meir M, Brugada P, de Asmundis C. Concomitant thoracoscopic left cardiac sympathectomy and RVOT epicardial ablation of the arrhythmogenic substrate in a patient with Long QT and Brugada syndromes related to uncommon sodium channel beta-subunit mutation. Pacing Clin Electrophysiol. 2021;44(7):1282&#x2013;1286. doi: 10.1111/pace.14215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14215</ArticleId><ArticleId IdType="pubmed">33687741</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin D, Bode WD, Heist EK, Lubitz SA, Santangeli P, Ruskin J, Mansour M. Catheter ablation for Brugada syndrome. J Innov Card Rhythm Manag. 2021;12(5):4520&#x2013;4524. doi: 10.19102/icrm.2021.120502.</Citation><ArticleIdList><ArticleId IdType="doi">10.19102/icrm.2021.120502</ArticleId><ArticleId IdType="pmc">PMC8139310</ArticleId><ArticleId IdType="pubmed">34035984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel O, Gamal W, Tarek A, Ibrahim W, Sayed M, Brugada J, Moreno J. Ablation of a life-threatening arrhythmia in a patient with Brugada syndrome. Glob Cardiol Sci Pract. 2021;2021(1):e202104. doi: 10.21542/gcsp.2021.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.21542/gcsp.2021.4</ArticleId><ArticleId IdType="pmc">PMC8133786</ArticleId><ArticleId IdType="pubmed">34036090</ArticleId></ArticleIdList></Reference><Reference><Citation>Guandalini GS, Marchlinski FE. Parahisian pacing to unmask Brugada pattern with concomitant left bundle branch block and to document epicardial ablation endpoint in Brugada syndrome. HeartRhythm Case Rep. 2021;7(6):382&#x2013;385. doi: 10.1016/j.hrcr.2021.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2021.03.009</ArticleId><ArticleId IdType="pmc">PMC8226308</ArticleId><ArticleId IdType="pubmed">34194985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C, Scheinman M, Hsia H. A Heartwarming story. JACC Clin Electrophysiol. 2021 doi: 10.1016/j.jacep.2021.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2021.06.007</ArticleId><ArticleId IdType="pubmed">34332875</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujino T, Yuzawa H, Shinohara M, Sekiguchi Y, Nogami A, Ikeda T. Transient, marked st-segment elevation during successful epicardial substrate ablation in a patient with Brugada syndrome. JACC Case Rep. 2019;1(3):301&#x2013;305. doi: 10.1016/j.jaccas.2019.06.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2019.06.030</ArticleId><ArticleId IdType="pmc">PMC8288584</ArticleId><ArticleId IdType="pubmed">34316812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakishita M, Kurita T, Matsuo K, Taguchi A, Suyama K, Shimizu W, Aihara N, Kamakura S, Yamamoto F, Kobayashi J, Kosakai Y, Ohe T. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol. 2000;36(5):1646&#x2013;1653. doi: 10.1016/s0735-1097(00)00932-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(00)00932-3</ArticleId><ArticleId IdType="pubmed">11079671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka S, Serizawa N, Kitamura K, Suzuki A, Suzuki T, Shiga T, Shoda M, Hagiwara N. An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Arrhythm. 2016;32(1):70&#x2013;73. doi: 10.1016/j.joa.2015.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joa.2015.10.007</ArticleId><ArticleId IdType="pmc">PMC4759121</ArticleId><ArticleId IdType="pubmed">26949435</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggebrecht H, Wieneke H, Erbel R. Image of the month Brugada-like ECG pattern in a patient with isolated right ventricular infarction. Herz. 2009;34(4):327. doi: 10.1007/s00059-009-3241-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00059-009-3241-6</ArticleId><ArticleId IdType="pubmed">19575165</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes GC, Fernandes A, Cardoso R, Nasi G, Rivera M, Mitrani RD, Goldberger JJ. Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review. Heart Rhythm. 2018;15(8):1140&#x2013;1147. doi: 10.1016/j.hrthm.2018.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2018.03.019</ArticleId><ArticleId IdType="pubmed">29572085</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33616221</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1594</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Artificial organs</Title><ISOAbbreviation>Artif Organs</ISOAbbreviation></Journal><ArticleTitle>Prophylactic mechanical circulatory support for protected ventricular tachycardia ablation: A meta-analysis of the literature.</ArticleTitle><Pagination><StartPage>987</StartPage><EndPage>997</EndPage><MedlinePgn>987-997</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aor.13945</ELocationID><Abstract><AbstractText>Acute hemodynamic decompensation (AHD) during ventricular tachycardia (VT) ablation occurs in about 11% of cases. Prophylactic use of temporary mechanical circulatory support (pro-tMCS) has been applied to prevent AHD during VT ablation, but evidence supporting this practice is still lacking. This systematic review and meta-analysis assessed the procedural characteristics and outcomes of pro-tMCS for VT ablation. PubMed/Medline was screened until February 2020. Articles including adults receiving pro-tMCS for VT ablation were included, and a meta-analysis to compare proMCS and no-tMCS was performed. Primary outcome was in-hospital/30-day mortality. Five observational studies presenting 400 procedures (pro-tMCS: n&#xa0;=&#xa0;187; no-tMCS: n&#xa0;=&#xa0;213) were included. Baseline characteristics were comparable between groups. Impella and TandemHeart were used in 86.6% and 13.4% of cases, respectively. In the pro-tMCS group, more VTs were induced (mean difference: 0.52, confidence interval [CI]: 0.26-0.77, P&#xa0;&lt;&#xa0;.0001), and patients remained in VT on average for 24.04&#xa0;minutes longer (CI: 18.28-29.80, P&#xa0;&lt;&#xa0;.00001). Procedural success was comparable between groups, as was VT recurrence. Pro-tMCS patients had an odds ratio of 0.55 (CI: 0.28-1.05, P&#xa0;=&#xa0;.07) for in-hospital/30-day mortality and 0.55 (CI: 0.32-0.94, P&#xa0;=&#xa0;.03) for mortality at follow-up. Sixty-four percent of no-tMCS patients received rescue tMCS. The most common tMCS-related complications were bleeding events. Pro-tMCS allowed for a prolonged time on VTs and the induction of more VTs. Although these advantages were not associated with differences in procedural success, VT recurrence, or in-hospital/30-day mortality in the overall population, pro-tMCS might improve long-term survival. Further prospective studies are urgently needed to confirm these results.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2238-1399</Identifier><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Heart and Vascular Center, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Napp</LastName><ForeName>L Christian</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0001-9945-0842</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraaier</LastName><ForeName>Karin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8589-5138</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Hart-en Vaatcentrum Leeuwarden, Medical Center Leeuwarden, Leeuwarden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bounader</LastName><ForeName>Karl</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5410-7917</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanke</LastName><ForeName>Jasmin S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-1434-6905</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dogan</LastName><ForeName>G&#xfc;nes</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5984-9426</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitto</LastName><ForeName>Jan D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0002-0344-1405</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorusso</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1777-2045</Identifier><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Heart and Vascular Center, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Artif Organs</MedlineTA><NlmUniqueID>7802778</NlmUniqueID><ISSNLinking>0160-564X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">shock</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>22</Day><Hour>9</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33616221</ArticleId><ArticleId IdType="doi">10.1111/aor.13945</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Mariani S, Napp LC, Lo Coco V, Delnoij TSR, Luermans J, Ter Bekke RMA, et al. Mechanical circulatory support for life-threatening arrhythmia: a systematic review. Int J Cardiol. 2020;308:42-9.</Citation></Reference><Reference><Citation>Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793-867.</Citation></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e272-391.</Citation></Reference><Reference><Citation>Sharma P, Tripathi B, Naraparaju V, Patel M, Bhagat A, Yerasi C, et al. Short term outcomes associated with inpatient ventricular tachycardia catheter ablation. Pacing Clin Electrophysiol. 2020;43:444-55.</Citation></Reference><Reference><Citation>Konig S, Ueberham L, Muller-Rothing R, Wiedemann M, Ulbrich M, Sause A, et al. Catheter ablation of ventricular arrhythmias and in-hospital mortality: insights from the German-wide Helios hospital network of 5052 cases. Europace. 2020;22:100-8.</Citation></Reference><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020;17:e2-154.</Citation></Reference><Reference><Citation>Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, Hutchinson MD, et al. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8:68-75.</Citation></Reference><Reference><Citation>Turagam MK, Vuddanda V, Koerber S, Garg J, Yarlagadda B, Dar T, et al. Percutaneous ventricular assist device in ventricular tachycardia ablation: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2018;55:197-205.</Citation></Reference><Reference><Citation>Virk SA, Keren A, John RM, Santageli P, Eslick A, Kumar S. Mechanical circulatory support during catheter ablation of ventricular tachycardia: indications and options. Heart Lung Circ. 2019;28:134-45.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Vallabhajosyula S, Vaidya VR, Patlolla SH, Desai V, Mulpuru SK, et al. Venoarterial extracorporeal membrane oxygenation support for ventricular tachycardia ablation: a systematic review. ASAIO J. 2020;66:980-5.</Citation></Reference><Reference><Citation>Subramaniam AV, Barsness GW, Vallabhajosyula S, Vallabhajosyula S. Complications of temporary percutaneous mechanical circulatory support for cardiogenic shock: an appraisal of contemporary literature. Cardiol Ther. 2019;8:211-28.</Citation></Reference><Reference><Citation>Masyuk M, Abel P, Hug M, Wernly B, Haneya A, Sack S, et al. Extracorporeal life support system during cardiovascular procedures: insights from the German Lifebridge registry. Artif Organs. 2020;44:1259-66.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.</Citation></Reference><Reference><Citation>Wallace B, Small K, Brodley C, Lau J, Trikalinos T. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. Proceedings of the ACM International Health Informatics Symposium (IHI); 2012. p. 819-24.</Citation></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester, UK: John Wiley &amp; Sons; 2019.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785-805.</Citation></Reference><Reference><Citation>Muser D, Liang JJ, Castro SA, Hayashi T, Enriquez A, Troutman GS, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Heart Rhythm. 2018;15:1500-6.</Citation></Reference><Reference><Citation>Mathuria N, Wu G, Rojas-Delgado F, Shuraih M, Razavi M, Civitello A, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017;48:27-34.</Citation></Reference><Reference><Citation>Aryana A, Gearoid O'Neill P, Gregory D, Scotti D, Bailey S, Brunton S, et al. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device. Heart Rhythm. 2014;11:1122-30.</Citation></Reference><Reference><Citation>Reddy YM, Chinitz L, Mansour M, Bunch TJ, Mahapatra S, Swarup V, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol. 2014;7:244-50.</Citation></Reference><Reference><Citation>Miller MA, Dukkipati SR, Mittnacht AJ, Chinitz JS, Belliveau L, Koruth JS, et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. J Am Coll Cardiol. 2011;58:1363-71.</Citation></Reference><Reference><Citation>Bunch TJ, Darby A, May HT, Ragosta M, Lim DS, Taylor AM, et al. Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace. 2012;14:709-14.</Citation></Reference><Reference><Citation>Aryana A, d'Avila A, Cool CL, Miller MA, Garcia FC, Supple GE, et al. Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: an analysis of the Medicare database. J Cardiovasc Electrophysiol. 2017;28:1295-302.</Citation></Reference><Reference><Citation>Miller MA, Dukkipati SR, Koruth JS, d'Avila A, Reddy VY. How to perform ventricular tachycardia ablation with a percutaneous left ventricular assist device. Heart Rhythm. 2012;9:1168-76.</Citation></Reference><Reference><Citation>Kumar S, Romero J, Mehta NK, Fujii A, Kapur S, Baldinger SH, et al. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Heart Rhythm. 2016;13:1957-63.</Citation></Reference><Reference><Citation>Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, Frankel DS, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13:1552-9.</Citation></Reference><Reference><Citation>Kitamura T, Nakajima M, Kawamura I, Ohbe H, Sasabuchi Y, Matsui H, et al. Patient characteristics, procedure details including catheter devices, and complications of catheter ablation for ventricular tachycardia: a nationwide observational study. J Arrhythm. 2020;36:464-70.</Citation></Reference><Reference><Citation>Turagam MK, Vuddanda V, Atkins D, Santangeli P, Frankel DS, Tung R, et al. Hemodynamic support in ventricular tachycardia ablation: an international VT Ablation Center Collaborative Group study. JACC Clin Electrophysiol. 2017;3:1534-43.</Citation></Reference><Reference><Citation>Palaniswamy C, Miller MA, Reddy VY, Dukkipati SR. Hemodynamic support for ventricular tachycardia ablation. Card Electrophysiol Clin. 2017;9:141-52.</Citation></Reference><Reference><Citation>Miller MA, Dukkipati SR, Chinitz JS, Koruth JS, Mittnacht AJ, Napolitano C, et al. Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythm Electrophysiol. 2013;6:151-9.</Citation></Reference><Reference><Citation>Ghanbari H, Baser K, Yokokawa M, Stevenson W, Della Bella P, Vergara P, et al. Noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes: a meta-analysis. Circ Arrhythm Electrophysiol. 2014;7:677-83.</Citation></Reference><Reference><Citation>Yokokawa M, Kim HM, Baser K, Stevenson W, Nagashima K, Della Bella P, et al. Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2015;65:1954-9.</Citation></Reference><Reference><Citation>Ostadal P, Mlcek M, Holy F, Horakova S, Kralovec S, Skoda J, et al. Direct comparison of percutaneous circulatory support systems in specific hemodynamic conditions in a porcine model. Circ Arrhythm Electrophysiol. 2012;5:1202-6.</Citation></Reference><Reference><Citation>Pappalardo F, Scandroglio AM, Latib A. Full percutaneous biventricular support with two Impella pumps: the Bi-Pella approach. ESC Heart Fail. 2018;5:368-71.</Citation></Reference><Reference><Citation>Lo Coco V, Swol J, De Piero ME, Massimi G, Chiarini G, Broman LM, et al. Dynamic extracorporeal life support: a novel management modality in temporary cardio-circulatory assistance. Artif Organs. 2020. [Epub ahead of print].</Citation></Reference><Reference><Citation>Lorusso R, Raffa GM, Heuts S, Lo Coco V, Meani P, Natour E, et al. Pulmonary artery cannulation to enhance extracorporeal membrane oxygenation management in acute cardiac failure. Interact Cardiovasc Thorac Surg. 2020;30:215-22.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39702597</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>19</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence in risk prediction and diagnosis of vertebral fractures.</ArticleTitle><Pagination><StartPage>30560</StartPage><MedlinePgn>30560</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">30560</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-75628-2</ELocationID><Abstract><AbstractText>With the increasing prevalence of vertebral fractures, accurate diagnosis and prognostication are essential. This study assesses the effectiveness of AI in diagnosing and predicting vertebral fractures through a systematic review and meta-analysis. A comprehensive search across major databases selected studies utilizing AI for vertebral fracture diagnosis or prognosis. Out of 14,161 studies initially identified, 79 were included, with 40 undergoing meta-analysis. Diagnostic models were stratified by pathology: non-pathological vertebral fractures, osteoporotic vertebral fractures, and vertebral compression fractures. The primary outcome measure was AUROC. AI showed high accuracy in diagnosing and predicting vertebral fractures: predictive AUROC&#x2009;=&#x2009;0.82, osteoporotic vertebral fracture diagnosis AUROC&#x2009;=&#x2009;0.92, non-pathological vertebral fracture diagnosis AUROC&#x2009;=&#x2009;0.85, and vertebral compression fracture diagnosis AUROC&#x2009;=&#x2009;0.87, all significant (p&#x2009;&lt;&#x2009;0.001). Traditional models had the highest median AUROC (0.90) for fracture prediction, while deep learning models excelled in diagnosing all fracture types. High heterogeneity (I&#xb2; &gt; 99%, p&#x2009;&lt;&#x2009;0.001) indicated significant variation in model design and performance. AI technologies show considerable promise in improving the diagnosis and prognostication of vertebral fractures, with high accuracy. However, observed heterogeneity and study biases necessitate further research. Future efforts should focus on standardizing AI models and validating them across diverse datasets to ensure clinical utility.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Namireddy</LastName><ForeName>Srikar R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Saran S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peerbhai</LastName><ForeName>Amaan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamath</LastName><ForeName>Abith G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramsay</LastName><ForeName>Daniele S C</ForeName><Initials>DSC</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponniah</LastName><ForeName>Hariharan Subbiah</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salih</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankovic</LastName><ForeName>Dragan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Mainz, Langenbeckstra&#xdf;e 1, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalasauskas</LastName><ForeName>Darius</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Mainz, Langenbeckstra&#xdf;e 1, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuhoff</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Spinal Surgery and Neurotraumatology, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Frankfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Mainz, Langenbeckstra&#xdf;e 1, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thavarajasingam</LastName><ForeName>Santhosh G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, UK. santhoshgthava@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Mainz, Langenbeckstra&#xdf;e 1, Mainz, Germany. santhoshgthava@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050815" MajorTopicYN="N">Fractures, Compression</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AI</Keyword><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">ML</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Non-pathological vertebral fractures</Keyword><Keyword MajorTopicYN="N">OF, VF</Keyword><Keyword MajorTopicYN="N">Osteoporotic vertebral fractures</Keyword><Keyword MajorTopicYN="N">Vertebral compression fractures</Keyword></KeywordList><CoiStatement>Declarations. All data and materials as well as software application support their published claims and comply with field standards. Consent to publish has been received from all participants. Previous presentation: None. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>20</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39702597</ArticleId><ArticleId IdType="pmc">PMC11659610</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-75628-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-75628-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ensrud, K. E. Epidemiology of fracture risk with advancing age. J. Gerontol. A Biol. Sci. Med. Sci.68, 1236&#x2013;1242 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23833201</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitney, E. &amp; Alastra, A. J. Vertebral Fracture. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">31613453</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, Y. et al. Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019. Spine J.22, 857&#x2013;868 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34906740</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas, S. S. et al. Rate and circumstances of clinical vertebral fractures in older men. Osteoporos. Int.19, 615&#x2013;623 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2492834</ArticleId><ArticleId IdType="pubmed">18038109</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevitt, M. C. et al. Risk factors for a first-incident radiographic vertebral fracture in women&#x2009;&#x2265;&#x2009;65 years of age: the study of osteoporotic fractures. J. Bone Miner. Res.20, 131&#x2013;140 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15619679</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage, J. W., Schroeder, G. D. &amp; Anderson, P. A. Vertebroplasty and kyphoplasty for the treatment of osteoporotic vertebral compression fractures. J. Am. Acad. Orthop. Surg.22, 653&#x2013;664 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25281260</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper, C., Atkinson, E. J., O&#x2019;Fallon, W. M. &amp; Melton, J. L. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985&#x2013;1989. J. Bone Miner. Res.7, 221&#x2013;227 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">1570766</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink, H. A. et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J. Bone Miner. Res.20, 1216&#x2013;1222 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15940375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensrud, K. E. et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. J. Am. Geriatr. Soc.48, 241&#x2013;249 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10733048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross, P. D. Clinical consequences of vertebral fractures. Am. J. Med.103, 30S-42S; discussion 42S-43S (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9302895</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, B. Artificial intelligence: review of current and future applications in medicine. Fed. Pract.38, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8815615</ArticleId><ArticleId IdType="pubmed">35136337</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport, T. &amp; Kalakota, R. The potential for artificial intelligence in healthcare. Future Healthc. J.6, 94&#x2013;98 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6616181</ArticleId><ArticleId IdType="pubmed">31363513</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Antari, M. A. Artificial intelligence for medical diagnostics&#x2014;existing and future AI technology! Diagnostics.13, 688 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9955430</ArticleId><ArticleId IdType="pubmed">36832175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwa, J., Munir, U., Nori, A. &amp; Williams, B. Artificial intelligence in healthcare: transforming the practice of medicine. Future Healthc. J.8, e188-e194 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285156</ArticleId><ArticleId IdType="pubmed">34286183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy, M. &amp; Harvey, H. Artificial intelligence in diagnostic imaging: impact on the radiography profession. Br. J. Radiol.93, 20190840 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362930</ArticleId><ArticleId IdType="pubmed">31821024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurmis, A. P. &amp; Ianunzio, J. R. Artificial intelligence in orthopedic surgery: evolution, current state and future directions. Arthroplasty.4, (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889658</ArticleId><ArticleId IdType="pubmed">35232490</ArticleId></ArticleIdList></Reference><Reference><Citation>De, A., Sarda, A., Gupta, S. &amp; Das, S. Use of artificial intelligence in dermatology. Indian J. Dermatol.65, 352 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640800</ArticleId><ArticleId IdType="pubmed">33165383</ArticleId></ArticleIdList></Reference><Reference><Citation>Tama, B. A., Kim, D. H., Kim, G., Kim, S. W. &amp; Lee, S. Recent advances in the application of artificial intelligence in otorhinolaryngology-head and neck surgery. Clin. Exp. Otorhinolaryngol.13, 326&#x2013;339 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7669308</ArticleId><ArticleId IdType="pubmed">32631041</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, L. et al. Using artificial intelligence to diagnose osteoporotic vertebral fractures on plain radiographs. J. Bone Miner. Res. (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37449775</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong, N. et al. Deep-learning-based detection of vertebral fracture and osteoporosis using lateral spine X-ray radiography. J. Bone Miner. Res.38, 887&#x2013;895 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37038364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff, R. F. et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann. Intern. Med.170, 51&#x2013;58 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30596875</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosmer, D. W. &amp; Lemeshow, S. Applied Logistic Regression. 2nd edn, 162&#x2013;164 (2000)</Citation></Reference><Reference><Citation>Collins, G. S., Reitsma, J. B., Altman, D. G. &amp; Moons, K. G. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ.350, g7594 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25569120</ArticleId></ArticleIdList></Reference><Reference><Citation>Heus, P. et al. Uniformity in measuring adherence to reporting guidelines: the example of TRIPOD for assessing completeness of reporting of prediction model studies. BMJ Open.9, e025611 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6501951</ArticleId><ArticleId IdType="pubmed">31023756</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y., Sun, X., Sui, X., Li, Y. &amp; Wang, Z. Application of bone alkaline phosphatase and 25-oxhydryl-vitamin D in diagnosis and prediction of osteoporotic vertebral compression fractures. J. Orthop. Surg. Res.18, 739 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10543335</ArticleId><ArticleId IdType="pubmed">37775805</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon, M. A. et al. Automated segmentation of the fractured vertebrae on CT and its applicability in a radiomics model to predict fracture malignancy. Sci. Rep.12, (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9038736</ArticleId><ArticleId IdType="pubmed">35468985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, Y., Lu, Q., Yuan, F. &amp; Chen, H. Comparison of the effectiveness of different machine learning algorithms in predicting new fractures after PKP for osteoporotic vertebral compression fractures. J. Orthop. Surg. Res.18, (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9869614</ArticleId><ArticleId IdType="pubmed">36683045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, X. et al. Prediction of subsequent osteoporotic vertebral compression fracture on CT radiography via deep learning. View (Beijing, China)3, (2022).</Citation></Reference><Reference><Citation>Kong, S. H. et al. Development of a spine X-ray-based fracture prediction model using a deep learning algorithm. Endocrinol. Metab.37, 674&#x2013;683 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9449110</ArticleId><ArticleId IdType="pubmed">35927066</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz, E. B. et al. Assessing attribution maps for explaining CNN-based vertebral fracture classifiers. Lect. Notes Comput. Sci.3, 3&#x2013;12 (2020).</Citation></Reference><Reference><Citation>Yilmaz, E. B. et al. Automated deep learning-based detection of osteoporotic fractures in CT images. Lect. Notes Comput. Sci.376, 376&#x2013;385 (2021).</Citation></Reference><Reference><Citation>Monchka, B. A., Kimelman, D., Lix, L. M. &amp; Leslie, W. D. Feasibility of a generalized convolutional neural network for automated identification of vertebral compression fractures: the Manitoba Bone Mineral Density Registry. Bone.150, 116017 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34020078</ArticleId></ArticleIdList></Reference><Reference><Citation>Monchka, B. A. et al. Development of a manufacturer-independent convolutional neural network for the automated identification of vertebral compression fractures in vertebral fracture assessment images using active learning. Bone.161, 116427 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35489707</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho, S. T. et al. Prediction of progressive collapse in osteoporotic vertebral fractures using conventional statistics and machine learning. Spine.48, 1535 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37235792</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui, C. et al. Radiomic modeling to predict risk of vertebral compression fracture after stereotactic body radiation therapy for spinal metastases. J. Neurosurg. Spine.36, 294&#x2013;302 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34560656</ArticleId></ArticleIdList></Reference><Reference><Citation>Seol, Y. et al. Predicting vertebral compression fracture prior to spinal SBRT using radiomics from planning CT. Eur. Spine J. (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37814013</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata, K. et al. Artificial intelligence for the detection of vertebral fractures on plain spinal radiography. Sci. Rep.10, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674499</ArticleId><ArticleId IdType="pubmed">33208824</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H. Y. et al. Application of deep learning algorithm to detect and visualize vertebral fractures on plain frontal radiographs. PLoS One&#xa0;16, e0245992 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7842883</ArticleId><ArticleId IdType="pubmed">33507982</ArticleId></ArticleIdList></Reference><Reference><Citation>Biamonte, E. et al. Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures. J. Endocrinol. Invest.45, 2007&#x2013;2017 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35751803</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomita, N., Cheung, Y. Y. &amp; Hassanpour, S. Deep neural networks for automatic detection of osteoporotic vertebral fractures on CT scans. Comput. Biol. Med.98, 8&#x2013;15 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29758455</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. C. et al. Can a deep-learning model for the automated detection of vertebral fractures approach the performance level of human subspecialists? Clin. Orthop. Relat. Res. (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8208416</ArticleId><ArticleId IdType="pubmed">33651768</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. et al. Automated detection and classification of acute vertebral body fractures using a convolutional neural network on computed tomography. J. Bone Miner. Res.14, (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083489</ArticleId><ArticleId IdType="pubmed">37051194</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, W. G. et al. The value of radiomics-based CT combined with machine learning in the diagnosis of occult vertebral fractures. BMC Musculoskelet. Disord.24, 819 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10580519</ArticleId><ArticleId IdType="pubmed">37848859</ArticleId></ArticleIdList></Reference><Reference><Citation>Eller-Vainicher, C. et al. Recognition of morphometric vertebral fractures by artificial neural networks: analysis from GISMO Lombardia database. PLoS One.6, e27277 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3208634</ArticleId><ArticleId IdType="pubmed">22076144</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlematter, U. J. et al. Vertebral body insufficiency fractures: detection of vertebrae at risk on standard CT images using texture analysis and machine learning. Eur. Radiol.29, 2207&#x2013;2217 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30519934</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolaes, J. et al. Towards improved identification of vertebral fractures in routine computed tomography (CT) scans: development and external validation of a machine learning algorithm. J. Bone Miner. Res.38, 1856&#x2013;1866 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37747147</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolaes, J. et al. External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans. Osteoporos. Int.35, 143&#x2013;152 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10786735</ArticleId><ArticleId IdType="pubmed">37674097</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. et al. Value of 18F-FDG-PET/CT radiomics combined with clinical variables in the differential diagnosis of malignant and benign vertebral compression fractures. EJNMMI Res.13, 89 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10567613</ArticleId><ArticleId IdType="pubmed">37819414</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolaes, J. et al. Detection of vertebral fractures in CT using 3D convolutional neural networks. Lect. Notes Comput. Sci.3, 3&#x2013;14 (2020).</Citation></Reference><Reference><Citation>Nicolaes, J. et al. External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans. Osteoporos. Int.35, 143&#x2013;152 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10786735</ArticleId><ArticleId IdType="pubmed">37674097</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabu, A. et al. Using artificial intelligence to diagnose fresh osteoporotic vertebral fractures on magnetic resonance images. Spine J. (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33722728</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoda, T. et al. Automated differentiation between osteoporotic vertebral fracture and malignant vertebral fracture on MRI using a deep convolutional neural network. Spine.47, E347-E352 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34919075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono, Y. et al. A deep learning-based model for classifying osteoporotic lumbar vertebral fractures on radiographs: a retrospective model development and validation study. J. Imaging.9, 187 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10532676</ArticleId><ArticleId IdType="pubmed">37754951</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, W. et al. A deep-learning model for identifying fresh vertebral compression fractures on digital radiography. Bone.32, 1496&#x2013;1505 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34553256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, D. H. et al. Automated vertebral segmentation and measurement of vertebral compression ratio based on deep learning in X-ray images. J. Digit. Imaging. (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455797</ArticleId><ArticleId IdType="pubmed">34236562</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiari-Correia, N. S. et al. A 3D radiomics-based artificial neural network model for benign versus malignant vertebral compression fracture classification in MRI. J. Digit. Imaging.36, 1565&#x2013;1577 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10406770</ArticleId><ArticleId IdType="pubmed">37253895</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, B. et al. Benign vs malignant vertebral compression fractures with MRI: a comparison between automatic deep learning network and radiologist&#x2019;s assessment. Eur. Radiol.33, 5060&#x2013;5068 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37162531</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan, S. et al. Differential diagnosis of benign and malignant vertebral compression fractures: comparison and correlation of radiomics and deep learning frameworks based on spinal CT and clinical characteristics. Eur. J. Radiol.165, 110899 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37300935</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, Q. et al. Generalizability of deep learning classification of spinal osteoporotic compression fractures on radiographs using an adaptation of the modified-2 algorithm-based qualitative criteria. Acad. Radiol.30, 2973&#x2013;2987 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10776803</ArticleId><ArticleId IdType="pubmed">37438161</ArticleId></ArticleIdList></Reference><Reference><Citation>Thawait, S. K. et al. Comparison of four prediction models to discriminate benign from malignant vertebral compression fractures according to MRI feature analysis. AJR Am. J. Roentgenol.200, 493&#x2013;502 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23436836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. et al. Differentiation of benign versus malignant indistinguishable vertebral compression fractures by different machine learning with MRI-based radiomic features. Eur. Radiol.33, 5069&#x2013;5076 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37099176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, S. M. et al. Diagnosis of osteoporotic vertebral compression fractures and fracture level detection using multitask learning with U-Net in lumbar spine lateral radiographs. Comput. Struct. Biotechnol. J. (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10345217</ArticleId><ArticleId IdType="pubmed">37457807</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, S. et al. Two-stream compare and contrast network for vertebral compression fracture diagnosis. IEEE Trans. Med. Imaging.40, 2496&#x2013;2506 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33999815</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi, C. et al. The early detection of osteoporosis in a cohort of healthcare workers: is there room for a screening program? J. Clin. Endocrinol. Metab.106, e485-e495 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7908569</ArticleId><ArticleId IdType="pubmed">33540940</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;zen, T., &#xd6;z&#x131;&#x15f;&#x131;k, L. &amp; Ba&#x15f;aran, N. &#xc7;. An overview and management of osteoporosis. Eur. J. Rheumatol.4, 46&#x2013;56 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5335887</ArticleId><ArticleId IdType="pubmed">28293453</ArticleId></ArticleIdList></Reference><Reference><Citation>Shams, R. A., Zowghi, D. &amp; Bano, M. AI and the quest for diversity and inclusion: a systematic literature review. AI Ethics.4, 73&#x2013;88 (2023).</Citation></Reference><Reference><Citation>Yin, J., Ngiam, K. Y. &amp; Teo, H. H. Role of artificial intelligence applications in real-life clinical practice: systematic review. J. Med. Internet Res.23, e25743 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103304</ArticleId><ArticleId IdType="pubmed">33885365</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittermaier, M., Raza, M. M. &amp; Kvedar, J. C. Bias in AI-based models for medical applications: challenges and mitigation strategies. NPJ Digit. Med.6, 27 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10264403</ArticleId><ArticleId IdType="pubmed">37311802</ArticleId></ArticleIdList></Reference><Reference><Citation>Marwaha, J. S. &amp; Kvedar, J. C. Crossing the chasm from model performance to clinical impact: the need to improve implementation and evaluation of AI. NPJ Digit. Med.5, 25 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8894388</ArticleId><ArticleId IdType="pubmed">35241790</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimpeanu, T. et al. Artificial intelligence development races in heterogeneous settings. Sci. Rep.12, 5729 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810789</ArticleId><ArticleId IdType="pubmed">35110627</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng, F. et al. AI support for accurate and fast radiological diagnosis of COVID-19: an international multicenter, multivendor CT study. Eur. Radiol.33, 4280&#x2013;4291 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9755771</ArticleId><ArticleId IdType="pubmed">36525088</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauling, C. et al. Commercially available artificial intelligence tools for fracture detection: the evidence. BJR Open.6, tzd005 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10860511</ArticleId><ArticleId IdType="pubmed">38352182</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29871807</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>267</Volume><PubDate><Year>2018</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies.</ArticleTitle><Pagination><StartPage>88</StartPage><EndPage>93</EndPage><MedlinePgn>88-93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2018.05.091</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(18)30210-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In patients with Chagas cardiomyopathy (ChCM), sudden cardiac death (SCD) is the leading cause of mortality. Implantable cardioverter-defibrillator (ICD) is a well-established therapy for secondary prevention in patients with structural heart disease, but there are conflicting opinions regarding its efficacy and safety in patients with ChCM. The aim of this meta-analysis was to assess the efficacy of the ICD for secondary prevention in patients with ChCM, comparing mortality as the primary outcome of patients treated with ICD with those treated with amiodarone.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched five databases for studies assessing mortality outcomes in patients with ChCM and sustained ventricular tachycardia (VT) treated with ICD implantation or with amiodarone. The results of studies were pooled using random-effects modeling.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no randomized clinical trial comparing efficacy of ICD versus medical treatment in patients with ChCM. Six observational studies were included, totalizing 115 patients in amiodarone group and 483 patients in ICD group. The mortality outcome in the ICD population was 9.7 per 100 patient-years of follow-up (95%CI 5.7-13.7) and 9.6 per 100 patient-years in the amiodarone group (95%CI 6.7-12.4) (p&#x202f;=&#x202f;0.95). Meta-regression did not show any association with LV ejection fraction (p&#x202f;=&#x202f;0.32), age (p&#x202f;=&#x202f;0.44), beta-blocker (p&#x202f;=&#x202f;0.33) or angiotensin-converting enzyme inhibitors (p&#x202f;=&#x202f;0.096) usage.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The best available evidence derived from small observational studies suggests that ICD therapy in secondary prevention of sudden death (VT or resuscitated SCD) is not associated with lower rate of all-cause mortality in patients with ChCM. Randomized controlled trials are needed to answer this question.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carmo</LastName><ForeName>Andre A L</ForeName><Initials>AAL</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas and Faculdade de Medicina, Universidade Federal de Minas Gerais, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sousa</LastName><ForeName>Marcos R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas and Faculdade de Medicina, Universidade Federal de Minas Gerais, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agudelo</LastName><ForeName>Juan F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Arrhythmia &amp; Electrophysiology Service, Hospital San Vicente de Paul, Medellin, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boersma</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha</LastName><ForeName>Manoel O C</ForeName><Initials>MOC</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas and Faculdade de Medicina, Universidade Federal de Minas Gerais, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Antonio L P</ForeName><Initials>ALP</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas and Faculdade de Medicina, Universidade Federal de Minas Gerais, Minas Gerais, Brazil. Electronic address: tom@hc.ufmg.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morillo</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002598" MajorTopicYN="Y">Chagas Cardiomyopathy</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amiodarone</Keyword><Keyword MajorTopicYN="N">Antiarrhythmic drugs</Keyword><Keyword MajorTopicYN="N">Chagas heart failure</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter-defibrillator</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29871807</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2018.05.091</ArticleId><ArticleId IdType="pii">S0167-5273(18)30210-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32989960</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2724-5772</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Minerva cardiology and angiology</Title><ISOAbbreviation>Minerva Cardiol Angiol</ISOAbbreviation></Journal><ArticleTitle>Factors associated with recurrent postinfarction ventricular tachycardia following ablation.</ArticleTitle><Pagination><StartPage>50</StartPage><EndPage>60</EndPage><MedlinePgn>50-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S2724-5683.20.05128-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Ablation of ventricular tachycardia is the main therapy for patients with drug-refractory ventricular tachycardia (VT). Although evidence suggests that VT ablation could lower the incidence of recurrent VT, many cases still develop VT in follow-up. In this study, we performed a systematic review and meta-analysis to examine risk factors for recurrent VT in patients with postinfarction VT who underwent VT ablation.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION">We comprehensively searched the databases of MEDLINE and EMBASE from inception to March 2020. Included studies were cohort studies, experimental trials, or randomized controlled trials that evaluate the risk of recurrent VT in postinfarction VT patients who underwent VT ablation. Data from each study were combined using random-effects.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS">Thirteen studies involving 1803 postinfarction patients who underwent VT ablation were included. Inducibility after the procedure (pooled HR=1.71, P&lt;0.001), lower baseline left ventricular ejection fraction (LVEF) (pooled HR=0.98, P&lt;0.001) and higher baseline New York Heart Association (NYHA) classification (pooled HR=1.34, P=0.003) were significantly associated with VT recurrence during the follow-up. There was no significant association between age, gender or diabetes mellitus and VT recurrence.</AbstractText><AbstractText Label="CONCLUSIONS">Our meta-analysis demonstrated that inducibility after the procedure, lower baseline LVEF and higher baseline NYHA classification were associated with an increased risk of VT recurrence in postinfarction VT patients who underwent VT ablation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kewcharoen</LastName><ForeName>Jakrin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA - jakrin@hawaii.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasitlumkum</LastName><ForeName>Narut</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titichoatrattana</LastName><ForeName>Sittinop</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wittayalikit</LastName><ForeName>Chutikarn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trongtorsak</LastName><ForeName>Angkawipa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanitsoraphan</LastName><ForeName>Chanavuth</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putthapiban</LastName><ForeName>Prapaipan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poonsombudlert</LastName><ForeName>Kittika</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rattanawong</LastName><ForeName>Pattara</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, Mayo Clinic, Phoenix, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Eugene H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Cardiol Angiol</MedlineTA><NlmUniqueID>101776555</NlmUniqueID><ISSNLinking>2724-5683</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>29</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32989960</ArticleId><ArticleId IdType="doi">10.23736/S2724-5683.20.05128-2</ArticleId><ArticleId IdType="pii">S0026-4725.20.05128-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35643798</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1444-2892</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart, lung &amp; circulation</Title><ISOAbbreviation>Heart Lung Circ</ISOAbbreviation></Journal><ArticleTitle>Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1064</StartPage><EndPage>1074</EndPage><MedlinePgn>1064-1074</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hlc.2022.02.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1443-9506(22)00112-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There are differences in substrate and ablation approaches for ventricular tachycardia (VT) in ischaemic (ICM) and non-ischaemic cardiomyopathy (NICM).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To perform a systematic review and meta-analysis comparing clinical and procedural characteristics/outcomes of VT ablation in ICM versus NICM.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases were searched for comparative studies reporting outcomes of VT ablation in patients with ICM and NICM. Primary outcomes were acute procedural success, VT recurrence and long-term mortality. Meta-analyses were performed using random-effects modelling.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-one (31) studies (7,473 patients; 4,418 ICM and 3,055 NICM) were included. Patients with ICM were significantly older (67.0 vs 55.3 yrs), more commonly male (89% vs 79%), had lower left ventricular ejection fraction (29% vs 38%) were less likely to undergo epicardial access (11% vs 36%) and were more likely to require haemodynamic support during ablation (relative risk [RR] 1.30; 95% CI 1.01-1.69). Acute procedural success (i.e. non-inducibility of VT) was higher in the ICM cohort (RR 1.10, 95% CI 1.05-1.15). Recurrence of VT at follow-up was significantly lower in the ICM cohort (RR 0.77; 95% CI 0.70-0.84). Peri-procedural mortality, incidence of procedural complications and long-term mortality were not significantly different between the cohorts.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NICM and ICM patients undergoing VT ablation are fundamentally different in their clinical characteristics, ablation approaches, acute procedural outcomes and likelihood of VA recurrence. VT ablation in NICM has a lower likelihood of procedural success with increased risk of VA recurrence, consistent with known challenging arrhythmia substrate.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanagaratnam</LastName><ForeName>Aran</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohaib A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Timmy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, NSW, Australia; Department of Cardiology, Royal Melbourne Hospital, Melbourne, Vic, Australia; Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Vic, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turnbull</LastName><ForeName>Samual</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Stuart P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Melbourne, Vic, Australia; Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Vic, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, NSW, Australia. Electronic address: saurabh.kumar@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Heart Lung Circ</MedlineTA><NlmUniqueID>100963739</NlmUniqueID><ISSNLinking>1443-9506</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Ischaemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Non-ischaemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmia</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35643798</ArticleId><ArticleId IdType="doi">10.1016/j.hlc.2022.02.014</ArticleId><ArticleId IdType="pii">S1443-9506(22)00112-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34375001</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>The Laryngoscope</Title><ISOAbbreviation>Laryngoscope</ISOAbbreviation></Journal><ArticleTitle>Autologous Lipoaugmentation Long-Term Clinical Outcomes: A Systematic Review.</ArticleTitle><Pagination><StartPage>1042</StartPage><EndPage>1053</EndPage><MedlinePgn>1042-1053</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.29802</ELocationID><Abstract><AbstractText Label="OBJECTIVES/HYPOTHESIS">Vocal fold (VF) lipoaugmentation can be employed to treat glottal insufficiency although variable data exist on its length of effectiveness. We aimed to review published long-term outcomes following lipoaugmentation across the literature and compile outcome data.</AbstractText><AbstractText Label="STUDY DESIGN">Systematic review.</AbstractText><AbstractText Label="METHODS">A systematic search in September 2020 of PubMed, MEDLINE, Cochrane Library, and Web of Science used the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines to identify 128 relevant articles related to VF lipoaugmentation effectiveness duration. Primary search terms included the following: vocal cord, fat, lipo, and atrophy. Forty-eight full-text articles were reviewed and 31 were included in the final analysis. Primary endpoints included the following: duration of effectiveness per patient-reported outcome measures, objective findings, and additional procedures performed. In addition, fat harvest location and processing techniques were recorded.</AbstractText><AbstractText Label="FINDINGS">Thirty-one studies totaling 764 patients were included in the review. Indications for augmentation were VF paralysis (N&#xa0;=&#xa0;690) and atrophy (N&#xa0;=&#xa0;74). Fat was harvested from the abdominal region in 21 studies (529 patients), the thigh/abdomen in 5 studies (91 patients), and buccal/submental region in 2 studies (33 patients). Processing techniques and injectable volume varied. Across included studies, only 11 of 764 patients (1.4%) reported no improvement in voice and/or swallowing. Within the first year, 71 of 608 patients (11.7%) reported a regression toward baseline. Beyond 1&#x2009;year and up to 8&#x2009;years, 27 of 214 patients (12.6%) reported regression from initial improvement. Thirty-three patients underwent additional procedures.</AbstractText><AbstractText Label="CONCLUSION">Although improvements in voice and swallowing after lipoaugmentation taper over time, most patients experienced long-term benefit. Laryngoscope, 132:1042-1053, 2022.</AbstractText><CopyrightInformation>Published 2021. This article is a U.S. Government work and is in the public domain in the USA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luke</LastName><ForeName>Alex S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logan</LastName><ForeName>Ashley M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-6665-4504</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gawlik</LastName><ForeName>Alexandria E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dion</LastName><ForeName>Gregory R</ForeName><Initials>GR</Initials><Identifier Source="ORCID">0000-0003-4389-3104</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Brooke Army Medical Center, JBSA Fort Sam Houston, Texas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dental and Craniofacial Trauma Research Department, U.S. Army Institute of Surgical Research, JBSA Fort Sam Houston, Texas, U.S.A.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Laryngoscope</MedlineTA><NlmUniqueID>8607378</NlmUniqueID><ISSNLinking>0023-852X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014182" MajorTopicYN="N">Transplantation, Autologous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014826" MajorTopicYN="Y">Vocal Cord Paralysis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014827" MajorTopicYN="Y">Vocal Cords</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Vocal fold</Keyword><Keyword MajorTopicYN="N">fat</Keyword><Keyword MajorTopicYN="N">injection</Keyword><Keyword MajorTopicYN="N">lipoaugmentation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34375001</ArticleId><ArticleId IdType="doi">10.1002/lary.29802</ArticleId></ArticleIdList><ReferenceList><Title>BIBLIOGRAPHY</Title><Reference><Citation>Brandenburg JH, Kirkham W, Koschkee D. Vocal cord augmentation with autogenous fat. Laryngoscope 1992;102:495-500.</Citation></Reference><Reference><Citation>Mikaelian DO, Lowry LD, Sataloff RT. Lipoinjection for unilateral vocal cord paralysis. Laryngoscope 1991;101:465-468.</Citation></Reference><Reference><Citation>McCulloch TM, Andrews BT, Hoffman HT, Graham SM, Karnell MP, Minnick C. Long-term follow-up of fat injection laryngoplasty for unilateral vocal cord paralysis. Laryngoscope 2002;112:1235-1238.</Citation></Reference><Reference><Citation>Dion GR, Nielsen SW. In-Office Laryngology Injections. Otolaryngol Clin North Am 2019;52:521-536.</Citation></Reference><Reference><Citation>van den Broek E, Heijnen BJ, Hendriksma M, et al. Bilateral vocal fold injection with autologous fat in patients with vocal fold atrophy with or without sulcus. Eur Arch Otorhinolaryngol 2019;276:2007-2013.</Citation></Reference><Reference><Citation>Lahav Y, Malka-Yosef L, Shapira-Galitz Y, Cohen O, Halperin D, Shoffel-Havakuk H. Vocal fold fat augmentation for atrophy, scarring, and unilateral paralysis: long-term functional outcomes. Otolaryngol Head Neck Surg 2021;164:631-638.</Citation></Reference><Reference><Citation>Fang TJ, Lee LA, Wang CJ, Li HY, Chiang HC. Intracordal fat assessment by 3-dimensional imaging after autologous fat injection in patients with thyroidectomy-induced unilateral vocal cord paralysis. Surgery 2009;146:82-87.</Citation></Reference><Reference><Citation>Hsiung MW, Lin YS, Su WF, Wang HW. Autogenous fat injection for vocal fold atrophy. Eur Arch Otorhinolaryngol 2003;260:469-474.</Citation></Reference><Reference><Citation>DeFatta RA, DeFatta RJ, Sataloff RT. Laryngeal lipotransfer: review of a 14-year experience. J Voice 2013;27:512-515.</Citation></Reference><Reference><Citation>Dursun G, Boynukalin S, Ozgursoy OB, Coruh I. Long-term results of different treatment modalities for glottic insufficiency. Am J Otolaryngol 2008;29:7-12.</Citation></Reference><Reference><Citation>Tamura E, Fukuda H, Tabata Y, Nishimura M. Use of the buccal fad pad for vocal cord augmentation. Acta Otolaryngol 2008;128:219-224.</Citation></Reference><Reference><Citation>Sato K, Umeno H, Nakashima T. Histological investigation of liposuctioned fat for injection laryngoplasty. Am J Otolaryngol 2005;26:219-225.</Citation></Reference><Reference><Citation>Sasai H, Watanabe Y, Muta H, et al. Long-term histological outcomes of injected autologous fat into human vocal folds after secondary laryngectomy. Otolaryngol Head Neck Surg 2005;132:685-688.</Citation></Reference><Reference><Citation>Shaw GY, Szewczyk MA, Searle J, Woodroof J. Autologous fat injection into the vocal folds: technical considerations and long-term follow-up. Laryngoscope 1997;107:177-186.</Citation></Reference><Reference><Citation>Cucchiani R, Corrales L. The effects of fat harvesting and preparation, air exposure, obesity, and stem cell enrichment on adipocyte viability prior to graft transplantation. Aesthet Surg J 2016;36:1164-1173.</Citation></Reference><Reference><Citation>Asilian A, Siadat AH, Iraji R. Comparison of fat maintenance in the face with centrifuge versus filtered and washed fat. J Res Med Sci 2014;19:556-561.</Citation></Reference><Reference><Citation>Minn KW, Min KH, Chang H, Kim S, Heo EJ. Effects of fat preparation methods on the viabilities of autologous fat grafts. Aesthetic Plast Surg 2010;34:626-631.</Citation></Reference><Reference><Citation>Kumar VA, Lewin JS, Ginsberg LE. CT assessment of vocal cord medialization. AJNR Am J Neuroradiol 2006;27:1643-1646.</Citation></Reference><Reference><Citation>Bauer CA, Valentino J, Hoffman HT. Long-term result of vocal cord augmentation with autogenous fat. Ann Otol Rhinol Laryngol 1995;104:871-874.</Citation></Reference><Reference><Citation>Pagano R, Morsomme D, Camby S, Lejeune L, Finck C. Long-term results of 18 fat injections in unilateral vocal fold paralysis. J Voice 2017;31:505.e501-505.e509.</Citation></Reference><Reference><Citation>Tran HV, Tran-Le PT, Nguyen TV. Treatment of vocal cord paralysis by autologous fat injection: our experience with 41 patients. Clin Otolaryngol 2019;44:76-80.</Citation></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1.</Citation></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647.</Citation></Reference><Reference><Citation>Chang HP, Chang SY. Autogenous fat intracordal injection as treatment for unilateral vocal palsy. Zhonghua Yi Xue Za Zhi (Taipei) 1996;58:114-120.</Citation></Reference><Reference><Citation>Oluwole M, Mills RP, Davis BC, Blair RL. The management of unilateral vocal cord palsy by augmentation using autologous fat. Clin Otolaryngol Allied Sci 1996;21:357-359.</Citation></Reference><Reference><Citation>Shindo ML, Zaretsky LS, Rice DH. Autologous fat injection for unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol 1996;105:602-606.</Citation></Reference><Reference><Citation>Laccourreye O, Crevier-Buchman L, Le Pimpec-Barthes F, Garcia D, Riquet M, Brasnu D. Recovery of function after intracordal autologous fat injection for unilateral recurrent laryngeal nerve paralysis. J Laryngol Otol 1998;112:1082-1084.</Citation></Reference><Reference><Citation>Laccourreye O, Paczona R, Ageel M, Hans S, Brasnu D, Crevier-Buchman L. Intracordal autologous fat injection for aspiration after recurrent laryngeal nerve paralysis. Eur Arch Otorhinolaryngol 1999;256:458-461.</Citation></Reference><Reference><Citation>Hsiung MW, Woo P, Minasian A, Schaefer Mojica J. Fat augmentation for glottic insufficiency. Laryngoscope 2000;110:1026-1033.</Citation></Reference><Reference><Citation>Tucker HM. Direct autogenous fat implantation for augmentation of the vocal folds. J Voice 2001;15:565-569.</Citation></Reference><Reference><Citation>Hsiung MW, Pai L, Wang HW. Correlation between voice handicap index and voice laboratory measurements in dysphonic patients. Eur Arch Otorhinolaryngol 2002;259:97-99.</Citation></Reference><Reference><Citation>Havas TE, Priestley KJ. Autologous fat injection laryngoplasty for unilateral vocal fold paralysis. ANZ J Surg 2003;73:938-943.</Citation></Reference><Reference><Citation>Laccourreye O, Papon JF, Kania R, Crevier-Buchman L, Brasnu D, Hans S. Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: long-term results from the patient's perspective. Laryngoscope 2003;113:541-545.</Citation></Reference><Reference><Citation>Cantarella G, Mazzola RF, Domenichini E, Arnone F, Maraschi B. Vocal fold augmentation by autologous fat injection with lipostructure procedure. Otolaryngol Head Neck Surg 2005;132:239-243.</Citation></Reference><Reference><Citation>Fang T-J, Li H-Y, Gliklich RE, Chen Y-H, Wang P-C, Chuang H-F. Outcomes of fat injection laryngoplasty in unilateral vocal cord paralysis. Arch Otolaryngol Head Neck Surg 2010;136:457-462.</Citation></Reference><Reference><Citation>Cantarella G, Baracca G, Forti S, Gaffuri M, Mazzola RF. Outcomes of structural fat grafting for paralytic and non-paralytic dysphonia. Acta Otorhinolaryngol Ital 2011;31:154-160.</Citation></Reference><Reference><Citation>Umeno H, Chitose S-I, Sato K, Ueda Y, Nakashima T. Long-term postoperative vocal function after thyroplasty type I and fat injection laryngoplasty. Ann Otol Rhinol Laryngol 2012;121:185-191.</Citation></Reference><Reference><Citation>Saibene AM, Pipolo C, Lorusso R, Portaleone SM, Felisati G. Transnasal endoscopic microfractured fat injection in glottic insufficiency. B-ENT (Leuven) 2015;11:229-234.</Citation></Reference><Reference><Citation>Lodder WL, Dikkers FG. Comparison of voice outcome after vocal fold augmentation with fat or calcium hydroxylapatite. Laryngoscope 2015;125:1161-1165.</Citation></Reference><Reference><Citation>Elbadan HEM, Hussein WKA, Elmaghraby RM. Transcervical fat injection laryngoplasty for unilateral vocal fold paralysis: an easy way to do the job. Eur Arch Otorhinolaryngol 2017;274:4161-4167.</Citation></Reference><Reference><Citation>Zelen&#xed;k K, Walderov&#xe1; R, Ku&#x10d;ov&#xe1; H, Jan&#x10d;atov&#xe1; D, Kom&#xed;nek P. Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection. Eur Arch Otorhinolaryngol 2017;274:3147-3151.</Citation></Reference><Reference><Citation>Dominguez LM, Ricardo Villarreal BS, Simpson B. Voice outcomes of lipoinjection versus medialization laryngoplasty for nonparalytic glottic insufficiency. Laryngoscope 2019;129:1164-1168.</Citation></Reference><Reference><Citation>Ricci Maccarini A, Stacchini M, Mozzanica F, et al. Efficacy of trans-nasal fiberendoscopic injection laryngoplasty with centrifuged autologous fat in the treatment of glottic insufficiency due to unilateral vocal fold paralysis. Acta Otorhinolaryngol Ital 2018;38:204-213.</Citation></Reference><Reference><Citation>Lasso JM, Poletti D, Scola B, G&#xf3;mez-Vilda P, Garc&#xed;a-Mart&#xed;n AI, Fern&#xe1;ndez-Santos ME. Injection laryngoplasty using autologous fat enriched with adipose-derived regenerative stem cells: a safe therapeutic option for the functional reconstruction of the glottal gap after unilateral vocal fold paralysis. Stem Cells Int 2018;2018:8917913.</Citation></Reference><Reference><Citation>Lin W-Y, Chang W-D, Ko L-W, Tsou Y-A, Chen S-H. Impact of patient-related factors on successful autologous fat injection laryngoplasty in thyroid surgical treated related unilateral vocal fold paralysis- observational study. Medicine 2020;99:e18579.</Citation></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.</Citation></Reference><Reference><Citation>Dominguez LM, Villarreal R, Simpson CB. Voice Outcomes of Lipoinjection Versus Medialization Laryngoplasty for Nonparalytic Glottic Insufficiency. Laryngoscope 2019;129:1164-1168.</Citation></Reference><Reference><Citation>Campbell GL, Laudenslager N, Newman J. The effect of mechanical stress on adipocyte morphology and metabolism. Am J Cosmet Surg 1987;4:89-94.</Citation></Reference><Reference><Citation>Kim JT, Sasidaran R. Buccal fat pad: an effective option for facial reconstruction and aesthetic augmentation. Aesthetic Plast Surg 2017;41:1362-1374.</Citation></Reference><Reference><Citation>Cohen SR, Fireman E, Hewett S, Saad A. Buccal fat pad augmentation for facial rejuvenation. Plast Reconstr Surg 2017;139:1273e-1276e.</Citation></Reference><Reference><Citation>Fang C, Patel P, Li H, et al. Physical, biochemical, and biologic properties of fat graft processed via different methods. Plast Reconstr Surg Glob Open 2020;8:e3010.</Citation></Reference><Reference><Citation>Bellini E, Grieco MP, Raposio E. The science behind autologous fat grafting. Ann Med Surg (Lond) 2017;24:65-73.</Citation></Reference><Reference><Citation>Carding PN, Wilson JA, MacKenzie K, Deary IJ. Measuring voice outcomes: state of the science review. J Laryngol Otol 2009;123:823-829.</Citation></Reference><Reference><Citation>Francis DO, Daniero JJ, Hovis KL, et al. Voice-related patient-reported outcome measures: a systematic review of instrument development and validation. J Speech Lang Hear Res 2017;60:62-88.</Citation></Reference><Reference><Citation>Rosen CA, Murry T, Zinn A, Zullo T, Sonbolian M. Voice handicap index change following treatment of voice disorders. J Voice 2000;14:619-623.</Citation></Reference><Reference><Citation>Young VN, Jeong K, Rothenberger SD, et al. Minimal clinically important difference of voice handicap index-10 in vocal fold paralysis. Laryngoscope 2018;128:1419-1424.</Citation></Reference><Reference><Citation>Kallogjeri D, Spitznagel EL Jr, Piccirillo JF. Importance of defining and interpreting a clinically meaningful difference in clinical research. JAMA Otolaryngol Head Neck Surg 2020;146:101-102.</Citation></Reference><Reference><Citation>Englert M, Lopes L, Vieira V, Behlau M. Accuracy of acoustic voice quality index and its isolated acoustic measures to discriminate the severity of voice disorders. J Voice 2020;S0892-1997:30293-30299. https://doi.org/10.1016/j.jvoice.2020.08.010.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25978326</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Protective versus Conventional Ventilation for Surgery: A Systematic Review and Individual Patient Data Meta-analysis.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>78</EndPage><MedlinePgn>66-78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000000706</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recent studies show that intraoperative mechanical ventilation using low tidal volumes (VT) can prevent postoperative pulmonary complications (PPCs). The aim of this individual patient data meta-analysis is to evaluate the individual associations between VT size and positive end-expiratory pressure (PEEP) level and occurrence of PPC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized controlled trials comparing protective ventilation (low VT with or without high levels of PEEP) and conventional ventilation (high VT with low PEEP) in patients undergoing general surgery. The primary outcome was development of PPC. Predefined prognostic factors were tested using multivariate logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen randomized controlled trials were included (2,127 patients). There were 97 cases of PPC in 1,118 patients (8.7%) assigned to protective ventilation and 148 cases in 1,009 patients (14.7%) assigned to conventional ventilation (adjusted relative risk, 0.64; 95% CI, 0.46 to 0.88; P &lt; 0.01). There were 85 cases of PPC in 957 patients (8.9%) assigned to ventilation with low VT and high PEEP levels and 63 cases in 525 patients (12%) assigned to ventilation with low VT and low PEEP levels (adjusted relative risk, 0.93; 95% CI, 0.64 to 1.37; P = 0.72). A dose-response relationship was found between the appearance of PPC and VT size (R2 = 0.39) but not between the appearance of PPC and PEEP level (R2 = 0.08).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These data support the beneficial effects of ventilation with use of low VT in patients undergoing surgery. Further trials are necessary to define the role of intraoperative higher PEEP to prevent PPC during nonopen abdominal surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>Ary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Intensive Care, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (A.S.N., S.N.T.H., J.M.B., M.W.H., E.K.W., M.J.S.); Department of Pneumology, Heart Institute (INCOR), Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil (A.S.N., C.S.V.B.); Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil (A.S.N., C.S.V.B.); Department of Anaesthesiology, D&#xfc;sseldorf University Hospital, D&#xfc;sseldorf, Germany (M. Beiderlinden, T.T.); Department of Anaesthesiology, Marienhospital Osnabr&#xfc;ck, Osnabr&#xfc;ck, Germany (M. Beiderlinden); Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota (M. Biehl, O.G., J.S.); Department of Anesthesiology, Hospital Universitar I Germans Trias I Pujol, Barcelona, Spain (J.C.); Department of Anesthesiology, University of Colorado, Aurora, Colorado (A.F.-B., P.M.); Department of Anesthesiology and Critical Care Medicine, Estaing University Hospital, Clermont-Ferrand, France (E.F.); Department of Medical Sciences, Section of Clinical Physiology, University Hospital, Uppsala, Sweden (G.H.); Department of Critical Care Medicine and Anesthesiology (SAR B), Saint Eloi University Hospital, Montpellier, France (S.J.); Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany (A.K., T.S.); Department of Anaesthesiology, Pharmacology and Intensive Care, Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland (M.L.); State Key Laboratory of Oncology of South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China (W.-Q.L.); Department of Anesthesiology, The Warren Alpert School of Brown University, Providence, Rhode Island (A.D.M.); Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York (S.G.M.); Department of Intensive Ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemmes</LastName><ForeName>Sabrine N T</ForeName><Initials>SN</Initials></Author><Author ValidYN="Y"><LastName>Barbas</LastName><ForeName>Carmen S V</ForeName><Initials>CS</Initials></Author><Author ValidYN="Y"><LastName>Beiderlinden</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Biehl</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Binnekade</LastName><ForeName>Jan M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Canet</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Fernandez-Bustamante</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Futier</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Gajic</LastName><ForeName>Ognjen</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Hedenstierna</LastName><ForeName>G&#xf6;ran</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Hollmann</LastName><ForeName>Markus W</ForeName><Initials>MW</Initials></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>Samir</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kozian</LastName><ForeName>Alf</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Licker</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Wen-Qian</ForeName><Initials>WQ</Initials></Author><Author ValidYN="Y"><LastName>Maslow</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials></Author><Author ValidYN="Y"><LastName>Memtsoudis</LastName><ForeName>Stavros G</ForeName><Initials>SG</Initials></Author><Author ValidYN="Y"><LastName>Reis Miranda</LastName><ForeName>Dinis</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Moine</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Paparella</LastName><ForeName>Domenico</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Putensen</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Scavonetto</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Werner</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Selmo</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Severgnini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Sprung</LastName><ForeName>Juraj</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sundar</LastName><ForeName>Sugantha</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Talmor</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Treschan</LastName><ForeName>Tanja</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Unzueta</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Weingarten</LastName><ForeName>Toby N</ForeName><Initials>TN</Initials></Author><Author ValidYN="Y"><LastName>Wolthuis</LastName><ForeName>Esther K</ForeName><Initials>EK</Initials></Author><Author ValidYN="Y"><LastName>Wrigge</LastName><ForeName>Hermann</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><CollectiveName>PROVE Network Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2015 Jul;123(1):12-4. doi: 10.1097/ALN.0000000000000707.</RefSource><PMID Version="1">25978325</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25978326</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000000706</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29113714</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7886</ISSN><JournalIssue CitedMedium="Internet"><Volume>154</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of visceral surgery</Title><ISOAbbreviation>J Visc Surg</ISOAbbreviation></Journal><ArticleTitle>Laparoscopic versus open colectomy for obstructing right colon cancer: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>387</StartPage><EndPage>399</EndPage><MedlinePgn>387-399</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jviscsurg.2017.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-7886(17)30114-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hemicolectomy is the treatment of choice for intestinal obstruction from right colon cancer. This review compares the laparoscopic vs open access in hemicolectomy for patients with right colon cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis of clinical studies published after January&#xa0;2017 was performed according to the Prisma guidelines. The study has been recorded on the Prospero register (CRD42016044108).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five studies were included for review. Only one anastomotic leak was reported in conventional open anastomosis group (1.9%) and none of the studies included in the meta-analysis reported re-operations during the first 30&#xa0;postoperative days. The 30-day postoperative mortality did not differ between the two groups. The length of incision, blood loss, early mobilization after surgery, the 30-day postoperative overall complication rate and hospital length of stay were significantly shorter in the laparoscopic group. The difference in the duration of procedure was statistically significant in favor of the open group. The number of dissected lymph nodes, the overall survival at 5&#xa0;years and time to flatus were described only in one study, without any significant difference. Finally, none of the trials reported any information concerning differences in the costs between the two techniques.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The better outcomes described in this study achieved with laparoscopy, must be interpreted with caution because of the small number of patients involved, the selection and publication bias and the low level of evidence of the analysed trials. Indeed, the advantages of a minimally invasive approach, which have been demonstrated by the present meta-analysis, should encourage the use of laparoscopy also in emergency setting.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cirocchi</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of general and oncologic surgery, university of Perugia, 1, via Tristano di Joannuccio, 05100 Terni, Italy. Electronic address: cirocchiroberto@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cesare Campanile</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>General surgery unit, Andosilla hospital, Civita Castellana, VT, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Saverio</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency surgery and trauma surgery unit, Maggiore hospital trauma center, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popivanov</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Military medical academy, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlini</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of legal medicine, university of Perugia, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pironi</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of surgical sciences, Sapienza university of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabola</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of gastrointestinal and general surgery, medical university of Wroc&#x142;aw, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vettoretto</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laparoscopic surgery unit, department of surgery, M Mellini hospital, Chiari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>J Visc Surg</MedlineTA><NlmUniqueID>101532664</NlmUniqueID><ISSNLinking>1878-7886</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Visc Surg. 2017 Dec;154(6):385-386. doi: 10.1016/j.jviscsurg.2017.10.011.</RefSource><PMID Version="1">29108719</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="N">Colectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007415" MajorTopicYN="N">Intestinal Obstruction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colon cancer</Keyword><Keyword MajorTopicYN="N">Colorectal surgery</Keyword><Keyword MajorTopicYN="N">Emergency surgery</Keyword><Keyword MajorTopicYN="N">Intestinal obstruction</Keyword><Keyword MajorTopicYN="N">Laparoscopic colectomy</Keyword><Keyword MajorTopicYN="N">Laparoscopy</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Right colectomy</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29113714</ArticleId><ArticleId IdType="doi">10.1016/j.jviscsurg.2017.09.002</ArticleId><ArticleId IdType="pii">S1878-7886(17)30114-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39023485</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation.</ArticleTitle><Pagination><StartPage>2049</StartPage><EndPage>2058</EndPage><MedlinePgn>2049-2058</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2024.04.037</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(24)00457-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Left ventricular assist device (LVAD) recipients have a higher incidence of ventricular tachycardia (VT). However, the role of VT ablation in this population is not well-established.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This single-center retrospective cohort study sought to examine the impact of post-LVAD implant VT ablation on survival.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study examined a cohort of patients that underwent LVAD implantation at Baylor St. Luke's Medical Center and Texas Heart Institute between January 2011 and January 2021. All-cause estimated mortality was compared across LVAD recipients based on the incidence of VT, timing of VT onset, and the occurrence and timing of VT ablation utilizing Kaplan-Meier survival analysis and Cox proportional hazards models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Post-implant VT occurred in 53% of 575 LVAD recipients. Higher mortality was seen among patients with post-implant VT within a year of implantation (HR: 1.62 [95%&#xa0;CI: 1.15-2.27]). Among this cohort, patients who were treated with a catheter ablation had superior survival compared with patients treated with medical therapy alone for the 45&#xa0;months following VT onset (HR: 0.48 [95%&#xa0;CI: 0.26-0.89]). Moreover, performance of an ablation in this population aligned mortality rates with those who did not experience post-implant VT (HR: 1.18 [95%&#xa0;CI: 0.71-1.98]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VT occurrence within 1 year of LVAD implantation was associated with worse survival. However, performance of VT ablation in this population was correlated with improved survival compared with medical management alone. Among patients with refractory VT, catheter ablation aligned survival with other LVAD participants without post-implant VT. Catheter ablation of VT is associated with improved survival in LVAD recipients, but further prospective randomized studies are needed to compare VT ablation to medical management in LVAD recipients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Patrick T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA. Electronic address: Patrick.Lynch@bcm.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maloof</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badjatiya</LastName><ForeName>Anish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safavi-Naeini</LastName><ForeName>Payam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segar</LastName><ForeName>Matthew W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jitae A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marashly</LastName><ForeName>Qussay</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Montefiore Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina-Razavi</LastName><ForeName>Joanna E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Leo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oberton</LastName><ForeName>Selby B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Lola X</ForeName><Initials>LX</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Civitello</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathuria</LastName><ForeName>Nilesh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasekh</LastName><ForeName>Abdi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saeed</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razavi</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Ajith</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chelu</LastName><ForeName>Mihail G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Cardiology), Baylor College of Medicine, Houston, Texas, USA; Texas Heart Institute, Houston, Texas, USA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA. Electronic address: Mihail.Chelu@bcm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">advanced heart failure</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">left ventricular assist device</Keyword><Keyword MajorTopicYN="N">mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">survival</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures Dr Chelu has received funding from Patient-Centered Outcomes Research Institute (PLACER grant 2021C3-24160). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>10</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39023485</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2024.04.037</ArticleId><ArticleId IdType="pii">S2405-500X(24)00457-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38717772</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Ventricular Arrhythmias After Primary Percutaneous Coronary Intervention for STEMI.</ArticleTitle><Pagination><StartPage>e2410288</StartPage><MedlinePgn>e2410288</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2410288</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2024.10288</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Currently, mortality risk for patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) with an uncomplicated postprocedure course is low. Less is known regarding the risk of in-hospital ventricular tachycardia (VT) and ventricular fibrillation (VF).</AbstractText><AbstractText Label="OBJECTIVE">To evaluate the risk of late VT and VF after primary PCI for STEMI.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cohort study included adults aged 18 years or older with STEMI treated with primary PCI between January 1, 2015, and December 31, 2018, identified in the US National Cardiovascular Data Registry Chest Pain-MI Registry. Data were analyzed from April to December 2020.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Multivariable logistic regression was used to evaluate the risk of late VT (&#x2265;7 beat run of VT during STEMI hospitalization &#x2265;1 day after PCI) or VF (any episode of VF&#x2265;1 day after PCI) associated with cardiac arrest and associations between late VT or VF and in-hospital mortality in the overall cohort and a cohort with uncomplicated STEMI without prior myocardial infarction or heart failure, systolic blood pressure less than 90 mm Hg, cardiogenic shock, cardiac arrest, reinfarction, or left ventricular ejection fraction (LVEF) less than 40%.</AbstractText><AbstractText Label="RESULTS">A total of 174&#x202f;126 eligible patients with STEMI were treated with primary PCI at 814 sites in the study; 15&#x202f;460 (8.9%) had VT or VF after primary PCI, and 4156 (2.4%) had late VT or VF. Among the eligible patients, 99&#x202f;905 (57.4%) at 807 sites had uncomplicated STEMI. The median age for patients with late VT or VF overall was 63 years (IQR, 55-73 years), and 75.5% were men; the median age for patients with late VT or VF with uncomplicated STEMI was 60 years (IQR, 53-69 years), and 77.7% were men. The median length of stay was 3 days (IQR, 2-7 days) for the overall cohort with late VT or VF and 3 days (IQR, 2-4 days) for the cohort with uncomplicated STEMI with late VT or VF. The risk of late VT or VF was 2.4% (overall) and 1.7% (uncomplicated STEMI). Late VT or VF with cardiac arrest occurred in 674 patients overall (0.4%) and in 117 with uncomplicated STEMI (0.1%). LVEF was the most significant factor associated with late VT or VF with cardiac arrest (adjusted odds ratio [AOR] for every 5-unit decrease &#x2264;40%: 1.67; 95% CI, 1.54-1.85). Late VT or VF events were associated with increased odds of in-hospital mortality in the overall cohort (AOR, 6.40; 95% CI, 5.63-7.29) and the cohort with uncomplicated STEMI (AOR, 8.74; 95% CI, 6.53-11.70).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this study, a small proportion of patients with STEMI treated with primary PCI had late VT or VF. However, late VT or VF with cardiac arrest was rare, particularly in the cohort with uncomplicated STEMI. This information may be useful when determining the optimal timing for hospital discharge after STEMI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rymer</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Duke University Hospital, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegermann</LastName><ForeName>Zachary K</ForeName><Initials>ZK</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Duke University Hospital, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tracy Y</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Patient-Centered Outcomes Research Institute, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smilowitz</LastName><ForeName>Nathaniel R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Medicine, NYU Langone Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>B Hadley</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Atrium Health Sanger Heart &amp; Vascular Institute, Charlotte, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jneid</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Texas Medical Branch, Galveston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamis-Holland</LastName><ForeName>Jacqueline E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Heart, Vascular &amp; Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Rymer reported receiving grants from Chiesi, the American College of Cardiology&#x2019;s National Cardiovascular Data Registry (NCDR), and Abiomed outside the submitted work. Dr Smilowitz reported receiving personal fees from Abbott Vascular outside the submitted work. Dr Tamis-Holland reported having stock ownership in Pfizer outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38717772</ArticleId><ArticleId IdType="pmc">PMC11079687</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.10288</ArticleId><ArticleId IdType="pii">2818409</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Orvin K, Eisen A, Goldenberg I, et al. . Outcome of contemporary acute coronary syndrome complicated by ventricular tachyarrhythmias. Europace. 2016;18(2):219-226. doi:10.1093/europace/euv027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euv027</ArticleId><ArticleId IdType="pubmed">25840284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Starr AZ, Lopes RD, et al. ; APEX AMI Investigators . Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301(17):1779-1789. doi:10.1001/jama.2009.600</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.600</ArticleId><ArticleId IdType="pubmed">19417195</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Yu J, Piccini JP, et al. . Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). Am J Cardiol. 2012;109(6):805-812. doi:10.1016/j.amjcard.2011.10.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2011.10.043</ArticleId><ArticleId IdType="pubmed">22196782</ArticleId></ArticleIdList></Reference><Reference><Citation>Askari AT, Shishehbor MH, Kaminski MA, Riley MJ, Hsu A, Lincoff AM; GUSTO-V Investigators . The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: insights from Global Use of Strategies to Open Coronary Arteries (GUSTO) V. Am Heart J. 2009;158(2):238-243. doi:10.1016/j.ahj.2009.05.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2009.05.023</ArticleId><ArticleId IdType="pubmed">19619700</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccini JP, Berger JS, Brown DL. Early sustained ventricular arrhythmias complicating acute myocardial infarction. Am J Med. 2008;121(9):797-804. doi:10.1016/j.amjmed.2008.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.04.024</ArticleId><ArticleId IdType="pubmed">18724970</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Stebbins AL, Califf RM, et al. ; GUSTO-III trial . Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Am Heart J. 2003;145(3):515-521. doi:10.1067/mhj.2003.170</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mhj.2003.170</ArticleId><ArticleId IdType="pubmed">12660676</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbari R, Risgaard B, Fosb&#xf8;l EL, et al. . Factors associated with and outcomes after ventricular fibrillation before and during primary angioplasty in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2015;116(5):678-685. doi:10.1016/j.amjcard.2015.05.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.05.037</ArticleId><ArticleId IdType="pubmed">26150175</ArticleId></ArticleIdList></Reference><Reference><Citation>Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A; the GUSTO Investigators . Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. Circulation. 1998;98(23):2567-2573. doi:10.1161/01.CIR.98.23.2567</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.98.23.2567</ArticleId><ArticleId IdType="pubmed">9843464</ArticleId></ArticleIdList></Reference><Reference><Citation>Fordyce CB, Al-Khalidi HR, Jollis JG, et al. ; STEMI Systems Accelerator Project . Association of rapid care process implementation on reperfusion times across multiple st-segment-elevation myocardial infarction networks. Circ Cardiovasc Interv. 2017;10(1):e004061. doi:10.1161/CIRCINTERVENTIONS.116.004061</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.116.004061</ArticleId><ArticleId IdType="pmc">PMC6561112</ArticleId><ArticleId IdType="pubmed">28082714</ArticleId></ArticleIdList></Reference><Reference><Citation>Jollis JG, Al-Khalidi HR, Roettig ML, et al. . Impact of regionalization of ST-segment-elevation myocardial infarction care on treatment times and outcomes for emergency medical services-transported patients presenting to hospitals with percutaneous coronary intervention: Mission: Lifeline Accelerator-2. Circulation. 2018;137(4):376-387. doi:10.1161/CIRCULATIONAHA.117.032446</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.032446</ArticleId><ArticleId IdType="pubmed">29138292</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. . 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91-e220. doi:10.1016/j.jacc.2017.10.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.10.054</ArticleId><ArticleId IdType="pubmed">29097296</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Gara PT, Kushner FG, Ascheim DD, et al. . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78-e140. doi:10.1016/j.jacc.2012.11.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.11.019</ArticleId><ArticleId IdType="pubmed">23256914</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson ED, Roe MT, Rumsfeld JS, et al. . A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009;2(5):491-499. doi:10.1161/CIRCOUTCOMES.108.847145</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.108.847145</ArticleId><ArticleId IdType="pubmed">20031882</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan JZ, Jentzer JC, Ward RC, et al. . Safe triage of STEMI patients to general telemetry units after successful primary percutaneous coronary intervention. Mayo Clin Proc Innov Qual Outcomes. 2021;5(6):1118-1127. doi:10.1016/j.mayocpiqo.2021.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8633820</ArticleId><ArticleId IdType="pubmed">34877476</ArticleId></ArticleIdList></Reference><Reference><Citation>Valley TS, Iwashyna TJ, Cooke CR, et al. . Intensive care use and mortality among patients with ST elevation myocardial infarction: retrospective cohort study. BMJ. 2019;365:l1927. doi:10.1136/bmj.l1927</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l1927</ArticleId><ArticleId IdType="pmc">PMC6547840</ArticleId><ArticleId IdType="pubmed">31164326</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31732195</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1916-7075</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Canadian journal of cardiology</Title><ISOAbbreviation>Can J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Left Ventricular Systolic Dysfunction and Cardiovascular Outcomes in Tetralogy of Fallot: Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>1784</StartPage><EndPage>1790</EndPage><MedlinePgn>1784-1790</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjca.2019.07.634</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0828-282X(19)31148-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although there are robust data about the pathophysiology and prognostic implications of left ventricular (LV) systolic dysfunction in patients with acquired heart disease, similar prognostic data about LV systolic dysfunction are sparse in the tetralogy of Fallot (TOF) population. The purpose of this study was to perform a meta-analysis of all studies that assessed the relationship between LV ejection fraction (LVEF) and cardiovascular adverse events (CAEs) defined as death, aborted sudden death, or sustained ventricular tachycardia.</AbstractText><AbstractText Label="METHODS">We used random-effects models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS">Of the 1,809 citations, 7 studies with 2,854 patients (age 28&#xa0;&#xb1; 4 years) were included. During 5.6 &#xb1; 3.4 years' follow-up, there were 82 deaths, 17 aborted sudden cardiac deaths, and 56 sustained ventricular tachycardia events. Overall, CAEs occurred in 5.1% (144 patients). As a continuous variable, LVEF was a predictor of CAE (HR 1.29, 95% CI, 1.09-1.53, P&#xa0;= 0.001) per 5% decrease in LVEF. Similarly, LVEF &lt; 40% was also a predictor of CAE (HR 3.22, 95% CI, 2.16-4.80, P &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS">LV systolic dysfunction was an independent predictor of CAE, and we observed a 30% increase in the risk of CAE for every 5% decrease in LVEF, and a 3-fold increase in the risk of CAE in patients with LVEF &lt;40% compared with other patients. These findings underscore the importance of incorporating LV systolic function in clinical risk stratification of patients with TOF and the need to explore new treatment options to address this problem.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Egbe</LastName><ForeName>Alexander C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine Mayo Clinic, Rochester, Minnesota, USA. Electronic address: egbe.alexander@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adigun</LastName><ForeName>Rosalyn</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Vidhu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Collin P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montori</LastName><ForeName>Victor M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>M Hassan</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akintoye</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>Heidi M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL141448</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Cardiol</MedlineTA><NlmUniqueID>8510280</NlmUniqueID><ISSNLinking>0828-282X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Can J Cardiol. 2019 Dec;35(12):1623-1625. doi: 10.1016/j.cjca.2019.10.003.</RefSource><PMID Version="1">31813498</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Can J Cardiol. 2020 Nov;36(11):1830. doi: 10.1016/j.cjca.2020.08.018.</RefSource><PMID Version="1">32882209</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013771" MajorTopicYN="N">Tetralogy of Fallot</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="N">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31732195</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2019.07.634</ArticleId><ArticleId IdType="pii">S0828-282X(19)31148-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28833780</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1460</StartPage><EndPage>1467</EndPage><MedlinePgn>1460-1467</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.13324</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Treatment refractory ventricular arrhythmias (VAs) are often driven and exacerbated by heightened sympathetic tone. We aim to conduct a systematic review and meta-analysis of published studies of a temporary percutaneous stellate ganglion block (SGB) on VA burden and defibrillation episodes in patients with treatment refractory VAs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Relevant studies from January 1960 through May 2017 were identified in PubMed and Google Scholar. We performed a patient-level analysis using Student's t-test to compare outcomes before and after SGB.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 22 unique case series with a total of 35 patients. Patients were 57 &#xb1; 17 years old and 69% were males with a high burden of VA. A unilateral (left)-sided SGB was used in 85.7% (30 of 35) of cases and the remaining were bilateral SGB. The use of a unilateral or bilateral SGB resulted in a significant reduction of VA episodes (24-hours pre: mean 16.5 [CI 9.7-23.1] events vs. post: mean 1.4 [CI 0.85-2.01] events; P&#xa0;=&#xa0;0.0002) and need for defibrillation (24-hours pre: mean 14.2 [CI 6.8-21.6] vs. post: mean 0.6 [CI 0.3-0.9]; P&#xa0;=&#xa0;0.0026). Furthermore, SGB was significantly associated with a reduction of VA burden regardless of etiology of cardiomyopathy, type of ventricular rhythm, and degree of contractile dysfunction. SGB was followed by surgical sympathectomy in 21% of cases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Early experience suggests that SGB is associated with an acute reduction in the VA burden and offers potential promise for a broader use in high-risk populations. Randomized controlled studies are needed to confirm the safety and efficacy of this therapy.</AbstractText><CopyrightInformation>&#xa9; 2017 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fudim</LastName><ForeName>Marat</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8671-7007</Identifier><AffiliationInfo><Affiliation>Duke Cardiology, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boortz-Marx</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Duke Anesthesiology - Division of Pain Medicine, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesh</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Duke Anesthesiology - Division of Pain Medicine, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldron</LastName><ForeName>Nathan H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Duke Anesthesiology, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qadri</LastName><ForeName>Yawar J</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Duke Anesthesiology - Division of Pain Medicine, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Chetan B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Duke Cardiology, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milano</LastName><ForeName>Carmelo A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Albert Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Duke Cardiology, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Joseph P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Duke Anesthesiology, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccini</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-0772-2404</Identifier><AffiliationInfo><Affiliation>Duke Cardiology, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Center for Atrial Fibrillation, Duke University Medical Center, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001340" MajorTopicYN="N">Autonomic Nerve Block</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013233" MajorTopicYN="N">Stellate Ganglion</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autonomic modulation</Keyword><Keyword MajorTopicYN="N">stellate ganglion block</Keyword><Keyword MajorTopicYN="N">sympathetic tone</Keyword><Keyword MajorTopicYN="N">treatment refractory ventricular arrhythmia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28833780</ArticleId><ArticleId IdType="doi">10.1111/jce.13324</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32581439</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0971-9261</ISSN><JournalIssue CitedMedium="Print"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Journal of Indian Association of Pediatric Surgeons</Title><ISOAbbreviation>J Indian Assoc Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Anterior Sagittal Anorectoplasty: Our Experience.</ArticleTitle><Pagination><StartPage>134</StartPage><EndPage>141</EndPage><MedlinePgn>134-141</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/jiaps.JIAPS_28_19</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Anterior sagittal anorectoplasty (ASARP) is accepted as one of the techniques for the repair of vestibular fistula (VF) and low-type anomalies, but some may have reservations.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The aim of the study is to describe the technique, important features, and functional and cosmetic outcomes of ASARP for the treatment of anorectal malformation (ARM) in females.</AbstractText><AbstractText Label="SETTINGS AND DESIGN" NlmCategory="METHODS">A prospective study was performed from 1992 to 2017.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study included 157 pediatric patients (aged 1-15 years) with diagnosis of ARMs with VF, perineal fistula (perineal ectopic anus), and rectovaginal fistula managed by ASARP.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most cases (36.94%) were 1-6 months' age group; 92.99% of patients (146) were having VF, 5.09% (8) perineal fistula, and 1.91% (3) rectovaginal fistula. Associated anomalies (37) were present in 19.75% (31) of patients. Primary ASARP was performed in 85.35% (134) of cases. The mean operative time was 105 (&#xb1;15) min. Intraoperative complications were seen in 3.82% (6) of patients. Early postoperative complications were seen in 5.09% (8) of patients - wound infection (4), wound dehiscence (3), and retraction of the rectum (1). Late complications were seen in 12.73% (20) of cases. Overall, five patients developed anal stenosis, two responded to dilatation therapy, and three required anoplasty. The external appearance of the perineum after the 3<sup>rd</sup> month (postoperatively) was satisfactory in 95.54% (150); overall, 4.46% (7) of patients required the second procedure. Stooling pattern could be assessed in 80.25% (126) of patients at 3 years' age group. Only one had poor outcome with severe soiling (incontinence) and perineal excoriation that also had myelomeningocele.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ASARP is an excellent procedure for VF as it results in optimal correction with minimal sphincteric damage, without additional complexity or difficulties. Primary ASARP is a quick and effective technique and does not require colostomy if performed after due preoperative gut preparation and by an experienced pediatric surgeon.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2020 Journal of Indian Association of Pediatric Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Ram Babu</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, SMS Medical College, Jaipur, Rajasthan, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, SMS Medical College, Jaipur, Rajasthan, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prabhakar</LastName><ForeName>Girish</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, SP Medical College, Bikaner, Rajasthan, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bawa</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, SP Medical College, Bikaner, Rajasthan, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatric Surgery, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Indian Assoc Pediatr Surg</MedlineTA><NlmUniqueID>101179870</NlmUniqueID><ISSNLinking>0971-9261</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anorectal malformation</Keyword><Keyword MajorTopicYN="N">anterior sagittal anorectoplasty</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">perineal fistula</Keyword><Keyword MajorTopicYN="N">rectovaginal fistula</Keyword><Keyword MajorTopicYN="N">vestibular fistula</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32581439</ArticleId><ArticleId IdType="pmc">PMC7302463</ArticleId><ArticleId IdType="doi">10.4103/jiaps.JIAPS_28_19</ArticleId><ArticleId IdType="pii">JIAPS-25-134</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wakhlu A, Pandey A, Prasad A, Kureel SN, Tandon RK, Wakhlu AK. Anterior sagittal anorectoplasty for anorectal malformations and perineal trauma in the female child. J Pediatr Surg. 1996;31:1236&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">8887092</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsawaf MI, Hashish MS. Anterior sagittal anorectoplasty with external sphincter preservation for the treatment of recto-vestibular fistula: A New approach. J Indian Assoc Pediatr Surg. 2018;23:4&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5772095</ArticleId><ArticleId IdType="pubmed">29386757</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Rao KL. Primary anorectoplasty in females with common anorectal malformations without colostomy. J Pediatr Surg. 2007;42:1103&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17560229</ArticleId></ArticleIdList></Reference><Reference><Citation>Harjai MM, Sethi N, Chandra N. Anterior sagittal anorectoplasty: An alternative to posterior approach in management of congenital vestibular fistula. Afr J Paediatr Surg. 2013;10:78&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">23860051</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a A, Devries PA. Posterior sagittal anorectoplasty: Important technical considerations and new applications. J Pediatr Surg. 1982;17:796&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pubmed">6761417</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada A, Kamata S, Imura K, Fukuzawa M, Kubota A, Yagi M. Anterior sagittal anorectoplasty for rectovestibular and anovestibular fistula. J Pediatr Surg. 1992;27:85&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1552453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakhlu A, Kureel SN, Tandon RK, Wakhlu AK. Long-term results of anterior sagittal anorectoplasty for the treatment of vestibular fistula. J Pediatr Surg. 2009;44:1913&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19853746</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada A, Tamada H, Tsuji H, Azuma T, Yagi M, Kubota A, et al. Anterior sagittal anorectoplasty as a redo operation for imperforate anus. J Pediatr Surg. 1993;28:933&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8229572</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez Mart&#xed;n R, Molina E, Cerd&#xe1; J, Estell&#xe9;s C, Casillas MA, Romero R, et al. Treatment of vestibular fistulas in older girls. Cir Pediatr. 2002;15:140&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12601970</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulshrestha S, Kulshrestha M, Singh B, Sarkar B, Chandra M, Gangopadhyay AN, et al. Anterior sagittal anorectoplasty for anovestibular fistula. Pediatr Surg Int. 2007;23:1191&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17899130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S, Arunachalam P, Sam CJ, Bal HS. Residual terminal bowel fistulating into the alimentary tract: A hitherto unreported complication of surgery for anorectal malformation. BMJ Case Rep 2017. 2017:pii: bcr2016218986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5278338</ArticleId><ArticleId IdType="pubmed">28115405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisku S, Barla RK, Sen S, Karl S, Mathai J, Varghese L. Rectovestibular fistula with vaginal atresia: Our experience and a proposed course of management. Pediatr Surg Int. 2014;30:633&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24793106</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a A, Hong A. Advances in the management of anorectal malformations. Am J Surg. 2000;180:370&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11137690</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehata SM. Prospective long-term functional and cosmetic results of ASARP versus PASRP in treatment of intermediate anorectal malformations in girls. Pediatr Surg Int. 2009;25:863&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19680667</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a A, Grasshoff S, Levitt M. Reoperations in anorectal malformations. J Pediatr Surg. 2007;42:318&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">17270542</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasool N, Khan MA, Aslam M, Safdar A. Anterior saggital anorectoplasty; the treatment of anorectal malformations in female children. Prof Med J. 2014;21:845&#x2013;50.</Citation></Reference><Reference><Citation>Aziz MA, Banu T, Prasad R, Khan AR. Primary anterior sagittal anorectoplasty for rectovestibular fistula. Asian J Surg. 2006;29:22&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16428093</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28901628</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1542-474X</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc</Title><ISOAbbreviation>Ann Noninvasive Electrocardiol</ISOAbbreviation></Journal><ArticleTitle>Total cosine R-to-T for predicting ventricular arrhythmic and mortality outcomes: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e12495</StartPage><MedlinePgn>e12495</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e12495</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/anec.12495</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The total cosine R-to-T (TCRT), a vectorcardiographic marker reflecting the spatial difference between the depolarization and repolarization wavefronts, has been used to predict ventricular tachycardia/fibrillation (VT/VF) and sudden cardiac death (SCD) in different clinical settings. However, its prognostic value has been controversial.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This systematic review and meta-analysis evaluated the significance of TRCT in predicting arrhythmic and/or mortality endpoints.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed and Embase databases were searched through December 31, 2016.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 890 studies identified initially, 13 observational studies were included in our meta-analysis. A total of 11,528 patients, mean age 47&#xa0;years old, 72% male, were followed for 43&#xa0;&#xb1;&#xa0;6&#xa0;months. Data from five studies demonstrated lower TCRT values in myocardial infarction patients with adverse events (syncope, ventricular arrhythmias, or sudden cardiac death) compared to those without these events (mean difference&#xa0;=&#xa0;-0.36&#xa0;&#xb1;&#xa0;0.05, p&#xa0;&lt;&#xa0;.001; I<sup>2</sup> &#xa0;=&#xa0;48%). By contrast, only two studies analyzed outcomes in heart failure, and pooled meta-analysis did not demonstrate significant difference in TCRT between event-positive and event-negative patients (mean difference&#xa0;=&#xa0;-0.01&#xa0;&#xb1;&#xa0;0.10, p&#xa0;&gt;&#xa0;.05; I<sup>2</sup> &#xa0;=&#xa0;80%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TCRT is lower in MI patients at high risk of adverse events when compared to those free from such events. It can provide additional risk stratification beyond the use of clinical parameters and traditional electrocardiogram markers. Its value in other diseases such as heart failure requires further studies.</AbstractText><CopyrightInformation>&#xa9; 2017 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Gary</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5510-1253</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Cheuk Wai</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgopoulos</LastName><ForeName>Stamatis</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yat Sun</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Bryan P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guangping</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciobanu</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Theodor Burghele Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali-Hasan-Al-Saegh</LastName><ForeName>Sadeq</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Sunny H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>William K K</ForeName><Initials>WKK</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazoukis</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampropoulos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wing Tak</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Lap Ah</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Division of Occupational and Environmental Health, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baranchuk</LastName><ForeName>Adrian M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-3042-6569</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Kingston General Hospital, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Letsas</LastName><ForeName>Konstantinos P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tong</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0482-0738</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>International Health Informatics Study (IHIS) Network</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Noninvasive Electrocardiol</MedlineTA><NlmUniqueID>9607443</NlmUniqueID><ISSNLinking>1082-720X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Noninvasive Electrocardiol. 2018 Jul;23(4):e12543. doi: 10.1111/anec.12543.</RefSource><PMID Version="1">29672998</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Noninvasive Electrocardiol. 2018 Jul;23(4):e12557. doi: 10.1111/anec.12557.</RefSource><PMID Version="1">29856095</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="Y">Death, Sudden, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014672" MajorTopicYN="N">Vectorcardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">risk stratification</Keyword><Keyword MajorTopicYN="N">sudden cardiac death</Keyword><Keyword MajorTopicYN="N">total cosine R-to-T</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmias</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28901628</ArticleId><ArticleId IdType="pmc">PMC6931891</ArticleId><ArticleId IdType="doi">10.1111/anec.12495</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acar, B. , Yi, G. , Hnatkova, K. , &amp; Malik, M. (1999). Spatial, temporal and wavefront direction characteristics of 12&#x2010;lead T&#x2010;wave morphology. Medical &amp; Biological Engineering &amp; Computing, 37, 574&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pubmed">10723894</ArticleId></ArticleIdList></Reference><Reference><Citation>Batchvarov, V. , Hnatkova, K. , Ghuran, A. , Poloniecki, J. , Camm, A. J. , &amp; Malik, M. (2003). Ventricular gradient as a risk factor in survivors of acute myocardial infarction. Pacing and Clinical Electrophysiology, 26, 373&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">12687848</ArticleId></ArticleIdList></Reference><Reference><Citation>Batchvarov, V. N. , Hnatkova, K. , Poloniecki, J. , Camm, A. J. , &amp; Malik, M. (2004). Prognostic value of heterogeneity of ventricular repolarization in survivors of acute myocardial infarction. Clinical Cardiology, 27, 653&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6654101</ArticleId><ArticleId IdType="pubmed">15562938</ArticleId></ArticleIdList></Reference><Reference><Citation>Belloch, J. A. , Guillem, M. S. , Climent, A. , Millet, J. , Husser, D. , &amp; Bollman, A. (2007). Comparison of different methods for the derivation of the vectorcardiogram from the ECG and morphology descriptors. Computers in Cardiology, 2007, 435&#x2013;438.</Citation></Reference><Reference><Citation>Gang, Y. , Hnatkova, K. , Mandal, K. , Ghuran, A. , &amp; Malik, M. (2004). Preoperative electrocardiographic risk assessment of atrial fibrillation after coronary artery bypass grafting. Journal of Cardiovascular Electrophysiology, 15, 1379&#x2013;1386.</Citation><ArticleIdList><ArticleId IdType="pubmed">15610283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hnatkova, K. , Ryan, S. J. , Bathen, J. , Acar, B. , Batchvarov, V. , Hoium, H. H. , &amp; Malik, M. (2001). T&#x2010;wave morphology differences between patients with and without arrhythmic complication of ischemic heart disease. Journal of Electrocardiology, 34, 113&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">11781944</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, H.&#x2010;C. , Lin, L.&#x2010;Y. , Yu, H.&#x2010;Y. , &amp; Ho, Y.&#x2010;L. (2009). Risk stratification by T&#x2010;wave morphology for cardiovascular mortality in patients with systolic heart failure. Europace, 11, 1522&#x2013;1528.</Citation><ArticleIdList><ArticleId IdType="pubmed">19819880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kentta, T. , Karsikas, M. , Junttila, M. J. , Perki&#xf6;m&#xe4;ki, J. S. , Sepp&#xe4;nen, T. , Kiviniemi, A. , &#x2026; Huikuri, H. V. (2011). QRS&#x2010;T morphology measured from exercise electrocardiogram as a predictor of cardiac mortality. Europace, 13, 701&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">21186225</ArticleId></ArticleIdList></Reference><Reference><Citation>Korhonen, P. , Husa, T. , Konttila, T. , Tierala, I. , M&#xe4;kij&#xe4;rvi, M. , V&#xe4;&#xe4;n&#xe4;nen, H. , &amp; Toivonen, L. (2009). Complex T&#x2010;wave morphology in body surface potential mapping in prediction of arrhythmic events in patients with acute myocardial infarction and cardiac dysfunction. Europace, 11, 514&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">19279023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, C. Y. , Lin, L. Y. , &amp; Chen, P. C. (2007). Analysis of T&#x2010;wave morphology from the 12&#x2010;lead electrocardiogram for prediction of long&#x2010;term prognosis in patients initiating haemodialysis. Nephrology, Dialysis, Transplantation, 22, 2645&#x2013;2652.</Citation><ArticleIdList><ArticleId IdType="pubmed">17452400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, Y. H. , Lin, L. Y. , Chen, Y. S. , Huang, H. C. , Lee, J. K. , Ho, Y. L. , Liao, L. C. , &amp; Chen, W. J. (2009). The association between t&#x2010;wave morphology and life&#x2010;threatening ventricular tachyarrhythmias in patients with congestive heart failure. Pacing and Clinical Electrophysiology, 32, 1173&#x2013;1177.</Citation><ArticleIdList><ArticleId IdType="pubmed">19719495</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik, M. , Hnatkova, K. , &amp; Batchvarov, V. N. (2004). Post infarction risk stratification using the 3&#x2010;D angle between QRS complex and T&#x2010;wave vectors. Journal of Electrocardiology, 37, 201&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">15534842</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher, D. , Liberati, A. , Tetzlaff, J. , &amp; Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta&#x2010;analyses: The PRISMA statement. BMJ, 339, b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono, T. , Saitoh, H. , Itakura, S. , Tateoka, K. , Ono, I. , Hnatkova, K. , &#x2026; Malik, M. (2006). Characteristics of a new repolarization descriptor substituted for T&#x2010;wave morphology analysis in patients with cardiomyopathy and myocardial infarction. Circulation Journal, 70, 1322&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pubmed">16998267</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkiomaki, J. S. , Hyytinen&#x2010;Oinas, M. , Karsikas, M. , Sepp&#xe4;nen, T. , Hnatkova, K. , Malik, M. , &amp; Huikuri, H. V. (2006). Usefulness of T&#x2010;wave loop and QRS complex loop to predict mortality after acute myocardial infarction. American Journal of Cardiology, 97, 353&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">16442395</ArticleId></ArticleIdList></Reference><Reference><Citation>Porthan, K. , Viitasalo, M. , Jula, A. , Reunanen, A. , Rapola, J. , V&#xe4;&#xe4;n&#xe4;nen, H. , &#x2026; Oikarinen, L. (2009). Predictive value of electrocardiographic QT interval and T&#x2010;wave morphology parameters for all&#x2010;cause and cardiovascular mortality in a general population sample. Heart Rhythm, 6, 1202&#x2013;1208, 8.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">19632634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, B. , Harding, S. , &amp; Larsen, P. (2016). Analysis of ECG measures of cardiac repolarization in relation to arrhythmic events in an implantable cardioverter defibrillator population. Annals of Noninvasive Electrocardiology, 22, e12390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6931576</ArticleId><ArticleId IdType="pubmed">27292910</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicente, J. , Johannesen, L. , Mason, J. W. , Crumb, W. J. , Pueyo, E. , Stockbridge, N. , &amp; Strauss, D. G. (2015). Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil. Journal of the American Heart Association, 4, e001615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579946</ArticleId><ArticleId IdType="pubmed">25870186</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabel, M. , Acar, B. , Klingenheben, T. , Franz, M. R. , Hohnloser, S. H. , &amp; Malik, M. (2000). Analysis of 12&#x2010;lead T&#x2010;wave morphology for risk stratification after myocardial infarction. Circulation, 102, 1252&#x2013;1257.</Citation><ArticleIdList><ArticleId IdType="pubmed">10982539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabel, M. , Malik, M. , Hnatkova, K. , Papademetriou, V. , Pittaras, A. , Fletcher, R. D. , &amp; Franz, M. R. (2002). Analysis of T&#x2010;wave morphology from the 12&#x2010;lead electrocardiogram for prediction of long&#x2010;term prognosis in male US veterans. Circulation, 105, 1066&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">11877356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. , Zhu, Q. , Zhu, L. , Jiang, H. , Xie, J. , Huang, W. , &amp; Xu, B. (2015). Spatial/frontal QRS&#x2010;T angle predicts all&#x2010;cause mortality and cardiac mortality: A meta&#x2010;analysis. PLoS One, 10, e0136174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4540436</ArticleId><ArticleId IdType="pubmed">26284799</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31157716</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2154-4212</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Female pelvic medicine &amp; reconstructive surgery</Title><ISOAbbreviation>Female Pelvic Med Reconstr Surg</ISOAbbreviation></Journal><ArticleTitle>Is a Postvoid Residual Necessary? A Randomized Trial of Two Postoperative Voiding Protocols.</ArticleTitle><Pagination><StartPage>e256</StartPage><EndPage>e260</EndPage><MedlinePgn>e256-e260</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SPV.0000000000000743</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study aimed to compare a backfill-assisted voiding trial (VT) with and without a postvoid residual (PVR) after pelvic reconstructive surgery.</AbstractText><AbstractText Label="METHODS">This was a nonblinded randomized controlled trial of women undergoing pelvic organ prolapse and/or stress incontinence surgery. Participants were randomized immediately after surgery to either a PVR VT or a PVR-free VT. Our primary outcome was the rate of VT failure at discharge. Secondary outcomes included days of catheterization, urinary tract infection (UTI), and prolonged voiding dysfunction. With a power of 80% and an &#x3b1; of 0.05, we needed 126 participants to detect a 25% difference in VT failure (60% in PVR VT vs 35% in PVR-free VT).</AbstractText><AbstractText Label="RESULTS">Participants were enrolled from March 2017 to October 2017. Of the 150 participants, mean age was 59 years, and 33% underwent vaginal hysterectomy, 48% underwent anterior repair, and 75% underwent midurethral sling. Seventy-five (50%) were randomized to PVR VT and 75 (50%) to PVR-free VT, with no differences in baseline demographic or intraoperative characteristics between the 2 groups. Our primary outcome, VT failure, was not significantly different (53% PVR VT vs 53% PVR-free VT, P = 1.0). There were no significant differences in days of postoperative catheterization (1 [0, 4] in PVR VT vs 1 [0, 4] in PVR-free VT, P = 0.90), UTI (20% PVR VT vs 20% PVR-free VT, P = 1.0), or postoperative voiding dysfunction (4% PVR VT vs 5% PVR-free VT, P = 1.0).</AbstractText><AbstractText Label="CONCLUSIONS">When performing a backfill-assisted VT, checking a PVR does not affect VT failure, postoperative duration of catheterization, UTI, or voiding dysfunction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 American Urogynecologic Society. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Willis-Gray</LastName><ForeName>Marcella G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of OB/GYN, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pulliam</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Renovia Inc, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husk</LastName><ForeName>Katherine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brueseke</LastName><ForeName>Taylor J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of California, Irvine, Irvine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geller</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>AnnaMarie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieter</LastName><ForeName>Alexis A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>From the Department of OB/GYN, Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina at Chapel Hill.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03009968</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Female Pelvic Med Reconstr Surg</MedlineTA><NlmUniqueID>101528690</NlmUniqueID><ISSNLinking>2151-8378</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056887" MajorTopicYN="N">Pelvic Organ Prolapse</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053825" MajorTopicYN="N">Suburethral Slings</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014546" MajorTopicYN="N">Urinary Catheterization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014550" MajorTopicYN="N">Urinary Incontinence, Stress</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016055" MajorTopicYN="N">Urinary Retention</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013520" MajorTopicYN="Y">Urologic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31157716</ArticleId><ArticleId IdType="doi">10.1097/SPV.0000000000000743</ArticleId><ArticleId IdType="pii">01436319-202102000-00014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geller EJ, Hankins KJ, Parnell BA, et al. Diagnostic accuracy of retrograde and spontaneous voiding trials for postoperative voiding dysfunction: a randomized controlled trial. Obstet Gynecol 2011;118(3):637&#x2013;642.</Citation></Reference><Reference><Citation>Schiotz HA, Tanbo TG. Postoperative voiding, bacteriuria and urinary tract infection with Foley catheterization after gynecological surgery. Acta Obstet Gynecol Scand 2006;85(4):476&#x2013;481.</Citation></Reference><Reference><Citation>Foster RT Sr., Borawski KM, South MM, et al. A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 2007;197(6):627 e621&#x2013;627 e624.</Citation></Reference><Reference><Citation>Hakvoort RA, Thijs SD, Bouwmeester FW, et al. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG 2011;118(9):1055&#x2013;1060.</Citation></Reference><Reference><Citation>Hakvoort RA, Burger MP, Emanuel MH, et al. A nationwide survey to measure practice variation of catheterisation management in patients undergoing vaginal prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct 2009;20(7):813&#x2013;818.</Citation></Reference><Reference><Citation>Sutkin G, Alperin M, Meyn L, et al. Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J 2010;21(8):955&#x2013;961.</Citation></Reference><Reference><Citation>Dieter AA, Amundsen CL, Edenfield AL, et al. Oral antibiotics to prevent postoperative urinary tract infection: a randomized controlled trial. Obstet Gynecol 2014;123(1):96&#x2013;103.</Citation></Reference><Reference><Citation>Dieter AA, Amundsen CL, Visco AG, et al. Treatment for urinary tract infection after midurethral sling: a retrospective study comparing patients who receive short-term postoperative catheterization and patients who pass a void trial on the day of surgery. Female Pelvic Med Reconstr Surg 2012;18(3):175&#x2013;178.</Citation></Reference><Reference><Citation>Elkadry EA, Kenton KS, FitzGerald MP, et al. Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 2003;189(6):1551&#x2013;1557; discussion 1557&#x2013;1558.</Citation></Reference><Reference><Citation>Pulvino JQ, Duecy EE, Buchsbaum GM, et al. Comparison of 2 techniques to predict voiding efficiency after inpatient urogynecologic surgery. J Urol 2010;184(4):1408&#x2013;1412.</Citation></Reference><Reference><Citation>Ingber MS, Vasavada SP, Moore CK, et al. Force of stream after sling therapy: safety and efficacy of rapid discharge care pathway based on subjective patient report. J Urol 2011;185(3):993&#x2013;997.</Citation></Reference><Reference><Citation>Tunitsky-Bitton E, Murphy A, Barber MD, et al. Assessment of voiding after sling: a randomized trial of 2 methods of postoperative catheter management after midurethral sling surgery for stress urinary incontinence in women. Am J Obstet Gynecol 2015;212(5):597 e591&#x2013;597 e599.</Citation></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol 2010;115(5):1063&#x2013;1070.</Citation></Reference><Reference><Citation>Barber MD, Kleeman S, Karram MM, et al. Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol 2008;111(3):611&#x2013;621.</Citation></Reference><Reference><Citation>Meekins AR, Siddiqui NY, Amundsen CL, et al. Improving postoperative efficiency: an algorithm for expedited void trials after urogynecologic surgery. South Med J 2017;110(12):785&#x2013;790.</Citation></Reference><Reference><Citation>Myers EM, Matthews CA, Crane AK, et al. Two techniques for assessing postoperative voiding function, a randomized trial. Int Urogynecol J 2017;28(10):1567&#x2013;1572.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39350646</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1932-8737</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical cardiology</Title><ISOAbbreviation>Clin Cardiol</ISOAbbreviation></Journal><ArticleTitle>Pulsed-Field Ablation in Management of Ventricular Tachycardia: A Systematic Review of Case Reports and Clinical Outcomes.</ArticleTitle><Pagination><StartPage>e70018</StartPage><MedlinePgn>e70018</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70018</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/clc.70018</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pulsed-field ablation (PFA) is a cutting-edge technique that employs non-thermal energy to cause cell death by inducing irreversible electroporation of cell membranes. This systematic review evaluates the PFA effectiveness as a potential alternative to radiofrequency and cryo-ablation for treating ventricular tachycardia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, Scopus, and Web of Science were systematically searched using keywords related to ventricular tachycardia and pulsed-field ablation. Eligible Studies evaluating this therapeutic approach for ventricular tachycardia were included in the final analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included six studies (five case reports and one case series) in our systematic review. Eight (88.8%) of procedures were successful with 100% long-term efficacy. No procedural complications or ventricular tachycardia (VT) recurrence were observed in the cases.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The absence of complications, high effectiveness, and long-term success rate make PFAs a good VT treatment option. However, PFA safety and efficacy studies for VT treatment are scarce. Thus, larger investigations on this topic are urgently needed.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Clinical Cardiology published by Wiley Periodicals, LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Askarinejad</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2803-079X</Identifier><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Institue, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohansal</LastName><ForeName>Erfan</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4095-4824</Identifier><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Institue, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabahizadeh</LastName><ForeName>Amirreza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hesami</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Rajaie Cardiovascular Medical and Research Institue, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adimi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Epidemiology Research Center, Rajaie Cardiovascular Medical and Research Institute, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haghjoo</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Institute, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Institute, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The authors received no specific funding for this work.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Cardiol</MedlineTA><NlmUniqueID>7903272</NlmUniqueID><ISSNLinking>0160-9289</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094143" MajorTopicYN="N">Case Reports as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">pulsed&#x2010;field ablation</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>3</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39350646</ArticleId><ArticleId IdType="pmc">PMC11442986</ArticleId><ArticleId IdType="doi">10.1002/clc.70018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ellenbogen K. A., Wan C., and Shavelle D. M., &#x201c;Outcome of Patients With In&#x2010;Hospital Ventricular Tachycardia and Ventricular Fibrillation Arrest While Using a Wearable Cardioverter Defibrillator,&#x201d; American Journal of Cardiology 121, no. 2 (2018): 205&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">29153771</ArticleId></ArticleIdList></Reference><Reference><Citation>McNally B., Robb R., Mehta M., et al., &#x201c;Out&#x2010;of&#x2010;Hospital Cardiac Arrest Surveillance&#x2014;Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005&#x2014;December 31, 2010,&#x201d; MMWR Surveillance Summaries 60, no. 8 (2011): 1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">21796098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang P. T., Shenasa M., and Boyle N. G., &#x201c;Ventricular Arrhythmias and Sudden Cardiac Death,&#x201d; Cardiac Electrophysiology Clinics 9, no. 4 (2017): 693&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">29173411</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker J., Wright M. J., and Tedrow U., &#x201c;Diagnosis and Management of Ventricular Tachycardia,&#x201d; Clinical Medicine 23, no. 5 (2023): 442&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10541285</ArticleId><ArticleId IdType="pubmed">37775174</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel M., Elsokkari I., and Sapp J. L., &#x201c;Ventricular Tachycardia Burden and Mortality: Association or Causality,&#x201d; Canadian Journal of Cardiology 38, no. 4 (2022): 454&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">35074416</ArticleId></ArticleIdList></Reference><Reference><Citation>Guandalini G. S., Liang J. J., and Marchlinski F. E., &#x201c;Ventricular Tachycardia Ablation: Past, Present, and Future Perspectives,&#x201d; JACC Clinical Electrophysiology 5, no. 12 (2019): 1363&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">31857035</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin E. M., Bogun F. M., Maury P., et al., &#x201c;2019 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias,&#x201d; EP Europace 21, no. 8 (2019): 1143&#x2013;1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967791</ArticleId><ArticleId IdType="pubmed">31075787</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastapur A., McBride D., Deshmukh A., et al., &#x201c;Complications of Catheter Ablation for Ventricular Tachycardia,&#x201d; Journal of Interventional Cardiac Electrophysiology 66, no. 1 (2023): 221&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">36053374</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyengar S. K., Iyengar S., and Srivathsan K., &#x201c;The Promise of Pulsed Field Ablation and the Challenges Ahead,&#x201d; Frontiers in Cardiovascular Medicine 10 (2023): 1235317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10627215</ArticleId><ArticleId IdType="pubmed">37937293</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter D. W., Kostecki G., Fish J. M., Jensen J. A., and Tandri H., &#x201c;In Vitro Cell Selectivity of Reversible and Irreversible: Electroporation in Cardiac Tissue,&#x201d; Circulation: Arrhythmia and Electrophysiology 14, no. 4 (2021): e008817.</Citation><ArticleIdList><ArticleId IdType="pubmed">33729827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley C. J. and Haines D. E., &#x201c;Pulsed Field Ablation for Pulmonary Vein Isolation in the Treatment of Atrial Fibrillation,&#x201d; Journal of Cardiovascular Electrophysiology 31, no. 8 (2020): 2136&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">32107812</ArticleId></ArticleIdList></Reference><Reference><Citation>Koruth J. S., Kuroki K., Iwasawa J., et al., &#x201c;Endocardial Ventricular Pulsed Field Ablation: A Proof&#x2010;of&#x2010;Concept Preclinical Evaluation,&#x201d; EP Europace 22, no. 3 (2020): 434&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7058968</ArticleId><ArticleId IdType="pubmed">31876913</ArticleId></ArticleIdList></Reference><Reference><Citation>Im S. I., Higuchi S., Lee A., et al., &#x201c;Pulsed Field Ablation of Left Ventricular Myocardium in a Swine Infarct Model,&#x201d; JACC: Clinical Electrophysiology 8, no. 6 (2022): 722&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">35738848</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M. J., McKenzie J. E., Bossuyt P. M., et al., &#x201c;The Prisma 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,&#x201d; International Journal of Surgery 88 (2021): 105906.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M., Hammady H., Fedorowicz Z., and Elmagarmid A., &#x201c;Rayyan&#x2014;A Web and Mobile App for Systematic Reviews,&#x201d; Systematic Reviews 5, no. 1 (2016): 210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S., Munn Z., Tufanaru C., Aromataris E., Sears K., and Sfetcu R., &#x201c;Chapter 7: Systematic Reviews of Etiology and Risk,&#x201d; in JBI Manual for Evidence Synthesis, eds. Aromataris E. and Munn Z. (JBI, 2020), 10.46658/JBIMES-20-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.46658/JBIMES-20-08</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn Z., Barker T. H., Moola S., et al., &#x201c;Methodological Quality of Case Series Studies: An Introduction to the JBI Critical Appraisal Tool,&#x201d; JBI Evidence Synthesis 18, no. 10 (2020): 2127&#x2013;2133.</Citation><ArticleIdList><ArticleId IdType="pubmed">33038125</ArticleId></ArticleIdList></Reference><Reference><Citation>Adragao P., Matos D., Carmo P., Costa F. M., and Ramos S., &#x201c;Pulsed&#x2010;Field Ablation vs Radiofrequency Ablation for Ventricular Tachycardia: First In&#x2010;Human Case of Histologic Lesion Analysis,&#x201d; Heart Rhythm 20, no. 10 (2023): 1395&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pubmed">37488032</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause U., Bergau L., Zabel M., M&#xfc;ller M. J., and Paul T., &#x201c;Flowerpower: Pulsed Field Ablation of Ventricular Tachycardia in a Patient With Ebstein's Anomaly,&#x201d; European Heart Journal &#x2010; Case Reports 7, no. 3 (2023): ytad093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9994587</ArticleId><ArticleId IdType="pubmed">36909835</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano&#x2010;Granero C., Hirokami J., Franco E., et al., &#x201c;Case Series of Ventricular Tachycardia Ablation With Pulsed&#x2010;Field Ablation,&#x201d; JACC: Clinical Electrophysiology 9, no. 9 (2023): 1990&#x2013;1994.</Citation><ArticleIdList><ArticleId IdType="pubmed">37227358</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C. A., Zaw M. T., Jackson N., Morris D., and Costanzo P., &#x201c;First Worldwide Use of Pulsed&#x2010;Field Ablation for Ventricular Tachycardia Ablation via a Retrograde Approach,&#x201d; Journal of Cardiovascular Electrophysiology 34, no. 8 (2023): 1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">37431271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouss A., van Stratum L., van der Voort P., and Dekker L., &#x201c;First in Human Pulsed Field Ablation to Treat Scar&#x2010;Related Ventricular Tachycardia in Ischemic Heart Disease: A Case Report,&#x201d; Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing 66, no. 3 (2023): 509&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">36308578</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyand S., L&#xf6;big S., and Seizer P., &#x201c;First in Human Focal Pulsed Field Ablation to Treat an Epicardial VT Focus With an Endocardial Approach in Non&#x2010;Ischemic Cardiomyopathy,&#x201d; Journal of Interventional Cardiac Electrophysiology 66, no. 5 (2023): 1057&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pubmed">36943652</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz D. F., Turakhia M. P., Sauer W. H., et al., &#x201c;Safety of Ventricular Tachycardia Ablation in Clinical Practice: Findings From 9699 Hospital Discharge Records,&#x201d; Circulation: Arrhythmia and Electrophysiology 8, no. 2 (2015): 362&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9893573</ArticleId><ArticleId IdType="pubmed">25688143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella P. D., Baratto F., Tsiachris D., et al., &#x201c;Management of Ventricular Tachycardia in the Setting of a Dedicated Unit for the Treatment of Complex Ventricular Arrhythmias: Long&#x2010;Term Outcome After Ablation,&#x201d; Circulation. 127, no. 13 (2013): 1359&#x2013;1368.</Citation><ArticleIdList><ArticleId IdType="pubmed">23439513</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogabathina H., Singireddy S., Shi R., et al., &#x201c;Does Micropuncture Technique Really Help Reduce Vascular Complications,&#x201d; Cardiovascular Revascularization Medicine 19, no. 7 Pt A (2018): 762&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">29691186</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam S., Schaller R. D., Shinn A., et al., &#x201c;Occurrence, Management, and Outcomes of Iatrogenic Arterial Dissection as a Complication of Catheter Ablation,&#x201d; JACC: Clinical Electrophysiology 8, no. 9 (2022): 1185&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pubmed">36137728</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart M. T., Haines D. E., Miklav&#x10d;i&#x10d; D., et al., &#x201c;Safety and Chronic Lesion Characterization of Pulsed Field Ablation in a Porcine Model,&#x201d; Journal of Cardiovascular Electrophysiology 32, no. 4 (2021): 958&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048690</ArticleId><ArticleId IdType="pubmed">33650743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotnik T., Rems L., Tarek M., and Miklav&#x10d;i&#x10d; D., &#x201c;Membrane Electroporation and Electropermeabilization: Mechanisms and Models,&#x201d; Annual Review of Biophysics 48 (2019): 63&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">30786231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartl S., Reinsch N., F&#xfc;ting A., and Neven K., &#x201c;Pearls and Pitfalls of Pulsed Field Ablation,&#x201d; Korean Circulation Journal 53, no. 5 (2023): 273&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10172271</ArticleId><ArticleId IdType="pubmed">37161743</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A., Haines D. E., Boersma L. V., et al., &#x201c;Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial,&#x201d; Circulation 147, no. 19 (2023): 1422&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10158608</ArticleId><ArticleId IdType="pubmed">36877118</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy V. Y., Dukkipati S. R., Neuzil P., et al., &#x201c;Pulsed Field Ablation of Paroxysmal Atrial Fibrillation,&#x201d; JACC: Clinical Electrophysiology 7, no. 5 (2021): 614&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">33933412</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R., Vaseghi M., Frankel D. S., et al., &#x201c;Freedom From Recurrent Ventricular Tachycardia After Catheter Ablation Is Associated With Improved Survival in Patients With Structural Heart Disease: An International VT Ablation Center Collaborative Group Study,&#x201d; Heart Rhythm 12, no. 9 (2015): 1997&#x2013;2007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4549209</ArticleId><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal O. R., Chow A. W. C., Markides V., Schilling R. J., Peters N. S., and Davies D. W., &#x201c;Long&#x2010;Term Results after Ablation of Infarct&#x2010;Related Ventricular Tachycardia,&#x201d; Heart Rhythm 2, no. 5 (2005): 474&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">15840470</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31318497</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1930-739X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Obesity (Silver Spring, Md.)</Title><ISOAbbreviation>Obesity (Silver Spring)</ISOAbbreviation></Journal><ArticleTitle>BMI, Waist Circumference, and Risk of Incident Vertebral Fracture in Women.</ArticleTitle><Pagination><StartPage>1513</StartPage><EndPage>1519</EndPage><MedlinePgn>1513-1519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/oby.22555</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The study aimed to investigate the association between BMI, waist circumference, and vertebral fracture (VF) risk in women.</AbstractText><AbstractText Label="METHODS">This prospective study was conducted in 54,934 Nurses' Health Study participants. BMI was assessed biennially, and waist circumference was assessed in the year 2000. Self-reports of VF were confirmed by record review. BMI reflects lean body mass, and waist circumference reflects abdominal adiposity when included in the same regression model.</AbstractText><AbstractText Label="RESULTS">This study included 536 VF cases (2002 to 2014). Compared with women with BMI of 21.0 to 24.9 kg/m<sup>2</sup> , the multivariable-adjusted relative risk (RR) of VF for women with BMI&#x2009;&#x2265;&#x2009;32.0 was 0.84 (95% CI: 0.61-1.14; P<sub>trend</sub> &#x2009;=&#x2009;0.08). After further adjustment for waist circumference, the multivariable-adjusted RR of VF for women with BMI&#x2009;&#x2265;&#x2009;32.0 was 0.70 (95% CI: 0.49-0.98; P<sub>trend</sub> &#x2009;=&#x2009;0.003). Compared with women with waist circumference &lt;&#x2009;71.0 cm, the multivariable-adjusted RR of VF for women with waist circumference&#x2009;&#x2265;&#x2009;108.0 cm was 1.76 (95% CI: 1.06-2.92; P<sub>trend</sub> &#x2009;=&#x2009;0.01), and after further adjustment for BMI, the multivariable-adjusted RR of VF was 2.49 (95% CI: 1.44-4.33; P<sub>trend</sub> &#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Greater lean body mass was independently associated with lower VF risk. Larger waist circumference was independently associated with higher VF risk. These findings suggest that fat distribution is an important predictor of VF and that avoiding central adiposity, as well as maintaining muscle mass, may potentially confer reduced risk of VF in older women.</AbstractText><CopyrightInformation>&#xa9; 2019 The Obesity Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paik</LastName><ForeName>Julie M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-1315-5445</Identifier><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>Harold N</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Endocrinology Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Jeffrey N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosner</LastName><ForeName>Bernard A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rimm</LastName><ForeName>Eric B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curhan</LastName><ForeName>Gary C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Harvard University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 DK100447</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 DK091417</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR075117</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 CA186107</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obesity (Silver Spring)</MedlineTA><NlmUniqueID>101264860</NlmUniqueID><ISSNLinking>1930-7381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Obesity (Silver Spring). 2019 Sep;27(9):1389. doi: 10.1002/oby.22596.</RefSource><PMID Version="1">31347790</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="Y">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055105" MajorTopicYN="Y">Waist Circumference</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflicts of Interest:</b> All authors state that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31318497</ArticleId><ArticleId IdType="mid">NIHMS1030973</ArticleId><ArticleId IdType="pmc">PMC6707901</ArticleId><ArticleId IdType="doi">10.1002/oby.22555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999;159: 1215&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pubmed">10371229</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd. Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res 2014;29: 581&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929546</ArticleId><ArticleId IdType="pubmed">23959594</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LJ 3rd, Kan SH, Frye MA, Wahner HW, O&#x2019;Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989;129: 1000&#x2013;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">2784934</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein EM, Liu XS, Nickolas TL, Cohen A, McMahon DJ, Zhou B, et al. Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab 2012;97: E1918&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674300</ArticleId><ArticleId IdType="pubmed">22821893</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers ER, Wilson SE. Biomechanics of osteoporosis and vertebral fracture. Spine (Phila Pa 1976) 1997;22: 25S&#x2013;31S.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431641</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen BA, Bouxsein ML. Biomechanics of vertebral fractures and the vertebral fracture cascade. Curr Osteoporos Rep 2010;8: 198&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">20838942</ArticleId></ArticleIdList></Reference><Reference><Citation>De Laet C, Kanis J, Od&#xe9;n A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005;16: 1330&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">15928804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewiecki EM, Bilezikian JP, Bonewald L, Compston JE, Heaney RP, Kiel DP, et al. Osteoporosis update: proceedings of the 2013 Santa Fe Bone Symposium. J Clin Densitom 2014;17: 330&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">24613387</ArticleId></ArticleIdList></Reference><Reference><Citation>Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 2011;124: 1043&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4897773</ArticleId><ArticleId IdType="pubmed">22017783</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen A, Dempster DW, Recker RR, Lappe JM, Zhou H, Zwahlen A, et al. Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab 2013;98: 2562&#x2013;2572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3667251</ArticleId><ArticleId IdType="pubmed">23515452</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer HE, Willett WC, Flint AJ, Feskanich D. Abdominal obesity and hip fracture: results from the Nurses&#x2019; Health Study and the Health Professionals Follow-up Study. Osteoporos Int 2016;27: 2127&#x2013;2136.</Citation><ArticleIdList><ArticleId IdType="pubmed">26849456</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson H, Kanis JA, Oden A, McCloskey E, Chapurlat RD, Christiansen C, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 2014;29: 223&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">23775829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaze AD, Rosen HN, Paik JM. A meta-analysis of the association between body mass index and risk of vertebral fracture. Osteoporos Int 2018;29: 31&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">29098347</ArticleId></ArticleIdList></Reference><Reference><Citation>Compston JE, Flahive J, Hosmer DW, Watts NB, Siris ES, Silverman S, et al. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res 2014;29: 487&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878680</ArticleId><ArticleId IdType="pubmed">23873741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Kuroda T, Saito M, Shiraki M. Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women. Osteoporos Int 2013;24: 69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">23229467</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Akesson K. Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 2006;17: 1065&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">16758143</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevitt MC, Cummings SR, Stone KL, Palermo L, Black DM, Bauer DC, et al. Risk factors for a first-incident radiographic vertebral fracture in women &gt; or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res 2005;20: 131&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">15619679</ArticleId></ArticleIdList></Reference><Reference><Citation>Papaioannou A, Joseph L, Ioannidis G, Berger C, Anastassiades T, Brown JP, et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2005;16: 568&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pubmed">15517191</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy DK, O&#x2019;Neill TW, Finn JD, Lunt M, Silman AJ, Felsenberg D, et al. Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 2003;14: 19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">12577181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimm E, Stampfer M, Colditz GA, Chute C, Litin L, Willett W. Validity of self-reported waist and hip circumference in men and women. Epidemiology 1990;1: 466&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">2090285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf A, Hunter D, Colditz G, Manson J, Stampfer M, Corsano K, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 1994;23: 991&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pubmed">7860180</ArticleId></ArticleIdList></Reference><Reference><Citation>Prochaska M, Taylor E, Vaidya A, Curhan G. Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones. Clin J Am Soc Nephrol 2017;12: 1284&#x2013;1290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544505</ArticleId><ArticleId IdType="pubmed">28576907</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Spiegelman D, Rimm EB, Rosner BA, Stampfer MJ, Barnett JB, et al. Validity of a Dietary Questionnaire Assessed by Comparison With Multiple Weighed Dietary Records or 24-Hour Recalls. Am J Epidemiol 2017;185: 570&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859994</ArticleId><ArticleId IdType="pubmed">28338828</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik JM, Rosen HN, Gordon CM, Curhan GC. Diuretic Use and Risk of Vertebral Fracture in Women. Am J Med 2016;129: 1299&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5118092</ArticleId><ArticleId IdType="pubmed">27542612</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik JM, Rosen HN, Gordon CM, Curhan GC. Proton Pump Inhibitor Use, H2-Receptor Antagonist Use, and Risk of Incident Clinical Vertebral Fracture in Women. Calcif Tissue Int 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6231994</ArticleId><ArticleId IdType="pubmed">29754277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu FB. Obesity epidemiology. Oxford University Press: Oxford; New York, 2008; 74&#x2013;76.</Citation></Reference><Reference><Citation>Willett W Nutritional epidemiology, Third edition Oxford University Press: Oxford; New York, 2013; 259&#x2013;60.</Citation></Reference><Reference><Citation>Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996;143: 228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">8561156</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 2007;92: 1640&#x2013;1646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868430</ArticleId><ArticleId IdType="pubmed">17299077</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbour KE, Zmuda JM, Boudreau R, Strotmeyer ES, Horwitz MJ, Evans RW, et al. Adipokines and the risk of fracture in older adults. J Bone Miner Res 2011;26: 1568&#x2013;1576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733555</ArticleId><ArticleId IdType="pubmed">21312272</ArticleId></ArticleIdList></Reference><Reference><Citation>Araneta MR, von Muhlen D, Barrett-Connor E. Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study. J Bone Miner Res 2009;24: 2016&#x2013;2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791515</ArticleId><ArticleId IdType="pubmed">19453256</ArticleId></ArticleIdList></Reference><Reference><Citation>Komorita Y, Iwase M, Fujii H, Ohkuma T, Ide H, Jodai-Kitamura T, et al. Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetologia 2017;60: 1922&#x2013;1930.</Citation><ArticleIdList><ArticleId IdType="pubmed">28721438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, et al. Determinants of bone mineral density in obese premenopausal women. Bone 2011;48: 748&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3073669</ArticleId><ArticleId IdType="pubmed">21195217</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredella MA, Lin E, Gerweck AV, Landa MG, Thomas BJ, Torriani M, et al. Determinants of bone microarchitecture and mechanical properties in obese men. J Clin Endocrinol Metab 2012;97: 4115&#x2013;4122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3485587</ArticleId><ArticleId IdType="pubmed">22933540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmann KN, Bruno AG, Bredella MA, Schorr M, Lawson EA, Gill CM, et al. Vertebral Strength and Estimated Fracture Risk Across the BMI Spectrum in Women. J Bone Miner Res 2016;31: 281&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4833882</ArticleId><ArticleId IdType="pubmed">26332401</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009;94: 3387&#x2013;3393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2741723</ArticleId><ArticleId IdType="pubmed">19531595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hind K, Pearce M, Birrell F. Total and Visceral Adiposity Are Associated With Prevalent Vertebral Fracture in Women but Not Men at Age 62 Years: The Newcastle Thousand Families Study. J Bone Miner Res 2017;32: 1109&#x2013;1115.</Citation><ArticleIdList><ArticleId IdType="pubmed">28261864</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell M, Mendes N, Miller KK, Rosen CJ, Lee H, Klibanski A, et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab 2010;95: 1247&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2841531</ArticleId><ArticleId IdType="pubmed">20080853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundh D, Rudang R, Zoulakis M, Nilsson AG, Darelid A, Lorentzon M. A High Amount of Local Adipose Tissue Is Associated With High Cortical Porosity and Low Bone Material Strength in Older Women. J Bone Miner Res 2016;31: 749&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pubmed">26588353</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JF, Davis M, Alexander R, Zemel BS, Mostoufi-Moab S, Shults J, et al. Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone 2013;53: 34&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3552077</ArticleId><ArticleId IdType="pubmed">23238122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrasseur NK, Achenbach SJ, Melton LJ, 3rd, Amin S, Khosla S. Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. J Bone Miner Res 2012;27: 2159&#x2013;2169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3645866</ArticleId><ArticleId IdType="pubmed">22623219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 2012;3: 260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429036</ArticleId><ArticleId IdType="pubmed">22934016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtarzadeh H, Anderson DE. The Role of Trunk Musculature in Osteoporotic Vertebral Fractures: Implications for Prediction, Prevention, and Management. Curr Osteoporos Rep 2016;14: 67&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hida T, Shimokata H, Sakai Y, Ito S, Matsui Y, Takemura M, et al. Sarcopenia and sarcopenic leg as potential risk factors for acute osteoporotic vertebral fracture among older women. Eur Spine J 2016;25: 3424&#x2013;3431.</Citation><ArticleIdList><ArticleId IdType="pubmed">25690348</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott D, Seibel M, Cumming R, Naganathan V, Blyth F, Le Couteur DG, et al. Sarcopenic Obesity and Its Temporal Associations With Changes in Bone Mineral Density, Incident Falls, and Fractures in Older Men: The Concord Health and Ageing in Men Project. J Bone Miner Res 2017;32: 575&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">27736026</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37365062</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2981</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical oncology (Royal College of Radiologists (Great Britain))</Title><ISOAbbreviation>Clin Oncol (R Coll Radiol)</ISOAbbreviation></Journal><ArticleTitle>A Meta-analysis of the Efficacy and Safety of Stereotactic Arrhythmia Radioablation (STAR) in Patients with Refractory Ventricular Tachycardia.</ArticleTitle><Pagination><StartPage>611</StartPage><EndPage>620</EndPage><MedlinePgn>611-620</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clon.2023.04.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0936-6555(23)00151-6</ELocationID><Abstract><AbstractText Label="AIMS">Reports of stereotactic arrhythmia radioablation (STAR) in patients with refractory ventricular tachycardia after catheter ablation are limited to small series. Here, we carried out a systematic review and meta-analysis of studies to better determine the efficacy and toxicity of STAR for ventricular tachycardia.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Following the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) and the Meta-analyses Of Observational Studies in Epidemiology (MOOSE) guidelines, eligible studies were identified on Medline, Embase, Cochrane Library and the proceedings of annual meetings to 10 February 2023. Efficacy was defined as a ventricular tachycardia burden reduction &gt;70% at 6 months; safety was defined as &lt;10% of any grade &#x2265;3 toxicity.</AbstractText><AbstractText Label="RESULTS">Seven observational studies with a total of 61 patients treated were included. At 6 months, the ventricular tachycardia burden reduction was 92% (95% confidence interval 85-100%) and use of fewer than two anti-arrhythmic drugs was seen in 85% (95% confidence interval 50-100). Six months after STAR, an 86% reduction (95% confidence interval 80-93) in the number of implantable cardioverter-defibrillator shocks was observed. The rates for improved, unchanged and decreased cardiac ejection fraction were 10%, 84% and 6%, respectively. Overall survival at 6 and 12 months was 89% (95% confidence interval 81-97) and 82% (95% confidence interval 65-98). The cardiac-specific survival at 6 months was 87%. Late grade 3 toxicity occurred in 2% (95% confidence interval 0-5%) with no grade 4-5 toxicity.</AbstractText><AbstractText Label="CONCLUSION">STAR demonstrated both satisfactory efficacy and safety for the management of refractory ventricular tachycardia and was also associated with a significant decline in anti-arrhythmic drugs consumption. These findings support the continued development of STAR as a treatment option.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viani</LastName><ForeName>G A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Ribeir&#xe3;o Preto Medical School, Department of Medical Imaging, Hematology and Oncology of University of S&#xe3;o Paulo (FMRP-USP), Ribeir&#xe3;o Preto, Brazil; Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. Electronic address: gusviani@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouveia</LastName><ForeName>A G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Radiation Oncology Department - Americas Oncologia, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavoni</LastName><ForeName>J F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Faculdade de Filosofia, Letras e Ci&#xea;ncias Naturais, Universidade de S&#xe3;o Paulo, Ribeir&#xe3;o Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louie</LastName><ForeName>A V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Detsky</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spratt</LastName><ForeName>D E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraes</LastName><ForeName>F Y</ForeName><Initials>FY</Initials><AffiliationInfo><Affiliation>Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Department of Oncology - Division of Radiation Oncology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Oncol (R Coll Radiol)</MedlineTA><NlmUniqueID>9002902</NlmUniqueID><ISSNLinking>0936-6555</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">stereotactic arrhythmia radioablation</Keyword><Keyword MajorTopicYN="N">stereotactic radiotherapy</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>21</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37365062</ArticleId><ArticleId IdType="doi">10.1016/j.clon.2023.04.004</ArticleId><ArticleId IdType="pii">S0936-6555(23)00151-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38198137</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer.</ArticleTitle><Pagination><StartPage>e2350950</StartPage><MedlinePgn>e2350950</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2350950</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2023.50950</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Women with early breast cancer (EBC) exposed to aromatase inhibitors (AIs) may experience fragility fractures despite treatment with bone-active drugs. Risk factors for fractures in patients receiving AIs and denosumab have not been explored to date.</AbstractText><AbstractText Label="OBJECTIVES">To evaluate whether an association exists between dual x-ray absorptiometry (DXA)-measured fat body mass (FBM) and vertebral fracture (VF) progression in postmenopausal women with EBC undergoing adjuvant therapy with AIs in combination with denosumab and to examine whether VF was associated with common risk factors for bone fracture and parameters of body composition other than FBM.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">For this prospective, single-center, cohort study, 237 patients with EBC who were undergoing adjuvant treatment with AIs and denosumab (60 mg every 6 months) were enrolled at the Breast Unit of the ASST Spedali Civili of Brescia from September 2014 to June 2018. Data analysis was conducted in June 2022.</AbstractText><AbstractText Label="EXPOSURE">Body composition parameters, bone mineral density, and morphometric VFs were assessed by DXA at study entry and after 18 months of therapy.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">VF progression, defined as either new or worsening of preexisting VFs, between the 2 time points.</AbstractText><AbstractText Label="RESULTS">Of the 237 patients enrolled (median [range] age, 61 [28-84] years), 17 (4.4%) reported VF progression. Univariable analysis found an association between VF progression and a history of clinical fractures (odds ratio [OR], 3.22; 95% CI, 1.19-8.74; P&#x2009;=&#x2009;.02), Fracture Risk Assessment Tool (FRAX) score for major fractures (OR, 4.42; 95% CI, 1.23-13.79; P&#x2009;=&#x2009;.04), percentage of FBM (OR, 6.04; 95% CI, 1.69-21.63; P&#x2009;=&#x2009;.006), and android fat (OR, 9.58; 95% CI, 1.17-78.21; P&#x2009;=&#x2009;.04) and an inverse association with appendicular lean mass index-FBM ratio (OR, 0.25, 95% CI, 0.08-0.82; P&#x2009;=&#x2009;.02). Multivariable analysis revealed percentage of FBM (OR, 5.41; 95% CI, 1.49-19.59; P&#x2009;=&#x2009;.01) and FRAX score (OR, 3.95; 95% CI, 1.09-14.39; P&#x2009;=&#x2009;.04) as independent variables associated with VF progression.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The findings of this study suggest that baseline FBM is an independent factor for VF progression in patients with EBC treated with adjuvant AIs and denosumab. This observation is new and indicates that diet and exercise may synergize with denosumab in the management of bone health in this patient setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cosentini</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersini</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SSVD Breast Unit, ASST Spedali Civili of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Mauro</LastName><ForeName>Pierluigi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamparini</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schivardi</LastName><ForeName>Greta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaudo</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Tecnologie Avanzate, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Meo</LastName><ForeName>Nunzia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Radiology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delbarba</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental Sciences, Unit of Endocrinology and Metabolism, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelli</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental Sciences, Unit of Endocrinology and Metabolism, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagan&#xe0;</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baronchelli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerci</LastName><ForeName>Greta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laini</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grisanti</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simoncini</LastName><ForeName>Edda Lucia</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>SSVD Breast Unit, ASST Spedali Civili of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farina</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Radiology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazziotti</LastName><ForeName>Gherardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Endocrinology, Diabetology and Medical Andrology Unit, Metabolic Bone Diseases and Osteoporosis Section, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berruti</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Bone Health Group of the ASST Spedali Civili, Brescia</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4EQZ6YO2HI</RegistryNumber><NameOfSubstance UI="D000069448">Denosumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JAMA Netw Open. 2024 Feb 5;7(2):e242491. doi: 10.1001/jamanetworkopen.2024.2491.</RefSource><PMID Version="1">38358745</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069448" MajorTopicYN="N">Denosumab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005216" MajorTopicYN="N">Fat Body</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050723" MajorTopicYN="Y">Fractures, Bone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Grisanti reported receiving personal fees from Roche, AstraZeneca, BMS, and Novartis; receiving a travel grant from Takeda; and receiving grants from AstraZeneca outside the submitted work. Dr Farina reported receiving personal fees from Siemens outside the submitted work. Dr Berruti reported receiving grants from Fondazione Beretta and receiving evaluation of body composition parameters from Tecnologie Avanzate during the conduct of the study. No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Boglioni</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Suffix>Dr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Calzoni</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Suffix>Dr</Suffix></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>7</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>10</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>10</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38198137</ArticleId><ArticleId IdType="pmc">PMC10782249</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.50950</ArticleId><ArticleId IdType="pii">2813803</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. doi:10.3322/caac.21654</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21654</ArticleId><ArticleId IdType="pubmed">33433946</ArticleId></ArticleIdList></Reference><Reference><Citation>Berruti A, Generali D, Kaufmann M, et al. . International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). J Natl Cancer Inst Monogr. 2011;2011(43):147-151. doi:10.1093/jncimonographs/lgr037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jncimonographs/lgr037</ArticleId><ArticleId IdType="pubmed">22043063</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson WF, Pfeiffer RM, Dores GM, Sherman ME. Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1899-1905. doi:10.1158/1055-9965.EPI-06-0191</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-06-0191</ArticleId><ArticleId IdType="pubmed">17035397</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowsett M, Cuzick J, Ingle J, et al. . Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol. 2010;28(3):509-518. doi:10.1200/JCO.2009.23.1274</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2009.23.1274</ArticleId><ArticleId IdType="pubmed">19949017</ArticleId></ArticleIdList></Reference><Reference><Citation>McCaig FM, Renshaw L, Williams L, et al. . A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2010;119(3):643-651. doi:10.1007/s10549-009-0646-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-009-0646-0</ArticleId><ArticleId IdType="pubmed">19941160</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaglio M, Sun Z, Price KN, et al. ; BIG 1-98 Collaborative and International Breast Cancer Study Groups . Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Ann Oncol. 2009;20(9):1489-1498. doi:10.1093/annonc/mdp033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdp033</ArticleId><ArticleId IdType="pmc">PMC2731016</ArticleId><ArticleId IdType="pubmed">19474112</ArticleId></ArticleIdList></Reference><Reference><Citation>Eastell R, Adams JE, Coleman RE, et al. . Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol. 2008;26(7):1051-1057. doi:10.1200/JCO.2007.11.0726</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2007.11.0726</ArticleId><ArticleId IdType="pubmed">18309940</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman RE, Banks LM, Girgis SI, et al. ; Intergroup Exemestane Study group . Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study. Lancet Oncol. 2007;8(2):119-127. doi:10.1016/S1470-2045(07)70003-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(07)70003-7</ArticleId><ArticleId IdType="pubmed">17267326</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestergaard P, Rejnmark L, Mosekilde L. Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer. Calcif Tissue Int. 2008;82(5):334-340. doi:10.1007/s00223-008-9132-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-008-9132-7</ArticleId><ArticleId IdType="pubmed">18463912</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman R, Hadji P, Body JJ, et al. ; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org . Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol. 2020;31(12):1650-1663. doi:10.1016/j.annonc.2020.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.07.019</ArticleId><ArticleId IdType="pubmed">32801018</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro CL, Van Poznak C, Lacchetti C, et al. . Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline. J Clin Oncol. 2019;37(31):2916-2946. doi:10.1200/JCO.19.01696</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.19.01696</ArticleId><ArticleId IdType="pubmed">31532726</ArticleId></ArticleIdList></Reference><Reference><Citation>FRAX. Strumento di calcolo. Accessed December 5, 2023. https://frax.shef.ac.uk/FRAX/tool.aspx?lang=it</Citation></Reference><Reference><Citation>Dalla Volta A, Mazziotti G, Maffezzoni F, et al. . Bone mineral density and FRAX score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies. J Clin Oncol. 2020;38(29):3363-3366. doi:10.1200/JCO.20.00434</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.20.00434</ArticleId><ArticleId IdType="pubmed">32603244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF) . European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3-44. doi:10.1007/s00198-018-4704-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-018-4704-5</ArticleId><ArticleId IdType="pmc">PMC7026233</ArticleId><ArticleId IdType="pubmed">30324412</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersini R, Monteverdi S, Mazziotti G, et al. . Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: a cross-sectional study. Bone. 2017;97(97):147-152. doi:10.1016/j.bone.2017.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2017.01.013</ArticleId><ArticleId IdType="pubmed">28104509</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca H, Moreira-Gon&#xe7;alves D, Coriolano HJA, Duarte JA. Bone quality: the determinants of bone strength and fragility. Sports Med. 2014;44(1):37-53. doi:10.1007/s40279-013-0100-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-013-0100-7</ArticleId><ArticleId IdType="pubmed">24092631</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteverdi S, Pedersini R, Gallo F, et al. . The interaction of lean body mass with fat body mass is associated with vertebral fracture prevalence in women with early breast cancer undergoing aromatase inhibitor therapy. JBMR Plus. 2020;5(2):e10440. doi:10.1002/jbm4.10440</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10440</ArticleId><ArticleId IdType="pmc">PMC7872339</ArticleId><ArticleId IdType="pubmed">33615109</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersini R, Amoroso V, Maffezzoni F, et al. . Association of fat body mass with vertebral fractures in postmenopausal women with early breast cancer undergoing adjuvant aromatase inhibitor therapy. JAMA Netw Open. 2019;2(9):e1911080. doi:10.1001/jamanetworkopen.2019.11080</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.11080</ArticleId><ArticleId IdType="pmc">PMC6777242</ArticleId><ArticleId IdType="pubmed">31560383</ArticleId></ArticleIdList></Reference><Reference><Citation>Siris ES, Chen YT, Abbott TA, et al. . Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164(10):1108-1112. doi:10.1001/archinte.164.10.1108</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.164.10.1108</ArticleId><ArticleId IdType="pubmed">15159268</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotti G, Vena W, Pedersini R, et al. . Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: reliability of who fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical practice. J Bone Oncol. 2022;33:100421. doi:10.1016/j.jbo.2022.100421</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbo.2022.100421</ArticleId><ArticleId IdType="pmc">PMC8928084</ArticleId><ArticleId IdType="pubmed">35310388</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Volta A, Caramella I, Di Mauro P, et al. . Role of body composition in the prediction of skeletal fragility induced by hormone deprivation therapies in cancer patients. Curr Oncol Rep. 2023;25(10):1141-1152. doi:10.1007/s11912-023-01447-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11912-023-01447-9</ArticleId><ArticleId IdType="pmc">PMC10556180</ArticleId><ArticleId IdType="pubmed">37624550</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapses SA, Pop LC, Wang Y. Obesity is a concern for bone health with aging. Nutr Res. 2017;39:1-13. doi:10.1016/j.nutres.2016.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2016.12.010</ArticleId><ArticleId IdType="pmc">PMC5385856</ArticleId><ArticleId IdType="pubmed">28385284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C, Tonks KT, Center JR, Samocha-Bonet D, Greenfield JR. Complex interplay among adiposity, insulin resistance and bone health. Clin Obes. 2018;8(2):131-139. doi:10.1111/cob.12240</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cob.12240</ArticleId><ArticleId IdType="pubmed">29334695</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukumar D, Schlussel Y, Riedt CS, Gordon C, Stahl T, Shapses SA. Obesity alters cortical and trabecular bone density and geometry in women. Osteoporos Int. 2011;22(2):635-645. doi:10.1007/s00198-010-1305-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-010-1305-3</ArticleId><ArticleId IdType="pmc">PMC2994953</ArticleId><ArticleId IdType="pubmed">20533027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnant M, Pfeiler G, Dubsky PC, et al. ; Austrian Breast and Colorectal Cancer Study Group . Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2015;386(9992):433-443. doi:10.1016/S0140-6736(15)60995-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60995-3</ArticleId><ArticleId IdType="pubmed">26040499</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495-1499. doi:10.1016/j.ijsu.2014.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.07.013</ArticleId><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Santini D, Greco C, Feo GDe. Linee guida metastasi ossee e salute dell&#x2019;osso. November 26, 2021. Accessed December 5, 2023. https://www.aiom.it/linee-guida-aiom-2021-metastasi-ossee-e-salute-dellosso/</Citation></Reference><Reference><Citation>Rossini M, Adami S, Bertoldo F, et al. . Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo. 2016;68(1):1-39. doi:10.4081/reumatismo.2016.870</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/reumatismo.2016.870</ArticleId><ArticleId IdType="pubmed">27339372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadji P, Aapro MS, Body JJ, et al. . Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol. 2017;7:1-12. doi:10.1016/j.jbo.2017.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbo.2017.03.001</ArticleId><ArticleId IdType="pmc">PMC5384888</ArticleId><ArticleId IdType="pubmed">28413771</ArticleId></ArticleIdList></Reference><Reference><Citation>Diacinti D, Del Fiacco R, Pisani D, et al. . Diagnostic performance of vertebral fracture assessment by the lunar iDXA scanner compared to conventional radiography. Calcif Tissue Int. 2012;91(5):335-342. doi:10.1007/s00223-012-9643-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-012-9643-0</ArticleId><ArticleId IdType="pubmed">22965625</ArticleId></ArticleIdList></Reference><Reference><Citation>Crans GG, Genant HK, Krege JH. Prognostic utility of a semiquantitative spinal deformity index. Bone. 2005;37(2):175-179. doi:10.1016/j.bone.2005.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2005.04.003</ArticleId><ArticleId IdType="pubmed">15922683</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacalone M, Agata Z, Cozzucoli PC, Alibrandi A. Bonferroni-Holm and permutation tests to compare health data: methodological and applicative issues. BMC Med Res Methodol. 2018;18(1):81. doi:10.1186/s12874-018-0540-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-018-0540-8</ArticleId><ArticleId IdType="pmc">PMC6054729</ArticleId><ArticleId IdType="pubmed">30029629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnant M, Pfeiler G, Steger GG, et al. ; Austrian Breast and Colorectal Cancer Study Group . Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019;20(3):339-351. doi:10.1016/S1470-2045(18)30862-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(18)30862-3</ArticleId><ArticleId IdType="pubmed">30795951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnant M, Frantal S, Pfeiler G, et al. . Long-term outcomes of adjuvant denosumab in breast cancer: Fracture reduction and survival results from 3,425 patients in the randomised, double-blind, placebo-controlled ABCSG-18 trial. J Clin Oncol. 2022;40(16_suppl):507. doi:10.1200/JCO.2022.40.16_suppl.507</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2022.40.16_suppl.507</ArticleId></ArticleIdList></Reference><Reference><Citation>Turcotte AF, O&#x2019;Connor S, Morin SN, et al. . Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0252487. doi:10.1371/journal.pone.0252487</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0252487</ArticleId><ArticleId IdType="pmc">PMC8186797</ArticleId><ArticleId IdType="pubmed">34101735</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassio A, Idolazzi L, Rossini M, et al. . The obesity paradox and osteoporosis. Eat Weight Disord. 2018;23(3):293-302. doi:10.1007/s40519-018-0505-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40519-018-0505-2</ArticleId><ArticleId IdType="pubmed">29637521</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini S, Pedersini R, Birtolo MF, et al. . Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors. J Endocrinol Invest. 2023;(0123456789). doi:10.1007/s40618-023-02174-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-023-02174-5</ArticleId><ArticleId IdType="pubmed">37592052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest. 2019;129(8):3214-3223. doi:10.1172/JCI125915</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI125915</ArticleId><ArticleId IdType="pmc">PMC6668701</ArticleId><ArticleId IdType="pubmed">31120440</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing B, Yu J, Zhang H, Li Y. RANKL inhibition: a new target of treating diabetes mellitus? Ther Adv Endocrinol Metab. Published online May 20, 2023. doi:10.1177/20420188231170754</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20420188231170754</ArticleId><ArticleId IdType="pmc">PMC10201162</ArticleId><ArticleId IdType="pubmed">37223831</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnotti GM, Styner M, Uzer G, et al. . Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity. Nat Rev Endocrinol. 2019;15(6):339-355. doi:10.1038/s41574-019-0170-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-019-0170-1</ArticleId><ArticleId IdType="pmc">PMC6520125</ArticleId><ArticleId IdType="pubmed">30814687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaji H. Effects of myokines on bone. Bonekey Rep. 2016;5:826. doi:10.1038/bonekey.2016.48</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bonekey.2016.48</ArticleId><ArticleId IdType="pmc">PMC4954587</ArticleId><ArticleId IdType="pubmed">27579164</ArticleId></ArticleIdList></Reference><Reference><Citation>Palumbo C, Dalla Volta A, Zamboni S, et al. . Effect of degarelix administration on bone health in prostate cancer patients without bone metastases: the Blade Study. J Clin Endocrinol Metab. 2022;107(12):3398-3407. doi:10.1210/clinem/dgac489</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac489</ArticleId><ArticleId IdType="pubmed">35971857</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Harvey NC, Cooper C, Johansson H, Od&#xe9;n A, McCloskey EV; Advisory Board of the National Osteoporosis Guideline Group . A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11(1):25. doi:10.1007/s11657-016-0278-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-016-0278-z</ArticleId><ArticleId IdType="pmc">PMC4978487</ArticleId><ArticleId IdType="pubmed">27465509</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40437308</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-2630</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>International ophthalmology</Title><ISOAbbreviation>Int Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Visual field outcomes after cataract surgery with or without microinvasive glaucoma surgery in open-angle glaucoma: a systematic review and meta-analysis of RCTs reporting visual field results.</ArticleTitle><Pagination><StartPage>215</StartPage><MedlinePgn>215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10792-025-03579-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the benefits of combining microinvasive glaucoma surgery (MIGS) with cataract surgery (CS) for visual field (VF) preservation in patients with primary open-angle glaucoma (POAG) and coexisting cataracts.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis were conducted on randomised controlled trials (RCTs) comparing MIGS&#x2009;+&#x2009;CS to CS alone in POAG patients with cataracts that specifically reported visual field outcomes. Studies included were required to report VF outcomes with a follow-up of at least 12&#xa0;months. Subanalysis focused on studies with 24-month follow-up durations, and consistent device used.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three RCTs encompassing 857 eyes were included, with 523 eyes in the MIGS&#x2009;+&#x2009;CS group and 334 in the CS group. MIGS&#x2009;+&#x2009;CS was associated with a statistically significant reduced rate of VF deterioration in Mean Deviation (MD) at the 24-month follow-up compared to CS alone (SMD 0.29; p&#x2009;=&#x2009;0.007), and a&#xa0;significant difference between groups in the rate of VF progression (MD 0.23 decibels (dB)/year; p&#x2009;=&#x2009;0.00001).&#xa0;However, there was no difference in IOP reduction (MD -0.46&#xa0;mmHg; p&#x2009;=&#x2009;0.40). The MIGS&#x2009;+&#x2009;CS group showed a significant reduction in medication use (MD -0.36 medications; p&#x2009;&lt;&#x2009;0.00001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Among the MIGS devices studied (iStent and Hydrus), combining them with cataract surgery provided VF benefits&#xa0;in terms of rate of deterioration and decline, and reduced medication dependence. Standardised follow-up and reporting practices are essential for evaluating MIGS's role in glaucoma management.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tukur</LastName><ForeName>Hajar Nasir</ForeName><Initials>HN</Initials><Identifier Source="ORCID">0009-0000-1281-7307</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Bah&#xe7;e&#x15f;ehir &#xdc;niversitesi, Istanbul, Turkey. hajar.tukur@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintanar-Haro</LastName><ForeName>Orlando Daniel</ForeName><Initials>OD</Initials><Identifier Source="ORCID">0000-0002-8955-213X</Identifier><AffiliationInfo><Affiliation>Division of Ophthalmology, Hospital Ju&#xe1;rez del Centro, Ministry of Health, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toygar</LastName><ForeName>Okan</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-1072-3574</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Bah&#xe7;e&#x15f;ehir &#xdc;niversitesi, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int Ophthalmol</MedlineTA><NlmUniqueID>7904294</NlmUniqueID><ISSNLinking>0165-5701</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="Y">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="Y">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002387" MajorTopicYN="Y">Cataract Extraction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002386" MajorTopicYN="Y">Cataract</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="Y">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="Y">Trabeculectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cataract surgery</Keyword><Keyword MajorTopicYN="N">Glaucoma</Keyword><Keyword MajorTopicYN="N">MIGS</Keyword><Keyword MajorTopicYN="N">Microinvasive glaucoma surgery</Keyword><Keyword MajorTopicYN="N">Visual field</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: The authors declare no competing interests. Consent to participate: Not applicable (systematic review and meta-analysis of published studies). Consent to publish: Not applicable (no individual patient data or images are contained in this paper). Ethics approval: As this is a systematic review and meta-analysis, formal ethical approval was not required. No individual patient data was used.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40437308</ArticleId><ArticleId IdType="doi">10.1007/s10792-025-03579-2</ArticleId><ArticleId IdType="pii">10.1007/s10792-025-03579-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology 121(11):2081&#x2013;2090. https://doi.org/10.1016/j.ophtha.2014.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2014.05.013</ArticleId><ArticleId IdType="pubmed">24974815</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma. JAMA 311(18):1901. https://doi.org/10.1001/jama.2014.3192</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.3192</ArticleId><ArticleId IdType="pubmed">24825645</ArticleId><ArticleId IdType="pmc">4523637</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) (2024) Ageing and health [Internet]. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health#:~Accessed 22 January 2025</Citation></Reference><Reference><Citation>McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R (2007) Impact of visual field loss on health-related quality of life in glaucoma. Ophthalmology 115(6):941&#x2013;8.e1. https://doi.org/10.1016/j.ophtha.2007.08.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2007.08.037</ArticleId><ArticleId IdType="pubmed">17997485</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbagwu M, Chapman R, Garcia K, Masseria C, Dickerson JE, Cantor LB (2024) Ab interno minimally invasive glaucoma surgery combined with cataract surgery and cataract surgery alone: IRIS&#xae; registry study. AJO Int 1(2):100015. https://doi.org/10.1016/j.ajoint.2024.100015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajoint.2024.100015</ArticleId></ArticleIdList></Reference><Reference><Citation>Microinvasive Glaucoma Surgery (MIGS) &#x2013; EyeWiki (2023, May 11). https://eyewiki.org/Microinvasive_Glaucoma_Surgery_(MIGS ). Accessed 22 January 2025</Citation></Reference><Reference><Citation>Tezel G (2021) Multifactorial pathogenic processes of retinal ganglion cell degeneration in glaucoma&#x2014;towards multi-target strategies for broader treatment effects. Cells 10(6):1372. https://doi.org/10.3390/cells10061372</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061372</ArticleId><ArticleId IdType="pubmed">34199494</ArticleId><ArticleId IdType="pmc">8228726</ArticleId></ArticleIdList></Reference><Reference><Citation>Craven RE, Katz JL, Wells JM, Giamporcaro JE (2012) Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg 38(8):1339&#x2013;1345. https://doi.org/10.1016/j.jcrs.2012.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrs.2012.03.025</ArticleId><ArticleId IdType="pubmed">22814041</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan JC, Gaskin DB, Xiang GY, Kong MB, McGuinness AA, Liu L, Brooks AMV, Ang GS (2024) Prospective, randomized controlled trial of cataract surgery vs combined cataract surgery with insertion of iStent inject. Ophthalmol Glaucoma 7(4):326&#x2013;334. https://doi.org/10.1016/j.ogla.2024.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ogla.2024.02.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed IIK, De Francesco T, Rhee D, McCabe C, Flowers B, Gazzard G et al (2022) Long-term outcomes from the HORIZON Randomized Trial for a Schlemm&#x2019;s canal microstent in combination cataract and glaucoma surgery. Ophthalmology 129(7):742&#x2013;751. https://doi.org/10.1016/j.ophtha.2022.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2022.02.021</ArticleId><ArticleId IdType="pubmed">35218867</ArticleId></ArticleIdList></Reference><Reference><Citation>Montesano G, Ometto G, Ahmed IIK, Ramulu PY, Chang DF, Crabb DP et al (2023) Five-year visual field outcomes of the HORIZON Trial. Am J Ophthalmol 251:143&#x2013;155. https://doi.org/10.1016/j.ajo.2023.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2023.02.008</ArticleId><ArticleId IdType="pubmed">36813144</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId><ArticleId IdType="pmc">3196245</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner ML, Taha AM, Yonamine S, Yu Y, Saifee M, Yang M et al (2022) Clinical and visual field outcomes following minimally invasive glaucoma surgery combined with cataract surgery. Clin Ophthalmol 16:3193&#x2013;203</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OPTH.S381368</ArticleId><ArticleId IdType="pubmed">36199804</ArticleId><ArticleId IdType="pmc">9529010</ArticleId></ArticleIdList></Reference><Reference><Citation>Laroche D, Nkrumah G, Ng C (2020) Combination microinvasive glaucoma surgery: 23-gauge cystotome goniotomy and intra-scleral ciliary sulcus suprachoroidal microtube surgery in refractory and severe glaucoma: A case series. Indian J Ophthalmol 68(11):2557</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_892_20</ArticleId><ArticleId IdType="pubmed">33120691</ArticleId><ArticleId IdType="pmc">7774211</ArticleId></ArticleIdList></Reference><Reference><Citation>Hengerer FH, Auffarth GU, Conrad-Hengerer I (2024) 7-year efficacy and safety of iStent inject trabecular micro-bypass in combined and standalone usage. Adv Ther 41(4):1481&#x2013;95</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-024-02788-y</ArticleId><ArticleId IdType="pubmed">38363465</ArticleId><ArticleId IdType="pmc">10960914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura-Abreu N, Garc&#xed;a-Feijoo J, Pazos M, Biarn&#xe9;s M, Morales-Fern&#xe1;ndez L, Mart&#xed;nez-De-La-Casa JM (2021) Twelve-month results of ab interno trabeculectomy with Kahook Dual Blade: an interventional, randomized, controlled clinical study. Graefes Arch Clin Exp Ophthalmol 259(9):2771&#x2013;2781. https://doi.org/10.1007/s00417-021-05213-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-021-05213-0</ArticleId><ArticleId IdType="pubmed">33907888</ArticleId></ArticleIdList></Reference><Reference><Citation>Vold S, Ahmed IIK, Craven ER, Mattox C, Stamper R, Packer M et al (2016) Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology 123(10):2103&#x2013;2112. https://doi.org/10.1016/j.ophtha.2016.06.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2016.06.032</ArticleId><ArticleId IdType="pubmed">27506486</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew NH, Akkach S, Casson RJ (2020) A review of aqueous outflow resistance and its relevance to microinvasive glaucoma surgery. Surv Ophthalmol 65(1):18&#x2013;31. https://doi.org/10.1016/j.survophthal.2019.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.survophthal.2019.08.002</ArticleId><ArticleId IdType="pubmed">31425701</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37850595</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Life-threatening cardiac arrhythmia and sudden death during electronic gaming: An international case series and systematic review.</ArticleTitle><Pagination><StartPage>1826</StartPage><EndPage>1833</EndPage><MedlinePgn>1826-1833</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2022.08.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(22)02284-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Electronic gaming has recently been reported as a precipitant of life-threatening cardiac arrhythmia in susceptible individuals.</AbstractText><AbstractText Label="OBJECTIVE">The purpose of this study was to describe the population at risk, the nature of cardiac events, and the type of game linked to cardiac arrhythmia associated with electronic gaming.</AbstractText><AbstractText Label="METHODS">A multisite international case series of suspected or proven cardiac arrhythmia during electronic gaming in children and a systematic review of the literature were performed.</AbstractText><AbstractText Label="RESULTS">Twenty-two patients (18 in the case series and 4 via systematic review; aged 7-16 years; 19 males [86%]) were identified as having experienced suspected or proven ventricular arrhythmia during electronic gaming; 6 (27%) had experienced cardiac arrest, and 4 (18%) died suddenly. A proarrhythmic cardiac diagnosis was known in 7 (31%) patients before their gaming event and was established afterward in 12 (54%). Ten patients (45%) had catecholaminergic polymorphic ventricular tachycardia, 4 (18%) had long QT syndrome, 2 (9%) were post-congenital cardiac surgery, 2 (9%) had "idiopathic" ventricular fibrillation, and 1 (after Kawasaki disease) had coronary ischemia. In 3 patients (14%), including 2 who died, the diagnosis remains unknown. In 13 (59%) patients for whom the electronic game details were known, 8 (62%) were war games.</AbstractText><AbstractText Label="CONCLUSION">Electronic gaming can precipitate lethal cardiac arrhythmias in susceptible children. The incidence appears to be low, but syncope in this setting should be investigated thoroughly. In children with proarrhythmic cardiac conditions, electronic war games in particular are a potent arrhythmic trigger.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2022. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lawley</LastName><ForeName>Claire M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>The Heart Centre for Children, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia; The University of Sydney Children's Hospital Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Department of Paediatric Cardiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. Electronic address: claire.lawley@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tester</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children's Heart Centre, The University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanatani</LastName><ForeName>Shubhayan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Children's Heart Centre, The University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prendiville</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiac Surgery, Children's Health Ireland at Crumlin, Dublin, Republic of Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beach</LastName><ForeName>Cheyenne M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pediatric Cardiology, Yale University School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinocur</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pediatric Cardiology, Yale University School of Medicine, New Haven, Connecticut; Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horie</LastName><ForeName>Minoru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Shiga University of Medical Science, Shiga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhm</LastName><ForeName>Jae-Sun</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Yongin Severance Hospital, College of Medicine, Yonsei University, Yongin, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khongphatthanayothin</LastName><ForeName>Apichai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Yongin Severance Hospital, College of Medicine, Yonsei University, Yongin, Gyeonggi-do, Republic of Korea; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pediatric Cardiology, Pediatric Electrophysiology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starling</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Paediatric Cardiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Yoko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatric Electrophysiology, Osaka City General Hospital, Miyakojima-hondori, Miyakojima-ku, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Maully J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skinner</LastName><ForeName>Jonathan R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>The Heart Centre for Children, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Heart Centre for Children, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C537182">Paroxysmal ventricular fibrillation</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Heart Rhythm. 2022 Nov;19(11):1834-1835. doi: 10.1016/j.hrthm.2022.08.028.</RefSource><PMID Version="1">37850596</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N" AutoHM="Y">Ventricular Fibrillation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018910" MajorTopicYN="Y">Video Games</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003645" MajorTopicYN="N">Death, Sudden</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescent</Keyword><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">Electronic gaming</Keyword><Keyword MajorTopicYN="N">Sudden cardiac death</Keyword><Keyword MajorTopicYN="N">Syncope</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37850595</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2022.08.003</ArticleId><ArticleId IdType="pii">S1547-5271(22)02284-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30847997</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Percutaneous left ventricular assist device support during ablation of ventricular tachycardia: A meta-analysis of current evidence.</ArticleTitle><Pagination><StartPage>886</StartPage><EndPage>895</EndPage><MedlinePgn>886-895</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.13907</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Catheter ablation of ventricular tachycardia (VT) can be an effective therapy to reduce VT burden, but often it is limited by the potential for hemodynamic instability. Percutaneous left ventricular assist devices (pLVADs) have been used to maintain hemodynamic support during VT ablation but the evidence regarding its clinical impact has been inconclusive.</AbstractText><AbstractText Label="METHODS AND RESULTS">We sought to assess the clinical impact of pLVAD when used in VT ablation by conducting a meta-analysis of the current evidence. We searched Pubmed and found nine observational studies that compared clinical outcomes of VT ablation in patients with pLVAD support to controls with no pLVAD support. The pooled data did not show a significant difference in mortality between both groups, nor a difference in acute procedural success or in recurrence of VT. There was also no difference in the number of patients receiving a cardiac transplant or being enrolled in the transplant list. Although there was no difference in the ablation time between the groups, patients in the pLVAD group had a longer total procedural time and more procedure-related adverse effects.</AbstractText><AbstractText Label="CONCLUSION">This meta-analysis did not show clinical benefits from using pLVAD support during VT ablation, whereas it was associated with longer procedure times and more complications. This study was, however, limited by the observational nature of the data. In view of these data, the risk and benefit of pLVAD support during VT ablation should be considered on an individual basis.</AbstractText><CopyrightInformation>&#xa9; 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luni</LastName><ForeName>Faraz Khan</ForeName><Initials>FK</Initials><Identifier Source="ORCID">0000-0003-3785-431X</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zungsontiporn</LastName><ForeName>Nath</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farid</LastName><ForeName>Talha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Louisville, Louisville, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Sonia Ali</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Sobia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Louisville, Louisville, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Link</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-5277-9296</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joglar</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, UT Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiovasc Electrophysiol. 2019 Oct;30(10):2187-2188. doi: 10.1111/jce.14047.</RefSource><PMID Version="1">31310362</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="Y">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ablation</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">percutaneous left ventricular assist device (pLVAD)</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30847997</ArticleId><ArticleId IdType="doi">10.1111/jce.13907</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18690637</PMID><DateCompleted><Year>2008</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>9</Issue><PubDate><Year>2008</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review of randomized controlled trials on the effectiveness of virtual reality training for laparoscopic surgery.</ArticleTitle><Pagination><StartPage>1088</StartPage><EndPage>1097</EndPage><MedlinePgn>1088-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.6344</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Surgical training has traditionally been one of apprenticeship. The aim of this review was to determine whether virtual reality (VR) training can supplement and/or replace conventional laparoscopic training in surgical trainees with limited or no laparoscopic experience.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized clinical trials addressing this issue were identified from The Cochrane Library trials register, Medline, Embase, Science Citation Index Expanded, grey literature and reference lists. Standardized mean difference was calculated with 95 per cent confidence intervals based on available case analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-three trials (mostly with a high risk of bias) involving 622 participants were included in this review. In trainees without surgical experience, VR training decreased the time taken to complete a task, increased accuracy and decreased errors compared with no training. In the same participants, VR training was more accurate than video trainer (VT) training. In participants with limited laparoscopic experience, VR training resulted in a greater reduction in operating time, error and unnecessary movements than standard laparoscopic training. In these participants, the composite performance score was better in the VR group than the VT group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">VR training can supplement standard laparoscopic surgical training. It is at least as effective as video training in supplementing standard laparoscopic training.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gurusamy</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hepatopancreatobiliary and Liver Transplant Surgery, University Department of Surgery, Royal Free and University College School of Medicine, University College London and Royal Free Hospital NHS Trust, London NW32QG, UK. kurinchi2k@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Palanivelu</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>B R</ForeName><Initials>BR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Surg. 2009 Feb;96(2):222; author reply 222-3. doi: 10.1002/bjs.6565.</RefSource><PMID Version="1">19160354</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003194" MajorTopicYN="N">Computer-Assisted Instruction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004503" MajorTopicYN="N">Education, Medical, Graduate</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004521" MajorTopicYN="N">Educational Measurement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013502" MajorTopicYN="N">General Surgery</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>73</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>8</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>9</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>8</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18690637</ArticleId><ArticleId IdType="doi">10.1002/bjs.6344</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24349972</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2225-319X</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of cardiothoracic surgery</Title><ISOAbbreviation>Ann Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Custodiol for myocardial protection and preservation: a systematic review.</ArticleTitle><Pagination><StartPage>717</StartPage><EndPage>728</EndPage><MedlinePgn>717-28</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3978/j.issn.2225-319X.2013.11.10</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Custodiol cardioplegia is attractive for minimally invasive cardiac surgery, as a single dose provides a long period of myocardial protection. Despite widespread use in Europe, there is little data confirming its efficacy compared with conventional (blood or crystalloid) cardioplegia. There is similar enthusiasm for its use in organ preservation for transplant, but also a lack of data. This systematic review aimed to assess the evidence for the efficacy of Custodiol in myocardial protection and as a preservation solution in heart transplant.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic searches were performed of six databases from inception to October 2013. Reviewers independently identified studies that compared Custodiol with conventional cardioplegia (blood or extracellular crystalloid) in adult patients for meta-analysis; large case series that reported results using Custodiol were analyzed. Next, we identified studies that compared Custodiol with other organ preservation solutions for organ preservation in heart transplant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen studies compared Custodiol with conventional cardioplegia for myocardial protection in adult cardiac surgery. No difference was identified in mortality; there was a trend for increased incidence of ventricular fibrillation in the Custodiol group that did not reach statistical significance. No difference was identified in studies that compared Custodiol with other solutions for heart transplant.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite widespread clinical use, the evidence supporting the superiority of Custodiol over other solutions for myocardial protection or organ preservation is limited. Large randomised trials are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Edelman</LastName><ForeName>J James B</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Australia; ; The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seco</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunne</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Royal Perth Hospital, Perth, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matzelle</LastName><ForeName>Shannon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Sir Charles Gairdner Hospital, Nedlands, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Sir Charles Gairdner Hospital, Nedlands, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joshi</LastName><ForeName>Pragnesh</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Tristan D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia; ; Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Michael K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia; ; Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia; ; Australian School of Advanced Medicine, Macquarie University, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bannon</LastName><ForeName>Paul G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia; ; Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallely</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>The Baird Institute; Sydney Medical School, University of Sydney, Sydney, Australia; ; Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia; ; Australian School of Advanced Medicine, Macquarie University, Sydney, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passage</LastName><ForeName>Jurgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Australia; ; Notre Dame Medical School, Fremantle, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Ann Cardiothorac Surg</MedlineTA><NlmUniqueID>101605877</NlmUniqueID><ISSNLinking>2225-319X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Custodiol solution</Keyword><Keyword MajorTopicYN="N">cardiac transplantation</Keyword><Keyword MajorTopicYN="N">heart arrest</Keyword><Keyword MajorTopicYN="N">histidine-tryptophan-ketoglutarate solution</Keyword><Keyword MajorTopicYN="N">induced</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24349972</ArticleId><ArticleId IdType="pmc">PMC3857005</ArticleId><ArticleId IdType="doi">10.3978/j.issn.2225-319X.2013.11.10</ArticleId><ArticleId IdType="pii">acs-02-06-717</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gebhard MM, Preusse CJ, Schnabel PA, et al. Different effects of cardioplegic solution HTK during single or intermittent administration. Thorac Cardiovasc Surg 1984;32:271-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6083614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980;28:295-302</Citation><ArticleIdList><ArticleId IdType="pubmed">6161427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretschneider HJ, H&#xfc;bner G, Knoll D, et al. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg (Torino) 1975;16:241-60</Citation><ArticleIdList><ArticleId IdType="pubmed">239002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 2003;75:S661-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12607709</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana FF, Shi WY, Hayward PA, et al. Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience. Eur J Cardiothorac Surg 2013;43:526-31</Citation><ArticleIdList><ArticleId IdType="pubmed">22665382</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji B, Liu J, Long C, et al. Potential risk of hyponatremia using histidine-tryptophan-ketoglutarate solution during pediatric cardiopulmonary bypass. Ann Thorac Surg 2012;93:2120-1; author reply 2121</Citation><ArticleIdList><ArticleId IdType="pubmed">22632526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JT, Park YH, Chang YE, et al. The effect of cardioplegic solution-induced sodium concentration fluctuation on postoperative seizure in pediatric cardiac patients. Ann Thorac Surg 2011;91:1943-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21511247</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenspurner H, Russ C, Uberfuhr P, et al. Myocardial preservation using HTK solution for heart transplantation. A multicenter study. Eur J Cardiothorac Surg 1993;7:414-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8398188</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;lscher M, Groenewoud AF. Current status of the HTK solution of Bretschneider in organ preservation. Transplant Proc 1991;23:2334-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1926380</ArticleId></ArticleIdList></Reference><Reference><Citation>Demmy TL, Biddle JS, Bennett LE, et al. Organ preservation solutions in heart transplantation--patterns of usage and related survival. Transplantation 1997;63:262-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9020328</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman JJ, Seco M, Dunne B, et al. Systematic review protocol: single-dose histidine-tryptophan-ketoglutarate vs. intermittent crystalloid or blood cardioplegia. Ann Cardiothorac Surg 2013;2:677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791192</ArticleId><ArticleId IdType="pubmed">24109584</ArticleId></ArticleIdList></Reference><Reference><Citation>Braathen B, Jeppsson A, Scherst&#xe9;n H, et al. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg 2011;141:995-1001</Citation><ArticleIdList><ArticleId IdType="pubmed">20800244</ArticleId></ArticleIdList></Reference><Reference><Citation>Careaga G, Salazar D, T&#xe9;llez S, et al. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients. Arch Med Res 2001;32:296-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11440787</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707010</ArticleId><ArticleId IdType="pubmed">19621070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderdiek U, Feindt P, Gams E.Aortocoronary bypass grafting: a comparison of HTK cardioplegia vs. intermittent aortic cross-clamping. Eur J Cardiothorac Surg 2000;18:393-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11024374</ArticleId></ArticleIdList></Reference><Reference><Citation>Imanaka K, Kyo S, Ogiwara M, et al. Mitral valve surgery under perfused ventricular fibrillation with moderate hypothermia. Circ J 2002;66:450-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12030338</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M, Pragliola C, Anselmi A, et al. Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery. Scand Cardiovasc J. 2013 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">24053647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kammerer I, Nagib R, Hipp G, et al. Myocardial Protection in Minimally Invasive Mitral Valve Surgery: Comparison of the Cold-Blood Cardioplegia of the Bretschneider Solution and the Warm-Blood Cardioplegia of the Calafiore Protocol. Arch Clin Exp Surg 2012;1:14-21</Citation></Reference><Reference><Citation>Sansone F, Punta G, Parisi F, et al. Right minithoracotomy versus full sternotomy for the aortic valve replacement: preliminary results. Heart Lung Circ 2012;21:169-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22071201</ArticleId></ArticleIdList></Reference><Reference><Citation>Scrascia G, Guida P, Rotunno C, et al. Myocardial protection during aortic surgery: comparison between Bretschneider-HTK and cold blood cardioplegia. Perfusion 2011;26:427-33</Citation><ArticleIdList><ArticleId IdType="pubmed">21665911</ArticleId></ArticleIdList></Reference><Reference><Citation>Demmy TL, Molina JE, Ward HB, et al. Custodiol versus Plegisol: A phase 3 multicentre myocardial protection study. Int J Angiol 2008;17:149-53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2727762</ArticleId><ArticleId IdType="pubmed">22477420</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan A, Sezgin A, Gultekin B, et al. Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection. Transplant Proc 2005;37:3219-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16213352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesenack C, Liebold A, Philipp A, et al. Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 2004;28:1082-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15554936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata J, Morishita K, Ito T, et al. Comparison of clinical outcome between histidine-triptophan-ketoglutalate solution and cold blood cardioplegic solution in mitral valve replacement. J Card Surg 1998;13:43-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9892485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachida M, Nonoyama M, Bonkohara Y, et al. Clinical assessment of prolonged myocardial preservation for patients with a severely dilated heart. Ann Thorac Surg 1997;64:59-63</Citation><ArticleIdList><ArticleId IdType="pubmed">9236335</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyersdorf F, Krause E, Sarai K, et al. Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery. Thorac Cardiovasc Surg 1990;38:20-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2106735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallandat Huet RC, Karliczek GF, van der Heide JN, et al. Clinical effect of Bretschneider-HTK and St. Thomas cardioplegia on hemodynamic performance after bypass measured using an automatic datalogging database system. Thorac Cardiovasc Surg 1988;36:151-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3145585</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Eusanio M, Pantaleo A, Murana G, et al. Frozen elephant trunk surgery-the Bologna&#x2019;s experience. Ann Cardiothorac Surg 2013;2:597-605</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791204</ArticleId><ArticleId IdType="pubmed">24109567</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami K, Zittermann A, Schulte-Eistrup S, et al. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg 2005;80:1699-705</Citation><ArticleIdList><ArticleId IdType="pubmed">16242441</ArticleId></ArticleIdList></Reference><Reference><Citation>Misfeld M, Davierwala P.Crystalloid-based cardioplegia for minimally invasive cardiac surgery. Semin Thorac Cardiovasc Surg 2012;24:305-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23465680</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha M, Baraki H, Maeding I, et al. Long-term results after aortic valve-sparing operation (David I). Eur J Cardiothorac Surg 2012;41:56-61; discussion 61-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241084</ArticleId><ArticleId IdType="pubmed">21632258</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha M, Martens A, Kr&#xfc;ger H, et al. Total aortic arch replacement with the elephant trunk technique: single-centre 30-year results. Eur J Cardiothorac Surg. 2013 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">23872461</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K, Wiesner G, Breuer T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008;107:1783-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19020118</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvador L, Mirone S, Bianchini R, et al. A 20-year experience with mitral valve repair with artificial chordae in 608 patients. J Thorac Cardiovasc Surg 2008;135:1280-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18544371</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis F, Kilger E, Beiras-Fernandez A, et al. Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 2006;61:938-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16978306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannata A, Botta L, Colombo T, et al. Does the cardioplegic solution have an effect on early outcomes following heart transplantation? Eur J Cardiothorac Surg 2012;41:e48-52; discussion e52-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">22423082</ArticleId></ArticleIdList></Reference><Reference><Citation>Garlicki M.May preservation solution affect the incidence of graft vasculopathy in transplanted heart? Ann Transplant 2003;8:19-24</Citation><ArticleIdList><ArticleId IdType="pubmed">12848379</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenspurner H, Russ C, Wagner F, et al. Comparison of UW versus HTK solution for myocardial protection in heart transplantation. Transpl Int 1994;7Suppl 1:S481-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11271286</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofler S, Bigdeli AK, Kaczmarek I, et al. Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center. Transpl Int 2009;22:1140-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19891043</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami K, Omoto T, B&#xf6;thig D, et al. Creatine kinase and troponin after myocardial preservation using HTK solution (Custoidol) for clinical heart transplantation. J Heart Lung Transplant 2003;22:192-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12581768</ArticleId></ArticleIdList></Reference><Reference><Citation>Guru V, Omura J, Alghamdi AA, et al. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation 2006;114:I331-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16820596</ArticleId></ArticleIdList></Reference><Reference><Citation>Fannelop T, Dahle GO, Salminen PR, et al. Multidose cold oxygenated blood is superior to a single dose of Bretschneider HTK-cardioplegia in the pig. Ann Thorac Surg 2009;87:1205-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19324152</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarsaether E, Stenberg TA, Jakobsen &#xd8;, et al. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas&#x2019; and histidine-tryptophan-ketoglutarate cardioplegia-- an experimental comparative study in pigs. Interact Cardiovasc Thorac Surg 2009;9:635-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19628529</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Liu J, Li S, et al. Which is the better option during neonatal cardiopulmonary bypass: HTK solution or cold blood cardioplegia? ASAIO J 2013;59:69-74</Citation><ArticleIdList><ArticleId IdType="pubmed">23263337</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojan M, Peperstraete H, Lilot M, et al. Cold histidine-tryptophan-ketoglutarate solution and repeated oxygenated warm blood cardioplegia in neonates with arterial switch operation. Ann Thorac Surg 2013;95:1390-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23462260</ArticleId></ArticleIdList></Reference><Reference><Citation>Korun O, &#xd6;zkan M, Terzi A, et al. The comparison of the effects of Bretschneider's histidine-tryptophan-ketoglutarate and conventional crystalloid cardioplegia on pediatric myocardium at tissue level. Artif Organs 2013;37:76-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23305576</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Feng Z, Zhao J, et al. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. ASAIO J 2008;54:470-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18812735</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad F, Couture P, Tousignant C, et al. The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management. Anesth Analg 2009;108:422-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19151265</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner G, Zapletal B, Schwarz C, et al. Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate--a retrospective study. J Cardiothorac Surg 2012;7:52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430602</ArticleId><ArticleId IdType="pubmed">22681759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lueck S, Preusse CJ, Welz A. Clinical relevance of HTK-induced hyponatremia. Ann Thorac Surg 2013;95:1844-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23608285</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh Y, Hashimoto M, Ku K, et al. Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function. Ann Thorac Surg 2000;69:107-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10654496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Huang CS, Kawamura T, et al. Histidine-tryptophan-ketoglutarate or celsior: which is more suitable for cold preservation for cardiac grafts from older donors? Ann Thorac Surg 2011;91:755-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21352993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Huang CS, Kawamura T, et al. Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia. Surgery 2010;148:463-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20627336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima ML, Fiorelli AI, Vassallo DV, et al. Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation. Rev Bras Cir Cardiovasc 2012;27:110-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22729308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackemann J, Gross W, Mory M, et al. Celsior versus custodiol: early postischemic recovery after cardioplegia and ischemia at 5 degrees C. Ann Thorac Surg 2002;74:522-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12173839</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40280495</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Antiosteoporosis medication in patients with posterior spine fusion: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1877</StartPage><EndPage>1898</EndPage><MedlinePgn>1877-1898</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2025.04.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(25)00204-9</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">Osteoporosis and osteopenia are common among patients undergoing posterior spine fusion surgery, presenting challenges such as pseudarthrosis, screw loosening, and poor patient outcomes. While pharmacological interventions are available, no consensus exists regarding the optimal perioperative treatment for these patients. Furthermore, the effectiveness of various treatment options in improving fusion rates and minimizing complications remains uncertain.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare the effects of teriparatide, bisphosphonates, denosumab, and romosozumab in patients with posterior spine fusion with low bone mineral density (BMD).</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">Adult patients with low BMD receiving osteoporosis medications and undergoing posterior spine fusion surgery.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Fusion rate, subsequent vertebral fracture (VF), screw loosening, cage subsidence, proximal junctional kyphosis (PJK), and patient-reported outcomes (PROs), particularly the Visual Analogue Scale (VAS) and Oswestry Disability Index (ODI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search was conducted using PubMed, EMBASE, and Cochrane Library. Two reviewers independently selected and assessed relevant studies. Four groups were analyzed to evaluate the comparative effectiveness of antiosteoporosis medication on the outcome measures: Bisphosphonate versus Control; Teriparatide versus Control; Teriparatide versus Bisphosphonate; and Denosumab versus Control.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Bisphosphonate showed reduced subsequent VFs (odds ratio [OR]=0.27, 95% confidence interval [CI]=0.09-0.81) and cage subsidence (OR=0.29, 95% CI=0.11-0.75) and improved ODI scores at 12 months (standardized mean difference [SMD] [95% CI]=-0.75 [-1.42, -0.08]) compared to the control. Teriparatide showed a higher fusion rate (OR=3.52, 95% CI=1.84-6.75), lower screw loosening (OR=0.23, 95% CI=0.09-0.60), and improved ODI scores at 24 months (SMD [95% CI]=-0.57 [-0.99, -0.15]) compared to the control. Moreover, teriparatide showed a higher fusion rate (OR=2.28, 95% CI=1.67-3.11), lower subsequent VF (OR=0.22, 95% CI=0.09-0.51), and improved VAS score for back pain (VASB) (mean difference [MD] [95% CI]=-0.30 [-0.54, -0.07]) and ODI (SMD [95% CI]=-0.38[-0.64, -0.12]) scores at 12 months compared to bisphosphonate. Denosumab showed no significant difference in fusion rate or other complications compared to control.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results indicated that teriparatide should be used as the first-line perioperative treatment for patients with poor bone quality scheduled for posterior spine fusion. Teriparatide exhibited better fusion rates and reduced complications than controls and bisphosphonates, resulting in improved PROs. Moreover, bisphosphonates can be utilized in patients with contraindications to teriparatide since the former prevents osteoporosis-related complications compared to controls, resulting in improved PROs. Further studies are warranted to evaluate the potential effects of denosumab and romosozumab.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>HyungSub</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>HyungJu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yonsei University College of Medicine, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suk</LastName><ForeName>Kyung-Soo</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Byung Ho</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Si Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hak-Sun</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Seong-Hwan</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sub-Ri</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Namhoo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Jae Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Ji-Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. Electronic address: kwonjjanng@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050071">Bone Density Conservation Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>10T9CSU89I</RegistryNumber><NameOfSubstance UI="D019379">Teriparatide</NameOfSubstance></Chemical><Chemical><RegistryNumber>4EQZ6YO2HI</RegistryNumber><NameOfSubstance UI="D000069448">Denosumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004164">Diphosphonates</NameOfSubstance></Chemical><Chemical><RegistryNumber>3VHF2ZD92J</RegistryNumber><NameOfSubstance UI="C557282">romosozumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="Y">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050071" MajorTopicYN="Y">Bone Density Conservation Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="Y">Osteoporosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019379" MajorTopicYN="N">Teriparatide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069448" MajorTopicYN="N">Denosumab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004164" MajorTopicYN="N">Diphosphonates</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bisphosphonate</Keyword><Keyword MajorTopicYN="N">Cage subsidence</Keyword><Keyword MajorTopicYN="N">Denosumab</Keyword><Keyword MajorTopicYN="N">Fusion</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Proximal junctional kyphosis</Keyword><Keyword MajorTopicYN="N">Romosozumab</Keyword><Keyword MajorTopicYN="N">Screw loosening</Keyword><Keyword MajorTopicYN="N">Teriparatide</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>7</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>26</Day><Hour>16</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>19</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40280495</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2025.04.018</ArticleId><ArticleId IdType="pii">S1529-9430(25)00204-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35880155</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5141</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of hand surgery global online</Title><ISOAbbreviation>J Hand Surg Glob Online</ISOAbbreviation></Journal><ArticleTitle>Peripheral Nerve Injury After Upper-Extremity Surgery Performed Under Regional Anesthesia: A Systematic Review.</ArticleTitle><Pagination><StartPage>201</StartPage><EndPage>207</EndPage><MedlinePgn>201-207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhsg.2022.04.011</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Peripheral nerve injury (PNI) is a known adverse event following upper-limb surgery performed under brachial plexus regional anesthesia (RA). When PNI is noted after surgery, patients and providers often have questions about which factors might have contributed to this complication. This systematic review evaluates the literature on hand and shoulder surgeries performed under ultrasound-guided, plexus RA to identify factors potentially associated with PNI, including the surgery location and block type. We hypothesized that shoulder surgery might be associated with an increased risk of PNI compared to hand surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systematic review of the relevant literature was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Only prospective studies on the use of ultrasound-guided, preoperative, brachial plexus RA for hand or shoulder surgery on adult patients were included. Study groups were categorized according to surgery location and block type and compared across a number of factors via univariate and multivariate analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 3,037 abstracts were screened; 192 full-text articles were independently reviewed by 2 of the authors; and 53 studies were included in the systematic review analysis. Following hand surgery, PNI was reported at an average rate of 1.35% &#xb1; 3.21% across 836 subjects in 40 study groups; after shoulder surgery, the average rate was 0.50% &#xb1; 1.57% across 3,383 subjects in 15 study groups. There was no statistically significant correlation between the incidence of PNI and surgery location (<i>P</i>&#xa0;=.70) or any of the most common approaches for brachial plexus anesthesia in the multivariate analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This systematic review of over 50 articles on upper-limb surgery performed under RA shows no association between the incidence of PNI and the location of surgery or type of brachial plexus block.</AbstractText><AbstractText Label="TYPE OF STUDY/LEVEL OF EVIDENCE" NlmCategory="UNASSIGNED">Diagnostic II.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silverstein</LastName><ForeName>Max Lester</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Division of Plastic and Reconstructive Surgery, Stanford Hospital and Clinics, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tevlin</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Plastic and Reconstructive Surgery, Stanford Hospital and Clinics, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higgins</LastName><ForeName>Kenneth Elliott</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Vermont Larner College of Medicine, Burlington, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedreira</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Plastic and Reconstructive Surgery, Stanford Hospital and Clinics, Palo Alto, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curtin</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Plastic and Reconstructive Surgery, Stanford Hospital and Clinics, Palo Alto, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Palo Alto Veterans Hospital, Palo Alto, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Hand Surg Glob Online</MedlineTA><NlmUniqueID>101759126</NlmUniqueID><ISSNLinking>2589-5141</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brachial plexus</Keyword><Keyword MajorTopicYN="N">Nerve injury</Keyword><Keyword MajorTopicYN="N">PNI</Keyword><Keyword MajorTopicYN="N">Regional anesthesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>2</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35880155</ArticleId><ArticleId IdType="pmc">PMC9308165</ArticleId><ArticleId IdType="doi">10.1016/j.jhsg.2022.04.011</ArticleId><ArticleId IdType="pii">S2589-5141(22)00057-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hadzic A., Williams B.A., Karaca P.E., et al. For outpatient rotator cuff surgery, nerve block anesthesia provides superior same-day recovery over general anesthesia. Anesthesiology. 2005;102(5):1001&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">15851888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie E.D., Tong D., Chung F., Norris A.M., Miniaci A., Vairavanathan S.D. Suprascapular nerve block for postoperative pain relief in arthroscopic shoulder surgery: a new modality? Anesth Analg. 1997;84(6):1306&#x2013;1312.</Citation><ArticleIdList><ArticleId IdType="pubmed">9174311</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V.W., Peng P.W., Kaszas Z., et al. A&#xa0;comparative study of general anesthesia, intravenous regional anesthesia, and axillary block for outpatient hand surgery: clinical outcome and cost analysis. Anesth Analg. 2001;93(5):1181&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11682392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadzic A., Arliss J., Kerimoglu B., et al. A&#xa0;comparison of infraclavicular nerve block versus general anesthesia for hand and wrist day-case surgeries. Anesthesiology. 2004;101(1):127&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15220781</ArticleId></ArticleIdList></Reference><Reference><Citation>Sites B.D., Taenzer A.H., Herrick M.D., et al. Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks: an analysis from a prospective clinical registry. Reg Anesth Pain Med. 2012;37(5):478&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">22705953</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal J.M., Barrington M.J., Brull R., et al. The second ASRA practice advisory on neurologic complications associated with regional anesthesia and pain medicine: executive summary 2015. Reg Anesth Pain Med. 2015;40(5):401&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">26288034</ArticleId></ArticleIdList></Reference><Reference><Citation>Droog W., Lin D.Y., van Wijk J.J., et al. Is it the surgery or the block? Incidence, risk factors, and outcome of nerve injury following upper extremity surgery. Plast Reconstr Surg Glob Open. 2019;7(9):e2458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6799396</ArticleId><ArticleId IdType="pubmed">31741818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwyer T., Henry P.D., Cholvisudhi P., Chan V.W., Theodoropoulos J.S., Brull R. Neurological complications related to elective orthopedic surgery: part 1: common shoulder and elbow procedures. Reg Anesth Pain Med. 2015;40(5):431&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pubmed">26192546</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgeat A., Ekatodramis G., Kalberer F., Benz C. Acute and nonacute complications associated with interscalene block and shoulder surgery: a prospective study. Anesthesiology. 2001;95(4):875&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">11605927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sviggum H.P., Jacob A.K., Mantilla C.B., Schroeder D.R., Sperling J.W., Hebl J.R. Perioperative nerve injury after total shoulder arthroplasty: assessment of risk after regional anesthesia. Reg Anesth Pain Med. 2012;37(5):490&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">22705952</ArticleId></ArticleIdList></Reference><Reference><Citation>Boardman N.D., III, Cofield R.H. Neurologic complications of shoulder surgery. Clin Orthop Relat Res. 1999;368(368):44&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">10613152</ArticleId></ArticleIdList></Reference><Reference><Citation>Candido K.D., Sukhani R., Doty R., II, et al. Neurologic sequelae after interscalene brachial plexus block for shoulder/upper arm surgery: the association of patient, anesthetic, and surgical factors to the incidence and clinical course. Anesth Analg. 2005;100(5):1489&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">15845712</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdecchia N., Johnson J., Baratz M., Orebaugh S. Neurologic complications in common wrist and hand surgical procedures. Orthop Rev (Pavia) 2018;10(1):7355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5937362</ArticleId><ArticleId IdType="pubmed">29770175</ArticleId></ArticleIdList></Reference><Reference><Citation>Seddon H.J. Three types of nerve injury. Brain. 1943;66(4):237&#x2013;288.</Citation></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapral S., Krafft P., Eibenberger K., Fitzgerald R., Gosch M., Weinstabl C. Ultrasound-guided supraclavicular approach for regional anesthesia of the brachial plexus. Anesth Analg. 1994;78(3):507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pubmed">8109769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ootaki C., Hayashi H., Amano M. Ultrasound-guided infraclavicular brachial plexus block: an alternative technique to anatomical landmark-guided approaches. Reg Anesth Pain Med. 2000;25(6):600&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">11097667</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams S.R., Chouinard P., Arcand G., et al. Ultrasound guidance speeds execution and improves the quality of supraclavicular block. Anesth Analg. 2003;97(5):1518&#x2013;1523.</Citation><ArticleIdList><ArticleId IdType="pubmed">14570678</ArticleId></ArticleIdList></Reference><Reference><Citation>Brull R., Lupu M., Perlas A., Chan V.W., McCartney C.J. Compared with dual nerve stimulation, ultrasound guidance shortens the time for infraclavicular block performance. Can J Anaesth. 2009;56(11):812&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">19728002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran D.Q., Clemente A., Tran D.Q., Finlayson R.J. A&#xa0;comparison between ultrasound-guided infraclavicular block using the "Double Bubble" sign and neurostimulation-guided axillary block. Anesth Analg. 2008;107(3):1075&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">18713932</ArticleId></ArticleIdList></Reference><Reference><Citation>Zencirci B. Comparision of nerve stimulator and ultrasonography as the techniques applied for brachial plexus anesthesia. Int Arch Med. 2011;4(1):4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035035</ArticleId><ArticleId IdType="pubmed">21255404</ArticleId></ArticleIdList></Reference><Reference><Citation>Holbrook H.S., Parker B.R. Peripheral nerve injury following interscalene blocks: a systematic review to guide orthopedic surgeons. Orthopedics. 2018;41(5):e598&#x2013;e606.</Citation><ArticleIdList><ArticleId IdType="pubmed">30125041</ArticleId></ArticleIdList></Reference><Reference><Citation>Azmin F., Choy Y. Regional infraclavicular blocks via the coracoid approach for below-elbow surgery: a comparison between ultrasound guidance with, or without, nerve stimulation. South Afr J Anaesth Analg. 2013;19(5):263&#x2013;269.</Citation></Reference><Reference><Citation>Imasogie N., Ganapathy S., Singh S., Armstrong K., Armstrong P. A&#xa0;prospective, randomized, double-blind comparison of ultrasound-guided axillary brachial plexus blocks using 2 versus 4 injections. Anesth Analg. 2010;110(4):1222&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pubmed">20142336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V.W., Perlas A., McCartney C.J., Brull R., Xu D., Abbas S. Ultrasound guidance improves success rate of axillary brachial plexus block. Can J Anaesth. 2007;54(3):176&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">17331928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderland S. A&#xa0;classification of peripheral nerve injuries producing loss of function. Brain. 1951;74(4):491&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">14895767</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E.J., Choi Y.M., Jang E.J., Kim J.Y., Kim T.K., Kim K.H. Neural ablation and regeneration in pain practice. Korean J Pain. 2016;29(1):3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731549</ArticleId><ArticleId IdType="pubmed">26839664</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvites R., Rita Caseiro A., Santos Pedrosa S., et al. Peripheral nerve injury and axonotmesis: state of the art and recent advances. Cogent Med. 2018;5(1):1466404.</Citation></Reference><Reference><Citation>Burnett M.G., Zager E.L. Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus. 2004;16(5):E1.</Citation><ArticleIdList><ArticleId IdType="pubmed">15174821</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell W.W. Evaluation and management of peripheral nerve injury. Clin Neurophysiol. 2008;119(9):1951&#x2013;1965.</Citation><ArticleIdList><ArticleId IdType="pubmed">18482862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambi U., Bhanupriya P., Hulkund S.Y., Prakashappa D.S. Comparison between perivascular and perineural ultrasound-guided axillary brachial plexus block using levobupivacaine: a prospective, randomised clinical study. Indian J Anaesth. 2015;59(10):658&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4645355</ArticleId><ArticleId IdType="pubmed">26644614</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcand G., Williams S.R., Chouinard P., et al. Ultrasound-guided infraclavicular versus supraclavicular block. Anesth Analg. 2005;101(3):886&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pubmed">16116009</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloc S., Mercadal L., Garnier T., et al. Comfort of the patient during axillary blocks placement: a randomized comparison of the neurostimulation and the ultrasound guidance techniques. Eur J Anaesthesiol. 2010;27(7):628&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">20299995</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin A., Nadeau M.J., Dion N., L&#xe9;vesque S., Nicole P.C., Turgeon A.F. Ultrasound-guided single-injection infraclavicular block versus ultrasound-guided double-injection axillary block: a noninferiority randomized controlled trial. Anesth Analg. 2016;122(1):273&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">26516803</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Iohom G., Mahon P., Shorten G. Efficacy of axillary versus infraclavicular brachial plexus block in preventing tourniquet pain: a randomised trial. Eur J Anaesthesiol. 2019;36(1):48&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">30461447</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A., Danelli G., Baciarello M., et al. A&#xa0;prospective, randomized comparison between ultrasound and nerve stimulation guidance for multiple injection axillary brachial plexus block. Anesthesiology. 2007;106(5):992&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pubmed">17457131</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary N., Kumar A., Kohli A., et al. Single-point versus double-point injection technique of ultrasound-guided supraclavicular block: a randomized controlled study. J&#xa0;Anaesthesiol Clin Pharmacol. 2019;35(3):373&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6748018</ArticleId><ArticleId IdType="pubmed">31543588</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgagn&#xe9;s M.C., L&#xe9;vesque S., Dion N., et al. A&#xa0;comparison of a single or triple injection technique for ultrasound-guided infraclavicular block: a prospective randomized controlled study. Anesth Analg. 2009;109(2):668&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pubmed">19608845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertikin A., Argun G., M&#x131;s&#x131;rl&#x131;o&#x11f;lu M., Ayd&#x131;n M., Ar&#x131;kan M., Kad&#x131;o&#x11f;ullar&#x131; N. Comparison between the two-injection technique and the four-injection technique in axillary brachial plexus block with articaine. Turk J Anaesthesiol Reanim. 2017;45(5):289&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5656164</ArticleId><ArticleId IdType="pubmed">29114414</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen B.S., Koscielniak-Nielsen Z.J., Jacobsen R.B., Rasmussen H., Hesselbjerg L. Procedural pain of an ultrasound-guided brachial plexus block: a comparison of axillary and infraclavicular approaches. Acta Anaesthesiol Scand. 2010;54(4):408&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">20055762</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredrickson M.J., Kilfoyle D.H. Neurological complication analysis of 1000 ultrasound guided peripheral nerve blocks for elective orthopaedic surgery: a prospective study. Anaesthesia. 2009;64(8):836&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">19604186</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredrickson M.J., Patel A., Young S., Chinchanwala S. Speed of onset of &#x201c;corner pocket supraclavicular&#x201d; and infraclavicular ultrasound guided brachial plexus block: a randomised observer-blinded comparison. Anaesthesia. 2009;64(7):738&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">19624628</ArticleId></ArticleIdList></Reference><Reference><Citation>Grape S., Pawa A., Weber E., Albrecht E. Retroclavicular vs supraclavicular brachial plexus block for distal upper limb surgery: a randomised, controlled, single-blinded trial. Br J Anaesth. 2019;122(4):518&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6435841</ArticleId><ArticleId IdType="pubmed">30857608</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussien R.M., Ibrahim D.A. Ultrasound guided axillary brachial plexus block versus supraclavicular block in emergency crushed hand patients: a comparative study. Open Anesthesiol J. 2018;12(1):34&#x2013;41.</Citation></Reference><Reference><Citation>Kavrut Ozturk N., Kavakli A.S. Comparison of the coracoid and retroclavicular approaches for ultrasound-guided infraclavicular brachial plexus block. J&#xa0;Anesth. 2017;31(4):572&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pubmed">28421316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kii N., Yamauchi M., Takahashi K., Yamakage M., Wada T. Differential axillary nerve block for hand or forearm soft-tissue surgery. J&#xa0;Anesth. 2014;28(4):549&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">24375222</ArticleId></ArticleIdList></Reference><Reference><Citation>Koscielniak-Nielsen Z.J., Frederiksen B.S., Rasmussen H., Hesselbjerg L. A&#xa0;comparison of ultrasound-guided supraclavicular and infraclavicular blocks for upper extremity surgery. Acta Anaesthesiol Scand. 2009;53(5):620&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">19419356</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F.C., Liou J.T., Tsai Y.F., et al. Efficacy of ultrasound-guided axillary brachial plexus block: a comparative study with nerve stimulator-guided method. Chang Gung Med J. 2005;28(6):396&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">16124155</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q., Yao W., Chai Y., et al. Comparison of ultrasound-guided supraclavicular and costoclavicular brachial plexus block using a modified double-injection technique: a randomized non-inferiority trial. Biosci Rep. 2020;40(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7284325</ArticleId><ArticleId IdType="pubmed">32441302</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q., Yao W., Shu H., Zhong M. Double-injection technique assisted by a nerve stimulator for ultrasound-guided supraclavicular brachial plexus block results in better distal sensory-motor block: a randomised controlled trial. Eur J Anaesthesiol. 2017;34(3):127&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">27798452</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauter A.R., Dodgson M.S., Stubhaug A., Halstensen A.M., Klaastad &#xd8;. Electrical nerve stimulation or ultrasound guidance for lateral sagittal infraclavicular blocks: a randomized, controlled, observer-blinded, comparative study. Anesth Analg. 2008;106(6):1910&#x2013;1915.</Citation><ArticleIdList><ArticleId IdType="pubmed">18499631</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha C., Kumar N., Kumar A., Kumar A., Kumar A. Comparative evaluation of two approaches of infraclavicular brachial plexus block for upper-limb surgeries. Saudi J Anaesth. 2019;13(1):35&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329239</ArticleId><ArticleId IdType="pubmed">30692886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivashanmugam T., Ray S., Ravishankar M., Jaya V., Selvam E., Karmakar M.K. Randomized comparison of extrafascial versus subfascial injection of local anesthetic during ultrasound-guided supraclavicular brachial plexus block. Reg Anesth Pain Med. 2015;40(4):337&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">26066385</ArticleId></ArticleIdList></Reference><Reference><Citation>Stav A., Reytman L., Stav M.Y., et al. Comparison of the supraclavicular, infraclavicular and axillary approaches for ultrasound-guided brachial plexus block for surgical anesthesia. Rambam Maimonides Med J. 2016;7(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839540</ArticleId><ArticleId IdType="pubmed">27101216</ArticleId></ArticleIdList></Reference><Reference><Citation>Strub B., Sonderegger J., Von Campe A., Gr&#xfc;nert J., Osterwalder J.J. What benefits does ultrasound-guided axillary block for brachial plexus anaesthesia offer over the conventional blind approach in hand surgery? J&#xa0;Hand Surg Eur Vol. 2011;36(9):778&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pubmed">21750097</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanyam R., Vaishnav V., Chan V.W., Brown-Shreves D., Brull R. Lateral versus medial needle approach for ultrasound-guided supraclavicular block: a randomized controlled trial. Reg Anesth Pain Med. 2011;36(4):387&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">21555965</ArticleId></ArticleIdList></Reference><Reference><Citation>Techasuk W., Gonz&#xe1;lez A.P., Bernucci F., Cupido T., Finlayson R.J., Tran D.Q. A&#xa0;randomized comparison between double-injection and targeted intracluster-injection ultrasound-guided supraclavicular brachial plexus block. Anesth Analg. 2014;118(6):1363&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pubmed">24842181</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedore T.R., YaDeau J.T., Maalouf D.B., et al. Comparison of the transarterial axillary block and the ultrasound-guided infraclavicular block for upper extremity surgery: a prospective randomized trial. Reg Anesth Pain Med. 2009;34(4):361&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">19574870</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazin M., Jensen K., Kristensen D.L., et al. Low-volume brachial plexus block providing surgical anesthesia for distal arm surgery comparing supraclavicular, infraclavicular, and axillary approach: a randomized observer blind trial. BioMed Res Int. 2016;2016:7094121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136641</ArticleId><ArticleId IdType="pubmed">27990435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.S., Chan W.S., Fang C., et al. Infraclavicular nerve block reduces postoperative pain after distal radial fracture fixation: a randomized controlled trial. BMC Anesthesiol. 2020;20(1):130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254671</ArticleId><ArticleId IdType="pubmed">32466746</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazer M.S., Finlayson R.J., Tran D.Q. A&#xa0;randomized comparison between infraclavicular block and targeted intracluster injection supraclavicular block. Reg Anesth Pain Med. 2015;40(1):11&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">25478758</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdallah F.W., Wijeysundera D.N., Laupacis A., et al. Subomohyoid anterior suprascapular block versus interscalene block for arthroscopic shoulder surgery: a multicenter randomized trial. Anesthesiology. 2020;132(4):839&#x2013;853.</Citation><ArticleIdList><ArticleId IdType="pubmed">32044802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayyanagouda B., Hosalli V., Kaur P., Ambi U., Hulkund S.Y. Hemi-diaphragmatic paresis following extrafascial versus conventional intrafascial approach for interscalene brachial plexus block: a double-blind randomised, controlled trial. Indian J Anaesth. 2019;63(5):375&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6530291</ArticleId><ArticleId IdType="pubmed">31142881</ArticleId></ArticleIdList></Reference><Reference><Citation>Desroches A., Klouche S., Schlur C., Bauer T., Waitzenegger T., Hardy P. Suprascapular nerve block versus interscalene block as analgesia after arthroscopic rotator cuff repair: a randomized controlled noninferiority trial. Arthroscopy. 2016;32(11):2203&#x2013;2209.</Citation><ArticleIdList><ArticleId IdType="pubmed">27177436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhir S., Sondekoppam R.V., Sharma R., Ganapathy S., Athwal G.S. A&#xa0;comparison of combined suprascapular and axillary nerve blocks to interscalene nerve block for analgesia in arthroscopic shoulder surgery: an equivalence study. Reg Anesth Pain Med. 2016;41(5):564&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">27380105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapral S., Greher M., Huber G., et al. Ultrasonographic guidance improves the success rate of interscalene brachial plexus blockade. Reg Anesth Pain Med. 2008;33(3):253&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">18433677</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Lin Y., Beathe J.C., et al. Superior trunk block: a phrenic-sparing alternative to the interscalene block: a randomized controlled trial. Anesthesiology. 2019;131(3):521&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">31283740</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Y.C., Koo Z.K., Ho V.W., Chang S.S., Manohara S., Tong Q.J. Randomized, controlled trial comparing respiratory and analgesic effects of interscalene, anterior suprascapular, and posterior suprascapular nerve blocks for arthroscopic shoulder surgery. Korean J Anesthesiol. 2020;73(5):408&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533176</ArticleId><ArticleId IdType="pubmed">32668833</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.S., Gordon M.A., Shaw P.M., Wilfred S., Shetty T., Yadeau J.T. A&#xa0;prospective clinical registry of ultrasound-guided regional anesthesia for ambulatory shoulder surgery. Anesth Analg. 2010;111(3):617&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">20686013</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.S., Zayas V.M., Gordon M.A., et al. A&#xa0;prospective, randomized, controlled trial comparing ultrasound versus nerve stimulator guidance for interscalene block for ambulatory shoulder surgery for postoperative neurological symptoms. Anesth Analg. 2009;109(1):265&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">19535720</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik T., Mass D., Cohn S. Postoperative analgesia in a prolonged continuous interscalene block versus single-shot block in outpatient arthroscopic rotator cuff repair: a prospective randomized study. Arthroscopy. 2016;32(8):1544&#x2013;1550.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">27107906</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoroha K.R., Lynch J.R., Keller R.A., et al. Liposomal bupivacaine versus interscalene nerve block for pain control after shoulder arthroplasty: a prospective randomized trial. J&#xa0;Shoulder Elbow Surg. 2016;25(11):1742&#x2013;1748.</Citation><ArticleIdList><ArticleId IdType="pubmed">27422692</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M.A., Gadsden J.C., Nedeljkovic S.S., et al. Brachial plexus block with liposomal bupivacaine for shoulder surgery improves analgesia and reduces opioid consumption: results from a multicenter, randomized, double-blind, controlled trial. Pain Med. 2020;21(2):387&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">31150095</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal G., Winger D.G., Cortazzo M., Kentor M.L., Orebaugh S.L. Neurologic outcomes after low-volume, ultrasound-guided interscalene block and ambulatory shoulder surgery. Reg Anesth Pain Med. 2016;41(4):477&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">27281729</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Kelly C., O'Brien T., Wilson J., Warner J.J. Ultrasound-guided interscalene block anesthesia for shoulder arthroscopy: a prospective study of 1319 patients. J&#xa0;Bone Joint Surg Am. 2012;94(22):2040&#x2013;2046.</Citation><ArticleIdList><ArticleId IdType="pubmed">23172321</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.J., Ge Y.L., Gao J., et al. Comparison of single- and triple-injection methods for ultrasound-guided interscalene brachial plexus blockade. Exp Ther Med. 2018;15(3):3006&#x2013;3011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5795379</ArticleId><ArticleId IdType="pubmed">29456706</ArticleId></ArticleIdList></Reference><Reference><Citation>Payton O.D., Jackson O., Di Fabio R.P. Churchill Livingstone; 1989. Manual of Physical Therapy.</Citation></Reference><Reference><Citation>Tubbs R.S., Rizk E., Shoja M.M., Loukas M., Barbaro N., Spinner R.J. Elsevier Science; 2015. Nerves and Nerve Injuries: Vol 2: Pain, Treatment, Injury, Disease and Future Directions.</Citation></Reference><Reference><Citation>Chemnitz A., Dahlin L.B., Carlsson I.K. Consequences and adaptation in daily life&#x2013;patients' experiences three decades after a nerve injury sustained in adolescence. BMC Musculoskelet Disord. 2013;14:252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765266</ArticleId><ArticleId IdType="pubmed">23968274</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray P.M., Hammert W.C. American Society for Surgery of the Hand; 2016. American Society for Surgery of the Hand. Hand Surgery Update VI.</Citation></Reference><Reference><Citation>Woolley E.J., Vandam L.D. Neurological sequelae of brachial plexus nerve block. Ann Surg. 1959;149(1):53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1450959</ArticleId><ArticleId IdType="pubmed">13617908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Park S.H., Shin H.Y., Choi Y.S. Brachial plexus injury as a complication after nerve block or vessel puncture. Korean J Pain. 2014;27(3):210&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4099233</ArticleId><ArticleId IdType="pubmed">25031806</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita A., Matsumoto M., Matsumoto S., Itoh M., Kawai K., Sakabe T. A&#xa0;comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg. 2003;97(2):512&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">12873946</ArticleId></ArticleIdList></Reference><Reference><Citation>Radwan I.A., Saito S., Goto F. The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth Analg. 2002;94(2):319&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">11812691</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock E.L., Brenner M.J., Fox I.K., Moradzadeh A., Hunter D.A., Mackinnon S.E. Ropivacaine-induced peripheral nerve injection injury in the rodent model. Anesth Analg. 2010;111(1):214&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">20442258</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal J.M. Effects of epinephrine in local anesthetics on the central and peripheral nervous systems: neurotoxicity and neural blood flow. Reg Anesth Pain Med. 2003;28(2):124&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">12677623</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Keefe D.M. Brachial plexus injury following axillary arteriography. Case report and review of the literature. J&#xa0;Neurosurg. 1980;53(6):853&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">7441349</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao B.E., Wilbourn A.J. Infraclavicular brachial plexus injury following axillary regional block. Muscle Nerve. 2004;30(1):44&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">15221877</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebou&#xe7;as F., Filho R.B., Filardis C., Pereira R.R., Cardoso A.A. Anatomical study of the musculocutaneous nerve in relation to the coracoid process. Rev Bras Ortop. 2010;45(4):400&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4799129</ArticleId><ArticleId IdType="pubmed">27022570</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas J., Familiari F., Bitzer A., Srikumaran U., Papalia R., McFarland E.G. Patient positioning in shoulder arthroscopy: which is best? Joints. 2019;7(2):46&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6930847</ArticleId><ArticleId IdType="pubmed">31879731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitman M.I., Nainzadeh N., Ergas E., Springer S. The use of somatosensory evoked potentials for detection of neuropraxia during shoulder arthroscopy. Arthroscopy. 1988;4(4):250&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">3233113</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjano P., Gonz&#xe1;lez B.G., Olmedo J.F., Perez-Espa&#xf1;a L.A., Munilla M.G. Complications in arthroscopic shoulder surgery. Arthroscopy. 1998;14(8):785&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">9848586</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane B.T., Tsui B.C.H. In: Complications of Regional Anesthesia. Finucane B.T., editor. Springer; 2007. Complications of brachial plexus anesthesia; pp. 121&#x2013;148.</Citation></Reference><Reference><Citation>Robinson L.R. Traumatic injury to peripheral nerves. Muscle Nerve. 2000;23(6):863&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pubmed">10842261</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson L.R. How electrodiagnosis predicts clinical outcome of focal peripheral nerve lesions. Muscle Nerve. 2015;52(3):321&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">25989907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26782682</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men.</ArticleTitle><Pagination><StartPage>1691</StartPage><EndPage>1699</EndPage><MedlinePgn>1691-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-015-3436-z</ELocationID><Abstract><AbstractText Label="UNLABELLED">This systematic review was performed to compare the diagnostic accuracy of vertebral fracture assessment (VFA) with that of spinal radiography for identification of vertebral fractures (VFs). VFA appeared to have moderate sensitivity and high specificity for detecting VFs when compared with spinal radiography.</AbstractText><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">VFs are recognized as the hallmark of osteoporosis, and a previous VF increases the risk of a future fracture. Therefore, the timely detection of VFs is important for prevention of further fractures. This systematic review examined the diagnostic accuracy of VFA using dual X-ray absorptiometry (DXA) to identify VFs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched for potentially relevant studies using electronic databases, including Ovid-Medline, Ovid-EMBASE, Cochrane library, and four Korean databases, from their inception to May 2013. We compared the diagnostic accuracy of VFA with that of spinal radiography for detection of VFs by analyzing the sensitivity and specificity using a 2&#x2009;&#xd7;&#x2009;2 contingency table. Subgroup analyses were also performed on studies with a low risk of bias and applicability.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twelve studies were analyzed for the diagnostic accuracy of VFA. The sensitivity and specificity were 0.70-0.93 and 0.95-1.00, respectively, analyzed on a per-vertebra basis, and 0.65-1.00 and 0.74-1.00 on a per-patient basis. The sensitivity and specificity of five studies in subgroups with a low risk of bias in the intervention test were 0.70-0.84 and 0.96-0.99, respectively. In studies with a low risk of bias in the patient selection, those based on a per-vertebra basis in three studies were 0.70-0.93 and 0.96-1.00, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VFA had moderate sensitivity and high specificity for detecting VF when compared with spinal radiography. However, the present findings are insufficient to assess whether spinal radiography should be replaced by VFA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>J-H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Y K</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>S-H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Y E</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pyo</LastName><ForeName>J H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Pharmaceutical Science and Regulation, Department of Pharmaceutical Science, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Y Y</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Hanyang University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>S-C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Y-K</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>D-Y</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, School of Medicine, Kyung Hee University Hospital, Seoul, 130-872, Republic of Korea. deogyoon@daum.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015663" MajorTopicYN="N">Osteoporosis, Postmenopausal</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vertebral fracture (VF)</Keyword><Keyword MajorTopicYN="N">Vertebral fracture assessment (VFA)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26782682</ArticleId><ArticleId IdType="doi">10.1007/s00198-015-3436-z</ArticleId><ArticleId IdType="pii">10.1007/s00198-015-3436-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Osteoporos Int. 2006 Feb;17 (2):281-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16172798</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Densitom. 2012 Jan-Mar;15(1):21-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22071029</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2004 Dec;19(12 ):1982-93</Citation><ArticleIdList><ArticleId IdType="pubmed">15537441</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone. 2003 Oct;33(4):522-32</Citation><ArticleIdList><ArticleId IdType="pubmed">14555255</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Radiol. 2009 Apr;70(1):142-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18242911</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2005 Dec;16(12 ):1513-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15834512</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2003 May;18(5):933-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12733735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone. 2012 Apr;50(4):836-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22316655</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2007 Sep;18(9):1271-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17340217</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Densitom. 2011 Jul-Sep;14 (3):348-53</Citation><ArticleIdList><ArticleId IdType="pubmed">21723763</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2000;11(8):660-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11095168</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint Bone Spine. 2014 Mar;81(2):149-53</Citation><ArticleIdList><ArticleId IdType="pubmed">23932727</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2003 Nov;14 (11):871-8</Citation><ArticleIdList><ArticleId IdType="pubmed">13680099</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2006;17(8):1189-95</Citation><ArticleIdList><ArticleId IdType="pubmed">16758133</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2009 Jul;20(7):1199-205</Citation><ArticleIdList><ArticleId IdType="pubmed">19083074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2011 Oct 18;155(8):529-36</Citation><ArticleIdList><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 Jul 21;339:b2700</Citation><ArticleIdList><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiol Med. 2012 Dec;117(8):1374-85</Citation><ArticleIdList><ArticleId IdType="pubmed">22744340</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Musculoskelet Radiol. 2002 Sep;6(3):241-52</Citation><ArticleIdList><ArticleId IdType="pubmed">12541202</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Feb 4;301(5):513-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19190316</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2006 Feb;21(2):466-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16234292</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2007 Nov;46(11):1667-71</Citation><ArticleIdList><ArticleId IdType="pubmed">17804453</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2011 Apr 28;364(17 ):1634-42</Citation><ArticleIdList><ArticleId IdType="pubmed">21524214</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Densitom. 2008 Jan-Mar;11(1):92-108</Citation><ArticleIdList><ArticleId IdType="pubmed">18442755</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint Bone Spine. 2009 May;76(3):241-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19196531</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2009 Jun;251(3):822-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19380691</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2008 Jan;23 (1):103-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17892377</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone. 2003 Oct;33(4):505-13</Citation><ArticleIdList><ArticleId IdType="pubmed">14555253</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 1999;10(3):214-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10525713</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2001;12 (4):302-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11420780</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcif Tissue Int. 2012 Nov;91(5):335-42</Citation><ArticleIdList><ArticleId IdType="pubmed">22965625</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1996 Nov 25;156(21):2469-75</Citation><ArticleIdList><ArticleId IdType="pubmed">8944740</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Densitom. 2006 Jan-Mar;9(1):66-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16731433</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 1997 Jan;12(1):152-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9240738</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2013 May;65(5):809-15</Citation><ArticleIdList><ArticleId IdType="pubmed">23212896</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26643098</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1608</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Best practice &amp; research. Clinical anaesthesiology</Title><ISOAbbreviation>Best Pract Res Clin Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative ventilation strategies to prevent postoperative pulmonary complications: Systematic review, meta-analysis, and trial sequential analysis.</ArticleTitle><Pagination><StartPage>331</StartPage><EndPage>340</EndPage><MedlinePgn>331-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpa.2015.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1521-6896(15)00060-9</ELocationID><Abstract><AbstractText>For many years, mechanical ventilation with high tidal volumes (V(T)) was common practice in operating theaters because this strategy recruits collapsed lung tissue, improves ventilation-perfusion mismatch, and thus decreases the need for high oxygen fractions. Positive end-expiratory pressure (PEEP) was seldom used because it could cause cardiac compromise. Increasing advances in the understanding of the mechanisms of ventilator-induced lung injury from animal studies and randomized controlled trials in patients with uninjured lungs in intensive care unit and operation room have pushed anesthesiologists to consider lung-protective strategies during intraoperative ventilation. These strategies at least include the use of low V(T), and perhaps also the use of PEEP, which when compared to high V(T) with low PEEP may prevent the occurrence of postoperative pulmonary complications (PPCs). Such protective effects, however, are likely ascribed to low V(T) rather than to PEEP. In fact, at least in nonobese patients undergoing open abdominal surgery, high PEEP does not protect against PPCs, and it can impair the hemodynamics. Further studies shall determine whether a strategy consisting of low V(T) combined with PEEP and recruitment maneuvers reduces PPCs in obese patients and other types of surgery (e.g., laparoscopic and thoracic), compared to low V(T) with low PEEP. Furthermore, the role of driving pressure for titrating ventilation settings in patients with uninjured lungs shall be investigated.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>Ary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil; Program of Post-Graduation, Research and Innovation, Faculdade de Medicina do ABC, Santo Andr&#xe9;, Brazil; Department of Intensive Care, Academic Medical Center at The University of Amsterdam, Amsterdam, The Netherlands. Electronic address: aryserpa@terra.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Center at The University of Amsterdam, Amsterdam, The Netherlands; Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center at The University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany; Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Best Pract Res Clin Anaesthesiol</MedlineTA><NlmUniqueID>101121446</NlmUniqueID><ISSNLinking>1753-3740</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055397" MajorTopicYN="N">Ventilator-Induced Lung Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PEEP</Keyword><Keyword MajorTopicYN="N">intraoperative ventilation</Keyword><Keyword MajorTopicYN="N">lung protection</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">pulmonary complications</Keyword><Keyword MajorTopicYN="N">tidal volume</Keyword><Keyword MajorTopicYN="N">trial sequential analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26643098</ArticleId><ArticleId IdType="doi">10.1016/j.bpa.2015.09.002</ArticleId><ArticleId IdType="pii">S1521-6896(15)00060-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31403976</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications after Cardiac Surgery.</ArticleTitle><Pagination><StartPage>1046</StartPage><EndPage>1062</EndPage><MedlinePgn>1046-1062</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000002909</ELocationID><Abstract><AbstractText Label="BACKGROUND">Compared with historic ventilation strategies, modern lung-protective ventilation includes lower tidal volumes (VT), lower driving pressures, and application of positive end-expiratory pressure (PEEP). The contributions of each component to an overall intraoperative protective ventilation strategy aimed at reducing postoperative pulmonary complications have neither been adequately resolved, nor comprehensively evaluated within an adult cardiac surgical population. The authors hypothesized that a bundled intraoperative protective ventilation strategy was independently associated with decreased odds of pulmonary complications after cardiac surgery.</AbstractText><AbstractText Label="METHODS">In this observational cohort study, the authors reviewed nonemergent cardiac surgical procedures using cardiopulmonary bypass at a tertiary care academic medical center from 2006 to 2017. The authors tested associations between bundled or component intraoperative protective ventilation strategies (VT below 8 ml/kg ideal body weight, modified driving pressure [peak inspiratory pressure - PEEP] below 16 cm H2O, and PEEP greater than or equal to 5 cm H2O) and postoperative outcomes, adjusting for previously identified risk factors. The primary outcome was a composite pulmonary complication; secondary outcomes included individual pulmonary complications, postoperative mortality, as well as durations of mechanical ventilation, intensive care unit stay, and hospital stay.</AbstractText><AbstractText Label="RESULTS">Among 4,694 cases reviewed, 513 (10.9%) experienced pulmonary complications. After adjustment, an intraoperative lung-protective ventilation bundle was associated with decreased pulmonary complications (adjusted odds ratio, 0.56; 95% CI, 0.42-0.75). Via a sensitivity analysis, modified driving pressure below 16 cm H2O was independently associated with decreased pulmonary complications (adjusted odds ratio, 0.51; 95% CI, 0.39-0.66), but VT below 8 ml/kg and PEEP greater than or equal to 5 cm H2O were not.</AbstractText><AbstractText Label="CONCLUSIONS">The authors identified an intraoperative lung-protective ventilation bundle as independently associated with pulmonary complications after cardiac surgery. The findings offer insight into components of protective ventilation associated with adverse outcomes and may serve as targets for future prospective interventional studies investigating the impact of specific protective ventilation strategies on postoperative outcomes after cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mathis</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>From the Departments of Anesthesiology (M.R.M., N.M.D., N.J.D., M.T.V., M.D.M., D.A.C., A.M.J., S.K., M.C.E.) Cardiac Surgery (D.S.L., J.W.H., R.J.S.), University of Michigan Medical School Department of Biostatistics, University of Michigan (M.Z.), Ann Arbor, Michigan Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville, Virginia (R.S.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duggal</LastName><ForeName>Neal M</ForeName><Initials>NM</Initials></Author><Author ValidYN="Y"><LastName>Likosky</LastName><ForeName>Donald S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Haft</LastName><ForeName>Jonathan W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Douville</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials></Author><Author ValidYN="Y"><LastName>Vaughn</LastName><ForeName>Michelle T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Maile</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Blank</LastName><ForeName>Randal S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Colquhoun</LastName><ForeName>Douglas A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Strobel</LastName><ForeName>Raymond J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Janda</LastName><ForeName>Allison M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Engoren</LastName><ForeName>Milo C</ForeName><Initials>MC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 HL141701</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS022535</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM103730</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR002242</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Anesthesiology. 2020 Jan;132(1):217. doi: 10.1097/ALN.0000000000003038.</RefSource><PMID Version="1">31651530</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2020 Jun;132(6):1610-1611. doi: 10.1097/ALN.0000000000003292.</RefSource><PMID Version="1">32287044</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2020 Jun;132(6):1611-1613. doi: 10.1097/ALN.0000000000003294.</RefSource><PMID Version="1">32287045</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2020 Jun;132(6):1611. doi: 10.1097/ALN.0000000000003293.</RefSource><PMID Version="1">32287046</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><u><b>Conflict of Interest</b></u>: The authors declare no competing interests beyond those described in the funding statement.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31403976</ArticleId><ArticleId IdType="mid">NIHMS1048111</ArticleId><ArticleId IdType="pmc">PMC6800803</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000002909</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zochios V, Klein AA, Gao F: Protective Invasive Ventilation in Cardiac Surgery: A Systematic Review With a Focus on Acute Lung Injury in Adult Cardiac Surgical Patients. J Cardiothorac Vasc Anesth 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">29199052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez J, Riera M, Amezaga R, Herrero J, Colomar A, Campillo-Artero C, Ibarra JI de, Bonnin O: Long-Term Mortality After Pneumonia in Cardiac Surgery Patients: A Propensity-Matched Analysis. J Intensive Care Med 2016; 31:34&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">24578466</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Culler SD, Dee AD, Simon AW: The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg 2008; 85:1980&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">18498806</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Delgado M, Navarrete-Sanchez I, Colmenero M: Preventing and managing perioperative pulmonary complications following cardiac surgery. Curr Opin Anaesthesiol 2014; 27:146&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pubmed">24514031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Delorme M, Bussieres J, Ouattara A: Perioperative ventilatory strategies in cardiac surgery. Best Pract Res Clin Anaesthesiol 2015; 29:381&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10068651</ArticleId><ArticleId IdType="pubmed">26643102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL: Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 2006; 296:1851&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">17047215</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolakis E, Filos KS, Koletsis E, Dougenis D: Lung dysfunction following cardiopulmonary bypass. J Card Surg 2010; 25:47&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">19549041</ArticleId></ArticleIdList></Reference><Reference><Citation>Slinger P, Kilpatrick B: Perioperative lung protection strategies in cardiothoracic anesthesia: are they useful? Anesthesiol Clin 2012; 30:607&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">23089498</ArticleId></ArticleIdList></Reference><Reference><Citation>Canet J, Gallart L, Gomar C, Paluzie G, Valles J, Castillo J, Sabate S, Mazo V, Briones Z, Sanchis J: Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 2010; 113:1338&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pubmed">21045639</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH: The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75:1856&#x2013;64; discussion 1864&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">12822628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brescia AA, Rankin JS, Cyr DD, Jacobs JP, Prager RL, Zhang M, Matsouaka RA, Harrington SD, Dokholyan RS, Bolling SF, Fishstrom A, Pasquali SK, Shahian DM, Likosky DS: Determinants of Variation in Pneumonia Rates After Coronary Artery Bypass Grafting. Ann Thorac Surg 2018; 105:513&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5783740</ArticleId><ArticleId IdType="pubmed">29174785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu WJ, Wang F, Liu JC: Effect of lung-protective ventilation with lower tidal volumes on clinical outcomes among patients undergoing surgery: a meta-analysis of randomized controlled trials. CMAJ 2015; 187:E101&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4330165</ArticleId><ArticleId IdType="pubmed">25512653</ArticleId></ArticleIdList></Reference><Reference><Citation>Guldner A, Kiss T, Serpa Neto A, Hemmes SN, Canet J, Spieth PM, Rocco PR, Schultz MJ, Pelosi P, Gama de Abreu M: Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology 2015; 123:692&#x2013;713</Citation><ArticleIdList><ArticleId IdType="pubmed">26120769</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Ochroch EA: Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in patients without acute lung injury. Cochrane Database Syst Rev 2015:CD011151.</Citation><ArticleIdList><ArticleId IdType="pubmed">26641378</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Hemmes SN, Barbas CS, Beiderlinden M, Biehl M, Binnekade JM, Canet J, Fernandez-Bustamante A, Futier E, Gajic O, Hedenstierna G, Hollmann MW, Jaber S, Kozian A, Licker M, Lin WQ, Maslow AD, Memtsoudis SG, Reis Miranda D, Moine P, Ng T, Paparella D, Putensen C, Ranieri M, Scavonetto F, Schilling T, Schmid W, Selmo G, Severgnini P, Sprung J, Sundar S, Talmor D, Treschan T, Unzueta C, Weingarten TN, Wolthuis EK, Wrigge H, Gama de Abreu M, Pelosi P, Schultz MJ: Protective versus Conventional Ventilation for Surgery: A Systematic Review and Individual Patient Data Meta-analysis. Anesthesiology 2015; 123:66&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pubmed">25978326</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SN, Barbas CS, Beiderlinden M, Fernandez-Bustamante A, Futier E, Gajic O, El-Tahan MR, Ghamdi AA, Gunay E, Jaber S, Kokulu S, Kozian A, Licker M, Lin WQ, Maslow AD, Memtsoudis SG, Reis Miranda D, Moine P, Ng T, Paparella D, Ranieri VM, Scavonetto F, Schilling T, Selmo G, Severgnini P, Sprung J, Sundar S, Talmor D, Treschan T, Unzueta C, Weingarten TN, Wolthuis EK, Wrigge H, Amato MB, Costa EL, de Abreu MG, Pelosi P, Schultz MJ: Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med 2016; 4:272&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, Stewart TE, Briel M, Talmor D, Mercat A, Richard JC, Carvalho CR, Brower RG: Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015; 372:747&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">25693014</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama H, Pettenuzzo T, Aoyama K, Pinto R, Englesakis M, Fan E: Association of Driving Pressure With Mortality Among Ventilated Patients With Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Crit Care Med 2018; 46:300&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">29135500</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ: High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet 2014; 384:495&#x2013;503</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW: Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth 2014; 113:97&#x2013;108</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9585620</ArticleId><ArticleId IdType="pubmed">24623057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Dionne S, Simard S, Bussieres J, Dagenais F: High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology 2012; 116:1072&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">22450472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Gomersall CD, Ng SK, Underwood MJ, Lee A: A randomized controlled trial of adaptive support ventilation mode to wean patients after fast-track cardiac valvular surgery. Anesthesiology 2015; 122:832&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">25569810</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesia Clinical Research Committee
at &lt;https://anes.med.umich.edu/research/acrc.html&gt;</Citation></Reference><Reference><Citation>Society of Thoracic Surgeons Adult Cardiac Surgery Database Data Specifications
2017. 
at &lt;https://www.sts.org/sites/default/files/documents/ACSD_DataSpecificationsV2_9.pdf&gt;</Citation></Reference><Reference><Citation>Freundlich RE, Kheterpal S: Perioperative effectiveness research using large databases. Best Pract Res Clin Anaesthesiol 2011; 25:489&#x2013;98</Citation><ArticleIdList><ArticleId IdType="pubmed">22099915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S: Clinical research using an information system: the multicenter perioperative outcomes group. Anesthesiol Clin 2011; 29:377&#x2013;88</Citation><ArticleIdList><ArticleId IdType="pubmed">21871400</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroyer AL, Edwards FH, Grover FL: Updates to the Data Quality Review Program: the Society of Thoracic Surgeons Adult Cardiac National Database. Ann Thorac Surg 1998; 65:1494&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">9594906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender SP, Paganelli WC, Gerety LP, Tharp WG, Shanks AM, Housey M, Blank RS, Colquhoun DA, Fernandez-Bustamante A, Jameson LC, Kheterpal S: Intraoperative Lung-Protective Ventilation Trends and Practice Patterns: A Report from the Multicenter Perioperative Outcomes Group. Anesth Analg 2015; 121:1231&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">26332856</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JP, He X, O&#x2019;Brien SM, Welke KF, Filardo G, Han JM, Ferraris VA, Prager RL, Shahian DM: Variation in ventilation time after coronary artery bypass grafting: an analysis from the society of thoracic surgeons adult cardiac surgery database. Ann Thorac Surg 2013; 96:757&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">23731610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Healy D, Aziz MF, Shanks AM, Freundlich RE, Linton F, Martin LD, Linton J, Epps JL, Fernandez-Bustamante A, Jameson LC, Tremper T, Tremper KK: Incidence, predictors, and outcome of difficult mask ventilation combined with difficult laryngoscopy: a report from the multicenter perioperative outcomes group. Anesthesiology 2013; 119:1360&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">24071617</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahian DM, O&#x2019;Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP: The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88:S2&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">19559822</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteve F, Lopez-Delgado JC, Javierre C, Skaltsa K, Carrio ML, Rodriguez-Castro D, Torrado H, Farrero E, Diaz-Prieto A, Ventura JL, Manez R: Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay. BMC Anesthesiol 2014; 14:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4448284</ArticleId><ArticleId IdType="pubmed">25928646</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Turanzas M, Ensor J, Wakefield C, Zhang K, Wallace SK, Price KJ, Nates JL: Cross-validation of a Sequential Organ Failure Assessment score-based model to predict mortality in patients with cancer admitted to the intensive care unit. J Crit Care 2012; 27:673&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">22762932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307:2526&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott TEF, Fowler AJ, Pelosi P, Gama de Abreu M, Moller AM, Canet J, Creagh-Brown B, Mythen M, Gin T, Lalu MM, Futier E, Grocott MP, Schultz MJ, Pearse RM: A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth 2018; 120:1066&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">29661384</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, Leva B, Rhodes A, Hoeft A, Walder B, Chew MS, Pearse RM: Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol 2015; 32:88&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha K, Vidal Melo MF, McLean DJ, Wanderer JP, Grabitz SD, Kurth T, Eikermann M: Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ 2015; 351:h3646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4501577</ArticleId><ArticleId IdType="pubmed">26174419</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin Jm, Fau-Paugam-Burtz C, Paugam-Burtz C, Fau-Pascal J, Pascal J, Fau-Eurin M, Eurin M, Fau-Neuschwander A, Neuschwander A, Fau-Marret E, Marret E, Fau-Beaussier M, Beaussier M, Fau-Gutton C, Gutton C, Fau-Lefrant J-Y, Lefrant Jy, Fau-Allaouchiche B, Allaouchiche B, Fau-Verzilli D, Verzilli D, Fau-Leone M, Leone M, Fau-De Jong A, De Jong A, Fau-Bazin J-E, Bazin Je, Fau-Pereira B, Pereira B, Fau-Jaber S, Jaber S: A trial of intraoperative low-tidal-volume ventilation in abdominal surgery 20130801 DCOM- 20130806</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz MJ, Haitsma JJ, Slutsky AS, Gajic O: What tidal volumes should be used in patients without acute lung injury? Anesthesiology 2007; 106:1226&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pubmed">17525599</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville NJ, Jewell ES, Duggal N, Blank R, Kheterpal S, Engoren MC, Mathis MR: Association of Intraoperative Ventilator Management With Postoperative Oxygenation, Pulmonary Complications, and Mortality 2019:p 1 doi:10.1213/ane.0000000000004191</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000004191</ArticleId><ArticleId IdType="pmc">PMC8592391</ArticleId><ArticleId IdType="pubmed">31107262</ArticleId></ArticleIdList></Reference><Reference><Citation>Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum JM, Stentz MJ, Dechert R, Jewell E, Engoren M, Rosenberg AL, Park PK: Preoperative and intraoperative predictors of postoperative acute respiratory distress syndrome in a general surgical population. Anesthesiology 2013; 118:19&#x2013;29</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3813014</ArticleId><ArticleId IdType="pubmed">23221870</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers J, Pullan M, Fabri B, McShane J, Shaw M, Mediratta N, Poullis M: Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur J Cardiothorac Surg 2013; 43:688&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pubmed">22833541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R: Regression Shrinkage and Selection Via the LASSO. J R Stat Soc Series B Stat Methodol 1996; 58:267&#x2013;88</Citation></Reference><Reference><Citation>Katz MH: Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003; 138:644&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pubmed">12693887</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens RS, Whitman GJ: Postoperative Critical Care of the Adult Cardiac Surgical Patient. Part I: Routine Postoperative Care 2015. 0617 DCOM- 20150826</Citation><ArticleIdList><ArticleId IdType="pubmed">25962078</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens RS, Whitman GJ: Postoperative Critical Care of the Adult Cardiac Surgical Patient: Part II: Procedure-Specific Considerations, Management of Complications, and Quality Improvement. Crit Care Med 2015; 43:1995&#x2013;2014</Citation><ArticleIdList><ArticleId IdType="pubmed">26136101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong WT, Lai VK, Chee YE, Lee A: Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev 2016; 9:Cd003587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457798</ArticleId><ArticleId IdType="pubmed">27616189</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M, Ahn HJ, Kim JA, Yang M, Heo BY, Choi JW, Kim YR, Lee SH, Jeong H, Choi SJ, Song IS: Driving Pressure during Thoracic Surgery: A Randomized Clinical Trial. Anesthesiology 2019; 130:385&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">30664548</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RG, Naidu B: Does a conservative fluid management strategy in the perioperative management of lung resection patients reduce the risk of acute lung injury? Interact Cardiovasc Thorac Surg 2012; 15:498&#x2013;504</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422923</ArticleId><ArticleId IdType="pubmed">22617510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristovska AM, Duch P, Allingstrup M, Afshari A: Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev 2017; 8:Cd012763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6483345</ArticleId><ArticleId IdType="pubmed">28806470</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy GS, Brull SJ: Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111:120&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">20442260</ArticleId></ArticleIdList></Reference><Reference><Citation>Damas P, Frippiat F, Ancion A, Canivet JL, Lambermont B, Layios N, Massion P, Morimont P, Nys M, Piret S, Lancellotti P, Wiesen P, D&#x2019;Orio V, Samalea N, Ledoux D: Prevention of ventilator-associated pneumonia and ventilator-associated conditions: a randomized controlled trial with subglottic secretion suctioning. Crit Care Med 2015; 43:22&#x2013;30</Citation><ArticleIdList><ArticleId IdType="pubmed">25343570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodpoor A, Hamishehkar H, Hamidi M, Shadvar K, Sanaie S, Golzari SE, Khan ZH, Nader ND: A prospective randomized trial of tapered-cuff endotracheal tubes with intermittent subglottic suctioning in preventing ventilator-associated pneumonia in critically ill patients. J Crit Care 2017; 38:152&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">27912161</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson WR, Chen L, Amato MBP, Brochard LJ: Fifty Years of Research in ARDS. Respiratory Mechanics in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2017; 196:822&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">28306327</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39314557</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review and Meta-Analysis of Catheter Ablation Versus Anti-arrhythmic Drugs for Treatment of Ventricular Arrhythmia.</ArticleTitle><Pagination><StartPage>e67649</StartPage><MedlinePgn>e67649</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e67649</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.67649</ELocationID><Abstract><AbstractText>Catheter ablation (CA) and anti-arrhythmic drugs (AADs) minimize implanted cardioverter-defibrillator (ICD) shocks in individuals with ischemic cardiomyopathy and an ICD, while the best strategy is still unknown. CA has been proposed as a potentially effective means of reducing the occurrence of ICD events in a number of studies; however, there were insufficient relevant dates from randomized controlled trials. A meta-analysis and systematic review of randomized controlled trials were carried out to evaluate the efficacy of CA for the prevention of VA in patients with ischemic heart disease. Cardiovascular mortality, an unscheduled hospitalization due to increasing heart failure, appropriate ICD shock, or serious treatment-related consequences comprised the composite primary outcome. AADs were examined in six trials (n = 1564; follow-up = 15 &#xb1; 8 months), while CA was evaluated in four trials (n = 682; follow-up = 12 &#xb1; 6 months). Both CA (odds ratio (OR) 0.65, 95% confidence interval (CI) 0.47-0.82, p = 0.001) and AADs (OR 0.76, 95% CI 0.32-0.84, p = 0.034) significantly reduced the number of suitable ICD interventions, with no discernible difference between the two treatment approaches. AADs were observed to reduce incorrect ICD interventions (OR 0.38, p = 0.001), but CA did not. During follow-up, there was no correlation seen between reduced mortality and either CA or AAD. When compared to AAD, CA decreased the composite endpoint of cardiovascular death, adequate ICD shock, heart failure-related hospitalization, or severe treatment-related consequences in ICD patients with ischemic cardiomyopathy and symptomatic VT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Rashid et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Atif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Fortis Hospital, Kolkata, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Mohammad Faisal</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Emergency Department, New Bombay Hospital, Mumbai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Javed</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Fortis Hospital, Kolkata, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-arrhythmic drugs</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>4</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39314557</ArticleId><ArticleId IdType="pmc">PMC11419583</ArticleId><ArticleId IdType="doi">10.7759/cureus.67649</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Moss AJ, Greenberg H, Case RB, et al. Circulation. 2004;110:3760&#x2013;3765.</Citation><ArticleIdList><ArticleId IdType="pubmed">15583079</ArticleId></ArticleIdList></Reference><Reference><Citation>Implantable cardioverter-defibrillators: expanding indications and technologies. Goldberger Z, Lampert R. JAMA. 2006;295:809&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">16478904</ArticleId></ArticleIdList></Reference><Reference><Citation>Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Sears SE Jr, Conti JB. Clin Cardiol. 2003;26:107&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6654275</ArticleId><ArticleId IdType="pubmed">12685615</ArticleId></ArticleIdList></Reference><Reference><Citation>Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Kamphuis HCM, de Leeuw JRJ, Derksen R, et al. Europace. 2003;5:381&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">14753636</ArticleId></ArticleIdList></Reference><Reference><Citation>Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K. Pacing Clin Electrophysiol. 2006;29:619&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">16784428</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic importance of defibrillator shocks in patients with heart failure. Poole JE, Johnson GW, Hellkamp AS, et al. N Engl J Med. 2008;359:1009&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922510</ArticleId><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>Prophylactic catheter ablation for the prevention of defibrillator therapy. Reddy VY, Reynolds MR, Neuzil P, et al. N Engl J Med. 2007;357:2657&#x2013;2665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390777</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Kuck KH, Schaumann A, Eckardt L, et al. Lancet. 2010;375:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. Connolly SJ, Dorian P, Roberts RS, et al. JAMA. 2006;295:165&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Dunbar SB, Dougherty CM, Sears SF, et al. Circulation. 2012;126:2146&#x2013;2172.</Citation><ArticleIdList><ArticleId IdType="pubmed">23008437</ArticleId></ArticleIdList></Reference><Reference><Citation>EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Pedersen CT, Kay GN, Kalman J, et al. Europace. 2014;16:1257&#x2013;1283.</Citation><ArticleIdList><ArticleId IdType="pubmed">25172618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. Sapp JL, Wells GA, Parkash R, et al. N Engl J Med. 2016;375:111&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiarrhythmic drugs or catheter ablation in the management of ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: a systematic review and meta-analysis of randomized controlled trials. Kheiri B, Barbarawi M, Zayed Y, et al. Circ Arrhythm Electrophysiol. 2019;12:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">31698933</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an international VT ablation center collaborative group study. Tung R, Vaseghi M, Frankel DS, et al. Heart Rhythm. 2015;12:1997&#x2013;2007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4549209</ArticleId><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Exner DV, Pinski SL, Wyse DG, et al. Circulation. 2001;103:2066&#x2013;2071.</Citation><ArticleIdList><ArticleId IdType="pubmed">11319196</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictors of mortality in patients with recurrent ICD shocks. Abdelwahab AM, Maclntyre CJ, Parkash Rr, Basta MN, Gardner MJ, Liu Ar Sapp J. Can J Cardial. 2007;23:191.</Citation></Reference><Reference><Citation>Quality of life in the Canadian implantable defibrillator study (CIDs) Irvine J, Dorian P, Baker B, et al. Am Heart J. 2002;144:282&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">12177646</ArticleId></ArticleIdList></Reference><Reference><Citation>Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG patch trial. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Pacing Clin Electrophysiol. 1999;22:1305&#x2013;1313.</Citation><ArticleIdList><ArticleId IdType="pubmed">10527011</ArticleId></ArticleIdList></Reference><Reference><Citation>Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF, Kadish A. Arch Intern Med. 2007;167:2226&#x2013;2232.</Citation><ArticleIdList><ArticleId IdType="pubmed">17998496</ArticleId></ArticleIdList></Reference><Reference><Citation>Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Schron EB, Exner DV, Yao Q, et al. Circulation. 2002;105:589&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">11827924</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of baseline antiarrhythmic drug on outcomes with ablation in ischemic ventricular tachycardia: a VANISH substudy (ventricular tachycardia ablation versus escalated antiarrhythmic drug therapy in ischemic heart disease) Parkash R, Nault I, Rivard L, et al. Circ Arrhythm Electrophysiol. 2018;11:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">29305400</ArticleId></ArticleIdList></Reference><Reference><Citation>Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. Arenal &#xc1;, &#xc1;vila P, Jim&#xe9;nez-Candil J, et al. J Am Coll Cardiol. 2022;79:1441&#x2013;1453.</Citation><ArticleIdList><ArticleId IdType="pubmed">35422240</ArticleId></ArticleIdList></Reference><Reference><Citation>A prospective, multicentre randomised controlled trial comparing catheter ablation versus antiarrhythmic drugs in patients with structural heart disease related ventricular tachycardia: the CAAD-VT trial protocol. Bennett RG, Campbell T, Garikapati K, et al. Heart Lung Circ. 2023;32:184&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">36599791</ArticleId></ArticleIdList></Reference><Reference><Citation>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG. Ann Intern Med. 2009;151:264&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. BMJ. 2011;343:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Santangeli P, Muser D, Maeda S, et al. Heart Rhythm. 2016;13:1552&#x2013;1559.</Citation><ArticleIdList><ArticleId IdType="pubmed">26961297</ArticleId></ArticleIdList></Reference><Reference><Citation>Updated September. The Cochrane Collaboration; 2008. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.1.</Citation></Reference><Reference><Citation>Bayesian analysis of the substrate ablation vs. antiarrhythmic drug therapy for symptomatic ventricular tachycardia trial. &#xc1;vila P, Berruezo A, Jim&#xe9;nez-Candil J, et al. Europace. 2023;25:181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10326301</ArticleId><ArticleId IdType="pubmed">37366571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventricular tachycardia and ICD therapy burden with catheter ablation versus escalated antiarrhythmic drug therapy. Samuel M, Healey JS, Nault I, et al. JACC Clin Electrophysiol. 2023;9:808&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">37380314</ArticleId></ArticleIdList></Reference><Reference><Citation>Cost effectiveness of ventricular tachycardia ablation versus escalation of antiarrhythmic drug therapy: the VANISH trial. Coyle K, Coyle D, Nault I, et al. JACC Clin Electrophysiol. 2018;4:660&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">29798795</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings. Della Bella P, De Ponti R, Uriarte JA, et al. Eur Heart J. 2002;23:414&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">11846499</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparative effectiveness of ventricular tachycardia ablation vs. escalated antiarrhythmic drug therapy by location of myocardial infarction: a sub-study of the VANISH trial. Samuel M, Rivard L, Nault I, et al. Europace. 2022;24:948&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9282915</ArticleId><ArticleId IdType="pubmed">34964475</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: impact of concomitant amiodarone therapy on short- and long-term clinical outcomes. Di Biase L, Romero J, Du X, et al. Heart Rhythm. 2021;18:885&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">33592323</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR, Crijns HJ, Aliot EM, et al. Circulation. 2011;124:2649&#x2013;2660.</Citation><ArticleIdList><ArticleId IdType="pubmed">22082672</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. Al-Khatib SM, Daubert JP, Anstrom KJ, et al. J Cardiovasc Electrophysiol. 2015;26:151&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">25332150</ArticleId></ArticleIdList></Reference><Reference><Citation>Safety and outcomes of ventricular tachycardia substrate ablation during sinus rhythm: a prospective multicenter registry. Fernandez-Armenta J, Soto-Iglesias D, Silva E, et al. JACC Clin Electrophysiol. 2020;6:1435&#x2013;1448.</Citation><ArticleIdList><ArticleId IdType="pubmed">33121673</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Eur J Epidemiol. 2016;31:337&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4877414</ArticleId><ArticleId IdType="pubmed">27209009</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: an analysis from the International VT ablation Center Collaborative Group. Tzou WS, Tung R, Frankel DS, et al. Heart Rhythm. 2017;14:991&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pubmed">28506710</ArticleId></ArticleIdList></Reference><Reference><Citation>Safety, long-term results, and predictors of recurrence after complete endocardial ventricular tachycardia substrate ablation in patients with previous myocardial infarction. Arenal &#xc1;, Hern&#xe1;ndez J, Calvo D, et al. Am J Cardiol. 2013;111:499&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">23228925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablation of stable VTS versus substrate ablation in ischemic cardiomyopathy: the Vista randomized multicenter trial. Di Biase L, Burkhardt JD, Lakkireddy D, et al. J Am Coll Cardiol. 2015;66:2872&#x2013;2882.</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiofrequency catheter ablation of ventricular tachycardia using combined endocardial techniques in patients with structural heart disease improves procedural effectiveness and reduces arrhythmia episodes. Karkowski G, Z&#x105;bek A, Szotek M, et al. Kardiol Pol. 2023;81:350&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">36475512</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23741926</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0001-5458</ISSN><JournalIssue CitedMedium="Print"><Volume>113</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Acta chirurgica Belgica</Title><ISOAbbreviation>Acta Chir Belg</ISOAbbreviation></Journal><ArticleTitle>Training models in laparoscopy: a systematic review comparing their effectiveness in learning surgical skills.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>95</EndPage><MedlinePgn>77-95</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Surgery has traditionally been learned on patients in the operating room, which is time-consuming, can have an impact on the patient outcomes, and is of variable effectiveness. As a result, surgical training models have been developed, which are compared in this systematic review.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched Pubmed, CENTRAL, and Science Citation index expanded for randomised clinical trials and randomised cross-over studies comparing laparoscopic training models. Studies comparing one model with no training were also included. The reference list of identified trials was searched for further relevant studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-eight trials evaluating several training forms and involving 1591 participants were included (four studies with a low risk of bias). Training (virtual reality (VR) or video trainer (VT)) versus no training improves surgical skills in the majority of trials. Both VR and VT are as effective in most studies. VR training is superior to traditional laparoscopic training in the operating room. Outcome results for VR robotic simulations versus robot training show no clear difference in effectiveness for either model. Only one trial included human cadavers and observed better results versus VR for one out of four scores. Contrasting results are observed when robotic technology is compared with manual laparoscopy.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">VR training and VT training are valid teaching models. Practicing on these models similarly improves surgical skills. A combination of both methods is recommended in a surgical curriculum. VR training is superior to unstructured traditional training in the operating room. The reciprocal effectiveness of the other models to learn surgical skills has not yet been established.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Willaert</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium. wouter.willaert@ugent.be</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van De Putte</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Van Renterghem</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Van Nieuwenhove</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ceelen</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Pattyn</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Chir Belg</MedlineTA><NlmUniqueID>0370571</NlmUniqueID><ISSNLinking>0001-5458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002102" MajorTopicYN="N">Cadaver</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002983" MajorTopicYN="Y">Clinical Competence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003194" MajorTopicYN="N">Computer-Assisted Instruction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008953" MajorTopicYN="Y">Models, Anatomic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="Y">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23741926</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32460366</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8159</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Pacing and clinical electrophysiology : PACE</Title><ISOAbbreviation>Pacing Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Role of cardiac sympathetic denervation in ventricular tachycardia: A meta-analysis.</ArticleTitle><Pagination><StartPage>828</StartPage><EndPage>837</EndPage><MedlinePgn>828-837</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pace.13968</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cardiac sympathetic denervation (CSD) is being used in the management of refractory ventricular tachycardia (VT) and electrical storm. However, data on the role of CSD in the management of ventricular arrhythmia is limited.</AbstractText><AbstractText Label="METHODS">We performed a meta-analysis of retrospective studies to calculate the pooled rate of freedom from VT and the standard mean difference of ICD shocks before and after CSD.</AbstractText><AbstractText Label="RESULTS">14 nonrandomized studies with a total of 311 patients with refractory VT or electrical storm were included. At a mean follow up of 15 &#xb1; 10.7 months, the pooled rate of freedom from VT (VT nonrecurrence rate) after CSD in all causes of arrhythmia was 60% (range 48.8% to 70%, I<sup>2&#xa0;&#xa0;</sup> =&#xa0;43%). When analysis was restricted to only arrhythmias caused by conditions other than catecholaminergic polymorphic ventricular tachycardia (CPVT) and long QT syndrome (LQTS), the pooled VT non-recurrence rate was 50% (range 41% to 58%, I<sup>2&#xa0;&#xa0;</sup> =&#xa0;5%). After CSD, mean total number of ICD shocks per person diminished by 3.01 (95% CI 1.09-4.94, P&#xa0;=&#xa0;.002, I<sup>2</sup> &#xa0;=&#xa0;96%) in overall analysis and by 0.97(95% CI 0.41-1.5, P&#xa0;=&#xa0;.001, I<sup>2</sup> &#xa0;=&#xa0;45%) when CPVT and LQTS were excluded.</AbstractText><AbstractText Label="CONCLUSION">In patients with refractory VT or electrical storm, CSD is associated with pooled VT nonrecurrence rate of 60% at a mean follow-up of 15 &#xb1; 10.7 months. CSD was also associated with significantly lower mean number ICD shocks per person. Further studies are needed to validate this finding in a prospective setting.</AbstractText><CopyrightInformation>&#xa9; 2020 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murtaza</LastName><ForeName>Ghulam</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, Kansas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Sharan P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Garden City Hospital, Garden City, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akella</LastName><ForeName>Krishna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, Kansas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turagam</LastName><ForeName>Mohit K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocca</LastName><ForeName>Domenico G Della</ForeName><Initials>DGD</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1492-2693</Identifier><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, Kansas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopinathannair</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, Kansas.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pacing Clin Electrophysiol</MedlineTA><NlmUniqueID>7803944</NlmUniqueID><ISSNLinking>0147-8389</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="N">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013562" MajorTopicYN="N">Sympathectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac denervation</Keyword><Keyword MajorTopicYN="N">cardiac sympathectomy</Keyword><Keyword MajorTopicYN="N">sympathetic denervation</Keyword><Keyword MajorTopicYN="N">ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32460366</ArticleId><ArticleId IdType="doi">10.1111/pace.13968</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Kuck KH, Schaumann A, Eckardt L, et&#xa0;al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31-40.</Citation></Reference><Reference><Citation>Mathuria N, Tung R, Shivkumar K. Advances in ablation of ventricular tachycardia in nonischemic cardiomyopathy. Curr Cardiol Rep. 2012;14:577-583.</Citation></Reference><Reference><Citation>Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol. 1998;32:1909-1915.</Citation></Reference><Reference><Citation>Villacast&#xed;n J, Almendral J, Arenal A, et&#xa0;al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation. 1996;93:753-762.</Citation></Reference><Reference><Citation>De Ferrari GM, Dusi V, Spazzolini C, et&#xa0;al. Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation. 2015;131:2185-2193.</Citation></Reference><Reference><Citation>Wilde AAM, Bhuiyan ZA, Crotti L, et&#xa0;al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358:2024-2029.</Citation></Reference><Reference><Citation>Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;285:903-904.</Citation></Reference><Reference><Citation>Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation. 1991;84:503-511.</Citation></Reference><Reference><Citation>Priori SG, Wilde AA, Horie M, et&#xa0;al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932-1963.</Citation></Reference><Reference><Citation>Shah R, Assis F, Alugubelli N, et&#xa0;al. Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with structural heart disease: a systematic review. Heart Rhythm. 2019;16:1499-1505.</Citation></Reference><Reference><Citation>Ajijola OA, Lellouche N, Bourke T, et&#xa0;al. Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol. 2012;59:91-92.</Citation></Reference><Reference><Citation>Assis FR, Krishnan A, Zhou X, et&#xa0;al. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2019;16:1003-1010. Jul.</Citation></Reference><Reference><Citation>Bourke T, Vaseghi M, Michowitz Y, et&#xa0;al. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation. 2010;121:2255-2262.</Citation></Reference><Reference><Citation>Cardona-Guarache R, Padala SK, Velazco-Davila L, et&#xa0;al. Stellate ganglion blockade and bilateral cardiac sympathetic denervation in patients with life-threatening ventricular arrhythmias. J Cardiovasc Electrophysiol. 2017;28:903-908.</Citation></Reference><Reference><Citation>Coleman MA, Bos JM, Johnson JN, et&#xa0;al. Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome. Circ Arrhythm Electrophysiol. 2012;5:782-788.</Citation></Reference><Reference><Citation>Okada DR, Assis FR, Gilotra NA, et&#xa0;al. Cardiac sympathectomy for refractory ventricular arrhythmias in cardiac sarcoidosis. Heart Rhythm. 2019 Sep;16:1408-1413.</Citation></Reference><Reference><Citation>Prabhu MA, Prasad SBV, Abhilash SP, Thajudeen A, R BK, Namboodiri N. Left sympathetic cardiac denervation in managing electrical storm: acute outcome and long term follow up. J Interv Card Electrophysiol. 2016;47:285-292.</Citation></Reference><Reference><Citation>Richardson T, Lugo R, Saavedra P, et&#xa0;al. Cardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablation. Heart Rhythm. 2018;15:56-62.</Citation></Reference><Reference><Citation>T&#xe9;llez LJ, Garz&#xf3;n JC, Vinck EE, Castellanos JD. Video-assisted thoracoscopic cardiac denervation of refractory ventricular arrhythmias and electrical storms: a single-center series. J Cardiothorac Surg. 2019;14:17.</Citation></Reference><Reference><Citation>Vaseghi M, Barwad P, Malavassi CFJ, et&#xa0;al. Cardiac sympathetic denervation for refractory ventricular arrhythmias. J Am Coll Cardiol. 2017;69:3070-3080.</Citation></Reference><Reference><Citation>Hofferberth SC, Cecchin F, Loberman D, Fynn-Thompson F. Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. J Thorac Cardiovasc Surg. 2014;147:404-409.</Citation></Reference><Reference><Citation>Methangkool E, Chua JH, Gopinath A, Shivkumar K, Mahajan A. Anesthetic considerations for thoracoscopic sympathetic ganglionectomy to treat ventricular tachycardia storm: a single-center experience. J Cardiothorac Vasc Anesth. 2014;28:69-75.</Citation></Reference><Reference><Citation>Saenz LC, Corrales FM, Bautista W, et&#xa0;al. Cardiac sympathetic denervation for intractable ventricular arrhythmias in Chagas disease. Heart Rhythm. 2016;13:1388-1394.</Citation></Reference><Reference><Citation>Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res. 2014;114:1004-1021.</Citation></Reference><Reference><Citation>Lukas A, Antzelevitch C. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation. 1993;88:2903-2915.</Citation></Reference><Reference><Citation>Cao JM, Fishbein MC, Han JB, et&#xa0;al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation. 2000;101:1960-1969.</Citation></Reference><Reference><Citation>Xie X, Visweswaran R, Guzman PA, Smith RM, Osborn JW, Tolkacheva EG. The effect of cardiac sympathetic denervation through bilateral stellate ganglionectomy on electrical properties of the heart. Am J Physiol Heart Circ Physiol. 2011;301:H192-199.</Citation></Reference><Reference><Citation>Yoshimoto M, Wehrwein EA, Novotny M, Swain GM, Kreulen DL, Osborn JW. Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta1-adrenoceptor blockade in the rat. Am J Physiol Heart Circ Physiol. 2008;295:H2447-2454.</Citation></Reference><Reference><Citation>Schwartz PJ, Verrier RL, Lown B. Effect of stellectomy and vagotomy on ventricular refractoriness in dogs. Circ Res. 1977;40:536-540.</Citation></Reference><Reference><Citation>Estes EH, Izlar HL. Recurrent ventricular tachycardia. A case successfully treated by bilateral cardiac sympathectomy. Am J Med. 1961;31:493-497.</Citation></Reference><Reference><Citation>Zipes DP, Festoff B, Schaal SF, Cox C, Sealy WC, Wallace AG. Treatment of ventricular arrhythmia by permanent atrial pacemaker and cardiac sympathectomy. Ann Intern Med. 1968;68:591-597.</Citation></Reference><Reference><Citation>Puddu PE, Jouve R, Langlet F, Guillen JC, Lanti M, Reale A. Prevention of postischemic ventricular fibrillation late after right or left stellate ganglionectomy in dogs. Circulation. 1988;77:935-946.</Citation></Reference><Reference><Citation>Schwartz PJ, Stone HL. Effects of unilateral stellectomy upon cardiac performance during exercise in dogs. Circ Res. 1979;44:637-645.</Citation></Reference><Reference><Citation>Schwartz PJ. The rationale and the role of left stellectomy for the prevention of malignant arrhythmias. Ann N Y Acad Sci. 1984;427:199-221.</Citation></Reference><Reference><Citation>Chung IH, Oh CS, Koh KS, Kim HJ, Paik HC, Lee DY. Anatomic variations of the T2 nerve root (including the nerve of Kuntz) and their implications for sympathectomy. J Thorac Cardiovasc Surg. 2002;123:498-501.</Citation></Reference><Reference><Citation>Vaseghi M, Gima J, Kanaan C, et&#xa0;al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: Intermediate and Long-Term Follow-Up. Heart Rhythm. 2014;11:360-366.</Citation></Reference><Reference><Citation>Collura CA, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm. 2009;6:752-759.</Citation></Reference><Reference><Citation>Ajijola OA, Vaseghi M, Mahajan A, Shivkumar K. Bilateral cardiac sympathetic denervation: why, who and when?. Expert Rev Cardiovasc Ther. 2012;10:947-949.</Citation></Reference><Reference><Citation>Schwartz PJ, Motolese M, Pollavini G, et&#xa0;al. Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J Cardiovasc Electrophysiol. 1992;3:2-16.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35759160</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies.</ArticleTitle><Pagination><StartPage>161</StartPage><EndPage>175</EndPage><MedlinePgn>161-175</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-022-01287-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In patients with cardiomyopathy, radiofrequency catheter ablation (CA) for ventricular tachycardia (VT) is an adjunctive and alternative treatment option to long-term anti-arrhythmic drug therapy. We sought to compare CA with medical therapy for the management of VT in patients with ischemic and non-ischemic cardiomyopathies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, Cochrane, and ClinicalTrials.gov databases were evaluated for relevant studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven studies with 2126 adult patients were included (711 in CA, 1415 in medical therapy). In the randomized controlled trial (RCT) analysis, CA reduced risk of recurrent VT (risk ratio (RR) 0.79 [95% CI 0.67 to 0.93], p&#x2009;=&#x2009;0.005), ICD shocks (RR 0.64 [95% CI 0.45 to 0.89] p&#x2009;=&#x2009;0.008), and cardiac hospitalizations (RR 0.76 [95% CI 0.63 to 0.92] p&#x2009;=&#x2009;0.005). There was no difference in all-cause mortality (RR 0.94, p&#x2009;=&#x2009;0.71). In combined RCT and observational study analysis, there was a trend for reduction in all-cause mortality (RR 0.75 [95% CI 0.55 to 1.02] p&#x2009;=&#x2009;0.07). In subgroup analysis of studies with mean left ventricular ejection fraction (LVEF)&#x2009;&lt;&#x2009;35%, CA demonstrated reduction in mortality (RR 0.71, p&#x2009;=&#x2009;0.004), ICD shocks (RR 0.63, p&#x2009;=&#x2009;0.03), VT recurrence (RR 0.76, p&#x2009;=&#x2009;0.004), and cardiac hospitalizations (RR 0.75, p&#x2009;=&#x2009;0.02). The subgroup of early CA prior to ICD shocks demonstrated reduction in ICD shocks (RR 0.57, p&#x2009;&lt;&#x2009;0.001) and VT recurrence (RR 0.74, p&#x2009;=&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CA for VT demonstrated a lower risk of VT recurrence, ICD shocks, and hospitalization in comparison to medical therapy. The subgroups of early CA and LVEF&#x2009;&lt;&#x2009;35% demonstrated better outcomes.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ravi</LastName><ForeName>Venkatesh</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-6826-9231</Identifier><AffiliationInfo><Affiliation>Warren Clinic Cardiology, Saint Francis Health System, 6151 South Yale Ave, Tulsa, OK, 74136, USA. venkateshravi.8711@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poudyal</LastName><ForeName>Abhushan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cook County Health, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanal</LastName><ForeName>Smriti</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cook County Health, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Charl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cook County Health, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vij</LastName><ForeName>Aviral</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cook County Health, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trohman</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aksu</LastName><ForeName>Tolga</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Yeditepe University Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Roderick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, University of Arizona College of Medicine, Phoenix, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santangeli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Hospital of University of Pennsylvania, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winterfield</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Parikshit S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Henry D</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Section of Electrophysiology, Division of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Interv Card Electrophysiol. 2023 Jan;66(1):177-178. doi: 10.1007/s10840-022-01309-7.</RefSource><PMID Version="1">35895221</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Medical therapy</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>27</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35759160</ArticleId><ArticleId IdType="doi">10.1007/s10840-022-01287-w</ArticleId><ArticleId IdType="pii">10.1007/s10840-022-01287-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91&#x2013;220. https://doi.org/10.1016/j.jacc.2017.10.054 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.10.054</ArticleId><ArticleId IdType="pubmed">29097296</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein AE, DiMarco JP, Ellenbogen KA, American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices), American Association for Thoracic Surgery; Society of Thoracic Surgeons, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51(21):e1-62. https://doi.org/10.1016/j.jacc.2008.02.032 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.02.032</ArticleId><ArticleId IdType="pubmed">18498951</ArticleId></ArticleIdList></Reference><Reference><Citation>Members Writing Committee, Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;S0735&#x2013;1097(21):08395&#x2013;9. https://doi.org/10.1016/j.jacc.2021.12.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120(22):2170&#x2013;6. https://doi.org/10.1161/CIRCULATIONAHA.109.853689 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.853689</ArticleId><ArticleId IdType="pubmed">19917887</ArticleId><ArticleId IdType="pmc">2922511</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657&#x2013;65. https://doi.org/10.1056/NEJMoa065457 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065457</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId><ArticleId IdType="pmc">2390777</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems S, Tilz RR, Steven D, BERLIN VT Investigators, et al. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141(13):1057&#x2013;67. https://doi.org/10.1161/CIRCULATIONAHA.119.043400 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043400</ArticleId><ArticleId IdType="pubmed">32000514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Schaumann A, Eckardt L, VTACH study group, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375(9708):31&#x2013;40. https://doi.org/10.1016/S0140-6736(09)61755-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61755-4</ArticleId><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima Silva G, Nunes-Ferreira A, Cortez-Dias N, de Sousa J, Pinto JF, Caldeira D. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2020;59(3):603&#x2013;16. https://doi.org/10.1007/s10840-020-00870-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-020-00870-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Bella P, Baratto F, Vergara P, et al. Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation. 2022. https://doi.org/10.1161/CIRCULATIONAHA.122.059598 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059598</ArticleId><ArticleId IdType="pubmed">35969654</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenal &#xc1;, &#xc1;vila P, Jim&#xe9;nez-Candil J, et al. Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol. 2022;79(15):1441&#x2013;53. https://doi.org/10.1016/j.jacc.2022.01.050 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.01.050</ArticleId><ArticleId IdType="pubmed">35422240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R, Xue Y, Chen M, Jiang C, et al; PAUSE-SCD Investigators. First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial. Circulation. 2022. https://doi.org/10.1161/CIRCULATIONAHA.122.060039 .</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, PRISMA Group. Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook .</Citation></Reference><Reference><Citation>Borenstein M, Hedges L, Higgins J, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.12</ArticleId><ArticleId IdType="pubmed">26061376</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman A, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence&#x2014;inconsistency. J Clin Epidemiol. 2011;64:1294&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.03.017</ArticleId><ArticleId IdType="pubmed">21803546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J, Harbord R. Funnel plots in meta-analysis. The Stata Journal: Promoting communications on statistics and Stata. 2004;4:127&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X0400400204</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Daubert JP, Anstrom KJ, et al. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2015;26(2):151&#x2013;7. https://doi.org/10.1111/jce.12567 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.12567</ArticleId><ArticleId IdType="pubmed">25332150</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111&#x2013;21. https://doi.org/10.1056/NEJMoa1513614 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1513614</ArticleId><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Tilz RR, Deneke T, SMS Investigators, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol. 2017;10(3):e004422. https://doi.org/10.1161/CIRCEP.116.004422 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.116.004422</ArticleId><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunch TJ, Weiss JP, Crandall BG, et al. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart Rhythm. 2014;11(4):533&#x2013;40. https://doi.org/10.1016/j.hrthm.2013.12.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2013.12.014</ArticleId><ArticleId IdType="pubmed">24333283</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez Candil J, Castro JC, Hern&#xe1;ndez J, et al. Timing of ablation and prognosis of patients with electrical storm and scar-related left ventricular dysfunction. Am J Cardiol. 2020;136:87&#x2013;93. https://doi.org/10.1016/j.amjcard.2020.09.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.09.010</ArticleId><ArticleId IdType="pubmed">32946863</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez BK, Baker WL, Konopka A, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020;17(1):e206&#x2013;19. https://doi.org/10.1016/j.hrthm.2019.04.024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.04.024</ArticleId><ArticleId IdType="pubmed">31082362</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Dorian P, Roberts RS, Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006;295(2):165&#x2013;71. https://doi.org/10.1001/jama.295.2.165 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.2.165</ArticleId><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2004;110(2):112&#x2013;6. https://doi.org/10.1161/01.CIR.0000134957.51747.6E .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000134957.51747.6E</ArticleId><ArticleId IdType="pubmed">15238454</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams ES, Viswanathan MN. Current and emerging antiarrhythmic drug therapy for ventricular tachycardia. Cardiol Ther. 2013;2(1):27&#x2013;46. https://doi.org/10.1007/s40119-013-0012-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-013-0012-5</ArticleId><ArticleId IdType="pubmed">25135287</ArticleId><ArticleId IdType="pmc">4107437</ArticleId></ArticleIdList></Reference><Reference><Citation>Brice&#xf1;o DF, Romero J, Villablanca PA, et al. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. Europace. 2018;20(1):104&#x2013;15. https://doi.org/10.1093/europace/eux109 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eux109</ArticleId><ArticleId IdType="pubmed">28575378</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Cochet H, Sacher F, et al. Impact of new technologies and approaches for post-myocardial infarction ventricular tachycardia ablation during long-term follow-up. Circ Arrhythm Electrophysiol. 2016;9(7):e003901. https://doi.org/10.1161/CIRCEP.116.003901 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.116.003901</ArticleId><ArticleId IdType="pubmed">27406604</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32229050</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>308</Volume><PubDate><Year>2020</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Mechanical circulatory support for life-threatening arrhythmia: A systematic review.</ArticleTitle><Pagination><StartPage>42</StartPage><EndPage>49</EndPage><MedlinePgn>42-49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2020.03.045</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(20)30394-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">The use of temporary mechanical circulatory support (tMCS) during arrhythmia is increasing, although available evidence for this indication is limited, with significant gaps of knowledge regarding appropriate timing, management and configuration. This systematic review sought to analyze the use of tMCS in patients with life-threatening arrhythmia.</AbstractText><AbstractText Label="METHODS">A systematic literature search identified 2529 references published until September 2019. Adult and pediatric patients diagnosed with all kind of life-threatening arrhythmia were included. tMCS was primarily compared to conventional non-tMCS therapies. Primary outcome measure was in-hospital or 30-day mortality.</AbstractText><AbstractText Label="RESULTS">19 non-randomized studies were selected, including 2465 adult and 82 pediatric patients. Primary outcome in tMCS patients varied widely (4-62%) with differences based on the use of prophylactic tMCS (4-21%) or rescue tMCS (58-62%). A substantial mortality benefit was observed among high-risk patients, as identified with PAINESD risk score or suffering from electrical storm and treated with prophylactic tMCS. During ablation procedures, tMCS patients showed higher rates of induced ventricular tachycardias (VTs), ablated VTs, VT termination and non-inducibility after ablation. Extracorporeal membrane oxygenation (ECMO) was applied in pediatric cases as hemodynamic protection for aggressive antiarrhythmic medical treatment with &gt;80% survival.</AbstractText><AbstractText Label="CONCLUSIONS">Prophylactic tMCS is associated with improved survival as compared to rescue or no-tMCS in patients with life-threatening arrhythmia, and may be considered in patients with high PAINESD risk score or suffering from electrical storm. ECMO can be advised as rescue and support therapy in pediatric cases requiring aggressive antiarrhythmic medical treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular, Surgery, Hannover Medical School, Hannover, Germany. Electronic address: Mariani.Silvia@mh-hannover.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Napp</LastName><ForeName>L Christian</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo Coco</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delnoij</LastName><ForeName>Thijs S R</ForeName><Initials>TSR</Initials><AffiliationInfo><Affiliation>Cardiology Department, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Intensive Care, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luermans</LastName><ForeName>Justin G L M</ForeName><Initials>JGLM</Initials><AffiliationInfo><Affiliation>Cardiology Department, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ter Bekke</LastName><ForeName>Rachel M A</ForeName><Initials>RMA</Initials><AffiliationInfo><Affiliation>Cardiology Department, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timmermans</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cardiology Department, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular, Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dogan</LastName><ForeName>Guenes</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular, Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitto</LastName><ForeName>Jan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular, Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maessen</LastName><ForeName>Jos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maesen</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorusso</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Cardiol. 2020 Nov 15;319:94-95. doi: 10.1016/j.ijcard.2020.05.063.</RefSource><PMID Version="1">32504720</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016027" MajorTopicYN="Y">Heart Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">ECMO</Keyword><Keyword MajorTopicYN="N">Electrical storm</Keyword><Keyword MajorTopicYN="N">Extracorporeal circulation</Keyword><Keyword MajorTopicYN="N">IABP</Keyword><Keyword MajorTopicYN="N">Impella</Keyword><Keyword MajorTopicYN="N">Mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList><CoiStatement>Declaration of competing interest L Christian Napp: consultant, proctoring and lecture honoraria from Abiomed, lecture honoraria from Abbott and Maquet. Jan D Schmitto and Guenes Dogan: consultant for Abbott and Medtronic. Roberto Lorusso: Principal Investigator &#x2013; PERSIST-AVR Study (sponsored by LivaNova); consultant LivaNova, EuroSets, Medtronic; advisory board PulseCath.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32229050</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2020.03.045</ArticleId><ArticleId IdType="pii">S0167-5273(20)30394-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27262840</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>2016</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2891</StartPage><EndPage>2900</EndPage><MedlinePgn>2891-900</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-016-3648-x</ELocationID><Abstract><AbstractText>Health-related quality of life in osteoporotic patients with vertebral fracture is of increasing interest, but relevant studies have yielded debatable results. This systematic review and meta-analysis of 16 observational studies demonstrate a clear association between physical health status and presence of vertebral fracture after accounting for age. This meta-analysis was conducted to identify if there are any differences between physical and/or mental health-related quality of life (HRQoL) in older people with osteoporosis based on conventional T-score definitions and the presence or absence of vertebral fracture. A comprehensive search was undertaken using the databases of PubMed, Embase, Medline, Web of Science, and the "grey" literature from 1950 to the end of April 2015. Search terms for vertebral fracture (VF) included VF, osteoporotic fracture, fragility fracture, and spinal fracture. Quality of life was searched using the following terms: quality of life, health-related quality of life, HRQoL, and QoL. Strict inclusion and exclusion criteria were used. The standardized mean difference (SMD) was calculated for each HRQoL domain by the difference in means between case and control groups divided by the pooled SD of participants. Sixteen eligible studies were identified involving 3131 men and women. There was evidence of publication bias and heterogeneity. The meta-analysis showed worse physical (SMD&#x2009;=&#x2009;0.53, 95&#xa0;% confidence interval (CI) 0.38 to 0.68; P&#x2009;&lt;&#x2009;0.001) and mental (SMD&#x2009;=&#x2009;0.19, 95&#xa0;% CI 0.05 to 0.33; P&#x2009;=&#x2009;0.009) HRQoL in osteoporotic older people with vertebral fracture compared to those without fracture. Similar differences were observed for physical HRQoL in further analyses accounting for possible confounding effects of age. Sub-analysis to assess associations between number/severity of fractures and time since fracture was not possible due to small numbers of studies that accounted for age. Osteoporotic older people with vertebral fracture have worse physical HRQoL than osteoporotic older people without vertebral fracture, even after accounting for age differences.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Sari</LastName><ForeName>U A</ForeName><Initials>UA</Initials><AffiliationInfo><Affiliation>Academic Rheumatology, Musculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol, BS10 5NB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobias</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academic Rheumatology, Musculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol, BS10 5NB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Academic Rheumatology, Musculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol, BS10 5NB, UK. Emma.Clark@bristol.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Osteoporos Int. 2016 Dec;27(12):3661. doi: 10.1007/s00198-016-3725-1.</RefSource><PMID Version="1">27503173</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Osteoporos Int. 2016 Dec;27(12):3663. doi: 10.1007/s00198-016-3726-0.</RefSource><PMID Version="1">27503174</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mental health</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Physical health</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27262840</ArticleId><ArticleId IdType="doi">10.1007/s00198-016-3648-x</ArticleId><ArticleId IdType="pii">10.1007/s00198-016-3648-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Rheumatol. 2008 Mar;27(3):327-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17851709</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Metab. 2005;23(2):167-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15750696</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2007 Jan;34(1):140-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17216681</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Osteoporos. 2012;7:101-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23225287</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 1999;10(2):150-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10501796</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2012 Dec;23(12):2749-68</Citation><ArticleIdList><ArticleId IdType="pubmed">22814944</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Policy. 1990 Dec;16(3):199-208</Citation><ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2004 Jan;15(1):80-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14593454</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicina (Kaunas). 2006;42(9):744-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17028473</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 1996 Mar;34(3):220-33</Citation><ArticleIdList><ArticleId IdType="pubmed">8628042</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Med Sci. 2011 Jun;7(3):476-85</Citation><ArticleIdList><ArticleId IdType="pubmed">22295032</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2005 Dec 01;3:78</Citation><ArticleIdList><ArticleId IdType="pubmed">16321148</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2004 Dec;15(12):975-80</Citation><ArticleIdList><ArticleId IdType="pubmed">15118812</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rheumatol. 2008 Feb;27(2):151-61</Citation><ArticleIdList><ArticleId IdType="pubmed">17646902</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2007 Jul;34(7):1551-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17516618</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2012 Jun 18;10 :74</Citation><ArticleIdList><ArticleId IdType="pubmed">22709379</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2005 Apr 20;5:13</Citation><ArticleIdList><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2000 Jul;15(7):1384-92</Citation><ArticleIdList><ArticleId IdType="pubmed">10893688</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2000 Apr;15(4):721-39</Citation><ArticleIdList><ArticleId IdType="pubmed">10780864</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2011 Apr 06;9:20</Citation><ArticleIdList><ArticleId IdType="pubmed">21470396</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2005 Dec;16(12 ):2175-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16220230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31743177</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Global and Regional Respiratory Mechanics During Robotic-Assisted Laparoscopic Surgery: A Randomized Study.</ArticleTitle><Pagination><StartPage>1564</StartPage><EndPage>1573</EndPage><MedlinePgn>1564-1573</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000004289</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pneumoperitoneum and nonphysiological positioning required for robotic surgery increase cardiopulmonary risk because of the use of larger airway pressures (Paws) to maintain tidal volume (VT). However, the quantitative partitioning of respiratory mechanics and transpulmonary pressure (PL) during robotic surgery is not well described. We tested the following hypothesis: (1) the components of driving pressure (transpulmonary and chest wall components) increase in a parallel fashion at robotic surgical stages (Trendelenburg and robot docking); and (2) deep, when compared to routine (moderate), neuromuscular blockade modifies those changes in PLs as well as in regional respiratory mechanics.</AbstractText><AbstractText Label="METHODS">We studied 35 American Society of Anesthesiologists (ASA) I-II patients undergoing elective robotic surgery. Airway and esophageal balloon pressures and respiratory flows were measured to calculate respiratory mechanics. Regional lung aeration and ventilation was assessed with electrical impedance tomography and level of neuromuscular blockade with acceleromyography. During robotic surgical stages, 2 crossover randomized groups (conditions) of neuromuscular relaxation were studied: Moderate (1 twitch in the train-of-four stimulation) and Deep (1-2 twitches in the posttetanic count).</AbstractText><AbstractText Label="RESULTS">Pneumoperitoneum was associated with increases in driving pressure, tidal changes in PL, and esophageal pressure (Pes). Steep Trendelenburg position during robot docking was associated with further worsening of the respiratory mechanics. The fraction of driving pressures that partitioned to the lungs decreased from baseline (63% &#xb1; 15%) to Trendelenburg position (49% &#xb1; 14%, P &lt; .001), due to a larger increase in chest wall elastance (Ecw; 12.7 &#xb1; 7.6 cm H2O&#xb7;L) than in lung elastance (EL; 4.3 &#xb1; 5.0 cm H2O&#xb7;L, P &lt; .001). Consequently, from baseline to Trendelenburg, the component of Paw affecting the chest wall increased by 6.6 &#xb1; 3.1 cm H2O, while PLs increased by only 3.4 &#xb1; 3.1 cm H2O (P &lt; .001). PL and driving pressures were larger at surgery end than at baseline and were accompanied by dorsal aeration loss. Deep neuromuscular blockade did not change respiratory mechanics, regional aeration and ventilation, and hemodynamics.</AbstractText><AbstractText Label="CONCLUSIONS">In robotic surgery with pneumoperitoneum, changes in ventilatory driving pressures during Trendelenburg and robot docking are distributed less to the lungs than to the chest wall as compared to routine mechanical ventilation for supine patients. This effect of robotic surgery derives from substantially larger increases in Ecw than ELs and reduces the risk of excessive PLs. Deep neuromuscular blockade does not meaningfully change global or regional lung mechanics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brand&#xe3;o</LastName><ForeName>Julio C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, UNIFESP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessa</LastName><ForeName>Marcos A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Cardiovascular Investigation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motta-Ribeiro</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Soshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paula</LastName><ForeName>Luis Felipe</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torsani</LastName><ForeName>Vinicius</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardio-Pulmonary Department, Pulmonary Division, Heart Institute (Incor), University of S&#xe3;o Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Linh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eikermann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl</LastName><ForeName>Douglas M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabatabaei</LastName><ForeName>Shahin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amato</LastName><ForeName>Marcelo B P</ForeName><Initials>MBP</Initials><AffiliationInfo><Affiliation>Cardio-Pulmonary Department, Pulmonary Division, Heart Institute (Incor), University of S&#xe3;o Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal Melo</LastName><ForeName>Marcos F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Anesth Analg. 2020 Apr;130(4):e118. doi: 10.1213/ANE.0000000000004640.</RefSource><PMID Version="1">33034983</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001900" MajorTopicYN="N" Type="Geographic">Boston</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018475" MajorTopicYN="N">Head-Down Tilt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061886" MajorTopicYN="Y">Neuromuscular Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011028" MajorTopicYN="Y">Pneumoperitoneum, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="N">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="Y">Respiratory Mechanics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055397" MajorTopicYN="N">Ventilator-Induced Lung Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31743177</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000004289</ArticleId><ArticleId IdType="pii">00000539-201912000-00022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22180126</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Safety and efficacy of the remote magnetic navigation for ablation of ventricular tachycardias--a systematic review.</ArticleTitle><Pagination><StartPage>65</StartPage><EndPage>71</EndPage><MedlinePgn>65-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-011-9645-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Remote magnetic navigation (RMN) is considered to be a solution for mapping and ablation of several arrhythmias. In this systematic review we aimed to assess the safety and efficacy of RMN in ablation of ventricular tachycardia (VT).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The National Library of Medicine's PubMed database was searched for articles containing any of a predetermined set of search terms that were published prior to November 1, 2011. Quality of evidence was rated using the GRADE system.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The database search resulted in 11 relevant articles evaluating the usefulness of RMN. Three groups of VTs were studied: VT in patients with ischemic cardiomyopathy (ICMP), non-ischemic cardiomyopathy (NICMP) and structurally normal hearts (SNH). The use of RMN in patients with ICMP has been associated with success rates ranging from 71 to 80%. RMN has been shown to be a feasible and effective method for ablation of VT in NICMP and SNH patients. Success rates between 50% and 100% have been reported in NICMP populations. Rates ranging from 86% to 100% have been reported for SNH patients. The lowest rates of arrhythmia recurrence are reported for SNH patients (0-17%). In ICMP and NICMP, recurrence rates of 0-30% and 14-50%, respectively, have been reported. One patient experienced total heart block, and one patient experienced a thromboembolic event after RMN catheter ablation procedures.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">RMN has been shown to be an effective and safe method for ablation of VT in various patient populations with low recurrence and complication rates. However, more comparative and randomized studies are necessary, and therefore the true value of RMN for VT ablation remains still unknown.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akca</LastName><ForeName>Ferdi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinical Electrophysiology, Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;nsesveren</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Jordaens</LastName><ForeName>Luc</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Szili-Torok</LastName><ForeName>Tamas</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012371" MajorTopicYN="N">Robotics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2011</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22180126</ArticleId><ArticleId IdType="pmc">PMC3342497</ArticleId><ArticleId IdType="doi">10.1007/s10840-011-9645-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. The New England Journal of Medicine. 2007;357:2657&#x2013;2665. doi: 10.1056/NEJMoa065457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065457</ArticleId><ArticleId IdType="pmc">PMC2390777</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. Acc/aha/esc 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385&#x2013;484. doi: 10.1161/CIRCULATIONAHA.106.178233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.178233</ArticleId><ArticleId IdType="pubmed">16935995</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation. 2008;117:462&#x2013;469. doi: 10.1161/CIRCULATIONAHA.106.686534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.686534</ArticleId><ArticleId IdType="pubmed">18172038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansch D, Oyang F, Antz M, Arentz T, Weber R, Val-Mejias JE, Ernst S, Kuck KH. Successful catheter ablation of electrical storm after myocardial infarction. Circulation. 2003;108:3011&#x2013;3016. doi: 10.1161/01.CIR.0000103701.30662.5C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000103701.30662.5C</ArticleId><ArticleId IdType="pubmed">14662718</ArticleId></ArticleIdList></Reference><Reference><Citation>Borger van der Burg AE, de Groot NM, van Erven L, Bootsma M, van der Wall EE, Schalij MJ. Long-term follow-up after radiofrequency catheter ablation of ventricular tachycardia: a successful approach? Journal of Cardiovascular Electrophysiology. 2002;13:417&#x2013;423. doi: 10.1046/j.1540-8167.2002.00417.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1540-8167.2002.00417.x</ArticleId><ArticleId IdType="pubmed">12030520</ArticleId></ArticleIdList></Reference><Reference><Citation>Aryana A, d&#x2019;Avila A, Heist EK, Mela T, Singh JP, Ruskin JN, Reddy VY. Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia. Circulation. 2007;115:1191&#x2013;1200.</Citation><ArticleIdList><ArticleId IdType="pubmed">17296855</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt JD, Saliba WI, Schweikert RA, Cummings J, Natale A. Remote magnetic navigation to map and ablate left coronary cusp ventricular tachycardia. Journal of Cardiovascular Electrophysiology. 2006;17:1142&#x2013;1144. doi: 10.1111/j.1540-8167.2006.00559.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2006.00559.x</ArticleId><ArticleId IdType="pubmed">16879625</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Biase L, Fahmy TS, Patel D, Bai R, Civello K, Wazni OM, Kanj M, Elayi CS, Ching CK, Khan M, Popova L, Schweikert RA, Cummings JE, Burkhardt JD, Martin DO, Bhargava M, Dresing T, Saliba W, Arruda M, Natale A. Remote magnetic navigation: human experience in pulmonary vein ablation. Journal of the American College of Cardiology. 2007;50:868&#x2013;874. doi: 10.1016/j.jacc.2007.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2007.05.023</ArticleId><ArticleId IdType="pubmed">17719473</ArticleId></ArticleIdList></Reference><Reference><Citation>Pflaumer A, Hessling G, Luik A, Wu J, Zrenner B. Remote magnetic catheter mapping and ablation of permanent junctional reciprocating tachycardia in a seven-year-old child. Journal of Cardiovascular Electrophysiology. 2007;18:882&#x2013;885. doi: 10.1111/j.1540-8167.2007.00778.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2007.00778.x</ArticleId><ArticleId IdType="pubmed">17331103</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis DR, Tang AS, Gollob MH, Lemery R, Green MS, Birnie DH. Remote magnetic navigation-assisted catheter ablation enhances catheter stability and ablation success with lower catheter temperatures. Pacing and Clinical Electrophysiology. 2008;31:893&#x2013;898. doi: 10.1111/j.1540-8159.2008.01105.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2008.01105.x</ArticleId><ArticleId IdType="pubmed">18684288</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwagten BK, Szili-Torok T, Rivero-Ayerza M, Jessurun E, Valk S, Jordaens LJ. Usefulness of remote magnetic navigation for ablation of ventricular arrhythmias originating from outflow regions. Netherlands Heart Journal. 2009;17:245&#x2013;249. doi: 10.1007/BF03086255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03086255</ArticleId><ArticleId IdType="pmc">PMC2711250</ArticleId><ArticleId IdType="pubmed">19789687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst S. Magnetic and robotic navigation for catheter ablation: &#x201c;joystick ablation&#x201d;. Journal of Interventional Cardiac Electrophysiology. 2008;23:41&#x2013;44. doi: 10.1007/s10840-008-9272-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-008-9272-8</ArticleId><ArticleId IdType="pubmed">18536985</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauernfeind T, Akca F, Schwagten B, de Groot N, Van Belle Y, Valk S, Ujvari B, Jordaens L, Szili-Torok T. The magnetic navigation system allows safety and high efficacy for ablation of arrhythmias. Europace. 2011;13:1015&#x2013;1021. doi: 10.1093/europace/eur073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eur073</ArticleId><ArticleId IdType="pmc">PMC3120134</ArticleId><ArticleId IdType="pubmed">21508006</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Yang B, Shan Q, Zou J, Chen M, Chen C, Hou X, Zhang F, Li WQ, Cao K, Tse HF. Initial clinical experience of remote magnetic navigation system for catheter mapping and ablation of supraventricular tachycardias. Journal of Interventional Cardiac Electrophysiology. 2009;25:171&#x2013;174. doi: 10.1007/s10840-008-9356-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-008-9356-5</ArticleId><ArticleId IdType="pubmed">19263204</ArticleId></ArticleIdList></Reference><Reference><Citation>Luthje L, Vollmann D, Seegers J, Dorenkamp M, Sohns C, Hasenfuss G, Zabel M. Remote magnetic versus manual catheter navigation for circumferential pulmonary vein ablation in patients with atrial fibrillation. Clin Res Cardiol 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203998</ArticleId><ArticleId IdType="pubmed">21706198</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwagten B, Witsenburg M, De Groot NM, Jordaens L, Szili-Torok T. Effect of magnetic navigation system on procedure times and radiation risk in children undergoing catheter ablation. The American Journal of Cardiology. 2010;106:69&#x2013;72. doi: 10.1016/j.amjcard.2010.01.371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2010.01.371</ArticleId><ArticleId IdType="pubmed">20609650</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst S, Hachiya H, Chun JK, Ouyang F. Remote catheter ablation of parahisian accessory pathways using a novel magnetic navigation system&#x2014;a report of two cases. Journal of Cardiovascular Electrophysiology. 2005;16:659&#x2013;662. doi: 10.1111/j.1540-8167.2005.40317.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2005.40317.x</ArticleId><ArticleId IdType="pubmed">15946368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst S, Ouyang F, Linder C, Hertting K, Stahl F, Chun J, Hachiya H, Krumsdorf U, Antz M, Kuck KH. Modulation of the slow pathway in the presence of a persistent left superior caval vein using the novel magnetic navigation system niobe. Europace. 2004;6:10&#x2013;14. doi: 10.1016/j.eupc.2003.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eupc.2003.09.011</ArticleId><ArticleId IdType="pubmed">14697720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappone C, Vicedomini G, Manguso F, Gugliotta F, Mazzone P, Gulletta S, Sora N, Sala S, Marzi A, Augello G, Livolsi L, Santagostino A, Santinelli V. Robotic magnetic navigation for atrial fibrillation ablation. Journal of the American College of Cardiology. 2006;47:1390&#x2013;1400. doi: 10.1016/j.jacc.2005.11.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.11.058</ArticleId><ArticleId IdType="pubmed">16580527</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghjoo M, Hindricks G, Bode K, Piorkowski C, Bollmann A, Arya A. Initial clinical experience with the new irrigated tip magnetic catheter for ablation of scar-related sustained ventricular tachycardia: a small case series. Journal of Cardiovascular Electrophysiology. 2009;20:935&#x2013;939. doi: 10.1111/j.1540-8167.2008.01416.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2008.01416.x</ArticleId><ArticleId IdType="pubmed">19175449</ArticleId></ArticleIdList></Reference><Reference><Citation>Latcu DG, Ricard P, Zarqane N, Yaici K, Rinaldi JP, Maluski A, Saoudi N. Robotic magnetic navigation for ablation of human arrhythmias: initial experience. Archives of Cardiovascular Diseases. 2009;102:419&#x2013;425. doi: 10.1016/j.acvd.2009.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2009.02.009</ArticleId><ArticleId IdType="pubmed">19520327</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Biase L, Santangeli P, Astudillo V, Conti S, Mohanty P, Mohanty S, Sanchez JE, Horton R, Thomas B, Burkhardt JD, Natale A. Endo-epicardial ablation of ventricular arrhythmias in the left ventricle with the remote magnetic navigation system and the 3.5-mm open irrigated magnetic catheter: results from a large single-center case&#x2013;control series. Heart Rhythm. 2010;7:1029&#x2013;1035. doi: 10.1016/j.hrthm.2010.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2010.04.036</ArticleId><ArticleId IdType="pubmed">20434589</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber D, Kottkamp H. Ablation of idiopathic ventricular tachycardia. Current Cardiology Reports. 2010;12:382&#x2013;388. doi: 10.1007/s11886-010-0121-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-010-0121-x</ArticleId><ArticleId IdType="pubmed">20526866</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamakura S, Shimizu W, Matsuo K, Taguchi A, Suyama K, Kurita T, Aihara N, Ohe T, Shimomura K. Localization of optimal ablation site of idiopathic ventricular tachycardia from right and left ventricular outflow tract by body surface ECG. Circulation. 1998;98:1525&#x2013;1533.</Citation><ArticleIdList><ArticleId IdType="pubmed">9769306</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs ME, Krause PC, Engelstein ED, Zipes DP, Miles WM. Ventricular tachycardias mimicking those arising from the right ventricular outflow tract. Journal of Cardiovascular Electrophysiology. 2000;11:45&#x2013;51. doi: 10.1111/j.1540-8167.2000.tb00735.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2000.tb00735.x</ArticleId><ArticleId IdType="pubmed">10695461</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmermans C, Rodriguez LM, Crijns HJ, Moorman AF, Wellens HJ. Idiopathic left bundle-branch block-shaped ventricular tachycardia may originate above the pulmonary valve. Circulation. 2003;108:1960&#x2013;1967. doi: 10.1161/01.CIR.0000095026.19339.BB.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000095026.19339.BB</ArticleId><ArticleId IdType="pubmed">14530199</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW. Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-David E, Arenal A, Rubio-Guivernau JL, del Castillo R, Atea L, Arbelo E, Caballero E, Celorrio V, Datino T, Gonzalez-Torrecilla E, Atienza F, Ledesma-Carbayo MJ, Bermejo J, Medina A, Fernandez-Aviles F. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. Journal of the American College of Cardiology. 2011;57:184&#x2013;194. doi: 10.1016/j.jacc.2010.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.07.043</ArticleId><ArticleId IdType="pubmed">21211689</ArticleId></ArticleIdList></Reference><Reference><Citation>Luthje L, Vollmann D, Seegers J, Sohns C, Hasenfuss G, Zabel M. Interference of remote magnetic catheter navigation and ablation with implanted devices for pacing and defibrillation. Europace. 2010;12:1574&#x2013;1580. doi: 10.1093/europace/euq300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euq300</ArticleId><ArticleId IdType="pubmed">20810533</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitel C, Hindricks G, Sommer P, Wetzel U, Bollmann A, Gaspar T, Piorkowski C, Arya A. Safety of remote magnetic navigation in patients with pacemakers and implanted cardioverter defibrillators. Journal of Cardiovascular Electrophysiology. 2010;21:1130&#x2013;1135. doi: 10.1111/j.1540-8167.2010.01777.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2010.01777.x</ArticleId><ArticleId IdType="pubmed">20455985</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrazin JF, Labounty T, Kuhne M, Crawford T, Armstrong WF, Desjardins B, Good E, Jongnarangsin K, Chugh A, Oral H, Pelosi F, Morady F, Bogun F. Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. Heart Rhythm. 2009;6:1543&#x2013;1549. doi: 10.1016/j.hrthm.2009.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2009.08.004</ArticleId><ArticleId IdType="pmc">PMC2792731</ArticleId><ArticleId IdType="pubmed">19879531</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsiyiannis WT, Melby DP, Matelski JL, Ervin VL, Laverence KL, Gornick CC. Feasibility and safety of remote-controlled magnetic navigation for ablation of atrial fibrillation. The American Journal of Cardiology. 2008;102:1674&#x2013;1676. doi: 10.1016/j.amjcard.2008.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.08.012</ArticleId><ArticleId IdType="pubmed">19064022</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya A, Kottkamp H, Piorkowski C, Bollmann A, Gerdes-Li JH, Riahi S, Esato M, Hindricks G. Initial clinical experience with a remote magnetic catheter navigation system for ablation of cavotricuspid isthmus-dependent right atrial flutter. Pacing and Clinical Electrophysiology. 2008;31:597&#x2013;603. doi: 10.1111/j.1540-8159.2008.01047.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2008.01047.x</ArticleId><ArticleId IdType="pubmed">18439175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray IB, Dukkipati S, Houghtaling C, McPherson CD, Kastelein N, Ruskin JN, Reddy VY. Initial experience with a novel remote-guided magnetic catheter navigation system for left ventricular scar mapping and ablation in a porcine model of healed myocardial infarction. Journal of Cardiovascular Electrophysiology. 2007;18:520&#x2013;525. doi: 10.1111/j.1540-8167.2007.00794.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2007.00794.x</ArticleId><ArticleId IdType="pubmed">17388912</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton AS, Rivero-Ayerza M, Knops P, Jordaens LJ. Magnetic navigation in left-sided AV reentrant tachycardias: preliminary results of a retrograde approach. Journal of Cardiovascular Electrophysiology. 2007;18:467&#x2013;472. doi: 10.1111/j.1540-8167.2007.00783.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2007.00783.x</ArticleId><ArticleId IdType="pubmed">17343720</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dockum WG, Kuijer JP, Gotte MJ, Ten Cate FJ, Ten Berg JM, Beek AM, Twisk JW, Marcus JT, Visser CA, van Rossum AC. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis. European Heart Journal. 2006;27:2833&#x2013;2839. doi: 10.1093/eurheartj/ehl358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehl358</ArticleId><ArticleId IdType="pubmed">17098761</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dockum WG, Beek AM, ten Cate FJ, ten Berg JM, Bondarenko O, Gotte MJ, Twisk JW, Hofman MB, Visser CA, van Rossum AC. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. 2005;111:2503&#x2013;2508. doi: 10.1161/01.CIR.0000165084.28065.01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000165084.28065.01</ArticleId><ArticleId IdType="pubmed">15867172</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Biase L, Burkhardt JD, Lakkireddy D, Pillarisetti J, Baryun EN, Biria M, Horton R, Sanchez J, Gallinghouse GJ, Bailey S, Beheiry S, Hongo R, Hao S, Tomassoni G, Natale A. Mapping and ablation of ventricular arrhythmias with magnetic navigation: comparison between 4- and 8-mm catheter tips. Journal of Interventional Cardiac Electrophysiology. 2009;26:133&#x2013;137. doi: 10.1007/s10840-009-9416-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-009-9416-5</ArticleId><ArticleId IdType="pubmed">19639398</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya A, Eitel C, Bollmann A, Wetzel U, Sommer P, Gaspar T, Husser D, Piorkowski C, Hindricks G. Catheter ablation of scar-related ventricular tachycardia in patients with electrical storm using remote magnetic catheter navigation. Pacing and Clinical Electrophysiology. 2010;33:1312&#x2013;1318. doi: 10.1111/j.1540-8159.2010.02818.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2010.02818.x</ArticleId><ArticleId IdType="pubmed">20723092</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton AS, Jordaens LJ. Remote magnetic navigation for mapping and ablating right ventricular outflow tract tachycardia. Heart Rhythm. 2006;3:691&#x2013;696. doi: 10.1016/j.hrthm.2006.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2006.01.028</ArticleId><ArticleId IdType="pubmed">16731472</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton AS, Res J, Mekel JM, Jordaens LJ. Use of advanced mapping and remote magnetic navigation to ablate left ventricular fascicular tachycardia. Pacing and Clinical Electrophysiology. 2006;29:685&#x2013;688. doi: 10.1111/j.1540-8159.2006.00420.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2006.00420.x</ArticleId><ArticleId IdType="pubmed">16784438</ArticleId></ArticleIdList></Reference><Reference><Citation>de Torres F, Szili-Torok T, Orellana FJ, Jordaens LJ. Ablation of idiopathic left ventricular tachycardia using remote magnetic navigation integrated with advanced mapping. Revista Espa&#xf1;ola de Cardiolog&#xed;a. 2008;61:1104&#x2013;1106.</Citation><ArticleIdList><ArticleId IdType="pubmed">18817691</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidou M, Koektuerk B, Wissner E, Schmidt B, Zerm T, Ouyang F, Kuck KH, Chun JK. Catheter ablation of right ventricular outflow tract tachycardia: a simplified remote-controlled approach. Europace. 2011;13:696&#x2013;700. doi: 10.1093/europace/euq510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euq510</ArticleId><ArticleId IdType="pubmed">21307021</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss C, Antz M, Eick O, Eshagzaiy K, Meinertz T, Willems S. Radiofrequency catheter ablation using cooled electrodes: impact of irrigation flow rate and catheter contact pressure on lesion dimensions. Pace-Pacing and Clinical Electrophysiology. 2002;25:463&#x2013;469. doi: 10.1046/j.1460-9592.2002.00463.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2002.00463.x</ArticleId><ArticleId IdType="pubmed">11991372</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwagten B, Bauernfeind T, De Groot N, Van Belle Y, Haitsma D, Jordaens L, Szili-Torok T. Usefulness of the magnetic navigation system in ablation of ventricular tachycardia: acute and follow-up results compared to manual ablation. European Heart Journal. 2010;31:932&#x2013;932.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36752462</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Matching Ablation Endpoints to Long-Term Outcome: The Prospective Multicenter Italian Ventricular Tachycardia&#xa0;Ablation Registry.</ArticleTitle><Pagination><StartPage>836</StartPage><EndPage>847</EndPage><MedlinePgn>836-847</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2022.10.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(22)01046-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Multicenter ventricular tachycardia (VT) ablation studies have shown poorer outcomes compared with single-center experiences. This difference could be related to heterogeneous mapping and ablation strategies.</AbstractText><AbstractText Label="OBJECTIVES">This study evaluated a homogenous simplified catheter ablation strategy for different substrates and compared the results with those of a single referral center.</AbstractText><AbstractText Label="METHODS">This was a multicenter prospective VT ablation registry of patients with the following 4 causes of VT: previous myocardial infarction; previous myocarditis; arrhythmogenic right ventricular dysplasia; or idiopathic dilated cardiomyopathy. The procedural protocol included precise mapping and ablation steps with the combined endpoint of late potential (LP) abolition and noninducibility of VT. The long-term primary efficacy endpoint was freedom from VT.</AbstractText><AbstractText Label="RESULTS">A total of 309 patients were enrolled. LPs were present in 70% of patients and were abolished in 83%. At the end of the procedure 74% of LPs were noninducible. The primary combined endpoint of LP abolition and noninducibility was achieved in 64% of patients with LPs at baseline. Freedom from VT at 12&#xa0;months was observed in 67% of patients. In the overall study group, VT inducibility was the only predictor of freedom from VT (P&#xa0;=&#xa0;0.013). In patients with LPs, the VT recurrence rate was lower both for patients with complete LP abolition (P&#xa0;=&#xa0;0.040) and for patients meeting the composite endpoint (P&#xa0;=&#xa0;0.035).</AbstractText><AbstractText Label="CONCLUSIONS">A standardized VT mapping and ablation technique reproduced the procedural outcomes of a single referral center in a multicenter prospective study. LP abolition and noninducibility were effective in reducing VT recurrences in patients with 4 causes of cardiomyopathy. (Ventricular Tachycardia Ablation Registry; NCT03649022).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Radinovic</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: radinovic.andrea@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peretto</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sgarito</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ARNAS Ospedale Civico, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cauti</LastName><ForeName>Filippo Maria</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Fatebenefratelli San Giovanni Calibita, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Antonello</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology unit Pertini Hospital- Azienda USL Roma B, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narducci</LastName><ForeName>Maria Lucia</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantovan</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Presidio Ospedaliero di Conegliano, Conegliano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaglione</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardinal Massaia Hospital of Asti, Asti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solimene</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Casa di Cura Montevergine, Mercogliano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scopinaro</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alessandria Hospital - SS. Antonio, Biagio, Cesare Arrigo, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tondo</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Heart Rhythm Center, Centro Cardiologico Monzino, IRCCS Dipartimento di Scienze Biomediche, Chirurgiche e Odontoiatriche Universit&#xe0; degli Studi di Miano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippini</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ospedale di Circolo di Busto Arsizio, Busto Arsizio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianco</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cattinara Hospital, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonso</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ULSS2 FELTRE- Ospedale, Feltre, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calzolari</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Electrophysiology, Division of Cardiology, Neuro-Cardio-Vascular Department, Hospital of Treviso, ULSS 2 "Marca Trevigiana," Treviso, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraris</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>A.O.U. Citt&#xe0; della Salute e della Scienza di Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zardini</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Zenda Ospedaliero-Universitaria di Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piacenti</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CNR - Area della Ricerca di Pisa Fondazione Toscana G. Monasterio, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Angelo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosica</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Bella</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03649022</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2023 Jun;9(6):848-850. doi: 10.1016/j.jacep.2022.12.013.</RefSource><PMID Version="1">37380317</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures This work was supported by Abbott for Contract Research Organisation activities. Dr Della Bella has served as a consultant for Abbott and Biosense; and has received research grants from Abbott, Biosense, Biotronik, and Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>8</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36752462</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2022.10.038</ArticleId><ArticleId IdType="pii">S2405-500X(22)01046-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39963873</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6817</ISSN><JournalIssue CitedMedium="Internet"><Volume>172</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</Title><ISOAbbreviation>Otolaryngol Head Neck Surg</ISOAbbreviation></Journal><ArticleTitle>Efficacy and Patient Satisfaction in Voice Feminization Procedures: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1521</StartPage><EndPage>1538</EndPage><MedlinePgn>1521-1538</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ohn.1173</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the efficacy and quality of life impact of voice feminization interventions in transgender women.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">We searched PubMed, EMBASE, Scopus, and Web of Science for RCTs and retrospective studies published between 2008 and 2023 that quantitatively evaluated any voice feminization procedure.</AbstractText><AbstractText Label="REVIEW METHODS" NlmCategory="METHODS">Studies in English reporting quantitative measures of efficacy were included. Studies using qualitative methodology were excluded. Risk of bias was assessed using Cochran tools and a random-effects model was applied using inverse-variance pooling. Primary outcomes were fundamental frequency [F0]/speaking fundamental frequency [SF0] and patient-reported outcomes (PROs) (PROSPERO: CRD42023476192).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four studies involving 893 participants showed significant SF0 improvements for voice therapy (VT, g&#x2009;=&#x2009;0.86, [0.46, 1.26], P&#x2009;&lt;&#x2009;.0001), Wendler glottoplasty (WG, g&#x2009;=&#x2009;1.21, [0.65, 1.77], P&#x2009;&lt;&#x2009;.0001), feminization laryngoplasty (FL, g&#x2009;=&#x2009;3.05, [2.24, 3.86], P&#x2009;&lt;&#x2009;.0001), and laser reduction glottoplasty (LRG, g&#x2009;=&#x2009;12.28, [8.19, 15.64], P&#x2009;&lt;&#x2009;.0001). PROs indicated enhanced quality of life for VT (g&#x2009;=&#x2009;1.32, [0.68, 1.96], P&#x2009;&lt;&#x2009;.0001), WG (g&#x2009;=&#x2009;1.82, [1.07, 2.57], P&#x2009;&lt;&#x2009;.0001), and LRG (g&#x2009;=&#x2009;1.90, [0.72, 3.07], P&#x2009;=&#x2009;.0015), with a strong correlation between pitch alteration and QoL (r&#xb2;&#x2009;=&#x2009;0.83, P&#x2009;=&#x2009;.0001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results indicate that both VT and surgical procedures enhance vocal pitch and strongly correlate with improved QoL. Our findings validate the role of voice feminization in gender-affirming care, though methodological limitations prevent evaluation of newer interventions.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Otolaryngology&#x2013;Head and Neck Surgery published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngology&#x2010;Head and Neck Surgery Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lanham</LastName><ForeName>Kristopher</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery/Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chicago Medical School, Rosalind Franklin University, North Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melnick</LastName><ForeName>Bradley A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Surgery/Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>West Virginia School of Osteopathic Medicine, Lewisburg, West Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Madeline J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Surgery/Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartler</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery/Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuentes</LastName><ForeName>Rolando J Casas</ForeName><Initials>RJC</Initials><AffiliationInfo><Affiliation>Department of Surgery/Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Kelly C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Surgery/Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galiano</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0001-9552-6483</Identifier><AffiliationInfo><Affiliation>Department of Surgery/Division of Plastic and Reconstructive Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Otolaryngol Head Neck Surg</MedlineTA><NlmUniqueID>8508176</NlmUniqueID><ISSNLinking>0194-5998</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="Y">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063106" MajorTopicYN="Y">Transgender Persons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014833" MajorTopicYN="N">Voice Quality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Wendler glottoplasty</Keyword><Keyword MajorTopicYN="N">fundamental frequency</Keyword><Keyword MajorTopicYN="N">gender dysphoria</Keyword><Keyword MajorTopicYN="N">patient&#x2010;reported outcomes</Keyword><Keyword MajorTopicYN="N">pitch alteration</Keyword><Keyword MajorTopicYN="N">transgender healthcare</Keyword><Keyword MajorTopicYN="N">voice feminization</Keyword><Keyword MajorTopicYN="N">voice therapy</Keyword></KeywordList><CoiStatement>None of the authors have any conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>18</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39963873</ArticleId><ArticleId IdType="pmc">PMC12035520</ArticleId><ArticleId IdType="doi">10.1002/ohn.1173</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oles N, Darrach H, Landford W, et al. Gender affirming surgery: a comprehensive, systematic review of all peer&#x2010;reviewed literature and methods of assessing patient&#x2010;centered outcomes (part 1: breast/chest, face, and voice). Ann Surg. 2022;275(1):e52&#x2010;e66. 10.1097/SLA.0000000000004728</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000004728</ArticleId><ArticleId IdType="pubmed">33443903</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadwick KA, Coleman R, Andreadis K, Pitti M, Rameau A. Outcomes of gender&#x2010;affirming voice and communication modification for transgender individuals. Laryngoscope. 2022;132(8):1615&#x2010;1621. 10.1002/lary.29946</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29946</ArticleId><ArticleId IdType="pubmed">34787313</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;lmaz T, &#xd6;zer F, Ayd&#x131;nl&#x131; FE. Laser reduction glottoplasty for voice feminization: experience on 28 patients. Ann Otol Rhinol Laryngol. 2021;130(9):1057&#x2010;1063. 10.1177/0003489421993728</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003489421993728</ArticleId><ArticleId IdType="pubmed">33567880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross M. Pitch&#x2010;raising surgery in male&#x2010;to&#x2010;female transsexuals. J Voice. 1999;13(2):246&#x2010;250. 10.1016/S0892-1997(99)80028-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0892-1997(99)80028-9</ArticleId><ArticleId IdType="pubmed">10442755</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson AP. Phonetic differences between male and female speech. Lang Linguistics Compass. 2009;3(2):621&#x2010;640. 10.1111/j.1749-818X.2009.00125.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-818X.2009.00125.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko&#xe7;ak I, Akp&#x131;nar ME, &#xc7;ak&#x131;r ZA, Do&#x11f;an M, Bengisu S, &#xc7;elikoyar MM. Laser reduction glottoplasty for managing androphonia after failed cricothyroid approximation surgery. J Voice. 2010;24(6):758&#x2010;764. 10.1016/j.jvoice.2009.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2009.06.004</ArticleId><ArticleId IdType="pubmed">19900788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastronikolis NS, Remacle M, Biagini M, Kiagiadaki D, Lawson G. Wendler glottoplasty: an effective pitch raising surgery in male&#x2010;to&#x2010;female transsexuals. J Voice. 2013;27(4):516&#x2010;522. 10.1016/j.jvoice.2013.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2013.04.004</ArticleId><ArticleId IdType="pubmed">23809571</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunachak S, Prakunhungsit S, Sujjalak K. Thyroid cartilage and vocal fold reduction: a new phonosurgical method for male&#x2010;to&#x2010;female transsexuals. Ann Otol Rhinol Laryngol. 2000;109(11):1082&#x2010;1086. 10.1177/000348940010901116</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348940010901116</ArticleId><ArticleId IdType="pubmed">11090002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HT. A new conceptual approach for voice feminization: 12 years of experience. Laryngoscope. 2017;127(5):1102&#x2010;1108. 10.1002/lary.26127</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.26127</ArticleId><ArticleId IdType="pubmed">27328327</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Trilles J, Brydges HT, et al. Meta&#x2010;analysis of validated quality of life outcomes following voice feminization in transwomen. J Craniofac Surg. 2024;35(1):53&#x2010;58. 10.1097/SCS.0000000000009742</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SCS.0000000000009742</ArticleId><ArticleId IdType="pubmed">37702532</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;lmaz T, Ku&#x15f;&#xe7;u O, S&#xf6;zen T, S&#xfc;sl&#xfc; AE. Anterior glottic web formation for voice feminization: experience of 27 patients. J Voice. 2017;31(6):757&#x2010;762. 10.1016/j.jvoice.2017.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2017.03.006</ArticleId><ArticleId IdType="pubmed">28372888</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuyen BA, Qian ZJ, Campbell RD, Erickson&#x2010;DiRenzo E, Thomas J, Sung CK. Feminization laryngoplasty: 17&#x2010;year review on long&#x2010;term outcomes, safety, and technique. Otolaryngol Head Neck Surg. 2022;167(1):112&#x2010;117. 10.1177/01945998211036870</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01945998211036870</ArticleId><ArticleId IdType="pubmed">34399638</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson JA. Pitch elevation in trangendered patients: anterior glottic web formation assisted by temporary injection augmentation. J Voice. 2014;28(6):816&#x2010;821. 10.1016/j.jvoice.2014.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2014.05.002</ArticleId><ArticleId IdType="pubmed">24962228</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hee Lee J, Humes LE. Effect of fundamental&#x2010;frequency and sentence&#x2010;onset differences on speech&#x2010;identification performance of young and older adults in a competing&#x2010;talker background. J Acoust Soc Am. 2012;132(3):1700&#x2010;1717. 10.1121/1.4740482</Citation><ArticleIdList><ArticleId IdType="doi">10.1121/1.4740482</ArticleId><ArticleId IdType="pmc">PMC3460987</ArticleId><ArticleId IdType="pubmed">22978898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Chong S, Chen Y, Wang T, Ng ML. Effect of language on voice quality: an acoustic study of bilingual speakers of Mandarin Chinese and English. Folia Phoniatr Logop. 2022;74(6):421&#x2010;430. 10.1159/000525649</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000525649</ArticleId><ArticleId IdType="pmc">PMC9808749</ArticleId><ArticleId IdType="pubmed">35764052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhard D. Pitch extraction and fundamental frequency: history and current techniques. Technical Report TR&#x2010;CS 2003&#x2010;06; 2003.</Citation></Reference><Reference><Citation>Casado JC, &#xd3;Connor C, Angulo MS, Adri&#xe1;n JA. Glotoplastia de Wendler y tratamiento logop&#xe9;dico en la feminizaci&#xf3;n de la voz en transexuales: resultados de la valoraci&#xf3;n pre&#x2010; vs. poscirug&#xed;a. Acta Otorrinolaringol Esp. 2016;67(2):83&#x2010;92. 10.1016/j.otoeng.2015.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otoeng.2015.02.003</ArticleId><ArticleId IdType="pubmed">26028541</ArticleId></ArticleIdList></Reference><Reference><Citation>Casado JC, Rodr&#xed;guez&#x2010;Parra MJ, Adri&#xe1;n JA. Voice feminization in male&#x2010;to&#x2010;female transgendered clients after Wendler's glottoplasty with vs. without voice therapy support. Eur Arch Otrhinolaryngol. 2017;274(4):2049&#x2010;2058. 10.1007/s00405-016-4420-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-016-4420-8</ArticleId><ArticleId IdType="pubmed">27942897</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapoport SK, Park C, Varelas EA, et al. 1&#x2010;year results of combined modified Wendler glottoplasty with voice therapy in transgender women. Laryngoscope. 2023;133(3):615&#x2010;620. 10.1002/lary.30225</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.30225</ArticleId><ArticleId IdType="pubmed">35634734</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain S, Campe L, Mirza N. Modification of Wendler glottoplasty for male to female gender transition. J Voice. 2023:S0892199723000279. In press. 10.1016/j.jvoice.2023.01.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2023.01.028</ArticleId><ArticleId IdType="pubmed">36967260</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwarsson J, Hollen Nielsen R, N&#xe6;s J. Mean fundamental frequency in connected speech and sustained vowel with and without a sentence&#x2010;frame. Logoped Phoniatr Vocol. 2020;45(2):91&#x2010;96. 10.1080/14015439.2019.1637455</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14015439.2019.1637455</ArticleId><ArticleId IdType="pubmed">31407616</ArticleId></ArticleIdList></Reference><Reference><Citation>Enzmann D. Notes on effect size measures for the difference of means from two independent groups: the case of Cohen's d and Hedges&#x2019; g. University of Hamburg, Institute of Criminal Sciences; 2015. 10.13140/2.1.1578.2725</Citation><ArticleIdList><ArticleId IdType="doi">10.13140/2.1.1578.2725</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;lmaz T. Sequential Wendler glottoplasty and laser reduction glottoplasty for voice feminization. Laryngoscope. 2023;134:1133&#x2010;1138. 10.1002/lary.30958</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.30958</ArticleId><ArticleId IdType="pubmed">37555644</ArticleId></ArticleIdList></Reference><Reference><Citation>Aires MM, De Vasconcelos D, Lucena JA, Gomes AOC, Moraes BT. Effect of Wendler glottoplasty on voice and quality of life of transgender women. Braz J Otorhinolaryngol. 2023;89(1):22&#x2010;29. 10.1016/j.bjorl.2021.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjorl.2021.06.010</ArticleId><ArticleId IdType="pmc">PMC9874341</ArticleId><ArticleId IdType="pubmed">34400103</ArticleId></ArticleIdList></Reference><Reference><Citation>D'haeseleer E, Papeleu T, Leyns C, Adriaansen A, Meerschman I, Tomassen P. Voice outcome of glottoplasty in trans women. J Voice. 2023:S0892199723000152. In press. 10.1016/j.jvoice.2023.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2023.01.013</ArticleId><ArticleId IdType="pubmed">36774262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora E, Cobeta I, Becerra A, Lucio MJ. Comparison of cricothyroid approximation and glottoplasty for surgical voice feminization in male&#x2010;to&#x2010;female transsexuals. Laryngoscope. 2018;128(9):2101&#x2010;2109. 10.1002/lary.27172</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.27172</ArticleId><ArticleId IdType="pubmed">29573435</ArticleId></ArticleIdList></Reference><Reference><Citation>Nerurkar NK, Nagree Z, Malik E, Jahnavi. Vocal outcomes following pitch alteration surgeries. Indian J Otolaryngol Head Neck Surg. 2023;75(4):2741&#x2010;2746. 10.1007/s12070-023-03837-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-023-03837-8</ArticleId><ArticleId IdType="pmc">PMC10645986</ArticleId><ArticleId IdType="pubmed">37974673</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SK, Chang J, Hu S, et al. Addition of Wendler glottoplasty to voice therapy improves trans female voice outcomes. Laryngoscope. 2021;131(7):1588&#x2010;1593. 10.1002/lary.29050</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29050</ArticleId><ArticleId IdType="pubmed">32846023</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrick G, Figol A, Anderson J, Lin RJ. Outcomes of gender affirming voice training: a comparison of hybrid and individual training modules. J Speech Lang Hear Res. 2022;65(2):501&#x2010;507. 10.1044/2021_JSLHR-21-00056</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2021_JSLHR-21-00056</ArticleId><ArticleId IdType="pubmed">35041797</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuyen B, Qian ZJ, Rakkar M, Thomas JP, Erickson&#x2010;DiRenzo E, Sung CK. Diagnosis and management of vocal complications after chondrolaryngoplasty. Laryngoscope. 2023;133(9):2301&#x2010;2307. 10.1002/lary.30518</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.30518</ArticleId><ArticleId IdType="pubmed">36576093</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyns C, Daelman J, Adriaansen A, et al. Short&#x2010;term acoustic effects of speech therapy in transgender women: a randomized controlled trial. Am J Speech Lang Pathol. 2023;32(1):145&#x2010;168. 10.1044/2022_AJSLP-22-00135</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2022_AJSLP-22-00135</ArticleId><ArticleId IdType="pubmed">36455242</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly V, Herteg&#xe5;rd S, Eriksson J, Nygren U, S&#xf6;dersten M. Effects of gender&#x2010;confirming pitch&#x2010;raising surgery in transgender women a long&#x2010;term follow&#x2010;up study of acoustic and patient&#x2010;reported data. J Voice. 2019;33(5):781&#x2010;791. 10.1016/j.jvoice.2018.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2018.03.005</ArticleId><ArticleId IdType="pubmed">30077418</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Brown SK, Hu S, et al. Effect of Wendler glottoplasty on acoustic measures of voice. Laryngoscope. 2021;131(3):583&#x2010;586. 10.1002/lary.28764</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28764</ArticleId><ArticleId IdType="pubmed">32598037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hancock AB, Garabedian LM. Transgender voice and communication treatment: a retrospective chart review of 25 cases. Int J Lang Commun Disord. 2013;48(1):54&#x2010;65. 10.1111/j.1460-6984.2012.00185.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-6984.2012.00185.x</ArticleId><ArticleId IdType="pubmed">23317384</ArticleId></ArticleIdList></Reference><Reference><Citation>Dacakis G, Davies S, Oates JM, Douglas JM, Johnston JR. Development and preliminary evaluation of the transsexual voice questionnaire for male&#x2010;to&#x2010;female transsexuals. J Voice. 2013;27(3):312&#x2010;320. 10.1016/j.jvoice.2012.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2012.11.005</ArticleId><ArticleId IdType="pubmed">23415146</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn S, Oates J, Dacakis G. Perceived gender and client satisfaction in transgender voice work: comparing self and listener rating scales across a training program. Folia Phoniatr Logop. 2022;74(5):364&#x2010;379. 10.1159/000521226</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000521226</ArticleId><ArticleId IdType="pubmed">34847562</ArticleId></ArticleIdList></Reference><Reference><Citation>T'Sjoen G, Moerman M, Van Borsel J, et al. Impact of voice in transsexuals. Int J Transgend. 2006;9(1):1&#x2010;7. 10.1300/J485v09n01_01</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J485v09n01_01</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensoussan Y, Park C, Johns M, et al. A comparison of an artificial intelligence tool to fundamental frequency as an outcome measure in people seeking a more feminine voice. Laryngoscope. 2021;131(11):2567&#x2010;2571. 10.1002/lary.29605</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29605</ArticleId><ArticleId IdType="pubmed">33973649</ArticleId></ArticleIdList></Reference><Reference><Citation>Meister J, K&#xfc;hn H, Shehata&#x2010;Dieler W, Hagen R, Kleinsasser N. Perceptual analysis of the male&#x2010;to&#x2010;female transgender voice after glottoplasty&#x2010;the telephone test: perceptual analysis of the transgender voice. Laryngoscope. 2017;127(4):875&#x2010;881. 10.1002/lary.26110</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.26110</ArticleId><ArticleId IdType="pubmed">27334765</ArticleId></ArticleIdList></Reference><Reference><Citation>Meister J, Hagen R, Shehata&#x2010;Dieler W, K&#xfc;hn H, Kraus F, Kleinsasser N. Pitch elevation in male&#x2010;to&#x2010;female transgender persons&#x2014;the W&#xfc;rzburg approach. J Voice. 2017;31(2):244.e7&#x2010;244.e15. 10.1016/j.jvoice.2016.07.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2016.07.018</ArticleId><ArticleId IdType="pubmed">27545073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28463896</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>267</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>A Meta-analysis of the Impact of Aspirin, Clopidogrel, and Dual Antiplatelet Therapy on Bleeding Complications in Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000002279</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to determine the bleeding risks associated with single (aspirin) and dual (aspirin + clopidogrel) antiplatelet therapy (DAPT) versus placebo or no treatment in adults undergoing noncardiac surgery.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA" NlmCategory="BACKGROUND">The impact of antiplatelet therapy on bleeding during noncardiac surgery remains controversial. A meta-analysis was performed to examine the risk associated with single and DAPT.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of antiplatelet therapy, noncardiac surgery, and perioperative bleeding was performed. Peer-reviewed sources and meeting abstracts from relevant societies were queried. Studies without a control group, or those that only examined patients with coronary stents, were excluded. Primary endpoints were transfusion and reintervention for bleeding.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 11,592 references, 46 studies met inclusion criteria. In a meta-analysis of &gt;30,000 patients, the relative risk (RR) of transfusion versus control was 1.14 [95% confidence interval (CI) 1.03-1.26, P = 0.009] for aspirin, and 1.33 (1.15-1.55, P = 0.001) for DAPT. Clopidogrel had an elevated risk, but data were too heterogeneous to analyze. The RR of bleeding requiring reintervention was not significantly higher for any agent compared to control [RR 0.96 (0.76-1.22, P = 0.76) for aspirin, 1.84 (0.87-3.87, P = 0.11) for clopidogrel, and 1.51 (0.92-2.49, P = 0.1) for DAPT]. Subanalysis of thoracic and abdominal procedures was similar. There was no difference in RR for myocardial infarction [1.06 (0.79-1.43)], stroke [0.97 (0.71-1.33)], or mortality [0.97 (0.87-1.1)].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Antiplatelet therapy at the time of noncardiac surgery confers minimal bleeding risk with no difference in thrombotic complications. In many cases, it is safe to continue antiplatelet therapy in patients with important indications for their use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Columbo</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Outcomes Group, Veterans Health Administration, White River Junction, VT.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Quality Scholars, Veterans Health Administration, White River Junction, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambour</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundling</LastName><ForeName>Rebecca A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chauhan</LastName><ForeName>Nirali B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bessen</LastName><ForeName>Sarah Y</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linshaw</LastName><ForeName>David L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Ravinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Outcomes Group, Veterans Health Administration, White River Junction, VT.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Quality Scholars, Veterans Health Administration, White River Junction, VT.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riblet</LastName><ForeName>Natalie B V</ForeName><Initials>NBV</Initials><AffiliationInfo><Affiliation>The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodney</LastName><ForeName>Philip P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Outcomes Group, Veterans Health Administration, White River Junction, VT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>A74586SNO7</RegistryNumber><NameOfSubstance UI="D000077144">Clopidogrel</NameOfSubstance></Chemical><Chemical><RegistryNumber>OM90ZUW7M1</RegistryNumber><NameOfSubstance UI="D013988">Ticlopidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg. 2018 Jan;267(1):11-12. doi: 10.1097/SLA.0000000000002411.</RefSource><PMID Version="1">28692473</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg. 2018 Aug;268(2):e33. doi: 10.1097/SLA.0000000000002453.</RefSource><PMID Version="1">28742706</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg. 2018 Aug;268(2):e33. doi: 10.1097/SLA.0000000000002452.</RefSource><PMID Version="1">28817442</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="Y">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077144" MajorTopicYN="N">Clopidogrel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013988" MajorTopicYN="N">Ticlopidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28463896</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000002279</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29098348</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>Self-reported everyday physical activities in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>19</StartPage><EndPage>29</EndPage><MedlinePgn>19-29</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-017-4287-6</ELocationID><Abstract><AbstractText Label="UNLABELLED">Previous work has shown that patients with vertebral fractures do less physical activity. However, the association between vertebral fracture and different components of physical activity is unclear. Our results suggest that vertebral fracture (VF) is associated with a reduction in activities involving bending, ambulation, and daily living, regardless of age.</AbstractText><AbstractText Label="INTRODUCTION">The aim of this study was to determine whether osteoporotic VF is associated with reduced self-reported everyday routine physical activity and/or ability (PAA).</AbstractText><AbstractText Label="METHODS">A comprehensive search was undertaken using the databases of PubMed, Embase, Medline, Web of Science, and the "grey" literature from 1950 to the end of July 2016. Standardised search terms for VF and PAAs were used. Four categories of PAA were included: (1) bending ability, (2) ambulatory activities, (3) reaching arms above shoulder level, and (4) activities of daily living (ADLs). Strict inclusion and exclusion criteria were used, and only studies that adjusted for age were included. For the meta-analysis, pooled OR and 95% confidence interval (CI) were calculated using a random-effects model.</AbstractText><AbstractText Label="RESULTS">Eleven studies in total were identified which had investigated the associations between the prevalent VF and the selected PAAs and expressed these as ORs or RR. Women (six studies) with VF had a 64% increase in difficulty forward bending compared to those without VF. Women (nine studies) with VF had a 27% increase in difficulty doing ambulatory activities, while no association was observed for men (four studies). Women also have 73% (five studies), 127% (three studies), and 100% (four studies) increase in difficulty reaching arms above shoulder, shopping, and preparing meals, respectively.</AbstractText><AbstractText Label="CONCLUSION">Studies consistently show women with VF have reduced everyday activities, while much less research has been carried out in men. This information may be useful when designing interventions to improve physical function in people with osteoporotic VFs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Sari</LastName><ForeName>U A</ForeName><Initials>UA</Initials><AffiliationInfo><Affiliation>Academic Rheumatology, Musculoskeletal Research Unit, School of Clinical Sciences, Southmead Hospital, University of Bristol, Westbury-on-Trym, Bristol, BS10 5NB, UK. ua14948@bristol.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, College of Medicine, Wasit University, Kut, Iraq. ua14948@bristol.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobias</LastName><ForeName>J H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Academic Rheumatology, Musculoskeletal Research Unit, School of Clinical Sciences, Southmead Hospital, University of Bristol, Westbury-on-Trym, Bristol, BS10 5NB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>E M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Academic Rheumatology, Musculoskeletal Research Unit, School of Clinical Sciences, Southmead Hospital, University of Bristol, Westbury-on-Trym, Bristol, BS10 5NB, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Activities of daily living</Keyword><Keyword MajorTopicYN="N">Ambulatory activities</Keyword><Keyword MajorTopicYN="N">Bending-related activities</Keyword><Keyword MajorTopicYN="N">Physical activity</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29098348</ArticleId><ArticleId IdType="doi">10.1007/s00198-017-4287-6</ArticleId><ArticleId IdType="pii">10.1007/s00198-017-4287-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2008 Jul;90(7):1479-86</Citation><ArticleIdList><ArticleId IdType="pubmed">18594096</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Public Health. 2007;52(1):8-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17966815</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 1951 Jun;11(6):1269-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14861651</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1994 Dec;50(4):1088-101</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Spine (Phila Pa 1976). 2012 Jun 1;37(13):1115-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22158062</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcif Tissue Int. 2000 Jan;66(1):47-52</Citation><ArticleIdList><ArticleId IdType="pubmed">10602844</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1996 Mar 23;312(7033):770</Citation><ArticleIdList><ArticleId IdType="pubmed">8605469</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2004 Sep;15(9):760-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15138664</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2002 May 18;359(9319):1761-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12049882</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Musculoskelet Disord. 2014 Nov 17;15:374</Citation><ArticleIdList><ArticleId IdType="pubmed">25403238</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2008 Jul;19(7):895-903</Citation><ArticleIdList><ArticleId IdType="pubmed">18071648</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2008 Oct;23 (10 ):1561-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18505372</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2013 Mar;24(3):877-85</Citation><ArticleIdList><ArticleId IdType="pubmed">22707064</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2001;10(4):307-17</Citation><ArticleIdList><ArticleId IdType="pubmed">11763244</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 1991 Aug;6(8):883-92</Citation><ArticleIdList><ArticleId IdType="pubmed">1785377</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2000 Oct;15(10 ):2019-25</Citation><ArticleIdList><ArticleId IdType="pubmed">11028456</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2000 Feb;15(2):278-83</Citation><ArticleIdList><ArticleId IdType="pubmed">10703929</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 1991 Mar;6(3):207-15</Citation><ArticleIdList><ArticleId IdType="pubmed">2035348</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1995 Sep;43(9):955-61</Citation><ArticleIdList><ArticleId IdType="pubmed">7657934</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2016 Oct;27(10):2891-900</Citation><ArticleIdList><ArticleId IdType="pubmed">27262840</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2005 Sep;16(9):1086-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15726295</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2000 Aug;15(8):1564-72</Citation><ArticleIdList><ArticleId IdType="pubmed">10934655</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerontologist. 1998 Aug;38(4):422-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9726129</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 1997 May;12(5):813-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9144348</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2002 Sep;13(9):723-30</Citation><ArticleIdList><ArticleId IdType="pubmed">12195536</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1996 Nov 25;156(21):2469-75</Citation><ArticleIdList><ArticleId IdType="pubmed">8944740</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2002 Apr;17(4):716-24</Citation><ArticleIdList><ArticleId IdType="pubmed">11918229</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 1996;6(3):228-32</Citation><ArticleIdList><ArticleId IdType="pubmed">8783297</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 1997 Jan;12(1):152-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9240738</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 2012 May;41(3):351-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22367357</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2009 Jul 21;6(7):e1000097</Citation><ArticleIdList><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36335616</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Clinical outcomes of radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy.</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>224</EndPage><MedlinePgn>219-224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.15739</ELocationID><Abstract><AbstractText Label="BACKGROUND">Monomorphic ventricular tachycardia (VT) is rare in patients with hypertrophic cardiomyopathy (HCM), management of which is challenging. Limited data exists on the utility of catheter ablation for the treatment of VT in this population.</AbstractText><AbstractText Label="OBJECTIVES">We aimed to assess clinical outcomes of catheter ablation for VT in HCM patients.</AbstractText><AbstractText Label="METHODS">A systematic search, without language restriction, using PubMed, EMBASE, SCOPUS, Google Scholar, and ClinicalTrials.gov was performed. The meta-analysis was performed using a meta-package for R version 4.0/RStudio version 1.2 and Freeman Tukey double arcsine method to establish the variance of raw proportions. Outcomes measured included (1) acute procedure success (defined as noninducible for clinical VT),&#xa0;(2) freedom from VT at follow-up, (3) mortality.</AbstractText><AbstractText Label="RESULTS">This systematic review of six studies (three from the&#xa0;United States and three from Japan) incorporated a total of 68 drug-refractory HCM patients who underwent VT radiofrequency catheter ablation (mean age 57.6&#x2009;&#xb1;&#x2009;13.3&#x2009;years, mean LVEF 45.8&#x2009;&#xb1;&#x2009;15.4%, 85% men, maximum septal wall thickness 17.4&#x2009;&#xb1;&#x2009;4.6&#x2009;mm, and 32.3% with an apical aneurysm). Acute procedural success was achieved in 84.5% patients (95% confidence interval&#xa0;[CI]: 70.6%-95.2%) with 27.9% patients had recurrent VT requiring multiple ablations (median 1, IQR 1-3). During the follow-up period (18.3&#x2009;&#xb1;&#x2009;11.7&#x2009;months), the pooled incidence of freedom from recurrent VT after index procedure was 70.2% (95% CI: 51.9%-86.2%), while after the last ablation was 82.8% (95% CI: 57%-99.2%). There were two deaths during follow-up, one from heart failure and one from SCD 0.8% (95% CI: 0%-5.8%).</AbstractText><AbstractText Label="CONCLUSION">The results of our pooled analysis demonstrated that catheter ablation for VT in HCM patients was associated with high acute procedural success, and reduced VT recurrence-findings comparable to previously published reports in other disease substrates.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Jalaj</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6857-7418</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kewcharoen</LastName><ForeName>Jakrin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Kuldeep</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1345-0719</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Beaumont Hospital, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turagam</LastName><ForeName>Mohit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhardwaj</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7734-8660</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contractor</LastName><ForeName>Tahmeed</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandapati</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1492-2693</Identifier><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute and Research Foundation, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="Y">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">death</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>6</Day><Hour>16</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36335616</ArticleId><ArticleId IdType="pmc">PMC10100142</ArticleId><ArticleId IdType="doi">10.1111/jce.15739</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dukkipati SR, d'Avila A, Soejima K, et al. Long&#x2010;term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy. Circ&#xa0;Arrhyt&#xa0;Electrophysiol. 2011;4:185&#x2010;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">21270104</ArticleId></ArticleIdList></Reference><Reference><Citation>Inada K, Seiler J, Roberts&#x2010;Thomson KC, et al. Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011;22:41&#x2010;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">20807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangeli P, Di Biase L, Lakkireddy D, et al. Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility. Heart Rhythm. 2010;7:1036&#x2010;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">20493276</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi M, Nogami A, Kurosaki K, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy and apical aneurysm. JACC&#xa0;Clin Electrophysiol. 2018;4:339&#x2010;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">30089559</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeemah QJ, Komatsu Y, Nogami A, et al. Catheter ablation of ventricular tachycardia in dilated&#x2010;phase hypertrophic cardiomyopathy: substrate characterization and ablation outcome. Pacing&#xa0;Clin&#xa0;Electrophysiol. 2022;45(6):773&#x2010;785. 10.1111/pace.14508</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14508</ArticleId><ArticleId IdType="pubmed">35430753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda A, Fukamizu S, Soejima K, et al. Clinical and electrophysiological characteristics in patients with sustained monomorphic reentrant ventricular tachycardia associated with dilated&#x2010;phase hypertrophic cardiomyopathy. Europace. 2012;14:734&#x2010;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">22048994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic cardiomyopathy with left ventricular apical aneurysm. J Am Coll Cardiol. 2017;69:761&#x2010;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">28209216</ArticleId></ArticleIdList></Reference><Reference><Citation>Matoh F, Satoh H, Shiraki K, et al. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Card Failure. 2007;13:372&#x2010;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">17602984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hocini M, Ramirez FD, Szumowski &#x141;, et al. Purkinje triggers of ventricular fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2021;32:2987&#x2010;2994.</Citation><ArticleIdList><ArticleId IdType="pubmed">34453363</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39002088</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1912</ISSN><JournalIssue CitedMedium="Internet"><Volume>397</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Naunyn-Schmiedeberg's archives of pharmacology</Title><ISOAbbreviation>Naunyn Schmiedebergs Arch Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a double-blind randomized controlled trial.</ArticleTitle><Pagination><StartPage>10191</StartPage><EndPage>10201</EndPage><MedlinePgn>10191-10201</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00210-024-03224-2</ELocationID><Abstract><AbstractText>Sodium-glucose transporter 2 (SGLT2) inhibitors such as empagliflozin are one of the main treatments for type 2 diabetes mellitus (DM2) and heart failure (HF). They have also demonstrated anti-arrhythmic effects in some preclinical and clinical studies. The purpose of this study was to assess the effects of empagliflozin on ventricular arrhythmias in HF patients with an implantable cardioverter-defibrillator (ICD). In a prospective double-blinded, randomized controlled trial of Iran County, Mashhad (72 patients 1:1), we compared the frequency and proportion of ventricular arrhythmias and ICD therapies during the 24&#xa0;weeks to the prior 24&#xa0;weeks. Results revealed that empagliflozin significantly reduced the frequency and proportion of ventricular tachycardia (VT)/fibrillation (VF) episodes (P&#x2009;=&#x2009;0.019 and 0.039, respectively). Moreover, it tended to reduce the frequency and proportion of ICD therapies, including anti-tachycardia pacing (ATP) and shock. Subgroup analysis of patients with or without any antiarrhythmic drugs (digoxin, mexiletine, amiodarone, or sotalol) revealed that only patients who were previously on the antiarrhythmic drugs benefit from empagliflozin antiarrhythmic effects. In conclusion, empagliflozin exhibits anti-arrhythmic effects in HF patients with an ICD. Larger and long-term clinical studies are still needed to investigate and confirm all positive effects of SGLT2 inhibitors in this regard. Trial registration number: IRCT20120520009801N7 (Approval date: June 11, 2022).</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abedi</LastName><ForeName>Farshad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadpour</LastName><ForeName>Amir Hooshang</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghavami</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heidari-Bakavoli</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jomezadeh</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. JomehzadehV@mums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tayyebi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Tayyebim@mums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Naunyn Schmiedebergs Arch Pharmacol</MedlineTA><NlmUniqueID>0326264</NlmUniqueID><ISSNLinking>0028-1298</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>HDC1R2M35U</RegistryNumber><NameOfSubstance UI="C570240">empagliflozin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005960">Glucosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001559">Benzhydryl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005960" MajorTopicYN="Y">Glucosides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="Y">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001559" MajorTopicYN="Y">Benzhydryl Compounds</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Empagliflozin</Keyword><Keyword MajorTopicYN="N">ICD</Keyword><Keyword MajorTopicYN="N">SGLT2 inhibitor</Keyword><Keyword MajorTopicYN="N">Shock</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmia</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval: The local Ethics Committee of Mashhad University of Medical Sciences (MUMS) approved the study protocol (reference number: IR.MUMS.REC.1401.052) and registered it on the Iranian registry of clinical trials as IRCT20120520009801N7 (approval date: June 11, 2022). All participants were explained and informed of the protocol of the study and signed written consent forms. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>21</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>14</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>13</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39002088</ArticleId><ArticleId IdType="doi">10.1007/s00210-024-03224-2</ArticleId><ArticleId IdType="pii">10.1007/s00210-024-03224-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Azam MA, Chakraborty P, Si D, Du B, Mass&#xe9; S, Lai PF, Ha AC, Nanthakumar K (2021) Anti-arrhythmic and inotropic effects of empagliflozin following myocardial ischemia. Life Sci 276:119440</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119440</ArticleId><ArticleId IdType="pubmed">33781832</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtain JP, Docherty KF, Jhund PS, Petrie MC, Inzucchi SE, K&#xf8;ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS (2021) Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF. Eur Heart J 42:3727&#x2013;3738</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab560</ArticleId><ArticleId IdType="pubmed">34448003</ArticleId><ArticleId IdType="pmc">8455345</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes GC, Fernandes A, Cardoso R, Penalver J, Knijnik L, Mitrani RD, Myerburg RJ, Goldberger JJ (2021) Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: a meta-analysis of 34 randomized controlled trials. Heart Rhythm 18:1098&#x2013;1105</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.03.028</ArticleId><ArticleId IdType="pubmed">33757845</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J (2020) Placebo-controlled, double-blind study of empagliflozin (EMPA) and implantable cardioverter-defibrillator (EMPA-ICD) in patients with type 2 diabetes (T2DM): rationale and design. Diabetes Ther 11:2739&#x2013;2755</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13300-020-00924-9</ArticleId><ArticleId IdType="pubmed">32968947</ArticleId><ArticleId IdType="pmc">7547938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghzally Y, Mahajan K (2023) Implantable Defibrillator. StatPearls Publishing, Treasure Island (FL). https://europepmc.org/article/nbk/nbk459196 . Accessed 31 Oct 2017</Citation></Reference><Reference><Citation>Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79:e263&#x2013;e421</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.012</ArticleId><ArticleId IdType="pubmed">35379503</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y, Yang R, Chen W, Ye Q (2022) Anti-arrhythmic effects of sodium-glucose co-transporter 2 inhibitors. Front Pharmacol 13:898718</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.898718</ArticleId><ArticleId IdType="pubmed">35814223</ArticleId><ArticleId IdType="pmc">9263384</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna VK, Khanna VK (2016) Implantable cardioverter defibrillators. Implantable Medical Electronics: Prosthetics, Drug Delivery, and Health Monitoring 293&#x2013;307</Citation></Reference><Reference><Citation>Kheiri B, Barbarawi M, Zayed Y, Hicks M, Osman M, Rashdan L, Kyi HH, Bachuwa G, Hassan M, Stecker EC (2019) Antiarrhythmic drugs or catheter ablation in the management of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Circ: Arrhythm Electrophysiol 12:e007600</Citation></Reference><Reference><Citation>Kolesnik E, Scherr D, Rohrer U, Benedikt M, Manninger M, Sourij H, von Lewinski D (2022) SGLT2 inhibitors and their antiarrhythmic properties. Int J Mol Sci 23:1678</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031678</ArticleId><ArticleId IdType="pubmed">35163599</ArticleId><ArticleId IdType="pmc">8835896</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AH, Aronow WS (2019) Prevention of recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators&#x2014;a network meta-analysis. Am J Ther 26:e469&#x2013;e480</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000000928</ArticleId><ArticleId IdType="pubmed">30946044</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B&#xf6;hm M, Burri H, Butler J, &#x10c;elutkien&#x117; J, Chioncel O (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 42:3599&#x2013;3726</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab368</ArticleId><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurray JJ, Solomon SD, Inzucchi SE, K&#xf8;ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B&#x11b;lohl&#xe1;vek J (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995&#x2013;2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1911303</ArticleId><ArticleId IdType="pubmed">31535829</ArticleId></ArticleIdList></Reference><Reference><Citation>Noyes K, Corona E, Veazie P, Dick AW, Zhao H, Moss AJ (2009) Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II. Am J Cardiovasc Drugs 9:393&#x2013;400</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11317980-000000000-00000</ArticleId><ArticleId IdType="pubmed">19929037</ArticleId><ArticleId IdType="pmc">4743243</ArticleId></ArticleIdList></Reference><Reference><Citation>Paasche A, Wiedmann F, Kraft M, Seibertz F, Herlt V, Blochberger PL, J&#xe1;vorszky N, Beck M, Weirauch L, Seeger T (2024) Acute antiarrhythmic effects of SGLT2 inhibitors&#x2013;dapagliflozin lowers the excitability of atrial cardiomyocytes. Basic Res Cardiol 119:93&#x2013;112</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-023-01022-0</ArticleId><ArticleId IdType="pubmed">38170280</ArticleId><ArticleId IdType="pmc">10837223</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383:1413&#x2013;1424</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2022190</ArticleId><ArticleId IdType="pubmed">32865377</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz SM, Massa C, Grzbiela A, Dengler W, Wiedemann G, Pauli P (2013) Implantable cardioverter defibrillator shocks are prospective predictors of anxiety. Heart Lung 42:105&#x2013;111</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2012.08.006</ArticleId><ArticleId IdType="pubmed">23110854</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva dos Santos D, Tura&#xe7;a LT, Coutinho KCdS, Barbosa RAQ, Polidoro JZ, Kasai-Brunswick TH, Campos de Carvalho AC, Girardi ACC (2023) Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1. Sci Rep 13:8689</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-35944-5</ArticleId><ArticleId IdType="pubmed">37248416</ArticleId><ArticleId IdType="pmc">10226982</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiles M (2019) Implantable cardioverter-defibrillators: Optimal programming. Up to Date</Citation></Reference><Reference><Citation>Vallon V (2015) The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu Rev Med 66:255&#x2013;270</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-051013-110046</ArticleId><ArticleId IdType="pubmed">25341005</ArticleId></ArticleIdList></Reference><Reference><Citation>von Lewinski D, Tripolt NJ, Sourij H, Pferschy PN, Oulhaj A, Alber H, Gwechenberger M, Martinek M, Seidl S, Moertl D (2022) Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial)&#x2013;a phase III study. Am Heart J 246:152&#x2013;160</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2022.01.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Liu Y, Wei X, Zhang X, Ye Y, Li W, Su X (2022) Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: a mini review. Front Cardiovasc Med 9:915455</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.915455</ArticleId><ArticleId IdType="pubmed">36003915</ArticleId><ArticleId IdType="pmc">9393294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C (2018) Ranolazine in high-risk patients with implanted cardioverter-defibrillators: the RAID trial. J Am Coll Cardiol 72:636&#x2013;645</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.04.086</ArticleId><ArticleId IdType="pubmed">30071993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38169203</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-6280</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Current problems in cardiology</Title><ISOAbbreviation>Curr Probl Cardiol</ISOAbbreviation></Journal><ArticleTitle>Ischemia testing and revascularization in patients with monomorphic ventricular tachycardia: A relic of the past?</ArticleTitle><Pagination><StartPage>102358</StartPage><MedlinePgn>102358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cpcardiol.2023.102358</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0146-2806(23)00775-2</ELocationID><Abstract><AbstractText>Testing for myocardial ischemia in patients presenting with sustained monomorphic Ventricular Tachycardia(VT) even without evidence of acute myocardial infarction is a tempting strategy that is frequently utilized in clinical practice. Monomorphic VT is mainly caused by re-entry around chronic myocardial scar and active ischemia has no role in its pathogenesis, thus making testing for ischemia futile, at least in theory. This systematic literature review sought to address the usefulness of ischemia testing (mainly coronary angiography) in patients presenting with monomorphic VT through 8 selected studies after evaluating a total of 130 published manuscripts. Particularly, we sought to unveil whether coronary angiography and possibly concomitant revascularization leads to lesser tachycardia recurrence. Our conclusion can be summarized as follows: this approach whether combined with revascularization or not, does not seem to reduce VT recurrence nor does it affect mortality in such patients. Even though most of the published literature points at this direction, validation from randomized controlled trials is imperative.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milaras</LastName><ForeName>Nikias</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Department of Cardiology, "Hippokration" General Hospital of Athens, Greece; School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece. Electronic address: nikiasmilaras@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kordalis</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsiachris</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakalidis</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntalakouras</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>State Department of Cardiology, "Hippokration" General Hospital of Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pamporis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Department of Cardiology, "Hippokration" General Hospital of Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dourvas</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Department of Cardiology, "Hippokration" General Hospital of Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apostolos</LastName><ForeName>Anastasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotiriou</LastName><ForeName>Zoi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arsenos</LastName><ForeName>Petros</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Archontakis</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Department of Cardiology, "Hippokration" General Hospital of Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsioufis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatzoulis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, Athens 11527, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sideris</LastName><ForeName>Skevos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Department of Cardiology, "Hippokration" General Hospital of Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Probl Cardiol</MedlineTA><NlmUniqueID>7701802</NlmUniqueID><ISSNLinking>0146-2806</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009204" MajorTopicYN="Y">Myocardial Revascularization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="Y">Coronary Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of competing interest This review does not directly or indirectly concern any commercial product. The authors have no financial or other interests that conflict with this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>12</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>3</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38169203</ArticleId><ArticleId IdType="doi">10.1016/j.cpcardiol.2023.102358</ArticleId><ArticleId IdType="pii">S0146-2806(23)00775-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36072869</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Safety and Efficacy of Stereotactic Arrhythmia Radioablation for the Treatment of Ventricular Tachycardia: A Systematic Review.</ArticleTitle><Pagination><StartPage>870001</StartPage><MedlinePgn>870001</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">870001</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2022.870001</ELocationID><Abstract><AbstractText>Catheter ablation (CA) is a fundamental therapeutic option for the treatment of recurrent ventricular arrhythmias. Notwithstanding the tremendous improvements in the available technology and the increasing amount of evidence in support of CA, in some patients the procedure fails, or is absolutely contraindicated due to technical or clinical issues. In these cases, the clinical management of patients is highly challenging, and mainly involves antiarrhythmic drugs escalation. Over the last 5 years, stereotactic arrhythmia radioablation (STAR) has been introduced into clinical practice, with several small studies reporting favorable arrhythmia-free outcomes, without severe side effects at a short to mid-term follow-up. In the present systematic review, we provide an overview of the available studies on stereotactic arrhythmia radioablation, by describing the potential indications and technical aspects of this promising therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Volpato, Compagnucci, Cipolletta, Parisi, Valeri, Carboni, Giovagnoni, Dello Russo and Casella.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Volpato</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Compagnucci</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cipolletta</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parisi</LastName><ForeName>Quintino</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valeri</LastName><ForeName>Yari</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carboni</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Anesthesia and Critical Care Unit, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giovagnoni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical, Special and Dental Sciences, Marche Polytechnic University, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dello Russo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casella</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical, Special and Dental Sciences, Marche Polytechnic University, Ancona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmia</Keyword><Keyword MajorTopicYN="N">electric storm</Keyword><Keyword MajorTopicYN="N">radioablation</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>2</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36072869</ArticleId><ArticleId IdType="pmc">PMC9441659</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.870001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace. (2019) 21:1143&#x2013;4. 10.1093/europace/euz132</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euz132</ArticleId><ArticleId IdType="pmc">PMC7967791</ArticleId><ArticleId IdType="pubmed">31075787</ArticleId></ArticleIdList></Reference><Reference><Citation>Compagnucci P, Volpato G, Falanga U, Cipolletta L, Conti M, Grifoni G, et al. Recent advances in three-dimensional electroanatomical mapping guidance for the ablation of complex atrial and ventricular arrhythmias. J Interv Card. (2021) 61:37&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">32451799</ArticleId></ArticleIdList></Reference><Reference><Citation>Branch CL, Jr, Coric D, Olds W, Eksktrand K. Stereotactic radiosurgery. A review of &#x201c;gamma knife&#x201d; and &#x201c;linac knife&#x201d; technology and the unit at the Wake Forest university medical center. N C Med J. (1992) 53:395&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1513382</ArticleId></ArticleIdList></Reference><Reference><Citation>Leksell L. A stereotaxic apparatus for intracerebral surgery. Acta Chir Scand. (1949) 99:229&#x2013;33.</Citation></Reference><Reference><Citation>Sharma A, Wong D, Weidlich G, Fogarty T, Jack A, Sumanaweera T, et al. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm. (2010) 7:802&#x2013;10. 10.1016/j.hrthm.2010.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2010.02.010</ArticleId><ArticleId IdType="pubmed">20156591</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. (2009) 6:e1000097. 10.1371/journal.pmed.1000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. (2017) 377:2325&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5764179</ArticleId><ArticleId IdType="pubmed">29236642</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth R, Cvek J, Knybel L, Jiravsky O, Molenda L, Kodaj M, et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace. (2019) 21:1088&#x2013;95. 10.1093/europace/euz133</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euz133</ArticleId><ArticleId IdType="pubmed">31121018</ArticleId></ArticleIdList></Reference><Reference><Citation>Yugo D, Lo LW, Wu YH, Chung FP, Lin YJ, Chang SL, et al. Case series on stereotactic body radiation therapy in non-ischemic cardiomyopathy patients with recurrent ventricular tachycardia. Pacing Clin Electrophysiol. (2021) 44:1085&#x2013;93. 10.1111/pace.14254</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14254</ArticleId><ArticleId IdType="pubmed">33932305</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd MS, Wight J, Schneider F, Hoskins M, Attia T, Escott C, et al. Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients. Heart Rhythm. (2020) 17:415&#x2013;22. 10.1016/j.hrthm.2019.09.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.09.028</ArticleId><ArticleId IdType="pubmed">31585181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin R, Hayase J, Hu P, Cao M, Deng J, Ajijola O, et al. Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience. J Interv Card Electrophysiol. (2021) 61:535&#x2013;43. 10.1007/s10840-020-00849-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-020-00849-0</ArticleId><ArticleId IdType="pubmed">32803639</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CG, Samson PP, Moore KMS, Hugo GD, Knutson N, Mutic S, et al. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. (2019) 139:313&#x2013;21. 10.1161/CIRCULATIONAHA.118.038261</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.038261</ArticleId><ArticleId IdType="pmc">PMC6331281</ArticleId><ArticleId IdType="pubmed">30586734</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianni C, Rivera D, Burkhardt JD, Pollard B, Gardner E, Maguire P, et al. Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia. Heart Rhythm. (2020) 17:1241&#x2013;8. 10.1016/j.hrthm.2020.02.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.02.036</ArticleId><ArticleId IdType="pubmed">32151737</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbucicchio C, Andreini D, Piperno G, Catto V, Conte E, Cattani F, et al. Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study. J Interv Card Electrophysiol. (2021) 62:427&#x2013;39. 10.1007/s10840-021-01060-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-021-01060-5</ArticleId><ArticleId IdType="pmc">PMC8490832</ArticleId><ArticleId IdType="pubmed">34609691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Bates M, Shepherd E, Riley S, Henshaw M, Metherall P, et al. Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience. Open Heart. (2021) 8:e001770. 10.1136/openhrt-2021-001770</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2021-001770</ArticleId><ArticleId IdType="pmc">PMC8611439</ArticleId><ArticleId IdType="pubmed">34815300</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian PC, Quadros K, Aguilar M, Wei C, Boeck M, Bredfeldt J, et al. Substrate modification using stereotactic radioablation to treat refractory ventricular tachycardia in patients with ischemic cardiomyopathy. JACC Clin Electrophysiol. (2021) 8:49&#x2013;58. 10.1016/j.jacep.2021.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2021.06.016</ArticleId><ArticleId IdType="pubmed">34364832</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumeau R, Ozsahin M, Schwitter J, Vallet V, Duclos F, Zeverino M, et al. Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation. Radiother Oncol. (2018) 128:189&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">29753550</ArticleId></ArticleIdList></Reference><Reference><Citation>Casella M, Bergonti M, Narducci ML, Persampieri S, Gasperetti A, Conte E, et al. Prior myocarditis and ventricular arrhythmias: the importance of scar pattern. Heart Rhythm. (2021) 18:589&#x2013;96. 10.1016/j.hrthm.2020.12.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.12.016</ArticleId><ArticleId IdType="pubmed">33348060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Beeckler C, Pike R, Parkash R, Gray CJ, Zeppenfeld K, et al. Initial human feasibility of infusion needle catheter ablation for refractory ventricular tachycardia. Circulation. (2013) 128:2289&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">24036605</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson WG, Tedrow UB, Reddy V, AbdelWahab A, Dukkipati S, John RM, et al. Infusion needle radiofrequency ablation for treatment of refractory ventricular arrhythmias. J Am Coll Cardiol. (2019) 73:1413&#x2013;25. 10.1016/j.jacc.2018.12.070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.12.070</ArticleId><ArticleId IdType="pubmed">30922472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tholakanahalli VN, Bertog S, Roukoz H, Shivkumar K. Catheter ablation of ventricular tachycardia using intracoronary wire mapping and coil embolization: description of a new technique. Heart Rhythm. (2013) 10:292&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23089899</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Bella P, Peretto G, Paglino G, Bisceglia C, Radinovic A, Sala S, et al. Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: safety and efficacy in a pilot cohort study. Heart Rhythm. (2020) 17:2111&#x2013;8. 10.1016/j.hrthm.2020.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.06.025</ArticleId><ArticleId IdType="pubmed">32599177</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Koruth J, Jais P, Petru J, Timko F, Skalsky I, et al. Ablation of atrial fibrillation with pulsed electric fields: an ultra-rapid, tissue-selective modality for cardiac ablation. JACC Clin Electrophysiol. (2018) 4:987&#x2013;95. 10.1016/j.jacep.2018.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2018.04.005</ArticleId><ArticleId IdType="pubmed">30139499</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangeli P, Hyman MC, Muser D, Callans DJ, Shivkumar K, Marchlinski FE. Outcomes of percutaneous trans-right atrial access to the left ventricle for catheter ablation of ventricular tachycardia in patients with mechanical aortic and mitral valves. JAMA Cardiol. (2020) 6:1&#x2013;6. 10.1001/jamacardio.2020.4414</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4414</ArticleId><ArticleId IdType="pmc">PMC7941197</ArticleId><ArticleId IdType="pubmed">32997112</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. (2003) 4:529&#x2013;36. 10.1016/s1470-2045(03)01191-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1470-2045(03)01191-4</ArticleId><ArticleId IdType="pubmed">12965273</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzile-Dugas E, Eisenberg MJ. Radiation-induced cardiovascular disease: review of an underrecognized pathology. J Am Heart Assoc. (2021) 10:e021686. 10.1161/JAHA.121.021686</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.021686</ArticleId><ArticleId IdType="pmc">PMC8649542</ArticleId><ArticleId IdType="pubmed">34482706</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo BW, Soltys SG, Wang L, Lo A, Fahimian BP, Iagaru A, et al. Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. Circ Arrhythm Electrophysiol. (2015) 8:748&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">26082532</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Ree MH, Blanck O, Limpens J, Lee CH, Balgobind BV, Dieleman EMT, et al. Cardiac radioablation-A systematic review. Heart Rhythm. (2020) 17:1381&#x2013;92. 10.1016/j.hrthm.2020.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.03.013</ArticleId><ArticleId IdType="pubmed">32205299</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug D, Blanck O, Andratschke N, Guckenberger M, Jumeau R, Mehrhof F, et al. Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia. Heart Rhythm. (2021) 18:2137&#x2013;45. 10.1016/j.hrthm.2021.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.08.004</ArticleId><ArticleId IdType="pubmed">34380072</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumeau R, Ozsahin M, Schwitter J, Elicin O, Reichlin T, Roten L, et al. Stereotactic radiotherapy for the management of refractory ventricular tachycardia: promise and future directions. Front Cardiovasc Med. (2020) 7:108. 10.3389/fcvm.2020.00108</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.00108</ArticleId><ArticleId IdType="pmc">PMC7329991</ArticleId><ArticleId IdType="pubmed">32671101</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs B, Mayinger M, Schindler M, Steffel J, Andratschke N, Saguner AM. Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease - A systematic review. Radiother Oncol. (2021) 162:132&#x2013;9. 10.1016/j.radonc.2021.06.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radonc.2021.06.036</ArticleId><ArticleId IdType="pubmed">34233215</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto-Iglesias D, Penela D, J&#xe1;uregui B, Acosta J, Fern&#xe1;ndez-Armenta J, Linhart M, et al. Cardiac magnetic resonance-guided ventricular tachycardia substrate ablation. JACC Clin Electrophysiol. (2020) 6:436&#x2013;47. 10.1016/j.jacep.2019.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2019.11.004</ArticleId><ArticleId IdType="pubmed">32327078</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz EP, Seidensaal K, Naumann P, Andr&#xe9; F, Katus HA, Debus J. Risen from the dead: cardiac stereotactic ablative radiotherapy as last rescue in a patient with refractory ventricular fibrillation storm. HeartRhythm Case Rep. (2019) 5:329&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6587041</ArticleId><ArticleId IdType="pubmed">31285992</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha MJ, Cuculich PS, Robinson CG, Chang JH. Tailored stereotactic radiotherapy technique using deep inspiration breath-hold to reduce stomach dose for cardiac radioablation. Radiat Oncol J. (2021) 39:167&#x2013;73. 10.3857/roj.2021.00276</Citation><ArticleIdList><ArticleId IdType="doi">10.3857/roj.2021.00276</ArticleId><ArticleId IdType="pmc">PMC8497870</ArticleId><ArticleId IdType="pubmed">34610655</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30415150</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Anesthetic challenges and outcomes for procedures in the intraoperative magnetic resonance imaging suite: A systematic review.</ArticleTitle><Pagination><StartPage>89</StartPage><EndPage>101</EndPage><MedlinePgn>89-101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2018.10.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(18)30909-7</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Hybrid operating room suites with intraoperative magnetic resonance imaging enable image guided surgery in a fully functional operating room environment. While this environment creates challenges to anesthetic care, the effects on anesthetic adverse events and outcomes are largely unknown. This systematic scoping review aims to map the existing knowledge about anesthetic care in advanced imaging hybrid operating rooms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A broad-based literature search was performed using the PubMed (Medline), Embase, Cochrane Library, Web of Science, and Google Scholar databases. References published in English between January 1994 and August 2017 were included. Quality of evidence was assessed using the GRADE guidelines.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-seven manuscripts were eligible for data collection. Adverse events were heterogeneously defined across 17 manuscripts and occurred in 0 to 100% (quality of evidence mostly very low). Monitoring difficulty was reported in 4 manuscripts of very low data quality. Interference between the magnet and the electrocardiogram was investigated in 2 manuscripts (quality of evidence low and very low, respectively). None of the reported events appeared to result in long-term patient harm. Author recommendations or a narrative review of the literature were provided in 40 manuscripts. Common safety concerns included lower equipment reliability, inaccessibility of the patient and airway, and the relative isolation of the suite (in relationship to other anesthesia care areas). Most authors also emphasized the importance of safety checklists, protocols, and provider training.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">While intraoperative magnetic resonance imaging hybrid operating rooms are increasingly utilized, the existing literature does not allow estimating adverse event rates in this location. Prospective studies quantifying the effect of the environment on anesthesia outcomes are lacking. Despite this, there is a broad consensus regarding the anesthetic and safety concerns. More research is needed to inform practice standards and training requirements for this challenging environment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schroeck</LastName><ForeName>Hedwig</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Geisel School of Medicine at Dartmouth College, 1 Rope Ferry Road, Hanover, NH 03755, USA; Department of Anesthesiology, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA. Electronic address: Hedwig.Schroeck@dartmouth.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welch</LastName><ForeName>Tasha L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: Welch.Tasha@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovner</LastName><ForeName>Michelle S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, Medical University of South Carolina, 165 Ashley Avenue, Suite 525CH, Charleston, SC 29425, USA. Electronic address: Rovner@musc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Heather A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Biomedical Libraries, Dartmouth College, 1 Medical Center Drive, Lebanon, NH 03756, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeck</LastName><ForeName>Florian R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Geisel School of Medicine at Dartmouth College, 1 Rope Ferry Road, Hanover, NH 03755, USA; White River Junction VA Medical Center, 215 N Main Street, White River Junction, VT 05009, USA; The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, USA. Electronic address: Florian.R.Schroeck@dartmouth.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>VA999999</GrantID><Acronym>ImVA</Acronym><Agency>Intramural VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009873" MajorTopicYN="N">Operating Rooms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025321" MajorTopicYN="N">Surgery, Computer-Assisted</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflicts of Interest:</b> none</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30415150</ArticleId><ArticleId IdType="mid">NIHMS1068802</ArticleId><ArticleId IdType="pmc">PMC7038577</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2018.10.022</ArticleId><ArticleId IdType="pii">S0952-8180(18)30909-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Practice Advisory on Anesthetic Care for Magnetic Resonance Imaging: An Updated Report by the American Society of Anesthesiologists Task Force on Anesthetic Care for Magnetic Resonance Imaging. Anesthesiology 2015;122:495&#x2013;520. doi:10.1097/ALN.0000000000000458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000458</ArticleId><ArticleId IdType="pubmed">25383571</ArticleId></ArticleIdList></Reference><Reference><Citation>Manninen PH, Kucharczyk W. A new frontier: magnetic resonance imaging-operating room. Journal of Neurosurgical Anesthesiology 2000;12:141&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10774611</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer DP, Manninen PH, McTaggart-Cowan RA. Anesthetic considerations for neurosurgery using intraoperative magnetic resonance imaging. Techniques in Neurosurgery 2002;7:308&#x2013;12.</Citation></Reference><Reference><Citation>McClain CD, Rockoff MA, Soriano SG. Anesthetic concerns for pediatric patients in an intraoperative MRI suite. Current Opinion in Anaesthesiology 2011;24:480&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21841476</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrichs B, Walsh RP . Intraoperative MRI for neurosurgical and general surgical interventions: Current Opinion in Anaesthesiology 2014;27:448&#x2013;52. doi:10.1097/ACO.0000000000000095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000095</ArticleId><ArticleId IdType="pubmed">24848271</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkow LC. Anesthetic management and human factors in the intraoperative MRI environment: Current Opinion in Anaesthesiology 2016;29:563&#x2013;7. doi:10.1097/ACO.0000000000000366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000366</ArticleId><ArticleId IdType="pubmed">27285726</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander E, Moriarty TM, Kikinis R, Black P, Jolesz FM. The present and future role of intraoperative MRI in neurosurgical procedures. Stereotact Funct Neurosurg 1997;68:10&#x2013;7. doi:10.1159/000099896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000099896</ArticleId><ArticleId IdType="pubmed">9711689</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston T, Moser R, Moeller K, Moriarty TM. Intraoperative MRI: Safety. Neurosurgery Clinics of North America 2009;20:147&#x2013;53. doi:10.1016/j.nec.2009.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nec.2009.04.007</ArticleId><ArticleId IdType="pubmed">19555876</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra C, Burkhardt J-K, Esposito G, Bozinov O, Pangalu A, Valavanis A, et al. Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging. Neurosurg Focus 2016;40:E17. doi:10.3171/2015.12.FOCUS15564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2015.12.FOCUS15564</ArticleId><ArticleId IdType="pubmed">26926057</ArticleId></ArticleIdList></Reference><Reference><Citation>Coburger J, Segovia von Riehm J, Ganslandt O, Wirtz CR, Renovanz M. Is There an Indication for Intraoperative MRI in Subtotal Resection of Glioblastoma? A Multicenter Retrospective Comparative Analysis. World Neurosurg 2018;110:e389&#x2013;97. doi:10.1016/j.wneu.2017.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2017.11.015</ArticleId><ArticleId IdType="pubmed">29138078</ArticleId></ArticleIdList></Reference><Reference><Citation>Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 2011;12:997&#x2013;1003. doi:10.1016/S1470-2045(11)70196-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(11)70196-6</ArticleId><ArticleId IdType="pubmed">21868284</ArticleId></ArticleIdList></Reference><Reference><Citation>Motomura K, Natsume A, Iijima K, Kuramitsu S, Fujii M, Yamamoto T, et al. Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas. J Neurosurg 2017;127:790&#x2013;7. doi:10.3171/2016.9.JNS16152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.9.JNS16152</ArticleId><ArticleId IdType="pubmed">28059650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacino MF, Huang SS, Keating RF, Gaillard WD, Oluigbo CO. An initial cost-effectiveness analysis of intraoperative magnetic resonance imaging (iMRI) in pediatric epilepsy surgery. Childs Nerv Syst 2018;34:495&#x2013;502. doi:10.1007/s00381-017-3658-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00381-017-3658-9</ArticleId><ArticleId IdType="pubmed">29159426</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallory MA, Sagara Y, Aydogan F, DeSantis S, Jayender J, Caragacianu D, et al. Feasibility of Intraoperative Breast MRI and the Role of Prone Versus Supine Positioning in Surgical Planning for Breast-Conserving Surgery. The Breast Journal 2017;23:713&#x2013;7. doi:10.1111/tbj.12796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbj.12796</ArticleId><ArticleId IdType="pmc">PMC5592119</ArticleId><ArticleId IdType="pubmed">28295903</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs-Buder T, Settembre N, Schmartz D. Hybridoperationssaal. Der Anaesthesist 2018;67:480&#x2013;7. doi:10.1007/s00101-018-0464-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00101-018-0464-z</ArticleId><ArticleId IdType="pubmed">29959499</ArticleId></ArticleIdList></Reference><Reference><Citation>Levac D, Colquhoun H, O&#x2019;Brien KK. Scoping studies: advancing the methodology. Implementation Science 2010;5. doi:10.1186/1748-5908-5-69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-5-69</ArticleId><ArticleId IdType="pmc">PMC2954944</ArticleId><ArticleId IdType="pubmed">20854677</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis K, Drey N, Gould D. What are scoping studies? A review of the nursing literature. Int J Nurs Stud 2009;46:1386&#x2013;400. doi:10.1016/j.ijnurstu.2009.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2009.02.010</ArticleId><ArticleId IdType="pubmed">19328488</ArticleId></ArticleIdList></Reference><Reference><Citation>Arksey H, O&#x2019;Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology 2005;8:19&#x2013;32. doi:10.1080/1364557032000119616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1364557032000119616</ArticleId></ArticleIdList></Reference><Reference><Citation>Colquhoun HL, Levac D, O&#x2019;Brien KK, Straus S, Tricco AC, Perrier L, et al. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol 2014;67:1291&#x2013;4. doi:10.1016/j.jclinepi.2014.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.03.013</ArticleId><ArticleId IdType="pubmed">25034198</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz HG, Kuehn D, Haberland N, Kalff R. Anesthesia management for spine surgery using spinal navigation in combination with computed tomography. Anesthesia and Analgesia 2003;97:863&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12933417</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. doi:10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mislow JMK, Golby AJ, Black PM. Origins of Intraoperative MRI. Magnetic Resonance Imaging Clinics of North America 2010;18:1&#x2013;10. doi:10.1016/j.mric.2009.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mric.2009.09.001</ArticleId><ArticleId IdType="pmc">PMC4120097</ArticleId><ArticleId IdType="pubmed">19962089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan&#x2014;a web and mobile app for systematic reviews. Systematic Reviews 2016;5. doi:10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction&#x2014;GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64:383&#x2013;94. doi:10.1016/j.jclinepi.2010.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.026</ArticleId><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Foroglou N, Zamani A, Black P. Intra-operative MRI (iop-MR) for brain tumour surgery. Br J Neurosurg 2009;23:14&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19234904</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrichs B, Walsh RP. Intraoperative magnetic resonance imaging for neurosurgical procedures: anesthetic implications. AANA Journal 2011;79:71&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21473229</ArticleId></ArticleIdList></Reference><Reference><Citation>McClain CD, Landrigan-Ossar M. Challenges in pediatric neuroanesthesia: awake craniotomy, intraoperative magnetic resonance imaging, and interventional neuroradiology. Anesthesiology Clinics 2014;32:83&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">24491651</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Maurtua M, Finnegan P. Anesthetic challenges during neurosurgical procedures using Intraoperative Magnetic Resonance Imaging Systems (IMRIS), literature review, and case report. Journal of Neurosurgical Anesthesiology 2013;25:449&#x2013;50.</Citation></Reference><Reference><Citation>Porteous J. Intraoperative MRI: the challenges of providing a safe environment for patients and personnel. ORNAC J 2014;32:12&#x2013;4, 16&#x2013;9, 22 passim.</Citation><ArticleIdList><ArticleId IdType="pubmed">25080779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis MJ, Smith ER, Orbach DB. The Hybrid Neurovascular Operating Room Intraoperative Imaging and Image-Guided Therapy, Springer; 2014, p. 301&#x2013;10.</Citation></Reference><Reference><Citation>Cowperthwaite L, Fearon MC. Guideline implementation: minimally invasive surgery, part 2&#x2014;hybrid ORs. AORN J 2017;106:145&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">28755666</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumae M, Koizumi J, Fukuyama H, Ishizaka H, Mizokami Y, Baba T, et al. World&#x2019;s first magnetic resonance imaging/x-ray/operating room suite: a significant milestone in the improvement of neurosurgical diagnosis and treatment 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">17695379</ArticleId></ArticleIdList></Reference><Reference><Citation>Abernethy LJ, Avula S, Hughes GM, Wright EJ, Mallucci CL. Intra-operative 3-T MRI for paediatric brain tumours: Challenges and perspectives. Pediatric Radiology 2012;42:147&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">22286342</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergese SD, Puente EG. Anesthesia in the intraoperative MRI environment. Neurosurgery Clinics of North America 2009;20:155&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">19555877</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkenstadt H, Perel A, Ram Z, Feldman Z, Nahtomi-Shick O, Hadani M. Anesthesia for magnetic resonance guided neurosurgery: initial experience with a new open magnetic resonance imaging system. Journal of Neurosurgical Anesthesiology 2001;13:158&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">11294459</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherkashin M, Berezina N, Serov A, Fedorov A, Andreev G, Kuplevatsky V. Safety Management for MR-Guided Interventions. Investigative Magnetic Resonance Imaging 2016;20:152&#x2013;7.</Citation></Reference><Reference><Citation>Darakchiev BJ, Tew JM Jr, Bohinski RJ, Warnick RE. Adaptation of a standard low-field (0.3-T) system to the operating room: Focus on pituitary adenomas. Neurosurgery Clinics of North America 2005;16:155&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">15561535</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried MP, Hsu L, Topulos GP, Jolesz FA. Image-guided surgery in a new magnetic resonance suite: preclinical considerations. Laryngoscope 1996;106:411&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8614214</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan TK, Goh J. The anaesthetist&#x2019;s role in the setting up of an intraoperative MR imaging facility. Singapore Medical Journal 2009;50:4&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">19224077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi R, Campos B, Haux D, Rieke J, Beigel B, Unterberg A. Assessing perioperative complications associated with use of intraoperative magnetic resonance imaging during glioma surgery - a single centre experience with 516 cases. British Journal of Neurosurgery 2016;30:397&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">27008572</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkholz T, Schmid M, Nimsky C, Schuttler J, Schmitz B. ECG artifacts during intraoperative high-field MRI scanning. Journal of Neurosurgical Anesthesiology 2004;16:271&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15557829</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhri XAF, Klimo P, Auschwitz TS, Whitehead MT, Boop FA. 3T intraoperative MRI for management of pediatric CNS neoplasms. American Journal of Neuroradiology 2014;35:2382&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965316</ArticleId><ArticleId IdType="pubmed">25059696</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox RG, Levy R, Hamilton MG, Ewen A, Farran P, Neil SG. Anesthesia can be safely provided for children in a high-field intraoperative magnetic resonance imaging environment. Paediatric Anaesthesia 2011;21:454&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21299683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried MP, Topulos G, Hsu L, Jalahej H, Gopal H, Lauretano A, et al. Endoscopic sinus surgery with magnetic resonance imaging guidance: initial patient experience. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 1998;119:374&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">9781994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmathulla G, Recinos PF, Traul DE, Avitsian R, Yunak M, Harper NT, et al. Surgical briefings, checklists, and the creation of an environment of safety in the neurosurgical intraoperative magnetic resonance imaging suite. Neurosurgical Focus 2012;33:E12. doi:10.3171/2012.9.FOCUS12260.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2012.9.FOCUS12260</ArticleId><ArticleId IdType="pubmed">23116092</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz B, Nimsky C, Wendel G, Wienerl J, Ganslandt O, Jacobi K, et al. Anesthesia during high-field intraoperative magnetic resonance imaging experience with 80 consecutive cases. Journal of Neurosurgical Anesthesiology 2003;15:255&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">12826974</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovski A, Francotte F, Vaz G, Fomekong E, Duprez T, Van Boven M, et al. Intraoperative magnetic resonance imaging at 3-T using a dual independent operating room-magnetic resonance imaging suite: development, feasibility, safety, and preliminary experience. Neurosurgery 2008;63:412&#x2013;24; discussion 424&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18812952</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja A, Tandon V, Suri A, Sarat Chandra P, Kale SS, Garg A, et al. Initial experience of using high field strength intraoperative MRI for neurosurgical procedures. J Clin Neurosci 2015;22:1326&#x2013;31. doi:10.1016/j.jocn.2015.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2015.02.027</ArticleId><ArticleId IdType="pubmed">26077939</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer DP, McTaggart Cowan RA, Falkenstein RJ, Sutherland GR. Intraoperative mobile magnetic resonance imaging for craniotomy lengthens the procedure but does not increase morbidity. Canadian Journal of Anaesthesia = Journal Canadien d&#x2019;anesthesie 2002;49:420&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11927485</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldaun MVC, Khawja SN, Levine NB, Rao G, Lang FF, Weinberg JS, et al. Awake craniotomy for gliomas in a high-field intraoperative magnetic resonance imaging suite: Analysis of 42 cases. Journal of Neurosurgery 2014;121:810&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25105702</ArticleId></ArticleIdList></Reference><Reference><Citation>Barua E, Johnston J, Fujii J, Dzwonczyk R, Chiocca E, Bergese S. Anesthesia for brain tumor resection using intraoperative magnetic resonance imaging (iMRI) with the Polestar N-20 system: experience and challenges. Journal of Clinical Anesthesia 2009;21:371&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19700282</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzwonczyk R, Fujii JT, Simonetti O, Nieves-Ramos R, Bergese SD. Electrical noise in the intraoperative magnetic resonance imaging setting. Anesthesia and Analgesia 2009;108:181&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5166575</ArticleId><ArticleId IdType="pubmed">19095847</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomekong E, Duprez T, Docquier MA, Ntsambi G, Maiter D, Raftopoulos C. Intraoperative 3T MRI for pituitary macroadenoma resection: Initial experience in 73 consecutive patients. Clinical Neurology and Neurosurgery 2014;126:143&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25255158</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Zhang H, Sun L. Effects of intraoperative magnetic resonance imaging on the neuromuscular blockade of vecuronium bromide in neurosurgery. Neurol Med Chir (Tokyo) 2013;53:201&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23615407</ArticleId></ArticleIdList></Reference><Reference><Citation>Iturri-Clavero F, Galbarriatu-Gutierrez L, Gonzalez-Uriarte A, Tamayo-Medel G, de Orte K, Martinez-Ruiz A, et al. &#x201c;Low-field&#x201d; intraoperative MRI: a new scenario, a new adaptation. Clinical Radiology 2016;71:1193&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27524673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamata K, Morioka N, Komayama N, Hasegawa H, Ohashi A, Maruyama T, et al. The incidence of intraoperative MRI related adverse events during awake craniotomy. International Journal of Computer Assisted Radiology and Surgery 2016;11:S231.</Citation></Reference><Reference><Citation>Panigrahi BP, Mittal S. Anesthetic implications for intraoperative high field magnetic resonance imaging in neurosurgery: A case series. Journal of Neurosurgical Anesthesiology 2008;20:312.</Citation></Reference><Reference><Citation>Panigrahi B. Anaesthetic implications for intraoperative high field magnetic resonance imaging in neurosurgery: Our experience. BrJAnaesth 2012;108:ii66.</Citation></Reference><Reference><Citation>Rao S, Avitsian R, Stapelfeldt W. Anesthetic considerations for intraoperative MRI (IMRI): Cleveland clinic experience. Journal of Neurosurgical Anesthesiology 2012;24:468.</Citation></Reference><Reference><Citation>Raymer T, Jones R, Grattan-Smith D. Maintaining MRI safety in an intra-operative environment. Pediatric Radiology 2017;47:S274&#x2013;5.</Citation></Reference><Reference><Citation>Ruskin KJ, Chang HW. Intraoperative MRI: Initial experience. European Journal of Anaesthesiology 2012;29:S2&#x2013;3.</Citation></Reference><Reference><Citation>Chowdhury T, Bergese SD, Soghomonyan S, Cappellani RB. The Role of Simulation in Planning Intraoperative Magnetic Resonance Imaging-Guided Neurosurgical Procedures: A Case Report. A A Case Rep 2017;8:158&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">27941480</ArticleId></ArticleIdList></Reference><Reference><Citation>Peruzzi P, Puente E, Bergese S, Chiocca EA, Pamir MN, Seifert V, et al. Intraoperative MRI (ioWIRI) in the Setting of Awake Craniotomies for Supratentorial Glioma Resection. Intraoperative Imaging, vol. 109, 2011, p. 43&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20960319</ArticleId></ArticleIdList></Reference><Reference><Citation>Takrouri MS, Shubbak FA, Al Hajjaj A, Del Maaestro RF, Soualmi L, Alkhodair MH, et al. Conscious sedation for awake craniotomy in intra-operative magnetic resonance imaging operating theatre (IMRI OT) environment. Middle East Journal of Anaesthesiology 2010;20:885&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">21526680</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan TK, Leong KW. Awake craniotomy in an intra-operative MRI environment. Anaesthesia 2009;64:575&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19413839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng JX, Tan TK. Managing cardiovascular incidents in the intra-operative magnetic resonance imaging (iMRI) environment: Lessons from three case studies. Proceedings of Singapore Healthcare 2011;20:301&#x2013;3.</Citation></Reference><Reference><Citation>Safety in magnetic resonance units: an update: Safety in magnetic resonance units. Anaesthesia 2010;65:766&#x2013;70. doi:10.1111/j.1365-2044.2010.06377.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2010.06377.x</ArticleId><ArticleId IdType="pmc">PMC2904502</ArticleId><ArticleId IdType="pubmed">20642539</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, He L, Qu W, Zhang C. Predictors of Intraoperative Pressure Injury in Patients Undergoing Major Hepatobiliary Surgery. J Wound Ostomy Continence Nurs 2017;44:445&#x2013;9. doi:10.1097/WON.0000000000000356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WON.0000000000000356</ArticleId><ArticleId IdType="pubmed">28877110</ArticleId></ArticleIdList></Reference><Reference><Citation>Piper KF, Tomlinson SB, Santangelo G, Van Galen J, DeAndrea-Lazarus I, Towner J, et al. Risk factors for wound complications following spine surgery. Surg Neurol Int 2017;8:269. doi:10.4103/sni.sni_306_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sni.sni_306_17</ArticleId><ArticleId IdType="pmc">PMC5682694</ArticleId><ArticleId IdType="pubmed">29184720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey M, Kirchen G, Bonaventura B, Rosborough K, Abdel-Rasoul M, Dzwonczyk R. Intraoperative MRI electrical noise and monitor ECG filters affect arrhythmia detection and identification. J Clin Monit Comput 2012;26:157&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">22389138</ArticleId></ArticleIdList></Reference><Reference><Citation>Taber KH, Hayman LA, Northrup SR, Maturi L. Vital sign changes during infant magnetic resonance examinations. J Magn Reson Imaging 1998;8:1252&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9848737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang B, Kaye AD, Diaz JH, Westlake B, Dutton RP, Urman RD. Interventional Procedures Outside of the Operating Room: Results From the National Anesthesia Clinical Outcomes Registry. J Patient Saf 2018;14:9&#x2013;16. doi:10.1097/PTS.0000000000000156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PTS.0000000000000156</ArticleId><ArticleId IdType="pubmed">29461406</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzner J, Posner KL, Domino KB. The risk and safety of anesthesia at remote locations: the US closed claims analysis. Curr Opin Anaesthesiol 2009;22:502&#x2013;8. doi:10.1097/ACO.0b013e32832dba50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e32832dba50</ArticleId><ArticleId IdType="pubmed">19506473</ArticleId></ArticleIdList></Reference><Reference><Citation>Melloni C. Anesthesia and sedation outside the operating room: how to prevent risk and maintain good quality: Current Opinion in Anaesthesiology 2007;20:513&#x2013;9. doi:10.1097/ACO.0b013e3282f06ba6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e3282f06ba6</ArticleId><ArticleId IdType="pubmed">17989542</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24226493</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Minerva anestesiologica</Title><ISOAbbreviation>Minerva Anestesiol</ISOAbbreviation></Journal><ArticleTitle>Protective lung ventilation in operating room: a systematic review.</ArticleTitle><Pagination><StartPage>726</StartPage><EndPage>735</EndPage><MedlinePgn>726-35</MedlinePgn></Pagination><Abstract><AbstractText>Postoperative pulmonary and extrapulmonary complications adversely affect clinical outcomes and healthcare utilization, so that prevention has become a measure of the quality of perioperative care. Mechanical ventilation is an essential support therapy to maintain adequate gas exchange during general anesthesia for surgery. Mechanical ventilation using high tidal volume (VT) (between 10 and 15 mL/kg) has been historically encouraged to prevent hypoxemia and atelectasis formation in anesthetized patients undergoing abdominal and thoracic surgery. However, there is accumulating evidence from both experimental and clinical studies that mechanical ventilation, especially the use of high VT and plateau pressure, may potentially aggravate or even initiate lung injury. Ventilator-associated lung injury can result from cyclic alveolar overdistension of non-dependent lung tissue, and repetitive opening and closing of dependent lung tissue resulting in ultrastructural damage at the junction of closed and open alveoli. Lung-protective ventilation, which refers to the use of lower VT and limited plateau pressure to minimize overdistension, and positive end-expiratory pressure to prevent alveolar collapse at end-expiration, was shown to improve outcome in critically ill patients with acute respiratory distress syndrome (ARDS). It has been recently suggested that this approach might also be beneficial in a broader population, especially in critically ill patients without ARDS at the onset of mechanical ventilation. There is, however, little evidence regarding a potential beneficial effect of lung protective ventilation during surgery, especially in patients with healthy lungs. Although surgical patients are frequently exposed to much shorter periods of mechanical ventilation, this is an important gap in knowledge given the number of patients receiving mechanical ventilation in the operating room. This review developed the benefits of lung protective ventilation during surgery and general anesthesia and offers some recommendations for mechanical ventilation in the surgical context.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Futier</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care B (DAR B), Saint Eloi Teaching Hospital, Montpellier University Hospital, Montpellier, France - s-jaber@chu-montpellier.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Constantin</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Anestesiol</MedlineTA><NlmUniqueID>0375272</NlmUniqueID><ISSNLinking>0375-9393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24226493</ArticleId><ArticleId IdType="pii">R02Y9999N00A0746</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35475882</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Mechanical Power during General Anesthesia and Postoperative Respiratory Failure: A Multicenter Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>54</EndPage><MedlinePgn>41-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004256</ELocationID><Abstract><AbstractText Label="BACKGROUND">Mechanical power during ventilation estimates the energy delivered to the respiratory system through integrating inspiratory pressures, tidal volume, and respiratory rate into a single value. It has been linked to lung injury and mortality in the acute respiratory distress syndrome, but little evidence exists regarding whether the concept relates to lung injury in patients with healthy lungs. This study hypothesized that higher mechanical power is associated with greater postoperative respiratory failure requiring reintubation in patients undergoing general anesthesia.</AbstractText><AbstractText Label="METHODS">In this multicenter, retrospective study, 230,767 elective, noncardiac adult surgical out- and inpatients undergoing general anesthesia between 2008 and 2018 at two academic hospital networks in Boston, Massachusetts, were included. The risk-adjusted association between the median intraoperative mechanical power, calculated from median values of tidal volume (Vt), respiratory rate (RR), positive end-expiratory pressure (PEEP), plateau pressure (Pplat), and peak inspiratory pressure (Ppeak), using the following formula: mechanical power (J/min) = 0.098 &#xd7; RR &#xd7; Vt &#xd7; (PEEP + &#xbd;[Pplat - PEEP] + [Ppeak - Pplat]), and postoperative respiratory failure requiring reintubation within 7 days, was assessed.</AbstractText><AbstractText Label="RESULTS">The median intraoperative mechanical power was 6.63 (interquartile range, 4.62 to 9.11) J/min. Postoperative respiratory failure occurred in 2,024 (0.9%) patients. The median (interquartile range) intraoperative mechanical power was higher in patients with postoperative respiratory failure than in patients without (7.67 [5.64 to 10.11] vs. 6.62 [4.62 to 9.10] J/min; P &lt; 0.001). In adjusted analyses, a higher mechanical power was associated with greater odds of postoperative respiratory failure (adjusted odds ratio, 1.31 per 5 J/min increase; 95% CI, 1.21 to 1.42; P &lt; 0.001). The association between mechanical power and postoperative respiratory failure was robust to additional adjustment for known drivers of ventilator-induced lung injury, including tidal volume, driving pressure, and respiratory rate, and driven by the dynamic elastic component (adjusted odds ratio, 1.35 per 5 J/min; 95% CI, 1.05 to 1.73; P = 0.02).</AbstractText><AbstractText Label="CONCLUSIONS">Higher mechanical power during ventilation is statistically associated with a greater risk of postoperative respiratory failure requiring reintubation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, the American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santer</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wachtendorf</LastName><ForeName>Luca J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Anesthesiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suleiman</LastName><ForeName>Aiman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houle</LastName><ForeName>Timothy T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fassbender</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Anesthesiology, Intensive Care Medicine, Pain and Palliative Care, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Herne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Eduardo L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Laboratory of Pneumology LIM-09, Department of Pneumology, Heart Institute (Incor), Hospital of the Medical College of the University of S&#xe3;o Paulo, Brazil; Research and Education Institute, Hospital S&#xed;rio-Libanes, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talmor</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eikermann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York; Department of Anaesthesiology and Intensive Care Medicine, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baedorf-Kassis</LastName><ForeName>Elias</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary and Critical Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaefer</LastName><ForeName>Maximilian S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Anesthesiology, Duesseldorf University Hospital, Duesseldorf, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesthesiology. 2022 Jul 1;137(1):6-8. doi: 10.1097/ALN.0000000000004240.</RefSource><PMID Version="1">35560172</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055397" MajorTopicYN="Y">Ventilator-Induced Lung Injury</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>12</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35475882</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004256</ArticleId><ArticleId IdType="pii">136245</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29270467</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2405-500X</ISSN><JournalIssue CitedMedium="Print"><Volume>3</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Efficacy of Stellate Ganglion Blockade in Managing Electrical Storm: A Systematic Review.</ArticleTitle><Pagination><StartPage>942</StartPage><EndPage>949</EndPage><MedlinePgn>942-949</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2017.06.006</ELocationID><Abstract><AbstractText Label="BACKGROUND">The efficacy of percutaneous stellate ganglion block (SGB) for managing electrical storm (ES) is not well understood.</AbstractText><AbstractText Label="OBJECTIVE">To characterize the efficacy of SGB as a treatment for ES.</AbstractText><AbstractText Label="METHODS">We conducted literature searches using PubMed/Medline and Google Scholar, for mixed combinations of terms including "stellate ganglion block", *ganglion block (ade)", "sympathetic block (ade)" and "arrhythmia", "ventricular arrhythmia (VA)" or "tachycardia" (VT), "ventricular fibrillation" (VF), "electrical storm". Inclusion criteria were presentation with guideline-defined ES and treatment with SGB. Exclusion criteria: presentation with any supraventricular arrhythmia, VA without ES, or surgical sympathectomy. Studies lacking basic demographic data, arrhythmia description, and outcomes were excluded.</AbstractText><AbstractText Label="RESULTS">Of 3,374 publications reviewed, 38 patients from 23 studies met study criteria (52 &#xb1; 19.1 years, 11 F, 17 with ischemic cardiomyopathy). Anti-arrhythmics were used in all patients. Mean Left ventricular ejection fraction was 31 &#xb1; 10%. ES was triggered by acute myocardial infarction in 15 patients and QT prolongation in 7 patients. The most common local anesthetic used for SGB was bupivacaine (0.25-0.5%). SGB resulted in a significant decrease in VA burden (12.4&#xb1;8.8 vs. 1.04&#xb1;2.12 episodes/day, p&lt; 0.001) and number of external and ICD shocks (10.0&#xb1;9.1 vs. 0.05&#xb1;0.22 shocks/day, p&lt; 0.01). Following SGB, 80.6% of patients survived to discharge.</AbstractText><AbstractText Label="CONCLUSION">SGB is an effective acute treatment for ES. However, larger prospective randomized studies are needed to better understand the role of SGB in ES and other VAs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Lingjin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chi-Hong</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shivkumar</LastName><ForeName>Kalyanam</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajijola</LastName><ForeName>Olujimi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP2 HL142045</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 HL125730</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL084261</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>Y8335394RO</RegistryNumber><NameOfSubstance UI="D002045">Bupivacaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001340" MajorTopicYN="N">Autonomic Nerve Block</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002045" MajorTopicYN="N">Bupivacaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013233" MajorTopicYN="N">Stellate Ganglion</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018084" MajorTopicYN="N">Ultrasonography, Interventional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Stellate ganglion block</Keyword><Keyword MajorTopicYN="N">autonomic nervous system</Keyword><Keyword MajorTopicYN="N">electrical storm</Keyword><Keyword MajorTopicYN="N">neuromodulation</Keyword><Keyword MajorTopicYN="N">sympathetic nerves</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29270467</ArticleId><ArticleId IdType="mid">NIHMS902084</ArticleId><ArticleId IdType="pmc">PMC5734652</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2017.06.006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Heart Rhythm. 2009;6:886&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pubmed">19467519</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao D, Sapp JL. Electrical storm: definitions, clinical importance, and treatment. Curr Opin Cardiol. 2013;28:72&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23160339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death,&#xc4;&#xee;executive summaryA report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. European Heart Journal. 2006;27:2099&#x2013;2140.</Citation><ArticleIdList><ArticleId IdType="pubmed">16923744</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circulation research. 2014;114:1004&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">24625726</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivkumar K, Ajijola OA, Anand I, et al. Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. J Physiol. 2016;594:3911&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945719</ArticleId><ArticleId IdType="pubmed">27114333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Lellouche N, Bourke T, et al. Bilateral Cardiac Sympathetic Denervation for the Management of Electrical Storm. Journal of the American College of Cardiology. 2012;59:91&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3470807</ArticleId><ArticleId IdType="pubmed">22192676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Vaseghi M, Mahajan A, Shivkumar K. Bilateral cardiac sympathetic denervation: why, who and when? Expert review of cardiovascular therapy. 2012;10:947&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551540</ArticleId><ArticleId IdType="pubmed">23030281</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi M, Gima J, Kanaan C, et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart rhythm. 2014;11:360&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4253031</ArticleId><ArticleId IdType="pubmed">24291775</ArticleId></ArticleIdList></Reference><Reference><Citation>Collura CA, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm. 2009;6:752&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19467503</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Liu Y, Yang F, Jiang G, Li C, Hu D, et al. Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome. Ann Thorac Surg. 2008;6:1955&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19022016</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;16:903&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">5112730</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitter-Hauge S, Storstein O. Surgical treatment of recurrent ventricular tachycardia. Br Heart J. 1973;11:1132&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC458767</ArticleId><ArticleId IdType="pubmed">4761114</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;15:1826&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">15051644</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz PJ, Zaza A, Locati E, Moss AJ. Stress and sudden death. The case of the long QT syndrome. Circulation. 1991;83:II71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">2009631</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagini A, Sabino F, Paladini G, et al. Treatment of perinfarction recurrent ventricular fibrillation by percutaneous pharmacological block of left stellate ganglion. Clin Cardiol. 1985;8:111&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3971606</ArticleId></ArticleIdList></Reference><Reference><Citation>Boe BA, Webster G, Asher Y, Tsao S, Suresh S, Steinhorn DM. Percutaneous, ultrasound-guided stellate ganglion nerve block suppresses recurrent ventricular fibrillation in an infant awaiting heart transplant. Circulation Arrhythmia and electrophysiology. 2012;5:e93&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">23074329</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadhinglajkar S, Sreedhar R, Unnikrishnan M, Namboodiri N. Electrical storm: Role of stellate ganglion blockade and anesthetic implications of left cardiac sympathetic denervation. Indian J Anaesth. 2013;57:397&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3800335</ArticleId><ArticleId IdType="pubmed">24163457</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Moran E, Sandin-Fuentes MG, Alvarez Lopez JC, Duro-Aguado I, Uruena-Martinez N, Hernandez-Luis C. Electrical storm secondary to acute myocardial infarction and heart failure treated with left stellate ganglion block. Rev Esp Cardiol. 2013;66:595&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24776216</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Moran E, Sliwinski-Herrera F, Cortes-Villar C, Sandin-Fuentes M, Pastor Baez G, San Roman A. Refractory Electrical Storm: A Role for Transient Sympathetic Blockade. Rev Esp Cardiol. 2016;69:76&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26699097</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman MA. Cardiac arrhythmias in acute central nervous system disease. Successful management with stellate ganglion block. Arch Intern Med. 1976;136:203&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">1247352</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayase J, Patel J, Narayan SM, Krummen DE. Percutaneous stellate ganglion block suppressing VT and VF in a patient refractory to VT ablation. Journal of cardiovascular electrophysiology. 2013;24:926&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733785</ArticleId><ArticleId IdType="pubmed">23574305</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoepp HW, Eggeling T, Hombach V. Pharmacologic blockade of the left stellate ganglion using a drug-reservoir-pump system. Chest. 1990;97:250&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">1967234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulata DF, Le-Wendling L, Boezaart AP, Hurley RW. Stellate ganglion local anesthetic blockade and neurolysis for the treatment of refractory ventricular fibrillation. A A Case Rep. 2015;4:49&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">25730409</ArticleId></ArticleIdList></Reference><Reference><Citation>Loyalka P, Hariharan R, Gholkar G, et al. Left stellate ganglion block for continuous ventricular arrhythmias during percutaneous left ventricular assist device support. Tex Heart Inst J. 2011;38:409&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3147196</ArticleId><ArticleId IdType="pubmed">21841870</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AA, Khan AA, Dingmann K, et al. Percutaneous inferior cervical sympathetic ganglion blockade for the treatment of ventricular tachycardia storm: case report and review of the literature. J Vasc Interv Neurol. 2014;7:48&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4280879</ArticleId><ArticleId IdType="pubmed">25566341</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesa A, Kaplan RF. Dysrhythmias controlled with stellate ganglion block in a child with diabetes and a variant of long QT syndrome. Reg Anesth. 1993;18:60&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">8095401</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair L, Tseng PS, Manninen PH, Teo WS. Anaesthetic management of idiopathic long QT syndrome--a case report. Ann Acad Med Singapore. 1994;23:582&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">7979136</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen H, Badskjaer J. Blockade of the left stellate ganglion. Treatment of ventricular arrhythmias in secondary QT prolongation. Ugeskr Laeger. 1986;148:3221&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3810919</ArticleId></ArticleIdList></Reference><Reference><Citation>Parris WC, Reddy BC, White HW, McGrath DM. Stellate ganglion blocks in pediatric patients. Anesth Analg. 1991;72:552&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">2006747</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel RA, Priore DL, Szeto WY, Slevin KA. Left stellate ganglion blockade for the management of drug-resistant electrical storm. Pain Med. 2011;12:1196&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21692973</ArticleId></ArticleIdList></Reference><Reference><Citation>Platia EV, Griffith LS, Watkins L, Mirowski M, Mower MM, Reid PR. Management of the prolonged QT syndrome and recurrent ventricular fibrillation with an implantable automatic cardioverter-defibrillator. Clin Cardiol. 1985;8:490&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">4042451</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu MA, Prasad SB, Abhilash SP, Thajudeen A, R BK, Namboodiri N. Left sympathetic cardiac denervation in managing electrical storm: acute outcome and long term follow up. J Interv Card Electrophysiol. 2016;47:285&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">27318998</ArticleId></ArticleIdList></Reference><Reference><Citation>Scanlon MM, Gillespie SM, Schaff HV, Cha YM, Wittwer ED. Urgent Ultrasound-Guided Bilateral Stellate Ganglion Blocks in a Patient With Medically Refractory Ventricular Arrhythmias. Crit Care Med. 2015;43:e316&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25978339</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DI, Jones C, Morris GK, Kralovic S, Massey HT, Sifain A. Trial ultrasound-guided continuous left stellate ganglion blockade before surgical gangliolysis in a patient with a left ventricular assist device and intractable ventricular tachycardia: a pain control application to a complex hemodynamic condition. Asaio J. 2015;61:104&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25303796</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan AY, Abdi S, Buxton AE, Anter E. Percutaneous stellate ganglia block for acute control of refractory ventricular tachycardia. Heart rhythm. 2012;9:2063&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22863887</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudim M, Boortz-Marx R, Patel CB, Sun AY, Piccini JP. Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks. J Cardiovasc Electrophysiol. 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">28019045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudim M, Boortz-Marx R, Patel CB, Sun AY, Piccini JP. Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks. Journal of cardiovascular electrophysiology. 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">28019045</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivkumar K, Ajijola OA, Anand I, et al. Clinical neurocardiology-defining the value of neuroscience-based cardiovascular therapeutics. J Physiol. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945719</ArticleId><ArticleId IdType="pubmed">27114333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardell JL, Andresen MC, Armour JA, et al. Translational Neurocardiology: preclinical models and cardioneural integrative aspects. J Physiol. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945715</ArticleId><ArticleId IdType="pubmed">27098459</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y, Wang L, Wang X, Tang Y, Cao F, Fang Y. Assessment of ventricular electrophysiological characteristics at periinfarct zone of postmyocardial infarction in rabbits following stellate ganglion block. J Cardiovasc Electrophysiol. 2012;23:S29&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">22994966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipes DP, Rubart M. Neural modulation of cardiac arrhythmias and sudden cardiac death. Heart Rhythm. 2006;3:108&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566299</ArticleId><ArticleId IdType="pubmed">16399065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Jung BC, Tan AY, Trang VQ, Gholmieh G, Han SW, et al. Spontaneous stellate ganglion nerve activity and ventricular arrhythmia in a canine model of sudden death. Heart Rhythm. 2008;5:131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18055272</ArticleId></ArticleIdList></Reference><Reference><Citation>Doytchinova A, Patel J, Zhou S, Chen LS, Lin H, Shen C, et al. Subcutaneous nerve activity and spontaneous ventricular arrhythmias in ambulatory dogs. Heart Rhythm. 2015;12:612&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4339615</ArticleId><ArticleId IdType="pubmed">25460171</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Yagishita D, Patel KJ, et al. Focal myocardial infarction induces global remodeling of cardiac sympathetic innervation: neural remodeling in a spatial context. American journal of physiology Heart and circulatory physiology. 2013;305:H1031&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3798751</ArticleId><ArticleId IdType="pubmed">23893167</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi M, Yamakawa K, Sinha A, et al. Modulation of regional dispersion of repolarization and T-peak to T-end interval by the right and left stellate ganglia. American journal of physiology Heart and circulatory physiology. 2013;305:H1020&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3798747</ArticleId><ArticleId IdType="pubmed">23893168</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagishita D, Chui RW, Yamakawa K, et al. Sympathetic Nerve Stimulation, Not Circulating Norepinephrine, Modulates T-Peak to T-End Interval by Increasing Global Dispersion of Repolarization. Circulation Arrhythmia and electrophysiology. 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4405126</ArticleId><ArticleId IdType="pubmed">25532528</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori SG, Corr PB. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. The American journal of physiology. 1990;258:H1796&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">2163219</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori SG, Mantica M, Schwartz PJ. Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation. Circulation. 1988;78:178&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">3383403</ArticleId></ArticleIdList></Reference><Reference><Citation>Irie T, Yamakawa K, Hamon D, Nakamura K, Shivkumar K, Vaseghi M. Cardiac Sympathetic Innervation Via the Middle Cervical and Stellate Ganglia and Anti-Arrhythmic Mechanism of Bilateral Stellectomy. Am J Physiol Heart Circ Physiol. 2016 ajpheart 00644 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5402012</ArticleId><ArticleId IdType="pubmed">28011590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Lux RL, Khahera A, et al. Sympathetic Modulation of Electrical Activation In Normal and Infarcted Myocardium: Implications for Arrhythmogenesis. Am J Physiol Heart Circ Physiol. 2017 ajpheart 00575 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5402014</ArticleId><ArticleId IdType="pubmed">28087519</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68:1476&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">27216111</ArticleId></ArticleIdList></Reference><Reference><Citation>Janes RD, Brandys JC, Hopkins DA, Johnstone DE, Murphy DA, Armour JA. Anatomy of human extrinsic cardiac nerves and ganglia. The American journal of cardiology. 1986;57:299&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">3946219</ArticleId></ArticleIdList></Reference><Reference><Citation>Herring N, Cranley J, Lokale MN, et al. The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability. Journal of molecular and cellular cardiology. 2012;52:667&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3314977</ArticleId><ArticleId IdType="pubmed">22172449</ArticleId></ArticleIdList></Reference><Reference><Citation>Herring N, Lokale MN, Danson EJ, Heaton DA, Paterson DJ. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. Journal of molecular and cellular cardiology. 2008;44:477&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">17996892</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucker IH, Patel KP, Schultz HD. Neurohumoral stimulation. Heart failure clinics. 2012;8:87&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3224981</ArticleId><ArticleId IdType="pubmed">22108729</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HJ, Wang W, Cornish KG, Rozanski GJ, Zucker IH. Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure. Hypertension. 2014;64:745&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4162756</ArticleId><ArticleId IdType="pubmed">24980663</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29897913</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.</ArticleTitle><Pagination><StartPage>e0196113</StartPage><MedlinePgn>e0196113</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0196113</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0196113</ELocationID><Abstract><AbstractText Label="BACKGROUND">Observational studies have indicated a high but heterogeneous prevalence of low bone mineral density (BMD) and vertebral fractures (VF) in patients with systemic lupus erythematosus (SLE). Therefore, the objectives of this systematic review and meta-regression were: 1) to compare BMD between SLE patients and healthy controls and 2) to evaluate the relationship between BMD and glucocorticoid therapy and VF in SLE patients.</AbstractText><AbstractText Label="METHODS AND FINDINGS">Articles were identified from electronic databases (PubMed, Embase, VHL, SciELO and the Cochrane Library). Prospective longitudinal and cross-sectional studies were considered for review. We evaluated the quality of the evidence included using the Oxford Centre for evidence-based medicine (EBM) Levels of Evidence. In total, 38 articles were identified and analyzed (3442 SLE cases and 6198 controls) in the analysis of BMD (9232 women and 408 men). There were significant differences in mean BMD between SLE patients and controls. BMD mean difference in cases/controls: -0.0566 95% CI (-0.071, -0.0439; p = &lt; 0.0001). When only SLE patients were analyzed, the BMD did not significantly differ between patients who had or had not received glucocorticoid (GCT) therapy. 694 SLE patients were included in the analysis of VF (189 with VF vs. 505 without VF). Patients with VF had lower BMD than patients without VF (BMD mean difference without VF/with VF: 0.033 (95%CI: 0.006-0.060); p-value: 0.0156).</AbstractText><AbstractText Label="CONCLUSIONS">Patients with SLE had lower BMD than healthy controls. Moreover, SLE patients with VF had lower BMD than patients without VF. However, our data did not show that GCT therapy had an impact on BMD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mendoza-Pinto</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Hospital de Especialidades, UMAE CMNMAC-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Rheumatology, Medicine School, Benem&#xe9;rita Universidad Aut&#xf3;noma de Puebla, Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Villarraga</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Artmedica IPS, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molano-Gonz&#xe1;lez</LastName><ForeName>Nicol&#xe1;s</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Herrera</LastName><ForeName>Erick A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Hospital de Especialidades, UMAE CMNMAC-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n-V&#xe1;zquez</LastName><ForeName>Mar&#xed;a de la Luz</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Hospital de Especialidades, UMAE CMNMAC-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montiel-Jarqu&#xed;n</LastName><ForeName>&#xc1;lvaro</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Research in Health Unit, UMAE, Instituto Mexicano del Seguro Social, M&#xe9;xico, Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Carrasco</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1696-9871</Identifier><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Hospital de Especialidades, UMAE CMNMAC-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Rheumatology, Medicine School, Benem&#xe9;rita Universidad Aut&#xf3;noma de Puebla, Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervera</LastName><ForeName>Ricard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="Y">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29897913</ArticleId><ArticleId IdType="pmc">PMC5999233</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0196113</ArticleId><ArticleId IdType="pii">PONE-D-17-37357</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhella D, Gallazzi M, et al. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol. 1999;26:1280&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10381043</ArticleId></ArticleIdList></Reference><Reference><Citation>Bultink IEM, Lems WF, Kostense PJ, Dijkmans B, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52:2044&#x2013;50. doi: 10.1002/art.21110
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21110</ArticleId><ArticleId IdType="pubmed">15986345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol. 1997;24:1922&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9330933</ArticleId></ArticleIdList></Reference><Reference><Citation>Almehed K, Hetenyi S, Ohlsson C, Carlsten H, Forsblad-d&#x2019;Elia H. Prevalence and risk factors of vertebral compression fractures in female SLE patients. Arthritis Res Ther. 2010;12:R153
doi: 10.1186/ar3104
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3104</ArticleId><ArticleId IdType="pmc">PMC2945052</ArticleId><ArticleId IdType="pubmed">20678217</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8607884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings SR, Black D. Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. Am J Med. 1995;98:24S&#x2013;28S.</Citation><ArticleIdList><ArticleId IdType="pubmed">7709929</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol. 2001;28:102&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11196509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza-Pinto C, Garc&#xed;a-Carrasco M, Sandoval-Cruz H, Esc&#xe1;rcega RO, Jim&#xe9;nez-Hern&#xe1;ndez M, Etchegaray-Morales I, et al. 
Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus. Clin Rheumatol. 2009;28:65&#x2013;70. doi: 10.1007/s10067-008-0984-z
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-008-0984-z</ArticleId><ArticleId IdType="pubmed">18670734</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, et al. 
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res. 2000;15:1384&#x2013;92. doi: 10.1359/jbmr.2000.15.7.1384
</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2000.15.7.1384</ArticleId><ArticleId IdType="pubmed">10893688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int. 2003;14:61&#x2013;8. doi: 10.1007/s00198-002-1316-9
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-002-1316-9</ArticleId><ArticleId IdType="pubmed">12577186</ArticleId></ArticleIdList></Reference><Reference><Citation>Li EK, Tam LS, Griffith JF, Zhu TY, Li TK, Li M, et al. 
High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol. 2009;36:1646&#x2013;52. doi: 10.3899/jrheum.081337
</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.081337</ArticleId><ArticleId IdType="pubmed">19605677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza-Pinto C, Garc&#xed;a-Carrasco M, Sandoval-Cruz H, Mu&#xf1;oz-Guarneros M, Esc&#xe1;rcega RO, Jim&#xe9;nez-Hern&#xe1;ndez M, et al. 
Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol. 2009;28:579&#x2013;85. doi: 10.1007/s10067-009-1105-3
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-009-1105-3</ArticleId><ArticleId IdType="pubmed">19224131</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Carrasco M, Mendoza-Pinto C, Leon-Vazquez M de la L, Mendez-Martinez S, Etchegaray-Morales I, Montiel-Jarquin A, et al. Incidence of Vertebral Fractures in Women with Systemic Lupus Erythematosus After 8 Years of Follow-Up. Calcif Tissue Int. 2017;</Citation><ArticleIdList><ArticleId IdType="pubmed">28508265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Yan S, Liu C, Xu Y, Wan L, Wang Y, et al. 
Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Osteoporos Int. 2016;1413&#x2013;23. doi: 10.1007/s00198-015-3449-7
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-015-3449-7</ArticleId><ArticleId IdType="pubmed">26753541</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman-Monte TC, Torrente-Segarra V, Vega-Vidal AL, Corzo P, Castro-Dominguez F, Ojeda F, et al. 
Bone mineral density and vitamin D status in systemic lupus erythematosus (SLE): A systematic review. Autoimmun Rev. Netherlands; 2017;16:1155&#x2013;9. doi: 10.1016/j.autrev.2017.09.011
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.09.011</ArticleId><ArticleId IdType="pubmed">28899800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaji H, Yamauchi M, Chihara K, Sugimoto T. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis. Endocr J. 2006;53:27&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">16543669</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535
doi: 10.1136/bmj.b2535
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Howick J, Chalmers I, Glasziou P, Greenhalgh T, C H, Liberati A, et al. &#x201c;The 2011 Oxford CEBM Levels of Evidence (Introductory Document)&#x201d; Oxford Cent: Evidence-Based Med.</Citation></Reference><Reference><Citation>Konstantopoulos S. Fixed effects and variance components estimation in three-level meta-analysis. Res Synth Methods. 2011;2:61&#x2013;76. doi: 10.1002/jrsm.35
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.35</ArticleId><ArticleId IdType="pubmed">26061600</ArticleId></ArticleIdList></Reference><Reference><Citation>V W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1&#x2013;48.</Citation></Reference><Reference><Citation>Chen CJ, Yen JH, Tsai WC, Lin MB, Hsu SC, Tsai JJ, et al. Decreased bone mineral density in premenopausal patients with systemic lupus erythematosus. Kaohsiung J Med Sci. 1996;12:567&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">8918077</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Ying SKY, To CH, Ma KM. Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study. Bone [Internet]. 2008;43:327&#x2013;31. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18515206
doi: 10.1016/j.bone.2008.04.003
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2008.04.003</ArticleId><ArticleId IdType="pubmed">18515206</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Wong SN, Ma KM. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus. Rheumatology. 2012;51:468&#x2013;75. doi: 10.1093/rheumatology/ker306
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ker306</ArticleId><ArticleId IdType="pubmed">22096013</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang XL, Griffith JF, Qin L, Hung VW, Kwok AW, Zhu TY, et al. 
SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength. Lupus. 2013;22:1162&#x2013;8. doi: 10.1177/0961203313498802
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313498802</ArticleId><ArticleId IdType="pubmed">23884986</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun YN, Feng XY, He L, Zeng LX, Hao ZM, Lv XH, et al. 
Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus. Biomed Res Int. United States; 2015;2015:510514
doi: 10.1155/2015/510514
</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/510514</ArticleId><ArticleId IdType="pmc">PMC4337055</ArticleId><ArticleId IdType="pubmed">25738154</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Fan P, Luo J, Wu S, Sun H, He L, et al. 
Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China. Lupus. England; 2017;26:289&#x2013;93. doi: 10.1177/0961203316664596
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316664596</ArticleId><ArticleId IdType="pubmed">27522093</ArticleId></ArticleIdList></Reference><Reference><Citation>Coimbra IB, Costallat LTL. Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset, plasmatic estradiol and immunosuppressive therapy. Joint Bone Spine. 2003;70:40&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12639616</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba VZC, Matos PG, da Silva Viana PR, Fernandes A, Sato EI, Lazaretti-Castro M. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus [Internet]. 2005;14:529&#x2013;33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16130509
doi: 10.1191/0961203305lu2154oa
</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203305lu2154oa</ArticleId><ArticleId IdType="pubmed">16130509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfa AC, Seguro LPC, Caparbo V, Bonfa E, Pereira RMR. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus. Osteoporos Int. 2015;26:1563&#x2013;71. doi: 10.1007/s00198-015-3029-x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-015-3029-x</ArticleId><ArticleId IdType="pubmed">25609157</ArticleId></ArticleIdList></Reference><Reference><Citation>Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis. 1995;54:274&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1005573</ArticleId><ArticleId IdType="pubmed">7763104</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons F, Peris P, Guanabens N, Font J, Huguet M, Espinosa G, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol. 1995;34:742&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7551659</ArticleId></ArticleIdList></Reference><Reference><Citation>Formiga F, Nolla JM, Mitjavila F, Bonnin R, Navarro MA, Moga I. Bone mineral density and hormonal status in men with systemic lupus erythematosus. Lupus. 1996;5:623&#x2013;6. doi: 10.1177/096120339600500612
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339600500612</ArticleId><ArticleId IdType="pubmed">9116708</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman-Monte TC, Torrente-Segarra V, Munoz-Ortego J, Mojal S, Carbonell-Abello J. Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region. Rheumatol Int. Germany; 2015;35:509&#x2013;15. doi: 10.1007/s00296-014-3087-y
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-014-3087-y</ArticleId><ArticleId IdType="pubmed">25030324</ArticleId></ArticleIdList></Reference><Reference><Citation>Alele JD, Kamen DL, Hunt KJ, Ramsey-Goldman R. Bone geometry profiles in women with and without SLE. J Bone Miner Res. 2011;26:2719&#x2013;26. doi: 10.1002/jbmr.466
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.466</ArticleId><ArticleId IdType="pmc">PMC4847947</ArticleId><ArticleId IdType="pubmed">21755534</ArticleId></ArticleIdList></Reference><Reference><Citation>Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int. 1999;18:137&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">10220833</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker A, Fischer R, Scherbaum WA, Schneider M. Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus. 2001;10:809&#x2013;14. doi: 10.1177/096120330101001108
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120330101001108</ArticleId><ArticleId IdType="pubmed">11789491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattoa HP, Kiss E, Bettembuk P, Balogh A. Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus. Rheumatol Int. 2001;21:97&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">11765229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattoa HP, Bettembuk P, Balogh A, Szegedi G, Kiss E. Bone mineral density in women with systemic lupus erythematosus. Clin Rheumatol. 2002;21:135&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">12086164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajeganova S, Gustafsson T, Jogestrand T, Frostegard J, Hafstrom I. Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study. Arthritis Res Ther. England; 2015;17:84
doi: 10.1186/s13075-015-0595-4
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0595-4</ArticleId><ArticleId IdType="pmc">PMC4407386</ArticleId><ArticleId IdType="pubmed">25885788</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhillon VB, Davies MC, Hall ML, Round JM, Ell PJ, Jacobs HS, et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. Ann Rheum Dis. 1990;49:624&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1004178</ArticleId><ArticleId IdType="pubmed">2396869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum. 1993;36:1726&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">8250992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen M, Halberg P, Kollerup G, Pedersen-Zbinden B, Horslev-Petersen K, Hyldstrup L, et al. Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. Scand J Rheumatol. 1998;27:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">9645415</ArticleId></ArticleIdList></Reference><Reference><Citation>Carli L, Tani C, Spera V, Vagelli R, Vagnani S, Mazzantini M, et al. 
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. Lupus Sci Med. England; 2016;3:e000098
doi: 10.1136/lupus-2015-000098
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2015-000098</ArticleId><ArticleId IdType="pmc">PMC4731833</ArticleId><ArticleId IdType="pubmed">26848397</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardinet D, Lef&#xe8;bvre C, Depresseux G, Lambert M, Devogelaer JP, Houssiau F. Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology (Oxford). 2000;39:389&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">10817771</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilboe IM, Kvien TK, Haugeberg G, Husby G. Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls. Ann Rheum Dis. 2000;59:110&#x2013;5. doi: 10.1136/ard.59.2.110
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.59.2.110</ArticleId><ArticleId IdType="pmc">PMC1753071</ArticleId><ArticleId IdType="pubmed">10666165</ArticleId></ArticleIdList></Reference><Reference><Citation>Redlich K, Ziegler S, Kiener HP, Spitzauer S, Stohlawetz P, Bernecker P, et al. 
Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59:308&#x2013;10. doi: 10.1136/ard.59.4.308
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.59.4.308</ArticleId><ArticleId IdType="pmc">PMC1753103</ArticleId><ArticleId IdType="pubmed">10733481</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyanov M, Robeva R, Popivanov P. Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol. 2003;22:318&#x2013;23. doi: 10.1007/s10067-003-0743-0
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-003-0743-0</ArticleId><ArticleId IdType="pubmed">14579164</ArticleId></ArticleIdList></Reference><Reference><Citation>Uaratanawong S, Deesomchoke U, Lertmaharit S, Uaratanawong S. Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol [Internet]. 2003;30:2365&#x2013;8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14677178
</Citation><ArticleIdList><ArticleId IdType="pubmed">14677178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak A, Lim JQ, Liu Y, Cheak AAC, Ho RCM. Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals. Rheumatol Int. 2013;33:299&#x2013;307. doi: 10.1007/s00296-012-2389-1
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-012-2389-1</ArticleId><ArticleId IdType="pubmed">22441963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J, Korswagen L-A, Schilder AM, van Tuyl LH, Dijkmans BAC, Lems WF, et al. 
Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int. 2013;24:1827&#x2013;33. doi: 10.1007/s00198-012-2157-9
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-012-2157-9</ArticleId><ArticleId IdType="pubmed">23052940</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa M, Kiyohara C, Horiuchi T, Tsukamoto H, Mitoma H, Kimoto Y, et al. 
Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus. Mod Rheumatol. 2013;23:765&#x2013;73. doi: 10.1007/s10165-012-0735-5
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10165-012-0735-5</ArticleId><ArticleId IdType="pubmed">22903260</ArticleId></ArticleIdList></Reference><Reference><Citation>Riggs BL, Melton LJ 3rd Iii, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, et al. 
Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004;19:1945&#x2013;54. doi: 10.1359/JBMR.040916
</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/JBMR.040916</ArticleId><ArticleId IdType="pubmed">15537436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bultink IEM, Lems WF. Systemic lupus erythematosus and fractures. RMD open [Internet]. 2015;1:e000069 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26557383%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4632145
doi: 10.1136/rmdopen-2015-000069
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2015-000069</ArticleId><ArticleId IdType="pmc">PMC4632145</ArticleId><ArticleId IdType="pubmed">26557383</ArticleId></ArticleIdList></Reference><Reference><Citation>Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, editors. Developing a Protocol for Observational Comparative Effectiveness Research: A User&#x2019;s Guide. Rockville (MD); 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">23469377</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102:274&#x2013;82. doi: 10.1172/JCI2799
</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI2799</ArticleId><ArticleId IdType="pmc">PMC508885</ArticleId><ArticleId IdType="pubmed">9664068</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res. 2001;16:97&#x2013;103. doi: 10.1359/jbmr.2001.16.1.97
</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2001.16.1.97</ArticleId><ArticleId IdType="pubmed">11149495</ArticleId></ArticleIdList></Reference><Reference><Citation>Akahoshi S, Sakai A, Arita S, Ikeda S, Morishita Y, Tsutsumi H, et al. 
Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs. J Bone Miner Metab. 2005;23:341&#x2013;50. doi: 10.1007/s00774-005-0611-x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-005-0611-x</ArticleId><ArticleId IdType="pubmed">16133683</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen S, Gudex C, Ahrberg F, Brixen K, Voss A. Bone geometry, volumetric bone mineral density, microarchitecture and estimated bone strength in Caucasian females with systemic lupus erythematosus. A cross-sectional study using HR-pQCT. Calcif Tissue Int. 2014;95:530&#x2013;9. doi: 10.1007/s00223-014-9918-8
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-014-9918-8</ArticleId><ArticleId IdType="pubmed">25326144</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang XL, Qin L, Kwok AW, Zhu TY, Kun EW, Hung VW, et al. 
Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: A case-control study using HR-pQCT. Osteoporos Int. 2013;24:1817&#x2013;26. doi: 10.1007/s00198-012-2177-5
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-012-2177-5</ArticleId><ArticleId IdType="pubmed">23104200</ArticleId></ArticleIdList></Reference><Reference><Citation>Li EK, Zhu TY, Tam LS, Hung VW, Griffith JF, Li TK, et al. 
Bone microarchitecture assessment by high-resolution peripheral quantitative computed tomography in patients with systemic lupus erythematosus taking corticosteroids. J Rheumatol. 2010;37:1473&#x2013;9. doi: 10.3899/jrheum.091231
</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.091231</ArticleId><ArticleId IdType="pubmed">20472932</ArticleId></ArticleIdList></Reference><Reference><Citation>Paupitz JA, Lima GL, Alvarenga JC, Oliveira RM, Bonfa E, Pereira RMR. Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus. Osteoporos Int. 2016;27:1839&#x2013;48. doi: 10.1007/s00198-015-3461-y
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-015-3461-y</ArticleId><ArticleId IdType="pubmed">26694597</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss RJ, Wick MC, Ackermann PW, Montgomery SM. Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases&#x2014;a case-control study with 53,108 patients with fracture. J Rheumatol. 2010;37:2247&#x2013;50. doi: 10.3899/jrheum.100363
</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.100363</ArticleId><ArticleId IdType="pubmed">20889599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekblom-Kullberg S, Kautiainen H, Alha P, Leirisalo-Repo M, Julkunen H. Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus. Scand J Rheumatol. 2013;42:390&#x2013;3. doi: 10.3109/03009742.2013.775331
</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009742.2013.775331</ArticleId><ArticleId IdType="pubmed">23721483</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone Density Threshold and Other Predictors of Vertebral Fracture in Patients Receiving Oral Glucocorticoid Therapy. Arthritis Rheum. 2003;48:3224&#x2013;9. doi: 10.1002/art.11283
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11283</ArticleId><ArticleId IdType="pubmed">14613287</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT GS (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Meta-regression chapter. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. 2011.</Citation></Reference><Reference><Citation>Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med. England; 2003;22:2113&#x2013;26. doi: 10.1002/sim.1461
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1461</ArticleId><ArticleId IdType="pubmed">12820277</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotondi MA, Donner A, Koval JJ. Evidence-based sample size estimation based upon an updated meta-regression analysis. Res Synth Methods. England; 2012;3:269&#x2013;84. doi: 10.1002/jrsm.1055
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1055</ArticleId><ArticleId IdType="pubmed">26053421</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidich AB. Meta-analysis in medical research. Hippokratia. Greece; 2010;14:29&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3049418</ArticleId><ArticleId IdType="pubmed">21487488</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31166234</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Association of Intraoperative Tidal Volumes and Acute Kidney Injury After Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>925</StartPage><EndPage>932</EndPage><MedlinePgn>925-932</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000004254</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with acute lung injury who received lower tidal volume (VT) ventilation had significantly fewer days with acute kidney injury (AKI) when compared to those receiving higher VTs. There is a paucity of studies on the relationship between intraoperative VTs and postoperative AKI in patients undergoing noncardiac surgery. We therefore sought to assess the association of mean delivered intraoperative VT per kilogram based on predicted body weight (PBW) and postoperative AKI.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study was conducted in a large tertiary multispecialty academic medical center. Adult patients who underwent noncardiac surgery between January 2005 and July 2016 under general anesthesia with endotracheal intubation and mechanical ventilation were included. A total of 41,224 patients were included in the study.The relationship between mean intraoperative VT per PBW and AKI was assessed using logistic regression, adjusting for prespecified potential confounding variables. The secondary outcomes were postoperative major pulmonary complications, myocardial injury after noncardiac surgery (MINS), and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">The incidence of AKI was 10.9% in the study population. Postoperative renal replacement therapy was required in 0.1% of patients. Higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of AKI. The estimated odds ratio for each 1 mL increase in VT per kilogram of PBW (1 unit) was 1.05 (95% confidence interval [CI], 1.02-1.08; P = .001), after adjusting for potential confounding variables. A higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of postoperative myocardial injury and was not significantly associated with major postoperative pulmonary complications or in-hospital mortality after noncardiac surgery.</AbstractText><AbstractText Label="CONCLUSIONS">In adult patients undergoing noncardiac surgery, higher delivered mean intraoperative VTs per PBW are associated with an increased odds of developing AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Argalious</LastName><ForeName>Maged Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesiology and the Center for Anesthesiology Education, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Guangmei</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Rajeev Krishnaney</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bhavani</LastName><ForeName>Sekar</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006335" MajorTopicYN="N">Heart Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="Y">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31166234</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000004254</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36228870</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Ventricular arrhythmias after fibroma resection: Are patients still at risk?</ArticleTitle><Pagination><StartPage>243</StartPage><EndPage>249</EndPage><MedlinePgn>243-249</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2022.10.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(22)02488-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Ventricular fibromas frequently present with life-threatening ventricular tachycardia (VT) or ventricular fibrillation (VF) in children. The long-term risk of sustained ventricular arrhythmias after surgical resection is unknown.</AbstractText><AbstractText Label="OBJECTIVES">The aims of this study were to quantify the VT/VF risk after surgical resection and to examine the results of early (during index surgical hospitalization) and late (&#x2265;3 months after surgery) postoperative ventricular stimulation (V-stim) studies.</AbstractText><AbstractText Label="METHODS">We performed a retrospective cohort study of all patients with ventricular fibromas who underwent surgical resection at our institution (2000-2020). The primary outcome was defined as recurrent VT/VF &#x2265;3 months after index surgical resection.</AbstractText><AbstractText Label="RESULTS">Forty-six patients with a median age at surgery of 2 years (range 0.3-18.9 years) formed our study cohort. Indications for surgery included cardiac arrest in 11 (24%), sustained VT in 16 (35%), premature ventricular contractions/nonsustained VT in 10 (22%), and hemodynamic abnormalities in 9 (20%). Of the 11 patients who presented with cardiac arrest, 4 underwent pre-resection implantable cardioverter-defibrillator (ICD) implantation, all of which were explanted at the time of surgery. An early postoperative V-stim study was performed in 26 (57%) patients, and all were negative for inducible VT/VF. Of the 13 late postoperative V-stim studies, 3 were positive: 2 underwent ICD implantation and 1 was initiated on amiodarone and underwent loop recorder implantation. At the time of last follow-up (median 1.5 years; range 0.3-16.5 years), 45 (98%) were free of clinical VT/VF and no patient with an ICD has received an appropriate shock.</AbstractText><AbstractText Label="CONCLUSION">Surgical resection of ventricular fibromas significantly reduces the risk of life-threatening arrhythmias in children; however, a small number of patients remain vulnerable.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Assaad</LastName><ForeName>Iqbal</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jurow</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dasgupta</LastName><ForeName>Soham</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Mark E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beroukhim</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Nido</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geva</LastName><ForeName>Tal</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Edward P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mah</LastName><ForeName>Douglas Y</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Leary</LastName><ForeName>Edward T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts. Electronic address: edward.oleary@cardio.chboston.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Heart Rhythm. 2023 Feb;20(2):250-251. doi: 10.1016/j.hrthm.2022.10.025.</RefSource><PMID Version="1">36336301</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiarrhythmic drug</Keyword><Keyword MajorTopicYN="N">Cardiac tumor</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Fibroma</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter-defibrillator</Keyword><Keyword MajorTopicYN="N">Programmed ventricular stimulation</Keyword><Keyword MajorTopicYN="N">Risk stratification</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmias</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>19</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36228870</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2022.10.003</ArticleId><ArticleId IdType="pii">S1547-5271(22)02488-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35006451</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis.</ArticleTitle><Pagination><StartPage>1313</StartPage><EndPage>1322</EndPage><MedlinePgn>1313-1322</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-021-06046-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study was conducted to investigate the prevalence of vertebral fracture (VF) and its risk in patients with rheumatoid arthritis (RA) as compared to healthy individuals, and to explore the underlying risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The electronic databases of PubMed, EMBASE, and the Cochrane Library were applied to search for the relevant literatures, which reported the prevalence of VF in both RA patients and healthy controls (up to Mar 31, 2021). The non-weighted prevalence of VF, pooled estimates of odds ratio (OR), and its 95% confidence intervals (CI) were calculated with the use of random-effects model; between-study heterogeneity was evaluated by Cochrane Q statistic, then was quantified with I<sup>2</sup>. Publication bias was evaluated using Egger's linear regression test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A number of 867 literatures were identified after searching for online databases, based on the inclusion and exclusion criteria, 11 eligible studies, which comprising 3805 RA patients and 59,517 healthy participants, were finally incorporated in meta-analysis. The results showed that RA patients had an increased prevalence of VF (20.29 vs 8.63%), and an elevated risk for VF (OR&#x2009;=&#x2009;3.04, 95% CI 1.97-4.71) as compared to healthy population. Additional subgroup analysis suggested that age, body mass index (BMI), disease activity, and drug therapy might be associated with risk of VF in RA.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Overall, our study demonstrated an increased risk of VF in patients with RA, suggesting that age, race, BMI, disease activity, and drug therapy may be represented as risk factors contributing to the occurrence of VF in RA. Key Points &#x2022; RA patients had the increased prevalence and risk of vertebral fracture (VF) as compared to healthy population. &#x2022; Age, race, BMI, disease activity, and drug therapy might be associated with VF in RA. &#x2022; Our findings would be helpful for the early evaluation of RA patients with high VF risk.</AbstractText><CopyrightInformation>&#xa9; 2022. International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The First Department of Orthopedics, Xinyu People's Hospital, 369 Xinxin Bei Road, Xinyu, 338000, Jiangxi, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jiang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Xigang District, Dalian, Liaoning, 116011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Minmin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The First Department of Orthopedics, Xinyu People's Hospital, 369 Xinxin Bei Road, Xinyu, 338000, Jiangxi, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiaohong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Xigang District, Dalian, Liaoning, 116011, People's Republic of China. 1206387866@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Kailong</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5178-9940</Identifier><AffiliationInfo><Affiliation>The First Department of Orthopedics, Xinyu People's Hospital, 369 Xinxin Bei Road, Xinyu, 338000, Jiangxi, People's Republic of China. 149101592@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bone fracture</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">RA</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>10</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35006451</ArticleId><ArticleId IdType="doi">10.1007/s10067-021-06046-2</ArticleId><ArticleId IdType="pii">10.1007/s10067-021-06046-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singh JA, Saag KG, Bridges SL Jr et al (2016) 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol 68(1):1&#x2013;26. https://doi.org/10.1002/art.39480</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39480</ArticleId><ArticleId IdType="pubmed">26545940</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroot EJ, Nieuwenhuizen MG, de Waal Malefijt MC et al (2001) Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum 44(6):1254&#x2013;1260. https://doi.org/10.1002/1529-0131(200106)44:6%3c1254::AID-ART216%3e3.0.CO;2-G</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200106)44:6&lt;1254::AID-ART216&gt;3.0.CO;2-G</ArticleId><ArticleId IdType="pubmed">11407683</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudan I, Sidhu S, Papana A et al (2015) Prevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysis. J Glob Health 5(1):010409. https://doi.org/10.7189/jogh.05.010409</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.05.010409</ArticleId><ArticleId IdType="pubmed">25969732</ArticleId><ArticleId IdType="pmc">4416333</ArticleId></ArticleIdList></Reference><Reference><Citation>Usenbo A, Kramer V, Young T et al (2015) Prevalence of arthritis in Africa: a systematic review and meta-analysis. PLoS ONE 10(8):e0133858. https://doi.org/10.1371/journal.pone.0133858</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0133858</ArticleId><ArticleId IdType="pubmed">26241756</ArticleId><ArticleId IdType="pmc">4524637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochi Y (2010) Genetic background of tolerance breakdown in rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi 33(2):48&#x2013;56. https://doi.org/10.2177/jsci.33.48</Citation><ArticleIdList><ArticleId IdType="doi">10.2177/jsci.33.48</ArticleId><ArticleId IdType="pubmed">20453439</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpizar-Rodriguez D, Finckh A (2017) Environmental factors and hormones in the development of rheumatoid arthritis. Semin Immunopathol 39(4):461&#x2013;468. https://doi.org/10.1007/s00281-017-0624-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0624-2</ArticleId><ArticleId IdType="pubmed">28451785</ArticleId></ArticleIdList></Reference><Reference><Citation>Deodhar AA, Woolf AD (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35(4):309&#x2013;322. https://doi.org/10.1093/rheumatology/35.4.309</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/35.4.309</ArticleId><ArticleId IdType="pubmed">8624634</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue AL, Wu SY, Jiang L et al (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) 96(36):e6983. https://doi.org/10.1097/MD.0000000000006983</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000006983</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux C (2011) Osteoporosis in inflammatory joint diseases. Osteoporos Int 22(2):421&#x2013;433. https://doi.org/10.1007/s00198-010-1319-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-010-1319-x</ArticleId><ArticleId IdType="pubmed">20552328</ArticleId></ArticleIdList></Reference><Reference><Citation>Vosse D, de Vlam K (2009) Osteoporosis in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 27(4 Suppl 55):S62&#x2013;S67</Citation><ArticleIdList><ArticleId IdType="pubmed">19822048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazi M, Kolta S, Briot K et al (2012) Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int 23(2):581&#x2013;587. https://doi.org/10.1007/s00198-011-1584-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-011-1584-3</ArticleId><ArticleId IdType="pubmed">21350894</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa TP, Geusens P, Bijlsma JW et al (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104&#x2013;3112. https://doi.org/10.1002/art.22117</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22117</ArticleId><ArticleId IdType="pubmed">17009229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong JJ, Xu SQ, Zong HX et al (2020) Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis. Clin Rheumatol 39(2):357&#x2013;364. https://doi.org/10.1007/s10067-019-04787-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-019-04787-9</ArticleId><ArticleId IdType="pubmed">31691041</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai K, Hanyu T, Sugitani H et al (2006) Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. J Bone Miner Metab 24(2):118&#x2013;124. https://doi.org/10.1007/s00774-005-0657-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-005-0657-9</ArticleId><ArticleId IdType="pubmed">16502118</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006&#x2013;1012. https://doi.org/10.1016/j.jclinepi.2009.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.005</ArticleId><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert K, Pages C, Ledru A et al (2005) Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience 133(4):925&#x2013;935. https://doi.org/10.1016/j.neuroscience.2005.03.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2005.03.034</ArticleId><ArticleId IdType="pubmed">15916860</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539&#x2013;1558. https://doi.org/10.1002/sim.1186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557&#x2013;560</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629&#x2013;634</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gua&#xf1;abens N, Olmos JM, Hernandez JL et al (2021) Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study. Osteoporos Int 32(7):1333&#x2013;1342. https://doi.org/10.1007/s00198-021-05824-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-021-05824-7</ArticleId><ArticleId IdType="pubmed">33459805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YF, Zong HX, Xu SQ et al (2021) Synergistic effect of sarcopenia and poor balance on osteoporotic vertebral fracture in Chinese patients with rheumatoid arthritis. Clin Rheumatol. https://doi.org/10.1007/s10067-021-05703-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05703-w</ArticleId><ArticleId IdType="pubmed">34767108</ArticleId><ArticleId IdType="pmc">8873115</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierini FS, Brom M, Scolnik M et al (2021) Osteoporotic fractures in rheumatoid arthritis patients in Argentina: a matched retrospective cohort study. Adv Rheumatol 61(1):21. https://doi.org/10.1186/s42358-021-00179-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-021-00179-3</ArticleId><ArticleId IdType="pubmed">33827708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HA, Lee HY, Jung JY et al (2020) Trabecular bone score is a useful parameter for the prediction of vertebral fractures in patients with polymyalgia rheumatica. J Clin Densitom 23(3):373&#x2013;380. https://doi.org/10.1016/j.jocd.2019.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2019.05.006</ArticleId><ArticleId IdType="pubmed">31174962</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauny M, Albuisson E, Bauer E et al (2019) Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls. Sci Rep 9(1):13323. https://doi.org/10.1038/s41598-019-49712-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49712-x</ArticleId><ArticleId IdType="pubmed">31527613</ArticleId><ArticleId IdType="pmc">6746735</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano T, Inui K, Tada M et al (2017) High frequency of vertebral fracture and low bone quality in patients with rheumatoid arthritis-Results from TOMORROW study. Mod Rheumatol 27(3):398&#x2013;404. https://doi.org/10.1080/14397595.2016.1213943</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14397595.2016.1213943</ArticleId><ArticleId IdType="pubmed">27484855</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Xu S, Ma X et al (2014) Exploration of risk factors on the occurrence of osteoporotic vertebral fracture in patients with rheumatoid arthritis. Zhonghua Nei Ke Za Zhi 53(11):852&#x2013;857</Citation><ArticleIdList><ArticleId IdType="pubmed">25586354</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan SL, Toomey L, Kotowicz MA et al (2014) Rheumatoid arthritis and incident fracture in women: a case-control study. BMC Musculoskelet Disord 15:13. https://doi.org/10.1186/1471-2474-15-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-15-13</ArticleId><ArticleId IdType="pubmed">24405804</ArticleId><ArticleId IdType="pmc">3893404</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma S, Delgado-Rodriguez M (2005) Assessment of publication bias in meta-analyses of cardiovascular diseases. J Epidemiol Community Health 59(10):864&#x2013;9. 59/10/864 [pii] https://doi.org/10.1136/jech.2005.033027</Citation></Reference><Reference><Citation>Goldring SR (2015) Inflammatory signaling induced bone loss. Bone 80:143&#x2013;149. https://doi.org/10.1016/j.bone.2015.05.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2015.05.024</ArticleId><ArticleId IdType="pubmed">26027506</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinlen L, Humphrey MB (2017) Skeletal complications of rheumatoid arthritis. Osteoporos Int 28(10):2801&#x2013;2812. https://doi.org/10.1007/s00198-017-4170-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-017-4170-5</ArticleId><ArticleId IdType="pubmed">28779302</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S, Hsieh E, Peng L et al (2018) Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int 29(6):1263&#x2013;1275. https://doi.org/10.1007/s00198-018-4473-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-018-4473-1</ArticleId><ArticleId IdType="pubmed">29546507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursum J, Britsemmer K, van Schaardenburg D et al (2009) High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis. Ann Rheum Dis 68(9):1512&#x2013;1513. https://doi.org/10.1136/ard.2008.105957</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2008.105957</ArticleId><ArticleId IdType="pubmed">19674990</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien CA, Jia D, Plotkin LI et al (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145(4):1835&#x2013;1841. https://doi.org/10.1210/en.2003-0990</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2003-0990</ArticleId><ArticleId IdType="pubmed">14691012</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparks JA (2019) Rheumatoid arthritis. Ann Intern Med 170(1):ITC1&#x2013;ITC16. https://doi.org/10.7326/AITC201901010</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC201901010</ArticleId><ArticleId IdType="pubmed">30596879</ArticleId></ArticleIdList></Reference><Reference><Citation>di Munno O, Mazzantini M, Sinigaglia L et al (2004) Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study. J Rheumatol 31(7):1305&#x2013;1309</Citation><ArticleIdList><ArticleId IdType="pubmed">15229948</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley LM, Leib ES, Cartularo KS et al (1997) Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 24(8):1489&#x2013;1494</Citation><ArticleIdList><ArticleId IdType="pubmed">9263140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bologna C, Edno L, Anaya JM et al (1994) Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients. Arthritis Rheum 37(12):1770&#x2013;1773. https://doi.org/10.1002/art.1780371210</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780371210</ArticleId><ArticleId IdType="pubmed">7986223</ArticleId></ArticleIdList></Reference><Reference><Citation>May KP, West SG, McDermott MT et al (1994) The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 37(2):201&#x2013;206. https://doi.org/10.1002/art.1780370208</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780370208</ArticleId><ArticleId IdType="pubmed">8129775</ArticleId></ArticleIdList></Reference><Reference><Citation>Westhovens R, Dequeker J (2000) Rheumatoid arthritis and osteoporosis. Z Rheumatol 59(Suppl 1):33&#x2013;38. https://doi.org/10.1007/s003930070036</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s003930070036</ArticleId><ArticleId IdType="pubmed">10769433</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon OC, Oh JS, Hong S et al (2019) Conventional synthetic disease-modifying antirheumatic drugs and bone mineral density in rheumatoid arthritis patients with osteoporosis: possible beneficial effect of leflunomide. Clin Exp Rheumatol 37(5):813&#x2013;819</Citation><ArticleIdList><ArticleId IdType="pubmed">30767868</ArticleId></ArticleIdList></Reference><Reference><Citation>Vis M, Wolbink GJ, Lodder MC et al (2003) Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. Arthritis Rheum 48(10):2996&#x2013;2997. https://doi.org/10.1002/art.11292</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11292</ArticleId><ArticleId IdType="pubmed">14558111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerbini CAF, Clark P, Mendez-Sanchez L et al (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28(2):429&#x2013;446. https://doi.org/10.1007/s00198-016-3769-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-016-3769-2</ArticleId><ArticleId IdType="pubmed">27796445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozen G, Pedro S, Wolfe F et al (2019) Medications associated with fracture risk in patients with rheumatoid arthritis. Ann Rheum Dis 78(8):1041&#x2013;1047. https://doi.org/10.1136/annrheumdis-2019-215328</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215328</ArticleId><ArticleId IdType="pubmed">31092411</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulson KA, Reed G, Gilliam BE et al (2009) Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol 15(4):155&#x2013;160. https://doi.org/10.1097/RHU.0b013e3181a5679d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0b013e3181a5679d</ArticleId><ArticleId IdType="pubmed">19363452</ArticleId></ArticleIdList></Reference><Reference><Citation>Malysheva K, de Rooij K, Lowik CW et al (2016) Interleukin 6/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts. Croat Med J 57(2):89&#x2013;98. https://doi.org/10.3325/cmj.2016.57.89</Citation><ArticleIdList><ArticleId IdType="doi">10.3325/cmj.2016.57.89</ArticleId><ArticleId IdType="pubmed">27106351</ArticleId><ArticleId IdType="pmc">4856197</ArticleId></ArticleIdList></Reference><Reference><Citation>Briot K, Rouanet S, Schaeverbeke T et al (2015) The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis. Joint Bone Spine 82(2):109&#x2013;115. https://doi.org/10.1016/j.jbspin.2014.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2014.10.015</ArticleId><ArticleId IdType="pubmed">25557658</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Shakra M, Zisman D, Balbir-Gurman A et al (2018) Effect of tocilizumab on fatigue and bone mineral density in patients with rheumatoid arthritis. Isr Med Assoc J 20(4):239&#x2013;244</Citation><ArticleIdList><ArticleId IdType="pubmed">29629732</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YM, Chen HH, Huang WN et al (2017) Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. PLoS ONE 12(11):e0188454. https://doi.org/10.1371/journal.pone.0188454</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0188454</ArticleId><ArticleId IdType="pubmed">29155868</ArticleId><ArticleId IdType="pmc">5695761</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami K, Kobayashi Y, Uehara S et al (2017) A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro. PLoS ONE 12(7):e0181126. https://doi.org/10.1371/journal.pone.0181126</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0181126</ArticleId><ArticleId IdType="pubmed">28708884</ArticleId><ArticleId IdType="pmc">5510865</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38714837</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5454</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>14</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Eye (London, England)</Title><ISOAbbreviation>Eye (Lond)</ISOAbbreviation></Journal><ArticleTitle>Assessing the value of the water drinking test in glaucoma-a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2688</StartPage><EndPage>2700</EndPage><MedlinePgn>2688-2700</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41433-024-03107-z</ELocationID><Abstract><AbstractText>This systematic review and meta-analysis examines the relationship between intraocular pressure (IOP) parameters derived from the water drinking test (WDT) and diurnal IOP monitoring, and evaluates the reproducibility of the WDT and its association with future glaucomatous visual field (VF) loss. A literature search was performed on PubMed, EMBASE, and Cochrane Library from inception to 31 March 2023. Cohort, cross-sectional and observational studies reporting WDT results in glaucoma patients were included. Meta analysis with random-effect model was performed using "metafor" package in R version 3.2.1. 641 studies were identified on initial literature search. 38 studies (2479 subjects) were included in final analysis. Meta-analytic estimates of 5 studies (310 subjects) found strong positive correlation in peak IOP between the WDT and diurnal IOP monitoring (r&#x2009;=&#x2009;0.92, 95% CI&#x2009;=&#x2009;0.75, 1.08, p&#x2009;&lt;&#x2009;0.0001). However, there was only weak positive correlation for IOP fluctuation between both methods (r&#x2009;=&#x2009;0.26, 95% CI&#x2009;=&#x2009;0.06,0.47, p&#x2009;&lt;&#x2009;0.0001). Meta-analytic estimates of 3 studies (189 subjects) suggested a trend of the diurnal peak IOP being lower than that derived from the WDT (MD&#x2009;=&#x2009;-2.37&#x2009;mmHg, 95% Limit of Agreement (LOA) =-5.58,0.84, p&#x2009;=&#x2009;0.147). Two studies found that a higher WDT peak IOP was associated with greater future VF progression. Two studies demonstrated good reproducibility in peak IOP measurements for WDTs conducted across different days. In conclusion, there was a strong positive correlation between IOP peak measurements from the WDT and diurnal IOP monitoring in glaucoma patients. The WDT peak IOP demonstrated good reproducibility and may be associated with greater future VF progression.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0003-5360-7658</Identifier><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goh</LastName><ForeName>Claire Xin Yi</ForeName><Initials>CXY</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betzler</LastName><ForeName>Bjorn Kaijun</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0002-4843-7514</Identifier><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heng</LastName><ForeName>Choon Pooh</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Clinical Research and Innovation Office, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ang</LastName><ForeName>Bryan Chin Hou</ForeName><Initials>BCH</Initials><Identifier Source="ORCID">0000-0001-8256-4894</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Tan Tock Seng Hospital, National Healthcare Group Eye Institute, Singapore, Singapore. drbryanang@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Woodlands Health, National Healthcare Group Eye Institute, Singapore, Singapore. drbryanang@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic, Department of Ophthalmology, Jacksonville, FL, USA. drbryanang@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eye (Lond)</MedlineTA><NlmUniqueID>8703986</NlmUniqueID><ISSNLinking>0950-222X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>059QF0KO0R</RegistryNumber><NameOfSubstance UI="D014867">Water</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004326" MajorTopicYN="Y">Drinking</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005901" MajorTopicYN="Y">Glaucoma</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="Y">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014065" MajorTopicYN="N">Tonometry, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="Y">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014867" MajorTopicYN="N">Water</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>&#x6458;&#x8981;: &#x672c;&#x7cfb;&#x7edf;&#x7efc;&#x8ff0;&#x548c;&#x835f;&#x8403;&#x5206;&#x6790;&#x4e86;&#x996e;&#x6c34;&#x5b9e;&#x9a8c; (WDT) &#x548c;&#x663c;&#x591c;&#x773c;&#x5185;&#x538b; (IOP) &#x53c2;&#x6570;&#x4e4b;&#x95f4;&#x7684;&#x5173;&#x7cfb;, &#x5e76;&#x4e14;&#x8bc4;&#x4f30;&#x4e86;&#x996e;&#x6c34;&#x5b9e;&#x9a8c;&#x7684;&#x53ef;&#x91cd;&#x590d;&#x6027;&#x53ca;&#x5176;&#x4e0e;&#x672a;&#x6765;&#x9752;&#x5149;&#x773c;&#x89c6;&#x91ce; (VF) &#x7f3a;&#x635f;&#x7684;&#x8054;&#x7cfb;&#x3002;&#x6211;&#x4eec;&#x5bf9;&#x622a;&#x6b62;&#x81f3;2023&#x5e74;3&#x6708;31&#x65e5;, &#x5728;PubMed&#x3001;EMBASE&#x548c;Cochrane&#x7b49;&#x6570;&#x636e;&#x5e93;&#x8fdb;&#x884c;&#x4e86;&#x6587;&#x732e;&#x68c0;&#x7d22;&#x3002;&#x7814;&#x7a76;&#x7eb3;&#x5165;&#x4e86;&#x62a5;&#x544a;&#x9752;&#x5149;&#x773c;&#x60a3;&#x8005;WDT&#x7ed3;&#x679c;&#x7684;&#x961f;&#x5217;&#x3001;&#x6a2a;&#x65ad;&#x9762;&#x548c;&#x89c2;&#x5bdf;&#x6027;&#x7814;&#x7a76;&#x3002;&#x4f7f;&#x7528;R&#x7248;&#x672c;3.2.1&#x4e2d;&#x7684;&#x201c;meta for&#x201d;&#x8f6f;&#x4ef6;&#x5305;&#x8fdb;&#x884c;&#x968f;&#x673a;&#x6548;&#x5e94;&#x6a21;&#x578b;&#x7684;&#x835f;&#x8403;&#x5206;&#x6790;&#x3002;&#x521d;&#x6b65;&#x6587;&#x732e;&#x68c0;&#x7d22;&#x5171;641&#x9879;&#x7814;&#x7a76;&#x3002;&#x7814;&#x7a76;&#x6700;&#x7ec8;&#x7eb3;&#x5165;&#x4e86;38&#x9879;&#x7814;&#x7a76; (2479&#x4f8b;&#x53d7;&#x8bd5;&#x8005;) &#x3002;5&#x9879;&#x7814;&#x7a76; (310&#x4f8b;&#x53d7;&#x8bd5;&#x8005;) &#x7684;&#x835f;&#x8403;&#x5206;&#x6790;&#x53d1;&#x73b0;, WDT&#x548c;&#x663c;&#x591c;IOP&#x76d1;&#x6d4b;&#x4e4b;&#x95f4;&#x7684;&#x5cf0;&#x503c;IOP&#x5b58;&#x5728;&#x5f88;&#x5f3a;&#x7684;&#x6b63;&#x76f8;&#x5173;&#x6027; (r&#x2009;=&#x2009;0.92, 95%CI&#x2009;=&#x2009;0.75, 1.08, p&#x2009;&lt;&#x2009;0.0001) &#x3002;&#x7136;&#x800c;, &#x4e24;&#x79cd;&#x65b9;&#x6cd5;&#x6d4b;&#x91cf;&#x7684;&#x773c;&#x538b;&#x6ce2;&#x52a8;&#x4ec5;&#x5448;&#x5fae;&#x5f31;&#x7684;&#x6b63;&#x76f8;&#x5173; (r&#x2009;=&#x2009;0.26, 95% CI&#x2009;=&#x2009;0.06, 0.47, p&#x2009;&lt;&#x2009;0.0001) &#x3002;3&#x9879;&#x7814;&#x7a76; (189&#x4f8b;&#x53d7;&#x8bd5;&#x8005;) &#x7684;Meta&#x5206;&#x6790;&#x8868;&#x660e;, &#x663c;&#x591c;&#x5cf0;&#x503c;IOP&#x6709;&#x4f4e;&#x4e8e;WDT&#x5f97;&#x51fa;&#x7684;&#x503c;&#x7684;&#x8d8b;&#x52bf; (MD&#x2009;=&#x2009;&#x2212;2.37&#x2009;mmHg, 95%&#x4e00;&#x81f4;&#x6027;&#x9650;&#x503c; (LOA) =&#x2212;5.58, 0.84, p&#x2009;=&#x2009;0.147) &#x3002;&#x4e24;&#x9879;&#x7814;&#x7a76;&#x53d1;&#x73b0;, &#x66f4;&#x9ad8;&#x7684;WDT&#x5cf0;&#x503c;IOP&#x4e0e;&#x66f4;&#x4e25;&#x91cd;&#x7684;&#x672a;&#x6765;&#x89c6;&#x91ce;&#x7f3a;&#x635f;&#x8fdb;&#x5c55;&#x6709;&#x5173;&#x3002;&#x4e24;&#x9879;&#x7814;&#x7a76;&#x8bc1;&#x660e;, &#x5728;&#x4e0d;&#x540c;&#x65e5;&#x671f;&#x8fdb;&#x884c;&#x7684;WDT&#x7684;&#x5cf0;&#x503c;IOP &#x6d4b;&#x91cf;&#x5177;&#x6709;&#x826f;&#x597d;&#x7684;&#x53ef;&#x91cd;&#x590d;&#x6027;&#x3002;&#x603b;&#x4e4b;, &#x5728;&#x9752;&#x5149;&#x773c;&#x60a3;&#x8005;&#x4e2d;, WDT&#x7684;IOP&#x5cf0;&#x503c;&#x6d4b;&#x91cf;&#x503c;&#x4e0e;&#x663c;&#x591c;IOP&#x76d1;&#x6d4b;&#x503c;&#x4e4b;&#x95f4;&#x5b58;&#x5728;&#x5f3a;&#x6b63;&#x76f8;&#x5173;&#x6027;&#x3002;WDT&#x5cf0;&#x503c;IOP&#x8868;&#x73b0;&#x51fa;&#x826f;&#x597d;&#x7684;&#x91cd;&#x73b0;&#x6027;, &#x53ef;&#x80fd;&#x4e0e;&#x672a;&#x6765;&#x66f4;&#x5927;&#x7684;VF&#x8fdb;&#x5c55;&#x76f8;&#x5173;&#x3002;.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.</CopyrightInformation></OtherAbstract><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>2</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>7</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38714837</ArticleId><ArticleId IdType="pmc">PMC11427712</ArticleId><ArticleId IdType="doi">10.1038/s41433-024-03107-z</ArticleId><ArticleId IdType="pii">10.1038/s41433-024-03107-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thomas S, Hodge W, Malvankar-Mehta M. The cost-effectiveness analysis of teleglaucoma screening device Bhattacharya S (ed). PLOS ONE. 2015;10:e0137913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4575061</ArticleId><ArticleId IdType="pubmed">26382956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121:2081&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">24974815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan MB, Mansberger SL, Lee PP. Understanding the importance of IOP variables in glaucoma: a systematic review. Surv Ophthalmol. 2009;54:643&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">19665744</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Zhang X, Chen Z, Wei Y, Ye Q, Fan Y, et al. Intraocular pressure and diurnal fluctuation of open-angle glaucoma and ocular hypertension: a baseline report from the LiGHT China trial cohort. Br J Ophthalmol. 2023;107:823&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10314016</ArticleId><ArticleId IdType="pubmed">35086806</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonas JB, Budde WM, Stroux A, Oberacher-Velten IM, J&#xfc;nemann A. Diurnal intraocular pressure profiles and progression of chronic open-angle glaucoma. Eye. 2007;21:948&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">16601737</ArticleId></ArticleIdList></Reference><Reference><Citation>Susanna R, Clement C, Goldberg I, Hatanaka M. Applications of the water drinking test in glaucoma management: water drinking test and glaucoma. Clin Exp Ophthalmol. 2017;45:625&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">28164419</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xf8;rskov K. the water provocative test. Acta Ophthalmol (Copenh). 2009;45:57&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">6072234</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo PY, Cheng TC, Md Din N. Water drinking test in glaucoma management: a review of the literature. Malays J Ophthalmol. 2022;4:252&#x2013;61.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawascale(NOS) for assessing the quality of non randomised studies in meta-analysis. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Rupinski MT, Dunlap WP. Approximating pearson product-moment correlations from Kendall&#x2019;s Tau and Spearman&#x2019;s Rho. Educ Psychol Meas. 1996;56:419&#x2013;29.</Citation></Reference><Reference><Citation>Welz T, Doebler P, Pauly M. Fisher transformation based confidence intervals of correlations in fixed&#x2010; and random&#x2010;effects meta&#x2010;analysis. Br J Math Stat Psychol. 2022;75:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">33934346</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaka MM. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J J Med Assoc Malawi. 2012;24:69&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3576830</ArticleId><ArticleId IdType="pubmed">23638278</ArticleId></ArticleIdList></Reference><Reference><Citation>Joosten A, Desebbe O, Suehiro K, Murphy LS-L, Essiet M, Alexander B, et al. Accuracy and precision of non-invasive cardiac output monitoring devices in perioperative medicine: a systematic review and meta-analysis. Br J Anaesth. 2017;118:298&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">28203792</ArticleId></ArticleIdList></Reference><Reference><Citation>Beheshti A, Chavanon M-L, Christiansen H. Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis. BMC Psychiatry. 2020;20:120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7069054</ArticleId><ArticleId IdType="pubmed">32164655</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolela Susanna C, Nicolela Susanna B, Nicolela Susanna F, Susanna Jr R Peak Intraocular Pressure Time during Water Drinking Test and Its Relationship with Glaucoma Severity. J. Ophthalmic Vis. Res. Available at: https://knepublishing.com/index.php/JOVR/article/view/10167 [Accessed June 17, 2023] (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8850851</ArticleId><ArticleId IdType="pubmed">35194493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadambi S, Balekudaru S, Lingam V, George R. Comparison of intraocular pressure variability detected by day diurnal variation to that evoked by water drinking. Indian J Ophthalmol. 2021;69:1414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302309</ArticleId><ArticleId IdType="pubmed">34011711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozyol P, &#xd6;zyol E, Baldemir E. Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test. Clin Ophthalmol. 2016; 10:1351&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969041</ArticleId><ArticleId IdType="pubmed">27555742</ArticleId></ArticleIdList></Reference><Reference><Citation>Razeghinejad MR, Tajbakhsh Z, Nowroozzadeh MH, Havens SJ, Ghate D, Gulati V. The water-drinking test revisited: an analysis of test results in subjects with glaucoma. Semin Ophthalmol 2018;33:517&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5701879</ArticleId><ArticleId IdType="pubmed">28537521</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida, Scoralick ALB I, Dias DT, Ushida M, Dorairaj S, Gracitelli CP, et al. Comparison between provocative test-based and long-term intraocular pressure parameters in patients with stable open-angle glaucoma. Eur J Ophthalmol. 2021;31:453&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32162542</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zyol E, &#xd6;zyol P, Karalezli A. Reproducibility of the water-drinking test in patients with exfoliation syndrome and exfoliative glaucoma. Acta Ophthalmol (Copenh). 2016;94:e795&#x2013;e798.</Citation><ArticleIdList><ArticleId IdType="pubmed">27316559</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasconcelos-Moraes CG, Susanna R. Correlation between the water drinking test and modified diurnal tension curve in untreated glaucomatous eyes. Clinics. 2008;63:433&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2664116</ArticleId><ArticleId IdType="pubmed">18719751</ArticleId></ArticleIdList></Reference><Reference><Citation>Susanna R, Hatanaka M, Vessani RM, Pinheiro A, Morita C. Correlation of asymmetric glaucomatous visual field damage and water-drinking test response. Investig Opthalmology Vis Sci. 2006;47:641.</Citation><ArticleIdList><ArticleId IdType="pubmed">16431962</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetrugno M, Sisto D, Trabucco T, Balducci F, Noci ND, Sborgia C. Water-drinking test in patients with primary open-angle glaucoma while treated with different topical medications. J Ocul Pharmacol Ther. 2005;21:250&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15969643</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez P, Trubnik V, Leiby BE, Hegarty SE, Razeghinejad R, Savant S, et al. A comparative study of the water drinking test in eyes with open-angle glaucoma and prior trabeculectomy or tube shunt. J Glaucoma. 2017;26:119&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">27875485</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina FMC, Rodrigues FKP, Pierre Filho PDTP, Matsuo T, Vasconcellos JPCD, Costa VP. Reproducibility of water drinking test performed at different times of the day. Arq Bras Oftalmol. 2009;72:283&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">19668954</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C-H, Lu D-W, Chang C-J, Chiang C-H, Chou P-I. The application of water drinking test on the evaluation of trabeculectomy patency. J Ocul Pharmacol Ther. 2000;16:37&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">10673129</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh-Meyer HV, Papchenko T, Tan Y, Gamble GD. Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test. Ophthalmology. 2008;115:1566&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">18321584</ArticleId></ArticleIdList></Reference><Reference><Citation>Germano RAS, Hatanaka M, Garcia AS, Germano FAS, Germano CS, Cid FB, et al. Compara&#xe7;&#xe3;o do efeito hipotensor entre latanoprosta versus trabeculoplastia seletiva a laser obtida com teste de sobrecarga h&#xed;drica. Arq. Bras. Oftalmol. 84. Available at: https://aboonline.org.br/details/6085/en-US/comparison-of-the-hypotensor-effect-between-latanoprost-versus-selective-laser-trabeculoplasty-obtained-with-the-water-drinking-test [Accessed July 1, 2023] (2021).</Citation></Reference><Reference><Citation>Mansouri K, Orguel S, Mermoud A, Haefliger I, Flammer J, Ravinet E, et al. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial. Br J Ophthalmol. 2008;92:332&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18211927</ArticleId></ArticleIdList></Reference><Reference><Citation>Louren&#xe7;o AS, Ara&#xfa;jo CCQD, Santos PMD, Prata TS, Lopes NLV, Santos RCRD, et al. Assessment of short-term intraocular pressure parameters in phakic and pseudophakic patients with primary open-angle glaucoma. Arq. Bras. Oftalmol. 2021; 84: 425-9. Available at: 10.5935/0004-2749.20210066 [Accessed June 17, 2023].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11878431</ArticleId><ArticleId IdType="pubmed">34320100</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H, Zhang Y, Han Y-P, Cheng Y, Li C-Y, Li C. Clinical features and correlation analysis of the 24h intraocular pressure and water drinking test in patients with primary open angle glaucoma and ocular hypertension. Int J Ophthalmol. 2023;12:278&#x2013;82.</Citation></Reference><Reference><Citation>Phu J, Masselos K, Kalloniatis M. Deployment of the water drinking test and iCare HOME phasing for intraocular pressure profiling in glaucoma evaluation. Optom Vis Sci. 2021;98:1321&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">34538849</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moraes CG, Susanna R, Sakata LM, Hatanaka M. Predictive value of the water drinking test and the risk of glaucomatous visual field progression. J Glaucoma. 2017;26:767&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">28731935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatanaka M, Sakata LM, Susanna R, Nascimento LTF, Vessani RM. Comparison of the intraocular pressure variation provoked by postural change and by the water drinking test in primary open-angle glaucoma and normal patients. J Glaucoma 2016;25:914&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27552503</ArticleId></ArticleIdList></Reference><Reference><Citation>Caiado RR, Badar&#xf3; E, Kasahara N. Intraocular pressure fluctuation in healthy and glaucomatous eyes: a comparative analysis between diurnal curves in supine and sitting positions and the water drinking test. Arq Bras Oftalmol. 2014;77:288&#x2013;92. 10.5935/0004-2749.20140073. Available at [Accessed June 17, 2023]</Citation><ArticleIdList><ArticleId IdType="pubmed">25494373</ArticleId></ArticleIdList></Reference><Reference><Citation>Firat PG, Dikci S, Firat &#x130;T, Demirel S, Firat M, &#xd6;zt&#xfc;rk E, et al. Correlation between intraocular pressure obtained with water drinking test versus modified diurnal tension curve measurement in pseudoexfoliation glaucoma. Int Ophthalmol. 2021;41:2879&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877501</ArticleId></ArticleIdList></Reference><Reference><Citation>Olatunji OP, Olawoye O, Ajayi B. Correlation and agreement between water drinking test and modified diurnal tension curve in untreated glaucoma patients in Nigeria. J Glaucoma 2020;29:498&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">32205828</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoralick ALB, Gracitelli CPB, Dias DT, Almeida I, Ushida M, Dorairaj S, et al. Lack of association between provocative test-based intraocular pressure parameters and functional loss in treated glaucoma patients. Arq Bras Oftalmol. 2019;82:176&#x2013;82. 10.5935/0004-2749.20190035. Available at: [Accessed June 17, 2023]</Citation><ArticleIdList><ArticleId IdType="pubmed">31116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon Y-C, Teng M-C, Lin P-W, Tsai J-C, Lai I-C. Intraocular pressure fluctuation after water drinking test in primary angle-closure glaucoma and primary open-angle glaucoma. Indian J Ophthalmol. 2016;64:919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322708</ArticleId><ArticleId IdType="pubmed">28112134</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocan MC, Kasim B, Muz E, Irkec M, Orhan M, Karabulut E, et al. Intraocular pressure characteristics of exfoliative glaucoma and exfoliation syndrome as determined with the water drinking test. J Glaucoma. 2016;25:301&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25642816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritch R, Kanadani FN, Moreira T, Campos L, Vianello M, Corradi J, et al. A new provocative test for glaucoma. J Curr Glaucoma Pract. 2016;10:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4875727</ArticleId><ArticleId IdType="pubmed">27231412</ArticleId></ArticleIdList></Reference><Reference><Citation>Babic M, De Moraes CG, Hatanaka M, Ju G, Susanna R. Reproducibility of the water drinking test in treated glaucomatous patients: Water drinking test reproducibility. Clin Exp Ophthalmol. 2015;43:228&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">25214176</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata R, Aihara M, Murata H, Saito H, Iwase A, Yasuda N, et al. Intraocular pressure change over a habitual 24-hour period after changing posture or drinking water and related factors in normal tension glaucoma. Investig Opthalmol Vis Sci. 2013;54:5313.</Citation><ArticleIdList><ArticleId IdType="pubmed">23821194</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlanetto RL, Facio AC, Hatanaka M, Junior RS. Correlation between central corneal thickness and intraocular pressure peak and fluctuation during the water drinking test in glaucoma patients. Clinics. 2010;65:967&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2972611</ArticleId><ArticleId IdType="pubmed">21120295</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moraes CGV, Furlanetto RL, Reis ASC, Vegini F, Cavalcanti NF, Susanna R Jr. Agreement between stress intraocular pressure and long-term intraocular pressure measurements in primary open angle glaucoma. Clin Exp Ophthalmol. 2009;37:270&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19472536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima VC, Prata TS, Lobo RAB, Paranhos A Jr. Correlation between water-drinking test outcomes and body mass index in primary open-angle glaucoma patients under clinical treatment. J Ocul Pharmacol Ther. 2008;24:513&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18800868</ArticleId></ArticleIdList></Reference><Reference><Citation>Susanna R. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma. Br J Ophthalmol. 2005;89:1298&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1772886</ArticleId><ArticleId IdType="pubmed">16170120</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros FA, Pinheiro A, Moura FC, Leal BC, Susanna R. Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther. 2002;18:489&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">12537675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatanaka M, Reis A, Sano ME, Susanna R. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (cosopt) on monotherapy with latanoprost (xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial. J Glaucoma 2010;19:331&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19730119</ArticleId></ArticleIdList></Reference><Reference><Citation>Germano RAS, Susanna R, De Moraes CG, Susanna BN, Susanna CN, Chibana MN. Effect of switching from latanoprost to bimatoprost in primary open-angle glaucoma patients who experienced intraocular pressure elevation during treatment. J Glaucoma. 2016;25:e359&#x2013;e366.</Citation><ArticleIdList><ArticleId IdType="pubmed">26900825</ArticleId></ArticleIdList></Reference><Reference><Citation>Susanna BN, Susanna CN, Susanna FN, Mota RT, Barbosa GCS, Lima VL, et al. Intraocular peak pressure in patients under treatment with fixed combination of bimatoprost/timolol/brimonidine once daily versus twice daily. J Glaucoma. 2022;31:e96&#x2013;e100.</Citation><ArticleIdList><ArticleId IdType="pubmed">35513899</ArticleId></ArticleIdList></Reference><Reference><Citation>Prze&#x17a;dziecka-Do&#x142;yk J, Wa&#x142;ek E, J&#xf3;&#x17a;wik A, Helemejko I, Asejczyk-Widlicka M, Misiuk-Hoj&#x142;o M. Short-time changes of intraocular pressure and biomechanics of the anterior segment of the eye during water drinking test in patients with XEN GelStent. J Clin Med. 2021;11:175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8745870</ArticleId><ArticleId IdType="pubmed">35011918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Fu J-L, Li Y-L, Li P, Lou F-L. Epidemiology and clinical characteristics of patients with glaucoma: an analysis of hospital data between 2003 and 2012. Indian J Ophthalmol. 2015;63:825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4730693</ArticleId><ArticleId IdType="pubmed">26669333</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DR Automated Static Perimetry. St Louis: Mosby Year Book; (1992).</Citation></Reference><Reference><Citation>Germano RAS, Hatanaka M, Garcia AS, Germano FAS, Germano CS, Cid FB, et al. Compara&#xe7;&#xe3;o do efeito hipotensor entre latanoprosta versus trabeculoplastia seletiva a laser obtida com teste de sobrecarga h&#xed;drica. Arq. Bras. Oftalmol. 84. Available at: http://aboonline.org.br/details/6085/en-US/comparacao-do-efeito-hipotensor-entre-latanoprosta-versus-trabeculoplastia-seletiva-a-laser-obtida-com-teste-de-sobrecarga-hidrica [Accessed June 17, 2023] (2021).</Citation></Reference><Reference><Citation>Anon. The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">11024415</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstas AGP. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;115:182.</Citation><ArticleIdList><ArticleId IdType="pubmed">9046252</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakakura S. Icare&amp;reg; rebound tonometers: review of their characteristics and ease of use. Clin Ophthalmol. 2018;ume 12:1245&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6047858</ArticleId><ArticleId IdType="pubmed">30034218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hille K, Draeger J, Eggers T, Stegmaier P. Technischer Aufbau, Kalibrierung und Ergebnisse mit einem neuen intraokularen Drucksensor mit telemetrischer &#xdc;bertragung1. Klin Monatsbl&#xe4;tter F&#xfc;r Augenheilkd. 2001;218:376&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">11417341</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi M, Leuenberger P, Bertrand D, Bertsch A, Renaud P. First steps toward noninvasive intraocular pressure monitoring with a sensing contact lens. Investig Opthalmology Vis Sci 2004;45:3113.</Citation><ArticleIdList><ArticleId IdType="pubmed">15326128</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunbar GE, Shen B, Aref A. The Sensimed Triggerfish contact lens sensor: efficacy, safety, and patient perspectives. Clin Ophthalmol. 2017;ume 11:875&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428792</ArticleId><ArticleId IdType="pubmed">28507427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamm ER, Fuchshofer R. What increases outflow resistance in primary open-angle glaucoma? Surv Ophthalmol. 2007;52:S101&#x2013;S104.</Citation><ArticleIdList><ArticleId IdType="pubmed">17998032</ArticleId></ArticleIdList></Reference><Reference><Citation>Diestelhorst M, Krieglstein GK. The effect of the water-drinking test on aqueous humor dynamics in healthy volunteers. Graefes Arch Clin Exp Ophthalmol. 1994;232:145&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8188063</ArticleId></ArticleIdList></Reference><Reference><Citation>Venugopal N. Water drinking test and angle closure glaucoma. Indian J Ophthalmol. 2015;63:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4399132</ArticleId><ArticleId IdType="pubmed">25827553</ArticleId></ArticleIdList></Reference><Reference><Citation>Razeghinejad R, Hossein Nowroozzadeh M Water-drinking Test and Pharmacologic Mydriasis as Provocative Tests in Primary Angle Closure Suspects. J. Ophthalmic Vis. Res. Available at: https://knepublishing.com/index.php/JOVR/article/view/4782 [Accessed January 7, 2024] (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6815332</ArticleId><ArticleId IdType="pubmed">31660105</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora KS, Jefferys JL, Maul EA, Quigley HA. Choroidal thickness change after water drinking is greater in angle closure than in open angle eyes. Investig Opthalmol. Vis Sci 2012;53:6393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6715336</ArticleId><ArticleId IdType="pubmed">22918644</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley HA, Friedman DS, Congdon NG. Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma. 2003;12:167&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">12671473</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasconcelos De Moraes CG, Castro Reis AS, De S&#xe1; Cavalcante AF, Sano ME, Susanna R. Choroidal expansion during the water drinking test. Graefes Arch Clin Exp Ophthalmol. 2009;247:385&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18987872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nongpiur ME, Foo VHX, De Leon JM, Baskaran M, Tun TA, Husain R, et al. Evaluation of choroidal thickness, intraocular pressure, and serum osmolality after the water drinking test in eyes with primary angle closure. Investig Opthalmol Vis Sci. 2015;56:2135.</Citation><ArticleIdList><ArticleId IdType="pubmed">25744978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansouri K, Medeiros FA, Marchase N, Tatham AJ, Auerbach D, Weinreb RN. Assessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomography. Ophthalmology. 2013;120:2508&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833954</ArticleId><ArticleId IdType="pubmed">24021895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusthaus JA, Meyer PAR, McCluskey PJ, Martin KR. Hemoglobin video imaging detects differences in aqueous outflow between eyes with and without glaucoma during the water drinking test. J Glaucoma. 2022;31:511&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">35394459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YR, Kook MS, Joe SG, Na JH, Han S, Kim S, et al. Circadian (24-hour) pattern of intraocular pressure and visual field damage in eyes with normal-tension glaucoma. Investig Opthalmol Vis Sci. 2012;53:881.</Citation><ArticleIdList><ArticleId IdType="pubmed">22266515</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstas AGP, Quaranta L, Mikropoulos DG, Nasr MB, Russo A, Jaffee HA, et al. Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma. J Ocul Pharmacol Ther. 2012;28:26&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">22004074</ArticleId></ArticleIdList></Reference><Reference><Citation>Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures. Surv Ophthalmol. 2000;44:367&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">10734239</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogagnolo P. Circadian variations in central corneal thickness and intraocular pressure in patients with glaucoma. Br J Ophthalmol. 2006;90:24&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1856876</ArticleId><ArticleId IdType="pubmed">16361661</ArticleId></ArticleIdList></Reference><Reference><Citation>Realini T, Gurka MJ, Weinreb RN. Reproducibility of central corneal thickness measurements in healthy and glaucomatous eyes. J Glaucoma. 2017;26:787&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5578894</ArticleId><ArticleId IdType="pubmed">28816818</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaarawy T, Flammer J, Haefliger IO. Reducing intraocular pressure: is surgery better than drugs? Eye. 2004;18:1215&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">15094737</ArticleId></ArticleIdList></Reference><Reference><Citation>Burr J, Azuara-Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma Cochrane Eyes and Vision Group (ed). Cochrane Database Syst Rev. Available at: 10.1002/14651858.CD004399.pub3 [Accessed September 15, 2023] (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11707325</ArticleId><ArticleId IdType="pubmed">22972069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Dai Y, Chen Y, Yu D-Y, Cringle SJ, Chen J, et al. Primary angle closure glaucoma: What we know and what we don&#x2019;t know. Prog Retin Eye Res. 2017;57:26&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">28039061</ArticleId></ArticleIdList></Reference><Reference><Citation>Waisbourd M, Savant SV, Sun Y, Martinez P, Myers JS. Water&#x2010;drinking test in primary angle&#x2010;closure suspect before and after laser peripheral iridotomy. Clin Exp Ophthalmol. 2016;44:89&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">26332426</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkana Y. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol. 2006;124:793.</Citation><ArticleIdList><ArticleId IdType="pubmed">16769832</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektas O-Y, L&#xfc;tjen-Drecoll E. Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res. 2009;88:769&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">19114037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35609728</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-8769</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>World neurosurgery</Title><ISOAbbreviation>World Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Radiotherapy and Radiosurgery in the Management of Optic Nerve Sheath Meningiomas: An International Systematic Review and Meta-Analysis of Twenty Studies.</ArticleTitle><Pagination><StartPage>e929</StartPage><EndPage>e944</EndPage><MedlinePgn>e929-e944</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2022.05.064</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-8750(22)00694-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Optic nerve sheath meningiomas (ONMs) are often managed with radiotherapy (RT) with the goal of achieving radiographic local control (LC) and preventing deterioration of visual acuity (VA). We aimed to perform a systematic review and meta-analysis of outcomes for patients with ONM treated with RT.</AbstractText><AbstractText Label="METHODS">The PICOS/PRISMA/MOOSE selection criteria were used to identify studies. Primary outcomes were stable or improved VA and radiographic LC at last follow-up. The secondary outcomes were incidences of radiation-induced retinopathy and xerophthalmia and stable or improved visual fields (VFs). Weighted random-effects meta-analyses using the DerSimonian and Laird methods were conducted to characterize effect sizes. Mixed-effects regression models were used to examine potential correlations between gross tumor volume (GTV) and outcomes.</AbstractText><AbstractText Label="RESULTS">In total, 444 patients with ONM across 20 published studies were included. The estimated LC rate was 99.8% (95% confidence interval [CI], 98.3%-100%), and the estimated proportion of patients with stable or improved VA or VF was 89.7% (95% CI, 86.2%-92.4%) and 93.3% (95% CI, 89.5%-95.8%), respectively. Estimated incidences of radiation-induced retinopathy and xerophthalmia were 7.2% and 10.1%, respectively. GTV was significantly associated with VA (P&#xa0;= 0.014) with estimated VA rates of 96.4%, 91.4%, and 80.5% for GTVs of 2.0, 3.0, and 4.0 cm<sup>3</sup>, respectively.</AbstractText><AbstractText Label="CONCLUSIONS">RT was well tolerated, with excellent LC achieved. Nearly 90% of patients noted either stability or improvement in VA and VF. Larger ONMs were associated with poorer VA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaishnav</LastName><ForeName>Yash J</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA. Electronic address: yash.vaishnav@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Raj</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Didwania</LastName><ForeName>Prabhanjan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Rady School of Management, University of California San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehrer</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakaeva</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Migliori</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheehan</LastName><ForeName>Jason P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trifiletti</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World Neurosurg</MedlineTA><NlmUniqueID>101528275</NlmUniqueID><ISSNLinking>1878-8750</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019583" MajorTopicYN="N">Dose Fractionation, Radiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008577" MajorTopicYN="Y">Meningeal Neoplasms</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008579" MajorTopicYN="Y">Meningioma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009900" MajorTopicYN="N">Optic Nerve</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019574" MajorTopicYN="Y">Optic Nerve Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011832" MajorTopicYN="Y">Radiation Injuries</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016634" MajorTopicYN="Y">Radiosurgery</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012164" MajorTopicYN="Y">Retinal Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014985" MajorTopicYN="Y">Xerophthalmia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dry eye</Keyword><Keyword MajorTopicYN="N">Local control</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Optic nerve sheath meningioma</Keyword><Keyword MajorTopicYN="N">Radiation retinopathy</Keyword><Keyword MajorTopicYN="N">Radiosurgery</Keyword><Keyword MajorTopicYN="N">Radiotherapy</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Visual acuity</Keyword><Keyword MajorTopicYN="N">Visual field</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>24</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35609728</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2022.05.064</ArticleId><ArticleId IdType="pii">S1878-8750(22)00694-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37819047</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2047-2412</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>European heart journal. Cardiovascular Imaging</Title><ISOAbbreviation>Eur Heart J Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study).</ArticleTitle><Pagination><StartPage>188</StartPage><EndPage>198</EndPage><MedlinePgn>188-198</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjci/jead261</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Conducting channels (CCs) detected by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) are related to ventricular tachycardia (VT). The aim of this work was to study the ability of post-ablation LGE-CMR to evaluate ablation lesions.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This is a prospective study of consecutive patients referred for a scar-related VT ablation. LGE-CMR was performed 6-12 months prior to ablation and 3-6 months after ablation. Scar characteristics of pre- and post-ablation LGE-CMR were compared. During the study period (March 2019-April 2021), 61 consecutive patients underwent scar-related VT ablation after LGE-CMR. Overall, 12 patients were excluded (4 had poor-quality LGE-CMR, 2 died before post-ablation LGE-CMR, and 6 underwent post-ablation LGE-CMR 12 months after ablation). Finally, 49 patients (age: 65.5 &#xb1; 9.8 years, 97.9% male, left ventricular ejection fraction: 34.8 &#xb1; 10.4%, 87.7% ischaemic cardiomyopathy) were included. Post-ablation LGE-CMR showed a decrease in the number (3.34 &#xb1; 1.03 vs. 1.6 &#xb1; 0.2; P &lt; 0.0001) and mass (8.45 &#xb1; 1.3 vs. 3.5 &#xb1; 0.6 g; P &lt; 0.001) of CCs. Arrhythmogenic CCs disappeared in 74.4% of patients. Dark core was detected in 75.5% of patients, and its presence was not related to CC reduction (52.2 &#xb1; 7.4% vs. 40.8 &#xb1; 10.6%, P = 0.57). VT recurrence after one year follow-up was 16.3%. The presence of two or more channels in the post-ablation LGE-CMR was a predictor of VT recurrence (31.82% vs. 0%, P = 0.0038) with a sensibility of 100% and specificity of 61% (area under the curve 0.82). In the same line, a reduction of CCs &lt; 55% had sensibility of 100% and specificity of 61% (area under the curve 0.83) to predict VT recurrence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Post-ablation LGE-CMR is feasible, and a reduction in the number of CCs is related with lower risk of VT recurrence. The dark core was not present in all patients. A decrease in VT substrate was also observed in patients without a dark core area in the post-ablation LGE-CMR.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roca-Luque</LastName><ForeName>Ivo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0731-3731</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Calvo</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garre</LastName><ForeName>Paz</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz-Perez</LastName><ForeName>Jose T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prat-Gonzalez</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Somonte</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferro</LastName><ForeName>Elisenda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinto</LastName><ForeName>Levio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarc&#xf3;n</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Althoff</LastName><ForeName>Till</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perea</LastName><ForeName>Rosario Jes&#xfa;s</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Diagn&#xf2;stic per la Imatge, Hospital Cl&#xed;nic, Universitat de Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figueras I Ventura</LastName><ForeName>Rosa M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Adas3D Medical S.L., Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guasch</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4238-5319</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolosana</LastName><ForeName>Jos&#xe9; Maria</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzatti</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morr-Verenzuela</LastName><ForeName>Carlos Igor</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta-Sanchez</LastName><ForeName>Andreu</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3510-1488</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbelo</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sitges</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1300-4732</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugada</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5662-8302</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mont</LastName><ForeName>Llu&#xed;s</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8115-5906</Identifier><AffiliationInfo><Affiliation>Arrhyhtmia Section, Institut Clinic Cardiovascular, Hospital Cl&#xed;nic, Universitat de Barcelona, Villarroel st. 170, Catalonia, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Emile Letang Grand of Hospital Clinic de Barcelona</Agency><Country/></Grant><Grant><GrantID>PI20/00693/CB16/11/00354</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>CB16/11/00354</GrantID><Agency>European Union</Agency><Country/></Grant><Grant><Agency>Generalitat de Catalunya</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Cardiovasc Imaging</MedlineTA><NlmUniqueID>101573788</NlmUniqueID><ISSNLinking>2047-2404</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>AU0V1LM3JT</RegistryNumber><NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Heart J Cardiovasc Imaging. 2024 Jan 29;25(2):199-200. doi: 10.1093/ehjci/jead275.</RefSource><PMID Version="1">37861369</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Eur Heart J Cardiovasc Imaging. 2024 Jan 29;25(2):e100. doi: 10.1093/ehjci/jead316.</RefSource><PMID Version="1">37988586</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019028" MajorTopicYN="N">Magnetic Resonance Imaging, Cine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002921" MajorTopicYN="N">Cicatrix</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005682" MajorTopicYN="N">Gadolinium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac magnetic resonance</Keyword><Keyword MajorTopicYN="N">late gadolinium enhancement</Keyword><Keyword MajorTopicYN="N">scar characterization</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia ablation</Keyword></KeywordList><CoiStatement>Conflict of interest: L.M. and J.B. report activities as a consultant, lecturer, and advisory board member for Abbott Medical, Boston Scientific, Biosense Webster, Medtronic, and Biotronik. They are also shareholders of Adas3D Medical S.L. I.R.-L. and A.P.-S. have served as a consultant for Biosense Webster, Medtronic, Boston Scientific, and Abbott Medical. M.S. reports activities as a consultant, lecturer, advisory board member, and grant recipient for Abbott Medical, Edwards Lifesciences, Sanofi, General Electric, and Medtronic. All other authors report that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>11</Day><Hour>14</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>11</Day><Hour>8</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37819047</ArticleId><ArticleId IdType="pmc">PMC10824475</ArticleId><ArticleId IdType="doi">10.1093/ehjci/jead261</ArticleId><ArticleId IdType="pii">7306657</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berruezo A, Fern&#xe1;ndez-Armenta J, Andreu D, Penela D, Herczku C, Evertz Ret al. . Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythm Electrophysiol 2015;8:326&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25583983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mountantonakis SE, Park RE, Frankel DS, Hutchinson MD, Dixit S, Cooper Jet al. . Relationship between voltage map &#x201c;channels&#x201d; and the location of critical isthmus sites in patients with post-infarction cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol 2013;61:2088&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">23524215</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu D, Ortiz-Perez JT, Boussy T, Fernandez-Armenta J, De Caralt TM, Perea RJet al. . Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation. Eur Heart J 2014;35:1316&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">24394378</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu D, Ortiz-Perez JT, Fernandez-Armenta J, Guiu E, Acosta J, Prat-Gonzalez Set al. . 3D delayed-enhanced magnetic resonance sequences improve conducting channel delineation prior to ventricular tachycardia ablation. Europace 2015;17:938&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">25616406</ArticleId></ArticleIdList></Reference><Reference><Citation>Piers SRD, Tao Q, Silva M DR, Siebelink HM, Schalij MJ, Van Der Geest RJet al. . CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia. JACC Cardiovasc Imaging 2014;7:774&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25051947</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez-Calvo S, Casanovas JM, Garre P, Ferr&#xf3; E, S&#xe1;nchez-Somonte P, Quinto Let al. . Evolution of deceleration zones during ventricular tachycardia ablation and relation with cardiac magnetic resonance. JACC Clin Electrophysiol 2023;9:779&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">37380313</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu D, Penela D, Acosta J, Perea RJ, Soto-iglesias D, De Caralt TMet al. . Cardiac magnetic resonance&#x2013;aided scar dechanneling: influence on acute and long-term outcomes. Heart Rhythm 2017;14:1121&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28760258</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Luque I, Rivas-Gandara N, Francisco-Pascual J, Rodriguez-Sanchez J, Cuellar-Calabria H, Rodriguez-Palomares Jet al. . Preprocedural imaging to guide transcoronary ethanol ablation for refractory septal ventricular tachycardia. J Cardiovasc Electrophysiol 2019;30:448&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">30556327</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinto L, Sanchez-Somonte P, Alarc&#xf3;n F, Garre P, Castillo &#xc0;, San Antonio Ret al. . Ventricular tachycardia burden reduction after substrate ablation: predictors of recurrence. Heart Rhythm 2021;18:896&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">33639298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15826268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhuva AN, Kellman P, Graham A, Ramlall M, Boubertakh R, Feuchter Pet al. . Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices. Int J Cardiol 2019;279:72&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30642645</ArticleId></ArticleIdList></Reference><Reference><Citation>Do DH, Eyvazian V, Bayoneta AJ, Hu P, Finn JP, Brad JSet al. . Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices. Heart Rhythm 2018;15:218&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823604</ArticleId><ArticleId IdType="pubmed">29017930</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbert S, Weber A, Nehrke K, Bornert P, Schnackenburg B, Oebel Set al. . Artefact-free late gadolinium enhancement imaging in patients with implanted cardiac devices using a modified broadband sequence: current strategies and results from a real-world patient cohort. Europace 2018;20:801&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28431009</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Luque I, Van Breukelen A, Alarcon F, Garre P, Tolosana JM, Borras Ret al. . Ventricular scar channel entrances identified by new wideband cardiac magnetic resonance sequence to guide ventricular tachycardia ablation in patients with cardiac defibrillators. Europace 2020;22:598&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">32101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafoori E, Kholmovski E, Thomas S, Silvernagel J, Nathan A, Nan Het al. . Characterization of gadolinium contrast enhancement of radiofrequency ablation lesions in predicting edema and chronic lesion size. Circ Arrhythm Electrophysiol 2017;10:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693314</ArticleId><ArticleId IdType="pubmed">29079664</ArticleId></ArticleIdList></Reference><Reference><Citation>Celik H, Ramanan V, Barry J, Ghate S, Leber V, Oduneye Set al. . Intrinsic contrast for characterization of acute radiofrequency ablation lesions. Circ Arrhythm Electrophysiol 2014;7:718&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">24988893</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabbagh GS, Ghannam M, Siontis KC, Attili A, Cochet H, Jais Pet al. . Magnetic resonance mapping of cathter ablation lesions after post-infarction ventricular tachycardia ablation. JACC Cardiovasc Imaging 2021;14:588&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33248970</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Vice-chair E, Chen Met al. . 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. EP Europace 2019;21:1143&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967791</ArticleId><ArticleId IdType="pubmed">31075787</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz Z, Shatz D, Raiman M, Upadhyay GA, Beaser AD, Besser SAet al. . Targeted ablation of ventricular tachycardia guided by wavefront discontinuities during sinus rhythm: a new functional substrate mapping strategy. Circulation 2019;140:1383&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">31533463</ArticleId></ArticleIdList></Reference><Reference><Citation>De Chillou C, Groben L, Magnin-poull I, Abdelaal A, Ammar S, Sellal Jet al. . Localizing the critical isthmus of postinfarct ventricular tachycardia : the value of pace-mapping during sinus rhythm. Heart Rhythm 2014;11:175&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">24513915</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Armenta J, Berruezo A, Andreu D, Camara O, Silva E, Serra Let al. . Three-dimensional architecture of scar and conducting channels based on high resolution ce-CMR insights for ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 2013;6:528&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">23685537</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Somonte P, Quinto L, Garre P, Zaraket F, Alarc&#xf3;n F, Borr&#xe0;s Ret al. . Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention. Heart Rhythm 2021;18:1336&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">33892202</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Bijl P, Delgado V, Bax JJ. Sudden cardiac death: the role of imaging. Int J Cardiol 2017;237:15&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28284506</ArticleId></ArticleIdList></Reference><Reference><Citation>Linhart M, Alarcon F, Borr&#xe0;s R, Benito EM, Chipa F, Cozzari Jet al. . Delayed gadolinium enhancement magnetic resonance imaging detected anatomic gap length in wide circumferential pulmonary vein ablation lesions is associated with recurrence of atrial fibrillation. Circ Arrhythm Electrophysiol 2018;11:e006659:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30562102</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinov B, Oebel S, Hilbert S, Loebe S, Arya A. Characteristics of the ablation lesions in cardiac magnetic resonance imaging after radiofrequency ablation of ventricular arrhythmias in relation to the procedural success. Am Heart J 2018;204:68&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">30077835</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickfield T, Kato R, Zviman MM, Lai S, Meininger G, Lardo ACet al. . Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2006;47:370&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2943962</ArticleId><ArticleId IdType="pubmed">16412863</ArticleId></ArticleIdList></Reference><Reference><Citation>Vunnam R, Ghzally Y, Mbbs JBM, See V, Maheshwari V, Imanli Het al. . Ventricular arrhythmia ablation lesions detectability. Pacing Clin Electrophysiol 2020;43:314&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">32052461</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40524976</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-5204</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Resuscitation plus</Title><ISOAbbreviation>Resusc Plus</ISOAbbreviation></Journal><ArticleTitle>Energy doses for paediatric defibrillation in cardiac arrest: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>100991</StartPage><MedlinePgn>100991</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100991</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resplu.2025.100991</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Early defibrillation is the foundation of treatment of shockable ventricular arrhythmias (VF, pVT) but optimal energy doses for initial and subsequent shocks in paediatric cardiac arrest remain controversial.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To assess the use of different energy doses for initial defibrillation in infants, children and adolescents with ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT) during cardiac arrest.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systematic review was performed by the ILCOR Paediatric Life Support Task force. This systematic review was prospectively registered as PROSPERO CRD42024548898. A search of PubMed, EMBASE, and Cochrane Controlled Register of Trials (CENTRAL) was performed for clinical trials and observational studies, published before 1 January 2025, involving cardiac defibrillation in infants and children (excluding newborn infants) in cardiac arrest. Investigators reviewed studies for relevance, extracted data, and assessed risk of bias using the ROBINS-I framework. Critical outcomes included survival to hospital discharge and return of spontaneous circulation. Results were compiled into a Summary of Findings table using the GRADEpro Guideline Development tool. Statistical calculations and Forest plot generation were performed using RevMan.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We identified 7 relevant observational studies. The majority of studies involved in-hospital cardiac arrest. The overall certainty of evidence was very low. Critical (survival to hospital discharge, return of spontaneous circulation) and important (termination of VF/pVT) outcomes were not significantly better or worse when initial defibrillation doses of &lt;1.5&#xa0;J/kg or &gt;2.5&#xa0;J/kg were used for children in cardiac arrest with a shockable rhythm compared with initial doses approximating 2&#xa0;J/kg.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The current available data suggest that outcomes are not significantly better or worse when initial defibrillation doses of &lt;1.5&#xa0;J/kg or &gt;2.5&#xa0;J/kg are used for children in cardiac arrest with a shockable rhythm (VF or pVT) compared with initial doses approximating 2&#xa0;J/kg. Well-designed randomised trials are needed to address this important question.</AbstractText><CopyrightInformation>&#xa9; 2025 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Acworth</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Department, Queensland Children's Hospital, Brisbane, Australia, Faculty of Medicine, University of Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Castillo</LastName><ForeName>Jimena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Paediatric Intensive Care Department, Hospital General Universitario Gregorio Maranon de Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiwari</LastName><ForeName>Lokesh Kumar</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Division of Pediatric Pulmonology and Intensive Care, Department of Paediatrics, All India Institute of Medical Sciences, Rishikesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkins</LastName><ForeName>Dianne</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Caen</LastName><ForeName>Allan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care, University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bansal</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Critical Care Unit, Advanced Pediatric Center, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couto</LastName><ForeName>Thomaz Bittencourt</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Centro de Simula&#xe7;&#xe3;o Real&#xed;stica and Faculdade Israelita de Ci&#xea;ncias da Sa&#xfa;de, Hospital Israelita Albert Einstein AND Pronto Socorro, Instituto da Crian&#xe7;a e do Adolescente do Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katzenschlager</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Heidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinman</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital and Harvard Medical School, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Herce</LastName><ForeName>Jesus</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Paediatric Intensive Care Department, Hospital General Universitario Gregorio Maranon de Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Ryan W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myburgh</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Child Health, University of the Free State, Bloemfontein, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadkarni</LastName><ForeName>Vinay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tijssen</LastName><ForeName>Janice A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Children's Hospital, London Health Sciences Centre, Paediatric Critical Care Medicine, Department of Paediatrics, Western University, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scholefield</LastName><ForeName>Barnaby R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Paediatric Critical Care, Hospital for Sick Children, Toronto and University of Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>International Liaison Committee on Resuscitation Paediatric Life Support Task Force</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Resusc Plus</MedlineTA><NlmUniqueID>101774410</NlmUniqueID><ISSNLinking>2666-5204</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Cardioversion</Keyword><Keyword MajorTopicYN="N">Defibrillation</Keyword><Keyword MajorTopicYN="N">Dose</Keyword><Keyword MajorTopicYN="N">Paediatric</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Monica Kleinman serves on the Editorial Board of the Resuscitation Journal. She was not involved in the editorial review or the decision to publish this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>17</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40524976</ArticleId><ArticleId IdType="pmc">PMC12169708</ArticleId><ArticleId IdType="doi">10.1016/j.resplu.2025.100991</ArticleId><ArticleId IdType="pii">S2666-5204(25)00128-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Atkins D.L., Everson-Stewart S., Sears G.K., et al. Epidemiology and outcomes from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest. Circulation. 2009;119:1484&#x2013;1491. [Resuscitation Outcomes Consortium I]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2679169</ArticleId><ArticleId IdType="pubmed">19273724</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Voorde P., Turner N.M., Djakow J., et al. European Resuscitation Council Guidelines 2021: paediatric life support. Resuscitation. 2021;161:327&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">33773830</ArticleId></ArticleIdList></Reference><Reference><Citation>ANZCOR. Guideline 12.2 &#x2013; Paediatric Advanced Life Support (PALS); 2021. Available at: https://www.anzcor.org/home/paediatric-advanced-life-support/guideline-12-2-paediatric-advanced-life-support-pals/.</Citation></Reference><Reference><Citation>Topjian A.A., Raymond T.T., Atkins D., et al. Part 4: pediatric basic and advanced life support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142:S469&#x2013;S523.</Citation><ArticleIdList><ArticleId IdType="pubmed">33081526</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercier E., Laroche E., Beck B., et al. Defibrillation energy dose during pediatric cardiac arrest: systematic review of human and animal model studies. Resuscitation. 2019;139:241&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">31029714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyme D.B., Zhou Y., Girotra S., et al. Improved survival to hospital discharge in pediatric in-hospital cardiac arrest using 2&#xa0;Joules/kilogram as first defibrillation dose for initial pulseless ventricular arrhythmia. Resuscitation. 2020;153:88&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">32522702</ArticleId></ArticleIdList></Reference><Reference><Citation>Maconochie I.K., Aickin R., Hazinski M.F., et al. International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation. 2020;2020(156):A120&#x2013;A155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7576321</ArticleId><ArticleId IdType="pubmed">33098916</ArticleId></ArticleIdList></Reference><Reference><Citation>Maconochie I.K., Aickin R., Hazinski M.F., et al. International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation. 2020;2020(142):S140&#x2013;S184.</Citation><ArticleIdList><ArticleId IdType="pubmed">33084393</ArticleId></ArticleIdList></Reference><Reference><Citation>Acworth J., del Castillo J., Tiwari L., DeCaen A. Energy doses for pediatric defibrillation during resuscitation. PROSPERO 2024. Available from https://www.crd.york.ac.uk/PROSPERO/view/CRD42024548898.</Citation></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at http://www.covidence.org.</Citation></Reference><Reference><Citation>Topjian A.A., Scholefield B.R., Pinto N.P., et al. P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in Children: an advisory statement from the International Liaison Committee on Resuscitation. Circulation. 2020;142:e246&#x2013;e261.</Citation><ArticleIdList><ArticleId IdType="pubmed">32967446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A., Hern&#xe1;n M.A., Reeves B.C., et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. [computer program]. McMaster University (developed by Evidence Prime). Available at https://www.gradepro.org/. Accessed 20 November 2023.</Citation></Reference><Reference><Citation>Review Manager (RevMan) [Computer program], version 8.14.0. [computer program]. Version 8.14.0. Copenhagen: The Cochrane Collaboration; 2024.</Citation></Reference><Reference><Citation>Gutgesell H.P., Tacker W.A., Geddes L.A. Energy dose for ventricular defibrillation of children. Pediatrics. 1976;58:898&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">995520</ArticleId></ArticleIdList></Reference><Reference><Citation>Meaney P.A., Nadkarni V.M., Atkins D.L., et al. Effect of defibrillation energy dose during in-hospital pediatric cardiac arrest. Pediatrics. 2011;127:e16&#x2013;e23.</Citation><ArticleIdList><ArticleId IdType="pubmed">21172997</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-N&#xfa;&#xf1;ez A., L&#xf3;pez-Herce J., del Castillo J., Bell&#xf3;n J.M. Shockable rhythms and defibrillation during in-hospital pediatric cardiac arrest. Resuscitation. 2014;85:387&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">24291590</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-N&#xfa;&#xf1;ez A., L&#xf3;pez-Herce J., Garc&#xed;a C., Dom&#xed;nguez P., Carrillo A., Bell&#xf3;n J.M. Pediatric defibrillation after cardiac arrest: initial response and outcome. Crit Care. 2006;10:R113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1751019</ArticleId><ArticleId IdType="pubmed">16882339</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibballs J., Carter B., Kiraly N.J., Ragg P., Clifford M. External and internal biphasic direct current shock doses for pediatric ventricular fibrillation and pulseless ventricular tachycardia. Pediatr Crit Care Med. 2011;12:14&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">20308928</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibballs J., Kinney S. A prospective study of outcome of in-patient paediatric cardiopulmonary arrest. Resuscitation. 2006;71:310&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">17069956</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossano J.W., Quan L., Kenney M.A., Rea T.D., Atkins D.L. Energy doses for treatment of out-of-hospital pediatric ventricular fibrillation. Resuscitation. 2006;70:80&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">16762479</ArticleId></ArticleIdList></Reference><Reference><Citation>Smida T., Cheskes S., Crowe R., et al. The association between initial defibrillation dose and outcomes following adult out-of-hospital cardiac arrest resuscitation: a retrospective, multi-agency study. Resuscitation. 2025;208</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11908921</ArticleId><ArticleId IdType="pubmed">39855423</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg M.D., Banville I.L., Chapman F.W., et al. Attenuating the defibrillation dosage decreases postresuscitation myocardial dysfunction in a swine model of pediatric ventricular fibrillation. Pediatr Crit Care Med. 2008;9:429&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2724893</ArticleId><ArticleId IdType="pubmed">18496405</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg R.A., Chapman F.W., Berg M.D., et al. Attenuated adult biphasic shocks compared with weight-based monophasic shocks in a swine model of prolonged pediatric ventricular fibrillation. Resuscitation. 2004;61:189&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">15135196</ArticleId></ArticleIdList></Reference><Reference><Citation>Haskell S.E., Atkins D.L. Defibrillation in children. J Emerg Trauma Shock. 2010;3:261&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2938491</ArticleId><ArticleId IdType="pubmed">20930970</ArticleId></ArticleIdList></Reference><Reference><Citation>Faddy S.C., Powell J., Craig J.C. Biphasic and monophasic shocks for transthoracic defibrillation: a meta analysis of randomised controlled trials. Resuscitation. 2003;58:9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">12867304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray J.M., Raymond T.T., Atkins D.L., et al. Inappropriate shock delivery is common during pediatric in-hospital cardiac arrest. Pediatr Crit Care Med. 2023;24:e390&#x2013;e396. [pediRES-Q Investigators]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10440232</ArticleId><ArticleId IdType="pubmed">37115167</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepard L.N., Nadkarni V.M., Ng K.C., Scholefield B.R., Ong G.Y. ILCOR pediatric life support recommendations translation to constituent council guidelines: an emphasis on similarities and differences. Resuscitation. 2024;201 [ILCOR Pediatric Life Support Task Force]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11905231</ArticleId><ArticleId IdType="pubmed">38777078</ArticleId></ArticleIdList></Reference><Reference><Citation>Topjian A.A., Scholefield B.R., Pinto N.P., et al. P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in Children: an advisory statement from the International Liaison Committee on Resuscitation. Resuscitation. 2021;162:351&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">33515637</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35820619</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>2054</StartPage><EndPage>2061</EndPage><MedlinePgn>2054-2061</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2022.07.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(22)02167-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is limited information on whether early catheter ablation (CA) for ventricular tachycardia (VT) is associated with better outcomes compared with alternative strategies in patients with implantable cardioverter-defibrillator (ICD).</AbstractText><AbstractText Label="OBJECTIVE">The purpose of this article was to assess the efficacy of early VT CA in patients with ICD.</AbstractText><AbstractText Label="METHODS">EMBASE, PubMed, and Cochrane were searched from inception to April 2022. Randomized controlled trials comparing the efficacy of early VT CA with control groups, both in patients with ICD, were included in the analysis. Data on effect estimates in individual studies were extracted and combined via random effects meta-analysis using the DerSimonian and Laird method, a generic inverse variance strategy.</AbstractText><AbstractText Label="RESULTS">Nine randomized controlled trials with 1106 patients (n = 1018, 92.1% with ischemic cardiomyopathy and n = 88, 7.9% with nonischemic cardiomyopathy) were evaluated. VT CA was associated with reduced VT recurrences (odds ratio [OR] 0.64; P = .007), appropriate ICD shocks (OR 0.53; P = .002), ICD therapies (OR 0.54; P&#xa0;=&#xa0;.002), and cardiovascular hospitalization (OR 0.67; P&#xa0;=&#xa0;.004). However, no significant differences were observed in terms of mortality rate, heart failure hospitalization, and quality of life between the early VT CA and control groups.</AbstractText><AbstractText Label="CONCLUSION">Early CA was beneficial in reducing VT burden and ICD therapies. However, it did not affect mortality rate and quality of life. Since most patients in the included studies presented with ischemic cardiomyopathy, further studies on nonischemic cardiomyopathy should be conducted to validate if early CA has similar outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prasitlumkum</LastName><ForeName>Narut</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of California Riverside, Riverside, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navaravong</LastName><ForeName>Leenhapong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Aditya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of California Riverside, Riverside, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Darshi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of California Riverside, Riverside, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheungpasitporn</LastName><ForeName>Wisit</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rattanawong</LastName><ForeName>Pattara</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunch</LastName><ForeName>T Jared</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jongnarangsin</LastName><ForeName>Krit</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Frankel Cardiovascular Center, University of Michigan Health, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chokesuwattanaskul</LastName><ForeName>Ronpichai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Cardiac Center, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand. Electronic address: drronpichaic@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Heart Rhythm. 2022 Dec;19(12):2062-2063. doi: 10.1016/j.hrthm.2022.07.024.</RefSource><PMID Version="1">35940459</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Early</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35820619</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.005</ArticleId><ArticleId IdType="pii">S1547-5271(22)02167-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35404130</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9034</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of laparoendoscopic &amp; advanced surgical techniques. Part A</Title><ISOAbbreviation>J Laparoendosc Adv Surg Tech A</ISOAbbreviation></Journal><ArticleTitle>Valveless Trocar Versus Standard Pneumoperitoneum Insufflation System in Minimally Invasive Surgery: Impact on Postoperative Pain. A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>978</StartPage><EndPage>986</EndPage><MedlinePgn>978-986</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/lap.2022.0022</ELocationID><Abstract><AbstractText><b><i>Background:</i></b> The benefits of a valid pneumoperitoneum in laparoscopic surgery are counterbalanced by the possible negative effects of increased abdominal pressure and carbon dioxide (CO<sub>2</sub>) insufflation, which are crucial factors in causing postoperative pain. The purpose of this work is to evaluate the effectiveness of the valveless trocar (VT) insufflation system in decreasing postoperative pain and influencing operative time, compared to a standard insufflation system. <b><i>Methods:</i></b> A systematic research was performed using MEDLINE, EMBASE, Central Cochrane Library, and CINAHL Plus for studies published up to June 2020. Randomized controlled trials (RCTs) on adult population evaluating the effects of VT versus a standard insufflation system in laparoscopic surgery and reporting postoperative pain level and operative time were included in the analysis. Data and study quality indicators were extracted independently by 2 authors using a standardized form. Statistical analysis was based on a random effect model, using the inverse variance method. <b><i>Results:</i></b> We identified 3 RCTs for a total of 245 patients. The meta-analysis showed a statistically significant reduction in shoulder pain with the use of VT at 24 hours: mean difference (MD) -7.9% (95% confidence interval [95% CI]: -1.29 to 0.29; <i>z</i>&#x2009;=&#x2009;3.08; <i>P</i>&#x2009;=&#x2009;.002) and a nonstatistically significant increase in operation time: MD 5.80 (95% CI: -8.93 to 20.54; <i>P</i>&#x2009;=&#x2009;.44). <b><i>Conclusion:</i></b> Our study suggests a better shoulder pain control at 24 hours postoperation using new-generation VT for laparoscopic surgery compared to standard insufflation system. Weak evidence of increased operating time with the VT was observed considering only two of the three RCTs. PROSPERO registration number: CRD42020191835.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Claroni</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3323-616X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morettini</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Research Institute on Sustainable Economic Growth of the National Research Council of Italy, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tola</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covotta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forastiere</LastName><ForeName>Ester</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torregiani</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Laparoendosc Adv Surg Tech A</MedlineTA><NlmUniqueID>9706293</NlmUniqueID><ISSNLinking>1092-6429</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007327" MajorTopicYN="Y">Insufflation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011027" MajorTopicYN="Y">Pneumoperitoneum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020069" MajorTopicYN="N">Shoulder Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013525" MajorTopicYN="N">Surgical Instruments</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">insufflation system</Keyword><Keyword MajorTopicYN="N">laparoscopic surgery</Keyword><Keyword MajorTopicYN="N">operative time</Keyword><Keyword MajorTopicYN="N">pneumoperitoneum</Keyword><Keyword MajorTopicYN="N">postoperative pain</Keyword><Keyword MajorTopicYN="N">valveless trocar</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>11</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35404130</ArticleId><ArticleId IdType="doi">10.1089/lap.2022.0022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35892906</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Clinical Characteristics, Genetic Findings and Arrhythmic Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia from China: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1104</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life12081104</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited cardiac ion channelopathy. The present study aims to examine the clinical characteristics, genetic basis, and arrhythmic outcomes of CPVT patients from China to elucidate the difference between CPVT patients in Asia and Western countries.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed and Embase were systematically searched for case reports or series reporting on CPVT patients from China until 19 February 2022 using the keyword: "Catecholaminergic Polymorphic Ventricular Tachycardia" or "CPVT", with the location limited to: "China" or "Hong Kong" or "Macau" in Embase, with no language or publication-type restriction. Articles that did not state a definite diagnosis of CPVT and articles with duplicate cases found in larger cohorts were excluded. All the included publications in this review were critically appraised based on the Joanna Briggs Institute Critical Appraisal Checklist. Clinical characteristics, genetic findings, and the primary outcome of spontaneous ventricular tachycardia/ventricular fibrillation (VT/VF) were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 58 unique cases from 15 studies (median presentation age: 8 (5.0-11.8) years old) were included. All patients, except one, presented at or before 19 years of age. There were 56 patients (96.6%) who were initially symptomatic. Premature ventricular complexes (PVCs) were present in 44 out of 51 patients (86.3%) and VT in 52 out of 58 patients (89.7%). Genetic tests were performed on 54 patients (93.1%) with a yield of 87%. RyR2, CASQ2, TERCL, and SCN10A mutations were found in 35 (71.4%), 12 (24.5%), 1 (0.02%) patient, and 1 patient (0.02%), respectively. There were 54 patients who were treated with beta-blockers, 8 received flecainide, 5 received amiodarone, 2 received verapamil and 2 received propafenone. Sympathectomy (<i>n</i> = 10), implantable cardioverter-defibrillator implantation (<i>n</i> = 8) and ablation (<i>n</i> = 1) were performed. On follow-up, 13 patients developed VT/VF.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This was the first systematic review of CPVT patients from China. Most patients had symptoms on initial presentation, with syncope as the presenting complaint. RyR2 mutation accounts for more than half of the CPVT cases, followed by CASQ2, TERCL and SCN10A mutations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Justin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4977-5435</Identifier><AffiliationInfo><Affiliation>Cardiac Electrophysiology Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sharen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jiandong</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3780-9033</Identifier><AffiliationInfo><Affiliation>School of Data Science, City University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeevaratnam</LastName><ForeName>Kamalan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakhani</LastName><ForeName>Ishan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radford</LastName><ForeName>Danny</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kent and Medway Medical School, Canterbury CT2 7FS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coakley-Youngs</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Kent and Medway Medical School, Canterbury CT2 7FS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pay</LastName><ForeName>Levent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul 34147, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;inier</LastName><ForeName>G&#xf6;ksel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul 34147, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altinsoy</LastName><ForeName>Meltem</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3494-5999</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara 06145, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behnoush</LastName><ForeName>Amir Hossein</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0002-9955-4227</Identifier><AffiliationInfo><Affiliation>Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran 1416643931, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmoudi</LastName><ForeName>Elham</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran 1416643931, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matusik</LastName><ForeName>Pawe&#x142; T</ForeName><Initials>PT</Initials><Identifier Source="ORCID">0000-0001-5788-575X</Identifier><AffiliationInfo><Affiliation>Department of Electrocardiology, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, 31-202 Krak&#xf3;w, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazoukis</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Larnaca General Hospital, Larnaca 6301, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, University of Nicosia, Nicosia 2408, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Zamora</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, Department of Cardiology, Delta Clinic, Rosario S2000, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Shaoying</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ziliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yunlong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Gary</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5510-1253</Identifier><AffiliationInfo><Affiliation>Cardiac Electrophysiology Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kent and Medway Medical School, Canterbury CT2 7FS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116014, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CPVT</Keyword><Keyword MajorTopicYN="N">RyR2</Keyword><Keyword MajorTopicYN="N">catecholaminergic polymorphic ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>4</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35892906</ArticleId><ArticleId IdType="pmc">PMC9330865</ArticleId><ArticleId IdType="doi">10.3390/life12081104</ArticleId><ArticleId IdType="pii">life12081104</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rucinski C., Winbo A., Marcondes L., Earle N., Stiles M., Stiles R., Hooks D., Neas K., Hayes I., Crawford J., et al. A Population-Based Registry of Patients with Inherited Cardiac Conditions and Resuscitated Cardiac Arrest. J. Am. Coll. Cardiol. 2020;75:2698&#x2013;2707. doi: 10.1016/j.jacc.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.004</ArticleId><ArticleId IdType="pubmed">32466885</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K.H., Lee S., Yin C., Liu T., Ngarmukos T., Conte G., Yan G.X., Sy R.W., Letsas K.P., Tse G. Brugada syndrome: A comprehensive review of pathophysiological mechanisms and risk stratification strategies. Int. J. Cardiol. Heart Vasc. 2020;26:100468. doi: 10.1016/j.ijcha.2020.100468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2020.100468</ArticleId><ArticleId IdType="pmc">PMC6974766</ArticleId><ArticleId IdType="pubmed">31993492</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Chen P., Li C., Tan L., Xu J., Wang H., Sun Y., Wang Y., Zhao C., Link M.S., et al. Genetic arrhythmias complicating patients with dilated cardiomyopathy. Heart Rhythm. 2020;17:305&#x2013;312. doi: 10.1016/j.hrthm.2019.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.09.012</ArticleId><ArticleId IdType="pubmed">31521807</ArticleId></ArticleIdList></Reference><Reference><Citation>Asatryan B., Schaller A., Seiler J., Servatius H., Noti F., Baldinger S.H., Tanner H., Roten L., Dillier R., Lam A., et al. Usefulness of Genetic Testing in Sudden Cardiac Arrest Survivors with or Without Previous Clinical Evidence of Heart Disease. Am. J. Cardiol. 2019;123:2031&#x2013;2038. doi: 10.1016/j.amjcard.2019.02.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2019.02.061</ArticleId><ArticleId IdType="pubmed">30975432</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiba T. Recent understanding of clinical sequencing and gene-based risk stratification in inherited primary arrhythmia syndrome. J. Cardiol. 2019;73:335&#x2013;342. doi: 10.1016/j.jjcc.2019.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2019.01.009</ArticleId><ArticleId IdType="pubmed">30910390</ArticleId></ArticleIdList></Reference><Reference><Citation>Munroe P.B., Addison S., Abrams D.J., Sebire N.J., Cartwright J., Donaldson I., Cohen M.M., Mein C., Tinker A., Harmer S.C., et al. Postmortem Genetic Testing for Cardiac Ion Channelopathies in Stillbirths. Circ. Genom. Precis. Med. 2018;11:e001817. doi: 10.1161/CIRCGEN.117.001817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGEN.117.001817</ArticleId><ArticleId IdType="pubmed">29874177</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner J.R., Winbo A., Abrams D., Vohra J., Wilde A.A. Channelopathies That Lead to Sudden Cardiac Death: Clinical and Genetic Aspects. Heart Lung Circ. 2019;28:22&#x2013;30. doi: 10.1016/j.hlc.2018.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2018.09.007</ArticleId><ArticleId IdType="pubmed">30389366</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse G., Zhou J., Lee S., Liu T., Bazoukis G., Mililis P., Wong I.C.K., Chen C., Xia Y., Kamakura T., et al. Incorporating Latent Variables Using Nonnegative Matrix Factorization Improves Risk Stratification in Brugada Syndrome. J. Am. Heart Assoc. 2020;9:e012714. doi: 10.1161/JAHA.119.012714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.012714</ArticleId><ArticleId IdType="pmc">PMC7763720</ArticleId><ArticleId IdType="pubmed">33170070</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori S.G., Wilde A.A., Horie M., Cho Y., Behr E.R., Berul C., Blom N., Brugada J., Chiang C.-E., Huikuri H., et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932&#x2013;1963. doi: 10.1016/j.hrthm.2013.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2013.05.014</ArticleId><ArticleId IdType="pubmed">24011539</ArticleId></ArticleIdList></Reference><Reference><Citation>Vemireddy L.P., Aqeel A., Ying G.W., Majlesi D., Woo V. A Rare Case of RYR2 Mutation Causing Sudden Cardiac Arrest Due to Catecholaminergic Polymorphic Ventricular Tachycardia. Cureus. 2021;13:e13417. doi: 10.7759/cureus.13417.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13417</ArticleId><ArticleId IdType="pmc">PMC7980721</ArticleId><ArticleId IdType="pubmed">33763313</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K., Titus E.W., Lieve K.V., Roston T.M., Mazzanti A., Deiter F.H., Denjoy I., Ingles J., Till J., Robyns T., et al. An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation. 2020;142:932&#x2013;947. doi: 10.1161/CIRCULATIONAHA.120.045723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.045723</ArticleId><ArticleId IdType="pmc">PMC7484339</ArticleId><ArticleId IdType="pubmed">32693635</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Guo R., Gao L., Cui L., Zhao Z., Yu X., Yuan Y., Xu X. CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia. Mol. Genet. Genom. Med. 2019;7:e949. doi: 10.1002/mgg3.949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.949</ArticleId><ArticleId IdType="pmc">PMC6825949</ArticleId><ArticleId IdType="pubmed">31482657</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotti L., Spazzolini C., Tester D.J., Ghidoni A., Baruteau A.E., Beckmann B.M., Behr E.R., Bennett J.S., Bezzina C.R., Bhuiyan Z.A., et al. Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry. Eur. Heart J. 2019;40:2964&#x2013;2975. doi: 10.1093/eurheartj/ehz311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz311</ArticleId><ArticleId IdType="pmc">PMC6748747</ArticleId><ArticleId IdType="pubmed">31170290</ArticleId></ArticleIdList></Reference><Reference><Citation>Badone B., Ronchi C., Kotta M.C., Sala L., Ghidoni A., Crotti L., Zaza A. Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes. Front. Cardiovasc. Med. 2018;5:176. doi: 10.3389/fcvm.2018.00176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2018.00176</ArticleId><ArticleId IdType="pmc">PMC6297375</ArticleId><ArticleId IdType="pubmed">30619883</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Jaimez J., Palomino Doza J., Ortega A., Macias-Ruiz R., Perin F., Rodriguez-Vazquez del Rey M.M., Ortiz-Genga M., Monserrat L., Barriales-Villa R., Blanca E., et al. Calmodulin 2 Mutation N98S Is Associated with Unexplained Cardiac Arrest in Infants Due to Low Clinical Penetrance Electrical Disorders. PLoS ONE. 2016;11:e0153851. doi: 10.1371/journal.pone.0153851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153851</ArticleId><ArticleId IdType="pmc">PMC4839566</ArticleId><ArticleId IdType="pubmed">27100291</ArticleId></ArticleIdList></Reference><Reference><Citation>Behere S.P., Weindling S.N. Catecholaminergic polymorphic ventricular tachycardia: An exciting new era. Ann. Pediatr. Cardiol. 2016;9:137&#x2013;146. doi: 10.4103/0974-2069.180645.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-2069.180645</ArticleId><ArticleId IdType="pmc">PMC4867798</ArticleId><ArticleId IdType="pubmed">27212848</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvage S.C., Chandrasekharan K.H., Jeevaratnam K., Dulhunty A.F., Thompson A.J., Jackson A.P., Huang C.L. Multiple targets for flecainide action: Implications for cardiac arrhythmogenesis. Br. J. Pharmacol. 2018;175:1260&#x2013;1278. doi: 10.1111/bph.13807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13807</ArticleId><ArticleId IdType="pmc">PMC5866987</ArticleId><ArticleId IdType="pubmed">28369767</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., Link M.S., Morin D.P. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT) Prog. Cardiovasc. Dis. 2019;62:227&#x2013;234. doi: 10.1016/j.pcad.2019.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2019.05.006</ArticleId><ArticleId IdType="pubmed">31078562</ArticleId></ArticleIdList></Reference><Reference><Citation>di Giovanni G., Ciconte G., Sieira J., Conte G., Chierchia G.-B., de Asmundis C., Brugada P., Baltogiannis G.G., Lysitsas D.N., Kolettis T.M. CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature. Front. Cardiovasc. Med. 2019;6:92. doi: 10.3389/fcvm.2019.00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2019.00092</ArticleId><ArticleId IdType="pmc">PMC6644488</ArticleId><ArticleId IdType="pubmed">31380394</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori S.G., Wilde A.A., Horie M., Cho Y., Behr E.R., Berul C., Blom N., Brugada J., Chiang C.-E., Huikuri H., et al. Executive Summary: HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. Heart Rhythm. 2013;10:e85&#x2013;e103. doi: 10.1016/j.hrthm.2013.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2013.07.021</ArticleId><ArticleId IdType="pubmed">23916535</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzanti A., Kukavica D., Trancuccio A., Memmi M., Bloise R., Gambelli P., Marino M., Ort&#xed;z-Genga M., Morini M., Monteforte N., et al. Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia Treated with &#x3b2;-Blockers. JAMA Cardiol. 2022;7:504&#x2013;512. doi: 10.1001/jamacardio.2022.0219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2022.0219</ArticleId><ArticleId IdType="pmc">PMC8968697</ArticleId><ArticleId IdType="pubmed">35353122</ArticleId></ArticleIdList></Reference><Reference><Citation>Roston T.M., Haji-Ghassemi O., LaPage M.J., Batra A.S., Bar-Cohen Y., Anderson C., Lau Y.R., Maginot K., Gebauer R.A., Etheridge S.P., et al. Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry. PLoS ONE. 2018;13:e0205925. doi: 10.1371/journal.pone.0205925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0205925</ArticleId><ArticleId IdType="pmc">PMC6221297</ArticleId><ArticleId IdType="pubmed">30403697</ArticleId></ArticleIdList></Reference><Reference><Citation>Roston T.M., Yuchi Z., Kannankeril P.J., Hathaway J., Vinocur J.M., Etheridge S.P., Potts J.E., Maginot K.R., Salerno J.C., Cohen M.I., et al. The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: Findings from an international multicentre registry. Europace. 2018;20:541&#x2013;547. doi: 10.1093/europace/euw389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euw389</ArticleId><ArticleId IdType="pmc">PMC6059141</ArticleId><ArticleId IdType="pubmed">28158428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi M., Denjoy I., Extramiana F., Maltret A., Buisson N.R., Lupoglazoff J.M., Klug D., Hayashi M., Takatsuki S., Villain E., et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation. 2009;119:2426&#x2013;2434. doi: 10.1161/CIRCULATIONAHA.108.829267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.829267</ArticleId><ArticleId IdType="pubmed">19398665</ArticleId></ArticleIdList></Reference><Reference><Citation>Leenhardt A., Lucet V., Denjoy I., Grau F., Ngoc D.D., Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512&#x2013;1519. doi: 10.1161/01.CIR.91.5.1512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.91.5.1512</ArticleId><ArticleId IdType="pubmed">7867192</ArticleId></ArticleIdList></Reference><Reference><Citation>Coumel P. Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: Report of four cases. Br. Heart J. 1978;40:28&#x2013;37.</Citation></Reference><Reference><Citation>Sumitomo N. Current topics in catecholaminergic polymorphic ventricular tachycardia. J. Arrhythm. 2016;32:344&#x2013;351. doi: 10.1016/j.joa.2015.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joa.2015.09.008</ArticleId><ArticleId IdType="pmc">PMC5063269</ArticleId><ArticleId IdType="pubmed">27761157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura M., Ohno S., Naiki N., Nagaoka I., Dochi K., Wang Q., Hasegawa K., Kimura H., Miyamoto A., Mizusawa Y., et al. Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan. Circ. J. 2013;77:1705&#x2013;1713. doi: 10.1253/circj.CJ-12-1460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-12-1460</ArticleId><ArticleId IdType="pubmed">23595086</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumitomo N., Harada K., Nagashima M., Yasuda T., Nakamura Y., Aragaki Y., Saito A., Kurosaki K., Jouo K., Koujiro M., et al. Catecholaminergic polymorphic ventricular tachycardia: Electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart. 2003;89:66&#x2013;70. doi: 10.1136/heart.89.1.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heart.89.1.66</ArticleId><ArticleId IdType="pmc">PMC1767500</ArticleId><ArticleId IdType="pubmed">12482795</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Li X.M., Ge H.Y., Zhang Y., Liu H.J., Li M.T. Investigation of Catecholaminergic Polymorphic Ventricular Tachycardia Children in China: Clinical Characteristics, Delay to Diagnosis, and Misdiagnosis. Chin. Med. J. 2018;131:2864&#x2013;2865. doi: 10.4103/0366-6999.246078.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.246078</ArticleId><ArticleId IdType="pmc">PMC6278178</ArticleId><ArticleId IdType="pubmed">30511691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Zhou J., Jeevaratnam K., Lakhani I., Wong W.T., Kei Wong I.C., Mak C., Mok N.S., Liu T., Zhang Q., et al. Arrhythmic Outcomes in Catecholaminergic Polymorphic Ventricular Tachycardia. medRxiv. 2021 doi: 10.1101/2021.01.04.21249214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.04.21249214</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak C.M., Chen S.P., Mok N.S., Siu W.K., Lee H.H., Ching C.K., Tsui P.T., Fong N.C., Yuen Y.P., Poon W.T., et al. Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: A 10-year regional laboratory experience. Hong Kong Med. J. 2018;24:340&#x2013;349. doi: 10.12809/hkmj176870.</Citation><ArticleIdList><ArticleId IdType="doi">10.12809/hkmj176870</ArticleId><ArticleId IdType="pubmed">29497013</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho Hui J., Athena Lee Y., Hui K., Zhou J., Satti D., Chung C., Radford D., Lakhani I., Behnoush A., Roever L., et al. Clinical characteristics, outcomes, and genetic findings of patients with catecholaminergic polymorphic ventricular tachycardia in Hong Kong: A systematic review. Ann. Clin. Cardiol. 2022;4:3&#x2013;8. doi: 10.4103/accj.Accj_2_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/accj.Accj_2_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S., Munn Z., Tufanaru C., Aromataris E., Sears K., Sfetcu R., Currie M., Qureshi R., Mattis P., Lisy K., et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E., Munn Z., editors. JBI Manual for Evidence Synthesis. JBI Adelaide; Adelaide, Australia: 2020.</Citation></Reference><Reference><Citation>Priori S.G., Chen S.R. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ. Res. 2011;108:871&#x2013;883. doi: 10.1161/CIRCRESAHA.110.226845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.110.226845</ArticleId><ArticleId IdType="pmc">PMC3085083</ArticleId><ArticleId IdType="pubmed">21454795</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405&#x2013;423. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok N.S., Lam C.W., Fong N.C., Hui Y.W., Choi Y.C., Chan K.Y. Cardiac ryanodine receptor gene (hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope. Chin. Med. J. 2006;119:2129&#x2013;2133. doi: 10.1097/00029330-200612020-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00029330-200612020-00018</ArticleId><ArticleId IdType="pubmed">17199967</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu T.C., Liu A.P., Lun K.S., Chung B.H., Yung T.C. Clinical and genetic profile of catecholaminergic polymorphic ventricular tachycardia in Hong Kong Chinese children. Hong Kong Med. J. 2016;22:314&#x2013;319. doi: 10.12809/hkmj154653.</Citation><ArticleIdList><ArticleId IdType="doi">10.12809/hkmj154653</ArticleId><ArticleId IdType="pubmed">27256466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge H.Y., Li X.M., Jiang H., Zhang Y., Liu H.J., Zheng X.C., Li M.T. Clinical challenges in the management of catecholaminergic polymorphic ventricular tachycardia in children. Zhonghua Er Ke Za Zhi. 2017;55:926&#x2013;931. doi: 10.3760/cma.j.issn.0578-1310.2017.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0578-1310.2017.12.012</ArticleId><ArticleId IdType="pubmed">29262473</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L., Cui L., Zheng L., Zhao Z., Li Q., Yu X., Wang J., Yuan Y. A novel variant of the CASQ2 gene in a Chinese family with catecholaminergic polymorphic ventricular tachycardia. Cardiol. J. 2018;25:756&#x2013;758. doi: 10.5603/CJ.2018.0155.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.2018.0155</ArticleId><ArticleId IdType="pubmed">30600839</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Li K., Chen D.H., Yang F., Li J.F., Xu B.H., Liu Y.W., She F., He R., Liu F., et al. Treatment efficiency evaluation of left cardiac sympathetic denervation for patients with inherited arrhythmia by exercise-stress test. Zhonghua Xin Xue Guan Bing Za Zhi. 2021;49:796&#x2013;801. doi: 10.3760/cma.j.cn112148-20200920-00747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112148-20200920-00747</ArticleId><ArticleId IdType="pubmed">34404189</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z.L., Zeng S.Y., Liang D.P., Liu T., Wang S.S., Zhang Z.W. Analysis of 30 cases of inherited cardiac arrhythmia syndrome in children. Zhonghua Er Ke Za Zhi. 2019;57:700&#x2013;704. doi: 10.3760/cma.j.issn.0578-1310.2019.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0578-1310.2019.09.010</ArticleId><ArticleId IdType="pubmed">31530356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D.S., Shen J.H., Lu J.P., Yu S.Y., Zhang G., Geng J., Shan Q.J. Clinical features of six patients with catecholaminergic polymorphic ventricular tachycardia. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40:844&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">23302672</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.W., Ji W., Zhu D.Q., Li F. Efficacy and safety of implantable cardioverter-defibrillator implantation in pediatric tachycardia cases. Zhonghua Er Ke Za Zhi. 2020;58:905&#x2013;909. doi: 10.3760/cma.j.cn112140-20200408-00361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112140-20200408-00361</ArticleId><ArticleId IdType="pubmed">33120462</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L., Hou C., Jiang X., Zhao J., Li Y., Xiao T. A compound heterozygosity of Tecrl gene confirmed in a catecholaminergic polymorphic ventricular tachycardia family. Eur. J. Med. Genet. 2019;62:103631. doi: 10.1016/j.ejmg.2019.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2019.01.018</ArticleId><ArticleId IdType="pubmed">30790670</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan H., Lu Y., Yan S., Qiao L., Hua Y., Li Y., Zhou K., Wang C. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T&gt;G for 6 years in a 9-year-old child. Medicine. 2018;97:e0368. doi: 10.1097/MD.0000000000010368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000010368</ArticleId><ArticleId IdType="pmc">PMC5916663</ArticleId><ArticleId IdType="pubmed">29668588</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., He S., Liao Z., Feng R., Liu R., Peng Y., Yu N., Qi H., Chen J., Huang Z., et al. Whole exome sequencing identified a pathogenic mutation in RYR2 in a Chinese family with unexplained sudden death. J. Electrocardiol. 2018;51:309&#x2013;315. doi: 10.1016/j.jelectrocard.2017.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2017.10.002</ArticleId><ArticleId IdType="pubmed">29132927</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou C., Jiang X., Zhang Y., Xu M., Sun X., Jia J., Li Y., Zhao Y., Xie L., Xiao T. A de novo heterozygous cardiac ryanodine receptor gene (RYR2) mutation in a catecholaminergic polymorphic ventricular tachycardia patient. Gene Rep. 2019;16:100439. doi: 10.1016/j.genrep.2019.100439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2019.100439</ArticleId></ArticleIdList></Reference><Reference><Citation>She Y., Li Y., Yu H., Zhou L. Ryanodine receptor 2 mutation: Not only catecholaminergic polymorphic ventricular tachycardia but also epileptiform discharges in electroencephalogram. Neurol. Asia. 2020;25:387&#x2013;394.</Citation></Reference><Reference><Citation>Xiong J., Liu X., Gong Y., Zhang P., Qiang S., Zhao Q., Guo R., Qian Y., Wang L., Zhu L., et al. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2. J. Mol. Cell. Cardiol. 2018;117:26&#x2013;35. doi: 10.1016/j.yjmcc.2018.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2018.02.014</ArticleId><ArticleId IdType="pubmed">29477366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Li A., Huang C.L.H., Wang G., Wang D. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A. Stem Cell Res. 2019;39:101509. doi: 10.1016/j.scr.2019.101509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2019.101509</ArticleId><ArticleId IdType="pubmed">31382203</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi G., Kopplin L.J., Tester D.J., Will M.L., Haglund C.M., Ackerman M.J. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation. 2004;110:2119&#x2013;2124. doi: 10.1161/01.CIR.0000144471.98080.CA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000144471.98080.CA</ArticleId><ArticleId IdType="pubmed">15466642</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa Y., Ueda K., Komura S., Washizuka T., Chinushi M., Inagaki N., Matsumoto Y., Hayashi T., Takahashi M., Nakano N., et al. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia. Int. J. Cardiol. 2005;99:343&#x2013;345. doi: 10.1016/j.ijcard.2003.11.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2003.11.050</ArticleId><ArticleId IdType="pubmed">15749201</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros-Domingo A., Bhuiyan Z.A., Tester D.J., Hofman N., Bikker H., van Tintelen J.P., Mannens M.M., Wilde A.A., Ackerman M.J. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: A comprehensive open reading frame mutational analysis. J. Am. Coll. Cardiol. 2009;54:2065&#x2013;2074. doi: 10.1016/j.jacc.2009.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.08.022</ArticleId><ArticleId IdType="pmc">PMC2880864</ArticleId><ArticleId IdType="pubmed">19926015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozawa J., Ohno S., Fujii Y., Makiyama T., Suzuki H., Saitoh A., Horie M. Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1- Modified Schwartz Score. Circ. J. 2018;82:2269&#x2013;2276. doi: 10.1253/circj.CJ-17-1032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-17-1032</ArticleId><ArticleId IdType="pubmed">29925740</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidelmann S.B., Smith E., Subrahmanyan L., Dykas D., Abou Ziki M.D., Azari B., Hannah-Shmouni F., Jiang Y., Akar J.G., Marieb M., et al. Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults. Circ. Cardiovasc. Genet. 2017;10:e001573. doi: 10.1161/CIRCGENETICS.116.001573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.116.001573</ArticleId><ArticleId IdType="pmc">PMC5245580</ArticleId><ArticleId IdType="pubmed">28087566</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen S.L., Hertz C.L., Ferrero-Miliani L., Dahl M., Weeke P.E., LuCamp, Ottesen G.L., Frank-Hansen R., Bundgaard H., Morling N. Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting. Eur. J. Hum. Genet. 2016;24:1797&#x2013;1802. doi: 10.1038/ejhg.2016.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2016.118</ArticleId><ArticleId IdType="pmc">PMC5117921</ArticleId><ArticleId IdType="pubmed">27650965</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallegos-Cortez A., Alonso-Ortiz N., Antunez-Arguellez E., Villarreal-Molina T., Totomoch-Serra A., Iturralde-Torres P., Marquez M.F. Catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2 mutation: Recreational cycling as a trigger of lethal arrhythmias. Arch. Med. Sci. 2020;16:466&#x2013;470. doi: 10.5114/aoms.2019.89691.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms.2019.89691</ArticleId><ArticleId IdType="pmc">PMC7069429</ArticleId><ArticleId IdType="pubmed">32190159</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori S.G., Napolitano C., Memmi M., Colombi B., Drago F., Gasparini M., DeSimone L., Coltorti F., Bloise R., Keegan R., et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69&#x2013;74. doi: 10.1161/01.CIR.0000020013.73106.D8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000020013.73106.D8</ArticleId><ArticleId IdType="pubmed">12093772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawata H., Ohno S., Aiba T., Sakaguchi H., Miyazaki A., Sumitomo N., Kamakura T., Nakajima I., Inoue Y.Y., Miyamoto K., et al. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations- Long-Term Prognosis After Initiation of Medical Treatment. Circ. J. 2016;80:1907&#x2013;1915. doi: 10.1253/circj.CJ-16-0250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-16-0250</ArticleId><ArticleId IdType="pubmed">27452199</ArticleId></ArticleIdList></Reference><Reference><Citation>Beery T.A., Shah M.J., Benson D.W. Genetic characterization of familial CPVT after 30 years. Biol. Res. Nurs. 2009;11:66&#x2013;72. doi: 10.1177/1099800409333369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1099800409333369</ArticleId><ArticleId IdType="pubmed">19398417</ArticleId></ArticleIdList></Reference><Reference><Citation>Postma A.V., Denjoy I., Hoorntje T.M., Lupoglazoff J.M., Da Costa A., Sebillon P., Mannens M.M., Wilde A.A., Guicheney P. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 2002;91:e21&#x2013;e26. doi: 10.1161/01.RES.0000038886.18992.6B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000038886.18992.6B</ArticleId><ArticleId IdType="pubmed">12386154</ArticleId></ArticleIdList></Reference><Reference><Citation>Terentyev D., Nori A., Santoro M., Viatchenko-Karpinski S., Kubalova Z., Gyorke I., Terentyeva R., Vedamoorthyrao S., Blom N.A., Valle G., et al. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ. Res. 2006;98:1151&#x2013;1158. doi: 10.1161/01.RES.0000220647.93982.08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000220647.93982.08</ArticleId><ArticleId IdType="pubmed">16601229</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappone C., Micaglio E., Locati E.T., Monasky M.M. The omics of channelopathies and cardiomyopathies: What we know and how they are useful. Eur. Heart J. Suppl. 2020;22:L105&#x2013;L109. doi: 10.1093/eurheartj/suaa146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suaa146</ArticleId><ArticleId IdType="pmc">PMC7904073</ArticleId><ArticleId IdType="pubmed">33654474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappone C., Ciconte G., Micaglio E., Monasky M.M. Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value. Eur. Heart J. 2021;42:1273&#x2013;1274. doi: 10.1093/eurheartj/ehab071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab071</ArticleId><ArticleId IdType="pmc">PMC8014514</ArticleId><ArticleId IdType="pubmed">33595071</ArticleId></ArticleIdList></Reference><Reference><Citation>Micaglio E., Monasky M.M., Bernardini A., Mecarocci V., Borrelli V., Ciconte G., Locati E.T., Piccoli M., Ghiroldi A., Anastasia L., et al. Clinical Considerations for a Family with Dilated Cardiomyopathy, Sudden Cardiac Death, and a Novel TTN Frameshift Mutation. Int. J. Mol. Sci. 2021;22:670. doi: 10.3390/ijms22020670.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020670</ArticleId><ArticleId IdType="pmc">PMC7826882</ArticleId><ArticleId IdType="pubmed">33445410</ArticleId></ArticleIdList></Reference><Reference><Citation>Monasky M.M., Micaglio E., Ciconte G., Pappone C. Brugada Syndrome: Oligogenic or Mendelian Disease? Int. J. Mol. Sci. 2020;21:1687. doi: 10.3390/ijms21051687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051687</ArticleId><ArticleId IdType="pmc">PMC7084676</ArticleId><ArticleId IdType="pubmed">32121523</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori S.G., Napolitano C. Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels. J. Clin. Investig. 2005;115:2033&#x2013;2038. doi: 10.1172/JCI25664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI25664</ArticleId><ArticleId IdType="pmc">PMC1180555</ArticleId><ArticleId IdType="pubmed">16075044</ArticleId></ArticleIdList></Reference><Reference><Citation>Roston T.M., Vinocur J.M., Maginot K.R., Mohammed S., Salerno J.C., Etheridge S.P., Cohen M., Hamilton R.M., Pflaumer A., Kanter R.J., et al. Catecholaminergic polymorphic ventricular tachycardia in children: Analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ. Arrhythm. Electrophysiol. 2015;8:633&#x2013;642. doi: 10.1161/CIRCEP.114.002217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.114.002217</ArticleId><ArticleId IdType="pmc">PMC4472494</ArticleId><ArticleId IdType="pubmed">25713214</ArticleId></ArticleIdList></Reference><Reference><Citation>Postma A.V., Denjoy I., Kamblock J., Alders M., Lupoglazoff J.M., Vaksmann G., Dubosq-Bidot L., Sebillon P., Mannens M.M., Guicheney P., et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J. Med. Genet. 2005;42:863&#x2013;870. doi: 10.1136/jmg.2004.028993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2004.028993</ArticleId><ArticleId IdType="pmc">PMC1735955</ArticleId><ArticleId IdType="pubmed">16272262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauce B., Rampazzo A., Basso C., Bagattin A., Daliento L., Tiso N., Turrini P., Thiene G., Danieli G.A., Nava A. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: Early diagnosis of asymptomatic carriers. J. Am. Coll. Cardiol. 2002;40:341&#x2013;349. doi: 10.1016/S0735-1097(02)01946-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(02)01946-0</ArticleId><ArticleId IdType="pubmed">12106942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallas D., Roston T.M., Franciosi S., Brett L., Sanatani S., Lieve K.V.V., Clur S.-A., Wilde A.A.M., Kwok S.-Y., Kannankeril P.J., et al. Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2021;18:1825&#x2013;1832. doi: 10.1016/j.hrthm.2021.07.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.07.061</ArticleId><ArticleId IdType="pubmed">34333088</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Werf C., Zwinderman A.H., Wilde A.A. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: State of the art and future developments. Europace. 2012;14:175&#x2013;183. doi: 10.1093/europace/eur277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eur277</ArticleId><ArticleId IdType="pubmed">21893508</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.-J., Lee K.Y., Kim S.L., Pasqualini F.S., Campbell P.H., Parker K.K., Pu W.T., Zhang D., Qi Y., Yang P., et al. Insights into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia from Engineered Human Heart Tissue. Circulation. 2019;140:390&#x2013;404. doi: 10.1161/CIRCULATIONAHA.119.039711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.039711</ArticleId><ArticleId IdType="pmc">PMC6750809</ArticleId><ArticleId IdType="pubmed">31311300</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadeh K., Achercouk Z., Fazmin I.T., Nantha Kumar N., Salvage S.C., Edling C.E., Huang C.L., Jeevaratnam K. Protein expression profiles in murine ventricles modeling catecholaminergic polymorphic ventricular tachycardia: Effects of genotype and sex. Ann. N. Y. Acad. Sci. 2020;1478:63&#x2013;74. doi: 10.1111/nyas.14426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14426</ArticleId><ArticleId IdType="pubmed">32713021</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Hothi S.S., Salvage S.C., Jeevaratnam K., Grace A.A., Huang C.L. Arrhythmic effects of Epac-mediated ryanodine receptor activation in Langendorff-perfused murine hearts are associated with reduced conduction velocity. Clin. Exp. Pharmacol. Physiol. 2017;44:686&#x2013;692. doi: 10.1111/1440-1681.12751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1440-1681.12751</ArticleId><ArticleId IdType="pmc">PMC5488224</ArticleId><ArticleId IdType="pubmed">28316073</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieve K.V., van der Werf C., Wilde A.A. Catecholaminergic Polymorphic Ventricular Tachycardia. Circ. J. 2016;80:1285&#x2013;1291. doi: 10.1253/circj.CJ-16-0326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-16-0326</ArticleId><ArticleId IdType="pubmed">27180891</ArticleId></ArticleIdList></Reference><Reference><Citation>Tulumen E., Schulze-Bahr E., Zumhagen S., Stallmeyer B., Seebohm G., Beckmann B.M., Kaab S., Rudic B., Liebe V., Wolpert C., et al. Early repolarization pattern: A marker of increased risk in patients with catecholaminergic polymorphic ventricular tachycardia. Europace. 2016;18:1587&#x2013;1592. doi: 10.1093/europace/euv357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euv357</ArticleId><ArticleId IdType="pubmed">26705564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciconte G., Monasky M.M., Santinelli V., Micaglio E., Vicedomini G., Anastasia L., Negro G., Borrelli V., Giannelli L., Santini F., et al. Brugada syndrome genetics is associated with phenotype severity. Eur. Heart J. 2021;42:1082&#x2013;1090. doi: 10.1093/eurheartj/ehaa942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa942</ArticleId><ArticleId IdType="pmc">PMC7955973</ArticleId><ArticleId IdType="pubmed">33221895</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse G., Wong S.T., Tse V., Yeo J.M. Depolarization vs. repolarization: What is the mechanism of ventricular arrhythmogenesis underlying sodium channel haploinsufficiency in mouse hearts? Acta Physiol. 2016;218:234&#x2013;235. doi: 10.1111/apha.12694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.12694</ArticleId><ArticleId IdType="pubmed">27084434</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse G. Both transmural dispersion of repolarization and of refractoriness are poor predictors of arrhythmogenicity: A role for iCEB (QT/QRS)? J. Geriatr. Cardiol. 2016;13:813&#x2013;814. doi: 10.11909/j.issn.1671-5411.2016.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.11909/j.issn.1671-5411.2016.09.007</ArticleId><ArticleId IdType="pmc">PMC5122509</ArticleId><ArticleId IdType="pubmed">27899948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse G. (Tpeak &#x2212; Tend)/QRS and (Tpeak &#x2212; Tend)/(QT &#xd7; QRS): Novel markers for predicting arrhythmic risk in the Brugada syndrome. Europace. 2017;19:696. doi: 10.1093/europace/euw194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euw194</ArticleId><ArticleId IdType="pubmed">28431069</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse G., Yan B.P. Novel arrhythmic risk markers incorporating QRS dispersion: QRSd &#xd7; (Tpeak &#x2212; Tend )/QRS and QRSd &#xd7; (Tpeak &#x2212; Tend )/(QT &#xd7; QRS) Ann. Noninvasive Electrocardiol. 2017;22:e12397. doi: 10.1111/anec.12397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anec.12397</ArticleId><ArticleId IdType="pmc">PMC6931740</ArticleId><ArticleId IdType="pubmed">27535213</ArticleId></ArticleIdList></Reference><Reference><Citation>Robyns T., Lu H.R., Gallacher D.J., Garweg C., Ector J., Willems R., Janssens S., Nuyens D. Evaluation of Index of Cardio-Electrophysiological Balance (iCEB) as a New Biomarker for the Identification of Patients at Increased Arrhythmic Risk. Ann. Noninvasive Electrocardiol. 2016;21:294&#x2013;304. doi: 10.1111/anec.12309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anec.12309</ArticleId><ArticleId IdType="pmc">PMC6931457</ArticleId><ArticleId IdType="pubmed">26305685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H.R., Yan G.X., Gallacher D.J. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: Beyond QT-prolongation and Torsades de Pointes (TdPs) J. Pharmacol. Toxicol. Methods. 2013;68:250&#x2013;259. doi: 10.1016/j.vascn.2013.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vascn.2013.01.003</ArticleId><ArticleId IdType="pubmed">23337247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse G. Novel conduction-repolarization indices for the stratification of arrhythmic risk. J. Geriatr. Cardiol. 2016;13:811&#x2013;812. doi: 10.11909/j.issn.1671-5411.2016.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.11909/j.issn.1671-5411.2016.09.008</ArticleId><ArticleId IdType="pmc">PMC5122508</ArticleId><ArticleId IdType="pubmed">27899947</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Werf C., Wilde A.A.M. Catecholaminergic polymorphic ventricular tachycardia: From bench to bedside. Heart. 2013;99:497&#x2013;504. doi: 10.1136/heartjnl-2012-302033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-302033</ArticleId><ArticleId IdType="pubmed">23390049</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle G., Volpe P., Arad M. Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): Comparative analysis of R33Q and D307H mutants. J. Muscle Res. Cell Motil. 2020;41:251&#x2013;258. doi: 10.1007/s10974-020-09587-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10974-020-09587-2</ArticleId><ArticleId IdType="pmc">PMC7666291</ArticleId><ArticleId IdType="pubmed">32902830</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning F., Luo L., Ahmad S., Valli H., Jeevaratnam K., Wang T., Guzadhur L., Yang D., Fraser J.A., Huang C.L., et al. The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles. Pflugers Arch. 2016;468:655&#x2013;665. doi: 10.1007/s00424-015-1750-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-015-1750-0</ArticleId><ArticleId IdType="pmc">PMC4792352</ArticleId><ArticleId IdType="pubmed">26545784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Wu J., Jeevaratnam K., King J.H., Guzadhur L., Ren X., Grace A.A., Lei M., Huang C.L., Fraser J.A. Conduction slowing contributes to spontaneous ventricular arrhythmias in intrinsically active murine RyR2-P2328S hearts. J. Cardiovasc. Electrophysiol. 2013;24:210&#x2013;218. doi: 10.1111/jce.12015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.12015</ArticleId><ArticleId IdType="pubmed">23131176</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohatgi R.K., Sugrue A., Bos J.M., Cannon B.C., Asirvatham S.J., Moir C., Owen H.J., Bos K.M., Kruisselbrink T., Ackerman M.J. Contemporary Outcomes in Patients With Long QT Syndrome. J. Am. Coll. Cardiol. 2017;70:453&#x2013;462. doi: 10.1016/j.jacc.2017.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.05.046</ArticleId><ArticleId IdType="pubmed">28728690</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh R., Amin A.S., Wilde A.A.M., Adler A., Abiusi E., Amenta S., Trevisan V., Novelli V., Gollob M.H., Care M., et al. Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death. Eur. Heart J. 2022;43:1500&#x2013;1510. doi: 10.1093/eurheartj/ehab687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab687</ArticleId><ArticleId IdType="pmc">PMC9009401</ArticleId><ArticleId IdType="pubmed">34557911</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscu-Gregor A., Marschall C., Rost I., Muntjes C., Schonecker A., Schuessler-Hahn F., Hohendanner F., Parwani A.S., Boldt L.-H., Ott C.-E., et al. Novel variants in TECRL cause recessive inherited CPVT type 3 with severe and variable clinical symptoms. J. Cardiovasc. Electrophysiol. 2020;31:1527&#x2013;1535. doi: 10.1111/jce.14446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14446</ArticleId><ArticleId IdType="pubmed">32173957</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Chen X.M., Barajas-Martinez H., Jiang H., Antzelevitch C., Hu D. Common variants in SCN10A gene associated with Brugada syndrome. Hum. Mol. Genet. 2021;31:157&#x2013;165. doi: 10.1093/hmg/ddab217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab217</ArticleId><ArticleId IdType="pmc">PMC8743002</ArticleId><ArticleId IdType="pubmed">34312669</ArticleId></ArticleIdList></Reference><Reference><Citation>Man J.C.K., Bosada F.M., Scholman K.T., Offerhaus J.A., Walsh R., van Duijvenboden K., van Eif V.W.W., Bezzina C.R., Verkerk A.O., Boukens B.J., et al. Variant Intronic Enhancer Controls SCN10A-short Expression and Heart Conduction. Circulation. 2021;144:229&#x2013;242. doi: 10.1161/CIRCULATIONAHA.121.054083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.054083</ArticleId><ArticleId IdType="pubmed">33910361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong L., Zhang M., Sridhar A., Darbar D. Pathogenic mutations perturb calmodulin regulation of Na(v)1.8 channel. Biochem. Biophys. Res. Commun. 2020;533:168&#x2013;174. doi: 10.1016/j.bbrc.2020.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.08.010</ArticleId><ArticleId IdType="pmc">PMC11038804</ArticleId><ArticleId IdType="pubmed">32948286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.T., Lee S., Zhou J., Chou O.H.I., Lee T.T.L., Leung K.S.K., Jeevaratnam K., Wong W.T., Liu T., Tse G. Clinical Characteristics, Genetic Basis and Healthcare Resource Utilisation and Costs in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia: A Retrospective Cohort Study. Rev. Cardiovasc. Med. 2022 doi: 10.20944/preprints202205.0119.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202205.0119.v1</ArticleId><ArticleId IdType="pmc">PMC11266943</ArticleId><ArticleId IdType="pubmed">39076628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30678785</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Catheter Ablation of Ventricular Tachycardia in Patients With a Ventricular Assist Device: A&#xa0;Systematic Review of Procedural Characteristics and&#xa0;Outcomes.</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>51</EndPage><MedlinePgn>39-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2018.08.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(18)30671-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This is a systematic review summarizing the procedural characteristics and outcomes of ventricular assist device (VAD)-related ventricular tachycardia (VT) ablation.</AbstractText><AbstractText Label="BACKGROUND">Drug-refractory VT refractory commonly develops post-VAD implantation. Procedural and outcome data come from small series or case reports.</AbstractText><AbstractText Label="METHODS">An electronic search was performed using major databases. Primary outcomes were VT recurrence, mortality, and cardiac transplantation. Secondary endpoints were acute procedural success and procedural complications.</AbstractText><AbstractText Label="RESULTS">Eighteen studies were included, with a total of 110 patients (mean age 59.6 &#xb1; 11 years, 89% men; VT storm 34%). Scar-related re-entry was the predominant mechanism of VT (90.3%) and cannula-related VT in 19.3% cases. Electroanatomical mapping interference occurred in 1.8% of cases; there were no reports of catheter entrapment. Noninducibility of clinical VT was achieved in 77.9%; procedural complications occurred in 9.4%. At a mean follow-up of 263.5 &#xb1; 267.0 days, VT recurred in 43.6%, 23.4% underwent cardiac transplant, and 48.1% died. There were no procedural-related deaths and no death was directly related to ventricular arrhythmia. In follow-up, there was a significant reduction in implantable cardioverter-defibrillator therapies or shocks (57.1% vs. 23.8%). Ablation allowed VT storm termination in 90% of patients.</AbstractText><AbstractText Label="CONCLUSIONS">VAD-related VT is predominantly related to pre-existing intrinsic myocardial scar rather than inflow cannula site insertion. Catheter ablation is a reasonable treatment strategy, albeit with expectedly high rate of recurrence, transplantation, and mortality related to severe underlying disease.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2019. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohaib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayward</LastName><ForeName>Christopher S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Heart Failure and Transplant Unit, Department of Cardiology, St. Vincent's Hospital, Darlinghurst, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muthiah</LastName><ForeName>Kavitha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Heart Failure and Transplant Unit, Department of Cardiology, St. Vincent's Hospital, Darlinghurst, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalman</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Westmead, Australia; Department of Cardiology, Westmead Applied Research Centre, University of Sydney, Westmead, Australia. Electronic address: saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2019 Jan;5(1):52-54. doi: 10.1016/j.jacep.2018.09.011.</RefSource><PMID Version="1">30678786</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016027" MajorTopicYN="N">Heart Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BIVAD</Keyword><Keyword MajorTopicYN="N">LVAD</Keyword><Keyword MajorTopicYN="N">RVAD</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">mechanical support</Keyword><Keyword MajorTopicYN="N">radiofrequency ablation</Keyword><Keyword MajorTopicYN="N">ventricular assist device</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30678785</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2018.08.009</ArticleId><ArticleId IdType="pii">S2405-500X(18)30671-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35187132</PMID><DateRevised><Year>2022</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of Amiodarone in Preventing the Occurrence of Reperfusion Ventricular Fibrillation After the Release of Aortic Cross-Clamp in Open-Heart Surgery Patients: A Meta-Analysis.</ArticleTitle><Pagination><StartPage>821938</StartPage><MedlinePgn>821938</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">821938</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2022.821938</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the efficiency of amiodarone in preventing the occurrence of reperfusion ventricular fibrillation (RVF) after aortic cross-clamp (ACC) release in patients undergoing open-heart surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched the Web of Science, Cochrane Library, EMBASE, and PubMed databases through January 2021 for relevant studies addressing the efficacy of amiodarone in preventing RVF after ACC release in patients undergoing cardiac surgery. A complete statistical analysis was performed using RevMan 5.3. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated to express the results of dichotomous outcomes using random or fixed-effect models. The chi-square test and <i>I</i> <sup>2</sup> test were used to calculate heterogeneity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven studies (856 enrolled patients; 311 in the amiodarone group, 268 in the lidocaine group, and 277 in the placebo group) were selected for the meta-analysis. The incidence of RVF was significantly decreased in the amiodarone group compared to the placebo group (RR = 0.69, 95%CI: 0.50-0.94, <i>P</i> = 0.02). However, amiodarone and lidocaine did not confer any significant difference (RR = 0.98, 95%CI: 0.61-1.59, <i>P</i> = 0.94). The percentage of patients requiring electric defibrillation counter shocks (DCSs) did not confer any significant difference between patients administered amiodarone and lidocaine or placebo (RR = 1.58, 95%CI: 0.29-8.74, <i>P</i> = 0.60; RR = 0.55, 95%CI: 0.27-1.10, <i>P</i> = 0.09; respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Amiodarone is more effective than a placebo in preventing RVF after ACC release in cardiac surgery. However, the amiodarone group required the same number of electrical DCSs to terminate RVF as the lidocaine or placebo groups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 He, Zhang and Xiong.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Li-Min</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>An</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amiodarone</Keyword><Keyword MajorTopicYN="N">aortic cross clamp</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">open-heart surgery</Keyword><Keyword MajorTopicYN="N">reperfusion ventricular fibrillation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35187132</ArticleId><ArticleId IdType="pmc">PMC8854653</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.821938</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Papakonstantinou NA, Baikoussis NG, Dedeilias P, Argiriou M, Charitos C. Cardiac surgery or interventional cardiology? Why not both? Let's go hybrid J Cardiol. (2017) 1:46&#x2013;56. 10.1016/j.jjcc.2016.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2016.09.007</ArticleId><ArticleId IdType="pubmed">27727088</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann Kreuziger L, Karkouti K, Tweddell J, Massicotte MP. Antithrombotic therapy management of adult and pediatric cardiac surgery patients. J Thromb Haemost. (2018) 11:2133&#x2013;46. 10.1111/jth.14276</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14276</ArticleId><ArticleId IdType="pubmed">30153372</ArticleId></ArticleIdList></Reference><Reference><Citation>Geissler H, Schlensak C, S&#xfc;dkamp M, Beyersdorf F. Heart valve surgery today: indications, operative technique, and selected aspects of postoperative care in acquired valvular heart disease. Dtsch Arztebl Int. (2009) 13:224&#x2013;33; quiz 34. 10.3238/arztebl.2009.0224</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2009.0224</ArticleId><ArticleId IdType="pmc">PMC2683397</ArticleId><ArticleId IdType="pubmed">19471589</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura T, Yatabe T, Yokoyama M. Prediction of ventricular fibrillation after release of aortic cross-clamping in cardiovascular surgery patients: a single center retrospective observation study. Anesthesiol Case Rep. (2020) 1:1&#x2013;6.</Citation></Reference><Reference><Citation>Yilmaz M, Aydin U, Arslan ZI, Balci C, Kocogullari CU, Ata Y, et al. . The effect of lidocaine and amiodarone on prevention of ventricular fibrillation in patients undergoing coronary artery bypass grafting. Heart Surg Forum. (2014) 5:E245&#x2013;9. 10.1532/HSF98.2014402</Citation><ArticleIdList><ArticleId IdType="doi">10.1532/HSF98.2014402</ArticleId><ArticleId IdType="pubmed">25367235</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Gu Q, Chen HW, Peng HM, Jia DY, Zhou Y, et al. . Efficacy of amiodarone and lidocaine for preventing ventricular fibrillation after aortic cross-clamp release in open heart surgery: a meta-analysis of randomized controlled trials. J Zhejiang Univ Sci B. (2017) 12:1113&#x2013;22. 10.1631/jzus.B1700229</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B1700229</ArticleId><ArticleId IdType="pmc">PMC5742294</ArticleId><ArticleId IdType="pubmed">29204991</ArticleId></ArticleIdList></Reference><Reference><Citation>Mita N, Kagaya S, Miyoshi S, Kuroda M. Prophylactic effect of amiodarone infusion on reperfusion ventricular fibrillation after release of aortic cross-clamp in patients with left ventricular hypertrophy undergoing aortic valve replacement: a randomized controlled trial. J Cardiothorac Vasc Anesth. (2019) 5:1205&#x2013;13. 10.1053/j.jvca.2018.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2018.10.005</ArticleId><ArticleId IdType="pubmed">30416026</ArticleId></ArticleIdList></Reference><Reference><Citation>Adameova A, Shah A K, Dhalla N S. Role of oxidative stress in the genesis of ventricular arrhythmias. Int J Mol Sci. (2020) 12:4200. 10.3390/ijms21124200</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21124200</ArticleId><ArticleId IdType="pmc">PMC7349053</ArticleId><ArticleId IdType="pubmed">32545595</ArticleId></ArticleIdList></Reference><Reference><Citation>Samantaray A, Chandra A, Panigrahi S. Amiodarone for the prevention of reperfusion ventricular fibrillation. J Cardiothorac Vasc Anesth. (2010) 2:239&#x2013;43. 10.1053/j.jvca.2009.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2009.07.007</ArticleId><ArticleId IdType="pubmed">19800815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauermann WJ, Pulido JN, Barbara DW, Abel MD, Li Z, Meade LA, et al. . Amiodarone versus lidocaine and placebo for the prevention of ventricular fibrillation after aortic crossclamping: a randomized, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg. (2012) 5:1229&#x2013;34. 10.1016/j.jtcvs.2012.06.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2012.06.039</ArticleId><ArticleId IdType="pubmed">22770549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoub CM, Sfeir PM, Bou-Khalil P, Azar M, Haddadin AS, Harfouch D, et al. . Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp. Eur J Anaesthesiol. (2009) 12:1056&#x2013;60. 10.1097/EJA.0b013e32832f0dfb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32832f0dfb</ArticleId><ArticleId IdType="pubmed">19809326</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal A, Chhabra L, Sciammarella JC, Cooper JS. Defibrillation. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright &#xa9; 2020, StatPearls Publishing LLC (2020).</Citation></Reference><Reference><Citation>Hippel&#xe4;inen MJ, Tuppurainen TT, Huttunen KT. Reperfusion ventricular fibrillation and electric countershocks during coronary artery bypass operations&#x2014;association with postoperative CK-MB release. Scand J Thorac Cardiovasc Surg. (1994) 2:73&#x2013;8. 10.3109/14017439409100166</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14017439409100166</ArticleId><ArticleId IdType="pubmed">7863289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar SK, Dasgupta CS, Goswami A. Effect of prophylactic amiodarone in patients with rheumatic valve disease undergoing valve replacement surgery. Ann Card Anaesth. (2011) 3:176&#x2013;82. 10.4103/0971-9784.83986</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.83986</ArticleId><ArticleId IdType="pubmed">21860188</ArticleId></ArticleIdList></Reference><Reference><Citation>Alizadeh-Ghavidel A, Nabavi S, Haghjoo M, Toutonchi Z, Mirmesdagh Y, Javadikasgari H. Amiodarone versus lidocaine for the prevention of reperfusion ventricular fibrillation: A randomized clinical trial. ARYA Atheroscler. (2013) 6:343&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3933055</ArticleId><ArticleId IdType="pubmed">24575137</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlan AD, Malmivaara A, Chou R, Maher CG, Deyo RA, Schoene M, et al. . 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine (Phila Pa 1976). (2015) 21:1660&#x2013;73. 10.1097/BRS.0000000000001061</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000001061</ArticleId><ArticleId IdType="pubmed">26208232</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu DL, Lu L, Zhu W, Li JH, Li HQ, Liu AJ, et al. . Xiaoxuming decoction for acute ischemic stroke: a systematic review and meta-analysis. J Ethnopharmacol. (2013) 1:1&#x2013;13. 10.1016/j.jep.2013.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2013.04.002</ArticleId><ArticleId IdType="pubmed">23583540</ArticleId></ArticleIdList></Reference><Reference><Citation>Komori S, Li B, Matsumura K, Takusagawa M, Sano S, Kohno I, et al. . Antiarrhythmic effect of magnesium sulfate against occlusion-induced arrhythmias and reperfusion-induced arrhythmias in anesthetized rats. Mol Cell Biochem. (1999) 1&#x2013;2:201&#x2013;8. 10.1023/A:1006938010925</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1006938010925</ArticleId><ArticleId IdType="pubmed">10544968</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayeem Ul. Hassan, Dar AM, Wani ML, Rather HA, Ganie FA. A comparative study on the effect of amiodarone and metaprolol for prevention of arrythmias after open heart surgery. Int Cardiovasc Res J. (2013) 1:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3987421</ArticleId><ArticleId IdType="pubmed">24757610</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyman MG, Wyman RM, Cannom DS, Criley JM. Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine. Am J Cardiol. (2004) 5:545&#x2013;51. 10.1016/j.amjcard.2004.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2004.05.014</ArticleId><ArticleId IdType="pubmed">15342281</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea RS, Kane-Gill SL, Rudis MI, Seybert AL, Oyen LJ, Ou NN, et al. . Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. Crit Care Med. (2006) 6:1617&#x2013;23. 10.1097/01.CCM.0000217965.30554.D8</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000217965.30554.D8</ArticleId><ArticleId IdType="pubmed">16614583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CH, Chang WT, Huang CH, Tsai MS, Yu PH, Wu YW, et al. . Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia. J Formos Med Assoc. (2020) 1 Pt 2:327&#x2013;34. 10.1016/j.jfma.2019.05.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2019.05.023</ArticleId><ArticleId IdType="pubmed">31255419</ArticleId></ArticleIdList></Reference><Reference><Citation>Elnakera A, Alawady TA. Continuous infusion of magnesium&#x2013;lidocaine mixture for prevention of ventricular arrhythmias during on-pump coronary artery bypass grafting surgery. Egypt J Anaesthesia. (2013) 4:419&#x2013;25. 10.1016/j.egja.2013.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.egja.2013.05.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovic T, Adnet F, Lapandry C. Successful resuscitation of ventricular fibrillation after low-dose amiodarone. Ann Emerg Med. (1998) 4:518&#x2013;9. 10.1016/S0196-0644(98)70191-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0196-0644(98)70191-X</ArticleId><ArticleId IdType="pubmed">9774944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoerner F, Semenas E. Resuscitation with amiodarone increases survival after hemorrhage and ventricular fibrillation in pigs. J Trauma Acute Care Surg. (2014) 6:1402&#x2013;8. 10.1097/TA.0000000000000243</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000000243</ArticleId><ArticleId IdType="pubmed">24854308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DK, Kim YJ, Kim G, Lee CA, Moon HJ, Oh J, et al. . Impact of early intravenous amiodarone administration on neurological outcome in refractory ventricular fibrillation: retrospective analysis of prospectively collected prehospital data. Scand J Trauma Resusc Emerg Med. (2019) 1:109. 10.1186/s13049-019-0688-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13049-019-0688-1</ArticleId><ArticleId IdType="pmc">PMC6902320</ArticleId><ArticleId IdType="pubmed">31823800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Jin Q, Zhang N, Pang Y, Ren S, Zhou J, et al. . The effects of acute amiodarone on short- and long-duration ventricular defibrillation threshold in canines. J Cardiovasc Pharmacol. (2011) 4:432&#x2013;8. 10.1097/FJC.0b013e318228a50c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e318228a50c</ArticleId><ArticleId IdType="pubmed">21709582</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier P, Timour Q, Morel E, Bui-Xuan B. Chronic oral amiodarone but not dronedarone therapy increases ventricular defibrillation threshold during acute myocardial ischemia in a closed-chest animal model. J Cardiovasc Pharmacol. (2012) 6:523&#x2013;8. 10.1097/FJC.0b013e31824d89fe</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e31824d89fe</ArticleId><ArticleId IdType="pubmed">22330675</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod SL, Iansavichene A, Cheskes S. Remote Ischemic Perconditioning to Reduce Reperfusion Injury During Acute ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis. J Am Heart Assoc. (2017) 5. 10.1161/JAHA.117.005522</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.005522</ArticleId><ArticleId IdType="pmc">PMC5524098</ArticleId><ArticleId IdType="pubmed">28515120</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinten-Johansen J, Yellon DM, Opie LH. Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation. (2005) 14:2085&#x2013;8. 10.1161/CIRCULATIONAHA.105.569798</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.569798</ArticleId><ArticleId IdType="pubmed">16203924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Qiao Z, Xu B. Effects of ischemic preconditioning on myocardium Caspase-3, SOCS-1, SOCS-3, TNF-&#x3b1; and IL-6 mRNA expression levels in myocardium IR rats. Mol Biol Rep. (2013) 10:5741&#x2013;8. 10.1007/s11033-013-2677-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-013-2677-1</ArticleId><ArticleId IdType="pubmed">24091940</ArticleId></ArticleIdList></Reference><Reference><Citation>Naase H, Harling L, Kidher E, Sepehripour A, Nguyen B, Kapelouzou A, et al. . Toll-like receptor 9 and the inflammatory response to surgical trauma and cardiopulmonary bypass. J Cardiothorac Surg. (2020) 1:137. 10.1186/s13019-020-01179-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01179-y</ArticleId><ArticleId IdType="pmc">PMC7291696</ArticleId><ArticleId IdType="pubmed">32527277</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto T, Watanabe Y, Kita S, Blaustein MP. Na+/Ca2+ exchange inhibitors: a new class of calcium regulators. Cardiovasc Hematol Disord Drug Targets. (2007) 3:188&#x2013;98. 10.2174/187152907781745288</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152907781745288</ArticleId><ArticleId IdType="pubmed">17896959</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32855882</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2164-2591</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Translational vision science &amp; technology</Title><ISOAbbreviation>Transl Vis Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Driving Skills Tested on Simulator After Strabismus Surgery: A Prospective Study.</ArticleTitle><Pagination><StartPage>36</StartPage><MedlinePgn>36</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">36</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1167/tvst.9.8.36</ELocationID><Abstract><AbstractText Label="PURPOSE">The sense of vision is responsible for 90% of the information obtained by the motorist. Improvement in binocular visual acuity (VA) and visual field (VF) achieved after strabismus surgery could have beneficial effects on driving. Our study sought to identify functional improvements (VA and VF) and improvements in driving ability following strabismus surgery.</AbstractText><AbstractText Label="METHODS">In a prospective cohort study, the following parameters are analyzed before and 3 months after strabismus surgery: simulated driving performance (including eye movements and actions on vehicle control), binocular VA, binocular VF, and self-confidence during driving.</AbstractText><AbstractText Label="RESULTS">Twenty patients participated in the study. The mean preoperative logMAR binocular VA and stereopsis do not significantly differ from the postoperative. The mean Esterman VF score increases from 91.3 (&#xb1;17.2) preoperatively to 96.9 (&#xb1;13.9) postoperatively (<i>P</i> = 0.045). The mean self-confidence directed at driving scores decreases from 20.5 (&#xb1;10.3) points before surgery to 11.0 (&#xb1;6.0) points after surgery (<i>P</i> &lt; 0.001). The distance at which the road signs are identified is significantly higher after surgery. The average speed of the vehicle and the speed near the targets (30 m) increase significantly after strabismus surgery. A significant decrease in ocular movements near targets is also observed. The number of brake pedal depressions and the rate of brake pedal depressions slightly decrease after surgery.</AbstractText><AbstractText Label="CONCLUSIONS">This study demonstrates the potential beneficial effects of strabismus surgery on driving ability, with significant improvements in self-confidence during driving, VF, and driving on a simulator.</AbstractText><AbstractText Label="TRANSLATIONAL RELEVANCE">This was the first study to use a driving simulator in strabismus.</AbstractText><CopyrightInformation>Copyright 2020 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Derhy</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Ophtalmologie, Centre Hospitalier Universitaire (CHU) - Universit&#xe9; de Strasbourg, Nouvel H&#xf4;pital Civil, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lithfous</LastName><ForeName>S&#xe9;gol&#xe8;ne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CI2N, Centre d'Investigations Neurocognitives &amp; Neurophysiologiques UMS 3489 CNRS / UdS . Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speeg</LastName><ForeName>Claude</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Ophtalmologie, Centre Hospitalier Universitaire (CHU) - Universit&#xe9; de Strasbourg, Nouvel H&#xf4;pital Civil, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaucher</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Ophtalmologie, Centre Hospitalier Universitaire (CHU) - Universit&#xe9; de Strasbourg, Nouvel H&#xf4;pital Civil, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Despres</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>CI2N, Centre d'Investigations Neurocognitives &amp; Neurophysiologiques UMS 3489 CNRS / UdS . Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dufour</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CI2N, Centre d'Investigations Neurocognitives &amp; Neurophysiologiques UMS 3489 CNRS / UdS . Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourcier</LastName><ForeName>Tristan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Ophtalmologie, Centre Hospitalier Universitaire (CHU) - Universit&#xe9; de Strasbourg, Nouvel H&#xf4;pital Civil, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauer</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophtalmologie, Centre Hospitalier Universitaire (CHU) - Universit&#xe9; de Strasbourg, Nouvel H&#xf4;pital Civil, Strasbourg, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transl Vis Sci Technol</MedlineTA><NlmUniqueID>101595919</NlmUniqueID><ISSNLinking>2164-2591</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009801" MajorTopicYN="N">Oculomotor Muscles</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013285" MajorTopicYN="Y">Strabismus</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015348" MajorTopicYN="Y">Vision, Binocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">driving simulator</Keyword><Keyword MajorTopicYN="N">strabismus surgery</Keyword><Keyword MajorTopicYN="N">visual field</Keyword></KeywordList><CoiStatement>Disclosure: D. Derhy, None; S. Lithfous, None; C. Speeg, None; D. Gaucher, None; O. Despres, None; A. Dufour, None; T. Bourcier, None; A. Sauer, None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32855882</ArticleId><ArticleId IdType="pmc">PMC7422777</ArticleId><ArticleId IdType="doi">10.1167/tvst.9.8.36</ArticleId><ArticleId IdType="pii">TVST-19-2145</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Owsley C, McGwin G Jr.. Vision and driving. Vision Res. 2010; 50: 2348&#x2013;2361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2975746</ArticleId><ArticleId IdType="pubmed">20580907</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JM, Drews-Botsch C, Pfeiffer MR, Curry AE. Driver licensing and motor vehicle crash rates among young adults with amblyopia and unilateral vision impairment. J AAPOS. 2019; 23: 230&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6690801</ArticleId><ArticleId IdType="pubmed">30769086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer A, Dietz K, Kolling G, Hart W, Schiefer U. The relevance of stereopsis for motorists: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2001; 239: 400&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">11561786</ArticleId></ArticleIdList></Reference><Reference><Citation>Casson EJ, Racette L.. Vision standards for driving in Canada and the United States. A review for the Canadian Ophthalmological Society. Can J Ophthalmol. 2000; 35: 192&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">10900516</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeffe JE, Jin CF, Weih LM, McCarty CA, Taylor HR. Vision impairment and older drivers: who's driving? Br J Ophthalmol. 2002; 86: 1118&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1771306</ArticleId><ArticleId IdType="pubmed">12234890</ArticleId></ArticleIdList></Reference><Reference><Citation>Owsley C, McGwin G Jr.. Vision impairment and driving. Surv Ophthalmol. 1999; 43: 535&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">10416796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood JM, Black AA. Ocular disease and driving. Clin Exp Optom. 2016; 99: 395&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">27156178</ArticleId></ArticleIdList></Reference><Reference><Citation>Agramunt S, Meuleners LB, Fraser ML, Chow KC, Ng JQ, Raja V. First and second eye cataract surgery and driver self-regulation among older drivers with bilateral cataract: a prospective cohort study. BMC Geriatr. 2018; 18: 51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5816381</ArticleId><ArticleId IdType="pubmed">29454304</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuleners LB, Agramunt S, Ng JQ, et al. .. The Cataract Extraction and Driving Ability Research Study Protocol: characterisation of deficits in driving performance and self-regulation among older drivers with bilateral cataract. Inj Prev. 2015; 21: 424&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">25344578</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz-Filho A, Boer ER, Elhosseiny A, Wu Z, Nakanishi M, Medeiros FA. Glaucoma and driving risk under simulated fog conditions. Transl Vis Sci Technol. 2016; 5: 15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5156445</ArticleId><ArticleId IdType="pubmed">27980878</ArticleId></ArticleIdList></Reference><Reference><Citation>Haymes SA, LeBlanc RP, Nicolela MT, Chiasson LA, Chauhan BC. Glaucoma and on-road driving performance. Invest Ophthalmol Vis Sci. 2008; 49: 3035&#x2013;3041.</Citation><ArticleIdList><ArticleId IdType="pubmed">18326696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubler TC, Kasneci E, Rosenstiel W, et al. .. Driving with glaucoma: task performance and gaze movements. Optom Vis Sci. 2015; 92: 1037&#x2013;1046.</Citation><ArticleIdList><ArticleId IdType="pubmed">26501733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SS, Black AA, Wood JM. Scanning behavior and daytime driving performance of older adults with glaucoma. J Glaucoma. 2018; 27: 558&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">29613977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi TL, He ZJ. Space perception of strabismic observers in the real world environment. Invest Ophthalmol Vis Sci. 2015; 56: 1761&#x2013;1768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4358738</ArticleId><ArticleId IdType="pubmed">25698702</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JD. Twenty-year follow-up of surgery for intermittent exotropia. J AAPOS. 2008; 12: 227&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">18455937</ArticleId></ArticleIdList></Reference><Reference><Citation>Durnian JM, Noonan CP, Marsh IB. The psychosocial effects of adult strabismus: a review. Br J Ophthalmol. 2011; 95: 450&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">20852320</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills MD, Coats DK, Donahue SP, Wheeler DT. Strabismus surgery for adults: a report by the American Academy of Ophthalmology. Ophthalmology. 2004; 111: 1255&#x2013;1262.</Citation><ArticleIdList><ArticleId IdType="pubmed">15177982</ArticleId></ArticleIdList></Reference><Reference><Citation>Leske DA, Hatt SR, Holmes JM. Test-retest reliability of health-related quality-of-life questionnaires in adults with strabismus. Am J Ophthalmol. 2010; 149: 672&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2859184</ArticleId><ArticleId IdType="pubmed">20138603</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman PM. Functional benefits of adult strabismus surgery. Am Orthopt J. 2010; 60: 43&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">21061883</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson S, Harrad RA, Morris M, Rumsey N. The psychosocial benefits of corrective surgery for adults with strabismus. Br J Ophthalmol. 2006; 90: 883&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1857157</ArticleId><ArticleId IdType="pubmed">16782950</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill K, Satterfield D, O'Hara M. Strabismus surgery on the elderly and the effects on disability. J AAPOS. 2010; 14: 196&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">20451866</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yan X, Li X, Xue Q. Drivers' eye movements as a function of collision avoidance warning conditions in red light running scenarios. Accid Anal Prev. 2016; 96: 185&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">27543896</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie AK, Harris JM. A link between attentional function, effective eye movements, and driving ability. J Exp Psychol Hum Percept Perform. 2017; 43: 381&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5279462</ArticleId><ArticleId IdType="pubmed">27893270</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37483593</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>966696</StartPage><MedlinePgn>966696</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">966696</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.966696</ELocationID><Abstract><AbstractText Label="BACKGROUND">Malignant glioma is the most common intracranial malignant tumor with the highest mortality. In the era of immunotherapy, it is important to determine what type of immunotherapy provides the best chance of survival.</AbstractText><AbstractText Label="METHOD">Here, the efficacy and safety of immunotherapy in high-grade glioma (HGG) were evaluated by systematic review and meta-analysis. The differences between various types of immunotherapy were explored. Retrieved hits were screened for inclusion in 2,317 articles. We extracted the overall survival (OS) and progression-free survival (PFS) hazard ratios (HRs) as two key outcomes for examining the efficacy of immunotherapy. We also analyzed data on the reported corresponding adverse events to assess the safety of immunotherapy. This study was registered with PROSPERO (CRD42019112356).</AbstractText><AbstractText Label="RESULTS">We included a total of 1,271 patients, of which 524 received a combination of immunotherapy and standard of care (SOC), while 747 received SOC alone. We found that immunotherapy extended the OS (HR = 0.74; 95% confidence interval [CI], 0.56-0.99; <i>Z</i> = -2.00, <i>P</i> = 0.0458 &lt; 0.05) and PFS (HR = 0.67; 95% CI, 0.45-0.99; <i>Z</i> = -1.99, <i>P</i> = 0.0466 &lt; 0.05), although certain adverse events occurred (proportion = 0.0773, 95% CI, 0.0589-0.1014). Our data have demonstrated the efficacy of the dendritic cell (DC) vaccine in prolonging the OS (HR = 0.38; 95% CI, 0.21-0.68; Z = -3.23; <i>P</i> = 0.0012 &lt; 0.05) of glioma patients. Oncolytic viral therapy (VT) only extended patient survival in a subgroup analysis (HR = 0.60; 95% CI, 0.45-0.80; <i>Z</i> = -3.53; <i>P</i> = 0.0004 &lt; 0.05). By contrast, immunopotentiation (IP) did not prolong OS (HR = 0.69; 95% CI, 0.50-0.96; <i>Z</i> = -2.23; <i>P</i> = 0.0256).</AbstractText><AbstractText Label="CONCLUSION">Thus, DC vaccination significantly prolonged the OS of HGG patients, however, the efficacy of VT and IP should be explored in further studies. All the therapeutic schemes evaluated were associated with certain side effects.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION">https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=112356.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Guo, Zhang, Xu, Sun, Chan, Zheng, Zhang and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Baofeng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Plastic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shengnan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, College of Basic Medical Sciences of Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Libo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, College of Basic Medical Sciences of Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jicheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Plastic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Wai-Lun</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, College of Basic Medical Sciences of Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jinnan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Plastic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, College of Basic Medical Sciences of Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059039" MajorTopicYN="N">Standard of Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005910" MajorTopicYN="Y">Glioma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="Y">Brain Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007167" MajorTopicYN="N">Immunotherapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">glioblastoma</Keyword><Keyword MajorTopicYN="N">glioma</Keyword><Keyword MajorTopicYN="N">high-grade</Keyword><Keyword MajorTopicYN="N">immunotherapy</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">radiotherapy</Keyword><Keyword MajorTopicYN="N">standard of care</Keyword><Keyword MajorTopicYN="N">temozolomide</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>4</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37483593</ArticleId><ArticleId IdType="pmc">PMC10357294</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.966696</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gritsch S, Batchelor TT, Gonzalez Castro LN. Diagnostic, therapeutic, and prognostic implications of the 2021 world health organization classification of tumors of the central nervous system. Cancer (2022) 128(1):47&#x2013;58. doi:&#xa0;10.1002/cncr.33918</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.33918</ArticleId><ArticleId IdType="pubmed">34633681</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesseling P, Capper D. Who 2016 classification of gliomas. Neuropathol Appl Neurobiol (2018) 44(2):139&#x2013;50. doi:&#xa0;10.1111/nan.12432</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12432</ArticleId><ArticleId IdType="pubmed">28815663</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. . The 2021 who classification of tumors of the central nervous system: a summary. Neuro Oncol (2021) 23(8):1231&#x2013;51. doi:&#xa0;10.1093/neuonc/noab106</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/noab106</ArticleId><ArticleId IdType="pmc">PMC8328013</ArticleId><ArticleId IdType="pubmed">34185076</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TW, Traphagen NA, Li J, Lewis LD, Lopes B, Asthagiri A, et al. . Tumor pharmacokinetics and pharmacodynamics of the Cdk4/6 inhibitor ribociclib in patients with recurrent glioblastoma. J Neurooncol (2019) 144(3):563&#x2013;72. doi:&#xa0;10.1007/s11060-019-03258-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-019-03258-0</ArticleId><ArticleId IdType="pmc">PMC6863163</ArticleId><ArticleId IdType="pubmed">31399936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. . Cbtrus statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2008-2012. Neuro Oncol (2015) 17 Suppl 4(Suppl 4):iv1&#x2013;iv62. doi:&#xa0;10.1093/neuonc/nov189</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/nov189</ArticleId><ArticleId IdType="pmc">PMC4623240</ArticleId><ArticleId IdType="pubmed">26511214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, et al. . Changing incidence and improved survival of gliomas. Eur J Cancer (2014) 50(13):2309&#x2013;18. doi:&#xa0;10.1016/j.ejca.2014.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2014.05.019</ArticleId><ArticleId IdType="pubmed">24972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekmezci M, Perry A. Practical molecular pathologic diagnosis of infiltrating gliomas. Surg Pathol Clinics (2015) 8:49&#x2013;61. doi:&#xa0;10.1016/j.path.2014.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.path.2014.10.004</ArticleId><ArticleId IdType="pubmed">25783821</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Tang L, Li X, Fan F, Liu Z. Immunotherapy for glioma: current management and future application. Cancer Lett (2020) 476:1&#x2013;12. doi:&#xa0;10.1016/j.canlet.2020.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2020.02.002</ArticleId><ArticleId IdType="pubmed">32044356</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol (2018) 15:422&#x2013;42. doi:&#xa0;10.1038/s41571-018-0003-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-018-0003-5</ArticleId><ArticleId IdType="pubmed">29643471</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip S, Miao J, Cahill DP, Iafrate AJ, Aldape K, Nutt CL, et al. . Msh6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. Clin Cancer Res (2009) 15(14):4622&#x2013;9. doi:&#xa0;10.1158/1078-0432.CCR-08-3012</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-08-3012</ArticleId><ArticleId IdType="pmc">PMC2737355</ArticleId><ArticleId IdType="pubmed">19584161</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho DY, Yang WK, Lee HC, Hsu DM, Lin HL, Lin SZ, et al. . Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase ii clinical trial. World Neurosurg (2012) 77(5-6):736&#x2013;44. doi:&#xa0;10.1016/j.wneu.2011.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2011.08.020</ArticleId><ArticleId IdType="pubmed">22120301</ArticleId></ArticleIdList></Reference><Reference><Citation>Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC, Due-Tonnesen P, Suso EM, et al. . Therapeutic vaccination against autologous cancer stem cells with mrna-transfected dendritic cells in patients with glioblastoma. Cancer Immunol Immunother (2013) 62(9):1499&#x2013;509. doi:&#xa0;10.1007/s00262-013-1453-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-013-1453-3</ArticleId><ArticleId IdType="pmc">PMC3755221</ArticleId><ArticleId IdType="pubmed">23817721</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Luo F, Tang C, Chen D, Qin Z, Hua W, et al. . Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase ii clinical trial. Cancer Immunol Immunother (2018) 67(11):1777&#x2013;88. doi:&#xa0;10.1007/s00262-018-2232-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-018-2232-y</ArticleId><ArticleId IdType="pmc">PMC11028057</ArticleId><ArticleId IdType="pubmed">30159779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainov NG. A phase iii clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther (2000) 11(17):2389&#x2013;401. doi:&#xa0;10.1089/104303400750038499</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/104303400750038499</ArticleId><ArticleId IdType="pubmed">11096443</ArticleId></ArticleIdList></Reference><Reference><Citation>Immonen A, Vapalahti M, Tyynela K, Hurskainen H, Sandmair A, Vanninen R, et al. . Advhsv-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther (2004) 10(5):967&#x2013;72. doi:&#xa0;10.1016/j.ymthe.2004.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2004.08.002</ArticleId><ArticleId IdType="pubmed">15509514</ArticleId></ArticleIdList></Reference><Reference><Citation>Westphal M, Yla-Herttuala S, Martin J, Warnke P, Menei P, Eckland D, et al. . Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (Aspect): a randomised, open-label, phase 3 trial. Lancet Oncol (2013) 14(9):823&#x2013;33. doi:&#xa0;10.1016/S1470-2045(13)70274-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(13)70274-2</ArticleId><ArticleId IdType="pubmed">23850491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji N, Weng D, Liu C, Gu Z, Chen S, Guo Y, et al. . Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma. Oncotarget (2016) 7(4):4369&#x2013;78. doi:&#xa0;10.18632/oncotarget.6737</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6737</ArticleId><ArticleId IdType="pmc">PMC4826211</ArticleId><ArticleId IdType="pubmed">26716896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler LA, Manzanera AG, Bell SD, Cavaliere R, McGregor JM, Grecula JC, et al. . Phase ii multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma. Neuro Oncol (2016) 18(8):1137&#x2013;45. doi:&#xa0;10.1093/neuonc/now002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/now002</ArticleId><ArticleId IdType="pmc">PMC4933478</ArticleId><ArticleId IdType="pubmed">26843484</ArticleId></ArticleIdList></Reference><Reference><Citation>Desjardins A, Gromeier M, Herndon JE, 2nd, Beaubier N, Bolognesi DP, Friedman AH, et al. . Recurrent glioblastoma treated with recombinant poliovirus. N Engl J Med (2018) 379(2):150&#x2013;61. doi:&#xa0;10.1056/NEJMoa1716435</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1716435</ArticleId><ArticleId IdType="pmc">PMC6065102</ArticleId><ArticleId IdType="pubmed">29943666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdahn U, Hau P, Stockhammer G, Venkataramana NK, Mahapatra AK, Suri A, et al. . Targeted therapy for high-grade glioma with the tgf-Beta2 inhibitor trabedersen: results of a randomized and controlled phase iib study. Neuro Oncol (2011) 13(1):132&#x2013;42. doi:&#xa0;10.1093/neuonc/noq142</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/noq142</ArticleId><ArticleId IdType="pmc">PMC3018908</ArticleId><ArticleId IdType="pubmed">20980335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursu R, Carpentier A, Metellus P, Lubrano V, Laigle-Donadey F, Capelle L, et al. . Intracerebral injection of cpg oligonucleotide for patients with De novo glioblastoma-a phase ii multicentric, randomised study. Eur J Cancer (2017) 73:30&#x2013;7. doi:&#xa0;10.1016/j.ejca.2016.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2016.12.003</ArticleId><ArticleId IdType="pubmed">28142059</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: cochrane book series (New York, US: John Wiley and Sons Ltd; ). (2008).</Citation></Reference><Reference><Citation>Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Response to: practical methods for incorporating summary time-to-Event data into meta. Authors&#x2019; Reply Trials (2013) 14:391. doi: 10.1186/1745-6215-14-391</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-14-391</ArticleId><ArticleId IdType="pubmed">24511621</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard I PJ. Meta-analysis with r. J Stat Softw (2016), 21&#x2013;104. doi:&#xa0;10.18637/jss.v070.b01</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v070.b01</ArticleId></ArticleIdList></Reference><Reference><Citation>Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, et al. . Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial. JAMA Oncol (2023) 9(1):112&#x2013;21. doi:&#xa0;10.1001/jamaoncol.2022.5370</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2022.5370</ArticleId><ArticleId IdType="pmc">PMC9673026</ArticleId><ArticleId IdType="pubmed">36394838</ArticleId></ArticleIdList></Reference><Reference><Citation>Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, et al. . First results on survival from a Large phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. J Transl Med (2018) 16(1):142. doi:&#xa0;10.1186/s12967-018-1507-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1507-6</ArticleId><ArticleId IdType="pmc">PMC5975654</ArticleId><ArticleId IdType="pubmed">29843811</ArticleId></ArticleIdList></Reference><Reference><Citation>Artene SA, Turcu-Stiolica A, Ciurea ME, Folcuti C, Tataranu LG, Alexandru O, et al. . Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials. Sci Rep (2018) 8(1):11800. doi:&#xa0;10.1038/s41598-018-30296-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30296-x</ArticleId><ArticleId IdType="pmc">PMC6081409</ArticleId><ArticleId IdType="pubmed">30087385</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv L, Huang J, Xi H, Zhou X. Efficacy and safety of dendritic cell vaccines for patients with glioblastoma: a meta-analysis of randomized controlled trials. Int Immunopharmacol (2020) 83:106336. doi:&#xa0;10.1016/j.intimp.2020.106336</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106336</ArticleId><ArticleId IdType="pubmed">32213460</ArticleId></ArticleIdList></Reference><Reference><Citation>Todo T, Ito H, Ino Y, Ohtsu H, Ota Y, Shibahara J, et al. . Intratumoral oncolytic herpes virus G47&#x394; for residual or recurrent glioblastoma: a phase 2 trial. Nat Med (2022) 28(8):1630&#x2013;9. doi:&#xa0;10.1038/s41591-022-01897-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01897-x</ArticleId><ArticleId IdType="pmc">PMC9388376</ArticleId><ArticleId IdType="pubmed">35864254</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirota H, Tross D, Klinman DM. Cpg oligonucleotides as cancer vaccine adjuvants. Vaccines (Basel) (2015) 3(2):390&#x2013;407. doi:&#xa0;10.3390/vaccines3020390</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines3020390</ArticleId><ArticleId IdType="pmc">PMC4494345</ArticleId><ArticleId IdType="pubmed">26343193</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpentier A, Metellus P, Ursu R, Zohar S, Lafitte F, Barrie M, et al. . Intracerebral administration of cpg oligonucleotide for patients with recurrent glioblastoma: a phase ii study. Neuro Oncol (2010) 12(4):401&#x2013;8. doi:&#xa0;10.1093/neuonc/nop047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/nop047</ArticleId><ArticleId IdType="pmc">PMC2940609</ArticleId><ArticleId IdType="pubmed">20308317</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, et al. . Tgfbeta drives immune evasion in genetically reconstituted colon cancer metastasis. Nature (2018) 554(7693):538&#x2013;43. doi:&#xa0;10.1038/nature25492</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25492</ArticleId><ArticleId IdType="pubmed">29443964</ArticleId></ArticleIdList></Reference><Reference><Citation>Uckun FM, Qazi S, Hwang L, Trieu VN. Recurrent or refractory high-grade gliomas treated by convection-enhanced delivery of a Tgfbeta2-targeting rna therapeutic: a post-hoc analysis with long-term follow-up. Cancers (Basel) (2019) 11(12):1892. doi:&#xa0;10.3390/cancers11121892</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers11121892</ArticleId><ArticleId IdType="pmc">PMC6966490</ArticleId><ArticleId IdType="pubmed">31795071</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang H, Liu C, Wang Z, Wu W, Zhang N, et al. . Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts. J Hematol Oncol (2022) 15(1):111. doi:&#xa0;10.1186/s13045-022-01325-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-022-01325-0</ArticleId><ArticleId IdType="pmc">PMC9386972</ArticleId><ArticleId IdType="pubmed">35978433</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol (2021) 16:223&#x2013;49. doi:&#xa0;10.1146/annurev-pathol-042020-042741</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-042020-042741</ArticleId><ArticleId IdType="pubmed">33197221</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang AC, Zappasodi R. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance. Nat Immunol (2022) 23(5):660&#x2013;70. doi:&#xa0;10.1038/s41590-022-01141-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01141-1</ArticleId><ArticleId IdType="pmc">PMC9106900</ArticleId><ArticleId IdType="pubmed">35241833</ArticleId></ArticleIdList></Reference><Reference><Citation>Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell (2021) 184(21):5309&#x2013;37. doi:&#xa0;10.1016/j.cell.2021.09.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.09.020</ArticleId><ArticleId IdType="pmc">PMC8767569</ArticleId><ArticleId IdType="pubmed">34624224</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, et al. . Immune and genomic correlates of response to anti-Pd-1 immunotherapy in glioblastoma. Nat Med (2019) 25(3):462&#x2013;9. doi:&#xa0;10.1038/s41591-019-0349-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0349-y</ArticleId><ArticleId IdType="pmc">PMC6810613</ArticleId><ArticleId IdType="pubmed">30742119</ArticleId></ArticleIdList></Reference><Reference><Citation>Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, et al. . Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial. JAMA Oncol (2020) 6(7):1003&#x2013;10. doi:&#xa0;10.1001/jamaoncol.2020.1024</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2020.1024</ArticleId><ArticleId IdType="pmc">PMC7243167</ArticleId><ArticleId IdType="pubmed">32437507</ArticleId></ArticleIdList></Reference><Reference><Citation>Schalper KA, Rodriguez-Ruiz ME, Diez-Valle R, Lopez-Janeiro A, Porciuncula A, Idoate MA, et al. . Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. Nat Med (2019) 25(3):470&#x2013;6. doi:&#xa0;10.1038/s41591-018-0339-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0339-5</ArticleId><ArticleId IdType="pubmed">30742120</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstock JD, Hoffman SE, Kappel AD, Valdes PA, Essayed W, Klinger NV, et al. . Immunotherapy approaches for the treatment of diffuse midline gliomas. Oncoimmunology (2022) 11(1):2124058. doi:&#xa0;10.1080/2162402X.2022.2124058</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2162402X.2022.2124058</ArticleId><ArticleId IdType="pmc">PMC9519005</ArticleId><ArticleId IdType="pubmed">36185807</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CE, Badie B, Barish ME, Weng L, Ostberg JR, Chang WC, et al. . Bioactivity and safety of Il13ralpha2-redirected chimeric antigen receptor Cd8+ T cells in patients with recurrent glioblastoma. Clin Cancer Res (2015) 21(18):4062&#x2013;72. doi:&#xa0;10.1158/1078-0432.CCR-15-0428</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-15-0428</ArticleId><ArticleId IdType="pmc">PMC4632968</ArticleId><ArticleId IdType="pubmed">26059190</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, et al. . Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med (2016) 375(26):2561&#x2013;9. doi:&#xa0;10.1056/NEJMoa1610497</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1610497</ArticleId><ArticleId IdType="pmc">PMC5390684</ArticleId><ArticleId IdType="pubmed">28029927</ArticleId></ArticleIdList></Reference><Reference><Citation>Keu KV, Witney TH, Yaghoubi S, Rosenberg J, Kurien A, Magnusson R, et al. . Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Sci Transl Med (2017) 9(373):eaag2196. doi:&#xa0;10.1126/scitranslmed.aag2196</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aag2196</ArticleId><ArticleId IdType="pmc">PMC5260938</ArticleId><ArticleId IdType="pubmed">28100832</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad N, Wang R, Li W, Zhang Z, Chang Y, Hu Y, et al. . A novel tancar targeting Il13r&#x3b1;2 and Epha2 for enhanced glioblastoma therapy. Mol Ther Oncolytics (2022) 24:729&#x2013;41. doi:&#xa0;10.1016/j.omto.2022.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omto.2022.02.012</ArticleId><ArticleId IdType="pmc">PMC8908045</ArticleId><ArticleId IdType="pubmed">35317513</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Aguilar B, Starr R, Alizadeh D, Brito A, Sarkissian A, et al. . Glioblastoma-targeted Cd4+ car T cells mediate superior antitumor activity. JCI Insight (2018) 3(10):e99048. doi:&#xa0;10.1172/jci.insight.99048</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.99048</ArticleId><ArticleId IdType="pmc">PMC6012522</ArticleId><ArticleId IdType="pubmed">29769444</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao H, Choi BD, Suryadevara CM, Sanchez-Perez L, Yang S, De Leon G, et al. . Egfrviii-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma. PloS One (2014) 9(4):e94281. doi:&#xa0;10.1371/journal.pone.0094281</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0094281</ArticleId><ArticleId IdType="pmc">PMC3983153</ArticleId><ArticleId IdType="pubmed">24722266</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke DM, Nasrallah MP, Desai A, Melenhorst JJ, Mansfield K, Morrissette JJD, et al. . A single dose of peripherally infused egfrviii-directed car T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci Transl Med (2017) 9(399):eaaa0984. doi:&#xa0;10.1126/scitranslmed.aaa0984</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa0984</ArticleId><ArticleId IdType="pmc">PMC5762203</ArticleId><ArticleId IdType="pubmed">28724573</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson U, Guo D, Malmer B, Bergenheim AT, Brannstrom T, Hedman H, et al. . Epidermal growth factor receptor family (Egfr, Erbb2-4) in gliomas and meningiomas. Acta Neuropathol (2004) 108(2):135&#x2013;42. doi:&#xa0;10.1007/s00401-004-0875-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0875-6</ArticleId><ArticleId IdType="pubmed">15148612</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Ying H, Zeng G, Wheeler CJ, Black KL, Yu JS. Her-2, Gp100, and mage-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Res (2004) 64(14):4980&#x2013;6. doi:&#xa0;10.1158/0008-5472.CAN-03-3504</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-03-3504</ArticleId><ArticleId IdType="pubmed">15256472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, et al. . Her2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial. JAMA Oncol (2017) 3(8):1094&#x2013;101. doi:&#xa0;10.1001/jamaoncol.2017.0184</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2017.0184</ArticleId><ArticleId IdType="pmc">PMC5747970</ArticleId><ArticleId IdType="pubmed">28426845</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfefferle A, Huntington ND. You have got a fast car: chimeric antigen receptor nk cells in cancer therapy. Cancers (Basel) (2020) 12(3):706. doi:&#xa0;10.3390/cancers12030706</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12030706</ArticleId><ArticleId IdType="pmc">PMC7140022</ArticleId><ArticleId IdType="pubmed">32192067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Zhao X, Li Z, Hu Y, Wang H. From car-T cells to car-nk cells: a developing immunotherapy method for hematological malignancies. Front Oncol (2021) 11:720501. doi:&#xa0;10.3389/fonc.2021.720501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.720501</ArticleId><ArticleId IdType="pmc">PMC8377427</ArticleId><ArticleId IdType="pubmed">34422667</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YJ, Mashouf LA, Lim M. Car T cell therapy in primary brain tumors: current investigations and the future. Front Immunol (2022) 13:817296. doi:&#xa0;10.3389/fimmu.2022.817296</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.817296</ArticleId><ArticleId IdType="pmc">PMC8899093</ArticleId><ArticleId IdType="pubmed">35265074</ArticleId></ArticleIdList></Reference><Reference><Citation>Balsari A, Tortoreto M, Besusso D, Petrangolini G, Sfondrini L, Maggi R, et al. . Combination of a cpg-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts. Eur J Cancer (2004) 40(8):1275&#x2013;81. doi:&#xa0;10.1016/j.ejca.2004.01.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2004.01.023</ArticleId><ArticleId IdType="pubmed">15110894</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y, Carpentier AF, Chen L, Boisserie G, Simon JM, Mazeron JJ, et al. . Successful combination of local cpg-odn and radiotherapy in malignant glioma. Int J Cancer (2005) 116(6):992&#x2013;7. doi:&#xa0;10.1002/ijc.21131</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.21131</ArticleId><ArticleId IdType="pubmed">15856470</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratesi G, Petrangolini G, Tortoreto M, Addis A, Belluco S, Rossini A, et al. . Therapeutic synergism of gemcitabine and cpg-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft. Cancer Res (2005) 65(14):6388&#x2013;93. doi:&#xa0;10.1158/0008-5472.CAN-05-0602</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-05-0602</ArticleId><ArticleId IdType="pubmed">16024642</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigel BJ, Rodeberg DA, Krieg AM, Blazar BR. Cpg oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma. Clin Cancer Res (2003) 9(8):3105&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">12912962</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen SH, Woroniecka K, Barbour AB, Fecci PE, Sanchez-Perez L, Sampson JH. Car T cells and checkpoint inhibition for the treatment of glioblastoma. Expert Opin Biol Ther (2020) 20(6):579&#x2013;91. doi:&#xa0;10.1080/14712598.2020.1727436</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2020.1727436</ArticleId><ArticleId IdType="pmc">PMC7202971</ArticleId><ArticleId IdType="pubmed">32027536</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y, Boesteanu AC, Binder ZA, Xu C, Reid RA, Rodriguez JL, et al. . Checkpoint blockade reverses anergy in il-13r&#x3b1;2 humanized scfv-based car T cells to treat murine and canine gliomas. Mol Ther Oncolytics (2018) 11:20&#x2013;38. doi:&#xa0;10.1016/j.omto.2018.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omto.2018.08.002</ArticleId><ArticleId IdType="pmc">PMC6174845</ArticleId><ArticleId IdType="pubmed">30306125</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Zheng M, Zhang Z, Tang X, Chen Y, Peng A, et al. . Interleukin-7-Loaded oncolytic adenovirus improves car-T cell therapy for glioblastoma. Cancer Immunol Immunother (2021) 70(9):2453&#x2013;65. doi:&#xa0;10.1007/s00262-021-02856-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-021-02856-0</ArticleId><ArticleId IdType="pmc">PMC10991970</ArticleId><ArticleId IdType="pubmed">33543339</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27574120</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>12</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Substrate-Based Ablation Versus Ablation Guided by Activation and Entrainment Mapping for Ventricular Tachycardia: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1437</StartPage><EndPage>1447</EndPage><MedlinePgn>1437-1447</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.13088</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Substrate-based ablation for scar-related ventricular tachycardia (VT) has gained prominence: however, there is limited data comparing it to ablation guided predominantly by activation and entrainment mapping of inducible and hemodynamically tolerated VTs. We compared the acute procedural efficacy and outcomes of predominantly substrate-based ablation versus ablation guided predominantly by activation and entrainment mapping.</AbstractText><AbstractText Label="METHODS AND RESULTS">Database searches through April 2016 identified 6 eligible studies (enrolling 403 patients, with 1 randomized study) comparing the 2 strategies. The relative risk of VT recurrence at follow-up was assessed as the primary outcome using a random-effects meta-analysis. Secondary endpoints of acute success (based on noninducibility of VT), procedural complications, and mortality were assessed using weighted mean difference with the random effects model. At a median follow-up of 18 months, the relative risk (RR) of VT recurrence was not significantly different with substrate-based versus activation/entrainment guided VT ablation (0.72, 95% confidence interval [CI] 0.44-1.18), P = 0.2). Acute success (RR 1.02, 95% CI 0.95-1.1, P = 0.6), procedural complications (RR 0.8, 95% CI 0.35-1.82, P = 0.5) cardiovascular mortality and total mortality did not differ significantly (RR 0.83, 95% CI 0.38-1.79, P = 0.6 and RR 0.76, 95% CI 0.36-1.59, P = 0.5, respectively).</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis demonstrates similar acute procedural efficacy, and complications, VT recurrence and mortality rates when comparing a predominantly substrate-based ablation strategy to a strategy guided predominantly by activation and entrainment mapping of inducible and hemodynamically tolerated VTs.</AbstractText><CopyrightInformation>&#xa9; 2016 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldinger</LastName><ForeName>Samuel H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Bern University Hospital and University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahida</LastName><ForeName>Saagar N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedrow</LastName><ForeName>Usha B</ForeName><Initials>UB</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>William G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">activation mapping</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">entrainment mapping</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">substrate mapping</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27574120</ArticleId><ArticleId IdType="doi">10.1111/jce.13088</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26695501</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>111</StartPage><EndPage>117</EndPage><MedlinePgn>111-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-015-0083-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with ischemic heart disease may have implantable cardioverter defibrillators (ICDs) implanted for primary or secondary prevention of sudden cardiac death. Although ICD shocks can be life saving, in some patients, they have been associated with increased mortality and/or morbidity. Several studies have suggested that catheter ablation may be superior to non-ablative strategies at preventing ICD shocks delivered for ventricular arrhythmias; however, this is still controversial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a meta-analysis of randomized controlled trials (RCTs) comparing catheter ablation with non-ablative strategies in treatment of ventricular tachycardia (VT) in patients with ischemic heart disease and an ICD. The primary endpoints of interest were recurrent episodes of VT and death. We used a binary random effects method to calculate the cumulative odds ratios (OR) for recurrent VT and deaths.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of a total of 643 potential citations, our search yielded three citations that met our inclusion and exclusion criteria. In the three trials, a total of 262 patients were randomized to ablation (n&#x2009;=&#x2009;129) or non-ablative interventions (beta-blockers&#x2009;&#xb1;&#x2009;use of antiarrhythmics) (n&#x2009;=&#x2009;133) group. The cumulative OR for recurrent VT was 0.471 (95% confidence interval (CI)&#x2009;=&#x2009;0.176-1.257) for catheter ablation compared with non-ablative strategies, and for death, it was 0.766 (95% CI&#x2009;=&#x2009;0.351-1.674). Excluding one study for being appreciably smaller than the other two, the OR for recurrent VT was 0.298 (95% CI&#x2009;=&#x2009;0.164-0.543).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this meta-analysis, the rate of recurrent VT was lower with VT catheter ablation compared with non-ablative strategies. There was not a significant difference in rate of death among patients receiving catheter ablation versus non-ablative strategies for management of VT. Given the lack of adequately powered RCTs comparing ablation versus medical management of VT in patients with ischemic heart disease and an ICD, larger studies with longer follow-up are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Divyang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasselblad</LastName><ForeName>Vic</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pokorney</LastName><ForeName>Sean D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daubert</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Khatib</LastName><ForeName>Sana M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA. alkha001@dm.duke.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA. alkha001@dm.duke.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">Ischemic heart disease</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26695501</ArticleId><ArticleId IdType="doi">10.1007/s10840-015-0083-4</ArticleId><ArticleId IdType="pii">10.1007/s10840-015-0083-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Circulation. 2004 Dec 21;110(25):3760-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15583079</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2003 Oct;5(4):381-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14753636</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2010 Jan;21(1):47-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19656251</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1997 Nov 27;337(22):1576-83</Citation><ArticleIdList><ArticleId IdType="pubmed">9411221</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1993 Feb;87(2):363-72</Citation><ArticleIdList><ArticleId IdType="pubmed">8425285</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2014 Feb 18;129(7):728-36</Citation><ArticleIdList><ArticleId IdType="pubmed">24211823</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Jan 11;295(2):165-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 2;375(9708):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Mar 21;346(12):877-83</Citation><ArticleIdList><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2009 Jun;11(6):771-817</Citation><ArticleIdList><ArticleId IdType="pubmed">19443434</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Sep 4;359(10):1009-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2015 Feb;26(2):151-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25332150</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 1993 Sep;14 Suppl E:120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8223748</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jun 29;342(26):1937-45</Citation><ArticleIdList><ArticleId IdType="pubmed">10874061</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1992 May;85(5):1666-74</Citation><ArticleIdList><ArticleId IdType="pubmed">1572025</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2011 Apr;8(4):503-10</Citation><ArticleIdList><ArticleId IdType="pubmed">21147263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kardiol Pol. 2009 Feb;67(2):123-7; discussion 128-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19288374</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Apr;11(4):533-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24333283</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2007 Nov 12;167(20):2226-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17998496</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2000 Jun;35(7):1905-14</Citation><ArticleIdList><ArticleId IdType="pubmed">10841242</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Dec 16;118(25):2773-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Feb 5;105(5):589-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11827924</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2002 Aug;144(2):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12177646</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2013 May;24(5):525-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23350967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35434669</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-5204</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Resuscitation plus</Title><ISOAbbreviation>Resusc Plus</ISOAbbreviation></Journal><ArticleTitle>Survival and neurological outcome after out-of-hospital cardiac arrest treated with and without mechanical circulatory support.</ArticleTitle><Pagination><StartPage>100230</StartPage><MedlinePgn>100230</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100230</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resplu.2022.100230</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="UNASSIGNED">The aim of this study was to describe the survival and neurological outcome in patients with OHCA treated with and without mechanical circulatory support (MCS).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a retrospective observational cohort study on patients with OHCA admitted to Aarhus University Hospital, Denmark, between January 2015 and December 2019. Kaplan-Meier estimates were used to evaluate 30-day and 30-180-day survival. Cox regression analysis was used to assess the association between covariates and one-year mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 1,015 patients admitted, 698 achieved return of spontaneous circulation (ROSC) before admission, 101 patients with refractory OHCA received mechanical circulatory support (MCS) and the remaining 216 patients with refractory OHCA did not receive MCS treatment. Survival to hospital discharge was 47% (478/1015). Good neurological outcome defined as Cerebral Performance Categories 1-2 were seen among 92% (438/478) of the patients discharged from hospital. Median low-flow was 15 [8-22] minutes in the ROSC group and 105 [94-123] minutes in the MCS group. Mortality rates were high within the first 30&#xa0;days, however; 30-180-day survival in patients discharged remained constant over time in both patients with ROSC on admission and patients admitted with MCS. Advanced age&#xa0;&gt;&#xa0;70&#xa0;years (hazard ratio (HR) 1.98, 95% confidence interval (CI) 1.11-3.49), pulseless electrical activity (HR 2.39, 95% CI 1.25-4.60) and asystole HR 2.70, 95% CI 1.25-5.95) as initial rhythms were associated with one-year mortality in patients with ROSC.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Short-term survival rates were high among patients with ROSC and patients receiving MCS. Among patients who survived to day 30, landmark analyses showed comparable 180-day survival in the two groups despite long low-flow times in the MCS group. Advanced age and initial non-shockable rhythms were independent predictors of one-year mortality in patients with ROSC on admission.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xf8;rk</LastName><ForeName>Sivagowry Rasalingam</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf8;tker</LastName><ForeName>Morten Thingemann</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Research and Development, Prehospital Emergency Medical Services, Central Denmark Region, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Mariann</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Vascular Surgery, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terkelsen</LastName><ForeName>Christian Juhl</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Danish Heart Foundation, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Resusc Plus</MedlineTA><NlmUniqueID>101774410</NlmUniqueID><ISSNLinking>2666-5204</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CPC, Cerebral performance category</Keyword><Keyword MajorTopicYN="N">CPR, Cardiopulmonary resuscitation</Keyword><Keyword MajorTopicYN="N">ECMO, Extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">ECPR, Extracorporeal cardiopulmonary resuscitation</Keyword><Keyword MajorTopicYN="N">EMS, Emergency medical service</Keyword><Keyword MajorTopicYN="N">Extracorporeal cardiopulmonary resuscitation</Keyword><Keyword MajorTopicYN="N">ICU, Intensive care unit</Keyword><Keyword MajorTopicYN="N">Impella</Keyword><Keyword MajorTopicYN="N">MCS, Mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">Mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">Neurological outcome</Keyword><Keyword MajorTopicYN="N">OHCA, Out-of-hospital cardiac arrest</Keyword><Keyword MajorTopicYN="N">Out-of-hospital cardiac arrest</Keyword><Keyword MajorTopicYN="N">PCI, Percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">ROSC, Return of spontaneous circulation</Keyword><Keyword MajorTopicYN="N">V-A, Veno-arterial</Keyword><Keyword MajorTopicYN="N">VF, Ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">VT, Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35434669</ArticleId><ArticleId IdType="pmc">PMC9010695</ArticleId><ArticleId IdType="doi">10.1016/j.resplu.2022.100230</ArticleId><ArticleId IdType="pii">S2666-5204(22)00030-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rea T.D., Eisenberg M.S., Becker L.J., Murray J.A., Hearne T. Temporal trends in sudden cardiac arrest: a 25-year emergency medical services perspective. Circulation. 2003;107:2780&#x2013;2785.</Citation><ArticleIdList><ArticleId IdType="pubmed">12756155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S., Gan Y., Jiang N., et al. The global survival rate among adult out-of-hospital cardiac arrest patients who received cardiopulmonary resuscitation: a systematic review and meta-analysis. Crit Care. 2020;24:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7036236</ArticleId><ArticleId IdType="pubmed">32087741</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdowski J., Berg R.A., Tijssen J.G., Koster R.W. Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. Resuscitation. 2010;81:1479&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pubmed">20828914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajino K., Iwami T., Daya M., et al. Impact of transport to critical care medical centers on outcomes after out-of-hospital cardiac arrest. Resuscitation. 2010;81:549&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">20303640</ArticleId></ArticleIdList></Reference><Reference><Citation>Tranberg T., Lippert F.K., Christensen E.F., et al. Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study. Eur Heart J. 2017;38:1645&#x2013;1652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451896</ArticleId><ArticleId IdType="pubmed">28369362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringgren KB, Christensen HC, Sch&#xf8;nau L, et al. Danish Cardiac Arrest Registry 2001-2018. (2018); 22 Mar 2021: https://hjertestopregister.dk/wp-content/uploads/2019/11/Dansk-Hjertestopregister-2018-2.pdf.</Citation></Reference><Reference><Citation>Perkins G.D., Jacobs I.G., Nadkarni V.M., et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update of the Utstein Resuscitation Registry Templates for Out-of-Hospital Cardiac Arrest: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia); and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Circulation. 2015;132:1286&#x2013;1300.</Citation><ArticleIdList><ArticleId IdType="pubmed">25391522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mork S.R., Stengaard C., Linde L., et al. Mechanical circulatory support for refractory out-of-hospital cardiac arrest: a Danish nationwide multicenter study. Crit Care. 2021;25:174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141159</ArticleId><ArticleId IdType="pubmed">34022934</ArticleId></ArticleIdList></Reference><Reference><Citation>Soar J., Bottiger B.W., Carli P., et al. European Resuscitation Council Guidelines 2021: Adult advanced life support. Resuscitation. 2021;161:115&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">33773825</ArticleId></ArticleIdList></Reference><Reference><Citation>Mork S.R., Frederiksen C.A., Nielsen R.R., et al. A systematic approach to weaning from extracorporeal membrane oxygenation in patients with refractory cardiac failure. Acta Anaesthesiol Scand. 2021;65:936&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">33728635</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">46957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wampler D.A., Collett L., Manifold C.A., Velasquez C., McMullan J.T. Cardiac arrest survival is rare without prehospital return of spontaneous circulation. Prehosp Emerg Care. 2012;16:451&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">22834854</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu T., Kinoshita K., Sakurai A., et al. Shorter time until return of spontaneous circulation is the only independent factor for a good neurological outcome in patients with postcardiac arrest syndrome. Emerg Med J. 2014;31:549&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078719</ArticleId><ArticleId IdType="pubmed">23639589</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard E.B.G., Sandbach D.D., Nicholls T.L., Wilson A.W., Ercole A. Prehospital determinants of successful resuscitation after traumatic and non-traumatic out-of-hospital cardiac arrest. Emerg Med J. 2019;36:333&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6582713</ArticleId><ArticleId IdType="pubmed">31003991</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrie J., Easton S., Naik V., Lockie C., Brett S.J., Stumpfle R. Hospital costs of out-of-hospital cardiac arrest patients treated in intensive care; a single centre evaluation using the national tariff-based system. BMJ Open. 2015;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4390724</ArticleId><ArticleId IdType="pubmed">25838503</ArticleId></ArticleIdList></Reference><Reference><Citation>Risgaard B., Lynge T.H., Wissenberg M., et al. Risk factors and causes of sudden noncardiac death: A nationwide cohort study in Denmark. Heart Rhythm. 2015;12:968&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pubmed">25614248</ArticleId></ArticleIdList></Reference><Reference><Citation>Granfeldt A., Adelborg K., Wissenberg M., et al. Severity of ischemic heart disease and presenting rhythm in patients with out-of-hospital cardiac arrest. Resuscitation. 2018;130:174&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">30031785</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia S., Drexel T., Bekwelem W., et al. Early Access to the Cardiac Catheterization Laboratory for Patients Resuscitated From Cardiac Arrest Due to a Shockable Rhythm: The Minnesota Resuscitation Consortium Twin Cities Unified Protocol. J Am Heart Assoc. 2016;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859384</ArticleId><ArticleId IdType="pubmed">26744380</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo J.W., Ng Z.H.C., Goh A.X.C., et al. Impact of Cardiac Arrest Centers on the Survival of Patients With Nontraumatic Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2021:e023806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9075197</ArticleId><ArticleId IdType="pubmed">34927456</ArticleId></ArticleIdList></Reference><Reference><Citation>Desch S., Freund A., Akin I., et al. Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation. N Engl J Med. 2021;385:2544&#x2013;2553.</Citation><ArticleIdList><ArticleId IdType="pubmed">34459570</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunau B., Reynolds J.C., Scheuermeyer F.X., et al. Comparing the prognosis of those with initial shockable and non-shockable rhythms with increasing durations of CPR: Informing minimum durations of resuscitation. Resuscitation. 2016;101:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">26851705</ArticleId></ArticleIdList></Reference><Reference><Citation>Herlitz J., Svensson L., Engdahl J., Silfverstolpe J. Characteristics and outcome in out-of-hospital cardiac arrest when patients are found in a non-shockable rhythm. Resuscitation. 2008;76:31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">17709164</ArticleId></ArticleIdList></Reference><Reference><Citation>Belohlavek J., Smalcova J., Rob D., et al. Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2022;327:737&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864504</ArticleId><ArticleId IdType="pubmed">35191923</ArticleId></ArticleIdList></Reference><Reference><Citation>Yannopoulos D., Bartos J., Raveendran G., et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396:1807&#x2013;1816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7856571</ArticleId><ArticleId IdType="pubmed">33197396</ArticleId></ArticleIdList></Reference><Reference><Citation>Scquizzato T., Bonaccorso A., Consonni M., et al. Extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest: A systematic review and meta-analysis of randomized and propensity score-matched studies. Artif Organs. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307006</ArticleId><ArticleId IdType="pubmed">35199375</ArticleId></ArticleIdList></Reference><Reference><Citation>Vase H., Christensen S., Christiansen A., et al. The Impella CP device for acute mechanical circulatory support in refractory cardiac arrest. Resuscitation. 2017;112:70&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">27751862</ArticleId></ArticleIdList></Reference><Reference><Citation>Stottrup N.B., Jakobsen L., Krusell L.R., Terkelsen C.J. Utility of Impella(R) left ventricular assist device during cardiac arrest: A case report. Int J Cardiol. 2016;225:111&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">27718442</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidsen C., Packer E.J.S., Loland K.H., et al. Impella use in acute myocardial infarction complicated by cardiogenic shock and cardiac arrest: Analysis of 10 years registry data. Resuscitation. 2019;140:178&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">31009694</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchal A.R., Bartos J.A., Cabanas J.G., et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142:S366&#x2013;S468.</Citation><ArticleIdList><ArticleId IdType="pubmed">33081529</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel N.J., Patel N., Bhardwaj B., et al. Trends in utilization of mechanical circulatory support in patients hospitalized after out-of-hospital cardiac arrest. Resuscitation. 2018;127:105&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">29674141</ArticleId></ArticleIdList></Reference><Reference><Citation>Extracoporeal Life Support Organization Registry Report &amp; International Summary of Statistics. 2021: https://www.elso.org/Registry/InternationalSummary.aspx.</Citation></Reference><Reference><Citation>Tram J., Pressman A., Chen N.W., et al. Percutaneous mechanical circulatory support and survival in patients resuscitated from Out of Hospital cardiac arrest: A study from the CARES surveillance group. Resuscitation. 2021;158:122&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">33253768</ArticleId></ArticleIdList></Reference><Reference><Citation>Miraglia D., Miguel L.A., Alonso W. Long-term neurologically intact survival after extracorporeal cardiopulmonary resuscitation for in-hospital or out-of-hospital cardiac arrest: A systematic review and meta-analysis. Resusc Plus. 2020;4:100045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8244502</ArticleId><ArticleId IdType="pubmed">34223320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wengenmayer T., Rombach S., Ramshorn F., et al. Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation (eCPR) Crit Care. 2017;21:157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480193</ArticleId><ArticleId IdType="pubmed">28637497</ArticleId></ArticleIdList></Reference><Reference><Citation>Debaty G., Babaz V., Durand M., et al. Prognostic factors for extracorporeal cardiopulmonary resuscitation recipients following out-of-hospital refractory cardiac arrest. A systematic review and meta-analysis. Resuscitation. 2017;112:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">28007504</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24879789</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-3084</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Circulation. Arrhythmia and electrophysiology</Title><ISOAbbreviation>Circ Arrhythm Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes: a meta-analysis.</ArticleTitle><Pagination><StartPage>677</StartPage><EndPage>683</EndPage><MedlinePgn>677-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCEP.113.001404</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although ventricular tachycardia (VT) ablation is a widely used therapy for patients with VT, the ideal end points for this procedure are not well defined. We performed a meta-analysis of the published literature to assess the predictive value of noninducibility of postinfarction VT for long-term outcomes after VT ablation.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We performed a systematic review of MEDLINE (1950-2013), EMBASE (1988-2013), the Cochrane Controlled Trials Register (Fourth Quarter, 2012), and reports presented at scientific meetings (1994-2013). Randomized controlled trials, case-control, and cohort studies of VT ablation were included. Outcomes reported in eligible studies were freedom from VT/ventricular fibrillation and all-cause mortality. Of the 3895 studies evaluated, we identified 8 cohort studies enrolling 928 patients for the meta-analysis. Noninducibility after VT ablation was associated with a significant increase in arrhythmia-free survival compared with partial success (odds ratio, 0.49; 95% confidence interval, 0.29-0.84; P=0.009) or failed ablation procedure (odds ratio, 0.10; 95% confidence interval, 0.06-0.18; P&lt;0.001). There was also a significant reduction in all-cause mortality if patients were noninducible after VT ablation compared with patients with partial success (odds ratio, 0.59; 95% confidence interval, 0.36-0.98; P=0.04) or failed ablation (odds ratio, 0.32; 95% confidence interval, 0.10-0.99; P=0.049).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Noninducibility of VT after VT ablation is associated with improved arrhythmia-free survival and all-cause mortality.</AbstractText><CopyrightInformation>&#xa9; 2014 American Heart Association, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghanbari</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baser</LastName><ForeName>Kazim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokokawa</LastName><ForeName>Miki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Bella</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergara</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deneke</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuck</LastName><ForeName>Karl-Heinz</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kottkamp</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fei</LastName><ForeName>She</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morady</LastName><ForeName>Fred</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogun</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor (H.G., K.B., M.Y., F.M., F.B.); Department of Internal Medicine, Cardiovascular Division, Brigham and Women Hospital, Boston, MA (W.S.); Arrhythmia Unit and Electrophysiology Laboratories, San Raffaele Hospital, Milano, Italy (P.D.B., P.V.); Klinik f&#xfc;r Kardiologie II, Herz- und Gef&#xe4;&#xdf;-Klinik GmbH, Bad Neustadt, Germany (T.D.); Hanseatisches Herzzentrum, Asklepios Klinik St. Georg, Hamburg, Germany (K.-H.K.); Department of Electrophysiology, Klinik Hirslanden, Z&#xfc;rich, Switzerland (H.K.); and Department of Internal Medicine, Division of Cardiology, Peking University Third Hospital, Beijing, China (S.F.). fbogun@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Arrhythm Electrophysiol</MedlineTA><NlmUniqueID>101474365</NlmUniqueID><ISSNLinking>1941-3084</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Circ Arrhythm Electrophysiol. 2014 Aug;7(4):567-9. doi: 10.1161/CIRCEP.114.001925.</RefSource><PMID Version="1">25140016</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002304" MajorTopicYN="N">Cardiac Pacing, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="Y">Electrophysiologic Techniques, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">tachycardia, ventricular</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24879789</ArticleId><ArticleId IdType="doi">10.1161/CIRCEP.113.001404</ArticleId><ArticleId IdType="pii">CIRCEP.113.001404</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27049318</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>The Influence of Perioperative Dexmedetomidine on Patients Undergoing Cardiac Surgery: A Meta-Analysis.</ArticleTitle><Pagination><StartPage>e0152829</StartPage><MedlinePgn>e0152829</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0152829</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0152829</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The use of dexmedetomidine may have benefits on the clinical outcomes of cardiac surgery. We conducted a meta-analysis comparing the postoperative complications in patients undergoing cardiac surgery with dexmedetomidine versus other perioperative medications to determine the influence of perioperative dexmedetomidine on cardiac surgery patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized or quasi-randomized controlled trials comparing outcomes in patients who underwent cardiac surgery with dexmedetomidine, another medication, or a placebo were retrieved from EMBASE, PubMed, the Cochrane Library, and Science Citation Index.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1702 patients in 14 studies met the selection criteria among 1,535 studies that fit the research strategy. Compared to other medications, dexmedetomidine has combined risk ratios of 0.28 (95% confidence interval [CI] 0.15, 0.55, P = 0.0002) for ventricular tachycardia, 0.35 (95% CI 0.20, 0.62, P = 0.0004) for postoperative delirium, 0.76 (95% CI 0.55, 1.06, P = 0.11) for atrial fibrillation, 1.08 (95% CI 0.74, 1.57, P = 0.69) for hypotension, and 2.23 (95% CI 1.36, 3.67, P = 0.001) for bradycardia. In addition, dexmedetomidine may reduce the length of intensive care unit (ICU) and hospital stay.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis revealed that the perioperative use of dexmedetomidine in patients undergoing cardiac surgery can reduce the risk of postoperative ventricular tachycardia and delirium, but may increase the risk of bradycardia. The estimates showed a decreased risk of atrial fibrillation, shorter length of ICU stay and hospitalization, and increased risk of hypotension with dexmedetomidine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Ju</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of California Davis Health System, Sacramento, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Fuhai</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of California Davis Health System, Sacramento, California, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="Y">Thoracic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>4</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27049318</ArticleId><ArticleId IdType="pmc">PMC4822865</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0152829</ArticleId><ArticleId IdType="pii">PONE-D-15-50468</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mangano DT. Assessment of the patient with cardiac disease: an anesthesiologist&#x2019;s paradigm. Anesthesiology. 1999; 91: 1521&#x2013;1526. 10.1097/00000542-199911000-00046</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199911000-00046</ArticleId><ArticleId IdType="pubmed">10551605</ArticleId></ArticleIdList></Reference><Reference><Citation>Coriat P, Beaussier M. Fast-tracking after coronary artery bypass graft surgery. Anesth Analg. 2001; 92: 1081&#x2013;1083. 10.1097/00000539-200105000-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200105000-00001</ArticleId><ArticleId IdType="pubmed">11323325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoy SM, Keating GM. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs. 2011; 71: 1481&#x2013;1501. 10.2165/11207190-000000000-00000</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11207190-000000000-00000</ArticleId><ArticleId IdType="pubmed">21812509</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YY, He B, Chen J, Wang ZN. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis. Crit Care. 2012; 16: R169 10.1186/cc11646</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11646</ArticleId><ArticleId IdType="pmc">PMC3682268</ArticleId><ArticleId IdType="pubmed">23016926</ArticleId></ArticleIdList></Reference><Reference><Citation>Asmussen S, Maybauer DM, Fraser JF, Jennings K, George S, Maybauer MO. A meta-analysis of analgesic and sedative effects of dexmedetomidine in burn patients. Burns. 2013; 39: 625&#x2013;631. 10.1016/j.burns.2013.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2013.01.008</ArticleId><ArticleId IdType="pubmed">23465796</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel VJ, Ahmed SS, Nitu ME, Rigby MR. Vasovagal syncope and severe bradycardia following intranasal dexmedetomidine for pediatric procedural sedation. Paediatr Anaesth. 2014; 24: 446&#x2013;448. 10.1111/pan.12368</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12368</ArticleId><ArticleId IdType="pubmed">24571687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachibana K, Hashimoto T, Kato R, Uchida Y, Ito R, Takita K, et al. Neonatal administration with dexmedetomidine does not impair the rat hippocampal synaptic plasticity later in adulthood. Paediatr Anaesth. 2012; 22: 713&#x2013;719. 10.1111/j.1460-9592.2012.03810.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2012.03810.x</ArticleId><ArticleId IdType="pubmed">22309594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalonen J, Hynynen M, Kuitunen A, Heikkil&#xe4; H, Perttil&#xe4; J, Salmenper&#xe4; M, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 1997; 86: 331&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054252</ArticleId></ArticleIdList></Reference><Reference><Citation>Talke P, Li J, Jain U, Leung J, Drasner K, Hollenberg M, et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology. 1995; 82: 620&#x2013;633. 10.1097/00000542-199503000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199503000-00003</ArticleId><ArticleId IdType="pubmed">7879930</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Naik JS, Scott Beattie W. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications. Am J Med. 2003; 114: 742&#x2013;752. 10.1016/s0002-9343(03)00165-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9343(03)00165-7</ArticleId><ArticleId IdType="pubmed">12829201</ArticleId></ArticleIdList></Reference><Reference><Citation>Biccard BM, Goga S, de Beurs J. Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of randomised controlled trials. Anaesthesia. 2008; 63: 4&#x2013;14. 10.1111/j.1365-2044.2007.05306.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2007.05306.x</ArticleId><ArticleId IdType="pubmed">18086064</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji F, Li Z, Nguyen H, Young N, Shi P, Fleming N, et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013; 127: 1576&#x2013;1584. 10.1161/CIRCULATIONAHA.112.000936</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.000936</ArticleId><ArticleId IdType="pmc">PMC3979354</ArticleId><ArticleId IdType="pubmed">23513068</ArticleId></ArticleIdList></Reference><Reference><Citation>Leino K, Hynynen M, Jalonen J, Salmenpera M, Scheinin H, Aantaa R, et al. Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol. 2011; 11: 9 10.1186/1471-2253-11-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-11-9</ArticleId><ArticleId IdType="pmc">PMC3123640</ArticleId><ArticleId IdType="pubmed">21605394</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, Zhao H, Wang C, Sun JJ, Lu K, Ma D. Dexmedetomidine attenuates oxidative stress induced lung alveolar epithelial cell apoptosis in vitro. Oxid Med Cell Longev. 2015; 2015: 358396 10.1155/2015/358396</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/358396</ArticleId><ArticleId IdType="pmc">PMC4369905</ArticleId><ArticleId IdType="pubmed">25838866</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZX, Huang CY, Hua YP, Huang WQ, Deng LH, Liu KX. Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial. Br J Anaesth. 2014; 112: 1055&#x2013;1064. 10.1093/bja/aeu132</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu132</ArticleId><ArticleId IdType="pubmed">24771805</ArticleId></ArticleIdList></Reference><Reference><Citation>Szumita PM, Baroletti SA, Anger KE, Wechsler ME. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm. 2007; 64: 37&#x2013;44. 10.2146/ajhp050508</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp050508</ArticleId><ArticleId IdType="pubmed">17189578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology. 2000; 93: 1345&#x2013;1349.</Citation><ArticleIdList><ArticleId IdType="pubmed">11046225</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett SM, Rebuck JA, Greene CM, Callas PW, Neale BW, Healey MA, et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med. 2005; 33: 940&#x2013;945. 10.1097/01.ccm.0000162565.18193.e5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000162565.18193.e5</ArticleId><ArticleId IdType="pubmed">15891317</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, Kane-Gill SL, Durtschi AJ. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother. 2004; 38: 1130&#x2013;1135. 10.1345/aph.1D615</Citation><ArticleIdList><ArticleId IdType="doi">10.1345/aph.1D615</ArticleId><ArticleId IdType="pubmed">15173557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingersoll-Weng E, Manecke GR Jr, Thistlethwaite PA. Dexmedetomidine and cardiac arrest. Anesthesiology. 2004; 100: 738&#x2013;739. 10.1097/00000542-200403000-00040</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200403000-00040</ArticleId><ArticleId IdType="pubmed">15108994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sichrovsky TC, Mittal S, Steinberg JS. Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg. 2008; 106: 1784&#x2013;1786. 10.1213/ane.0b013e318172fafc</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318172fafc</ArticleId><ArticleId IdType="pubmed">18499610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ickeringill M, Shehabi Y, Adamson H, Ruettimann U. Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: hemodynamic effects and efficacy. Anaesth Intensive Care. 2004; 32: 741&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pubmed">15648981</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehabi Y, Grant P, Wolfenden H, Hammond N, Bass F, Campbell M, et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial. Anesthesiology. 2009; 111: 1075&#x2013;1084. 10.1097/ALN.0b013e3181b6a783</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181b6a783</ArticleId><ArticleId IdType="pubmed">19786862</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009; 50: 206&#x2013;217. 10.1176/appi.psy.50.3.206</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.50.3.206</ArticleId><ArticleId IdType="pubmed">19567759</ArticleId></ArticleIdList></Reference><Reference><Citation>Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009; 301: 489&#x2013;499. 10.1001/jama.2009.56</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.56</ArticleId><ArticleId IdType="pubmed">19188334</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007; 298: 2644&#x2013;2653. 10.1001/jama.298.22.2644</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.22.2644</ArticleId><ArticleId IdType="pubmed">18073360</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928 10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Guo R, Sun L. Dexmedetomidine for preventing sevoflurane-related emergence agitation in children: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand. 2014; 58: 642&#x2013;650. 10.1111/aas.12292</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12292</ArticleId><ArticleId IdType="pubmed">24588393</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG. Cochrane handbook for systematic reviews of interventions Oxford:Wiley; 2008.</Citation></Reference><Reference><Citation>Balkanay OO, Goksedef D, Omeroglu SN, Ipek G. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg. 2015; 20: 209&#x2013;214. 10.1093/icvts/ivu367</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivu367</ArticleId><ArticleId IdType="pubmed">25392341</ArticleId></ArticleIdList></Reference><Reference><Citation>Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003; 17: 576&#x2013;584. 10.1016/s1053-0770(03)00200-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1053-0770(03)00200-3</ArticleId><ArticleId IdType="pubmed">14579210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, Zhang H, Huang L, Liu Y, Liu F, Dong Z. Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Exp Ther Med. 2013; 6: 497&#x2013;502. 10.3892/etm.2013.1183</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2013.1183</ArticleId><ArticleId IdType="pmc">PMC3786847</ArticleId><ArticleId IdType="pubmed">24137215</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaman Y, Abud B, Tekgul ZT, Cakmak M, Yildiz M, Gonullu M. Effects of dexmedetomidine and propofol on sedation in patients after coronary artery bypass graft surgery in a fast-track recovery room setting. J Anesth. 2015; 29: 522&#x2013;528. 10.1007/s00540-015-1975-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-015-1975-2</ArticleId><ArticleId IdType="pubmed">25617159</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JB, Bang SH, Chee HK, Kim JS, Lee SA, Shin JK. Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean J Thorac Cardiovasc Surg. 2014; 47: 249&#x2013;254. 10.5090/kjtcs.2014.47.3.249</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2014.47.3.249</ArticleId><ArticleId IdType="pmc">PMC4157475</ArticleId><ArticleId IdType="pubmed">25207222</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosun Z, Baktir M, Kahraman HC, Baskol G, Guler G, Boyaci A. Does dexmedetomidine provide cardioprotection in coronary artery bypass grafting with cardiopulmonary bypass? A pilot study. J Cardiothorac Vasc Anesth. 2013; 27: 710&#x2013;715. 10.1053/j.jvca.2012.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.12.013</ArticleId><ArticleId IdType="pubmed">23725681</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd Aziz N, Chue MC, Yong CY, Hassan Y, Awaisu A, Hassan J, et al. Efficacy and safety of dexmedetomidine versus morphine in post-operative cardiac surgery patients. Int J Clin Pharm. 2011; 33: 150&#x2013;154. 10.1007/s11096-011-9480-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11096-011-9480-7</ArticleId><ArticleId IdType="pubmed">21744187</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil MA, Abdel Azeem MS. The impact of dexmedetomidine infusion in sparing morphine consumption in off-pump coronary artery bypass grafting. Semin Cardiothorac Vasc Anesth. 2013; 17: 66&#x2013;71. 10.1177/1089253212463969</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1089253212463969</ArticleId><ArticleId IdType="pubmed">23108415</ArticleId></ArticleIdList></Reference><Reference><Citation>Polderman KH, Smit E. Dealing with the delirium dilemma. Crit Care. 2005; 9: 335&#x2013;336. 10.1186/cc3755</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3755</ArticleId><ArticleId IdType="pmc">PMC1269468</ArticleId><ArticleId IdType="pubmed">16137377</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK. Delirium in older persons. N Engl J Med. 2006; 354: 1157&#x2013;1166. 10.1056/NEJMra052321</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra052321</ArticleId><ArticleId IdType="pubmed">16540616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004; 291: 1753&#x2013;1762. 10.1001/jama.291.14.1753</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.14.1753</ArticleId><ArticleId IdType="pubmed">15082703</ArticleId></ArticleIdList></Reference><Reference><Citation>Milbrandt EB, Deppen S, Harrison PL, Shintani AK, Speroff T, Stiles RA, et al. Costs associated with delirium in mechanically ventilated patients. Critical Care Medicine. 2004; 32: 955&#x2013;962. 10.1097/01.ccm.0000119429.16055.92</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000119429.16055.92</ArticleId><ArticleId IdType="pubmed">15071384</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000; 90: 699&#x2013;705. 10.1097/00000539-200003000-00035</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200003000-00035</ArticleId><ArticleId IdType="pubmed">10702460</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E, Ramsay G, Mantz J, Sum-Ping ST. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med. 2003; 18: 29&#x2013;41. 10.1177/0885066602239122</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066602239122</ArticleId><ArticleId IdType="pubmed">15189665</ArticleId></ArticleIdList></Reference><Reference><Citation>Maze M, Scarfini C, Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin. 2001; 17: 881&#x2013;897. 10.1016/S0749-0704(05)70185-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0749-0704(05)70185-8</ArticleId><ArticleId IdType="pubmed">11762266</ArticleId></ArticleIdList></Reference><Reference><Citation>Videira RL, Ferreira RM. Dexmedetomidine and asystole. Anesthesiology. 2004; 101: 1479&#x2013;1480. 10.1097/00000542-200412000-00037</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200412000-00037</ArticleId><ArticleId IdType="pubmed">15564965</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariscalco G, Klersy C, Zanobini M, Banach M, Ferrarese S, Borsani P, et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation. 2008; 118: 1612&#x2013;1618. 10.1161/CIRCULATIONAHA.108.777789</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.777789</ArticleId><ArticleId IdType="pubmed">18824644</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar D, Burt ME, Bains MS, Leung DH. Symptomatic tachydys-rhythmias after esophagectomy: incidence and outcome measures. Ann Thorac Surg. 1996; 61: 1506&#x2013;1509. 10.1016/0003-4975(96)00111-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(96)00111-7</ArticleId><ArticleId IdType="pubmed">8633967</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar D, Roistacher N, Burt M, Reinsel RA, Ginsberg RJ, Wilson RS. Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. Chest. 1995; 108: 349&#x2013;354. 10.1378/chest.108.2.349</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.108.2.349</ArticleId><ArticleId IdType="pubmed">7634865</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpole DH, Liptay MJ, DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996; 61: 977&#x2013;982. 10.1016/0003-4975(95)01174-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(95)01174-9</ArticleId><ArticleId IdType="pubmed">8619729</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanczyk CA, Goldman L, Marcantonio ER, Orav EJ, Lee TH. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med. 1998; 129: 279&#x2013;285. 10.7326/0003-4819-129-4-199808150-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-129-4-199808150-00003</ArticleId><ArticleId IdType="pubmed">9729180</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor GJ, Malik SA, Colliver JA, Dove JT, Moses HW, Mikell FL, et al. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am J Cardiol. 1987; 60: 905&#x2013;907. 10.1016/0002-9149(87)91045-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(87)91045-9</ArticleId><ArticleId IdType="pubmed">3661408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai D, Xu G, Feng L, Yu J, Banchs J, Vaporciyan AA, et al. Dexmedetomidine does not reduce atrial fibrillation after lung cancer surgery. J Cardiothorac Vasc Anesth. 2015; 29: 396&#x2013;401. 10.1053/j.jvca.2014.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2014.05.013</ArticleId><ArticleId IdType="pubmed">25440618</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38460413</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Comparison of volume-controlled ventilation, pressure-controlled ventilation and pressure-controlled ventilation-volume guaranteed in infants and young children in the prone position: A prospective randomized study.</ArticleTitle><Pagination><StartPage>111440</StartPage><MedlinePgn>111440</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111440</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00069-2</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">To explore if the pressure-controlled ventilation (PCV) and pressure-controlled ventilation-volume guaranteed (PCV-VG) modes are superior to volume-controlled ventilation (VCV) in optimizing intraoperative respiratory mechanics in infants and young children in the prone position.</AbstractText><AbstractText Label="DESIGN">A single-center prospective randomized study.</AbstractText><AbstractText Label="SETTING">Children's Hospital, Zhejiang University School of Medicine.</AbstractText><AbstractText Label="PATIENTS">Pediatric patients aged 1&#xa0;month to 3&#xa0;years undergoing elective spinal cord detethering surgery.</AbstractText><AbstractText Label="INTERVENTIONS">Patients were randomly allocated to the VCV group, PCV group and PCV-VG group. The target tidal volume (V<sub>T</sub>) was 8&#xa0;mL/kg and the respiratory rate (RR) was adjusted to maintain a constant end tidal CO<sub>2</sub>.</AbstractText><AbstractText Label="MEASUREMENTS">The primary outcome was intraoperative peak airway pressure (Ppeak). Secondary outcomes included other respiratory and ventilation variables, gas exchange values, serum lung injury biomarkers concentration, hemodynamic parameters and postoperative respiratory complications.</AbstractText><AbstractText Label="MAIN RESULTS">A total of 120 patients were included in the final analysis (40 in each group). The VCV group showed higher Ppeak at T2 (10&#xa0;min after prone positioning) and T3 (30&#xa0;min after prone positioning) than the PCV and PCV-VG groups (T2: P&#xa0;=&#xa0;0.015 and P&#xa0;=&#xa0;0.002, respectively; T3: P&#xa0;=&#xa0;0.007 and P&#xa0;=&#xa0;0.009, respectively). The prone-related decrease in dynamic compliance was prevented by PCV and PCV-VG ventilation modalities at T2 and T3 than by VCV (T2: P&#xa0;=&#xa0;0.008 and P&#xa0;=&#xa0;0.015, respectively; T3: P&#xa0;=&#xa0;0.015 and P&#xa0;=&#xa0;0.014, respectively). Additionally, there were no significant differences in other secondary outcomes among the three groups.</AbstractText><AbstractText Label="CONCLUSION">In infants and young children undergoing spinal cord detethering surgery in the prone position, PCV-VG may be a better ventilation mode due to its ability to mitigate the increase in Ppeak and decrease in Cdyn while maintaining consistent V<sub>T</sub>.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Chunying</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Hongmin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Zhipeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yaoqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jinjin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Research Center, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qixing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Research Center, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310052, China. Electronic address: qixingchen@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016684" MajorTopicYN="N">Prone Position</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="N">Respiratory Mechanics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mechanical ventilation mode</Keyword><Keyword MajorTopicYN="N">Pediatrics</Keyword><Keyword MajorTopicYN="N">Prone position</Keyword><Keyword MajorTopicYN="N">Respiratory mechanics</Keyword><Keyword MajorTopicYN="N">Spinal cord detethering surgery</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>7</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>9</Day><Hour>18</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38460413</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111440</ArticleId><ArticleId IdType="pii">S0952-8180(24)00069-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38560817</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>14</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Prognostic Value of Complete Resection of the High-Frequency Oscillation Area in Intracranial EEG: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e209216</StartPage><MedlinePgn>e209216</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e209216</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000209216</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">High-frequency oscillations (HFOs; ripples 80-250 Hz; fast ripples [FRs] 250-500 Hz) recorded with intracranial electrodes generated excitement and debate about their potential to localize epileptogenic foci. We performed a systematic review and meta-analysis on the prognostic value of complete resection of the HFOs-area (crHFOs-area) for epilepsy surgical outcome in intracranial EEG (iEEG) accessing multiple subgroups.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Embase, and Web of Science for original research from inception to October 27, 2022. We defined favorable surgical outcome (FSO) as Engel class I, International League Against Epilepsy class 1, or seizure-free status. The prognostic value of crHFOs-area for FSO was assessed by (1) the pooled FSO proportion after crHFOs-area; (2) FSO for crHFOs-area vs without crHFOs-area; and (3) the predictive performance. We defined high combined prognostic value as FSO proportion &gt;80% + FSO crHFOs-area &gt;without crHFOs-area + area under the curve (AUC) &gt;0.75 and examined this for the clinical subgroups (study design, age, diagnostic type, HFOs-identification method, HFOs-rate thresholding, and iEEG state). Temporal lobe epilepsy (TLE) was compared with extra-TLE through dichotomous variable analysis. Individual patient analysis was performed for sex, affected hemisphere, MRI findings, surgery location, and pathology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1,387 studies screened, 31 studies (703 patients) met our eligibility criteria. Twenty-seven studies (602 patients) analyzed FRs and 20 studies (424 patients) ripples. Pooled FSO proportion after crHFOs-area was 81% (95% CI 76%-86%) for FRs and 82% (73%-89%) for ripples. Patients with crHFOs-area achieved more often FSO than those without crHFOs-area (FRs odds ratio [OR] 6.38, 4.03-10.09, <i>p</i> &lt; 0.001; ripples 4.04, 2.32-7.04, <i>p</i> &lt; 0.001). The pooled AUCs were 0.81 (0.77-0.84) for FRs and 0.76 (0.72-0.79) for ripples. Combined prognostic value was high in 10 subgroups: retrospective, children, long-term iEEG, threshold (FRs and ripples) and automated detection and interictal (FRs). FSO after complete resection of FRs-area (crFRs-area) was achieved less often in people with TLE than extra-TLE (OR 0.37, 0.15-0.89, <i>p</i> = 0.006). Individual patient analyses showed that crFRs-area was seen more in patients with FSO with than without MRI lesions (<i>p</i> = 0.02 after multiple correction).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Complete resection of the brain area with HFOs is associated with good postsurgical outcome. Its prognostic value holds, especially for FRs, for various subgroups. The use of HFOs for extra-TLE patients requires further evidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ziyi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>From the Department of Neurology and Neurosurgery (Z.W., J.G., M.v.t.K., S.H., M.Z.), University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Part of ERN EpiCARE, the Netherlands; Department of Pediatrics (J.J.), University of Calgary, Alberta Children's Hospital, Calgary, Canada; and Stichting Epilepsie Instellingen Nederland (SEIN) (M.Z.), Heemstede, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jiaojiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Department of Neurology and Neurosurgery (Z.W., J.G., M.v.t.K., S.H., M.Z.), University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Part of ERN EpiCARE, the Netherlands; Department of Pediatrics (J.J.), University of Calgary, Alberta Children's Hospital, Calgary, Canada; and Stichting Epilepsie Instellingen Nederland (SEIN) (M.Z.), Heemstede, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van 't Klooster</LastName><ForeName>Maryse</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Neurology and Neurosurgery (Z.W., J.G., M.v.t.K., S.H., M.Z.), University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Part of ERN EpiCARE, the Netherlands; Department of Pediatrics (J.J.), University of Calgary, Alberta Children's Hospital, Calgary, Canada; and Stichting Epilepsie Instellingen Nederland (SEIN) (M.Z.), Heemstede, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoogteijling</LastName><ForeName>Sem</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Neurology and Neurosurgery (Z.W., J.G., M.v.t.K., S.H., M.Z.), University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Part of ERN EpiCARE, the Netherlands; Department of Pediatrics (J.J.), University of Calgary, Alberta Children's Hospital, Calgary, Canada; and Stichting Epilepsie Instellingen Nederland (SEIN) (M.Z.), Heemstede, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Department of Neurology and Neurosurgery (Z.W., J.G., M.v.t.K., S.H., M.Z.), University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Part of ERN EpiCARE, the Netherlands; Department of Pediatrics (J.J.), University of Calgary, Alberta Children's Hospital, Calgary, Canada; and Stichting Epilepsie Instellingen Nederland (SEIN) (M.Z.), Heemstede, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zijlmans</LastName><ForeName>Maeike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Neurology and Neurosurgery (Z.W., J.G., M.v.t.K., S.H., M.Z.), University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Part of ERN EpiCARE, the Netherlands; Department of Pediatrics (J.J.), University of Calgary, Alberta Children's Hospital, Calgary, Canada; and Stichting Epilepsie Instellingen Nederland (SEIN) (M.Z.), Heemstede, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Neurology. 2024 Aug 13;103(3):e209599. doi: 10.1212/WNL.0000000000209599.</RefSource><PMID Version="1">38950336</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069280" MajorTopicYN="Y">Electrocorticography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058256" MajorTopicYN="N">Brain Waves</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>17</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38560817</ArticleId><ArticleId IdType="pmc">PMC11175645</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000209216</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Tisi J, Bell GS, Peacock JL, et al. . The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet. 2011;378(9800):1388-1395. doi:10.1016/S0140-6736(11)60890-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60890-8</ArticleId><ArticleId IdType="pubmed">22000136</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol. 2008;7(6):525-537. doi:10.1016/S1474-4422(08)70109-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70109-1</ArticleId><ArticleId IdType="pubmed">18485316</ArticleId></ArticleIdList></Reference><Reference><Citation>Zijlmans M, Zweiphenning W, van Klink N. Changing concepts in presurgical assessment for epilepsy surgery. Nat Rev Neurol. 2019;15(10):594-606. doi:10.1038/s41582-019-0224-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0224-y</ArticleId><ArticleId IdType="pubmed">31341275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zweiphenning W, Klooster MAV, van Klink NEC, et al. . Intraoperative electrocorticography using high-frequency oscillations or spikes to tailor epilepsy surgery in the Netherlands (the HFO trial): a randomised, single-blind, adaptive non-inferiority trial. Lancet Neurol. 2022;21(11):982-993. doi:10.1016/S1474-4422(22)00311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00311-8</ArticleId><ArticleId IdType="pmc">PMC9579052</ArticleId><ArticleId IdType="pubmed">36270309</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi L, Fan X, Tao XR, et al. . Identifying the epileptogenic zone with the relative strength of high-frequency oscillation: a stereoelectroencephalography study. Front Hum Neurosci. 2020;14:186. doi:10.3389/fnhum.2020.00186</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2020.00186</ArticleId><ArticleId IdType="pmc">PMC7296092</ArticleId><ArticleId IdType="pubmed">32581741</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuraba R, Iwasaki M, Okumura E, et al. . High frequency oscillations are less frequent but more specific to epileptogenicity during rapid eye movement sleep. Clin Neurophysiol. 2016;127(1):179-186. doi:10.1016/j.clinph.2015.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2015.05.019</ArticleId><ArticleId IdType="pubmed">26073183</ArticleId></ArticleIdList></Reference><Reference><Citation>Usui N, Terada K, Baba K, et al. . Clinical significance of ictal high frequency oscillations in medial temporal lobe epilepsy. Clin Neurophysiol. 2011;122(9):1693-1700. doi:10.1016/j.clinph.2011.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2011.02.006</ArticleId><ArticleId IdType="pubmed">21398175</ArticleId></ArticleIdList></Reference><Reference><Citation>Nariai H, Hussain SA, Bernardo D, et al. . Prospective observational study: fast ripple localization delineates the epileptogenic zone. Clin Neurophysiol. 2019;130(11):2144-2152. doi:10.1016/j.clinph.2019.08.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.08.026</ArticleId><ArticleId IdType="pubmed">31569042</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara H, Leach JL, Greiner HM, et al. . Resection of ictal high frequency oscillations is associated with favorable surgical outcome in pediatric drug resistant epilepsy secondary to tuberous sclerosis complex. Epilepsy Res. 2016;126:90-97. doi:10.1016/j.eplepsyres.2016.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eplepsyres.2016.07.005</ArticleId><ArticleId IdType="pubmed">27450371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JR, Koo DL, Joo EY, et al. . Resection of individually identified high-rate high-frequency oscillations region is associated with favorable outcome in neocortical epilepsy. Epilepsia. 2014;55(11):1872-1883. doi:10.1111/epi.12808</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.12808</ArticleId><ArticleId IdType="pubmed">25266626</ArticleId></ArticleIdList></Reference><Reference><Citation>Boran E, Ramantani G, Krayenb&#xfc;hl N, et al. . High-density ECoG improves the detection of high frequency oscillations that predict seizure outcome. Clin Neurophysiol. 2019;130(10):1882-1888. doi:10.1016/j.clinph.2019.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.07.008</ArticleId><ArticleId IdType="pubmed">31404865</ArticleId></ArticleIdList></Reference><Reference><Citation>Modur PN, Zhang S, Vitaz TW. Ictal high-frequency oscillations in neocortical epilepsy: implications for seizure localization and surgical resection. Epilepsia. 2011;52(10):1792-1801. doi:10.1111/j.1528-1167.2011.03165.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2011.03165.x</ArticleId><ArticleId IdType="pmc">PMC3188690</ArticleId><ArticleId IdType="pubmed">21762451</ArticleId></ArticleIdList></Reference><Reference><Citation>van't Klooster MA, van Klink NE, Leijten FS, et al. . Residual fast ripples in the intraoperative corticogram predict epilepsy surgery outcome. Neurology. 2015;85(2):120-128. doi:10.1212/WNL.0000000000001727</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001727</ArticleId><ArticleId IdType="pubmed">26070338</ArticleId></ArticleIdList></Reference><Reference><Citation>van Klink NEC, Van't Klooster MA, Zelmann R, et al. . High frequency oscillations in intra-operative electrocorticography before and after epilepsy surgery. Clin Neurophysiol. 2014;125(11):2212-2219. doi:10.1016/j.clinph.2014.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.03.004</ArticleId><ArticleId IdType="pubmed">24704141</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J, Wu JY, Perucca P, et al. . Removing high-frequency oscillations: a prospective multicenter study on seizure outcome. Neurology. 2018;91(11):e1040-e1052. doi:10.1212/WNL.0000000000006158</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006158</ArticleId><ArticleId IdType="pmc">PMC6140372</ArticleId><ArticleId IdType="pubmed">30120133</ArticleId></ArticleIdList></Reference><Reference><Citation>Roehri N, Pizzo F, Lagarde S, et al. . High-frequency oscillations are not better biomarkers of epileptogenic tissues than spikes. Ann Neurol. 2018;83(1):84-97. doi:10.1002/ana.25124</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25124</ArticleId><ArticleId IdType="pubmed">29244226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloss D, Nevitt SJ, Staba R. The role of high-frequency oscillations in epilepsy surgery planning. Cochrane Database Syst Rev. 2017;10:CD010235. doi:10.1002/14651858.CD010235.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010235.pub3</ArticleId><ArticleId IdType="pmc">PMC6485644</ArticleId><ArticleId IdType="pubmed">28981957</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain SA, Mathern GW, Sankar R, Wu JY. Prospective and &#x201c;live&#x201d; fast ripple detection and localization in the operating room: impact on epilepsy surgery outcomes in children. Epilepsy Res. 2016;127:344-351. doi:10.1016/j.eplepsyres.2016.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eplepsyres.2016.09.017</ArticleId><ArticleId IdType="pubmed">27721161</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedele T, Burnos S, Boran E, et al. . Resection of high frequency oscillations predicts seizure outcome in the individual patient. Sci Rep. 2017;7(1):13836. doi:10.1038/s41598-017-13064-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13064-1</ArticleId><ArticleId IdType="pmc">PMC5653833</ArticleId><ArticleId IdType="pubmed">29062105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Xu J, Liu T, et al. . Diagnostic value of high-frequency oscillations for the epileptogenic zone: a systematic review and meta-analysis. Seizure. 2022;99:82-90. doi:10.1016/j.seizure.2022.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2022.05.003</ArticleId><ArticleId IdType="pubmed">35609497</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O'Connell D, et al. . The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Accessed January 4, 2022. www.ohri.ca/programs/clinical_epidemiology/oxford.asp</Citation></Reference><Reference><Citation>Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240(4857):1285-1293. doi:10.1126/science.3287615</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3287615</ArticleId><ArticleId IdType="pubmed">3287615</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CM, Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg. 2005;79(1):16-20. doi:10.1016/j.athoracsur.2004.09.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2004.09.040</ArticleId><ArticleId IdType="pubmed">15620907</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara H, Greiner HM, Lee KH, et al. . Resection of ictal high-frequency oscillations leads to favorable surgical outcome in pediatric epilepsy. Epilepsia. 2012;53(9):1607-1617. doi:10.1111/j.1528-1167.2012.03629.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2012.03629.x</ArticleId><ArticleId IdType="pmc">PMC3520059</ArticleId><ArticleId IdType="pubmed">22905734</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandrannair R, Ochi A, Imai K, et al. . Epileptic spasms in older pediatric patients: MEG and ictal high-frequency oscillations suggest focal-onset seizures in a subset of epileptic spasms. Epilepsy Res. 2008;78(2-3):216-224. doi:10.1016/j.eplepsyres.2007.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eplepsyres.2007.12.007</ArticleId><ArticleId IdType="pubmed">18215506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, So NK, Jin B, et al. . Interictal ripples nested in epileptiform discharge help to identify the epileptogenic zone in neocortical epilepsy. Clin Neurophysiol. 2017;128(6):945-951. doi:10.1016/j.clinph.2017.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2017.03.033</ArticleId><ArticleId IdType="pubmed">28412559</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushara O, Zhou G, Sharma A, et al. . High-frequency oscillations in tumor-related epilepsy. J Clin Neurophysiol. 2023;40(7):567-573. doi:10.1097/WNP.0000000000000930</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNP.0000000000000930</ArticleId><ArticleId IdType="pubmed">35344517</ArticleId></ArticleIdList></Reference><Reference><Citation>Feyissa AM, Worrell GA, Tatum WO, et al. . High-frequency oscillations in awake patients undergoing brain tumor-related epilepsy surgery. Neurology. 2018;90(13):e1119-e1125. doi:10.1212/WNL.0000000000005216</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005216</ArticleId><ArticleId IdType="pmc">PMC5880636</ArticleId><ArticleId IdType="pubmed">29490917</ArticleId></ArticleIdList></Reference><Reference><Citation>van Klink NEC, Zweiphenning W, Ferrier CH, et al. . Can we use intraoperative high-frequency oscillations to guide tumor-related epilepsy surgery? Epilepsia. 2021;62(4):997-1004. doi:10.1111/epi.16845</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.16845</ArticleId><ArticleId IdType="pmc">PMC8248094</ArticleId><ArticleId IdType="pubmed">33617688</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SA, Staba RJ, Sharan A, et al. . Accuracy of high-frequency oscillations recorded intraoperatively for classification of epileptogenic regions. Sci Rep. 2021;11(1):21388. doi:10.1038/s41598-021-00894-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00894-3</ArticleId><ArticleId IdType="pmc">PMC8560764</ArticleId><ArticleId IdType="pubmed">34725412</ArticleId></ArticleIdList></Reference><Reference><Citation>van't Klooster MA, van Klink NEC, Zweiphenning W, et al. . Tailoring epilepsy surgery with fast ripples in the intraoperative electrocorticogram. Ann Neurol. 2017;81(5):664-676. doi:10.1002/ana.24928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24928</ArticleId><ArticleId IdType="pubmed">28380659</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SA, Berry B, Chervoneva I, et al. . Visually validated semi-automatic high-frequency oscillation detection aides the delineation of epileptogenic regions during intra-operative electrocorticography. Clin Neurophysiol. 2018;129(10):2089-2098. doi:10.1016/j.clinph.2018.06.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.06.030</ArticleId><ArticleId IdType="pubmed">30077870</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu HY, Lin CF, Chou CC, et al. . Outcomes of hippocampus-sparing lesionectomy for temporal lobe epilepsy and the significance of intraoperative hippocampography. Clin Neurophysiol. 2021;132(3):746-755. doi:10.1016/j.clinph.2020.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.12.008</ArticleId><ArticleId IdType="pubmed">33571882</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J, Zijlmans M, Zelmann R, et al. . High-frequency electroencephalographic oscillations correlate with outcome of epilepsy surgery. Ann Neurol. 2010;67(2):209-220. doi:10.1002/ana.21847</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21847</ArticleId><ArticleId IdType="pmc">PMC3769290</ArticleId><ArticleId IdType="pubmed">20225281</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;ller Y, Kutil R, Klaffenb&#xf6;ck L, et al. . High-frequency oscillations in epilepsy and surgical outcome. A meta-analysis. Front Hum Neurosci. 2015;9:574. doi:10.3389/fnhum.2015.00574</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2015.00574</ArticleId><ArticleId IdType="pmc">PMC4611152</ArticleId><ArticleId IdType="pubmed">26539097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Maturana MI, Burkitt AN, Cook MJ, Grayden DB. High-frequency oscillations in epilepsy: what have we learned and what needs to be addressed. Neurology. 2021;96(9):439-448. doi:10.1212/WNL.0000000000011465</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011465</ArticleId><ArticleId IdType="pubmed">33408149</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimakopoulos V, M&#xe9;gevand P, Boran E, et al. . Blinded study: prospectively defined high-frequency oscillations predict seizure outcome in individual patients. Brain Commun. 2021;3:fcab209. doi:10.1093/braincomms/fcab209</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab209</ArticleId><ArticleId IdType="pmc">PMC8445392</ArticleId><ArticleId IdType="pubmed">34541534</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevalainen P, von Ellenrieder N, Klime&#x161; P, Dubeau F, Frauscher B, Gotman J. Association of fast ripples on intracranial EEG and outcomes after epilepsy surgery. Neurology. 2020;95(16):e2235-e2245. doi:10.1212/WNL.0000000000010468</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010468</ArticleId><ArticleId IdType="pmc">PMC7713787</ArticleId><ArticleId IdType="pubmed">32753439</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamilia E, Park EH, Percivati S, et al. . Surgical resection of ripple onset predicts outcome in pediatric epilepsy. Ann Neurol. 2018;84(3):331-346. doi:10.1002/ana.25295</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25295</ArticleId><ArticleId IdType="pubmed">30022519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JY, Sankar R, Lerner JT, Matsumoto JH, Vinters HV, Mathern GW. Removing interictal fast ripples on electrocorticography linked with seizure freedom in children. Neurology. 2010;75(19):1686-1694. doi:10.1212/WNL.0b013e3181fc27d0</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181fc27d0</ArticleId><ArticleId IdType="pmc">PMC3033604</ArticleId><ArticleId IdType="pubmed">20926787</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamilia E, Dirodi M, Alhilani M, et al. . Scalp ripples as prognostic biomarkers of epileptogenicity in pediatric surgery. Ann Clin Transl Neurol. 2020;7(3):329-342. doi:10.1002/acn3.50994</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50994</ArticleId><ArticleId IdType="pmc">PMC7086004</ArticleId><ArticleId IdType="pubmed">32096612</ArticleId></ArticleIdList></Reference><Reference><Citation>Windhager PF, Marcu AV, Trinka E, Bathke A, H&#xf6;ller Y. Are high frequency oscillations in scalp EEG related to age? Front Neurol. 2021;12:722657. doi:10.3389/fneur.2021.722657</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.722657</ArticleId><ArticleId IdType="pmc">PMC8829347</ArticleId><ArticleId IdType="pubmed">35153968</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang CX, Li XN, Yan JQ, et al. . Determining the quantitative threshold of high-frequency oscillation distribution to delineate the epileptogenic zone by automated detection. Front Neurol. 2018;9:889. doi:10.3389/fneur.2018.00889</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00889</ArticleId><ArticleId IdType="pmc">PMC6243027</ArticleId><ArticleId IdType="pubmed">30483204</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Yu T, Ren Z, et al. . Localization of the epileptogenic zone by multimodal neuroimaging and high-frequency oscillation. Front Hum Neurosci. 2021;15:677840. doi:10.3389/fnhum.2021.677840</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2021.677840</ArticleId><ArticleId IdType="pmc">PMC8217465</ArticleId><ArticleId IdType="pubmed">34168546</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama T, McCoy B, Go CY, et al. . Focal resection of fast ripples on extraoperative intracranial EEG improves seizure outcome in pediatric epilepsy. Epilepsia. 2011;52(10):1802-1811. doi:10.1111/j.1528-1167.2011.03199.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2011.03199.x</ArticleId><ArticleId IdType="pubmed">21801168</ArticleId></ArticleIdList></Reference><Reference><Citation>Okanishi T, Akiyama T, Tanaka S, et al. . Interictal high frequency oscillations correlating with seizure outcome in patients with widespread epileptic networks in tuberous sclerosis complex. Epilepsia. 2014;55(10):1602-1610. doi:10.1111/epi.12761</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.12761</ArticleId><ArticleId IdType="pubmed">25196064</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez Ot&#xe1;rula KA, Tan YL, Hall JA, et al. . Postsurgical seizure outcome in temporal lobe epilepsy patients with normal or subtle, nonspecific MRI findings. J Neurosurg. 2022;137(2):442-448. doi:10.3171/2021.10.JNS2127</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2021.10.JNS2127</ArticleId><ArticleId IdType="pubmed">34972090</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z, Zhang C, Wang X, et al. . Is intracranial electroencephalography mandatory for MRI-negative neocortical epilepsy surgery? J Neurosurg. 2022:1-11. doi:10.3171/2022.8.JNS22995</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2022.8.JNS22995</ArticleId><ArticleId IdType="pubmed">36242573</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland NC, Englot DJ, Cage TA, Sughrue ME, Barbaro NM, Chang EF. A meta-analysis of predictors of seizure freedom in the surgical management of focal cortical dysplasia. J Neurosurg. 2012;116(5):1035-1041. doi:10.3171/2012.1.JNS111105</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2012.1.JNS111105</ArticleId><ArticleId IdType="pubmed">22324422</ArticleId></ArticleIdList></Reference><Reference><Citation>Willard A, Antonic-Baker A, Chen Z, O'Brien TJ, Kwan P, Perucca P. Seizure outcome after surgery for MRI-diagnosed focal cortical dysplasia: a systematic review and meta-analysis. Neurology. 2022;98(3):e236-e248. doi:10.1212/WNL.0000000000013066</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000013066</ArticleId><ArticleId IdType="pubmed">34893558</ArticleId></ArticleIdList></Reference><Reference><Citation>eReferences e1-e4 are listed at</Citation></Reference><Reference><Citation>links.lww.com/XXX.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40381757</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-6280</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Current problems in cardiology</Title><ISOAbbreviation>Curr Probl Cardiol</ISOAbbreviation></Journal><ArticleTitle>Incidence and outcomes of acute myocardial infarction with arrhythmic onset: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>103077</StartPage><MedlinePgn>103077</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cpcardiol.2025.103077</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0146-2806(25)00099-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Patients with acute coronary syndrome (ACS) have concomitant ventricular arrhythmic events (VA). Literature data are conflicting regarding short- and long-term prognosis. International guidelines do not recommend defibrillator (ICD) implantation in the first 40 days after a myocardial infarction. However, some patients may have an increased arrhythmic risk and deserve closer monitoring.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of our study was to define the incidence of arrhythmic events in a population of patients admitted for ACS to the Cardiac Intensive Care Unit (CICU) of a tertiary center and to determine the short- and long-term prognosis in patients with arrhythmic onset compared with patients without arrhythmic onset.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a single-center retrospective cohort data analysis of 1587 consecutive patients admitted with a diagnosis of ACS to the CICU of Niguarda Hospital of Milan, from 2014 to 2022. We classified the patients into two groups according to the arrhythmias at presentation: VA (sustained VT or VF) and no-VA. Kaplan-Meier (KM) estimated the probability of remaining event free in the time after ACS and were compared between VA and no-VA groups, using the log-rank test. Cox regression analysis was used to explore the association of specific variables with the occurrence of cardiac events in univariate and multivariate analysis. Statistical analyses were performed with R 42.0 statistical package (R Core Team, Vienna, Austria).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 1587 ASC patients, 4.6 % had arrhythmic onset (4.0 had a diagnosis of VF and 0.6 % of VT). Patients with VA were significantly younger (63 y. vs 67 y., p = 0.026) and had a lower incidence of cardiovascular risk factors, such as hypertension and dyslipidemia, compared with no-VA group. VA group had a higher risk of arrhythmias during the hospitalization (9.6 % vs 1.3 %, p &lt; 0.001) and had a clinical course characterized by a significantly higher use of mechanical support with intra-aortic balloon pumps (IABP, 35.6 % vs. 6.8 %, p &lt; 0.001) and a greater use of inotropic drugs (34 % vs. 9 %, p &lt; 0.001). We observed in VA group a six-fold increase in-hospital mortality (23 % vs 4 %, p &lt; 0.001), identifying arrhythmic presentation as a marker of worse in-hospital prognosis in patients admitted with ACS. Likewise, mortality at 40 days after the acute event was higher in the VA group than in the no-VA group (22 % vs. 5 %, p &lt; 0.001). Conversely, during a median follow-up of 5.9 years, VA onset did not affect long-term mortality in patients discharged alive.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this long-term follow-up retrospective registry involving a large cohort of patients with ACS admitted to the CICU, concomitant VA at admission was found to be linked with an increase in in-hospital arrhythmic complications and in-hospital mortality. The mortality rate at 40 days post-ACS was also notably higher in the VA group. This study underscores the complexity of arrhythmic presentation in ACS patients, emphasizing the critical need for vigilant monitoring throughout their hospitalization and particularly in the initial 6 weeks following the event index. This heightened surveillance is justified by the documented elevated levels of morbidity and mortality during this phase.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varrenti</LastName><ForeName>Marisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solfanelli</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa, 1035-1039, 00189 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernasconi</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bicocca Bioinformatics Biostatistics and Bioimaging Center, School of Medicine and Surgery, University of Milano-Bicocca, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regazzetti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy; Department of Medicine and Surgery, Bicocca University, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galasso</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy; Department of Medicine and Surgery, Bicocca University, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preda</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbonaro</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baroni</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gigli</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracini</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargiu</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavecchia</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viola</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villanova</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oreglia</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannattasio</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy; Department of Medicine and Surgery, Bicocca University, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzone</LastName><ForeName>Patrizio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy. Electronic address: Patrizio.mazzone@ospedaleniguarda.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacco</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Probl Cardiol</MedlineTA><NlmUniqueID>7701802</NlmUniqueID><ISSNLinking>0146-2806</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Sudden death</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmia</Keyword></KeywordList><CoiStatement>Declaration of competing interest There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>12</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>18</Day><Hour>17</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>17</Day><Hour>19</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40381757</ArticleId><ArticleId IdType="doi">10.1016/j.cpcardiol.2025.103077</ArticleId><ArticleId IdType="pii">S0146-2806(25)00099-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31621201</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1747-0803</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Congenital heart disease</Title><ISOAbbreviation>Congenit Heart Dis</ISOAbbreviation></Journal><ArticleTitle>Left cardiac sympathetic denervation in the management of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: A meta-regression.</ArticleTitle><Pagination><StartPage>1102</StartPage><EndPage>1112</EndPage><MedlinePgn>1102-1112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/chd.12855</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Left cardiac sympathetic denervation (LCSD) has been proposed as useful therapy for long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT), in addition to anti-arrhythmic agents and implantable cardioverter defibrillators. This study aimed to assess the current evidence for LCSD and compare the open vs the video-assisted thoracoscopic surgery (VATS) approaches.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, Embase and Cochrane library databases were searched up to December 2018 for studies reporting the long-term outcomes of LCSD in LQTS, CPVT patients. The incidence of cardiac events (CEs) before and after surgery, the change in QTc interval, and surgical complications were pooled to estimate the efficacy of LCSD. Meta-regression was used to estimate the effects of surgical approach (open vs VATS) on outcomes following LCSD.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-seven papers met our inclusion criteria (647 patients). VATS was used in 408 patients (63.1%), open surgery in 239 (36.9%). Mean follow-up was 32.3&#xa0;&#xb1;&#xa0;32.5 months. Postsurgery, 398/585 patients (68.0%) were free of CEs and QTc decreased from 522&#xa0;&#xb1;&#xa0;61.6&#xa0;ms to 494&#xa0;&#xb1;&#xa0;52.3&#xa0;ms. Meta-regression showed no differences between the two approaches in the incidence of CEs and surgical complications. VATS was associated with a smaller reduction in QTc (&#x3b2;-coefficient -20.04, 95% CI -36.82 to -3.27, P&#xa0;=&#xa0;.019).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">LCSD was associated with a reduction in the incidence of CEs in LQTS, CPVT patients and in the duration of QTc. Open surgery was associated with a greater reduction in QTc. Due to the limitations that hindered our study, a randomized trial is warranted to fully establish LCSD safety and efficacy.</AbstractText><CopyrightInformation>&#xa9; 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sgr&#xf2;</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5151-8342</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Ayala</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7787-0640</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Southwest Sydney Clinical School, Liverpool Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Congenit Heart Dis</MedlineTA><NlmUniqueID>101256510</NlmUniqueID><ISSNLinking>1747-079X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="N">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004554" MajorTopicYN="N">Electric Countershock</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="Y">innervation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008133" MajorTopicYN="N">Long QT Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013562" MajorTopicYN="N">Sympathectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020775" MajorTopicYN="Y">Thoracic Surgery, Video-Assisted</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000098850" MajorTopicYN="N">Polymorphic Catecholaminergic Ventricular Tachycardia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CPVT</Keyword><Keyword MajorTopicYN="N">VATS</Keyword><Keyword MajorTopicYN="N">long QT syndrome</Keyword><Keyword MajorTopicYN="N">sudden cardiac death</Keyword><Keyword MajorTopicYN="N">sympathectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31621201</ArticleId><ArticleId IdType="doi">10.1111/chd.12855</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18):1761-1767.</Citation></Reference><Reference><Citation>Lieve KV, van der Werf C, Wilde AA. Catecholaminergic polymorphic ventricular tachycardia. Circ J. 2016;80(6):1285-1291.</Citation></Reference><Reference><Citation>Webster G, Berul CI. An update on channelopathies: from mechanisms to management. Circulation. 2013;127(1):126-140.</Citation></Reference><Reference><Citation>Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106(1):69-74.</Citation></Reference><Reference><Citation>Priori SG, Blomstr&#xf6;m-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-2867.</Citation></Reference><Reference><Citation>Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101(6):616-623.</Citation></Reference><Reference><Citation>Schwartz PJ, Spazzolini C, Priori SG, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) registry. Circulation. 2010;122(13):1272-1282.</Citation></Reference><Reference><Citation>Odero A, Bozzani A, De Ferrari GM, Schwartz PJ. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. Heart Rhythm. 2010;7(8):1161-1165.</Citation></Reference><Reference><Citation>Schwartz PJ. Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications. Heart Rhythm. 2010;7(9):1330-1332.</Citation></Reference><Reference><Citation>Schwartz PJ. Cardiac sympathetic denervation to prevent life-threatening arrhythmias. Nat Rev Cardiol. 2014;11(6):346-353.</Citation></Reference><Reference><Citation>Schwartz PJ. The rationale and the role of left stellectomy for the prevention of malignant arrhythmias. Ann N Y Acad Sci. 1984;427:199-221.</Citation></Reference><Reference><Citation>Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37(7):1034-1040.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;2009(339):b2535.</Citation></Reference><Reference><Citation>The NIH Quality Assessment Tool for Case Series Studies. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed December 2018.</Citation></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785-1805.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation></Reference><Reference><Citation>Antiel RM, Bos JM, Joyce DD, et al. Quality of life after videoscopic left cardiac sympathetic denervation in patients with potentially life-threatening cardiac channelopathies/cardiomyopathies. Heart Rhythm. 2016;13(1):62-69.</Citation></Reference><Reference><Citation>Atallah J, Fynn-Thompson F, Cecchin F, DiBardino DJ, Walsh EP, Berul CI. Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias. Ann Thorac Surg. 2008;86(5):1620-1625.</Citation></Reference><Reference><Citation>Bos JM, Bos KM, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders. Circ Arrhythm Electrophysiol. 2013;6(4):705-711.</Citation></Reference><Reference><Citation>Coleman MA, Bos JM, Johnson JN, et al. Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome. Circ Arrhythm Electrophysiol. 2012;5(4):782-788.</Citation></Reference><Reference><Citation>Collura CA, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm. 2009;6(6):752-759.</Citation></Reference><Reference><Citation>Costello JP, Wilson JK, Louis C, et al. Surgical cardiac denervation therapy for treatment of congenital ion channelopathies in pediatric patients: a contemporary, single institutional experience. World J Pediatr Congenit Heart Surg. 2015;6(1):33-38.</Citation></Reference><Reference><Citation>De Ferrari GM, Dusi V, Spazzolini C, et al. Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation. 2015;131(25):2185-2193.</Citation></Reference><Reference><Citation>Desimone CV, Bos JM, Bos KM, et al. Effects on repolarization using dynamic QT interval monitoring in long-QT patients following left cardiac sympathetic denervation. J Cardiovasc Electrophysiol. 2015;26(4):434-439.</Citation></Reference><Reference><Citation>Epstein AE, Rosner MJ, Hageman GR, Baker JH 2nd, Plumb VJ, Kay GN. Posterior left thoracic cardiac sympathectomy by surgical division of the sympathetic chain: an alternative approach to treatment of the long QT syndrome. Pacing Clin Electrophysiol. 1996;19(7):1095-1104.</Citation></Reference><Reference><Citation>Garvey EM, Papez AL, Notrica DM, et al. Thoracoscopic cardiac sympathetic denervation: adjunct therapy for secondary prevention of life-threatening ventricular arrhythmias in children. J Laparoendosc Adv Surg Tech A. 2018;28(11):1387-1392.</Citation></Reference><Reference><Citation>Hofferberth SC, Cecchin F, Loberman D, Fynn-Thompson F. Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. J Thorac Cardiovasc Surg. 2014;147(1):404-409.</Citation></Reference><Reference><Citation>Jang SY, Cho Y, Kim NK, et al. Video-assisted thoracoscopic left cardiac sympathetic denervation in patients with hereditary ventricular arrhythmias. Pacing Clin Electrophysiol. 2017;40(3):232-241.</Citation></Reference><Reference><Citation>Li C, Hu D, Shang L, et al. Surgical left cardiac sympathetic denervation for long QT syndrome: effects on QT interval and heart rate. Heart Vessels. 2005;20(4):137-141.</Citation></Reference><Reference><Citation>Li J, Liu Y, Yang F, et al. Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome. Ann Thorac Surg. 2008;86(6):1955-1958.</Citation></Reference><Reference><Citation>Li J, Wang L, Wang J. Video-assisted thoracoscopic sympathectomy for congenital long QT syndromes. Pacing Clin Electrophysiol. 2003;26(4 Pt 1):870-873.</Citation></Reference><Reference><Citation>Li K, Yang J, Guo W, et al. Video-assisted thoracoscopic left cardiac sympathetic denervation in Chinese patients with long QT syndrome. Int Heart J. 2018;59(6):1346-1351.</Citation></Reference><Reference><Citation>Marai I, Boulos M, Khoury A. Left cardiac sympathetic denervation in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia. Isr Med Assoc J. 2015;17(9):538-540.</Citation></Reference><Reference><Citation>McNamara C, Cullen P, Rackauskas M, et al. Left cardiac sympathetic denervation: case series and technical report. Ir J Med Sci. 2017;186(3):607-613.</Citation></Reference><Reference><Citation>Olde Nordkamp LRA, Driessen AHG, Odero A, et al. Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J. 2014;22(4):160-166.</Citation></Reference><Reference><Citation>Ouriel K, Moss AJ. Long QT syndrome: an indication for cervicothoracic sympathectomy. Cardiovasc Surg. 1995;3(5):475-478.</Citation></Reference><Reference><Citation>Schneider AE, Bos JM, Ackerman MJ. Effect of left cardiac sympathetic denervation on the electromechanical window in patients with either type 1 or type 2 long QT syndrome: a pilot study. Congenit Heart Dis. 2016;11(5):437-443.</Citation></Reference><Reference><Citation>Schneider HE, Steinmetz M, Krause U, Kriebel T, Ruschewski W, Paul T. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome. Clin Res Cardiol. 2013;102(1):33-42.</Citation></Reference><Reference><Citation>Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109(15):1826-1833.</Citation></Reference><Reference><Citation>Tarrado X, Sarquella-Brugada G, Saura L, Manzanares A, Julia V, Ribo JM. Left cardiac sympathetic denervation in congenital ventricular arrythmias: initial experience. Cir Pediatr. 2014;27(2):98-101.</Citation></Reference><Reference><Citation>Upadya M, Misquith J, Rao R. Anaesthesia for left thoracoscopic sympathectomy for refractory long QT syndrome: three case reports. South Afr J Anaesth Analg. 2016;22(5):156-159.</Citation></Reference><Reference><Citation>Waddell-Smith KE, Ertresvaag KN, Li J, et al. Physical and psychological consequences of left cardiac sympathetic denervation in long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol. 2015;8(5):1151-1158.</Citation></Reference><Reference><Citation>Wilde AAM, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358(19):2024-2029.</Citation></Reference><Reference><Citation>Schwartz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA: WB Saunders Co; 1990:330-343.</Citation></Reference><Reference><Citation>Schwartz PJ. QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. J Cardiovasc Electrophysiol. 2001;12:1074-1077.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29680972</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>207</StartPage><EndPage>215</EndPage><MedlinePgn>207-215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-018-0376-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Catheter ablation is proven to be an effective strategy for drug refractory ventricular tachycardia (VT) in ischemic cardiomyopathy. However, the appropriate timing of VT ablation and identifying the group of patients that may receive the greatest benefit remains uncertain. There is limited data on the effect on prophylactic catheter ablation (PCA) in the prevention of implantable cardioverter defibrillator (ICD) therapy, electrical storm, and mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a comprehensive literature search through November 1, 2017, for all eligible studies comparing PCA + ICD versus ICD only in eligible patients with ischemic cardiomyopathy. Clinical outcomes included all ICD therapies including ICD shocks and electrical storm. Additional outcomes included all-cause mortality, cardiovascular mortality, and complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three randomized controlled trials (RCTs) (N&#x2009;=&#x2009;346) met inclusion criteria. PCA was associated with a significantly lower ICD therapies (OR 0.49; CI 0.28 to 0.87; p&#x2009;=&#x2009;0.01) including ICD shocks [OR 0.38; CI 0.22 to 0.64; p&#x2009;=&#x2009;0.0003) and electrical storm (OR 0.55; CI 0.30 to 1.01; p&#x2009;=&#x2009;0.05) when compared with ICD only. There was no significant difference in all-cause mortality (OR 0.77; CI 0.41 to 1.46; p&#x2009;=&#x2009;0.42), cardiovascular mortality (OR 0.49; CI 0.16 to 1.50; p&#x2009;=&#x2009;0.21), and major adverse events (OR 1.45; CI 0.52 to 4.01; p&#x2009;=&#x2009;0.47) between two groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results suggest prophylactic catheter ablation decreases ICD therapies, including shocks and electrical storm with no improvement in overall mortality. There is a need for future carefully designed randomized clinical trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Atti</LastName><ForeName>Varunsiri</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0151-1545</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Michigan State University, East Lansing, MI, USA. varunsiri7@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuddanda</LastName><ForeName>Venkat</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turagam</LastName><ForeName>Mohit K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Helmsley Electrophysiology Center, Mount Sinai School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vemula</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Sparrow Hospital, Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Zubair</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagam</LastName><ForeName>Himakar</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yandrapalli</LastName><ForeName>Srikanth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, New York Medical College, Valhalla, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jazayeri</LastName><ForeName>Mohammad-Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute, Kansas University Hospital, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koerber</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Electrophysiology, Medical University of South Carolina, Columbia, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Juan Viles</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Center, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Helmsley Electrophysiology Center, Mount Sinai School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute, Kansas University Hospital, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011322" MajorTopicYN="N">Primary Prevention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electrical storm</Keyword><Keyword MajorTopicYN="N">ICD shock</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia ablation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29680972</ArticleId><ArticleId IdType="doi">10.1007/s10840-018-0376-5</ArticleId><ArticleId IdType="pii">10.1007/s10840-018-0376-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heart Rhythm. 2016 Aug;13(8):1748-54</Citation><ArticleIdList><ArticleId IdType="pubmed">27050910</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18387436</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Clin Electrophysiol. 2017 Jul;3(7):767-778</Citation><ArticleIdList><ArticleId IdType="pubmed">29759543</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2011 Oct;22(10):1123-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21539642</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1997 Nov 27;337(22):1576-83</Citation><ArticleIdList><ArticleId IdType="pubmed">9411221</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2001 Aug 7;104(6):664-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11489772</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Jul 14;375(2):111-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cardiovasc Med. 2017 Oct;27(7):506-513</Citation><ArticleIdList><ArticleId IdType="pubmed">28625728</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2014 Jun;7(3):424-35</Citation><ArticleIdList><ArticleId IdType="pubmed">24833642</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Clin Electrophysiol. 2018 Mar;4(3):374-382</Citation><ArticleIdList><ArticleId IdType="pubmed">30089564</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2015 Sep;12(9):1997-2007</Citation><ArticleIdList><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Jan 11;295(2):165-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2017 Mar;10(3):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 2;375(9708):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Mar 21;346(12):877-83</Citation><ArticleIdList><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2009 Jun;11(6):771-817</Citation><ArticleIdList><ArticleId IdType="pubmed">19443434</ArticleId></ArticleIdList></Reference><Reference><Citation>Card Electrophysiol Clin. 2017 Mar;9(1):153-165</Citation><ArticleIdList><ArticleId IdType="pubmed">28167083</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2000 Mar 21;101(11):1288-96</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1991 Oct;18(4):1005-14</Citation><ArticleIdList><ArticleId IdType="pubmed">1894846</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrhythm Electrophysiol Rev. 2015 Dec;4(3):177-83</Citation><ArticleIdList><ArticleId IdType="pubmed">26835122</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2014 Jan 21;129(3):e28-e292</Citation><ArticleIdList><ArticleId IdType="pubmed">24352519</ArticleId></ArticleIdList></Reference><Reference><Citation>J Arrhythm. 2015 Jun;31(3):122-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26336545</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrhythm Electrophysiol Rev. 2017 Aug;6(3):125-128</Citation><ArticleIdList><ArticleId IdType="pubmed">29018520</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Sep 4;359(10):1009-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2012 Oct 23;126(17):2146-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23008437</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2018 Mar;15(3):355-362</Citation><ArticleIdList><ArticleId IdType="pubmed">29030235</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2015 Dec 29;66(25):2872-2882</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Lung Circ. 2012 Jun;21(6-7):402-12</Citation><ArticleIdList><ArticleId IdType="pubmed">22237136</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2012 Jul 10;60(2):132-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22766340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2010 May 25;55(21):2366-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20488308</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Oct;11(10):e166-96</Citation><ArticleIdList><ArticleId IdType="pubmed">25179489</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2012 Aug;9(8):1192-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22465295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 Aug 18;151(4):264-9, W64</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 2009 Mar;84(3):289-97</Citation><ArticleIdList><ArticleId IdType="pubmed">19252119</ArticleId></ArticleIdList></Reference><Reference><Citation>Card Electrophysiol Clin. 2017 Mar;9(1):25-46</Citation><ArticleIdList><ArticleId IdType="pubmed">28167084</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2016 Jul;13(7):1552-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26961297</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2014 Nov;11(11):2056-63</Citation><ArticleIdList><ArticleId IdType="pubmed">25016150</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Jan 29;117(4):462-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18172038</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2010 Jul;21(7):799-803</Citation><ArticleIdList><ArticleId IdType="pubmed">20132389</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Oct 18;343:d5928</Citation><ArticleIdList><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2002 Aug;144(2):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12177646</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2007 Nov;4(11):1395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">17954398</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1144-51</Citation><ArticleIdList><ArticleId IdType="pubmed">25262159</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35578170</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative low tidal volume ventilation and the risk of ICD-10 coded delirium and the use for antipsychotic medications.</ArticleTitle><Pagination><StartPage>149</StartPage><MedlinePgn>149</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">149</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-022-01689-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Low tidal volume (V<sub>T</sub>) ventilation and its associated increase in arterial carbon dioxide (PaCO<sub>2</sub>) may affect postoperative neurologic function. We aimed to test the hypothesis that intraoperative low V<sub>T</sub> ventilation affect the incidence of postoperative ICD-10 coded delirium and/or the need for antipsychotic medications.</AbstractText><AbstractText Label="METHODS">This is a post-hoc analysis of a large randomized controlled trial evaluating low vs. conventional V<sub>T</sub> ventilation during major non-cardiothoracic, non-intracranial surgery. The primary outcome was the incidence of ICD-10 delirium and/or the use of antipsychotic medications during hospital stay, and the absolute difference with its 95% confidence interval (CI) was calculated.</AbstractText><AbstractText Label="RESULTS">We studied 1206 patients (median age of 64 [55-72] years, 59.0% males, median ARISCAT of 26 [19-37], and 47.6% of ASA 3). ICD-10 coded delirium and /or antipsychotic medication use was diagnosed in 11.2% with similar incidence between low and conventional V<sub>T</sub> ventilation (11.1% vs. 11.3%; absolute difference, -0.24 [95%CI, -3.82 to 3.32]; p&#x2009;=&#x2009;0.894). There was no interaction between allocation group and type of surgery.</AbstractText><AbstractText Label="CONCLUSION">In adult patients undergoing major surgery, low V<sub>T</sub> ventilation was not associated with increased risk of ICD-10 delirium and/or the use of antipsychotic medications during hospital stay.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ANZCTR Identifier: ACTRN12614000790640 .</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karalapillai</LastName><ForeName>Dharshi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia. dharshi.karalapillai@austin.org.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia. dharshi.karalapillai@austin.org.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia. dharshi.karalapillai@austin.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>Ary Serpa</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellard</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearce</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oughton</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galtieri</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appu</LastName><ForeName>Sree</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastwood</LastName><ForeName>Glenn</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation (DARE) Centre, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Daryl A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ANZCTR</DataBankName><AccessionNumberList><AccessionNumber>ACTRN12614000790640</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="Y">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="N">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delirium</Keyword><Keyword MajorTopicYN="N">Postoperative</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Tidal volume</Keyword></KeywordList><CoiStatement>The original trial was investigator-initiated research funded by Australian and New Zealand College of Anaesthetists grant ANZAC16/008. Dr Peyton reported receipt of personal fees from Maquet Critical Care outside of the submitted work. Dr Wilson reported receipt of personal fees from Fisher Paykel outside of the submitted work. Dr Serpa Neto reported receiving personal fees from Dr&#xe4;ger outside of the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35578170</ArticleId><ArticleId IdType="pmc">PMC9109306</ArticleId><ArticleId IdType="doi">10.1186/s12871-022-01689-3</ArticleId><ArticleId IdType="pii">10.1186/s12871-022-01689-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, Ellard L, Hu R, Pearce B, et al. Effect of Intraoperative Low Tidal Volume vs Conventional Tidal Volume on Postoperative Pulmonary Complications in Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2020;324:848&#x2013;858. doi: 10.1001/jama.2020.12866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="pubmed">32870298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kety SS, Schmidt CF. The effects of active and passive hyperventilation on cerebral blood flow, cerebral oxygen consumption, cardiac output, and blood pressure of normal young men. J Clin Invest. 1946;25:107&#x2013;119. doi: 10.1172/JCI101680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI101680</ArticleId><ArticleId IdType="pubmed">21016304</ArticleId></ArticleIdList></Reference><Reference><Citation>Kety SS, Schmidt CF. The Effects of Altered Arterial Tensions of Carbon Dioxide and Oxygen on Cerebral Blood Flow and Cerebral Oxygen Consumption of Normal Young Men. J Clin Invest. 1948;27:484&#x2013;492. doi: 10.1172/JCI101995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI101995</ArticleId><ArticleId IdType="pmc">PMC439519</ArticleId><ArticleId IdType="pubmed">16695569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, et al. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med. 2017;43:1075&#x2013;1084. doi: 10.1007/s00134-017-4807-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4807-z</ArticleId><ArticleId IdType="pubmed">28466149</ArticleId></ArticleIdList></Reference><Reference><Citation>Eastwood GM, Schneider AG, Suzuki S, Peck L, Young H, Tanaka A, et al. Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial) Resuscitation. 2016;104:83&#x2013;90. doi: 10.1016/j.resuscitation.2016.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2016.03.023</ArticleId><ArticleId IdType="pubmed">27060535</ArticleId></ArticleIdList></Reference><Reference><Citation>Young GB, DeRubeis DA. Coma and impaired consciousness: a clinical perspective. In: Young GB, Ropper AH, Bolton CF, editors. Metabolic encephalopathies. New York (US): McGraw- Hill Companies; 1998. p. 307e92.</Citation></Reference><Reference><Citation>Kilburn K. Neurologic manifestations of respiratory failure. Arch Intern Med. 1965;116:409e15. doi: 10.1001/archinte.1965.03870030089015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1965.03870030089015</ArticleId><ArticleId IdType="pubmed">14325915</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q, Li L, Yang M, Sun L, Li R, Huang R, et al. Moderate hypercapnia may not contribute to postoperative delirium in patients undergoing bronchoscopic intervention. Medicine (Baltimore) 2019;98:e15906. doi: 10.1097/MD.0000000000015906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000015906</ArticleId><ArticleId IdType="pmc">PMC6709007</ArticleId><ArticleId IdType="pubmed">31145352</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q, Li L, Duomao L, Duomao L, Renjiao L, et al. Effects of acute hypercapnia on cognitive function in patients undergoing bronchoscope intervention. J Thorac Dis. 2019;11:1065&#x2013;1071. doi: 10.21037/jtd.2018.12.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2018.12.15</ArticleId><ArticleId IdType="pmc">PMC6462695</ArticleId><ArticleId IdType="pubmed">31019796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li Z, Yu Y, Li B, Shao G, Wang Q, et al. Risk factors contributing to postoperative delirium in geriatric patients postorthopedic surgery. Asia Pac Psychiatry. 2015;7:375&#x2013;382. doi: 10.1111/appy.12193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/appy.12193</ArticleId><ArticleId IdType="pubmed">26097170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C, Churilov L, Cowie D, Tan CO, Hu R, Tremewen D, et al. Randomised controlled trial to investigate the relationship between mild hypercapnia and cerebral oxygen saturation in patients undergoing major surgery. BMJ Open. 2020;10:e029159. doi: 10.1136/bmjopen-2019-029159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-029159</ArticleId><ArticleId IdType="pmc">PMC7045198</ArticleId><ArticleId IdType="pubmed">32066598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazemi AK, Gowd AK, Carmouche JJ, Kates SL, Albert TJ, Behrend CJ. Prevention and Management of Postoperative Delirium in Elderly Patients Following Elective Spinal Surgery. Clin Spine Surg. 2017;30:112&#x2013;119. doi: 10.1097/BSD.0000000000000467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BSD.0000000000000467</ArticleId><ArticleId IdType="pubmed">28141603</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Lu Y, Liu M, Zou Z, Wang L, Xu FY, et al. Strategies for prevention of postoperative delirium: a systematic review and meta-analysis of randomized trials. Crit Care. 2013;17:R47. doi: 10.1186/cc12566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12566</ArticleId><ArticleId IdType="pmc">PMC3672487</ArticleId><ArticleId IdType="pubmed">23506796</ArticleId></ArticleIdList></Reference><Reference><Citation>Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443&#x2013;451. doi: 10.1001/jama.2010.1013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1013</ArticleId><ArticleId IdType="pubmed">20664045</ArticleId></ArticleIdList></Reference><Reference><Citation>Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, et al. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012;367:30&#x2013;39. doi: 10.1056/NEJMoa1112923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1112923</ArticleId><ArticleId IdType="pmc">PMC3433229</ArticleId><ArticleId IdType="pubmed">22762316</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK. One-year health care costs associated with delirium in the elderly population. Arch Intern Med. 2008;168:27&#x2013;32. doi: 10.1001/archinternmed.2007.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2007.4</ArticleId><ArticleId IdType="pmc">PMC4559525</ArticleId><ArticleId IdType="pubmed">18195192</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner LA. Postoperative delirium. part 2: detection, prevention and treatment. Eur J Anaesthesiol. 2011;28:723&#x2013;32. doi: 10.1097/EJA.0b013e328349b7db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328349b7db</ArticleId><ArticleId IdType="pubmed">21912241</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, Ellard L, Hu R, Pearce B, et al. Low tidal volume ventilation during anaesthesia for major surgery: protocol and statistical analysis plan. Crit Care Resusc. 2019;21:243&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">31778630</ArticleId></ArticleIdList></Reference><Reference><Citation>Danivas V, Venkatasubramanian G. Current perspectives on chlorpromazine equivalents: Comparing apples and oranges! Indian Journal of Psychiatry. 2013;55:207&#x2013;208. doi: 10.4103/0019-5545.105522.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5545.105522</ArticleId><ArticleId IdType="pmc">PMC3696254</ArticleId><ArticleId IdType="pubmed">23825865</ArticleId></ArticleIdList></Reference><Reference><Citation>Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 2015;69:440&#x2013;447. doi: 10.1111/pcn.12275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.12275</ArticleId><ArticleId IdType="pubmed">25601291</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369:428&#x2013;437. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D, Matalanis G, Martensson J, Robbins R, Shaw M, Seevanayagam S. Predictors and outcomes of cardiac surgery-associated delirium. A single centre retrospective cohort study. Heart Lung Circ. 2019;28:455&#x2013;463. doi: 10.1016/j.hlc.2018.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2018.01.007</ArticleId><ArticleId IdType="pubmed">29454582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta F, Lauretta MP, Borozdina A, Mizikov VM, Rosa G. Postoperative delirium: risk factors, diagnosis and perioperative care. Minerva Anestesiol. 2013;79:1066&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pubmed">23511351</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner LA. Postoperative delirium. Part 1: pathophysiology and risk factors. Eur J Anaesthesiol. 2011;28:628&#x2013;36. doi: 10.1097/EJA.0b013e328349b7f5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328349b7f5</ArticleId><ArticleId IdType="pubmed">21785356</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Hu J, Ma D. Postoperative delirium: perioperative assessment, risk reduction, and management. Br J Anaesth. 2020;125:492&#x2013;504. doi: 10.1016/j.bja.2020.06.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.06.063</ArticleId><ArticleId IdType="pubmed">32798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutch WAC, El-Gabalawy R, Girling L, Kilborn K, Jacobsohn E. End-Tidal Hypocapnia Under Anesthesia Predicts Postoperative Delirium. Front Neurol. 2018;9:678. doi: 10.3389/fneur.2018.00678.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00678</ArticleId><ArticleId IdType="pmc">PMC6108130</ArticleId><ArticleId IdType="pubmed">30174647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendlebury ST, Lovett NG, Thomson RJ, Smith SC. Impact of a system-wide multicomponent intervention on administrative diagnostic coding for delirium and other cognitive frailty syndromes: observational prospective study. Clin Med (Lond) 2020;20(5):454&#x2013;464. doi: 10.7861/clinmed.2019-0470.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2019-0470</ArticleId><ArticleId IdType="pmc">PMC7539726</ArticleId><ArticleId IdType="pubmed">32934037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Lee J, Kim CA, Huybrechts KF, Bateman BT, Patorno E, Marcantonio ER. Evaluation of algorithms to identify delirium in administrative claims and drug utilization database. Pharmacoepidemiol Drug Saf. 2017;&#xa0;26(8):945&#x2013;953. doi: 10.1002/pds.4226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4226</ArticleId><ArticleId IdType="pmc">PMC5583076</ArticleId><ArticleId IdType="pubmed">28485014</ArticleId></ArticleIdList></Reference><Reference><Citation>Iamaroon A, Wongviriyawong T, Sura-arunsumrit P, Wiwatnodom N, Rewuri N, Chaiwat O. Incidence of and risk factors for postoperative delirium in older adult patients undergoing noncardiac surgery: a prospective study. BMC Geriatr. 2020;20:40. doi: 10.1186/s12877-020-1449-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-1449-8</ArticleId><ArticleId IdType="pmc">PMC6998823</ArticleId><ArticleId IdType="pubmed">32013872</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941&#x2013;8. doi: 10.7326/0003-4819-113-12-941.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-113-12-941</ArticleId><ArticleId IdType="pubmed">2240918</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon K, Inouye MD MPH. Confusion assessment method: training manual and coding guide, Copyright 2003.</Citation></Reference><Reference><Citation>Bilotta F, Rosa G. General anesthesia and postoperative cognitive dysfunction. J Alzheimer Dis Parkinsonism. 2012;2:e113.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38844620</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1084</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European radiology</Title><ISOAbbreviation>Eur Radiol</ISOAbbreviation></Journal><ArticleTitle>Role of cardiac magnetic resonance in stratifying arrhythmogenic risk in mitral valve prolapse patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>7321</StartPage><EndPage>7333</EndPage><MedlinePgn>7321-7333</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00330-024-10815-3</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To perform a systematic review and meta-analysis of studies investigating the diagnostic value of cardiac magnetic resonance (CMR) features for arrhythmic risk stratification in mitral valve prolapse (MVP) patients.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">EMBASE, PubMed/MEDLINE, and CENTRAL were searched for studies reporting MVP patients who underwent CMR with assessment of: left ventricular (LV) size and function, mitral regurgitation (MR), prolapse distance, mitral annular disjunction (MAD), curling, late gadolinium enhancement (LGE), and T1 mapping, and reported the association with arrhythmia. The primary endpoint was complex ventricular arrhythmias (co-VAs)&#xa0;as defined by any non-sustained ventricular tachycardia, sustained ventricular tachycardia, ventricular fibrillation, or aborted sudden cardiac death. Meta-analysis was performed when at least three studies investigated a CMR feature. PROSPERO registration number: CRD42023374185.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The meta-analysis included 11 studies with 1278 patients. MR severity, leaflet length/thickness, curling, MAD distance, and mapping techniques were not meta-analyzed as reported in &lt;&#x2009;3 studies. LV end-diastolic volume index, LV ejection fraction, and prolapse distance showed small non-significant effect sizes. LGE showed a strong and significant association with co-VA with a LogORs of 2.12 (95% confidence interval (CI): [1.00, 3.23]), for MAD the log odds-ratio was 0.95 (95% CI: [0.30, 1.60]). The predictive accuracy of LGE was substantial, with a hierarchical summary ROC AUC of 0.83 (95% CI: [0.69, 0.91]) and sensitivity and specificity rates of 0.70 (95% CI: [0.41, 0.89]) and 0.80 (95% CI: [0.67, 0.89]), respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study highlights the role of LGE as the key CMR feature for arrhythmia risk stratification in MVP patients. MAD might complement arrhythmic risk stratification.</AbstractText><AbstractText Label="CLINICAL RELEVANCE STATEMENT" NlmCategory="CONCLUSIONS">LGE is a key factor for arrhythmogenic risk in MVP patients, with additional contribution from MAD. Combining MRI findings with clinical characteristics is critical for evaluating and accurately stratifying arrhythmogenic risk in MVP patients.</AbstractText><AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">MVP affects 2-3% of the population, with some facing increased risk for arrhythmia. LGE can assess arrhythmia risk, and MAD may further stratify patients. CMR is critical for MVP arrhythmia risk stratification, making it essential in a comprehensive evaluation.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gatti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8168-5280</Identifier><AffiliationInfo><Affiliation>Department of Surgical Sciences, Radiology Unit, University of Turin, Turin, Italy. m.gatti@unito.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santonocito</LastName><ForeName>Ambra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Radiology Unit, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papa</LastName><ForeName>Francesco Pio</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Radiology Unit, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ascenzo</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department Cardiovascular and Thoracic, Citt&#xe0; della Salute e della Scienza Hospital, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Filippo</LastName><ForeName>Ovidio</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department Cardiovascular and Thoracic, Citt&#xe0; della Salute e della Scienza Hospital, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallone</LastName><ForeName>Guglielmo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department Cardiovascular and Thoracic, Citt&#xe0; della Salute e della Scienza Hospital, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmisano</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistelli</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department Cardiovascular and Thoracic, Citt&#xe0; della Salute e della Scienza Hospital, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Ferrari</LastName><ForeName>Gaetano Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department Cardiovascular and Thoracic, Citt&#xe0; della Salute e della Scienza Hospital, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esposito</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giustetto</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department Cardiovascular and Thoracic, Citt&#xe0; della Salute e della Scienza Hospital, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fonio</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Radiology Unit, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faletti</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Radiology Unit, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Radiol</MedlineTA><NlmUniqueID>9114774</NlmUniqueID><ISSNLinking>0938-7994</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008945" MajorTopicYN="Y">Mitral Valve Prolapse</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Fibrosis</Keyword><Keyword MajorTopicYN="N">Mitral valve prolapse</Keyword><Keyword MajorTopicYN="N">Risk stratification</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmias</Keyword></KeywordList><CoiStatement>The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>7</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>6</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38844620</ArticleId><ArticleId IdType="pmc">PMC11519141</ArticleId><ArticleId IdType="doi">10.1007/s00330-024-10815-3</ArticleId><ArticleId IdType="pii">10.1007/s00330-024-10815-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hayek E, Gring CN, Griffin BP (2005) Mitral valve prolapse. Lancet 365:507&#x2013;518. 10.1016/S0140-6736(05)17869-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15705461</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed LA, Levy D, Levine RA et al (1999) Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341:1&#x2013;7. 10.1056/NEJM199907013410101</Citation><ArticleIdList><ArticleId IdType="pubmed">10387935</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalliah CJ, Mahajan R, Elliott AD et al (2019) Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart 105:144&#x2013;151. 10.1136/heartjnl-2017-312932</Citation><ArticleIdList><ArticleId IdType="pubmed">30242141</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Iliceto S, Thiene G, Perazzolo Marra M (2019) Mitral valve prolapse, ventricular arrhythmias, and sudden death. Circulation 140:952&#x2013;964. 10.1161/CIRCULATIONAHA.118.034075</Citation><ArticleIdList><ArticleId IdType="pubmed">31498700</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbag A, Essayagh B, Barrera JDR et al (2022) EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace 24:1981&#x2013;2003. 10.1093/europace/euac125</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11636573</ArticleId><ArticleId IdType="pubmed">35951656</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveri F, Kakargias F, Panday P et al (2021) Arrhythmic mitral valve prolapse: diagnostic parameters for high&#x2010;risk patients: a systematic review and meta&#x2010;analysis. Pacing Clin Electrophysiol 44:1746&#x2013;1755. 10.1111/pace.14338</Citation><ArticleIdList><ArticleId IdType="pubmed">34397120</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahanian A, Beyersdorf F, Praz F et al (2022) 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43:561&#x2013;632. 10.1093/eurheartj/ehab395</Citation><ArticleIdList><ArticleId IdType="pubmed">34453165</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Perazzolo Marra M, Rizzo S et al (2015) Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation 132:556&#x2013;566. 10.1161/CIRCULATIONAHA.115.016291</Citation><ArticleIdList><ArticleId IdType="pubmed">26160859</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazzolo Marra M, Basso C, De Lazzari M et al (2016) Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging 9:e005030. 10.1161/CIRCIMAGING.116.005030</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4991345</ArticleId><ArticleId IdType="pubmed">27516479</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui AH, Roujol S, Foppa M et al (2017) Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart 103:204&#x2013;209. 10.1136/heartjnl-2016-309303</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5237392</ArticleId><ArticleId IdType="pubmed">27515954</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradella S, Grazzini G, Brandani M et al (2019) Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping. Eur Radiol 29:1546&#x2013;1554. 10.1007/s00330-018-5634-5</Citation><ArticleIdList><ArticleId IdType="pubmed">30088066</ArticleId></ArticleIdList></Reference><Reference><Citation>Enriquez A, Shirai Y, Huang J et al (2019) Papillary muscle ventricular arrhythmias in patients with arrhythmic mitral valve prolapse: Electrophysiologic substrate and catheter ablation outcomes. J Cardiovasc Electrophysiol 30:827&#x2013;835. 10.1111/jce.13900</Citation><ArticleIdList><ArticleId IdType="pubmed">30843306</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TKM, Kwon DH, Abou-Hassan O et al (2021) Strain evaluation for mitral annular disjunction by echocardiography and magnetic resonance imaging: a case-control study. Int J Cardiol 334:154&#x2013;156. 10.1016/j.ijcard.2021.04.052</Citation><ArticleIdList><ArticleId IdType="pubmed">33932426</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant Dit Beaufils A-L, Huttin O, Jobbe-Duval A et al (2021) Replacement myocardial fibrosis in patients with mitral valve prolapse. Circulation 143:1763&#x2013;1774. 10.1161/CIRCULATIONAHA.120.050214</Citation><ArticleIdList><ArticleId IdType="pubmed">33706538</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavon AG, Arangalage D, Pascale P et al (2021) Myocardial extracellular volume by T1 mapping: a new marker of arrhythmia in mitral valve prolapse. J Cardiovasc Magn Reson 23:102. 10.1186/s12968-021-00797-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438990</ArticleId><ArticleId IdType="pubmed">34517908</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti M, Palmisano A, Esposito A et al (2021) Feature tracking myocardial strain analysis in patients with bileaflet mitral valve prolapse: relationship with LGE and arrhythmias. Eur Radiol 31:7273&#x2013;7282. 10.1007/s00330-021-07876-z</Citation><ArticleIdList><ArticleId IdType="pubmed">33870458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-H, Uhm J-S, Suh YJ et al (2021) Usefulness of cardiac magnetic resonance images for prediction of sudden cardiac arrest in patients with mitral valve prolapse: a multicenter retrospective cohort study. BMC Cardiovasc Disord 21:546. 10.1186/s12872-021-02362-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600905</ArticleId><ArticleId IdType="pubmed">34789163</ArticleId></ArticleIdList></Reference><Reference><Citation>Figliozzi S, Georgiopoulos G, Lopes PM et al (2023) Myocardial fibrosis at cardiac MRI helps predict adverse clinical outcome in patients with mitral valve prolapse. Radiology 306:112&#x2013;121. 10.1148/radiol.220454</Citation><ArticleIdList><ArticleId IdType="pubmed">36098639</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29:372:n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan M, Ansari MT, Berkman ND et al (2008) Assessing the risk of bias of individual studies in systematic reviews of health care interventions. In: Methods guide for effectiveness and comparative effectiveness reviews. Agency for Healthcare Research and Quality, Rockville</Citation><ArticleIdList><ArticleId IdType="pubmed">22479713</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavich M, Palmisano A, Pannone L et al (2019) Hidden danger behind the prolapse. Circ Cardiovasc Imaging 12:e009639. 10.1161/CIRCIMAGING.119.009639</Citation><ArticleIdList><ArticleId IdType="pubmed">31569957</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergara P, Scarf&#xf2; I, Esposito A et al (2021) Characterization of the electrophysiological substrate in patients with Barlow&#x2019;s disease. J Cardiovasc Electrophysiol 32:3179&#x2013;3186. 10.1111/jce.15270</Citation><ArticleIdList><ArticleId IdType="pubmed">34664762</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito A, Gatti M, Trivieri MG et al (2023) Imaging for the assessment of the arrhythmogenic potential of mitral valve prolapse. Eur Radiol. 10.1007/s00330-023-10413-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11164824</ArticleId><ArticleId IdType="pubmed">38078997</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sadawi M, Aslam F, Tao M et al (2023) Association of late gadolinium enhancement in cardiac magnetic resonance with mortality, ventricular arrhythmias, and heart failure in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis. Heart Rhythm O2 4:241&#x2013;250. 10.1016/j.hroo.2023.01.001</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10134398</ArticleId><ArticleId IdType="pubmed">37124560</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivulescu M, Aabel EW, Gjertsen E et al (2022) Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse. Europace 24:1156&#x2013;1163. 10.1093/europace/euac017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9301977</ArticleId><ArticleId IdType="pubmed">35226070</ArticleId></ArticleIdList></Reference><Reference><Citation>Zugwitz D, Fung K, Aung N et al (2022) Mitral annular disjunction assessed using CMR imaging. JACC Cardiovasc Imaging 15:1856&#x2013;1866. 10.1016/j.jcmg.2022.07.015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640354</ArticleId><ArticleId IdType="pubmed">36280553</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo P, Andrade MJ, Aguiar C et al (2010) Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography. Cardiovasc Ultrasound 8:53. 10.1186/1476-7120-8-53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014886</ArticleId><ArticleId IdType="pubmed">21143934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalarus Z, Mairesse GH, Sokal A et al (2023) Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper. Europace 25:185&#x2013;198. 10.1093/europace/euac144</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10112840</ArticleId><ArticleId IdType="pubmed">36256580</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29572085</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Ablation strategies for the management of symptomatic Brugada syndrome: A systematic review.</ArticleTitle><Pagination><StartPage>1140</StartPage><EndPage>1147</EndPage><MedlinePgn>1140-1147</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2018.03.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(18)30233-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Ablation approaches have been described for the management of symptomatic ventricular arrhythmias in patients with Brugada syndrome, but this treatment is still considered experimental.</AbstractText><AbstractText Label="OBJECTIVE">We aimed to perform a systematic review of the current evidence on the use of catheter ablation in Brugada syndrome.</AbstractText><AbstractText Label="METHODS">MEDLINE, Embase, and Scopus were searched for articles describing the use of catheter ablation for ventricular arrhythmia management in Brugada syndrome.</AbstractText><AbstractText Label="RESULTS">We included 11 case series and 11 case reports including a total of 233 patients. Ablation strategies included epicardial mapping with substrate modification (n = 180; 77.3%), endocardial-only mapping with substrate modification (n = 17; 7.3%), ventricular fibrillation (VF)-triggering premature ventricular complex ablation (n = 5; 2.1%), and mixed approaches (n = 31; 13.3%). During a 2.5- to 78-month follow-up period, the success rates in preventing ventricular tachycardia or VF (VT/VF) were 96.7%, 70.6%, and 80% with epicardial, endocardial, and triggering premature ventricular complex ablation approaches, respectively. Among patients who underwent both epicardial and endocardial mapping, there was no identifiable endocardial substrate in 92.9% of cases. Elimination of type 1 Brugada-pattern electrocardiogram was attained in 98.3% and 34.8% of the epicardial and endocardial ablation groups, respectively. VT/VF occurred in 7 of 9 patients (77.8%) who had persistent or recurrent J-ST elevation and in none of the 24 patients with complete resolution during follow-up. Pharmacologic provocation augmented the abnormal area.</AbstractText><AbstractText Label="CONCLUSION">Epicardial substrate modification appears to be more effective than endocardial-only approach in preventing VT/VF. Persistent or recurrent J-ST elevation appears to represent a marker of failure of ablation. Ablation seems to be an acceptable strategy for patients with Brugada syndrome and VT/VF.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Gilson C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Ciencias Medicas, Universidade Federal da Paraiba, Joao Pessoa, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Rhanderson</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Johns Hopkins University, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasi</LastName><ForeName>Guilherme</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitrani</LastName><ForeName>Raul D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberger</LastName><ForeName>Jeffrey J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: j-goldberger@miami.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053840" MajorTopicYN="N">Brugada Syndrome</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056149" MajorTopicYN="Y">Epicardial Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brugada syndrome</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Endocardium</Keyword><Keyword MajorTopicYN="N">Epicardial mapping</Keyword><Keyword MajorTopicYN="N">Premature ventricular complex</Keyword><Keyword MajorTopicYN="N">Substrate modification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29572085</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2018.03.019</ArticleId><ArticleId IdType="pii">S1547-5271(18)30233-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25022927</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-2035</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of cardiovascular medicine (Hagerstown, Md.)</Title><ISOAbbreviation>J Cardiovasc Med (Hagerstown)</ISOAbbreviation></Journal><ArticleTitle>Therapeutic hypothermia in the intensive cardiac care unit.</ArticleTitle><Pagination><StartPage>363</StartPage><EndPage>371</EndPage><MedlinePgn>363-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2459/JCM.0000000000000108</ELocationID><Abstract><AbstractText>Therapeutic hypothermia has demonstrated to improve both survival and neurological outcome in patients who experienced an out-of-hospital cardiac arrest. Nevertheless, many aspects of its clinical application are still controversial. Current guidelines recommend to cool patients who survive a cardiac arrest due to either ventricular fibrillation or ventricular tachycardia, whereas the beneficial effect of lowering body temperature in nonshockable rhythms is still questionable due to the lack of randomized controlled trial involving this subgroup of patients. Although therapeutic hypothermia is often begun before hospital arrival, the optimal time to start cooling is still a matter of debate. Furthermore, different methods are available to low body temperature, but no direct comparisons are available to establish which device performs better than others, and a combination of external and endovascular cooling is usually preferred. The present review is aimed at summarizing the available evidence supporting the use in clinical practice of mild hypothermia in comatose survivors from cardiac arrest and at evaluating its adverse events and their treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Picchi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>aDepartment of Cardiology, Misericordia Hospital, Grosseto bDepartment of Medical and Surgical Critical Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>Serafina</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Gensini</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Med (Hagerstown)</MedlineTA><NlmUniqueID>101259752</NlmUniqueID><ISSNLinking>1558-2027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002300" MajorTopicYN="N">Cardiac Care Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075202" MajorTopicYN="N">Contraindications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="N">Electroconvulsive Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="N">Hypothermia, Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066829" MajorTopicYN="N">Neuroprotection</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25022927</ArticleId><ArticleId IdType="doi">10.2459/JCM.0000000000000108</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33357646</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-3763</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Indian heart journal</Title><ISOAbbreviation>Indian Heart J</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation of scar based ventricular tachycardia - Procedural characteristics and outcomes.</ArticleTitle><Pagination><StartPage>563</StartPage><EndPage>569</EndPage><MedlinePgn>563-569</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ihj.2020.09.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0019-4832(20)30232-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ventricular tachycardia (VT) is a major cause of morbidity in patients with cardiomyopathy. Radiofrequency ablation has emerged as the mainstay of the management of recurrent sustained VT in these patients. We describe the clinical characteristics, procedural and medium term outcomes of patients undergoing ablation of scar VT in a tertiary care center in India.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a single-center descriptive cohort study. All patients who underwent ablation for scar related VT were included. Endpoints were immediate procedural success, procedural complications and recurrence during follow up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 72 patients with scar VT underwent ablation with electroanatomic mapping. Previous myocardial infarction (MI) was the commonest etiology (69.4%) with arrhythmogenic right ventricular cardiomyopathy (ARVC) being the next common (19.4%). Acute procedural success was achieved in 69.4% patients, partial success in 9.7% and failure in 1 patient (1.4%). Outcome was labeled indeterminate in 19.4% who did not undergo post ablation VT induction. Procedural complications were seen in 4%. Follow up data was available in 95% of the patients with a mean follow up of 28.9&#xa0;&#xb1;&#xa0;22.8 months. At one year, freedom from VT was 83.8% and mortality was 13.2%. Overall mortality during follow up was 22.1% while VT recurrence was seen in 35.3%. Recurrence rate was higher in ARVC as compared to previous MI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Ablation of scar VT has high acute success rates. Ablation is safe with low risk of major complications. Rates of recurrence are higher in patients with ARVC as compared to post MI VT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Ashutosh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramasamy</LastName><ForeName>Sakthivel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodore</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anantharaj</LastName><ForeName>Avinash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>Ajith Ananthakrishna</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satheesh</LastName><ForeName>Santhosh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvaraj</LastName><ForeName>Raja J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. Electronic address: raja.selvaraj@jipmer.edu.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian Heart J</MedlineTA><NlmUniqueID>0374675</NlmUniqueID><ISSNLinking>0019-4832</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Electroanatomic mapping</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>28</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33357646</ArticleId><ArticleId IdType="pmc">PMC7772601</ArticleId><ArticleId IdType="doi">10.1016/j.ihj.2020.09.009</ArticleId><ArticleId IdType="pii">S0019-4832(20)30232-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Bakker J.M., van Capelle F.J., Janse M.J. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988 Mar;77(3):589&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">3342490</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchlinski F.E., Callans D.J., Gottlieb C.D. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000 Mar 21;101(11):1288&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;s P., Maury P., Khairy P. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012;125(18):2184&#x2013;2196. doi: 10.1161/CIRCULATIONAHA.111.043216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.043216</ArticleId><ArticleId IdType="pubmed">22492578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck K.-H., Schaumann A., Eckardt L. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet Lond Engl. 2010 Jan 2;375(9708):31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson W.G., Wilber D.J., Natale A. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008 Dec 16;118(25):2773&#x2013;2782.</Citation><ArticleIdList><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy V.Y., Reynolds M.R., Neuzil P. Prophylactic catheter ablation for the prevention of defibrillator therapy. N&#xa0;Engl J Med. 2007 Dec 27;357(26):2657&#x2013;2665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390777</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinov B., Fiedler L., Sch&#xf6;nbauer R. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation. 2014 Feb 18;129(7):728&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">24211823</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A., Kilicaslan F., Schweikert R.A. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation. 2005 Jun 21;111(24):3209&#x2013;3216.</Citation><ArticleIdList><ArticleId IdType="pubmed">15956125</ArticleId></ArticleIdList></Reference><Reference><Citation>Berruezo A., Fern&#xe1;ndez-Armenta J., Mont L. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012 Feb;5(1):111&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22205683</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Biase L., Burkhardt J.D., Lakkireddy D. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial. J&#xa0;Am Coll Cardiol. 2015 Dec 29;66(25):2872&#x2013;2882.</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Armenta J., Andreu D., Penela D. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014 May;11(5):747&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561159</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda M., Kojodjojo P., Tung S. Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. J&#xa0;Am Heart Assoc. 2013 May 31;2(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3698765</ArticleId><ArticleId IdType="pubmed">23727700</ArticleId></ArticleIdList></Reference><Reference><Citation>Berte B., Sacher F., Venlet J. VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study. J&#xa0;Cardiovasc Electrophysiol. 2016 Jan;27(1):80&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">26471955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp J.L., Wells G.A., Parkash R. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N&#xa0;Engl J Med. 2016 Jul 14;375(2):111&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32416063</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1916-7075</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Canadian journal of cardiology</Title><ISOAbbreviation>Can J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Mortality and Ventricular Tachycardia in Patients With Repaired Tetralogy of Fallot: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>1815</StartPage><EndPage>1825</EndPage><MedlinePgn>1815-1825</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjca.2020.01.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0828-282X(20)30059-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with repaired tetralogy of Fallot (rTOF) have increased risk for mortality, sudden cardiac death, and ventricular tachycardia (VT). The aim of this systematic review and meta-analysis is to offer an updated analysis of risk factors following significant changes in surgical and perioperative management.</AbstractText><AbstractText Label="METHODS">A meta-analysis based on the published literature between 2008 and 2018 was conducted. Endpoints were VT, cardiac mortality/VT, and all-cause mortality/VT. Studies with &#x2265;100 patients and &#x2265;10 events were included.</AbstractText><AbstractText Label="RESULTS">Fifteen studies including 7218 patients (average age 27.5 years) were analyzed. Risk factors for VT included older age (per 1 year, odds ratio [OR]: 1.039; 95% confidence interval [CI]: 1.025-1.053), older age at corrective surgery (per 1 year, OR: 1.034; CI: 1.017-1.051), previous palliative shunt (OR: 3.063; CI: 1.525-6.151), number of thoracotomies (OR: 1.416; CI: 1.249-1.604), longer QRS duration (per 1 ms, OR: 1.031; CI: 1.008-1.055), and at least moderate right-ventricular dysfunction (OR: 2.160; CI_ 1.311-3.560). Additional risk factors for cardiac death/VT were previous ventriculotomy (OR: 2.269; CI: 1.226-4.198), lower left-ventricular ejection fraction (per 1%, OR: 1.049; CI: 1.029-1.071), and higher right-ventricular end diastolic volume (per 1 mL/m<sup>2</sup>, OR: 1.009; CI: 1.002-1.016). Supraventricular tachycardia/atrial fibrillation was an additional risk factor for all-cause mortality/VT (OR: 1.939; CI: 1.088-3.457).</AbstractText><AbstractText Label="CONCLUSIONS">The study highlights the importance of preservation of biventricular systolic function on late outcomes. Ventricular function appears to have a greater impact on outcomes than the severity of pulmonary regurgitation alone in this patient population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Possner</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Stephanie Y</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alahdab</LastName><ForeName>Fares</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Mayo Evidence-based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokma</LastName><ForeName>Jouke P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Academic Medical Center Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lubert</LastName><ForeName>Adam M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khairy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Montr&#xe9;al Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>M Hassan</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Mayo Evidence-based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Ali</LastName><ForeName>Walid</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, CHU-ME Sainte Justine and the Montr&#xe9;al Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokop</LastName><ForeName>Larry J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czosek</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldtman</LastName><ForeName>Gruschen R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA; Adult Congenital Heart Disease, Heart Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsaied</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Heart Institute, Cincinnati Children`s Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, Ohio, USA. Electronic address: Tarek.Alsaied@cchmc.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Cardiol</MedlineTA><NlmUniqueID>8510280</NlmUniqueID><ISSNLinking>0828-282X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013771" MajorTopicYN="N">Tetralogy of Fallot</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32416063</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2020.01.023</ArticleId><ArticleId IdType="pii">S0828-282X(20)30059-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34187530</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative protective ventilation in patients undergoing major neurosurgical interventions: a randomized clinical trial.</ArticleTitle><Pagination><StartPage>184</StartPage><MedlinePgn>184</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">184</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-021-01404-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Post-operative pulmonary complications (PPC) can develop in up to 13% of patients undergoing neurosurgical procedures and may adversely affect clinical outcome. The use of intraoperative lung protective ventilation (LPV) strategies, usually including the use of a low V<sub>t</sub>, low PEEP and low plateau pressure, seem to reduce the risk of PPC and are strongly recommended in almost all surgical procedures. Nonetheless, feasibility of LPV strategies in neurosurgical patients are still debated because the use of low Vt during LPV might result in hypercapnia with detrimental effects on cerebrovascular physiology. Aim of our study was to determine whether LPV strategies would be feasible compared with a control group in adult patients undergoing cranial or spinal surgery.</AbstractText><AbstractText Label="METHODS">This single-centre, pilot randomized clinical trial was conducted at the University Hospital "Maggiore della Carit&#xe0;" (Novara, Italy). Adult patients undergoing major cerebral or spinal neurosurgical interventions with risk index for pulmonary post-operative complications &gt;&#x2009;2 and not expected to need post-operative intensive care unit (ICU) admission were considered eligible. Patients were randomly assigned to either LPV (Vt&#x2009;=&#x2009;6&#x2009;ml/kg of ideal body weight (IBW), respiratory rate initially set at 16 breaths/min, PEEP at 5 cmH2O and application of a recruitment manoeuvre (RM) immediately after intubation and at every disconnection from the ventilator) or control treatment (Vt&#x2009;=&#x2009;10&#x2009;ml/kg of IBW, respiratory rate initially set at 6-8 breaths/min, no PEEP and no RM). Primary outcomes of the study were intraoperative adverse events, the level of cerebral tension at dura opening and the intraoperative control of PaCO<sub>2.</sub> Secondary outcomes were the rate of pulmonary and extrapulmonary complications, the number of unplanned ICU admissions, ICU and hospital lengths of stay and mortality.</AbstractText><AbstractText Label="RESULTS">A total of 60 patients, 30 for each group, were randomized. During brain surgery, the number of episodes of intraoperative hypercapnia and grade of cerebral tension were similar between patients randomized to receive control or LPV strategies. No difference in the rate of intraoperative adverse events was found between groups. The rate of postoperative pulmonary and extrapulmonary complications and major clinical outcomes were similar between groups.</AbstractText><AbstractText Label="CONCLUSIONS">LPV strategies in patients undergoing major neurosurgical intervention are feasible. Larger clinical trials are needed to assess their role in postoperative clinical outcome improvements.</AbstractText><AbstractText Label="TRIAL REGISTRATION">registered on the Australian New Zealand Clinical Trial Registry ( www.anzctr.org.au ), registration number ACTRN12615000707561.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, University Hospital of Padua, Via Giustiniani 2, Padova, Italy. laurapasin1704@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montagnini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konrad</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murabito</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelaia</LastName><ForeName>Corrado</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rondi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellapiazza</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Sant'Andrea Hospital, ASL VC, Vercelli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cammarota</LastName><ForeName>Gianmaria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaschetto</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, "Maggiore Della Carit&#xe0;" Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, University Hospital of Padua, Via Giustiniani 2, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mechanical ventilation</Keyword><Keyword MajorTopicYN="N">Neurosurgery</Keyword><Keyword MajorTopicYN="N">Postoperative pulmonary complications</Keyword></KeywordList><CoiStatement>No conflict related to the present work. Dr. Navalesi&#x2019;s research laboratory has received equipment and grants from Maquet Critical Care, Draeger and Intersurgical S.p.A. He also received honoraria/speaking fees from Maquet Critical Care, Orionpharma, Philips, Resmed, MSD and Novartis. Dr. Navalesi contributed to the development of the helmet Next, whose licence for patent belongs to Intersurgical S.P.A., and receives royalties for that invention. Dr. Longhini and Dr. Navalesi contributed to the development of a new device not discussed in the present study (European Patent number 3320941, released on 5th August 2020). The remaining authors have no conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34187530</ArticleId><ArticleId IdType="pmc">PMC8241565</ArticleId><ArticleId IdType="doi">10.1186/s12871-021-01404-8</ArticleId><ArticleId IdType="pii">10.1186/s12871-021-01404-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372(9633):139&#x2013;144. doi: 10.1016/S0140-6736(08)60878-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60878-8</ArticleId><ArticleId IdType="pubmed">18582931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Bustamante A, Frendl G, Sprung J, Kor DJ, Subramaniam B, Martinez Ruiz R, Lee JW, Henderson WG, Moss A, Mehdiratta N, Colwell MM, Bartels K, Kolodzie K, Giquel J, Vidal Melo MF. Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the perioperative research network investigators. JAMA Surg. 2017;152(2):157&#x2013;166. doi: 10.1001/jamasurg.2016.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4065</ArticleId><ArticleId IdType="pmc">PMC5334462</ArticleId><ArticleId IdType="pubmed">27829093</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Hemmes SNT, Serpa Neto A, Bluth T, Canet J, Hiesmayr M, Hollmann MW, Mills GH, Vidal Melo MF, Putensen C, et al. Intraoperative ventilator settings and their association with postoperative pulmonary complications in neurosurgical patients: post-hoc analysis of LAS VEGAS study. BMC Anesthesiol. 2020;20(1):73. doi: 10.1186/s12871-020-00988-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-00988-x</ArticleId><ArticleId IdType="pmc">PMC7114790</ArticleId><ArticleId IdType="pubmed">32241266</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SN, Barbas CS, Beiderlinden M, Fernandez-Bustamante A, Futier E, Gajic O, El-Tahan MR, Ghamdi AA, Gunay E, et al. Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med. 2016;4(4):272&#x2013;280. doi: 10.1016/S2213-2600(16)00057-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00057-6</ArticleId><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Young CC, Harris EM, Vacchiano C, Bodnar S, Bukowy B, Elliott RRD, Migliarese J, Ragains C, Trethewey B, Woodward A, Gama de Abreu M, Girard M, Futier E, Mulier JP, Pelosi P, Sprung J. Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations. Br J Anaesth. 2019;123(6):898&#x2013;913. doi: 10.1016/j.bja.2019.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.08.017</ArticleId><ArticleId IdType="pubmed">31587835</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazo V, Sabate S, Canet J, Gallart L, de Abreu MG, Belda J, Langeron O, Hoeft A, Pelosi P. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology. 2014;121(2):219&#x2013;231. doi: 10.1097/ALN.0000000000000334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000334</ArticleId><ArticleId IdType="pubmed">24901240</ArticleId></ArticleIdList></Reference><Reference><Citation>LAS VEGAS investigators Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS - an observational study in 29 countries. Eur J Anaesthesiol. 2017;34(8):492&#x2013;507. doi: 10.1097/EJA.0000000000000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000646</ArticleId><ArticleId IdType="pmc">PMC5502122</ArticleId><ArticleId IdType="pubmed">28633157</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Gelb AW. Regulation of cerebral autoregulation by carbon dioxide. Anesthesiology. 2015;122(1):196&#x2013;205. doi: 10.1097/ALN.0000000000000506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000506</ArticleId><ArticleId IdType="pubmed">25401418</ArticleId></ArticleIdList></Reference><Reference><Citation>Komjati K, Greenberg JH, Reivich M, Sandor P. Interactions between the endothelium-derived relaxing factor/nitric oxide system and the endogenous opiate system in the modulation of cerebral and spinal vascular CO2 responsiveness. J Cereb Blood Flow Metab. 2001;21(8):937&#x2013;944. doi: 10.1097/00004647-200108000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004647-200108000-00006</ArticleId><ArticleId IdType="pubmed">11487729</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock AK, Opalak CF, Workman KG, Broaddus WC. Safety outcomes following spine and cranial neurosurgery: evidence from the National Surgical Quality Improvement Program. J Neurosurg Anesthesiol. 2018;30(4):328&#x2013;336. doi: 10.1097/ANA.0000000000000474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000474</ArticleId><ArticleId IdType="pubmed">29135700</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh S, Shim JK, Ha Y, Kim YS, Lee H, Kwak YL. Ventilation with high or low tidal volume with PEEP does not influence lung function after spinal surgery in prone position: a randomized controlled trial. J Neurosurg Anesthesiol. 2018;30(3):237&#x2013;245. doi: 10.1097/ANA.0000000000000428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000428</ArticleId><ArticleId IdType="pubmed">28338504</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663&#x2013;694. doi: 10.7326/0003-4819-134-8-200104170-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-134-8-200104170-00012</ArticleId><ArticleId IdType="pubmed">11304107</ArticleId></ArticleIdList></Reference><Reference><Citation>Arozullah AM, Khuri SF, Henderson WG, Daley J. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med. 2001;135(10):847&#x2013;857. doi: 10.7326/0003-4819-135-10-200111200-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-135-10-200111200-00005</ArticleId><ArticleId IdType="pubmed">11712875</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, Marret E, Beaussier M, Gutton C, Lefrant JY, Allaouchiche B, Verzilli D, Leone M, de Jong A, Bazin JE, Pereira B, Jaber S. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428&#x2013;437. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Severgnini P, Selmo G, Lanza C, Chiesa A, Frigerio A, Bacuzzi A, Dionigi G, Novario R, Gregoretti C, de Abreu MG, Schultz MJ, Jaber S, Futier E, Chiaranda M, Pelosi P. Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function. Anesthesiology. 2013;118(6):1307&#x2013;1321. doi: 10.1097/ALN.0b013e31829102de.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31829102de</ArticleId><ArticleId IdType="pubmed">23542800</ArticleId></ArticleIdList></Reference><Reference><Citation>Citerio G, Pesenti A, Latini R, Masson S, Barlera S, Gaspari F, Franzosi MG. A multicentre, randomised, open-label, controlled trial evaluating equivalence of inhalational and intravenous anaesthesia during elective craniotomy. Eur J Anaesthesiol. 2012;29(8):371&#x2013;379. doi: 10.1097/EJA.0b013e32835422db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32835422db</ArticleId><ArticleId IdType="pubmed">22569025</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, de la Brutel Riviere A, Van Meeteren NL. preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA. 2006;296(15):1851&#x2013;1857. doi: 10.1001/jama.296.15.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.296.15.1851</ArticleId><ArticleId IdType="pubmed">17047215</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Hemmes SN, Barbas CS, Beiderlinden M, Biehl M, Binnekade JM, Canet J, Fernandez-Bustamante A, Futier E, Gajic O, et al. Protective versus conventional ventilation for surgery: a systematic review and individual patient data meta-analysis. Anesthesiology. 2015;123(1):66&#x2013;78. doi: 10.1097/ALN.0000000000000706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000706</ArticleId><ArticleId IdType="pubmed">25978326</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M, Diaper J, Villiger Y, Spiliopoulos A, Licker V, Robert J, Tschopp JM. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi: 10.1186/cc7762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7762</ArticleId><ArticleId IdType="pmc">PMC2689485</ArticleId><ArticleId IdType="pubmed">19317902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundar S, Novack V, Jervis K, Bender SP, Lerner A, Panzica P, Mahmood F, Malhotra A, Talmor D. Influence of low tidal volume ventilation on time to extubation in cardiac surgical patients. Anesthesiology. 2011;114(5):1102&#x2013;1110. doi: 10.1097/ALN.0b013e318215e254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318215e254</ArticleId><ArticleId IdType="pmc">PMC3500383</ArticleId><ArticleId IdType="pubmed">21430518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Dionne S, Simard S, Bussieres J, Dagenais F. High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology. 2012;116(5):1072&#x2013;1082. doi: 10.1097/ALN.0b013e3182522df5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182522df5</ArticleId><ArticleId IdType="pubmed">22450472</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalapillai D, Weinberg L, Peyton P, Ellard L, Hu R, Pearce B, Tan CO, Story D, O'Donnell M, Hamilton P, et al. Effect of intraoperative low tidal volume vs conventional tidal volume on postoperative pulmonary complications in patients undergoing major surgery: a randomized clinical trial. JAMA. 2020;324(9):848&#x2013;858. doi: 10.1001/jama.2020.12866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12866</ArticleId><ArticleId IdType="pmc">PMC7489812</ArticleId><ArticleId IdType="pubmed">32870298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014;384(9942):495&#x2013;503. doi: 10.1016/S0140-6736(14)60416-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60416-5</ArticleId><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluth T, Serpa Neto A, Schultz MJ, Pelosi P, Gama de Abreu M, Bobek I, Canet JC, Cinnella G, de Baerdemaeker L, Gregoretti C, et al. Effect of intraoperative high positive end-expiratory pressure (PEEP) with recruitment maneuvers vs low PEEP on postoperative pulmonary complications in obese patients: a randomized clinical trial. JAMA. 2019;321(23):2292&#x2013;2305. doi: 10.1001/jama.2019.7505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.7505</ArticleId><ArticleId IdType="pmc">PMC6582260</ArticleId><ArticleId IdType="pubmed">31157366</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis SG, Bombardieri AM, Ma Y, Girardi FP. The effect of low versus high tidal volume ventilation on inflammatory markers in healthy individuals undergoing posterior spine fusion in the prone position: a randomized controlled trial. J Clin Anesth. 2012;24(4):263&#x2013;269. doi: 10.1016/j.jclinane.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2011.08.003</ArticleId><ArticleId IdType="pmc">PMC3288806</ArticleId><ArticleId IdType="pubmed">22001758</ArticleId></ArticleIdList></Reference><Reference><Citation>Brian JE., Jr Carbon dioxide and the cerebral circulation. Anesthesiology. 1998;88(5):1365&#x2013;1386. doi: 10.1097/00000542-199805000-00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199805000-00029</ArticleId><ArticleId IdType="pubmed">9605698</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E, Wilcox ME, Brower RG, Stewart TE, Mehta S, Lapinsky SE, Meade MO, Ferguson ND. Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med. 2008;178(11):1156&#x2013;1163. doi: 10.1164/rccm.200802-335OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200802-335OC</ArticleId><ArticleId IdType="pubmed">18776154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SC, Adams AB, Simonson DA, Dries DJ, Broccard AF, Hotchkiss JR, Marini JJ. Transient hemodynamic effects of recruitment maneuvers in three experimental models of acute lung injury. Crit Care Med. 2004;32(12):2378&#x2013;2384. doi: 10.1097/01.CCM.0000147444.58070.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000147444.58070.72</ArticleId><ArticleId IdType="pubmed">15599139</ArticleId></ArticleIdList></Reference><Reference><Citation>Canfran S, Gomez de Segura IA, Cediel R, Garcia-Fernandez J. Effects of fluid load on cardiovascular function during stepwise lung recruitment manoeuvre in healthy dogs. Vet J. 2013;197(3):800&#x2013;805. doi: 10.1016/j.tvjl.2013.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvjl.2013.05.013</ArticleId><ArticleId IdType="pubmed">23791733</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouz K, Hoppe P, Briesenick L, Saugel B. Intraoperative hypotension: pathophysiology, clinical relevance, and therapeutic approaches. Indian J Anaesth. 2020;64(2):90&#x2013;96. doi: 10.4103/ija.IJA_939_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_939_19</ArticleId><ArticleId IdType="pmc">PMC7017666</ArticleId><ArticleId IdType="pubmed">32139925</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold GE, Tange M, Jensen TM, Ottesen S. &#x2018;Subdural&#x2019; pressure measurement during craniotomy. Correlation with tactile estimation of dural tension and brain herniation after opening of dura. Br J Neurosurg. 1996;10(1):69&#x2013;75. doi: 10.1080/02688699650040548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02688699650040548</ArticleId><ArticleId IdType="pubmed">8672261</ArticleId></ArticleIdList></Reference><Reference><Citation>Hol L, Nijbroek S, Schultz MJ. Perioperative lung protection: clinical implications. Anesth Analg. 2020;131(6):1721&#x2013;1729. doi: 10.1213/ANE.0000000000005187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005187</ArticleId><ArticleId IdType="pubmed">33186160</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36700361</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Effects of virtual tour on perioperative pediatric anxiety.</ArticleTitle><Pagination><StartPage>377</StartPage><EndPage>386</EndPage><MedlinePgn>377-386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.14639</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is a high incidence of perioperative anxiety in the pediatric population, with adverse side effects, such as emergency delirium and maladaptive postoperative behaviors.</AbstractText><AbstractText Label="AIMS">The study's objective was to compare the level of preoperative anxiety in children after standard preparation plus a virtual tour of the operating room vs. standard preparation alone.</AbstractText><AbstractText Label="PATIENTS/METHODS">This was a prospective single-center, randomized, controlled, blinded trial with parallel assignment, registered as NCT04043663. Eligible subjects were healthy children (ASA I-II) aged 4-12, scheduled for outpatient surgery. Five visits were conducted during the study, two at the hospital and three over the phone. Variables assessed were child's anxiety through the modified Yale Perioperative Anxiety Scale, demographic data, cooperation with induction through the Induction Compliance Checklist, preoperative parental anxiety through the State-Trait Anxiety Inventory and Anxiety Visual Analog Scale, the postoperative delirium degree through the Pediatric Anesthesia Emergence Delirium Scale, the presence of behavioral changes through the Post Hospitalization Behavior Questionnaire for Ambulatory Surgery, and the overall parental satisfaction.</AbstractText><AbstractText Label="RESULTS">A total of 125 participants were included; 61 (48.8%) of them were randomized to the Virtual Tour Group (VT+) and 64 (51.2%) to the Non-virtual Tour Group (VT-). Yale Preoperative Anxiety Scale results in VT+ vs. VT- were mean 27.26 vs. 32.57, and median 23.4 (CI 95% 23.4-23.4) vs. 23.4 (CI 95% 23.4-33.4), (p&#xa0;=&#xa0;.0086). In the VT+ group, satisfaction was higher for questions one (p&#xa0;=&#xa0;.0213), three (p&#xa0;=&#xa0;&lt;.0001), and four (p&#xa0;=&#xa0;.0130). Throughout the study, we observed a significant reduction in perioperative anxiety in the VT+ group, facilitating anesthetic induction in perfect (p&#xa0;=&#xa0;.018) and moderate compliance (p&#xa0;=&#xa0;.0428). The other variables did not show statistically significant differences.</AbstractText><AbstractText Label="CONCLUSION">Our study confirms previous studies that found virtual tours for perioperative patients may reduce perioperative anxiety and improve satisfaction. We found no impact on longer-term outcomes.</AbstractText><CopyrightInformation>&#xa9; 2023 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franco Castanys</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2313-1818</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Care and Pain Medicine. Division of Pediatric Anesthesia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez Carri&#xf3;n</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Care and Pain Medicine. Division of Pediatric Anesthesia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf3;denas G&#xf3;mez</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Care and Pain Medicine. Division of Pediatric Anesthesia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clemente Garc&#xed;a</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Care and Pain Medicine. Division of Pediatric Anesthesia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melero Mascaray</LastName><ForeName>Al&#xed;cia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Care and Pain Medicine. Division of Pediatric Anesthesia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janeiro Amela</LastName><ForeName>Marisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Care and Pain Medicine. Division of Pediatric Anesthesia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busquets Bonet</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative Care and Pain Medicine. Division of Pediatric Anesthesia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="Y">Anxiety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="Y">Emergence Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">emergence delirium</Keyword><Keyword MajorTopicYN="N">pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">perioperative anxiety</Keyword><Keyword MajorTopicYN="N">postoperative maladaptive disorders</Keyword><Keyword MajorTopicYN="N">virtual tour</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>3</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36700361</ArticleId><ArticleId IdType="doi">10.1111/pan.14639</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Zainal Abidin H, Omar SC, Mazlan MZ, et al. Postoperative maladaptive behavior, preoperative anxiety and emergence delirium in children undergone general anesthesia: A Narrative Review. Glob Pediatr Heal. 2021;8.</Citation></Reference><Reference><Citation>Fortier MA, Kain ZN. Treating perioperative anxiety and pain in children: a tailored and innovative approach. Paediatr Anaesth. 2015;25(1):27-35.</Citation></Reference><Reference><Citation>Mehrota S. Postoperative anaesthetic concerns in children: postoperative pain, emergence delirium and postoperative nausea and vomiting. Indian J Anaesth. 2019;63(9):763-770.</Citation></Reference><Reference><Citation>Kotiniemi LH, Ryh&#xe4;nen PT, Moilanen IK. Behavioural changes in children following day-case surgery: a 4-week follow-up of 551 children. Anaesthesia. 1997;52(10):970-976.</Citation></Reference><Reference><Citation>Kain ZN, Caldwell-Andrews AA, Mayes LC, et al. Family-centered preparation for surgery improves perioperative outcomes in children: a randomized controlled trial. Anesthesiology. 2007;106(1):65-74.</Citation></Reference><Reference><Citation>Yuki K, Daaboul DG. Postoperative maladaptive behavioral changes in children. Middle East J Anesthesiol. 2011;21(2):183-192.</Citation></Reference><Reference><Citation>Manyande A, Cyna AM, Yip P, Chooi C, Middleton P. Non-pharmacological interventions for assisting the induction of anaesthesia in children. Cochrane Database Syst Rev. 2015;2015(7):CD006447.</Citation></Reference><Reference><Citation>Banchs RJ, Lerman J. Preoperative anxiety management, emergence delirium, and postoperative behavior. Anesthesiol Clin. 2014;32(1):1-23.</Citation></Reference><Reference><Citation>AY AL-S, Al-Oran HM, Obeidat H, Hamlan AM, Moxham L. Preparing the family and children for surgery. Crit Care Nurs Q. 2017;40(2):99-107.</Citation></Reference><Reference><Citation>Vogt L, Klasen M, Rossaint R, Goeretz U, Ebus P, Sopka S. Virtual reality tour to reduce perioperative anxiety in an operating setting before anesthesia: randomized clinical trial. J Med Internet Res. 2021;23(9):e28018.</Citation></Reference><Reference><Citation>Ryu JH, Oh AY, Yoo HJ, Kim JH, Park JW, Han SH. The effect of an immersive virtual reality tour of the operating theater on emergence delirium in children undergoing general anesthesia: a randomized controlled trial. Paediatr Anaesth. 2019;29(1):98-105.</Citation></Reference><Reference><Citation>Kain ZN, Mayes LC, Cicchetti DV, Bagnall AL, Finley JD, Hofstadter MB. The Yale preoperative anxiety scale: how does it compare with a &#x201c;gold standard&#x201d;? Anesth Analg. 1997;85(4):783-788.</Citation></Reference><Reference><Citation>Jerez C, Ull&#xe1;n AM, L&#xe1;zaro JJ. Fiabilidad y validez de la versi&#xf3;n espa&#xf1;ola de la escala de evaluaci&#xf3;n de la ansiedad prequir&#xfa;rgica pedi&#xe1;trica modified Yale Preoperative Anxiety Scale. Rev Esp Anestesiol Reanim. 2016;63(6):320-326.</Citation></Reference><Reference><Citation>Julian LJ. Measures of anxiety: state-trait anxiety inventory (STAI), Beck anxiety inventory (BAI), and hospital anxiety and depression scale-anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011;63:S467-S472.</Citation></Reference><Reference><Citation>Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology. 2004;100(5):1138-1145.</Citation></Reference><Reference><Citation>Iacobucci T, Federico B, Pintus C, de Francisci G. Evaluation of satisfaction level by parents and children following pediatric anesthesia. Paediatr Anaesth. 2005;15(4):314-320.</Citation></Reference><Reference><Citation>Zauner A, Pinilla A, Benitez D, et al. Postanesthesia evaluation of emotional and psychological satisfaction in a Hispanic population. Paediatr Anaesth. 2017;27(2):147-152.</Citation></Reference><Reference><Citation>Vieco-Garc&#xed;a A, L&#xf3;pez-Picado A, Fuentes M, et al. Comparison of different scales for the evaluation of anxiety and compliance with anesthetic induction in children undergoing scheduled major outpatient surgery. Perioper Med (Lond). 2021;10(1):58.</Citation></Reference><Reference><Citation>Jerez-Molina C, L&#xe1;zaro-Alcay JJ, Ull&#xe1;n-de la Fuente AM. Adaptaci&#xf3;n transcultural de la escala induction compliance checklist para la evaluaci&#xf3;n del comportamiento del ni&#xf1;o durante la inducci&#xf3;n de la anestesia. Enferm Clin. 2018;28(4):260-265.</Citation></Reference><Reference><Citation>Kain ZN, Mayes LC, Caldwell-Andrews AA, Karas DE, McClain BC. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics. 2006;118(2):651-658.</Citation></Reference><Reference><Citation>Alberto Vieco Garc&#xed;a. Valoraci&#xf3;n de la ansiedad perioperatoria en ni&#xf1;os sometidos a cirug&#xed;a mayor ambulatoria. Universidad COMPLUTENSE de Madrid FACULTAD de MEDICINA.&#xa0;PhD&#xa0;Project. 2018.</Citation></Reference><Reference><Citation>Wennstr&#xf6;m B, T&#xf6;rnhage C-J, Nasic S, Hedelin H, Bergh I. The perioperative dialogue reduces postoperative stress in children undergoing day surgery as confirmed by salivary cortisol. Paediatr Anaesth. 2011;21(10):1058-1065.</Citation></Reference><Reference><Citation>Ryu JH, Park SJ, Park JW, et al. Randomized clinical trial of immersive virtual reality tour of the operating theatre in children before anaesthesia. Br J Surg. 2017;104(12):1628-1633.</Citation></Reference><Reference><Citation>Eijlers R, Dierckx B, Staals LM, et al. Virtual reality exposure before elective day care surgery to reduce anxiety and pain in children: a randomised controlled trial. Eur J Anaesthesiol. 2019;36(10):728-737.</Citation></Reference><Reference><Citation>Koo C-H, Park J-W, Ryu J-H, Han S-H. The effect of virtual reality on preoperative anxiety: a meta-analysis of randomized controlled trials. J Clin Med. 2020;9(10):3151.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36868342</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1891</ISSN><JournalIssue CitedMedium="Internet"><Volume>251</Volume><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>American journal of ophthalmology</Title><ISOAbbreviation>Am J Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Long-Term Visual Field Outcomes After Ahmed Glaucoma Valve Implantation.</ArticleTitle><Pagination><StartPage>173</StartPage><EndPage>188</EndPage><MedlinePgn>173-188</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajo.2023.02.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9394(23)00083-1</ELocationID><Abstract><AbstractText Label="PURPOSE">To measure visual field (VF) rates of change after Ahmed Glaucoma Valve (AGV) implantation and to investigate risk factors for progression.</AbstractText><AbstractText Label="DESIGN">Retrospective, clinical cohort study.</AbstractText><AbstractText Label="METHODS">Patients who underwent AGV implantation with at least 4 eligible postoperative VFs and 2 years of follow-up were included. Baseline, intraoperative, and postoperative data were collected. VF progression was explored with 3 methods: mean deviation (MD) rate; glaucoma rate index (GRI); and pointwise linear regression (PLR). For a subset of eyes with sufficient preoperative and postoperative VFs, rates were compared between the 2 periods.</AbstractText><AbstractText Label="RESULTS">A total of 173 eyes were included. The intraocular pressure (IOP) and number of glaucoma medications were significantly reduced from a median (interquartile range [IQR]) of 23.5 (12.1) mm Hg at baseline to 12.8 (4.0) mm Hg at final follow-up, and from (mean &#xb1; SD) 3.3 &#xb1; 1.2 to 2.2 &#xb1; 1.4, respectively. A total of 38 eyes (22%) showed VF progression, and 101 eyes (58%) were stable as assessed by all 3 methods, which accounted for 80% of all eyes. The rate of VF decline by MD and GRI was a median (IQR) of -0.30 (0.8) dB/y and -2.30 (10.6) (of -100), respectively. When comparing progression before and after surgery, the reduction was not statistically significant with any of the methods. The peak IOP (after 3 postoperative months) was associated with VF deterioration, with a 7% increase in risk per each additional millimeter of mercury (mm Hg).</AbstractText><AbstractText Label="CONCLUSIONS">To our knowledge, this is the largest published series reporting long-term VF outcomes after glaucoma drainage device implantation. There is a continued, significant rate of VF decline after AGV surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khaliliyeh</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Glaucoma Division (D.K., E.M., J.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Gainza</LastName><ForeName>Agustina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Jules Stein Eye Institute, University of California Los Angeles (UCLA), Los Angeles, California, USA; Hospital Italiano de Buenos Aires (A.D.G.), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Glaucoma Division (D.K., E.M., J.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caprioli</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Glaucoma Division (D.K., E.M., J.C.). Electronic address: caprioli@jsei.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Ophthalmol</MedlineTA><NlmUniqueID>0370500</NlmUniqueID><ISSNLinking>0002-9394</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005901" MajorTopicYN="Y">Glaucoma</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020327" MajorTopicYN="Y">Glaucoma Drainage Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019919" MajorTopicYN="N">Prosthesis Implantation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36868342</ArticleId><ArticleId IdType="doi">10.1016/j.ajo.2023.02.021</ArticleId><ArticleId IdType="pii">S0002-9394(23)00083-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33825206</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8159</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pacing and clinical electrophysiology : PACE</Title><ISOAbbreviation>Pacing Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Outcomes of manual versus remote magnetic navigation for catheter ablation of ventricular tachycardia: a systematic review and updated meta-analysis.</ArticleTitle><Pagination><StartPage>1102</StartPage><EndPage>1114</EndPage><MedlinePgn>1102-1114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pace.14231</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Ventricular tachycardia (VT) ablation is a complex procedure that requires remarkable catheter manipulation skill, great mapping accuracy and catheter stability, and can expose patients to serious complications. Magnetic navigation system (RMN)-guided ablation and contact force-sensing (CFS) catheters have the potential to overcome these obstacles. We performed a systematic review and updated meta-analysis of all available studies evaluating the outcomes of VT ablation by using RMN-guided compared to manual navigation (MAN)-guided, with and without CFS catheters.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE/PubMed, Cochrane, and Google Scholar were searched for randomized controlled trials (RCT) or observational studies with multivariate adjustment comparing RMN-guided versus MAN-guided VT ablation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen studies enrolling 1348 patients (656 RMN-guided vs. 692 MAN-guided) were included. CFS catheter were used in 14% of MAN-guided patients. In comparison to MAN-guided and CFS-guided, RMN-guided VT ablation was associated with a significant higher acute ablation success (OR 2.32, 1.66-3.23 and OR 2.91, 1.29-6.53, respectively) but similar results in term of long-term VT recurrence (OR 0.75, 0.56-1.01 and OR 0.79, 0.27-2.36, respectively). RMN-guided showed a better safety profile (for all complications, OR 0.52, 0.34-0.81) and allowed a significant x-ray reduction compared to MAN-guided (OR 0.21, 0.14-0.32) and CFS-guided VT ablation (OR 0.23, 0.11-0.52, all 95% CI).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">RMN-guided was superior to MAN-guided and CFS-guided VT ablation in term of acute ablation success, all complications endpoint, and reduction of fluoroscopy exposure, but did not reduce long-term VT recurrence. Large prospective multicenter randomized trials are needed to confirm these findings.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blandino</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1542-8646</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Mauriziano Umberto I Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Mauriziano Umberto I Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sibona Masi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Mauriziano Umberto I Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzanti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Molecular Cardiology, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ascenzo</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, AOU Citt&#xe0; della Salute e della Scienza, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grossi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Mauriziano Umberto I Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musumeci</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Mauriziano Umberto I Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pacing Clin Electrophysiol</MedlineTA><NlmUniqueID>7803944</NlmUniqueID><ISSNLinking>0147-8389</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008280" MajorTopicYN="Y">Magnetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025321" MajorTopicYN="N">Surgery, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">contact force-sensing catheter</Keyword><Keyword MajorTopicYN="N">manual navigation</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">remote magnetic navigation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33825206</ArticleId><ArticleId IdType="doi">10.1111/pace.14231</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Hosseini SM, Rozen G, Saleh A, et&#xa0;al. Catheter ablation for cardiac arrhythmias. utilization and in-hospital complications, 2000 to 2013. J Am Coll Cardiol EP. 2017;3:1240-1248.</Citation></Reference><Reference><Citation>Faddis MN, Blume W, Finney J, et&#xa0;al. Novel, magnetically guided catheter for endocardial mapping and radiofrequency catheter ablation. Circulation. 2002;106:2980-2985.</Citation></Reference><Reference><Citation>Yokoyama K, Nakagawa H, Shah DC, et&#xa0;al. Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol. 2008;1:354-362.</Citation></Reference><Reference><Citation>Ernst S, Ouyang F, Linder C, et&#xa0;al. Initial experience with remote catheter ablation using a novel magnetic navigation system: magnetic remote catheter ablation. Circulation. 2004;109:1472-1475.</Citation></Reference><Reference><Citation>Bradfield J, Tung R, Mandapati R, Boyle NG, Shivkumar K. Catheter ablation utilizing remote magnetic navigation: a review of applications and outcomes. Pacing Clin Electrophysiol. 2012:351021-1034.</Citation></Reference><Reference><Citation>Akca F, &#xd6;nsesveren I, Jordaens L, Szili-Torok T. Safety and efficacy of the remote magnetic navigation for ablation of ventricular tachycardias: a systematic review. J Interv Card Electrophysiol. 2012;34:65-71.</Citation></Reference><Reference><Citation>Turagam MK, Atkins D, Tung R, et&#xa0;al. A meta-analysis of manual versus remote magnetic navigation for ventricular tachycardia ablation. J Interv Card Electrophysiol. 2017;49:227-235.</Citation></Reference><Reference><Citation>Di Biase L, Santangeli P, Astudillo V, et&#xa0;al. Endo-epicardial ablation of ventricular arrhythmias in the left ventricle with the Remote Magnetic Navigation System and the 3.5-mm open irrigated magnetic catheter: results from a large single-center case-control series. Heart Rhythm. 2010;7:1029-1035.</Citation></Reference><Reference><Citation>Bauernfeind T, Akca F, Schwagten B, et&#xa0;al. The magnetic navigation system allows safety and high efficacy for ablation of arrhythmias. Europace. 2011;13:1015-1021.</Citation></Reference><Reference><Citation>Dinov B, Sch&#xf6;nbauer R, Wojdyla-Hordynska A, et&#xa0;al. Long-term efficacy of single procedure remote magnetic catheter navigation for ablation of ischemic ventricular tachycardia: a retrospective study. J Cardiovasc Electrophysiol. 2012;23:499-505.</Citation></Reference><Reference><Citation>Szili-Torok T, Schwagten B, Akca F, et&#xa0;al. Catheter ablation of ventricular tachycardias using remote magnetic navigation: a consecutive case-control study. J Cardiovasc Electrophysiol. 2012;23:948-954.</Citation></Reference><Reference><Citation>Akca F, Theuns DA, Abkenari LD, de Groot NM, Jordaens L, Szili-Torok T. Outcomes of repeat catheter ablation using magnetic navigation or conventional ablation. Europace. 2013;15:1426-1431.</Citation></Reference><Reference><Citation>Zhang F, Yang B, Chen H, et&#xa0;al. Magnetic versus manual catheter navigation for mapping and ablation of right ventricular outflow tract ventricular arrhythmias: a randomized controlled study. Heart Rhythm. 2013;10:1178-1183.</Citation></Reference><Reference><Citation>Akca F, Janse P, Theuns DA, Szili-Torok T. A prospective study on safety of catheter ablation procedures: contact force guided ablation could reduce the risk of cardiac perforation. Int J Cardiol. 2015;179:441-448.</Citation></Reference><Reference><Citation>Hendriks AA, Akca F, Dabiri Abkenari L, et&#xa0;al. Safety and clinical outcome of catheter ablation of ventricular arrhythmias using contact force sensing: consecutive case series. J Cardiovasc Electrophysiol. 2015;26:1224-1229.</Citation></Reference><Reference><Citation>Kawamura M, Scheinman MM, Tseng ZH, Lee BK, Marcus GM, Badhwar N. Comparison of remote magnetic navigation ablation and manual ablation of idiopathic ventricular arrhythmia after failed manual ablation. J Interv Card Electrophysiol. 2017;48:35-42.</Citation></Reference><Reference><Citation>Bassil G, Liu CF, Markowitz SM, et&#xa0;al. Comparison of robotic magnetic navigation-guided and manual catheter ablation of ventricular arrhythmias arising from the papillary muscles. Europace. 2018;20:ii5-ii10.</Citation></Reference><Reference><Citation>de Vries LJ, Hendriks AA, Yap SC, Theuns DAMJ, van Domburg RT, Szili-Torok T. Procedural and long-term outcome after catheter ablation of idiopathic outflow tract ventricular arrhythmias: comparing manual, contact force, and magnetic navigated ablation. Europace. 2018;20:ii22-ii27.</Citation></Reference><Reference><Citation>Qian P, De Silva K, Kumar S, et&#xa0;al. Early and long-term outcomes after manual and remote magnetic navigation-guided catheter ablation for ventricular tachycardia. Europace. 2018;20:ii11-ii21.</Citation></Reference><Reference><Citation>Shauer A, De Vries LJ, Akca F, et&#xa0;al. Remote magnetic navigation vs. manually controlled catheter ablation of right ventricular outflow tract arrhythmias: a retrospective study. Europace. 2018;20:ii28-ii32.</Citation></Reference><Reference><Citation>Wittkampf FH, Nakagawa H. RF catheter ablation: lessons on lesions. Pacing Clin Electrophysiol. 2006;29:1285-1297.</Citation></Reference><Reference><Citation>Ariyarathna N, Kumar S, Thomas SP, Stevenson WG, Michaud GF. Role of contact force sensing in catheter ablation of cardiac arrhythmias: evolution or history repeating itself?. JACC Clin Electrophysiol. 2018;4:707-723.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation></Reference><Reference><Citation>Altman DG, Schulz KF, Moher D, et&#xa0;al. CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-694.</Citation></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et&#xa0;al. Meta-analysis of observational studies in epidemiology: proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.</Citation></Reference><Reference><Citation>Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7:16.</Citation></Reference><Reference><Citation>Demazumder D, Mirotznik M, Schwartzman D. Biophysics of radiofrequency ablation using an irrigated electrode. J Interv Card Electrophysiol. 2001;5:377-389.</Citation></Reference><Reference><Citation>Avitall B, Mughal K, Hare J, Helms R, Krum D. The effects of electrode-tissue contact on radiofrequency lesion generation. Pacing Clin Electrophysiol. 1997;20:2899-2910.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28552749</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>The T<sub>peak</sub> - T<sub>end</sub> interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1131</StartPage><EndPage>1137</EndPage><MedlinePgn>1131-1137</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2017.05.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(17)30645-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">The T<sub>peak</sub> - T<sub>end</sub> interval (the interval from the peak to the end of the T wave), an electrocardiographic marker reflecting transmural dispersion of repolarization, has been used to predict ventricular tachycardia/fibrillation (VT/VF) and sudden cardiac death in different clinical settings.</AbstractText><AbstractText Label="OBJECTIVE">This systematic review and meta-analysis evaluated the significance of the T<sub>peak</sub> - T<sub>end</sub> interval in predicting arrhythmic and/or mortality end points.</AbstractText><AbstractText Label="METHODS">PubMed, Embase, Cochrane Library, and CINAHL Plus databases were searched through November 30,&#xa0;2016.</AbstractText><AbstractText Label="RESULTS">Of the 854 studies identified initially, 33 observational studies involving 155,856 patients were included in our meta-analysis. T<sub>peak</sub> - T<sub>end</sub> interval prolongation (mean cutoff value 103.3 &#xb1; 17.4 ms) was a significant predictor of the arrhythmic or mortality outcomes (odds ratio [OR] 1.14; 95% confidence interval [CI] 1.11-1.17; P &lt; .001). When different end points were analyzed, the ORs were as follows: VT/VF, 1.10 (95% CI 1.06-1.13; P &lt; .0001); sudden cardiac death, 1.27 (95% CI 1.17-1.39; P &lt; .0001); cardiovascular death, 1.40 (95% CI 1.19-1.64; P &lt; .0001); and all-cause mortality, 4.56 (95% CI 0.62-33.68; P &lt; .0001). Subgroup analysis for each disease revealed that the risk of VT/VF or death was highest for Brugada syndrome (OR 5.68; 95% CI 1.57-20.53; P &lt; .01), followed by hypertension (OR 1.52; 95% CI 1.26-1.85; P &lt; .0001), heart failure (OR 1.07; 95% CI 1.04-1.11; P &lt; .0001), and ischemic heart disease (OR 1.06; 95% CI 1.02-1.10; P = 0.001).</AbstractText><AbstractText Label="CONCLUSION">The T<sub>peak</sub> - T<sub>end</sub> interval is a useful risk stratification tool in different diseases and in the general population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China; School of Health Sciences, University of Manchester, Manchester, United Kingdom. Electronic address: tseg@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wing Tak</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgopoulos</LastName><ForeName>Stamatis</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Letsas</LastName><ForeName>Konstantinos P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassiliou</LastName><ForeName>Vassilios S</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Norwich Medical School, University of East Anglia, Norwich, United Kingdom; Royal Brompton Hospital and Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yat Sun</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Bryan P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Sunny Hei</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>William K K</ForeName><Initials>WKK</Initials><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China; Department of Anaesthesia and Intensive Care, State Key Laboratory of Digestive Disease, LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, SAR, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciobanu</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Theodor Burghele Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guangping</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shenthar</LastName><ForeName>Jayaprakash</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Electrophysiology Unit, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saguner</LastName><ForeName>Ardan M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Heart Center, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali-Hasan-Al-Saegh</LastName><ForeName>Sadeq</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhardwaj</LastName><ForeName>Aishwarya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, State University of New York at Buffalo, Buffalo, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawant</LastName><ForeName>Abhishek C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, State University of New York at Buffalo, Buffalo, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yunlong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Gan-Xin</ForeName><Initials>GX</Initials><AffiliationInfo><Affiliation>Lankenau Institute for Medical Research and Lankenau Medical Center, Wynnewood, Pennsylvania; Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China. Electronic address: liutongdoc@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiovasc Electrophysiol. 2018 May;29(5):767-770. doi: 10.1111/jce.13474.</RefSource><PMID Version="1">29512226</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dispersion of repolarization</Keyword><Keyword MajorTopicYN="N">Risk stratification</Keyword><Keyword MajorTopicYN="N">Sudden cardiac death</Keyword><Keyword MajorTopicYN="N">T(peak) &#x2212; T(end)</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28552749</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2017.05.031</ArticleId><ArticleId IdType="pii">S1547-5271(17)30645-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33723693</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>435</StartPage><EndPage>443</EndPage><MedlinePgn>435-443</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-020-00848-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Although implantable cardioverter defibrillator (ICD) could prevent the sudden death of ventricular tachycardia (VT) in patients with ischemic heart disease, it could not effectively prevent the recurrence of ventricular tachycardia. Several studies have suggested that catheter ablation may effectively decrease the incidence of ICD events, but relevant dates from randomized controlled trials were limited.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis of randomized controlled trials were performed to evaluate the effect of catheter ablation for the prevention of VT in patients with ischemic heart disease. Random-effects model with inverse-variance weighting method was used to pool odds ratios. Egger method was performed to evaluate whether there was public bias in each outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four studies enrolling a total of 605 patients were included in the present meta-analysis. Compared with the control group (ICD&#x2009;&#xb1;&#x2009;AAD), catheter ablation could significantly reduce the incidence of ICD therapy (OR, 0.49; 95% CI, 0.28&#x2009;~&#x2009;0.87), ICD shock (OR, 0.50; 95% CI, 0.28&#x2009;~&#x2009;0.87), VT storm (OR, 0.60; 95% CI, 0.40&#x2009;~&#x2009;0.90), and cardiovascular-related hospitalization (OR, 0.66; 95% CI, 0.45&#x2009;~&#x2009;0.9). But there was no significant difference among the risk of all-cause mortality (OR, 0.89; 95% CI, 0.59&#x2009;~&#x2009;1.34), cardiovascular mortality (OR, 0.76; 95% CI, 0.44&#x2009;~&#x2009;1.30), and complication (OR, 0.89; 95% CI, 0.30&#x2009;~&#x2009;2.67).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results showed that catheter ablation combined with ICD could reduce ICD therapy, ICD shock, and VT storm in patients with ischemic heart disease, but there was no improvement in all-cause mortality. Meanwhile, it also provided a basic guidance for the design of larger clinical randomized trials with longer follow-up in the future.</AbstractText><CopyrightInformation>&#xa9; 2020. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guolin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology; Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology; Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Qijian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiology; Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Tiewei</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0953-6552</Identifier><AffiliationInfo><Affiliation>Department of Cardiology; Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China. ltw200145@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing, China. ltw200145@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">Ischemic heart disease</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33723693</ArticleId><ArticleId IdType="pmc">PMC8376706</ArticleId><ArticleId IdType="doi">10.1007/s10840-020-00848-1</ArticleId><ArticleId IdType="pii">10.1007/s10840-020-00848-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295:809&#x2013;818. doi: 10.1001/jama.295.7.809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.7.809</ArticleId><ArticleId IdType="pubmed">16478904</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922510</ArticleId><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial. Circulation. 2002;105:589&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">11827924</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15583079</ArticleId></ArticleIdList></Reference><Reference><Citation>Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF, et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med. 2007;167:2226&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17998496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamphuis HCM, de Leeuw JRJ, Derksen R, Hauer RNW, Winnubst JAM. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. EP Europace. 2003;5:381&#x2013;389. doi: 10.1016/S1099-5129(03)00078-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1099-5129(03)00078-3</ArticleId><ArticleId IdType="pubmed">14753636</ArticleId></ArticleIdList></Reference><Reference><Citation>Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, et al. Quality of life in the Canadian implantable defibrillator study (CIDS) Am Heart J. 2002;144:282&#x2013;289. doi: 10.1067/mjh.2002.124049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mjh.2002.124049</ArticleId><ArticleId IdType="pubmed">12177646</ArticleId></ArticleIdList></Reference><Reference><Citation>MacIntyre CJ, Sapp JL. Treatment of persistent ventricular tachycardia: drugs or ablation? Trends Cardiovasc Med. 2017;27:506&#x2013;513. doi: 10.1016/j.tcm.2017.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2017.05.004</ArticleId><ArticleId IdType="pubmed">28625728</ArticleId></ArticleIdList></Reference><Reference><Citation>Back S, Kowey P. Strategies to reduce recurrent shocks due to ventricular arrhythmias in patients with an implanted cardioverter-defibrillator. Arrhythmia Electrophysiol Rev. 2019;8:99&#x2013;104. doi: 10.15420/aer.2018.55.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/aer.2018.55.5</ArticleId><ArticleId IdType="pmc">PMC6528055</ArticleId><ArticleId IdType="pubmed">31114683</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks AA, Szili-Torok T. Editor&#x2019;s choice-the treatment of electrical storm: an educational review. Eur Heart J Acute Cardiovasc Care. 2018;7:478&#x2013;483. doi: 10.1177/2048872618781358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872618781358</ArticleId><ArticleId IdType="pmc">PMC6282269</ArticleId><ArticleId IdType="pubmed">30035628</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA. 2006;295:165&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">16403928</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, Frankel DS, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13:1552&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26961297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontogiannis C, Tampakis K, Georgiopoulos G, Bartoletti S, Papageorgiou C, Anninos H, et al. Electrical storm: current evidence, clinical implications, and future perspectives. Curr Cardiol Rep. 2019;21:96.</Citation><ArticleIdList><ArticleId IdType="pubmed">31352528</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, And TPG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264&#x2013;269. doi: 10.7326/0003-4819-151-4-200908180-00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-4-200908180-00135</ArticleId><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr&#xe9;taz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled sms (Substrate Modification Study). Circ Arrhythm Electrophysiol. 2017;10(3):e004422.</Citation><ArticleIdList><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390777</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc. 2009;84:289&#x2013;297. doi: 10.4065/84.3.289.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/84.3.289</ArticleId><ArticleId IdType="pmc">PMC2664600</ArticleId><ArticleId IdType="pubmed">19252119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajijola OA, Tung R, Shivkumar K. Ventricular tachycardia in ischemic heart disease substrates. Indian Heart J. 2014;66:S24&#x2013;S34. doi: 10.1016/j.ihj.2013.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ihj.2013.12.039</ArticleId><ArticleId IdType="pmc">PMC4237298</ArticleId><ArticleId IdType="pubmed">24568826</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunbar SB, Dougherty CM, Sears SF, Carroll DL, Goldstein NE, Mark DB, et al. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation. 2012;126:2146&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">23008437</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 1996;335:1933&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">8960472</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882&#x2013;1890. doi: 10.1056/NEJM199912163412503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199912163412503</ArticleId><ArticleId IdType="pubmed">10601507</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems S, Tilz RR, Steven D, Kaab S, Wegscheider K, Geller L, et al. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141:1057&#x2013;1067. doi: 10.1161/CIRCULATIONAHA.119.043400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043400</ArticleId><ArticleId IdType="pubmed">32000514</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori SG, Blomstr&#xf6;m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pubmed">26320108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an international VT ablation center collaborative group study. Heart Rhythm. 2015;12:1997&#x2013;2007. doi: 10.1016/j.hrthm.2015.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.05.036</ArticleId><ArticleId IdType="pmc">PMC4549209</ArticleId><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32478430</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2022</StartPage><EndPage>2031</EndPage><MedlinePgn>2022-2031</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.14593</ELocationID><Abstract><AbstractText Label="BACKGROUND">The pathologic process of ARVC (arrhythmogenic right ventricular cardiomyopathy) typically originates in the epicardium or subepicardial layers with progression toward endocardium. However, in the most recent ARVC international task force consensus statement, epicardial ventricular tachycardia (VT) ablation is recommended as a Class I indication only in patients with at least one failed endocardial VT ablation attempt.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this meta-analysis is to assess the outcomes of ARVC patients undergoing combined endo-epicardial VT ablation, as compared to endocardial ablation alone.</AbstractText><AbstractText Label="METHODS">A systematic review of PubMed, Embase, and Cochrane was performed for studies reporting clinical outcomes of endo-epicardial VT ablation vs endocardial-only VT ablation in patients with ARVC. Fixed-Effect model was used if I<sub>2</sub> &lt; 25 and the Random-Effects Model was used if I<sub>2</sub> &#x2265; 25%.</AbstractText><AbstractText Label="RESULTS">Nine studies consisting of 452 patients were included (mean age 42.3&#x2009;&#xb1;&#x2009;5.7&#x2009;years; 70% male). After a mean follow-up of 48.1&#x2009;&#xb1;&#x2009;21.5&#x2009;months, endo-epicardial ablation was associated with 42% relative risk reduction in VA recurrence as opposed to endocardial ablation alone (risk ratio [RR], 0.58; 95% confidence interval [CI], 0.45-0.75; P&#x2009;&lt;&#x2009;.0001). No significant differences were noted between endo-epicardial and endocardial VT ablation groups in terms of all-cause mortality (RR, 1.19; 95% CI, 0.03-47.08; P&#x2009;=&#x2009;.93) and acute procedural complications (RR, 5.39; 95% CI, 0.60-48.74; P&#x2009;=&#x2009;.13).</AbstractText><AbstractText Label="CONCLUSIONS">Our findings suggest that in patients with ARVC, endo-epicardial VT ablation is associated with a significant reduction in VA recurrence as opposed to endocardial ablation alone, without a significant difference in all-cause mortality or acute procedural complications.</AbstractText><CopyrightInformation>&#xa9; 2020 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6420-8669</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Kavisha</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6416-5910</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briceno</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3962-1248</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alviz</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5417-9777</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabr</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7129-5550</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivedi</LastName><ForeName>Chintan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Sanghamitra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6601-944X</Identifier><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Rocca</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ahmad</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ruike</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Henan Provincial People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rios</LastName><ForeName>Saul</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6774-5849</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerna</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Xianfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantino</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9770-8675</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Dong</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1492-2693</Identifier><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute, HCA Midwest Health, Kansas City, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5487-0728</Identifier><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6508-4047</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019571" MajorTopicYN="Y">Arrhythmogenic Right Ventricular Dysplasia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004699" MajorTopicYN="N">Endocardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010496" MajorTopicYN="N">Pericardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmogenic right ventricular cardiomyopathy</Keyword><Keyword MajorTopicYN="N">endocardial ablation</Keyword><Keyword MajorTopicYN="N">endocardial-epicardial ablation</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia recurrence</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32478430</ArticleId><ArticleId IdType="doi">10.1111/jce.14593</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Te Riele AS, James CA, Philips B, et al. Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol. 2013;24(12):1311-1320.</Citation></Reference><Reference><Citation>Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94(5):983-991.</Citation></Reference><Reference><Citation>Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2009;120(5):366-375.</Citation></Reference><Reference><Citation>Bai R, Di Biase L, Shivkumar K, et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4(4):478-485.</Citation></Reference><Reference><Citation>Berruezo A, Fern&#xe1;ndez-Armenta J, Mont L, et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012;5(1):111-121.</Citation></Reference><Reference><Citation>Philips B, te Riele AS, Sawant A, et al. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2015;12(4):716-725.</Citation></Reference><Reference><Citation>Romero J, Cerrud-Rodriguez RC, Di Biase L, et al. Combined endocardial-epicardial versus endocardial catheter ablation alone for ventricular tachycardia in structural heart disease: a systematic review and meta-analysis. JACC Clin Electrophysiol. 2019;5(1):13-24.</Citation></Reference><Reference><Citation>Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Eur Heart J. 2015;36(46):3227-3237.</Citation></Reference><Reference><Citation>Berte B, Sacher F, Venlet J, et al. VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study. J Cardiovasc Electrophysiol. 2016;27(1):80-87.</Citation></Reference><Reference><Citation>Mahida S, Venlet J, Saguner AM, et al. Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: results from a multicenter study. Heart Rhythm. 2019;16(4):536-543.</Citation></Reference><Reference><Citation>Mathew S, Saguner AM, Schenker N, et al. Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: a sequential approach. J Am Heart Assoc. 2019;8(5):e010365.</Citation></Reference><Reference><Citation>M&#xfc;ssigbrodt A, Efimova E, Knopp H, et al. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation? J Interv Card Electrophysiol. 2017;48(2):193-199.</Citation></Reference><Reference><Citation>Philips B, Madhavan S, James C, et al. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol. 2012;5(3):499-505.</Citation></Reference><Reference><Citation>Santangeli P, Zado ES, Supple GE, et al. Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8(6):1413-1421.</Citation></Reference><Reference><Citation>Santangeli P, Tung R, Xue Y, et al. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry. JACC Clin Electrophysiol. 2019;5(1):55-65.</Citation></Reference><Reference><Citation>Wei W, Liao H, Xue Y, et al. Long-term outcomes of radio-frequency catheter ablation on ventricular tachycardias due to arrhythmogenic right ventricular cardiomyopathy: a single center experience. PLOS One. 2017;12(1):e0169863.</Citation></Reference><Reference><Citation>Dalal D, Jain R, Tandri H, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2007;50(5):432-440.</Citation></Reference><Reference><Citation>Verma A, Kilicaslan F, Schweikert RA, et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation. 2005;111(24):3209-3216.</Citation></Reference><Reference><Citation>Souissi Z, Boul&#xe9; S, Hermida JS, et al. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry. Europace. 2018;20(2):362-369.</Citation></Reference><Reference><Citation>Romero J, Shivkumar K, Di Biase L, et al. Mastering the art of epicardial access in cardiac electrophysiology. Heart Rhythm. 2019;16(11):1738-1749.</Citation></Reference><Reference><Citation>Orgeron GM, James CA, Te Riele A, et al. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia/cardiomyopathy: predictors of appropriate therapy, outcomes, and complications. J Am Heart Assoc. 2017;6(6):e006242.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34139353</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-8769</ISSN><JournalIssue CitedMedium="Internet"><Volume>153</Volume><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>World neurosurgery</Title><ISOAbbreviation>World Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Association Between Bone Cement Augmentation and New Vertebral Fractures in Patients with Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>98</StartPage><EndPage>108.e3</EndPage><MedlinePgn>98-108.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2021.06.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-8750(21)00851-2</ELocationID><Abstract><AbstractText Label="PURPOSE">To investigate the association between bone cement augmentation and new vertebral fractures (VF) in patients with osteoporotic vertebral compression fractures (OVCFs).</AbstractText><AbstractText Label="METHODS">A literature search of PubMed, EMBASE, and the Cochrane Library was conducted from 1987 to December 31, 2020, to identify randomized controlled trials that compared bone cement augmentation with non-bone cement treatments in patients with OVCFs. The clinical incidence of new VF and the risk of new adjacent vertebral fractures (AVF) after treatment were calculated. The indexes of the risk ratio or odds ratio, and 95% confidence intervals were determined with RevMan 5.2 software.</AbstractText><AbstractText Label="RESULTS">A total of 13 randomized controlled trials involving 1949 participants were included in the final quantitative analysis. There was no significant association between bone cement augmentation and the clinical incidence of new VF during the 6-month and 12-month follow-ups or the whole follow-up period. However, there was a significantly lower clinical incidence of new VF in patients who received bone cement augmentation compared with non-bone cement treatments during 24 months or more of follow-up. Pooled data from the relevant trials demonstrated that the risk of new AVF in bone cement augmentation was significantly higher than that in non-bone cement treatments.</AbstractText><AbstractText Label="CONCLUSIONS">Although the use of bone cement augmentation in OVCFs significantly increased the risk of new AVF compared with non-bone cement treatments, it was not significantly associated with a higher clinical incidence of new VF.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Qinghua</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China; Department of Osteoporosis, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Osteoporosis, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Keliang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiaosheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Osteoporosis, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, P. R. China. Electronic address: lxshengtcm@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World Neurosurg</MedlineTA><NlmUniqueID>101528275</NlmUniqueID><ISSNLinking>1878-8750</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001843" MajorTopicYN="N">Bone Cements</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050815" MajorTopicYN="N">Fractures, Compression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cement augmentation</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">New vertebral fractures</Keyword><Keyword MajorTopicYN="N">Osteoporotic vertebral compression fractures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>17</Day><Hour>20</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34139353</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2021.06.023</ArticleId><ArticleId IdType="pii">S1878-8750(21)00851-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36110477</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Diagnosing Torsades De Pointes Based on Correlation to QT Interval: A Systematic Review.</ArticleTitle><Pagination><StartPage>e27833</StartPage><MedlinePgn>e27833</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e27833</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.27833</ELocationID><Abstract><AbstractText>Torsades de Pointes (TdP) is a rare form of tachyarrhythmia which can potentially be fatal due to its tendency to degenerate into ventricular fibrillation. It&#xa0;is described as a polymorphic ventricular tachycardia characterized by twisting of the QRS complexes around the electrocardiogram (ECG) baseline in patients with a prolonged QT interval. Prolonged QT interval is known as long QT syndrome. Torsades de Poccurs most commonly in patients with an extended QT interval duration, and even though monitoring an ECG can assist in its prevention, there is no&#xa0;defined duration of a QT interval that can lead to an increased risk of Torsades de Pointes. So, it is hard to determine what QT interval constitutes enough risk for Torsades de Pointes to require intervention. The QT interval duration also depends on other factors, namely heart rate (HR) and other factors such as drugs, congenital diseases, and a combination of both. In this study, we considered various causes of QT prolongation but mainly focused on congenital diseases, drugs, or perioperative risk of QT prolongation and the correlation with the risk of impending TdP. By following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and researching studies on various databases, namely PubMed, Science Direct, Medline, and CiNii we were able to find various systematic reviews and articles showing the association between prolonged QT interval and its degeneration into TdP. This review encourages further research into this topic to understand the implications of QT prolongation and how it can help save the lives of patients with known long QT syndrome, or those on QT prolonging drugs with simple ECG monitoring and treatment for the respective cause.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, Kahlon et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kahlon</LastName><ForeName>Simranjit S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sikandar</LastName><ForeName>Rabia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tejovath</LastName><ForeName>Sreedevi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Shaalina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Danial</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiology and Public Health, Ministry of Public Health, Doha, QAT.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K Patel</LastName><ForeName>Khushbu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peddemul</LastName><ForeName>Aishwarya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Obstetrics and Gynecology, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mostafa</LastName><ForeName>Jihan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">drug-induced long qt syndrome</Keyword><Keyword MajorTopicYN="N">long qt syndrome</Keyword><Keyword MajorTopicYN="N">qt interval prolongation</Keyword><Keyword MajorTopicYN="N">qt prolongation and risk of torsades</Keyword><Keyword MajorTopicYN="N">torsades</Keyword><Keyword MajorTopicYN="N">torsades de pointes (tdp)</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>16</Day><Hour>2</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36110477</ArticleId><ArticleId IdType="pmc">PMC9462954</ArticleId><ArticleId IdType="doi">10.7759/cureus.27833</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Treat your heart right: 125 sayings and quotes about heart disease.  [
Feb;
2022 
];https://parade.com/1187612/michelleparkerton/quotes-about-heart-disease/ 2022 </Citation></Reference><Reference><Citation>Cohagan B, Brandis D. Treasure Island, FL, USA: StatPearls; 2022. Torsade de Pointes.</Citation><ArticleIdList><ArticleId IdType="pubmed">29083738</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Malik M, Camm AJ. Drug Saf. 2001;24:323&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">11419561</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical practice. Long-QT syndrome. Roden DM. N Engl J Med. 2008;358:169&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184962</ArticleId></ArticleIdList></Reference><Reference><Citation>The long QT syndrome. Prospective longitudinal study of 328 families. Moss AJ, Schwartz PJ, Crampton RS, et al. Circulation. 1991;84:1136&#x2013;1144.</Citation><ArticleIdList><ArticleId IdType="pubmed">1884444</ArticleId></ArticleIdList></Reference><Reference><Citation>ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to revise the 2002 guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction) Anderson JL, Adams CD, Antman EM, et al. J Am Coll Cardiol. 2007;50:0.</Citation></Reference><Reference><Citation>Drug-induced prolongation of the QT interval. Roden DM. N Engl J Med. 2004;350:1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">14999113</ArticleId></ArticleIdList></Reference><Reference><Citation>Perioperative torsade de pointes: a systematic review of published case reports. Johnston J, Pal S, Nagele P. Anesth Analg. 2013;117:559&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3750104</ArticleId><ArticleId IdType="pubmed">23744954</ArticleId></ArticleIdList></Reference><Reference><Citation>Predicting drug-induced QT prolongation and torsades de pointes. Roden DM. J Physiol. 2016;594:2459&#x2013;2468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4850203</ArticleId><ArticleId IdType="pubmed">26660066</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug-induced long QT syndrome. Kannankeril P, Roden DM, Darbar D. Pharmacol Rev. 2010;62:760&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993258</ArticleId><ArticleId IdType="pubmed">21079043</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. QJM. 2007;100:609&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">17881416</ArticleId></ArticleIdList></Reference><Reference><Citation>Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Shimizu W, Ohe T, Kurita T, et al. Circulation. 1991;84:1915&#x2013;1923.</Citation><ArticleIdList><ArticleId IdType="pubmed">1657447</ArticleId></ArticleIdList></Reference><Reference><Citation>Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holter recordings. Findings in normal patients and patients with long QT syndrome. H Hirao, W Shimizu, T Kurita, K Suyama, N Aihara, S Kamakura, K Shimomura. J Am Coll Cardiol. 1996;28:1269&#x2013;1277.</Citation><ArticleIdList><ArticleId IdType="pubmed">1572038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Priori SG, Corr PB. Am J Physiol. 1990;258:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">2163219</ArticleId></ArticleIdList></Reference><Reference><Citation>Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holter recordings. Findings in normal patients and patients with long QT syndrome. Merri M, Moss AJ, Benhorin J, Locati EH, Alberti M, Badilini F. Circulation. 1992;85:1816&#x2013;1821.</Citation><ArticleIdList><ArticleId IdType="pubmed">1572038</ArticleId></ArticleIdList></Reference><Reference><Citation>Reentrant ventricular arrhythmias in the late myocardial infarction period: mechanism by which a short-long-short cardiac sequence facilitates the induction of reentry. el-Sherif N, Gough WB, Restivo M. Circulation. 1991;83:268&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">1984885</ArticleId></ArticleIdList></Reference><Reference><Citation>The long QT syndromes: a critical review, new clinical observations and a uniting hypothesis. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. Prog Cardiovasc Dis. 1988;31:115&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">3047813</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: role of M cells in the generation of U waves, triggered activity and torsade de pointes. Antzelevitch C, Sicouri S. J Am Coil Cardiol. 1994;23:259&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">8277090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37833194</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Respiratory mechanics and mechanical power during low vs. high positive end-expiratory pressure in obese surgical patients - A sub-study of the PROBESE randomized controlled trial.</ArticleTitle><Pagination><StartPage>111242</StartPage><MedlinePgn>111242</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2023.111242</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(23)00192-7</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">We aimed to characterize intra-operative mechanical ventilation with low or high positive end-expiratory pressure (PEEP) and recruitment manoeuvres (RM) regarding intra-tidal recruitment/derecruitment and overdistension using non-linear respiratory mechanics, and mechanical power in obese surgical patients enrolled in the PROBESE trial.</AbstractText><AbstractText Label="DESIGN">Prospective, two-centre substudy of the international, multicentre, two-arm, randomized-controlled PROBESE trial.</AbstractText><AbstractText Label="SETTING">Operating rooms of two European University Hospitals.</AbstractText><AbstractText Label="PATIENTS">Forty-eight adult obese patients undergoing abdominal surgery.</AbstractText><AbstractText Label="INTERVENTIONS">Intra-operative protective ventilation with either PEEP of 12 cmH<sub>2</sub>O and repeated RM (HighPEEP+RM) or 4 cmH<sub>2</sub>O without RM (LowPEEP).</AbstractText><AbstractText Label="MEASUREMENTS">The index of intra-tidal recruitment/de-recruitment and overdistension (%E<sub>2</sub>) as well as airway pressure, tidal volume (V<sub>T</sub>), respiratory rate (RR), resistance, elastance, and mechanical power (MP) were calculated from respiratory signals recorded after anesthesia induction, 1&#xa0;h thereafter, and end of surgery (EOS).</AbstractText><AbstractText Label="MAIN RESULTS">Twenty-four patients were analyzed in each group. PEEP was higher (mean&#xa0;&#xb1;&#xa0;SD, 11.7&#xa0;&#xb1;&#xa0;0.4 vs. 3.7&#xa0;&#xb1;&#xa0;0.6 cmH<sub>2</sub>O, P&#xa0;&lt;&#xa0;0.001) and driving pressure lower (12.8&#xa0;&#xb1;&#xa0;3.5 vs. 21.7&#xa0;&#xb1;&#xa0;6.8 cmH<sub>2</sub>O, P&#xa0;&lt;&#xa0;0.001) during HighPEEP+RM than LowPEEP, while V<sub>T</sub> and RR did not differ significantly (7.3&#xa0;&#xb1;&#xa0;0.6 vs. 7.4&#xa0;&#xb1;&#xa0;0.8&#xa0;ml&#x2219;kg<sup>-1</sup>, P&#xa0;=&#xa0;0.835; and 14.6&#xa0;&#xb1;&#xa0;2.5 vs. 15.7&#xa0;&#xb1;&#xa0;2.0&#xa0;min<sup>-1</sup>, P&#xa0;=&#xa0;0.150, respectively). %E<sub>2</sub> was higher in HighPEEP+RM than in LowPEEP following induction (-3.1&#xa0;&#xb1;&#xa0;7.2 vs. -12.4&#xa0;&#xb1;&#xa0;10.2%; P&#xa0;&lt;&#xa0;0.001) and subsequent timepoints. Total resistance and elastance (13.3&#xa0;&#xb1;&#xa0;3.8 vs. 17.7&#xa0;&#xb1;&#xa0;6.8 cmH<sub>2</sub>O&#x2219;l&#x2219;s<sup>-2</sup>, P&#xa0;=&#xa0;0.009; and 15.7&#xa0;&#xb1;&#xa0;5.5 vs. 28.5&#xa0;&#xb1;&#xa0;8.4 cmH<sub>2</sub>O&#x2219;l, P&#xa0;&lt;&#xa0;0.001, respectively) were lower during HighPEEP+RM than LowPEEP. Additionally, MP was lower in HighPEEP+RM than LowPEEP group (5.0&#xa0;&#xb1;&#xa0;2.2 vs. 10.4&#xa0;&#xb1;&#xa0;4.7&#xa0;J&#x2219;min<sup>-1</sup>, P&#xa0;&lt;&#xa0;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">In this sub-cohort of PROBESE, intra-operative ventilation with high PEEP and RM reduced intra-tidal recruitment/de-recruitment as well as driving pressure, elastance, resistance, and mechanical power, as compared with low PEEP.</AbstractText><AbstractText Label="TRIAL REGISTRATION">The PROBESE study was registered at www.</AbstractText><AbstractText Label="CLINICALTRIALS">gov, identifier: NCT02148692 (submission for registration on May 23, 2014).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scharffenberg</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandelli</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Largo Rosanna Benzi 8, 16131 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bluth</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonassi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Largo Rosanna Benzi 8, 16131 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wittenstein</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teichmann</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birr</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiss</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307 Dresden, Germany; Department of Anaesthesiology, Intensive-, Pain- and Palliative Care Medicine, Radebeul Hospital, Academic Hospital of the Technische Universit&#xe4;t Dresden, Heinrich-Zille-Strasse 13, 01445 Radebeul, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Largo Rosanna Benzi 8, 16131 Genoa, Italy; Anesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Largo Rosanna Benzi, 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Largo Rosanna Benzi 8, 16131 Genoa, Italy; Anesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Largo Rosanna Benzi, 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Laboratory of Experimental Intensive Care &amp; Anesthesiology (L E I C A), Amsterdam University Medical Centers, location AMC, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307 Dresden, Germany; Department of Intensive Care and Resuscitation, Anesthesiology Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, 44195, OH, USA; Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, 44195, OH, USA. Electronic address: gamadem@ccf.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huhle</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PROBESE-investigators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Protective Ventilation Network</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Clinical Trials Network of the European Society of Anaesthesiology and Intensive Care</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02148692</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="N">Respiratory Mechanics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Intraoperative ventilation</Keyword><Keyword MajorTopicYN="N">Lung recruitment</Keyword><Keyword MajorTopicYN="N">Mechanical power</Keyword><Keyword MajorTopicYN="N">Mechanical ventilation</Keyword><Keyword MajorTopicYN="N">Positive end-expiratory pressure</Keyword><Keyword MajorTopicYN="N">Respiratory mechanics</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest MGA received consultation fees from Ambu (Ballerup, Denmark), Dr&#xe4;ger Medical (L&#xfc;beck, Germany), ZOLL (Minneapolis, MN, USA), Lungpacer (Vancouver, B.C., Canada) and Merck (London, UK). The other authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>14</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37833194</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2023.111242</ArticleId><ArticleId IdType="pii">S0952-8180(23)00192-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34905056</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1945-7197</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>The Journal of clinical endocrinology and metabolism</Title><ISOAbbreviation>J Clin Endocrinol Metab</ISOAbbreviation></Journal><ArticleTitle>Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy.</ArticleTitle><Pagination><StartPage>e2167</StartPage><EndPage>e2176</EndPage><MedlinePgn>e2167-e2176</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1210/clinem/dgab899</ELocationID><Abstract><AbstractText Label="CONTEXT">Patients with adrenocortical carcinoma (ACC) are frequently on mitotane therapy for a long time period. The drug exerts adrenolytic activity requiring glucocorticoid supplementation, which can be potentially detrimental for bone.</AbstractText><AbstractText Label="OBJECTIVE">To explore whether mitotane with/without chemotherapy is associated with an increased proportion of morphometric vertebral fractures (VFs) in ACC patients. Secondary objectives were proportion of patients with VF progression, or worsening of the spinal deformity index (SDI) during mitotane therapy; and to explore predictive factors of VF progression and a prognostic role of VF progression.</AbstractText><AbstractText Label="METHODS">Multicenter, retrospective cohort study of patients with ACC who received mitotane alone or in association to chemotherapy, recruited from January 2010 to January 2020 in 2 reference centers in Italy and France.</AbstractText><AbstractText Label="RESULTS">A significant increase in the frequency of VFs before and after mitotane therapy was seen both in Italian (28.3% vs 47.8%, P = .04) and French (17.8% vs 35.6%, P = .04) series. VF progression was observed in 39.1%, and 28.9% of patients, respectively. Baseline VFs and increased patient body mass index, but not the dose of cortisol supplementation, showed an independent association with VF progression at multivariate analysis. Among the 72 advanced ACC patients, progression of VFs was associated with a poorer survival.</AbstractText><AbstractText Label="CONCLUSION">The administration of mitotane with/without chemotherapy in ACC patients impairs bone health independently from cortisol supplementation. Appropriate preventive measures to decrease the fracture risk should be implemented in these patients.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cosentini</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grisanti</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6922-1934</Identifier><AffiliationInfo><Affiliation>Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadoux</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine and Endocrine Oncology, and Interventional Medicine, Institute Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lib&#xe8;</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Cochin Hospital, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frigerio</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Radiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagan&#xe0;</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deschamps</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Interventional Radiology, Institute Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamparini</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamartina</LastName><ForeName>Livia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine and Endocrine Oncology, and Interventional Medicine, Institute Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersini</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valsecchi</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Radiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maroldi</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Radiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Ghuzlan</LastName><ForeName>Abir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine and Endocrine Oncology, and Interventional Medicine, Institute Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terzolo</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4171-2851</Identifier><AffiliationInfo><Affiliation>Internal Medicine, Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Orbassano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasparotti</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia. ASST Spedali Civili Hospital, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baudin</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2198-3582</Identifier><AffiliationInfo><Affiliation>Department of Nuclear Medicine and Endocrine Oncology, and Interventional Medicine, Institute Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berruti</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3956-0043</Identifier><AffiliationInfo><Affiliation>Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Fondazione Beretta</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Endocrinol Metab</MedlineTA><NlmUniqueID>0375362</NlmUniqueID><ISSNLinking>0021-972X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>78E4J5IB5J</RegistryNumber><NameOfSubstance UI="D008939">Mitotane</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000306" MajorTopicYN="Y">Adrenal Cortex Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018268" MajorTopicYN="Y">Adrenocortical Carcinoma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008939" MajorTopicYN="N">Mitotane</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adrenal tumor</Keyword><Keyword MajorTopicYN="N">bone health</Keyword><Keyword MajorTopicYN="N">mitotane</Keyword><Keyword MajorTopicYN="N">steroid supplementation</Keyword><Keyword MajorTopicYN="N">vertebral fractures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>14</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34905056</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgab899</ArticleId><ArticleId IdType="pii">6461116</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30678778</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for&#xa0;Ventricular Tachycardia in Structural&#xa0;Heart Disease: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>24</EndPage><MedlinePgn>13-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2018.08.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(18)30672-8</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study sought to determine whether combined endocardial-epicardial (endo-epi) ablation was superior to endocardial only ablation in patients with scar-related ventricular tachycardia (VT).</AbstractText><AbstractText Label="BACKGROUND">Limited single-center studies suggest that combined endo-epi ablation strategy may be superior to endocardial ablation (endo) alone in patients with nonischemic cardiomyopathy (NICM) and arrhythmogenic right ventricular cardiomyopathy (ARVC), and ischemic cardiomyopathy (ICM).</AbstractText><AbstractText Label="METHODS">A systematic review of Medline, Cochrane, and Embase databases was performed for studies that reported outcomes comparing endo-epi with endo VT ablation alone.</AbstractText><AbstractText Label="RESULTS">Seventeen studies consisting of 975 patients were included (mean 56 &#xb1; 10 years of age; 79% male; NICM in 36.6%; ICM in 32.8%; and ARVC in 30.6%). After a mean follow-up of 27 &#xb1; 21 months, endo-epi ablation was associated with a 35% reduction in risk of VT recurrence compared with endocardial ablation alone (risk ratio [RR]: 0.65; 95% confidence interval [CI]: 0.55 to 0.78; p&#xa0;&lt; 0.001). Sensitivity analysis showed lower risk of VT recurrence in ICM (RR: 0.43; 95% CI: 0.28 to 0.67; p&#xa0;= 0.0002) and ARVC (RR: 0.59; 95% CI: 0.43 to 0.82; p&#xa0;= 0.0002), with a nonsignificant trend in NICM (RR: 0.87; 95% CI: 0.70 to 1.08; p&#xa0;= 0.20). Endo-epi, compared with endo ablation, was associated with reduced all-cause mortality (RR: 0.56; 95% CI: 0.32 to 0.97; p&#xa0;= 0.04). Acute procedural complications were higher with the endo-epi approach (RR: 2.62; 95% CI: 0.91 to 7.52; p&#xa0;= 0.07).</AbstractText><AbstractText Label="CONCLUSIONS">This meta-analysis suggests that a combined endo-epi ablation is associated with a lower risk of VT&#xa0;recurrence and subsequent mortality than endo only VT ablation in patients with scar-related VT. Procedural complications, however, are higher with the endo-epi approach.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2019. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerrud-Rodriguez</LastName><ForeName>Roberto C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alviz</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grupposo</LastName><ForeName>Vito</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerna</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avendano</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrhythmia Services, Department of Medicine, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedrow</LastName><ForeName>Usha</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Cardiac Arrhythmia Service, Heart and Vascular Center, Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Roderick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Arrhythmia Care, Heart and Vascular Center, Pritzker School of Medicine, The University of Chicago Medicine, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Applied Research Centre, University of Sydney, Sydney, New South Wales, Australia. Electronic address: Saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2019 Jan;5(1):25-27. doi: 10.1016/j.jacep.2018.09.003.</RefSource><PMID Version="1">30678783</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VT recurrence</Keyword><Keyword MajorTopicYN="N">arrhythmogenic right ventricular cardiomyopathy</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">endocardial ablation</Keyword><Keyword MajorTopicYN="N">epicardial ablation</Keyword><Keyword MajorTopicYN="N">ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">nonischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">structural heart disease</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30678778</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2018.08.010</ArticleId><ArticleId IdType="pii">S2405-500X(18)30672-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40237657</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0974-5181</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of cardiac anaesthesia</Title><ISOAbbreviation>Ann Card Anaesth</ISOAbbreviation></Journal><ArticleTitle>Sedation Versus General Anesthesia for Ablation of Ventricular Arrhythmias: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>119</StartPage><EndPage>127</EndPage><MedlinePgn>119-127</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/aca.aca_229_24</ELocationID><Abstract><AbstractText>Ventricular arrhythmias (VA), including ventricular tachycardia and fibrillation, are critical cardiac conditions that are often managed by catheter ablation among those unresponsive to pharmacologic therapy. The choice of anesthesia and sedation regimens for VA ablations may impact arrhythmia inducibility and hemodynamic stability, which can affect procedural success and complication rates. This systematic review and meta-analysis aimed to compare the efficacy and safety of sedation versus general anesthesia (GA) among patients undergoing VA ablation. The review was prospectively registered on PROSPERO (CRD42023441553). Database searches were conducted across five major databases from inception to March 9, 2024 to identify randomized trials or observational studies including adult patients undergoing ablations for VA. Screening and data extraction were completed in duplicate. Risk-of-bias assessments were conducted using ROBINS-I as all included studies were observational, and the quality of evidence was evaluated using the GRADE framework. Six observational studies (N = 16,435) were included. No significant differences were found between sedation and GA for total procedure time (MD: -14.16 minutes; 95%CI: -38.61 to 10.29 minutes), arrhythmia non-inducibility (RR: 0.73; 95% CI: 0.33-1.58), acute ablation success (RR: 1.06; 95% CI: 0.65-1.71), or procedural complications (RR: 0.72; 95% CI: 0.28-1.85). However, sedation was associated with significantly lower intraprocedural hemodynamic instability (RR: 0.28; 95% CI: 0.12-0.70). These findings indicate that while sedation and GA have comparable outcomes, sedation may be associated with less hemodynamic instability during VA ablation. However, more high-quality studies are needed to confirm these results.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Annals of Cardiac Anaesthesia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Shubh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jiawen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zubair</LastName><ForeName>Areeba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heybati</LastName><ForeName>Kiyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Alix School of Medicine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heybati</LastName><ForeName>Shayan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Oswin</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>UBC Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Umaima</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry (Windsor), Western University, Windsor, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahir</LastName><ForeName>Umair</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramaraju</LastName><ForeName>Harikrishnaa B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>VCU School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Chi Y</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Michael G. DeGroote School of Medicine (Waterloo Regional Campus), McMaster University, Kitchener, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhivagaran</LastName><ForeName>Thanansayan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry (Windsor), Western University, Windsor, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rayner</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krever</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Research, Sinai Health System, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woelber</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowlgi</LastName><ForeName>Gurukripa N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramakrishna</LastName><ForeName>Harish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Ann Card Anaesth</MedlineTA><NlmUniqueID>9815987</NlmUniqueID><ISSNLinking>0971-9784</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">sedation</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>14</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>14</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40237657</ArticleId><ArticleId IdType="pmc">PMC12058075</ArticleId><ArticleId IdType="doi">10.4103/aca.aca_229_24</ArticleId><ArticleId IdType="pii">00660469-202504000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace. 2019;21:1143&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967791</ArticleId><ArticleId IdType="pubmed">31075787</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MA, Dukkipati SR, Mittnacht AJ, Chinitz JS, Belliveau L, Koruth JS, et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. J Am Coll Cardiol. 2011;58:1363&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">21920266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel JE, Hutchinson MD, Marchlinski FE. Remifentanil-midazolam sedation provides hemodynamic stability and comfort during epicardial ablation of ventricular tachycardia. J Cardiovasc Electrophysiol. 2011;22:464&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20812933</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti S, Sabatino F, Cascino A, Ferrara G, Sgarito G. Dexmedetomidine for sedation during epicardial ablation for ventricular tachycardia: A single-center experience. J Interv Card Electrophysiol. 2023;66:79&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">36018425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wutzler A, Rolf S, Huemer M, Parwani AS, Boldt LH, Herberger E, et al. Safety aspects of deep sedation during catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012;35:38&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">22054234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazawa S, Sieira J, Bala G, Miraglia V, Al Housari M, Strazdas A, et al. Impact of anesthetic management on catheter ablation for premature ventricular complexes: Insights during the COVID-19 outbreak. J Interv Card Electrophysiol. 2023;66:2135&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10182347</ArticleId><ArticleId IdType="pubmed">37178190</ArticleId></ArticleIdList></Reference><Reference><Citation>Newstead B, Bradburn S, Appelboam A, Reuben A, Harris A, Hudson A, et al. Propofol for adult procedural sedation in a UK emergency department: Safety profile in 1008 cases. Br J Anaesth. 2013;111:651&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23661404</ArticleId></ArticleIdList></Reference><Reference><Citation>Servatius H, Hoefeler T, Hoffmann BA, Sultan A, L&#xfc;ker J, Sch&#xe4;ffer B, et al. Propofol sedation administered by cardiologists without assisted ventilation is safe for patients undergoing catheter ablation for ventricular tachycardia. Europace. 2013;6(15):ii189.</Citation><ArticleIdList><ArticleId IdType="pubmed">27247017</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc; F, Lin J, Benditt DG. Conscious sedation and anesthesia in the cardiac electrophysiology laboratory. J Cardiovasc Electrophysiol. 2013;24:237&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">23130937</ArticleId></ArticleIdList></Reference><Reference><Citation>Wutzler A, Mueller A, Loehr L, Huemer M, Parwani AS, Attanasio P, et al. Minimal and deep sedation during ablation of ventricular tachycardia. Int J Cardiol. 2014;172:161&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24447761</ArticleId></ArticleIdList></Reference><Reference><Citation>Nof E, Reichlin T, Enriquez AD, Ng J, Nagashima K, Tokuda M, et al. Impact of general anesthesia on initiation and stability of VT during catheter ablation. Heart Rhythm. 2015;12:2213&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26072026</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021;18:e1003583. doi:10.1371/journal.pmed.1003583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007028</ArticleId><ArticleId IdType="pubmed">33780438</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. The Cochrane Collaboration. Chichester, UK; 2021. editors: Cochrane Handbook for Systematic Reviews of Interventions (v6.2)</Citation></Reference><Reference><Citation>Schiavo JH. PROSPERO: An International Register of Systematic Review Protocols. Med Ref Serv Q. 2019;38:171&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">31173570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellermeyer L, Harnke B, Knight S. Covidence and Rayyan. J Med Libr Assoc University Library System, University of Pittsburgh, 1062018.  Retrieved from:https://jmla.pitt.edu/ojs/jmla/article/view/513 .</Citation></Reference><Reference><Citation>Shi J, Luo D, Wan X, Liu Y, Liu J, Bian Z, et al. Detecting the skewness of data from the five-number summary and its application in meta-analysis. Stat Methods Med Res. 2023;32:1338&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">37161735</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai S, Zhou J, Pan J. Estimating the sample mean and standard deviation from order statistics and sample size in meta-analysis. Stat Methods Med Res. 2021;30:2701&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">34668458</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath S, Katzenschlager S, Zimmer AJ, Seitel A, Steele R, Benedetti A. Standard error estimation in meta-analysis of studies reporting medians. Stat Methods Med Res. 2023;32:373&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">36412105</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A DEPRESsion Screening Data (DEPRESSD) Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2020;29:2520&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390706</ArticleId><ArticleId IdType="pubmed">32292115</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: A practical tutorial. Evid Based Ment Health. 2019;22:153&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing?Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53:1119&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">11106885</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med. 2003;22:2113&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">12820277</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L, Brignardello-Petersen R, Hultcrantz M, Mustafa RA, Murad MH, Iorio A, Traversy G, et al. GRADE Guidance 34: Update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol. 2022;150:216&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">35934265</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol. 2011;64:1283&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009;1:51&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256489</ArticleId><ArticleId IdType="pubmed">22263004</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines:1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Dada R, McGuire JA, Hayanga JWA. Anesthetic management for ventricular tachycardia ablation: A national anesthesia clinical outcomes registry analysis. Anesth Analg. 2022;134:137&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">38233244</ArticleId></ArticleIdList></Reference><Reference><Citation>Dada RS, McGuire JA, Hayanga JWA, Thibault D, Schwartzman D, Ellison M, et al. Anesthetic management for ventricular tachycardia ablation: A national anesthesia clinical outcomes registry analysis. J Cardiothorac Vasc Anesth. 2024;38:675&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">38233244</ArticleId></ArticleIdList></Reference><Reference><Citation>Woelber T, Dhawan R, Killu AM, Heybati K, Desimone CV, Deshmukh AJ, et al. A comparison of general anesthesia versus monitored anesthesia care during catheter ablation for ventricular tachycardia. Eur Heart J. 2023;44(Suppl_2):ehad655&#x2013;383.</Citation></Reference><Reference><Citation>Ballout JA, Wazni OM, Tarakji KG, Saliba WI, Kanj M, Diab M, et al. Catheter ablation in patients with cardiogenic shock and refractory ventricular tachycardia. Circ Arrhythm Electrophysiol. 2020;13:e007669. doi:10.1161/CIRCEP. 119.007669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7285871</ArticleId><ArticleId IdType="pubmed">32281407</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Bella P, Radinovic A, Limite LR, Baratto F. Mechanical circulatory support in the management of life-threatening arrhythmia. Europace. 2021;23:1166&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">33382868</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto F, Pappalardo F, Oloriz T, Bisceglia C, Vergara P, Silberbauer J, et al. Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2016;9:e004492. doi:10.1161/CIRCEP. 116.004492.</Citation><ArticleIdList><ArticleId IdType="pubmed">27932426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27536534</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2193-1801</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>SpringerPlus</Title><ISOAbbreviation>Springerplus</ISOAbbreviation></Journal><ArticleTitle>Intraoperative mechanical ventilation strategies in patients undergoing one-lung ventilation: a meta-analysis.</ArticleTitle><Pagination><StartPage>1251</StartPage><MedlinePgn>1251</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1251</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-016-2867-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative pulmonary complications (PPCs), which are not uncommon in one-lung ventilation, are among the main causes of postoperative death after lung surgery. Intra-operative ventilation strategies can influence the incidence of PPCs. High tidal volume (V T) and increased airway pressure may lead to lung injury, while pressure-controlled ventilation and lung-protective strategies with low V T may have protective effects against lung injury. In this meta-analysis, we aim to investigate the effects of different ventilation strategies, including pressure-controlled ventilation (PCV), volume-controlled ventilation (VCV), protective ventilation (PV) and conventional ventilation (CV), on PPCs in patients undergoing one-lung ventilation. We hypothesize that both PV with low V T and PCV have protective effects against PPCs in one-lung ventilation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search (PubMed, EMBASE, the Cochrane Library, and Ovid MEDLINE; in May 2015) was performed for randomized trials comparing PCV with VCV or comparing PV with CV in one-lung ventilation. Methodological quality was evaluated using the Cochrane tool for risk. The primary outcome was the incidence of PPCs. The secondary outcomes included the length of hospital stay, intraoperative plateau airway pressure (Pplateau), oxygen index (PaO2/FiO2) and mean arterial pressure (MAP).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this meta-analysis, 11 studies (436 patients) comparing PCV with VCV and 11 studies (657 patients) comparing PV with CV were included. Compared to CV, PV decreased the incidence of PPCs (OR 0.29; 95&#xa0;% CI 0.15-0.57; P&#xa0;&lt;&#xa0;0.01) and intraoperative Pplateau (MD -3.75; 95&#xa0;% CI -5.74 to -1.76; P&#xa0;&lt;&#xa0;0.01) but had no significant influence on the length of hospital stay or MAP. Compared to VCV, PCV decreased intraoperative Pplateau (MD -1.46; 95&#xa0;% CI -2.54 to -0.34; P&#xa0;=&#xa0;0.01) but had no significant influence on PPCs, PaO2/FiO2 or MAP.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PV with low V T was associated with the reduced incidence of PPCs compared to CV. However, PCV and VCV had similar effects on the incidence of PPCs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, 1#Shuai fuyuan, Dongcheng District, Beijing, 100730 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaowen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, 1#Shuai fuyuan, Dongcheng District, Beijing, 100730 China ; Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 33# Shijingshan District, Beijing, 100144 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yuguang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, 1#Shuai fuyuan, Dongcheng District, Beijing, 100730 China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, 1#Shuai fuyuan, Dongcheng District, Beijing, 100730 China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Springerplus</MedlineTA><NlmUniqueID>101597967</NlmUniqueID><ISSNLinking>2193-1801</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Conventional ventilation</Keyword><Keyword MajorTopicYN="N">One lung ventilation</Keyword><Keyword MajorTopicYN="N">Pressure-controlled ventilation</Keyword><Keyword MajorTopicYN="N">Protective ventilation</Keyword><Keyword MajorTopicYN="N">Volume-controlled ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27536534</ArticleId><ArticleId IdType="pmc">PMC4972804</ArticleId><ArticleId IdType="doi">10.1186/s40064-016-2867-0</ArticleId><ArticleId IdType="pii">2867</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al Shehri AM, El-Tahan MR, Al Metwally R, Qutub H, Ghoneimy YF, Regal MA, Zien H. Right ventricular function during one-lung ventilation: effects of pressure-controlled and volume-controlled ventilation. J Cardiothorac Vasc Anesth. 2014;28:892&#x2013;896. doi: 10.1053/j.jvca.2013.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.09.012</ArticleId><ArticleId IdType="pubmed">24447503</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank RS, Colquhoun DA, Durieux ME, Kozower BD, McMurry TL, Bender SP, Naik BI. Management of one-lung ventilation: impact of tidal volume on complications after thoracic surgery. Anesthesiology. 2016;124(6):1286&#x2013;1295. doi: 10.1097/ALN.0000000000001100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001100</ArticleId><ArticleId IdType="pubmed">27011307</ArticleId></ArticleIdList></Reference><Reference><Citation>Boules NS, Ghobrial HZ. Efficiency of the newly introduced ventilatory mode &#x201c;pressure controlled ventilation-volume guaranteed&#x201d; in thoracic surgery with one lung ventilation. Egypt J Anaesth. 2011;27:113&#x2013;119. doi: 10.1016/j.egja.2011.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.egja.2011.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YS, Shim JK, Na S, Hong SB, Hong YW, Oh YJ. Pressure-controlled versus volume-controlled ventilation during one-lung ventilation in the prone position for robot-assisted esophagectomy. Surg Endosc. 2009;23:2286&#x2013;2291. doi: 10.1007/s00464-008-0310-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-008-0310-5</ArticleId><ArticleId IdType="pubmed">19184209</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Rocca G, Coccia C. Acute lung injury in thoracic surgery. Curr Opin Anaesthesiol. 2013;26(1):40&#x2013;46. doi: 10.1097/ACO.0b013e32835c4ea2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e32835c4ea2</ArticleId><ArticleId IdType="pubmed">23235524</ArticleId></ArticleIdList></Reference><Reference><Citation>Guldner A, Kiss T, Serpa Neto A, Hemmes SN, Canet J, Spieth PM, Rocco PR, Schultz MJ, Pelosi P, Gama de Abreu M. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology. 2015;123(3):692&#x2013;713. doi: 10.1097/ALN.0000000000000754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000754</ArticleId><ArticleId IdType="pubmed">26120769</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Shen H, Li X, Chen J. Effects of volume-controlled ventilation and pressure-controlled volume-guaranteed mode during one-lung ventilation on circulation, pulmonary function and lung injury. [Chinese] Zhonghua Yi Xue Za Zhi. 2014;94:1006&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pubmed">24851689</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung JD, Kim SH, Yu BS, Kim HJ. Effects of a preemptive alveolar recruitment strategy on arterial oxygenation during one-lung ventilation with different tidal volumes in patients with normal pulmonary function test. Korean J Anesthesiol. 2014;67:96&#x2013;102. doi: 10.4097/kjae.2014.67.2.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2014.67.2.96</ArticleId><ArticleId IdType="pmc">PMC4166395</ArticleId><ArticleId IdType="pubmed">25237445</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M, de Perrot M, Spiliopoulos A, Robert J, Diaper J, Chevalley C, Tschopp JM. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg. 2003;97(6):1558&#x2013;1565. doi: 10.1213/01.ANE.0000087799.85495.8A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000087799.85495.8A</ArticleId><ArticleId IdType="pubmed">14633519</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin WQ, Lu XY, Cao LH, Wen LL, Bai XH, Zhong ZJ. Effects of the lung protective ventilatory strategy on proinflammatory cytokine release during one-lung ventilation. Chin J Cancer. 2008;27:870&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pubmed">18710624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohser J. Evidence-based management of one-lung ventilation. Anesthesiol Clin. 2008;26(2):241&#x2013;272. doi: 10.1016/j.anclin.2008.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2008.01.011</ArticleId><ArticleId IdType="pubmed">18456211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohser J, Slinger P. Lung injury after one-lung ventilation: a review of the pathophysiologic mechanisms affecting the ventilated and the collapsed lung. Anesth Analg. 2015;121(2):302&#x2013;318. doi: 10.1213/ANE.0000000000000808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000808</ArticleId><ArticleId IdType="pubmed">26197368</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumb AB, Slinger P. Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications. Anesthesiology. 2015;122(4):932&#x2013;946. doi: 10.1097/ALN.0000000000000569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000569</ArticleId><ArticleId IdType="pubmed">25587641</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslow AD, Stafford TS, Davignon KR, Ng T. A randomized comparison of different ventilator strategies during thoracotomy for pulmonary resection. J Thorac Cardiovasc Surg. 2013;146:38&#x2013;44. doi: 10.1016/j.jtcvs.2013.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.01.021</ArticleId><ArticleId IdType="pubmed">23380515</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelet P, D&#x2019;Journo XB, Roch A, Doddoli C, Marin V, Papazian L, Decamps I, Bregeon F, Thomas P, Auffray JP. Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology. 2006;105:911&#x2013;919. doi: 10.1097/00000542-200611000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200611000-00011</ArticleId><ArticleId IdType="pubmed">17065884</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes FR, Pardo DF, Charr&#xed;s H, Tellez LJ, Garz&#xf3;n JC, Osorio C. Comparison of two protective lung ventilatory regimes on oxygenation during one-lung ventilation: a randomized controlled trial. J Cardiothorac Surg. 2010;5:99. doi: 10.1186/1749-8090-5-99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-5-99</ArticleId><ArticleId IdType="pmc">PMC2987929</ArticleId><ArticleId IdType="pubmed">21044330</ArticleId></ArticleIdList></Reference><Reference><Citation>Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol (1985) 2005;98(1):390&#x2013;403. doi: 10.1152/japplphysiol.00733.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00733.2004</ArticleId><ArticleId IdType="pubmed">15591309</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Hemmes SN, Barbas CS, Beiderlinden M, Fernandez-Bustamante A, Futier E, Gajic O, El-Tahan MR, Ghamdi AA, Gunay E, Jaber S, Kokulu S, Kozian A, Licker M, Lin WQ, Maslow AD, Memtsoudis SG, Miranda DR, Moine P, Ng T, Paparella D, Ranieri VM, Scavonetto F, Schilling T, Selmo G, Severgnini P, Sprung J, Sundar S, Talmor D, Treschan T, Unzueta C, Weingarten TN, Wolthuis EK, Wrigge H, Amato MB, Costa EL, de Abreu MG, Pelosi P, Schultz MJ (2016) Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med</Citation><ArticleIdList><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardos PC, Garutti I, Pi&#xf1;eiro P, Olmedilla L, Gala F. Effects of ventilatory mode during one-lung ventilation on intraoperative and postoperative arterial oxygenation in thoracic surgery. J Cardiothorac Vasc Anesth. 2009;23:770&#x2013;774. doi: 10.1053/j.jvca.2009.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2009.06.002</ArticleId><ArticleId IdType="pubmed">19700345</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrucci N, De Feo C. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev. 2013;2:Cd003844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6517299</ArticleId><ArticleId IdType="pubmed">23450544</ArticleId></ArticleIdList></Reference><Reference><Citation>Prospective Register of Ongoing Systematic Reviews. http://www.crd.york.ac.uk/prospero. Accessed 18 June 2015</Citation></Reference><Reference><Citation>Pu J, Liu Z, Yang L, Wang Y, Jiang J. Applications of pressure control ventilation volume guaranteed during one-lung ventilation in thoracic surgery. Int J Clin Exp Med. 2014;7:1094&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057867</ArticleId><ArticleId IdType="pubmed">24955188</ArticleId></ArticleIdList></Reference><Reference><Citation>Qutub H, El-Tahan MR, Mowafi HA, El Ghoneimy YF, Regal MA, Al Saflan AA. Effect of tidal volume on extravascular lung water content during one-lung ventilation for video-assisted thoracoscopic surgery: a randomised, controlled trial. Eur J Anaesthesiol. 2014;31(9):466&#x2013;473. doi: 10.1097/EJA.0000000000000072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000072</ArticleId><ArticleId IdType="pubmed">24690891</ArticleId></ArticleIdList></Reference><Reference><Citation>Roze H, Lafargue M, Perez P, Tafer N, Batoz H, Germain C, Janvier G, Ouattara A. Reducing tidal volume and increasing positive end-expiratory pressure with constant plateau pressure during one-lung ventilation: effect on oxygenation. Br J Anaesth. 2012;108(6):1022&#x2013;1027. doi: 10.1093/bja/aes090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes090</ArticleId><ArticleId IdType="pubmed">22466821</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling T, Kozian A, Huth C, Buhling F, Kretzschmar M, Welte T, Hachenberg T. The pulmonary immune effects of mechanical ventilation in patients undergoing thoracic surgery. Anesth Analg. 2005;101(4):957&#x2013;965. doi: 10.1213/01.ane.0000172112.02902.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000172112.02902.77</ArticleId><ArticleId IdType="pubmed">16192502</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Hemmes SN, Barbas CS, Beiderlinden M, Biehl M, Binnekade JM, Canet J, Fernandez-Bustamante A, Futier E, Gajic O, Hedenstierna G, Hollmann MW, Jaber S, Kozian A, Licker M, Lin WQ, Maslow AD, Memtsoudis SG, Reis Miranda D, Moine P, Ng T, Paparella D, Putensen C, Ranieri M, Scavonetto F, Schilling T, Schmid W, Selmo G, Severgnini P, Sprung J, Sundar S, Talmor D, Treschan T, Unzueta C, Weingarten TN, Wolthuis EK, Wrigge H, Gama de Abreu M, Pelosi P, Schultz MJ. Protective versus conventional ventilation for surgery: a systematic review and individual patient data meta-analysis. Anesthesiology. 2015;123(1):66&#x2013;78. doi: 10.1097/ALN.0000000000000706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000706</ArticleId><ArticleId IdType="pubmed">25978326</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Schultz MJ, Gama de Abreu M. Intraoperative ventilation strategies to prevent postoperative pulmonary complications: systematic review, meta-analysis, and trial sequential analysis. Best Pract Res Clin Anaesthesiol. 2015;29(3):331&#x2013;340. doi: 10.1016/j.bpa.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2015.09.002</ArticleId><ArticleId IdType="pubmed">26643098</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Zhong M, Wu W, Wang H, Feng M, Tan L, Wang Q. The impact of tidal volume on pulmonary complications following minimally invasive esophagectomy: a randomized and controlled study. J Thorac Cardiovasc Surg. 2013;146:1267&#x2013;1274. doi: 10.1016/j.jtcvs.2013.06.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.06.043</ArticleId><ArticleId IdType="pubmed">23993028</ArticleId></ArticleIdList></Reference><Reference><Citation>Song SY, Jung JY, Cho MS, Kim JH, Ryu TH, Kim BI. Volume-controlled versus pressure-controlled ventilation-volume guaranteed mode during one-lung ventilation. Korean J Anesthesiol. 2014;67(4):258&#x2013;263. doi: 10.4097/kjae.2014.67.4.258.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2014.67.4.258</ArticleId><ArticleId IdType="pmc">PMC4216788</ArticleId><ArticleId IdType="pubmed">25368784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungur Ulke Z, Kose B, Camci E, Yavru A, Koltka K, Toker A, Dilge S, Senturk M. Effects of lower tidal volumes on oxygenation during one-lung ventilation. Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi. 2011;17:5&#x2013;11.</Citation></Reference><Reference><Citation>Tugrul M, Camci E, Karadeniz H, Senturk M, Pembeci K, Akpir K. Comparison of volume controlled with pressure controlled ventilation during one-lung anaesthesia. Br J Anaesth. 1997;79(3):306&#x2013;310. doi: 10.1093/bja/79.3.306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/79.3.306</ArticleId><ArticleId IdType="pubmed">9389846</ArticleId></ArticleIdList></Reference><Reference><Citation>Unzueta MC, Casas JI, Moral MV. Pressure-controlled versus volume-controlled ventilation during one-lung ventilation for thoracic surgery. Anesth Analg. 2007;104:1029&#x2013;1033. doi: 10.1213/01.ane.0000260313.63893.2f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000260313.63893.2f</ArticleId><ArticleId IdType="pubmed">17456648</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe9;gh T, Juh&#xe1;sz M, Szatm&#xe1;ri S, Enyedi A, Sessler DI, Szegedi LL, F&#xfc;lesdi B. Effects of different tidal volumes for one-lung ventilation on oxygenation with open chest condition and surgical manipulation: a randomised cross-over trial. Minerva Anestesiol. 2013;79:24&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">23135690</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Ahn HJ, Kim K, Kim JA, Yi CA, Kim MJ, Kim HJ. Does a protective ventilation strategy reduce the risk of pulmonary complications after lung cancer surgery?: a randomized controlled trial. Chest. 2011;139:530&#x2013;537. doi: 10.1378/chest.09-2293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-2293</ArticleId><ArticleId IdType="pubmed">20829341</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye FF, Li LW. Effects of different ventilation modes for one-lung ventilation anesthesia on respiratory function and F(A)/F(I) changes during sevoflurane inhalation. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(4):714&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pubmed">21515479</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23450544</PMID><DateCompleted><Year>2013</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2013</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Lung protective ventilation strategy for the acute respiratory distress syndrome.</ArticleTitle><Pagination><StartPage>CD003844</StartPage><MedlinePgn>CD003844</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD003844</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD003844.pub4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with acute respiratory distress syndrome and acute lung injury require mechanical ventilatory support. Acute respiratory distress syndrome and acute lung injury are further complicated by ventilator-induced lung injury. Lung protective ventilation strategies may lead to improved survival. This systematic review is an update of a Cochrane review originally published in 2003 and updated in 2007.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the effects of ventilation with lower tidal volume on morbidity and mortality in patients aged 16 years or older affected by acute respiratory distress syndrome and acute lung injury. A secondary objective was to determine whether the comparison between low and conventional tidal volume was different if a plateau airway pressure of greater than 30 to 35 cm H20 was used.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">In our previous 2007 updated review, we searched databases from inception until 2006. In this third updated review, we searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL and the Web of Science from 2006 to September 2012. We also updated our search of databases of ongoing research and of reference lists from 2006 to September 2012.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We included randomized controlled trials comparing ventilation using either a lower tidal volume (Vt) or low airway driving pressure (plateau pressure 30 cm H2O or less), resulting in a tidal volume of 7 ml/kg or less, versus ventilation that used Vt in the range of 10 to 15 ml/kg in adults (16 years old or older) with acute respiratory distress syndrome and acute lung injury.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">We independently assessed trial quality and extracted data. Wherever appropriate, results were pooled. We applied fixed-effect and random-effects models.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We did not find any new study which were eligible for inclusion in this update. The total number of studies remained unchanged, six trials involving 1297 patients. Five trials had a low risk of bias. One trial had an unclear risk of bias. Mortality at day 28 was significantly reduced by lung-protective ventilation with a relative risk (RR) of 0.74 (95% confidence interval (CI) 0.61 to 0.88); hospital mortality was reduced with a RR of 0.80 (95% CI 0.69 to 0.92). Overall mortality was not significantly different if a plateau pressure less than or equal to 31 cm H2O in the control group was used (RR 1.13, 95% CI 0.88 to 1.45). There was insufficient evidence for morbidity and long-term outcomes.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical heterogeneity, such as different lengths of follow up and higher plateau pressure in control arms in two trials, makes the interpretation of the combined results difficult. Mortality was significantly reduced at day 28 and at the end of the hospital stay. The effects on long-term mortality are unknown, although the possibility of a clinically relevant benefit cannot be excluded. Ventilation with lower tidal volumes is becoming a routine strategy of treatment of acute respiratory distress syndrome and acute lung injury, stopping investigators from carrying out additional trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petrucci</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Azienda Ospedaliera Desenzano, Desenzano, Italy.nicola.petrucci.1@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Feo</LastName><ForeName>Carlo</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003844. doi: 10.1002/14651858.CD003844.pub3.</RefSource><PMID Version="1">17636739</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D055371" MajorTopicYN="N">Acute Lung Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None known</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>2</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23450544</ArticleId><ArticleId IdType="pmc">PMC6517299</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD003844.pub4</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Amato 1998 {published data only}</Title><Reference><Citation>Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Paula Pinto Schettino G, et al. Effect of a protective&#x2010;ventilation strategy on mortality in the acute respiratory distress syndrome. New England Journal of Medicine 1998;338:347&#x2010;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">9449727</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ARDS Network 2000 {published data only}</Title><Reference><Citation>The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New England Journal of Medicine 2000;342:1301&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10793162</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brochard 1998 {published data only}</Title><Reference><Citation>Brochard L, Roudot&#x2010;Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez&#x2010;Mondejar E, et al. Tidal volume reduction for prevention of ventilator induced lung injury in acute respiratory distress syndrome. The multicenter trial group on tidal volume reduction in ARDS. American Journal of Respiratory and Critical Care Medicine 1998;158:1831&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9847275</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brower 1999 {published data only}</Title><Reference><Citation>Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P Jr, Wiener CM, et al. Prospective, randomized controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Critical Care Medicine 1999;27:1492&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10470755</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stewart 1998 {published data only}</Title><Reference><Citation>Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, et al. Evaluation of a ventilation strategy to prevent barotrauma in patient at high risk for acute respiratory distress syndrome. Pressure and volume limited ventilation strategy group. New England Journal of Medicine 1998;338:355&#x2010;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">9449728</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Villar 2006 {published data only}</Title><Reference><Citation>Villar J, Kacmarek RM, Perez&#x2010;Mendez L, Aguirre&#x2010;Jaime A. A high positive end&#x2010;expiration pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Critical Care Medicine 2006;34(5):1311&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16557151</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Brower 2004 {published data only}</Title><Reference><Citation>Brower RG, Lanken PN, MacIntyre N. Higher versus lower positive end&#x2010;expiratory pressures in patients with the acute respiratory distress syndrome. New England Journal of Medicine 2004;351:327&#x2010;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">15269312</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Esteban 2000 {published data only}</Title><Reference><Citation>Esteban A, Alia I, Gordo F, Pablo R, Suarez J, Gonzales G, et al. Prospective randomized trial comparing pressure&#x2010;controlled ventilation and volume&#x2010;controlled ventilation in ARDS. For the Spanish Lung Failure Collaborative Group. Chest 2000;117:1690&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10858404</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meade 2008 {published data only}</Title><Reference><Citation>Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end&#x2010;expiratory pressure for acute lung injury and acute respiratory distress syndrome. JAMA 2008;299(6):637&#x2010;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">18270352</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mercat 2008 {published data only}</Title><Reference><Citation>Mercat A, Richard JCM, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end&#x2010;expiratory pressure setting in adult with acute lung injury and acute respiratory distress syndrome. JAMA 2008;299(6):646&#x2010;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18270353</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ranieri 1999 {published data only}</Title><Reference><Citation>Ranieri VM, Suter PM, Tortorella C, Tullio R, Dayer JM, Brienza A, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. JAMA 1999;282:54&#x2010;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">10404912</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rappaport 1994 {published data only}</Title><Reference><Citation>Rappaport SH, Shpiner R, Yoshihara G, Wright J, Chang P, Abraham E. Randomized, prospective trial of pressure&#x2010;limited versus volume&#x2010;controlled ventilation in severe respiratory failure. Critical Care Medicine 1994;22:22&#x2010;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">8124968</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Artigas 1998</Title><Reference><Citation>Artigas A, Bernard GR, Carlet J. The American&#x2010;European Consensus Conference on ARDS, Part 2. Intensive Care Medicine 1998;24:378&#x2010;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">9609420</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bernard 1994</Title><Reference><Citation>Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American&#x2010;European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine 1994;149:818&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">7509706</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cooper 1999</Title><Reference><Citation>Cooper AB, Ferguson ND, Hanly PJ, Meade MO, Kachura JR, Granton JT, et al. Long&#x2010;term follow up of survivors of acute lung injury: lack of effect of a ventilation strategy to prevent barotrauma. Critical Care Medicine 1999;27:2616&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10628599</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Davidson 1999</Title><Reference><Citation>Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically control patients. JAMA 1999;281:354&#x2010;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">9929089</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Deeks 2001</Title><Reference><Citation>Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta&#x2010;analysis. In: Egger M, Smith GD, Altman DG editor(s). Systematc Reviews. London: BMJ Books, 2001:285&#x2010;312.</Citation></Reference></ReferenceList><ReferenceList><Title>Dowdy 2006</Title><Reference><Citation>Dowdy DW, Eid MP, Dennison CR, Mendez&#x2010;Tellez PA, Herridge MS, Guallar E, et al. Quality of life after acute respiratory distress syndrome: a meta&#x2010;analysis. Intensive Care Medicine 2006;32:1115&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">16783553</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dreyfuss 1998</Title><Reference><Citation>Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume and positive end&#x2010;expiratory pressure. American Review of Respiratory Diseases 1998;137:1159&#x2010;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">3057957</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Eichacker 2002</Title><Reference><Citation>Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C. Meta&#x2010;analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. American Journal of Respiratory and Critical Care Medicine 2002;166:1510&#x2010;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12406836</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Esteban 2008</Title><Reference><Citation>Esteban A, Ferguson ND, Meade MO, Frutos&#x2010;Vivar F, Apezteguia C, Brochard L, et al. Evolution of mechanical ventilation in response to clinical research. American Journal of Respiratory and Critical Care Medicine 2008;177:170&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17962636</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Feihl 1994</Title><Reference><Citation>Feihl F, Perret C. Permissive hypercapnia: how permissive should we be?. American Journal of Respiratory and Critical Care Medicine 1994;150:1722&#x2010;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">7952641</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Frutos&#x2010;Vivar 2004</Title><Reference><Citation>Frutos&#x2010;Vivar F, Nin N, Esteban A. Epidemiology of acute lung injury and acute respiratory distress syndrome. Current Opinion in Critical Care 2004;10:1&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15166842</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gattinoni 1995</Title><Reference><Citation>Gattinoni L, Pelosi P, Crotti S, Valenza F. Effects of positive end&#x2010;expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 1995;151:1807&#x2010;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">7767524</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gattinoni 2002</Title><Reference><Citation>Gattinoni L, Chiumello D, Russo R. Reduced tidal volumes and lung protective ventilatory strategy: where do we go from here?. Current Opinion in Critical Care 2002;8:45&#x2010;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">12205406</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hickling 1990</Title><Reference><Citation>Hickling KG, Henderson SJ, Jackson R. Low mortality associated with volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Medicine 1990;16:372&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2246418</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hickling 1994</Title><Reference><Citation>Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low&#x2010;volume, pressure limited ventilation with permissive hypercapnia: a prospective study. Critical Care Medicine 1994;22:1568&#x2010;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">7924367</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2002</Title><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta&#x2010;analysis. Statistics in Medicine 2002;21:1539&#x2010;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Knaus 1985</Title><Reference><Citation>Knaus WA, Wagner DP, Draper EA, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985;13:818&#x2010;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Knaus 1991</Title><Reference><Citation>Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619&#x2010;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">1959406</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marini 1990</Title><Reference><Citation>Marini JJ. Lung mechanics in the adult respiratory distress syndrome. Clinical Chest Medicine 1990;11:673&#x2010;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">2268995</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Monchi 1998</Title><Reference><Citation>Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. American Journal of Respiratory and Critical Care Medicine 1998;158:1076&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">9769263</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Murray 1988</Title><Reference><Citation>Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. American Review of Respiratory Diseases 1988;138:720&#x2010;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3202424</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Orme 2003</Title><Reference><Citation>Orme J, Romney JS, Hopkins RO, Pope D, Chan KJ, Thomsen G, et al. Pulmonary function and health related quality of life in survivors of ARDS. American Journal of Respiratory and Critical Care Medicine 2003;167:690&#x2010;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12493646</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrucci 2003</Title><Reference><Citation>Petrucci N. Tidal volumes in ARDS and meta&#x2010;analysis. American Journal of Respiratory and Critical Care Medicine 2003;167:935&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12653110</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ranieri 1997</Title><Reference><Citation>Ranieri VM, Brienza N, Santostasi S, Puntillo F, Mascia L. Impairment of lung and chest wall mechanics in patients with acute respiratory distress syndrome. Role of abdominal distension. American Journal of Respiratory and Critical Care Medicine 1997;156:1082&#x2010;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">9351606</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ranieri 2012</Title><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012;307(23):2526&#x2010;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Roupie 1999</Title><Reference><Citation>Roupie E, Lepage E, Wysocki M, Fagon JY, Chastre J, Dreyfuss D, et al. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. SRLF Collaborative group on mechanical ventilation. Societe de Reanimation de Langue Francaise. Intensive Care Medicine 1999;25:920&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10501746</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Petrucci 2004a</Title><Reference><Citation>Petrucci N, Iacovelli W. Ventilation with lower tidal volume versus traditional tidal volumes in adult for acute lung injury and acute respiratory distress syndrome. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003844]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003844</ArticleId><ArticleId IdType="pubmed">15106222</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrucci 2004b</Title><Reference><Citation>Petrucci N, Iacovelli W. Ventilation with lower tidal volume. A quantitative systematic review of randomized controlled trials. Anesthesia and Analgesia 2004;99:193&#x2010;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">15281529</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrucci 2004c</Title><Reference><Citation>Petrucci N, Icovelli W. Ventilation with lower tidal volume versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003844.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003844.pub2</ArticleId><ArticleId IdType="pubmed">15106222</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Petrucci 2007</Title><Reference><Citation>Petrucci N, Iacovelli W. Lung protection ventilation strategy for the acute respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003844.pub3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003844.pub3</ArticleId><ArticleId IdType="pubmed">17636739</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39097491</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4898</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of pediatric urology</Title><ISOAbbreviation>J Pediatr Urol</ISOAbbreviation></Journal><ArticleTitle>The value of home-uroflowmetry in evaluation of voiding function in children with overactive bladder.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>295</EndPage><MedlinePgn>289-295</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpurol.2024.07.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1477-5131(24)00363-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Overactive bladder (OAB) in children is clinically common and seriously affects the physical and mental health of children. The voiding frequency (VF) is an important basis for the diagnosis of OAB. The emergence of home-uroflowmetry (HUF) has allowed the patients to record the VF while recording the uroflowmetry at home, and the voiding at home can show the real voiding situation. However, the use of HUF to assess OAB in children and its clinical significance has not been reported in the literature. Thus, this study investigate the value of HUF in evaluation of voiding function in children with OAB and survey the VF of healthy children in Mainland China.</AbstractText><AbstractText Label="MATERIALS AND METHODS">From May 2021 to July 2023, 52 children with OAB aged 7-10 years, 48 age-matched volunteers (control group) accepted HUF. Daytime VF and nighttime VF, voided volume (VV) per time, 24-h voided volume (24h-VV), maximum flow rate (Qmax), voiding time (VT), and uroflow pattern were recorded and compute corrected maximum urine flow rate (cQmax). VF in 600 health pupils (7-10 years) from five primary schools in Henan Province China were selected for questionnaire survey by cross-sectional survey and multi-stage sampling methods.</AbstractText><AbstractText Label="RESULTS">52 children with OAB and 48 healthy children completed the available 48-h HUF recordings. 24-hour, daytime, and nighttime VF, and cQmax were higher in the OAB group than in the control group (P&#xa0;&lt;&#xa0;0.05). However, average VV, Qmax, and VT were lower in the OAB group than in the control group (P&#xa0;&lt;&#xa0;0.05). There was no significant difference in 24h-VV between two groups (P&#xa0;&gt;&#xa0;0.05). A total of 502 questionnaires qualified for statistical analysis, and the 24h-VF was 6.3&#xa0;&#xb1;&#xa0;0.95 times, daytime VF was 5.6&#xa0;&#xb1;&#xa0;0.89 times, and nighttime VF was 0.7&#xa0;&#xb1;&#xa0;0.59 times. There was no significant difference in the comparison of 24-h, daytime, and nighttime VF between boys and girls and in the comparison of VF by age (P&#xa0;&gt;&#xa0;0.05). Compared with the results of the questionnaire, the difference of VF in HUF control group was not statistically significant (P&#xa0;&gt;&#xa0;0.05).</AbstractText><AbstractText Label="CONCLUSIONS">The VF in children is similar to that of adults and the HUF is a useful tool with the ability to more realistically record changes in voiding function in children with OAB.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Paediatric Urodynamic Centre and Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan 450052, China; Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhaokai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Paediatric Urodynamic Centre and Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan 450052, China; Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Zhengzhou University Surgical Reception Centre, Henan 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Qingsong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Yibo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Paediatric Urodynamic Centre and Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan 450052, China; Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xingchen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China; Department of Gynecology, Xinyang Central Hospital, Xinyang 464000, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Paediatric Urodynamic Centre and Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan 450052, China; Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Paediatric Urodynamic Centre and Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan 450052, China; Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jinhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangzhou Women and Children's Medical Center, Guangzhou 510000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>Israel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Urology, Section of Pediatric Urology, Yale University, New Haven, CT 06520 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamperis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Adolescent Health, Aarhus University Hospital, Palle Juul-Jensens Blvd. 99, 8200 Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rittig</LastName><ForeName>S&#xf8;ren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Adolescent Health, Aarhus University Hospital, Palle Juul-Jensens Blvd. 99, 8200 Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qingwei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Paediatric Urodynamic Centre and Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan 450052, China; Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Jian Guo</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Paediatric Urodynamic Centre and Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan 450052, China; Henan Joint International Paediatric Urodynamic Laboratory, Henan 450052, China. Electronic address: wenjg@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Pediatr Urol</MedlineTA><NlmUniqueID>101233150</NlmUniqueID><ISSNLinking>1477-5131</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053201" MajorTopicYN="Y">Urinary Bladder, Overactive</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014563" MajorTopicYN="Y">Urodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014554" MajorTopicYN="Y">Urination</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012212" MajorTopicYN="Y">Rheology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Home-uroflowmetry</Keyword><Keyword MajorTopicYN="N">Overactive bladder</Keyword><Keyword MajorTopicYN="N">Qmax</Keyword><Keyword MajorTopicYN="N">Voiding frequency</Keyword></KeywordList><CoiStatement>Conflict of interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>16</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>4</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>3</Day><Hour>21</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39097491</ArticleId><ArticleId IdType="doi">10.1016/j.jpurol.2024.07.007</ArticleId><ArticleId IdType="pii">S1477-5131(24)00363-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30089564</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Early Versus Late Referral for Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease: A Systematic Review and Meta-Analysis of Clinical Outcomes.</ArticleTitle><Pagination><StartPage>374</StartPage><EndPage>382</EndPage><MedlinePgn>374-382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2017.12.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(17)31250-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This was a meta-analysis of published studies to examine the impact of early referral on outcomes after catheter ablation for ventricular tachycardia (VT) in patients with structural heart disease.</AbstractText><AbstractText Label="BACKGROUND">Patients are frequently referred for VT ablation after failure of antiarrhythmic drugs to control VT. Some studies have suggested that early referral might confer better outcomes.</AbstractText><AbstractText Label="METHODS">An electronic search was performed using major databases. The primary outcomes were long-term VT recurrence and total mortality. Secondary outcomes were acute procedural success and acute complications.</AbstractText><AbstractText Label="RESULTS">Three studies were included with a total of 980 patients (mean age 64 &#xb1; 12 years, 71% males). Mean follow-up was 29 &#xb1; 27 months. Early referral for VT ablation was associated with decreased VT recurrence and acute complications compared with late referral (relative risk: 0.69 [95% confidence interval: 0.58 to 0.82], p&#xa0;&lt; 0.0001 and relative risk: 0.50 [95% confidence interval: 0.27 to 0.93], p&#xa0;= 0.03, respectively). There was no significant difference between early and late referral for total mortality and acute success.</AbstractText><AbstractText Label="CONCLUSIONS">Late referral for VT ablation was associated with worse outcomes (VT recurrence and acute complications)&#xa0;in patients with structural heart disease, which suggests that early referral for VT ablation might be a reasonable consideration in this patient population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 American College of Cardiology Foundation. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quispe</LastName><ForeName>Renato</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Xianfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ningbo First Hospital, Zhejiang Sheng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briceno</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avendano</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedrow</LastName><ForeName>Usha</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital Heart &amp; Vascular Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Roy M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaud</LastName><ForeName>Gregory F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>William G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital Heart &amp; Vascular Center, Harvard Medical School, Boston, Massachusetts; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital Heart &amp; Vascular Center, Harvard Medical School, Boston, Massachusetts; Department of Cardiology, Westmead Hospital, Westmead Applied Research Centre, University of Sydney, Westmead, New South Wales, Australia. Electronic address: saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2018 Mar;4(3):383-385. doi: 10.1016/j.jacep.2018.01.002.</RefSource><PMID Version="1">30089565</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VT recurrence</Keyword><Keyword MajorTopicYN="N">acute complications</Keyword><Keyword MajorTopicYN="N">antiarrhythmic drugs</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">early referral</Keyword><Keyword MajorTopicYN="N">ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">nonischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30089564</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2017.12.008</ArticleId><ArticleId IdType="pii">S2405-500X(17)31250-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29655948</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>267</Volume><PubDate><Year>2018</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>113</EndPage><MedlinePgn>107-113</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2018.03.127</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(17)36660-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Current ventricular tachycardia (VT) management in patients with ischemic cardiomyopathy (ICM) includes optimal medical therapy, ICDs device therapy, and antiarrhythmic medications. Data about outcomes of catheter ablation (CA) in these patients is scarce. We aimed to perform a meta-analysis of RCTs to compare outcomes of CA vs conventional management of VT in ICM patients who had ICD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis of published RCTs between January 1970 and December 2016 were performed. Random effects DerSimonian-Laird risk ratios (RR) were calculated. Sensitivity analyses using fixed-effects summary odds ratios (OR) were performed using Peto model. Outcomes of interest were: all-cause mortality (ACM), cardiovascular death (CVD), CV disease-related hospitalization, VT storms, and ICD shocks.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">4 RCTs were identified (521 patients (261 had CA), mean age: 66.4&#x202f;&#xb1;&#x202f;1.7&#x202f;years, 91.5% male, mean follow-up: 19&#x202f;months). No difference observed between VT ablation and conventional management regarding ACM (RR 0.94, 95% CI, 0.66-1.32, p&#x202f;=&#x202f;0.70) or CVD (RR 0.82, 95% CI, 0.52-1.29, p&#x202f;=&#x202f;0.39). VT ablation was associated with less CV disease-related hospitalization (RR 0.72, 95% CI, 0.54-0.96, p&#x202f;=&#x202f;0.02), VT storms (RR 0.71, 95% CI, 0.52-0.97, p&#x202f;=&#x202f;0.03), and trend towards reducing ICD shocks (RR 0.59, 95% CI, 0.34-1.05, p&#x202f;=&#x202f;0.07). In sensitivity analysis using fixed-effects OR, CA was associated with significant reduction in ICD shocks.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In patients with ICM, VT ablation reduced CV disease-related hospitalization, VT storms, and ICD shocks when compared to conventional management with no mortality benefit over a relatively short mean follow-up period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maskoun</LastName><ForeName>Waddah</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Henry Ford Health System, Detroit, MI, United States. Electronic address: wmaskou1@hfhs.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saad</LastName><ForeName>Marwan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States; Division of Cardiovascular Medicine, Ain Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abualsuod</LastName><ForeName>Amjad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nairooz</LastName><ForeName>Ramez</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Southern California, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Indiana University Health, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Cardiol. 2018 Sep 15;267:118-119. doi: 10.1016/j.ijcard.2018.05.125.</RefSource><PMID Version="1">29885831</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">Ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29655948</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2018.03.127</ArticleId><ArticleId IdType="pii">S0167-5273(17)36660-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32948937</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>603</StartPage><EndPage>616</EndPage><MedlinePgn>603-616</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-020-00870-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Ventricular tachycardia (VT) is a frequent cause of mortality and morbidity in patients with ischemic heart disease (IHD). We aim to perform a systematic review and meta-analysis of randomized controlled trials (RCT) of radiofrequency catheter ablation (RCA) of VT in patients with IHD and to discuss its appropriate timing and limitations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature searches of MEDLINE, CENTRAL, the Cochrane Database of Systematic Reviews, Health Technology Assessment, and PsycINFO were performed in February 2020. RCTs comparing RCA vs conventional management for VT in patients with IHD and previous or planned implantable cardioverter defibrillator (ICD) were identified. Clinical outcomes included all-cause mortality, cardiovascular mortality, cardiovascular hospitalization, VT storm, recurrent VT/ventricular fibrillation (VF), appropriate ICD therapies, and appropriate ICD shocks. Using a random-effects model, relative risk (RR) and 95% confidence intervals (CI) were calculated for each outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 6 RCTs (N&#xa0;=&#x2009;791) met inclusion criteria. RCA was associated with significantly lower VT storm (RR 0.70; CI<sub>95%</sub> 0.51 to 0.94, p&#xa0;=&#x2009;0.02) and appropriate ICD therapies (RR 0.69; CI<sub>95%</sub> 0.54 to 0.88, p&#xa0;=&#x2009;0.003), including appropriate ICD shocks (RR 0.66; CI<sub>95%</sub> 0.47 to 0.92, p&#xa0;=&#x2009;0.02). There was no significant difference in all-cause or cardiovascular mortality, cardiovascular hospitalization, and recurrent VT/VF.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Radiofrequency catheter ablation for VT in patients with IHD was associated with a reduced risk of VT storm, ICD therapies, and ICD shocks. There is a need for future carefully designed RCTs that incorporate improved RCA procedural aspects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lima da Silva</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3138-8354</Identifier><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, CHULN Hospital de Santa Maria, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal. gustavolssilva@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiac Rhythm Abnormalities Unit, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Universidade de Lisboa, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal. gustavolssilva@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nunes-Ferreira</LastName><ForeName>Afonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, CHULN Hospital de Santa Maria, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Pharmacology and Therapeutics Unit, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Universidade de Lisboa, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortez-Dias</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, CHULN Hospital de Santa Maria, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiac Rhythm Abnormalities Unit, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Universidade de Lisboa, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sousa</LastName><ForeName>Jo&#xe3;o</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, CHULN Hospital de Santa Maria, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiac Rhythm Abnormalities Unit, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Universidade de Lisboa, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J Pinto</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, CHULN Hospital de Santa Maria, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiac Rhythm Abnormalities Unit, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Universidade de Lisboa, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Pharmacology and Therapeutics Unit, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Universidade de Lisboa, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldeira</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, CHULN Hospital de Santa Maria, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Pharmacology and Therapeutics Unit, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Universidade de Lisboa, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Av Prof. Egas Moniz, 1649-028, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="N">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Ischemic heart disease</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>19</Day><Hour>5</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32948937</ArticleId><ArticleId IdType="doi">10.1007/s10840-020-00870-3</ArticleId><ArticleId IdType="pii">10.1007/s10840-020-00870-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30089555</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Multicenter Study of Ischemic Ventricular&#xa0;Tachycardia Ablation With&#xa0;Decrement-Evoked Potential (DEEP)&#xa0;Mapping With Extra Stimulus.</ArticleTitle><Pagination><StartPage>307</StartPage><EndPage>315</EndPage><MedlinePgn>307-315</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2017.12.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(17)31242-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The authors conducted a multicenter study of decrement-evoked potential (DEEP)-based functional ventricular tachycardia (VT) substrate modification to evaluate if such a mechanistic and physiological strategy is feasible and efficient in clinical practice and provides reduction in the VT burden.</AbstractText><AbstractText Label="BACKGROUND">Only a fraction of the myocardium targeted in current VT substrate modification procedures is involved in the initiation and perpetuation of VT. The physiological basis of the DEEP strategy for identification of areas of initiation and maintenance of VT was recently established.</AbstractText><AbstractText Label="METHODS">We included 20 consecutive patients with ischemic cardiomyopathy. During substrate mapping, fractionated and late potentials (LPs) were tagged, and an extra stimulus was performed to determine which LPs displayed decrement&#xa0;(DEEPs). All patients underwent DEEP-focused ablation: elimination of DEEP&#xa0;+ further radiofrequency (RF) if VT was still inducible. Patients were followed during 6 months.</AbstractText><AbstractText Label="RESULTS">Patients were predominantly male (95%), and their mean age was 64.6 &#xb1; 17.1 years. Mean left ventricular ejection fraction was 33.4 &#xb1; 11.4%. Mean ablation time was 30.6 &#xb1; 20.4 min. Specificity of DEEPs&#xa0;to detect the isthmus of VT was better than that of LPs (0.97 [95% confidence interval [CI]: 0.95 to 0.98] vs. 0.82 [95% CI: 0.73 to 0.89]), without significant differences in terms of sensitivity (0.61 [95% CI: 0.52 to 0.69] vs. 0.60&#xa0;[95% CI: 0.44 to 0.74], respectively). Fifteen of 20 (75%) patients were free of any VT after DEEP-RF at 6 months of follow-up and there was a strong reduction in VT burden compared to 6 months pre-ablation.</AbstractText><AbstractText Label="CONCLUSIONS">In a multicenter prospective study, DEEP substrate mapping identified the functional substrate critical to the VT circuit with high specificity. DEEP-guided VT ablation, by its physiological nature, may enable greater access&#xa0;to&#xa0;focused ablation therapy for patients requiring VT treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Porta-S&#xe1;nchez</LastName><ForeName>Andreu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Department de Medicina, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>John Hunter Hospital, Newcastle, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukac</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>&#xc5;rhus University Hospital, Skejby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kristiansen</LastName><ForeName>Steen Buus</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>&#xc5;rhus University Hospital, Skejby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Jan Moller</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>&#xc5;rhus University Hospital, Skejby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gizurarson</LastName><ForeName>Sigfus</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mass&#xe9;</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labos</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>McGill University, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viswanathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Andrew C T</ForeName><Initials>ACT</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Downar</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanthakumar</LastName><ForeName>Kumaraswamy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada. Electronic address: kumar.nanthakumar@uhn.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2018 Mar;4(3):328-330. doi: 10.1016/j.jacep.2018.02.004.</RefSource><PMID Version="1">30089557</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025321" MajorTopicYN="N">Surgery, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">mapping</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">nonischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">substrate ablation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30089555</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2017.12.005</ArticleId><ArticleId IdType="pii">S2405-500X(17)31242-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34732114</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-5453</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Current drug metabolism</Title><ISOAbbreviation>Curr Drug Metab</ISOAbbreviation></Journal><ArticleTitle>Comparison of Intra and Post-operative Sedation Efficacy of Dexmedetomidinemidazolam and Dexmedetomidine-propofol for Major Abdominal Surgery.</ArticleTitle><Pagination><StartPage>45</StartPage><EndPage>56</EndPage><MedlinePgn>45-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1389200222666211103121832</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effectiveness and side effects of dexmedetomidine (DEX) in combination with midazolam and propofol have not been comparatively studied in a single clinical trial as sedative agents to general anesthesia before.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study is to compare intra and post-operative sedation between DEX-Midazolam and DEX-Propofol in patients who underwent major abdominal surgery on the duration of general anesthesia, hemodynamic and sedation effect.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">This prospective, randomized, double-blinded clinical trial included 50 patients who were 20 to 60 years of age and admitted for major abdominal surgery. The patients were randomly assigned by a computer-generated random numbers table to sedation with DEX plus midazolam (DM group) (n=25) or DEX plus propofol (DP group) (n=25). In the DM group, patients received a bolus dose of 0.1 mg/kg of midazolam and immediately initiated the intravenous (i.v.) infusion of DEX 1 &#x3bc;g/kg over a 10 min and 0.5 &#x3bc;g/kg/hr by continuous i.v. infusion within operation period. In the DP group, patients received pre-anesthetic i.v. DEX 1 &#x3bc;g/kg over 15 min before anesthesia induction and 0.2-1 &#x3bc;g/kg/hr by continuous i.v. infusion during the operative period. After preoxygenation for at least 2 min, during the surgery, patients received propofol infusion dose of 250 &#x3bc;g/kg/min for 15 min then a basal infusion dose of 50 &#x3bc;g/kg/min. The bispectral index (BIS) value, as well as mean arterial pressure (MAP), heart rate (HR), respiratory rate (RR), oxygen saturation (SaO2), percutaneous arterial oxygen saturation (SpO2) and end-tidal carbon dioxide tension (ETCO2) were recorded before anesthesia (T0), during anesthesia (at 15-min intervals throughout the surgical procedure), by a blinded observer. Evidence of apnea, hypotension, hypertension and hypoxemia were recorded during surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The hemodynamic changes, including HR, MAP, BIS, VT, SaO<sub>2</sub>, and RR had a downward tendency with time, but no significant difference was observed between the groups (P&gt;0.05). However, the two groups showed no significant differences in ETCO2 and SPO<sub>2</sub> values in any of the assessed interval (P&gt;0.05). In this study, the two groups showed no significant differences in the incidence of nausea, vomiting, coughing, apnea, hypotension, hypertension, bradycardia and hypoxemia (P&gt;0.05). Respiratory depression and serious adverse events were not reported in either group. Extubation time after surgery was respectively 6.3 &#xb1; 1.7 and 5.8 &#xb1; 1.4 hr. in the DM and DP groups and the difference was not statistically significant (P= 0.46).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study showed no significant differences between the groups in hemodynamic and respiratory changes in each of the time intervals. There were also no significant differences between the two groups in the incidence of complication intra and post-operative. Further investigations are required to specify the optimum doses of using drugs which provide safety in cardiovascular and respiratory system without adverse disturbance during surgery.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the Second Hospital of Yulin, Yulin, Shanxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the Hospital of Traditional Chinese Medicine of Yulin, Yulin, Shanxi Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019SF-154</GrantID><Agency>Science and Technology Development of Shaanxi Province, China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Drug Metab</MedlineTA><NlmUniqueID>100960533</NlmUniqueID><ISSNLinking>1389-2002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>R60L0SM5BC</RegistryNumber><NameOfSubstance UI="D008874">Midazolam</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001049" MajorTopicYN="N">Apnea</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008874" MajorTopicYN="N">Midazolam</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dexmedetomidine</Keyword><Keyword MajorTopicYN="N">abdominal surgery</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">midazolam</Keyword><Keyword MajorTopicYN="N">propofol</Keyword><Keyword MajorTopicYN="N">sedation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34732114</ArticleId><ArticleId IdType="doi">10.2174/1389200222666211103121832</ArticleId><ArticleId IdType="pii">CDM-EPUB-118671</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28069835</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study.</ArticleTitle><Pagination><StartPage>512</StartPage><EndPage>519</EndPage><MedlinePgn>512-519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euw406</ELocationID><Abstract><AbstractText Label="AIMS">Ventricular tachycardia (VT) substrate ablation is based on detailed electroanatomical maps (EAM). This study analyses whether high-density multielectrode mapping (MEM) is superior to conventional point-by-point mapping (PPM) in guiding VT substrate ablation procedures.</AbstractText><AbstractText Label="METHODS AND RESULTS">This was a randomized controlled study (NCT02083016). Twenty consecutive ischemic patients undergoing VT substrate ablation were randomized to either group A [n&#x2009;=&#x2009;10; substrate mapping performed first by PPM (Navistar) and secondly by MEM (PentaRay) ablation guided by PPM] or group B [n&#x2009;=&#x2009;10; substrate mapping performed first by MEM and second by PPM ablation guided by MEM]. Ablation was performed according to the scar-dechanneling technique. Late potential (LP) pairs were defined as a Navistar-LP and a PentaRay-LP located within a three-dimensional distance of&#x2009;&#x2264;&#x2009;3&#x2009;mm. Data obtained from EAM, procedure time, radiofrequency time, and post-ablation VT inducibility were compared between groups. Larger bipolar scar areas were obtained with MEM (55.7&#xb1;31.7 vs. 50.5&#xb1;26.6&#x2009;cm2; P&#x2009;=&#x2009;0.017). Substrate mapping time was similar with MEM (19.7&#xb1;7.9&#x2009;minutes) and PPM (25&#xb1;9.2&#x2009;minutes); P&#x2009;=&#x2009;0.222. No differences were observed in the number of LPs identified within the scar by MEM vs. PPM (73&#xb1;50 vs. 76&#xb1;52 LPs per patient, respectively; P&#x2009;=&#x2009;0.965). A total of 1104 LP pairs were analysed. Using PentaRay, far-field/LP ratio was significantly lower (0.58&#xb1;0.4 vs. 1.64&#xb1;1.1; P&#x2009;=&#x2009;0.01) and radiofrequency time was shorter [median (interquartile range) 12 (7-20) vs. 22 (17-33) minutes; P&#x2009;=&#x2009;0.023]. No differences were observed in VT inducibility after procedure.</AbstractText><AbstractText Label="CONCLUSION">MEM with PentaRay catheter provided better discrimination of LPs due to a lower sensitivity for far-field signals. Ablation guided by MEM was associated with a shorter radiofrequency time.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penela</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreu</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlosena</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassanelli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarc&#xf3;n</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soto-Iglesias</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korshunov</LastName><ForeName>Viatcheslav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borras</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linhart</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Mikel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Armenta</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mont</LastName><ForeName>Lluis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berruezo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic and IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="N">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062906" MajorTopicYN="N">Cardiac Catheters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="Y">Electrophysiologic Techniques, Cardiac</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006329" MajorTopicYN="N">Heart Conduction System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28069835</ArticleId><ArticleId IdType="doi">10.1093/europace/euw406</ArticleId><ArticleId IdType="pii">euw406</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27521538</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>222</Volume><PubDate><Year>2016</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.</ArticleTitle><Pagination><StartPage>689</StartPage><EndPage>695</EndPage><MedlinePgn>689-695</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2016.07.200</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(16)31592-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">At present, the role of ventricular tachycardia (VT) non-inducibility after ablation in patients with non-ischemic cardiomyopathy (NICM) remains controversial. We conducted a meta-analysis of the published literature to assess whether VT non-inducibility after ablation could predict reduced VT recurrence and mortality in patients with NICM.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, ScienceDirect, and the Cochrane library were searched for studies evaluating the effects of VT non-inducibility after catheter ablation on the long-term outcome in NICM patients with sustained VT. Results were analyzed using a fixed-effect model, and the data were pooled using RevMan 5.3 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four observational studies were identified (736 participants, mean follow-up time: 22months). NICM patients with VT inducibility after ablation had a higher risk of VT recurrence (odds ratio [OR]=5.83, 95% confidence interval [CI] 4.07-8.37; P&lt;0.00001) and all-cause mortality (OR=3.55, 95% CI 1.62-7.78; P=0.002) compared with VT non-inducibility. Similarly in the subgroup analysis, patients with VT inducibility showed a higher risk of VT recurrence from non-ischemic dilated cardiomyopathy (OR=3.92, 95% CI 2.36-6.50; P&lt;0.00001) and arrhythmogenic right ventricular dysplasia/cardiomyopathy (OR=5.37, 95% CI 2.20-13.10; P=0.0002). Additionally, meta-analysis also showed that combined endo-epicardial ablation significantly reduced the risk of VT recurrence compared with endocardial-only ablation (OR=2.02, 95% CI 1.19-3.44; P=0.009; mean follow-up time: 22months).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Recent evidence has shown that VT non-inducibility after ablation is a predictor for reduced VT recurrence and mortality compared with VT inducibility in NICM patients with sustained VT. In addition, endocardial plus adjuvant epicardial ablation provides better long-term arrhythmia-free survival than endocardial ablation alone.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jinzhu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Qiongqiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Wengen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhenyan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jianhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Kui</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China; Jiangxi Key Laboratory of Molecular Medicine, Nanchang 330006, China. Electronic address: hongkui88@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056149" MajorTopicYN="N">Epicardial Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Recurrence</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27521538</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2016.07.200</ArticleId><ArticleId IdType="pii">S0167-5273(16)31592-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24570557</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2014</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1816-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Asian cardiovascular &amp; thoracic annals</Title><ISOAbbreviation>Asian Cardiovasc Thorac Ann</ISOAbbreviation></Journal><ArticleTitle>Ventricular tachyarrhythmia after coronary bypass surgery: incidence and outcome.</ArticleTitle><Pagination><StartPage>551</StartPage><EndPage>557</EndPage><MedlinePgn>551-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0218492312462225</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ventricular tachyarrhythmia after coronary artery bypass graft is common and the occurrence has been described, but the incidence and risk factors are not well defined.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the incidence of arrhythmias and to detect high-risk populations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective study, 856 consecutive patients undergoing coronary artery bypass graft were monitored for new-onset ventricular tachyarrhythmias: non-sustained monomorphic ventricular tachyarrhythmia, sustained monomorphic ventricular tachyarrhythmia, sustained polymorphic ventricular tachyarrhythmia, and ventricular fibrillation. Detailed analyses of the clinical, demographic, echocardiographic, and surgical findings and arrhythmias occurrence was carried out during 6 months of follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of ventricular tachyarrhythmia was 26.6% (17.6% non-sustained monomorphic ventricular tachycardia, 5.5% sustained monomorphic ventricular tachycardia, 0.8% sustained polymorphic ventricular tachycardia, and 2.7% ventricular fibrillation). The strongest degrees of statistical significance were for low ejection fraction (p&#x2009;=&#x2009;0.01) and ischemic heart disease (p&#x2009;=&#x2009;0.02). The incidence of ventricular fibrillation (61%) was greatest in the first 48&#x2009;h after surgery. Postoperative myocardial infarction (p&#x2009;=&#x2009;0.03) and hemodynamic instability (p&#x2009;=&#x2009;0.05) were also predictors of arrhythmia occurrence. Recurrence of arrhythmia was highest in the ventricular fibrillation group (52%). The correlations between tachyarrhythmia, age, sex, electrolyte disorders, body mass index, and systemic or pulmonary hypertension were not significant.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In view of the strong relationship between ventricular arrhythmias and low ejection fraction, ischemic heart disease, coronary artery disease severity, postoperative myocardial infection, and hemodynamic impairment, continuous monitoring is necessary, especially in the first 48&#x2009;h after coronary artery bypass surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadr-Ameli</LastName><ForeName>Mohammad Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alizadeh</LastName><ForeName>Abolfath</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ghasemi</LastName><ForeName>Valiollah</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Heidarali</LastName><ForeName>Mona</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Asian Cardiovasc Thorac Ann</MedlineTA><NlmUniqueID>9503417</NlmUniqueID><ISSNLinking>0218-4923</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmias</Keyword><Keyword MajorTopicYN="N">coronary artery bypass</Keyword><Keyword MajorTopicYN="N">intra-aortic balloon pump</Keyword><Keyword MajorTopicYN="N">ischemic heart disease</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24570557</ArticleId><ArticleId IdType="doi">10.1177/0218492312462225</ArticleId><ArticleId IdType="pii">0218492312462225</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34113881</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Heart rhythm O2</Title><ISOAbbreviation>Heart Rhythm O2</ISOAbbreviation></Journal><ArticleTitle>Preventive versus deferred catheter ablation of myocardial infarct-associated ventricular tachycardia: A meta-analysis.</ArticleTitle><Pagination><StartPage>275</StartPage><EndPage>282</EndPage><MedlinePgn>275-282</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hroo.2020.08.001</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal timing of catheter ablation for the treatment of ventricular tachycardia (VT) in patients with ischemic cardiomyopathy remains unclear. Studies examining the impact of early preventive ablation of VT on rates of implantable cardioverter-defibrillator (ICD) therapies and mortality have been limited by small sample size.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To conduct a meta-analysis of randomized controlled trials (RCTs) comparing initial catheter ablation and ICD implantation (preventive ablation arm) vs ICD implantation alone (deferred ablation arm) in patients with ischemic cardiomyopathy and VT.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The primary endpoint was the incidence of appropriate ICD therapy during follow-up. Secondary endpoints included appropriate ICD shock, VT storm, procedural complications, and mortality. Sensitivity analysis, meta-regression, and evaluation of bias were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four RCTs (n = 505) fulfilled inclusion criteria. During follow-up (mean &gt;22 months for all RCTs), preventive ablation was associated with a significant reduction in ICD therapies (odds ratio [95% confidence interval]: 0.53 [0.36-0.78]). The occurrence of ICD shocks and VT storm were also significantly reduced in the preventive ablation group. Among patients with left ventricular ejection fraction (LVEF) &gt;30%, preventive ablation was associated with marked reduction in ICD therapy when compared to deferred ablation (odds ratio [95% confidence interval]: 0.37 [0.19-0.72]). Overall, there was no difference in mortality between treatment groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preventive catheter ablation in patients with ischemic cardiomyopathy decreases ICD therapies, ICD shocks, and VT storm without increasing complications, particularly in patients with LVEF &gt;30%. However, early preventive ablation is not associated with any benefit in mortality.</AbstractText><CopyrightInformation>&#xa9; 2020 Heart Rhythm Society. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kampaktsis</LastName><ForeName>Polydoros N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doulamis</LastName><ForeName>Ilias P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzani</LastName><ForeName>Aspasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Jim W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Weill Cornell Medicine - New York Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm O2</MedlineTA><NlmUniqueID>101768511</NlmUniqueID><ISSNLinking>2666-5018</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter-defibrillator</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Preventive ablation</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34113881</ArticleId><ArticleId IdType="pmc">PMC8183888</ArticleId><ArticleId IdType="doi">10.1016/j.hroo.2020.08.001</ArticleId><ArticleId IdType="pii">S2666-5018(20)30110-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moss A.J., Zareba W., Hall W.J. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardy G.H., Lee K.L., Mark D.B. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">15659722</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunbar S.B., Dougherty C.M., Sears S.F. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation. 2012;126:2146&#x2013;2172.</Citation><ArticleIdList><ArticleId IdType="pubmed">23008437</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole J.E., Johnson G.W., Hellkamp A.S. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922510</ArticleId><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin E.M., Bogun F.M., Maury P. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020;17:e2&#x2013;e154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8453449</ArticleId><ArticleId IdType="pubmed">31085023</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R., Vaseghi M., Frankel D.S. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015;12:1997&#x2013;2007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4549209</ArticleId><ArticleId IdType="pubmed">26031376</ArticleId></ArticleIdList></Reference><Reference><Citation>Atti V., Vuddanda V., Turagam M.K. Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2018;53:207&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">29680972</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilz R.R., Eitel C., Lyan E. Preventive ventricular tachycardia ablation in patients with ischaemic cardiomyopathy: meta-analysis of randomised trials. Arrhythmia Electrophysiol Rev. 2019;8:173&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6702470</ArticleId><ArticleId IdType="pubmed">31463054</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems S., Tilz R.R., Steven D. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): A multicenter randomized trial. Circulation. 2020;141:1057&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pubmed">32000514</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A., Altman D.G., Tetzlaff J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Altman D.G., G&#xf8;tzsche P.C. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G., Oxman A.D., Akl E.A. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck K.-H., Schaumann A., Eckardt L. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20109864</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy V.Y., Reynolds M.R., Neuzil P. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657&#x2013;2665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390777</ArticleId><ArticleId IdType="pubmed">18160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck K.-H., Tilz R.R., Deneke T. Impact of substrate modification by catheter ablation on implantable cardioverter&#x2013;defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study) Circ Arrhythm Electrophysiol. 2017;10(3)</Citation><ArticleIdList><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchlinski F.E., Callans D.J., Gottlieb C.D., Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101:1288&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725289</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson W.G., Wilber D.J., Natale A. Multicenter Thermocool VT Ablation Trial Investigators. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118:2773&#x2013;2782.</Citation><ArticleIdList><ArticleId IdType="pubmed">19064682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanner H., Hindricks G., Volkmer M. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol. 2010;21:47&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">19656251</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivkumar K. Catheter ablation of ventricular arrhythmias. N Engl J Med. 2019;380:1555&#x2013;1564.</Citation><ArticleIdList><ArticleId IdType="pubmed">30995375</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacher F., Roberts-Thomson K., Maury P. Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol. 2010;55:2366&#x2013;2372.</Citation><ArticleIdList><ArticleId IdType="pubmed">20488308</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Biase L., Burkhardt J.D., Lakkireddy D. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: The VISTA randomized multicenter trial. J Am Coll Cardiol. 2015;66:2872&#x2013;2882.</Citation><ArticleIdList><ArticleId IdType="pubmed">26718674</ArticleId></ArticleIdList></Reference><Reference><Citation>Berruezo A., Fern&#xe1;ndez-Armenta J., Andreu D. Scar dechanneling: New method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythm Electrophysiol. 2015;8:326&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">25583983</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterfield J.R., Kent A.R., Karst E. Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm. 2018;15:355&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">29030235</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31150816</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation versus medical therapy for treatment of ventricular tachycardia associated with structural heart disease: Systematic review and meta-analysis of randomized controlled trials and comparison with observational studies.</ArticleTitle><Pagination><StartPage>1484</StartPage><EndPage>1491</EndPage><MedlinePgn>1484-1491</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2019.05.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(19)30536-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Catheter ablation (CA) is an established therapeutic modality for ventricular tachycardia (VT).</AbstractText><AbstractText Label="OBJECTIVE">We compared the clinical outcomes of CA for VT vs medical therapy from all previously performed randomized controlled trials (RCTs) and compared these to contemporary observational studies.</AbstractText><AbstractText Label="METHODS">A comprehensive database search through to August 2018 identified 8 eligible studies enrolling 797 patients.</AbstractText><AbstractText Label="RESULTS">In RCTs, VT recurrence and electrical VT storm were significantly reduced in the CA group vs medical therapy group (relative risk [RR] 0.78, 95% confidence interval [CI] 0.64-0.95, P = .01; RR 0.70, 95% CI 0.51-0.94, P = .02, respectively) at a mean follow-up of 22 months. All-cause or cardiac-specific mortality did not differ significantly (RR 0.92, 95% CI 0.67-1.27, P = .62; RR 0.82, 95% CI 0.54-1.26, P = .37, respectively). In 4 observational studies, including 3065 patients with a mean follow-up of 18.2 months, VT recurrence and mortality were significantly lower as compared to the RCTs (28.6% vs 39%, P &lt; .001; 13.2% vs 18%, P&#xa0;= .01, respectively) despite greater incidence of electrical storm (33.2% vs 17%, P &lt; .001), higher prevalence of nonischemic substrate (46.4% vs 3.6%, P &lt; .001), and lower rate of implanted ICDs (68% vs 94.7%, P &lt; .001).</AbstractText><AbstractText Label="CONCLUSION">Meta-analysis of RCT data shows that CA is superior to medical therapy for predominantly postinfarct, scar-related VT in terms of VT recurrence and electrical VT storm, with no reduction in mortality. Real-world observational studies also demonstrate significant reduction in VT recurrence and mortality, despite a sicker cohort, demonstrating replicability and translation of RCT data in the real world.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2019. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia; Department of Cardiology, Westmead Hospital, Sydney, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariyarathna</LastName><ForeName>Nilshan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Sohaib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivic</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Clara K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalman</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Melbourne Hospital, Faculty of Medicine, Dentistry, and Health Science, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Westmead Hospital, Sydney, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, Australia. Electronic address: saurabh.kumar@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="N">Defibrillators, Implantable</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiarrhythmic therapy</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31150816</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2019.05.026</ArticleId><ArticleId IdType="pii">S1547-5271(19)30536-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24020382</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9042</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of neurotrauma</Title><ISOAbbreviation>J Neurotrauma</ISOAbbreviation></Journal><ArticleTitle>Medical and surgical management after spinal cord injury: vasopressor usage, early surgerys, and complications.</ArticleTitle><Pagination><StartPage>284</StartPage><EndPage>291</EndPage><MedlinePgn>284-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/neu.2013.3061</ELocationID><Abstract><AbstractText>The optimal mean arterial blood pressure for maintenance of spinal cord perfusion is not known. Our aim was to describe vasopressor usage and examine their effects in patients with spinal cord injury (SCI). We undertook a retrospective cohort study of 131 patients with SCI who received any kind of vasopressors to maintain blood pressure in the neurocritical care unit of a Level 1 trauma center (2005-2011). Vasopressor usage and complications were obtained from the medical record. Neurological outcomes were evaluated by the American Spinal Injury Association score. Dopamine was the most commonly used vasopressor (48.0%), followed by phenylephrine (45.0%), norepinephrine (5.0%), epinephrine (1.5%), and vasopressin (0.5%). Logistic regression analysis demonstrated that complications (e.g., ventricular tachycardia, troponin elevation, atrial fibrillation, heart rate &gt;130 or &lt;50, etc.) due to vasopressors were independently associated with the overall usages of dopamine (odds ratio [OR] 8.97; p&lt;0.001) and phenylephrine (OR, 5.92; p=0.004), age &#x2265;60 years old (OR, 5.16; p=0.013), and complete SCI (OR, 3.23; p=0.028). There was no difference in neurological improvement with either dopamine (OR, 1.16; p=0.788) or phenylephrine (OR 0.96; p=0.940). Incomplete SCI (OR, 2.64; p=0.019) and surgery &lt;24&#x2009;h after SCI (OR, 4.25; p=0.025) were independently associated with improved outcome. In summary, vasopressors are associated with increased complications in SCI patients. Further prospective studies are required in order to determine the potential benefits and risks of blood pressure management in patients with SCI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Tomoo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>1 Department of Neurological Surgery, University of California San Francisco , San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manley</LastName><ForeName>Geoffrey T</ForeName><Initials>GT</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Nihari</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Whetstone</LastName><ForeName>William D</ForeName><Initials>WD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurotrauma</MedlineTA><NlmUniqueID>8811626</NlmUniqueID><ISSNLinking>0897-7151</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="Y">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="N">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24020382</ArticleId><ArticleId IdType="doi">10.1089/neu.2013.3061</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39941531</PMID><DateRevised><Year>2025</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Quantitative Analysis of Propofol Dosage in Cannabis Users: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">858</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14030858</ELocationID><Abstract><AbstractText><b>Background</b>: Rising cannabis use poses significant challenges in the administration of general anesthetics, particularly propofol, due to potential alterations in pharmacodynamics caused by tetrahydrocannabinol and its interactions with central nervous system receptors. This systematic review and meta-analysis aims to consolidate the existing literature to quantify propofol requirements in cannabis users, highlighting the complex relationship between cannabis use and anesthetic management. <b>Methods</b>: A systematic search of English-language literature was conducted to identify studies with data on propofol dosing in adult cannabis users. Propofol requirements were defined as the total intraoperative dose needed to achieve and maintain adequate sedation or anesthesia, assessed using parameters like monitoring and procedural tolerance. A random-effects model was used with DerSimonian-Laird estimations for pooled effect sizes and 95% confidence intervals. Heterogeneity was assessed using I<sup>2</sup> and Cochran's Q statistics, and sensitivity analysis was conducted by grouping publications by design, size, and quality. <b>Results</b>: Eight qualified studies were identified with 2268 patients included. Patients who used cannabis were typically younger and more likely to smoke tobacco than non-users. Propofol requirements were significantly higher in cannabis users, who required an average additional dose of 47.33 mg compared to non-users. Subgroup analyses revealed that cannabis users undergoing general anesthesia needed an additional 30.57 mg intraoperatively, while those undergoing sedation for endoscopic procedures required an additional 53.02 mg. <b>Conclusions</b>: These results underscore the need for personalized anesthetic plans to accommodate physiological variations in cannabis users. However, the lack of standardized definitions for propofol requirements and the heterogeneity across studies necessitate caution in interpretation. The observed increase in propofol requirements suggests altered central nervous system sensitivities and receptor changes in cannabis users, emphasizing the need for further research to establish clear definitions, elucidate underlying mechanisms, and refine clinical guidelines for anesthetic management in this population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Maxwell B</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0003-1191-4134</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Larner College of Medicine, University of Vermont, Burlington, VT 054052, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binda</LastName><ForeName>Dhanesh D</ForeName><Initials>DD</Initials><Identifier Source="ORCID">0000-0002-5490-2013</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Montefiore Einstein Medical Center, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nozari</LastName><ForeName>Ala</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5755-6347</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Joseph M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Larner College of Medicine, Burlington, VT 05405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dienes</LastName><ForeName>Erin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0001-5912-3414</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>William E</ForeName><Initials>WE</Initials><Identifier Source="ORCID">0000-0002-4915-2553</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Larner College of Medicine, Burlington, VT 05405, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthetic dosage</Keyword><Keyword MajorTopicYN="N">anesthetic management</Keyword><Keyword MajorTopicYN="N">cannabis use</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">pharmacological interactions</Keyword><Keyword MajorTopicYN="N">propofol</Keyword><Keyword MajorTopicYN="N">tetrahydrocannabinol</Keyword></KeywordList><CoiStatement>Ala Nozari served as a consultant for Third Pole Therapeutics and the Takeda Pharmaceutical Company. No conflicts of interest are relevant to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>13</Day><Hour>11</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>13</Day><Hour>11</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>13</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39941531</ArticleId><ArticleId IdType="pmc">PMC11818839</ArticleId><ArticleId IdType="doi">10.3390/jcm14030858</ArticleId><ArticleId IdType="pii">jcm14030858</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chiu R.G., Patel S., Siddiqui N., Nunna R.S., Mehta A.I. Cannabis Abuse and Perioperative Complications Following Inpatient Spine Surgery in the United States. Spine. 2021;46:734&#x2013;743. doi: 10.1097/BRS.0000000000004035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000004035</ArticleId><ArticleId IdType="pubmed">33769411</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipari R.N. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. SAMHSA; Rockville, MD, USA: 2018.</Citation></Reference><Reference><Citation>2021 NSDUH Annual National Report|CBHSQ Data.  [(accessed on 6 December 2024)]; Available online:  https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report.</Citation></Reference><Reference><Citation>National Institute on Drug Abuse  Marijuana and Hallucinogen Use, Binge Drinking Reached Historic Highs Among Adults 35 to 50|National Institute on Drug Abuse (NIDA)  [(accessed on 6 December 2024)]; Available online:  https://nida.nih.gov/news-events/news-releases/2023/08/marijuana-and-hallucinogen-use-binge-drinking-reached-historic-highs-among-adults-35-to-50.</Citation></Reference><Reference><Citation>Khelemsky Y., Goldberg A.T., Hurd Y.L., Winkel G., Ninh A., Qian L., Oprescu A., Ciccone J., Katz D.J. Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana (Cannabinoids) for Treatment of Pain: A Prospective Population Survey. Reg. Anesth. Pain Med. 2017;42:652&#x2013;659. doi: 10.1097/AAP.0000000000000654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0000000000000654</ArticleId><ArticleId IdType="pubmed">28796754</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapani G.M., Altomare C., Sanna E., Biggio G., Liso G. Propofol in Anesthesia. Mechanism of Action, Structure-Activity Relationships, and Drug Delivery. Curr. Med. Chem. 2000;7:249&#x2013;271. doi: 10.2174/0929867003375335.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867003375335</ArticleId><ArticleId IdType="pubmed">10637364</ArticleId></ArticleIdList></Reference><Reference><Citation>Habchi K.M., Li M.T., Mallard C.A., Baker M., Ortega R. The Anesthesiologist&#x2019;s Armamentarium: From Recreation to Medication and Back. J. Anesth. Hist. 2020;6:17&#x2013;26. doi: 10.1016/j.janh.2019.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.janh.2019.04.002</ArticleId><ArticleId IdType="pubmed">32473762</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.H., Sideris A., Ladha K.S., Johnson R.L., Wu C.L. Cannabis and Cannabinoids in the Perioperative Period. Anesthesia Analg. 2024;138:16&#x2013;30. doi: 10.1213/ANE.0000000000006070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006070</ArticleId><ArticleId IdType="pubmed">35551150</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand P.-A., Paris A., Bein B., Meybohm P., Scholz J., Ohnesorge H., Tonner P.H. Propofol sedation is reduced by delta9-tetrahydrocannabinol in mice. Anesth. Analg. 2008;107:102&#x2013;106. doi: 10.1213/ane.0b013e318173287a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318173287a</ArticleId><ArticleId IdType="pubmed">18635473</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslonka M.A., Schertz A.R., Markowski L.M., Miller P.J. Sedation challenges in patients with E-cigarette, or vaping, product use-associated lung injury (EVALI) BMJ Case Rep. 2020;13:e233866. doi: 10.1136/bcr-2019-233866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-233866</ArticleId><ArticleId IdType="pmc">PMC7470641</ArticleId><ArticleId IdType="pubmed">32878850</ArticleId></ArticleIdList></Reference><Reference><Citation>Farasatinasab M., Nasiripour S., Aghabiklooei A. Effect of cannabis use on propofol requirement for ICU sedation. Anaesthesiol. Intensive Ther. 2022;54:344&#x2013;345. doi: 10.5114/ait.2022.121002.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2022.121002</ArticleId></ArticleIdList></Reference><Reference><Citation>Richtig G., Bosse G., Arlt F., von Heymann C. Cannabis consumption before surgery may be associated with increased tolerance of anesthetic drugs: A case report. Int. J. Case Rep. Images. 2015;6:436&#x2013;439. doi: 10.5348/ijcri-201573-CR-10534.</Citation><ArticleIdList><ArticleId IdType="doi">10.5348/ijcri-201573-CR-10534</ArticleId></ArticleIdList></Reference><Reference><Citation>Symons I.E. Cannabis smoking and anaesthesia. Anaesthesia. 2002;57:1142&#x2013;1143. doi: 10.1046/j.1365-2044.2002.288312.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2044.2002.288312.x</ArticleId><ArticleId IdType="pubmed">12392470</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker F., Baric A., Sekharan L., James E., Farook F., Itrat Q., Jagadheesan K. Anaesthetic safety with undisclosed substance misuse during electroconvulsive therapy. Australas. Psychiatry. 2022;30:278&#x2013;279. doi: 10.1177/10398562211057076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10398562211057076</ArticleId><ArticleId IdType="pubmed">35073783</ArticleId></ArticleIdList></Reference><Reference><Citation>Twardowski M.A., Link M.M., Twardowski N.M. Effects of Cannabis Use on Sedation Requirements for Endoscopic Procedures. J. Am. Osteopat. Assoc. 2019;119:307&#x2013;311. doi: 10.7556/jaoa.2019.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.7556/jaoa.2019.052</ArticleId><ArticleId IdType="pubmed">30985870</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangwani P., Lillian D., Dobbins J., Feng C., Vorrasi J., Kolokythas A. Is Recreational Marijuana Use Associated With Changes in the Vital Signs or Anesthetic Requirements During Intravenous Sedation? J. Oral Maxillofac. Surg. 2023;81:527&#x2013;535. doi: 10.1016/j.joms.2023.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joms.2023.01.007</ArticleId><ArticleId IdType="pubmed">36746375</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung B.G., Ma M.W., Scolaro J.A., Nelson A.M. Cannabis Exposure Decreases Need for Blood Pressure Support During General Anesthesia in Orthopedic Trauma Surgery. Cannabis Cannabinoid Res. 2022;7:328&#x2013;335. doi: 10.1089/can.2021.0009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/can.2021.0009</ArticleId><ArticleId IdType="pmc">PMC9225405</ArticleId><ArticleId IdType="pubmed">34227872</ArticleId></ArticleIdList></Reference><Reference><Citation>Flisberg P., Paech M., Shah T., Ledowski T., Kurowski I., Parsons R. Induction dose of propofol in patients using cannabis. Eur. J. Anaesthesiol. 2009;26:192&#x2013;195. doi: 10.1097/EJA.0b013e328319be59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e328319be59</ArticleId><ArticleId IdType="pubmed">19237981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.-X.B., Bean B.P. Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels. J. Neurosci. 2021;41:6371&#x2013;6387. doi: 10.1523/JNEUROSCI.3216-20.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3216-20.2021</ArticleId><ArticleId IdType="pmc">PMC8318087</ArticleId><ArticleId IdType="pubmed">34131037</ArticleId></ArticleIdList></Reference><Reference><Citation>Laudanski K., Wain J. Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. J. Clin. Med. 2022;11:558. doi: 10.3390/jcm11030558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030558</ArticleId><ArticleId IdType="pmc">PMC8836924</ArticleId><ArticleId IdType="pubmed">35160010</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander J.C., Joshi G.P. A review of the anesthetic implications of marijuana use. Proc. Bayl. Univ. Med. Cent. 2019;32:364&#x2013;371. doi: 10.1080/08998280.2019.1603034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08998280.2019.1603034</ArticleId><ArticleId IdType="pmc">PMC6650211</ArticleId><ArticleId IdType="pubmed">31384188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha K.S., Manoo V., Virji A.-F., Hanlon J.G., Mclaren-Blades A., Goel A., Wijeysundera D.N., Kotra L.P., Ibarra C., Englesakis M., et al. The Impact of Perioperative Cannabis Use: A Narrative Scoping Review. Cannabis Cannabinoid Res. 2019;4:219&#x2013;230. doi: 10.1089/can.2019.0054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/can.2019.0054</ArticleId><ArticleId IdType="pmc">PMC6922064</ArticleId><ArticleId IdType="pubmed">31872058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosirog J., Bouvette C., Pannu J., Gondal J., Madhoun M. Marijuana and endoscopy: The effects of marijuana on sedation. Gastrointest. Endosc. 2024;100:177&#x2013;182. doi: 10.1016/j.gie.2024.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2024.01.013</ArticleId><ArticleId IdType="pubmed">38215858</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J., Bossuyt P., Boutron I., Hoffmann T., Mulrow C., Shamseer L., Tetzlaff J., Aki E., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>R: The R Project for Statistical Computing.  [(accessed on 29 March 2024)].  Available online:  https://www.r-project.org/</Citation></Reference><Reference><Citation>Aleissa M.M., Ahern K.L., Stern G.M. Peri-operative opioid and sedation requirements in patients who use marijuana and are undergoing total knee or total hip arthroplasty: A retrospective study. J. Clin. Anesth. 2020;66:109953. doi: 10.1016/j.jclinane.2020.109953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2020.109953</ArticleId><ArticleId IdType="pubmed">32619794</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmen I.C., Beach J.P., Kaizer A.M., Gumidyala R. The association between preoperative cannabis use and intraoperative inhaled anesthetic consumption: A retrospective study. J. Clin. Anesth. 2020;67:109980. doi: 10.1016/j.jclinane.2020.109980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2020.109980</ArticleId><ArticleId IdType="pubmed">32653758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.S., Nagra N., La Selva D., Kozarek R.A., Ross A., Weigel W., Beecher R., Chiorean M., Gluck M., Boden E., et al. Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult to Sedate. Clin. Gastroenterol. Hepatol. 2021;19:180&#x2013;188. doi: 10.1016/j.cgh.2020.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.09.018</ArticleId><ArticleId IdType="pubmed">32931961</ArticleId></ArticleIdList></Reference><Reference><Citation>Imasogie N., Rose R.V., Wilson A. High quantities: Evaluating the association between cannabis use and propofol anesthesia during endoscopy. PLoS ONE. 2021;16:e0248062. doi: 10.1371/journal.pone.0248062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248062</ArticleId><ArticleId IdType="pmc">PMC7932135</ArticleId><ArticleId IdType="pubmed">33661987</ArticleId></ArticleIdList></Reference><Reference><Citation>King D.D., Stewart S.A., Collins-Yoder A., Fleckner T., Price L.L. Anesthesia for Patients Who Self-Report Cannabis (Marijuana) Use Before Esophagogastroduodenoscopy: A Retrospective Review. AANA J. 2021;89:205&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8764743</ArticleId><ArticleId IdType="pubmed">34042571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripperger D., Atte A., Ritto F. Cannabis Users Require More Anesthetic Agents for General Anesthesia in Ambulatory Oral and Maxillofacial Surgery Procedures. J. Oral Maxillofac. Surg. 2023;81:1460&#x2013;1465. doi: 10.1016/j.joms.2023.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joms.2023.09.008</ArticleId><ArticleId IdType="pubmed">37783364</ArticleId></ArticleIdList></Reference><Reference><Citation>Huson H.B., Granados T.M., Rasko Y. Surgical considerations of marijuana use in elective procedures. Heliyon. 2018;4:e00779. doi: 10.1016/j.heliyon.2018.e00779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2018.e00779</ArticleId><ArticleId IdType="pmc">PMC6139487</ArticleId><ArticleId IdType="pubmed">30225378</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhing M.R., Beno D.W.A., Jiyamapa-Serna V.A., Chen Y., Galinsky R.E., Hall S.D., Kimura R.E. the effect of anesthesia and surgery on CYP3A activity in rats. Drug Metab. Dispos. 2004;32:1325&#x2013;1330. doi: 10.1124/dmd.104.000927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/dmd.104.000927</ArticleId><ArticleId IdType="pubmed">15319324</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelling G., Hauer D., Azad S.C., Schmoelz M., Chouker A., Schmidt M., Hornuss C., Rippberger M., Briegel J., Thiel M., et al. Effects of General Anesthesia on Anandamide Blood Levels in Humans. Anesthesiology. 2006;104:273&#x2013;277. doi: 10.1097/00000542-200602000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200602000-00012</ArticleId><ArticleId IdType="pubmed">16436846</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal H., Awad H.H., Ghali J.K. Role of cannabis in cardiovascular disorders. J. Thorac. Dis. 2017;9:2079&#x2013;2092. doi: 10.21037/jtd.2017.06.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2017.06.104</ArticleId><ArticleId IdType="pmc">PMC5542986</ArticleId><ArticleId IdType="pubmed">28840009</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu P., Boulanger A., Desroches J., Clark A.J. Medical cannabis: Considerations for the anesthesiologist and pain physician. Can. J. Anaesth. 2016;63:608&#x2013;624. doi: 10.1007/s12630-016-0598-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-016-0598-x</ArticleId><ArticleId IdType="pubmed">26850063</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S., Schwenk E.S., Sondekoppam R.V., Clarke H., Zakowski M., Rzasa-Lynn R.S., Yeung B., Nicholson K., Schwartz G., Hooten W.M., et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg. Anesth. Pain Med. 2023;48:97&#x2013;117. doi: 10.1136/rapm-2022-104013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2022-104013</ArticleId><ArticleId IdType="pubmed">36596580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C.J., Galettis P., Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br. J. Clin. Pharmacol. 2018;84:2477&#x2013;2482. doi: 10.1111/bcp.13710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.13710</ArticleId><ArticleId IdType="pmc">PMC6177698</ArticleId><ArticleId IdType="pubmed">30001569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetrault J.M., Crothers K., Moore B.A., Mehra R., Concato J., Fiellin D.A. Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review. Arch. Intern. Med. 2007;167:221&#x2013;228. doi: 10.1001/archinte.167.3.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.3.221</ArticleId><ArticleId IdType="pmc">PMC2720277</ArticleId><ArticleId IdType="pubmed">17296876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong G.T.C., Irwin M.G. Poisoning with illicit substances: Toxicology for the anaesthetist. Anaesthesia. 2013;68((Suppl. S1)):117&#x2013;124. doi: 10.1111/anae.12053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12053</ArticleId><ArticleId IdType="pubmed">23210561</ArticleId></ArticleIdList></Reference><Reference><Citation>Combined Beta-Agonists and Anticholinergics Compared to Beta-Agonists Alone for Adults with Asthma Treated in Emergency Departments.  [(accessed on 6 December 2024)].  Available online:  https://www.cochrane.org/CD001284/AIRWAYS_combined-beta-agonists-and-anticholinergics-compared-beta-agonists-alone-adults-asthma-treated.</Citation></Reference><Reference><Citation>Echeverria-Villalobos M., Todeschini A.B., Stoicea N., Fiorda-Diaz J., Weaver T., Bergese S.D. Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations. J. Clin. Anesth. 2019;57:41&#x2013;49. doi: 10.1016/j.jclinane.2019.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2019.03.011</ArticleId><ArticleId IdType="pubmed">30852326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan T.J., Belani K.G., Bergese S., Chung F., Diemunsch P., Habib A.S., Jin Z., Kovac A.L., Meyer T.A., Urman R.D., et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth. Analg. 2020;131:411&#x2013;448. doi: 10.1213/ANE.0000000000004833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004833</ArticleId><ArticleId IdType="pubmed">32467512</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenne J., Burney E., Mauer K., Orina J., Philipp T., Yoo J. Risks associated with chronic cannabis use on opioid use, length of stay, and revision rate for patients undergoing posterior lumbar interbody fusion. Spine J. 2024;24:851&#x2013;857. doi: 10.1016/j.spinee.2024.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2024.01.011</ArticleId><ArticleId IdType="pubmed">38309626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekrami E., Sari S., Kopac O., Wang D., Mascha E.J., Stamper S., Esa W.A.S., Nair H., Ruetzler K., Turan A. Association Between Cannabis Use and Opioid Consumption, Pain, and Respiratory Complications After Surgery: A Retrospective Cohort Analysis. Anesth. Analg. 2024;139:724&#x2013;733. doi: 10.1213/ANE.0000000000006785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006785</ArticleId><ArticleId IdType="pubmed">38190341</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumrak K. In the Weeds: Nation&#x2019;s First Guidelines for Management of Perioperative Patients on Cannabis. ASA Monit. 2024;88:30&#x2013;33. doi: 10.1097/01.ASM.0001008300.88901.d7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASM.0001008300.88901.d7</ArticleId></ArticleIdList></Reference><Reference><Citation>Potnuru P.P., Jonna S., Williams G.W. Cannabis Use Disorder and Perioperative Complications. JAMA Surg. 2023;158:935&#x2013;944. doi: 10.1001/jamasurg.2023.2403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2023.2403</ArticleId><ArticleId IdType="pmc">PMC10323761</ArticleId><ArticleId IdType="pubmed">37405729</ArticleId></ArticleIdList></Reference><Reference><Citation>King D.D., Gill C.J., Cadieux C.S., Singh N. The role of stigma in cannabis use disclosure: An exploratory study. Harm Reduct. J. 2024;21:21. doi: 10.1186/s12954-024-00929-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12954-024-00929-8</ArticleId><ArticleId IdType="pmc">PMC10811895</ArticleId><ArticleId IdType="pubmed">38273362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicket M.C., Stone E.M., McGinty E.E. Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs. JAMA Netw. Open. 2023;6:e2249797. doi: 10.1001/jamanetworkopen.2022.49797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.49797</ArticleId><ArticleId IdType="pmc">PMC9857553</ArticleId><ArticleId IdType="pubmed">36607641</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanoski K., Pauly B., Inglis D., Cameron F., Haddad T., Phillips J., Phillips P., Rosen C., Schlotter G., Hartney E., et al. Defining culturally safe primary care for people who use substances: A participatory concept mapping study. BMC Health Serv. Res. 2020;20:1060. doi: 10.1186/s12913-020-05915-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-05915-x</ArticleId><ArticleId IdType="pmc">PMC7685616</ArticleId><ArticleId IdType="pubmed">33228650</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M.B., Liu E.C., Bully M.A., Hsieh A., Nozari A., Tuler M., Binda D.D. Overcoming Barriers: A Comprehensive Review of Chronic Pain Management and Accessibility Challenges in Rural America. Healthcare. 2024;12:1765. doi: 10.3390/healthcare12171765.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare12171765</ArticleId><ArticleId IdType="pmc">PMC11394986</ArticleId><ArticleId IdType="pubmed">39273789</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco C.M., Gaylord S.A., Faurot K., Weinberg J.M., Gardiner P., Roth I., Barnhill J.L., Thomas H.N., Dhamne S.C., Lathren C., et al. The design and methods of the OPTIMUM study: A multisite pragmatic randomized clinical trial of a telehealth group mindfulness program for persons with chronic low back pain. Contemp. Clin. Trials. 2021;109:106545. doi: 10.1016/j.cct.2021.106545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2021.106545</ArticleId><ArticleId IdType="pmc">PMC8691659</ArticleId><ArticleId IdType="pubmed">34455111</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M.B., Hsieh A., Gupta V., Kim Y., Merriel M., Nozari A., Binda D. The Color of Climate Change: Can Choice of Anesthetic Be Institutionally Racist? Anesth. Analg. 2024;138:1154&#x2013;1158. doi: 10.1213/ANE.0000000000006809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006809</ArticleId><ArticleId IdType="pubmed">38771597</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhre W., O&#x2019;Reilly-Shah V., Van Cleve W. Cannabis use is associated with a small increase in the risk of postoperative nausea and vomiting: A retrospective machine-learning causal analysis. BMC Anesthesiol. 2020;20:115. doi: 10.1186/s12871-020-01036-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01036-4</ArticleId><ArticleId IdType="pmc">PMC7236204</ArticleId><ArticleId IdType="pubmed">32423445</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahan A., Hooten W.M., Furnish T. Cannabis Use and Anesthesia. Adv. Anesth. 2024;42:85&#x2013;96. doi: 10.1016/j.aan.2024.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aan.2024.07.007</ArticleId><ArticleId IdType="pubmed">39443052</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel A., McGuinness B., Jivraj N.K., Wijeysundera D.N., Mittleman M.A., Bateman B.T., Clarke H., Kotra L.P., Ladha K.S. Cannabis Use Disorder and Perioperative Outcomes in Major Elective Surgeries: A Retrospective Cohort Analysis. Anesthesiology. 2020;132:625&#x2013;635. doi: 10.1097/ALN.0000000000003067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003067</ArticleId><ArticleId IdType="pubmed">31789638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Chung T., Dey A., Bae S.W. Exploring Algorithmic Explainability: Generating Explainable AI Insights for Personalized Clinical Decision Support Focused on Cannabis Intoxication in Young Adults; Proceedings of the 2024 International Conference on Activity and Behavior Computing (ABC); Oita, Japan; Kitakyushu, Japan. 29&#x2013;31 May 2024;</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/abc61795.2024.10652070</ArticleId><ArticleId IdType="pmc">PMC11586775</ArticleId><ArticleId IdType="pubmed">39600343</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton J.E., Bolen S.D., Mascha E.J. Publication Bias: The Elephant in the Review. Anesth. Analg. 2016;123:812&#x2013;813. doi: 10.1213/ANE.0000000000001596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001596</ArticleId><ArticleId IdType="pmc">PMC5482177</ArticleId><ArticleId IdType="pubmed">27636569</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zt&#xfc;rk E., Aydo&#x11f;an M.S., Karaaslan K., Do&#x11f;an Z., Topuz U. Does smoking increase the anesthetic requirement? Turk. J. Med Sci. 2019;49:1271&#x2013;1276. doi: 10.3906/sag-1602-57.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-1602-57</ArticleId><ArticleId IdType="pmc">PMC7018217</ArticleId><ArticleId IdType="pubmed">31648428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajdeya R., Rouhizadeh M., Cook R.L., Ison R.L., Bai C., Jugl S., Gao H., Mardini M.T., Zandbiglari K., Adiba F.I. Cannabis Use and Inhalational Anesthesia Administration in Older Adults: A Propensity-matched Retrospective Cohort Study. Anesthesiology. 2024;141:870&#x2013;880. doi: 10.1097/ALN.0000000000005146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000005146</ArticleId><ArticleId IdType="pmc">PMC11461122</ArticleId><ArticleId IdType="pubmed">38980341</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28575378</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>104</StartPage><EndPage>115</EndPage><MedlinePgn>104-115</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/eux109</ELocationID><Abstract><AbstractText Label="AIMS">To compare the long-term outcomes of standard ablation of stable ventricular tachycardia (VT) vs. substrate modification, and of complete vs. incomplete substrate modification in patients with structural heart disease (SHD) presenting with VT.</AbstractText><AbstractText Label="METHODS AND RESULTS">An electronic search was performed using major databases. The main outcomes were a composite of long-term ventricular arrhythmia (VA) recurrence and all-cause mortality of standard ablation of stable VT vs. substrate modification, and long-term VA recurrence in complete vs. incomplete substrate modification. Six studies were included for the comparison of standard ablation of stable VT vs. substrate modification, with a total of 396 patients (mean age 63 &#xb1; 10 years, 87% males), and seven studies were included to assess the impact of extensive substrate modification, with a total of 391 patients (mean age 64 &#xb1; years, 90% males). More than 70% of all the patients included had ischaemic cardiomyopathy. Substrate modification was associated with decreased composite VA recurrence/all-cause mortality compared to standard ablation of stable VTs [risk ratio (RR) 0.57, 95% confidence interval (CI) 0.40-0.81]. Complete substrate modification was associated with decreased VA recurrence as compared to incomplete substrate modification (RR 0.39, 95% CI 0.27-0.58).</AbstractText><AbstractText Label="CONCLUSION">In patients with SHD who had VT related mainly to ischaemic substrates, there was a significantly lower risk of the composite primary outcome of long-term VA recurrence and all-cause mortality among those undergoing substrate modification compared to standard ablation. Long-term success is improved when performing complete substrate modification.</AbstractText><CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. &#xa9; The Author 2017. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brice&#xf1;o</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villablanca</LastName><ForeName>Pedro A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Londo&#xf1;o</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maraj</LastName><ForeName>Ilir</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batul</LastName><ForeName>Syeda Atiqa</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madan</LastName><ForeName>Nidhi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Jignesh</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagannath</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Sanghamitra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Prasant</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianni</LastName><ForeName>Carola</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Rocca</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabri</LastName><ForeName>Ahlam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Soo G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, 107 W. Dean Keeton, BME Building, 78712, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Stanford Arrhythmia Service, Stanford University, 300 Pasteur Drive, 94305 Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Case Western Reserve University, University Hospitals of Cleveland, 11100 Euclid Avenue, 44106-5038 Cleveland, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interventional Electrophysiology, Department of Cardiology, Scripps Clinic, 10666 N Torrey Pines Road, 92037, La Jolla, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dell Medical School, 1501 Red River St, Austin, TX 78701, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arrhythmia Services California Pacific Medical Center, 2100 Webster Street, 94115, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University of Foggia, viale L Pinto, 1, 71100, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute Heart and Vascular Department, St. David's Medical Center, 3000 N. IH 35 Suite 720, 78705, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, 107 W. Dean Keeton, BME Building, 78712, Austin, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University of Foggia, viale L Pinto, 1, 71100, Foggia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D055011" MajorTopicYN="Y">Ablation Techniques</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Activation/entrainment mapping</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Substrate modification</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28575378</ArticleId><ArticleId IdType="doi">10.1093/europace/eux109</ArticleId><ArticleId IdType="pii">3855685</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38037556</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-9676</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of liver transplantation</Title><ISOAbbreviation>J Liver Transpl</ISOAbbreviation></Journal><ArticleTitle>Vascular thrombosis after pediatric liver transplantation: Is prevention achievable?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">100185</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.liver.2023.100185</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Vascular thromboses (VT) are life-threatening events after pediatric liver transplantation (LT). Single-center studies have identified risk factors for intra-abdominal VT, but large-scale pediatric studies are lacking.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This multicenter retrospective cohort study of isolated pediatric LT recipients assessed pre- and perioperative variables to determine VT risk factors and anticoagulation-associated bleeding complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Within seven postoperative days, 31/331 (9.37%) patients developed intra-abdominal VT. Open fascia occurred more commonly in patients with VT (51.61 vs 23.33%) and remained the only independent risk factor in multivariable analysis (OR = 2.84, <i>p</i> = 0.012). Patients with VT received more blood products (83.87 vs 50.00%), had significantly higher rates of graft loss (22.58 vs 1.33%), infection (50.00 vs 20.60%), and unplanned return to the operating room (70.97 vs 16.44%) compared to those without VT. The risk of bleeding was similar (<i>p</i> = 0.2) between patients on and off anticoagulation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Prophylactic anticoagulation did not increase bleeding complications in this cohort. The only independent factor associated with VT was open fascia, likely a graft/recipient size mismatch surrogate, supporting the need to improve surgical techniques to prevent VT that may not be modifiable with anticoagulation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, Department of Pediatrics, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Elise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, Department of Pediatrics, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltramo</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Children's Hospital of Los Angeles, Department of Anesthesiology Critical Care, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nares</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Miami Miller School of Medicine, Department of Pediatrics, Miami, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeyapalan</LastName><ForeName>Asumthia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Miami Miller School of Medicine, Department of Pediatrics, Miami, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcamo</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, Department of Critical Care Medicine, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monde</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Georgetown University Hospital, Department of Pediatrics, Washington DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridall</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine, Department of Pediatrics, Aurora, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamath</LastName><ForeName>Sameer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke University, Department of Pediatrics, Durham, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betters</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vanderbilt University, Department of Pediatrics, Nashville, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowan</LastName><ForeName>Courtney</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Indiana University School of Medicine, Department of Pediatrics, Indianapolis, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangus</LastName><ForeName>Richard Shane</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Indiana University School of Medicine, Department of Surgery, Indianapolis, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaushik</LastName><ForeName>Shubhi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mount Sinai School of Medicine, Department of Pediatrics, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Hospital at Montefiore, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinter</LastName><ForeName>Matt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of California San Francisco, Department of Pediatrics, San Francisco, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resch</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Minnesota, Department of Pediatrics, Minneapolis, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maue</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Indiana University School of Medicine, Department of Pediatrics, Indianapolis, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL146936</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HL150244</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>J Liver Transpl</MedlineTA><NlmUniqueID>9918715987806676</NlmUniqueID><ISSNLinking>2666-9676</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hepatic artery thrombosis</Keyword><Keyword MajorTopicYN="N">Pediatric liver transplantation</Keyword><Keyword MajorTopicYN="N">Portal vein thrombosis</Keyword><Keyword MajorTopicYN="N">Vascular complications</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest Dr. Zinter&#x2019;s institution received funding from the National Heart, Lung, and Blood Institute (NHLBI) (K23HL146936). Drs. Zinter and Rowan received support for article research from the National Institutes of Health (NIH). Dr. Mangus received funding from F. Kohler-Chemie. Dr. Rowan&#x2019;s institution received funding from the NHLBI K23; she received funding from the NIH (K23HL150244). The remaining authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>3</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38037556</ArticleId><ArticleId IdType="mid">NIHMS1944338</ArticleId><ArticleId IdType="pmc">PMC10686788</ArticleId><ArticleId IdType="doi">10.1016/j.liver.2023.100185</ArticleId><ArticleId IdType="pii">100185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ng VL, Alonso EM, Bucuvalas JC, Cohen G, Limbers CA, Varni JW, Mazariegos G, et al. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr 2012;160:820&#x2013;826.e823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4144332</ArticleId><ArticleId IdType="pubmed">22192813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieders E, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, Zwaveling JH, Bijleveld CM, et al. Early vascular complications after pediatric liver transplantation. Liver Transpl 2000;6:326&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">10827234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly DA, Bucuvalas JC, Alonso EM, Karpen SJ, Allen U, Green M, Farmer D, et al. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:798&#x2013;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">23836431</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeek TA, Stine JG, Saner FH, Bezinover D. Hypercoagulability in End-stage Liver Disease: review of Epidemiology, Etiology, and Management. Transplant Direct 2018;4:e403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6233657</ArticleId><ArticleId IdType="pubmed">30534594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma N, Song Z, Dong C, Sun C, Meng X, Zhang W, Wang K, et al. Risk factors of hepatic artery thrombosis in pediatric deceased donor liver transplantation. Pediatr Surg Int 2019;35:853&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31203384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng V, Anand R, Martz K, Fecteau A. Liver retransplantation in children: a SPLIT database analysis of outcome and predictive factors for survival. Am J Transplant 2008;8:386&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">18211508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebel NH, Hsu EK, Dick AAS, Shaffer ML, Carlin K, Horslen SP. Decreased incidence of hepatic artery thrombosis in pediatric liver transplantation using technical variant grafts: report of the society of pediatric liver transplantation experience. J Pediatr 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9380891</ArticleId><ArticleId IdType="pubmed">32585237</ArticleId></ArticleIdList></Reference><Reference><Citation>Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. Thromboembolism prophylaxis in orthopaedics: an update. EFORT Open Rev 2018;3:136&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5941651</ArticleId><ArticleId IdType="pubmed">29780621</ArticleId></ArticleIdList></Reference><Reference><Citation>Voulgarelis S, Vitola B, Lerret SM, Hong JC, Scott JP. Perioperative anticoagulation practices for pediatric liver transplantation. Pediatr Transplant 2018;22:e13193.</Citation><ArticleIdList><ArticleId IdType="pubmed">29663585</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacoti M, Ruggeri GM, Colombo G, Bonanomi E, Lussana F. Thrombosis prophylaxis in pediatric liver transplantation: a systematic review. World J Hepatol 2018;10:752&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6206147</ArticleId><ArticleId IdType="pubmed">30386468</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Maue DK, Martinez M, Alcamo A, Beltramo F, Betters K, Nares M, Jeyapalan A, et al. Critical care and mechanical ventilation practices surrounding liver transplantation in children: a multicenter collaborative. Pediatr Crit Care Med 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">36278882</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacoti M, Corbella D, Fazzi F, Rapido F, Bonanomi E. Coagulopathy and transfusion therapy in pediatric liver transplantation. World J Gastroenterol 2016;22:2005&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4726674</ArticleId><ArticleId IdType="pubmed">26877606</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SK, Yi NJ, Hong K, Han ES, Lee JM, Choi Y, Lee KW, et al. Risk factors affecting outcomes in pediatric liver transplantation: a real-world single-center experience. Ann Transplant 2021;26:e929145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168285</ArticleId><ArticleId IdType="pubmed">34045429</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai CS, Sharma S, Gruessner A, Fishbein T, Kaufman S, Khan KM. Effect of small donor weight and donor-recipient weight ratio on the outcome of liver transplantation in children. Pediatr Transplant 2015;19:366&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25819141</ArticleId></ArticleIdList></Reference><Reference><Citation>Shackleton CR, Goss JA, Swenson K, Colquhoun SD, Seu P, Kinkhabwala MM, Rudich SM, et al. The impact of microsurgical hepatic arterial reconstruction on the outcome of liver transplantation for congenital biliary atresia. Am J Surg 1997;173:431&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9168083</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SS, Ramos-Gonzalez G, Staffa SJ, Labib Z, Kim HB, Vakili K. Donor-to-recipient weight ratio is a risk factor for hepatic artery thrombosis after whole-liver transplantation in children under 25kg. Pediatr Transplant 2020;24:e13623.</Citation><ArticleIdList><ArticleId IdType="pubmed">31828929</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirouzu Y, Kasahara M, Morioka D, Sakamoto S, Taira K, Uryuhara K, Ogawa K, et al. Vascular reconstruction and complications in living donor liver transplantation in infants weighing less than 6 kgs: the Kyoto experience. Liver Transpl 2006;12:1224&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">16868949</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R, Group SR. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant 2007;7:2165&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">17608834</ArticleId></ArticleIdList></Reference><Reference><Citation>Englesbe MJ, Kelly B, Goss J, Fecteau A, Mitchell J, Andrews W, Krapohl G, et al. Reducing pediatric liver transplant complications: a potential roadmap for transplant quality improvement initiatives within North America. Am J Transplant 2012;12:2301&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429726</ArticleId><ArticleId IdType="pubmed">22883313</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana A, Pallister Z, Halazun K, Cotton R, Guiteau J, Nalty CC, O&#x2019;Mahony CA, et al. Pediatric Liver Transplant Center Volume and the Likelihood of Transplantation. Pediatrics 2015;136:e99&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">26077479</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35427808</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0849</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European journal of medical genetics</Title><ISOAbbreviation>Eur J Med Genet</ISOAbbreviation></Journal><ArticleTitle>Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: An international retrospective cohort study.</ArticleTitle><Pagination><StartPage>104503</StartPage><MedlinePgn>104503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejmg.2022.104503</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1769-7212(22)00084-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Heritable thoracic aortic diseases (HTAD), typically entailing aortic complications, can be caused by pathogenic variants or likely pathogenic variants (PV/LPVs) in several genes, including fibrillin1 (FBN1), Actin Alpha2 (ACTA2) and genes encoding components of the transforming growth factor (TGF)-&#x3b2; signaling pathway. In addition to aortic complications, non-aortic cardiac disease such as impaired myocardial function and/or arrhythmia have been increasingly reported, mainly in Marfan syndrome with underlying FBN1 PV/LPVs and are acknowledged as additional causes of morbidity and mortality. The prevalence of these manifestations in the various HTAD entities is largely unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This international multicentre retrospective study collected data on patients with HTAD presenting non-aortic cardiac disease. A total of 9 centers from 7 different countries participated. Patients 12 years or older carrying a PV/LPV in one of the following genes: FBN1, TGFBR1, TGFBR2, TGFB2, TGFB3, SMAD3 and ACTA2 were screened. Non-aortic cardiac disease included impaired myocardial function and/or arrhythmia. Impaired myocardial function was defined as (a)symptomatic reduced ejection fraction (EF&lt;50%). Arrhythmias included atrial fibrillation (AF), atrial flutter (AFL), ventricular tachycardia (VT), ventricular fibrillation (VF) and (aborted) sudden cardiac death (presumed arrhythmogenic) (SCD).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Medical records of 3219 patients with HTAD were screened (2761, 385 and 73 carrying a PV/LPV in FBN1, in a TGF-&#x3b2; signaling gene and in ACTA2 respectively). Non-aortic cardiac disease was reported 142 times in 101 patients (3.1%) (age 37 [range 12-77] years, 39% female): 88 patients carrying an FBN1 PV/LPV and 13 carrying a PV/LPV in one of the TGF-&#x3b2; signaling genes. Neither impaired myocardial function nor arrhythmia was reported in screened patients carrying a PV/LPV in ACTA2. Among the 142 reported non-aortic cardiac diseases, 68 (48%) were impaired myocardial function, 47 (33%) were AF/AFL and 27 (19%) were VT/VF/SCD. Among the patients with non-aortic cardiac disease, prior cardiac surgery was noted in 80% and severe valvular disease (valvular surgery or severe valvular regurgitation) in 58%, while 18% of the patients developed non-aortic cardiac disease in the absence of any of the latter.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with HTAD, arrhythmia and impaired myocardial function was reported in patients with PV/LPVs in FBN1 and in the TGF-&#x3b2; signaling genes and not in patients harboring PV/LPVs in ACTA2. Though infrequent, non-aortic cardiac disease should be acknowledged as potentially severe, also occurring in young patients with no underlying significant valvular or aortic disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Demolder</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium; Department of Cardiology, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianco</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pediatric Cardiology Department, Universitat Aut&#xf2;noma Barcelona, Hospital Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caruana</LastName><ForeName>Maryanne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Mater Dei Hospital, Birkirkara Bypass, Malta; VASCERN HTAD Affiliated Partner Centre, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervi</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evangelista</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, CIBER-CV, Spain; VASCERN HTAD European Reference Centre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jondeau</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>VASCERN HTAD European Reference Centre, Belgium; Centre de r&#xe9;f&#xe9;rence pour le syndrome de Marfan et apparent&#xe9;s, AP-HP, H&#xf4;pital Bichat, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buttigieg</LastName><ForeName>Lisa Lauren</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Mater Dei Hospital, Birkirkara Bypass, Malta; VASCERN HTAD Affiliated Partner Centre, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Sainz</LastName><ForeName>&#xc1;ngela</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, CIBER-CV, Spain; VASCERN HTAD European Reference Centre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delm&#xe1;s</LastName><ForeName>Elena Monta&#xf1;&#xe9;s</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Instituto Pedi&#xe1;trico del Coraz&#xf3;n, Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pini</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Genetic Centre, IRCCS Policlinico San Donato, San Donato Milanese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabat&#xe9;-Rot&#xe9;s</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Cardiology Department, Universitat Aut&#xf2;noma Barcelona, Hospital Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sz&#xf6;cs</LastName><ForeName>Katalin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>VASCERN HTAD European Reference Centre, Belgium; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Hospital Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tchitchinadze</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>VASCERN HTAD European Reference Centre, Belgium; Centre de r&#xe9;f&#xe9;rence pour le syndrome de Marfan et apparent&#xe9;s, AP-HP, H&#xf4;pital Bichat, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixid&#xf3;-Tura</LastName><ForeName>Gisela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, CIBER-CV, Spain; VASCERN HTAD European Reference Centre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Kodolitsch</LastName><ForeName>Yskert</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>VASCERN HTAD European Reference Centre, Belgium; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Hospital Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mui&#xf1;o-Mosquera</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium; VASCERN HTAD European Reference Centre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Backer</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium; VASCERN HTAD European Reference Centre, Belgium; Department of Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium; Department of Cardiology, Ghent University Hospital, Ghent, Belgium. Electronic address: Julie.DeBacker@UGent.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Med Genet</MedlineTA><NlmUniqueID>101247089</NlmUniqueID><ISSNLinking>1769-7212</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000199">Actins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000199" MajorTopicYN="N">Actins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001018" MajorTopicYN="Y">Aortic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008382" MajorTopicYN="Y">Marfan Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35427808</ArticleId><ArticleId IdType="doi">10.1016/j.ejmg.2022.104503</ArticleId><ArticleId IdType="pii">S1769-7212(22)00084-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32268210</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2763</ISSN><JournalIssue CitedMedium="Internet"><Volume>136</Volume><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Bone</Title><ISOAbbreviation>Bone</ISOAbbreviation></Journal><ArticleTitle>Identification of prevalent vertebral fractures using Vertebral Fracture Assessment (VFA) in asymptomatic postmenopausal women: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>115358</StartPage><MedlinePgn>115358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bone.2020.115358</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S8756-3282(20)30138-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Vertebral fracture (VF) is the most common osteoporotic fracture in postmenopausal women, although most VFs are subclinical. Prevalent VFs are a significant predictor of subsequent fracture and therefore, identification of VF improves the identification of those with high fracture risk. The aim of present study was to systematically review the literature that assessed the prevalence of VF in asymptomatic postmenopausal women, using Vertebral Fracture Assessment (VFA) by dual-energy X-ray absorptiometry.</AbstractText><AbstractText Label="METHOD">Medline, Web of Science and Cochrane databases were searched between Jan 1st, 2000 and Jan 31st, 2018, for publications in English that reported the prevalence of VFA-detected VF in asymptomatic postmenopausal women. We also searched for reports, conference papers and grey literature. Reviewers screened studies for eligibility and extracted data for included studies. Random effects meta-analyses were performed to calculate the prevalence of VF. The presence of publication bias was assessed using funnel plots by precision and Egger's Test of the Intercept.</AbstractText><AbstractText Label="RESULTS">A total of 1777 articles were identified, 94 studies were fully reviewed and 28 studies (n&#xa0;=&#xa0;25,418) met the inclusion criteria and were analyzed. More than two thirds of the studies were cross-sectional and the sample size varied widely across the studies (from 63 to 5156). The mean age ranged from 59.5 to 86.2&#xa0;years old. The prevalence of osteoporosis and osteopenia varied between 6-57.0% and 25.1-58.9%, respectively. However, among women who had prevalent VFs, up to 43% had osteopenia and as many as 32% had normal bone density. The weighted pooled prevalence of VFA-detected VF in asymptomatic women was 28% (95% CI: 23%-32%).</AbstractText><AbstractText Label="CONCLUSION">VFA is able to identify prevalent VF in asymptomatic postmenopausal women. The use of VFA identified an average of 28% of asymptomatic women with VFs, many of whom did not have a diagnosis of osteoporosis. Implementation of VFA as a routine screening tool may detect high risk women. Detection of VF might lead to pharmacological treatment in individuals who may not otherwise be treated.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jingyan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Social and Economic Research and Policy (ISERP), Columbia University, New York, NY, USA; Patient Health and Impact, Pfizer Inc., New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Yushan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, The Affiliated Hospital of Medical School, Ningbo University, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieves</LastName><ForeName>Jeri W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; Hospital for Special Surgery, New York, NY, USA. Electronic address: jwn5@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bone</MedlineTA><NlmUniqueID>8504048</NlmUniqueID><ISSNLinking>1873-2763</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015663" MajorTopicYN="Y">Osteoporosis, Postmenopausal</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="Y">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Postmenopausal women</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Vertebral Fracture Assessment</Keyword><Keyword MajorTopicYN="N">Vertebral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32268210</ArticleId><ArticleId IdType="doi">10.1016/j.bone.2020.115358</ArticleId><ArticleId IdType="pii">S8756-3282(20)30138-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39110371</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1863-2491</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of robotic surgery</Title><ISOAbbreviation>J Robot Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis compared the safety and effectiveness of the AirSeal system with traditional pneumoperitoneum systems in robot-assisted laparoscopic urologic surgery.</ArticleTitle><Pagination><StartPage>311</StartPage><MedlinePgn>311</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11701-024-02061-y</ELocationID><Abstract><AbstractText>This study aimed to analyze perioperative results in robot-assisted laparoscopic urological surgeries, comparing the AirSeal system with traditional pneumoperitoneum systems. This study adhered to the PRISMA guidelines for conducting systematic reviews and meta-analyses. Extensive searches were conducted in PubMed, EMBASE, and Google Scholar, including randomized controlled trials (RCTs) and cohort studies up to June 15, 2024. A combined examination of the studies found that the AirSeal system had superior results in terms of surgery duration, end-tidal carbon dioxide levels, and tidal volume compared to the traditional pneumoperitoneum system. During robotic-assisted partial nephrectomy, the AirSeal team experienced a notable decrease in surgical time, ETCO2, and VT. In addition, the occurrence of SCE was lower in the AirSeal group. However, there were no significant differences observed between the groups regarding EBL, LOHS, overall complications, and major complications. Compared to conventional pneumoperitoneum systems, the AirSeal system offers several advantages in robot-assisted laparoscopic urological surgery: reduced operative time, lower end-tidal CO<sub>2</sub> pressure, and decreased tidal volume. Furthermore, implementing the AirSeal system does not lead to higher rates of complications, estimated blood loss, or lengthier hospital stays.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Urology, Langzhong People's Hospital, Sichuan Province, Nanchong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, Langzhong People's Hospital, Sichuan Province, Nanchong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yan-Xin</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Langzhong People's Hospital, Sichuan Province, Nanchong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Urology, Langzhong People's Hospital, Sichuan Province, Nanchong, China. uroyang@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Robot Surg</MedlineTA><NlmUniqueID>101300401</NlmUniqueID><ISSNLinking>1863-2483</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011028" MajorTopicYN="Y">Pneumoperitoneum, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013520" MajorTopicYN="Y">Urologic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="Y">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009392" MajorTopicYN="N">Nephrectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AirSeal</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Robot-assisted</Keyword><Keyword MajorTopicYN="N">Urology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>7</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>7</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>7</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39110371</ArticleId><ArticleId IdType="doi">10.1007/s11701-024-02061-y</ArticleId><ArticleId IdType="pii">10.1007/s11701-024-02061-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barczy&#x144;ski M, Herman RM (2002) Influence of different pressures of pneumoperitoneum on the autonomic system function during laparoscopy. Folia Med Cracov 43(1&#x2013;2):51&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">12815798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazebroek EJ, Haitsma JJ, Lachmann B et al (2002) Impact of carbon dioxide and helium insufflation on cardiorespiratory function during prolonged pneumoperitoneum in an experimental rat model. Surg Endosc 16(7):1073&#x2013;1078. https://doi.org/10.1007/s00464-001-8248-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-001-8248-x</ArticleId><ArticleId IdType="pubmed">12165825</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamine TH, Papavassiliou E, Schneider BE (2014) Effect of abdominal insufflation for laparoscopy on intracranial pressure. JAMA Surg 149(4):380&#x2013;382. https://doi.org/10.1001/jamasurg.2013.3024</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2013.3024</ArticleId><ArticleId IdType="pubmed">24522521</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh BK, Shah VR, Modi PR, Butala BP, Parikh GP (2013) Anaesthesia for laparoscopic kidney transplantation: influence of trendelenburg position and CO2 pneumoperitoneum on cardiovascular, respiratory and renal function. Indian J Anaesth 57(3):253&#x2013;258. https://doi.org/10.4103/0019-5049.115607</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.115607</ArticleId><ArticleId IdType="pubmed">23983283</ArticleId><ArticleId IdType="pmc">3748679</ArticleId></ArticleIdList></Reference><Reference><Citation>Oksar M, Akbulut Z, Ocal H, Balbay MD, Kanbak O (2014) Anesthetic considerations for robotic cystectomy: a prospective study. Braz J Anesthesiol 64(2):109&#x2013;115. https://doi.org/10.1016/j.bjane.2013.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjane.2013.09.008</ArticleId><ArticleId IdType="pubmed">24794453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gainsburg DM (2012) Anesthetic concerns for robotic-assisted laparoscopic radical prostatectomy. Minerva Anestesiol 78(5):596&#x2013;604</Citation><ArticleIdList><ArticleId IdType="pubmed">22415437</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Muhsin HM, Humphreys MR (2016) Advances in laparoscopic urologic surgery techniques. F1000Res. https://doi.org/10.12688/f1000research.7660.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.7660.1</ArticleId><ArticleId IdType="pubmed">27134743</ArticleId><ArticleId IdType="pmc">4841198</ArticleId></ArticleIdList></Reference><Reference><Citation>Annino F (2017) Robotic partial nephrectomy performed with airseal versus a standard CO2 pressure pneumoperitoneum insufflator: a prospective comparative study. Surg Endosc 31(4):1583&#x2013;1590</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-016-5144-y</ArticleId><ArticleId IdType="pubmed">27495337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Zou Q, Jiang B, Li Q (2024) Perioperative outcomes and safety of valveless insufflation system in minimally invasive urological surgery: a systematic review and meta-analysis. Int J Surg. https://doi.org/10.1097/JS9.0000000000001634</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JS9.0000000000001634</ArticleId><ArticleId IdType="pubmed">39715142</ArticleId><ArticleId IdType="pmc">11634115</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A (2020) DEPRESsion Screening data (DEPRESSD) collaboration estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res 29(9):2520&#x2013;2537. https://doi.org/10.1177/0962280219889080</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280219889080</ArticleId><ArticleId IdType="pubmed">32292115</ArticleId><ArticleId IdType="pmc">7390706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoub CH, Armache AK, El-Asmar JM et al (2023) The impact of AirSeal&#xae; on complications and pain management during robotic-assisted radical prostatectomy: a single-tertiary center study. World J Urol 41(10):2685&#x2013;2692. https://doi.org/10.1007/s00345-023-04573-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-023-04573-y</ArticleId><ArticleId IdType="pubmed">37704868</ArticleId></ArticleIdList></Reference><Reference><Citation>George AK, Wimhofer R, Viola KV et al (2015) Utilization of a novel valveless trocar system during robotic-assisted laparoscopic prostatectomy. World J Urol 33(11):1695&#x2013;1699. https://doi.org/10.1007/s00345-015-1521-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-015-1521-8</ArticleId><ArticleId IdType="pubmed">25725807</ArticleId></ArticleIdList></Reference><Reference><Citation>Horstmann M, Horton K, Kurz M, Padevit C, John H (2013) Prospective comparison between the airseal &#xae; system valve-less trocar and a standard versaport &#x2122; plus V2 trocar in robotic-assisted radical prostatectomy. J Endourol 27(5):579&#x2013;582. https://doi.org/10.1089/end.2012.0632</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/end.2012.0632</ArticleId><ArticleId IdType="pubmed">23186377</ArticleId></ArticleIdList></Reference><Reference><Citation>Otaola-Arca H, Mej&#xed;as O, Bravo JC et al (2023) Impact of insufflator/aspirator versus exclusive insufflator during robotic radical prostatectomy: a comparative prospective cohort study. Ann Med Surg (Lond) 85(5):1480&#x2013;1485. https://doi.org/10.1097/MS9.0000000000000512</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MS9.0000000000000512</ArticleId><ArticleId IdType="pubmed">37229062</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahait M, Cockrell R, Yezdani M et al (2019) Improved outcomes utilizing a valveless-trocar system during robot-assisted radical prostatectomy RARP. JSLS 23(1):e2018.00085. https://doi.org/10.4293/JSLS.2018.00085</Citation><ArticleIdList><ArticleId IdType="doi">10.4293/JSLS.2018.00085</ArticleId><ArticleId IdType="pubmed">30740014</ArticleId><ArticleId IdType="pmc">6364705</ArticleId></ArticleIdList></Reference><Reference><Citation>Abaza R, Martinez O, Murphy C (2021) Randomized controlled comparison of valveless trocar (AirSeal) vs standard insufflator with ultralow pneuomoperitoneum during robotic prostatectomy. J Endourol 35(7):1020&#x2013;1024. https://doi.org/10.1089/end.2020.1025</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/end.2020.1025</ArticleId><ArticleId IdType="pubmed">33349135</ArticleId></ArticleIdList></Reference><Reference><Citation>Covotta M, Claroni C, Torregiani G et al (2017) A prospective, randomized, clinical trial on the effects of a valveless trocar on respiratory mechanics during robotic radical cystectomy: a pilot study. Anesth Analg 124(6):1794&#x2013;1801. https://doi.org/10.1213/ANE.0000000000002027</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002027</ArticleId><ArticleId IdType="pubmed">28452822</ArticleId></ArticleIdList></Reference><Reference><Citation>Desroches B, Porter J, Bhayani S, Figenshau R, Liu PY, Stifelman M (2021) Comparison of the safety and efficacy of valveless and standard insufflation during robotic partial nephrectomy: a prospective, randomized. Multi-institutional Trial Urol 153:185&#x2013;191. https://doi.org/10.1016/j.urology.2021.01.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2021.01.047</ArticleId><ArticleId IdType="pubmed">33577899</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng TS, Heulitt G, Islam A, Porter JR (2021) Comparison of valve-less and standard insufflation on pneumoperitoneum-related complications in robotic partial nephrectomy: a prospective randomized trial. J Robot Surg 15(3):381&#x2013;388. https://doi.org/10.1007/s11701-020-01117-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11701-020-01117-z</ArticleId><ArticleId IdType="pubmed">32632561</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei M, Yang W, Zhou J et al (2024) Comparison of airseal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial. World J Urol 42(1):90. https://doi.org/10.1007/s00345-024-04819-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-024-04819-3</ArticleId><ArticleId IdType="pubmed">38381369</ArticleId><ArticleId IdType="pmc">10881696</ArticleId></ArticleIdList></Reference><Reference><Citation>Herati AS, Atalla MA, Rais-Bahrami S, Andonian S, Vira MA, Kavoussi LR (2009) A new valve-less trocar for urologic laparoscopy: initial evaluation. J Endourol 23(9):1535&#x2013;1539. https://doi.org/10.1089/end.2009.0376</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/end.2009.0376</ArticleId><ArticleId IdType="pubmed">19694520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H, Clymer JW, Chen BPH et al (2018) Prolonged operative duration is associated with complications: a systematic review and meta-analysis. J Surg Res 229:134&#x2013;144. https://doi.org/10.1002/aorn.12794</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aorn.12794</ArticleId><ArticleId IdType="pubmed">29936980</ArticleId></ArticleIdList></Reference><Reference><Citation>Celarier S, Monziols S, C&#xe9;l&#xe9;rier B et al (2021) Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial. Br J Surg 108(8):998&#x2013;1005. https://doi.org/10.1093/bjs/znab069</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjs/znab069</ArticleId><ArticleId IdType="pubmed">33755088</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H, Chen BPH, Soleas IM, Ferko NC, Cameron CG, Hinoul P (2017) Prolonged operative duration increases risk of surgical site infections: a systematic review. Surg Infect (Larchmt) 18(6):722&#x2013;735. https://doi.org/10.1089/sur.2017.089</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2017.089</ArticleId><ArticleId IdType="pubmed">28832271</ArticleId></ArticleIdList></Reference><Reference><Citation>Procter LD, Davenport DL, Bernard AC, Zwischenberger JB (2010) General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay. J Am Coll Surg 210(1):60-65e2. https://doi.org/10.1016/j.jamcollsurg.2009.09.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2009.09.034</ArticleId><ArticleId IdType="pubmed">20123333</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillelsohn JH, Friedlander JI, Bagadiya N et al (2013) Masked pneumothorax: risk of valveless trocar systems. J Urol 189(3):955&#x2013;959. https://doi.org/10.1016/j.juro.2012.08.244</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2012.08.244</ArticleId><ArticleId IdType="pubmed">23017523</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauh R, Hemmerling TM, Rist M, Jacobi KE (2001) Influence of pneumoperitoneum and patient positioning on respiratory system compliance. J Clin Anesth 13(5):361&#x2013;365. https://doi.org/10.1016/s0952-8180(01)00286-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0952-8180(01)00286-0</ArticleId><ArticleId IdType="pubmed">11498317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall AP, Bhatt S, Oh TE (1995) Pulmonary consequences of carbon dioxide insufflation for laparoscopic cholecystectomies. Anaesthesia 50(4):286&#x2013;289. https://doi.org/10.1111/j.1365-2044.1995.tb04600.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.1995.tb04600.x</ArticleId><ArticleId IdType="pubmed">7747841</ArticleId></ArticleIdList></Reference><Reference><Citation>Razdan S, Ucpinar B, Okhawere KE, Badani KK (2023) The role of airseal in robotic urologic surgery: a systematic review. J Laparoendosc Adv Surg Tech 33(1):21&#x2013;31. https://doi.org/10.1089/lap.2022.0153</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2022.0153</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao K, Reichert J, Beebe DS, Fowler JM, Belani KG (1999) Carbon dioxide embolism during laparoscopy: effect of insufflation pressure in pigs. JSLS 3(2):91&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">10444005</ArticleId><ArticleId IdType="pmc">3015330</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40580760</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2653</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia</Title><ISOAbbreviation>J Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Stereotactic radiosurgery for optic nerve sheath meningiomas: A comprehensive systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>111432</StartPage><MedlinePgn>111432</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jocn.2025.111432</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0967-5868(25)00405-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Optic nerve sheath meningiomas (ONSMs) are rare brain neoplastic lesions that account for 2% of meningiomas. Despite the benign and slow-growing behavior of ONSMs, these lesions can result in irreversible blindness. Radiotherapy (RT) is one of the main therapeutic options for the management of ONSMs. Stereotactic radiosurgery (SRS) has demonstrated favorable outcomes in patients with ONSMs. This systematic review and meta-analysis aimed to evaluate local control (LC), preservation of visual field (VF)/visual acuity (VA), and radiation-induced neuropathy/retinopathy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">On March 17, 2025, four electronic databases, PubMed, Embase, Scopus, and Web of Science, were searched. Studies that evaluated the efficacy and safety of SRS in ONSMs were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven studies involving 149 patients were included. The mean follow-up duration ranged from 30 to 116.86&#xa0;months. The meta-analysis reported a pooled LC rate of 95&#xa0;% (95&#xa0;% CI: 90&#xa0;%-98&#xa0;%). The pooled estimates for VA and VF preservation were 91&#xa0;% (95&#xa0;% CI: 76&#xa0;%-100&#xa0;%) and 94&#xa0;% (95&#xa0;% CI: 68&#xa0;%-100&#xa0;%), respectively. Additionally, the meta-analysis found a pooled radiation-induced neuropathy/retinopathy rate of 0&#xa0;% (95&#xa0;% CI: 0&#xa0;%-3%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SRS demonstrated promising clinical and radiological outcomes in patients with ONSMs. SRS has comparable results to those of the other RT modalities. Further studies with large sample sizes are required to compare SRS and RT modalities.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hajikarimloo</LastName><ForeName>Bardia</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Virginia, Charlottesville, VA, USA. Electronic address: bardii47@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tos</LastName><ForeName>Salem M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadzadeh</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Skull Base Research Center, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahabi</LastName><ForeName>Kimiya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amjadzadeh</LastName><ForeName>Mohammadreza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golkar</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvani</LastName><ForeName>Mohammadamin Sabbagh</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habibi</LastName><ForeName>Mohammad Amin</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Clin Neurosci</MedlineTA><NlmUniqueID>9433352</NlmUniqueID><ISSNLinking>0967-5868</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008577" MajorTopicYN="Y">Meningeal Neoplasms</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008579" MajorTopicYN="Y">Meningioma</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019574" MajorTopicYN="Y">Optic Nerve Neoplasms</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016634" MajorTopicYN="Y">Radiosurgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cyberknife</Keyword><Keyword MajorTopicYN="N">Gamma knife</Keyword><Keyword MajorTopicYN="N">Meningioma</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Optic Nerve</Keyword><Keyword MajorTopicYN="N">Optic nerve sheath</Keyword><Keyword MajorTopicYN="N">Radiosurgery</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>9</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>4</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>28</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40580760</ArticleId><ArticleId IdType="doi">10.1016/j.jocn.2025.111432</ArticleId><ArticleId IdType="pii">S0967-5868(25)00405-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38326210</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Association between self-reported functional capacity and general postoperative complications: analysis of predefined outcomes of the MET-REPAIR international cohort study.</ArticleTitle><Pagination><StartPage>811</StartPage><EndPage>814</EndPage><MedlinePgn>811-814</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2024.01.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(24)00005-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany; CARID (Cardiovascular Research Institute D&#xfc;sseldorf), University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M'Pembele</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany; CARID (Cardiovascular Research Institute D&#xfc;sseldorf), University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany. Electronic address: Rene.MPembele@med.uni-duesseldorf.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nienhaus</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany; CARID (Cardiovascular Research Institute D&#xfc;sseldorf), University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauermann</LastName><ForeName>Eckhard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ionescu</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care I, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krak&#xf3;w, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Hert</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Ghent University Hospital, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipovic</LastName><ForeName>Miodrag</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, Rescue and Pain Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beck-Schimmer</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Anaesthesiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadaro</LastName><ForeName>Savino</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matute</LastName><ForeName>Purificaci&#xf3;n</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Hospital Clinic of Barcelona, Universidad de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolliger</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turhan</LastName><ForeName>Sanem C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and ICU, Ankara University Medical School, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Waes</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University Medical Center Utrecht, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagarto</LastName><ForeName>Filipa</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hospital Beatriz &#xc2;ngelo, Loures, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodoraki</LastName><ForeName>Kassiani</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care, Karolinska Hospital and Institution for Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillmann</LastName><ForeName>Hans-J&#xf6;rg</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzzetti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Department, University Hospital, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotfis</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wulf</LastName><ForeName>Hinnerk</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, University Hospital Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larmann</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corneci</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Carol Davila University of Medicine and Pharmacy Bucharest Head of Anesthesia and Intensive Care Department I, Central Military Emergency University Hospital "Dr. Carol Davila", Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chammartin</LastName><ForeName>Fr&#xe9;d&#xe9;rique</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howell</LastName><ForeName>Simon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lurati Buse</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany; CARID (Cardiovascular Research Institute D&#xfc;sseldorf), University Hospital D&#xfc;sseldorf, Heinrich Heine University D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>MET: Reevaluation for Perioperative Cardiac Risk Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Br J Anaesth. 2024 Jun;132(6):1346-1347. doi: 10.1016/j.bja.2024.03.002.</RefSource><PMID Version="1">38521659</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">effort tolerance</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">preoperative</Keyword><Keyword MajorTopicYN="N">risk assessment</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Roth</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>M'Pembele</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nienhaus</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kemper</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kohaupt</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Witzler</LastName><ForeName>Jette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tuzhikov</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stroda</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tenge</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Huhn</LastName><ForeName>Ragnar</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schultze</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Verbarg</LastName><ForeName>Nele</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gehrke</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Klemann</LastName><ForeName>Anna Katharina</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hageb&#xf6;lling</LastName><ForeName>Friederike</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Albrecht</LastName><ForeName>Svenja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Marburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stroeder</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital Marburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schubert</LastName><ForeName>Ann-Kristin</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>University Hospital Marburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Espeter</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Heidelberg University Hospital, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Russe</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Heidelberg University Hospital, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Weigand</LastName><ForeName>Markus A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Heidelberg University Hospital, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bergmann</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University Hospital Knappschaftskrankenhaus Bochum, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Unterberg</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Knappschaftskrankenhaus Bochum, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bischoff</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Marien Hospital Herne, Ruhr University Bochum, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pirzer</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Augsburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rach</LastName><ForeName>Patric Rene</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Augsburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ott</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinikum Augsburg, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zarbock</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kowark</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital RWTH Aachen, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Neumann</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marchand</LastName><ForeName>Bahareh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sponholz</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rueffert</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Helios Klinik Schkeuditz, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kramer</LastName><ForeName>Mira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Witten / Herdecke - Hospital Center Merheim Cologne, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Piekarski</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University Hospital Frankfurt, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carollo</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Novazzi</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Toso</LastName><ForeName>Fiorenza</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bacuzzi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ragazzi</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arcispedale Sant'Anna Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Volta</LastName><ForeName>Carlo Alberto</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Arcispedale Sant'Anna Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Giorgi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arcispedale Sant'Anna Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bacer</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Azienda USL Di Bologna, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Federico</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Azienda USL Di Bologna, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chiumello</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vetrugno</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Asuiud, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Castella</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ospedale San Raffaele IRCCS, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tesoro</LastName><ForeName>Simonetta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Perugia Hospital Santa Maria della Misericordia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cotoia</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital of Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bignami</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliero universitaria di Parma, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bellissima</LastName><ForeName>Agrippino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arnas Garibaldi, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Policlinico P. Giaccone, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Crisman</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Azienda Sanitaria Universitaria Integrata di Trieste, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Toninelli</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASST Spedali Civili Brescia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Piazza</LastName><ForeName>Ornella</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University of Salerno-AOU San Giovanni di Dio e Ruggi D'Aragona, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mirabella</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bossolasco</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ASL CN1, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bona</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>FPO IRCCS CANDIOLO, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Perdomo</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nic. UB. Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coca-Martinez</LastName><ForeName>Miquel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nic. UB. Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carrami&#xf1;ana</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nic. UB. Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Serv&#xe9;n</LastName><ForeName>Marta Gin&#xe9;</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Hospital de la Santa Creu i Sant Pau, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Astrid Batalla</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Hospital de la Santa Creu i Sant Pau, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gil S&#xe1;nchez</LastName><ForeName>Jos&#xe9; Maria</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital de la Santa Creu i Sant Pau, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Becerra-Bola&#xf1;os</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Gran Canaria Doctor Negrin, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rodr&#xed;guez-P&#xe9;rez</LastName><ForeName>Aurelio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Gran Canaria Doctor Negrin, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soler</LastName><ForeName>Anna Artigas</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Corporacio sanitaria Parc Tauli, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Basso</LastName><ForeName>Morena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Corporacio sanitaria Parc Tauli, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Font</LastName><ForeName>Anna Peig</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Corporacio sanitaria Parc Tauli, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vernetta</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundacion Puigvert, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Julia Hernando</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Princesa, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Enrique Alday</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Princesa, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Olivares</LastName><ForeName>Mercedes Cabellos</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>University Hospital of Guadalajara, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marco</LastName><ForeName>Gregorio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Santa Maria, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lopez</LastName><ForeName>Maria Bermudez</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Hospital Universitario Lucus Augusti, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barrio</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitari Doctor Peset, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>For&#xe9;s</LastName><ForeName>Mar&#xed;a Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Hospital Arnau De Vilanova-Lliria, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Boix</LastName><ForeName>Estefan&#xed;a</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Arnau De Vilanova-Lliria, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ayuso</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario Pr&#xed;ncipe de Asturias, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Petre</LastName><ForeName>Bogdan Sorel</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Central Military University Emergency Hospital from Romania, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oprea</LastName><ForeName>Ioana Sorina</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Central Military University Emergency Hospital from Romania, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lati&#x219;</LastName><ForeName>Mihai Dan</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Central Military University Emergency Hospital from Romania, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Margarit</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Regional Institute of Gastroenterology and Hepatology "Prof Dr Octavian Fodor" Cluj Napoca, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vasian</LastName><ForeName>Horatiu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Regional Institute of Gastroenterology and Hepatology "Prof Dr Octavian Fodor" Cluj Napoca, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tomescu</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>C&#xee;ndea</LastName><ForeName>Iulia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Constanta County Emergency Clinical Hospital, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dirzu</LastName><ForeName>Dan Sebastian</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Emergency county hospital cluj, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Copotoiu</LastName><ForeName>Sanda-Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Spital Clinic Judetean de Urgenta Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moise</LastName><ForeName>Alida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Prof Dr Gerota Hospital, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bubenek-Turconi</LastName><ForeName>Serban</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Institute for CardioVascular Diseases Prof. Dr. C.C.Iliescu, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Valeanu</LastName><ForeName>Liana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Emergency Institute for CardioVascular Diseases Prof. Dr. C.C.Iliescu, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wanner</LastName><ForeName>Patrick Mark</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Kantonsspital St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Djurdjevic</LastName><ForeName>Mirjana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kantonsspital St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nuth</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kantonsspital St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Seeberger</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Basel University Hospital, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Goettel</LastName><ForeName>Nicolai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Basel University Hospital, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kamber</LastName><ForeName>Firmin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Basel University Hospital, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ganter</LastName><ForeName>Michael Thomas</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Kantonsspital Winterthur, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gerber</LastName><ForeName>Thomas Jan</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Kantonsspital Winterthur, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schneebeli</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kantonsspital Winterthur, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pregernig</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Zurich, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grape</LastName><ForeName>Sina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H&#xf4;pital du Valais, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tomala</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Bernardo Bollen</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>&#x17b;ukowski</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pomeranian Medical University, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zegan-Bara&#x144;ska</LastName><ForeName>Ma&#x142;gorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pomeranian Medical University, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karolak</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pomeranian Medical University, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Krzych</LastName><ForeName>Lukasz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical University of Silesia, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Czajka</LastName><ForeName>Szymon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical University of Silesia, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Studzi&#x144;ska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St John Grande Hospital, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kluzik</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Heliodor Swiecicki Clinical Hospital at Poznan University of Medical Sciences, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koszel</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Heliodor Swiecicki Clinical Hospital at Poznan University of Medical Sciences, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pabja&#x144;czyk</LastName><ForeName>Izabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>The University Hospital in Krakow, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gajdosz</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St. Raphael Hospital, Poland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Erkoc</LastName><ForeName>Suheyla Karadag</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Ankara University Medical School, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meco</LastName><ForeName>Basak Ceyda</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Ankara University Medical School, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koltka</LastName><ForeName>Ahmet Kemalettin</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Istanbul University Istanbul Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dincer</LastName><ForeName>Muserref Beril</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Istanbul University Istanbul Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ekmek&#xe7;i</LastName><ForeName>Perihan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ufuk University Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Kemal Tolga</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Kocaeli Derince Training and Research Hospital, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Solmaz</LastName><ForeName>Filiz Alkaya</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Suleyman Demirel University School of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ozcelik</LastName><ForeName>Menekse</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ankara University School of Medicine Cebeci Hospital, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arun</LastName><ForeName>Oguzhan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Selcuk University Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dilmen</LastName><ForeName>Ozlem Korkmaz</ForeName><Initials>OK</Initials><AffiliationInfo><Affiliation>Istanbul University- Cerrahpasa, Cerrahpasa Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Preckel</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, location AMC, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hollmann</LastName><ForeName>Markus W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, location AMC, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hazen</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University Medical Center Utrecht, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Donald de Boer</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Martini General Hospital Groningen, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Epema</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Medical Center Groningen (UMCG), Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koopman</LastName><ForeName>Seppe</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Maasstad Hospital, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Van Lier</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Erasmus MC, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Beatriz &#xc2;ngelo, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carr&#xe3;o</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Beatriz &#xc2;ngelo, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital Beatriz &#xc2;ngelo, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mour&#xe3;o</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coelho</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Baixo Vouga, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Vila Nova de Gaia / Espinho, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cabral</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital de Santo Esp&#xed;rito da Ilha Terceira, E.P.E.R., Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Afonso</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Entre Douro e Vouga, EPE, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zenha</LastName><ForeName>S&#xe9;rgio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Central do Funchal, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ramos</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital de Sta. Marta, CHLC, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hip&#xf3;lito</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital de Braga, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vasilaki</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>General Hospital of Athens "G. Gennimatas", Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Andreeva</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Hospital of Athens "G. Gennimatas", Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zaimi</LastName><ForeName>Donika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>General Hospital of Thessaloniki "Ippokratio", Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chalkias</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tzaneio General Hospital of Piraeus, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Spyraki</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital of Patras, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rekatsina</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aretaieion University Hospital, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tsaousi</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ahepa University Hospital, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wrightington, Wigan and Leigh NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meier</LastName><ForeName>Sonja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Guys and St Thomas NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Madhuri</LastName><ForeName>Thumuluru Kavitha</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Royal Surrey NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Latham</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Bolton Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Knock</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>York Teaching Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Drummond</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Royal Oldham Hospital - The Pennine Acute Hospitals NHS Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ramsden</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Queen Victoria Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kubisz-Pudelko</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Yeovil Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal Bournemouth Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moppett</LastName><ForeName>Iain</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Nottingham University Hospital: Queen's Medical Centre, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>St James' University Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stockport NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Reschreiter</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Poole Hospital NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Innes</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Musgrove Park Hospital, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Link&#xf6;ping University Hospital, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kalman</LastName><ForeName>Sigridur</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Karolinska University Hospital and Karolinska Institutet, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wallden</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sundsvall Hospital, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schening</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Karolinska Institute Physiology and Pharmacology, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jonikaite</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Uppsala University Hospital, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Enlund</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Uppsala University, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Baerdemaeker</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Morrison</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Antwerp University Hospital, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rex</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospitals Leuven, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alexis</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Saint-Pierre, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khoronenko</LastName><ForeName>Viktoria E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>P.A. Herzen Moscow Cancer Research Institute, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ovezov</LastName><ForeName>Alexey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Moscow Regional Research Clinical Institute, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Belskii</LastName><ForeName>Vladislav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Privolzhskiy District Medical Center, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kaznacheeva</LastName><ForeName>Kseniya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Privolzhskiy District Medical Center, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gritsan</LastName><ForeName>Alexey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Krasnoyrask Regional Clinical Hospital, Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kuzmanovska</LastName><ForeName>Biljana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinic for Anesthesiology, Reanimation and Inrrrtensive Care Medicine, Republic of North Macedonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Malinovska-Nikolovska</LastName><ForeName>Liljana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>GOB 8-mi Septemvri, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barisin</LastName><ForeName>Stjepan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Dubrava, J.J. Strossmayer University of Osijek, Faculty of Medicine, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Poredos</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Medical Centre Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arabadzhieva</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital Kaneff Ruse, Bulgaria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Unic-Stojanovic</LastName><ForeName>Dragana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Institute Dedinje, Serbia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Golubovi&#x107;</LastName><ForeName>Mladjan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Center Nis, Serbia, Serbia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kotzinger</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Klinikum Wels Grieskirchen, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Des Deserts</LastName><ForeName>Marc Danguy</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Military Teaching Hospital Clermont Tonnerre, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ducrocq</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinique du Mill&#xe9;naire, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Buggy</LastName><ForeName>Donal J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Mater University Hospital, University College Dublin, Ireland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bonnet</LastName><ForeName>Jean Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Mater University Hospital, University College Dublin, Ireland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cusack</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mater University Hospital, University College Dublin, Ireland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Calleja</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Malta.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hasani</LastName><ForeName>Antigona</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Prishtina, Faculty of Medicine, Kosovo.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nallbani</LastName><ForeName>Rajmonda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Prishtina, Faculty of Medicine, Kosovo.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>8</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>22</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38326210</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2024.01.003</ArticleId><ArticleId IdType="pii">S0007-0912(24)00005-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16417031</PMID><DateCompleted><Year>2006</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0899-823X</ISSN><JournalIssue CitedMedium="Print"><Volume>26</Volume><Issue>12</Issue><PubDate><Year>2005</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Infection control and hospital epidemiology</Title><ISOAbbreviation>Infect Control Hosp Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis.</ArticleTitle><Pagination><StartPage>916</StartPage><EndPage>922</EndPage><MedlinePgn>916-22</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To review the evidence evaluating perioperative intranasal mupirocin for the prevention of surgical-site infections according to type of surgical procedure.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of published clinical trials.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Studies included were either randomized clinical trial or prospective trials at a single institution that measured outcomes both before and after an institution-wide intervention (before-after trial). In all studies, intervention and control groups differed only by the use of perioperative intranasal mupirocin in the intervention group.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients undergoing general or nongeneral surgery (eg, cardiothoracic surgery, orthopedic surgery, and neurosurgery).</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">Risk of surgical-site infection following perioperative intranasal mupirocin versus usual care.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three randomized and four before-after trials met the inclusion criteria. No reduction in surgical-site infection rate was seen in randomized general surgery trials (summary estimates: 8.4% in the mupirocin group and 8.1% in the control group; relative risk [RR], 1.04; 95% confidence interval [CI95], 0.81 to 1.33). In nongeneral surgery, the use of mupirocin was associated with a reduction in surgical-site infection in randomized trials (summary estimates: 6.0% in the mupirocin group and 7.6% in the control group; RR, 0.80; CI95, 0.58 to 1.10) and in before-after trials (summary estimates: 1.7% in the mupirocin group and 4.1% in the control group; RR, 0.40; CI95, 0.29 to 0.56).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative intranasal mupirocin appears to decrease the incidence of surgical-site infection when used as prophylaxis in nongeneral surgery. Given its low risk and low cost, use of perioperative intranasal mupirocin should be considered in these settings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kallen</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>VA Outcomes Group, VA Medical Center, White River Junction, VT 05009, USA. Alexander.J.Kallen@dartmouth.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Chad T</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Robin J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Control Hosp Epidemiol</MedlineTA><NlmUniqueID>8804099</NlmUniqueID><ISSNLinking>0899-823X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>D0GX863OA5</RegistryNumber><NameOfSubstance UI="D016712">Mupirocin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016712" MajorTopicYN="N">Mupirocin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>21</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>4</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16417031</ArticleId><ArticleId IdType="doi">10.1086/505453</ArticleId><ArticleId IdType="pii">S0195941700051833</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25796995</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1570</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Resuscitation</Title><ISOAbbreviation>Resuscitation</ISOAbbreviation></Journal><ArticleTitle>Effects of in-hospital low targeted temperature after out of hospital cardiac arrest: A systematic review with meta-analysis of randomized clinical trials.</ArticleTitle><Pagination><StartPage>8</StartPage><EndPage>18</EndPage><MedlinePgn>8-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resuscitation.2015.02.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0300-9572(15)00123-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We performed this systematic review to evaluate the effectiveness of in-hospital low targeted temperature in adult patients after out of hospital cardiac arrest on survival and neurologic performance.</AbstractText><AbstractText Label="DATA SOURCE" NlmCategory="METHODS">We systematically searched MEDLINE and PUBMED from inception to April 2014.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Citations were screened for studies evaluating the effect of in-hospital low targeted temperature in patients following out of hospital cardiac arrest.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">We analyzed randomized control trials (RCTs) that included adult patients resuscitated from out of hospital cardiac arrest, reporting mortality at hospital discharge and comparing in-hospital low targeted temperature with a control group.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">This meta-analysis included 6 RCTs and 1418 adult patients. In-hospital low targeted (low T) temperature was associated to a reduction in mortality at hospital discharge and at 6 months when compared with in-hospital targeted and not targeted temperature while there was no reduction in mortality comparing low and high targeted temperature. In patients with initial ventricular fibrillation/ventricular tachycardia rhythm of out of hospital cardiac arrest, low T was associated with a reduction in short and long-term mortality when compared with no targeted temperature while not when compared to high targeted temperature. Low T was associated with good neurologic performance at hospital discharge compared with in-hospital high or not targeted temperature.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In-hospital low targeted temperature (&lt;4 &#xb0;C) improved short and long-term mortality when compared to no targeted temperature. In contrast, low T did not improve outcome compared with a slightly higher targeted temperature (&#x2248; 36 &#xb0;C).</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive and Odonthostomatological Sciences, University of Naples "Federico II", Naples, Italy. Electronic address: vargas.maria82@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Servillo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive and Odonthostomatological Sciences, University of Naples "Federico II", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutherasan</LastName><ForeName>Yuda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Gonz&#xe1;lez</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research Unit, Hospital Universitario Dr. Negr&#xed;n, Las Palmas de Gran Canaria, Spain; Critical Patient Translational Research Group, Department of Anesthesiology, Intensive Care and Pain Management, Hospital Cl&#xed;nico Universitario, Instituto de Investigaci&#xf3;n Sanitaria (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunetti</LastName><ForeName>Iole</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>AOU IRCCS San Martino-IST, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, AOU IRCCS San Martino-IST, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Resuscitation</MedlineTA><NlmUniqueID>0332173</NlmUniqueID><ISSNLinking>0300-9572</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="N">Emergency Medical Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="N">Hypothermia, Induced</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058687" MajorTopicYN="N">Out-of-Hospital Cardiac Arrest</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">In hospital</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Neurologic performance</Keyword><Keyword MajorTopicYN="N">Targeted temperature</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25796995</ArticleId><ArticleId IdType="doi">10.1016/j.resuscitation.2015.02.038</ArticleId><ArticleId IdType="pii">S0300-9572(15)00123-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30087385</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials.</ArticleTitle><Pagination><StartPage>11800</StartPage><MedlinePgn>11800</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11800</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-30296-x</ELocationID><Abstract><AbstractText>Immunotherapy holds great promise in the treatment of high grade glioma (HGG). We performed a comprehensive meta-analysis of clinical trials involving dendritic cell (DC) therapy and viral therapy (VT) for the treatment of HGG, in order to assess their clinical impact in comparison to standard treatments in terms of overall survival (OS) and progression-free survival (PFS). To our knowledge, this is the first meta-analysis to evaluate VT for the treatment of HGG, allowing comparison of different immunotherapeutic approaches. Thirteen eligible studies of 1043 cases were included in the meta-analysis. For DC vaccination, in terms of OS, both newly diagnosed patients (HR, 0.65) and patients who suffered from recurrent HGGs (HR&#x2009;=&#x2009;0.63) presented markedly improved results compared to the control groups. PFS was also improved (HR&#x2009;=&#x2009;0.49) but was not statistically significant (p&#x2009;=&#x2009;0.1). A slight improvement was observed for newly diagnosed patients receiving VT in terms of OS (HR&#x2009;=&#x2009;0.88) while PFS was inferior for patients in the experimental arm (HR&#x2009;=&#x2009;1.16). Our results show that DC therapy greatly improves OS for patients with both newly diagnosed and recurrent HGGs. VT, however, did not provide any statistically significant improvements in terms of OS and PFS for patients with newly diagnosed HGGs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Artene</LastName><ForeName>Stefan-Alexandru</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Unit of Biochemistry, University of Medicine and Pharmacy of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turcu-Stiolica</LastName><ForeName>Adina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1374-276X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of Medicine and Pharmacy of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciurea</LastName><ForeName>Marius Eugen</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Plastic Surgery Clinic, Emergency County Hospital of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folcuti</LastName><ForeName>Catalin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit of Biochemistry, University of Medicine and Pharmacy of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tataranu</LastName><ForeName>Ligia Gabriela</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Emergency Clinical Hospital "Bagdasar-Arseni", Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexandru</LastName><ForeName>Oana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purcaru</LastName><ForeName>Oana Stefana</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Unit of Biochemistry, University of Medicine and Pharmacy of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tache</LastName><ForeName>Daniela Elise</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Unit of Biochemistry, University of Medicine and Pharmacy of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boldeanu</LastName><ForeName>Mihail Virgil</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0003-2481-6138</Identifier><AffiliationInfo><Affiliation>Department of Immunology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silosi</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Medicine and Pharmacy of Craiova, Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dricu</LastName><ForeName>Anica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Biochemistry, University of Medicine and Pharmacy of Craiova, Craiova, Romania. anica.dricu@live.co.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000637" MajorTopicYN="Y">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005910" MajorTopicYN="N">Glioma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30087385</ArticleId><ArticleId IdType="pmc">PMC6081409</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-30296-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-30296-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine. 2005;352:987&#x2013;996. doi: 10.1056/NEJMoa043330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa043330</ArticleId><ArticleId IdType="pubmed">15758009</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunological reviews. 2006;213:48&#x2013;65. doi: 10.1111/j.1600-065X.2006.00441.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2006.00441.x</ArticleId><ArticleId IdType="pmc">PMC2633103</ArticleId><ArticleId IdType="pubmed">16972896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. Journal of neuroscience research. 1991;28:254&#x2013;260. doi: 10.1002/jnr.490280213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490280213</ArticleId><ArticleId IdType="pubmed">2033653</ArticleId></ArticleIdList></Reference><Reference><Citation>Laman JD, Weller RO. Drainage of cells and soluble antigen from the CNS to regional lymph nodes. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology. 2013;8:840&#x2013;856. doi: 10.1007/s11481-013-9470-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9470-8</ArticleId><ArticleId IdType="pmc">PMC7088878</ArticleId><ArticleId IdType="pubmed">23695293</ArticleId></ArticleIdList></Reference><Reference><Citation>Safdari H, Hochberg FH, Richardson EP., Jr. Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas. Surgical neurology. 1985;23:221&#x2013;226. doi: 10.1016/0090-3019(85)90086-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-3019(85)90086-2</ArticleId><ArticleId IdType="pubmed">2983448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagzag D, et al. Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain. Laboratory investigation; a journal of technical methods and pathology. 2005;85:328&#x2013;341. doi: 10.1038/labinvest.3700233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3700233</ArticleId><ArticleId IdType="pubmed">15716863</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, et al. Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance. PloS one. 2015;10:e0126022. doi: 10.1371/journal.pone.0126022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0126022</ArticleId><ArticleId IdType="pmc">PMC4433225</ArticleId><ArticleId IdType="pubmed">25978454</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JF, et al. Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors. Neuro-oncology. 2009;11:394&#x2013;402. doi: 10.1215/15228517-2008-104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1215/15228517-2008-104</ArticleId><ArticleId IdType="pmc">PMC2743219</ArticleId><ArticleId IdType="pubmed">19028999</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecci PE, et al. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer research. 2006;66:3294&#x2013;3302. doi: 10.1158/0008-5472.CAN-05-3773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-05-3773</ArticleId><ArticleId IdType="pubmed">16540683</ArticleId></ArticleIdList></Reference><Reference><Citation>Batich KA, Swartz AM, Sampson JH. Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma. Expert opinion on biological therapy. 2015;15:79&#x2013;94. doi: 10.1517/14712598.2015.972361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2015.972361</ArticleId><ArticleId IdType="pubmed">25327832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashley DM, et al. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. The Journal of experimental medicine. 1997;186:1177&#x2013;1182. doi: 10.1084/jem.186.7.1177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.186.7.1177</ArticleId><ArticleId IdType="pmc">PMC2199074</ArticleId><ArticleId IdType="pubmed">9314567</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani N, et al. Proliferating dendritic cell progenitors in human blood. The Journal of experimental medicine. 1994;180:83&#x2013;93. doi: 10.1084/jem.180.1.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.180.1.83</ArticleId><ArticleId IdType="pmc">PMC2191538</ArticleId><ArticleId IdType="pubmed">8006603</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. The Journal of experimental medicine. 1994;179:1109&#x2013;1118. doi: 10.1084/jem.179.4.1109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.179.4.1109</ArticleId><ArticleId IdType="pmc">PMC2191432</ArticleId><ArticleId IdType="pubmed">8145033</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair, S., Archer, G. E. &amp; Tedder, T. F. Isolation and generation of human dendritic cells. Current protocols in immunology Chapter 7, Unit732, 10.1002/0471142735.im0732s99 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4559332</ArticleId><ArticleId IdType="pubmed">23129155</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonuleit H, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. European journal of immunology. 1997;27:3135&#x2013;3142. doi: 10.1002/eji.1830271209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830271209</ArticleId><ArticleId IdType="pubmed">9464798</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte S, Carle G, Faneca H, de Lima MC, Pierrefite-Carle V. Suicide gene therapy in cancer: where do we stand now? Cancer letters. 2012;324:160&#x2013;170. doi: 10.1016/j.canlet.2012.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2012.05.023</ArticleId><ArticleId IdType="pubmed">22634584</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomicic MT, Thust R, Kaina B. Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation. Oncogene. 2002;21:2141&#x2013;2153. doi: 10.1038/sj.onc.1205280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1205280</ArticleId><ArticleId IdType="pubmed">11948397</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiocca EA, Rabkin SD. Oncolytic viruses and their application to cancer immunotherapy. Cancer immunology research. 2014;2:295&#x2013;300. doi: 10.1158/2326-6066.CIR-14-0015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2326-6066.CIR-14-0015</ArticleId><ArticleId IdType="pmc">PMC4303349</ArticleId><ArticleId IdType="pubmed">24764576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler SE, Speranza MC, Cho CF, Chiocca EA. Oncolytic Viruses in Cancer Treatment: A Review. JAMA oncology. 2017;3:841&#x2013;849. doi: 10.1001/jamaoncol.2016.2064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2016.2064</ArticleId><ArticleId IdType="pubmed">27441411</ArticleId></ArticleIdList></Reference><Reference><Citation>Melcher A, Parato K, Rooney CM, Bell JC. Thunder and lightning: immunotherapy and oncolytic viruses collide. Molecular therapy: the journal of the American Society of Gene Therapy. 2011;19:1008&#x2013;1016. doi: 10.1038/mt.2011.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2011.65</ArticleId><ArticleId IdType="pmc">PMC3129809</ArticleId><ArticleId IdType="pubmed">21505424</ArticleId></ArticleIdList></Reference><Reference><Citation>Stupp R, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet. Oncology. 2009;10:459&#x2013;466. doi: 10.1016/S1470-2045(09)70025-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(09)70025-7</ArticleId><ArticleId IdType="pubmed">19269895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong DS, et al. Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in Korea. Oncotarget. 2017;8:7003&#x2013;7013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5351686</ArticleId><ArticleId IdType="pubmed">27690294</ArticleId></ArticleIdList></Reference><Reference><Citation>Batich KA, et al. Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. Clinical cancer research: an official journal of the American Association for Cancer Research. 2017;23:1898&#x2013;1909. doi: 10.1158/1078-0432.CCR-16-2057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-16-2057</ArticleId><ArticleId IdType="pmc">PMC5559300</ArticleId><ArticleId IdType="pubmed">28411277</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CN, et al. A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia. 2011;18:1048&#x2013;1054. doi: 10.1016/j.jocn.2010.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2010.11.034</ArticleId><ArticleId IdType="pubmed">21715171</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho DY, et al. Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial. World neurosurgery. 2012;77:736&#x2013;744. doi: 10.1016/j.wneu.2011.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2011.08.020</ArticleId><ArticleId IdType="pubmed">22120301</ArticleId></ArticleIdList></Reference><Reference><Citation>Jie X, et al. Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma. Cell biochemistry and biophysics. 2012;62:91&#x2013;99. doi: 10.1007/s12013-011-9265-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-011-9265-6</ArticleId><ArticleId IdType="pubmed">21909820</ArticleId></ArticleIdList></Reference><Reference><Citation>Vik-Mo EO, et al. Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer immunology, immunotherapy: CII. 2013;62:1499&#x2013;1509. doi: 10.1007/s00262-013-1453-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-013-1453-3</ArticleId><ArticleId IdType="pmc">PMC3755221</ArticleId><ArticleId IdType="pubmed">23817721</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler CJ, Das A, Liu G, Yu JS, Black KL. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clinical cancer research: an official journal of the American Association for Cancer Research. 2004;10:5316&#x2013;5326. doi: 10.1158/1078-0432.CCR-04-0497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-04-0497</ArticleId><ArticleId IdType="pubmed">15328167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka R, et al. Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial. Clinical cancer research: an official journal of the American Association for Cancer Research. 2005;11:4160&#x2013;4167. doi: 10.1158/1078-0432.CCR-05-0120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-05-0120</ArticleId><ArticleId IdType="pubmed">15930352</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu JS, et al. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer research. 2004;64:4973&#x2013;4979. doi: 10.1158/0008-5472.CAN-03-3505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-03-3505</ArticleId><ArticleId IdType="pubmed">15256471</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler LA, et al. Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma. Neuro-oncology. 2016;18:1137&#x2013;1145. doi: 10.1093/neuonc/now002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/now002</ArticleId><ArticleId IdType="pmc">PMC4933478</ArticleId><ArticleId IdType="pubmed">26843484</ArticleId></ArticleIdList></Reference><Reference><Citation>Westphal M, et al. Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. The Lancet. Oncology. 2013;14:823&#x2013;833. doi: 10.1016/S1470-2045(13)70274-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(13)70274-2</ArticleId><ArticleId IdType="pubmed">23850491</ArticleId></ArticleIdList></Reference><Reference><Citation>Stragliotto G, et al. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. International journal of cancer. 2013;133:1204&#x2013;1213. doi: 10.1002/ijc.28111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.28111</ArticleId><ArticleId IdType="pubmed">23404447</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainov NG. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Human gene therapy. 2000;11:2389&#x2013;2401. doi: 10.1089/104303400750038499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/104303400750038499</ArticleId><ArticleId IdType="pubmed">11096443</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J, et al. Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review. Oncology research. 2016;24:117&#x2013;128. doi: 10.3727/096504016X14612603423511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096504016X14612603423511</ArticleId><ArticleId IdType="pmc">PMC7838606</ArticleId><ArticleId IdType="pubmed">27296952</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. The interventional effect of new drugs combined with the Stupp protocol on glioblastoma: A network meta-analysis. Clinical neurology and neurosurgery. 2017;159:6&#x2013;12. doi: 10.1016/j.clineuro.2017.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2017.05.015</ArticleId><ArticleId IdType="pubmed">28514722</ArticleId></ArticleIdList></Reference><Reference><Citation>Weller M, et al. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. The Lancet. Oncology. 2017;18:1373&#x2013;1385. doi: 10.1016/S1470-2045(17)30517-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(17)30517-X</ArticleId><ArticleId IdType="pubmed">28844499</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao JX, et al. Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis. PloS one. 2014;9:e107173. doi: 10.1371/journal.pone.0107173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0107173</ArticleId><ArticleId IdType="pmc">PMC4162602</ArticleId><ArticleId IdType="pubmed">25215607</ArticleId></ArticleIdList></Reference><Reference><Citation>Artene SA, et al. Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis. OncoTargets and therapy. 2016;9:6669&#x2013;6677. doi: 10.2147/OTT.S112842.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OTT.S112842</ArticleId><ArticleId IdType="pmc">PMC5108618</ArticleId><ArticleId IdType="pubmed">27877052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampling R, et al. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene therapy. 2000;7:859&#x2013;866. doi: 10.1038/sj.gt.3301184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gt.3301184</ArticleId><ArticleId IdType="pubmed">10845724</ArticleId></ArticleIdList></Reference><Reference><Citation>Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature medicine. 1995;1:938&#x2013;943. doi: 10.1038/nm0995-938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0995-938</ArticleId><ArticleId IdType="pubmed">7585221</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiocca EA, et al. A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Molecular therapy: the journal of the American Society of Gene Therapy. 2004;10:958&#x2013;966. doi: 10.1016/j.ymthe.2004.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2004.07.021</ArticleId><ArticleId IdType="pubmed">15509513</ArticleId></ArticleIdList></Reference><Reference><Citation>Csatary LK, et al. MTH-68/H oncolytic viral treatment in human high-grade gliomas. Journal of neuro-oncology. 2004;67:83&#x2013;93. doi: 10.1023/B:NEON.0000021735.85511.05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:NEON.0000021735.85511.05</ArticleId><ArticleId IdType="pubmed">15072452</ArticleId></ArticleIdList></Reference><Reference><Citation>Shand N, et al. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Human gene therapy. 1999;10:2325&#x2013;2335. doi: 10.1089/10430349950016979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/10430349950016979</ArticleId><ArticleId IdType="pubmed">10515452</ArticleId></ArticleIdList></Reference><Reference><Citation>Immonen A, et al. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Molecular therapy: the journal of the American Society of Gene Therapy. 2004;10:967&#x2013;972. doi: 10.1016/j.ymthe.2004.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2004.08.002</ArticleId><ArticleId IdType="pubmed">15509514</ArticleId></ArticleIdList></Reference><Reference><Citation>Soderberg-Naucler C, Johnsen JI. Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options. World journal of experimental medicine. 2015;5:1&#x2013;10. doi: 10.5493/wjem.v5.i1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5493/wjem.v5.i1.1</ArticleId><ArticleId IdType="pmc">PMC4308527</ArticleId><ArticleId IdType="pubmed">25699229</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornara O, et al. Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact. Cell death and differentiation. 2016;23:261&#x2013;269. doi: 10.1038/cdd.2015.91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.91</ArticleId><ArticleId IdType="pmc">PMC4716305</ArticleId><ArticleId IdType="pubmed">26138445</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Research synthesis methods. 2010;1:97&#x2013;111. doi: 10.1002/jrsm.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.12</ArticleId><ArticleId IdType="pubmed">26061376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi: 10.1186/1745-6215-8-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-8-16</ArticleId><ArticleId IdType="pmc">PMC1920534</ArticleId><ArticleId IdType="pubmed">17555582</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38996090</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>28</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Oral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia: An observational study.</ArticleTitle><Pagination><StartPage>e38839</StartPage><MedlinePgn>e38839</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38839</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000038839</ELocationID><Abstract><AbstractText>Left ventricular assist devices (LVADs) are widely used as end-stage therapy in patients with advanced heart failure, whereas implantation increases the risks of development of sustained ventricular tachycardia at the later postimplantation stage. Therefore, this study aimed to evaluate the clinical efficacy of orally administered amiodarone and propranolol in 3 patients with ventricular tachycardia (VT) after LVAD implantation who were resistant to initial anti-antiarrhythmic drugs. This retrospective cohort study consisted of the initial evaluation of the clinical data of 14 adult patients who underwent implantation of LVAD between January 2019 and March 2021. A total of 3 patients with resistant VT were finally included. In all cases, the patients were initially administered amiodarone in the different doses intravenously to stabilize the critical condition, whereas its oral form along with that of propranolol was used as maintenance therapy in the first 2 cases. In the third case, amiodarone was withdrawn because of the risk of development of hyperthyroidism, while oral propranolol was used in the treatment. The assessment in the 16-month follow-up period after discharge did not show presence of non-sustained and sustained VT in all 3 cases. In the ventricular arrhythmia-free group, the total mortality rate within the follow-up period was 11.1&#x2005;&#xb1;&#x2005;7.78 months in the 3 patients. We suggest that maintenance oral therapy of propranolol and amiodarone can significantly decrease the risks of complications in patients with VT after implantation of ventricular assist device in the long term.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arslan</LastName><ForeName>Abdulla</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2355-3524</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zkaya</LastName><ForeName>&#xd6;yk&#xfc; G&#xfc;lmez</ForeName><Initials>&#xd6;G</Initials><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aytemiz</LastName><ForeName>Fatih</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiology Department, Manisa State Hospital, Manisa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altay</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zcan</LastName><ForeName>Emin Evren</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Cardiology Department, Dokuz Eyl&#xfc;l University Izmir Medical and Research Center, Bal&#xe7;ova/Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;&#xe7;&#xfc;kaksu</LastName><ForeName>Deniz S&#xfc;ha</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakuy</LastName><ForeName>Vedat</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozan</LastName><ForeName>&#xd6;mer</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pehlivano&#x11f;lu</LastName><ForeName>Se&#xe7;kin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade/Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber><NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9Y8NXQ24VQ</RegistryNumber><NameOfSubstance UI="D011433">Propranolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000638" MajorTopicYN="Y">Amiodarone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011433" MajorTopicYN="Y">Propranolol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="Y">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>15</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38996090</ArticleId><ArticleId IdType="pmc">PMC11245262</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000038839</ArticleId><ArticleId IdType="pii">00005792-202407120-00003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boruah P, Saqib N, Barooah J, et al. . Left ventricular assist device: what the internist needs to know. A review of the literature. Cureus. 2019;11:e4399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6559676</ArticleId><ArticleId IdType="pubmed">31245189</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoruk A, Sherazi S, Massey HT, et al. . Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device. Heart Rhythm. 2016;13:1052&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26829113</ArticleId></ArticleIdList></Reference><Reference><Citation>Markham DW, Fu Q, Palmer MD, et al. . Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and non-pulsatile left ventricular assist devices. Circ Heart Fail. 2013;6:293&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23250982</ArticleId></ArticleIdList></Reference><Reference><Citation>Welp H, Rukosujew A, Tjan TD, et al. . Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin&#x2013;angiotensin system in patients with end-stage heart failure. Thorac Cardiovasc Surg. 2010;58:S185&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20101537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasin T, Matsuzawa Y, Guddeti RR, et al. . Attenuation in peripheral endothelial function after continuous flow left ventricular assist device therapy is associated with cardiovascular adverse events. Circ J. 2015;79:770&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25739569</ArticleId></ArticleIdList></Reference><Reference><Citation>Starling RC, Naka Y, Boyle AJ, et al. . Results of the Post-U.S. food and drug administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;57:1890&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21545946</ArticleId></ArticleIdList></Reference><Reference><Citation>Efimova E, Fischer J, Bertagnolli L, et al. . Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study. Heart Rhythm. 2017;14:1812&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28756099</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;im&#x15f;ek E, &#xd6;zcan EE, Demir E, et al. . Sol Ventrik&#xfc;l Destek Cihazi Olan Bir Hastada Ventrik&#xfc;ler Ta&#x15f;ikardi Ablasyonu ablation of ventricular tachycardia in a patient with a left ventricular assist device. Turk Kardiyol Dern Ars. 2020;48:58&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">31974318</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenyo A, Rao M, Koneru S, et al. . Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol. 2012;23:515&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">22081967</ArticleId></ArticleIdList></Reference><Reference><Citation>Greet BD, Pujara D, Burkland D, et al. . Incidence, predictors, and significance of ventricular arrhythmias in patients with continuous-flow left ventricular assist devices: a 15-year institutional experience. JACC Clin Electrophysiol. 2018;4:257&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">29749947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzidou S, Kontogiannis C, Tsilimigras DI, et al. . Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator. J Am Coll Cardiol. 2018;71:1897&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">29699616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatano M, Jimba T, Fujiwara T, et al. . Late-Onset right ventricular failure after continuous-flow left ventricular assist device implantation: case presentation and review of the literature. J Cardiol. 2022;80:110&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">34974940</ArticleId></ArticleIdList></Reference><Reference><Citation>Refaat M, Chemaly E, Lebeche D, et al. . Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol. 2008;31:1246&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752870</ArticleId><ArticleId IdType="pubmed">18811803</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss JD, Flatley EE, Beaser AD, et al. . Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience. JACC Clin Electrophysiol. 2017;3:1412&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">29759673</ArticleId></ArticleIdList></Reference><Reference><Citation>Slaughter MS, Pagani FD, Rogers JG, et al. .; HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced HF. J Heart Lung Transplant. 2010;29(Suppl):S1&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">20181499</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SJ, Milano CA, Tatooles AJ, et al. .; HeartMate II Clinical Investigators. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5:241&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22282104</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourque D, Daoust R, Huard V, et al. . Beta-Blockers for the treatment of cardiac arrest from ventricular fibrillation? Resuscitation. 2007;75:434&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">17764805</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ferrari GM, Landolina M, Mantica M, et al. . Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction. Am Heart J. 1995;130:473&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">7661063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bristow MR, Ginsburg R, Umans V, et al. . Beta 1- and Beta 2-Adrenergic-Receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">2876788</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson JL, Rodier HE, Green LS. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol. 1983;51:1196&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">6132549</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JD, Piacentino V, Rothman S, et al. . Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail. 2005;11:227&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15812752</ArticleId></ArticleIdList></Reference><Reference><Citation>Margulies KB. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail. 2002;8(Suppl):S500&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12555165</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedi M, Kormos R, Winowich S, et al. . Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">17437746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziv O, Dizon J, Thosani A, et al. . Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45:1428&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">15862414</ArticleId></ArticleIdList></Reference><Reference><Citation>Oswald H, Schultz-Wildelau C, Gardiwal A, et al. . Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010;12:593&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20406799</ArticleId></ArticleIdList></Reference><Reference><Citation>Garan AR, Yuzefpolskaya M, Colombo PC, et al. . Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol. 2013;61:2542&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23643502</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantillon DJ, Tarakji KG, Kumbhani DJ, et al. . Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7:466&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">20178869</ArticleId></ArticleIdList></Reference><Reference><Citation>Raasch H, Jensen BC, Chang PP, et al. . Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164:373&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22980304</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray KT, Reilly C, Koshakji RP, et al. . Suppression of ventricular arrhythmias in man by d-propranolol independent of betaadrenergic receptor blockade. J Clin Invest. 1990;85:836&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC296501</ArticleId><ArticleId IdType="pubmed">2155929</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38596663</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1177-5467</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Clinical ophthalmology (Auckland, N.Z.)</Title><ISOAbbreviation>Clin Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Phacoemulsification versus Laser Peripheral Iridotomy for Treating Primary Angle Closure Glaucoma: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1023</StartPage><EndPage>1032</EndPage><MedlinePgn>1023-1032</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/OPTH.S446285</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Primary Angle Closure Glaucoma (PACG), is caused by narrowing the iridocorneal angle and increases the risk of blockage in the trabecular meshwork. Phacoemulsification and laser peripheral iridotomy (LPI) effectively control IOP elevation and widen the angle. This systematic review and meta-analysis compared Phacoemulsification and LPI Effectiveness for PACG.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched Medline, Embase, and CENTRAL. We included randomized controlled trials (RCTs) that compared Phacoemulsification and LPI for individuals with PACG. We sought to evaluate the following outcomes: mean IOP, number of glaucoma medications, visual acuity (VA), visual field (VF) progression, peripheral anterior synechiae (PAS), Shaffer gonioscopy grading, central corneal thickness (CCT), central endothelial cell density (CECD), and poor response to surgery. The standardized mean difference (SMD) was used to represent continuous outcomes, while the risk ratio (RR) was used to represent dichotomous outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">5 RCTs that enrolled 917 participants were deemed eligible. The phacoemulsification group showed statistically significance lower mean CCT and CECD and lower risk of poor response to surgery compared to LPI (SMD = -1.10; 95% -1.50, -0.70; P&lt;0.001, SMD -366.12; 95% -652.59, -79.65; P=0.01, and RR 0.35; 95% 0.23, 0.54; P&lt;0.001 respectively). There were no significant improvement in IOP and number of medications between both groups (SMD = -0.74; 95% CI = -2.26, 0.78; P=0.34, and SMD -17.58; 95% CI = -50.28, 15.12; P=0.29 respectively). Finally, there were also no significant differences in VA, VF progression, PAS, and mean Shaffer gonioscopy grading between both groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Phacoemulsification showed statistically significant lower mean corneal thickness, central endothelial cell density, and lower risk of poor response to surgery compared to LPI. However, there were no significant differences in mean IOP, number of medications, VA, VF progression, PAS, and mean Shaffer gonioscopy grading between Phacoemulsification and LPI.</AbstractText><CopyrightInformation>&#xa9; 2024 Sharif et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharif</LastName><ForeName>Rahaf K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aljahdali</LastName><ForeName>Faisal F</ForeName><Initials>FF</Initials><Identifier Source="ORCID">0000-0002-7665-9210</Identifier><AffiliationInfo><Affiliation>College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aljabri</LastName><ForeName>Hind M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alomari</LastName><ForeName>Lugean K</ForeName><Initials>LK</Initials><Identifier Source="ORCID">0000-0001-9484-3321</Identifier><AffiliationInfo><Affiliation>College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagim</LastName><ForeName>Renad A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alamri</LastName><ForeName>Duaa M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshehri</LastName><ForeName>Merai A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Surgery, College of Medicine, University of Bisha, Bisha, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshigari</LastName><ForeName>Rayan Abdullah</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Glaucoma Section, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Clin Ophthalmol</MedlineTA><NlmUniqueID>101321512</NlmUniqueID><ISSNLinking>1177-5467</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">glaucoma</Keyword><Keyword MajorTopicYN="N">iridotomy</Keyword><Keyword MajorTopicYN="N">laser</Keyword><Keyword MajorTopicYN="N">phacoemulsification</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38596663</ArticleId><ArticleId IdType="pmc">PMC11001549</ArticleId><ArticleId IdType="doi">10.2147/OPTH.S446285</ArticleId><ArticleId IdType="pii">446285</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sun X, Dai Y, Chen Y, et al. Primary angle closure glaucoma: what we know and what we don&#x2019;t know. Prog Retin Eye Res. 2017;57:26&#x2013;45. doi:10.1016/j.preteyeres.2016.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preteyeres.2016.12.003</ArticleId><ArticleId IdType="pubmed">28039061</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-S&#xe1;nchez BC, Tatham AJ. Acute angle closure glaucoma. Br J Hosp Med. 2019;80(12):C174&#x2013;C179. doi:10.12968/hmed.2019.80.12.C174</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/hmed.2019.80.12.C174</ArticleId><ArticleId IdType="pubmed">31822188</ArticleId></ArticleIdList></Reference><Reference><Citation>Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081&#x2013;2090. doi:10.1016/j.ophtha.2014.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2014.05.013</ArticleId><ArticleId IdType="pubmed">24974815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan PP, Pang JC, Tham CC. Acute primary angle closure&#x2013;treatment strategies, evidences and economical considerations. EYE. 2019;33(1):110&#x2013;119. doi:10.1038/s41433-018-0278-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-018-0278-x</ArticleId><ArticleId IdType="pmc">PMC6328531</ArticleId><ArticleId IdType="pubmed">30467424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang PX, Koh VTC, Loon SC. Laser iridotomy and the corneal endothelium: a systemic review. Acta Ophthalmol. 2014;92(7):604&#x2013;616. doi:10.1111/aos.12367</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.12367</ArticleId><ArticleId IdType="pubmed">24528451</ArticleId></ArticleIdList></Reference><Reference><Citation>Javanbakht M, Azuara-Blanco A, Burr JM, et al. Early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma: an economic evaluation based on data from the EAGLE trial. BMJ Open. 2017;7(1):e013254. doi:10.1136/bmjopen-2016-013254</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-013254</ArticleId><ArticleId IdType="pmc">PMC5253715</ArticleId><ArticleId IdType="pubmed">28087548</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmasari AZ, Indri Wahyuni I, Djuari L. Comparison of Intraocular Pressure after Phacoemulsification Compared to Laser Peripheral Iridotomy (LPI) in Acute Primary Angle Closure (APAC) Patients: a Systematic Review. J Curr Med Res Opin. 2022;5(12):1510&#x2013;1519.</Citation></Reference><Reference><Citation>Xie J, Li P, Han B, Patel S. Meta-analysis of phacoemulsification and laser peripheral iridotomy in the treatment of primary angle-closure glaucoma. J Ophthalmol. 2023;2023:6732424. doi:10.1155/2023/6732424</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/6732424</ArticleId><ArticleId IdType="pmc">PMC10132899</ArticleId><ArticleId IdType="pubmed">37124065</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(2):d5928. doi:10.1136/bmj.d5928</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M Comprehensive meta-analysis V2 [Computer software and manual]; 2005:24.</Citation></Reference><Reference><Citation>Copenhagen J. D.T.N.C.C., Cochrane Collaboration, Review manager. (version 5.3)[computer software].2014.</Citation></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560. doi:10.1136/bmj.327.7414.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Libr. 2019;10:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1). doi:10.1186/1471-2288-5-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuara-Blanco A, Burr J, Ramsay C, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet. 2016;388(10052):1389&#x2013;1397. doi:10.1016/S0140-6736(16)30956-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)30956-4</ArticleId><ArticleId IdType="pubmed">27707497</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan PP, Tang FY, Leung DY, Lam TC, Baig N, Tham CC. Ten-year clinical outcomes of acute primary angle closure randomized to receive early phacoemulsification versus laser peripheral iridotomy. J Glaucoma. 2021;30(4):332&#x2013;339. doi:10.1097/IJG.0000000000001799</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IJG.0000000000001799</ArticleId><ArticleId IdType="pubmed">33769358</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias-Santos A, Ferreira J, Abeg&#xe3;o Pinto L, et al. Phacoemulsification versus peripheral iridotomy in the management of chronic primary angle closure: long-term follow-up. Int Ophthalmol. 2015;35(2):173&#x2013;178. doi:10.1007/s10792-014-9926-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-014-9926-8</ArticleId><ArticleId IdType="pubmed">24728533</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain R, Gazzard G, Aung T, et al. Initial management of acute primary angle closure: a randomized trial comparing phacoemulsification with laser peripheral iridotomy. Ophthalmology. 2012;119(11):2274&#x2013;2281. doi:10.1016/j.ophtha.2012.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2012.06.015</ArticleId><ArticleId IdType="pubmed">22885123</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell WG, Azuara-Blanco A, Foster PJ, et al. Predictors of long-term intraocular pressure control after lens extraction in primary angle closure glaucoma: results from the EAGLE trial. Br J Ophthalmol. 2023;107(8):1072&#x2013;1078. doi:10.1136/bjophthalmol-2021-319765</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2021-319765</ArticleId><ArticleId IdType="pubmed">35387778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissing A, Rivier D, Zaninetti M, Shaarawy T, Mermoud A, Roy S. Ten years follow-up after deep sclerectomy with collagen implant. J Glaucoma. 2008;17(8):680&#x2013;686. doi:10.1097/IJG.0b013e318182ed9e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IJG.0b013e318182ed9e</ArticleId><ArticleId IdType="pubmed">19092466</ArticleId></ArticleIdList></Reference><Reference><Citation>Amerasinghe N, Aung T. Angle-closure: risk factors, diagnosis and treatment. In: Progress in Brain Research. Elsevier; 2008:31&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">18929100</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright C, Tawfik MA, Waisbourd M, Katz LJ. Primary angle-closure glaucoma: an update. Acta Ophthalmol. 2016;94(3):217&#x2013;225. doi:10.1111/aos.12784</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.12784</ArticleId><ArticleId IdType="pubmed">26119516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarongoy P, Ho CL, Walton DS, et al. Changes in the anterior chamber configuration after small-incision cataract surgery with posterior chamber intraocular lens implantation. Am J Ophthalmol. 1997;54(2):775&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">9402823</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CH, Hung PT. Intraocular lens position and anterior chamber angle changes after cataract extraction in eyes with primary angle-closure glaucoma. J Cataract Refract Surg. 1997;23(7):1109&#x2013;1113. doi:10.1016/S0886-3350(97)80089-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0886-3350(97)80089-2</ArticleId><ArticleId IdType="pubmed">9379386</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts TV, Francis IC, Lertusumitkul S, Kappagoda MB, Coroneo MT. Primary phacoemulsification for uncontrolled angle-closure glaucoma. J Cataract Refract Surg. 2000;26(7):1012&#x2013;1016. doi:10.1016/S0886-3350(00)00358-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0886-3350(00)00358-8</ArticleId><ArticleId IdType="pubmed">10946192</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobi PC, Dietlein TS, L&#xfc;ke C, Engels B, Krieglstein GK. Primary phacoemulsification and intraocular lens implantation for acute angle-closure glaucoma. Ophthalmology. 2002;109(9):1597&#x2013;1603. doi:10.1016/S0161-6420(02)01123-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-6420(02)01123-5</ArticleId><ArticleId IdType="pubmed">12208704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyatt H, Ghosh J. Behaviour of an iris model and the pupil block hypothesis. Br J Ophthalmol. 1970;54(3):177&#x2013;185. doi:10.1136/bjo.54.3.177</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.54.3.177</ArticleId><ArticleId IdType="pmc">PMC1207667</ArticleId><ArticleId IdType="pubmed">5428643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe RF. Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma. Br J Ophthalmol. 1970;54(3):161&#x2013;169. doi:10.1136/bjo.54.3.161</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.54.3.161</ArticleId><ArticleId IdType="pmc">PMC1207665</ArticleId><ArticleId IdType="pubmed">5428641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe RF. Causes of shallow anterior chamber in primary angle-closure glaucoma: ultrasonic biometry of normal and angle-closure glaucoma eyes. Am J Ophthalmol. 1969;67(1):87&#x2013;93. doi:10.1016/0002-9394(69)90012-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9394(69)90012-9</ArticleId><ArticleId IdType="pubmed">5782866</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming Zhi Z, Lim ASM, Yin Wong T. A pilot study of lens extraction in the management of acute primary angle-closure glaucoma. Am J Ophthalmol. 2003;135(4):534&#x2013;536. doi:10.1016/S0002-9394(02)02108-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9394(02)02108-6</ArticleId><ArticleId IdType="pubmed">12654372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T, Toguri I, Onizuka N, Matsuura T. Phacoemulsi- fication and intraocular lens implantation for angle closure glaucoma after the relief of pupillary block. Ophthalmologica. 2003;217(5):325&#x2013;328. doi:10.1159/000071346</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000071346</ArticleId><ArticleId IdType="pubmed">12913321</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J-K, Lai P-C. Unusual presentation of angle-closure glaucoma treated by phacoemulsification. J Cataract Refract Surg. 2004;30(6):1371&#x2013;1373. doi:10.1016/j.jcrs.2003.10.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrs.2003.10.027</ArticleId><ArticleId IdType="pubmed">15177620</ArticleId></ArticleIdList></Reference><Reference><Citation>Harasymowycz PJ, Papamatheakis DG, Ahmed I, et al. Phacoemulsification and goniosynechialysis in the management of unresponsive primary angle closure. J Glaucoma. 2005;14(3):186&#x2013;189. doi:10.1097/01.ijg.0000159131.38828.85</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ijg.0000159131.38828.85</ArticleId><ArticleId IdType="pubmed">15870598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka A, Kondo T, Kikuchi M, et al. Cataract surgery for residual angle closure after peripheral laser iridotomy. Ophthalmology. 2005;112(6):974&#x2013;979. doi:10.1016/j.ophtha.2004.12.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2004.12.042</ArticleId><ArticleId IdType="pubmed">15885784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai JSM, Tham CCY, Chan JCH. The clinical outcomes of cataract extraction by phacoemulsification in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: a prospective case series. J Glaucoma. 2006;15(4):346. doi:10.1097/01.ijg.0000212231.65545.9a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ijg.0000212231.65545.9a</ArticleId><ArticleId IdType="pubmed">16378018</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CJ-L, Cheng C-Y, Wu CW, Lau L-I, Chou JC, Hsu W-M. Factors predicting intraocular pressure control after phacoemulsification in angle-closure glaucoma. Arch Ophthalmol. 2006;124(10):1390&#x2013;1394. doi:10.1001/archopht.124.10.1390</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archopht.124.10.1390</ArticleId><ArticleId IdType="pubmed">17030705</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaizumi M, Takaki Y, Yamashita H. Phacoemulsification and intraocular lens implantation for acute angle closure not treated or previously treated by laser iridotomy. J Cataract Refract Surg. 2006;32(1):85&#x2013;90. doi:10.1016/j.jcrs.2005.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrs.2005.11.014</ArticleId><ArticleId IdType="pubmed">16516784</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28385642</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1570</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Resuscitation</Title><ISOAbbreviation>Resuscitation</ISOAbbreviation></Journal><ArticleTitle>Outcome among VF/VT patients in the LINC (LUCAS IN cardiac arrest) trial-A randomised, controlled trial.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>162</EndPage><MedlinePgn>155-162</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resuscitation.2017.04.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0300-9572(17)30156-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The LINC trial evaluated two ALS-CPR algorithms for OHCA patients, consisting of 3min' mechanical chest compression (LUCAS) cycles with defibrillation attempt through compressions vs. 2min' manual compressions with compression pause for defibrillation. The PARAMEDIC trial, using 2min' algorithm found worse outcome for patients with initial VF/VT in the LUCAS group and they received more adrenalin compared to the manual group. We wanted to evaluate if these algorithms had any outcome effect for patients still in VF/VT after the initial defibrillation and how adrenalin timing impacted it.</AbstractText><AbstractText Label="METHOD">Both groups received manual chest compressions first. Based on non-electronic CPR process documentation, outcome, neurologic status and its relation to CPR duration prior to the first detected return of spontaneous circulation (ROSC), time to defibrillation and adrenalin given were analysed in the subgroup of VF/VT patients.</AbstractText><AbstractText Label="RESULTS">Seven hundred and fifty-seven patients had still VF/VT after initial chest compressions combined with a defibrillation attempt (374 received mechanical CPR) or not (383 received manual CPR). No differences were found for ROSC (mechanical CPR 58.3% vs. manual CPR 58.6%, p=0.94), or 6-month survival with good neurologic outcome (mechanical CPR 25.1% vs. manual CPR 23.0%, p=0.50). A significant difference was found regarding the time from start of manual chest compression to the first defibrillation (mechanical CPR: 4 (2-5) min vs manual CPR 3 (2-4) min, P&lt;0.001). The time from the start of manual chest compressions to ROSC was longer in the mechanical CPR group.</AbstractText><AbstractText Label="CONCLUSIONS">No difference in short- or long-term outcomes was found between the 2 algorithms for patients still in VF/VT after the initial defibrillation. The time to the 1st defibrillation and the interval between defibrillations were longer in the mechanical CPR group without impacting the overall outcome. The number of defibrillations required to achieve ROSC or adrenalin doses did not differ between the groups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hardig</LastName><ForeName>Bjarne Madsen</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Physio-Control, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindgren</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences/Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;stlund</LastName><ForeName>Ollie</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herlitz</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Health Sciences, Research Centre PreHospen, University of Bor&#xe5;s, The Prehospital Research Centre of Western Sweden, Bor&#xe5;s, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsten</LastName><ForeName>Rolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences/Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubertsson</LastName><ForeName>Sten</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences/Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden. Electronic address: sten.rubertsson@akademiska.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Resuscitation</MedlineTA><NlmUniqueID>0332173</NlmUniqueID><ISSNLinking>0300-9572</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YKH834O4BH</RegistryNumber><NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="N">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004554" MajorTopicYN="N">Electric Countershock</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058687" MajorTopicYN="N">Out-of-Hospital Cardiac Arrest</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adrenaline</Keyword><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Defibrillation</Keyword><Keyword MajorTopicYN="N">Mechanical chest compressions</Keyword><Keyword MajorTopicYN="N">Outcome</Keyword><Keyword MajorTopicYN="N">Ventricular fibrillation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28385642</ArticleId><ArticleId IdType="doi">10.1016/j.resuscitation.2017.04.005</ArticleId><ArticleId IdType="pii">S0300-9572(17)30156-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40294736</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes (BRAVE).</ArticleTitle><Pagination><StartPage>1975</StartPage><EndPage>1983</EndPage><MedlinePgn>1975-1983</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2025.04.033</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(25)02381-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Catheter ablation has emerged as a promising treatment to prevent ventricular fibrillation (VF) in Brugada syndrome (BrS). However, evidence from a prospective, randomized clinical trial is lacking.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes trial is a prospective, multicenter, 2-arm, randomized (1:1), open-label clinical study designed to evaluate the efficacy and safety of ablation therapy in patients with symptomatic BrS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled patients with symptomatic BrS with an implantable cardioverter-defibrillator. Patients were randomized to ablation therapy or control groups. Ablation targeted arrhythmogenic areas identified through electroanatomical mapping, predominantly at the right ventricular epicardium. The primary outcome was the first occurrence of VF or death. One interim analysis was planned after 50 patients were randomized.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 67 patients screened, 52 were randomized (25 to ablation, 25 to control, 2 withdrawals), and 15 declined randomizations but remained in a registry (10 chose ablation, 5 opted against ablation). After 3 years of follow-up, the ablation group had significantly fewer VF events than the control group (hazard ratio, 0.288; P = .0184). At the interim analysis, the Data Safety Monitoring Board recommended early trial termination. Among all ablation recipients (including crossovers and registry participants), 83% remained VF free after a single procedure and 90% after a repeat ablation. Complications of ablation included 1 hemopericardium without a long-term sequel.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Epicardial substrate ablation significantly reduces VF recurrence in patients with symptomatic BrS with implantable cardioverter-defibrillators and seems safe, supporting its potential role as a first-line therapy to prevent recurrent VF in patients with symptomatic BrS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nademanee</LastName><ForeName>Koonlawee</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Heart Institute, Bumrungrad Hospital, Bangkok, Thailand; Pacific Rim Electrophysiology Research Institute, Las Vegas, Nevada. Electronic address: wee@pacificrimep.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wongcharoen</LastName><ForeName>Wanwarang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chimparlee</LastName><ForeName>Nitinan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chokesuwattanaskul</LastName><ForeName>Ronpichai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annueypol</LastName><ForeName>Montawatt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phusunti</LastName><ForeName>Keerapa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Maharat Nakhon Ratchasima Hospital, Nakorn Ratchasima, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahasatas</LastName><ForeName>Dujdao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prechawat</LastName><ForeName>Somchai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasertwitayakij</LastName><ForeName>Narawudt</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makarawate</LastName><ForeName>Pattarapong</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutjaporn</LastName><ForeName>Boosamas</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilde</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands; Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drew</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pacific Rim Electrophysiology Research Institute, Las Vegas, Nevada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Postema</LastName><ForeName>Pieter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands; Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngarmukos</LastName><ForeName>Tachapong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardhanabhuti</LastName><ForeName>Saran</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pacific Rim Electrophysiology Research Institute, Las Vegas, Nevada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veerakul</LastName><ForeName>Gumpanart</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Bangkok Heart Hospital, Bangkok General Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wandee</LastName><ForeName>Pharawee</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauleekoonphairoj</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poovorawan</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khongphatthanyaothin</LastName><ForeName>Apichai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="Y">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053840" MajorTopicYN="Y">Brugada Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="N">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Brugada syndrome</Keyword><Keyword MajorTopicYN="N">Implantable cardioverter-defibrillator</Keyword><Keyword MajorTopicYN="N">Sudden death</Keyword><Keyword MajorTopicYN="N">Ventricular fibrillation</Keyword></KeywordList><CoiStatement>Disclosures Dr Nademanee receives a research grant and royalty from Biosense Webster Inc, and all other coauthors have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>29</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>19</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40294736</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2025.04.033</ArticleId><ArticleId IdType="pii">S1547-5271(25)02381-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39849420</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>The effect of anesthesia on postoperative cognitive dysfunction in adults undergoing cataract surgery: a systematic review.</ArticleTitle><Pagination><StartPage>35</StartPage><MedlinePgn>35</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">35</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-025-02897-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">We systematically reviewed the evidence on the effect of anesthetic methods and drugs on the incidence of postoperative cognitive dysfunction (POCD) after cataract surgery.</AbstractText><AbstractText Label="METHODS">The Web of Science, PubMed, and Scopus databases were searched for relevant English reports published from 2000 to August 2024. After full-text screening and checking the quality assessment of each article using the JBI checklist, 9 relevant articles were included in this study. The included articles were reviewed to explain how different anesthetic modalities and drugs may affect the incidence of POCD after cataract surgery. Our study aimed to systematically investigate the relationship between various methods of anesthesia and POCD for people undergoing cataract surgery.</AbstractText><AbstractText Label="RESULTS">We included 9 clinical trials with 1014 participants, which analyzed the incidence of POCD after anesthetic interventions. Four articles compared the effect of anesthetic modality interventions on POCD and five studies compared the effect of anesthetic drugs on POCD. The studies used various cognitive measurement scales, including the Mini-Mental State Examination, Neurobehavioral Rating Scale, Blessed Orientation-Memory-Concentration Test, Iowa Satisfaction with Anesthesia scale, PALT, and VF test. All articles that compared local and topical anesthesia found no statistically significant difference in the incidence of cognitive dysfunction at postop days 1 and 7. General anesthesia may cause POCD approximately twofold than local anesthesia. Ketamine, Midazolam, or Dexmedetomidine seemed to reduce postoperative cognitive complications compared to the control group&#x200c;&#x200c;.</AbstractText><AbstractText Label="CONCLUSIONS">This systematic review investigates how different anesthetic techniques and drugs may affect the incidence of POCD. The available literature is far from being conclusive and further studies are needed to reach any significant conclusions. It is necessary to adopt an appropriate anesthesia method for elderly and high-risk patients, especially people who have a history of cognitive problems&#x200c;&#x200c; undergoing elective cataract surgery, to reduce cognitive complications after surgery.&#x200c;.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Foroughi</LastName><ForeName>Elaheh</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brogi</LastName><ForeName>Etrusca</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroscience Intensive Care Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. etrusca.brogi@ospedaleniguarda.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forfori</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universita di Pisa, Medical, Molecular, and Critical Area Pathology, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashemi</LastName><ForeName>Seyyed Taghi</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Isfahan University of Medical Sciences, Isfahan, Iran. st_hashemi@med.mui.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002387" MajorTopicYN="Y">Cataract Extraction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079690" MajorTopicYN="Y">Postoperative Cognitive Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Anesthetic modalities</Keyword><Keyword MajorTopicYN="N">Cataract surgery</Keyword><Keyword MajorTopicYN="N">Cognition complications</Keyword><Keyword MajorTopicYN="N">Postoperative cognitive dysfunction (POCD)</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: IRB Information: not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>24</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39849420</ArticleId><ArticleId IdType="pmc">PMC11755816</ArticleId><ArticleId IdType="doi">10.1186/s12871-025-02897-3</ArticleId><ArticleId IdType="pii">10.1186/s12871-025-02897-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Urits I, Orhurhu V, Jones M, Hoyt D, Seats A,Viswanath OJTjoa, et al. Current perspectives on postoperative cognitive dysfunction in the ageing population. 2019;47(6):439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6886822</ArticleId><ArticleId IdType="pubmed">31828240</ArticleId></ArticleIdList></Reference><Reference><Citation>Poorzamany Nejat Kermany M, Dahi M, Yamini Sharif R, Radpay B. Comparison of the effects of dexmedetomidine and remifentanil on cognition state after cataract surgery. Anesth Pain Med. 2016;6(3):e33448. 10.5812/aapm.33448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018133</ArticleId><ArticleId IdType="pubmed">27642574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S-H, Ji M-H, Gao D-P, Li W-Y. Yang J-JJUjoms. Association between perioperative blood transfusion and early postoperative cognitive dysfunction in aged patients following total hip replacement surgery. 2014;119(3):262&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4116766</ArticleId><ArticleId IdType="pubmed">24345210</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Gara BP, Mueller A, Gasangwa DVI, Patxot M, Shaefi S, Khabbaz K, Banner-Goodspeed V, Pascal-Leone A, Marcantonio ER, Subramaniam B. Prevention of Early Postoperative Decline: A Randomized, Controlled Feasibility Trial of Perioperative Cognitive Training. Anesth Analg. 2020;130(3):586&#x2013;95. 10.1213/ANE.0000000000004469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154961</ArticleId><ArticleId IdType="pubmed">31569161</ArticleId></ArticleIdList></Reference><Reference><Citation>Li WX, Luo RY, Chen C, Li X, Ao JS, Liu Y, Yin YQ. Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: a randomized controlled preliminary trial. Chin Med J (Engl). 2019;132(4):437-45. 10.1097/CM9.0000000000000098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6595716</ArticleId><ArticleId IdType="pubmed">30707179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancelin M-L, DeRoquefeuil G, Scali J, Bonnel F, Adam J-F, Cheminal J-C, et al. Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents. 2010;22(s3):S105&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078520</ArticleId><ArticleId IdType="pubmed">20858969</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Lu W, Jiang X, Xiong C, Chai H, Cai L, et al. Current progress on neuroinflammation-mediated postoperative cognitive dysfunction: an update. 2023;23(10):1077&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">36411553</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges J, Moreira J, Moreira A, Santos A. Abelha FJJRBdA. Impact of postoperative cognitive decline in quality of life: a prospective study. 2017;67(4):362&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28412051</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK. Delirium in older persons. N Engl J Med. 2006;354(11):1157-65. 10.1056/NEJMra052321. Erratum in: N Engl J Med. 2006;354(15):1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">16540616</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiner S, Silverstein JH. Postoperative delirium and cognitive dysfunction. Br J Anaesth. 2009;103 Suppl 1(Suppl 1):i41-46. 10.1093/bja/aep291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791855</ArticleId><ArticleId IdType="pubmed">20007989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall TA, McGwin G Jr. Owsley CJJotAGS. Effect of cataract surgery on cognitive function in older adults. 2005;53(12):2140&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16398899</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorofeeva GJMP. The influence of the chosen method of anesthesia on the severity of postoperative cognitive dysfunction in patients with ophthalmic surgery. 2021;26(1):122.</Citation></Reference><Reference><Citation>Smith GT, Chen TJ, Shah NM, Agrest B. Grotticelli JJFiA. Anesthesia-mediated neuroinflammatory sequelae in post operative cognitive dysfunction: mechanisms and therapeutic implications. 2024;3:1281034.</Citation></Reference><Reference><Citation>Karhunen U, J&#xf6;nn G. A comparison of memory function following local and general anaesthesia for extraction of senile cataract. Acta Anaesthesiol Scand. 1982;26(4):291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7124302</ArticleId></ArticleIdList></Reference><Reference><Citation>Naghibi K, Shafa A, Hirmanpour A. Sabaghi BJJoIMS. The impact of general anesthesia vs local anesthesia with intravenous sedation on the incidence of postoperative cognitive dysfunction after cataract surgery in elderly patients. 2016;34(372):134&#x2013;42.</Citation></Reference><Reference><Citation>Zhang Y, Shan G-J, Zhang Y-X, Cao S-J, Zhu S-N, Li H-J, et al. Propofol compared with sevoflurane general anaesthesia is associated with decreased delayed neurocognitive recovery in older adults. 2018;121(3):595&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">30115258</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathy W, Hussein M, Khalil H. Comparative effect of local anesthesia with lidocaine 2% versus topical anesthesia on cognitive function in ophthalmic surgery. Anesthesiol Pain Med. 2019;9(6):e97172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118683</ArticleId><ArticleId IdType="pubmed">32280618</ArticleId></ArticleIdList></Reference><Reference><Citation>Oriby ME, Elrashidy AA, Elsharkawy A, Ahmed SA. Effects of ketamine or dexmedetomidine on postoperative cognitive dysfunction after cataract surgery: A randomized controlled trial. Indian J Anaesth. 2023;67(2):186&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10121090</ArticleId><ArticleId IdType="pubmed">37091455</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#x131;l&#x131;&#xe7; Y, Bilge&#xe7; MD, Sar&#x131;o&#x11f;lan BT, Kayhan GE, G&#xfc;le&#xe7; MS, &#xd6;zer AJEMJ. Impact of topical and local anesthesia on postoperative cognitive functions in geriatrics undergoing cataract surgery. 2021;111&#x2013;7.</Citation></Reference><Reference><Citation>Elsaid MA. Elgazar AFJTSJoMS. Ketamine versus Dexmedetomidine for Postoperative Cognitive Dysfunction after Cataract Surgery: A retrospective Study. 2021;2021(1):23&#x2013;8.</Citation></Reference><Reference><Citation>K&#x131;l&#x131;&#xe7; Y, Bilge&#xe7; M, Sar&#x131;o&#x11f;lan B, Kayhan GE, G&#xfc;le&#xe7; M,&#xd6;zer AJJoS, et al. Role of anesthesia type on cognitive functions in adults undergoing cataract surgery. 2020;4(12):1112&#x2013;5.</Citation></Reference><Reference><Citation>Mansouri N, Nasrollahi K, Shetabi H. Prevention of Cognitive Dysfunction after Cataract Surgery with Intravenous Administration of Midazolam and Dexmedetomidine in Elderly Patients Undergoing Cataract Surgery. Adv Biomed Res. 2019;8(1):6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6385669</ArticleId><ArticleId IdType="pubmed">30820427</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathy W, Hussein M, Khalil H. Effect of local anesthesia (with lidocaine vs bupivacaine) on cognitive function in patients undergoing elective cataract surgery. Local Reg Anesth. 2018;12:1-6. 10.2147/LRA.S185367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6318706</ArticleId><ArticleId IdType="pubmed">30643450</ArticleId></ArticleIdList></Reference><Reference><Citation>Naghibi K, Shetabi H, Nasrollahi K. Mansouri NJJoIMS. The effect of intravenous midazolam and dexmedetomidine on prevention of cognitive dysfunction after cataract surgery in the elderly patients under general anesthesia compared with the control group. 2018;36(504):1395&#x2013;400.</Citation></Reference><Reference><Citation>Askarianfard N, Nasrollahi K, Shetabi H. Naghibi KJJoIMS. A Comparative Study of the Effects of Two Different Levels of End-Tidal Carbon Dioxide Pressure on Cognitive Dysfunction in Elderly Patients, after Cataract Surgery under General Anesthesia. 2019;37(533):747&#x2013;53.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, medicine PGJAoi. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. World Alzheimer Report 2015. The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends: Alzheimer&#x2019;s Disease International; 2015.</Citation></Reference><Reference><Citation>Suraarunsumrit P, Srinonprasert V, Kongmalai T, Suratewat S, Chaikledkaew U, Rattanasiri S, et al. Outcomes associated with postoperative cognitive dysfunction: a systematic review and meta-analysis. 2024;53(7):afae160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11277860</ArticleId><ArticleId IdType="pubmed">39058915</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P, Blumenthal J, Hoffman B, Davis RD. Palmer SJAJoT. Postoperative cognitive dysfunction and mortality following lung transplantation. 2018;18(3):696&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5820215</ArticleId><ArticleId IdType="pubmed">29087035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zywiel MG, Prabhu A, Perruccio AV, Gandhi RJCO. Research&#xae; R. The influence of anesthesia and pain management on cognitive dysfunction after joint arthroplasty: a systematic review. 2014;472:1453&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3971229</ArticleId><ArticleId IdType="pubmed">24186470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Basu M, Kirtania J, Sarbapalli D, Pal R, Kar S, et al. Impact of general versus epidural anesthesia on early post-operative cognitive dysfunction following hip and knee surgery. 2011;4(1):23&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3097574</ArticleId><ArticleId IdType="pubmed">21633563</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason SE, Noel-Storr A. Ritchie CWJJoAsD. The impact of general and regional anesthesia on the incidence of post-operative cognitive dysfunction and post-operative delirium: a systematic review with meta-analysis. 2010;22(s3):S67&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">20858956</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Liu L, Zhao B, Wang Y, Yu S, Wang HJJCPSP. Effect of general and non-general anesthesia on postoperative cognitive dysfunction. 2020;30(4):407&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32513362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudetz J, Iqbal Z, Gandhi S, Patterson K, Byrne A, Hudetz A, et al. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. 2009;53(7):864&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">19422355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou N, Chen C, Liu Y, Yu Z, Chen Y. Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis. Ther Adv Psychopharmacol. 2023;13:20451253231200260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10617260</ArticleId><ArticleId IdType="pubmed">37915364</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasc&#xf3;n-Mart&#xed;nez DM, Fres&#xe1;n-Orellana A, Ochar&#xe1;n-Hern&#xe1;ndez ME, Genis-Zarate JH, Castellanos-Olivares AJA. Analgesia. The effects of ketamine on cognitive function in elderly patients undergoing ophthalmic surgery: a pilot study. 2016;122(4):969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">26771268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell RFJP. Ketamine for chronic non-cancer pain. 2009;141(3):210&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19128879</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Xu S, Zhang Y, Huang YJB. Behavior. Effects of anesthetic adjunctive agents on postoperative cognitive dysfunction in elderly patients undergoing noncardiac surgery: A Bayesian network meta-analysis. 2023;13(8): e3149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10454282</ArticleId><ArticleId IdType="pubmed">37431799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamperti M, Romero CS, Guarracino F, Cammarota G, Vetrugno L, Tufegdzic B, et al. Preoperative assessment of adults undergoing elective noncardiac surgery: Updated guidelines from the European Society of Anaesthesiology and Intensive Care. 2025;42(1):1&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">39492705</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecorella G, De Rosa F, Licchelli M, Panese G, Carugno JT, Morciano A, et al. Postoperative cognitive disorders and delirium in gynecologic surgery: Which surgery and anesthetic techniques to use to reduce the risk? 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38557928</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaput AJ. Bryson GLJCJoAJcda. Postoperative delirium: risk factors and management: continuing professional development. 2012;59(3):304&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">22311257</ArticleId></ArticleIdList></Reference><Reference><Citation>Contin A, Perez-Jara J, Alonso-Contin A, Enguix A, Ramos FJIjogp. Postoperative delirium after elective orthopedic surgery. 2005;20(6).</Citation><ArticleIdList><ArticleId IdType="pubmed">15962354</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31724106</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-187X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>American journal of cardiovascular drugs : drugs, devices, and other interventions</Title><ISOAbbreviation>Am J Cardiovasc Drugs</ISOAbbreviation></Journal><ArticleTitle>Dexmedetomidine Reduces Atrial Fibrillation After Adult Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>281</EndPage><MedlinePgn>271-281</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40256-019-00380-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dexmedetomidine has been shown to have antiarrhythmic effects by exhibiting sympatholytic properties and activating the vagus nerve in preclinical studies. Results from clinical trials of dexmedetomidine on atrial fibrillation (AF) following adult cardiac surgery are controversial.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We searched EMBASE, PubMed and Cochrane CENTRAL databases for randomized controlled trials (RCTs) comparing the antiarrhythmic effect of dexmedetomidine versus placebo or other anesthetic drugs in adult patients undergoing cardiac surgery. The primary outcome was the incidence of AF. The secondary outcomes were ventricular arrhythmias [ventricular fibrillation (VF), ventricular tachycardia (VT)], mechanical ventilation (MV) duration, intensive care unit (ICU) length of stay, and hospital length of stay, and all-cause mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen trials with a total of 1684 study patients were selected. Compared with controls, dexmedetomidine significantly reduced the incidence of postoperative AF [odds ratio (OR) 0.75; 95% confidence interval (CI) 0.58-0.97; P = 0.03] and VT (OR 0.23; 95% CI 0.11-0.48; P &lt; 0.0001). No significant difference for the incidence of VF existed (OR 0.80; 95% CI 0.21-3.03; P = 0.74). There was no significant difference between groups in MV duration [weighted mean difference (WMD) -&#x2009;0.10; 95% CI -&#x2009;0.42 to 0.21; P = 0.52], postoperative ICU stay (WMD -&#x2009;0.49; 95% CI -&#x2009;2.64 to 1.66; P = 0.65), hospital stay (WMD -&#x2009;0.01; 95% CI -&#x2009;0.16 to 0.13; P = 0.88) and mortality (OR 0.59; 95% CI 0.15-2.37; P = 0.46).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative administration of dexmedetomidine in adult patients undergoing cardiac surgery reduced the incidence of postoperative AF and VT. But there was no significant difference in incidence of VF, MV duration, ICU stay, hospital stay and mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of anesthesiology, Beijing Daxing Maternal and Child Care Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Suozhu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Feiping</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhen</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Haidian District, Beijing, 100038, China. heart2008whu@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Am J Cardiovasc Drugs</MedlineTA><NlmUniqueID>100967755</NlmUniqueID><ISSNLinking>1175-3277</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31724106</ArticleId><ArticleId IdType="doi">10.1007/s40256-019-00380-2</ArticleId><ArticleId IdType="pii">10.1007/s40256-019-00380-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33036946</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7533</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</Title><ISOAbbreviation>Surg Obes Relat Dis</ISOAbbreviation></Journal><ArticleTitle>A clinical trial of volume- versus pressure-controlled intraoperative ventilation during laparoscopic bariatric surgeries.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>89</EndPage><MedlinePgn>81-89</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.soard.2020.08.034</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1550-7289(20)30502-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intra-operative ventilation is often challenging in patients with morbid obesity undergoing bariatric surgery.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To test the noninferiority of pressure-controlled ventilation (PCV) to volume-controlled ventilation (VCV) in respiratory mechanics.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Bariatric Surgery Center, Iran.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a randomized open-labeled clinical trial, 66 individuals with morbid obesity undergoing laparoscopic bariatric surgeries underwent intraoperative ventilation with either PCV or VCV. The measurements taken were peak and mean airway pressures (H<sub>2</sub>O), partial pressure of arterial oxygen (PaO<sub>2</sub>), partial pressure of arterial carbon dioxide (PaCO<sub>2</sub>) and end-tidal carbon dioxide (CO<sub>2</sub>). We additionally collected pulse-oximetric oxygen saturation, inspiratory concentration of oxygen (FiO<sub>2</sub>), and hemodynamic variables. Data were analyzed with repeated measures over the time of intubation, after peritoneal insufflation, and every 15 minutes, thereafter up to one hour.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">PCV mode was successful to sustain adequate ventilation in 97% of the patients, which was similar to the 94% success rate of the VCV mode. Peak airway pressure increased 6 cmH<sub>2</sub>O and end-tidal CO<sub>2</sub> rose by 5 mm Hg after abdominal insufflation in both groups (P = .850 and .376). Alveolar-arterial oxygen gradient similarly increased within 30 minutes after tracheal intubation both in PCV and VCV groups, with small trend of being higher in the VCV group. The ratio of dead space to tidal volumes (VD/VT) did not have a meaningful change (P = .724).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PCV was noninferior to VCV during laparoscopic bariatric surgery. Either mode of ventilation could be alternatively used during the anesthesia care of these patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghodraty</LastName><ForeName>Mohammad Reza</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pournajafian</LastName><ForeName>Ali Reza</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavoosian</LastName><ForeName>Sina Dokht</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khatibi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safari</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motlagh</LastName><ForeName>Soudabeh Djalali</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abhari</LastName><ForeName>Mariam Biglari</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafighnia</LastName><ForeName>Shora</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porhomayon</LastName><ForeName>Jahan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University at Buffalo, Buffalo, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nader</LastName><ForeName>Nader D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University at Buffalo, Buffalo, New York, United States. Electronic address: nnader@buffalo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Obes Relat Dis</MedlineTA><NlmUniqueID>101233161</NlmUniqueID><ISSNLinking>1550-7289</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bariatric surgery</Keyword><Keyword MajorTopicYN="N">Intraoperative ventilation</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Pressure-controlled ventilation</Keyword><Keyword MajorTopicYN="N">Volume-controlled ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>10</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33036946</ArticleId><ArticleId IdType="doi">10.1016/j.soard.2020.08.034</ArticleId><ArticleId IdType="pii">S1550-7289(20)30502-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37983980</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0539</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS</Title><ISOAbbreviation>J Plast Reconstr Aesthet Surg</ISOAbbreviation></Journal><ArticleTitle>Operative options for extracranial nasal dermoid cysts: A meta-analysis.</ArticleTitle><Pagination><StartPage>171</StartPage><EndPage>181</EndPage><MedlinePgn>171-181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjps.2023.10.114</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1748-6815(23)00686-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Nasal dermoid cysts are surgically treated using external incision, open rhinoplasty, transnasal endoscopy, or combined approaches. It is unclear how these approaches differ with regard to the incidence of adverse events.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review of studies on the surgical management of midline nasal dermoids. Following data abstraction, we carried out a series of single-arm meta-analyses to estimate summary risks of recurrence and combined adverse events (recurrence, revision, infection, or readmission) according to the surgical approach.</AbstractText><AbstractText Label="RESULTS">Forty-three eligible studies published between 1958 and 2020 reported on 439 cases of nasal dermoid cysts. Treatment approaches included external incision (25 studies), rhinoplasty (15 studies), and transnasal endoscopy (5 studies). To our knowledge, no study has compared outcome incidence between the surgical approaches. External incision had the lowest summary incidence of both recurrence (1.78% [95% CI: 0.57%, 3.65%]) and combined adverse events (4.94% [95% CI: 2.72%, 7.77%]). Rhinoplasty had a higher incidence of recurrence (4.81% [95% CI: 0.91%, 11.6%]) and combined adverse events (8.32% [95% CI: 2.77%, 16.5%]), and transnasal endoscopy had the highest incidence of recurrence (the only reported adverse event; 7.89% [95% CI: 0%, 28.9%]).</AbstractText><AbstractText Label="CONCLUSION">Our results suggest that the incidence of adverse events was lowest among patients who were subjected to external incision for nasal dermoid removal. Incidence was higher for patients who underwent rhinoplasty and the highest for patients who underwent transnasal endoscopy. Future work on this topic should include well-designed prospective studies that compare rates of adverse events and cosmetic outcomes between surgical approaches.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kohan</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Larner College of Medicine, University of Vermont, Burlington, VT, United States. Electronic address: Joshua.kohan@med.uvm.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGee</LastName><ForeName>Shayan A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Larner College of Medicine, University of Vermont, Burlington, VT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Self</LastName><ForeName>Quinn</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Larner College of Medicine, University of Vermont, Burlington, VT, United States; University of Vermont Medical Center, Division of Otolaryngology - Head &amp; Neck Surgery, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahern</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Surgical Research, Burlington, VT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hersey</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Vermont Libraries, Burlington, VT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Malley</LastName><ForeName>Donna L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>University of Vermont Libraries, Burlington, VT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostby</LastName><ForeName>Erin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Larner College of Medicine, University of Vermont, Burlington, VT, United States; University of Vermont Medical Center, Division of Otolaryngology - Head &amp; Neck Surgery, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Plast Reconstr Aesthet Surg</MedlineTA><NlmUniqueID>101264239</NlmUniqueID><ISSNLinking>1748-6815</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003884" MajorTopicYN="Y">Dermoid Cyst</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009669" MajorTopicYN="Y">Nose Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012225" MajorTopicYN="Y">Rhinoplasty</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004724" MajorTopicYN="N">Endoscopy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Congenital mass</Keyword><Keyword MajorTopicYN="N">Craniofacial mass</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Midline dermoid</Keyword><Keyword MajorTopicYN="N">Nasal dermoid</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>20</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>20</Day><Hour>17</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37983980</ArticleId><ArticleId IdType="doi">10.1016/j.bjps.2023.10.114</ArticleId><ArticleId IdType="pii">S1748-6815(23)00686-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29475875</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e007748</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.117.007748</ELocationID><Abstract><AbstractText Label="BACKGROUND">Ventricular arrhythmias are common in patients with left ventricular assist devices (LVADs) but are often hemodynamically tolerated. Optimal implantable cardioverter defibrillator (ICD) tachy-programming strategies in patients with LVAD have not been determined. We sought to determine if an ultra-conservative ICD programming strategy in patients with LVAD affects ICD shocks.</AbstractText><AbstractText Label="METHODS AND RESULTS">Adult patients with an existing ICD undergoing continuous flow LVAD implantation were randomized to standard ICD programming by their treating physician or an ultra-conservative ICD programming strategy utilizing maximal allowable intervals to detection in the ventricular fibrillation and ventricular tachycardia zones with use of ATP. Patients with cardiac resynchronization therapy (CRT) devices were also randomized to CRT ON or OFF. Patients were followed a minimum of 6&#xa0;months. The primary outcome was time to first ICD shock. Among the 83 patients studied, we found no statistically significant difference in time to first ICD shock or total ICD shocks between groups. In the ultra-conservative group 16% of patients experienced at least one shock compared with 21% in the control group (<i>P</i>=0.66). There was no difference in mortality, arrhythmic hospitalization, or hospitalization for heart failure. In the 41 patients with CRT ICDs fewer shocks were observed with CRT-ON but this was not statistically significant: 10% of patients with CRT-ON (n=21) versus 38% with CRT-OFF (n=20) received shocks (<i>P</i>=0.08).</AbstractText><AbstractText Label="CONCLUSIONS">An ultra-conservative programming strategy did not reduce ICD shocks. Programming restrictions on ventricular tachycardia and ventricular fibrillation zone therapy should be reconsidered for the LVAD population. The role of CRT in patients with LVAD warrants further investigation.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">URL: https://www.clinicaltrials.gov. Unique identifier: NCT01977703.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Travis D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology, Vanderbilt Heart and Vascular Institute, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hale</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology, Vanderbilt Heart and Vascular Institute, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arteaga</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Centre, St. George's University School of Medicine, Grenada, West Indies.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keebler</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Advanced Heart Failure, Vanderbilt Heart and Vascular Institute, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlendorf</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Advanced Heart Failure, Vanderbilt Heart and Vascular Institute, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danter</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Vanderbilt Heart and Vascular Institute, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Vanderbilt Heart and Vascular Institute, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindenfeld</LastName><ForeName>JoAnn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Advanced Heart Failure, Vanderbilt Heart and Vascular Institute, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Arrhythmia and Electrophysiology, Vanderbilt Heart and Vascular Institute, Nashville, TN christopher.ellis@vanderbilt.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01977703</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058406" MajorTopicYN="Y">Cardiac Resynchronization Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004554" MajorTopicYN="N">Electric Countershock</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011475" MajorTopicYN="N">Prosthesis Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013714" MajorTopicYN="N" Type="Geographic">Tennessee</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="Y">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac resynchronization therapy</Keyword><Keyword MajorTopicYN="N">implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">left ventricular assist device</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>3</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29475875</ArticleId><ArticleId IdType="pmc">PMC5866326</ArticleId><ArticleId IdType="doi">10.1161/JAHA.117.007748</ArticleId><ArticleId IdType="pii">JAHA.117.007748</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp&#x2010;Channing N, Davidson&#x2010;Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD&#x2010;HeFT) Investigators . Amiodarone or an implantable cardioverter&#x2013;defibrillator for congestive heart failure. N Engl J Med. 2005;352:225&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">15659722</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">11907286</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933&#x2013;1940.</Citation><ArticleIdList><ArticleId IdType="pubmed">8960472</ArticleId></ArticleIdList></Reference><Reference><Citation>The AVID Investigators . A comparison of antiarrhythmic&#x2010;drug therapy with implantable defibrillators in patients resuscitated from near&#x2010;fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576&#x2013;1584.</Citation><ArticleIdList><ArticleId IdType="pubmed">9411221</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882&#x2013;1890.</Citation><ArticleIdList><ArticleId IdType="pubmed">10601507</ArticleId></ArticleIdList></Reference><Reference><Citation>Group M&#x2010;HS . Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in&#x2010;congestive heart failure (MERIT&#x2010;HF). Lancet. 1999;353:2001&#x2013;2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">10376614</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device&#x2010;based therapy of cardiac rhythm abnormalities. Circulation. 2013;127:e283&#x2013;e352.</Citation><ArticleIdList><ArticleId IdType="pubmed">23255456</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, Morgan JA, Arabia F, Bauman ME, Buchholz HW, Deng M, Dickstein ML, El&#x2010;Banayosy A, Elliot T, Goldstein DJ, Grady KL, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte MP, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov EV, Eduardo Rame J, Russell SD, Sorensen EN, Sun B, Strueber M, Mangi AA, Petty MG, Rogers J; International Society for Heart and Lung Transplantation . The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">23352391</ArticleId></ArticleIdList></Reference><Reference><Citation>Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The role of implantable cardioverter&#x2010;defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2013;6:668&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">23873139</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakil K, Kazmirczak F, Sathnur N, Adabag S, Cantillon DJ, Kiehl EL, Koene R, Cogswell R, Anand I, Roukoz H. Implantable cardioverter&#x2010;defibrillator use&#xa0;in patients with left ventricular assist devices: a systematic review and meta&#x2010;analysis. JACC Heart Fail. 2016;4:772&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">27395347</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NG, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter&#x2010;defibrillator. Heart Rhythm. 2010;7:466&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">20178869</ArticleId></ArticleIdList></Reference><Reference><Citation>Garan AR, Yuzefpolskaya M, Colombo PC, Morrow JP, Te&#x2010;Frey R, Dano D, Takayama H, Naka Y, Garan H, Jorde UP, Uriel N. Ventricular arrhythmias and implantable cardioverter&#x2010;defibrillator therapy in patients with continuous&#x2010;flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol. 2013;61:2542&#x2013;2550.</Citation><ArticleIdList><ArticleId IdType="pubmed">23643502</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S, Garg L, Nanda S, Sharma A, Bhatia N, Manda Y, Singh A, Fegley M, Shirani J. The role of implantable cardioverter&#x2010;defibrillators in patients with continuous flow left ventricular assist devices&#x2014;a meta&#x2010;analysis. Int J Cardiol. 2016;222:379&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">27505320</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC, Brieke A, Sauer WH. Implantable cardioverter&#x2010;defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010;29:771&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">20347337</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantillon DJ, Saliba WI, Wazni OM, Kanj M, Starling RC, Tang WHW, Wilkoff BL. Low cardiac output associated with ventricular tachyarrhythmias in continuous&#x2010;flow LVAD recipients with a concomitant ICD (LoCo VT Study). J Heart Lung Transplant. 2014;33:318&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">24559946</ArticleId></ArticleIdList></Reference><Reference><Citation>Healy C, Viles&#x2010;Gonzalez JF, Sacher F, Coffey JO, d'Avila A. Management of ventricular arrhythmias in patients with mechanical ventricular support devices. Curr Cardiol Rep. 2015;17:59.</Citation><ArticleIdList><ArticleId IdType="pubmed">26072439</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgibbon J, Kman NE, Gorgas D. Asymptomatic sustained polymorphic ventricular tachycardia in a patient with a left ventricular assist device: case report and what the emergency physician should know. J Emerg Med. 2016;50:e135&#x2013;e141.</Citation><ArticleIdList><ArticleId IdType="pubmed">26899195</ArticleId></ArticleIdList></Reference><Reference><Citation>Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long&#x2010;term left ventricular assist devices. J Am Coll Cardiol. 1994;24:1688&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pubmed">7963116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kociol RD. Time for MADIT&#x2010;VAD? JACC Heart Fail. 2016;4:780&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pubmed">27686925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutyifa V. Is there a need for an implantable cardioverter defibrillator in patients with left ventricular assist devices? Time for MADIT&#x2010;VAD! Expert Rev Med Devices. 2016;14:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">27860486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinathannair R, Birks EJ, Trivedi JR, McCants KC, Sutton BS, Deam AG, Slaughter MS, Hottigoudar RU. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous&#x2010;flow left ventricular assist devices. J Card Fail. 2015;21:226&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">25528199</ArticleId></ArticleIdList></Reference><Reference><Citation>Schleifer JW, Mookadam F, Kransdorf EP, Nanda U, Adams JC, Cha S, Pajaro OE, Steidley DE, Scott RL, Carvajal T, Saadiq RA, Srivathsan K. Effect of continued cardiac resynchronization therapy on ventricular arrhythmias after left ventricular assist device implantation. Am J Cardiol. 2016;118:556&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">27328958</ArticleId></ArticleIdList></Reference><Reference><Citation>Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al&#x2010;Ahmad A, McNitt S, Foster E, Huang DT, Klein HU, Zareba W, Eldar M, Goldenberg I. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT&#x2010;CRT (Multicenter Automatic Defibrillator Implantation Trial&#x2010;Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011;57:2416&#x2013;2423.</Citation><ArticleIdList><ArticleId IdType="pubmed">21658562</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40689693</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1646-0758</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Acta medica portuguesa</Title><ISOAbbreviation>Acta Med Port</ISOAbbreviation></Journal><ArticleTitle>Antithrombotic Treatment After Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Procedures: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>528</StartPage><EndPage>537</EndPage><MedlinePgn>528-537</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.20344/amp.22905</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">While antithrombotic therapy following transcatheter valve implantation has been extensively studied in various clinical trials, there remains a notable gap in evidence regarding the optimal approach following valve-in-valve (ViV), valve-in-ring (ViR) and valve-in-mitral annular calcification (ViMAC) procedures, warranting further assessment. This gap is particularly concerning due to the apparent increased risk of thrombosis associated with ViV interventions. The aim of this systematic review was to explore the potential benefits of anticoagulation in ViV, ViR, and ViMAC procedures.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials, as well as the grey literature, for observational and interventional studies published until December 2023. Trials were included if a comparative analysis between the two antithrombotic strategies was feasible and excluded if patients under 18 years old were analysed. The primary efficacy endpoints were incidence of clinical and total valve thrombosis (VT), major bleeding was the sole safety primary endpoint. Additional analyses were performed regarding valves in the mitral position and valve type. The risk of bias was evaluated using the Newcastle-Ottawa scale. Data was assessed using the Review Manager 5.4 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of five observational and one case series were included (n = 614 on anticoagulation and n = 468 on antiplatelets), comprising a total of 1082 participants. Clinical VT rates were 4.2% for all procedures, and patients on anticoagulants were associated with a a lower risk of clinical VT (1.1% vs 8.3%; OR: 0.18; 95% CI: 0.07 - 0.42, I2: 0%) and total VT (1.3% vs 8.5%; OR: 0.16; 95% CI: 0.07 - 0.37, I2: 0%). Regarding bleeding events, the existing literature did not provide adequate information to enable a thorough analysis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study suggests a potential benefit of anticoagulation regimens to decrease the high rates of VT following valve-in-valve, valve-in-ring and valve-in-mitral annular calcification procedures. However, the lack of randomized controlled trials and data on bleeding and mortality emphasises the necessity for further research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Terleira Batista</LastName><ForeName>Gon&#xe7;alo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia. Centro Hospitalar e Universit&#xe1;rio de Coimbra. Coimbra. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Gon&#xe7;alo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia. Centro Hospitalar e Universit&#xe1;rio de Coimbra. Coimbra. &amp; Faculdade de Medicina. Universidade de Coimbra. Coimbra. &amp; Coimbra Institute for Clinical and Biomedical Research (iCBR). Coimbra. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado Silva</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia. Centro Hospitalar e Universit&#xe1;rio de Coimbra. Coimbra. &amp; Faculdade de Medicina. Universidade de Coimbra. Coimbra. &amp; Coimbra Institute for Clinical and Biomedical Research (iCBR). Coimbra. Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gon&#xe7;alves</LastName><ForeName>Lino</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia. Centro Hospitalar e Universit&#xe1;rio de Coimbra. Coimbra. &amp; Faculdade de Medicina. Universidade de Coimbra. Coimbra. &amp; Coimbra Institute for Clinical and Biomedical Research (iCBR). Coimbra. Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Portugal</Country><MedlineTA>Acta Med Port</MedlineTA><NlmUniqueID>7906803</NlmUniqueID><ISSNLinking>0870-399X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="Y">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006350" MajorTopicYN="Y">Heart Valve Prosthesis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006349" MajorTopicYN="N">Heart Valve Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anticoagulants/administration &amp; dosage</Keyword><Keyword MajorTopicYN="N">Bioprosthesis</Keyword><Keyword MajorTopicYN="N">Cardiac Catheterization</Keyword><Keyword MajorTopicYN="N">Heart Valve Prosthesis</Keyword><Keyword MajorTopicYN="N">Heart Valve Prosthesis Implantation</Keyword><Keyword MajorTopicYN="N">Thrombosis/prevention &amp; control</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>4</Day><Hour>0</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>9</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40689693</ArticleId><ArticleId IdType="doi">10.20344/amp.22905</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40103188</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Endo-Epicardial vs. Endocardial-Only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy: The EPIC-VT Trial Design.</ArticleTitle><Pagination><StartPage>1038</StartPage><EndPage>1045</EndPage><MedlinePgn>1038-1045</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.16630</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Radiofrequency ablation is a cornerstone therapy for patients with ischemic cardiomyopathy (ICM) presenting with ventricular tachycardia (VT). In this context, ablation is typically performed endocardially as a first-line approach. However, despite acute procedural success, the risk of recurrence remains high, potentially due to the presence of epicardial substrate. Several observational studies have suggested the potential benefits of a first-line endo-epicardial approach in decreasing recurrence. In this context, the EPIC-VT trial was designed to compare endocardial-only ablation versus combined endo-epicardial ablation as a first-line approach in ICM patients with VT.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The EPIC-VT trial is a prospective, multicenter, controlled, randomized, open-label superiority trial with two parallel groups (endocardial-only approach vs. combined endo-epicardial approach) in a 1:1 ratio. The primary objective of this study is to demonstrate that a combined endo-epicardial approach reduces the risk of VT recurrence compared to an endocardial approach alone in patients with ICM. Patients will be followed for 2 years after the procedure.</AbstractText><AbstractText Label="RESULTS AND CONCLUSION" NlmCategory="CONCLUSIONS">To date, only retrospective studies have compared VA recurrences in patients with ICM, depending on whether ablation was performed using an endocardial or an endo-epicardial approach, with conflicting results. A meta-analysis suggested an advantage of the endo-epicardial approach over the endocardial approach (odds ratio&#x2009;=&#x2009;0.39 [95% CI: 0.18-0.83]). However, the level of evidence remains low, and no controlled randomized study has confirmed this hypothesis. If the EPIC-VT study confirms the superiority of a first-line endo-epicardial approach, such strategy could become the preferred option for VT ablation in ICM, thereby reducing the risk of VA recurrence.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Rapha&#xeb;l P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Univ Rennes, CHU Rennes, INSERM, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groussin</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Univ Rennes, CHU Rennes, INSERM, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bessi&#xe8;re</LastName><ForeName>Francis</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Champ-Rigot</LastName><ForeName>Laure</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5769-4398</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital of Caen, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gourraud</LastName><ForeName>Jean-Baptiste</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Cardiology, CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepage</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, CHU Angers, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansourati</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, CHU Brest, Brest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massoulie</LastName><ForeName>Gr&#xe9;goire</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9547-0835</Identifier><AffiliationInfo><Affiliation>CHU Clermont-Ferrand, Cardiology Department, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maury</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4800-1841</Identifier><AffiliationInfo><Affiliation>Centre Hospitalier Universitaire de Toulouse, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ninni</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CHU Lille, Institut Coeur-Poumons, Cardiac Intensive Care Unit, Department of Cardiology, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierre</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiac Surgery, Tours University Hospital, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacher</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Cardiologique du Haut-L&#xe9;v&#xea;que, Universit&#xe9; Bordeaux II, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varlet</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>European Georges Pompidou Hospital, Cardiology Department, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waintraub</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, CHU Piti&#xe9; Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locher</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Univ Rennes, CHU Rennes, INSERM, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavin</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Univ Rennes, CHU Rennes, INSERM, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mabo</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Univ Rennes, CHU Rennes, INSERM, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leclercq</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Univ Rennes, CHU Rennes, INSERM, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benali</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Saint-&#xc9;tienne University Hospital Center, Saint-&#xc9;tienne University, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004699" MajorTopicYN="Y">Endocardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074099" MajorTopicYN="N">Equivalence Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010496" MajorTopicYN="Y">Pericardium</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epicardial</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>14</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>19</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40103188</ArticleId><ArticleId IdType="pmc">PMC12075910</ArticleId><ArticleId IdType="doi">10.1111/jce.16630</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Narins C. R., Aktas M. K., Chen A. Y., et al., &#x201c;Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy,&#x201d; JACC: Clinical Electrophysiology 8, no. 1 (January 2022): 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792162</ArticleId><ArticleId IdType="pubmed">34454875</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Khatib S. M., Stevenson W. G., Ackerman M. J., et al., &#x201c;2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society,&#x201d; Journal of the American College of Cardiology 72, no. 14 (October 2018): 91.</Citation><ArticleIdList><ArticleId IdType="pubmed">29097296</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin E. M., Bogun F. M., Maury P., et al., &#x201c;2019 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias: Executive Summary,&#x201d; Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology 22, no. 3 (March 2020): 450&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pubmed">31995197</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivkumar K., &#x201c;Catheter Ablation of Ventricular Arrhythmias,&#x201d; New England Journal of Medicine 380, no. 16 (April 2019): 1555&#x2013;1564.</Citation><ArticleIdList><ArticleId IdType="pubmed">30995375</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenal &#xc1;., &#xc1;vila P., Jim&#xe9;nez&#x2010;Candil J., et al., &#x201c;Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia,&#x201d; Journal of the American College of Cardiology 79, no. 15 (April 2022): 1441&#x2013;1453.</Citation><ArticleIdList><ArticleId IdType="pubmed">35422240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R., Xue Y., Chen M., et al., &#x201c;First&#x2010;Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE&#x2010;SCD Randomized Trial,&#x201d; Circulation 145, no. 25 (2022): 1839&#x2013;1849.</Citation><ArticleIdList><ArticleId IdType="pubmed">35507499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp J. L., Wells G. A., Parkash R., et al., &#x201c;Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drugs,&#x201d; New England Journal of Medicine 375, no. 2 (July 2016): 111&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp J. L., Tang A. S. L., Parkash R., et al., &#x201c;Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia,&#x201d; New England Journal of Medicine 392 (2025): 737&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pubmed">39555820</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R., Raiman M., Liao H., et al., &#x201c;Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia,&#x201d; Journal of the American College of Cardiology 75, no. 8 (March 2020): 884&#x2013;897.</Citation><ArticleIdList><ArticleId IdType="pubmed">32130924</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosa E., Scanavacca M., D'avila A., and Pilleggi E., &#x201c;A New Technique to Perform Epicardial Mapping in the Electrophysiology Laboratory,&#x201d; Journal of Cardiovascular Electrophysiology 7, no. 6 (June 1996): 531&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">8743758</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisceglia C., Limite L. R., Baratto F., D'Angelo G., Cireddu M., and Della Bella P., &#x201c;Road&#x2010;Map to Epicardial Approach for Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Results From a 10&#x2010;Year Tertiary&#x2010;Center Experience,&#x201d; Circulation: Arrhythmia and Electrophysiology 17, no. 7 (July 2024): e012181.</Citation><ArticleIdList><ArticleId IdType="pubmed">38836351</ArticleId></ArticleIdList></Reference><Reference><Citation>Assis F. R. and Tandri H., &#x201c;Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy,&#x201d; Cardiac Electrophysiology Clinics 12, no. 3 (September 2020): 329&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">32771187</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadek M. M., Muser D., Santangeli P., and Marchlinski F. E., &#x201c;Epicardial Ablation in Nonischemic Ventricular Tachyardia,&#x201d; Cardiac Electrophysiology Clinics 12, no. 3 (September 2020): 321&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">32771186</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta J., Fern&#xe1;ndez&#x2010;Armenta J., Penela D., et al., &#x201c;Infarct Transmurality as a Criterion for First&#x2010;Line Endo&#x2010;Epicardial Substrate&#x2010;Guided Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy,&#x201d; Heart Rhythm 13, no. 1 (January 2016): 85&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">26165946</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Biase L., Santangeli P., Burkhardt D. J., et al., &#x201c;Endo&#x2010;Epicardial Homogenization of the Scar Versus Limited Substrate Ablation for the Treatment of Electrical Storms in Patients With Ischemic Cardiomyopathy,&#x201d; Journal of the American College of Cardiology 60, no. 2 (July 2012): 132&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">22766340</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo M., S&#xe1;nchez&#x2010;G&#xf3;mez J. M., Ferrero de Loma&#x2010;Osorio A., et al., &#x201c;Endo&#x2010;Epicardial Versus Only&#x2010;Endocardial Ablation as a First Line Strategy for the Treatment of Ventricular Tachycardia in Patients With Ischemic Heart Disease,&#x201d; Circulation: Arrhythmia and Electrophysiology 8, no. 4 (August 2015): 882&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pubmed">26056239</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahara S., Tung R., Ramirez R. J., et al., &#x201c;Characterization of the Arrhythmogenic Substrate in Ischemic and Nonischemic Cardiomyopathy,&#x201d; Journal of the American College of Cardiology 55, no. 21 (May 2010): 2355&#x2013;2365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2896717</ArticleId><ArticleId IdType="pubmed">20488307</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R., Michowitz Y., Yu R., et al., &#x201c;Epicardial Ablation of Ventricular Tachycardia:An Institutional Experience of Safety and Efficacy,&#x201d; Heart Rhythm 10, no. 4 (April 2013): 490&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">23246598</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergara P., Trevisi N., Ricco A., et al., &#x201c;Late Potentials Abolition as an Additional Technique for Reduction of Arrhythmia Recurrence in Scar Related Ventricular Tachycardia Ablation,&#x201d; Journal of Cardiovascular Electrophysiology 23, no. 6 (June 2012): 621&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">22486970</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero J., Patel K., Briceno D., et al., &#x201c;Endo&#x2010;Epicardial Ablation vs Endocardial Ablation for the Management of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy: A Systematic Review and Meta&#x2010;Analysis,&#x201d; Journal of Cardiovascular Electrophysiology 31, no. 8 (August 2020): 2022&#x2013;2031.</Citation><ArticleIdList><ArticleId IdType="pubmed">32478430</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso R., Assis F. R., and D'Avila A., &#x201c;Endo&#x2010;Epicardial vs Endocardial&#x2010;Only Catheter Ablation of Ventricular Tachycardia: A Meta&#x2010;Analysis,&#x201d; Journal of Cardiovascular Electrophysiology 30, no. 9 (September 2019): 1537&#x2013;1548.</Citation><ArticleIdList><ArticleId IdType="pubmed">31172632</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J. M., Kienzle M. G., Harken A. H., and Josephson M. E., &#x201c;Subendocardial Resection for Ventricular Tachycardia: Predictors of Surgical Success,&#x201d; Circulation 70, no. 4 (October 1984): 624&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">6478565</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems S., Tilz R. R., Steven D., et al., &#x201c;Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial,&#x201d; Circulation 141, no. 13 (March 2020): 1057&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pubmed">32000514</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerstenfeld E. P., &#x201c;Recurrent Ventricular Tachycardia After Catheter Ablation in Post&#x2010;Infarct Cardiomyopathy,&#x201d; Journal of the American College of Cardiology 61, no. 1 (2013): 74&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">23122794</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokokawa M., Desjardins B., Crawford T., Good E., Morady F., and Bogun F., &#x201c;Reasons for Recurrent Ventricular Tachycardia After Catheter Ablation of Post&#x2010;Infarction Ventricular Tachycardia,&#x201d; Journal of the American College of Cardiology 61, no. 1 (January 2013): 66&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">23122796</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty S., Trivedi C., Di Biase L., et al., &#x201c;Endocardial Scar&#x2010;Homogenization With vs Without Epicardial Ablation in VT Patients With Ischemic Cardiomyopathy,&#x201d; JACC: Clinical Electrophysiology 8, no. 4 (April 2022): 453&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">35246406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35958824</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>An Updated Review of Driving-Pressure Guided Ventilation Strategy and Its Clinical Application.</ArticleTitle><Pagination><StartPage>6236438</StartPage><MedlinePgn>6236438</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6236438</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/6236438</ELocationID><Abstract><AbstractText>Traditional lung-protective ventilation strategies (LPVS) are currently used to reduce the incidence of postoperative pulmonary complications (PPCs), including low tidal volume (VT), positive end-expiratory pressure (PEEP), low inspiratory plateau pressure (Pplat), permissive hypercapnia, and recruitment maneuver (RM). However, a meta-analysis showed that high driving pressure was closely associated with the incidence of PPCs, but not with PEEP or VT, which led to the driving pressure-guided ventilation strategy. Some studies have proved that the driving pressure-guided ventilation strategy is superior to the traditional LPVS in reducing the incidence of PPCs. The purpose of this review is to present the current research progress and application of driving pressure-guided ventilation strategy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Guanyu Yang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Guanyu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Chunhui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Zhentao</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-1471-1236</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="Y">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that there is no conflict of interest regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>3</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35958824</ArticleId><ArticleId IdType="pmc">PMC9363222</ArticleId><ArticleId IdType="doi">10.1155/2022/6236438</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coppola S., Caccioppola A., Froio S., et al. Effect of mechanical power on intensive care mortality in ARDS patients. Critical Care . 2020;24(1):p. 246. doi: 10.1186/s13054-020-02963-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02963-x</ArticleId><ArticleId IdType="pmc">PMC7245621</ArticleId><ArticleId IdType="pubmed">32448389</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuramoto H., Shimojo N., Jesmin S., et al. Repeated open endotracheal suctioning causes gradual desaturation but does not exacerbate lung injury compared to closed endotracheal suctioning in a rabbit model of ARDS. BMC Anesthesiology . 2013;13(1):p. 47. doi: 10.1186/1471-2253-13-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-13-47</ArticleId><ArticleId IdType="pmc">PMC3878988</ArticleId><ArticleId IdType="pubmed">24308643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Park J. Y., Kim D. H., et al. Incidence and risk factors of pulmonary complications after robot-assisted laparoscopic prostatectomy: a retrospective observational analysis of 2208 patients at a large single center. Journal of Clinical Medicine . 2019;8(10):p. 1509. doi: 10.3390/jcm8101509.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8101509</ArticleId><ArticleId IdType="pmc">PMC6833011</ArticleId><ArticleId IdType="pubmed">31547129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergez M., Fritsch N., Tran-Van D., et al. PEEP titration in moderate to severe ARDS: plateau versus transpulmonary pressure. Annals of Intensive Care . 2019;9(1):p. 81. doi: 10.1186/s13613-019-0554-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-019-0554-3</ArticleId><ArticleId IdType="pmc">PMC6635540</ArticleId><ArticleId IdType="pubmed">31312921</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E., Constantin J. M., Paugam-Burtz C., et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. The New England Journal of Medicine . 2013;369(5):428&#x2013;437. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg N. M., Steinberg B. E., Lee W. L., Wijeysundera D. N., Kavanagh B. P. Lung-protective ventilation in the operating room. Anesthesiology . 2014;121(1):184&#x2013;188. doi: 10.1097/ALN.0000000000000274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000274</ArticleId><ArticleId IdType="pubmed">24781494</ArticleId></ArticleIdList></Reference><Reference><Citation>Severgnini P., Selmo G., Lanza C., et al. Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function. Anesthesiology . 2013;118(6):1307&#x2013;1321. doi: 10.1097/ALN.0b013e31829102de.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31829102de</ArticleId><ArticleId IdType="pubmed">23542800</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato M. B., Meade M. O., Slutsky A. S., et al. Driving pressure and survival in the acute respiratory distress syndrome. The New England Journal of Medicine . 2015;372(8):747&#x2013;755. doi: 10.1056/NEJMsa1410639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1410639</ArticleId><ArticleId IdType="pubmed">25693014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahetya S. K., Mallow C., Sevransky J. E., et al. Association between hospital mortality and inspiratory airway pressures in mechanically ventilated patients without acute respiratory distress syndrome: a prospective cohort study. Critical Care . 2019;23(1):p. 367. doi: 10.1186/s13054-019-2635-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2635-y</ArticleId><ArticleId IdType="pmc">PMC6868689</ArticleId><ArticleId IdType="pubmed">31752980</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaporidi K., Psarologakis C., Proklou A., et al. Driving pressure during proportional assist ventilation: an observational study. Annals of Intensive Care . 2019;9(1):p. 1. doi: 10.1186/s13613-018-0477-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0477-4</ArticleId><ArticleId IdType="pmc">PMC6314935</ArticleId><ArticleId IdType="pubmed">30603960</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M., Ahn H. J., Kim J. A., et al. Driving pressure during thoracic surgery. Anesthesiology . 2019;130(3):385&#x2013;393. doi: 10.1097/ALN.0000000000002600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002600</ArticleId><ArticleId IdType="pubmed">30664548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L., Carlesso E., Caironi P. Stress and strain within the lung. Current Opinion in Critical Care . 2012;18(1):42&#x2013;47. doi: 10.1097/MCC.0b013e32834f17d9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e32834f17d9</ArticleId><ArticleId IdType="pubmed">22157254</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieman G. F., Satalin J., Andrews P., Habashi N. M., Gatto L. A. Lung stress, strain, and energy load: engineering concepts to understand the mechanism of ventilator-induced lung injury (VILI) Intensive Care Medicine Experimental . 2016;4(1):p. 16. doi: 10.1186/s40635-016-0090-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-016-0090-5</ArticleId><ArticleId IdType="pmc">PMC4912503</ArticleId><ArticleId IdType="pubmed">27316442</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams E. C., Motta-Ribeiro G. C., Vidal Melo M. F. Driving pressure and transpulmonary pressure: how do we guide safe mechanical ventilation? Anesthesiology . 2019;131(1):155&#x2013;163. doi: 10.1097/ALN.0000000000002731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002731</ArticleId><ArticleId IdType="pmc">PMC6639048</ArticleId><ArticleId IdType="pubmed">31094753</ArticleId></ArticleIdList></Reference><Reference><Citation>Protti A., Cressoni M., Santini A., et al. Lung stress and strain during mechanical ventilation. American Journal of Respiratory and Critical Care Medicine . 2011;183(10):1354&#x2013;1362. doi: 10.1164/rccm.201010-1757OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201010-1757OC</ArticleId><ArticleId IdType="pubmed">21297069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiumello D., Carlesso E., Brioni M., Cressoni M. Airway driving pressure and lung stress in ARDS patients. Critical Care . 2016;20(1):p. 276. doi: 10.1186/s13054-016-1446-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1446-7</ArticleId><ArticleId IdType="pmc">PMC4993008</ArticleId><ArticleId IdType="pubmed">27545828</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida T., Fujino Y., Amato M. B., Kavanagh B. P. Fifty years of research in ARDS. Spontaneous breathing during mechanical ventilation. Risks, mechanisms, and management. American journal of respiratory and critical care medicine . 2017;195(8):985&#x2013;992. doi: 10.1164/rccm.201604-0748CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201604-0748CP</ArticleId><ArticleId IdType="pubmed">27786562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C., Suarez-Sipmann F., Tusman G., et al. Open lung approach versus standard protective strategies: effects on driving pressure and ventilatory efficiency during anesthesia - a pilot, randomized controlled trial. PLoS One . 2017;12(5, article e0177399) doi: 10.1371/journal.pone.0177399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177399</ArticleId><ArticleId IdType="pmc">PMC5426745</ArticleId><ArticleId IdType="pubmed">28493943</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira S. M., Tucci M. R., Morais C., et al. Individual positive end-expiratory pressure settings optimize intraoperative mechanical ventilation and reduce postoperative atelectasis. Anesthesiology . 2018;129(6):1070&#x2013;1081. doi: 10.1097/ALN.0000000000002435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002435</ArticleId><ArticleId IdType="pubmed">30260897</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira Romano M. L., Maia I. S., Laranjeira L. N., et al. Driving pressure-limited strategy for patients with acute respiratory distress syndrome. A pilot randomized clinical trial. Annals of the American Thoracic Society . 2020;17(5):596&#x2013;604. doi: 10.1513/AnnalsATS.201907-506OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201907-506OC</ArticleId><ArticleId IdType="pubmed">32069068</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauf A., Sachdev A., Venkataraman S. T., Dinand V. Dynamic airway driving pressure and outcomes in children with acute hypoxemic respiratory failure. Respiratory Care . 2021;66(3):403&#x2013;409. doi: 10.4187/respcare.08024.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.08024</ArticleId><ArticleId IdType="pubmed">33024000</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank R. S., Colquhoun D. A., Durieux M. E., et al. Management of one-lung ventilation. Anesthesiology . 2016;124(6):1286&#x2013;1295. doi: 10.1097/ALN.0000000000001100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001100</ArticleId><ArticleId IdType="pubmed">27011307</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto A. S., Hemmes S. N., Barbas C. S., et al. Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. The Lancet. Respiratory medicine . 2016;4(4):272&#x2013;280. doi: 10.1016/S2213-2600(16)00057-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00057-6</ArticleId><ArticleId IdType="pubmed">26947624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis M. R., Duggal N. M., Likosky D. S., et al. Intraoperative mechanical ventilation and postoperative pulmonary complications after cardiac surgery. Anesthesiology . 2019;131(5):1046&#x2013;1062. doi: 10.1097/ALN.0000000000002909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002909</ArticleId><ArticleId IdType="pmc">PMC6800803</ArticleId><ArticleId IdType="pubmed">31403976</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadaro S., Grasso S., Karbing D. S., et al. Physiological effects of two driving pressure-based methods to set positive end-expiratory pressure during one lung ventilation. Journal of clinical monitoring and computing . 2021;35(5):1149&#x2013;1157. doi: 10.1007/s10877-020-00582-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-020-00582-z</ArticleId><ArticleId IdType="pmc">PMC7439797</ArticleId><ArticleId IdType="pubmed">32816177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellani G., Grassi A., Sosio S., et al. Driving pressure is associated with outcome during assisted ventilation in acute respiratory distress syndrome. Anesthesiology . 2019;131(3):594&#x2013;604. doi: 10.1097/ALN.0000000000002846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002846</ArticleId><ArticleId IdType="pubmed">31335543</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15281529</PMID><DateCompleted><Year>2004</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-2999</ISSN><JournalIssue CitedMedium="Print"><Volume>99</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Ventilation with smaller tidal volumes: a quantitative systematic review of randomized controlled trials.</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>200</EndPage><MedlinePgn>193-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/01.ANE.0000118102.93688.97</ELocationID><Abstract><AbstractText>In this quantitative systematic review we assessed the effects of ventilation with smaller tidal volume (VT) on morbidity and mortality in patients aged 16 yr or older affected by acute lung injury and acute respiratory distress syndrome. Five randomized trials (1202 patients) comparing ventilation using smaller VT and/or low airway driving pressure (plateau pressure 30 cm H2O or less), resulting in VT of 7 mL/kg or less versus ventilation that uses VT in the range of 10 to 15 mL/kg, were identified after a systematic search of The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, databases of current research, reference lists, and "gray literature." Mortality at day 28 was significantly reduced by lung-protective ventilation (relative risk [RR], 0.74; confidence interval [CI], 0.61-0.88), whereas beneficial effect on long-term mortality was uncertain (RR, 0.84; CI, 0.68-1.05). The comparison between small and conventional VT was not significantly different if a plateau pressure less than or equal to 31 cm H2O in the control group was used (RR, 1.13; CI, 0.88-1.45). Clinical heterogeneity, such as different lengths of follow-up and higher plateau pressures in control arms in two trials, make the interpretation of the combined results difficult.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petrucci</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia &amp; Intensive Care, Azienda Ospedaliera Desenzano, Desenzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacovelli</LastName><ForeName>Walter</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="N">Lung Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>39</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>8</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15281529</ArticleId><ArticleId IdType="doi">10.1213/01.ANE.0000118102.93688.97</ArticleId><ArticleId IdType="pii">00000539-200407000-00039</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roupie E, Lepage E, Wysocki M, et al. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. Intensive Care Med 1999;25:920&#x2013;9.</Citation></Reference><Reference><Citation>Lewandowski K. Epidemiological data challenge ARDS/ALI. Intensive Care Med 1999;25:884&#x2013;6.</Citation></Reference><Reference><Citation>Davidson TA, Caldwell ES, Curtis JR. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999;281:354&#x2013;60.</Citation></Reference><Reference><Citation>Marini JJ. Lung mechanics in the adult respiratory distress syndrome. Clinical Chest Med 1990;11:673&#x2013;90.</Citation></Reference><Reference><Citation>Parker JC, Hernandez LA, Peevy KJ. Mechanism of ventilator induced lung injury. Crit Care Med 1993;21:131&#x2013;43.</Citation></Reference><Reference><Citation>Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume and positive end-expiratory pressure. Am Rev Respir Dis 1998;137:1159&#x2013;64.</Citation></Reference><Reference><Citation>Hickling KG, Henderson SJ, Jackson R. Low mortality associated with volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990;16:372&#x2013;7.</Citation></Reference><Reference><Citation>Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 1994;22:1568&#x2013;78.</Citation></Reference><Reference><Citation>Artigas A, Bernard GR, Carlet J. The American-European consensus conference on ARDS, part 2. Intensive Care Med 1998; 24:378&#x2013;98.</Citation></Reference><Reference><Citation>Roupie E, Dambrosio M, Servillo G, et al. Titration of tidal volume and induced hypercapnia in acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:121&#x2013;8.</Citation></Reference><Reference><Citation>Feihl F, Perret C. Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994;150:1722&#x2013;37.</Citation></Reference><Reference><Citation>Eichacker PQ, Gerstenberger EP, Banks SM, et al. Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002;166:1510&#x2013;4.</Citation></Reference><Reference><Citation>Steinbrook R. Trial design and patient safety. The debate continues. N Engl J Med 2003;349:620&#x2013;30.</Citation></Reference><Reference><Citation>Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818&#x2013;24.</Citation></Reference><Reference><Citation>Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720&#x2013;3.</Citation></Reference><Reference><Citation>Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986;7:267&#x2013;75.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539&#x2013;58.</Citation></Reference><Reference><Citation>Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, eds. Systematc reviews. London: BMJ books, 2001:285&#x2013;312.</Citation></Reference><Reference><Citation>Rappaport SH, Shpiner R, Yoshihara G, et al. Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med 1994;22:22&#x2013;32.</Citation></Reference><Reference><Citation>Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. JAMA 1999;282:54&#x2013;77.</Citation></Reference><Reference><Citation>Esteban A, Alia I, Gordo F, et al. Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS. Chest 2000;117:1690&#x2013;6.</Citation></Reference><Reference><Citation>Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338:347&#x2013;54.</Citation></Reference><Reference><Citation>Brochard L, Roudot-Thoraval F, Roupie E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:1831&#x2013;8.</Citation></Reference><Reference><Citation>Stewart TE, Meade MO, Cook DJ, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome: pressure and volume limited ventilation strategy group. N Engl J Med 1998;338:355&#x2013;61.</Citation></Reference><Reference><Citation>Brower RG, Shanholtz CB, Fessler HE, et al. Prospective, randomized controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999;27:1492&#x2013;8.</Citation></Reference><Reference><Citation>The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301&#x2013;8.</Citation></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818&#x2013;29.</Citation></Reference><Reference><Citation>Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619&#x2013;36.</Citation></Reference><Reference><Citation>Gattinoni L, Pelosi P, Crotti S, Valenza F. Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:1807&#x2013;14.</Citation></Reference><Reference><Citation>Ranieri VM, Mascia L, Fiore T, et al. Cardiorespiratory effects of positive end-expiratory pressure during progressive tidal volume reduction (permissive hypercapnia) in patients with acute respiratory distress syndrome. Anesthesiology 1995;83:710&#x2013;20.</Citation></Reference><Reference><Citation>Glasziou PP, Irwing LM. An evidence-based approach to individualising treatment. BMJ 1995;311:1356&#x2013;9.</Citation></Reference><Reference><Citation>Cooper AB, Ferguson ND, Hanly PJ, et al. Long-term follow up of survivors of acute lung injury: lack of effect of a ventilation strategy to prevent barotrauma. Crit Care Med 1999;27:2616&#x2013;21.</Citation></Reference><Reference><Citation>Orme J, Romney JS, Hopkins RO, et al. Pulmonary function and health related quality of life in survivors of ARDS. Am J Respir Crit Care Med 2003;167:690&#x2013;4.</Citation></Reference><Reference><Citation>Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. BMJ 313:735&#x2013;8.</Citation></Reference><Reference><Citation>Ranieri VM, Brienza N, Santostasi S, et al. Impairment of lung and chest wall mechanics in patients with acute respiratory distress syndrome: role of abdominal distension. Am J Respir Crit Care Med 1997;156:1082&#x2013;91.</Citation></Reference><Reference><Citation>Steinbrook R. How best to ventilate? N Engl J Med 2003;348:1393&#x2013;401.</Citation></Reference><Reference><Citation>Gattinoni L, Chiumello D, Russo R. Reduced tidal volumes and lung protective ventilatory strategies: where do we go from here? Curr Opin Crit Care 2002;8:45&#x2013;50.</Citation></Reference><Reference><Citation>Monchi M, Bellenfant F, Cariou A, et al. Early predictive factors of survival in the acute respiratory distress syndrome: a multivariate analysis. Am J Respir Crit Care Med 1998;158:1076&#x2013;81.</Citation></Reference><Reference><Citation>Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993;341:418&#x2013;22.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40472946</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jun</Month><Day>03</Day></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Prolonged hospitalization after catheter ablation of ventricular tachycardia: Predictors and outcomes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(25)02524-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2025.05.063</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In patients with structural heart disease undergoing catheter ablation of ventricular tachycardia (VT), prolonged postablation hospitalization may be a predictor of poor outcomes.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study sought to identify predictors of prolonged hospitalization after VT ablation and their impact on subsequent outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study analyzed 318 patient cases undergoing VT ablation from January 2022 to October 2024. Prolonged hospitalization was defined as postablation length of stay of &gt; 3 days. Predictors of prolonged hospitalization were identified through multivariable logistic regression, and associations with adverse outcomes, including mortality, left ventricular assist device implantation, and cardiac transplant, were assessed using Cox survival analysis. Substratified analysis was performed based on the Prediction of Acute In-Hospital Events After Defibrillator Implantation Score (PAINESD) (high-risk [PAINESD of &#x2265; 17] and low/moderate risk [PAINESD of &lt; 17] strata).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Prolonged postablation hospitalization was observed in 95 cases (29.9%). Independent predictors included New York Heart Association class &gt; II (odds ratio [OR] 3.12, P &lt; .001), moderate/severe right ventricular dysfunction (OR 3.54, P = .012), nonelective ablation (OR 7.42, P &lt; .001) and acute procedural complication/pericardial effusion (OR 4.30, P = .048). Prolonged procedural duration (&gt; 255 minutes) was a significant predictor in low-/moderate-risk patients (OR 2.89, P = .010) but not in high-risk patients. Prolonged postablation hospitalization was associated with a higher risk of mortality, left ventricular assist device implantation, or transplant in high-risk patients (hazard ratio 3.35, P = .008), but not in low-/moderate-risk patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Prolonged postablation hospitalization after VT ablation adversely affects outcomes in high-risk patients but not in low-/moderate-risk patients. Procedural factors, such as prolonged ablation duration, are modifiable predictors in low-/moderate-risk populations. Baseline disease severity factors dominate in high-risk groups. Tailored perioperative strategies are needed to optimize outcomes in high-risk patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Calcagno</LastName><ForeName>Tess</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cesmat</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sipko</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baranowski</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhargava</LastName><ForeName>Mandeep</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Mina K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dresing</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Ayman A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irefin</LastName><ForeName>Samuel A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of General Anesthesiology, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanj</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kochar</LastName><ForeName>Arshneel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>David O</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saliba</LastName><ForeName>Walid I</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taigen</LastName><ForeName>Tyler L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varma</LastName><ForeName>Niraj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higuchi</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakhla</LastName><ForeName>Shady</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Justin Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wazni</LastName><ForeName>Oussama M</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santangeli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sroubek</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiac Electrophysiology Section, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address: sroubej@ccf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">NYHA class</Keyword><Keyword MajorTopicYN="N">PAINESD</Keyword><Keyword MajorTopicYN="N">Prolonged hospitalization</Keyword><Keyword MajorTopicYN="N">Renal dysfunction</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList><CoiStatement>Disclosures Dr Dresing has received speaking honoraria from Medtronic and Boston Scientific. Dr Hussein receives research grant support from Boston Scientific. Dr Callahan has served as a consultant for Abbott, Boston Scientific, Medtronic, Philips, and ShockWave. Dr Kanj has received speaking honorarium from Boston Scientific and has served as a consultant for Boston Scientific. Dr Martin has served as a consultant for Medtronic. Dr Saliba has served as a consultant for Biosense Webster and Boston Scientific and as an advisory board member for Abbott, Biosense Webster, Boston Scientific, and Phillips. Dr Taigen has served as a consultant for Biosense Webster and Medtronic. Dr Varma has served as a consultant for Abbott, Biotronik, Boston Scientific, and Medtronic. Drs Higuchi and Lee have served as consultants for Abbott. Drs Wazni and Santangeli have served as consultants for Abbott, Biosense Webster, Boston Scientific, and Medtronic. Dr Sroubek has served as a consultant for Abbott and receives research grant support from Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>6</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>6</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>5</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40472946</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2025.05.063</ArticleId><ArticleId IdType="pii">S1547-5271(25)02524-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33784987</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Lung-protective mechanical ventilation for patients undergoing abdominal laparoscopic surgeries: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>95</StartPage><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">95</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-021-01318-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pneumoperitoneum and Trendelenburg position in laparoscopic surgeries could contribute to postoperative pulmonary dysfunction. In recent years, intraoperative lung-protective mechanical ventilation (LPV) has been reportedly able to attenuate ventilator-induced lung injuries (VILI). Our objectives were to test the hypothesis that LPV could improve intraoperative oxygenation function, pulmonary mechanics and early postoperative atelectasis in laparoscopic surgeries.</AbstractText><AbstractText Label="METHODS">In this randomized controlled clinical trial, 62 patients indicated for elective abdominal laparoscopic surgeries with an expected duration of greater than 2&#x2009;h were randomly assigned to receive either lung-protective ventilation (LPV) with a tidal volume (Vt) of 7&#x2009;ml&#x2009;kg<sup>-&#x2009;1</sup> ideal body weight (IBW), 10 cmH<sub>2</sub>O positive end-expiratory pressure (PEEP) combined with regular recruitment maneuvers (RMs) or conventional ventilation (CV) with a Vt of 10&#x2009;ml&#x2009;kg<sup>-&#x2009;1</sup> IBW, 0 cmH<sub>2</sub>O in PEEP and no RMs. The primary endpoints were the changes in the ratio of PaO<sub>2</sub> to FiO<sub>2</sub> (P/F). The secondary endpoints were the differences between the two groups in PaO<sub>2</sub>, alveolar-arterial oxygen gradient (A-aO<sub>2</sub>), intraoperative pulmonary mechanics and the incidence of atelectasis detected on chest x-ray on the first postoperative day.</AbstractText><AbstractText Label="RESULTS">In comparison to CV group, the intraoperative P/F and PaO<sub>2</sub> in LPV group were significantly higher while the intraoperative A-aO<sub>2</sub> was clearly lower. C<sub>dyn</sub> and C<sub>stat</sub> at all the intraoperative time points in LPV group were significantly higher compared to CV group (p&#x2009;&lt;&#x2009;0.05). There were no differences in the incidence of atelectasis on day one after surgery between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS">Lung protective mechanical ventilation significantly improved intraoperative pulmonary oxygenation function and pulmonary compliance in patients experiencing various abdominal laparoscopic surgeries, but it could not ameliorate early postoperative atelectasis and oxygenation function on the first day after surgery.</AbstractText><AbstractText Label="TRIAL REGISTRATION">https://www.clinicaltrials.gov/identifier: NCT04546932 (09/05/2020).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Trung Kien</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0002-2451-5397</Identifier><AffiliationInfo><Affiliation>Center of Emergency, Critical Care Medicine and Clinical Toxicology, 103 Military Hospital, Vietnam Military Medical University, 261 Phung Hung road, Ha Dong District, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Viet Luong</ForeName><Initials>VL</Initials><Identifier Source="ORCID">0000-0003-1456-8177</Identifier><AffiliationInfo><Affiliation>Critical Care Unit, National Burn Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Truong Giang</ForeName><Initials>TG</Initials><Identifier Source="ORCID">0000-0002-0166-0778</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic surgery, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>Duc Hanh</ForeName><Initials>DH</Initials><Identifier Source="ORCID">0000-0002-4912-5088</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Ngoc Quynh</ForeName><Initials>NQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, Vietnam National Cancer Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>The Anh</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0002-6748-720X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam. qy.theanh@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Anh Nguyet</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0003-3976-6399</Identifier><AffiliationInfo><Affiliation>Department of Urology, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Quang Huy</ForeName><Initials>QH</Initials><Identifier Source="ORCID">0000-0001-7008-8229</Identifier><AffiliationInfo><Affiliation>Center of Emergency, Critical Care Medicine and Clinical Toxicology, 103 Military Hospital, Vietnam Military Medical University, 261 Phung Hung road, Ha Dong District, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Chi Tue</ForeName><Initials>CT</Initials><Identifier Source="ORCID">0000-0001-9817-1219</Identifier><AffiliationInfo><Affiliation>Center of Emergency, Critical Care Medicine and Clinical Toxicology, 103 Military Hospital, Vietnam Military Medical University, 261 Phung Hung road, Ha Dong District, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Dang Thu</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Medicine, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04546932</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001261" MajorTopicYN="N">Pulmonary Atelectasis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055397" MajorTopicYN="N">Ventilator-Induced Lung Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Low tidal volume</Keyword><Keyword MajorTopicYN="N">Lung-protective ventilation</Keyword><Keyword MajorTopicYN="N">Positive end-expiratory pressure</Keyword><Keyword MajorTopicYN="N">Recruitment maneuvers</Keyword></KeywordList><CoiStatement>No author has any conflict of interest regarding the publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33784987</ArticleId><ArticleId IdType="pmc">PMC8008676</ArticleId><ArticleId IdType="doi">10.1186/s12871-021-01318-5</ArticleId><ArticleId IdType="pii">10.1186/s12871-021-01318-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duggan M, Kavanagh BP. Pulmonary atelectasis: a pathogenic perioperative entity. Anesthesiology. 2005;102(4):838&#x2013;854. doi: 10.1097/00000542-200504000-00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200504000-00021</ArticleId><ArticleId IdType="pubmed">15791115</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson L, Spahn DR. New concepts of atelectasis during general anaesthesia. Br J Anaesth. 2003;91(1):61&#x2013;72. doi: 10.1093/bja/aeg085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeg085</ArticleId><ArticleId IdType="pubmed">12821566</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso S, Terragni P, Mascia L, Fanelli V, Quintel M, Herrmann P, et al. Airway pressure-time curve profile (stress index) detects tidal recruitment/hyperinflation in experimental acute lung injury. Crit Care Med. 2004;32(4):1018&#x2013;1027. doi: 10.1097/01.CCM.0000120059.94009.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000120059.94009.AD</ArticleId><ArticleId IdType="pubmed">15071395</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedenstierna G, Edmark L. The effects of anesthesia and muscle paralysis on the respiratory system. Intensive Care Med. 2005;31(10):1327&#x2013;1335. doi: 10.1007/s00134-005-2761-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2761-7</ArticleId><ArticleId IdType="pubmed">16132894</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, et al. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009;111(5):979&#x2013;987. doi: 10.1097/ALN.0b013e3181b87edb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181b87edb</ArticleId><ArticleId IdType="pubmed">19809292</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi G, Wolthuis EK, Bresser P, Levi M, van der Poll T, Dzoljic M, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology. 2006;105(4):689&#x2013;695. doi: 10.1097/00000542-200610000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200610000-00013</ArticleId><ArticleId IdType="pubmed">17006066</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolthuis EK, Choi G, Dessing MC, Bresser P, Lutter R, Dzoljic M, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology. 2008;108(1):46&#x2013;54. doi: 10.1097/01.anes.0000296068.80921.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000296068.80921.10</ArticleId><ArticleId IdType="pubmed">18156881</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusman G, Bohm SH, Warner DO, Sprung J. Atelectasis and perioperative pulmonary complications in high-risk patients. Curr Opin Anaesthesiol. 2012;25(1):1&#x2013;10. doi: 10.1097/ACO.0b013e32834dd1eb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e32834dd1eb</ArticleId><ArticleId IdType="pubmed">22113182</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaber S, Coisel Y, Chanques G, Futier E, Constantin JM, Michelet P, et al. A multicentre observational study of intra-operative ventilatory management during general anaesthesia: tidal volumes and relation to body weight. Anaesthesia. 2012;67(9):999&#x2013;1008. doi: 10.1111/j.1365-2044.2012.07218.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2012.07218.x</ArticleId><ArticleId IdType="pubmed">22708696</ArticleId></ArticleIdList></Reference><Reference><Citation>Haliloglu M, Bilgili B, Ozdemir M, Umuroglu T, Bakan N. Low tidal volume positive end-expiratory pressure versus high tidal volume zero-positive end-expiratory pressure and postoperative pulmonary functions in robot-assisted laparoscopic radical prostatectomy. Med Princ Pract. 2017;26(6):573&#x2013;578. doi: 10.1159/000484693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484693</ArticleId><ArticleId IdType="pmc">PMC5848477</ArticleId><ArticleId IdType="pubmed">29131002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen JK, Anthony DG, Li L, Wheeler D, Sessler DI, Bashour CA. Comparison of positive end-expiratory pressure of 8 versus 5 cm H2O on outcome after cardiac operations. J Intensive Care Med. 2015;30(6):338&#x2013;343. doi: 10.1177/0885066613519571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066613519571</ArticleId><ArticleId IdType="pubmed">24488037</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Miranda D, Gommers D, Struijs A, Dekker R, Mekel J, Feelders R, et al. Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg. 2005;28(6):889&#x2013;895. doi: 10.1016/j.ejcts.2005.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.10.007</ArticleId><ArticleId IdType="pubmed">16271479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusman G, Bohm SH, Suarez-Sipmann F, Turchetto E. Alveolar recruitment improves ventilatory efficiency of the lungs during anesthesia. Can J Anaesth. 2004;51(7):723&#x2013;727. doi: 10.1007/BF03018433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03018433</ArticleId><ArticleId IdType="pubmed">15310643</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428&#x2013;437. doi: 10.1056/NEJMoa1301082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301082</ArticleId><ArticleId IdType="pubmed">23902482</ArticleId></ArticleIdList></Reference><Reference><Citation>Maracaja-Neto LF, Vercosa N, Roncally AC, Giannella A, Bozza FA, Lessa MA. Beneficial effects of high positive end-expiratory pressure in lung respiratory mechanics during laparoscopic surgery. Acta Anaesthesiol Scand. 2009;53(2):210&#x2013;217. doi: 10.1111/j.1399-6576.2008.01826.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2008.01826.x</ArticleId><ArticleId IdType="pubmed">19175578</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Ravagnan I, Giurati G, Panigada M, Bottino N, Tredici S, et al. Positive end-expiratory pressure improves respiratory function in obese but not in normal subjects during anesthesia and paralysis. Anesthesiology. 1999;91(5):1221&#x2013;1231. doi: 10.1097/00000542-199911000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199911000-00011</ArticleId><ArticleId IdType="pubmed">10551570</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinnella G, Grasso S, Spadaro S, Rauseo M, Mirabella L, Salatto P, et al. Effects of recruitment maneuver and positive end-expiratory pressure on respiratory mechanics and transpulmonary pressure during laparoscopic surgery. Anesthesiology. 2013;118(1):114&#x2013;122. doi: 10.1097/ALN.0b013e3182746a10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182746a10</ArticleId><ArticleId IdType="pubmed">23196259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouadma L, Dreyfuss D, Ricard JD, Martet G, Saumon G. Mechanical ventilation and hemorrhagic shock-resuscitation interact to increase inflammatory cytokine release in rats. Crit Care Med. 2007;35(11):2601&#x2013;2606. doi: 10.1097/01.CCM.0000286398.78243.CE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000286398.78243.CE</ArticleId><ArticleId IdType="pubmed">17828032</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsten J, Luepschen H, Grossherr M, Bruch HP, Leonhardt S, Gehring H, et al. Effect of PEEP on regional ventilation during laparoscopic surgery monitored by electrical impedance tomography. Acta Anaesthesiol Scand. 2011;55(7):878&#x2013;886. doi: 10.1111/j.1399-6576.2011.02467.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2011.02467.x</ArticleId><ArticleId IdType="pubmed">21658014</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009;37(9):2642&#x2013;2647. doi: 10.1097/CCM.0b013e3181a590da.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181a590da</ArticleId><ArticleId IdType="pubmed">19602972</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannesson M, Le Manach Y, Hofer CK, Goarin JP, Lehot JJ, Vallet B, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a &#x201c;gray zone&#x201d; approach. Anesthesiology. 2011;115(2):231&#x2013;241. doi: 10.1097/ALN.0b013e318225b80a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318225b80a</ArticleId><ArticleId IdType="pubmed">21705869</ArticleId></ArticleIdList></Reference><Reference><Citation>Biais M, de Courson H, Lanchon R, Pereira B, Bardonneau G, Griton M, et al. Mini-fluid challenge of 100 ml of crystalloid predicts fluid responsiveness in the operating room. Anesthesiology. 2017;127(3):450&#x2013;456. doi: 10.1097/ALN.0000000000001753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001753</ArticleId><ArticleId IdType="pubmed">28640019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu AL, Cai XZ, Gao XJ, Zhang ZW, Ma ZS, Ma LL, et al. Determinants of immediate extubation in the operating room after total thoracoscopic closure of congenital heart defects. Med Princ Pract. 2013;22(3):234&#x2013;238. doi: 10.1159/000345844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000345844</ArticleId><ArticleId IdType="pmc">PMC5586751</ArticleId><ArticleId IdType="pubmed">23296121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung J, Whalen FX, Comfere T, Bosnjak ZJ, Bajzer Z, Gajic O, et al. Alveolar recruitment and arterial desflurane concentration during bariatric surgery. Anesth Analg. 2009;108(1):120&#x2013;127. doi: 10.1213/ane.0b013e31818db6c7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e31818db6c7</ArticleId><ArticleId IdType="pubmed">19095839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YH. Randomised controlled trials (RCTs)--sample size: the magic number? Singap Med J. 2003;44(4):172&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">12952027</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi X, Cui Y, Wang C, Guo L, Sun B, Shi J, et al. Low tidal volume with PEEP and recruitment expedite the recovery of pulmonary function. Int J Clin Exp Pathol. 2015;8(11):14305&#x2013;14314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4713532</ArticleId><ArticleId IdType="pubmed">26823746</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung J, Whalley DG, Falcone T, Wilks W, Navratil JE, Bourke DL. The effects of tidal volume and respiratory rate on oxygenation and respiratory mechanics during laparoscopy in morbidly obese patients. Anesth Analg. 2003;97(1):268&#x2013;274. doi: 10.1213/01.ANE.0000067409.33495.1F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000067409.33495.1F</ArticleId><ArticleId IdType="pubmed">12818980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung J, Whalley DG, Falcone T, Warner DO, Hubmayr RD, Hammel J. The impact of morbid obesity, pneumoperitoneum, and posture on respiratory system mechanics and oxygenation during laparoscopy. Anesth Analg. 2002;94(5):1345&#x2013;1350. doi: 10.1097/00000539-200205000-00056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200205000-00056</ArticleId><ArticleId IdType="pubmed">11973218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazebroek EJ, Haitsma JJ, Lachmann B, Bonjer HJ. Mechanical ventilation with positive end-expiratory pressure preserves arterial oxygenation during prolonged pneumoperitoneum. Surg Endosc. 2002;16(4):685&#x2013;689. doi: 10.1007/s00464-001-8174-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-001-8174-y</ArticleId><ArticleId IdType="pubmed">11972215</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusman G, Bohm SH, De Anda GV, do Campo JL, Lachmann B. &#x2018;Alveolar recruitment strategy&#x2019; improves arterial oxygenation during general anaesthesia. Br J Anaesth. 1999;82(1):8&#x2013;13. doi: 10.1093/bja/82.1.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/82.1.8</ArticleId><ArticleId IdType="pubmed">10325828</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang CK, Yap J, Chen PP. The effect of an alveolar recruitment strategy on oxygenation during laparascopic cholecystectomy. Anaesth Intensive Care. 2003;31(2):176&#x2013;180. doi: 10.1177/0310057X0303100206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X0303100206</ArticleId><ArticleId IdType="pubmed">12712781</ArticleId></ArticleIdList></Reference><Reference><Citation>Whalen FX, Gajic O, Thompson GB, Kendrick ML, Que FL, Williams BA, et al. The effects of the alveolar recruitment maneuver and positive end-expiratory pressure on arterial oxygenation during laparoscopic bariatric surgery. Anesth Analg. 2006;102(1):298&#x2013;305. doi: 10.1213/01.ane.0000183655.57275.7a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000183655.57275.7a</ArticleId><ArticleId IdType="pubmed">16368847</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SJ. In: AS. T. Advances in respiratory life support. Hoyt JW, editor. Philadelphia: WB Saunders; 1991.</Citation></Reference><Reference><Citation>Liu J, Meng Z, Lv R, Zhang Y, Wang G, Xie J. Effect of intraoperative lung-protective mechanical ventilation on pulmonary oxygenation function and postoperative pulmonary complications after laparoscopic radical gastrectomy. Braz J Med Biol Res. 2019;52(6):e8523. doi: 10.1590/1414-431x20198523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431x20198523</ArticleId><ArticleId IdType="pmc">PMC6556971</ArticleId><ArticleId IdType="pubmed">31166383</ArticleId></ArticleIdList></Reference><Reference><Citation>Feihl F, Perret C. Permissive hypercapnia. How permissive should we be? Am J Respir Crit Care Med. 1994;150(6 Pt 1):1722&#x2013;1737. doi: 10.1164/ajrccm.150.6.7952641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.150.6.7952641</ArticleId><ArticleId IdType="pubmed">7952641</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenza F, Chevallard G, Fossali T, Salice V, Pizzocri M, Gattinoni L. Management of mechanical ventilation during laparoscopic surgery. Best Pract Res Clin Anaesthesiol. 2010;24(2):227&#x2013;241. doi: 10.1016/j.bpa.2010.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2010.02.002</ArticleId><ArticleId IdType="pubmed">20608559</ArticleId></ArticleIdList></Reference><Reference><Citation>Strang CM, Hachenberg T, Freden F, Hedenstierna G. Development of atelectasis and arterial to end-tidal PCO2-difference in a porcine model of pneumoperitoneum. Br J Anaesth. 2009;103(2):298&#x2013;303. doi: 10.1093/bja/aep102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep102</ArticleId><ArticleId IdType="pubmed">19443420</ArticleId></ArticleIdList></Reference><Reference><Citation>Perilli V, Sollazzi L, Bozza P, Modesti C, Chierichini A, Tacchino RM, et al. The effects of the reverse trendelenburg position on respiratory mechanics and blood gases in morbidly obese patients during bariatric surgery. Anesth Analg. 2000;91(6):1520&#x2013;1525. doi: 10.1097/00000539-200012000-00041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200012000-00041</ArticleId><ArticleId IdType="pubmed">11094011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong CM, Xu DZ, Lu Q, Cheng Y, Pisarenko V, Doucet D, et al. Low tidal volume and high positive end-expiratory pressure mechanical ventilation results in increased inflammation and ventilator-associated lung injury in normal lungs. Anesth Analg. 2010;110(6):1652&#x2013;1660. doi: 10.1213/ANE.0b013e3181cfc416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181cfc416</ArticleId><ArticleId IdType="pubmed">20103541</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Duggal NM, Likosky DS, Haft JW, Douville NJ, Vaughn MT, et al. Intraoperative mechanical ventilation and postoperative pulmonary complications after cardiac surgery. Anesthesiology. 2019;131(5):1046&#x2013;1062. doi: 10.1097/ALN.0000000000002909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002909</ArticleId><ArticleId IdType="pmc">PMC6800803</ArticleId><ArticleId IdType="pubmed">31403976</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundquist H, Hedenstierna G, Strandberg A, Tokics L, Brismar B. CT-assessment of dependent lung densities in man during general anaesthesia. Acta Radiol. 1995;36(6):626&#x2013;632. doi: 10.3109/02841859509176761.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02841859509176761</ArticleId><ArticleId IdType="pubmed">8519574</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Goldner M, McKibben A, Adams A, Eccher G, Caironi P, et al. Recruitment and derecruitment during acute respiratory failure: an experimental study. Am J Respir Crit Care Med. 2001;164(1):122&#x2013;130. doi: 10.1164/ajrccm.164.1.2007010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.164.1.2007010</ArticleId><ArticleId IdType="pubmed">11435250</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce CJ, Williams AB. Kinetics of absorption atelectasis during anesthesia: a mathematical model. J Appl Physiol (1985) 1999;86(4):1116&#x2013;1125. doi: 10.1152/jappl.1999.86.4.1116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1999.86.4.1116</ArticleId><ArticleId IdType="pubmed">10194192</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothen HU, Sporre B, Engberg G, Wegenius G, Hogman M, Hedenstierna G. Influence of gas composition on recurrence of atelectasis after a reexpansion maneuver during general anesthesia. Anesthesiology. 1995;82(4):832&#x2013;842. doi: 10.1097/00000542-199504000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199504000-00004</ArticleId><ArticleId IdType="pubmed">7717553</ArticleId></ArticleIdList></Reference><Reference><Citation>Juno J, Marsh HM, Knopp TJ, Rehder K. Closing capacity in awake and anesthetized-paralyzed man. J Appl Physiol Respir Environ Exerc Physiol. 1978;44(2):238&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">632164</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, Gong H, Zhang L, Wang Y, Tian Y. Effect of low tidal volume ventilation on atelectasis in patients during general anesthesia: a computed tomographic scan. J Clin Anesth. 2007;19(2):125&#x2013;129. doi: 10.1016/j.jclinane.2006.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2006.08.008</ArticleId><ArticleId IdType="pubmed">17379125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusca M, Proietti S, Schnyder P, Frascarolo P, Hedenstierna G, Spahn DR, et al. Prevention of atelectasis formation during induction of general anesthesia. Anesth Analg. 2003;97(6):1835&#x2013;1839. doi: 10.1213/01.ANE.0000087042.02266.F6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000087042.02266.F6</ArticleId><ArticleId IdType="pubmed">14633570</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh D, Kurosawa S, Kirino W, Wagatsuma T, Ejima Y, Yoshida A, et al. Impact of changes of positive end-expiratory pressure on functional residual capacity at low tidal volume ventilation during general anesthesia. J Anesth. 2012;26(5):664&#x2013;669. doi: 10.1007/s00540-012-1411-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-012-1411-9</ArticleId><ArticleId IdType="pmc">PMC3468745</ArticleId><ArticleId IdType="pubmed">22584817</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Guttmann J, Moller K. Adaptive SLICE method: an enhanced method to determine nonlinear dynamic respiratory system mechanics. Physiol Meas. 2012;33(1):51&#x2013;64. doi: 10.1088/0967-3334/33/1/51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0967-3334/33/1/51</ArticleId><ArticleId IdType="pubmed">22155927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregoretti C, Pelosi P. A physiologically oriented approach to the perioperative period: the role of the anaesthesiologist. Best Pract Res Clin Anaesthesiol. 2010;24(2):vii&#x2013;viii. doi: 10.1016/j.bpa.2010.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2010.03.001</ArticleId><ArticleId IdType="pubmed">20608552</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23647246</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1651-2006</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Scandinavian cardiovascular journal : SCJ</Title><ISOAbbreviation>Scand Cardiovasc J</ISOAbbreviation></Journal><ArticleTitle>Three-dimensional localization versus fluoroscopically only guided ablations: a meta-analysis.</ArticleTitle><Pagination><StartPage>200</StartPage><EndPage>209</EndPage><MedlinePgn>200-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3109/14017431.2013.797099</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Data regarding efficacy and safety of three-dimensional localization systems (3D) are limited. We performed a meta-analysis of randomized trials comparing combined fluoroscopy- and 3D guided to fluoroscopically-only guided procedures.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A systematic search was performed using multiple databases between 1990 and 2010. Outcomes were acute and long-term success, ablation, procedure and fluoroscopic times, radiation dose (RD), and complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen studies involving 1292 patients were identified. 3D were tested against fluoroscopic guidance in 666 patients for supraventricular tachycardia (SVT), atrial flutter (AFL), atrial fibrillation (AF), and ventricular tachycardia (VT). Acute and long-term freedom from arrhythmia was not significantly different between 3D and control for AFL (acute success, 97% vs. 93%, p = 0.57; chronic success, 93% vs. 96%, p = 0.90) or for SVT (acute success, 94% vs. 100%, p = 0.36; chronic success, 88% vs. 88%, p = 0.80). A shorter fluoroscopic time was achieved with 3D in AFL (p &lt; 0.001) and in SVT (p = 0.002). RD was significantly less for both AFL (p = 0.002) and SVT (p = 0.01). Ablation and procedure time and complications were not statistically different.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Success, procedure time, and complications were similar between fluoroscopy- and 3D-guided ablations. Fluoroscopic time and RD were significantly reduced for ablation of AFL and SVT with 3D.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shurrab</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Arrhythmia Services, Schulich Heart Center, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. Mohammed.Shurrab@sunnybrook.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laish-Farkash</LastName><ForeName>Avishag</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lashevsky</LastName><ForeName>Ilan</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Morriello</LastName><ForeName>Florence</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sheldon Michael</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Richard John</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Harindra Channa</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Pinter</LastName><ForeName>Arnold</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Newman</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Crystal</LastName><ForeName>Eugene</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Scand Cardiovasc J</MedlineTA><NlmUniqueID>9708377</NlmUniqueID><ISSNLinking>1401-7431</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005471" MajorTopicYN="N">Fluoroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="Y">Imaging, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011829" MajorTopicYN="N">Radiation Dosage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011857" MajorTopicYN="Y">Radiographic Image Interpretation, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015641" MajorTopicYN="Y">Radiography, Interventional</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025321" MajorTopicYN="Y">Surgery, Computer-Assisted</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23647246</ArticleId><ArticleId IdType="doi">10.3109/14017431.2013.797099</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33179155</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>First-line ablation of ventricular tachycardia in ischemic cardiomyopathy: stratification of outcomes by left ventricular function.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>400</EndPage><MedlinePgn>391-400</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-020-00912-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">First-line catheter ablation of ventricular tachycardia/ventricular fibrillation (VT/VF) in patients with ischemic cardiomyopathy (ICM) has been associated with improved outcomes; however, most benefit seems to be in patients with moderately depressed left ventricular ejection fraction (LVEF). Herein, outcomes were stratified based on LVEF.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A meta-analysis of randomized controlled trials (RCTs) evaluating first-line ablation versus medical therapy in patients with VT and ICM was performed. Risk estimates and 95% confidence intervals (CI) were measured.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four RCTs with a total of 505 patients (mean age 66&#x2009;&#xb1;&#x2009;9&#xa0;years, 89% male, 80% with previous revascularization) were included. Mean LVEF was 35&#x2009;&#xb1;&#x2009;8%. At a mean follow-up of 24&#x2009;&#xb1;&#x2009;9&#xa0;months, a significant benefit in survival-free from appropriate implantable cardioverter-defibrillator (ICD) therapies was observed in all patients undergoing first-line catheter ablation compared with medical management (RR 0.70, 95% CI 0.56-0.86). In patients with moderately depressed LVEF (&gt;&#x2009;30-50%), first-line VT ablation was associated with a statistically significant reduction in the composite endpoint of survival free from VT/VF and appropriate ICD therapies (HR 0.52, 95% CI 0.36-0.76), whereas there was no difference in patients with severely depressed LVEF (&#x2264;30%) (HR 0.56, 95% CI 0.24-1.32). Funnel plots did not show asymmetry suggesting lack of bias.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with ICM and VT undergoing first-line ablation have a significantly lower rate of appropriate ICD therapies without a mortality difference compared with patients receiving an initial approach based on medical therapy. The beneficial effect of a first-line ablation approach was only observed in patients with moderately depressed LVEF (&gt;&#x2009;30-50%).</AbstractText><CopyrightInformation>&#xa9; 2020. Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brice&#xf1;o</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Kavisha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaqat</LastName><ForeName>Wasla</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Dong</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alviz</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ruike</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Henan Provincial People's Hospital, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute, Overland Park, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocca</LastName><ForeName>Domenico Della</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantino</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopinathannair</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kansas City Heart Rhythm Institute, Overland Park, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Biase</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6508-4047</Identifier><AffiliationInfo><Affiliation>Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA. dibbia@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, USA. dibbia@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>12</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33179155</ArticleId><ArticleId IdType="doi">10.1007/s10840-020-00912-w</ArticleId><ArticleId IdType="pii">10.1007/s10840-020-00912-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Bakker JM, van Capelle FJ, Janse MJ, Wilde AA, Coronel R, Becker AE, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77:589&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.77.3.589</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020;17:e2&#x2013;e154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA. 2006;295:165&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.2.165</ArticleId></ArticleIdList></Reference><Reference><Citation>Briceno DF, Romero J, Villablanca PA, et al. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. Europace. 2018;20:104&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eux109</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr&#xe9;taz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61755-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou WS, et al. Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol. 2017;69:2105&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.02.044</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa071098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041489</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1513614</ArticleId></ArticleIdList></Reference><Reference><Citation>Haqqani HM, Kalman JM, Roberts-Thomson KC, Balasubramaniam RN, Rosso R, Snowdon RL, et al. Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia. J Am Coll Cardiol. 2009;54:166&#x2013;73.</Citation></Reference><Reference><Citation>Romero J, Di Biase L, Diaz JC, et al. Early versus late referral for catheter ablation of ventricular tachycardia in patients with structural heart disease: a systematic review and meta-analysis of clinical outcomes. JACC Clin Electrophysiol. 2018;4:374&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2017.12.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an international VT ablation center collaborative group study. Heart Rhythm. 2015;12:1997&#x2013;2007.</Citation></Reference><Reference><Citation>Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (substrate modification study). Circ Arrhythm Electrophysiol. 2017;10:e004422. https://doi.org/10.1161/CIRCEP.116.004422 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.116.004422</ArticleId><ArticleId IdType="pubmed">28292751</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems S, Tilz RR, Steven D, K&#xe4;&#xe4;b S, Wegscheider K, Gell&#xe9;r L, et al. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141:1057&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043400</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschabrunn CM, Roujol S, Nezafat R, Faulkner-Jones B, Buxton AE, Josephson ME, et al. A swine model of infarct-related reentrant ventricular tachycardia: electroanatomic, magnetic resonance, and histopathological characterization. Heart Rhythm. 2016;13:262&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.07.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenal A, Perez-David E, Avila P, et al. Noninvasive identification of epicardial ventricular tachycardia substrate by magnetic resonance-based signal intensity mapping. Heart Rhythm. 2014;11:1456&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2014.04.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero J, Cerrud-Rodriguez RC, Di Biase L, et al. Combined endocardial-epicardial versus endocardial catheter ablation alone for ventricular tachycardia in structural heart disease: a systematic review and meta-analysis. JACC Clin Electrophysiol. 2019;5:13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2018.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, et al. Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm. 2018;15:355&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2017.10.009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16490088</PMID><DateCompleted><Year>2006</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1155-5645</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2006</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Randomized controlled trial comparing the laryngeal tube and the laryngeal mask in pediatric patients.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>257</EndPage><MedlinePgn>251-7</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The laryngeal tube (LT) is a supraglottic ventilatory device used in adults. However, there is limited information about LT use in pediatric patients. This randomized controlled study compares LT with laryngeal mask (LMA) for airway management during spontaneous or assisted ventilation and during fiberoptic laryngoscopy in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirty children under 10-years old, ASA I-II, scheduled for minor general surgery, Mallampati score I-II, fasted and premedicated were included. Patients with upper respiratory infection, craniofacial malformation, intracranial hypertension, emergency surgery were excluded. The primary outcome measure was the proportion of patients in whom effective spontaneous or assisted ventilation [Vt &gt; or = 4 ml.kg(-1), SpO2 &gt; or = 95% with FiO2 0.4, P(E)CO2 &lt; or = 7.2 kPa (55 mmHg)] was achieved after 3 min of LT or LMA cuff inflation. The secondary endpoint was the proportion of patients in whom fiberoptic laryngoscopy resulted in identification of the vocal cords.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven children with LMA and two children in LT group had adequate spontaneous or assisted ventilation after initial positioning (P &lt; 0.01). After head extension or device repositioning 15 of 15 patients in LMA group had adequate ventilation compared with 11 of 15 patients in LT group (P &lt; 0.05). The vocal cords could be observed with fiberoptic laryngoscopy in 11 LMA group patients compared with no patients in the LT group (P &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The LT is less effective than the LMA to allow adequate spontaneous or assisted ventilation and for fiberoptic evaluation of the airway in children under 10 years old.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bortone</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Azienda Ospedaliera di Parma, Parma, Italy. lbortone@ao.pr.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingelmo</LastName><ForeName>Pablo M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>De Ninno</LastName><ForeName>Ges&#xf9;</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Tosi</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Caffini</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Trenchi</LastName><ForeName>Juna</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mergoni</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Martorana</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007828" MajorTopicYN="N">Laryngoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>2</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>2</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16490088</ArticleId><ArticleId IdType="doi">10.1111/j.1460-9592.2005.01756.x</ArticleId><ArticleId IdType="pii">PAN1756</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37931874</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-8769</ISSN><JournalIssue CitedMedium="Internet"><Volume>181</Volume><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>World neurosurgery</Title><ISOAbbreviation>World Neurosurg</ISOAbbreviation></Journal><ArticleTitle>General Anesthesia Versus Conscious Sedation for Acute Ischemic Stroke Endovascular Therapy: A Meta Analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>161</StartPage><EndPage>170.e2</EndPage><MedlinePgn>161-170.e2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2023.10.143</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1878-8750(23)01549-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Endovascular thrombectomy (E.V.T.) is the primary treatment for acute ischemic stroke (AIS). Nevertheless, the optimal choice of anesthetic modality during E.V.T. remains uncertain. This systematic review and meta-analysis aim to summarize existing literature from randomized controlled trials (RCTs) to guide the selection of the most appropriate anesthetic modality for AIS patients undergoing E.V.T.</AbstractText><AbstractText Label="METHODS">By a thorough search strategy, RCTs comparing general anesthesia (G.A.) and conscious sedation (C.S.) in E.V.T. for AIS patients were identified. Eligible studies were independently screened, and relevant data were extracted. The analysis employed pooled risk ratio for dichotomous outcomes and the mean difference for continuous ones. RCTs quality was assessed using the Cochrane Risk of Bias assessment tool&#xa0;1.</AbstractText><AbstractText Label="RESULTS">In the functional independence outcome (mRS scores 0-2), the pooled analysis did not favor either G.A. or C.S. arms, with an RR of 1.10 [0.95, 1.27] (P&#xa0;=&#xa0;0.19). Excellent (mRS 0-1) and poor (&#x2265;3) recovery outcomes did not significantly differ between G.A. and C.S. groups, with RR values of 1.03 [0.80, 1.33] (P&#xa0;=&#xa0;0.82) and 0.93 [0.84, 1.03] (P&#xa0;=&#xa0;0.16), respectively. Successful recanalization significantly favored G.A. over C.S. (RR 1.13 [1.07, 1.20], P&#xa0;&gt;&#xa0;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">G.A. had superior recanalization rates in AIS patients undergoing endovascular therapy, but functional outcomes, mortality, and NIHSS scores were similar. Secondary outcomes showed no significant differences, except for a higher risk of hypotension with G.A. More trials are required to determine the optimal anesthesia approach for thrombectomy in AIS patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Salihi</LastName><ForeName>Mohammed Maan</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA. Electronic address: mohammed.wwt@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saha</LastName><ForeName>Ram</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayyad</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Hamad General Hospital, Doha, Qatar; Department of Neurosurgery, Saarland University Hospital, Homburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Jebur</LastName><ForeName>Maryam Sabah</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>College of Medicine/ University of Baghdad, Baghdad, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Salihi</LastName><ForeName>Yezan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Medicine/ University of Baghdad, Baghdad, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalal</LastName><ForeName>Shamser Singh</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Radiology, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Adnan I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Zeenat Qureshi Stroke Institute and University of Missouri, Columbia, Missouri, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World Neurosurg</MedlineTA><NlmUniqueID>101528275</NlmUniqueID><ISSNLinking>1878-8750</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>World Neurosurg. 2024 Sep;189:517. doi: 10.1016/j.wneu.2024.05.182.</RefSource><PMID Version="1">39252353</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000777" MajorTopicYN="Y">Anesthetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="N">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIS</Keyword><Keyword MajorTopicYN="N">Acute ischemic stroke</Keyword><Keyword MajorTopicYN="N">Cerebrovascular accident</Keyword><Keyword MajorTopicYN="N">Conscious sedation</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>7</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>19</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37931874</ArticleId><ArticleId IdType="doi">10.1016/j.wneu.2023.10.143</ArticleId><ArticleId IdType="pii">S1878-8750(23)01549-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22879631</PMID><DateCompleted><Year>2012</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1945-7197</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>10</Issue><PubDate><Year>2012</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The Journal of clinical endocrinology and metabolism</Title><ISOAbbreviation>J Clin Endocrinol Metab</ISOAbbreviation></Journal><ArticleTitle>Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women.</ArticleTitle><Pagination><StartPage>3807</StartPage><EndPage>3814</EndPage><MedlinePgn>3807-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1210/jc.2012-2346</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Although sphingosine 1-phosphate (S1P) plays diverse roles in bone metabolism, the most prominent role seems to be the augmentation of bone resorption.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of the study was to investigate the possibility of using S1P as a predictor for osteoporotic vertebral fracture (VF) risk.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">This was a case-control study conducted in a clinical unit in Korea.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Sixty-nine cases having radiological VF and 69 age- and body mass index-matched controls among 460 eligible postmenopausal women participated in the study.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Lateral thoracolumbar radiographs, bone mineral density (BMD), bone turnover markers, and plasma S1P levels were obtained from all subjects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">S1P levels were markedly higher in subjects with VF (7.49&#xb1;3.44 &#x3bc;mol/liter) than in those without VF (5.58&#xb1;2.01 &#x3bc;mol/liter; P=0.001) and increased in a dose-response manner as the number of VF increased (P for the trend&lt;0.001), even after adjustment for lumbar spine BMD and potential confounders. The odds ratio for VF was markedly higher in subjects in the highest S1P quartile category compared with those in the lowest S1P quartile category after adjustment for confounders (odds ratio 9.33, 95% confidence interval 2.68-32.49). S1P levels were inversely correlated with BMD at various sites (P=0.015 to 0.044), whereas they were positively correlated with bone resorption markers (P=0.016 to 0.098).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings suggest that plasma S1P may be a potential biomarker for the risk of VF, independent of BMD, in postmenopausal women.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Beom-Jun</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap2-Dong, Songpa-Gu, Seoul 138-736, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Jung-Min</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sun-Young</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Young-Sun</ForeName><Initials>YS</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Hun</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Kyeong-Hye</ForeName><Initials>KH</Initials></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Eun-Hee</ForeName><Initials>EH</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sang-Wook</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae-Ho</ForeName><Initials>TH</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Shin-Yoon</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ghi Su</ForeName><Initials>GS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Endocrinol Metab</MedlineTA><NlmUniqueID>0375362</NlmUniqueID><ISSNLinking>0021-972X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008246">Lysophospholipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>26993-30-6</RegistryNumber><NameOfSubstance UI="C060506">sphingosine 1-phosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>NGZ37HRE42</RegistryNumber><NameOfSubstance UI="D013110">Sphingosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008246" MajorTopicYN="N">Lysophospholipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015663" MajorTopicYN="N">Osteoporosis, Postmenopausal</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013110" MajorTopicYN="N">Sphingosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013904" MajorTopicYN="N">Thoracic Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22879631</ArticleId><ArticleId IdType="doi">10.1210/jc.2012-2346</ArticleId><ArticleId IdType="pii">jc.2012-2346</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39139861</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1880-4276</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of arrhythmia</Title><ISOAbbreviation>J Arrhythm</ISOAbbreviation></Journal><ArticleTitle>Long-term outcomes of ventricular tachycardia ablation in repaired tetralogy of Fallot: Systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>935</StartPage><EndPage>947</EndPage><MedlinePgn>935-947</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/joa3.13095</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Ventricular tachycardia (VT) remains a risk in repaired Tetralogy of Fallot (rTOF); however, long-term benefits of VT ablation have not been established. This study compares the outcomes of rTOF patients with and without VT ablation.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched multiple databases examining the outcomes of rTOF patients who had undergone VT ablation compared to those without ablation. Primary outcomes were VT recurrence, sudden cardiac death (SCD), and all-cause mortality. Subgroup analysis was conducted based on the type of ablation (catheter and surgical). Slow-conducting anatomical isthmus (SCAI)-based catheter ablation (CA) was also analyzed separately. The secondary outcome was the risk factors for the pre-ablation history of VT.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Fifteen cohort studies with 1459 patients were included, 21.4% exhibited VTs. SCAI was found in 30.4% of the population, with 3.7% of non-inducible VT. Factors significantly associated with VT before ablation included a history of ventriculostomy, QRS duration &#x2265;180&#x2009;ms, fragmented QRS, moderate to severe pulmonary regurgitation, high premature ventricular contractions burden, late gadolinium enhancement, and SCAI. Ablation was only beneficial in reducing VTs recurrence in SCAI-based CA (risk ratio (RR) 0.11; 95% CI 0.03 to 0.33. <i>p</i>&#x2009;&lt;&#x2009;0.001; I<sup>2</sup>&#x2009;=&#x2009;0%) with no recurrence in patients with preventive ablation (mean follow-up time 91.14&#x2009;&#xb1;&#x2009;77.81&#x2009;months). The outcomes of VT ablation indicated a favorable trend concerning SCD and all-cause mortality (RR 0.49 and 0.44, respectively); however, they were statistically insignificant.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">SCAI-based CA has significant advantages in reducing VT recurrence in rTOF patients. Risk stratification plays a key role in determining the decision to perform ablation.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Journal of Arrhythmia published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prana Jagannatha</LastName><ForeName>Gusti Ngurah</ForeName><Initials>GN</Initials><Identifier Source="ORCID">0000-0001-7371-4520</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine Udayana University, Prof. dr. I.G.N.G Ngoerah General Hospital Denpasar Bali Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendel</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5612-8113</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine Sultan Sulaiman Government Hospital Serdang Bedagai North Sumatra Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labi</LastName><ForeName>Nikita Pratama Toding</ForeName><Initials>NPT</Initials><Identifier Source="ORCID">0009-0005-5895-643X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine Sam Ratulangi University Manado North Sulawesi Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aji</LastName><ForeName>Wingga Chrisna</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Muhammadiyah Yogyakarta University Yogyakarta Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosasih</LastName><ForeName>Anastasya Maria</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-8018-2283</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine Udayana University, Prof. dr. I.G.N.G Ngoerah General Hospital Denpasar Bali Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adrian</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0007-7209-7680</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine Udayana University, Prof. dr. I.G.N.G Ngoerah General Hospital Denpasar Bali Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Liyis</LastName><ForeName>Bryan Gervais</ForeName><Initials>BG</Initials><Identifier Source="ORCID">0000-0002-8272-754X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine Udayana University, Prof. dr. I.G.N.G Ngoerah General Hospital Denpasar Bali Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pertiwi</LastName><ForeName>Putu Febry Krisna</ForeName><Initials>PFK</Initials><Identifier Source="ORCID">0009-0004-0370-9733</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine Udayana University, Prof. dr. I.G.N.G Ngoerah General Hospital Denpasar Bali Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antara</LastName><ForeName>I Made Putra Swi</ForeName><Initials>IMPS</Initials><Identifier Source="ORCID">0000-0002-1865-4163</Identifier><AffiliationInfo><Affiliation>Division of Electrophysiology and Cardiac Pacing, Department of Cardiology and Vascular Medicine, Faculty of Medicine Udayana University, Prof. dr. I.G.N.G Ngoerah General Hospital Denpasar Bali Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Arrhythm</MedlineTA><NlmUniqueID>101263026</NlmUniqueID><ISSNLinking>1880-4276</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ablation</Keyword><Keyword MajorTopicYN="N">slow&#x2010;conducting anatomical isthmus</Keyword><Keyword MajorTopicYN="N">sudden cardiac death</Keyword><Keyword MajorTopicYN="N">tetralogy of Fallot</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>14</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39139861</ArticleId><ArticleId IdType="pmc">PMC11317698</ArticleId><ArticleId IdType="doi">10.1002/joa3.13095</ArticleId><ArticleId IdType="pii">JOA313095</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khairy P, Ionescu&#x2010;Ittu R, MacKie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56(14):1149&#x2013;1157.</Citation><ArticleIdList><ArticleId IdType="pubmed">20863956</ArticleId></ArticleIdList></Reference><Reference><Citation>Marelli AJ, Ionescu&#x2010;Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">24944314</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264&#x2013;2272.</Citation><ArticleIdList><ArticleId IdType="pubmed">21098444</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen MI, Khairy P, Zeppenfeld K, van Hare GF, Lakkireddy DR, Triedman JK. Preventing arrhythmic death in patients with tetralogy of Fallot: JACC review topic of the week. J Am Coll Cardiol. 2021;77:761&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pubmed">33573746</ArticleId></ArticleIdList></Reference><Reference><Citation>Diller GP, Kempny A, Liodakis E, Alonso&#x2010;Gonzalez R, Inuzuka R, Uebing A, et&#xa0;al. Left ventricular longitudinal function predicts life&#x2010;threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot. Circulation. 2012;125(20):2440&#x2013;2446.</Citation><ArticleIdList><ArticleId IdType="pubmed">22496160</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, et&#xa0;al. Sudden cardiac death in adult congenital heart disease. Circulation. 2012;126(16):1944&#x2013;1954.</Citation><ArticleIdList><ArticleId IdType="pubmed">22991410</ArticleId></ArticleIdList></Reference><Reference><Citation>Possner M, Tseng SY, Alahdab F, Bokma JP, Lubert AM, Khairy P, et&#xa0;al. Risk factors for mortality and ventricular tachycardia in patients with repaired tetralogy of Fallot: a systematic review and meta&#x2010;analysis. Can J Cardiol. 2020;36:1815&#x2013;1825.</Citation><ArticleIdList><ArticleId IdType="pubmed">32416063</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbe AC, Miranda WR, Madhavan M, Ammash NM, Missula VR, Al&#x2010;Otaibi M, et&#xa0;al. Cardiac implantable electronic devices in adults with tetralogy of Fallot. Heart. 2019;105(7):538&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658101</ArticleId><ArticleId IdType="pubmed">30377259</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldmann V, Bouzeman A, Duthoit G, Koutbi L, Bessiere F, Labombarda F, et&#xa0;al. Long&#x2010;term follow&#x2010;up of patients with tetralogy of Fallot and implantable cardioverter defibrillator: the DAI&#x2010;T4F Nationwide registry. Circulation. 2020;142(17):1612&#x2013;1622.</Citation><ArticleIdList><ArticleId IdType="pubmed">32998542</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et&#xa0;al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922510</ArticleId><ArticleId IdType="pubmed">18768944</ArticleId></ArticleIdList></Reference><Reference><Citation>Santharam S, Hudsmith L, Thorne S, Clift P, Marshall H, de Bono J. Long&#x2010;term follow&#x2010;up of implantable cardioverter&#x2010;defibrillators in adult congenital heart disease patients: indications and outcomes. Europace. 2017;19:407.</Citation><ArticleIdList><ArticleId IdType="pubmed">27234868</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger EV, Zeppenfeld K, DeWitt ES, Duarte VE, Egbe AC, Haeffele C, et&#xa0;al. Arrhythmias in repaired tetralogy of Fallot: a scientific statement from the American Heart Association. Circ Arrhythm Electrophysiol. 2022;15(11):e000084. 10.1161/HAE.0000000000000084</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HAE.0000000000000084</ArticleId><ArticleId IdType="pubmed">36263773</ArticleId></ArticleIdList></Reference><Reference><Citation>Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta&#x2010;analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg. 2011;39(2):91&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">21145753</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et&#xa0;al. The Newcastle&#x2010;Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta&#x2010;analyses. The Ottawa Hospital Research Institute
2021. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid&#x2010;range, and/or mid&#x2010;quartile range. Stat Methods Med Res. 2018;27(6):1785&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et&#xa0;al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Vol 372. The BMJ: BMJ Publishing Group; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Dersimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C. Papers bias in meta&#x2010;analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawada S, Chakraborty P, Downar E, Sanchez AP, Sathananthan G, Bhaskaran A, et&#xa0;al. The role of ablation in prevention of recurrent implantable cardioverter defibrillator shocks in patients with tetralogy of Fallot. CJC Open. 2021;3(5):619&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134918</ArticleId><ArticleId IdType="pubmed">34027366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapel GFL, Brouwer C, Jalal Z, Sacher F, Venlet J, Schalij MJ, et&#xa0;al. Slow conducting Electroanatomic isthmuses: an important link between QRS duration and ventricular tachycardia in tetralogy of Fallot. JACC Clin Electrophysiol. 2018;4(6):781&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">29929672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapel GFL, Sacher F, Dekkers OM, Watanabe M, Blom NA, Thambo JB, et&#xa0;al. Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired tetralogy of Fallot. Eur Heart J. 2017;38(4):268&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">28182233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessi&#xe8;re F, Gardey K, Bouzeman A, Duthoit G, Koutbi L, Labombarda F, et&#xa0;al. Impact of pulmonary valve replacement on ventricular arrhythmias in patients with tetralogy of Fallot and implantable cardioverter&#x2010;defibrillator. JACC Clin Electrophysiol. 2021;7(10):1285&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pubmed">33933408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghonim S, Ernst S, Keegan J, Giannakidis A, Spadotto V, Voges I, et&#xa0;al. Three&#x2010;dimensional late gadolinium enhancement cardiovascular magnetic resonance predicts Inducibility of ventricular tachycardia in adults with repaired tetralogy of Fallot. Circ Arrhythm Electrophysiol. 2020;13(11):e008321.</Citation><ArticleIdList><ArticleId IdType="pubmed">33022183</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider HE, Schill M, Kriebel T, Paul T. Value of dynamic substrate mapping to identify the critical diastolic pathway in postoperative ventricular reentrant tachycardias after surgical repair of tetralogy of Fallot. J Cardiovasc Electrophysiol. 2012;23(9):930&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pubmed">22812535</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldmann V, Bessi&#xe8;re F, Gardey K, Bakloul M, Belli E, Bonnet D, et&#xa0;al. Systematic electrophysiological study prior to pulmonary valve replacement in tetralogy of Fallot: a prospective multicenter study. Circ Arrhythm Electrophysiol. 2023;16(6):e011745.</Citation><ArticleIdList><ArticleId IdType="pubmed">37170812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura Y, Wallet J, Jongbloed MRM, Blom NA, Bertels R, Lamb HJ, et&#xa0;al. Non&#x2010;invasive identification of slow conducting anatomical isthmuses in patients with tetralogy of Fallot by 3D late gadolinium enhancement cardiovascular magnetic resonance imaging. MedRxiv. 2023.</Citation></Reference><Reference><Citation>Bouyer B, Jalal Z, Daniel Ramirez F, Derval N, Iriart X, Duchateau J, et&#xa0;al. Electrophysiological study prior to planned pulmonary valve replacement in patients with repaired tetralogy of Fallot. J Cardiovasc Electrophysiol. 2023;34(6):1395&#x2013;1404.</Citation><ArticleIdList><ArticleId IdType="pubmed">37232426</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu SN, Huang SC, Wang JK, Lu CW, Chang LY, Lin MT, et&#xa0;al. Implantable cardioverter defibrillator therapy in repaired tetralogy of Fallot after pulmonary valve replacement: implications for the mechanism of ventricular arrhythmia. Int J Cardiol. 2017;249:156&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">29121719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol. 2002;40(9):1675&#x2013;1680.</Citation><ArticleIdList><ArticleId IdType="pubmed">12427422</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison DA, Harris L, Siu SC, Macloghlin CJ, Connelly MS, Webb GD, et&#xa0;al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol. 1997;30(5):1368&#x2013;1373.</Citation><ArticleIdList><ArticleId IdType="pubmed">9350941</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotes AS, Connolly HM, Warnes CA, Ammash NM, Phillips SD, Dearani JA, et&#xa0;al. Ventricular arrhythmia risk stratification in patients with tetralogy of fallot at the time of pulmonary valve replacement. Circ Arrhythm Electrophysiol. 2015;8(1):110&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">25416756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu A, Ruckdeschel E, Sauer WH, Collins KK, Kay JD, Khanna A, et&#xa0;al. Perioperative electrophysiology study in patients with tetralogy of Fallot undergoing pulmonary valve replacement will identify those at high risk of subsequent ventricular tachycardia. Heart Rhythm. 2018;15(5):679&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">29330130</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner KG, O'brien PKH, Rhodes J, Kaur A, Robinson DA, Payne DD. Expanding the indications for pulmonary valve replacement after repair of tetralogy of Fallot. Ann Thorac Surg. 2003;76:1066&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pubmed">14529986</ArticleId></ArticleIdList></Reference><Reference><Citation>
Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, et&#xa0;al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation [Internet]. 2001;103:2489. Available from: http://www.circulationaha.org&#x2013;2494.
</Citation><ArticleIdList><ArticleId IdType="pubmed">11369690</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamlou T, Silber I, Lao R, McCrindle BW, Harris L, Downar E, et&#xa0;al. Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery. Ann Thorac Surg. 2006;81(5):1786&#x2013;1793.</Citation><ArticleIdList><ArticleId IdType="pubmed">16631673</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, et&#xa0;al. Implantable cardioverter&#x2010;defibrillators in tetralogy of Fallot. Circulation. 2008;117(3):363&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">18172030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bricen&#xf5; DF, Romero J, Villablanca PA, London&#xf5; A, Diaz JC, Maraj I, et&#xa0;al. Long&#x2010;term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta&#x2010;analysis. Europace. 2018;20:104&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">28575378</ArticleId></ArticleIdList></Reference><Reference><Citation>de Groot NMS, Lukac P, Schalij MJ, Makowski K, Szili&#x2010;Torok T, Jordaens L, et&#xa0;al. Long&#x2010;term outcome of ablative therapy of post&#x2010;operative atrial tachyarrhythmias in patients with tetralogy of Fallot: a European multi&#x2010;centre study. Europace. 2012;14(4):522&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">21971346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapel GFL, Reichlin T, Wijnmaalen AP, Piers SRD, Holman ER, Tedrow UB, et&#xa0;al. Re&#x2010;entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease. Circ Arrhythm Electrophysiol. 2015;8(1):102&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">25422392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapel GFL, Laranjo S, Blom NA, Hazekamp MG, Schalij MJ, Bartelings MM, et&#xa0;al. Impact of surgery on presence and dimensions of anatomical isthmuses in tetralogy of Fallot. Heart. 2018;104:1200&#x2013;1207.</Citation><ArticleIdList><ArticleId IdType="pubmed">29305559</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JP, Seki A, Shannon KM, Mandapati R, Tung R, Fishbein MC. Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of fallot. Circ Arrhythm Electrophysiol. 2013;6(5):905&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pubmed">23884199</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeppenfeld K, Schalij MJ, Bartelings MM, Tedrow UB, Koplan BA, Soejima K, et&#xa0;al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: Electroanatomic identification of the critical right ventricular isthmus. Circulation. 2007;116(20):2241&#x2013;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">17967973</ArticleId></ArticleIdList></Reference><Reference><Citation>Madaffari A, Rivetti L, K&#xfc;hne M, Knecht S, Osswald S, Sticherling C. Ventricular tachycardia catheter ablation after repaired tetralogy of Fallot: how to overcome an electrical short circuit. Vol 22. Europace. Oxford University Press; 2020. p. 1687. 10.1093/europace/euaa167</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euaa167</ArticleId><ArticleId IdType="pubmed">33175985</ArticleId></ArticleIdList></Reference><Reference><Citation>Takigawa M, Martin R, Kitamura T, Capellino S, Ja&#xef;s P, Sacher F. Dual&#x2010;loop circuit of ventricular tachycardia in repaired tetralogy of Fallot patient. Europace. 2017;19(10):1669.</Citation><ArticleIdList><ArticleId IdType="pubmed">29016767</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehmeijer JT, Brouwer TF, Limpens J, Knops RE, Bouma BJ, Mulder BJM, et&#xa0;al. Implantable cardioverter&#x2010;defibrillators in adults with congenital heart disease: a systematic review and meta&#x2010;analysis. Eur Heart J. 2016;37(18):1439&#x2013;1448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4914887</ArticleId><ArticleId IdType="pubmed">26873095</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27687346</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Comparison of volume-controlled ventilation and pressure-controlled ventilation volume guaranteed during laparoscopic surgery in Trendelenburg position.</ArticleTitle><Pagination><StartPage>55</StartPage><EndPage>61</EndPage><MedlinePgn>55-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2016.03.053</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(16)30089-7</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">To analyze the effects of pressure-controlled ventilation-volume guaranteed (PCV-VG) and volume controlled ventilation (VCV) on airway pressures and respiratory and circulatory indicators during laparoscopic surgery in Trendelenburg position.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective randomized comparative clinical study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Tertiary hospital.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Forty ASA physical status 1 and 2 patients who underwent elective laparoscopic surgery in Trendelenburg position.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomly allocated to either VCV group (n=20) or the PCV-VG group (n=20). After induction of anesthesia, for both modes of ventilation, the target tidal volume (VT) was 8mL/kg and the respiratory rate was adjusted to avoid hypercarbia.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The peak and mean inspiratory pressures, dynamic compliance, exhaled VT, oxygenation index and physiological dead space were calculated and recorded at T1, 5minutes after induction of anesthesia in supine position, T2, 5minutes after stabilization of pneumoperitoneum, T3 and T4, 15 and 60minutes after 30&#xb0; Trendelenburg position with pneumoperitoneum respectively.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">PCV-VG group had significantly lower peak inspiratory pressure and greater dynamic compliance than VCV group (P&lt;.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients who underwent laparoscopic surgery in Trendelenburg position, PCV-VG was superior to VCV in its ability to provide ventilation with lower peak inspiratory pressure and greater dynamic compliance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Assad</LastName><ForeName>Osama M</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: osamaasaad72@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Sayed</LastName><ForeName>Ayman A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Mohamed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="N">Blood Gas Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018475" MajorTopicYN="N">Head-Down Tilt</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="N">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015656" MajorTopicYN="Y">Respiratory Mechanics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Laparoscopic surgery</Keyword><Keyword MajorTopicYN="N">Mechanical ventilation</Keyword><Keyword MajorTopicYN="N">Trendelenburg position</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27687346</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2016.03.053</ArticleId><ArticleId IdType="pii">S0952-8180(16)30089-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34628421</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-481X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of glaucoma</Title><ISOAbbreviation>J Glaucoma</ISOAbbreviation></Journal><ArticleTitle>Surgical Outcomes of Visco-Circumferential-Suture-Trabeculotomy Versus Rigid Probe Trabeculotomy in Primary Congenital Glaucoma: A 3-Year Randomized Controlled Study.</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>53</EndPage><MedlinePgn>48-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/IJG.0000000000001944</ELocationID><Abstract><AbstractText Label="PURPOSE">The aim was to compare the long-term surgical outcomes of visco-circumferential-suture-trabeculotomy (VCST) and rigid probe viscotrabeculotomy (VT) in patients with primary congenital glaucoma (PCG).</AbstractText><AbstractText Label="PATIENTS AND METHODS">The study was conducted on 84 (47 right) eyes of 49 (32 males) children PCG to the pediatric ophthalmology unit of Mansoura Ophthalmic Center of Mansoura University, Egypt between 2015 and 2018. An initial office examination was followed by an examination under general anesthesia to establish the diagnosis of PCG. The children were then scheduled for surgery and the eyes randomly assigned to VCST or VT. Follow-up visits were scheduled at the first day, first week, first, and third months and then every 3 months for 1 year.</AbstractText><AbstractText Label="RESULTS">The mean&#xb1;SD age of the study children at presentation was 4.8&#xb1;2.1 and 4.9&#xb1;1.7 months in the VCST and the VT groups, respectively (P=0.827). The mean&#xb1;SD preoperative intraocular pressure (IOP) was 29.13&#xb1;3.3 and 29.89&#xb1;3.2&#x2009;mm&#x2009;Hg in the VCST and VT groups, respectively (P=0.292) and 11.9&#xb1;1.3 and 13.8&#xb1;1.2&#x2009;mm&#x2009;Hg at the end of 36 moths of follow-up (P&lt;0.001). The IOP at all follow-up time points (except at the third month, P=0.924) was statistically significantly less in the VCST group than in the VT group (at week 1, month 1, 6, 9, 12, 18, 24, 30, and 36 the P&lt;0.001). The cumulative probability of success was 100%, 95%, 90%, and 90%, respectively in VSCT and 100%, 72.7%, 97.7%, 90.9%, and 84% in VT at 12, 24, 30, and 36 months.</AbstractText><AbstractText Label="CONCLUSIONS">Both VCST and VT were effective and safe for lowering the IOP in PCG with VCST providing a marginal advantage over VT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elwehidy</LastName><ForeName>Ahmed S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Faculty of Medicine, Mansoura University, Mansoura.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayoumi</LastName><ForeName>Nader H L</ForeName><Initials>NHL</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abd Elfattah</LastName><ForeName>Dina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Faculty of Medicine, Mansoura University, Mansoura.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagras</LastName><ForeName>Sherein M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Faculty of Medicine, Mansoura University, Mansoura.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Glaucoma</MedlineTA><NlmUniqueID>9300903</NlmUniqueID><ISSNLinking>1057-0829</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006871" MajorTopicYN="Y">Hydrophthalmos</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013537" MajorTopicYN="N">Sutures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="Y">Trabeculectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure: The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>10</Day><Hour>21</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34628421</ArticleId><ArticleId IdType="doi">10.1097/IJG.0000000000001944</ArticleId><ArticleId IdType="pii">00061198-202201000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bouhenni RA, Ricker I, Hertle RW. Prevalence and clinical characteristics of childhood glaucoma at a Tertiary Care Children&#x2019;s Hospital. J Glaucoma. 2019;28:655&#x2013;659.</Citation></Reference><Reference><Citation>Gagrani M, Garg I, Ghate D. Surgical interventions for primary congenital glaucoma. Cochrane Database Syst Rev. 2020;8:CD008213.</Citation></Reference><Reference><Citation>Kessel L, Pedersen KB, Siersma V, et al. Long-term success after trabeculotomy in primary congenital glaucoma&#x2014;a study with up to 35 years follow-up. Acta Ophthalmol. 2021;99:362&#x2013;368.</Citation></Reference><Reference><Citation>Badawi AH, Al-Muhaylib AA, Al Owaifeer AM, et al. Primary congenital glaucoma: an updated review. Saudi J Ophthalmol. 2019;33:382&#x2013;388.</Citation></Reference><Reference><Citation>Elwehidy AS, Hagras SM, Bayoumi N, et al. Five-year results of viscotrabeculotomy versus conventional trabeculotomy in primary congenital glaucoma: a randomized controlled study. Eur J Ophthalmol. 2021;31:786&#x2013;795.</Citation></Reference><Reference><Citation>Beck AD, Lynn MJ, Crandall J, et al. Surgical outcomes with 360-degree suture trabeculotomy in poor-prognosis primary congenital glaucoma and glaucoma associated with congenital anomalies or cataract surgery. J AAPOS. 2011;15:54&#x2013;58.</Citation></Reference><Reference><Citation>El Sayed Y, Gawdat G. Two-year results of microcatheter-assisted trabeculotomy in paediatric glaucoma: a randomized controlled study. Acta Ophthalmol. 2017;95:e713&#x2013;e719.</Citation></Reference><Reference><Citation>Mendicino ME, Lynch MG, Drack A, et al. Long-term surgical and visual outcomes in primary congenital glaucoma: 360&#xb0; trabeculotomy versus goniotomy. J AAPOS. 2000;4:205&#x2013;210.</Citation></Reference><Reference><Citation>Mocan MC, Mehta AA, Aref AA. Update in genetics and surgical management of primary congenital glaucoma. Turk J Ophthalmol. 2019;49:347&#x2013;355.</Citation></Reference><Reference><Citation>Lee SJ, Kim S, Rim TH, et al. Incidence, comorbidity, and mortality of primary congenital glaucoma in Korea from 2001 to 2015: a nationwide population-based study. Korean J Ophthalmol. 2020;34:316&#x2013;321.</Citation></Reference><Reference><Citation>Elksne E, Baumane K, Ozolins A, et al. The epidemiological and clinical findings from the latvian registry of primary congenital glaucoma and evaluation of prognostic factors. Medicina (Kaunas). 2021;57:44.</Citation></Reference><Reference><Citation>Bayoumi NH. Surgical management of glaucoma after congenital cataract surgery. J Pediatr Ophthalmol Strabismus. 2015;52:213&#x2013;220.</Citation></Reference><Reference><Citation>Bayoumi NH. Surgical management of primary congenital glaucoma in egypt. J Egypt Ophthalmol Soc. 2016;109:85&#x2013;92.</Citation></Reference><Reference><Citation>Abu-Amero KK, Edward DP Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A. Primary congenital glaucoma. GeneReviews&#xae;. Seattle, WA: University of Washington, Seattle; 2004:1993&#x2013;2021.</Citation></Reference><Reference><Citation>Al-Hazmi A, Awad A, Zwaan J, et al. Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol. 2005;89:449&#x2013;453.</Citation></Reference><Reference><Citation>Farid MF, Anany M, Awwad MA. Surgical outcomes of primary congenital glaucoma in children under one year from the Nile Delta. Clin Ophthalmol. 2021;15:1145&#x2013;1151.</Citation></Reference><Reference><Citation>Beck AD, Lynch MG. 360 degrees trabeculotomy for primary congenital glaucoma. Arch Ophthalmol. 1995;113:1200&#x2013;1202.</Citation></Reference><Reference><Citation>El Sayed YM, Gawdat GI. Microcatheter-assisted trabeculotomy versus 2-site trabeculotomy with the rigid probe trabeculotome in primary congenital glaucoma. J Glaucoma. 2018;27:371&#x2013;376.</Citation></Reference><Reference><Citation>Shi Y, Wang H, Oatts J, et al. Ab interno vs ab externo microcatheter-assisted trabeculotomy for primary congenital glaucoma with clear cornea. Clin Exp Ophthalmol. 2020;48:1201&#x2013;1209.</Citation></Reference><Reference><Citation>Meyer G, Schwenn O, Pfeiffer N, et al. Trabeculotomy in congenital glaucoma. Graefe&#x2019;s Arch Clin Exp Ophthalmol. 2000;238:207&#x2013;213.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39886726</PMID><DateRevised><Year>2025</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Impact of Imaging and Pharmacological Treatment Strategies in Refractory Ventricular Tachycardia in Critically Ill Patients: A Systematic Review.</ArticleTitle><Pagination><StartPage>e76641</StartPage><MedlinePgn>e76641</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e76641</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.76641</ELocationID><Abstract><AbstractText>Ventricular tachycardia (VT) is a life-threatening arrhythmia often leading to sudden cardiac death, particularly in critically ill patients. Refractory VT, characterized by recurrent episodes requiring intervention, poses unique challenges for management, necessitating advanced diagnostic and therapeutic strategies. This systematic review evaluates the impact of imaging and pharmacological treatments in managing refractory VT in critically ill patients. A systematic literature search was conducted using keywords such as "refractory ventricular tachycardia", "critical illness", "imaging techniques", "pharmacological treatments", "antiarrhythmic drugs", "ICD interventions", and "non-invasive therapy". Databases searched included PubMed, Google Scholar, and Cochrane Library, identifying 1590 publications. After screening, 11 studies meeting the inclusion criteria were included in this review. Oral procainamide significantly reduced VT episodes but caused severe side effects in certain patients. Noninvasive interventions such as transcutaneous magnetic stimulation (TcMS) and noninvasive electrophysiology-guided radioablation reduced VT burden and antiarrhythmic drug (AAD) use, with TcMS decreasing VT episodes in the sham group (P &lt; 0.001). Stereotactic body radiation therapy (SBRT) and stereotactic arrhythmia radiotherapy (STAR) reduced VT episodes. Ultrasound-guided stellate ganglion blockade decreased VT episodes (P &lt; 0.001) within 24 hours. Catheter ablation improved composite outcomes, including ICD shocks and heart failure hospitalizations, compared to AAD therapy. Quality of life significantly improved with noninvasive therapies, though SBRT presented rare complications like pneumonitis. Imaging and pharmacological interventions effectively reduce VT burden and ICD interventions while showing varying safety profiles. However, the limited sample sizes, short follow-up durations, and heterogeneity across studies highlight the need for further high-quality research to establish long-term efficacy and safety.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Cisneros Clavijo et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cisneros Clavijo</LastName><ForeName>Paulina Elizabeth</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Endovascular Surgery, Enrique Garc&#xe9;s Hospital, Quito, ECU.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hemodynamics, General and Interventional Cardioangiology, Pontificia Universidad Cat&#xf3;lica del Ecuador, Quito, ECU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunay Silva</LastName><ForeName>Alexis Agustin</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Hospital Barros Luco Trudeau, San Miguel, CHL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorado Ram&#xed;rez</LastName><ForeName>John Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Internal Medicine, Instituto Mexicano del Seguro Social, San Luis Potos&#xed;, MEX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez Correa</LastName><ForeName>Juan Felipe</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Medicine, Universidad del Rosario, Bogot&#xe1;, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montenegro Cadena</LastName><ForeName>Yesith Mauricio</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Medicine, Universidad Cooperativa de Colombia, Pasto, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez Arelio</LastName><ForeName>Luis Alberto</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Medicine, Centro de Integraci&#xf3;n para Adictos y Familiares, Monte F&#xe9;nix, Mexico City, MEX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vi&#xf1;an Andino</LastName><ForeName>Adriana Viviana</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Medicine, Ministry of Public Health, Ecuador, Quito, ECU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortes Sanchez</LastName><ForeName>Daniel Ricardo</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Medicine, Universidad Surcolombiana, Neiva, COL.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine, Hospital Universitario Hernando Moncaleano Perdomo, Neiva, COL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez Casta&#xf1;o</LastName><ForeName>Edgard Andres</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Medicine, Universidad Santiago de Cali, Cali, COL.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiarrhythmic drugs</Keyword><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">icd interventions</Keyword><Keyword MajorTopicYN="N">imaging techniques</Keyword><Keyword MajorTopicYN="N">pharmacological treatments</Keyword><Keyword MajorTopicYN="N">refractory ventricular tachycardia</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>31</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39886726</ArticleId><ArticleId IdType="pmc">PMC11779688</ArticleId><ArticleId IdType="doi">10.7759/cureus.76641</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Foth C, Gangwani MK, Ahmed I, Alvey H. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2023. Ventricular tachycardia.</Citation><ArticleIdList><ArticleId IdType="pubmed">30422549</ArticleId></ArticleIdList></Reference><Reference><Citation>Definition of ventricular tachycardia. Nikolic G. Am J Cardiol. 1982;50:1197&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">7137043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventricular arrhythmias and sudden cardiac death. Tang PT, Shenasa M, Boyle NG. Card Electrophysiol Clin. 2017;9:693&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">29173411</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and prognosis of sustained arrhythmias in critically ill patients. Annane D, S&#xe9;bille V, Duboc D, Le Heuzey JY, Sadoul N, Bouvier E, Bellissant E. Am J Respir Crit Care Med. 2008;178:20&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">18388358</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventricular tachycardia burden and mortality: association or causality? Samuel M, Elsokkari I, Sapp JL. https://doi.org/10.1016/j.cjca.2022.01.016. Can J Cardiol. 2022;38:454&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">35074416</ArticleId></ArticleIdList></Reference><Reference><Citation>Accelerated idioventricular rhythm. Jakkoju A, Jakkoju R, Subramaniam PN, Glancy DL. Proc (Bayl Univ Med Cent) 2018;31:506&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499534</ArticleId><ArticleId IdType="pubmed">31080367</ArticleId></ArticleIdList></Reference><Reference><Citation>Community first responders for out-of-hospital cardiac arrest in adults and children. Barry T, Doheny MC, Masterson S, et al. Cochrane Database Syst Rev. 2019;7:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6641654</ArticleId><ArticleId IdType="pubmed">31323120</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation. Tagami T, Yasunaga H, Yokota H. Crit Care. 2017;21:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360060</ArticleId><ArticleId IdType="pubmed">28320450</ArticleId></ArticleIdList></Reference><Reference><Citation>Non-invasive cardiac radiation for ablation of ventricular tachycardia: a new therapeutic paradigm in electrophysiology. Kim EJ, Davogustto G, Stevenson WG, John RM. Arrhythm Electrophysiol Rev. 2018;7:8&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5889801</ArticleId><ArticleId IdType="pubmed">29636967</ArticleId></ArticleIdList></Reference><Reference><Citation>How imaging techniques improve ventricular arrhythmia ablation: a multimodality-based approach. Robles AG, Jan M, Proli&#x10d; Kalin&#x161;ek T, et al. J Clin Med. 2023;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10706885</ArticleId><ArticleId IdType="pubmed">38068472</ArticleId></ArticleIdList></Reference><Reference><Citation>Stereotactic arrhythmia radioablation (STAR) opens a new era in the treatment of arrhythmias? Zhang S, Hu L, Tang H, Liao L, Li X. Front Cardiovasc Med. 2024;11:1449028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11469775</ArticleId><ArticleId IdType="pubmed">39399514</ArticleId></ArticleIdList></Reference><Reference><Citation>Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease - a systematic review. Kovacs B, Mayinger M, Schindler M, Steffel J, Andratschke N, Saguner AM. Radiother Oncol. 2021;162:132&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">34233215</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral procainamide as pharmacological treatment of recurrent and refractory ventricular tachyarrhythmias: a single-center experience. Toniolo M, Muser D, Grilli G, et al. Heart Rhythm O2. 2021;2:840&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8710645</ArticleId><ArticleId IdType="pubmed">34988535</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of transcutaneous magnetic stimulation in patients with ventricular tachycardia storm: a randomized clinical trial. Markman TM, Pothineni NV, Zghaib T, et al. JAMA Cardiol. 2022;7:445&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8851364</ArticleId><ArticleId IdType="pubmed">35171197</ArticleId></ArticleIdList></Reference><Reference><Citation>Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial. van der Ree MH, Dieleman EM, Visser J, et al. Europace. 2023;25:1015&#x2013;1024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10062344</ArticleId><ArticleId IdType="pubmed">36746553</ArticleId></ArticleIdList></Reference><Reference><Citation>Long term follow-up of stereotactic body radiation therapy for refractory ventricular tachycardia in advanced heart failure patients. Wight J, Bigham T, Schwartz A, et al. Front Cardiovasc Med. 2022;9:849113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9098944</ArticleId><ArticleId IdType="pubmed">35571173</ArticleId></ArticleIdList></Reference><Reference><Citation>Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Robinson CG, Samson PP, Moore KM, et al. Circulation. 2019;139:313&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6331281</ArticleId><ArticleId IdType="pubmed">30586734</ArticleId></ArticleIdList></Reference><Reference><Citation>Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias. Fudim M, Qadri YJ, Waldron NH, et al. JACC Clin Electrophysiol. 2020;6:562&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">32439042</ArticleId></ArticleIdList></Reference><Reference><Citation>Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia. Ho G, Atwood TF, Bruggeman AR, et al. Heart Rhythm O2. 2021;2:511&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505208</ArticleId><ArticleId IdType="pubmed">34667967</ArticleId></ArticleIdList></Reference><Reference><Citation>Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. Arenal &#xc1;, &#xc1;vila P, Jim&#xe9;nez-Candil J, et al.  https://doi.org/10.1016/j.jacc.2022.01.050. J Am Coll Cardiol. 2022;79:1441&#x2013;1453.</Citation><ArticleIdList><ArticleId IdType="pubmed">35422240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. Sapp JL, Wells GA, Parkash R, et al.  https://doi.org/10.1056/nejmoa1513614. N Engl J Med. 2016;375:111&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">27149033</ArticleId></ArticleIdList></Reference><Reference><Citation>Live integration of comprehensive cardiac CT with electroanatomical mapping in patients with refractory ventricular tachycardia. Conte E, Carbucicchio C, Catto V, et al. J Cardiovasc Comput Tomogr. 2022;16:262&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">34991995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial. Deyell MW, Doucette S, Parkash R, et al. Europace. 2022;24:1112&#x2013;1118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9301970</ArticleId><ArticleId IdType="pubmed">35030257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38590464</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Comparison of Short-Arm Immobilization and Long-Arm Immobilization in Conservatively Managed Distal Radius Fractures: A Meta-Analysis and Systematic Review.</ArticleTitle><Pagination><StartPage>e55813</StartPage><MedlinePgn>e55813</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e55813</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.55813</ELocationID><Abstract><AbstractText>Distal radius fractures are often treated conservatively with immobilization. Immobilizing above the elbow limits forearm rotation, though recent literature has suggested the effects on radiographic or functional outcomes may be negligible. This systematic review and meta-analysis aimed to analyze the radiographic and functional outcome scores of distal radius fractures managed with short-arm (SA) immobilization and long-arm (LA) immobilization. An electronic systematic search was performed of the PubMed and EMBASE databases from inception to October 5, 2022. All randomized controlled trials (RCTs) involving patients with acute distal radius fractures undergoing nonoperative treatment (involving application/maintenance of immobilization) comparing above-elbow versus below-elbow constructs were included. The outcomes of interest were changes in radiographic parameters (loss of volar tilt [VT], radial height [RH], and radial inclination [RI]), loss of reduction, requirement for surgery, and patient-reported functional outcomes (Disabilities of the Arm, Shoulder, or Hand [DASH] or Quick DASH survey). The Cochrane Risk of Bias Tool 2.0 was used for study quality assessment. The effect size of the interventions was assessed using random effect models to calculate mean differences (MDs) for continuous variables and odds ratios (ORs) for categorical variables. Standardized mean difference (SMD) was calculated for patient-reported functional outcome scores. Nine studies involving 983 cases were included, including 497 SA and 486 LA. No statistically significant differences were observed with regards to VT (<i>P&#xa0;</i>= 0.83), RH (<i>P&#xa0;</i>= 0.81), RI (<i>P&#xa0;</i>= 0.35), loss of reduction (<i>P&#xa0;</i>= 0.33), requirement for surgery (<i>P&#xa0;</i>= 0.33), or patient-reported functional outcomes (<i>P&#xa0;</i>= 0.10). There was no difference in radiographic outcomes, need for surgery, or functional scores among patients treated with SA and LA immobilization. Utilizing SA immobilization is a safe option for conservative management of distal radius fractures and the benefits of mitigating complications associated with LA immobilization may supersede the theoretical limited forearm rotational stability observed with SA immobilization. Further study is required to determine the optimal method of SA immobilization.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Chaudhry et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chaudhry</LastName><ForeName>Yash P</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Orthopedic Surgery, Philadelphia College of Osteopathic Medicine, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morway</LastName><ForeName>Genoveffa R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Orthopedic Surgery, Philadelphia College of Osteopathic Medicine, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadelis</LastName><ForeName>Efstratios A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Orthopedic Surgery, Philadelphia College of Osteopathic Medicine, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doerr</LastName><ForeName>Nikki A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Orthopedic Surgery, Philadelphia College of Osteopathic Medicine, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graf</LastName><ForeName>Kenneth W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Orthopedics and Traumatology, Cooper University Hospital, Camden, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mashru</LastName><ForeName>Rakesh P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Orthopedics and Traumatology, Cooper University Hospital, Camden, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolch</LastName><ForeName>Henry J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Orthopedics and Traumatology, Cooper University Hospital, Camden, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">distal radius fracture</Keyword><Keyword MajorTopicYN="N">immobilization</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">nonoperative treatment</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>3</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38590464</ArticleId><ArticleId IdType="pmc">PMC10999297</ArticleId><ArticleId IdType="doi">10.7759/cureus.55813</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Distal radius fractures in the elderly. Levin LS, Rozell JC, Pulos N. J Am Acad Orthop Surg. 2017;25:179&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">28199291</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspects of current management of distal radius fractures in the elderly individuals. Arora R, Gabl M, Erhart S, Schmidle G, Dallapozza C, Lutz M. Geriatr Orthop Surg Rehabil. 2011;2:187&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3609400</ArticleId><ArticleId IdType="pubmed">23569689</ArticleId></ArticleIdList></Reference><Reference><Citation>Is a short arm cast appropriate for stable distal radius fractures in patients older than 55 years? A randomized prospective multicentre study. Park MJ, Kim JP, Lee HI, Lim TK, Jung HS, Lee JS. J Hand Surg Eur Vol. 2017;42:487&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">28490225</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical outcomes comparison of distal radius fractures between two conservative treatment methods: Below-arm cast versus reverse sugar tong splint. &#xc7;amur S, Bayram S, Polat &#xd6;, &#xd6;zcan MS, Bat&#x131;bay SG. J Orthop Sci. 2021;26:804&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pubmed">32962906</ArticleId></ArticleIdList></Reference><Reference><Citation>Evidence-based review of distal radius fractures. Mauck BM, Swigler CW. Orthop Clin North Am. 2018;49:211&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">29499822</ArticleId></ArticleIdList></Reference><Reference><Citation>Early results after Colles' fracture: functional bracing in supination vs dorsal plaster immobilization. B&#xfc;nger C, S&#xf8;lund K, Rasmussen P. Arch Orthop Trauma Surg (1978) 1984;103:251&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">6391415</ArticleId></ArticleIdList></Reference><Reference><Citation>A comparison of sugar-tong and volar-dorsal splints for provisional immobilization of distal radius fractures in the adult population. Jackson T, Maulsby E, Wilson D, Lalka A, Scott F. Eur J Orthop Surg Traumatol. 2021;31:229&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">32793994</ArticleId></ArticleIdList></Reference><Reference><Citation>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG. Int J Surg. 2010;8:336&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>RoB 2: a revised tool for assessing risk of bias in randomised trials. Sterne JA, Savovi&#x107; J, Page MJ, et al. BMJ. 2019;366:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk-of-bias visualization (Robvis): an R package and shiny web app for visualizing risk-of-bias assessments. McGuinness LA, Higgins JP. Res Synth Methods. 2021;12:55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">32336025</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Savovi&#x107; J, Page MJ, Elbers RG, Sterne JAC. Cochrane Handbook for Systematic Reviews of Interventions Version 6.4. Chichester, UK: John Wiley &amp; Sons; 2023. Chapter 8: Assessing Risk of Bias in a Randomized Trial.</Citation></Reference><Reference><Citation>A comparison of immediate postreduction splinting constructs for controlling initial displacement of fractures of the distal radius: a prospective randomized study of long-arm versus short-arm splinting. Bong MR, Egol KA, Leibman M, Koval KJ. J Hand Surg Am. 2006;31:766&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713840</ArticleId></ArticleIdList></Reference><Reference><Citation>Below-elbow or above-elbow cast for conservative treatment of extra-articular distal radius fractures with dorsal displacement: a prospective randomized trial. Caruso G, Tonon F, Gildone A, et al. J Orthop Surg Res. 2019;14:477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6937655</ArticleId><ArticleId IdType="pubmed">31888682</ArticleId></ArticleIdList></Reference><Reference><Citation>Short arm cast is as effective as long arm cast in maintaining distal radius fracture reduction: results of the SLA-VER noninferiority trial. Dib G, Maluta T, Cengarle M, Bernasconi A, Marconato G, Corain M, Magnan B. World J Orthop. 2022;13:802&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9516624</ArticleId><ArticleId IdType="pubmed">36189333</ArticleId></ArticleIdList></Reference><Reference><Citation>Which immobilization is better for distal radius fracture? A prospective randomized trial. Gamba C, Fernandez FA, Llavall MC, Diez XL, Perez FS. Int Orthop. 2017;41:1723&#x2013;1727.</Citation><ArticleIdList><ArticleId IdType="pubmed">28578470</ArticleId></ArticleIdList></Reference><Reference><Citation>A prospective randomized controlled trial comparing circumferential casting and splinting in displaced Colles fractures. Grafstein E, Stenstrom R, Christenson J, et al. CJEM. 2010;12:192&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">20522283</ArticleId></ArticleIdList></Reference><Reference><Citation>The effect of long arm cast and thumb Spica arm cast in the treatment of patients with distal radius fractures: a randomized clinical trial. Mahmoudi S, Ghane MR, Javadzadeh HR, Hesarikia H, Goodarzi H. Trauma Monthly. 2019;24:0.</Citation></Reference><Reference><Citation>No benefit for elbow blocking on conservative treatment of distal radius fractures: a 6-month randomized controlled trial. Okamura A, de Moraes VY, Neto JR, Tamaoki MJ, Faloppa F, Belloti JC. PLoS One. 2021;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8191961</ArticleId><ArticleId IdType="pubmed">34111160</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical and radiographic comparison of splinting constructs for distal radius fractures: an effort to free the elbow. Stevens NM, Pean C, Norris Z, Tejwani N. J Orthop Trauma. 2022;36:465&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">35234732</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology of distal radius fractures: a detailed survey on a large sample of patients in a suburban area. Candela V, Di Lucia P, Carnevali C, Milanese A, Spagnoli A, Villani C, Gumina S. J Orthop Traumatol. 2022;23:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9428104</ArticleId><ArticleId IdType="pubmed">36040542</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgical plating vs closed reduction for fractures in the distal radius in older patients: a randomized clinical trial. Lawson A, Naylor JM, Buchbinder R, et al. JAMA Surg. 2021;156:229&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7807386</ArticleId><ArticleId IdType="pubmed">33439250</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia and osteoporosis in a geriatric population: Is there a common link? Downey CL, Young A, Burton EF, Graham SM, Macfarlane RJ, Tsapakis EM, Tsiridis E. World J Orthop. 2017;8:412&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5434348</ArticleId><ArticleId IdType="pubmed">28567345</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of dementia and cognitive impairment among older adults with hip fractures. Seitz DP, Adunuri N, Gill SS, Rochon PA. J Am Med Dir Assoc. 2011;12:556&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">21450227</ArticleId></ArticleIdList></Reference><Reference><Citation>Pressure ulcers in orthopaedics. Remaley DT, Jaeblon T. J Am Acad Orthop Surg. 2010;18:568&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pubmed">20810938</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcome assessment in the treatment of A2-OTA type fractures of the distal radius by short arm cast versus long arm cast. Kachooei AR, Peivandi MT, Ebrahimzadeh MH, et al.  http://www.researchgate.net/publication/271292320 Ann Biol Res. 2013;4:247&#x2013;251.</Citation></Reference><Reference><Citation>Cast and splint immobilization: complications. Halanski M, Noonan KJ. J Am Acad Orthop Surg. 2008;16:30&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">18180390</ArticleId></ArticleIdList></Reference><Reference><Citation>Below- or above-elbow immobilization in conservative treatment of distal radius fractures: a systematic review and meta-analysis. Saka N, Hoshika S, Inoue M, Watanabe J, Banno M. Injury. 2022;53:250&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">34961625</ArticleId></ArticleIdList></Reference><Reference><Citation>The effect of immobilization position on functional outcomes and complications associated with the conservative treatment of distal radius fractures: a systematic review. Jamnik AA, Pirkle S, Chacon J, Xiao AX, Wagner ER, Gottschalk MB. J Hand Surg Glob Online. 2022;4:25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8991451</ArticleId><ArticleId IdType="pubmed">35415593</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22492430</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-3084</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Circulation. Arrhythmia and electrophysiology</Title><ISOAbbreviation>Circ Arrhythm Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.</ArticleTitle><Pagination><StartPage>499</StartPage><EndPage>505</EndPage><MedlinePgn>499-505</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCEP.111.968677</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prior studies evaluating the efficacy of catheter ablation of ventricular tachycardia (VT) among patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) have reported varied outcomes. More recently, studies have suggested that an epicardial ablation is necessary for improved outcomes after catheter ablation of VT. The overall objective of the present study was to assess the efficacy of radiofrequency catheter ablation (RFA) of VT in ARVD/C, with particular focus on newer ablation strategies, including epicardial catheter ablation.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">The study population included 87 patients with ARVD/C who underwent a total of 175 RFA procedures between 1992 and 2011 at 80 different electrophysiology centers. Recurrence of VT following RFA and effect of RFA on the burden of VT were assessed. The mean age of the cohort was 38&#xb1;13 years. Over a mean follow-up of 88.3&#xb1;66 months, the overall freedom from VT of the 175 procedures was 47%, 21%, and 15%, at 1, 5, and 10 years, respectively. The cumulative freedom from VT following epicardial RFA was 64% and 45% at 1 and 5 years, respectively, which was significantly longer than endocardial RFA (P=0.021). Survival free of VT among procedures with 3D electroanatomic mapping was significantly longer compared to those without (P=0.016). Burden of VT was reduced irrespective of the ablation strategy (P&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although VT recurrences are common, RFA results in a significant reduction in the burden of VT in patients with ARVD/C. Further, although the use of 3D electroanatomic mapping systems and epicardial ablation strategies are associated with longer survival free of VT, recurrence rates remain considerable.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Philips</LastName><ForeName>Binu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD 21287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madhavan</LastName><ForeName>Srinivasa</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Tichnell</LastName><ForeName>Crystal</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Brittney</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Dalal</LastName><ForeName>Darshan</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Bhonsale</LastName><ForeName>Aditya</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Nazarian</LastName><ForeName>Saman</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Judge</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Stuart D</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Theodore</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Calkins</LastName><ForeName>Hugh</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Tandri</LastName><ForeName>Harikrishna</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL093350</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Arrhythm Electrophysiol</MedlineTA><NlmUniqueID>101474365</NlmUniqueID><ISSNLinking>1941-3084</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019571" MajorTopicYN="N">Arrhythmogenic Right Ventricular Dysplasia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004699" MajorTopicYN="N">Endocardium</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22492430</ArticleId><ArticleId IdType="doi">10.1161/CIRCEP.111.968677</ArticleId><ArticleId IdType="pii">CIRCEP.111.968677</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedBookArticle><BookDocument><PMID Version="1">37703389</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK594736</ArticleId><ArticleId IdType="doi">10.25302/12.2020.CE.13046173</ArticleId></ArticleIdList><Book><Publisher><PublisherName>Patient-Centered Outcomes Research Institute (PCORI)</PublisherName><PublisherLocation>Washington (DC)</PublisherLocation></Publisher><BookTitle book="pcori122020ce1304617">Comparing Surgical Treatments for Cervical Spondylotic Myelopathy&#x2014;The CSM-S Trial</BookTitle><PubDate><Year>2020</Year><Month>12</Month></PubDate><AuthorList Type="authors" CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghogawala</LastName><ForeName>Zoher</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Alan L. and Jacqueline B. Stuart Spine Research Center, Department of Neurosurgery, Lahey Hospital &amp; Medical Center, Burlington, Massachusetts</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Tufts University School of Medicine, Boston, Massachusetts</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunbar</LastName><ForeName>Melissa R.</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Alan L. and Jacqueline B. Stuart Spine Research Center, Department of Neurosurgery, Lahey Hospital &amp; Medical Center, Burlington, Massachusetts</Affiliation></AffiliationInfo></Author></AuthorList><CollectionTitle book="pcoricollect">PCORI Final Research Reports</CollectionTitle><ELocationID EIdType="doi">10.25302/12.2020.CE.13046173</ELocationID><Medium>Internet</Medium></Book><Language>eng</Language><PublicationType UI="D016454">Review</PublicationType><Abstract><AbstractText Label="BACKGROUND">Cervical spondylotic myelopathy (CSM) is the most common cause of spinal cord dysfunction in the world. The optimal surgical approach for treating CSM is not known. For over 60 years, there has been active debate advocating either ventral or dorsal surgical approaches for treating CSM. Most agree that decompression of the spinal cord and fusion of the spinal column results in clinical improvement; however, clinical improvement does not occur in up to 30% of treated patients. Furthermore, complications of surgery are common and differ among the various surgical approaches. There is global variation in how cervical myelopathy is treated. From a clinical effectiveness and safety perspective, there is an urgent need to determine which procedure (ie, ventral or dorsal) is more effective and in which type of patient with cervical myelopathy.</AbstractText><AbstractText Label="OBJECTIVES">The Cervical Spondylotic Myelopathy&#x2013;Surgical (CSM-S) trial was a randomized prospective study conducted to compare the effectiveness of a ventral vs dorsal approach to surgery for patients with multilevel CSM. Another goal of the study was to compare dorsal laminoplasty (DL) with ventral fusion (VF) and dorsal fusion (DF) strategies in a nonrandomized comparison. The trial consisted of 3 specific aims to test the following: <i>Specific Aim 1: </i> 1a.. Whether ventral surgery is associated with superior Physical Component Summary (PCS) scores of the Short-Form Health Survey-36 (SF-36) at 1-year follow-up compared with dorsal (DF or DL) surgery. 1b.. Compared with preoperative baseline status, whether both ventral and dorsal surgery for CSM improve symptoms of spinal cord dysfunction using the modified Japanese Orthopaedic Association (mJOA) score. <i>Specific Aim 2: </i> 2.. From a patient perspective, whether health resource use (out-of-pocket expenses and loss of productivity) for VF, DF, and DL surgery are different. <i>Specific Aim 3: </i> 3.. Whether cervical sagittal balance postoperatively is a significant predictor of SF-36 PCS score outcome.</AbstractText><AbstractText Label="METHODS">We conducted a multicenter prospective randomized controlled trial with patients aged 45 to 80 years with multilevel CSM. Patients were screened and enrolled over a 4-year period (2014-2018) from 16 sites. Patients were randomly assigned to ventral or dorsal surgery (2:3 randomization); the dorsal surgical approach (DF or DL) was at the discretion of surgeon and patient (ie, not randomly assigned). The primary outcome measure was the SF-36 PCS score. A clinically meaningful difference in SF-36 PCS scores is defined as 5 points. Secondary outcome assessments (Neck Disability Index [NDI], mJOA, and EuroQol-5 Dimension [EQ-5D]), along with patient work status, were obtained preoperatively, 3 months, 6 months, and 1 year postoperatively. Complications were assessed by an independent study coordinator, who was blinded to other outcome data at 1 month and at 1 year postoperatively. Health resource use was measured using patient health diaries.</AbstractText><AbstractText Label="RESULTS">A total of 16 sites randomly assigned 163 patients: 63 (38.7%) were randomly assigned to ventral surgery and 100 (61.3%) to dorsal. Average age was 62 years and 49% were male. Baseline characteristics were comparable between ventral and dorsal groups. After random assignment there was a 3.1% crossover rate. A total of 155 (95%) patients provided 1-year follow-up. There were 2.8 levels of spinal canal stenosis in patients enrolled in the study with no significant differences at baseline among the groups. Analysis as randomized demonstrated no difference in improvement in SF-36 PCS score at 1 year between ventral and dorsal surgery (5.90 ventral vs 6.22 dorsal; mean difference = 0.32; 95% CI, &#x2212;2.62 to 3.26; <i>P</i> = .8372). We conducted a planned analysis of patients as treated. Sixty-six patients ultimately underwent VF and 97 underwent dorsal surgery (69 DF and 28 DL). Regardless of strategy, patients demonstrated significant change from baseline in NDI (14.6 VF, 10.4 DF, 17.7 DL), mJOA (2.2 VF, 1.9 DF, 2.4 DL), and EQ-5D scores (0.14 VF, 0.12 DF, 0.19 DL) over a 1-year period postoperatively. DL had a superior primary outcome, the SF-36 PCS score (9.78), compared with VF (5.74; mean difference = 4.04; 95% CI, 0.13-7.95, <i>P</i> = .043) and DF (4.99; mean difference = 4.78; 95% CI, 0.13-9.44; <i>P</i> = .044). Patients undergoing VF and DF surgeries experienced a greater number of complications at 1 month postoperatively than did patients undergoing DL (42.4% VF vs 27.5% DF vs 10.7% DL; <i>P</i> = .007). At 1 year, the proportion of patients working before surgery (68/163) who returned to work was similar among the 3 groups (85.2% VF vs 75.9% DF vs 90.9% DL).</AbstractText><AbstractText Label="CONCLUSIONS">Overall, patients with CSM randomly assigned to a ventral vs dorsal approach had similar 1-year outcomes. Compared with patients who had VF (n = 66) or DF (n = 69), the subgroup of patients, who at the discretion of the surgeon had DL (n = 28), experienced greater improvement in health-related quality of life, fewer complications, and less ongoing outpatient physical therapy and opioid usage at 1 year.</AbstractText><AbstractText Label="LIMITATIONS">The comparison of laminoplasty with DF or VF is limited by the potential for confounding by indication. Although baseline characteristics, including levels of spinal cord compression, were similar among all 3 surgical cohorts, there might have been anatomical features that influenced the choice of surgical approach (DF vs DL) that also influenced study outcomes independently of whether dorsal patients had laminoplasty or laminectomy with fusion (confounding by indication).</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Lahey Hospital &amp; Medical Center. All Rights Reserved.</CopyrightInformation></Abstract></BookDocument><PubmedBookData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37703389</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31195395</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0356</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>3</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Respiration; international review of thoracic diseases</Title><ISOAbbreviation>Respiration</ISOAbbreviation></Journal><ArticleTitle>A Calibration Technique for the Estimation of Lung Volumes in Nonintubated Subjects by Electrical Impedance Tomography.</ArticleTitle><Pagination><StartPage>189</StartPage><EndPage>197</EndPage><MedlinePgn>189-197</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000499159</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Electrical impedance tomography (EIT) is a bedside monitoring technique of the respiratory system that measures impedance changes within the thorax. The close correlation between variations in impedance (&#x394;Z) and lung volumes (Vt) is known. Unless Vt is measured by an external reference (e.g., spirometry), its absolute value (in milliliters) cannot be determined; however, measurement of Vt would be useful in nonintubated subjects.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To validate a simplified and feasible calibration method of EIT, which allows estimation of Vt in nonintubated subjects.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We performed a prospective study on 13 healthy volunteers. Subjects breathed 10 times in a nonexpandable "calibration balloon" with a known volume while wearing the EIT belt. The relationship between &#x394;Z and the balloon volume was calculated (&#x394;Z/Vt). Subsequently, subjects were connected to a mechanical ventilator by a mouthpiece under different settings. Vt was calculated from EIT measurements (VtEIT) by means of the &#x394;Z/Vt coefficient and&#xa0;compared with the value obtained from the ventilator&#xa0;(Vtflow).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a close correlation between Vtflow and VtEIT (r2 = 0.89). The fit equation was VtEIT = 0.9 &#xd7; Vtflow +10.1. The highest correlation was found at positive endexpiratory pressure (PEEP) 0 (mean: VtEIT = 0.93 &#xd7; Vtflow) versus PEEP 8 (mean: VtEIT = 0.8 &#xd7; Vtflow), p = 0.01. No differences in the fit equation were found between pressure support ventilation (PSV) 0 and PSV 8, p = 0.50. Further analysis showed no statistically significant differences between sex, height, and BMI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A simple and fast EIT calibration technique enables reliable, noninvasive monitoring of Vt in nonintubated subjects.</AbstractText><CopyrightInformation>&#xa9; 2019 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sosio</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellani</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy, giacomo.bellani1@unimib.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency and Intensive Care, San Gerardo Hospital, Monza, Italy, giacomo.bellani1@unimib.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villa</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lupieri</LastName><ForeName>Ermes</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauri</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care, and Emergency, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foti</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency and Intensive Care, San Gerardo Hospital, Monza, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Respiration</MedlineTA><NlmUniqueID>0137356</NlmUniqueID><ISSNLinking>0025-7931</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002138" MajorTopicYN="N">Calibration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017097" MajorTopicYN="Y">Electric Impedance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008176" MajorTopicYN="N">Lung Volume Measurements</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="N">Point-of-Care Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014054" MajorTopicYN="N">Tomography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electrical impedance tomography</Keyword><Keyword MajorTopicYN="N">Respiratory monitoring</Keyword><Keyword MajorTopicYN="N">Spontaneous ventilation</Keyword><Keyword MajorTopicYN="N">Tidal volume</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31195395</ArticleId><ArticleId IdType="doi">10.1159/000499159</ArticleId><ArticleId IdType="pii">000499159</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28843606</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Impact of Low Tidal Volumes During One-Lung Ventilation. A Meta-Analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>1767</StartPage><EndPage>1773</EndPage><MedlinePgn>1767-1773</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2017.06.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(17)30541-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The link between ventilation strategies and perioperative outcomes remains one of the fundamental paradigms of thoracic anaesthesia. During one-lung ventilation (OLV), one lung is excluded from gas exchange and ventilation is directed at the dependent lung. The authors hypothesised that the use of low tidal volumes (V<sub>T</sub>) during OLV provides adequate gas exchange and improves postoperative outcome.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Meta-analysis of randomized clinical trials.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Thoracic surgery.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients undergoing OLV.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The authors performed a meta-analysis of all randomized trials on low versus high V<sub>T</sub> during OLV in patients undergoing thoracic surgery. Outcomes of the study were gas exchange and airway pressures during and after OLV, postoperative pulmonary complications (PPCs), and hospital stay (HLOS). Fourteen randomized trials were selected, but only a few of them contained one outcome of interest. Low V<sub>T</sub> was associated with lower arterial oxygen tension, lower airway pressures, and higher arterial carbon dioxide tension at specific time points during OLV. Low V<sub>T</sub> was associated with preserved gas exchange after OLV, lower incidence of pulmonary infiltrations, and acute respiratory distress syndrome. Incidences of PPCs and HLOS were similar.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The use of low V<sub>T</sub> reduces airway pressure but worsens gas exchange during OLV. Preservation of postoperative oxygenation and reduction in infiltrates suggest a lung-protective modality with no demonstrable impact on PPCs and HLOS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Tahan</LastName><ForeName>Mohamed R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Anesthesiology Department, University of Dammam, Al Khubar, Saudi Arabia; Cardiothoracic Anaesthesia and Surgical Intensive Care, Mansoura University, Mansoura City, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Sant'Antonio Hospital, Padova, Italy. Electronic address: laurapasin1704@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marczin</LastName><ForeName>Nandor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Royal Brompton and Harefield NHS Foundation Trust, London, UK; Section of Anaesthesia, Pain Medicine, and Intensive Care, Imperial College London, London, UK; Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="N">Blood Gas Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061810" MajorTopicYN="N">One-Lung Ventilation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">one-lung ventilation</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">ventilator-induced lung injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28843606</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2017.06.015</ArticleId><ArticleId IdType="pii">S1053-0770(17)30541-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29759607</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Amiodarone Discontinuation or Dose Reduction Following Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease.</ArticleTitle><Pagination><StartPage>503</StartPage><EndPage>511</EndPage><MedlinePgn>503-511</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2016.11.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(16)30466-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study sought to examine long-term outcomes in patients with structural heart disease in whom amiodarone was reduced/discontinued after ventricular tachycardia (VT) ablation.</AbstractText><AbstractText Label="BACKGROUND">VT in patients with structural heart disease increases morbidity and mortality. Amiodarone can decrease VT burden, but long-term use may result in organ toxicities and possibly increased mortality. Catheter ablation can also decrease VT burden. Whether amiodarone can be safely reduced/discontinued following ablation remains unknown.</AbstractText><AbstractText Label="METHODS">We studied consecutive patients undergoing VT ablation from 2008 to 2011, typically followed by noninvasive programmed stimulation several days later. Patients were divided into 3 groups by amiodarone use: group A-amiodarone reduced/discontinued following ablation; group B-amiodarone not reduced; group C-not on amiodarone at time of ablation. Baseline characteristics and outcomes were compared between groups.</AbstractText><AbstractText Label="RESULTS">Overall, 231 patients (90% male; mean age: 63.4 &#xb1; 12.9 years; 53.7% ischemic cardiomyopathy) were included (group A: 99 patients; group B: 29 patients; group C: 103 patients). Group B patients were older with more advanced heart failure. Group A patients less frequently had inducible VT at the end of ablation or noninvasive programmed stimulation. In follow-up, 1-year VT-free survival was similar between groups (p&#xa0;= 0.10). Mortality was highest in group B (p&#xa0;&lt; 0.001). Higher amiodarone dose after ablation (hazard ratio: 1.23; 95% confidence interval: 1.03 to 1.47; p&#xa0;= 0.02) was independently associated with shorter time to death.</AbstractText><AbstractText Label="CONCLUSIONS">After successful VT ablation, as confirmed by noninducibility at the end of ablation and noninvasive programmed stimulation, amiodarone may be safely reduced/discontinued without an unacceptable increase in VT&#xa0;recurrence. Reduction/discontinuation of amiodarone should be considered an important goal of VT ablation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jackson J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santangeli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaller</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Supple</LastName><ForeName>Gregory E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutchinson</LastName><ForeName>Mathew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Fermin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixit</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epstein</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callans</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchlinski</LastName><ForeName>Francis E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frankel</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Electrophysiology Section, Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: david.frankel@uphs.upenn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>N3RQ532IUT</RegistryNumber><NameOfSubstance UI="D000638">Amiodarone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Clin Electrophysiol. 2017 May;3(5):512-513. doi: 10.1016/j.jacep.2016.12.014.</RefSource><PMID Version="1">29759608</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000638" MajorTopicYN="N">Amiodarone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057915" MajorTopicYN="N">Drug Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amiodarone</Keyword><Keyword MajorTopicYN="N">antiarrhythmic drug</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29759607</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2016.11.005</ArticleId><ArticleId IdType="pii">S2405-500X(16)30466-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38919405</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1177-5467</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Clinical ophthalmology (Auckland, N.Z.)</Title><ISOAbbreviation>Clin Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Insights into Visual Outcomes and Determinants in Pituitary Adenoma Surgery: A 5-Year Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>1779</StartPage><EndPage>1788</EndPage><MedlinePgn>1779-1788</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/OPTH.S463303</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">To investigate the long-term visual outcome and their determinants after an operation in Thai pituitary adenoma (PA).</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">A retrospective cohort study was conducted on PA patients who underwent surgery at Rajavithi Hospital. Baseline characteristics and visual parameters, including visual acuity (VA) and visual field (VF), were analyzed in relation to the visual prognosis outcome. The outcome was defined as VA improvement at 1-year postoperatively. Visual parameters were measured at each follow-up visit and compared. Factors for improved visual prognosis were evaluated using logistic regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total cohort of 87 patients (64.37% female), 62.07% showed improvement in visual outcome. Most improvement occurred immediately after surgery, evident at the 1-month visit. The mean follow-up time was 47.45 months (&#xb1;28.49 SD), mean difference in VA improvement at 1-year was -0.56 logMAR (95% CI -0.73, -0.47). In multivariable logistic regression model, prolonged onset duration was associated with a reduced odds of improved visual outcome, with an odds ratio (OR) of 0.946 (95% CI 0.899-0.996, p = 0.034). Baseline characteristics, tumor volume, Hardy and Knops classification, and surgical approaches were not identified as significant predictors.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Both TSS and transcranial approaches are effective for pituitary adenoma. A prompt operation is recommended for patients with prolonged onset duration, with thorough discussion on poor postoperative visual outcomes.</AbstractText><CopyrightInformation>&#xa9; 2024 Kemchoknatee et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kemchoknatee</LastName><ForeName>Parinee</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7153-0813</Identifier><AffiliationInfo><Affiliation>Division of Neuro-Ophthalmology, Department of Ophthalmology, Rajavithi Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Rangsit University, Rajavithi Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singhakul</LastName><ForeName>Chotika</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Neuro-Ophthalmology, Department of Ophthalmology, Rajavithi Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arjkongharn</LastName><ForeName>Niracha</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4707-2530</Identifier><AffiliationInfo><Affiliation>Division of Neuro-Ophthalmology, Department of Ophthalmology, Rajavithi Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vongsa</LastName><ForeName>Nattaporn</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0001-7841-0013</Identifier><AffiliationInfo><Affiliation>Division of Neuro-Ophthalmology, Department of Ophthalmology, Rajavithi Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangon</LastName><ForeName>Duanghathai</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0006-4640-0861</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Rangsit University, Rajavithi Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Srisombut</LastName><ForeName>Thansit</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6284-9590</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Sawanpracharak Hospital, Nakhon Sawan, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Clin Ophthalmol</MedlineTA><NlmUniqueID>101321512</NlmUniqueID><ISSNLinking>1177-5467</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Thai</Keyword><Keyword MajorTopicYN="N">pituitary adenoma</Keyword><Keyword MajorTopicYN="N">transcranial surgery</Keyword><Keyword MajorTopicYN="N">transsphenoidal surgery</Keyword><Keyword MajorTopicYN="N">visual outcome</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38919405</ArticleId><ArticleId IdType="pmc">PMC11198008</ArticleId><ArticleId IdType="doi">10.2147/OPTH.S463303</ArticleId><ArticleId IdType="pii">463303</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jho DH, Biller BM, Agarwalla PK, Swearingen B. Pituitary apoplexy: large surgical series with grading system. World Neurosurg. 2014;82(5):781&#x2013;790. doi:10.1016/j.wneu.2014.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2014.06.005</ArticleId><ArticleId IdType="pubmed">24915069</ArticleId></ArticleIdList></Reference><Reference><Citation>Giritharan S, Gnanalingham K, Kearney T. Pituitary apoplexy - bespoke patient management allows good clinical outcome. Clin Endo. 2016;85(3):415&#x2013;422. doi:10.1111/cen.13075</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.13075</ArticleId><ArticleId IdType="pubmed">27038242</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh TD, Valizadeh N, Meyer FB, Atkinson JL, Erickson D, Rabinstein AA. Management and outcomes of pituitary apoplexy. J Neurosurg. 2015;122(6):1450&#x2013;1457. doi:10.3171/2014.10.JNS141204</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2014.10.JNS141204</ArticleId><ArticleId IdType="pubmed">25859804</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanson P, Wolf P. Clinically non-functioning pituitary adenomas. Presse Med. 2021;50(4):104086. doi:10.1016/j.lpm.2021.104086</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2021.104086</ArticleId><ArticleId IdType="pubmed">34718111</ArticleId></ArticleIdList></Reference><Reference><Citation>Uy B, Wilson B, Kim WJ, Prashant G, Bergsneider M. Visual Outcomes After Pituitary Surgery. Neurosurg Clin N Am. 2019;30(4):483&#x2013;489. doi:10.1016/j.nec.2019.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nec.2019.06.002</ArticleId><ArticleId IdType="pubmed">31471055</ArticleId></ArticleIdList></Reference><Reference><Citation>Abouaf L, Vighetto A, Lebas M. Neuro-ophthalmologic exploration in non-functioning pituitary adenoma. Ann Endocrinol. 2015;76(3):210&#x2013;219. doi:10.1016/j.ando.2015.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ando.2015.04.006</ArticleId><ArticleId IdType="pubmed">26070465</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchfelder M, Schlaffer SM, Zhao Y. The optimal surgical techniques for pituitary tumors. Best Pract Res Clin Endocri Metab. 2019;33(2):101299. doi:10.1016/j.beem.2019.101299</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2019.101299</ArticleId><ArticleId IdType="pubmed">31431397</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH, Kang MS, Kim SY, et al. Analysis of factors affecting visual field recovery following surgery for pituitary adenoma. Int Ophthalmol. 2021;41(6):2019&#x2013;2026. doi:10.1007/s10792-021-01757-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-021-01757-6</ArticleId><ArticleId IdType="pubmed">33625650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Zhang ZQ, Ma CY, Chen SH, Chen XJ. Predictive factors of visual function recovery after pituitary adenoma resection: a literature review and Meta-analysis. Int J Ophthalmol. 2017;10(11):1742&#x2013;1750. doi:10.18240/ijo.2017.11.17</Citation><ArticleIdList><ArticleId IdType="doi">10.18240/ijo.2017.11.17</ArticleId><ArticleId IdType="pmc">PMC5686375</ArticleId><ArticleId IdType="pubmed">29181320</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon CH, Hwang SC, Kim BT, Ohn YH, Park TK. Visual prognostic value of optical coherence tomography and photopic negative response in chiasmal compression. Invest Ophthalmol Vis Sci. 2011;52(11):8527&#x2013;8533. doi:10.1167/iovs.11-8034</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.11-8034</ArticleId><ArticleId IdType="pubmed">21960556</ArticleId></ArticleIdList></Reference><Reference><Citation>Grkovi&#x107; D, Bedov T. Outcome of visual acuity after surgical removal of pituitary adenomas. Srp Arh Celok Lek. 2013;141(5&#x2013;6):296&#x2013;303. doi:10.2298/SARH1306296G</Citation><ArticleIdList><ArticleId IdType="doi">10.2298/SARH1306296G</ArticleId><ArticleId IdType="pubmed">23858796</ArticleId></ArticleIdList></Reference><Reference><Citation>Thotakura AK, Patibandla MR, Panigrahi MK, Addagada GC. Predictors of visual outcome with transsphenoidal excision of pituitary adenomas having suprasellar extension: a prospective series of 100 cases and brief review of the literature. Asian J Neurosurg. 2017;12(1):1&#x2013;5. doi:10.4103/1793-5482.149995</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1793-5482.149995</ArticleId><ArticleId IdType="pmc">PMC5379778</ArticleId><ArticleId IdType="pubmed">28413523</ArticleId></ArticleIdList></Reference><Reference><Citation>Butenschoen VM, Schwendinger N, von Werder A, et al. Visual acuity and its postoperative outcome after transsphenoidal adenoma resection. Neurosurg Rev. 2021;44(4):2245&#x2013;2251. doi:10.1007/s10143-020-01408-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10143-020-01408-x</ArticleId><ArticleId IdType="pmc">PMC8338826</ArticleId><ArticleId IdType="pubmed">33040306</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram PR, Sellamuthu P, Ghani ARI. Factors affecting visual field outcome post-surgery in sellar region tumors: retrospective study. Malays J Med Sci. 2017;24(6):58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5771516</ArticleId><ArticleId IdType="pubmed">29379387</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson LN, Guy ME, Krohel GB, Madsen RW. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107(3):521&#x2013;526. doi:10.1016/s0161-6420(99)00133-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0161-6420(99)00133-5</ArticleId><ArticleId IdType="pubmed">10711891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DK, Sung MS, Park SW. Factors influencing visual field recovery after transsphenoidal resection of a pituitary adenoma. Korean J Ophthalmol. 2018;32(6):488&#x2013;496. doi:10.3341/kjo.2017.0094</Citation><ArticleIdList><ArticleId IdType="doi">10.3341/kjo.2017.0094</ArticleId><ArticleId IdType="pmc">PMC6288018</ArticleId><ArticleId IdType="pubmed">30549473</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr G, Hardy J, Comtois R, Beauregard H. Surgical management of giant pituitary adenomas. Can J Neurol Sci. 1990;17(1):62&#x2013;66. doi:10.1017/S0317167100030055</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100030055</ArticleId><ArticleId IdType="pubmed">2311019</ArticleId></ArticleIdList></Reference><Reference><Citation>Knosp E, Kitz K, Steiner E, Matula C. Pituitary adenomas with parasellar invasion. Acta Neurochir Suppl. 1991;53:65&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">1803887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho RW, Huang HM, Ho JT. The influence of pituitary adenoma size on vision and visual outcomes after trans-sphenoidal adenectomy: a report of 78 cases. J Korean Neurosurg Soc. 2015;57(1):23&#x2013;31. doi:10.3340/jkns.2015.57.1.23</Citation><ArticleIdList><ArticleId IdType="doi">10.3340/jkns.2015.57.1.23</ArticleId><ArticleId IdType="pmc">PMC4323501</ArticleId><ArticleId IdType="pubmed">25674340</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagoe NN, Essuman VA, Bankah P, et al. Visual outcome of patients with pituitary adenomas following surgery and its contributory factors at a tertiary hospital in Ghana. Ethiop J Health Sci. 2019;29(1):895&#x2013;902. doi:10.4314/ejhs.v29i1.11</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ejhs.v29i1.11</ArticleId><ArticleId IdType="pmc">PMC6341437</ArticleId><ArticleId IdType="pubmed">30700957</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghvaei M, Sadrehosseini SM, Ostadrahimi N, Sarraf P, Zeinalizadeh M. Preoperative visual evoked potential in the prediction of visual outcome after pituitary macroadenomas surgery. Pituitary. 2019;22(4):397&#x2013;404. doi:10.1007/s11102-019-00969-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11102-019-00969-5</ArticleId><ArticleId IdType="pubmed">31140112</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Uehara H, Takeishi G, et al. Characteristics of preoperative visual disturbance and visual outcome after endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary adenoma in elderly patients. World Neurosurg. 2019;126:e706&#x2013;e12. doi:10.1016/j.wneu.2019.02.132</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2019.02.132</ArticleId><ArticleId IdType="pubmed">30849556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Brommer B, Tian X, et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature. 2020;588:(7836):124&#x2013;9. doi:10.1038/s41586-020-2975-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2975-4</ArticleId><ArticleId IdType="pmc">PMC7752134</ArticleId><ArticleId IdType="pubmed">33268865</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnanalingham KK, Bhattacharjee S, Pennington R, Ng J, Mendoza N. The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psych. 2005;76(3):415&#x2013;419. doi:10.1136/jnnp.2004.035576</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2004.035576</ArticleId><ArticleId IdType="pmc">PMC1739567</ArticleId><ArticleId IdType="pubmed">15716538</ArticleId></ArticleIdList></Reference><Reference><Citation>Luomaranta T, Raappana A, Saarela V, Liinamaa MJ. Factors affecting the visual outcome of pituitary adenoma patients treated with endoscopic transsphenoidal surgery. World Neurosurg. 2017;105:422&#x2013;431. doi:10.1016/j.wneu.2017.05.144</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2017.05.144</ArticleId><ArticleId IdType="pubmed">28583452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Chat Fong N, Mak CH, Steffi CSY, Wing SK, Shing TT, Ching CF. A factorial analysis on visual outcomes of transsphenoidal surgery for pituitary macroadenoma. Asian J Neurosurg. 2022;17(2):280&#x2013;285. doi:10.1055/s-0042-1751011</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1751011</ArticleId><ArticleId IdType="pmc">PMC9473845</ArticleId><ArticleId IdType="pubmed">36120608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cennamo G, Solari D, Montorio D, et al. Early vascular modifications after endoscopic endonasal pituitary surgery: the role of OCT-angiography. PLoS One. 2020;15(10):e0241295. doi:10.1371/journal.pone.0241295</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241295</ArticleId><ArticleId IdType="pmc">PMC7595382</ArticleId><ArticleId IdType="pubmed">33119707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamblin R, Fountas A, Lithgow K, et al. Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. Eur J Endocrinol. 2023;189(1):87&#x2013;95. doi:10.1093/ejendo/lvad070</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejendo/lvad070</ArticleId><ArticleId IdType="pubmed">37345849</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangeul L, Pouchelon G, Telley L, Lefort S, Luscher C, Jabaudon D. A cross-modal genetic framework for the development and plasticity of sensory pathways. Nature. 2016;538(7623):96&#x2013;98. doi:10.1038/nature19770</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19770</ArticleId><ArticleId IdType="pubmed">27669022</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AR, Cooper PR, Kupersmith MJ, Flamm ES, Ransohoff J. Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery. 1985;17(3):446&#x2013;452. doi:10.1227/00006123-198509000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/00006123-198509000-00008</ArticleId><ArticleId IdType="pubmed">4047355</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahangiri A, Lamborn KR, Blevins L, Kunwar S, Aghi MK. Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss. J Neurosurg. 2012;116(2):283&#x2013;289. doi:10.3171/2011.6.JNS101663</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2011.6.JNS101663</ArticleId><ArticleId IdType="pubmed">21740118</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell M. Recovery of vision following transsphenoidal surgery for pituitary adenomas. Br J Neurosurg. 1995;9(3):367&#x2013;374. doi:10.1080/02688699550041377</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02688699550041377</ArticleId><ArticleId IdType="pubmed">7546358</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S, Mishra RC, Gurjar HK, Garg K. Transcranial surgery for pituitary tumors: A &#x201c;community neurosurgery experience&#x201d;. Neurol India. 2022;70(5):2039&#x2013;2046. doi:10.4103/0028-3886.359173</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0028-3886.359173</ArticleId><ArticleId IdType="pubmed">36352606</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Liu H, Man S, et al. Endoscopic vs. microscopic transsphenoidal surgery for the treatment of pituitary adenoma: A meta-analysis. Front Surg. 2021;8:806855. doi:10.3389/fsurg.2021.806855</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2021.806855</ArticleId><ArticleId IdType="pmc">PMC8847202</ArticleId><ArticleId IdType="pubmed">35187049</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S, Wang Z, Kang X, Xin W, Li X. A meta-analysis of endoscopic vs. microscopic transsphenoidal surgery for non-functioning and functioning pituitary adenomas: Comparisons of efficacy and safety. Front Neurol. 2021;12:614382. doi:10.3389/fneur.2021.614382</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.614382</ArticleId><ArticleId IdType="pmc">PMC8021708</ArticleId><ArticleId IdType="pubmed">33833725</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu SY, Du Q, Yao SY, et al. Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis. J Cell Mol Med. 2018;22(3):2023&#x2013;2027. doi:10.1111/jcmm.13445</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13445</ArticleId><ArticleId IdType="pmc">PMC5824383</ArticleId><ArticleId IdType="pubmed">29314715</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Sharma BS. Giant pituitary adenomas--an enigma revisited. Microsurgical treatment strategies and outcome in a series of 250 patients. Br J Neurosurg. 2010;24(1):31&#x2013;39. doi:10.3109/02688690903370305</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02688690903370305</ArticleId><ArticleId IdType="pubmed">20158350</ArticleId></ArticleIdList></Reference><Reference><Citation>Toader C, Bratu BG, Mohan AG, Bentia D, Ciurea AV. comparison of transcranial and transsphenoidal approaches in intra and suprasellar pituitary adenomas - systematic review. Acta Endocrinol. 2023;19(2):228&#x2013;233. doi:10.4183/aeb.2023.228</Citation><ArticleIdList><ArticleId IdType="doi">10.4183/aeb.2023.228</ArticleId><ArticleId IdType="pmc">PMC10614591</ArticleId><ArticleId IdType="pubmed">37908878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cennamo G, Solari D, Montorio D, et al. The role of OCT- angiography in predicting anatomical and functional recovery after endoscopic endonasal pituitary surgery: a 1-year longitudinal study. PLoS One. 2021;16(12):e0260029. doi:10.1371/journal.pone.0260029</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260029</ArticleId><ArticleId IdType="pmc">PMC8638874</ArticleId><ArticleId IdType="pubmed">34855775</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Zhang Z, Ma C, Chen S, Chen X. Quantitative analysis of retinal layers on three-dimensional spectral-domain optical coherence tomography for pituitary adenoma. PLoS One. 2017;12(6):12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5476276</ArticleId><ArticleId IdType="pubmed">28628662</ArticleId></ArticleIdList></Reference><Reference><Citation>Glebauskiene B, Liutkeviciene R, Zlatkute E, Kriauciuniene L, Zaliuniene D. Association of retinal nerve fibre layer thickness with quantitative magnetic resonance imaging data of the optic chiasm in pituitary adenoma patients. J Clin Neurosci. 2018;50:1&#x2013;6. doi:10.1016/j.jocn.2018.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2018.01.005</ArticleId><ArticleId IdType="pubmed">29398198</ArticleId></ArticleIdList></Reference><Reference><Citation>Uvelius E, Valdemarsson S, Bengzon J, Hammar B, Siesj&#xf6; P. Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery. Brain Spine. 2023;3:102667. doi:10.1016/j.bas.2023.102667</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bas.2023.102667</ArticleId><ArticleId IdType="pmc">PMC10668060</ArticleId><ArticleId IdType="pubmed">38020979</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37166486</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2753-670X</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>04</Day></PubDate></JournalIssue><Title>Interdisciplinary cardiovascular and thoracic surgery</Title><ISOAbbreviation>Interdiscip Cardiovasc Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>The impact of mitral valve surgery on ventricular arrhythmias in patients with Barlow's disease: preliminary results of a prospective study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ivad073</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/icvts/ivad073</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Aim of this study was to evaluate arrhythmic burden of patients with Barlow's disease and significant mitral regurgitation (MR) and assess the impact of mitral repair on ventricular arrhythmias (VA) in this group of subjects.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We prospectively included 88 consecutive patients with Barlow's disease referred to our Institution from February 2021 to May 2022. All enrolled patients underwent 24-h Holter monitoring before surgery. Sixty-three of them completed 3&#x2009;months echocardiographic and Holter follow-up. Significant arrhythmic burden was defined as &#x2265;1% premature ventricular beats/24&#x2009;h or at least one episode of non-sustained ventricular tachycardia (VT), VT or ventricular fibrillation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, 29 patients (33%) were arrhythmogenic (AR), while 59 (67%) were not [non-arrhythmogenic (NAR)]. AR subjects tended to be more often females with history of palpitations. Sixty-three patients completed 3-months follow-up. Twenty of them (31.7%) were AR at baseline and 43 (68.3%) were not. Among AR patients, 9 (45%) remained AR after mitral surgery, while 11 (55%) became NAR. Considering NAR subjects at baseline, after mitral valve repair 8 (18.6%) evolved into AR, while 35 (81.4%) remained NAR. A higher prevalence of pre-operative MAD was found among patients experiencing VA reduction if compared with patients who remained arrhythmogenic (63.6% vs 11.1%, P&#x2009;=&#x2009;0.028).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In our experience, one-third of Barlow's patients referred for mitral surgery showed a significant arrhythmic burden. Almost half of the subjects arrhythmogenic at baseline were free from significant VA after mitral repair. However, a minority (18.6%) of subjects without arrhythmic burden at baseline experienced significant VA at follow-up.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ascione</LastName><ForeName>Guido</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7727-0573</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azzola Guicciardi</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorusso</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boccellino</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Echocardiography Laboratory, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapenna</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Forno</LastName><ForeName>Benedetto</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0081-6232</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carino</LastName><ForeName>Davide</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8775-3464</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisogno</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmisano</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1564-2060</Identifier><AffiliationInfo><Affiliation>Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Angelo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Arrhythmology and Cardiac Electrophysiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Bella</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8346-1387</Identifier><AffiliationInfo><Affiliation>Department of Arrhythmology and Cardiac Electrophysiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esposito</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1170-6266</Identifier><AffiliationInfo><Affiliation>Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agricola</LastName><ForeName>Eustachio</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4834-2187</Identifier><AffiliationInfo><Affiliation>Echocardiography Laboratory, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfieri</LastName><ForeName>Ottavio</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-1065-8052</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castiglioni</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maisano</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergara</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Arrhythmology and Cardiac Electrophysiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bonis</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9329-7437</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Interdiscip Cardiovasc Thorac Surg</MedlineTA><NlmUniqueID>9918540787006676</NlmUniqueID><ISSNLinking>2753-670X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Barlow&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Mitral annular disjunction</Keyword><Keyword MajorTopicYN="N">Mitral regurgitation</Keyword><Keyword MajorTopicYN="N">Mitral valve repair</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmias</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37166486</ArticleId><ArticleId IdType="pmc">PMC10212537</ArticleId><ArticleId IdType="doi">10.1093/icvts/ivad073</ArticleId><ArticleId IdType="pii">7160147</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancellotti EP, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA. et al.; On behalf of the Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">23733442</ArticleId></ArticleIdList></Reference><Reference><Citation>Delling FN, Vasan RS.. Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation 2014;129:2158&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052751</ArticleId><ArticleId IdType="pubmed">24867995</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlow JB, Bosman CK, Pocock WA, Marchand P.. Late systolic murmurs and non-ejection (&#x201c;mid-late&#x201d;) systolic clicks. An analysis of 90 patients. Br Heart J 1968;30:203&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC487607</ArticleId><ArticleId IdType="pubmed">5642419</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalliah CJ, Mahajan R, Elliott AD, Haqqani H, Lau DH, Vohra JK. et al. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart 2019;105:144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30242141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram CS, Syed FF, Ferguson ME, Johnson JN, Enriquez-Sarano M, Cetta F. et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol 2013;62:222&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">23563135</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Iliceto S, Thiene G, Perazzolo Marra M.. Mitral valve prolapse, ventricular arrhythmias, and sudden death. Circulation 2019;140:952&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">31498700</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani A. et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation 2015;132:556&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">26160859</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wijngaarden AL, de Riva M, Hiemstra YL, van der Bijl P, Fortuni F, Baxet JJ. et al. Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation. Heart 2021;107:411&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33004425</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant Dit Beaufils AL, Huttin O, Jobbe-Duval A, Senage T, Filippetti L, Piriou N. et al. Replacement myocardial fibrosis in patients with mitral valve prolapse: relation to mitral regurgitation, ventricular remodeling, and arrhythmia. Circulation 2021;143:1763&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">33706538</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthukumar L, Rahman F, Jan MF, Shaikh A, Kalvin L, Dhala A. et al. The Pickelhaube Sign: novel echocardiographic risk marker for malignant mitral valve prolapse syndrome. JACC Cardiovasc Imaging 2017;10:1078&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">28017396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermakov S, Gulhar R, Lim L, Bibby D, Fang Q, Nah G. et al. Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse. Heart 2019;105:1063&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658737</ArticleId><ArticleId IdType="pubmed">30755467</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergara P, Altizio S, Falasconi G, Pannone L, Gulletta S, Della Bella P.. Electrophysiological substrate in patients with Barlow&#x2019;s disease. Arrhythm Electrophysiol Rev 2021;10:33&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8076976</ArticleId><ArticleId IdType="pubmed">33936741</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigioni F, Enriquez-Sarano M, Ling LH, Bailey KR, Seward JB, Tajik AJ. et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 1999;34:2078&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">10588227</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J. et al.; ESC/EACTS Scientific Document Group. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">34453165</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaoka H, Funabashi N, Uehara M, Iida Y, Kobayashi Y.. Diagnostic accuracy of CT for the detection of left ventricular myocardial fibrosis in various myocardial diseases. Int J Cardiol 2017;228:375&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27866030</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantegazza V, Volpato V, Gripari P, Ghulam Ali S, Fusini L, Italiano G. et al. Multimodality imaging assessment of mitral annular disjunction in mitral valve prolapse. Heart 2021;107:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">32723759</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F. et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143:E35&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">33332149</ArticleId></ArticleIdList></Reference><Reference><Citation>Zugwitz D, Fung K, Aung N, Rauseo E, McCracken C, Cooper J. et al. Mitral annular disjunction assessed using CMR imaging: insights from the UK biobank population study. JACC Cardiovasc Imaging 2022;15:1856&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640354</ArticleId><ArticleId IdType="pubmed">36280553</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbag A, Essayagh B, Barrera JDR, Basso C, Berni A, Cosyns B. et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed by the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace 2022;24:1981&#x2013;2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11636573</ArticleId><ArticleId IdType="pubmed">35951656</ArticleId></ArticleIdList></Reference><Reference><Citation>Al'Aref SJ, Ip JE, Markowitz SM, Liu CF, Thomas G, Frenkel D. et al. Differentiation of papillary muscle from fascicular and mitral annular ventricular arrhythmias in patients with and without structural heart disease. Circ Arrhythm Electrophysiol 2015;8:616&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">25925230</ArticleId></ArticleIdList></Reference><Reference><Citation>Naksuk N, Syed FF, Krittanawong C, Anderson MJ, Ebrille E, DeSimone CV. et al. The effect of mitral valve surgery on ventricular arrhythmia in patients with bileaflet mitral valve prolapse. Indian Pacing Electrophysiol J 2016;16:187&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5219837</ArticleId><ArticleId IdType="pubmed">28401865</ArticleId></ArticleIdList></Reference><Reference><Citation>Essayagh B, Sabbag A, Antoine C, Benfari G, Batista R, Yang LT. et al. The mitral annular disjunction of mitral valve prolapse: presentation and outcome. JACC Cardiovasc Imaging 2021;14:2073&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">34147457</ArticleId></ArticleIdList></Reference><Reference><Citation>Essayagh B, Mantovani F, Benfari G, Maalouf JF, Mankad S, Thapa P. et al. Mitral annular disjunction of degenerative mitral regurgitation: three-dimensional evaluation and implications for mitral repair. J Am Soc Echocardiogr 2022;35:165&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">34517112</ArticleId></ArticleIdList></Reference><Reference><Citation>Faletra FF, Leo LA, Paiocchi VL, Schlossbauer SA, Pavon AG, Ho SY. et al. Morphology of mitral annular disjunction in mitral valve prolapse. J Am Soc Echocardiogr 2022;35:176&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">34508838</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocock WA, Barlow JB, Marcus RH, Barlow CW.. Mitral valvuloplasty for life-threatening ventricular arrhythmias in mitral valve prolapse. Am Heart J 1991;121:199&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">1985363</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbadi DR, Purbey R, Poornima IG.. Mitral valve repair is an effective treatment for ventricular arrhythmias in mitral valve prolapse syndrome. Int J Cardiol 2014;177:e16&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25149408</ArticleId></ArticleIdList></Reference><Reference><Citation>Reece IJ, Cooley DA, Painvin GA, Okereke OU, Powers PL, Pechacek LW. et al. Surgical treatment of mitral systolic click syndrome: results in 37 patients. Ann Thorac Surg 1985;39:155&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">3970609</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaidya VR, DeSimone CV, Damle N, Naksuk N, Syed FF, Ackerman MJ. et al. Reduction in malignant ventricular arrhythmia and appropriate shocks following surgical correction of bileaflet mitral valve prolapse. J Interv Card Electrophysiol 2016;46:137&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4925199</ArticleId><ArticleId IdType="pubmed">26768434</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunec-Keller M, Scharf C, Radulovic J, Berdat PA, Attenhofer Jost CH, Vogt P. et al. Barlow disease: effect of mitral valve repair on ventricular arrhythmias in 82 patients in a retrospective long-term study. J Cardiovasc Surg (Torino) 2022;63:514&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">35588312</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27180621</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Substrate modification or ventricular tachycardia induction, mapping, and ablation as the first step? A randomized study.</ArticleTitle><Pagination><StartPage>1589</StartPage><EndPage>1595</EndPage><MedlinePgn>1589-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2016.05.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(16)30275-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">The role and optimal sequence of ventricular tachycardia (VT) induction, mapping, and ablation when combined with substrate modification is unclear.</AbstractText><AbstractText Label="OBJECTIVE">The purpose of this study was to test the benefits of starting the scar-related VT ablation procedure with substrate modification vs the standard protocol of VT induction, mapping, and ablation as the first step.</AbstractText><AbstractText Label="METHODS">Forty-eight consecutive patients with structural heart disease and clinical VTs were randomized to simplified substrate ablation procedure with scar dechanneling as the first step (group 1, n = 24) or standard procedure with VT induction, mapping, and ablation followed by scar dechanneling (group 2, n = 24). Procedure and fluoroscopy times, the need for external cardioversion, acute results, and VT recurrence during follow-up were compared between groups.</AbstractText><AbstractText Label="RESULTS">Thirty-seven patients had ischemic cardiomyopathy, 10 nonischemic cardiomyopathy, and 1 arrhythmogenic cardiomyopathy. Before substrate ablation, 32 VTs were induced and targeted for ablation in 23 patients of group 2. Procedure time (209 &#xb1; 70 minutes vs 262 &#xb1; 63 minutes; P = .009), fluoroscopy time (14 &#xb1; 6 minutes vs 21&#xb1; 9 minutes; P = .005), and electrical cardioversion (25% vs 54%; P = .039) were lower in group 1. After substrate ablation, 16 patients (66%) of group 1 and 12 patients (50%) of group 2 were noninducible (P = .242). End-procedure success (after residual inducible VT ablation) was achieved in 87.5% and 70.8% of patients, respectively (P = .155). There were no differences in VT recurrence rate between groups during a mean follow-up of 22 &#xb1; 14 months (log rank, P = .557).</AbstractText><AbstractText Label="CONCLUSION">VT induction and mapping before substrate ablation prolongs the procedure, radiation exposure, and the need for electrical cardioversion without improving acute results and long-term ablation outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Armenta</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penela</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreu</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evertz</LastName><ForeName>Reinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korshunov</LastName><ForeName>Viatcheslav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassanelli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Mikel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guasch</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbelo</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mar&#xed;a Tolosana</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mont</LastName><ForeName>Lluis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berruezo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arrhythmia Section, Cardiology Department, Thorax Institute, Hospital Cl&#xed;nic, Universitat de Barcelona, Barcelona, Spain,; IDIBAPS (Institut d'Investigaci&#xf3; Agust&#xed; Pi i Sunyer), Barcelona, Spain. Electronic address: berruezo@clinic.ub.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018780" MajorTopicYN="N">Body Surface Potential Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Nonischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Substrate ablation</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27180621</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2016.05.013</ArticleId><ArticleId IdType="pii">S1547-5271(16)30275-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37250262</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0970-9185</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>Journal of anaesthesiology, clinical pharmacology</Title><ISOAbbreviation>J Anaesthesiol Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The respiratory and hemodynamic effects of alveolar recruitment in cirrhotic patients undergoing liver resection surgery: A randomized controlled trial.</ArticleTitle><Pagination><StartPage>113</StartPage><EndPage>120</EndPage><MedlinePgn>113-120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/joacp.joacp_188_21</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="UNASSIGNED">Extensive surgical retraction combined with general anesthesia increase alveolar collapse. The primary aim of our study was to investigate the effect of alveolar recruitment maneuver (ARM) on arterial oxygenation tension (PaO<sub>2</sub>). The secondary aim was to observe its effect on hemodynamics parameters in hepatic patients during liver resection, to investigate its impact on blood loss, postoperative pulmonary complications (PPC), remnant liver function tests, and on the outcome.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">Adult patients scheduled for liver resection were randomized into two groups: ARM (<i>n</i> = 21) and control (C) (<i>n</i> = 21). Stepwise ARM was initiated after intubation and was repeated post-retraction. Pressure-control ventilation mode was adjusted to deliver a tidal volume (<i>V<sub>t</sub></i>) of 6 mL/kg and an inspiratory-to-expiratory time (<i>I:E</i>) ratio of 1:2 with an optimal positive end-expiratory pressure (PEEP) for the ARM group. In the C group, a fixed PEEP (5 cmH<sub>2</sub>O) was applied. Invasive intra-arterial blood pressure (IBP), central venous pressure (CVP), electrical cardiometry (EC), alanine transaminase (ALT, U/L), and aspartate aminotransferase (AST, U/L) blood levels were monitored.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">ARM increased PEEP, dynamic compliances, and arterial oxygenation, but reduced ventilator driving pressure compared to group C <i>(P</i> &lt; 0.01). IBP, cardiac output (CO), and stroke volume variation were not affected by the higher PEEP in the ARM group (<i>P</i> &gt; 0.05) but the CVP increased significantly (<i>P</i> = 0.001). Blood loss was not different between the ARM and C groups (1700 (1150-2000) mL vs 1110 (900-2400) mL, respectively and <i>P</i> = 0.57). ARM reduced postoperative oxygen desaturation; however, it did not affect the increase in remnant liver enzymes and was comparable to group C (ALT, <i>P</i> = 0.54, AST, <i>P</i> = 0.41).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">ARM improved intraoperative lung mechanics and reduced oxygen desaturation episodes in recovery, but not PPC or ICU stay. ARM was tolerated with minimal cardiac and systemic hemodynamic effects.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2022 Journal of Anaesthesiology Clinical Pharmacology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halawa</LastName><ForeName>Naglaa Moustafa</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, National Liver Institute, Menoufia University, Sheeben Elkom City, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Sayed</LastName><ForeName>Amani Mamdouh</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, National Liver Institute, Menoufia University, Sheeben Elkom City, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Ezzeldin Saleh</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, Faculty of Medicine, Menoufia University, Sheeben Elkom City, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khater</LastName><ForeName>Yehia H</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yassen</LastName><ForeName>Khaled Ahmed</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Anaesthesia Department, National Liver Institute, Menoufia University, Sheeben Elkom City, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgery Department, College of Medicine, King Faisal University, Al Hasa, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Anaesthesiol Clin Pharmacol</MedlineTA><NlmUniqueID>9516972</NlmUniqueID><ISSNLinking>0970-9185</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">cardiac</Keyword><Keyword MajorTopicYN="N">cirrhosis</Keyword><Keyword MajorTopicYN="N">hepatectomy</Keyword><Keyword MajorTopicYN="N">liver</Keyword><Keyword MajorTopicYN="N">lung</Keyword><Keyword MajorTopicYN="N">recruitment</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37250262</ArticleId><ArticleId IdType="pmc">PMC10220178</ArticleId><ArticleId IdType="doi">10.4103/joacp.joacp_188_21</ArticleId><ArticleId IdType="pii">JOACP-39-113</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AbdelWahab M, ElHusseiny T, ElHanafy E, El Shobary M, Hamdy E. Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. Langenbecks Arch Surg. 2010;395:625&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">20358380</ArticleId></ArticleIdList></Reference><Reference><Citation>Paugam-Burtz C, Wendon J, Belghiti J, Mantz J. Case scenario:Postoperative liver failure after liver resection in a cirrhotic patient. Anesthesiology. 2012;116:705&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">22293716</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller S, Hillings&#xf8; J, Christensen E, Henriksen JH. Arterial hypoxaemia in cirrhosis:Fact or fiction?Gut. 1998;42:868&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1727147</ArticleId><ArticleId IdType="pubmed">9691928</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhuri AH, Chandra S, Aggarwal G, Uppal R. Predictors of postoperative pulmonary complications after liver resection:Results from a tertiary care intensive care unit. Indian J Crit Care Med. 2014;18:358&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071679</ArticleId><ArticleId IdType="pubmed">24987234</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepere V, Vanier A, Loncar Y, Lemoine L, Vaillant JC, Monsel A, et al. Risk factors for pulmonary complications after hepatic resection:Role of intraoperative. J Crit Care Med. 2014;18:358&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5477742</ArticleId><ArticleId IdType="pubmed">28633644</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Collino F, Maiolo G, Rapetti F, Romitti F, Tonetti T, et al. Positive end-expiratory pressure:How to set it at the individual level. Ann Transl Med. 2017;5:288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5537121</ArticleId><ArticleId IdType="pubmed">28828363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kredel M, Muellenbach RM, Brock RW, Wilckens HH, Brederlau J, Roewer N, et al. Liver dysfunction after lung recruitment manoeuvres during pressure-controlled ventilation in experimental acute respiratory distress. Critical Care. 2007;11:R13. doi:10.1186/cc5674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2151872</ArticleId><ArticleId IdType="pubmed">17261192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Cao R, Li G, Gong T, Ou Y, Huang J. The effect of lung recruitment maneuvers on postoperative pulmonary complications for patients undergoing general anesthesia:A meta-analysis. PLoS One. 2019;14:e0217405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6541371</ArticleId><ArticleId IdType="pubmed">31141541</ArticleId></ArticleIdList></Reference><Reference><Citation>Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P. Continuous positive airway pressure for treatment of postoperative hypoxemia:A randomized controlled trial. JAMA. 2005;293:589&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">15687314</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui N, Arzola C, Teresi J, Fox G, Guerina L, Friedman Z. Predictors of desaturation in the postoperative anesthesia care unit:An observational study. J Clin Anesth. 2013;25:612&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24095886</ArticleId></ArticleIdList></Reference><Reference><Citation>Yassen K, Lotfy M, Miligi A, Sallam A, Hegazi EAR, Afifi M. Patient-controlled analgesia with and without transverse abdominis plane and rectus sheath space block in cirrhotic patients undergoing liver resection. J Anaesthesiol Clin Pharmacol. 2019;35:58&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6495621</ArticleId><ArticleId IdType="pubmed">31057242</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput RS, Das S, Chauhan S, Bisoi AK, Vasdev S. Comparison of cardiac output measurement by noninvasive method with electrical cardiometry and invasive method with thermodilution technique in patients undergoing coronary artery bypass grafting. World J Cardiovasc Surg. 2014;4:123&#x2013;30.</Citation></Reference><Reference><Citation>Abou-Khaber H, El-Mehalawy A, Nasreldin M, El-Far W. Stepwise PEEP elevation with determination of the alveolar collapsing pressure versus sustained lung inflation as a recruitment maneuver in patients with ARDS. J Am Sci. 2011;7:742&#x2013;9.</Citation></Reference><Reference><Citation>Killeen PR. An alternative to null-hypothesis significance tests. Psychol Sci. 2005;16:345&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1473027</ArticleId><ArticleId IdType="pubmed">15869691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial):A multicenter randomised controlled trial. Lancet. 2014;384:495&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C, Suarez-Sipmann F, Tusman G, Le&#xf3;n I, Romero E, Gracia E, et al. Open lung approach versus standard protective strategies:Effects on driving pressure and ventilatory efficiency during anesthesia-A pilot, randomized controlled trial. PLoS One. 2017;12:e0177399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5426745</ArticleId><ArticleId IdType="pubmed">28493943</ArticleId></ArticleIdList></Reference><Reference><Citation>Severgnini P, Selmo G, Lanza C, Chiesa A, Frigerio A, Bacuzzi A, et al. Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function. Anesthesiology. 2013;118:1307&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">23542800</ArticleId></ArticleIdList></Reference><Reference><Citation>Whalen FX, Gajic O, Thompson GB, Kendrick ML, Que FL, Williams BA, et al. The effects of the alveolar recruitment maneuver and positive end-expiratory pressure on arterial oxygenation during laparoscopic bariatric surgery. Anesth Analg. 2006;102:298&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">16368847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Kim WH, Ryu HG, Lee HC, Chung EJ, Yang SM, et al. Stroke volume variation&#x2013;guided versus central venous pressure&#x2013;guided low central venous pressure with milrinone during living donor hepatectomy:A randomized double-blinded clinical trial. Anesth Analg. 2017;125:423&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">28632543</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson CJE, Kosmoliaptsis V, Randle LV, Gimson AE, Brais R, Klinck JR, et al. Normothermic perfusion in the assessment and preservation of declined livers before transplantation:Hyperoxia and vasoplegia-important lessons from the first 12 cases. Transplantation. 2017;101:1084&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642347</ArticleId><ArticleId IdType="pubmed">28437389</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradini SG, Elisei W, De Marco R, Siciliano M, Iappelli M, Pugliese F, et al. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl. 2005;11:140&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">15666381</ArticleId></ArticleIdList></Reference><Reference><Citation>McNally SJ, Revie EJ, Massie LJ, McKeown DW, Parks RW, Garden OJ, et al. Factors in perioperative care that determine blood loss in liver surgery. HPB. 2012;14:236&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3371209</ArticleId><ArticleId IdType="pubmed">22404261</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ES, Hallet J, Hanna SS, Law CH, Coburn NG, Tarshis J, et al. Is central venous pressure still relevant in the contemporary era of liver resection? J Surg Res. 2016;200:139&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">26342837</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack L, Capitanich P, Qui&#xf1;onez E. Liver surgery in the presence of cirrhosis or steatosis:Is morbidity increased? Patient Saf Surg. 2008;2:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390525</ArticleId><ArticleId IdType="pubmed">18439273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackl C, Schlitt HJ, Renner P, Lang SA. Liver surgery in cirrhosis and portal hypertension. World J Gastroenterol. 2016;22:2725&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777995</ArticleId><ArticleId IdType="pubmed">26973411</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Sun YM, Wu FX, Yang LQ, Lu ZJ, Yu WF. Controlled low central venous pressure reduces blood loss and transfusion requirements in hepatectomy. World J Gastroenterol. 2014;20:303&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3886023</ArticleId><ArticleId IdType="pubmed">24415886</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuschwander A, Futier E, Jaber S, Pereira B, Eurin M, Marret E, et al. The effects of intraoperative lung protective ventilation with positive end-expiratory pressure on blood loss during hepatic resection surgery:A secondary analysis of data from a published randomised control trial (IMPROVE) Eur J Anaesthesiol. 2016;33:292&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26716865</ArticleId></ArticleIdList></Reference><Reference><Citation>Halawa NM, Elshafie MA, Fernandez JG, Metwally AA, Yassen KA. Respiratory and hemodynamic effects of prophylactic alveolar recruitment during liver transplant:A randomized controlled trial. Exp Clin Transplant. 2021;19:462&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">33736584</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH. Perioperative lung-protective ventilation strategy reduces postoperative pulmonary complications in patients undergoing thoracic and major abdominal surgery. Korean J Anesthesiol. 2016;69:3&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4754263</ArticleId><ArticleId IdType="pubmed">26885294</ArticleId></ArticleIdList></Reference><Reference><Citation>The PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthiology. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial) multicenter randomized controlled trial. Lancet. 2014;384:495&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682759</ArticleId><ArticleId IdType="pubmed">24894577</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39340514</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8473</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses</Title><ISOAbbreviation>J Perianesth Nurs</ISOAbbreviation></Journal><ArticleTitle>Evaluating Prone Cardiopulmonary Resuscitation Techniques in the Surgical Settings: A Systematic Review of Case Studies.</ArticleTitle><Pagination><StartPage>725</StartPage><EndPage>737</EndPage><MedlinePgn>725-737</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jopan.2024.07.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1089-9472(24)00378-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Examine the prone cardiopulmonary resuscitation techniques in patients undergoing surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using the preferred reporting items for systematic reviews and meta-analysis guidelines, PubMed, CINAHL, Cochrane Library, Google Scholar, and gray literature databases were searched to obtain eligible studies. The methodological quality of the case studies was assessed using the tool proposed by Murad and colleagues. Case reports involving surgical patients in a prone position were included.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">A total of 21 patients undergoing neurologic or spinal surgeries were evaluated. The most common cardiac rhythms observed before arrest were pulseless electrical activity, asystole, ventricular tachycardia, ventricular fibrillation, and sudden bradycardia. The etiologies of the cardiac arrests included venous air embolism, hemorrhagic shock, and hypovolemia. Posterior compressions at T7 to T9 vertebral segment, with or without counterpressure, were immediately instituted. Return of spontaneous circulation was achieved in each instance, with an average time to return of spontaneous circulation of 5.60&#xa0;minutes. Using a quality assessment tool, we determined that all case reports were of high quality and exhibited a low risk of bias.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prone resuscitation during neurosurgical or spinal surgeries has demonstrated promising outcomes. Additionally, the findings of this review further emphasize the need to train health care personnel in the techniques of prone cardiopulmonary resuscitation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Texas Wesleyan University, Fort Worth, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tubog</LastName><ForeName>Tito D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Texas Wesleyan University, Fort Worth, TX. Electronic address: tdtubog@txwes.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Perianesth Nurs</MedlineTA><NlmUniqueID>9610507</NlmUniqueID><ISSNLinking>1089-9472</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="Y">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016684" MajorTopicYN="N">Prone Position</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACLS</Keyword><Keyword MajorTopicYN="N">cardiopulmonary resuscitation</Keyword><Keyword MajorTopicYN="N">chest compression</Keyword><Keyword MajorTopicYN="N">operating room</Keyword><Keyword MajorTopicYN="N">prone CPR</Keyword><Keyword MajorTopicYN="N">prone position</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors of this paper did not receive any funding from any organization&#xa0;commercial and noncommercial and have no relevant financial and nonfinancial relationships to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>2</Day><Hour>3</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>10</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340514</ArticleId><ArticleId IdType="doi">10.1016/j.jopan.2024.07.011</ArticleId><ArticleId IdType="pii">S1089-9472(24)00378-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32452974</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1529-7535</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies</Title><ISOAbbreviation>Pediatr Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Outcomes After In-Hospital Pediatric Recurrent Cardiac Arrests.</ArticleTitle><Pagination><StartPage>e981</StartPage><EndPage>e987</EndPage><MedlinePgn>e981-e987</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PCC.0000000000002427</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The objective of this study is to determine outcomes of recurrent cardiac arrest events in the general pediatric inpatient population.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study of inpatients in a single institution.</AbstractText><AbstractText Label="SETTING">A tertiary care free-standing children's hospital.</AbstractText><AbstractText Label="PATIENTS">All patients less than 18 years old at Seattle Children's Hospital with recurrent cardiac arrest events occurring from January 1, 2010, to March 1, 2018, were included.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Overall survival to hospital discharge was 50% and all survivors had a good neurologic outcome, defined as Pediatric Cerebral Performance Category of 3 or less, or unchanged from baseline. Survival among patients who received extracorporeal life support was 43% and among those who received extracorporeal cardiopulmonary resuscitation, 33%. Initial arrest factors associated with survival included initial rhythm of ventricular tachycardia or ventricular fibrillation, shorter duration of cardiopulmonary resuscitation, and absence of multiple organ dysfunction. Additionally, nonsurvivors had more severe metabolic acidosis in the prearrest and postarrest period.</AbstractText><AbstractText Label="CONCLUSIONS">Survival after pediatric in-hospital recurrent cardiac arrest is higher than previously reported. There is also evidence that initial rhythm other than ventricular tachycardia/ventricular fibrillation and longer duration of cardiopulmonary resuscitation as well as multiple organ dysfunction and more severe lactic acidosis in the peri-arrest period are associated with poor outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Stephanie R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Seattle Children's Hospital, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brogan</LastName><ForeName>Thomas V</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Seattle Children's Hospital, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMullan</LastName><ForeName>D Michael</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Congenital Cardiac Surgery, Seattle Children's Hospital, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Joan S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Seattle Children's Hospital, Seattle, WA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Crit Care Med</MedlineTA><NlmUniqueID>100954653</NlmUniqueID><ISSNLinking>1529-7535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Pediatr Crit Care Med. 2020 Nov;21(11):1012-1013. doi: 10.1097/PCC.0000000000002465.</RefSource><PMID Version="1">33136992</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="Y">Cardiopulmonary Resuscitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32452974</ArticleId><ArticleId IdType="doi">10.1097/PCC.0000000000002427</ArticleId><ArticleId IdType="pii">00130478-202011000-00038</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tress EE, Kochanek PM, Saladino RA, et al. Cardiac arrest in children. J Emerg Trauma Shock. 2010; 3:267&#x2013;272</Citation></Reference><Reference><Citation>de Mos N, van Litsenburg RR, McCrindle B, et al. Pediatric in-intensive-care-unit cardiac arrest: Incidence, survival, and predictive factors. Crit Care Med. 2006; 34:1209&#x2013;1215</Citation></Reference><Reference><Citation>Girotra S, Spertus JA, Li Y, et al.; American Heart Association Get With the Guidelines&#x2013;Resuscitation Investigators. Survival trends in pediatric in-hospital cardiac arrests: An analysis from get with the guidelines-resuscitation. Circ Cardiovasc Qual Outcomes. 2013; 6:42&#x2013;49</Citation></Reference><Reference><Citation>Matos RI, Watson RS, Nadkarni VM, et al.; American Heart Association&#x2019;s Get With The Guidelines&#x2013;Resuscitation (Formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests. Circulation. 2013; 127:442&#x2013;451</Citation></Reference><Reference><Citation>Samson RA, Nadkarni VM, Meaney PA, et al.; American Heart Association National Registry of CPR Investigators. Outcomes of in-hospital ventricular fibrillation in children. N Engl J Med. 2006; 354:2328&#x2013;2339</Citation></Reference><Reference><Citation>Gupta P, Pasquali SK, Jacobs JP, et al.; American Heart Association&#x2019;s Get With the Guidelines&#x2013;Resuscitation Investigators. Outcomes following single and recurrent in-hospital cardiac arrests in children with heart disease: A report from American Heart Association&#x2019;s Get With the Guidelines Registry-Resuscitation. Pediatr Crit Care Med. 2016; 17:531&#x2013;539</Citation></Reference><Reference><Citation>Callaway CW, Donnino MW, Fink EL, et al. Part 8: Post-cardiac arrest care: 2015 American Heart Associaton Guidelines Update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015; 132Suppl 2S465&#x2013;S482</Citation></Reference><Reference><Citation>Brogan TV, Lequier L, Lorusso R. (Eds): Extracorporeal Life Support: The ELSO Red Book. Fifth Edition, Ann Arbor, MI: Extracorporeal Life Support Organization. 2017</Citation></Reference><Reference><Citation>Bembea MM, Ng DK, Rizkalla N, et al.; American Heart Association&#x2019;s Get With The Guidelines &#x2013; Resuscitation Investigators. Outcomes after extracorporeal cardiopulmonary resuscitation of pediatric in-hospital cardiac arrest: A report from the Get With the Guidelines-Resuscitation and the Extracorporeal Life Support Organization Registries. Crit Care Med. 2019; 47:e278&#x2013;e285</Citation></Reference><Reference><Citation>Fiser DH. Assessing the outcome of pediatric intensive care. J Pediatr. 1992; 121:68&#x2013;74</Citation></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfuntion in pediatrics. Pediatr Crit Care Med. 2005; 6:2&#x2013;8</Citation></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2:1&#x2013;138</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38078905</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2023</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">RP88638</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.88638</ELocationID><Abstract><AbstractText>Sudden cardiac death (SCD) from ventricular tachycardia/fibrillation (VT/VF) is a leading cause of death, but current therapies are limited. Despite extensive research on drugs targeting sarcolemmal ion channels, none have proven sufficiently effective for preventing SCD. Sarcoplasmic ryanodine receptor 2 (RyR2) Ca<sup>2+</sup> release channels, the downstream effectors of sarcolemmal ion channels, are underexplored in this context. Recent evidence implicates reactive oxygen species (ROS)-mediated oxidation and hyperactivity of RyR2s in the pathophysiology of SCD. We tested the hypothesis that RyR2 inhibition of failing arrhythmogenic hearts reduces sarcoplasmic Ca<sup>2+</sup> leak and repolarization lability, mitigates VT/VF/SCD and improves contractile function. We used a guinea pig model that replicates key clinical aspects of human nonischemic HF, such as a prolonged QT interval, a high prevalence of spontaneous arrhythmic SCD, and profound Ca<sup>2+</sup> leak via a hyperactive RyR2. HF animals were randomized to receive dantrolene (DS) or placebo in early or chronic HF. We assessed the incidence of VT/VF and SCD (primary outcome), ECG heart rate and QT variability, echocardiographic left ventricular (LV) structure and function, immunohistochemical LV fibrosis, and sarcoplasmic RyR2 oxidation. DS treatment prevented VT/VF and SCD by decreasing dispersion of repolarization and ventricular arrhythmias. Compared to placebo, DS lowered resting heart rate, preserved chronotropic competency during transient &#x3b2;-adrenergic challenge, and improved heart rate variability and cardiac function. Inhibition of RyR2 hyperactivity with dantrolene mitigates the vicious cycle of sarcoplasmic Ca<sup>2+</sup> leak-induced increases in diastolic Ca<sup>2+</sup> and ROS-mediated RyR2 oxidation, thereby reducing repolarization lability and protecting against VT/VF/SCD. Moreover, the consequent increase in sarcoplasmic Ca<sup>2+</sup> load improves contractile function. These potentially life-saving effects of RyR2 inhibition warrant further investigation, such as clinical studies of repurposing dantrolene as a potential new therapy for heart failure and/or SCD.</AbstractText><CopyrightInformation>&#xa9; 2023, Joshi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joshi</LastName><ForeName>Pooja</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1415-1251</Identifier><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estes</LastName><ForeName>Shanea</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeMazumder</LastName><ForeName>Deeptankar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Section of Cardiac Electrophysiology, Division of Cardiology, Department of Internal Medicine, Veterans Affairs Pittsburgh Health System, Pittsburgh, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Cardiac Electrophysiology, Division of Cardiology, Department of Internal Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knollmann</LastName><ForeName>Bjorn C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Swati</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4692-6848</Identifier><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>19SFRN34830019</GrantID><Acronym>AHA</Acronym><Agency>American Heart Association-American Stroke Association</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2 HL157941</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL144980</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2HL157941</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>4R00HK130662</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 HL130662</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019837">Ryanodine Receptor Calcium Release Channel</NameOfSubstance></Chemical><Chemical><RegistryNumber>F64QU97QCR</RegistryNumber><NameOfSubstance UI="D003620">Dantrolene</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 Aug 22:2023.01.29.526151. doi: 10.1101/2023.01.29.526151.</RefSource><PMID Version="1">37662391</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019837" MajorTopicYN="N">Ryanodine Receptor Calcium Release Channel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003620" MajorTopicYN="N">Dantrolene</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Each year, more than 300,000 people experience cardiac arrest or sudden cardiac death. Sudden cardiac death is caused by irregular heartbeats known as ventricular tachycardia or ventricular fibrillation, which prevent the heart from pumping blood. During a regular heart rhythm, the heart muscles contract and relax, regulated by a coordinated rise and fall of calcium ions within heart cells. In the cells of diseased hearts, on the other hand, calcium leaks out of a compartment known as the sarcoplasmic reticulum in an uncontrolled manner. This happens because an ion channel in the membrane of the sarcoplasmic reticulum known as ryanodine receptor 2 becomes hyperactive and releases calcium in an uncontrolled manner. This abnormal calcium release leads to irregular calcium waves, which can make the heart&#x2019;s electrical properties unstable, causing ventricular tachycardia, ventricular fibrillation and sudden cardiac death. Joshi et al. tested whether dantrolene, a molecule that blocks ryanodine receptor 2, can stop calcium leaks from the sarcoplasmic reticulum and prevent lethal arrhythmias and sudden cardiac death in failing hearts. To investigate this, Joshi et al. induced heart failure in guinea pigs that have abnormal heart calcium signalling similar to human heart failure, and then treated the animals with either dantrolene or a placebo. The results indicate that blocking ryanodine receptor 2 hyperactivity with dantrolene prevents lethal arrhythmias and sudden cardiac death by blocking calcium leaks and by preventing the instability of the electrical properties of the heart. Additionally, Joshi et al. found that dantrolene also improved the diseased heart&#x2019;s ability to pump adequate amounts of blood, allowing failing hearts to meet increased cardiovascular demands, and thereby improving the heart&#x2019;s overall function. The proposed studies come from a strong clinical need to improve bad outcomes in people who keep having fatal heart rhythm episodes despite getting the best medical care. Many heart failure patients are plagued by recurrent defibrillator shocks to abort sudden cardiac death from relentless lethal heart rhythms. These shocks are painful, injure the heart, and worsen the quality of life. Unfortunately, management options are extremely limited for these patients. The findings of Joshi et al. indicate that dantrolene may be a potential treatment for people with fatal heart rhythms who are at risk of sudden cardiac death and could have a positive impact on these people&#x2019;s quality of life. However, before this can happen, dantrolene will first have to be thoroughly tested to ensure effectivity and safety in humans. In any case, Joshi et al. have opened a new avenue in the search for medications to treat deadly arrhythmias and sudden cardiac death.</AbstractText><CopyrightInformation>&#xa9; 2023, Joshi et al.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cavia porcellus</Keyword><Keyword MajorTopicYN="N">guinea pig</Keyword><Keyword MajorTopicYN="N">medicine</Keyword><Keyword MajorTopicYN="N">murine</Keyword></KeywordList><CoiStatement>PJ, SE, DD, BK, SD No competing interests declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38078905</ArticleId><ArticleId IdType="pmc">PMC10712946</ArticleId><ArticleId IdType="doi">10.7554/eLife.88638</ArticleId><ArticleId IdType="pii">88638</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e272&#x2013;e391. doi: 10.1161/CIR.0000000000000549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000549</ArticleId><ArticleId IdType="pubmed">29084731</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado FJ, Valdivia HH. Mechanisms of ryanodine receptor 2 dysfunction in heart failure. Nature Reviews. Cardiology. 2020;17:748. doi: 10.1038/s41569-020-00443-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00443-x</ArticleId><ArticleId IdType="pubmed">32901150</ArticleId></ArticleIdList></Reference><Reference><Citation>Azam MA, Chakraborty P, Bokhari MM, Dadson K, Du B, Mass&#xe9; S, Si D, Niri A, Aggarwal AK, Lai PFH, Riazi S, Billia F, Nanthakumar K. Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice. Heart Rhythm O2. 2021;2:733&#x2013;741. doi: 10.1016/j.hroo.2021.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hroo.2021.08.008</ArticleId><ArticleId IdType="pmc">PMC8710625</ArticleId><ArticleId IdType="pubmed">34988524</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz H, Nathoo N, Ajlan M, Toscani B, Sirois C, Bracco D, Kornbluth M, Bernier ML. Bilateral cardiac sympathectomy and extrapericardial coil implantation for the management of electrical storm. JACC. Case Reports. 2021;3:491&#x2013;495. doi: 10.1016/j.jaccas.2020.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.12.029</ArticleId><ArticleId IdType="pmc">PMC8311051</ArticleId><ArticleId IdType="pubmed">34317565</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertero E, Maack C. Calcium signaling and reactive oxygen species in mitochondria. Circulation Research. 2018;122:1460&#x2013;1478. doi: 10.1161/CIRCRESAHA.118.310082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.310082</ArticleId><ArticleId IdType="pubmed">29748369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridge JH, Smolley JR, Spitzer KW. The relationship between charge movements associated with ICa and INa-Ca in cardiac myocytes. Science. 1990;248:376&#x2013;378. doi: 10.1126/science.2158147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2158147</ArticleId><ArticleId IdType="pubmed">2158147</ArticleId></ArticleIdList></Reference><Reference><Citation>Butrous GS, Gough WB, Restivo M, Yang H, el-Sherif N. Adrenergic effects on reentrant ventricular rhythms in subacute myocardial infarction. Circulation. 1992;86:247&#x2013;254. doi: 10.1161/01.cir.86.1.247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.86.1.247</ArticleId><ArticleId IdType="pubmed">1617776</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Wen MS, Lee HL, Chang PC, Wo HT, Yeh SJ, Wu D. Dantrolene suppresses ventricular ectopy and arrhythmogenicity with acute myocardial infarction in a langendorff-perfused pacing-induced heart failure rabbit model. Journal of Cardiovascular Electrophysiology. 2014;25:431&#x2013;439. doi: 10.1111/jce.12320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.12320</ArticleId><ArticleId IdType="pubmed">24237771</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran J, Hinton MJ, R&#xed;os E, Bers DM, Shannon TR. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circulation Research. 2007;100:391&#x2013;398. doi: 10.1161/01.RES.0000258172.74570.e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000258172.74570.e6</ArticleId><ArticleId IdType="pubmed">17234966</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran J, Tang L, Roof SR, Velmurugan S, Millard A, Shonts S, Wang H, Santiago D, Ahmad U, Perryman M, Bers DM, Mohler PJ, Ziolo MT, Shannon TR, Beard N. Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation. PLOS ONE. 2014;9:e87495. doi: 10.1371/journal.pone.0087495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087495</ArticleId><ArticleId IdType="pmc">PMC3911966</ArticleId><ArticleId IdType="pubmed">24498331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cviji&#x107; M, Antoli&#x10d; B, Klemen L, Zupan I. Repolarization heterogeneity in patients with cardiac resynchronization therapy and its relation to ventricular tachyarrhythmias. Heart Rhythm. 2018;15:1784&#x2013;1790. doi: 10.1016/j.hrthm.2018.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2018.06.023</ArticleId><ArticleId IdType="pubmed">29908369</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey S, DeMazumder D, Sidor A, Foster DB, O&#x2019;Rourke B. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure. Circulation Research. 2018;123:356&#x2013;371. doi: 10.1161/CIRCRESAHA.118.312708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.312708</ArticleId><ArticleId IdType="pmc">PMC6057154</ArticleId><ArticleId IdType="pubmed">29898892</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrev D, Wehrens XHT. Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease. Circulation Research. 2014;114:1311&#x2013;1319. doi: 10.1161/CIRCRESAHA.114.300568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.114.300568</ArticleId><ArticleId IdType="pmc">PMC4008932</ArticleId><ArticleId IdType="pubmed">24723656</ArticleId></ArticleIdList></Reference><Reference><Citation>Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW. Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo. New England Journal of Medicine. 1991;324:781&#x2013;788. doi: 10.1056/NEJM199103213241201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199103213241201</ArticleId><ArticleId IdType="pubmed">1900101</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisner DA, Kashimura T, O&#x2019;Neill SC, Venetucci LA, Trafford AW. What role does modulation of the ryanodine receptor play in cardiac inotropy and arrhythmogenesis? Journal of Molecular and Cellular Cardiology. 2009;46:474&#x2013;481. doi: 10.1016/j.yjmcc.2008.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2008.12.005</ArticleId><ArticleId IdType="pubmed">19150449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellison GM, Torella D, Karakikes I, Purushothaman S, Curcio A, Gasparri C, Indolfi C, Cable NT, Goldspink DF, Nadal-Ginard B. Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. The Journal of Biological Chemistry. 2007;282:11397&#x2013;11409. doi: 10.1074/jbc.M607391200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M607391200</ArticleId><ArticleId IdType="pmc">PMC2276680</ArticleId><ArticleId IdType="pubmed">17237229</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer TH, Maier LS, Sossalla S. The ryanodine receptor leak: how a tattered receptor plunges the failing heart into crisis. Heart Failure Reviews. 2013;18:475&#x2013;483. doi: 10.1007/s10741-012-9339-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-012-9339-6</ArticleId><ArticleId IdType="pmc">PMC3677980</ArticleId><ArticleId IdType="pubmed">22932727</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster DB, Liu T, Kammers K, O&#x2019;Meally R, Yang N, Papanicolaou KN, Talbot CC, Jr, Cole RN, O&#x2019;Rourke B. Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death. Journal of Proteome Research. 2016;15:3009&#x2013;3028. doi: 10.1021/acs.jproteome.6b00149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.6b00149</ArticleId><ArticleId IdType="pmc">PMC5779628</ArticleId><ArticleId IdType="pubmed">27399916</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008;118:2022&#x2013;2028. doi: 10.1161/CIRCULATIONAHA.107.748962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.748962</ArticleId><ArticleId IdType="pmc">PMC2777708</ArticleId><ArticleId IdType="pubmed">18955671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez DR, Beigi F, Treuer AV, Hare JM. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. PNAS. 2007;104:20612&#x2013;20617. doi: 10.1073/pnas.0706796104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0706796104</ArticleId><ArticleId IdType="pmc">PMC2154479</ArticleId><ArticleId IdType="pubmed">18077344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez DR, Treuer AV, Castellanos J, Dulce RA, Hare JM. Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure. The Journal of Biological Chemistry. 2010;285:28938&#x2013;28945. doi: 10.1074/jbc.M110.154948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.154948</ArticleId><ArticleId IdType="pmc">PMC2937920</ArticleId><ArticleId IdType="pubmed">20643651</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths EJ. Species dependence of mitochondrial calcium transients during excitation-contraction coupling in isolated cardiomyocytes. Biochemical and Biophysical Research Communications. 1999;263:554&#x2013;559. doi: 10.1006/bbrc.1999.1311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1999.1311</ArticleId><ArticleId IdType="pubmed">10491330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton S, Terentyeva R, Martin B, Perger F, Li J, Stepanov A, Bonilla IM, Knollmann BC, Radwa&#x144;ski PB, Gy&#xf6;rke S, Belevych AE, Terentyev D. Increased RyR2 activity is exacerbated by calcium leak-induced mitochondrial ROS. Basic Research in Cardiology. 2020;115:38. doi: 10.1007/s00395-020-0797-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-020-0797-z</ArticleId><ArticleId IdType="pmc">PMC7244455</ArticleId><ArticleId IdType="pubmed">32444920</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y. Oxidation of Ryanodine Receptors Promotes Ca2+ Leaka. Hypertension. 2021;77:59&#x2013;71. doi: 10.1161/HYPERTENSIONAHA.120.15561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15561</ArticleId><ArticleId IdType="pubmed">33249863</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D, Xiao B, Yang D, Wang R, Choi P, Zhang L, Cheng H, Chen SRW. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR) PNAS. 2004;101:13062&#x2013;13067. doi: 10.1073/pnas.0402388101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402388101</ArticleId><ArticleId IdType="pmc">PMC516517</ArticleId><ArticleId IdType="pubmed">15322274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. The American Journal of Physiology. 1998;275:C1&#x2013;C24. doi: 10.1152/ajpcell.1998.275.1.C1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.1998.275.1.C1</ArticleId><ArticleId IdType="pubmed">9688830</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan A, Suarez-Pierre A, Crawford TC, Zhou X, Russell SD, Berger RD, Calkins H, Baumgartner WA, Tandri H, Mandal K. Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia. The Annals of Thoracic Surgery. 2018;105:e51&#x2013;e53. doi: 10.1016/j.athoracsur.2017.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.09.023</ArticleId><ArticleId IdType="pubmed">29362191</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer GA. Effects of digitalis on myocardial ionic exchange. Circulation. 1972;46:180&#x2013;187. doi: 10.1161/01.cir.46.1.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.46.1.180</ArticleId><ArticleId IdType="pubmed">4263007</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Ting, Takimoto E, Dimaano VL, DeMazumder D, Kettlewell S, Smith G, Sidor A, Abraham TP, O&#x2019;Rourke B. Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure. Circulation Research. 2014;115:44&#x2013;54. doi: 10.1161/CIRCRESAHA.115.303062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.303062</ArticleId><ArticleId IdType="pmc">PMC4219273</ArticleId><ArticleId IdType="pubmed">24780171</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Xiong F, Qi XY, Xiao J, Villeneuve L, Abu-Taha I, Dobrev D, Huang C, Nattel S. Altered calcium handling produces reentry-promoting action potential alternans in atrial fibrillation-remodeled hearts. JCI Insight. 2020;5:e133754. doi: 10.1172/jci.insight.133754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.133754</ArticleId><ArticleId IdType="pmc">PMC7205430</ArticleId><ArticleId IdType="pubmed">32255765</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Yang N, Sidor A, O&#x2019;Rourke B. MCU Overexpression Rescues Inotropy and Reverses Heart Failure by Reducing SR Ca2+ Leak. Circulation Research. 2021;128:1191&#x2013;1204. doi: 10.1161/CIRCRESAHA.120.318562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.318562</ArticleId><ArticleId IdType="pmc">PMC8049980</ArticleId><ArticleId IdType="pubmed">33522833</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLennan DH, Chen SRW. Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes. The Journal of Physiology. 2009;587:3113&#x2013;3115. doi: 10.1113/jphysiol.2009.172155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.172155</ArticleId><ArticleId IdType="pmc">PMC2727021</ArticleId><ArticleId IdType="pubmed">19567749</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner A, Min JY, Haake N, Hirt S, Simon R. Dantrolene sodium improves the force-frequency relationship and beta-adregenic responsiveness in failing human myocardium. European Journal of Heart Failure. 1999;1:177&#x2013;186. doi: 10.1016/s1388-9842(99)00017-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1388-9842(99)00017-3</ArticleId><ArticleId IdType="pubmed">10937928</ArticleId></ArticleIdList></Reference><Reference><Citation>Milberg P, Pott C, Frommeyer G, Fink M, Ruhe M, Matsuda T, Baba A, Klocke R, Quang TH, Nikol S, Stypmann J, Osada N, M&#xfc;ller FU, Breithardt G, Noble D, Eckardt L. Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure. Heart Rhythm. 2012;9:570&#x2013;578. doi: 10.1016/j.hrthm.2011.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2011.11.004</ArticleId><ArticleId IdType="pubmed">22075452</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata S, Minobe W, Bristow MR, Leinwand LA. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circulation Research. 2000;86:386&#x2013;390. doi: 10.1161/01.res.86.4.386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.86.4.386</ArticleId><ArticleId IdType="pubmed">10700442</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto S, O-Uchi J, Kawai M, Hoshina T, Kusakari Y, Komukai K, Sasaki H, Hongo K, Kurihara S. Protein kinase A-dependent phosphorylation of ryanodine receptors increases Ca2+ leak in mouse heart. Biochemical and Biophysical Research Communications. 2009;390:87&#x2013;92. doi: 10.1016/j.bbrc.2009.09.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.09.071</ArticleId><ArticleId IdType="pubmed">19781523</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaienko R, Bovo E, Zima AV. Redox dependent modifications of ryanodine receptor: basic mechanisms and implications in heart diseases. Frontiers in Physiology. 2018;9:1775. doi: 10.3389/fphys.2018.01775.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01775</ArticleId><ArticleId IdType="pmc">PMC6291498</ArticleId><ArticleId IdType="pubmed">30574097</ArticleId></ArticleIdList></Reference><Reference><Citation>Nofi C, Zhang K, Tang YD, Li Y, Migirov A, Ojamaa K, Gerdes AM, Zhang Y. Chronic dantrolene treatment attenuates cardiac dysfunction and reduces atrial fibrillation inducibility in a rat myocardial infarction heart failure model. Heart Rhythm O2. 2020;1:126&#x2013;135. doi: 10.1016/j.hroo.2020.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hroo.2020.03.004</ArticleId><ArticleId IdType="pmc">PMC8183840</ArticleId><ArticleId IdType="pubmed">34113867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogrodnik J, Niggli E. Increased Ca(2+) leak and spatiotemporal coherence of Ca(2+) release in cardiomyocytes during beta-adrenergic stimulation. The Journal of Physiology. 2010;588:225&#x2013;242. doi: 10.1113/jphysiol.2009.181800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.181800</ArticleId><ArticleId IdType="pmc">PMC2821561</ArticleId><ArticleId IdType="pubmed">19900959</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogwizd SM, McKenzie JP, Cain ME. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation. 1998;98:2404&#x2013;2414. doi: 10.1161/01.cir.98.22.2404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.98.22.2404</ArticleId><ArticleId IdType="pubmed">9832485</ArticleId></ArticleIdList></Reference><Reference><Citation>Remme CA, Bezzina CR. Genetic modulation of cardiac repolarization reserve. Heart Rhythm. 2007;4:608&#x2013;610. doi: 10.1016/j.hrthm.2007.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2007.02.025</ArticleId><ArticleId IdType="pubmed">17467629</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson T, Lugo R, Saavedra P, Crossley G, Clair W, Shen S, Estrada JC, Montgomery J, Shoemaker MB, Ellis C, Michaud GF, Lambright E, Kanagasundram AN. Cardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablation. Heart Rhythm. 2018;15:56&#x2013;62. doi: 10.1016/j.hrthm.2017.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2017.09.006</ArticleId><ArticleId IdType="pubmed">28917558</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. The New England Journal of Medicine. 1994;330:235&#x2013;241. doi: 10.1056/NEJM199401273300402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199401273300402</ArticleId><ArticleId IdType="pubmed">8272084</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlotthauer K, Bers DM. Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization: underlying mechanism and threshold for triggered action potentials. Circulation Research. 2000;87:774&#x2013;780. doi: 10.1161/01.res.87.9.774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.87.9.774</ArticleId><ArticleId IdType="pubmed">11055981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedej S. Subclinical abnormalities in sarcoplasmic reticulum ca. Journal of the American College of Cardiology. 2014;63:1569&#x2013;1579. doi: 10.1016/j.jacc.2013.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.11.010</ArticleId><ArticleId IdType="pubmed">24315909</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan J, Kushnir A, Betzenhauser MJ, Reiken S, Li J, Lehnart SE, Lindegger N, Mongillo M, Mohler PJ, Marks AR. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. The Journal of Clinical Investigation. 2010;120:4388&#x2013;4398. doi: 10.1172/JCI32726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI32726</ArticleId><ArticleId IdType="pmc">PMC2993575</ArticleId><ArticleId IdType="pubmed">21099118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shusterman V, Goldberg A, London B. Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans. Circulation. 2006;113:2880&#x2013;2887. doi: 10.1161/CIRCULATIONAHA.105.607895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.607895</ArticleId><ArticleId IdType="pubmed">16785339</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TW. Digitalis: mechanisms of action and clinical use. The New England Journal of Medicine. 1988;318:358&#x2013;365. doi: 10.1056/NEJM198802113180606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198802113180606</ArticleId><ArticleId IdType="pubmed">3277052</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo B, Kovacs T, Lazzara R. Role of calcium loading in early afterdepolarizations generated by Cs+ in canine and guinea pig Purkinje fibers. Journal of Cardiovascular Electrophysiology. 1995;6:796&#x2013;812. doi: 10.1111/j.1540-8167.1995.tb00356.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.1995.tb00356.x</ArticleId><ArticleId IdType="pubmed">8542076</ArticleId></ArticleIdList></Reference><Reference><Citation>Takano M, Kinoshita H, Shioya T, Itoh M, Nakao K, Kuwahara K. Pathophysiological remodeling of mouse cardiac myocytes expressing dominant negative mutant of neuron restrictive silencing factor. Circulation Journal. 2010;74:2712&#x2013;2719. doi: 10.1253/circj.cj-10-0652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.cj-10-0652</ArticleId><ArticleId IdType="pubmed">21048325</ArticleId></ArticleIdList></Reference><Reference><Citation>Terentyev D, Gy&#xf6;rke I, Belevych AE, Terentyeva R, Sridhar A, Nishijima Y, de Blanco EC, Khanna S, Sen CK, Cardounel AJ, Carnes CA, Gy&#xf6;rke S. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure. Circulation Research. 2008;103:1466&#x2013;1472. doi: 10.1161/CIRCRESAHA.108.184457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.108.184457</ArticleId><ArticleId IdType="pmc">PMC3274754</ArticleId><ArticleId IdType="pubmed">19008475</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cardiac Arrhythmia Suppression Trial II Investigators Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The New England Journal of Medicine. 1992;327:227&#x2013;233. doi: 10.1056/NEJM199207233270403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199207233270403</ArticleId><ArticleId IdType="pubmed">1377359</ArticleId></ArticleIdList></Reference><Reference><Citation>Tygesen H, Wettervik C, Claes G, Drott C, Emanuelsson H, Solem J, Lomsky M, R&#xe5;dberg G, Wennerblom B. Long-term effect of endoscopic transthoracic sympathicotomy on heart rate variability and QT dispersion in severe angina pectoris. International Journal of Cardiology. 1999;70:283&#x2013;292. doi: 10.1016/s0167-5273(99)00101-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0167-5273(99)00101-1</ArticleId><ArticleId IdType="pubmed">10501343</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchinoumi H, Yano M, Suetomi T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. Circulation Research. 2010;106:1413&#x2013;1424. doi: 10.1161/CIRCRESAHA.109.209312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.209312</ArticleId><ArticleId IdType="pmc">PMC2862146</ArticleId><ArticleId IdType="pubmed">20224043</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdivia CR, Chu WW, Pu J, Foell JD, Haworth RA, Wolff MR, Kamp TJ, Makielski JC. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. Journal of Molecular and Cellular Cardiology. 2005;38:475&#x2013;483. doi: 10.1016/j.yjmcc.2004.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2004.12.012</ArticleId><ArticleId IdType="pubmed">15733907</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oort RJ, McCauley MD, Dixit SS, Pereira L, Yang Y, Respress JL, Wang Q, De Almeida AC, Skapura DG, Anderson ME, Bers DM, Wehrens XHT. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation. 2010;122:2669&#x2013;2679. doi: 10.1161/CIRCULATIONAHA.110.982298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.982298</ArticleId><ArticleId IdType="pmc">PMC3075419</ArticleId><ArticleId IdType="pubmed">21098440</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi M, Barwad P, Malavassi Corrales FJ, Tandri H, Mathuria N, Shah R, Sorg JM, Gima J, Mandal K, S&#xe0;enz Morales LC, Lokhandwala Y, Shivkumar K. Cardiac sympathetic denervation for refractory ventricular arrhythmias. Journal of the American College of Cardiology. 2017;69:3070&#x2013;3080. doi: 10.1016/j.jacc.2017.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.04.035</ArticleId><ArticleId IdType="pmc">PMC6330109</ArticleId><ArticleId IdType="pubmed">28641796</ArticleId></ArticleIdList></Reference><Reference><Citation>Waddell HMM, Zhang JZ, Hoeksema KJ, McLachlan JJ, McLay JC, Jones PP. Oxidation of RyR2 Has a Biphasic Effect on the Threshold for Store Overload-Induced Calcium Release. Biophysical Journal. 2016;110:2386&#x2013;2396. doi: 10.1016/j.bpj.2016.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.04.036</ArticleId><ArticleId IdType="pmc">PMC4906161</ArticleId><ArticleId IdType="pubmed">27276257</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrens XHT, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. PNAS. 2006;103:511&#x2013;518. doi: 10.1073/pnas.0510113103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0510113103</ArticleId><ArticleId IdType="pmc">PMC1334677</ArticleId><ArticleId IdType="pubmed">16407108</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrens XHT. Leaky ryanodine receptors cause delayed afterdepolarizations and ventricular arrhythmias. European Heart Journal. 2007;28:1054&#x2013;1056. doi: 10.1093/eurheartj/ehm068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehm068</ArticleId><ArticleId IdType="pubmed">17459904</ArticleId></ArticleIdList></Reference><Reference><Citation>Wier WG, Egan TM, L&#xf3;pez&#x2010;L&#xf3;pez JR, Balke CW. Local control of excitation&#x2010;contraction coupling in rat heart cells. The Journal of Physiology. 1994;474:463&#x2013;471. doi: 10.1113/jphysiol.1994.sp020037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1994.sp020037</ArticleId><ArticleId IdType="pmc">PMC1160337</ArticleId><ArticleId IdType="pubmed">8014907</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalin K, Liosis S, Palade E, Fink T, Schierholz S, Sawan N, Eitel C, Heeger CH, Sciacca V, Sano M, Vogler J, Tilz RR. Cardiac sympathetic denervation in patients with nonischemic cardiomyopathy and refractory ventricular arrhythmias: a single-center experience. Clinical Research in Cardiology. 2021;110:21&#x2013;28. doi: 10.1007/s00392-020-01643-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01643-8</ArticleId><ArticleId IdType="pubmed">32328735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamiri N, Mass&#xe9; S, Ramadeen A, Kusha M, Hu X, Azam MA, Liu J, Lai PFH, Vigmond EJ, Boyle PM, Behradfar E, Al-Hesayen A, Waxman MB, Backx P, Dorian P, Nanthakumar K. Dantrolene improves survival after ventricular fibrillation by mitigating impaired calcium handling in animal models. Circulation. 2014;129:875&#x2013;885. doi: 10.1161/CIRCULATIONAHA.113.005443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.005443</ArticleId><ArticleId IdType="pubmed">24403563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoni FL, Simas R, da Silva RG, Breithaupt-Faloppa AC, Coutinho E Silva RDS, Jatene FB, Moreira LFP. Bilateral sympathectomy improves postinfarction left ventricular remodeling and function. The Journal of Thoracic and Cardiovascular Surgery. 2017;153:855&#x2013;863. doi: 10.1016/j.jtcvs.2016.11.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.11.037</ArticleId><ArticleId IdType="pubmed">27998611</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Liu Y, Xiong L, Quan D, He Y, Tang Y, Huang H, Huang C. Cardiac sympathetic afferent denervation protects against ventricular arrhythmias by modulating cardiac sympathetic nerve activity during acute myocardial infarction. Medical Science Monitor. 2019;25:1984&#x2013;1993. doi: 10.12659/MSM.914105.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.914105</ArticleId><ArticleId IdType="pmc">PMC6436207</ArticleId><ArticleId IdType="pubmed">30877783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovascular Research. 2006;71:310&#x2013;321. doi: 10.1016/j.cardiores.2006.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2006.02.019</ArticleId><ArticleId IdType="pubmed">16581043</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25332150</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8167</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of cardiovascular electrophysiology</Title><ISOAbbreviation>J Cardiovasc Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.</ArticleTitle><Pagination><StartPage>151</StartPage><EndPage>157</EndPage><MedlinePgn>151-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jce.12567</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">We conducted this pilot randomized clinical trial to determine the feasibility of a large clinical trial aimed at testing whether early use of catheter ablation of ventricular tachycardia (VT) is superior to antiarrhythmic medications at reducing mortality.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Patients were enrolled at 4 sites if they had ischemic heart disease, an implantable cardioverter defibrillator (ICD), and received &#x2265;1 ICD shock or &#x2265;3 antitachycardia pacing therapies for VT. Patients were randomized to 2 arms: (1) antiarrhythmic medication (n = 14) and (2) catheter ablation (n = 13); patients were followed at 3 and 6 months. Endpoints included recurrent VT, time to first ICD therapy for VT, and death. Of 243 screened patients, 27 were enrolled. Main reasons for screen failures were: (1) patient was already on an antiarrhythmic medication (88 [41%]), (2) VT due to a reversible cause (23 [11%]), and (3) incessant VT (20 [9%]). Fourteen patients had recurrent VT, 8 (62%) in the ablation arm and 6 (43%) in the antiarrhythmic medication arm. Median time to recurrent VT was 75 days (25th, 75th: 51, 89) in the ablation arm and 57 days (30, 145) in the antiarrhythmic arm. Four patients died, 2 in each arm.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This clinical trial shows that most patients in clinical practice have already failed antiarrhythmic drug therapy before catheter ablation is considered, and the VT recurrence rates and death in these patients are high. For a large clinical trial to be feasible, factors limiting early consideration of catheter ablation need to be identified and addressed.</AbstractText><CopyrightInformation>&#xa9; 2014 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Khatib</LastName><ForeName>Sana M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daubert</LastName><ForeName>James P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Anstrom</LastName><ForeName>Kevin J</ForeName><Initials>KJ</Initials></Author><Author ValidYN="Y"><LastName>Daoud</LastName><ForeName>Emile G</ForeName><Initials>EG</Initials></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Saba</LastName><ForeName>Samir</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials></Author><Author ValidYN="Y"><LastName>Reece</LastName><ForeName>Tammy</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Pokorney</LastName><ForeName>Sean D</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Granger</LastName><ForeName>Christopher B</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Paul L</ForeName><Initials>PL</Initials></Author><Author ValidYN="Y"><LastName>Mark</LastName><ForeName>Daniel B</ForeName><Initials>DB</Initials></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>William G</ForeName><Initials>WG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Electrophysiol</MedlineTA><NlmUniqueID>9010756</NlmUniqueID><ISSNLinking>1045-3873</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017147" MajorTopicYN="Y">Defibrillators, Implantable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004554" MajorTopicYN="N">Electric Countershock</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CALYPSO</Keyword><Keyword MajorTopicYN="N">antiarrhythmic medications</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">implantable cardioverter defibrillator</Keyword><Keyword MajorTopicYN="N">ischemic heart disease</Keyword><Keyword MajorTopicYN="N">ventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25332150</ArticleId><ArticleId IdType="doi">10.1111/jce.12567</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15120824</PMID><DateCompleted><Year>2004</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0735-1097</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>9</Issue><PubDate><Year>2004</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Predictors of new malignant ventricular arrhythmias after coronary surgery: a case-control study.</ArticleTitle><Pagination><StartPage>1630</StartPage><EndPage>1638</EndPage><MedlinePgn>1630-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We sought to investigate the relationship between perioperative factors and the occurrence of ventricular tachycardia (VT) and ventricular fibrillation (VF), as well as the impact of VT/VF on early and late mortality.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Both VT and VF are rare but serious complications after coronary artery bypass graft surgery (CABG), and their etiology and implications remain uncertain.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data on 4,411 consecutive patients undergoing CABG (1,154 [25.8%] had off-pump surgery) between April 1996 and September 2001 were extracted from a prospective database and analyzed. Odds ratios (ORs) describing associations between possible risk factors and VT/VF were estimated separately. Factors observed to be significantly associated with VT/VF were further investigated using multivariate logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty-nine patients suffered VT/VF (1.6%). There were 61 (1.4%) in-hospital/30-day deaths, 15 among patients who had postoperative VT/VF (21.7%). Patient factors independently associated with an increase in the odds of VT/VF included age &lt;65 years, female gender, body mass index &lt;25 kg/m(2), unstable angina, moderate or poor ejection fraction, and the need for inotropes and an intra-aortic balloon pump (OR 1.72 to 4.47, p &lt; 0.05). After adjustment, off-pump surgery was associated with a substantial but nonsignificant protective effect against VT/VF (OR 0.53, 95% confidence interval [CI] 0.25 to 1.13; p = 0.10). Actuarial survival at two years was 98.2% among patients who had VT/VF and who survived to discharge/30 days, compared with 97.0% for the control group (adjusted hazard ratio 0.96 (95% CI 0.40 to 2.31, p = 0.92).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of VT/VF is low in patients undergoing coronary surgery but is associated with high in-hospital mortality. The late survival of the discharged VT/VF patients compares favorably with that of controls.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ascione</LastName><ForeName>Raimondo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United Kingdom. R.Ascione@bristol.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeves</LastName><ForeName>Barnaby C</ForeName><Initials>BC</Initials></Author><Author ValidYN="Y"><LastName>Santo</LastName><ForeName>Kirkpatrick</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Nouman</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Angelini</LastName><ForeName>Gianni D</ForeName><Initials>GD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="Y">Coronary Artery Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003327" MajorTopicYN="N">Coronary Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2003</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>5</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>6</Month><Day>21</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>5</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15120824</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2003.11.056</ArticleId><ArticleId IdType="pii">S073510970400350X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18406039</PMID><DateCompleted><Year>2008</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0300-9572</ISSN><JournalIssue CitedMedium="Print"><Volume>78</Volume><Issue>1</Issue><PubDate><Year>2008</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Resuscitation</Title><ISOAbbreviation>Resuscitation</ISOAbbreviation></Journal><ArticleTitle>Anti-arrhythmic and vasopressor medications for the treatment of ventricular fibrillation in severe hypothermia: a systematic review of the literature.</ArticleTitle><Pagination><StartPage>21</StartPage><EndPage>29</EndPage><MedlinePgn>21-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resuscitation.2008.01.025</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the rate of return of spontaneous circulation (ROSC) in animal models performing resuscitation from induced ventricular fibrillation (VF) in severe hypothermia (&lt;30 degrees C).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A medical literature database search from 1966 to present was performed identifying placebo controlled trials using anti-arrhythmic or vasopressor medications to treat ventricular fibrillation in the setting of severe hypothermia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">7 controlled studies were identified (n=117) testing 6 combinations of resuscitative medications. ROSC rates for treatment versus control groups were as follows: amiodarone (6% vs. 18%, p=0.6, n=34), bretylium (35% vs. 35%, p=1.0, n=40), intermediate- and high-dose epinephrine (adrenaline) (36% vs. 27%, p=1.0, n=22), vasopressin (60% vs. 0%, p&lt;0.0001, n=39), vasopressin and amiodarone (0% vs. 0%, p=NS, n=11), low-dose epinephrine and amiodarone (91% vs. 30%, p=0.0075, n=21). Cumulatively, among all studies administering vasopressors, the rate of ROSC was 62% in treatment groups contrasted to 17% in control groups (p&lt;0.0001, n=77).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In controlled animal models of severe hypothermia, ROSC rates for induced ventricular fibrillation are higher with utilization of vasopressor medications. Current guidelines which recommend withholding these medications in the setting of hypothermic cardiac arrest should be re-evaluated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wira</LastName><ForeName>Charles R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Surgery, Section of Emergency Medicine, Yale School of Medicine, New Haven, CT 06510, USA. charles.wira@yale.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Joseph U</ForeName><Initials>JU</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Gerard</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Donnino</LastName><ForeName>Michael W</ForeName><Initials>MW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Resuscitation</MedlineTA><NlmUniqueID>0332173</NlmUniqueID><ISSNLinking>0300-9572</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>11000-17-2</RegistryNumber><NameOfSubstance UI="D014667">Vasopressins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007035" MajorTopicYN="N">Hypothermia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014667" MajorTopicYN="N">Vasopressins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>47</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>4</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>11</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>4</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18406039</ArticleId><ArticleId IdType="doi">10.1016/j.resuscitation.2008.01.025</ArticleId><ArticleId IdType="pii">S0300-9572(08)00110-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34236526</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1862-3514</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>Archives of osteoporosis</Title><ISOAbbreviation>Arch Osteoporos</ISOAbbreviation></Journal><ArticleTitle>The aging spine: the effect of vertebral fragility fracture on sagittal alignment.</ArticleTitle><Pagination><StartPage>109</StartPage><MedlinePgn>109</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11657-021-00975-w</ELocationID><Abstract><AbstractText Label="UNLABELLED">Our study investigates the relationship, in the aging population, between vertebral fractures, spinal alignment, and quality of life. Kyphotic fractures were related to more significant disability and impaired spinopelvic alignment. The spinal malalignment was strongly associated with fractures in the thoracolumbar junction vertebrae and the absence of powerful compensatory mechanisms as thoracic hypokyphosis and lower lumbar hyperlordosis.</AbstractText><AbstractText Label="INTRODUCTION">In adult spine deformity (ASD), the sagittal imbalance is defined by the deformity in the sagittal plane that causes the need for greater use of muscle strength to maintain an upright static posture or walking. Fragility vertebral fractures (VF) and ASD are frequent causes of spinal morbidity in the elderly. The prevalence of both ASD and VF increases with aging. Although these two clinical conditions insist on the same population, little is known about the interactions between sagittal imbalance and vertebral fracture (VF) deformity. The aim of our work is to examine the associations between vertebral fractures, sagittal alignment, and their impact on the quality of life scores in elderly patients.</AbstractText><AbstractText Label="METHODS">A retrospective cohort study of 110 patients of both sexes, from a spine surgery waiting list, with at least one VF with&#x2009;&#x2265;&#x2009;5&#xb0; of kyphosis and a full-standing X-ray.</AbstractText><AbstractText Label="INDEPENDENT VARIABLES">the presence of VF with kyphotic deformity&#x2009;&#x2265;&#x2009;10&#xb0;, fracture level, degree of kyphosis (deformity) of the fracture, number of fractures, spinopelvic angular parameters, demographic parameters, and scales of evaluation of the health-related quality of life.</AbstractText><AbstractText Label="RESULTS">A total of 110 patients with mean age 73.8&#x2009;&#xb1;&#x2009;5.2, of which 70 women (63%) were included in the study. Subjects with at least one VF&#x2009;&#x2265;&#x2009;10&#xb0; presented greater disability and an overall worse sagittal spinal alignment (no VF10&#xb0; vs VF10&#xb0;: TPA 21.30&#x2009;&#xb1;&#x2009;11.5 vs 26.51&#x2009;&#xb1;&#x2009;12.6, p&#x2009;=&#x2009;0.041) and more disability (no VF10&#xb0; vs VF10&#xb0;: ODI 41.91&#x2009;&#xb1;&#x2009;16.9 vs 54.67&#x2009;&#xb1;&#x2009;15.8, p&#x2009;&lt;&#x2009;0.001) than patients with less degree of vertebral deformity. Significant compensatory mechanisms involved the thoracic area and the lower lumbar region.</AbstractText><AbstractText Label="CONCLUSION">Kyphotic VFs were associated with severe alterations of sagittal spine alignment and perceived disability. Subjects with sagittal imbalance have a greater degree of deformity in the thoracolumbar junction area. Thoracic hypokyphosis and lower lumbar hyperlordosis are effective compensatory mechanisms in case of lumbar or thoracic fracture, respectively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Langella</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8639-8480</Identifier><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy. Francesco.langella.md@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balestrino</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurosurgery and Neurotraumatology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damilano</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchinato</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biber</LastName><ForeName>Zeno</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Casa Di Cura 'Sileno E Anna Rizzola', San Don&#xe0; di Piave, Venezia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paoletta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iolascon</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamartina</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peretti</LastName><ForeName>Giuseppe M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berjano</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Osteoporos</MedlineTA><NlmUniqueID>101318988</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="Y">Spinal Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adult spine deformity</Keyword><Keyword MajorTopicYN="N">Compensatory mechanism</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Sagittal imbalance</Keyword><Keyword MajorTopicYN="N">Spine osteoarthritis</Keyword><Keyword MajorTopicYN="N">Vertebral deformity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34236526</ArticleId><ArticleId IdType="doi">10.1007/s11657-021-00975-w</ArticleId><ArticleId IdType="pii">10.1007/s11657-021-00975-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bess S, Line B, Fu K-M et al (2016) The health impact of symptomatic adult spinal deformity: comparison of deformity types to United States population norms and chronic diseases. Spine 41:224&#x2013;233. https://doi.org/10.1097/BRS.0000000000001202</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000001202</ArticleId><ArticleId IdType="pubmed">26571174</ArticleId><ArticleId IdType="pmc">4718181</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab F, Dubey A, Gamez L et al (2005) Adult scoliosis: prevalence, SF-36, and nutritional parameters in an elderly volunteer population. Spine 30:1082&#x2013;1085. https://doi.org/10.1097/01.brs.0000160842.43482.cd</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.brs.0000160842.43482.cd</ArticleId><ArticleId IdType="pubmed">15864163</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab F, Ungar B, Blondel B et al (2012) Scoliosis research society&#x2014;Schwab adult spinal deformity classification: a validation study. Spine 37:1077&#x2013;1082. https://doi.org/10.1097/BRS.0b013e31823e15e2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e31823e15e2</ArticleId><ArticleId IdType="pubmed">22045006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafage V, Schwab F, Patel A et al (2009) Pelvic tilt and truncal inclination: two key radiographic parameters in the setting of adults with spinal deformity. Spine 34:E599-606. https://doi.org/10.1097/BRS.0b013e3181aad219</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e3181aad219</ArticleId><ArticleId IdType="pubmed">19644319</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CS, Lee CK, Kim YT et al (2001) Dynamic sagittal imbalance of the spine in degenerative flat back: significance of pelvic tilt in surgical treatment. Spine 26:2029&#x2013;2035. https://doi.org/10.1097/00007632-200109150-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200109150-00017</ArticleId><ArticleId IdType="pubmed">11547204</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellis&#xe9; F, Vila-Casademunt A, Issa D et al (2014) Impact on health related quality of life of adult spinal deformity (ASD) compared with other chronic conditions. Eur Spine J 23:S493</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-3036-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnell O, Kanis JA (2004) An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15:897&#x2013;902. https://doi.org/10.1007/s00198-004-1627-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-004-1627-0</ArticleId><ArticleId IdType="pubmed">15490120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, McCloskey EV, Johansson H et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23&#x2013;57. https://doi.org/10.1007/s00198-012-2074-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-012-2074-y</ArticleId><ArticleId IdType="pubmed">23079689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Lee HS, Shin JK et al (2013) Prediction of sagittal balance in patients with osteoporosis using spinopelvic parameters. Eur Spine J 22:1053&#x2013;1058. https://doi.org/10.1007/s00586-013-2672-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-2672-1</ArticleId><ArticleId IdType="pubmed">23354778</ArticleId><ArticleId IdType="pmc">3657054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-L, Shi L-T, Tang P-F et al (2017) Correlation analysis of osteoporotic vertebral compression fractures and spinal sagittal imbalance. Orthopade 46:249&#x2013;255. https://doi.org/10.1007/s00132-016-3359-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00132-016-3359-1</ArticleId><ArticleId IdType="pubmed">28116458</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey JH, Lane JM (1985) Structural scoliosis in osteoporotic women. Clin Orthop Relat Res 195:216&#x2013;223. https://doi.org/10.1097/00003086-198505000-00025</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003086-198505000-00025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismael M, Villafa&#xf1;e JH, Cabitza F et al (2018) Spine surgery registries: hope for evidence-based spinal care? J Spine Surg (Hong Kong) 4:456&#x2013;458. https://doi.org/10.21037/jss.2018.05.19</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jss.2018.05.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairbank JC, Pynsent PB (2000) The Oswestry disability index. Spine 25:2940&#x2013;52. discussion 2952. https://doi.org/10.1097/00007632-200011150-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200011150-00017</ArticleId><ArticleId IdType="pubmed">11074683</ArticleId></ArticleIdList></Reference><Reference><Citation>Langella F, Barletta P, Baroncini A et al (2021) The use of electronic PROMs provides same outcomes as paper version in a spine surgery registry. Results from a prospective cohort study. Eur Spine J. https://doi.org/10.1007/s00586-021-06834-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-021-06834-z</ArticleId><ArticleId IdType="pubmed">34081185</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannion AF, Vila-Casademunt A, Domingo-S&#xe0;bat M et al (2016) The Core Outcome Measures Index (COMI) is a responsive instrument for assessing the outcome of treatment for adult spinal deformity. Eur Spine J 25:2638&#x2013;2648. https://doi.org/10.1007/s00586-015-4292-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-015-4292-4</ArticleId><ArticleId IdType="pubmed">26519374</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert TJ, Purtill J, Mesa J et al (1995) Health outcome assessment before and after adult deformity surgery: a prospective study. Spine 20:2002&#x2013;2005. https://doi.org/10.1097/00007632-199509150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199509150-00009</ArticleId><ArticleId IdType="pubmed">8578376</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjano P, Damilano M, Bozzaro M et al (2013) Standing lateral lumbar spine and pelvis (SLLP) radiograph: a screening, reduced radiation method, for sagittal imbalance. Eur Spine J 22 Suppl 6:S842&#x2013;S846. https://doi.org/10.1007/s00586-013-3026-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-3026-8</ArticleId><ArticleId IdType="pubmed">24072339</ArticleId></ArticleIdList></Reference><Reference><Citation>Langella F, Villafa&#xf1;e JH, Damilano M et al (2017) Predictive accuracy of surgimap surgical planning for sagittal imbalance: a cohort study. Spine 42(22):E1297&#x2013;E1304. https://doi.org/10.1097/BRS.0000000000002230</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000002230</ArticleId><ArticleId IdType="pubmed">28542103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamartina C, Berjano P (2014) Classification of sagittal imbalance based on spinal alignment and compensatory mechanisms. Eur Spine J 23:1177&#x2013;1189. https://doi.org/10.1007/s00586-014-3227-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-014-3227-9</ArticleId><ArticleId IdType="pubmed">24682355</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu DC, Chou D (2007) Flatback syndrome - iatrogenic etiologie through previous fusion. Neurosurg Clin N Am 18:289&#x2013;294</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nec.2007.01.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagrone MO, Bradford DS, Moe JH et al (1988) Treatment of symptomatic flatback after spinal fusion. J Bone Joint Surg Am 70:569&#x2013;580</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-198870040-00014</ArticleId></ArticleIdList></Reference><Reference><Citation>Farcy J-PC, Schwab FJ (1997) Management of flatback and related kyphotic decompensation syndromes. Spine 22:2452&#x2013;2457. https://doi.org/10.1097/00007632-199710150-00025</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199710150-00025</ArticleId><ArticleId IdType="pubmed">9355229</ArticleId></ArticleIdList></Reference><Reference><Citation>Boos N, Weissbach S, Rohrbach H et al (2002) Classification of age-related changes in lumbar intervertebral discs. Spine 27:2631&#x2013;2644. https://doi.org/10.1097/00007632-200212010-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200212010-00002</ArticleId><ArticleId IdType="pubmed">12461389</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelb DEE, Lenke LGG, Bridwell KHH et al (1995) An analysis of sagittal spinal alignment in 100 asymptomatic middle and older aged volunteers. Spine 20:1351&#x2013;1358</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199520120-00005</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkkola R, Kormano M (1992) Lumbar disc and back muscle degeneration on MRI: correlation to age and body mass. J Spinal Disord 5:86&#x2013;92. https://doi.org/10.1097/00002517-199203000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002517-199203000-00011</ArticleId><ArticleId IdType="pubmed">1571617</ArticleId></ArticleIdList></Reference><Reference><Citation>Boden S, Davis D, Dina T et al (1990) Abnormal magnetic-resonance scans of the cervical spine in asymptomatic subjects. J Bone Jt Surg 72:403&#x2013;408</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-199072030-00013</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrey C, Roussouly P, Perrin G, Le Huec JC (2011) Sagittal balance disorders in severe degenerative spine. Can we identify the compensatory mechanisms? Eur Spine J 20:1&#x2013;8. https://doi.org/10.1007/s00586-011-1930-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-011-1930-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Korovessis P, Dimas A, Iliopoulos P, Lambiris E (2002) Correlative analysis of lateral vertebral radiographic variables and medical outcomes study short-form health survey: a comparative study in asymptomatic volunteers versus patients with low back pain. J Spinal Disord Tech 15:384&#x2013;390. https://doi.org/10.1097/00024720-200210000-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024720-200210000-00007</ArticleId><ArticleId IdType="pubmed">12394662</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson RP, Peterson MD, McManus AC, Hales C (1998) Compensatory spinopelvic balance over the hip axis and better reliability in measuring lordosis to the pelvic radius on standing lateral radiographs of adult volunteers and patients. Spine 23:1750&#x2013;1767. https://doi.org/10.1097/00007632-199808150-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199808150-00008</ArticleId><ArticleId IdType="pubmed">9728376</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Huec JC, Aunoble S, Philippe L, Nicolas P (2011) Pelvic parameters: origin and significance. Eur Spine J 20:1&#x2013;8. https://doi.org/10.1007/s00586-011-1940-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-011-1940-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrey C, Jund J, Noseda O, Roussouly P (2007) Sagittal balance of the pelvis-spine complex and lumbar degenerative diseases. A comparative study about 85 cases. Eur Spine J 16:1459&#x2013;1467. https://doi.org/10.1007/s00586-006-0294-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-006-0294-6</ArticleId><ArticleId IdType="pubmed">17211522</ArticleId><ArticleId IdType="pmc">2200735</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson RP, McManus AC (1994) Radiographic analysis of sagittal plane alignment and balance in standing volunteers and patients with low back pain matched for age, sex, and size A prospective controlled clinical study. Spine 19:1611&#x2013;1618</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199407001-00010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafage R, Schwab F, Challier V et al (2016) Defining spino-pelvic alignment thresholds: should operative goals in adult spinal deformity surgery account for age? Spine 41(1):62&#x2013;68. https://doi.org/10.1097/BRS.0000000000001171</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000001171</ArticleId><ArticleId IdType="pubmed">26689395</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnake KJ, Blattert TR, Hahn P et al (2018) Classification of osteoporotic thoracolumbar spine fractures: recommendations of the spine section of the German Society for Orthopaedics and Trauma (DGOU). Glob Spine J 8:46S-49S. https://doi.org/10.1177/2192568217717972</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568217717972</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung HJ, Park Y-S, Seo H-Y et al (2017) Quality of life in patients with osteoporotic vertebral compression fractures. J Bone Metab 24:187. https://doi.org/10.11005/jbm.2017.24.3.187</Citation><ArticleIdList><ArticleId IdType="doi">10.11005/jbm.2017.24.3.187</ArticleId><ArticleId IdType="pubmed">28955695</ArticleId><ArticleId IdType="pmc">5613024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall SE, Criddle RA, Comito TL, Prince RL (1999) A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int 9:508&#x2013;515. https://doi.org/10.1007/s001980050178</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001980050178</ArticleId><ArticleId IdType="pubmed">10624458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36093646</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-7401</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Technology and health care : official journal of the European Society for Engineering and Medicine</Title><ISOAbbreviation>Technol Health Care</ISOAbbreviation></Journal><ArticleTitle>Intraoperative lung-protective ventilation adjusting tidal volume to a plateau pressure restriction in elderly patients: A randomized controlled clinical trial.</ArticleTitle><Pagination><StartPage>539</StartPage><EndPage>551</EndPage><MedlinePgn>539-551</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/THC-220144</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lung-protective ventilation (LPV) strategies have been considered as best practice in the care of critically patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to investigate the effects individualized perioperative LPV with a positive end-expiratory pressure (PEEP) and low tidal volumes (VT) based on a target airway plateau pressure (Pplat) in patients during and after an operation compared with conventional ventilation in elderly patients during abdominal surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty-one elderly patients with American Society of Anesthesiologists (ASA) I to III undergoing open abdominal surgery received either conventional ventilation (8 ml/kg-1VT; CV group) or LPV (VT was adjusted to a target Pplat [&#x2a7d; 20 cm H2O]) in the volume-controlled mode with PEEP (9 cm H2O; LPV group) ventilation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in the LPV group showed significantly lower pH values (7.30 &#xb1; 0.07 vs. 7.38 &#xb1; 0.05, P&lt; 0.001) and respiratory indexes than that of CV group (0.806 &#xb1; 0.339 vs. 0.919 &#xb1; 0.300, P= 0.043) at the end of surgery. Compared with the CV group, the dynamic lung compliance (33.39 &#xb1; 3.163 vs. 30.15 &#xb1; 2.572, P&lt; 0.001) was significantly higher, and the body temperature remained significantly more favorable in the LPV group (35.9 &#xb1; 0.3 vs. 35.1 &#xb1; 0.4, P&lt; 0.001). Patients in the LPV group had significantly faster postoperative recovery than that of the CV group (P&lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study showed that LPV could be beneficial for ventilation, core body temperature, and postoperative recovery in elderly patients with healthy lungs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Chunshan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Peng</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiang</ForeName><Initials>X</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Technol Health Care</MedlineTA><NlmUniqueID>9314590</NlmUniqueID><ISSNLinking>0928-7329</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="Y">Positive-Pressure Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Tidal volume</Keyword><Keyword MajorTopicYN="N">airway plateau pressure</Keyword><Keyword MajorTopicYN="N">lung function</Keyword><Keyword MajorTopicYN="N">positive end-expiratory pressure</Keyword><Keyword MajorTopicYN="N">postoperative recovery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>12</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36093646</ArticleId><ArticleId IdType="doi">10.3233/THC-220144</ArticleId><ArticleId IdType="pii">THC220144</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32034474</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2218</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Surgical endoscopy</Title><ISOAbbreviation>Surg Endosc</ISOAbbreviation></Journal><ArticleTitle>Postoperative drain after transoral endoscopic thyroidectomy vestibular approach (TOETVA) with single incision.</ArticleTitle><Pagination><StartPage>358</StartPage><EndPage>366</EndPage><MedlinePgn>358-366</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00464-020-07408-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To find the optimal size of a drain for the reliable drainage and the best cosmetic result in TOETVA. To explore the normal drainage flow rate after TOETVA.</AbstractText><AbstractText Label="METHODS">A prospective randomized controlled trial was performed in a single center from December 2016 to December 2018. One hundred and fifty-three (153) patients had TOETVA with a single incision and were randomly divided into two groups. Self-made drainage tubes with a small diameter (outer diameter 2.0&#xa0;mm, inner diameter 1.0&#xa0;mm) were used in 80 patients (experimental group). No.&#xa0;8 tubes were used in 73 patients (control group). The clinical characteristics and results between both groups were compared by t test or chi-square test, and the results of normal drainage flow rate were calculated.</AbstractText><AbstractText Label="RESULTS">The experimental group had a longer intraoperative tube-inserting time, compared with the control group (9.5&#x2009;&#xb1;&#x2009;2.5&#xa0;min vs. 5.6&#x2009;&#xb1;&#x2009;1.4&#xa0;min, p&#x2009;=&#x2009;0.001), a smaller scar six months after the operation (1.8&#x2009;&#xb1;&#x2009;2.3&#xa0;mm vs. 3.1&#x2009;&#xb1;&#x2009;2.6&#xa0;mm, p&#x2009;=&#x2009;0.002), and a lower Vancouver Scar Scale score at both one month (3.20&#x2009;&#xb1;&#x2009;1.44 vs. 4.19&#x2009;&#xb1;&#x2009;1.92, p&#x2009;=&#x2009;0.001) and six months after the operation(1.43&#x2009;&#xb1;&#x2009;1.84 vs. 2.40&#x2009;&#xb1;&#x2009;2.37, p&#x2009;=&#x2009;0.006). The drainage volume, pain score on the first day, postoperative complications (tube blockage, air leakage, subcutaneous hydrops, hematoma, regional infection), and the extubation time were not significantly different. The average drainage of 148 patients without postoperative complications was 78.3&#x2009;&#xb1;&#x2009;10.9&#xa0;ml. The cumulative drainage within 8&#xa0;h, and 32&#xa0;h after the operation accounted for 53.2% and 91.9% of the total drainage, respectively. The residual drainage at 32&#xa0;h was estimated to be 6.5&#x2009;&#xb1;&#x2009;2.9&#xa0;ml (P95&#x2009;=&#x2009;11.0&#xa0;ml). A linear regression equation between total volume (V<sub>t</sub>) and the size of resected tissue (S) was established: V<sub>t</sub>&#x2009;=&#x2009;1.625&#xa0;S&#x2009;+&#x2009;56.604 (p&#x2009;=&#x2009;0.0001).</AbstractText><AbstractText Label="CONCLUSION">In TOETVA, a small drain can provide a good cosmetic appearance and reliable drainage. The main exudation period of the wound is within 8&#xa0;h after the operation. If a residual volume of less than 11&#xa0;ml is considered to be self-absorbable, the shortest safe extubation point for 95% of patients should be 32&#xa0;h after the operation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zeyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xiaowei</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-3028-1045</Identifier><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China. xiaoweipeng619@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Chunliu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Dajiang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ou</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Anji</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology Plastic Surgery/Head and Neck Surgery, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410008, Hunan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Endosc</MedlineTA><NlmUniqueID>8806653</NlmUniqueID><ISSNLinking>0930-2794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004322" MajorTopicYN="N">Drainage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004724" MajorTopicYN="N">Endoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057605" MajorTopicYN="N">Natural Orifice Endoscopic Surgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013965" MajorTopicYN="N">Thyroidectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Drainage</Keyword><Keyword MajorTopicYN="N">RCT</Keyword><Keyword MajorTopicYN="N">Transoral endoscopic thyroidectomy vestibular approach</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32034474</ArticleId><ArticleId IdType="doi">10.1007/s00464-020-07408-8</ArticleId><ArticleId IdType="pii">10.1007/s00464-020-07408-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wilhelm T, Harlaar JJ, Kerver A et al (2010) Surgical anatomy of the floor of the oral cavity and the cervical spaces as a rationale for trans-oral, minimal-invasive endoscopic surgical procedures: results of anatomical studies. Eur Arch Otorhinolaryngol 267(8):1285&#x2013;1290</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-010-1219-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Zhai H, Liu W et al (2014) Thyroidectomy: a novel endoscopic oral vestibular approach. Surgery 155(1):33&#x2013;38</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2013.06.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Wu GY, Tian W et al (2018) Chinese experts concensus on transoral endoscopic thyroidectomy vestibular approach. Chin J Pract Surg 38(10):1104&#x2013;1107</Citation></Reference><Reference><Citation>Jitpratoom P, Ketwong K, Sasanakietkul T et al (2016) Transoral endoscopic thyroidectomy vestibular approach (TOETVA) for Graves' disease: a comparison of surgical results with open thyroidectomy. Gland Surg 5(6):546&#x2013;552</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/gs.2016.11.04</ArticleId></ArticleIdList></Reference><Reference><Citation>Anuwong A, Ketwong K, Jitpratoom P et al (2018) Safety and outcomes of the transoral endoscopic thyroidectomy vestibular approach. JAMA Surg 153(1):21&#x2013;27</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2017.3366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Yu X, Wang P et al (2016) Implementation of intraoperative neuromonitoring for transoral endoscopic thyroid surgery: a preliminary report. J Laparoendosc Adv Surg Tech A 26(12):965&#x2013;971</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2016.0291</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Peng XW, Li Z (2018) Application of transoral endoscopic thyroidectomy for benign thyroid nodule. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 32(13):972&#x2013;975</Citation><ArticleIdList><ArticleId IdType="pubmed">29986556</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Zheng H, Wang X et al (2019) Comparison of transoral endoscopic thyroidectomy vestibular approach, total endoscopic thyroidectomy via areola approach, and conventional open thyroidectomy: a retrospective analysis of safety, trauma, and feasibility of central neck dissection in the treatment of papillary thyroid carcinoma. Surg Endosc 34(6):268&#x2013;274</Citation><ArticleIdList><ArticleId IdType="pubmed">31346748</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Li Z, Li H et al (2019) The clinical application of mental nerve dissection in transoral endoscopic thyroidectomy via an oral vestibular approach. Surg Endosc 34:153&#x2013;158</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-019-06743-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng XW, Li H, Li Z et al (2017) Modified transoral endoscopic thyroid surgery for treatment of thyroid cancer: operative steps and video. Gland Surg 6(6):742&#x2013;744</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/gs.2017.07.11</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae SH, Bae YC (2014) Analysis of frequency of use of different scar assessment scales based on the scar condition and treatment method. Arch Plast Surg 41(2):111&#x2013;115</Citation><ArticleIdList><ArticleId IdType="doi">10.5999/aps.2014.41.2.111</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Liu W, Tao H et al (2018) Efficacy and safety of negative pressure versus natural drainage after thyroid surgery: a systematic review and meta-analysis. Medicine (Baltimore) 97(31):e11576</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalski LP, Sanabria A, Vartanian JG et al (2012) Total thyroidectomy with ultrasonic scalpel: a multicenter, randomized controlled trial. Head Neck 34(6):805&#x2013;812</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.21815</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongekkasit I, Jitpratoom P, Sasanakietkul T et al (2019) Transoral Endoscopic Thyroidectomy for Thyroid Cancer. Endocrinol Metab Clin North Am 48(1):165&#x2013;180</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2018.11.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Caruso E, Sun H et al (2019) Classifying pain in transoral endoscopic thyroidectomy. J Endocrinol Invest 42(11):1345&#x2013;1351</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-019-01071-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrissey AT, Chau J, Yunker WK et al (2008) Comparison of drain versus no drain thyroidectomy: randomized prospective clinical trial. J Otolaryngol Head Neck Surg 37(1):43&#x2013;47</Citation><ArticleIdList><ArticleId IdType="pubmed">18479627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Yin Z, Cheng R (2015) Clinical investigation of drainage volume variation after initial thyroidectomy. Chin J Bases Clin General Surg 22(07):799&#x2013;802</Citation></Reference><Reference><Citation>Yuan WZ, Li BG, Zhang YG et al (2018) Post thyroidectomy drainage, solutions, debate and compromise. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 32(9):705&#x2013;707</Citation><ArticleIdList><ArticleId IdType="pubmed">29771091</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods RS, Woods JF, Duignan ES et al (2014) Systematic review and meta-analysis of wound drains after thyroid surgery. Br J Surg 101(5):446&#x2013;456</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9448</ArticleId></ArticleIdList></Reference><Reference><Citation>Portinari M, Carcoforo P (2017) The application of drains in thyroid surgery. Gland Surg 6(5):563&#x2013;573</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/gs.2017.07.04</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu R, Wang J, Li J et al (2018) The learning curve for surgeons regarding endoscopic thyroidectomy via the oral-vestibular approach. Surg Laparosc Endosc Percutan Tech 28(6):380&#x2013;384</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLE.0000000000000578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Park D, Kim HY (2019) Robotic transoral thyroidectomy: Total thyroidectomy and ipsilateral central neck dissection with da Vinci Xi Surgical System. Head Neck 41(5):1536&#x2013;1540</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.25661</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Peng XW, Li Z et al (2019) The clinical applied analysis of the modified transoral endoscopic thyroidectomy vestibular approach. Zhonghua Wai Ke Za Zhi 57(9):686&#x2013;690</Citation><ArticleIdList><ArticleId IdType="pubmed">31474061</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15846712</PMID><DateCompleted><Year>2005</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>2</Issue><PubDate><Year>2005</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Medical versus surgical interventions for open angle glaucoma.</ArticleTitle><Pagination><StartPage>CD004399</StartPage><MedlinePgn>CD004399</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Open angle glaucoma (OAG) is the commonest cause of irreversible blindness worldwide.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To study the relative effects of medical and surgical treatment of OAG.</AbstractText><AbstractText Label="SEARCH STRATEGY" NlmCategory="METHODS">We searched the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 1, 2005), MEDLINE (1966 to February 2005), EMBASE (1988 to February 2005), and reference lists of articles. We also contacted researchers in the field.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Randomised controlled trials comparing medications to surgery in adults.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two authors independently assessed trial quality and extracted data. We contacted trial investigators for missing information.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Four trials involving 888 participants with previously untreated OAG were included. Surgery was Scheie's procedure in one trial and trabeculectomy in three trials. In three trials, primary medication was usually pilocarpine, in one trial a beta-blocker. In the most recent trial, participants with mild OAG, progressive visual field (VF) loss, after adjustment for cataract surgery, was not significantly different for medications compared to trabeculectomy (Odds ratio (OR) 0.74; 95% CI 0.54 to 1.01). Reduction of vision, with a higher risk of developing cataract (OR 2.69, 95%% CI 1.64 to 4.42), and more patient discomfort was more likely with trabeculectomy than medication. There is some evidence, from three trials, for people with moderately advanced glaucoma that medication is associated with more progressive VF loss and 6 to 8 mmHg less intraocular pressure (IOP) lowering than surgery, either by a Scheie's procedure or trabeculectomy. There was a trend towards an increased risk of failed IOP control over time for initial pilocarpine treatment compared to trabeculectomy. In the longer-term (two trials) the risk of failure was significantly greater with medication than trabeculectomy (OR 3.90, 95% CI 1.60 to 9.53; HR 7.27, 95% CI 2.23 to 25.71). Medicine and surgery have evolved since these trials were undertaken, and additionally the evidence is potentially subject to detection and attrition bias.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Evidence from one trial suggests, for mild OAG, that VF deterioration up to five-years is not significantly different whether treatment is initiated with medication or trabeculectomy. Reduced vision, cataract and eye discomfort are more likely with trabeculectomy. There is some evidence, for more severe OAG, that initial medication (pilocarpine, now rarely used as first line medication) is associated with greater VF deterioration than surgery. In general, surgery lowers IOP more than medication. There was no evidence to determine the effectiveness of contemporary medication (prostaglandin analogues, alpha2-agonists and topical carbonic anhydrase inhibitors) compared to surgery in severe OAG, and in people of black African ethnic origin who have a greater risk of more severe open angle glaucoma. More research is required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burr</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Services Research Unit, University of Aberdeen, Foresterhill Lea, Aberdeen, UK, AB 2ZD25. j.m.burr@abdn.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azuara-Blanco</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Avenell</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>01MI4Q9DI3</RegistryNumber><NameOfSubstance UI="D010862">Pilocarpine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004399. doi: 10.1002/14651858.CD004399.pub3.</RefSource><PMID Version="1">22972069</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010862" MajorTopicYN="N">Pilocarpine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014130" MajorTopicYN="N">Trabeculectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>65</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>4</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>7</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>4</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15846712</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD004399.pub2</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>